PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Mehta, R; Steinkraus, KA; Sutphin, GL; Ramos, FJ; Shamieh, LS; Huh, A; Davis, C; Chandler-Brown, D; Kaeberlein, M				Mehta, Ranjana; Steinkraus, Katherine A.; Sutphin, George L.; Ramos, Fresnida J.; Shamieh, Lara S.; Huh, Alexander; Davis, Christina; Chandler-Brown, Devon; Kaeberlein, Matt			Proteasomal Regulation of the Hypoxic Response Modulates Aging in C-elegans	SCIENCE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; LIFE-SPAN; DIETARY RESTRICTION; LONGEVITY; PROTEOTOXICITY; PROTEIN; DAF-16; FAMILY; ADAPTATION; EXTENSION	The Caenorhabditis elegans von Hippel-Lindau tumor suppressor homolog VHL-1 is a cullin E3 ubiquitin ligase that negatively regulates the hypoxic response by promoting ubiquitination and degradation of the hypoxic response transcription factor HIF-1. Here, we report that loss of VHL-1 significantly increased life span and enhanced resistance to polyglutamine and beta-amyloid toxicity. Deletion of HIF-1 was epistatic to VHL-1, indicating that HIF-1 acts downstream of VHL-1 to modulate aging and proteotoxicity. VHL-1 and HIF-1 control longevity by a mechanism distinct from both dietary restriction and insulin-like signaling. These findings define VHL-1 and the hypoxic response as an alternative longevity and protein homeostasis pathway.	[Mehta, Ranjana; Steinkraus, Katherine A.; Ramos, Fresnida J.; Shamieh, Lara S.; Huh, Alexander; Davis, Christina; Chandler-Brown, Devon; Kaeberlein, Matt] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Sutphin, George L.] Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Kaeberlein, M (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	kaeber@u.washington.edu	Sutphin, George L./AAE-6151-2020	Sutphin, George/0000-0002-3659-4678	Alzheimers Association [IIRG-07-60158]; Glenn/AFAR (American Federation for Aging Research) award; NIH [1R01AG031108-01, P30AG013280]; Hereditary Disease Foundation; NATIONAL INSTITUTE ON AGING [P30AG013280, R01AG031108] Funding Source: NIH RePORTER	Alzheimers Association(Alzheimer's Association); Glenn/AFAR (American Federation for Aging Research) award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hereditary Disease Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We would like to thank B. Kennedy and P. Kapahi for helpful discussion. Strains were provided by the Caenorhabditis Genetics Center. This work was supported by Alzheimers Association grant IIRG-07-60158, a Glenn/AFAR (American Federation for Aging Research) Breakthroughs in Gerontology award, and NIH grant 1R01AG031108-01 to M.K. R.M. and K.A.S. were supported by postdoctoral fellowships from the Hereditary Disease Foundation. G.L.S., L.S.S., and F.J.R. were supported by NIH grant P30AG013280. M.K. is an Ellison Medical Foundation New Scholar in Aging.	Bosu DR, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-7; Cohen E, 2008, NAT REV NEUROSCI, V9, P759, DOI 10.1038/nrn2474; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Gerstbrein B, 2005, AGING CELL, V4, P127, DOI 10.1111/j.1474-9726.2005.00153.x; Ghazi A, 2007, P NATL ACAD SCI USA, V104, P5947, DOI 10.1073/pnas.0700638104; Hansen M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040024; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Hoogewijs D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-356; Jia KL, 2007, AUTOPHAGY, V3, P597, DOI 10.4161/auto.4989; Jiang HQ, 2001, P NATL ACAD SCI USA, V98, P7916, DOI 10.1073/pnas.141234698; Kaeberlein M, 2007, AGING CELL, V6, P731, DOI 10.1111/j.1474-9726.2007.00341.x; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kim W, 2003, CURR OPIN GENET DEV, V13, P55, DOI 10.1016/S0959-437X(02)00010-2; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Lee GD, 2006, AGING CELL, V5, P515, DOI 10.1111/j.1474-9726.2006.00241.x; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; McElwee JJ, 2004, J BIOL CHEM, V279, P44533, DOI 10.1074/jbc.M406207200; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Scott BA, 2002, SCIENCE, V296, P2388, DOI 10.1126/science.1072302; Steinkraus KA, 2008, AGING CELL, V7, P394, DOI 10.1111/j.1474-9726.2008.00385.x; Treinin M, 2003, PHYSIOL GENOMICS, V14, P17, DOI 10.1152/physiolgenomics.00179.2002; Yun C, 2008, P NATL ACAD SCI USA, V105, P7094, DOI 10.1073/pnas.0707025105	25	168	210	5	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2009	324	5931					1196	1198		10.1126/science.1173507	http://dx.doi.org/10.1126/science.1173507			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450OG	19372390	Green Accepted			2022-12-01	WOS:000266410100045
J	Shukla, VK; Doyon, Y; Miller, JC; DeKelver, RC; Moehle, EA; Worden, SE; Mitchell, JC; Arnold, NL; Gopalan, S; Meng, XD; Choi, VM; Rock, JM; Wu, YY; Katibah, GE; Zhifang, G; McCaskill, D; Simpson, MA; Blakeslee, B; Greenwalt, SA; Butler, HJ; Hinkley, SJ; Zhang, L; Rebar, EJ; Gregory, PD; Urnov, FD				Shukla, Vipula K.; Doyon, Yannick; Miller, Jeffrey C.; DeKelver, Russell C.; Moehle, Erica A.; Worden, Sarah E.; Mitchell, Jon C.; Arnold, Nicole L.; Gopalan, Sunita; Meng, Xiangdong; Choi, Vivian M.; Rock, Jeremy M.; Wu, Ying-Ying; Katibah, George E.; Zhifang, Gao; McCaskill, David; Simpson, Matthew A.; Blakeslee, Beth; Greenwalt, Scott A.; Butler, Holly J.; Hinkley, Sarah J.; Zhang, Lei; Rebar, Edward J.; Gregory, Philip D.; Urnov, Fyodor D.			Precise genome modification in the crop species Zea mays using zinc-finger nucleases	NATURE			English	Article							HOMOLOGOUS RECOMBINATION; MEDIATED TRANSFORMATION; GENE; EXPRESSION; MAIZE; CLEAVAGE; SEQUENCE; CELLS; MUTAGENESIS; DISRUPTION	Agricultural biotechnology is limited by the inefficiencies of conventional random mutagenesis and transgenesis. Because targeted genome modification in plants has been intractable(1), plant trait engineering remains a laborious, time-consuming and unpredictable undertaking. Here we report a broadly applicable, versatile solution to this problem: the use of designed zinc-finger nucleases (ZFNs) that induce a double-stranded break at their target locus(2). We describe the use of ZFNs to modify endogenous loci in plants of the crop species Zea mays. We show that simultaneous expression of ZFNs and delivery of a simple heterologous donor molecule leads to precise targeted addition of an herbicide-tolerance gene at the intended locus in a significant number of isolated events. ZFN-modified maize plants faithfully transmit these genetic changes to the next generation. Insertional disruption of one target locus, IPK1, results in both herbicide tolerance and the expected alteration of the inositol phosphate profile in developing seeds. ZFNs can be used in any plant species amenable to DNA delivery; our results therefore establish a new strategy for plant genetic manipulation in basic science and agricultural applications.	[Shukla, Vipula K.; Worden, Sarah E.; Mitchell, Jon C.; Arnold, Nicole L.; Zhifang, Gao; McCaskill, David; Simpson, Matthew A.; Blakeslee, Beth; Greenwalt, Scott A.; Butler, Holly J.] Dow AgroSci, Indianapolis, IN 46268 USA; [Doyon, Yannick; Miller, Jeffrey C.; DeKelver, Russell C.; Moehle, Erica A.; Gopalan, Sunita; Meng, Xiangdong; Choi, Vivian M.; Rock, Jeremy M.; Wu, Ying-Ying; Katibah, George E.; Hinkley, Sarah J.; Zhang, Lei; Rebar, Edward J.; Gregory, Philip D.; Urnov, Fyodor D.] Point Richmond Tech Ctr, Richmond, CA 94804 USA	Dow Chemical Company	Shukla, VK (corresponding author), Dow AgroSci, 9330 Zionsville Rd, Indianapolis, IN 46268 USA.	vkshukla@dow.com		Gregory, Philip/0000-0001-9249-2468; Rock, Jeremy/0000-0002-9310-951X; Doyon, Yannick/0000-0002-3889-9563				Armstrong C. L., 1991, Maize Genetics Cooperation News Letter, P92; Bibikova M, 2001, MOL CELL BIOL, V21, P289, DOI 10.1128/MCB.21.1.289-297.2001; Bibikova M, 2002, GENETICS, V161, P1169; BUSCHER BAP, 1995, J CHROMATOGR A, V712, P235, DOI 10.1016/0021-9673(95)00202-X; Cai CQ, 2009, PLANT MOL BIOL, V69, P699, DOI 10.1007/s11103-008-9449-7; Carroll D, 2008, GENE THER, V15, P1463, DOI 10.1038/gt.2008.145; CHRISTENSEN AH, 1992, PLANT MOL BIOL, V18, P675, DOI 10.1007/BF00020010; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Fang JM, 2005, NAT BIOTECHNOL, V23, P584, DOI 10.1038/nbt1087; Frame BR, 2002, PLANT PHYSIOL, V129, P13, DOI 10.1104/pp.000653; GORDONKAMM WJ, 1990, PLANT CELL, V2, P603, DOI 10.1105/tpc.2.7.603; Hsu FF, 2003, J MASS SPECTROM, V38, P447, DOI 10.1002/jms.457; Iida S, 2005, PLANT MOL BIOL, V59, P205, DOI 10.1007/s11103-005-2162-x; Isalan M, 2001, METHOD ENZYMOL, V340, P593; Isalan M, 2001, NAT BIOTECHNOL, V19, P656, DOI 10.1038/90264; Jasin M, 1996, TRENDS GENET, V12, P224, DOI 10.1016/0168-9525(96)10019-6; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lloyd A, 2005, P NATL ACAD SCI USA, V102, P2232, DOI 10.1073/pnas.0409339102; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; MADDALONI M, 1989, NUCLEIC ACIDS RES, V17, P7532, DOI 10.1093/nar/17.18.7532; Maeder ML, 2008, MOL CELL, V31, P294, DOI 10.1016/j.molcel.2008.06.016; MCELROY D, 1990, PLANT CELL, V2, P163, DOI 10.1105/tpc.2.2.163; MILLER J, 1985, EMBO J, V4, P1609, DOI 10.1002/j.1460-2075.1985.tb03825.x; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Moehle EA, 2007, P NATL ACAD SCI USA, V104, P3055, DOI 10.1073/pnas.0611478104; Pabo CO, 2001, ANNU REV BIOCHEM, V70, P313, DOI 10.1146/annurev.biochem.70.1.313; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Petolino JF, 2000, PLANT CELL REP, V19, P781, DOI 10.1007/s002999900180; Porteus MH, 2006, MOL THER, V13, P438, DOI 10.1016/j.ymthe.2005.08.003; Porteus MH, 2003, SCIENCE, V300, P763, DOI 10.1126/science.1078395; Puchta H, 2005, J EXP BOT, V56, P1, DOI 10.1093/jxb/eri025; Puchta H, 2002, PLANT MOL BIOL, V48, P173, DOI 10.1023/A:1013761821763; Raboy V, 2003, PHYTOCHEMISTRY, V64, P1033, DOI 10.1016/S0031-9422(03)00446-1; Raboy V, 2001, TRENDS PLANT SCI, V6, P458, DOI 10.1016/S1360-1385(01)02104-5; Sambrook J., 1989, MOL CLONING LAB MANU, V3; Skoglund E, 1997, J AGR FOOD CHEM, V45, P431, DOI 10.1021/jf9603238; Stevenson-Paulik J, 2005, P NATL ACAD SCI USA, V102, P12612, DOI 10.1073/pnas.0504172102; Sun YJ, 2007, PLANT PHYSIOL, V144, P1278, DOI 10.1104/pp.107.095455; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Wei F, 2007, PLOS GENET, V3, P1254, DOI 10.1371/journal.pgen.0030123; WOHLLEBEN W, 1988, GENE, V70, P25, DOI 10.1016/0378-1119(88)90101-1; Wright DA, 2005, PLANT J, V44, P693, DOI 10.1111/j.1365-313X.2005.02551.x	44	563	683	5	217	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2009	459	7245					437	U156		10.1038/nature07992	http://dx.doi.org/10.1038/nature07992			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448DQ	19404259				2022-12-01	WOS:000266243700048
J	Rybczynski, N; Dawson, MR; Tedford, RH				Rybczynski, Natalia; Dawson, Mary R.; Tedford, Richard H.			A semi-aquatic Arctic mammalian carnivore from the Miocene epoch and origin of Pinnipedia	NATURE			English	Article							PHYLOGENY; IMPACT	Modern pinnipeds (seals, sea lions and the walrus) are semi-aquatic, generally marine carnivores the limbs of which have been modified into flippers. Recent phylogenetic studies using morphological and molecular evidence support pinniped monophyly, and suggest a sister relationship with ursoids(1,2) (for example bears) or musteloids(3-7) (the clade that includes skunks, badgers, weasels and otters). Although the position of pinnipeds within modern carnivores appears moderately well resolved, fossil evidence of the morphological steps leading from a terrestrial ancestor to the modern marine forms has been weak or contentious. The earliest well-represented fossil pinniped is Enaliarctos, a marine form with flippers, which had appeared on the northwestern shores of North America by the early Miocene epoch(8,9). Here we report the discovery of a nearly complete skeleton of a new semi-aquatic carnivore from an early Miocene lake deposit in Nunavut, Canada, that represents a morphological link in early pinniped evolution. The new taxon retains a long tail and the proportions of its fore-and hindlimbs are more similar to those of modern terrestrial carnivores than to modern pinnipeds. Morphological traits indicative of semi-aquatic adaptation include a forelimb with a prominent deltopectoral ridge on the humerus, a posterodorsally expanded scapula, a pelvis with relatively short ilium, a shortened femur and flattened phalanges, suggestive of webbing. The new fossil shows evidence of pinniped affinities and similarities to the early Oligocene Amphicticeps from Asia and the late Oligocene and Miocene Potamotherium from Europe. The discovery suggests that the evolution of pinnipeds included a freshwater transitional phase, and may support the hypothesis that the Arctic was an early centre of pinniped evolution.	[Rybczynski, Natalia] Canadian Museum Nat, Ottawa, ON K1P 6P4, Canada; [Dawson, Mary R.] Carnegie Museum Nat Hist, Pittsburgh, PA 15213 USA; [Tedford, Richard H.] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA	American Museum of Natural History (AMNH)	Rybczynski, N (corresponding author), Canadian Museum Nat, POB 3443 STN D, Ottawa, ON K1P 6P4, Canada.	nrybczynski@mus-nature.ca						Arnason U, 2006, MOL PHYLOGENET EVOL, V41, P345, DOI 10.1016/j.ympev.2006.05.022; Baskin Jon A., 1998, P152, DOI 10.1017/CBO9780511529924.011; Bebej RM, 2009, J MAMM EVOL, V16, P77, DOI 10.1007/s10914-008-9099-1; BERTA A, 1989, SCIENCE, V244, P60, DOI 10.1126/science.244.4900.60; DARWIN C, 1880, ORIGIN SPECIES MEANS, P180; DAVIES JL, 1958, GEOGR REV, V48, P474, DOI 10.2307/211670; Demere TA, 2003, B AM MUS NAT HIST, P32, DOI 10.1206/0003-0090(2003)279<0032:C>2.0.CO;2; Finarelli J, 2008, J MAMM EVOL, V15, P231, DOI 10.1007/s10914-008-9074-x; FISH FE, 1994, J MAMMAL, V75, P989, DOI 10.2307/1382481; Fish Frank E., 2001, P261; Flynn JJ, 2005, SYST BIOL, V54, P317, DOI 10.1080/10635150590923326; FLYNN JJ, 1988, PHYLOGENY CLASSIFICA, V2, P73; Hunt Robert M. Jr, 1994, Proceedings of the San Diego Society of Natural History, V29, P57; JESSBERGER EK, 1988, METEORITICS, V23, P233, DOI 10.1111/j.1945-5100.1988.tb01285.x; Matthew W. D., 1915, Annals of the New York Academy of Sciences, V24; Mitchell E., 1973, Bulletin Am Mus nat Hist, V151, P203; Mors Thomas, 2000, Senckenbergiana Lethaea, V80, P257; Orlov J. A., 1933, Travaux de l'Institut Paleozoologique Acad Sci URSS, V2, P165; Sato JJ, 2006, ZOOL SCI, V23, P125, DOI 10.2108/zsj.23.125; SAVAGE R. J. G., 1957, PROC ZOOL SOC LONDON, V129, P151; SCHMIDT-KITTLER N, 1981, Eclogae Geologicae Helvetiae, V74, P753; Sherlock SC, 2005, METEORIT PLANET SCI, V40, P1777, DOI 10.1111/j.1945-5100.2005.tb00146.x; Swofford DL, 2002, PAUP PHYLOGENETIC AN; TEDFORD RH, 1976, SYST ZOOL, V25, P363, DOI 10.2307/2412511; Tedford Richard H., 2004, P169; Thewissen JGM, 2007, NATURE, V450, P1190, DOI 10.1038/nature06343; Wang XM, 2005, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2005)483[0001:AAAACF]2.0.CO;2; WHITLOCK C, 1990, ARCTIC, V43, P324; WOLSAN M, 1993, ACTA THERIOL, V38, P345, DOI 10.4098/AT.arch.93-29; [No title captured]	30	76	79	2	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	2009	458	7241					1021	1024		10.1038/nature07985	http://dx.doi.org/10.1038/nature07985			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436KL	19396145				2022-12-01	WOS:000265412900041
J	Wieffer, M; Maritzen, T; Haucke, V				Wieffer, Marnix; Maritzen, Tanja; Haucke, Volker			SnapShot: Endocytic Trafficking	CELL			English	Editorial Material							MEMBRANE		[Wieffer, Marnix; Maritzen, Tanja; Haucke, Volker] Free Univ Berlin, D-1000 Berlin, Germany; [Wieffer, Marnix; Maritzen, Tanja; Haucke, Volker] Charite Univ Med Berlin, D-13353 Berlin, Germany; [Haucke, Volker] Leibniz Inst Mol Pharmacol, Berlin, Germany	Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP)	Wieffer, M (corresponding author), Free Univ Berlin, D-1000 Berlin, Germany.			Haucke, Volker/0000-0003-3119-6993; Maritzen, Tanja/0000-0003-4993-0340				Leonard D, 2008, J CELL SCI, V121, P3445, DOI 10.1242/jcs.031484; Lundmark R, 2008, CURR BIOL, V18, P1802, DOI 10.1016/j.cub.2008.10.044; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Pryor PR, 2008, CELL, V134, P817, DOI 10.1016/j.cell.2008.07.023; Puertollano R, 2004, EMBO REP, V5, P942, DOI 10.1038/sj.embor.7400249; Romer W, 2007, NATURE, V450, P670, DOI 10.1038/nature05996; Schmid EM, 2007, NATURE, V448, P883, DOI 10.1038/nature06031; Takei K, 2001, TRENDS CELL BIOL, V11, P385, DOI 10.1016/S0962-8924(01)02082-7; Traub LM, 2003, J CELL BIOL, V163, P203, DOI 10.1083/jcb.200309175; Ungewickell EJ, 2007, CURR OPIN CELL BIOL, V19, P417, DOI 10.1016/j.ceb.2007.05.003	10	45	45	0	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 17	2009	137	2							382.e1	10.1016/j.cell.2009.04.012	http://dx.doi.org/10.1016/j.cell.2009.04.012			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	437AB	19379701	Bronze			2022-12-01	WOS:000265456800030
J	Akopyants, NS; Kimblin, N; Secundino, N; Patrick, R; Peters, N; Lawyer, P; Dobson, DE; Beverley, SM; Sacks, DL				Akopyants, Natalia S.; Kimblin, Nicola; Secundino, Nagila; Patrick, Rachel; Peters, Nathan; Lawyer, Phillip; Dobson, Deborah E.; Beverley, Stephen M.; Sacks, David L.			Demonstration of Genetic Exchange During Cyclical Development of Leishmania in the Sand Fly Vector	SCIENCE			English	Article							TRYPANOSOMA-BRUCEI; GENOMIC ORGANIZATION; DONOVANI COMPLEX; MAJOR FRIEDLIN; RECOMBINATION; TRANSMISSION; EXPRESSION; VIRULENCE; MARKER; CROSS	Genetic exchange has not been shown to be a mechanism underlying the extensive diversity of Leishmania parasites. We report here evidence that the invertebrate stages of Leishmania are capable of having a sexual cycle consistent with a meiotic process like that described for African trypanosomes. Hybrid progeny were generated that bore full genomic complements from both parents, but kinetoplast DNA maxicircles from one parent. Mating occurred only in the sand fly vector, and hybrids were transmitted to the mammalian host by sand fly bite. Genetic exchange likely contributes to phenotypic diversity in natural populations, and analysis of hybrid progeny will be useful for positional cloning of the genes controlling traits such as virulence, tissue tropism, and drug resistance.	[Kimblin, Nicola; Secundino, Nagila; Patrick, Rachel; Peters, Nathan; Lawyer, Phillip; Sacks, David L.] NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Akopyants, Natalia S.; Dobson, Deborah E.; Beverley, Stephen M.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Washington University (WUSTL)	Sacks, DL (corresponding author), NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA.	dsacks@nih.gov	Peters, Nathan/AAW-8289-2020; Secundino, Nagila/AAM-4553-2020	Peters, Nathan/0000-0002-2548-9581; Beverley, Stephen/0000-0001-5319-0811	Intramural Research Program of the NIH; National Institute of Allergy and Infectious Diseases (NIAID) [A1029646, A1020941]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000256, R01AI029646] Funding Source: NIH RePORTER	Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported in part by the Intramural Research Program of the NIH, National Institute of Allergy and Infectious Diseases (NIAID), and in part by NIAID grant support (S.M.B., D.E.D., and N.S.A. A1029646 and A1020941). We thank K. Owens for inventorying and shipping parasite strains; K. Beacht for mouse infection studies; and M. Grigg, L. Miller, and A. Sher for critical review of the manuscript. Maxicircle sequences have been submitted to GenBank and had been assigned accession numbers FJ349262 to FJ349263 (12S rRNA) and FJ349264 to FJ349265 (Divergent region).	Capul AA, 2007, INFECT IMMUN, V75, P4629, DOI 10.1128/IAI.00735-07; Capul AA, 2007, J BIOL CHEM, V282, P14006, DOI 10.1074/jbc.M610869200; CRUZ AK, 1993, P NATL ACAD SCI USA, V90, P1599, DOI 10.1073/pnas.90.4.1599; Dobson DE, 2006, MOL BIOCHEM PARASIT, V146, P231, DOI 10.1016/j.molbiopara.2005.12.012; Dobson DE, 2003, J BIOL CHEM, V278, P28840, DOI 10.1074/jbc.M302728200; Gaunt MW, 2003, NATURE, V421, P936, DOI 10.1038/nature01438; GIBSON W, 1992, MOL BIOCHEM PARASIT, V51, P189, DOI 10.1016/0166-6851(92)90069-V; Grigg ME, 2001, SCIENCE, V294, P161, DOI 10.1126/science.1061888; Heitman J, 2006, CURR BIOL, V16, pR711, DOI 10.1016/j.cub.2006.07.064; Hope M, 1999, MOL BIOCHEM PARASIT, V104, P1, DOI 10.1016/S0166-6851(99)00103-6; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; JENNI L, 1986, NATURE, V322, P173, DOI 10.1038/322173a0; JOSHI PB, 1995, GENE, V156, P145, DOI 10.1016/0378-1119(95)00042-5; KELLY JM, 1991, MOL BIOCHEM PARASIT, V46, P253, DOI 10.1016/0166-6851(91)90049-C; Lukes J, 2007, P NATL ACAD SCI USA, V104, P9375, DOI 10.1073/pnas.0703678104; Martinez-Calvillo S, 2001, MOL BIOCHEM PARASIT, V116, P147, DOI 10.1016/S0166-6851(01)00310-3; Mauricio IL, 1999, PARASITOLOGY, V119, P237, DOI 10.1017/S0031182099004710; MOODY ME, 1993, GENETICS, V134, P649; Nolder D, 2007, AM J TROP MED HYG, V76, P573, DOI 10.4269/ajtmh.2007.76.573; Ravel C, 1998, PARASITOL TODAY, V14, P301, DOI 10.1016/S0169-4758(98)01275-7; Ravel C, 2006, INT J PARASITOL, V36, P1383, DOI 10.1016/j.ijpara.2006.06.019; Rose MD, 1996, ANNU REV CELL DEV BI, V12, P663, DOI 10.1146/annurev.cellbio.12.1.663; Schwenkenbecher JM, 2006, INT J PARASITOL, V36, P237, DOI 10.1016/j.ijpara.2005.09.010; Thiel T, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh006; Tibayrenc M., 1993, Archives de l'Institut Pasteur de Tunis, V70, P375; TURNER CMR, 1995, EXP PARASITOL, V80, P234, DOI 10.1006/expr.1995.1029	26	224	226	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 10	2009	324	5924					265	268		10.1126/science.1169464	http://dx.doi.org/10.1126/science.1169464			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430WX	19359589	Green Accepted			2022-12-01	WOS:000265024400050
J	Ingolia, NT; Ghaemmaghami, S; Newman, JRS; Weissman, JS				Ingolia, Nicholas T.; Ghaemmaghami, Sina; Newman, John R. S.; Weissman, Jonathan S.			Genome-Wide Analysis in Vivo of Translation with Nucleotide Resolution Using Ribosome Profiling	SCIENCE			English	Article							OPEN READING FRAMES; NON-AUG CODONS; SACCHAROMYCES-CEREVISIAE; MESSENGER-RNA; PROTEIN-SYNTHESIS; EUKARYOTIC TRANSLATION; GENE-EXPRESSION; INITIATION; YEAST; MICRORNAS	Techniques for systematically monitoring protein translation have lagged far behind methods for measuring messenger RNA ( mRNA) levels. Here, we present a ribosome-profiling strategy that is based on the deep sequencing of ribosome-protected mRNA fragments and enables genome-wide investigation of translation with subcodon resolution. We used this technique to monitor translation in budding yeast under both rich and starvation conditions. These studies defined the protein sequences being translated and found extensive translational control in both determining absolute protein abundance and responding to environmental stress. We also observed distinct phases during translation that involve a large decrease in ribosome density going from early to late peptide elongation as well as widespread regulated initiation at non-adenine-uracil-guanine (AUG) codons. Ribosome profiling is readily adaptable to other organisms, making high-precision investigation of protein translation experimentally accessible.	[Ingolia, Nicholas T.] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco	Ingolia, NT (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA.	ingolia@cmp.ucsf.edu		Weissman, Jonathan/0000-0003-2445-670X	NIH [AG10770]; Ruth L. Kirschstein National Research Service Award [GM080853]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM080853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG010770] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank C. Chu, J. deRisi, and K. Fischer for help with sequencing; D. Bartel, H. Guo, D. Herschlag, J. Hollien, S. Luo, and G. Schroth for helpful discussions of RNA methods; P. Walter and T. Aragon for the use of a density gradient fractionator; the 2008 Woods Hole Physiology course students for data analysis; and members of the Weissman lab, L. Lareau, and T. Ingolia for critical commentary on the manuscript. Sequencing data have been deposited in the National Center for Biotechnology Information's Gene Expression Omnibus (www.ncbi.nlm.nih.gov/geo/) under accession number GSE13750. This investigation was supported by a NIH P01 grant (AG10770) and a Ruth L. Kirschstein National Research Service Award (GM080853) (to N.T.I.) and by the Howard Hughes Medical Institute (to J.S.W.). N.T.I. and J.S.W. are the inventors on a patent application, assigned to the Regents of the University of California, on the ribosome profiling and sequencing library generation techniques described in this work. S.G. and J.R.S.N. developed a microarray-based approach that served as a proof of principle for the present studies; N.T.I. and J.S.W. designed the experiments; N.T.I. performed the experiments and analyzed the data; and N.T.I. and J.S.W. interpreted the results and wrote the manuscript.	Arava Y, 2005, NUCLEIC ACIDS RES, V33, P2421, DOI 10.1093/nar/gki331; Arava Y, 2003, P NATL ACAD SCI USA, V100, P3889, DOI 10.1073/pnas.0635171100; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Berezikov E, 2006, NAT GENET, V38, pS2, DOI 10.1038/ng1794; Brown PO, 1999, NAT GENET, V21, P33, DOI 10.1038/4462; Chang KJ, 2004, J BIOL CHEM, V279, P13778, DOI 10.1074/jbc.M311269200; Chen SJ, 2008, J BIOL CHEM, V283, P3173, DOI 10.1074/jbc.M706968200; de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341; GRANT CM, 1995, NUCLEIC ACIDS RES, V23, P3980, DOI 10.1093/nar/23.19.3980; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; HINNEBUSCH AG, 1988, MICROBIOL REV, V52, P248, DOI 10.1128/MMBR.52.2.248-273.1988; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Jorgensen P, 2004, GENE DEV, V18, P2491, DOI 10.1101/gad.1228804; Kapp LD, 2004, ANNU REV BIOCHEM, V73, P657, DOI 10.1146/annurev.biochem.73.030403.080419; Komar AA, 1999, FEBS LETT, V462, P387, DOI 10.1016/S0014-5793(99)01566-5; Lakkaraju AKK, 2008, CELL, V133, P440, DOI 10.1016/j.cell.2008.02.049; Meijer HA, 2002, BIOCHEM J, V367, P1, DOI 10.1042/BJ20011706; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Namy O, 2004, MOL CELL, V13, P157, DOI 10.1016/S1097-2765(04)00031-0; NELSON RJ, 1992, CELL, V71, P97, DOI 10.1016/0092-8674(92)90269-I; Pleiss JA, 2007, MOL CELL, V27, P928, DOI 10.1016/j.molcel.2007.07.018; ROMANIUK E, 1982, EUR J BIOCHEM, V125, P639, DOI 10.1111/j.1432-1033.1982.tb06730.x; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sonenberg N, 2007, MOL CELL, V28, P721, DOI 10.1016/j.molcel.2007.11.018; STEITZ JA, 1969, NATURE, V224, P957, DOI 10.1038/224957a0; Tang HL, 2004, J BIOL CHEM, V279, P49656, DOI 10.1074/jbc.M408081200; Touriol C, 2003, BIOL CELL, V95, P169, DOI 10.1016/S0248-4900(03)00033-9; Vilela C, 2003, MOL MICROBIOL, V49, P859, DOI 10.1046/j.1365-2958.2003.03622.x; WOLIN SL, 1988, EMBO J, V7, P3559, DOI 10.1002/j.1460-2075.1988.tb03233.x; YOON H, 1992, MOL MICROBIOL, V6, P1413, DOI 10.1111/j.1365-2958.1992.tb00861.x; Zhang ZH, 2005, CURR GENET, V48, P77, DOI 10.1007/s00294-005-0001-x	35	2280	2406	13	357	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 10	2009	324	5924					218	223		10.1126/science.1168978	http://dx.doi.org/10.1126/science.1168978			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430WX	19213877	Green Accepted			2022-12-01	WOS:000265024400037
J	Turnipseed, M; Crowder, LB; Sagarin, RD; Roady, SE				Turnipseed, Mary; Crowder, Larry B.; Sagarin, Raphael D.; Roady, Stephen E.			Legal Bedrock for Rebuilding America's Ocean Ecosystems	SCIENCE			English	Editorial Material									[Turnipseed, Mary; Roady, Stephen E.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Crowder, Larry B.] Duke Univ, Nicholas Sch Environm, Ctr Marine Conservat, Beaufort, NC 28516 USA; [Sagarin, Raphael D.] Duke Univ, Nicholas Inst Environm Policy Solut, Durham, NC 27708 USA; [Roady, Stephen E.] Duke Univ, Sch Law, Durham, NC 27708 USA; [Roady, Stephen E.] Earthjustice, Washington, DC 20036 USA	Duke University; Duke University; Duke University; Duke University	Turnipseed, M (corresponding author), Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA.	mary.turnipseed@duke.edu						[Anonymous], 1983, FED REGISTER, V48; Archer J. H., 1994, PUBLIC TRUST DOCTRIN; Crowder LB, 2006, SCIENCE, V313, P617, DOI 10.1126/science.1129706; Douvere F, 2008, MAR POLICY, V32, P762, DOI 10.1016/j.marpol.2008.03.021; McLeod K.L., 2005, SCI CONSENSUS STATEM; PARENTEAU PA, 2008, OCEAN COASTAL LAW PO, pCH19; *PEW OC COMM, 2003, AM LIV OC CHART COUR; Rosenberg AA, 2006, FRONT ECOL ENVIRON, V4, P303, DOI 10.1890/1540-9295(2006)4[303:RUFPAP]2.0.CO;2; Ruhl J. B., 2006, SE ENV LAW J, V15, P223; SHACKEROFF JS, ECOSYSTEM B IN PRESS; Turnipseed M, 2009, ECOL LAW QUART, V36, P1; *US COMM OC POL, 2004, OC BLUEPR 21 CENT FI; 2007, GLOBAL MARITIME BOUN; [No title captured]	14	30	32	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 10	2009	324	5924					183	184		10.1126/science.1170889	http://dx.doi.org/10.1126/science.1170889			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	430WX	19359567	Green Submitted			2022-12-01	WOS:000265024400023
J	Kalaany, NY; Sabatini, DM				Kalaany, Nada Y.; Sabatini, David M.			Tumours with PI3K activation are resistant to dietary restriction	NATURE			English	Article							GROWTH-FACTOR-I; CALORIC RESTRICTION; LIFE-SPAN; PHOSPHATIDYLINOSITOL 3-KINASES; ENERGY RESTRICTION; HUMAN CANCER; CELL-GROWTH; MUTATIONS; INSULIN; GENE	Dietary restriction delays the incidence and decreases the growth of various types of tumours, but the mechanisms underlying the sensitivity of tumours to food restriction remain unknown. Here we show that certain human cancer cell lines, when grown as tumour xenografts in mice, are highly sensitive to the anti-growth effects of dietary restriction, whereas others are resistant. Cancer cells that form dietary-restriction-resistant tumours carry mutations that cause constitutive activation of the phosphatidylinositol-3-kinase (PI3K) pathway and in culture proliferate in the absence of insulin or insulin-like growth factor 1. Substitution of an activated mutant allele of PI3K with wild-type PI3K in otherwise isogenic cancer cells, or the restoration of PTEN expression in a PTEN-null cancer cell line, is sufficient to convert a dietary-restriction-resistant tumour into one that is dietary-restriction-sensitive. Dietary restriction does not affect a PTEN-null mouse model of prostate cancer, but it significantly decreases tumour burden in a mouse model of lung cancer lacking constitutive PI3K signalling. Thus, the PI3K pathway is an important determinant of the sensitivity of tumours to dietary restriction, and activating mutations in the pathway may influence the response of cancers to dietary restriction-mimetic therapies.	[Kalaany, Nada Y.; Sabatini, David M.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Kalaany, Nada Y.; Sabatini, David M.] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA; [Kalaany, Nada Y.; Sabatini, David M.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Sabatini, David M.] Broad Inst, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Sabatini, DM (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	sabatini@wi.mit.edu		/0000-0002-1446-7256; Kalaany, Nada/0000-0001-7489-1035	Alexander and Margaret Stewart Trust Award; David H. Koch Cancer Research Award; National Institutes of Health [R01 AI04389, R01 CA129105]; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [R01CA129105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047389] Funding Source: NIH RePORTER	Alexander and Margaret Stewart Trust Award; David H. Koch Cancer Research Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank B. Vogelstein for providing the isogenic DLD-1 cell lines and M. M. Georgescu for the doxycycline-inducible U87-MG cell line; T. Jacks for the KRAS<SUP>LA2</SUP>; p53<SUP>LSL/WT</SUP> mice and H. Wu for the Pb-Cre; PTEN<SUP>L/L</SUP> mice; F. Reinhardt for assistance with animal experiments; R. Bronson for histological analysis; the Histology Facility at the Koch Institute for Integrative Cancer Research and the Histology Core Laboratory at MIT for assistance with sectioning and immunohistochemistry; the Imaging Platform at the Broad Institute for assistance with image analysis; R. Weinberg, D. Guertin, Y. Chudnovsky and Y. Sancak for critical reading of the manuscript; and members of the Sabatini and Weinberg laboratories for support and discussions. This research is supported by the Alexander and Margaret Stewart Trust Award, the David H. Koch Cancer Research Award and National Institutes of Health grants R01 AI04389 and R01 CA129105. D. M. S. is an investigator of the Howard Hughes Medical Institute.	BREESE CR, 1991, J GERONTOL, V46, pB180, DOI 10.1093/geronj/46.5.B180; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; CHENEY KE, 1983, J GERONTOL, V38, P420, DOI 10.1093/geronj/38.4.420; CHENEY KE, 1980, EXP GERONTOL, V15, P237, DOI 10.1016/0531-5565(80)90029-7; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Fu Z, 2008, ONCOGENE, V27, P2312, DOI 10.1038/onc.2008.24; Gupta S, 2007, CELL, V129, P957, DOI 10.1016/j.cell.2007.03.051; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Kalaany NY, 2005, CELL METAB, V1, P231, DOI 10.1016/j.cmet.2005.03.001; Kang SY, 2005, P NATL ACAD SCI USA, V102, P802, DOI 10.1073/pnas.0408864102; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; KLURFELD DM, 1989, J NUTR, V119, P286, DOI 10.1093/jn/119.2.286; Kritchevsky D, 2001, J NUTR SCI VITAMINOL, V47, P13, DOI 10.3177/jnsv.47.13; Lamprecht MR, 2007, BIOTECHNIQUES, V42, P71, DOI 10.2144/000112257; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63; Miller FR, 2000, J NATL CANCER I, V92, P1185, DOI 10.1093/jnci/92.14.1185A; MORESCHI C, 1909, ZTSCHR IMMUNITAETSFO, V2, P651; Pugh TD, 1999, CANCER RES, V59, P1642; Radu A, 2003, MOL CELL BIOL, V23, P6139, DOI 10.1128/MCB.23.17.6139-6149.2003; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; Rous P, 1914, J EXP MED, V20, P413, DOI 10.1084/jem.20.4.413; RUGGERI BA, 1989, CANCER RES, V49, P4130; Saal LH, 2005, CANCER RES, V65, P2554, DOI 10.1158/0008-5472-CAN-04-3913; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sell C, 2003, HORM METAB RES, V35, P705, DOI 10.1055/s-2004-814156; TANNENBAUM A, 1949, CANCER RES, V9, P724; TANNENBAUM A, 1953, CANCER RES, V13, P532; Thompson HJ, 2003, J MAMMARY GLAND BIOL, V8, P133, DOI 10.1023/A:1025743607445; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wapnir IL, 1996, BREAST CANCER RES TR, V41, P15, DOI 10.1007/BF01807032; WEINDRUCH R, 1982, SCIENCE, V215, P1415, DOI 10.1126/science.7063854; Zhao JJ, 2005, P NATL ACAD SCI USA, V102, P18443, DOI 10.1073/pnas.0508988102; Zhu ZJ, 1997, CARCINOGENESIS, V18, P1007, DOI 10.1093/carcin/18.5.1007	38	333	345	2	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 9	2009	458	7239					725	U61		10.1038/nature07782	http://dx.doi.org/10.1038/nature07782			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433GZ	19279572	Green Accepted			2022-12-01	WOS:000265193600032
J	West, SD; McBeath, HA; Stradling, JR				West, Sophie D.; McBeath, Helen A.; Stradling, John R.			Easily Missed? Obstructive sleep apnoea in adults	BMJ-BRITISH MEDICAL JOURNAL			English	Article							POSITIVE AIRWAY PRESSURE; PREVALENCE; RISK; MEN		[West, Sophie D.; Stradling, John R.] Churchill Hosp, Oxford Ctr Resp Med, Sleep Unit, Oxford OX3 7LJ, England; [McBeath, Helen A.] St Clements Surg, Oxford OX4 1JS, England	University of Oxford	West, SD (corresponding author), Churchill Hosp, Oxford Ctr Resp Med, Sleep Unit, Oxford OX3 7LJ, England.	sophie@west66.freeserve.co.uk		Stradling, John/0000-0003-4971-5018				[Anonymous], 2008, BBC NEWS; Cross MD, 2008, THORAX, V63, P578, DOI 10.1136/thx.2007.081877; Dancey DR, 2003, CHEST, V123, P1544, DOI 10.1378/chest.123.5.1544; DAVIES RJO, 1992, THORAX, V47, P101, DOI 10.1136/thx.47.2.101; Giles TL, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001106.pub2; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kohler M, 2008, EUR RESPIR J, V32, P1488, DOI 10.1183/09031936.00026608; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; Netzer NC, 1999, ANN INTERN MED, V131, P485, DOI 10.7326/0003-4819-131-7-199910050-00002; *NIH CLIN EXC, 2008, COST TEMPL CONT POS; Pepperell JCT, 2002, LANCET, V359, P204, DOI 10.1016/S0140-6736(02)07445-7; STRADLING JR, 1991, THORAX, V46, P85, DOI 10.1136/thx.46.2.85; Sundaram S, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001004.pub2; Teran-Santos J, 1999, NEW ENGL J MED, V340, P847, DOI 10.1056/NEJM199903183401104; Wang HQ, 2007, J AM COLL CARDIOL, V49, P1625, DOI 10.1016/j.jacc.2006.12.046; West SD, 2006, THORAX, V61, P945, DOI 10.1136/thx.2005.057745; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	17	8	8	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 7	2009	338								b1165	10.1136/bmj.b1165	http://dx.doi.org/10.1136/bmj.b1165			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	431ZH	19351671				2022-12-01	WOS:000265102800001
J	Hulme, PE; Pysek, P; Nentwig, W; Vila, M				Hulme, Philip E.; Pysek, Petr; Nentwig, Wolfgang; Vila, Montserrat			Will Threat of Biological Invasions Unite the European Union?	SCIENCE			English	Editorial Material							PATHWAYS		[Hulme, Philip E.] Lincoln Univ, Bioprotect Res Ctr, Canterbury, New Zealand; [Pysek, Petr] Acad Sci Czech Republ, Inst Bot, CZ-25243 Pruhonice, Czech Republic; [Pysek, Petr] Charles Univ Prague, Dept Ecol, CZ-12801 Vinicna 7, Czech Republic; [Nentwig, Wolfgang] Univ Bern, Inst Ecol & Evolut, CH-3012 Bern, Switzerland; [Vila, Montserrat] CSIC, EBD, E-41092 Seville, Spain	Lincoln University - New Zealand; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; Charles University Prague; University of Bern; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Hulme, PE (corresponding author), Lincoln Univ, Bioprotect Res Ctr, POB 84, Canterbury, New Zealand.	philip.hulme@lincoln.ac.nz	Hulme, Philip/F-7454-2011; Nentwig, Wolfgang/A-6624-2011; Vila, Montserrat/D-9339-2013; Pysek, Petr/B-1957-2012	Hulme, Philip/0000-0001-5712-0474; Vila, Montserrat/0000-0003-3171-8261; 				Balmford A, 2005, SCIENCE, V307, P212, DOI 10.1126/science.1106281; *CZ PRES EU GOV CZ, WORK PROGR PRIOR CZ; DAISIE, 2009, HDB AL SPEC EUR; *EC, 2008, 789 COM EC; EEA (EEA European Enviroment Agency), 2007, HALT LOSS BIOD 2010; *EUR COMM, 2007, SINGL MARK GOODS; Flash Eurobarometer 219, 2007, ATT EUR ISS BIOD; Genovesi P, 2005, BIOL INVASIONS, V7, P127, DOI 10.1007/s10530-004-9642-9; Hulme PE, 2008, J APPL ECOL, V45, P403, DOI 10.1111/j.1365-2664.2007.01442.x; Hulme PE, 2006, J APPL ECOL, V43, P835, DOI 10.1111/j.1365-2664.2006.01227.x; Hulme Philip E., 2007, V25, P56; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Lodge DM, 2006, ECOL APPL, V16, P2035, DOI 10.1890/1051-0761(2006)016[2035:BIRFUP]2.0.CO;2; McGeoch MA, 2006, CONSERV BIOL, V20, P1635, DOI 10.1111/j.1523-1739.2006.00579.x; Vila M, 2010, FRONT ECOL ENVIRON, V8, P135, DOI 10.1890/080083; 2007, EFSAJ, V468, P1; 2007, EFSAJ, V539, P1	17	246	256	2	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2009	324	5923					40	41		10.1126/science.1171111	http://dx.doi.org/10.1126/science.1171111			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	427TN	19342572	Green Submitted			2022-12-01	WOS:000264802100020
J	Warren, WS; Jenista, E; Branca, RT; Chen, X				Warren, Warren S.; Jenista, Elizabeth; Branca, Rosa Tamara; Chen, Xin			Increasing Hyperpolarized Spin Lifetimes Through True Singlet Eigenstates	SCIENCE			English	Article							MAGNETIC-RESONANCE SPECTRA; POLARIZATION; NMR	The sensitivity limitations for magnetic resonance imaging of organic molecules have recently been addressed by hyperpolarization methods, which prepare excess nuclear spin polarization. This approach can increase sensitivity by orders of magnitude, but the enhanced signal relaxes away in tens of seconds, even in favorable cases. Here we show theoretically that singlet states between strongly coupled spins in molecules can be used to store and retrieve population in very-long-lived disconnected eigenstates, as long as the coupling between the spins substantially exceeds both the couplings to other spins and the resonance frequency difference between them. Experimentally, 2,3-carbon-13-labeled diacetyl has a disconnected eigenstate that can store population for minutes and is read out by hydration to make the two spins inequivalent.	[Warren, Warren S.] Duke Univ, Dept Chem, Durham, NC 27708 USA; Duke Univ, Ctr Mol & Biomol Imaging, Durham, NC 27708 USA	Duke University; Duke University	Warren, WS (corresponding author), Duke Univ, Dept Chem, Durham, NC 27708 USA.	warren.warren@duke.edu			NIH [EB02122]; North Carolina Biotechnology Center; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB002122] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); North Carolina Biotechnology Center; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the NIH under grant EB02122 and by the North Carolina Biotechnology Center. We thank D. Bhattacharyya for his help in determining optimal conditions to hyperpolarize diacetyl; M. Jenista for help with calculations; T. Ribiero for his assistance in running NMR spectra; L. Bouchard for discussions of singlet character in strongly coupled systems; and S. Craig, E. Toone, D. Coltart, and M. S. Warren for particularly useful discussions on the chemistry of these compounds. A provisional patent has been submitted on this work by W.S.W. and Duke University.	ABRAGAM A, 1978, REP PROG PHYS, V41, P395, DOI 10.1088/0034-4885/41/3/002; ABRAHAM RJ, 1961, CAN J CHEM, V39, P216, DOI 10.1139/v61-025; Ahuja P, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2778429; ANET FA, 1961, CAN J CHEM, V39, P2262, DOI 10.1139/v61-300; BECKER ED, 2000, HIGH RESOLUTION NMR, P171; Bell R.P., 1966, ADV PHYS ORG CHEM, V4, P1, DOI DOI 10.1016/S0065-3160(08)60351-2; BOWERS CR, 1987, J AM CHEM SOC, V109, P5541, DOI 10.1021/ja00252a049; Carravetta M, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1893983; Carravetta M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.153003; Day IJ, 2007, MAGN RESON CHEM, V45, P1018, DOI 10.1002/mrc.2090; DELCAMPO G, 1992, ANALYST, V117, P1343, DOI 10.1039/an9921701343; Gabellieri C, 2008, J AM CHEM SOC, V130, P4598, DOI 10.1021/ja8001293; Golman K, 2003, P NATL ACAD SCI USA, V100, P10435, DOI 10.1073/pnas.1733836100; Golman K, 2001, MAGNET RESON MED, V46, P1, DOI 10.1002/mrm.1152; Golman K, 2006, CANCER RES, V66, P10855, DOI 10.1158/0008-5472.CAN-06-2564; Hall DA, 1997, SCIENCE, V276, P930, DOI 10.1126/science.276.5314.930; HOECKER W. H., 1942, Journal of Dairy Science, V25, P175, DOI 10.3168/jds.S0022-0302(42)95279-2; Jakobsen JA, 2005, EUR RADIOL, V15, P941, DOI 10.1007/s00330-004-2601-0; Kiselyov AS, 2006, CHEM BIOL DRUG DES, V68, P308, DOI 10.1111/j.1747-0285.2006.00456.x; Kurhanewicz J, 2008, J NUCL MED, V49, P341, DOI 10.2967/jnumed.107.045112; MacFall JR, 1996, RADIOLOGY, V200, P553, DOI 10.1148/radiology.200.2.8685356; McCarney ER, 2007, P NATL ACAD SCI USA, V104, P1754, DOI 10.1073/pnas.0610540104; Merritt ME, 2007, P NATL ACAD SCI USA, V104, P19773, DOI 10.1073/pnas.0706235104; MUSHER JI, 1962, TETRAHEDRON, V18, P791, DOI 10.1016/S0040-4020(01)92729-2; Natterer J, 1997, PROG NUCL MAG RES SP, V31, P293, DOI 10.1016/S0079-6565(97)00007-1; POPLE JA, 1957, CAN J CHEM, V35, P1060, DOI 10.1139/v57-143; SAUPE A, 1965, Z NATURFORSCH PT A, VA 20, P572; van Rooy FGBGJ, 2007, AM J RESP CRIT CARE, V176, P498, DOI 10.1164/rccm.200611-1620OC	28	169	171	1	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2009	323	5922					1711	1714		10.1126/science.1167693	http://dx.doi.org/10.1126/science.1167693			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	424IG	19325112	Green Accepted, Green Submitted			2022-12-01	WOS:000264559800035
J	Watson, M; McPherson, A; Murray, SA				Watson, Max; McPherson, Alan; Murray, Scott A.			Should hospices be exempt from following national cardiopulmonary resuscitation guidelines? Yes	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Watson, Max] No Ireland Hosp, Belfast BT15 3LH, Antrim, North Ireland; [Watson, Max] Univ Ulster, Coleraine, Ireland; [Murray, Scott A.] Univ Edinburgh, Primary Palliat Care Res Grp, Div Community Hlth Sci, Gen Practice Sect, Edinburgh EH8 9YL, Midlothian, Scotland	Ulster University; University of Edinburgh	Watson, M (corresponding author), No Ireland Hosp, Belfast BT15 3LH, Antrim, North Ireland.	max.watson@nihospicec.org						[Anonymous], NAT SURV PAT ACT DAT; *ROYAL COLL NURS B, 2007, DEC REL CARD RES JOI; Twycross R, 2003, INTRO PALLIATIVE CAR	3	4	4	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 26	2009	338								b965	10.1136/bmj.b965	http://dx.doi.org/10.1136/bmj.b965			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	425LR	19325181				2022-12-01	WOS:000264639700005
J	Husseini, A; Abu-Rmeileh, NME; Mikki, N; Ramahi, TM; Abu Ghosh, H; Barghuthi, N; Khalili, M; Bjertness, E; Holmboe-Ottesen, G; Jervell, J				Husseini, Abdullatif; Abu-Rmeileh, Niveen M. E.; Mikki, Nahed; Ramahi, Tarik M.; Abu Ghosh, Heidar; Barghuthi, Nadim; Khalili, Mohammad; Bjertness, Espen; Holmboe-Ottesen, Gerd; Jervell, Jak			Health in the Occupied Palestinian Territory 3 Cardiovascular diseases, diabetes mellitus, and cancer in the occupied Palestinian territory	LANCET			English	Article							CORONARY-HEART-DISEASE; PREVENTING CHRONIC DISEASES; UNIVERSITY-STUDENTS; MEDITERRANEAN DIET; METABOLIC SYNDROME; PUBLIC-HEALTH; RISK-FACTORS; OBESITY; ADOLESCENTS; UNDERNUTRITION	Heart disease, cerebrovascular disease, and cancer are the major causes of morbidity and mortality in the occupied Palestinian territory, resulting in a high direct cost of care, high indirect cost in loss of production, and much societal stress. The rates of the classic risk factors for atherosclerotic disease-namely, hypertension, diabetes mellitus, tobacco smoking, and dyslipidaemia-are high and similar to those in neighbouring countries. The urbanisation and continuing nutritional change from a healthy Mediterranean diet to an increasingly western-style diet is associated with reduced activity, obesity and a loss of the protective effect of the traditional diet. Rates of cancer seem to be lower than those in neighbouring countries, with the leading causes of death being lung cancer in Palestinian men and breast cancer in women. The response of society and the health-care system to this epidemic is inadequate. A large proportion of health-care expenditure is on expensive curative care outside the area. Effective comprehensive prevention programmes should be implemented, and the health-care system should be redesigned to address these diseases.	[Husseini, Abdullatif; Abu-Rmeileh, Niveen M. E.; Mikki, Nahed] Birzeit Univ, Inst Community & Publ Hlth, POB 14, Birzeit, Israel; [Mikki, Nahed; Bjertness, Espen; Holmboe-Ottesen, Gerd; Jervell, Jak] Univ Oslo, Inst Gen Practice & Community Med, Oslo, Norway; [Ramahi, Tarik M.] Yale Univ, Council Middle E Studies, New Haven, CT USA; [Abu Ghosh, Heidar] Palestinian Med Relief Soc, Chron Dis Ctr, Ramallah, Palestine; [Barghuthi, Nadim] Minist Hlth, Dept Noncommunicable dis, Ramallah, Palestine; [Khalili, Mohammad] UN, Relief & Works Agcy, Jerusalem, Israel; [Bjertness, Espen] Tibet Univ, Coll Med, Lhasa, Peoples R China	Birzeit University; University of Oslo; Yale University; Tibet University	Husseini, A (corresponding author), Birzeit Univ, Inst Community & Publ Hlth, POB 14, Birzeit, Israel.	abdullatif@birzeit.edu	Abu-Rmeileh, Niveen ME/H-7135-2019; Husseini, Abdullatif/E-8377-2015	Husseini, Abdullatif/0000-0001-8767-5956	Norwegian Programme for Development, Research and Education	Norwegian Programme for Development, Research and Education	We thank the Lancet Palestine Steering Group (lain Chalmers, Rita Giacaman, Jennifer Leaning, Harry Shannon, and Huda Zurayk) for reading, discussing, and commenting on several drafts of this report; Graham Watt, and Karl Sabbagh for their valuable comments and support; Medical Aid for Palestinians UK, University of Oslo, Institute for General Practice and Community Medicine, and the Norwegian Programme for Development, Research and Education for their financial contributions that made the workshops related to this Series possible; and the reviewers ofthis report, whose comments improved this final draft substantially for their support and valuable advice.	Abdul-Rahim HF, 2003, INT J OBESITY, V27, P140, DOI 10.1038/sj.ijo.0802160; Abdul-Rahim HF, 2001, DIABETES CARE, V24, P275, DOI 10.2337/diacare.24.2.275; ABDULRAHIM HF, 2002, U OSLO, P35; Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Abudayya A, 2007, NUTR RES, V27, P762, DOI 10.1016/j.nutres.2007.09.017; ABURMEILEH NME, 2008, PREV CHRONIC DIS, P5; Al Sabbah H, 2007, PUBLIC HEALTH NUTR, V10, P739, DOI 10.1017/S1368980007665501; Al-Isa AN, 2004, EUR J CLIN NUTR, V58, P1273, DOI 10.1038/sj.ejcn.1601961; Al-Rukban MO, 2003, SAUDI MED J, V24, P27; Al-Saeed WY, 2007, OBES REV, V8, P93, DOI 10.1111/j.1467-789X.2006.00287.x; Al-Sendi AM, 2003, EUR J CLIN NUTR, V57, P471, DOI 10.1038/sj.ejcn.1601560; Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; Batniji R, 2008, LANCET, V372, P805, DOI 10.1016/S0140-6736(08)61334-3; Beaglehole R, 2007, LANCET, V370, P2152, DOI 10.1016/S0140-6736(07)61700-0; BENDEL M, 2005, BREAST CANC GAZA STR, P1; Berenson GS, 2005, NEUROBIOL AGING, V26, P303, DOI 10.1016/j.neurobiolaging.2004.05.009; Britt K, 2007, ENDOCR-RELAT CANCER, V14, P907, DOI 10.1677/ERC-07-0137; *CENTR BUR STAT, HLTH SURV 2003 2004; *DEP HLTH, 1946, ANN HLTH REP 1945; Dominguez LJ, 2020, ENCYCLOPEDIA OF BIOMEDICAL GERONTOLOGY, VOL 2, P400, DOI [10.1097/00008469-200410000-00014, 10.1016/B978-0-12-801238-3.62178-5]; Epping-Jordan JE, 2005, LANCET, V366, P1667, DOI 10.1016/S0140-6736(05)67342-4; FARRAKH A, GLOBAL BURDEN CANC; Freedman L. S., CANC INCIDENCE 4 MEM; Gaziano TA, 2007, LANCET, V370, P1939, DOI 10.1016/S0140-6736(07)61697-3; Giacaman R., 1994, HLTH CONDITIONS SERV; Giacaman R, 2009, LANCET, V373, P837, DOI 10.1016/S0140-6736(09)60107-0; Hamdan M, 2003, HEALTH POLICY, V64, P243, DOI 10.1016/S0168-8510(03)00004-6; Husseini A, 2000, DIABETIC MED, V17, P746, DOI 10.1046/j.1464-5491.2000.00355.x; HUSSEINI A, 2002, THESIS U OSLO PALEST, P32; Jabara R, 2007, ISRAEL MED ASSOC J, V9, P316; Jackson M, 2002, PUBLIC HEALTH NUTR, V5, P281, DOI 10.1079/PHN2002262; *JORD MED ASS, 2008, MED HUM RES PAL; JUBRAN J, 2005, HLTH SEGREGATION H I; KALUSKI DN, 2008, PUBLIC HEALTH NUTR, P1; Kandela P, 2000, LANCET, V356, P1175, DOI 10.1016/S0140-6736(05)72871-3; Kark JD, 2000, LANCET, V356, P1410, DOI 10.1016/S0140-6736(00)02849-X; Kark JD, 2006, INT J EPIDEMIOL, V35, P448, DOI 10.1093/ije/dyl012; Khatib O, 2004, East Mediterr Health J, V10, P778; Kligler IJ, 1932, ANN AM ACAD POLIT SS, V164, P167, DOI 10.1177/000271623216400119; Kulwicki A, 2003, PUBLIC HEALTH NURS, V20, P177, DOI 10.1046/j.0737-1209.2003.20304.x; La Vecchia C, 2004, PUBLIC HEALTH NUTR, V7, P965, DOI 10.1079/PHN2004562; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; MASTERMAN EW, 1920, HYGIENE DIS PALESTIN; Mataria A, 2009, LANCET, V373, P1207, DOI 10.1016/S0140-6736(09)60111-2; Maziak W, 2004, ANN EPIDEMIOL, V14, P646, DOI 10.1016/j.annepidem.2003.11.003; Maziak W, 2004, INT J TUBERC LUNG D, V8, P882; *MIN HLTH, 2004, QUAL IMPR PROGR PAL; *MIN HLTH, 2002, HLTH STAT PAL 2001; *MIN HLTH, 2005, HLTH STAT PAL 2004; *MIN HLTH, 2006, HLTH STAT PAL 2005; *MIN HLTH, 2002, CANC 1995 2000; *MIN HLTH, 2003, HLTH STAT PAL 2002; *MIN HLTH, 2004, HLTH STAT PAL 2003; *MIN HLTH, 2001, CANC INC PAL 1998 19; *MIN HLTH, NAT STRAT HLTH PLAN; Palestinian Central Bureau of Statistics, 2007, PAL FAM HLTH SURV 20; Popkin BM, 1998, PUBLIC HEALTH NUTR, V1, P5, DOI 10.1079/PHN19980004; Rahim HFA, 2009, LANCET, V373, P967, DOI 10.1016/S0140-6736(09)60108-2; RIONDA Z, 2000, BURDEN DIS W BANK GA; Roglic G, 2005, DIABETES CARE, V28, P2130, DOI 10.2337/diacare.28.9.2130; Salameh Shaden, 2008, J Cardiometab Syndr, V3, P26, DOI 10.1111/j.1559-4572.2008.07315.x; SALHAB A, 2005, PALESTINIAN NATL CAN; Sawaya AL, 2003, NUTR REV, V61, P168, DOI 10.1301/nr.2003.may.168-175; Shamseddine A, 2004, ANN EPIDEMIOL, V14, P663, DOI 10.1016/j.annepidem.2003.12.002; Stabouli S, 2005, J PEDIATR-US, V147, P651, DOI 10.1016/j.jpeds.2005.06.008; Stene LCM, 1999, EUR J CLIN NUTR, V53, P953, DOI 10.1038/sj.ejcn.1600878; Stene LCM, 2001, EUR J CLIN NUTR, V55, P805, DOI 10.1038/sj.ejcn.1601230; Strong K, 2005, LANCET, V366, P1578, DOI 10.1016/S0140-6736(05)67341-2; *UN REL WORKS AG, 2007, ANN REP DEP HLTH; *UN REL WORKS AG H, 2005, TECHN INSTR MAN PROT; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Warren Charles W., 2008, Morbidity and Mortality Weekly Report, V57, P1; Weiss R, 2004, NEW ENGL J MED, V350, P2362, DOI 10.1056/NEJMoa031049; *WFP FAO, 2007, COMPR FOOD SEC VUL A; WHO, 2008, ACC HLTH SERV PAL PE; *WHO EMRO, COUNTR PROF WHO E ME; *WHO EMRO, REG DAT NONC DIS THE; World Health Organization, 2005, PREVENTING CHRONIC D; Yach D, 2002, TOB CONTROL, V11, P252, DOI 10.1136/tc.11.3.252; BTSELEM SEPARATION B	80	96	97	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 21	2009	373	9668					1041	1049		10.1016/S0140-6736(09)60109-4	http://dx.doi.org/10.1016/S0140-6736(09)60109-4			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	422AA	19268350				2022-12-01	WOS:000264398200032
J	Zhang, Q; Li, YL; Tsien, RW				Zhang, Qi; Li, Yulong; Tsien, Richard W.			The Dynamic Control of Kiss-And-Run and Vesicular Reuse Probed with Single Nanoparticles	SCIENCE			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; ADRENAL CHROMAFFIN CELLS; READILY RELEASABLE POOL; HIPPOCAMPAL SYNAPSES; SYNAPTIC VESICLES; QUANTUM DOTS; FUSION PORE; TRANSMITTER RELEASE; EXOCYTOSIS; NEURONS	Vesicular secretion of neurotransmitter is essential for neuronal communication. Kiss-and-run is a mode of membrane fusion and retrieval without the full collapse of the vesicle into the plasma membrane and de novo regeneration. The importance of kiss-and-run during efficient neurotransmission has remained in doubt. We developed an approach for loading individual synaptic vesicles with single quantum dots. Their size and pH-dependent photoluminescence change allowed us to distinguish kiss-and-run from full-collapse fusion and to track single vesicles through multiple rounds of kiss-and-run and reuse, without perturbing vesicle cycling. Kiss-and-run dominated at the beginning of stimulus trains, reflecting the preference of vesicles with high release probability. Its incidence was increased by rapid firing, a response appropriate to shape the kinetics of neurotransmission during a wide range of firing patterns.	[Zhang, Qi; Li, Yulong; Tsien, Richard W.] Stanford Univ, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA	Stanford University	Tsien, RW (corresponding author), Stanford Univ, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA.	rwtsien@stanford.edu		Li, Yulong/0000-0002-9166-9919	Grass Foundation; National Institute of Mental Health; Burnett Family Fund; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064070] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K99DA025143] Funding Source: NIH RePORTER	Grass Foundation; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Burnett Family Fund; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank N. C. Harata for help with high-frequency imaging and data analysis, R. J. Reimer and members of the Tsien lab for comments, J. W. Mulholland and J. J. Perrino for help with imaging, and X. Gao and M. Bruchez for consultation on quantum dots. Supported by grants from the Grass Foundation (Q.Z.), the National Institute of Mental Health, and the Burnett Family Fund (R.W.T.).	Alivisatos AP, 2005, ANNU REV BIOMED ENG, V7, P55, DOI 10.1146/annurev.bioeng.7.060804.100432; An S, 2004, CURR OPIN NEUROBIOL, V14, P522, DOI 10.1016/j.conb.2004.08.008; Aravanis AM, 2003, NATURE, V423, P643, DOI 10.1038/nature01686; ARTALEJO CR, 1995, P NATL ACAD SCI USA, V92, P8328, DOI 10.1073/pnas.92.18.8328; Balaji J, 2007, P NATL ACAD SCI USA, V104, P20576, DOI 10.1073/pnas.0707574105; Chan SA, 2001, J PHYSIOL-LONDON, V537, P871; Chen X, 2008, J NEUROSCI, V28, P1894, DOI 10.1523/JNEUROSCI.4518-07.2008; Choi S, 2003, PHILOS T ROY SOC B, V358, P695, DOI 10.1098/rstb.2002.1249; Cui BX, 2007, P NATL ACAD SCI USA, V104, P13666, DOI 10.1073/pnas.0706192104; Dahan M, 2003, SCIENCE, V302, P442, DOI 10.1126/science.1088525; DETOLEDO GA, 1993, NATURE, V363, P554, DOI 10.1038/363554a0; Edwards RH, 2007, NEURON, V55, P835, DOI 10.1016/j.neuron.2007.09.001; Fernandez-Alfonso T, 2004, NEURON, V41, P943, DOI 10.1016/S0896-6273(04)00113-8; Fesce Riccardo, 1994, Trends in Cell Biology, V4, P1, DOI 10.1016/0962-8924(94)90025-6; Franks KM, 2003, J NEUROSCI, V23, P3186; Fulop T, 2005, J NEUROSCI, V25, P7324, DOI 10.1523/JNEUROSCI.2042-05.2005; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; Gao XH, 2002, J BIOMED OPT, V7, P532, DOI 10.1117/1.1506706; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; Harata NC, 2006, NEURON, V49, P243, DOI 10.1016/j.neuron.2005.12.018; He LM, 2006, NATURE, V444, P102, DOI 10.1038/nature05250; Heine M, 2008, SCIENCE, V320, P201, DOI 10.1126/science.1152089; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Howarth M, 2005, P NATL ACAD SCI USA, V102, P7583, DOI 10.1073/pnas.0503125102; Jackson MB, 2006, ANNU REV BIOPH BIOM, V35, P135, DOI 10.1146/annurev.biophys.35.040405.101958; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Mueller VJ, 2004, J NEUROSCI, V24, P2004, DOI 10.1523/JNEUROSCI.4080-03.2004; Nirmal M, 1996, NATURE, V383, P802, DOI 10.1038/383802a0; Pyle JL, 2000, NEURON, V28, P221, DOI 10.1016/S0896-6273(00)00098-2; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Smith SM, 2008, TRENDS NEUROSCI, V31, P559, DOI 10.1016/j.tins.2008.08.005; Staal RGW, 2004, NAT NEUROSCI, V7, P341, DOI 10.1038/nn1205; Stevens CF, 2000, P NATL ACAD SCI USA, V97, P12828, DOI 10.1073/pnas.230438697; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Taraska JW, 2003, P NATL ACAD SCI USA, V100, P2070, DOI 10.1073/pnas.0337526100; Valtorta F, 2001, TRENDS CELL BIOL, V11, P324, DOI 10.1016/S0962-8924(01)02058-X; Voglmaier SM, 2006, NEURON, V51, P71, DOI 10.1016/j.neuron.2006.05.027; Zhang Q, 2007, P NATL ACAD SCI USA, V104, P17843, DOI 10.1073/pnas.0706906104; Zhou Q, 2000, J PHYSIOL-LONDON, V525, P195, DOI 10.1111/j.1469-7793.2000.t01-1-00195.x	39	252	257	1	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2009	323	5920					1448	1453		10.1126/science.1167373	http://dx.doi.org/10.1126/science.1167373			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417TP	19213879	Green Accepted			2022-12-01	WOS:000264101700032
J	Quirke, P; Steele, R; Monson, J; Grieve, R; Khanna, S; Couture, J; O'Callaghan, C; Myint, AS; Bessell, E; Thompson, LC; Parmar, M; Stephens, RJ; Sebag-Montefiore, D				Quirke, Phil; Steele, Robert; Monson, John; Grieve, Robert; Khanna, Subhash; Couture, Jean; O'Callaghan, Chris; Myint, Arthur Sun; Bessell, Eric; Thompson, Lindsay C.; Parmar, Mahesh; Stephens, Richard J.; Sebag-Montefiore, David		MRC CR07 NCIC-CTG CO16 Trial; NCRI Colorectal Canc Study Grp	Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial	LANCET			English	Article							TOTAL MESORECTAL EXCISION; RESECTION MARGIN INVOLVEMENT; PREOPERATIVE RADIOTHERAPY; POSTOPERATIVE CHEMORADIOTHERAPY; ABDOMINOPERINEAL EXCISION; SURGICAL RESECTION; SURVIVAL; CARCINOMA; MULTICENTER; STOCKHOLM	Background Local recurrence rates in operable rectal cancer are improved by radiotherapy (with or without chemotherapy) and surgical techniques such as total mesorectal excision. However, the contributions of surgery and radiotherapy to outcomes are unclear. We assessed the effect of the involvement of the circumferential resection margin and the plane of surgery achieved. Methods In this prospective study, the plane of surgery achieved and the involvement of the circumferential resection margin were assessed by local pathologists, using a standard pathological protocol in 1156 patients with operable rectal cancer from the CR07 and NCIC-CTG CO16 trial, which compared short-course (5 days) preoperative radiotherapy and selective postoperative chemoradiotherapy, between March, 1998, and August, 2005. All analyses were by intention to treat. This trial is registered, number ISRCTN 28785842. Findings 128 patients (11%) had involvement of the circumferential resection margin, and the plane of surgery achieved was classified as good (mesorectal) in 604 (52%), intermediate (intramesorectal) in 398 (34%), and poor (muscularis propria plane) in 154 (13%). We found that both a negative circumferential resection margin and a superior plane of surgery achieved were associated with low local recurrence rates. Hazard ratio (HR) was 0 - 32 (95% CI 0.16-0.63, p=0.0011) with 3-year local recurrence rates of 6% (5-8%) and 17% (10-26%) for patients who were negative and positive for circumferential resection margin, respectively. For plane of surgery achieved, HRs for mesorectal and intramesorectal groups compared with the muscularis propria group were 0 - 32 (0.16-0.64) and 0.48 (0.25-0.93), respectively. At 3 years, the estimated local recurrence rates were 4% (3-6%) for mesorectal, 7% (5-11%) for intramesorectal, and 13% (8-21%) for muscularis propria groups. The benefit of short-course preoperative radiotherapy did not differ in the three plane of surgery groups (p=0.30 for trend). Patients in the short-course preoperative radiotherapy group who had a resection in the mesorectal plane had a 3-year local recurrence rate of only 1%. Interpretation In rectal cancer, the plane of surgery achieved is an important prognostic factor for local recurrence. Short-course preoperative radiotherapy reduced the rate of local recurrence for all three plane of surgery groups, almost abolishing local recurrence in short-course preoperative radiotherapy patients who had a resection in the mesorectal plane. The plane of surgery achieved should therefore be assessed and reported routinely. Funding Medical Research Council (UK) and the National Cancer Institute of Canada.	[Quirke, Phil] Univ Leeds, Leeds Inst Mol Med, St James Univ Hosp, Leeds LS9 7TF, W Yorkshire, England; [Quirke, Phil] Univ Leeds, Leeds LS9 7TF, W Yorkshire, England; [Steele, Robert] Ninewells Hosp, Dundee DD1 9SY, Scotland; [Monson, John] Castle Hill Hosp, Kingston Upon Hull, N Humberside, England; [Grieve, Robert] Walsgrave Gen Hosp, Coventry CV2 2DY, W Midlands, England; [Khanna, Subhash] Leicester Royal Infirm, Leicester, Leics, England; [Couture, Jean; O'Callaghan, Chris] Natl Canc Inst Canada, Kingston, ON, Canada; [Myint, Arthur Sun] Clatterbridge Ctr Oncol, Wirral, Merseyside, England; [Bessell, Eric] City Hosp Nottingham, Nottingham, England; [Thompson, Lindsay C.; Parmar, Mahesh; Stephens, Richard J.] MRC, Clin Trial Unit, London, England	Saint James's University Hospital; University of Leeds; University of Leeds; University of Dundee; University of Hull; University of Leicester; Queens University - Canada; Canadian Cancer Trials Group; Clatterbridge Cancer Centre; Nottingham University Hospital NHS Trust; Nottingham City Hospital; Medical Research Council Clinical Trials Unit	Quirke, P (corresponding author), Univ Leeds, Leeds Inst Mol Med, St James Univ Hosp, Wellcome Trust Brenner Bldg,Beckett St, Leeds LS9 7TF, W Yorkshire, England.	patpq@leeds.ac.uk	Quirke, Philip/AAI-1362-2019; Myint, Arthur Sun/AAO-7695-2020	Myint, Arthur Sun/0000-0001-5323-5696; Steele, Robert JC/0000-0003-4248-6785; Quirke, Philip/0000-0002-3597-5444; Sebag-Montefiore, David/0000-0002-5978-9259	Medical Research Council (MRC); Canadian Cancer Society; Yorkshire Cancer Research; Experimental Cancer Medicine Centre programme; Trial Management Group; Protocol Development Group; Independent Data Monitoring Committee; Trial Steering Committee; MRC [MC_U122861325] Funding Source: UKRI; Medical Research Council [MC_U122861325] Funding Source: researchfish	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Yorkshire Cancer Research; Experimental Cancer Medicine Centre programme; Trial Management Group; Protocol Development Group; Independent Data Monitoring Committee; Trial Steering Committee; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the Medical Research Council (MRC) and the Canadian Cancer Society for supporting this study; the Yorkshire Cancer Research and the Experimental Cancer Medicine Centre programme, ",Inch supported PQ; the Trial Management Group, other members of the Protocol Development Group, the Independent Data Monitoring Committee, the Trial Steering Committee, the staff at the MRC Clinical Trial Unit, arid the oncologists, surgeons, pathologists, research staff. arid all the patients who participated in this trial.	ADAM IJ, 1994, LANCET, V344, P707, DOI 10.1016/S0140-6736(94)92206-3; Birbeck KF, 2002, ANN SURG, V235, P449, DOI 10.1097/00000658-200204000-00001; Birgisson H, 2005, J CLIN ONCOL, V23, P8697, DOI 10.1200/JCO.2005.02.9017; Cedermark B, 1996, ANN SURG ONCOL, V3, P423; CEDERMARK B, 1995, CANCER-AM CANCER SOC, V75, P2269, DOI 10.1002/1097-0142(19950501)75:9<2269::AID-CNCR2820750913>3.0.CO;2-I; Dahlberg M, 2002, INT J RADIAT ONCOL, V54, P654, DOI 10.1016/S0360-3016(02)02880-8; Dexter SPL, 2001, GUT, V48, P667, DOI 10.1136/gut.48.5.667; Folkesson J, 2005, J CLIN ONCOL, V23, P5644, DOI 10.1200/JCO.2005.08.144; Guillou PJ, 2005, LANCET, V365, P1718, DOI 10.1016/S0140-6736(05)66545-2; HEALD RJ, 1986, LANCET, V1, P1479; HOHENBERGER W, 1997, RECTAL CANC SURG OPT, P353; Kapiteijn E, 2002, BRIT J SURG, V89, P1142, DOI 10.1046/j.1365-2168.2002.02196.x; Kapiteijn E, 2001, NEW ENGL J MED, V345, P638, DOI 10.1056/NEJMoa010580; MACFARLANE JK, 1993, LANCET, V341, P457, DOI 10.1016/0140-6736(93)90207-W; Marr R, 2005, ANN SURG, V242, P74, DOI 10.1097/01.sla.0000167926.60908.15; Martling A, 2005, BRIT J SURG, V92, P225, DOI 10.1002/bjs.4834; MCCALL JL, 1995, INT J COLORECTAL DIS, V10, P126, DOI 10.1007/BF00298532; Nagtegaal ID, 2005, J CLIN ONCOL, V23, P9257, DOI 10.1200/JCO.2005.02.9231; Nagtegaal ID, 2002, J CLIN ONCOL, V20, P1729, DOI 10.1200/JCO.2002.07.010; Nagtegaal ID, 2002, AM J SURG PATHOL, V26, P350, DOI 10.1097/00000478-200203000-00009; Pahlman L, 1997, NEW ENGL J MED, V336, P980; QUIRKE P, 1986, LANCET, V2, P996, DOI 10.1016/s0140-6736(86)92612-7; Quirke P, 2003, LANCET ONCOL, V4, P695, DOI 10.1016/S1470-2045(03)01248-8; QUIRKE P, 1997, RECTAL CANC SURG OPT, P63; SAGAR PM, 1993, BRIT J SURG, V80, P1386, DOI 10.1002/bjs.1800801109; Sauer R, 2004, NEW ENGL J MED, V351, P1731, DOI 10.1056/NEJMoa040694; Sauerbrei W, 2006, COMPUT STAT DATA AN, V50, P3464, DOI 10.1016/j.csda.2005.07.015; Sauerbrei W, 2007, STAT MED, V26, P5512, DOI 10.1002/sim.3148; Sebag-Montefiore D, 2009, LANCET, V373, P811, DOI 10.1016/S0140-6736(09)60484-0; West NP, 2008, LANCET ONCOL, V9, P857, DOI 10.1016/S1470-2045(08)70181-5; West NP, 2008, J CLIN ONCOL, V26, P3517, DOI 10.1200/JCO.2007.14.5961; Wibe A, 2002, BRIT J SURG, V89, P327, DOI 10.1046/j.0007-1323.2001.02024.x; Wibe A, 2002, DIS COLON RECTUM, V45, P857, DOI 10.1007/s10350-004-6317-7	33	709	738	0	25	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 7	2009	373	9666					821	828		10.1016/S0140-6736(09)60485-2	http://dx.doi.org/10.1016/S0140-6736(09)60485-2			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	416BT	19269520	Green Published			2022-12-01	WOS:000263980900032
J	Kozhimannil, KB; Pereira, MA; Harlow, BL				Kozhimannil, Katy Backes; Pereira, Mark A.; Harlow, Bernard L.			Association Between Diabetes and Perinatal Depression Among Low-Income Mothers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POSTPARTUM MOOD DISORDERS; ADMINISTRATIVE DATA; PSYCHIATRIC DIAGNOSES; POSTNATAL DEPRESSION; MAJOR DEPRESSION; PREGNANCY; WOMEN; PREVALENCE; RISK; MEDICAID	Context Perinatal depression affects at least 10% to 12% of new mothers, and diabetes complicates up to 9% of pregnancies. Prior research shows a higher rate of major depression among individuals with diabetes. Objective To examine the association between diabetes and depression during pregnancy and the postpartum period among a sample of low- income women. Design, Setting, and Patients Retrospective cohort study using data from New Jersey's Medicaid administrative claims database of 11 024 women who gave birth between July 1, 2004, and September 30, 2006, and who were continuously enrolled in Medicaid for 6 months prior to delivery and 1 year after giving birth. Main Outcome Measures Multivariate logistic regression was used to assess the association between prepregnancy diabetes or gestational diabetes and perinatal depression. Depression was defined as an International Classification of Diseases, Ninth Revision, diagnosis for depression or a prescription drug claim for an antidepressant medication, and diabetes was defined as having a diabetes diagnosis or filling a prescription for a diabetes medication. Both measures were assessed during the 6 months prior to and up to 1 year following delivery. Results In the sample of women who gave birth, 15.2% ( n= 100) with prepregnancy or gestational diabetes and 8.5% ( n= 886) without diabetes were depressed during pregnancy or postpartum. After adjusting for age, race, year of delivery, and gestational age at birth, women with diabetes compared with those without diabetes had nearly double the odds of experiencing depression during the perinatal period ( odds ratio, 1.85; 95% confidence interval, 1.45- 2.36). Women with diabetes and no prenatal indication of depression ( n= 62, 9.6%) had higher odds than their counterparts without diabetes ( n= 604, 5.9%) of receiving a postpartum depression diagnosis or taking an antidepressant medication in the year following delivery ( odds ratio, 1.69; 95% confidence interval, 1.27- 2.23). Conclusion Prepregnancy or gestational diabetes was independently associated with perinatal depression, including new onset of postpartum depression, in our sample of low-income new mothers.	[Pereira, Mark A.; Harlow, Bernard L.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55454 USA; [Kozhimannil, Katy Backes] Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA USA; [Kozhimannil, Katy Backes] Harvard Pilgrim Hlth Care, Boston, MA USA	University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care	Harlow, BL (corresponding author), Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, 1300 S 2nd St,Ste 300, Minneapolis, MN 55454 USA.	harlow@umn.edu		Harlow, Bernard/0000-0002-6735-8862; Pereira, Mark/0000-0002-6704-5276	Fellowship in Pharmaceutical Policy Research at the Department of Ambulatory Care and Prevention, Harvard Medical School; Harvard University Dissertation Completion Grant; Harvard University PhD Program in Health Policy; Harvard Pilgrim Health Care Foundation	Fellowship in Pharmaceutical Policy Research at the Department of Ambulatory Care and Prevention, Harvard Medical School; Harvard University Dissertation Completion Grant; Harvard University PhD Program in Health Policy; Harvard Pilgrim Health Care Foundation	This study was supported by the Fellowship in Pharmaceutical Policy Research at the Department of Ambulatory Care and Prevention, Harvard Medical School; a Harvard University Dissertation Completion Grant; the Harvard University PhD Program in Health Policy; and the Harvard Pilgrim Health Care Foundation.	Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x; American College of Obstetricians and Gynecologists, 2001, CLIN MAN GUID OBST G; Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069; [Anonymous], 2005, PERINATAL DEPRESSION; Brummelte S, 2006, HORM BEHAV, V50, P370, DOI 10.1016/j.yhbeh.2006.04.008; Busch AB, 2006, MED CARE, V44, P506, DOI 10.1097/01.mlr.0000215890.30756.b2; Chen TH, 2006, MED HYPOTHESES, V66, P820, DOI 10.1016/j.mehy.2005.09.032; Crowther CA, 2005, NEW ENGL J MED, V352, P2477, DOI 10.1056/NEJMoa042973; de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015; Evans J, 2001, BRIT MED J, V323, P257, DOI 10.1136/bmj.323.7307.257; Evers IN, 2004, BMJ-BRIT MED J, V328, P915, DOI 10.1136/bmj.38043.583160.EE; Feig DS, 2002, LANCET, V359, P1690, DOI 10.1016/S0140-6736(02)08599-9; Fergerson SS, 2002, AM J OBSTET GYNECOL, V186, P899, DOI 10.1067/mob.2002.123404; Gavin NI, 2005, OBSTET GYNECOL, V106, P1071, DOI 10.1097/01.AOG.0000183597.31630.db; Gilmer T, 2001, MED CARE, V39, P1188, DOI 10.1097/00005650-200111000-00006; Golden SH, 2007, PSYCHOSOM MED, V69, P529, DOI 10.1097/PSY.0b013e3180f61c5c; GOTLIB IH, 1989, J CONSULT CLIN PSYCH, V57, P269, DOI 10.1037/0022-006X.57.2.269; HOBFOLL SE, 1995, J CONSULT CLIN PSYCH, V63, P445, DOI 10.1037/0022-006X.63.3.445; Iezzoni LI, 1997, ANN INTERN MED, V127, P666, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00048; *KAIS COMM MED UN, 2007, NEW JERS US STAT MED; Kammerer M, 2006, ARCH WOMEN MENT HLTH, V9, P187, DOI 10.1007/s00737-006-0131-2; Knutson KL, 2008, ANN NY ACAD SCI, V1129, P287, DOI 10.1196/annals.1417.033; Knutson KL, 2006, ARCH INTERN MED, V166, P1768, DOI 10.1001/archinte.166.16.1768; Kressin NR, 2003, AM J PUBLIC HEALTH, V93, P1734, DOI 10.2105/AJPH.93.10.1734; Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934; Metzger BE, 2007, DIABETES CARE, V30, pS251, DOI 10.2337/dc07-s225; Mezey G, 2005, BJOG-INT J OBSTET GY, V112, P197, DOI 10.1111/j.1471-0528.2004.00307.x; Murray L, 1996, CHILD DEV, V67, P2512, DOI 10.2307/1131637; OHARA MW, 1991, J ABNORM PSYCHOL, V100, P63, DOI 10.1037/0021-843X.100.1.63; Pignone MP, 2002, ANN INTERN MED, V136, P765, DOI 10.7326/0003-4819-136-10-200205210-00013; Ramchandani P, 2005, LANCET, V365, P2201, DOI 10.1016/S0140-6736(05)66778-5; Rich-Edwards JW, 2006, J EPIDEMIOL COMMUN H, V60, P221, DOI 10.1136/jech.2005.039370; Ritter C, 2000, HEALTH PSYCHOL, V19, P576, DOI 10.1037/0278-6133.19.6.576; SCHWARTZ AH, 1980, AM J PUBLIC HEALTH, V70, P406, DOI 10.2105/AJPH.70.4.406; SEGUIN L, 1995, OBSTET GYNECOL, V85, P583, DOI 10.1016/0029-7844(94)00449-N; Setse R, 2008, MATERN CHILD HLTH J, V12, P119, DOI 10.1007/s10995-007-0211-6; Spettell CM, 2003, HEALTH SERV RES, V38, P1081, DOI 10.1111/1475-6773.00164; STEIN A, 1991, BRIT J PSYCHIAT, V158, P46, DOI 10.1192/bjp.158.1.46; STOWE ZN, 1995, AM J OBSTET GYNECOL, V173, P639, DOI 10.1016/0002-9378(95)90296-1; Waldo DP, 2004, HEALTH CARE FINANC R, V26, P61; Walkup JT, 2000, ADM POLICY MENT HLTH, V27, P129, DOI 10.1023/A:1021308007343; Weech-Maldonado R, 2003, HEALTH SERV RES, V38, P789, DOI 10.1111/1475-6773.00147; Weinberg MK, 1998, J CLIN PSYCHIAT, V59, P53; Zhang XP, 2005, AM J EPIDEMIOL, V161, P652, DOI 10.1093/aje/kwi089	44	124	130	0	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 25	2009	301	8					842	847		10.1001/jama.2009.201	http://dx.doi.org/10.1001/jama.2009.201			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	410WV	19244191				2022-12-01	WOS:000263609900025
J	Schmitt, J; Romanos, M; Schmitt, NM; Meurer, M; Kirch, W				Schmitt, Jochen; Romanos, Marcel; Schmitt, Natalie M.; Meurer, Michael; Kirch, Wilhelm			Atopic Eczema and Attention-Deficit/Hyperactivity Disorder in a Population-Based Sample of Children and Adolescents	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							DERMATITIS; ADHD		[Schmitt, Jochen; Meurer, Michael] Tech Univ Dresden, Dept Dermatol, Med Fac Carl Gustav Carus, Dresden, Germany; [Romanos, Marcel] Univ Wurzburg, Dept Child & Adolescent Psychiat Psychosomat & Ps, Hosp Clin, Wurzburg, Germany; [Schmitt, Natalie M.; Kirch, Wilhelm] Tech Univ Dresden, Inst Clin Pharmacol, Med Fac Carl Gustav Carus, Dresden, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Wurzburg; Technische Universitat Dresden; Carl Gustav Carus University Hospital	Schmitt, J (corresponding author), Tech Univ Dresden, Dept Dermatol, Med Fac Carl Gustav Carus, Dresden, Germany.	jochen.schmitt@uniklinikum-dresden.de	Romanos, Marcel/D-7695-2017	Romanos, Marcel/0000-0001-7628-8299				Birnbaum HG, 2005, CURR MED RES OPIN, V21, P195, DOI 10.1185/030079904X20303; Lewis-Jones S, 2006, INT J CLIN PRACT, V60, P984, DOI 10.1111/j.1742-1241.2006.01047.x; Pelsser LMJ, 2009, PEDIAT ALLERG IMM-UK, V20, P107, DOI 10.1111/j.1399-3038.2008.00749.x; Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942; Smaldone A, 2007, PEDIATRICS, V119, pS29, DOI 10.1542/peds.2006-2089F; Williams HC, 2005, NEW ENGL J MED, V352, P2314, DOI 10.1056/NEJMcp042803	6	135	140	0	14	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 18	2009	301	7					724	726		10.1001/jama.2009.136	http://dx.doi.org/10.1001/jama.2009.136			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	407MX	19224748				2022-12-01	WOS:000263370100014
J	Takeuchi, JK; Bruneau, BG				Takeuchi, Jun K.; Bruneau, Benoit G.			Directed transdifferentiation of mouse mesoderm to heart tissue by defined factors	NATURE			English	Article							CHROMATIN-REMODELING COMPLEX; ANTEROPOSTERIOR AXIS; STEM-CELLS; MESP1; DIFFERENTIATION; TRANSCRIPTION; GENE; EXPRESSION; INDUCTION; MYOCARDIN	Heart disease is the leading cause of mortality and morbidity in the western world. The heart has little regenerative capacity after damage, leading to much interest in understanding the factors required to produce new cardiac myocytes. Despite a robust understanding of the molecular networks regulating cardiac differentiation(1,2), no single transcription factor or combination of factors has been shown to activate the cardiac gene program de novo in mammalian cells or tissues. Here we define the minimal requirements for transdifferentiation of mouse mesoderm to cardiac myocytes. We show that two cardiac transcription factors, Gata4 and Tbx5, and a cardiac-specific subunit of BAF chromatin-remodelling complexes, Baf60c (also called Smarcd3), can direct ectopic differentiation of mouse mesoderm into beating cardiomyocytes, including the normally non-cardiogenic posterior mesoderm and the extraembryonic mesoderm of the amnion. Gata4 with Baf60c initiated ectopic cardiac gene expression. Addition of Tbx5 allowed differentiation into contracting cardiomyocytes and repression of non-cardiac mesodermal genes. Baf60c was essential for the ectopic cardiogenic activity of Gata4 and Tbx5, partly by permitting binding of Gata4 to cardiac genes, indicating a novel instructive role for BAF complexes in tissues-specific regulation. The combined function of these factors establishes a robust mechanism for controlling cellular differentiation, and may allow reprogramming of new cardiomyocytes for regenerative purposes.	[Takeuchi, Jun K.; Bruneau, Benoit G.] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Takeuchi, Jun K.] Tokyo Inst Technol, Global Edge Inst, Div Cardiovasc Res, Midori Ku, Kanagawa 2268503, Japan; [Bruneau, Benoit G.] Univ Calif San Francisco, Dept Pediat, Cardiovasc Res Inst, San Francisco, CA 94158 USA; [Bruneau, Benoit G.] Univ Calif San Francisco, Inst Regenerat Med, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; Tokyo Institute of Technology; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Bruneau, BG (corresponding author), Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA.	takeuchi.j.ab@m.titech.ac.jp; bbruneau@gladstone.ucsf.edu		Bruneau, Benoit/0000-0002-0804-7597	Human Frontiers Science Program CDA; MEXT's program for young independent researchers; Mitsubishi Foundation; Takeda Science Foundation; NHLBI [R01HL085860]; NIH/NCRR [C06 RR018928]; William H. Younger, Jr; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085860] Funding Source: NIH RePORTER	Human Frontiers Science Program CDA(Human Frontier Science Program); MEXT's program for young independent researchers; Mitsubishi Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); William H. Younger, Jr; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank K. Koshiba-Takeuchi for assistance with immunohistochemistry, H. Ogawa for advice on chromatin immunoprecipitation, B. L. Black and D. Srivastava for discussions and expression constructs, G. R. Crabtree, M. Nemer, E. N. Olson and Y. Saga for expression constructs, and G. Howard and S. Ordway for editorial assistance. This work was supported by Human Frontiers Science Program CDA and short-term fellowships (J. K. T.), MEXT's program for young independent researchers ( J. K. T.), Mitsubishi Foundation (J. K. T.), the Takeda Science Foundation ( J. K. T.) and NHLBI (R01HL085860, B. G. B.). This work was also supported by an NIH/NCRR grant (C06 RR018928, J. David Gladstone Institutes) and by William H. Younger, Jr ( B. G. B.).	Black JC, 2006, MOL CELL, V23, P809, DOI 10.1016/j.molcel.2006.07.018; Bondue A, 2008, CELL STEM CELL, V3, P69, DOI 10.1016/j.stem.2008.06.009; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Creemers EE, 2006, MOL CELL, V23, P83, DOI 10.1016/j.molcel.2006.05.026; David R, 2008, NAT CELL BIOL, V10, P338, DOI 10.1038/ncb1696; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Kinder SJ, 1999, DEVELOPMENT, V126, P4691; Lange M, 2008, GENE DEV, V22, P2370, DOI 10.1101/gad.471408; Latinkic BV, 2003, DEVELOPMENT, V130, P3865, DOI 10.1242/dev.00599; Laugwitz KL, 2008, DEVELOPMENT, V135, P193, DOI 10.1242/dev.001883; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; Lickert H, 2004, NATURE, V432, P107, DOI 10.1038/nature03071; Lindsley RC, 2008, CELL STEM CELL, V3, P55, DOI 10.1016/j.stem.2008.04.004; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Marvin MJ, 2001, GENE DEV, V15, P316, DOI 10.1101/gad.855501; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; Reiter JF, 1999, GENE DEV, V13, P2983, DOI 10.1101/gad.13.22.2983; Saga Y, 1999, DEVELOPMENT, V126, P3437; Schultheiss TM, 1997, GENE DEV, V11, P451, DOI 10.1101/gad.11.4.451; Simone C, 2004, NAT GENET, V36, P738, DOI 10.1038/ng1378; Small EM, 2005, DEVELOPMENT, V132, P987, DOI 10.1242/dev.01684; Srivastava D, 2006, CELL, V126, P1037, DOI 10.1016/j.cell.2006.09.003; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Wu JI, 2009, CELL, V136, P200, DOI 10.1016/j.cell.2009.01.009; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Yamamoto M, 2004, NATURE, V428, P387, DOI 10.1038/nature02418; Zhao R, 2008, DEV BIOL, V317, P614, DOI 10.1016/j.ydbio.2008.03.013; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	30	388	416	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 4	2009	459	7247					708	U112		10.1038/nature08039	http://dx.doi.org/10.1038/nature08039			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453KF	19396158	Green Accepted			2022-12-01	WOS:000266608600045
J	Spencer, SL; Gaudet, S; Albeck, JG; Burke, JM; Sorger, PK				Spencer, Sabrina L.; Gaudet, Suzanne; Albeck, John G.; Burke, John M.; Sorger, Peter K.			Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosis	NATURE			English	Article							TUMOR-CELL; PROTEIN; ACTIVATION; NOISE; ROBUSTNESS; EXPRESSION; FAMILY; KILL	In microorganisms, noise in gene expression gives rise to cell-to-cell variability in protein concentrations(1-7). In mammalian cells, protein levels also vary(8-10) and individual cells differ widely in their responsiveness to uniform physiological stimuli(11-15). In the case of apoptosis mediated by TRAIL (tumour necrosis factor (TNF)related apoptosis-inducing ligand) it is common for some cells in a clonal population to die while others survive-a striking divergence in cell fate. Among cells that die, the time between TRAIL exposure and caspase activation is highly variable. Here we image sister cells expressing reporters of caspase activation and mitochondrial outer membrane permeabilization after exposure to TRAIL. We show that naturally occurring differences in the levels or states of proteins regulating receptor-mediated apoptosis are the primary causes of cell-to-cell variability in the timing and probability of death in human cell lines. Protein state is transmitted from mother to daughter, giving rise to transient heritability in fate, but protein synthesis promotes rapid divergence so that sister cells soon become no more similar to each other than pairs of cells chosen at random. Our results have implications for understanding 'fractional killing' of tumour cells after exposure to chemotherapy, and for variability in mammalian signal transduction in general.	[Spencer, Sabrina L.; Gaudet, Suzanne; Albeck, John G.; Burke, John M.; Sorger, Peter K.] Harvard Univ, Sch Med, Dept Syst Biol, Ctr Cell Decis Proc, Boston, MA 02115 USA; [Spencer, Sabrina L.] MIT, Cambridge, MA 02139 USA	Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Sorger, PK (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Ctr Cell Decis Proc, Boston, MA 02115 USA.	peter_sorger@hms.harvard.edu		Altan-Bonnet, Gregoire/0000-0002-7283-3162; Sorger, Peter/0000-0002-3364-1838; SPENCER, SABRINA/0000-0002-5798-3007; Gaudet, Suzanne/0000-0002-5701-2825	National Institute of Health [GM68762, CA112967]; NATIONAL CANCER INSTITUTE [U54CA112967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068762] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Flusberg, S. Govind, L. Kleiman, A. Letai, B. Millard, R. Milo, T. Norman, J. Paulsson and R. Ward for their help. This work was supported by National Institute of Health (NIH grants) GM68762 and CA112967.	Albeck JG, 2008, MOL CELL, V30, P11, DOI 10.1016/j.molcel.2008.02.012; Albeck JG, 2008, PLOS BIOL, V6, P2831, DOI 10.1371/journal.pbio.0060299; Ashkenazi A, 2008, J CLIN INVEST, V118, P1979, DOI 10.1172/JCI34359; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; BERENBAUM MC, 1972, CANCER CHEMOTH REP 1, V56, P563; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Boatright KM, 2004, BIOCHEM J, V382, P651, DOI 10.1042/BJ20040809; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Chaudhary PM, 1997, IMMUNITY, V7, P821, DOI 10.1016/S1074-7613(00)80400-8; Cohen AA, 2008, SCIENCE, V322, P1511, DOI 10.1126/science.1160165; Colman-Lerner A, 2005, NATURE, V437, P699, DOI 10.1038/nature03998; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Feinerman O, 2008, SCIENCE, V321, P1081, DOI 10.1126/science.1158013; Fuentes-Prior P, 2004, BIOCHEM J, V384, P201, DOI 10.1042/BJ20041142; Geva-Zatorsky N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100068; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Goldstein JC, 2000, ANN NY ACAD SCI, V926, P132; Kaufmann BB, 2007, PLOS BIOL, V5, P1973, DOI 10.1371/journal.pbio.0050239; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Rando OJ, 2007, CELL, V128, P655, DOI 10.1016/j.cell.2007.01.023; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; Wagner KW, 2007, NAT MED, V13, P1070, DOI 10.1038/nm1627; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	29	695	711	0	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2009	459	7245					428	U144		10.1038/nature08012	http://dx.doi.org/10.1038/nature08012			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448DQ	19363473	Green Accepted			2022-12-01	WOS:000266243700046
J	Kuo, WJ; Sjostrom, T; Chen, YP; Wang, YH; Huang, CY				Kuo, Wen-Jui; Sjoestroem, Tomas; Chen, Yu-Ping; Wang, Yen-Hsiang; Huang, Chen-Ying			Intuition and Deliberation: Two Systems for Strategizing in the Brain	SCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; WORKING-MEMORY; FUNCTIONAL NEUROANATOMY; CORTICAL NETWORK; NEURAL BASIS; SALIENCE; PRECUNEUS; RESPONSES; FEEL; FMRI	Dual-process theories distinguish between intuition (fast and emotional) and reasoning (slow and controlled) as a basis for human decision-making. We contrast dominance-solvable games, which can be solved by step-by-step deliberative reasoning, with pure coordination games, which must be solved intuitively. Using functional magnetic resonance imaging, we found that the middle frontal gyrus, the inferior parietal lobule, and the precuneus were more active in dominance-solvable games than in coordination games. The insula and anterior cingulate cortex showed the opposite pattern. Moreover, precuneus activity correlates positively with how "effortful" a dominance-solvable game is, whereas insula activity correlates positively with how "effortless" a coordination game is.	[Chen, Yu-Ping; Huang, Chen-Ying] Natl Taiwan Univ, Dept Econ, Taipei 10764, Taiwan; [Kuo, Wen-Jui] Natl Yang Ming Univ, Inst Neurosci, Taipei 112, Taiwan; [Sjoestroem, Tomas] Rutgers State Univ, Dept Econ, New Brunswick, NJ 08901 USA; [Wang, Yen-Hsiang] Natl Taiwan Univ, Dept Elect Engn, Taipei 10764, Taiwan	National Taiwan University; National Yang Ming Chiao Tung University; Rutgers State University New Brunswick; National Taiwan University	Huang, CY (corresponding author), Natl Taiwan Univ, Dept Econ, Taipei 10764, Taiwan.	chenying@ntu.edu.tw	Huang, Chen-Ying/M-1704-2018; Sjostrom, Tomas/AAB-9239-2020	Huang, Chen-Ying/0000-0003-2897-642X; Sjostrom, Tomas/0000-0003-2835-0953	National Science Council of Taiwan [NSC 94-2415-H-002-004]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	We thank M. Hsu for helpful comments on the manuscript and J.-Y. Leu, J.T.-Y. Wang, D. Niddam, and participants at many seminars for discussions. Technical assistance from C.-R. Chou, C.-T. Chen, C.-H. Lan, S.-C. Lin, K.-L. Chen, Y.-Y. Chung, W.-Y. Lin, S. Hsu, R. Chen, and the National Taiwan University Hospital MRI Laboratory is greatly appreciated. This work was supported by the National Science Council of Taiwan (grant NSC 94-2415-H-002-004).	Atherton M, 2003, COGNITIVE BRAIN RES, V16, P26, DOI 10.1016/S0926-6410(02)00207-0; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; BARDSLEY N, 2008, 200817 CTR DEC RES E; Bartels A, 2000, NEUROREPORT, V11, P3829, DOI 10.1097/00001756-200011270-00046; Berryhill ME, 2008, NEUROPSYCHOLOGIA, V46, P1775, DOI 10.1016/j.neuropsychologia.2008.03.005; Bhatt M, 2005, GAME ECON BEHAV, V52, P424, DOI 10.1016/j.geb.2005.03.007; Blood AJ, 2001, P NATL ACAD SCI USA, V98, P11818, DOI 10.1073/pnas.191355898; CAMERER C, 2003, BEHAV GAME THEORY EX, pCH5; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; D'Esposito M, 2007, PHILOS T R SOC B, V362, P761, DOI 10.1098/rstb.2007.2086; Davis KD, 2005, J NEUROSCI, V25, P8402, DOI 10.1523/JNEUROSCI.2315-05.2005; Downar J, 2002, J NEUROPHYSIOL, V87, P615, DOI 10.1152/jn.00636.2001; Downar J, 2000, NAT NEUROSCI, V3, P277, DOI 10.1038/72991; Fincham JM, 2002, P NATL ACAD SCI USA, V99, P3346, DOI 10.1073/pnas.052703399; Gallagher HL, 2002, NEUROIMAGE, V16, P814, DOI 10.1006/nimg.2002.1117; Goel V, 2001, NEUROPSYCHOLOGIA, V39, P901, DOI 10.1016/S0028-3932(01)00024-0; Jung RE, 2007, BEHAV BRAIN SCI, V30, P135, DOI 10.1017/S0140525X07001185; Kahneman D, 2003, AM PSYCHOL, V58, P697, DOI 10.1037/0003-066X.58.9.697; KYLLONEN PC, 1990, INTELLIGENCE, V14, P389, DOI 10.1016/S0160-2896(05)80012-1; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; MEHTA J, 1994, AM ECON REV, V84, P658; Mendres KA, 2000, ANIM BEHAV, V60, P523, DOI 10.1006/anbe.2000.1512; Muller NG, 2006, NEUROSCIENCE, V139, P51, DOI 10.1016/j.neuroscience.2005.09.018; Newman SD, 2003, NEUROPSYCHOLOGIA, V41, P1668, DOI 10.1016/S0028-3932(03)00091-5; Noveck IA, 2004, CORTEX, V40, P613, DOI 10.1016/S0010-9452(08)70157-6; Rubinstein A, 2007, ECON J, V117, P1243, DOI 10.1111/j.1468-0297.2007.02081.x; Schaeffer J, 2007, SCIENCE, V317, P1518, DOI 10.1126/science.1144079; Schelling T.C., 1958, J CONFLICT RESOLUT, V2, P203, DOI [10.1177/002200275800200301, DOI 10.1177/002200275800200301]; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Smith EE, 1998, P NATL ACAD SCI USA, V95, P12061, DOI 10.1073/pnas.95.20.12061; Stanovich KE, 2000, BEHAV BRAIN SCI, V23, P645, DOI 10.1017/S0140525X00003435; Taylor KS, 2009, HUM BRAIN MAPP, V30, P2731, DOI 10.1002/hbm.20705; Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255; Wallentin M, 2008, HUM BRAIN MAPP, V29, P524, DOI 10.1002/hbm.20413; Wallentin M, 2006, NEUROIMAGE, V32, P1850, DOI 10.1016/j.neuroimage.2006.05.002; Winston JS, 2002, NAT NEUROSCI, V5, P277, DOI 10.1038/nn816; Woodward J, 2007, J PHYSIOL-PARIS, V101, P179, DOI 10.1016/j.jphysparis.2007.12.003	41	78	82	5	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 24	2009	324	5926					519	522		10.1126/science.1165598	http://dx.doi.org/10.1126/science.1165598			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	436JU	19390048	Green Submitted			2022-12-01	WOS:000265411200049
J	Brewer, PG; Peltzer, ET				Brewer, Peter G.; Peltzer, Edward T.			Limits to Marine Life	SCIENCE			English	Editorial Material							OCEAN ACIDIFICATION; CONSEQUENCES		[Brewer, Peter G.; Peltzer, Edward T.] Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA	Monterey Bay Aquarium Research Institute	Brewer, PG (corresponding author), Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA.	brpe@mbari.org		Brewer, Peter/0000-0002-5448-0199; Peltzer, Edward/0000-0003-2821-3553				Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Gattuso JP, 1998, GLOBAL PLANET CHANGE, V18, P37, DOI 10.1016/S0921-8181(98)00035-6; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; REDFIELD AC, 1963, SEA, V2; Rue EL, 1997, DEEP-SEA RES PT I, V44, P113, DOI 10.1016/S0967-0637(96)00088-X; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; SABINE CL, 2005, ORNLCDIAC145 US DOE; Stramma L, 2008, SCIENCE, V320, P655, DOI 10.1126/science.1153847	10	133	136	3	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2009	324	5925					347	348		10.1126/science.1170756	http://dx.doi.org/10.1126/science.1170756			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433QT	19372421				2022-12-01	WOS:000265221600030
J	Heiman, MG; Shaham, S				Heiman, Maxwell G.; Shaham, Shai			DEX-1 and DYF-7 Establish Sensory Dendrite Length by Anchoring Dendritic Tips during Cell Migration	CELL			English	Article							NERVOUS-SYSTEM; C-ELEGANS; BASEMENT-MEMBRANE; ZONA-PELLUCIDA; EXPRESSION; PROTEIN; MECHANISMS; DOMAIN; MOUSE; GENE	Cells are devices whose structures delimit function. For example, in the nervous system, neuronal and glial shapes dictate paths of information flow. To understand how cells acquire their shapes, we examined the formation of a sense organ in C. elegans. Using time-lapse imaging, we found that sensory dendrites form by stationary anchoring of dendritic tips during cell-body migration. Agenetic screen identified DEX-1 and DYF-7, extracellular proteins required for dendritic tip anchoring, which act cooperatively at the time and place of anchoring. DEX-1 and DYF-7 contain, respectively, zonadhesin and zona pellucida domains, and DYF-7 self-associates into multimers important for anchoring. Thus, unlike other dendrites, amphid dendritic tips are positioned by DEX-1 and DYF-7 without the need for long-range guidance cues. In sequence and function, DEX-1 and DYF-7 resemble tectorins, which anchor stereocilia in the inner ear, suggesting that a sensory dendrite anchor may have evolved into part of a mechanosensor.	[Heiman, Maxwell G.; Shaham, Shai] Rockefeller Univ, New York, NY 10065 USA	Rockefeller University	Shaham, S (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10065 USA.	shaham@rockefeller.edu		Heiman, Maxwell/0000-0002-2557-6490	NIH [1R01NS064273]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064273] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Yun Lu for preparing the electron micrograph in Figure S1B; Valeri Thomson, the Rockefeller University Bio- Imaging Resource Center, and members of Ulrike Gaul's laboratory for technical help; Cori Bargmann, Alison North, and members of the Shaham laboratory for comments on the manuscript; and Myriam Heiman. M. G. H. was a fellow of the Jane Coffin Childs Memorial Fund for Medical Research. S. S. is a Klingenstein Fellow in the Neurosciences and a Monique Weill-Caulier Scholar. This work was supported in part by a grant from the Patterson Trust and by NIH grant 1R01NS064273 to S. S.	ALTMAN J, 1990, EXP NEUROL, V107, P23, DOI 10.1016/0014-4886(90)90060-6; Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Bargmann C.I., 2006, WORMBOOK, P1, DOI [10.1895/wormbook.1.123.1, DOI 10.1895/WORMBOOK.1.123.1]; Benard CY, 2006, DEVELOPMENT, V133, P3329, DOI 10.1242/dev.02507; Bi M, 2003, BIOCHEM J, V375, P477, DOI 10.1042/BJ20030753; BRENNER S, 1974, GENETICS, V77, P71; Chen H, 1996, J STRUCT BIOL, V116, P56, DOI 10.1006/jsbi.1996.0010; Chung YD, 2001, NEURON, V29, P415, DOI 10.1016/S0896-6273(01)00215-X; Di Schiavi E, 2005, EUR J NEUROSCI, V21, P3291, DOI 10.1111/j.1460-9568.2005.04164.x; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Gao FB, 2007, CURR OPIN NEUROBIOL, V17, P525, DOI 10.1016/j.conb.2007.08.004; Gilmour D, 2004, NAT NEUROSCI, V7, P491, DOI 10.1038/nn1235; Halfter W, 2002, J NEUROSCI, V22, P6029; Hao JC, 2001, NEURON, V32, P25, DOI 10.1016/S0896-6273(01)00448-2; HARDY DM, 1995, J BIOL CHEM, V270, P26025, DOI 10.1074/jbc.270.44.26025; Haubst N, 2006, DEVELOPMENT, V133, P3245, DOI 10.1242/dev.02486; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Jovine L, 2005, ANNU REV BIOCHEM, V74, P83, DOI 10.1146/annurev.biochem.74.082803.133039; Jovine Luca, 2006, BMC Biochem, V7, P11, DOI 10.1186/1471-2091-7-11; Kerjan G, 2005, NAT NEUROSCI, V8, P1516, DOI 10.1038/nn1555; Kim S, 2000, SCIENCE, V288, P150, DOI 10.1126/science.288.5463.150; Landmann F, 2004, DEV BIOL, V265, P478, DOI 10.1016/j.ydbio.2003.09.009; Legan PK, 1997, J BIOL CHEM, V272, P8791, DOI 10.1074/jbc.272.13.8791; LI XJ, 1995, J BIOL CHEM, V270, P17674, DOI 10.1074/jbc.270.30.17674; MANGO SE, 1994, DEVELOPMENT, V120, P3019; Matsushita F, 2000, BIOCHEM BIOPH RES CO, V268, P275, DOI 10.1006/bbrc.2000.2104; Monne M, 2008, NATURE, V456, P653, DOI 10.1038/nature07599; Nguyen CQ, 1999, DEV BIOL, V207, P86, DOI 10.1006/dbio.1998.9173; Noctor SC, 2002, J NEUROSCI, V22, P3161, DOI 10.1523/JNEUROSCI.22-08-03161.2002; Paley W., 1803, NATURAL THEOLOGY EVI; Parrish JZ, 2007, ANNU REV NEUROSCI, V30, P399, DOI 10.1146/annurev.neuro.29.051605.112907; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; Petit C, 2001, ANNU REV GENET, V35, P589, DOI 10.1146/annurev.genet.35.102401.091224; Renaud J, 2008, NAT NEUROSCI, V11, P440, DOI 10.1038/nn2064; Russell IJ, 2007, NAT NEUROSCI, V10, P215, DOI 10.1038/nn1828; Shaham S, 2006, CURR OPIN NEUROBIOL, V16, P522, DOI 10.1016/j.conb.2006.08.001; Solecki DJ, 2006, GENE DEV, V20, P2639, DOI 10.1101/gad.1462506; Solecki DJ, 2004, NAT NEUROSCI, V7, P1195, DOI 10.1038/nn1332; STARICH TA, 1995, GENETICS, V139, P171; Stiernagle Theresa, 2006, WormBook, P1; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Troemel ER, 1999, CELL, V99, P387, DOI 10.1016/S0092-8674(00)81525-1; Verhoeven K, 1998, NAT GENET, V19, P60, DOI 10.1038/ng0598-60; WARD S, 1975, J COMP NEUROL, V160, P313, DOI 10.1002/cne.901600305; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; WHITE JG, 1976, PHILOS T R SOC B, V275, P327, DOI 10.1098/rstb.1976.0086; Williams DW, 2004, J NEUROSCI, V24, P1541, DOI 10.1523/JNEUROSCI.4521-03.2004; Wu GY, 2003, J COMP NEUROL, V459, P392, DOI 10.1002/cne.10618; Yaron A, 2007, DEV NEUROBIOL, V67, P1216, DOI 10.1002/dneu.20512; Yu RYL, 2000, EMBO J, V19, P3542, DOI 10.1093/emboj/19.14.3542; Zallen JA, 1999, DEVELOPMENT, V126, P3679	51	112	117	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 17	2009	137	2					344	355		10.1016/j.cell.2009.01.057	http://dx.doi.org/10.1016/j.cell.2009.01.057			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	437AB	19344940	Green Accepted, Bronze			2022-12-01	WOS:000265456800026
J	Pantilat, SZ				Pantilat, Steven Z.			Communicating With Seriously Ill Patients Better Words to Say	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE; END; SKILLS		Univ Calif San Francisco, Dept Med, Div Hosp Med, Palliat Care Program, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Pantilat, SZ (corresponding author), Univ Calif San Francisco, Dept Med, Div Hosp Med, Palliat Care Program, Box 0903,521 Parnassus Ave,Ste C-126, San Francisco, CA 94143 USA.	stevep@medicine.ucsf.edu						Apa Pesidential Task Force, 2006, AM PSYCHOL, V61, P271, DOI 10.1037/0003-066X.61.4.271; Block S D, 1998, J Palliat Med, V1, P347, DOI 10.1089/jpm.1998.1.347; Jackson VA, 2008, J PALLIAT MED, V11, P893, DOI 10.1089/jpm.2007.2480; Lautrette A, 2007, NEW ENGL J MED, V356, P469, DOI 10.1056/NEJMoa063446; Lienard A, 2006, ANN ONCOL, V17, P1450, DOI 10.1093/annonc/mdl142; Lo B, 2005, JAMA-J AM MED ASSOC, V294, P1810, DOI 10.1001/jama.294.14.1810; Meisel A, 2000, JAMA-J AM MED ASSOC, V284, P2495, DOI 10.1001/jama.284.19.2495; QUILL TE, 1995, ANN INTERN MED, V122, P368, DOI 10.7326/0003-4819-122-5-199503010-00008; Quill TE, 2001, ANN INTERN MED, V135, P551, DOI 10.7326/0003-4819-135-7-200110020-00022; Saba GW, 2006, ANN FAM MED, V4, P54, DOI 10.1370/afm.393; Schofield PE, 2003, ANN ONCOL, V14, P48, DOI 10.1093/annonc/mdg010; Selph RB, 2008, J GEN INTERN MED, V23, P1311, DOI 10.1007/s11606-008-0643-8; Stapleton RD, 2006, CRIT CARE MED, V34, P1679, DOI 10.1097/01.CCM.0000218409.58256.AA; Tulsky JA, 2005, JAMA-J AM MED ASSOC, V294, P359, DOI 10.1001/jama.294.3.359	14	33	33	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 25	2009	301	12					1279	1281		10.1001/jama.2009.396	http://dx.doi.org/10.1001/jama.2009.396			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	423JO	19318656				2022-12-01	WOS:000264492800029
J	Liti, G; Carter, DM; Moses, AM; Warringer, J; Parts, L; James, SA; Davey, RP; Roberts, IN; Burt, A; Koufopanou, V; Tsai, IJ; Bergman, CM; Bensasson, D; O'Kelly, MJT; van Oudenaarden, A; Barton, DBH; Bailes, E; Ba, ANN; Jones, M; Quail, MA; Goodhead, I; Sims, S; Smith, F; Blomberg, A; Durbin, R; Louis, EJ				Liti, Gianni; Carter, David M.; Moses, Alan M.; Warringer, Jonas; Parts, Leopold; James, Stephen A.; Davey, Robert P.; Roberts, Ian N.; Burt, Austin; Koufopanou, Vassiliki; Tsai, Isheng J.; Bergman, Casey M.; Bensasson, Douda; O'Kelly, Michael J. T.; van Oudenaarden, Alexander; Barton, David B. H.; Bailes, Elizabeth; Ba, Alex N. Nguyen; Jones, Matthew; Quail, Michael A.; Goodhead, Ian; Sims, Sarah; Smith, Frances; Blomberg, Anders; Durbin, Richard; Louis, Edward J.			Population genomics of domestic and wild yeasts	NATURE			English	Article							SENSU-STRICTO COMPLEX; SACCHAROMYCES-CEREVISIAE; DIVERSITY; EVOLUTION; PARADOXUS; KUDRIAVZEVII; GENES; LIFE; WINE	Since the completion of the genome sequence of Saccharomyces cerevisiae in 1996 (refs 1, 2), there has been a large increase in complete genome sequences, accompanied by great advances in our understanding of genome evolution. Although little is known about the natural and life histories of yeasts in the wild, there are an increasing number of studies looking at ecological and geographic distributions(3,4), population structure(5-8) and sexual versus asexual reproduction(9,10). Less well understood at the whole genome level are the evolutionary processes acting within populations and species that lead to adaptation to different environments, phenotypic differences and reproductive isolation. Here we present one- to fourfold or more coverage of the genome sequences of over seventy isolates of the baker's yeast S. cerevisiae and its closest relative, Saccharomyces paradoxus. We examine variation in gene content, single nucleotide polymorphisms, nucleotide insertions and deletions, copy numbers and transposable elements. We find that phenotypic variation broadly correlates with global genome-wide phylogenetic relationships. S. paradoxus populations are well delineated along geographic boundaries, whereas the variation among worldwide S. cerevisiae isolates shows less differentiation and is comparable to a single S. paradoxus population. Rather than one or two domestication events leading to the extant baker's yeasts, the population structure of S. cerevisiae consists of a few well-defined, geographically isolated lineages and many different mosaics of these lineages, supporting the idea that human influence provided the opportunity for cross-breeding and production of new combinations of pre-existing variations.	[Carter, David M.; Moses, Alan M.; Parts, Leopold; Jones, Matthew; Quail, Michael A.; Goodhead, Ian; Sims, Sarah; Smith, Frances; Durbin, Richard] Wellcome Trust Sanger Inst, Cambridge CB10 1HH, England; [Liti, Gianni; Barton, David B. H.; Bailes, Elizabeth; Louis, Edward J.] Univ Nottingham, Queens Med Ctr, Inst Genet, Nottingham NG7 2UH, England; [Moses, Alan M.; Ba, Alex N. Nguyen] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON M5S 2J4, Canada; [Warringer, Jonas; Blomberg, Anders] Univ Gothenburg, Lundberg Lab, Dept Cell & Mol Biol, S-41390 Gothenburg, Sweden; [James, Stephen A.; Davey, Robert P.; Roberts, Ian N.] Inst Food Res, Inst Food Res, Natl Collect Yeast Cultures, Norwich NR4 7UA, Norfolk, England; [Burt, Austin; Koufopanou, Vassiliki; Tsai, Isheng J.] Univ London Imperial Coll Sci Technol & Med, Div Biol, Ascot SL5 7PY, Berks, England; [Bergman, Casey M.; Bensasson, Douda] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [O'Kelly, Michael J. T.; van Oudenaarden, Alexander] MIT, Dept Phys, Cambridge, MA 02139 USA	Wellcome Trust Sanger Institute; University of Nottingham; University of Toronto; University of Gothenburg; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia; Imperial College London; University of Manchester; Massachusetts Institute of Technology (MIT)	Durbin, R (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1HH, England.	rd@sanger.ac.uk; ed.louis@nottingham.ac.uk	Tsai, Isheng Jason/ABB-8273-2021; van Oudenaarden, Alexander/AAA-1705-2019; Quail, michael/ABE-6131-2020; Roberts, Ian N/B-9743-2008; Liti, Gianni/I-9929-2014; Bergman, Casey/F-7854-2010; Durbin, Richard/AAE-7178-2019; Warringer, Jonas/B-8520-2013; Goodhead, Ian/ABC-9200-2020; Louis, Edward/B-7920-2008; Tsai, Isheng J/H-6606-2014	Tsai, Isheng Jason/0000-0002-2123-5058; Bergman, Casey/0000-0002-5462-9854; Durbin, Richard/0000-0002-9130-1006; Warringer, Jonas/0000-0001-6144-2740; Louis, Edward/0000-0003-1157-3608; Bensasson, Douda/0000-0002-9015-2707; Davey, Robert/0000-0002-5589-7754; Blomberg, Anders/0000-0002-1260-3920; Parts, Leopold/0000-0002-2618-670X; Goodhead, Ian/0000-0002-3110-9442; Burt, Austin/0000-0001-5146-9640; Liti, Gianni/0000-0002-2318-0775	The Wellcome Trust; Royal Society and the Biotechnology and Biological Sciences Research Council (BBSRC); BBSRC; Swedish Research Council; Swedish Foundation for Strategic Research; National Environment Research Council (NERC); Wellcome Trust; NERC; Canada Foundation for Innovation; National Science Foundation; National Institutes of Health; Hertz fellowship; Biotechnology and Biological Sciences Research Council [BBS/E/F/00042258, BB/F015216/1] Funding Source: researchfish; Natural Environment Research Council [NE/D008824/1] Funding Source: researchfish; BBSRC [BB/F015216/1] Funding Source: UKRI; NERC [NE/D008824/1] Funding Source: UKRI	The Wellcome Trust(Wellcome TrustEuropean Commission); Royal Society and the Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); National Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Wellcome Trust(Wellcome TrustEuropean Commission); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hertz fellowship; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank all the members of the Sanger sequencing production teams for generating the sequence data. We thank members of the Durbin and Louis laboratories and C. Nieduszynski for comments and suggestions, L. Kruglyak and J. Schacherer for sharing their unpublished manuscript and R. Ames and S. Lovell for sharing unpublished results. We also thank the British Council and Chinese Academy of Sciences for providing the opportunity to design and develop this project. Research at the Wellcome Trust Sanger Institute ( D. M. C., A. M. M., L. P, M. J., M. A. Q., I. G., S. S., F. S. and R. D.) is supported by The Wellcome Trust. G. L., D. B. H. B., E. B. and E. J. L. were supported by the Wellcome Trust, the Royal Society and the Biotechnology and Biological Sciences Research Council ( BBSRC). S. A. J., R. P. D. and I. N. R. were supported by the BBSRC. A. B. and J. W. were supported by the Swedish Research Council and the Swedish Foundation for Strategic Research. A. B. and V. K. were supported by the National Environment Research Council (NERC) and I. J. T. was supported by the Wellcome Trust. D. B. was supported by NERC. A. M. M. was supported by the Canada Foundation for Innovation. M. J. T. O. and A. v. O. were supported by the National Science Foundation, the National Institutes of Health and a Hertz fellowship.	Aa E, 2006, FEMS YEAST RES, V6, P702, DOI 10.1111/j.1567-1364.2006.00059.x; BULMER M, 1991, GENETICS, V129, P897; CARTER DM, 2005, SACCHAROMYCES GENOME; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Demogines A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000103; Diamond J, 2002, NATURE, V418, P700, DOI 10.1038/nature01019; Fay JC, 2005, PLOS GENET, V1, P66, DOI 10.1371/journal.pgen.0010005; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Koufopanou V, 2006, PHILOS T R SOC B, V361, P1941, DOI 10.1098/rstb.2006.1922; Kuehne HA, 2007, CURR BIOL, V17, P407, DOI 10.1016/j.cub.2006.12.047; Legras JL, 2007, MOL ECOL, V16, P2091, DOI 10.1111/j.1365-294X.2007.03266.x; Liti G, 2005, YEAST, V22, P177, DOI 10.1002/yea.1200; Liti G, 2006, GENETICS, V174, P839, DOI 10.1534/genetics.106.062166; Mancera E, 2008, NATURE, V454, P479, DOI 10.1038/nature07135; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Mewes HW, 1997, NATURE, V387, P7, DOI 10.1038/387s007; Naumov GI, 2000, INT J SYST EVOL MICR, V50, P1931, DOI 10.1099/00207713-50-5-1931; Pretorius IS, 2000, YEAST, V16, P675, DOI 10.1002/1097-0061(20000615)16:8<675::AID-YEA585>3.0.CO;2-B; Pritchard JK, 2000, GENETICS, V155, P945; Ruderfer DM, 2006, NAT GENET, V38, P1077, DOI 10.1038/ng1859; Sampaio JP, 2008, APPL ENVIRON MICROB, V74, P2144, DOI 10.1128/AEM.02396-07; Siva Nayanah, 2008, Nat Biotechnol, V26, P256, DOI 10.1038/nbt0308-256b; Sniegowski Paul D., 2002, FEMS Yeast Research, V1, P299, DOI 10.1016/S1567-1356(01)00043-5; TAJIMA F, 1989, GENETICS, V123, P585; Tsai IJ, 2008, P NATL ACAD SCI USA, V105, P4957, DOI 10.1073/pnas.0707314105; Warringer J, 2003, YEAST, V20, P53, DOI 10.1002/yea.931; Wei W, 2007, P NATL ACAD SCI USA, V104, P12825, DOI 10.1073/pnas.0701291104; Wiens F, 2008, P NATL ACAD SCI USA, V105, P10426, DOI 10.1073/pnas.0801628105	29	1026	1041	4	246	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 19	2009	458	7236					337	341		10.1038/nature07743	http://dx.doi.org/10.1038/nature07743			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420JH	19212322	Green Submitted, Green Accepted			2022-12-01	WOS:000264285600041
J	Hammell, CM; Lubin, I; Boag, PR; Blackwell, TK; Ambros, V				Hammell, Christopher M.; Lubin, Isabella; Boag, Peter R.; Blackwell, T. Keith; Ambros, Victor			nhl-2 Modulates MicroRNA Activity in Caenorhabditis elegans	CELL			English	Article							MEDIATED TRANSLATIONAL REPRESSION; PHYSIOLOGICAL GERMLINE APOPTOSIS; C-ELEGANS; RING FINGER; P-BODIES; RNA; GW182; PROTEIN; COMPLEX; DEADENYLASE	TRIM-NHL proteins represent a large class of metazoan proteins implicated in development and disease. We demonstrate that a C. elegans TRIM-NHL protein, NHL-2, functions as a cofactor for the microRNA-induced silencing complex (miRISC) and thereby enhances the posttranscriptional repression of several genetically verified microRNA targets, including hbl-1 and let-60/Ras (by the let-7 family of microRNAs) and cog-1 (by the lsy-6 microRNA). NHL-2 is localized to cytoplasmic P-bodies and physically associates with the P-body protein CGH-1 and the core miRISC components ALG-1/2 and AIN-1. nhl-2 and cgh-1 mutations compromise the repression of microRNA targets in vivo but do not affect microRNA biogenesis, indicating a role for an NHL-2: CGH-1 complex in the effector phase of miRISC activity. We propose that the NHL-2: CGH-1 complex functions in association with mature miRISC to modulate the efficacy of microRNA: target interactions in response to physiological and developmental signals, thereby ensuring the robustness of genetic regulatory pathways regulated by microRNAs.	[Hammell, Christopher M.; Lubin, Isabella; Ambros, Victor] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Boag, Peter R.; Blackwell, T. Keith] Harvard Univ, Sch Med, Harvard Stem Cell Inst, Dept Pathol,Joslin Diabet Ctr, Boston, MA 02215 USA	University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.	Ambros, V (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA.	victor.ambros@umassmed.edu		Boag, Peter/0000-0002-0889-0859; Hammell, Christopher/0000-0002-5961-0976	NIH [F32 GM69186]; National Institutes of Health [GM30428, GM63826]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030428, F32GM069186, R01GM063826, R01GM034028] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Thanks to members of the Ambros laboratory and M. Hammell for thoughtful critiques of the data and the manuscript. We thank C. Mello and M. Han for antisera and worm strains and the Caenorhabditis Genetics Center for worm strains. C. M. H. was supported by an NIH postdoctoral fellowship (F32 GM69186). P. R. B. was supported by a fellowship from the M. R. Reinhard Family Foundation. V. A. and T. K. B. were supported by grants from the National Institutes of Health (GM30428 and GM63826, respectively).	Abbott AL, 2005, DEV CELL, V9, P403, DOI 10.1016/j.devcel.2005.07.009; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; BEITEL GJ, 1990, NATURE, V348, P503, DOI 10.1038/348503a0; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Boag PR, 2008, J CELL BIOL, V182, P543, DOI 10.1083/jcb.200801183; Boag PR, 2005, DEVELOPMENT, V132, P4975, DOI 10.1242/dev.02060; BRENNER S, 1974, GENETICS, V77, P71; Chu CY, 2006, PLOS BIOL, V4, P1122, DOI 10.1371/journal.pbio.0040210; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; Coller JM, 2001, RNA, V7, P1717, DOI 10.1017/S135583820101994X; Ding L, 2005, MOL CELL, V19, P437, DOI 10.1016/j.molcel.2005.07.013; Eulalio A, 2008, NAT STRUCT MOL BIOL, V15, P346, DOI 10.1038/nsmb.1405; Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024; Eulalio A, 2007, GENE DEV, V21, P2558, DOI 10.1101/gad.443107; Glasscock E, 2005, GENETICS, V170, P1677, DOI 10.1534/genetics.105.043174; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Hall TMT, 2005, CURR OPIN STRUC BIOL, V15, P367, DOI 10.1016/j.sbi.2005.04.004; Hammell CM, 2008, RNA BIOL, V5, P123, DOI 10.4161/rna.5.3.6570; HAN M, 1990, GENETICS, V126, P899; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Li M, 2005, DEV CELL, V9, P415, DOI 10.1016/j.devcel.2005.08.002; Liu JD, 2005, NAT CELL BIOL, V7, P1261, DOI 10.1038/ncb1333; Mathonnet G, 2007, SCIENCE, V317, P1764, DOI 10.1126/science.1146067; Matthews JM, 2002, IUBMB LIFE, V54, P351, DOI 10.1080/15216540216035; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Navarro RE, 2001, DEVELOPMENT, V128, P3221; Neumuller RA, 2008, NATURE, V454, P241, DOI 10.1038/nature07014; Palmer RE, 2002, DEV BIOL, V252, P202, DOI 10.1006/dbio.2002.0850; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Rajyaguru P, 2009, TRENDS CELL BIOL, V19, P24, DOI 10.1016/j.tcb.2008.11.001; Rehwinkel J, 2005, RNA, V11, P1640, DOI 10.1261/rna.2191905; Sarin S, 2007, GENETICS, V176, P2109, DOI 10.1534/genetics.107.075648; Slack FJ, 2000, MOL CELL, V5, P659, DOI 10.1016/S1097-2765(00)80245-2; Slack FJ, 1998, TRENDS BIOCHEM SCI, V23, P474, DOI 10.1016/S0968-0004(98)01299-7; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Wang BB, 2006, MOL CELL, V22, P553, DOI 10.1016/j.molcel.2006.03.034; Zhang L, 2007, MOL CELL, V28, P598, DOI 10.1016/j.molcel.2007.09.014	40	128	142	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 6	2009	136	5					926	938		10.1016/j.cell.2009.01.053	http://dx.doi.org/10.1016/j.cell.2009.01.053			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	415JU	19269369	Green Accepted, Bronze			2022-12-01	WOS:000263930900015
J	Benitez, MA				Benitez, Mary Ann			Climate change could affect mosquito-borne diseases in Asia	LANCET			English	Editorial Material																			0	24	27	0	14	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR-APR	2009	373	9669					1070	1070		10.1016/S0140-6736(09)60634-6	http://dx.doi.org/10.1016/S0140-6736(09)60634-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427IS	19338070				2022-12-01	WOS:000264773600013
J	Chapman, HA; Kim, DA; Susskind, JM; Anderson, AK				Chapman, H. A.; Kim, D. A.; Susskind, J. M.; Anderson, A. K.			In Bad Taste: Evidence for the Oral Origins of Moral Disgust	SCIENCE			English	Article							ANGER	In common parlance, moral transgressions "leave a bad taste in the mouth." This metaphor implies a link between moral disgust and more primitive forms of disgust related to toxicity and disease, yet convincing evidence for this relationship is still lacking. We tested directly the primitive oral origins of moral disgust by searching for similarity in the facial motor activity evoked by gustatory distaste (elicited by unpleasant tastes), basic disgust (elicited by photographs of contaminants), and moral disgust (elicited by unfair treatment in an economic game). We found that all three states evoked activation of the levator labii muscle region of the face, characteristic of an oral-nasal rejection response. These results suggest that immorality elicits the same disgust as disease vectors and bad tastes.	[Chapman, H. A.; Kim, D. A.; Susskind, J. M.; Anderson, A. K.] Univ Toronto, Dept Psychol, Toronto, ON M5S 3G3, Canada; [Anderson, A. K.] Baycrest Ctr Geriatr Care, Rotman Res Inst, Toronto, ON M6A 2E1, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Baycrest	Chapman, HA (corresponding author), Univ Toronto, Dept Psychol, Toronto, ON M5S 3G3, Canada.	hanah@aclab.ca; anderson@psych.utoronto.ca		Kim, David/0000-0003-0151-5121	Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs Program	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chairs Program(Canada Research Chairs)	Supported by the Natural Sciences and Engineering Research Council of Canada and by the Canada Research Chairs Program (A.K.A.). We thank G. Cosgrove, S. Couto, R. Landy, A. Meyers, J. Robinson, and M. Sutrisno for assistance in collecting and processing the data, and W. Grabski for technical assistance.	Bloom Paul, 2005, DESCARTES BABY SCI C; Calder AJ, 2000, NAT NEUROSCI, V3, P1077, DOI 10.1038/80586; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; Darwin C., 1872, EXPRESS EMOT MAN, DOI [10.1037/10001-000, DOI 10.1037/10001-000]; Garcia J., 1975, OLFACTION TASTE, P39, DOI DOI 10.1016/B978-0-12-209750-8.50014-7; Greene J, 2002, TRENDS COGN SCI, V6, P517, DOI 10.1016/S1364-6613(02)02011-9; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; HAGER P. E.-W. F.-J., 2002, FACIAL ACTION CODING; Haidt J, 2007, SCIENCE, V316, P998, DOI 10.1126/science.1137651; Harmon-Jones E, 2003, PERS INDIV DIFFER, V35, P995, DOI 10.1016/S0191-8869(02)00313-6; HENRICH SR, 2004, FDN HUMAN SOCIALITY; Jones D, 2007, NATURE, V447, P768, DOI 10.1038/447768a; Koenigs M, 2007, NATURE, V446, P908, DOI 10.1038/nature05631; Kohlberg L., 1969, HDB SOCIALIZATION TH, P347, DOI [DOI 10.12691/EDUCATION-3-9-16, 10.12691/EDUCATION-3-9-16]; LOFTUS GR, 1994, PSYCHON B REV, V1, P476, DOI 10.3758/BF03210951; Matsumoto D., 1988, JAPANESE CAUCASIAN F; Moll J, 2005, COGN BEHAV NEUROL, V18, P68, DOI 10.1097/01.wnn.0000152236.46475.a7; Nabi RL, 2002, COGNITION EMOTION, V16, P695, DOI 10.1080/02699930143000437; Phillips ML, 1997, NATURE, V389, P495, DOI 10.1038/39051; Rozin P, 1999, J PERS SOC PSYCHOL, V76, P574, DOI 10.1037/0022-3514.76.4.574; ROZIN P, 1994, J PERS SOC PSYCHOL, V66, P870, DOI 10.1037//0022-3514.66.5.870; Rozin P., 2000, HDB EMOTIONS, V2nd ed., P637; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Schnall S, 2008, PERS SOC PSYCHOL B, V34, P1096, DOI 10.1177/0146167208317771; Simmons A, 2008, NEUROSCI LETT, V430, P92, DOI 10.1016/j.neulet.2007.10.030; Susskind JM, 2008, NAT NEUROSCI, V11, P843, DOI 10.1038/nn.2138; Tassinary L., 2000, HDB PSYCHOPHYSIOLOGY, P163; Turiel E., 1987, EMERGENCE MORALITY Y, P155; VRANA SR, 1993, PSYCHOPHYSIOLOGY, V30, P279, DOI 10.1111/j.1469-8986.1993.tb03354.x	30	421	436	2	134	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2009	323	5918					1222	1226		10.1126/science.1165565	http://dx.doi.org/10.1126/science.1165565			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	411XT	19251631				2022-12-01	WOS:000263687600041
J	Liaw, YF; Chu, CM				Liaw, Yun-Fan; Chu, Chia-Ming			Hepatitis B virus infection	LANCET			English	Review							E-ANTIGEN SEROCONVERSION; LIVER-DISEASE PROGRESSION; CORE PROMOTER MUTATIONS; HBEAG-POSITIVE PATIENTS; ACUTE VIRAL-HEPATITIS; TERM-FOLLOW-UP; NATURAL-HISTORY; HEPATOCELLULAR-CARCINOMA; GENOTYPE-C; PEGINTERFERON ALPHA-2A	Since the introduction of the hepatitis B vaccine and other preventive measures, the worldwide prevalence of hepatitis B infection has fallen. However, chronic infection remains a challenging global health problem, with more than 350 million people chronically infected and at risk of hepatic decompensation, cirrhosis, and hepatocellular carcinoma. An improved understanding of hepatitis B virology, immunology, and the natural course of chronic infection, has identified hepatitis B virus replication as the key driver of immune-mediated liver injury and disease progression. The approval of potent oral antiviral agents has revolutionised hepatitis B treatment since 1998. Conventional and pegylated interferon alfa and nucleoside and nucleotide analogues are widely authorised treatments, and monotherapy with these drugs greatly suppresses virus replication, reduces hepatitis activity, and halts disease progression. However, hepatitis B virus is rarely eliminated, and drug resistance is a major drawback during long term therapy. The development of new drugs and strategies is needed to improve treatment outcomes.	[Liaw, Yun-Fan; Chu, Chia-Ming] Chang Gung Univ, Chang Gung Mem Hosp, Liver Res Unit, Coll Med, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University	Liaw, YF (corresponding author), Chang Gung Univ, Chang Gung Mem Hosp, Liver Res Unit, Coll Med, 199 Tung Hwa North Rd, Taipei, Taiwan.	liveryfl@so-net.net.tw	Liaw, Yun-Fan/B-4305-2009		Chang-Gung Medical Research Fund; Prosperous Foundation, Taipei, Taiwan	Chang-Gung Medical Research Fund; Prosperous Foundation, Taipei, Taiwan	We thank Chang-Gung Medical Research Fund and the Prosperous Foundation, Taipei, Taiwan, for long term grant support: Elicit Donaldson and Eric Matluck for English editing; and Su-Chiung Chu for secretarial assistance.	Bertoletti A, 2003, ANTIVIR RES, V60, P61, DOI 10.1016/j.antiviral.2003.08.012; Boni C, 1998, J CLIN INVEST, V102, P968, DOI 10.1172/JCI3731; Bonino F, 2007, GUT, V56, P699, DOI 10.1136/gut.2005.089722; Bonino F, 2003, J HEPATOL, V39, pS160, DOI 10.1016/S0168-8278(03)00319-2; Bortolotti F, 2006, HEPATOLOGY, V43, P556, DOI 10.1002/hep.21077; BOTHA JF, 1984, LANCET, V1, P1210; Brunetto MR, 2002, J HEPATOL, V36, P263, DOI 10.1016/S0168-8278(01)00266-5; Chan HLY, 2004, GUT, V53, P1494, DOI 10.1136/gut.2003.033324; Chen CH, 2007, GASTROENTEROLOGY, V133, P1466, DOI 10.1053/j.gastro.2007.09.002; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; Chen HL, 2004, HEPATOLOGY, V39, P58, DOI 10.1002/hep.20006; Chen YC, 2002, GASTROENTEROLOGY, V123, P1084, DOI 10.1053/gast.2002.36026; Chen YC, 2007, HEPATOL INT, V1, P267, DOI 10.1007/s12072-007-5001-0; Chien RN, 1999, HEPATOLOGY, V30, P770, DOI 10.1002/hep.510300313; Chien RN, 2003, J HEPATOL, V38, P322, DOI 10.1016/S0168-8278(02)00419-1; Chien RN, 2006, ANTIVIR THER, V11, P947; Chien YC, 2006, EPIDEMIOL REV, V28, P126, DOI 10.1093/epirev/mxj010; Chou YC, 2008, GUT, V57, P91, DOI 10.1136/gut.2006.114066; Chu CM, 2007, J VIRAL HEPATITIS, V14, P147, DOI 10.1111/j.1365-2893.2006.00810.x; Chu CM, 2007, HEPATOL INT, V1, P311, DOI 10.1007/s12072-007-9002-9; Chu CM, 2007, GASTROENTEROLOGY, V133, P1458, DOI 10.1053/j.gastro.2007.08.039; Chu CM, 2007, HEPATOLOGY, V45, P1187, DOI 10.1002/hep.21612; Chu CJ, 2003, HEPATOLOGY, V38, P619, DOI 10.1053/jhep.2003.50352; Chu CJ, 2002, GASTROENTEROLOGY, V122, P1756, DOI 10.1053/gast.2002.33588; CHU CM, 1995, GASTROENTEROLOGY, V109, P1926, DOI 10.1016/0016-5085(95)90760-2; Chu CM, 2006, SEMIN LIVER DIS, V26, P142, DOI 10.1055/s-2006-939752; Chu CM, 2005, J HEPATOL, V43, P411, DOI 10.1016/j.jhep.2005.03.018; Chu CM, 2005, INFECTION, V33, P136, DOI 10.1007/s15010-005-4094-4; Chu CM, 2002, J CLIN MICROBIOL, V40, P16, DOI 10.1128/JCM.40.1.16-21.2002; Chu CM, 2004, AM J MED, V116, P829, DOI 10.1016/j.amjmed.2003.12.040; CHU CM, 1985, HEPATOLOGY, V5, P431, DOI 10.1002/hep.1840050315; Cooksley WGE, 2003, J VIRAL HEPATITIS, V10, P298, DOI 10.1046/j.1365-2893.2003.00450.x; Craxi A, 2003, J HEPATOL, V39, pS99, DOI 10.1016/S0168-8278(03)00154-5; Di Marco V, 2004, HEPATOLOGY, V40, P883, DOI 10.1002/hep.20381; Dienstag JL, 2003, GASTROENTEROLOGY, V124, P105, DOI 10.1053/gast.2003.50013; Duong TN, 2004, J MED VIROL, V72, P551, DOI 10.1002/jmv.20044; Fattovich G, 2002, AM J GASTROENTEROL, V97, P2886, DOI 10.1111/j.1572-0241.2002.07057.x; Fattovich G, 2008, GUT, V57, P84, DOI 10.1136/gut.2007.128496; Feld JJ, 2007, HEPATOLOGY, V46, P1057, DOI 10.1002/hep.21811; Flink HJ, 2006, AM J GASTROENTEROL, V101, P2523, DOI 10.1111/j.1572-0241.2006.00812.x; Fontana RJ, 2002, GASTROENTEROLOGY, V123, P719, DOI 10.1053/gast.2002.35352; Fried MW, 2008, HEPATOLOGY, V47, P428, DOI 10.1002/hep.22065; Friedt M, 1999, HEPATOLOGY, V29, P1252, DOI 10.1002/hep.510290418; Gish RG, 2006, CLIN GASTROENTEROL H, V4, P666, DOI 10.1016/j.cgh.2006.03.017; Gish RG, 2007, GASTROENTEROLOGY, V133, P1437, DOI 10.1053/j.gastro.2007.08.025; Guidotti LG, 1999, SCIENCE, V284, P825, DOI 10.1126/science.284.5415.825; Hadziyannis SJ, 2007, HEPATOL INT, V1, P281, DOI 10.1007/s12072-007-9004-7; Hadziyannis SJ, 2006, GASTROENTEROLOGY, V131, P1743, DOI 10.1053/j.gastro.2006.09.020; Hann HWL, 2003, LIVER TRANSPLANT, V9, P49, DOI 10.1053/jlts.2003.50005; Hoofnagle JH, 2007, HEPATOLOGY, V45, P1056, DOI 10.1002/hep.21627; Hsu YS, 2002, HEPATOLOGY, V35, P1522, DOI 10.1053/jhep.2002.33638; Hui CK, 2007, HEPATOLOGY, V46, P395, DOI 10.1002/hep.21724; Ikeda K, 2006, AM J MED, V119, P977, DOI 10.1016/j.amjmed.2005.02.033; Iloeje UH, 2007, CLIN GASTROENTEROL H, V5, P921, DOI 10.1016/j.cgh.2007.06.015; Iloeje UH, 2006, GASTROENTEROLOGY, V130, P678, DOI 10.1053/j.gastro.2005.11.016; Janssen HLA, 2005, LANCET, V365, P123, DOI 10.1016/S0140-6736(05)17701-0; Kao JH, 2000, GASTROENTEROLOGY, V118, P554, DOI 10.1016/S0016-5085(00)70261-7; Kao JH, 2003, GASTROENTEROLOGY, V124, P327, DOI 10.1053/gast.2003.50053; Kao JH, 2007, HEPATOL INT, V1, P415, DOI 10.1007/s12072-007-9033-2; Lai CL, 2007, NEW ENGL J MED, V357, P2576, DOI 10.1056/NEJMoa066422; Lai CL, 2003, LANCET, V362, P2089, DOI 10.1016/S0140-6736(03)15108-2; Lai CL, 2006, NEW ENGL J MED, V354, P1011, DOI 10.1056/NEJMoa051287; Lai CL, 2005, GASTROENTEROLOGY, V129, P528, DOI [10.1053/j.gastro.2005.05.053, 10.1016/j.gastro.2005.05.053]; Lai M, 2007, J HEPATOL, V47, P760, DOI 10.1016/j.jhep.2007.07.022; Lampertico PF, 2007, GASTROENTEROLOGY, V133, P1445, DOI 10.1053/j.gastro.2007.08.079; Lau G, 2007, HEPATOL INT, V1, P316, DOI 10.1007/s12072-007-9006-5; Lau GKK, 2008, HEPATOL INT, V2, P152, DOI 10.1007/s12072-008-9056-3; Lau GKK, 2005, NEW ENGL J MED, V352, P2682, DOI 10.1056/NEJMoa043470; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; Liaw YF, 1999, HEPATOLOGY, V30, P567, DOI 10.1002/hep.510300221; LIAW YF, 1988, HEPATOLOGY, V8, P493, DOI 10.1002/hep.1840080310; Liaw YF, 2004, GASTROENTEROLOGY, V126, P1024, DOI 10.1053/j.gastro.2004.01.011; Liaw YF, 2003, J GASTROEN HEPATOL, V18, P246, DOI 10.1046/j.1440-1746.2003.02976.x; Liaw YF, 2004, NEW ENGL J MED, V351, P1521, DOI 10.1056/NEJMoa033364; Liaw YF, 2008, HEPATOL INT, V2, P263, DOI 10.1007/s12072-008-9080-3; Liaw YF, 2006, LIVER INT, V26, P23, DOI 10.1111/j.1478-3231.2006.01372.x; Liaw YF, 2006, ANTIVIR THER, V11, P669; Lin HH, 2003, J MED VIROL, V69, P466, DOI 10.1002/jmv.10332; Lin SM, 2007, J HEPATOL, V46, P45, DOI 10.1016/j.jhep.2006.08.021; Livingston SE, 2007, GASTROENTEROLOGY, V133, P1452, DOI 10.1053/j.gastro.2007.08.010; Lok AS, 2007, HEPATOLOGY, V46, P254, DOI 10.1002/hep.21698; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; Maini MK, 2000, J EXP MED, V191, P1269, DOI 10.1084/jem.191.8.1269; Manesis EK, 2006, J HEPATOL, V45, P343, DOI 10.1016/j.jhep.2006.07.001; Manno M, 2004, GASTROENTEROLOGY, V127, P756, DOI 10.1053/j.gastro.2004.06.021; Marcellin P, 2004, NEW ENGL J MED, V351, P1206, DOI 10.1056/NEJMoa040431; Marcellin P, 2003, NEW ENGL J MED, V348, P808, DOI 10.1056/NEJMoa020681; MARCELLIN P, 2008, HEPATOL INT, V2, pA139; MARCELLIN P, 2008, HEPATOL INT, V2, pA114; McKnight C. A., 2007, Morbidity and Mortality Weekly Report, V56, P1164; MCMAHON BJ, 1985, J INFECT DIS, V151, P599, DOI 10.1093/infdis/151.4.599; McMahon BJ, 2001, ANN INTERN MED, V135, P759, DOI 10.7326/0003-4819-135-9-200111060-00006; Milich D, 2003, HEPATOLOGY, V38, P1075, DOI 10.1053/jhep.2003.50453; Murray JM, 2005, P NATL ACAD SCI USA, V102, P17780, DOI 10.1073/pnas.0508913102; Ni YH, 2007, GASTROENTEROLOGY, V132, P2340, DOI 10.1053/j.gastro.2007.03.111; Ni YH, 2007, GASTROENTEROLOGY, V132, P1287, DOI 10.1053/j.gastro.2007.02.055; Ni YH, 2004, GASTROENTEROLOGY, V127, P1733, DOI 10.1053/j.gastro.2004.09.048; Niederau C, 1996, NEW ENGL J MED, V334, P1422, DOI 10.1056/NEJM199605303342202; OKADA K, 1976, NEW ENGL J MED, V294, P746, DOI 10.1056/NEJM197604012941402; Ong SC, 2008, HEPATOLOGY, V47, P1108, DOI 10.1002/hep.22138; Papatheodoridis GV, 2005, HEPATOLOGY, V42, P121, DOI 10.1002/hep.20760; Park BK, 2007, J GASTROEN HEPATOL, V22, P383, DOI 10.1111/j.1440-1746.2007.04857.x; Perrillo RP, 2002, HEPATOLOGY, V36, P186, DOI 10.1053/jhep.2002.34294; Piratvisuth T, 2008, HEPATOL INT, V2, P102, DOI 10.1007/s12072-007-9022-5; Raimondo G, 2007, J HEPATOL, V46, P160, DOI 10.1016/j.jhep.2006.10.007; Rapti I, 2007, HEPATOLOGY, V45, P307, DOI 10.1002/hep.21534; Rehermann B, 1996, NAT MED, V2, P1104, DOI 10.1038/nm1096-1104; Rehermann B, 2007, SEMIN LIVER DIS, V27, P152, DOI 10.1055/s-2007-979468; Sanchez-Tapias JM, 2002, GASTROENTEROLOGY, V123, P1848, DOI 10.1053/gast.2002.37041; Sumi H, 2003, HEPATOLOGY, V37, P19, DOI 10.1053/jhep.2003.50036; SUMMERS J, 1982, CELL, V29, P403, DOI 10.1016/0092-8674(82)90157-X; Sung JJY, 2008, J HEPATOL, V48, P728, DOI 10.1016/j.jhep.2007.12.026; Tassopoulos NC, 1999, HEPATOLOGY, V29, P889, DOI 10.1002/hep.510290321; Thimme R, 2003, J VIROL, V77, P68, DOI 10.1128/JVI.77.1.68-76.2003; van Zonneveld M, 2004, HEPATOLOGY, V39, P804, DOI 10.1002/hep.20128; Visvanathan K, 2006, SEMIN LIVER DIS, V26, P104, DOI 10.1055/s-2006-939755; Wasley Annemarie, 2008, Morbidity and Mortality Weekly Report, V57, P1; Yang HI, 2002, NEW ENGL J MED, V347, P168, DOI 10.1056/NEJMoa013215; YF Liaw, 2006, ASIA PACIFIC POCKET; Yu MW, 2005, JNCI-J NATL CANCER I, V97, P265, DOI 10.1093/jnci/dji043; Yu MW, 2000, J NATL CANCER I, V92, P1159, DOI 10.1093/jnci/92.14.1159; Yuen MF, 2004, HEPATOLOGY, V39, P1694, DOI 10.1002/hep.20240; Yuen MF, 2004, J HEPATOL, V41, P119, DOI 10.1016/j.jhep.2004.03.004; Yuen MF, 2005, GUT, V54, P1610, DOI 10.1136/gut.2005.065136; Yuen MF, 2003, CLIN INFECT DIS, V36, P979, DOI 10.1086/374226; Yuen MF, 2003, HEPATOLOGY, V37, P562, DOI 10.1053/jhep.2003.50098; Yuen MF, 2002, J INFECT DIS, V186, P1335, DOI 10.1086/344327; Zacharakis GH, 2005, J MED VIROL, V77, P173, DOI 10.1002/jmv.20434; Zoulim F, 2008, J HEPATOL, V48, pS2, DOI 10.1016/j.jhep.2008.01.011; Zuckerman J, 2007, LANCET INFECT DIS, V7, P410, DOI 10.1016/S1473-3099(07)70136-6; [No title captured]	131	958	1050	4	216	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 14	2009	373	9663					582	592		10.1016/S0140-6736(09)60207-5	http://dx.doi.org/10.1016/S0140-6736(09)60207-5			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	406ZO	19217993				2022-12-01	WOS:000263333600037
J	Calcraft, PJ; Ruas, M; Pan, Z; Cheng, XT; Arredouani, A; Hao, XM; Tang, JS; Rietdorf, K; Teboul, L; Chuang, KT; Lin, PH; Xiao, R; Wang, CB; Zhu, YM; Lin, YK; Wyatt, CN; Parrington, J; Ma, JJ; Evans, AM; Galione, A; Zhu, MX				Calcraft, Peter J.; Ruas, Margarida; Pan, Zui; Cheng, Xiaotong; Arredouani, Abdelilah; Hao, Xuemei; Tang, Jisen; Rietdorf, Katja; Teboul, Lydia; Chuang, Kai-Ting; Lin, Peihui; Xiao, Rui; Wang, Chunbo; Zhu, Yingmin; Lin, Yakang; Wyatt, Christopher N.; Parrington, John; Ma, Jianjie; Evans, A. Mark; Galione, Antony; Zhu, Michael X.			NAADP mobilizes calcium from acidic organelles through two-pore channels	NATURE			English	Article							ADENINE-DINUCLEOTIDE PHOSPHATE; CYCLIC ADP-RIBOSE; PANCREATIC BETA-CELLS; CA2+ RELEASE; INOSITOL TRISPHOSPHATE; RYANODINE RECEPTORS; STORES; HEART; MECHANISM; MESSENGER	Ca2+ mobilization from intracellular stores represents an important cell signalling process(1) that is regulated, in mammalian cells, by inositol-1,4,5-trisphosphate (InsP(3)), cyclic ADP ribose and nicotinic acid adenine dinucleotide phosphate (NAADP). InsP(3) and cyclic ADP ribose cause the release of Ca2+ from sarcoplasmic/endoplasmic reticulum stores by the activation of InsP(3) and ryanodine receptors (InsP(3)Rs and RyRs). In contrast, the nature of the intracellular stores targeted by NAADP and the molecular identity of the NAADP receptors remain controversial(1,2), although evidence indicates that NAADP mobilizes Ca2+ from lysosome-related acidic compartments(3,4). Here we show that two-pore channels (TPCs) comprise a family of NAADP receptors, with human TPC1 (also known as TPCN1) and chicken TPC3 (TPCN3) being expressed on endosomal membranes, and human TPC2 (TPCN2) on lysosomal membranes when expressed in HEK293 cells. Membranes enriched with TPC2 show high affinity NAADP binding, and TPC2 underpins NAADP-induced Ca2+ release from lysosome-related stores that is subsequently amplified by Ca2+-induced Ca2+ release by InsP3Rs. Responses to NAADP were abolished by disrupting the lysosomal proton gradient and by ablating TPC2 expression, but were only attenuated by depleting endoplasmic reticulum Ca2+ stores or by blocking InsP3Rs. Thus, TPCs form NAADP receptors that release Ca2+ from acidic organelles, which can trigger further Ca2+ signals via sarcoplasmic/endoplasmic reticulum. TPCs therefore provide new insights into the regulation and organization of Ca2+ signals in animal cells, and will advance our understanding of the physiological role of NAADP.	[Hao, Xuemei; Tang, Jisen; Xiao, Rui; Wang, Chunbo; Zhu, Yingmin; Lin, Yakang; Zhu, Michael X.] Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA; [Hao, Xuemei; Tang, Jisen; Xiao, Rui; Wang, Chunbo; Zhu, Yingmin; Lin, Yakang; Zhu, Michael X.] Ohio State Univ, Ctr Mol Neurobiol, Columbus, OH 43210 USA; [Calcraft, Peter J.; Wyatt, Christopher N.; Evans, A. Mark] Univ Edinburgh, Coll Med & Vet Med, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland; [Ruas, Margarida; Cheng, Xiaotong; Arredouani, Abdelilah; Rietdorf, Katja; Chuang, Kai-Ting; Parrington, John; Galione, Antony] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England; [Pan, Zui; Lin, Peihui; Ma, Jianjie] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Physiol & Biophys, Piscataway, NJ 08854 USA; [Hao, Xuemei] Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China; [Teboul, Lydia] MRC Harwell, Mary Lyon Ctr, Didcot OX11 0RD, Oxon, England	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Edinburgh; University of Oxford; Rutgers State University New Brunswick; Rutgers State University Medical Center; Peking University; MRC Harwell	Zhu, MX (corresponding author), Ohio State Univ, Dept Neurosci, 1060 Carmack Rd, Columbus, OH 43210 USA.	zhu.55@osu.ed	arredouani, abdelilah/Q-9650-2019; Teboul, Lydia/P-2428-2019; Xiao, Rui/G-1193-2011; Lin, Pei-Hui/I-3011-2015; Galione, Antony/E-5884-2011	Teboul, Lydia/0000-0002-2789-8637; Lin, Pei-Hui/0000-0002-3894-5099; arredouani, abdelilah/0000-0002-5060-916X; Galione, Antony/0000-0002-4132-7646; Pan, Zui/0000-0003-4105-901X; Xiao, Rui/0000-0001-5541-6685; Ruas, Margarida/0000-0002-4872-7618	UK Wellcome Trust [070772]; British Heart Foundation; US National Institutes of Health; American Heart Association; British Heart Foundation [FS/05/050]; US National Institutes of Health [P30-NS045758]; MRC [MC_UP_1502/1] Funding Source: UKRI; Medical Research Council [MC_UP_1502/1] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081654] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS056942, R01NS042183, P30NS045758] Funding Source: NIH RePORTER	UK Wellcome Trust(Wellcome Trust); British Heart Foundation(British Heart Foundation); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); British Heart Foundation(British Heart Foundation); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the UK Wellcome Trust and the British Heart Foundation to A. G., J. P. and A. M. E., the US National Institutes of Health to M. X. Z. and J. M., and the American Heart Association to M. X. Z. A. G. was a Wellcome Senior Research Fellow in basic Biomedical Science. The work of A. M. E. was funded by a Wellcome Trust Project Grant (CNW, reference number 070772) and a British Heart Foundation Studentship (PJC, reference number FS/05/050). Part of the work of M. X. Z. was made possible by US National Institutes of Health grant P30-NS045758. We thank T. Kong and W. Li for the HepG2 cell line, O. Ogunbayo for technical assistance, and F. Platt, A. Morgan and M. Viapiano for help with the manuscript.	Anderson PAV, 2001, COMP BIOCHEM PHYS B, V129, P17, DOI 10.1016/S1096-4959(01)00376-1; Aoyama M, 2004, J CELL SCI, V117, P2813, DOI 10.1242/jcs.01136; Bak J, 2001, CURR BIOL, V11, P987, DOI 10.1016/S0960-9822(01)00269-X; Bak J, 1999, CURR BIOL, V9, P751, DOI 10.1016/S0960-9822(99)80335-2; Berg I, 2000, J CELL BIOL, V150, P581, DOI 10.1083/jcb.150.3.581; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Boittin FX, 2002, CIRC RES, V91, P1168, DOI 10.1161/01.RES.0000047507.22487.85; Cancela JM, 1999, NATURE, V398, P74, DOI 10.1038/18032; Cancela JM, 2000, EMBO J, V19, P2549, DOI 10.1093/emboj/19.11.2549; Churchill GC, 2001, EMBO J, V20, P2666, DOI 10.1093/emboj/20.11.2666; Churchill GC, 2002, CELL, V111, P703, DOI 10.1016/S0092-8674(02)01082-6; Dammermann W, 2005, J BIOL CHEM, V280, P21394, DOI 10.1074/jbc.M413085200; Galione A, 2002, CELL CALCIUM, V32, P343, DOI 10.1016/S0143416002001902; Genazzani AA, 1996, BIOCHEM J, V315, P721, DOI 10.1042/bj3150721; Gerasimenko JV, 2003, J CELL BIOL, V163, P271, DOI 10.1083/jcb.200306134; Ishibashi K, 2000, BIOCHEM BIOPH RES CO, V270, P370, DOI 10.1006/bbrc.2000.2435; Kinnear NP, 2004, J BIOL CHEM, V279, P54319, DOI 10.1074/jbc.M406132200; LEE HC, 1995, J BIOL CHEM, V270, P2152, DOI 10.1074/jbc.270.5.2152; Lee HC, 2000, J CELL SCI, V113, P4413; Macgregor A, 2007, J BIOL CHEM, V282, P15302, DOI 10.1074/jbc.M611167200; Masgrau R, 2003, CURR BIOL, V13, P247, DOI 10.1016/S0960-9822(03)00041-1; Mitchell KJ, 2003, J BIOL CHEM, V278, P11057, DOI 10.1074/jbc.M210257200; Mojzisova A, 2001, PFLUG ARCH EUR J PHY, V441, P674, DOI 10.1007/s004240000465; Morgan A. J., 2006, METHODS CALCIUM SIGN, P267; Patel S, 2000, J BIOL CHEM, V275, P36495, DOI 10.1074/jbc.C000458200; Patel S, 2000, BIOCHEM J, V352, P725, DOI 10.1042/0264-6021:3520725; Peiter E, 2005, NATURE, V434, P404, DOI 10.1038/nature03381; Stryke D, 2003, NUCLEIC ACIDS RES, V31, P278, DOI 10.1093/nar/gkg064; van Koppen CJ, 2001, LIFE SCI, V68, P2535, DOI 10.1016/S0024-3205(01)01049-9; Yamasaki M, 2004, J BIOL CHEM, V279, P7234, DOI 10.1074/jbc.M311088200	30	553	570	0	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2009	459	7246					596	U130		10.1038/nature08030	http://dx.doi.org/10.1038/nature08030			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449ZS	19387438	Green Accepted			2022-12-01	WOS:000266370500045
J	Choi, CM; Vilain, S; Langen, M; Van Kelst, S; De Geest, N; Yan, J; Verstreken, P; Hassan, BA				Choi, Ching Man; Vilain, Sven; Langen, Marion; Van Kelst, Sofie; De Geest, Natalie; Yan, Jiekun; Verstreken, Patrik; Hassan, Bassem A.			Conditional Mutagenesis in Drosophila	SCIENCE			English	Article							GENE		[Choi, Ching Man; Vilain, Sven; Langen, Marion; Van Kelst, Sofie; De Geest, Natalie; Yan, Jiekun; Verstreken, Patrik; Hassan, Bassem A.] VIB, Dept Mol & Dev Genet, B-3000 Louvain, Belgium; [Choi, Ching Man; Vilain, Sven; Langen, Marion; Van Kelst, Sofie; De Geest, Natalie; Yan, Jiekun; Verstreken, Patrik; Hassan, Bassem A.] Katholieke Univ Leuven, Sch Med, Ctr Human Genet, B-3000 Louvain, Belgium; [Choi, Ching Man; Vilain, Sven; Verstreken, Patrik; Hassan, Bassem A.] Katholieke Univ Leuven, Grp Biomed, Doctoral Program Mol & Dev Genet, B-3000 Louvain, Belgium; [Langen, Marion; Verstreken, Patrik; Hassan, Bassem A.] Katholieke Univ Leuven, Grp Biomed, Doctoral Program Mol & Cognit Neurosci, B-3000 Louvain, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; KU Leuven	Hassan, BA (corresponding author), VIB, Dept Mol & Dev Genet, B-3000 Louvain, Belgium.	Bassem.Hassan@med.kuleuven.be	Hassan, Bassem A/D-5221-2012; Vilain, Sven/AHA-7944-2022; Verstreken, Patrik/AAC-7591-2022	Hassan, Bassem A/0000-0001-9533-4908; Verstreken, Patrik/0000-0002-5073-5393; Langen, Marion/0000-0001-6109-6593	VIB; Impuls; CREA; GOA; K. U. Leuven [G.0542.08N, G.0543.08N]; FWO [G.0542.08N, G.0543.08N]; Marie Curie [MEXT-CT-2006-042267]; Flemish government	VIB; Impuls; CREA; GOA; K. U. Leuven(KU Leuven); FWO(FWO); Marie Curie(European Commission); Flemish government(European Commission)	We thank A. Jarman, H. Bellen, M. Calos, J. Bischof, K. Basler, J. Bateman, T. Wu, A. Roebroeck, as well as the Developmental Studies Hybridoma Bank (DSHB) and the Bloomington Stock Center, for sharing flies and reagents. We thank X. Quan, S. Aerts, J. Kasprowicz, and S. Kuenen for useful discussion and technical assistance. This work was supported by VIB (B.A.H., P.V.), and Impuls, CREA, and GOA (Geconcerteerd Onderzoeks Acties) grants from K. U. Leuven and FWO (Fonds Wetenschaplijke Onderzoek) grants G.0542.08N and G.0543.08N to B.A.H. as well as Research fund K. U. Leuven, and a Marie Curie Excellence grant (MEXT-CT-2006-042267) to P.V. S.V. was partially supported by a K.U. Leuven Methusalem grant from the Flemish government. pSTAR GenBank accession number is FJ710212.	Bateman JR, 2006, GENETICS, V173, P769, DOI 10.1534/genetics.106.056945; Gong WJ, 2003, P NATL ACAD SCI USA, V100, P2556, DOI 10.1073/pnas.0535280100; JARMAN AP, 1995, DEVELOPMENT, V121, P2019; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Rooke JE, 2000, METH MOL B, V137, P15; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426	6	41	41	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2009	324	5923					54	54		10.1126/science.1168275	http://dx.doi.org/10.1126/science.1168275			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427TN	19342580				2022-12-01	WOS:000264802100028
J	Omabegho, T; Sha, R; Seeman, NC				Omabegho, Tosan; Sha, Ruojie; Seeman, Nadrian C.			A Bipedal DNA Brownian Motor with Coordinated Legs	SCIENCE			English	Article							DOUBLE-CROSSOVER MOLECULES; SINGLE-STRANDED-DNA; FLEXIBILITY; TRANSPORT; KINETICS	A substantial challenge in engineering molecular motors is designing mechanisms to coordinate the motion between multiple domains of the motor so as to bias random thermal motion. For bipedal motors, this challenge takes the form of coordinating the movement of the biped's legs so that they can move in a synchronized fashion. To address this problem, we have constructed an autonomous DNA bipedal walker that coordinates the action of its two legs by cyclically catalyzing the hybridization of metastable DNA fuel strands. This process leads to a chemically ratcheted walk along a directionally polar DNA track. By covalently cross-linking aliquots of the walker to its track in successive walking states, we demonstrate that this Brownian motor can complete a full walking cycle on a track whose length could be extended for longer walks. We believe that this study helps to uncover principles behind the design of unidirectional devices that can function without intervention. This device should be able to fulfill roles that entail the performance of useful mechanical work on the nanometer scale.	[Sha, Ruojie; Seeman, Nadrian C.] NYU, Dept Chem, New York, NY 10003 USA; [Omabegho, Tosan] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	New York University; Harvard University	Seeman, NC (corresponding author), NYU, Dept Chem, New York, NY 10003 USA.	ned.seeman@nyu.edu			National Institute of General Medical Sciences; NSF; Army Research Office; Office of Naval Research; New York Nano-Bio-Molecular Information Technology Incubator program of the Department of Energy; W. M. Keck Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM029554] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NSF(National Science Foundation (NSF)); Army Research Office; Office of Naval Research(Office of Naval Research); New York Nano-Bio-Molecular Information Technology Incubator program of the Department of Energy; W. M. Keck Foundation(W.M. Keck Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Mao, H. Yan, and N. Jonoska for critical reading of the manuscript. This research has been supported by grants to N.C.S. from the National Institute of General Medical Sciences, NSF, the Army Research Office, the Office of Naval Research, the New York Nano-Bio-Molecular Information Technology Incubator program of the Department of Energy, and the W. M. Keck Foundation.	Astumian RD, 1997, SCIENCE, V276, P917, DOI 10.1126/science.276.5314.917; Bois JS, 2005, NUCLEIC ACIDS RES, V33, P4090, DOI 10.1093/nar/gki721; FISCHER SG, 1979, CELL, V16, P191, DOI 10.1016/0092-8674(79)90200-9; FU TJ, 1994, J MOL BIOL, V236, P91, DOI 10.1006/jmbi.1994.1121; FU TJ, 1993, BIOCHEMISTRY-US, V32, P3211, DOI 10.1021/bi00064a003; GIA O, 1992, BIOCHEMISTRY-US, V31, P11818, DOI 10.1021/bi00162a021; Green SJ, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.238101; Kay ER, 2007, ANGEW CHEM INT EDIT, V46, P72, DOI 10.1002/anie.200504313; Mai J, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.011102; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Mills JB, 1999, J MOL BIOL, V285, P245, DOI 10.1006/jmbi.1998.2287; Pei R, 2006, J AM CHEM SOC, V128, P12693, DOI 10.1021/ja058394n; Sa-Ardyen P, 2003, BIOPHYS J, V84, P3829, DOI 10.1016/S0006-3495(03)75110-8; Saffarian S, 2004, SCIENCE, V306, P108, DOI 10.1126/science.1099179; Shapiro E, 2006, SCI AM, V294, P44, DOI 10.1038/scientificamerican0506-44; Sherman WB, 2004, NANO LETT, V4, P1203, DOI 10.1021/nl049527q; Shin JS, 2004, J AM CHEM SOC, V126, P10834, DOI 10.1021/ja047543j; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; Tian Y, 2005, ANGEW CHEM INT EDIT, V44, P4355, DOI 10.1002/anie.200500703; Turberfield AJ, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.118102; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Yin P, 2008, NATURE, V451, P318, DOI 10.1038/nature06451; Yurke B, 2000, NATURE, V406, P605, DOI 10.1038/35020524	24	450	464	4	241	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2009	324	5923					67	71		10.1126/science.1170336	http://dx.doi.org/10.1126/science.1170336			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427TN	19342582	Green Accepted			2022-12-01	WOS:000264802100032
J	Alberti, S; Halfmann, R; King, O; Kapila, A; Lindquist, S				Alberti, Simon; Halfmann, Randal; King, Oliver; Kapila, Atul; Lindquist, Susan			A Systematic Survey Identifies Prions and Illuminates Sequence Features of Prionogenic Proteins	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; YEAST PRIONS; HET-S; ENVIRONMENTAL-STRESS; GENETIC-VARIATION; AMYLOID FIBRILS; SUP35 PROTEIN; PSI+ PRION; RICH PRION; IN-VITRO	Prions are proteins that convert between structurally and functionally distinct states, one or more of which is transmissible. In yeast, this ability allows them to act as non-Mendelian elements of phenotypic inheritance. To further our understanding of prion biology, we conducted a bioinformatic proteome-wide survey for prionogenic proteins in S. cerevisiae, followed by experimental investigations of 100 prion candidates. We found an unexpected amino acid bias in aggregation-prone candidates and discovered that 19 of these could also form prions. At least one of these prion proteins, Mot3, produces a bona fide prion in its natural context that increases population-level phenotypic heterogeneity. The self-perpetuating states of these proteins present a vast source of heritable phenotypic variation that increases the adaptability of yeast populations to diverse environments.	[Alberti, Simon; Halfmann, Randal; King, Oliver; Kapila, Atul; Lindquist, Susan] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Lindquist, Susan] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Halfmann, Randal; Kapila, Atul; Lindquist, Susan] MIT, Dept Biol, Cambridge, MA 02139 USA; [King, Oliver] Boston Biomed Res Inst, Watertown, MA 02472 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Boston Biomedical Research Institute	Lindquist, S (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	lindquist_admin@wi.mit.edu	Alberti, Simon/ABB-8277-2021; Alberti, Simon/B-2822-2017	Halfmann, Randal/0000-0002-6592-1471; Alberti, Simon/0000-0003-4017-6505	G. Harold and Leila Y. Mathers Foundation; NIH [GM025874]; HHMI; Deutsche Forschungsgemeinschaft (DFG); NSF; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025874, R37GM025874] Funding Source: NIH RePORTER	G. Harold and Leila Y. Mathers Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the G. Harold and Leila Y. Mathers Foundation, NIH grant GM025874, and HHMI. S.A. was supported by a fellowship of the Deutsche Forschungsgemeinschaft (DFG). R.H. was supported by a fellowship of the NSF. We are grateful to Ndubuisi Azubuine and Tsering Nanchung for constant supply of plates and media. We thank Sherwin Chan and Gerald Fink for contributing the URA3-HIS5 plasmid. We thank Jijun Dong for assisting with TEM, and members of the Lindquist lab for critical reading of the manuscript.	Abramova N, 2001, J BACTERIOL, V183, P2881, DOI 10.1128/JB.183.9.2881-2887.2001; AIGLE M, 1975, MOL GEN GENET, V136, P327, DOI 10.1007/BF00341717; Alberti S, 2007, YEAST, V24, P913, DOI 10.1002/yea.1502; Alexandrov IM, 2008, J BIOL CHEM, V283, P15185, DOI 10.1074/jbc.M802071200; Bagriantsev SN, 2006, METHOD ENZYMOL, V412, P33, DOI 10.1016/S0076-6879(06)12003-0; Baskakov IV, 2007, BBA-MOL BASIS DIS, V1772, P692, DOI 10.1016/j.bbadis.2006.07.007; Brachmann A, 2005, EMBO J, V24, P3082, DOI 10.1038/sj.emboj.7600772; Bradley ME, 2002, P NATL ACAD SCI USA, V99, P16392, DOI 10.1073/pnas.152330699; Chernoff YO, 2000, MOL MICROBIOL, V35, P865, DOI 10.1046/j.1365-2958.2000.01761.x; Chernoff YO, 2007, FEBS LETT, V581, P3695, DOI 10.1016/j.febslet.2007.04.075; de la Paz ML, 2004, P NATL ACAD SCI USA, V101, P87, DOI 10.1073/pnas.2634884100; Derkatch IL, 2001, CELL, V106, P171, DOI 10.1016/S0092-8674(01)00427-5; Derkatch IL, 2000, EMBO J, V19, P1942, DOI 10.1093/emboj/19.9.1942; Diaz-Avalos R, 2005, P NATL ACAD SCI USA, V102, P10165, DOI 10.1073/pnas.0504599102; Douglas PM, 2008, P NATL ACAD SCI USA, V105, P7206, DOI 10.1073/pnas.0802593105; Du ZQ, 2008, NAT GENET, V40, P460, DOI 10.1038/ng.112; Eaglestone SS, 1999, EMBO J, V18, P1974, DOI 10.1093/emboj/18.7.1974; Edskes HK, 1999, P NATL ACAD SCI USA, V96, P1498, DOI 10.1073/pnas.96.4.1498; Ganusova EE, 2006, MOL CELL BIOL, V26, P617, DOI 10.1128/MCB.26.2.617-629.2006; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; GRIFFITH JS, 1967, NATURE, V215, P1043, DOI 10.1038/2151043a0; Grishin AV, 1998, GENETICS, V149, P879; Halfmann Randal, 2008, J Vis Exp, DOI 10.3791/838; Harrison PM, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-6-r40; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Hongay C, 2002, EMBO J, V21, P4114, DOI 10.1093/emboj/cdf415; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; King OD, 2007, THEOR POPUL BIOL, V72, P560, DOI 10.1016/j.tpb.2007.08.006; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; LeVine H, 1997, ARCH BIOCHEM BIOPHYS, V342, P306, DOI 10.1006/abbi.1997.0137; Li LM, 2000, SCIENCE, V287, P661, DOI 10.1126/science.287.5453.661; LIEBMAN SW, 1979, J BACTERIOL, V139, P1068, DOI 10.1128/JB.139.3.1068-1071.1979; Liu JJ, 2002, P NATL ACAD SCI USA, V99, P16446, DOI 10.1073/pnas.252652099; Liu JJ, 1999, NATURE, V400, P573, DOI 10.1038/23048; LUND PM, 1981, GENET RES, V37, P173, DOI 10.1017/S0016672300020140; Maddelein ML, 2002, P NATL ACAD SCI USA, V99, P7402, DOI 10.1073/pnas.072199199; MASISON DC, 1995, SCIENCE, V270, P93, DOI 10.1126/science.270.5233.93; Michelitsch MD, 2000, P NATL ACAD SCI USA, V97, P11910, DOI 10.1073/pnas.97.22.11910; Mrsa V, 1999, J BACTERIOL, V181, P3076, DOI 10.1128/JB.181.10.3076-3086.1999; Mukhopadhyay S, 2007, P NATL ACAD SCI USA, V104, P2649, DOI 10.1073/pnas.0611503104; Nakayashiki T, 2005, P NATL ACAD SCI USA, V102, P10575, DOI 10.1073/pnas.0504882102; Namy O, 2008, NAT CELL BIOL, V10, P1069, DOI 10.1038/ncb1766; Osherovich LZ, 2004, PLOS BIOL, V2, P442, DOI 10.1371/journal.pbio.0020086; Osherovich LZ, 2001, CELL, V106, P183, DOI 10.1016/S0092-8674(01)00440-8; Patel BK, 2007, J MOL BIOL, V365, P773, DOI 10.1016/j.jmb.2006.10.069; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Perrett S, 2008, CURR OPIN STRUC BIOL, V18, P52, DOI 10.1016/j.sbi.2007.12.005; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; RAM AFJ, 1994, YEAST, V10, P1019, DOI 10.1002/yea.320100804; Ross ED, 2005, P NATL ACAD SCI USA, V102, P12825, DOI 10.1073/pnas.0506136102; Ross ED, 2005, NAT CELL BIOL, V7, P1039, DOI 10.1038/ncb1105-1039; Ross ED, 2004, MOL CELL BIOL, V24, P7206, DOI 10.1128/MCB.24.16.7206-7213.2004; Sabate R, 2007, J MOL BIOL, V370, P768, DOI 10.1016/j.jmb.2007.05.014; Salnikova AB, 2005, J BIOL CHEM, V280, P8808, DOI 10.1074/jbc.M410150200; Santoso A, 2000, CELL, V100, P277, DOI 10.1016/S0092-8674(00)81565-2; Saupe SJ, 2000, CURR OPIN MICROBIOL, V3, P608, DOI 10.1016/S1369-5274(00)00148-X; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Shkundina IS, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1519, DOI 10.1134/S0006297907130081; Shorter J, 2005, NAT REV GENET, V6, P435, DOI 10.1038/nrg1616; Shorter J, 2008, EMBO J, V27, P2712, DOI 10.1038/emboj.2008.194; Si K, 2003, CELL, V115, P879, DOI 10.1016/S0092-8674(03)01020-1; Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8; Sparrer HE, 2000, SCIENCE, V289, P595, DOI 10.1126/science.289.5479.595; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; Taneja V, 2007, MOL CELL, V27, P67, DOI 10.1016/j.molcel.2007.05.027; Taylor KL, 1999, SCIENCE, V283, P1339, DOI 10.1126/science.283.5406.1339; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; True HL, 2004, NATURE, V431, P184, DOI 10.1038/nature02885; Tuite MF, 2003, NAT REV MOL CELL BIO, V4, P878, DOI 10.1038/nrm1247; Tuite M, 2008, BIOCHEM SOC T, V36, P1083, DOI 10.1042/BST0361083; Tyedmers J, 2008, PLOS BIOL, V6, P2605, DOI 10.1371/journal.pbio.0060294; Vitrenko YA, 2007, J BIOL CHEM, V282, P1779, DOI 10.1074/jbc.M609269200; Wang XL, 2006, PROTEINS, V63, P297, DOI 10.1002/prot.20761; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Zenthon JF, 2006, EUKARYOT CELL, V5, P217, DOI 10.1128/EC.5.2.217-225.2006	77	701	715	4	74	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 2	2009	137	1					146	158		10.1016/j.cell.2009.02.044	http://dx.doi.org/10.1016/j.cell.2009.02.044			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	427XV	19345193	Green Accepted, Bronze, Green Submitted			2022-12-01	WOS:000264813300021
J	Francis, NJ; Follmer, NE; Simon, MD; Aghia, G; Butler, JD				Francis, Nicole J.; Follmer, Nicole E.; Simon, Matthew D.; Aghia, George; Butler, Jeffrey D.			Polycomb Proteins Remain Bound to Chromatin and DNA during DNA Replication In Vitro	CELL			English	Article							GENOME-WIDE ANALYSIS; SIMIAN VIRUS-40 DNA; EARLY MOUSE EMBRYOS; HISTONE H3; TRANSCRIBING POLYMERASE; DROSOPHILA-MELANOGASTER; POLYTENE CHROMOSOMES; H2A UBIQUITYLATION; REPRESSIVE COMPLEX; CELLS	The transcriptional status of a gene can be maintained through multiple rounds of cell division during development. This epigenetic effect is believed to reflect heritable changes in chromatin folding and histone modifications or variants at target genes, but little is known about how these chromatin features are inherited through cell division. A particular challenge for maintaining transcription states is DNA replication, which disrupts or dilutes chromatin-associated proteins and histone modifications. PRC1-class Polycomb group protein complexes are essential for development and are thought to heritably silence transcription by altering chromatin folding and histone modifications. It is not known whether these complexes and their effects are maintained during DNA replication or subsequently re-established. We find that when PRC1-class Polycomb complex-bound chromatin or DNA is replicated in vitro, Polycomb complexes remain bound to replicated templates. Retention of Polycomb proteins through DNA replication may contribute to maintenance of transcriptional silencing through cell division.	[Francis, Nicole J.; Follmer, Nicole E.; Aghia, George; Butler, Jeffrey D.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Simon, Matthew D.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Simon, Matthew D.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA	Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Francis, NJ (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 7 Divin Ave, Cambridge, MA 02138 USA.	francis@mcb.harvard.edu	Simon, Matthew/ABF-9127-2020	Simon, Matthew/0000-0001-7423-5265	National Institutes of Health [GM078456-01]; Searle Scholar award; March of Dimes Basil O'Connor Scholar award; Helen Hay Whitney fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078456] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searle Scholar award; March of Dimes Basil O'Connor Scholar award(March of Dimes); Helen Hay Whitney fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Kingston, T. Maniatis, W. M. Michael, N. Kleckner, A. Murray, A. Mazo, L. Kobrossy, B. Lengsfeld, and S. Lo for advice and support throughout the project and J. Muller, R. Jones, B. Stillman, and W. M. Michael for reagents. This work was supported by the National Institutes of Health (GM078456-01), a Searle Scholar award and a March of Dimes Basil O'Connor Scholar award to N.J.F., and a Helen Hay Whitney fellowship to M.D.S.	Abmayr S. M., 2006, CURRENT PROTOCOLS MO, P1211; Aggarwal BD, 2004, NATURE, V430, P372, DOI 10.1038/nature02694; Annunziato AT, 2005, J BIOL CHEM, V280, P12065, DOI 10.1074/jbc.R400039200; Azuara V, 2006, NAT PROTOC, V1, P2171, DOI 10.1038/nprot.2006.353; Benson LJ, 2006, J BIOL CHEM, V281, P9287, DOI 10.1074/jbc.M512956200; Beuchle D, 2001, DEVELOPMENT, V128, P993; BONNEANDREA C, 1990, NATURE, V343, P719, DOI 10.1038/343719a0; Breiling A, 2001, NATURE, V412, P651, DOI 10.1038/35088090; Brown JL, 1998, MOL CELL, V1, P1057, DOI 10.1016/S1097-2765(00)80106-9; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Carruthers LM, 1999, METHOD ENZYMOL, V304, P19; CLARK DJ, 1992, CELL, V71, P11, DOI 10.1016/0092-8674(92)90262-B; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; Dodd IB, 2007, CELL, V129, P813, DOI 10.1016/j.cell.2007.02.053; Elderkin S, 2007, MOL CELL, V28, P107, DOI 10.1016/j.molcel.2007.08.009; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Francis NJ, 2001, MOL CELL, V8, P545, DOI 10.1016/S1097-2765(01)00316-1; Grimaud C, 2006, CHROMOSOME RES, V14, P363, DOI 10.1007/s10577-006-1069-y; Groth A, 2007, CELL, V128, P721, DOI 10.1016/j.cell.2007.01.030; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; JACKMAN J, 2003, METHODS SYNCHRONIZIN; Kind J, 2008, CELL, V133, P813, DOI 10.1016/j.cell.2008.04.036; King IFG, 2005, MOL CELL BIOL, V25, P6578, DOI 10.1128/MCB.25.15.6578-6591.2005; King IFG, 2002, MOL CELL BIOL, V22, P7919, DOI 10.1128/MCB.22.22.7919-7928.2002; Klymenko T, 2006, GENE DEV, V20, P1110, DOI 10.1101/gad.377406; Kohn KW, 2008, MOL BIOL CELL, V19, P1, DOI 10.1091/mbc.E07-06-0528; Kwong C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000178; Lagarou A, 2008, GENE DEV, V22, P2799, DOI 10.1101/gad.484208; LANFORD RE, 1988, VIROLOGY, V167, P72, DOI 10.1016/0042-6822(88)90055-4; Lavigne M, 2004, MOL CELL, V13, P415, DOI 10.1016/S1097-2765(04)00006-1; Levine SS, 2002, MOL CELL BIOL, V22, P6070, DOI 10.1128/MCB.22.17.6070-6078.2002; LI JJ, 1984, P NATL ACAD SCI-BIOL, V81, P6973, DOI 10.1073/pnas.81.22.6973; Logie C, 1997, EMBO J, V16, P6772, DOI 10.1093/emboj/16.22.6772; Marchetti M, 2003, DEVELOPMENT, V130, P3683, DOI 10.1242/dev.00587; Mihaly J, 1998, MOL CELL, V1, P1065, DOI 10.1016/S1097-2765(00)80107-0; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Mishra RK, 2001, MOL CELL BIOL, V21, P1311, DOI 10.1128/MCB.21.4.1311-1318.2001; Mito Y, 2007, SCIENCE, V315, P1408, DOI 10.1126/science.1134004; Mohd-Sarip A, 2005, GENE DEV, V19, P1755, DOI 10.1101/gad.347005; Mohd-Sarip A, 2006, MOL CELL, V24, P91, DOI 10.1016/j.molcel.2006.08.007; Moshkin YM, 2001, P NATL ACAD SCI USA, V98, P570, DOI 10.1073/pnas.021353598; Ng RK, 2008, CELL CYCLE, V7, P1173, DOI 10.4161/cc.7.9.5791; Nightingale KP, 2006, CURR OPIN GENET DEV, V16, P125, DOI 10.1016/j.gde.2006.02.015; Papp B, 2006, GENE DEV, V20, P2041, DOI 10.1101/gad.388706; Pietersen AM, 2008, CURR OPIN CELL BIOL, V20, P201, DOI 10.1016/j.ceb.2008.01.004; POLACH KJ, 1995, J MOL BIOL, V254, P130, DOI 10.1006/jmbi.1995.0606; Poux S, 2001, DEVELOPMENT, V128, P75; Puschendorf M, 2008, NAT GENET, V40, P411, DOI 10.1038/ng.99; Rastegar M, 2004, MOL CELL BIOL, V24, P8090, DOI 10.1128/MCB.24.18.8090-8103.2004; Ringrose L, 2004, MOL CELL, V16, P641, DOI 10.1016/j.molcel.2004.10.015; Ringrose L, 2007, CURR OPIN CELL BIOL, V19, P290, DOI 10.1016/j.ceb.2007.04.010; SANCHEZ JA, 1992, J CELL SCI, V103, P907; Saurin AJ, 2001, NATURE, V412, P655, DOI 10.1038/35088096; Schnitzler G R, 2001, Curr Protoc Mol Biol, VChapter 21, DOI 10.1002/0471142727.mb2105s50; Schwartz YB, 2005, MOL CELL BIOL, V25, P432, DOI 10.1128/MCB.25.1.432-439.2005; Schwartz YB, 2008, CURR OPIN CELL BIOL, V20, P266, DOI 10.1016/j.ceb.2008.03.002; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; Sif S, 2001, GENE DEV, V15, P603, DOI 10.1101/gad.872801; Simon JA, 2002, CURR OPIN GENET DEV, V12, P210, DOI 10.1016/S0959-437X(02)00288-5; Simon MD, 2007, CELL, V128, P1003, DOI 10.1016/j.cell.2006.12.041; STILLMAN BW, 1985, MOL CELL BIOL, V5, P2051, DOI 10.1128/MCB.5.8.2051; STUDITSKY VM, 1994, CELL, V76, P371, DOI 10.1016/0092-8674(94)90343-3; Terranova R, 2008, DEV CELL, V15, P668, DOI 10.1016/j.devcel.2008.08.015; Utley RT, 1998, NATURE, V394, P498, DOI 10.1038/28886; Walter J, 1998, MOL CELL, V1, P519, DOI 10.1016/S1097-2765(00)80052-0; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang L, 2004, MOL CELL, V14, P637, DOI 10.1016/j.molcel.2004.05.009	71	132	133	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 2	2009	137	1					110	122		10.1016/j.cell.2009.02.017	http://dx.doi.org/10.1016/j.cell.2009.02.017			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	427XV	19303136	Green Accepted, Bronze			2022-12-01	WOS:000264813300018
J	Xiu, XA; Puskar, NL; Shanata, JAP; Lester, HA; Dougherty, DA				Xiu, Xinan; Puskar, Nyssa L.; Shanata, Jai A. P.; Lester, Henry A.; Dougherty, Dennis A.			Nicotine binding to brain receptors requires a strong cation-pi interaction	NATURE			English	Article							ACETYLCHOLINE-RECEPTORS; ION CHANNELS; M2 DOMAIN; AGONISTS; ACHBP; SITE; ACTIVATION; TOLERANCE; COMPLEXES; CHEMISTRY	Nicotine addiction begins with high-affinity binding of nicotine to acetylcholine (ACh) receptors in the brain. The end result is over 4,000,000 smoking-related deaths annually worldwide and the largest source of preventable mortality in developed countries. Stress reduction, pleasure, improved cognition and other central nervous system effects are strongly associated with smoking. However, if nicotine activated ACh receptors found in muscle as potently as it does brain ACh receptors, smoking would cause intolerable and perhaps fatal muscle contractions. Despite extensive pharmacological, functional and structural studies of ACh receptors, the basis for the differential action of nicotine on brain compared with muscle ACh receptors has not been determined. Here we show that at the alpha 4 beta 2 brain receptors thought to underlie nicotine addiction, the high affinity for nicotine is the result of a strong cation-pi interaction to a specific aromatic amino acid of the receptor, TrpB. In contrast, the low affinity for nicotine at the muscle-type ACh receptor is largely due to the fact that this key interaction is absent, even though the immediate binding site residues, including the key amino acid TrpB, are identical in the brain and muscle receptors. At the same time a hydrogen bond from nicotine to the backbone carbonyl of TrpB is enhanced in the neuronal receptor relative to the muscle type. A point mutation near TrpB that differentiates alpha 4 beta 2 and muscle-type receptors seems to influence the shape of the binding site, allowing nicotine to interact more strongly with TrpB in the neuronal receptor. ACh receptors are established therapeutic targets for Alzheimer's disease, schizophrenia, Parkinson's disease, smoking cessation, pain, attention-deficit hyperactivity disorder, epilepsy, autism and depression(1). Along with solving a chemical mystery in nicotine addiction, our results provide guidance for efforts to develop drugs that target specific types of nicotinic receptors.	[Xiu, Xinan; Puskar, Nyssa L.; Shanata, Jai A. P.; Dougherty, Dennis A.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Lester, Henry A.] CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Dougherty, DA (corresponding author), CALTECH, Div Chem & Chem Engn, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	dadougherty@caltech.edu		Shanata, Jai/0000-0003-3588-040X	NIH [NS 34407, NS 11756]; California Tobacco-Related Disease Research Program of the University of California [16RT-0160]; NRSA; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS034407, R01NS011756, R01NS034407] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017279] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Tobacco-Related Disease Research Program of the University of California(University of California System); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank B. N. Cohen for advice on single-channel recording and analysis. This work was supported by the NIH (NS 34407; NS 11756) and the California Tobacco-Related Disease Research Program of the University of California, grant number 16RT-0160. J.A.P.S. was partially supported by an NRSA training grant.	Beene DL, 2002, BIOCHEMISTRY-US, V41, P10262, DOI 10.1021/bi020266d; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Cashin AL, 2005, J AM CHEM SOC, V127, P350, DOI 10.1021/ja0461771; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Coe JW, 2005, J MED CHEM, V48, P3474, DOI 10.1021/jm050069n; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; Deechongkit S, 2004, NATURE, V430, P101, DOI 10.1038/nature02611; Dougherty DA, 2008, J ORG CHEM, V73, P3667, DOI 10.1021/jo8001722; Dougherty DA, 2008, CHEM REV, V108, P1642, DOI 10.1021/cr078207z; England PM, 1999, CELL, V96, P89, DOI 10.1016/S0092-8674(00)80962-9; FILATOV GN, 1995, MOL PHARMACOL, V48, P379; Fonck C, 2005, J NEUROSCI, V25, P11396, DOI 10.1523/JNEUROSCI.3597-05.2005; Gotti C, 2006, TRENDS PHARMACOL SCI, V27, P482, DOI 10.1016/j.tips.2006.07.004; Grutter T, 2003, EMBO J, V22, P1990, DOI 10.1093/emboj/cdg197; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Kearney PC, 1996, MOL PHARMACOL, V50, P1401; Koh JT, 1997, BIOCHEMISTRY-US, V36, P11314, DOI 10.1021/bi9707685; Kuryatov A, 2005, MOL PHARMACOL, V68, P1839, DOI 10.1124/mol.105.012419; LABARCA C, 1995, NATURE, V376, P514, DOI 10.1038/376514a0; Mansvelder HD, 2002, NEURON, V33, P905, DOI 10.1016/S0896-6273(02)00625-6; MCMANUS OB, 1987, PFLUG ARCH EUR J PHY, V410, P530, DOI 10.1007/BF00586537; Moroni M, 2006, MOL PHARMACOL, V70, P755, DOI 10.1124/mol.106.023044; Nashmi R, 2007, J NEUROSCI, V27, P8202, DOI 10.1523/JNEUROSCI.2199-07.2007; Nelson ME, 2003, MOL PHARMACOL, V63, P332, DOI 10.1124/mol.63.2.332; Nowak MW, 1998, METHOD ENZYMOL, V293, P504; Romanelli MN, 2007, CHEMMEDCHEM, V2, P746, DOI 10.1002/cmdc.200600207; SINE SM, 1995, NEURON, V15, P229, DOI 10.1016/0896-6273(95)90080-2; Sixma TK, 2003, ANNU REV BIOPH BIOM, V32, P311, DOI 10.1146/annurev.biophys.32.110601.142536; Talley TT, 2006, BIOCHEMISTRY-US, V45, P8894, DOI 10.1021/bi060534y; Tapper AR, 2004, SCIENCE, V306, P1029, DOI 10.1126/science.1099420; Zhong WG, 1998, P NATL ACAD SCI USA, V95, P12088, DOI 10.1073/pnas.95.21.12088	31	279	286	2	122	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2009	458	7237					534	U10		10.1038/nature07768	http://dx.doi.org/10.1038/nature07768			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423YJ	19252481	Green Accepted			2022-12-01	WOS:000264532400050
J	Weijers, D; Friml, J				Weijers, Dolf; Friml, Jiri			SnapShot: Auxin Signaling and Transport	CELL			English	Editorial Material							PLANT DEVELOPMENT; RECEPTORS; TIR1		[Weijers, Dolf] Wageningen Univ, NL-6703 HA Wageningen, Netherlands; VIB, B-9052 Ghent, Belgium; [Friml, Jiri] Univ Ghent, B-9052 Ghent, Belgium	Wageningen University & Research; Flanders Institute for Biotechnology (VIB); Ghent University	Weijers, D (corresponding author), Wageningen Univ, NL-6703 HA Wageningen, Netherlands.		Weijers, Dolf/ABI-1332-2020; Friml, Jiri/D-9511-2012; Weijers, Dolf/A-2076-2010	Weijers, Dolf/0000-0003-4378-141X; Friml, Jiri/0000-0002-8302-7596; Weijers, Dolf/0000-0003-4378-141X				Badescu GO, 2006, TRENDS PLANT SCI, V11, P217, DOI 10.1016/j.tplants.2006.03.001; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Kleine-Vehn J, 2008, ANNU REV CELL DEV BI, V24, P447, DOI 10.1146/annurev.cellbio.24.110707.175254; Mockaitis K, 2008, ANNU REV CELL DEV BI, V24, P55, DOI 10.1146/annurev.cellbio.23.090506.123214; Szemenyei H, 2008, SCIENCE, V319, P1384, DOI 10.1126/science.1151461; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Tao Y, 2008, CELL, V133, P164, DOI 10.1016/j.cell.2008.01.049; Vieten A, 2007, TRENDS PLANT SCI, V12, P160, DOI 10.1016/j.tplants.2007.03.006	8	33	37	3	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 20	2009	136	6					1172	U200	1172.e1	10.1016/j.cell.2009.03.009	http://dx.doi.org/10.1016/j.cell.2009.03.009			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	422CE	19303857	Green Published, Bronze			2022-12-01	WOS:000264403900021
J	Wong, RHF; Chang, I; Hudak, CSS; Hyun, S; Kwan, HY; Sul, HS				Wong, Roger H. F.; Chang, Inhwan; Hudak, Carolyn S. S.; Hyun, Suzanne; Kwan, Hiu-Yee; Sul, Hei Sook			A Role of DNA-PK for the Metabolic Gene Regulation in Response to Insulin	CELL			English	Article							FATTY-ACID SYNTHASE; MITOCHONDRIAL GLYCEROL-3-PHOSPHATE ACYLTRANSFERASE; DEPENDENT PROTEIN-KINASE; UPSTREAM STIMULATORY FACTORS; HORMONAL-REGULATION; IN-VIVO; NUTRITIONAL REGULATION; TRANSGENIC MICE; E-BOX; PROMOTER	Fatty acid synthase (FAS) is a central enzyme in lipogenesis and transcriptionally activated in response to feeding and insulin signaling. The transcription factor USF is required for the activation of FAS transcription, and we show here that USF phosphorylation by DNA-PK, which is dephosphorylated by PP1 in response to feeding, triggers a switch-like mechanism. Under fasting conditions, USF-1 is deacetylated by HDAC9, causing promoter inactivation. In contrast, feeding induces the recruitment of DNA-PK to USF-1 and its phosphorylation, which then allows recruitment of P/CAF, resulting in USF-1 acetylation and FAS promoter activation. DNA break/repair components associated with USF induce transient DNA breaks during FAS activation. In DNA-PK-deficient SCID mice, feeding-induced USF-1 phosphorylation/acetylation, DNA breaks, and FAS activation leading to lipogenesis are impaired, resulting in decreased triglyceride levels. Our study demonstrates that a kinase central to the DNA damage response mediates metabolic gene activation.	[Wong, Roger H. F.; Chang, Inhwan; Hudak, Carolyn S. S.; Hyun, Suzanne; Kwan, Hiu-Yee; Sul, Hei Sook] Univ Calif Berkeley, Dept Nutrit Sci & Toxicol, Berkeley, CA 94720 USA; [Wong, Roger H. F.; Sul, Hei Sook] Univ Calif Berkeley, Comparat Biochem Program, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Sul, HS (corresponding author), Univ Calif Berkeley, Dept Nutrit Sci & Toxicol, Berkeley, CA 94720 USA.	hsul@nature.berkeley.edu	Wong, Hoi Fung Roger/F-2044-2013; Han, Zaiqi/AAI-2233-2019	KWAN, Hiu Yee/0000-0002-6088-7323	NIH [DK81098, DK75682]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075682, T32DK061918, R01DK081098] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grant DK81098 and DK75682 to H. S. S. We are grateful to Drs. Tony Kouzarides, Kathy Meek, Arthur Zelent, Angus Lamond, Moshe Oren, and Jerry Shay for various HAT, DNA-PK, HDAC9, PP1, -0.7 p53-Luc and Kus constructs, respectively. We thank YongEun Lee, Shelley Ling, Nicole Cho, Eunice Kim, Philip Lee, JiHyun (Amy) Cho, Aabid Farukhi, Sue Lee, and Helen Wong for excellent technical assistance; Jenny Huang, Aditi Ananth, Melanie Ma, Fanny Yan, and Nayoung Bae for assistance; and Drs. Mary Ann Williams, Jen-Chywan (Wally) Wang, and Maryam Ahmadian for critical reading of the manuscript. We also thank Dr. Donald Scott for nuclear run-on protocol, and we thank Dr. Daniel P. Cashman for critical discussions of the data and review of the manuscript.	Allen PB, 1998, J BIOL CHEM, V273, P4089, DOI 10.1074/jbc.273.7.4089; Brady MJ, 2001, RECENT PROG HORM RES, V56, P157, DOI 10.1210/rp.56.1.157; Casado M, 1999, J BIOL CHEM, V274, P2009, DOI 10.1074/jbc.274.4.2009; Collis SJ, 2005, ONCOGENE, V24, P949, DOI 10.1038/sj.onc.1208332; Corre S, 2005, PIGM CELL RES, V18, P337, DOI 10.1111/j.1600-0749.2005.00262.x; Danska JS, 1996, MOL CELL BIOL, V16, P5507; Dircks LK, 1997, BBA-LIPID LIPID MET, V1348, P17, DOI 10.1016/S0005-2760(97)00106-9; Douglas P, 2001, J BIOL CHEM, V276, P18992, DOI 10.1074/jbc.M011703200; Douglas P, 2007, MOL CELL BIOL, V27, P1581, DOI 10.1128/MCB.01962-06; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Feng JH, 2004, J BIOL CHEM, V279, P41189, DOI 10.1074/jbc.M406731200; Griffin MJ, 2007, J BIOL CHEM, V282, P5453, DOI 10.1074/jbc.M610566200; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Hashimoto M, 2003, J RADIAT RES, V44, P151, DOI 10.1269/jrr.44.151; JERKINS AA, 1995, J BIOL CHEM, V270, P1416, DOI 10.1074/jbc.270.38.22135; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Latasa MJ, 2000, P NATL ACAD SCI USA, V97, P10619, DOI 10.1073/pnas.180306597; Latasa MJ, 2003, MOL CELL BIOL, V23, P5896, DOI 10.1128/MCB.23.16.5896-5907.2003; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; Mejat A, 2005, NAT NEUROSCI, V8, P313, DOI 10.1038/nn1408; Moon YS, 2000, J BIOL CHEM, V275, P10121, DOI 10.1074/jbc.275.14.10121; MOUSTAID N, 1991, J BIOL CHEM, V266, P18550; MOUSTAID N, 1993, BIOCHEM J, V292, P767, DOI 10.1042/bj2920767; MOUSTAID N, 1994, J BIOL CHEM, V269, P5629; Pajukanta P, 2004, NAT GENET, V36, P371, DOI 10.1038/ng1320; PAULAUSKIS JD, 1989, J BIOL CHEM, V264, P574; PAULAUSKIS JD, 1988, J BIOL CHEM, V263, P7049; Printen JA, 1997, SCIENCE, V275, P1475, DOI 10.1126/science.275.5305.1475; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; SAWADOGO M, 1985, CELL, V43, P165, DOI 10.1016/0092-8674(85)90021-2; Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656; SHIN DH, 1991, J BIOL CHEM, V266, P23834; Soncini M, 1995, J BIOL CHEM, V270, P30339, DOI 10.1074/jbc.270.51.30339; Su HS, 2000, J NUTR, V130, p315S, DOI 10.1093/jn/130.2.315S; Sul HS, 1998, ANNU REV NUTR, V18, P331, DOI 10.1146/annurev.nutr.18.1.331; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; WANG D, 1995, J BIOL CHEM, V270, P28716, DOI 10.1074/jbc.270.48.28716; Wang D, 1997, J BIOL CHEM, V272, P26367, DOI 10.1074/jbc.272.42.26367; Wang D, 1998, J BIOL CHEM, V273, P25420, DOI 10.1074/jbc.273.39.25420; West AG, 2004, MOL CELL, V16, P453, DOI 10.1016/j.molcel.2004.10.005; YET SF, 1995, BIOCHEMISTRY-US, V34, P7303, DOI 10.1021/bi00022a003; YET SF, 1993, BIOCHEMISTRY-US, V32, P9486, DOI 10.1021/bi00087a029	42	178	185	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 20	2009	136	6					1056	1072		10.1016/j.cell.2008.12.040	http://dx.doi.org/10.1016/j.cell.2008.12.040			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	422CE	19303849	Green Accepted, Bronze			2022-12-01	WOS:000264403900012
J	Phillips, OL; Aragao, LEOC; Lewis, SL; Fisher, JB; Lloyd, J; Lopez-Gonzalez, G; Malhi, Y; Monteagudo, A; Peacock, J; Quesada, CA; van der Heijden, G; Almeida, S; Amaral, I; Arroyo, L; Aymard, G; Baker, TR; Banki, O; Blanc, L; Bonal, D; Brando, P; Chave, J; de Oliveira, ACA; Cardozo, ND; Czimczik, CI; Feldpausch, TR; Freitas, MA; Gloor, E; Higuchi, N; Jimenez, E; Lloyd, G; Meir, P; Mendoza, C; Morel, A; Neill, DA; Nepstad, D; Patino, S; Penuela, MC; Prieto, A; Ramirez, F; Schwarz, M; Silva, J; Silveira, M; Thomas, AS; ter Steege, H; Stropp, J; Vasquez, R; Zelazowski, P; Davila, EA; Andelman, S; Andrade, A; Chao, KJ; Erwin, T; Di Fiore, A; Honorio, E; Keeling, H; Killeen, TJ; Laurance, WF; Cruz, AP; Pitman, NCA; Vargas, PN; Ramirez-Angulo, H; Rudas, A; Salamao, R; Silva, N; Terborgh, J; Torres-Lezama, A				Phillips, Oliver L.; Aragao, Luiz E. O. C.; Lewis, Simon L.; Fisher, Joshua B.; Lloyd, Jon; Lopez-Gonzalez, Gabriela; Malhi, Yadvinder; Monteagudo, Abel; Peacock, Julie; Quesada, Carlos A.; van der Heijden, Geertje; Almeida, Samuel; Amaral, Ieda; Arroyo, Luzmila; Aymard, Gerardo; Baker, Tim R.; Banki, Olaf; Blanc, Lilian; Bonal, Damien; Brando, Paulo; Chave, Jerome; Alves de Oliveira, Atila Cristina; Cardozo, Nallaret Davila; Czimczik, Claudia I.; Feldpausch, Ted R.; Freitas, Maria Aparecida; Gloor, Emanuel; Higuchi, Niro; Jimenez, Eliana; Lloyd, Gareth; Meir, Patrick; Mendoza, Casimiro; Morel, Alexandra; Neill, David A.; Nepstad, Daniel; Patino, Sandra; Cristina Penuela, Maria; Prieto, Adriana; Ramirez, Fredy; Schwarz, Michael; Silva, Javier; Silveira, Marcos; Thomas, Anne Sota; ter Steege, Hans; Stropp, Juliana; Vasquez, Rodolfo; Zelazowski, Przemyslaw; Alvarez Davila, Esteban; Andelman, Sandy; Andrade, Ana; Chao, Kuo-Jung; Erwin, Terry; Di Fiore, Anthony; Honorio C, Euridice; Keeling, Helen; Killeen, Tim J.; Laurance, William F.; Pena Cruz, Antonio; Pitman, Nigel C. A.; Nunez Vargas, Percy; Ramirez-Angulo, Hirma; Rudas, Agustin; Salamao, Rafael; Silva, Natalino; Terborgh, John; Torres-Lezama, Armando			Drought Sensitivity of the Amazon Rainforest	SCIENCE			English	Article							TROPICAL FORESTS; CLIMATE-CHANGE; CARBON; MORTALITY; IMPACT; TREE; DYNAMICS; EXCHANGE; TRENDS; XYLEM	Amazon forests are a key but poorly understood component of the global carbon cycle. If, as anticipated, they dry this century, they might accelerate climate change through carbon losses and changed surface energy balances. We used records from multiple long-term monitoring plots across Amazonia to assess forest responses to the intense 2005 drought, a possible analog of future events. Affected forest lost biomass, reversing a large long-term carbon sink, with the greatest impacts observed where the dry season was unusually intense. Relative to pre-2005 conditions, forest subjected to a 100-millimeter increase in water deficit lost 5.3 megagrams of aboveground biomass of carbon per hectare. The drought had a total biomass carbon impact of 1.2 to 1.6 petagrams (1.2 x 10(15) to 1.6 x 10(15) grams). Amazon forests therefore appear vulnerable to increasing moisture stress, with the potential for large carbon losses to exert feedback on climate change.	[Phillips, Oliver L.; Lewis, Simon L.; Lloyd, Jon; Lopez-Gonzalez, Gabriela; Peacock, Julie; Quesada, Carlos A.; van der Heijden, Geertje; Baker, Tim R.; Feldpausch, Ted R.; Gloor, Emanuel; Patino, Sandra; Schwarz, Michael; Chao, Kuo-Jung; Keeling, Helen] Univ Leeds, Sch Geog, Leeds LS2 9JT, W Yorkshire, England; [Aragao, Luiz E. O. C.; Lewis, Simon L.; Fisher, Joshua B.; Lloyd, Jon; Malhi, Yadvinder; Morel, Alexandra; Silva, Javier; Zelazowski, Przemyslaw] Univ Oxford, Environm Change Inst, Sch Geog & Environm, Oxford OX1 3QY, England; [Monteagudo, Abel; Vasquez, Rodolfo; Pena Cruz, Antonio] Jardin Bot Missouri, Oxapampa, Pasco, Peru; [Quesada, Carlos A.; Amaral, Ieda; Alves de Oliveira, Atila Cristina; Andrade, Ana; Laurance, William F.] Inst Nacl de Pesquisas da Amazonia, BR-69060011 Manaus, Amazonas, Brazil; [Almeida, Samuel; Freitas, Maria Aparecida; Salamao, Rafael] Museu Paraense Emilio Goeldi, BR-66077830 Belem, Para, Brazil; [Amaral, Ieda; Andelman, Sandy] Conservat Int, Trop Ecol Assessment & Monitoring Network, Arlington, VA 22202 USA; [Arroyo, Luzmila; Killeen, Tim J.] Museo Hist Nat Noel Kempff Mercado, Santa Cruz, Bolivia; [Arroyo, Luzmila; Neill, David A.] Missouri Bot Garden, St Louis, MO 63166 USA; [Aymard, Gerardo] Univ Nacl Expt Los Llanos Occidentales Ezequiel Z, Herbario Univ PORTI, Programa Ciencias Agro & Mar, Mesa De Cavacas 3350, Portuguesa, Venezuela; [Banki, Olaf] Natl Herbarium Nederland, NL-3584 CS Utrecht, Netherlands; [Blanc, Lilian; Patino, Sandra] CIRAD, UMR EcoFoG, Kourou 97387, French Guiana; [Bonal, Damien] INRA, UMR EcoFoG, Kourou 97387, French Guiana; [Brando, Paulo] Inst Pesquisa Ambiental Amazonia, BR-66035 Belem, Para, Brazil; [Brando, Paulo] Univ Florida, Dept Bot, Gainesville, FL 32611 USA; [Brando, Paulo] Univ Florida, Sch Nat Resources & Environm, Gainesville, FL 32611 USA; [Chave, Jerome] Univ Toulouse 3, Lab EDB, F-31062 Toulouse, France; [Cardozo, Nallaret Davila; Ramirez, Fredy] Univ Nacl Amazonia Peruana, Iquitos, Loreto, Peru; [Czimczik, Claudia I.] Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA; [Higuchi, Niro] Inst Nacl de Pesquisas da Amazonia, Dept Silvicultura Trop, Manaus, Amazonas, Brazil; [Jimenez, Eliana; Cristina Penuela, Maria] Univ Nacl Colombia, Leticia, Amazonas, Colombia; [Lloyd, Gareth] Natl Australia Bank, UB2211, Docklands, Vic 3008, Australia; [Meir, Patrick] Univ Edinburgh, Sch Geosci, Edinburgh EH8 9XP, Midlothian, Scotland; [Mendoza, Casimiro] FOMABO Manejo Forestal Tierras Trop Bolivia, Sacta, Bolivia; [Neill, David A.] Jatun Sacha Fdn, Quito, Ecuador; [Nepstad, Daniel] Woods Hole Res Ctr, Falmouth, MA 02540 USA; [Nepstad, Daniel] Gordon & Betty Moore Fdn, San Francisco, CA 94129 USA; [Prieto, Adriana] Inst Alexander von Humboldt, Villa De Leyva, Boyaca, Colombia; [Schwarz, Michael] Univ Bayreuth, Bayreuth Ctr Ecol & Environm Res, D-95440 Bayreuth, Germany; [Silveira, Marcos] Univ Fed Acre, Dept Ciencias Nat, BR-69910900 Rio Branco, AC, Brazil; [Thomas, Anne Sota] Humboldt Univ, Fac Agr & Hort, D-10557 Berlin, Germany; [ter Steege, Hans; Stropp, Juliana] Univ Utrecht, Fac Sci, Dept Biol, Inst Environm Biol, NL-3584 CA Utrecht, Netherlands; [Alvarez Davila, Esteban] Univ Tolima, Fac Ingn Forestal, Ibague 546, Colombia; [Erwin, Terry] Smithsonian Inst, Natl Museum Nat Hist, Dept Entomol, Washington, DC 20013 USA; [Di Fiore, Anthony] NYU, Dept Anthropol, Ctr Study Human Origins, New York, NY 10003 USA; [Honorio C, Euridice] Inst Invest Amazonia Peruana, Loreto, Peru; [Laurance, William F.] Smithsonian Trop Res Inst, Balboa, Ancon, Panama; [Pitman, Nigel C. A.] Ctr Invest & Capacitac Rio de Los Amigos, Madre De Dios, Peru; [Nunez Vargas, Percy] Univ Nacl San Antonio Abad Cusco, Cuzco, Peru; [Ramirez-Angulo, Hirma; Torres-Lezama, Armando] Univ Los Andes, Fac Ciencias Forestales, INDEFOR, Merida, Venezuela; [Rudas, Agustin] Univ Nacl Colombia, Inst Ciencias Nat, Bogota, Colombia; [Silva, Natalino] Serv Florestal Brasileiro, BR-70818900 Brasilia, DF, Brazil; [Terborgh, John] Duke Univ, Ctr Trop Conservat, Durham, NC 27708 USA	University of Leeds; University of Oxford; Institute Nacional de Pesquisas da Amazonia; Museu Paraense Emilio Goeldi; Conservation International; Missouri Botanical Gardens; CIRAD; INRAE; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universidad Nacional de la Amazonia Peruana; University of California System; University of California Irvine; Institute Nacional de Pesquisas da Amazonia; Universidad Nacional de Colombia; University of Edinburgh; Woods Hole Research Center; University of Bayreuth; Universidade Federal do Acre (UFAC); Humboldt University of Berlin; Utrecht University; Universidad del Tolima; Smithsonian Institution; Smithsonian National Museum of Natural History; New York University; Smithsonian Institution; Smithsonian Tropical Research Institute; Universidad Nacional de San Antonio Abad del Cusco; University of Los Andes Venezuela; Universidad Nacional de Colombia; Duke University	Phillips, OL (corresponding author), Univ Leeds, Sch Geog, Leeds LS2 9JT, W Yorkshire, England.	o.phillips@leeds.ac.uk	van der Heijden, Geertje/AAB-4102-2019; Morel, Alexandra/J-4071-2019; Pitman, Nigel C A/A-7681-2008; Phillips, Oliver L/A-1523-2011; Feldpausch, Ted/ABH-3123-2020; Meir, Patrick/J-8344-2012; Higuchi, Niro/ABC-8890-2020; Lloyd, Jonathan J/F-8893-2010; Coronado, Eurídice Nora Honorio/K-3412-2015; Aymard, Gerardo/ABE-9203-2020; BONAL, Damien/B-2384-2009; Alvarez-Davila, Esteban/AAP-4231-2020; Laurance, William F/B-2709-2012; Feldpausch, Ted/D-3436-2009; Stropp, Juliana/AAF-7946-2020; Steege, Hans ter/B-5866-2011; Andrade, Ana Cristina/E-8218-2013; Brando, Paulo M/C-4302-2012; aragao, luiz eoc/G-8387-2012; Brando, Paulo/AAC-9396-2019; Higuchi, Niro/J-1287-2016; Higuchi, Niro/ABC-9134-2020; Silveira, Marcos/H-7906-2013; Ramirez, Fredy/R-1522-2016	van der Heijden, Geertje/0000-0002-2110-5173; Morel, Alexandra/0000-0002-0905-8079; Pitman, Nigel C A/0000-0002-9211-2880; Phillips, Oliver L/0000-0002-8993-6168; Feldpausch, Ted/0000-0002-6631-7962; Lloyd, Jonathan J/0000-0002-5458-9960; Coronado, Eurídice Nora Honorio/0000-0003-2314-590X; Aymard, Gerardo/0000-0001-9405-0508; Alvarez-Davila, Esteban/0000-0001-9032-0099; Laurance, William F/0000-0003-4430-9408; Feldpausch, Ted/0000-0002-6631-7962; Stropp, Juliana/0000-0002-2831-4066; Steege, Hans ter/0000-0002-8738-2659; Brando, Paulo M/0000-0001-8952-7025; aragao, luiz eoc/0000-0002-4134-6708; Brando, Paulo/0000-0001-8952-7025; Higuchi, Niro/0000-0002-1203-4502; Higuchi, Niro/0000-0002-1203-4502; Silveira, Marcos/0000-0003-0485-7872; Penuela Mora, Maria Cristina/0000-0002-9611-1359; Silva, Jose/0000-0003-4068-2432; Czimczik, Claudia/0000-0002-8251-6603; Banki, Olaf/0000-0001-6197-9951; Lopez-Gonzalez, Gabriela/0000-0002-0814-8830; Zelazowski, Przemyslaw/0000-0003-0442-2529; Neill, David Alan/0000-0002-5143-9430; Jimenez, Eliana M./0000-0002-8610-1771; Lewis, Simon/0000-0002-8066-6851; Fisher, Joshua/0000-0003-4734-9085; Ramirez, Fredy/0000-0003-2441-9984; Blanc, Lilian/0000-0003-3605-4230	Leverhulme Trust; NERC [NE/B503384/1, NE/D01025X/1, NER/A/S/2003/00608/2]; WOTRO [W84-581]; Royal Society; University of Leeds; Gordon and Betty Moore Foundation; NERC [NE/D010306/1] Funding Source: UKRI; Natural Environment Research Council [NE/D01025X/1, NE/B503384/1, NE/D010306/1] Funding Source: researchfish	Leverhulme Trust(Leverhulme Trust); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); WOTRO; Royal Society(Royal Society of London); University of Leeds; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This paper is a product of the RAINFOR network. Funding for the 2006 recensuses came primarily from a Natural Environment Research Council (NERC) Urgency Grant. The results summarized here also depend on contributions from numerous field assistants and rural communities in Brazil, Bolivia, Colombia, Ecuador, French Guiana, Guyana, Peru, and Venezuela, many previously acknowledged. I. Huamantupa, N. Jaramillo, N. Saavedram (Peru), V. Pena (Ecuador), J.-C. Arias, and D. Navarrete (Colombia) assisted with recent censuses. We thank CNPQ (Brazil), MCT (Brazil), Ministerio del Medio Ambiente, Vivienda y Desarrollo Territorial (Colombia), Ministerio de Ambiente (Ecuador), the Forestry Commission (Guyana), INRENA (Peru), and Ministerio del Ambiente para el Poder Popular (Venezuela) for research permissions, and the Large Scale Biosphere-Atmosphere Experiment in Amazonia (LBA) for logistical support. This paper was supported by the Leverhulme Trust (O.L.P.), NERC grants NE/B503384/1 and NE/D01025X/1 (O.L.P.), NER/A/S/2003/00608/2 (Y.M.), WOTRO (W84-581) (H.t.S., O.B.), the Royal Society (S.L.L., Y.M.), University of Leeds (T.R.B., K.-J.C., G.L.-G.), and a Gordon and Betty Moore Foundation grant to RAINFOR. Some of the data used in these analyses were collected with support from the TEAM Network of Conservation International, funded by the Gordon and Betty Moore Foundation. We thank D. Galbraith, L. Anderson, C. Michelaki, J. Ratnam, and M. Wagner for discussions; three anonymous reviewers for comments on the manuscript; M. Garcia-Hernandez for help in managing co-author contributions; and A. Manson and D. Appleyard for help in creating the figures.	Aragao LEOC, 2007, GEOPHYS RES LETT, V34, DOI [10.1029/2006GL028946, 10.1029/2006GL028946.]; Baker TR, 2004, PHILOS T R SOC B, V359, P353, DOI 10.1098/rstb.2003.1422; Bonal D, 2008, GLOBAL CHANGE BIOL, V14, P1917, DOI 10.1111/j.1365-2486.2008.01610.x; Brando PM, 2008, PHILOS T R SOC B, V363, P1839, DOI 10.1098/rstb.2007.0031; Christensen J.H., 2007, CLIMATE CHANGE 2007; Condit R, 2004, J TROP ECOL, V20, P51, DOI 10.1017/S0266467403001081; CONDIT R, 1995, ECOL MONOGR, V65, P419, DOI 10.2307/2963497; Cox PM, 2008, NATURE, V453, P212, DOI 10.1038/nature06960; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Engelbrecht BMJ, 2007, NATURE, V447, P80, DOI 10.1038/nature05747; Graham EA, 2003, P NATL ACAD SCI USA, V100, P572, DOI 10.1073/pnas.0133045100; Hacke UG, 2001, OECOLOGIA, V126, P457, DOI 10.1007/s004420100628; Harris PP, 2008, PHILOS T R SOC B, V363, P1753, DOI 10.1098/rstb.2007.0037; Hasler N, 2007, J HYDROMETEOROL, V8, P380, DOI 10.1175/JHM587.1; Huete AR, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025583; Ichii K, 2005, GLOBAL PLANET CHANGE, V48, P274, DOI 10.1016/j.gloplacha.2005.02.005; Lewis SL, 2004, PHILOS T ROY SOC B, V359, P421, DOI 10.1098/rstb.2003.1431; Li WH, 2008, PHILOS T R SOC B, V363, P1767, DOI 10.1098/rstb.2007.0022; Malhi Y, 2000, TRENDS ECOL EVOL, V15, P332, DOI 10.1016/S0169-5347(00)01906-6; Malhi Y, 2008, SCIENCE, V319, P169, DOI 10.1126/science.1146961; Marengo JA, 2008, J CLIMATE, V21, P495, DOI 10.1175/2007JCLI1600.1; McDowell N, 2008, NEW PHYTOL, V178, P719, DOI 10.1111/j.1469-8137.2008.02436.x; Meir P, 2008, PHILOS T R SOC B, V363, P1849, DOI 10.1098/rstb.2007.0021; *NAT OC ATM ADM, 2008, TRENDS ATM CARB DIOX; Nemani RR, 2003, SCIENCE, V300, P1560, DOI 10.1126/science.1082750; Nepstad DC, 2007, ECOLOGY, V88, P2259, DOI 10.1890/06-1046.1; Phillips OL, 1998, SCIENCE, V282, P439, DOI 10.1126/science.282.5388.439; Salazar LF, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029695; Saleska SR, 2007, SCIENCE, V318, P612, DOI 10.1126/science.1146663; TYREE MT, 1989, ANNU REV PLANT PHYS, V40, P19, DOI 10.1146/annurev.pp.40.060189.000315; von Randow C, 2004, THEOR APPL CLIMATOL, V78, P5, DOI 10.1007/s00704-004-0041-z; Williamson GB, 2000, CONSERV BIOL, V14, P1538, DOI 10.1046/j.1523-1739.2000.99298.x	32	1156	1188	27	835	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2009	323	5919					1344	1347		10.1126/science.1164033	http://dx.doi.org/10.1126/science.1164033			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414PC	19265020	Green Published, Green Accepted, Green Submitted			2022-12-01	WOS:000263876700042
J	Hugonnet, JE; Tremblay, LW; Boshoff, HI; Barry, CE; Blanchard, JS				Hugonnet, Jean-Emmanuel; Tremblay, Lee W.; Boshoff, Helena I.; Barry, Clifton E., III; Blanchard, John S.			Meropenem-Clavulanate Is Effective Against Extensively Drug-Resistant Mycobacterium tuberculosis	SCIENCE			English	Article							BETA-LACTAM ANTIBIOTICS; PERSISTENCE; INHIBITION; ACID	beta-lactam antibiotics are ineffective against Mycobacterium tuberculosis, being rapidly hydrolyzed by the chromosomally encoded blaC gene product. The carbapenem class of beta-lactams are very poor substrates for BlaC, allowing us to determine the three-dimensional structure of the covalent BlaC-meropenem covalent complex at 1.8 angstrom resolution. When meropenem was combined with the beta-lactamase inhibitor clavulanate, potent activity against laboratory strains of M. tuberculosis was observed [minimum inhibitory concentration (MICmeropenem) less than 1 microgram per milliliter], and sterilization of aerobically grown cultures was observed within 14 days. In addition, this combination exhibited inhibitory activity against anaerobically grown cultures that mimic the "persistent" state and inhibited the growth of 13 extensively drug-resistant strains of M. tuberculosis at the same levels seen for drug-susceptible strains. Meropenem and clavulanate are Food and Drug Administration-approved drugs and could potentially be used to treat patients with currently untreatable disease.	[Hugonnet, Jean-Emmanuel; Tremblay, Lee W.; Blanchard, John S.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Boshoff, Helena I.; Barry, Clifton E., III] NIAID, TB Res Stn, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA	Yeshiva University; Albert Einstein College of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Blanchard, JS (corresponding author), Albert Einstein Coll Med, Dept Biochem, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	blanchar@aecom.yu.edu	Barry, Clifton E/H-3839-2012; Barry, Clifton E/ABE-7992-2020; HUGONNET, Jean-Emmanuel/ABC-7914-2021; HUGONNET, Jean-Emmanuel/H-3581-2014	Barry, Clifton E/0000-0002-2927-270X; Barry, Clifton E/0000-0002-2927-270X; HUGONNET, Jean-Emmanuel/0000-0003-4150-0944; HUGONNET, Jean-Emmanuel/0000-0003-4150-0944	NIH [AI33696]; National Institute of Allergy and Infectious Diseases; Bill and Melinda Gates Foundation; Wellcome Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000693, ZIAAI000783, R01AI033696] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors wish to thank J. Chan and E. Russel for help in the Wayne model studies and H. Xiao for assistance in mass spectrometry. This work was supported partially by the NIH (AI33696 to J.S.B.); in part by the Intramural Research Program of the NIH, National Institute of Allergy and Infectious Diseases; and in part by a grant from the Bill and Melinda Gates Foundation and the Wellcome Trust through the Grand Challenges in Global Health Initiative. A provisional U.S. patent application was filed on 27 May 2008 related to this work. Structure coordinates have been deposited as Protein Data Bank identification code 3DWZ.	Boshoff HIM, 2005, NAT REV MICROBIOL, V3, P70, DOI 10.1038/nrmicro1065; Bush K, 1998, ADV EXP MED BIOL, V456, P71; Chambers HF, 1998, CLIN INFECT DIS, V26, P874, DOI 10.1086/513945; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; CYNAMON MH, 1983, ANTIMICROB AGENTS CH, V24, P429, DOI 10.1128/AAC.24.3.429; Dincer I, 2004, INT J ANTIMICROB AG, V23, P408, DOI 10.1016/j.ijantimicag.2003.09.023; EASTON CJ, 1982, BIOCHEMISTRY-US, V21, P2857, DOI 10.1021/bi00541a008; Fleming A, 1929, BRIT J EXP PATHOL, V10, P226; Flores AR, 2005, MICROBIOL-SGM, V151, P521, DOI 10.1099/mic.0.27629-0; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Gomez JE, 2004, TUBERCULOSIS, V84, P29, DOI 10.1016/j.tube.2003.08.003; Hugonnet JE, 2007, BIOCHEMISTRY-US, V46, P11998, DOI 10.1021/bi701506h; Jeon CY, 2008, CLIN INFECT DIS, V46, P42, DOI 10.1086/524017; Lavollay M, 2008, J BACTERIOL, V190, P4360, DOI 10.1128/JB.00239-08; Segura C, 1998, ANTIMICROB AGENTS CH, V42, P1524, DOI 10.1128/AAC.42.6.1524; Tremblay LW, 2008, BIOCHEMISTRY-US, V47, P5312, DOI 10.1021/bi8001055; Wang F, 2006, ANTIMICROB AGENTS CH, V50, P2762, DOI 10.1128/AAC.00320-06; Wayne LG, 1996, INFECT IMMUN, V64, P2062, DOI 10.1128/IAI.64.6.2062-2069.1996; Zhang Y, 2004, FRONT BIOSCI-LANDMRK, V9, P1136, DOI 10.2741/1291	19	366	380	3	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2009	323	5918					1215	1218		10.1126/science.1167498	http://dx.doi.org/10.1126/science.1167498			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411XT	19251630	Green Accepted			2022-12-01	WOS:000263687600039
J	Varagunam, M; Yaqoob, MM; Dohler, B; Opelz, G				Varagunam, Mira; Yaqoob, Muhammad M.; Doehler, Bernd; Opelz, Gerhard			C3 Polymorphisms and Allograft Outcome in Renal Transplantation.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COMPLEMENT C3; MOLECULAR ANALYSIS; REJECTION; ALLOTYPES; COMPONENT	Background: Complement activation plays a role in the development of chronic allograft nephropathy, a common cause of late allograft loss. The role of two complement component 3 (C3) allotypes, called C3F (fast) and C3S (slow) on the basis of their electrophoretic motility, in the long-term outcome of renal allografts remains controversial. Methods: We selected a random sample of 1147 donor and recipient pairs from the Collaborative Transplant Study DNA bank, and their DNA specimens were genotyped for the C3F and C3S alleles. The genotyping results were analyzed according to allograft outcome. Transplants were divided into four groups, according to the recipient and donor genotypes: SS recipient and FS or FF donor (the standard for comparison, since this combination has been reported to have the best outcome), SS recipient and donor, FS or FF recipient and SS donor, and FS or FF recipient and donor. Results: Baseline characteristics of the four transplant groups were similar. The hazard ratios for allograft survival in the SS recipient and FS or FF donor group as compared with the other three groups (SS recipient and donor, FS or FF recipient and SS donor, and FS or FF recipient and donor) were not significant: 0.90 (95% confidence interval [CI], 0.7 to 1.14; P=0.33), 0.87 (95% CI, 0.65 to 1.16; P=0.33), and 0.89 (95% CI, 0.65 to 1.23; P=0.48), respectively. The four groups had similar patient-survival rates and similar cumulative rates of acute rejection and allograft dysfunction, as assessed by means of serum creatinine levels. Conclusions: Our results suggest that transplantation of FS or FF kidneys to SS recipients is not advantageous, possibly because chronic allograft nephropathy is a multifaceted disease involving the interplay of many biologic pathways. N Engl J Med 2009;360:874-80.	[Varagunam, Mira; Yaqoob, Muhammad M.] Barts & London Queen Marys Sch Med & Dent, London, England; [Varagunam, Mira; Yaqoob, Muhammad M.] Natl Hlth Serv Trust, London, England; [Doehler, Bernd; Opelz, Gerhard] Univ Heidelberg, Dept Transplantat Immunol, Heidelberg, Germany	University of London; Queen Mary University London; Ruprecht Karls University Heidelberg	Yaqoob, MM (corresponding author), Royal London Hosp, Dept Renal Med & Transplantat, London E1 1BB, England.	m.m.yaqoob@qmul.ac.uk			Renal Unit, Barts; London National Health Service Trust; Department of Transplantation Immunology, University of Heidelberg	Renal Unit, Barts; London National Health Service Trust; Department of Transplantation Immunology, University of Heidelberg	Supported by grants from the Renal Unit, Barts and the London National Health Service Trust, and the Department of Transplantation Immunology, University of Heidelberg.; No potential conflict of interest relevant to this article was reported.	ANDREWS PA, 1995, EUR J IMMUNOL, V25, P1087, DOI 10.1002/eji.1830250434; Andrews PA, 1995, TRANSPLANTATION, V60, P1342; ARVILOMMI H, 1974, NATURE, V251, P740, DOI 10.1038/251740a0; BARTOK I, 1995, J IMMUNOL, V154, P5367; BOTTO M, 1990, J EXP MED, V172, P1011, DOI 10.1084/jem.172.4.1011; Brown KM, 2006, NEW ENGL J MED, V354, P2014, DOI 10.1056/NEJMoa052825; Feucht HE, 2003, AM J TRANSPLANT, V3, P646, DOI 10.1034/j.1600-6143.2003.00171.x; FINN JE, 1994, NEPHROL DIAL TRANSPL, V9, P1564; Heinold A, 2008, AM J TRANSPLANT, V8, P95, DOI 10.1111/j.1600-6143.2007.02042.x; POZNANSKY MC, 1989, J IMMUNOL, V143, P3860; POZNANSKY MC, 1989, J IMMUNOL, V143, P1254; Pratt JR, 2002, NAT MED, V8, P582, DOI 10.1038/nm0602-582; RAMBAUSEK M, 1987, Nephrology Dialysis Transplantation, V2, P208; Sacks SH, 2003, CURR OPIN IMMUNOL, V15, P487, DOI 10.1016/S0952-7915(03)00100-6; Soulillou J, 2006, NEW ENGL J MED, V354, P2060, DOI 10.1056/NEJMe068066; Tang S, 1999, J IMMUNOL, V162, P4336; TEISBERG P, 1970, VOX SANG, V19, P47, DOI 10.1111/j.1423-0410.1970.tb01494.x; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618; Yates PJ, 2006, TRANSPL IMMUNOL, V16, P148, DOI 10.1016/j.trim.2006.10.001	19	60	62	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 26	2009	360	9					874	880		10.1056/NEJMoa0801861	http://dx.doi.org/10.1056/NEJMoa0801861			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	411CD	19246358	Bronze			2022-12-01	WOS:000263624700005
J	Sidebotham, P; Pearson, G				Sidebotham, Peter; Pearson, Gale			Responding to and learning from childhood deaths	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							UNEXPECTED DEATH; SUDDEN		[Sidebotham, Peter] Univ Warwick, Hlth Sci Res Inst, Coventry CV4 7AL, W Midlands, England; [Pearson, Gale] Birmingham Childrens Hosp, Birmingham B4 6NH, W Midlands, England	University of Warwick; University of Birmingham	Sidebotham, P (corresponding author), Univ Warwick, Hlth Sci Res Inst, Coventry CV4 7AL, W Midlands, England.	p.sidebotham@warwick.ac.uk	Sidebotham, Peter D/E-3011-2010	Sidebotham, Peter D/0000-0003-4891-6926				Axford N., 2005, CHILD DEATH SIGNIFIC; Bunting L., 2005, CHILD ABUSE REV, V14, P82, DOI DOI 10.1002/CAR.886; Dent A, 1996, ARCH DIS CHILD, V74, P522, DOI 10.1136/adc.74.6.522; *DEP ED SKILLS, 2006, WORK TOG SAF CHILDR; Durfee M, 2002, CHILD ABUSE NEGLECT, V26, P619, DOI 10.1016/S0145-2134(02)00337-X; Fleming P., 2000, SUDDEN UNEXPECTED DE; Livesey A, 2005, BRIT MED J, V330, P227, DOI 10.1136/bmj.38323.652523.F7; *OFF NAT STAT, 2007, MORT STAT CHILDH INF; Onwuachi-Saunders C, 1999, Inj Prev, V5, P276; PEARSON GEE, 2008, WHY CHILDREN DIE PIL; Reder P, 1999, LOST INNOCENTS FOLLO; Rimsza ME, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.1.e11; *ROY COLL PATH ROY, 2004, SUDD UN DEATH INF MU; SIDEBOTHAM P, 2007, UNEXPECTED DEATH CHI, P97; SIDEBOTHAM P, 2007, UNEXPECTED DEATH CHI, P10; Sidebotham P., 2008, PREVENTING CHILDHOOD	16	15	15	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 23	2009	338								b531	10.1136/bmj.b531	http://dx.doi.org/10.1136/bmj.b531			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	417DP	19237412				2022-12-01	WOS:000264056000018
J	Pollock, JD; Koustova, E; Hoffman, A; Shurtleff, D; Volkow, ND				Pollock, Jonathan D.; Koustova, Elena; Hoffman, Allison; Shurtleff, David; Volkow, Nora D.			Treatments for nicotine addiction should be a top priority	LANCET			English	Editorial Material									[Pollock, Jonathan D.; Koustova, Elena; Hoffman, Allison; Shurtleff, David; Volkow, Nora D.] NIDA, NIH, US Dept HHS, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Pollock, JD (corresponding author), NIDA, NIH, US Dept HHS, Bethesda, MD 20892 USA.	jpollock@mail.nih.gov	Pollock, Jonathan D/B-1554-2009		NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000550] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 DA999999] Funding Source: Medline	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Armour B. S., 2005, Morbidity and Mortality Weekly Report, V54, P625; BONNIE RJ, 2007, ENDING TOBACCO PROBL; *CDCP, 1965, SMOK TOB US PERC AD; *INF HEALTHC, 2007, THER AN PHARM R D AN; SACHS DP, 2008, CHEST, V134; Shiffman S, 2008, AM J PREV MED, V34, P102, DOI 10.1016/j.amepre.2007.09.033; United States Department of Health and Human Services, 2000, HLTH PEOPL 2010, V2; Welch HG, 2000, JAMA-J AM MED ASSOC, V283, P2975, DOI 10.1001/jama.283.22.2975	8	17	17	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 15	2009	374	9689					513	514		10.1016/S0140-6736(09)60352-4	http://dx.doi.org/10.1016/S0140-6736(09)60352-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	484BX	19394686	Green Accepted			2022-12-01	WOS:000269019400010
J	Lopez-Aviles, S; Kapuy, O; Novak, B; Uhlmann, F				Lopez-Aviles, Sandra; Kapuy, Orsolya; Novak, Bela; Uhlmann, Frank			Irreversibility of mitotic exit is the consequence of systems-level feedback	NATURE			English	Article							ANAPHASE PROMOTING COMPLEX; CELL-CYCLE; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; PHOSPHATASE CDC14; PROTEIN-KINASE; PHOSPHORYLATION; APC; PROTEOLYSIS; INHIBITOR	The eukaryotic cell cycle comprises an ordered series of events, orchestrated by the activity of cyclin-dependent kinases (Cdks), leading from chromosome replication during S phase to their segregation in mitosis. The unidirectionality of cell-cycle transitions is fundamental for the successful completion of this cycle. It is thought that irrevocable proteolytic degradation of key cell-cycle regulators makes cell-cycle transitions irreversible, thereby enforcing directionality(1-3). Here we have experimentally examined the contribution of cyclin proteolysis to the irreversibility of mitotic exit, the transition from high mitotic Cdk activity back to low activity in G1. We show that forced cyclin destruction in mitotic budding yeast cells efficiently drives mitotic exit events. However, these remain reversible after termination of cyclin proteolysis, with recovery of the mitotic state and cyclin levels. Mitotic exit becomes irreversible only after longer periods of cyclin degradation, owing to activation of a double-negative feedback loop involving the Cdk inhibitor Sic1 (refs 4, 5). Quantitative modelling suggests that feedback is required to maintain low Cdk activity and to prevent cyclin resynthesis. Our findings demonstrate that the unidirectionality of mitotic exit is not the consequence of proteolysis but of systems-level feedback required to maintain the cell cycle in a new stable state.	[Lopez-Aviles, Sandra; Uhlmann, Frank] Canc Res UK London Res Inst, Chromosome Segregat Lab, London WC2A 3PX, England; [Kapuy, Orsolya; Novak, Bela] Univ Oxford, Dept Biochem, Oxford Ctr Integrat Syst Biol, Oxford OX1 3QU, England; [Kapuy, Orsolya] Budapest Univ Technol & Econ, H-1521 Budapest, Hungary	Cancer Research UK; University of Oxford; Budapest University of Technology & Economics	Uhlmann, F (corresponding author), Canc Res UK London Res Inst, Chromosome Segregat Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	frank.uhlmann@cancer.org.uk	Novak, Bela/D-5365-2009	Novak, Bela/0000-0002-6961-1366; Lopez-Aviles, Sandra/0000-0002-0498-1331; Uhlmann, Frank/0000-0002-3527-6619	European Commission Marie Curie Individual Fellowship; BBSRC; EC FP7	European Commission Marie Curie Individual Fellowship(European CommissionEuropean Commission Joint Research Centre); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EC FP7(European Commission)	We thank C. Bouchoux, J. Kilmartin, E. Schwob and W. Zachariae for antibodies and constructs, and members of our laboratory for discussion and critical reading of the manuscript. This work was supported by a European Commission Marie Curie Individual Fellowship to S. L.-A., and the BBSRC and EC FP7 (O. K.).	Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Cross FR, 2002, MOL BIOL CELL, V13, P52, DOI 10.1091/mbc.01-05-0265; DONOVAN JD, 1994, GENE DEV, V8, P1640, DOI 10.1101/gad.8.14.1640; FOIANI M, 1994, MOL CELL BIOL, V14, P923, DOI 10.1128/MCB.14.2.923; Higuchi T, 2005, NATURE, V433, P171, DOI 10.1038/nature03240; IRNIGER S, 1995, CELL, V81, P269, DOI 10.1016/0092-8674(95)90337-2; Jaspersen SL, 1999, CURR BIOL, V9, P227, DOI 10.1016/S0960-9822(99)80111-0; Juang YL, 1997, SCIENCE, V275, P1311, DOI 10.1126/science.275.5304.1311; Khmelinskii A, 2007, J CELL BIOL, V177, P981, DOI 10.1083/jcb.200702145; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; Kramer ER, 2000, MOL BIOL CELL, V11, P1555, DOI 10.1091/mbc.11.5.1555; MOLL T, 1991, CELL, V66, P743, DOI 10.1016/0092-8674(91)90118-I; Nguyen VQ, 2001, NATURE, V411, P1068, DOI 10.1038/35082600; NOVAK B, 1993, J CELL SCI, V106, P1153; Novak B, 2007, NAT CELL BIOL, V9, P724, DOI 10.1038/ncb0707-724; Pereira G, 2003, SCIENCE, V302, P2120, DOI 10.1126/science.1091936; Pic-Taylor A, 2004, MOL CELL BIOL, V24, P10036, DOI 10.1128/MCB.24.22.10036-10046.2004; Pomerening JR, 2008, MOL BIOL CELL, V19, P3426, DOI 10.1091/mbc.E08-02-0172; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Potapova TA, 2006, NATURE, V440, P954, DOI 10.1038/nature04652; Queralt E, 2006, CELL, V125, P719, DOI 10.1016/j.cell.2006.03.038; Reed SI, 2003, NAT REV MOL CELL BIO, V4, P855, DOI 10.1038/nrm1246; Reynolds D, 2003, GENE DEV, V17, P1789, DOI 10.1101/gad.1074103; Schwab M, 2001, EMBO J, V20, P5165, DOI 10.1093/emboj/20.18.5165; Shirayama M, 1998, EMBO J, V17, P1336, DOI 10.1093/emboj/17.5.1336; Shirayama M, 1999, NATURE, V402, P203, DOI 10.1038/46080; Verma R, 1997, SCIENCE, V278, P455, DOI 10.1126/science.278.5337.455; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Yeong FM, 2000, MOL CELL, V5, P501, DOI 10.1016/S1097-2765(00)80444-X; Zachariae W, 1998, SCIENCE, V282, P1721, DOI 10.1126/science.282.5394.1721	30	75	75	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2009	459	7246					592	595		10.1038/nature07984	http://dx.doi.org/10.1038/nature07984			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449ZS	19387440	Green Accepted			2022-12-01	WOS:000266370500044
J	Klin, A; Lin, DJ; Gorrindo, P; Ramsay, G; Jones, W				Klin, Ami; Lin, David J.; Gorrindo, Phillip; Ramsay, Gordon; Jones, Warren			Two-year-olds with autism orient to non-social contingencies rather than biological motion	NATURE			English	Article							PERCEPTION; FACE; AREA; RECOGNITION; FIXATION; DEFICITS; INFANTS	Typically developing human infants preferentially attend to biological motion within the first days of life(1). This ability is highly conserved across species(2,3) and is believed to be critical for filial attachment and for detection of predators(4). The neural underpinnings of biological motion perception are overlapping with brain regions involved in perception of basic social signals such as facial expression and gaze direction(5), and preferential attention to biological motion is seen as a precursor to the capacity for attributing intentions to others(6). However, in a serendipitous observation(7), we recently found that an infant with autism failed to recognize point-light displays of biological motion, but was instead highly sensitive to the presence of a non-social, physical contingency that occurred within the stimuli by chance. This observation raised the possibility that perception of biological motion may be altered in children with autism from a very early age, with cascading consequences for both social development and the lifelong impairments in social interaction that are a hallmark of autism spectrum disorders(8). Here we show that two-year-olds with autism fail to orient towards point-light displays of biological motion, and their viewing behaviour when watching these point-light displays can be explained instead as a response to non-social, physical contingencies-physical contingencies that are disregarded by control children. This observation has far-reaching implications for understanding the altered neurodevelopmental trajectory of brain specialization in autism(9).	[Klin, Ami; Lin, David J.; Gorrindo, Phillip; Ramsay, Gordon; Jones, Warren] Yale Univ, Sch Med, Yale Child Study Ctr, New Haven, CT 06519 USA; [Ramsay, Gordon] Haskins Labs Inc, New Haven, CT 06511 USA; [Jones, Warren] Yale Univ, Sch Med, Interdepartmental Neurosci Program, New Haven, CT 06520 USA	Yale University; Yale University; Haskins Laboratories; Yale University	Klin, A (corresponding author), Yale Univ, Sch Med, Yale Child Study Ctr, New Haven, CT 06519 USA.	ami.klin@yale.edu; warren.jones@yale.edu		Gorrindo, Phillip/0000-0002-0296-8790	National Institutes of Mental Health [U54-MH66494]; Autism Speaks; Simons Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH066494] Funding Source: NIH RePORTER	National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Autism Speaks; Simons Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by a grant from the National Institutes of Mental Health (U54-MH66494), by Autism Speaks (piloting of methods), and by the Simons Foundation ( current methodological developments). We wish to thank the families of the children included in this study for their time and participation. We would also like to thank F. Shic for conceptual discussions and thoughts on methods. We would like to thank L. Dickholtz, A. Kord, L. Else and M. Campisi for their assistance in creating the biological motion stimuli. We also wish to thank K. Carr, A. Blank, A. Bhatt, S. Shultz and K. Knoch for their help in this research project, and our colleagues K. Chawarska, R. Paul and F. Volkmar for conceptual discussions and for their contributions to the clinical characterization of the samples.	Bidet-Caulet A, 2005, NEUROIMAGE, V28, P132, DOI 10.1016/j.neuroimage.2005.06.018; BLAKE R, 1993, PSYCHOL SCI, V4, P54, DOI 10.1111/j.1467-9280.1993.tb00557.x; Blake R, 2003, PSYCHOL SCI, V14, P151, DOI 10.1111/1467-9280.01434; BREDIN H, 2006, IET INT C VIS INF EN, P255; Chawarska K., 2008, AUTISM SPECTRUM DISO; CHEN PY, 2002, CORRELATION PARAMETR, P20; Dalton KM, 2005, NAT NEUROSCI, V8, P519, DOI 10.1038/nn1421; Driver J, 2000, CURR BIOL, V10, pR731, DOI 10.1016/S0960-9822(00)00740-5; FOX R, 1982, SCIENCE, V218, P486, DOI 10.1126/science.7123249; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; Hershey J, 2000, ADV NEUR IN, V12, P813; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; Johnson MH, 2006, CURR BIOL, V16, pR376, DOI 10.1016/j.cub.2006.04.008; Johnson MH, 2001, NAT REV NEUROSCI, V2, P475, DOI 10.1038/35081509; Jokisch D, 2005, EUR J NEUROSCI, V21, P3439, DOI 10.1111/j.1460-9568.2005.04145.x; Jones W, 2008, ARCH GEN PSYCHIAT, V65, P946, DOI 10.1001/archpsyc.65.8.946; Jordan H, 2002, PSYCHOL SCI, V13, P162, DOI 10.1111/1467-9280.00429; Klin A, 2002, ARCH GEN PSYCHIAT, V59, P809, DOI 10.1001/archpsyc.59.9.809; Klin A, 2003, PHILOS T R SOC B, V358, P345, DOI 10.1098/rstb.2002.1202; Klin A, 2008, DEVELOPMENTAL SCI, V11, P40, DOI 10.1111/j.1467-7687.2007.00608.x; LEIGH RJ, 1999, NEUROLOGY EYE MOVEME, P94; Neri P, 1998, NATURE, V395, P894, DOI 10.1038/27661; Omori E, 1996, INT J COMPARAT PSYCH, V9, P92; Oram MW, 1996, J NEUROPHYSIOL, V76, P109, DOI 10.1152/jn.1996.76.1.109; Pavlova M, 2000, PERCEPT PSYCHOPHYS, V62, P889, DOI 10.3758/BF03212075; Pelphrey KA, 2005, CEREB CORTEX, V15, P1866, DOI 10.1093/cercor/bhi064; Rabiner L. R., 1978, THEORY APPL DIGITAL; Regolin L, 2000, ANIM COGN, V3, P53, DOI 10.1007/s100710050050; Reid VM, 2006, NEUROSCI LETT, V395, P211, DOI 10.1016/j.neulet.2005.10.080; Schultz RT, 2005, INT J DEV NEUROSCI, V23, P125, DOI 10.1016/j.ijdevneu.2004.12.012; Simion F, 2008, P NATL ACAD SCI USA, V105, P809, DOI 10.1073/pnas.0707021105; Tchorz J, 2002, SPEECH COMMUN, V38, P1, DOI 10.1016/S0167-6393(01)00040-1; Thompson JC, 2005, J NEUROSCI, V25, P9059, DOI 10.1523/JNEUROSCI.2129-05.2005; Vallortigara G, 2005, PLOS BIOL, V3, P1312, DOI 10.1371/journal.pbio.0030208; Volkmar FR, 2004, J CHILD PSYCHOL PSYC, V45, P135, DOI 10.1046/j.0021-9630.2003.00317.x; VONCOLLANI E, 2001, BINOMIAL DISTRIBUTIO, P182	36	521	539	5	154	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 14	2009	459	7244					257	U142		10.1038/nature07868	http://dx.doi.org/10.1038/nature07868			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	445FR	19329996	Green Accepted			2022-12-01	WOS:000266036100042
J	Li, CJ; Vagin, VV; Lee, SH; Xu, J; Ma, SM; Xi, HL; Seitz, H; Horwich, MD; Syrzycka, M; Honda, BM; Kittler, ELW; Zapp, ML; Klattenhoff, C; Schulz, N; Theurkauf, WE; Weng, ZP; Zamore, PD				Li, Chengjian; Vagin, Vasily V.; Lee, Soohyun; Xu, Jia; Ma, Shengmei; Xi, Hualin; Seitz, Herve; Horwich, Michael D.; Syrzycka, Monika; Honda, Barry M.; Kittler, Ellen L. W.; Zapp, Maria L.; Klattenhoff, Carla; Schulz, Nadine; Theurkauf, William E.; Weng, Zhiping; Zamore, Phillip D.			Collapse of Germline piRNAs in the Absence of Argonaute3 Reveals Somatic piRNAs in Flies	CELL			English	Article							EMBRYONIC AXIS SPECIFICATION; SELFISH GENETIC ELEMENTS; DROSOPHILA-MELANOGASTER; FLAMENCO GENE; PIWI; PATHWAY; AUBERGINE; PROTEIN; GYPSY; ENCODES	Piwi-interacting RNAs (piRNAs) silence transposons in animal germ cells. piRNAs are thought to derive from long transcripts spanning transposon-rich genomic loci and to direct an autoamplification loop in which an antisense piRNA, bound to Aubergine or Piwi protein, triggers production of a sense piRNA bound to the PIWI protein Argonaute3 (Ago3). In turn, the new piRNA is envisioned to produce a second antisense piRNA. Here, we describe strong loss-of-function mutations in ago3, allowing a direct genetic test of this model. We find that Ago3 acts to amplify piRNA pools and to enforce on them an antisense bias, increasing the number of piRNAs that can act to silence transposons. We also detect a second, Ago3-independent piRNA pathway centered on Piwi. Transposons targeted by this second pathway often reside in the flamenco locus, which is expressed in somatic ovarian follicle cells, suggesting a role for piRNAs beyond the germline.	[Lee, Soohyun; Xu, Jia; Weng, Zhiping] Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01605 USA; [Li, Chengjian; Vagin, Vasily V.; Ma, Shengmei; Seitz, Herve; Horwich, Michael D.; Zamore, Phillip D.] Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA; [Li, Chengjian; Vagin, Vasily V.; Ma, Shengmei; Seitz, Herve; Horwich, Michael D.; Zamore, Phillip D.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA; [Kittler, Ellen L. W.; Zapp, Maria L.; Klattenhoff, Carla; Schulz, Nadine; Theurkauf, William E.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Kittler, Ellen L. W.; Zapp, Maria L.] Univ Massachusetts, Sch Med, Ctr AIDS Res, Worcester, MA 01605 USA; [Lee, Soohyun; Xi, Hualin] Boston Univ, Bioinformat Program, Boston, MA 02215 USA; [Xi, Hualin] Pfizer Inc, Computat Sci Ctr Emphasis, Cambridge, MA 02139 USA; [Syrzycka, Monika; Honda, Barry M.] Simon Fraser Univ, Burnaby, BC V5A 1S6, Canada	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Boston University; Pfizer; Simon Fraser University	Weng, ZP (corresponding author), Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01605 USA.	zhiping.weng@umassmed.edu; phillip.zamore@umassmed.edu	Xu, Jia/F-7750-2012; Seitz, Hervé/AAE-6487-2019; Zamore, Phillip D/A-8941-2013	Seitz, Hervé/0000-0001-8172-5393; Theurkauf, William/0000-0001-7342-1912; Xu, Jia/0000-0003-3921-018X; Lee, Soohyun/0000-0002-3594-6213; Zamore, Phillip/0000-0002-4505-9618	National Institutes of Health [GM62862, GM65236]; Natural Sciences and Engineering Research Council of Canada [GM050898, HD049116]; Canadian Institutes of Health Research; Pfizer, Inc; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD049116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062862, R01GM050898, R37GM062862, R01GM065236] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Pfizer, Inc(Pfizer); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Mikiko and Haruhiko Siomi and Greg Hannon for antibodies, Erica Selva for flies expressing nanos-Gal4 from a transgene on the second chromosome, Paul Lasko for GFP-Vasa flies, Bradley Till for assistance with tilling primer design, Alicia Boucher for assistance with fly husbandry, Gwen Farley for technical assistance, and members of the Zamore and Weng laboratories for advice, suggestions, and critical comments on the text. This work was supported in part by grants from the National Institutes of Health to P.D.Z. (GM62862 and GM65236) and W.E.T. (GM050898 and HD049116) and from the Natural Sciences and Engineering Research Council of Canada and the Canadian Institutes of Health Research to B.M.H. H.X. was supported in part by Pfizer, Inc.	Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Aravin AA, 2001, CURR BIOL, V11, P1017, DOI 10.1016/S0960-9822(01)00299-8; Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Aravin AA, 2008, MOL CELL, V31, P785, DOI 10.1016/j.molcel.2008.09.003; BALAKIREVA MD, 1992, NUCLEIC ACIDS RES, V20, P3731, DOI 10.1093/nar/20.14.3731; Batista PJ, 2008, MOL CELL, V31, P67, DOI 10.1016/j.molcel.2008.06.002; BOZZETTI MP, 1995, P NATL ACAD SCI USA, V92, P6067, DOI 10.1073/pnas.92.13.6067; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Chambeyron S, 2008, P NATL ACAD SCI USA, V105, P14964, DOI 10.1073/pnas.0805943105; Cook HA, 2004, CELL, V116, P817, DOI 10.1016/S0092-8674(04)00250-8; Cooper JL, 2008, FLY, V2, P300, DOI 10.4161/fly.7366; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Cox DN, 2000, DEVELOPMENT, V127, P503; Das PP, 2008, MOL CELL, V31, P79, DOI 10.1016/j.molcel.2008.06.003; Desset S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001526; Findley SD, 2003, DEVELOPMENT, V130, P859, DOI 10.1242/dev.00310; Forstemann K, 2007, CELL, V130, P287, DOI 10.1016/j.cell.2007.05.056; Fuller Margaret T., 1993, P71; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Grimson A, 2008, NATURE, V455, P1193, DOI 10.1038/nature07415; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Harris AN, 2001, DEVELOPMENT, V128, P2823; Horwich MD, 2007, CURR BIOL, V17, P1265, DOI 10.1016/j.cub.2007.06.030; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; Klattenhoff C, 2007, DEV CELL, V12, P45, DOI 10.1016/j.devcel.2006.12.001; Koundakjian EJ, 2004, GENETICS, V167, P203, DOI 10.1534/genetics.167.1.203; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; LIANG L, 1994, DEVELOPMENT, V120, P1201; Lim AK, 2007, P NATL ACAD SCI USA, V104, P6714, DOI 10.1073/pnas.0701920104; LIVAK KJ, 1990, GENETICS, V124, P303; LIVAK KJ, 1984, GENETICS, V107, P611; MALONE CD, 2009, CELL IN PRESS, V137, DOI DOI 10.1016/J.CELL.2009.03.040; Mevel-Ninio M, 2007, GENETICS, V175, P1615, DOI 10.1534/genetics.106.068106; Nishida KM, 2007, RNA, V13, P1911, DOI 10.1261/rna.744307; PALUMBO G, 1994, GENETICS, V138, P1181; Pane A, 2007, DEV CELL, V12, P851, DOI 10.1016/j.devcel.2007.03.022; PELISSON A, 1994, EMBO J, V13, P4401, DOI 10.1002/j.1460-2075.1994.tb06760.x; Pelisson A, 2007, J VIROL, V81, P1951, DOI 10.1128/JVI.01980-06; PIMPINELLI S, 1985, GENETICS, V109, P701; PRUDHOMME N, 1995, GENETICS, V139, P697; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Sarot E, 2004, GENETICS, V166, P1313, DOI 10.1534/genetics.166.3.1313; Schmidt A, 1999, GENETICS, V151, P749; SCHUPBACH T, 1991, GENETICS, V129, P1119; Specchia V, 2008, GENETICS, V178, P1271, DOI 10.1534/genetics.107.078626; Stapleton W, 2001, CHROMOSOMA, V110, P228, DOI 10.1007/s004120100136; THEURKAUF WE, 1994, METHOD CELL BIOL, V44, P489, DOI 10.1016/S0091-679X(08)60928-0; Tomari Y, 2004, CELL, V116, P831, DOI 10.1016/S0092-8674(04)00218-1; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Wang G, 2008, CURR BIOL, V18, P861, DOI 10.1016/j.cub.2008.05.009; Williams RW, 2002, P NATL ACAD SCI USA, V99, P6889, DOI 10.1073/pnas.072190799; Wilson JE, 1996, DEVELOPMENT, V122, P1631; Yin H, 2007, NATURE, V450, P304, DOI 10.1038/nature06263	54	390	402	0	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 1	2009	137	3					509	521		10.1016/j.cell.2009.04.027	http://dx.doi.org/10.1016/j.cell.2009.04.027			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	440CV	19395009	Green Accepted, Bronze, Green Submitted			2022-12-01	WOS:000265677200020
J	Brownell, KD; Frieden, TR				Brownell, Kelly D.; Frieden, Thomas R.			Ounces of Prevention - The Public Policy Case for Taxes on Sugared Beverages	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							METAANALYSIS; CONSUMPTION		[Brownell, Kelly D.] Yale Univ, Rudd Ctr Food Policy & Obes, New Haven, CT 06520 USA	Yale University	Brownell, KD (corresponding author), Yale Univ, Rudd Ctr Food Policy & Obes, New Haven, CT 06520 USA.			Frieden, Thomas/0000-0002-4759-2256				Forshee RA, 2008, AM J CLIN NUTR, V87, P1662, DOI 10.1093/ajcn/87.6.1662; Ludwig DS, 2001, LANCET, V357, P505, DOI 10.1016/S0140-6736(00)04041-1; Nielsen SJ, 2004, AM J PREV MED, V27, P205, DOI 10.1016/j.amepre.2004.05.005; Nielson SJ, 2005, AM J PREV MED, V28, P413, DOI 10.1016/j.amepre.2005.03.007; Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782; 2008, BEVERAGE DIGEST 1121, P3	6	303	309	0	63	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 30	2009	360	18					1805	1808		10.1056/NEJMp0902392	http://dx.doi.org/10.1056/NEJMp0902392			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	438MU	19357400	Bronze			2022-12-01	WOS:000265560300001
J	Gupta, A; Urquhart, DS; Donovan, S; Bush, A				Gupta, Atul; Urquhart, Donald S.; Donovan, Sarah; Bush, Andrew			Picture quiz A 4 year old boy with recurrent wheeze and chest infections	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							NORTH-AMERICAN-SOCIETY; GASTROESOPHAGEAL-REFLUX; PEDIATRIC-GASTROENTEROLOGY; INFANTS; CHILDREN; PREVALENCE; DIAGNOSIS; ASTHMA		[Gupta, Atul; Urquhart, Donald S.; Donovan, Sarah; Bush, Andrew] Royal Brompton Hosp, Dept Paediat Resp Med, London SW3 6NP, England	Royal Brompton Hospital	Gupta, A (corresponding author), Royal Brompton Hosp, Dept Paediat Resp Med, London SW3 6NP, England.	atulgupta@doctors.org.uk			Medical Research Council [G0400503B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		[Anonymous], 1992, J PEDIAT GASTROENTER, V14, P467; BLACK DD, 1990, GASTROENTEROLOGY, V98, P1408, DOI 10.1016/0016-5085(90)91069-I; BUTS JP, 1986, EUR J PEDIATR, V145, P396, DOI 10.1007/BF00439246; Chang AB, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004823.pub3; CHEN PH, 1991, J PEDIATR GASTR NUTR, V13, P16, DOI 10.1097/00005176-199107000-00003; Chernick V, 2006, KENDIGS DISORDERS RE; COLLETTI RB, 1995, J PEDIATR GASTR NUTR, V21, P253, DOI 10.1097/00005176-199510000-00002; Coughlan JL, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001496; CUCCHIARA S, 1990, GUT, V31, P129, DOI 10.1136/gut.31.2.129; Dhillon AS, 2004, ACTA PAEDIATR, V93, P88, DOI 10.1080/08035250310007934; EKSTROM T, 1989, THORAX, V44, P19, DOI 10.1136/thx.44.1.19; EULER AR, 1981, GASTROENTEROLOGY, V80, P957; Keady S, 2007, ARCH DIS CHILDHOOD-E, V92, pEP114, DOI 10.1136/adc.2006.106328; Little JP, 1997, ANN OTO RHINOL LARYN, V106, P1; Lopez-Alonso M, 2006, PEDIATRICS, V118, pE299, DOI 10.1542/peds.2005-3140; Mahajan L, 1998, PEDIATRICS, V101, P260, DOI 10.1542/peds.101.2.260; MALFROOT A, 1987, PEDIATR PULM, V3, P208, DOI 10.1002/ppul.1950030403; Mattioli G, 2006, DIGEST DIS SCI, V51, P2341, DOI 10.1007/s10620-006-9374-z; McGovern MC, 2004, ARCH DIS CHILD, V89, P1043, DOI 10.1136/adc.2003.031740; Rudolph CD, 2001, J PEDIATR GASTR NUTR, V32, pS1, DOI 10.1097/00005176-200100002-00001; Sifrim D, 2008, DIGEST LIVER DIS, V40, P161, DOI 10.1016/j.dld.2007.10.023; Tighe MP, 2009, ARCH DIS CHILDHOOD-E, V94, P18, DOI 10.1136/adc.2008.145169; TOLIA V, 1990, J PEDIATR GASTR NUTR, V10, P426, DOI 10.1097/00005176-199005000-00002; TUCCI F, 1993, J PEDIATR GASTR NUTR, V17, P265, DOI 10.1097/00005176-199310000-00006; Washington N, 1999, ARCH DIS CHILD, V81, P309, DOI 10.1136/adc.81.4.309	25	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 29	2009	338								b1255	10.1136/bmj.b1255	http://dx.doi.org/10.1136/bmj.b1255			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	440JW	19403569				2022-12-01	WOS:000265697600002
J	Bowman, DMJS; Balch, JK; Artaxo, P; Bond, WJ; Carlson, JM; Cochrane, MA; D'Antonio, CM; DeFries, RS; Doyle, JC; Harrison, SP; Johnston, FH; Keeley, JE; Krawchuk, MA; Kull, CA; Marston, JB; Moritz, MA; Prentice, IC; Roos, CI; Scott, AC; Swetnam, TW; van der Werf, GR; Pyne, SJ				Bowman, David M. J. S.; Balch, Jennifer K.; Artaxo, Paulo; Bond, William J.; Carlson, Jean M.; Cochrane, Mark A.; D'Antonio, Carla M.; DeFries, Ruth S.; Doyle, John C.; Harrison, Sandy P.; Johnston, Fay H.; Keeley, Jon E.; Krawchuk, Meg A.; Kull, Christian A.; Marston, J. Brad; Moritz, Max A.; Prentice, I. Colin; Roos, Christopher I.; Scott, Andrew C.; Swetnam, Thomas W.; van der Werf, Guido R.; Pyne, Stephen J.			Fire in the Earth System	SCIENCE			English	Review							FOREST-FIRES; CLIMATE; EXPANSION; HISTORY; ECOSYSTEMS; EVOLUTION; SYNCHRONY; EMISSIONS; ECOLOGY; CYCLE	Fire is a worldwide phenomenon that appears in the geological record soon after the appearance of terrestrial plants. Fire influences global ecosystem patterns and processes, including vegetation distribution and structure, the carbon cycle, and climate. Although humans and fire have always coexisted, our capacity to manage fire remains imperfect and may become more difficult in the future as climate change alters fire regimes. This risk is difficult to assess, however, because fires are still poorly represented in global models. Here, we discuss some of the most important issues involved in developing a better understanding of the role of fire in the Earth system.	[Balch, Jennifer K.] Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93101 USA; [Johnston, Fay H.] Univ Tasmania, Menzies Res Inst, Hobart, Tas 7001, Australia; [Balch, Jennifer K.] Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA; [Balch, Jennifer K.] Woods Hole Res Ctr, Woods Hole, MA 02543 USA; [Artaxo, Paulo] Univ Sao Paulo, Inst Fis, BR-05508900 Sao Paulo, Brazil; [Bond, William J.] Univ Cape Town, Dept Bot, ZA-7925 Cape Town, South Africa; [Carlson, Jean M.] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; [Cochrane, Mark A.] S Dakota State Univ, Geog Informat Sci Ctr Excellence, Brookings, SD 57007 USA; [D'Antonio, Carla M.] Univ Calif Santa Barbara, Environm Studies Program, Santa Barbara, CA 93106 USA; [D'Antonio, Carla M.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [DeFries, Ruth S.] Columbia Univ, New York, NY 10027 USA; [Doyle, John C.] CALTECH, Dept Control & Dynam Syst, Pasadena, CA 91125 USA; [Harrison, Sandy P.] Univ Bristol, Sch Geog Sci, Bristol BS8 1SS, Avon, England; [Keeley, Jon E.] US Geol Survey, Western Ecol Res Ctr, Sequoia Kings Canyon Field Stn, Three Rivers, CA 93271 USA; [Keeley, Jon E.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA; [Krawchuk, Meg A.; Moritz, Max A.] Univ Calif Berkeley, Ecosyst Sci Div, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Kull, Christian A.] Monash Univ, Sch Geog & Environm Sci, Melbourne, Vic 3800, Australia; [Marston, J. Brad] Brown Univ, Dept Phys, Providence, RI 02912 USA; [Prentice, I. Colin] Univ Bristol, QUEST, Dept Earth Sci, Bristol BS8 1RJ, Avon, England; [Roos, Christopher I.] Ohio State Univ, Dept Anthropol, Columbus, OH 43210 USA; [Scott, Andrew C.] Royal Holloway Univ London, Dept Earth Sci, Egham TW20 0EX, Surrey, England; [Swetnam, Thomas W.] Univ Arizona, Tree Ring Res Lab, Tucson, AZ 85721 USA; [van der Werf, Guido R.] Vrije Univ Amsterdam, Fac Earth & Life Sci, Dept Hydrol & Geoenvironm Sci, NL-1081 HV Amsterdam, Netherlands; [Pyne, Stephen J.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA	National Center for Ecological Analysis & Synthesis; University of Tasmania; Menzies Institute for Medical Research; Yale University; Woods Hole Research Center; Universidade de Sao Paulo; University of Cape Town; University of California System; University of California Santa Barbara; South Dakota State University; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Columbia University; California Institute of Technology; University of Bristol; United States Department of the Interior; United States Geological Survey; University of California System; University of California Los Angeles; University of California System; University of California Berkeley; Monash University; Brown University; University of Bristol; University System of Ohio; Ohio State University; University of London; Royal Holloway University London; University of Arizona; Vrije Universiteit Amsterdam; Arizona State University; Arizona State University-Tempe	Balch, JK (corresponding author), Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93101 USA.	balch@nceas.ucsb.edu	Scott, Andrew C/C-6661-2008; Cochrane, Mark A/A-1735-2018; Bond, William/AAY-7631-2020; Marston, Brad/B-3144-2012; van der Werf, Guido/M-8260-2016; Artaxo, Paulo/E-8874-2010; Swetnam, Thomas/A-6052-2008; Kull, Christian A/C-5806-2015; Nahas, Alberth/C-8379-2013; Roos, Christopher/F-3379-2011; Bowman, David M.J.S./A-2930-2011	Scott, Andrew C/0000-0002-1998-3508; Cochrane, Mark A/0000-0002-4573-568X; van der Werf, Guido/0000-0001-9042-8630; Artaxo, Paulo/0000-0001-7754-3036; Swetnam, Thomas/0000-0001-7268-2184; Bowman, David M.J.S./0000-0001-8075-124X; Johnston, Fay Helena/0000-0002-5150-8678; Harrison, Sandy/0000-0001-5687-1903; Roos, Christopher/0000-0001-8754-7655; Kull, Christian/0000-0002-7516-7898; Bond, William/0000-0002-3441-2084	Kavli Institute for Theoretical Physics (KITP); National Center for Ecological Analysis and Synthesis (NCEAS); NSF [PHY05-51164, DEB-0553768]; University of California, Santa Barbara; State of California; Instituto do Milenio Program; U.S. Geological Survey; Natural Environment Research Council [quest010001, NE/E007600/1, NE/E006183/1] Funding Source: researchfish; NERC [NE/E006183/1, NE/E007600/1, quest010001] Funding Source: UKRI	Kavli Institute for Theoretical Physics (KITP); National Center for Ecological Analysis and Synthesis (NCEAS); NSF(National Science Foundation (NSF)); University of California, Santa Barbara(University of California System); State of California; Instituto do Milenio Program; U.S. Geological Survey(United States Geological Survey); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank L. Curran, M. Einhorn, D. Gross, S. Hampton, D. Nepstad, and R. Whittaker for encouraging this synthesis, and G. Williamson for assistance with Fig. 2. This work was conducted as part of the Pyrogeography and Climate Change Working Group supported by the Kavli Institute for Theoretical Physics (KITP) and the National Center for Ecological Analysis and Synthesis (NCEAS), funded by NSF grants PHY05-51164 and DEB-0553768, respectively; the University of California, Santa Barbara; and the State of California. Additional support was provided by NCEAS (to J.K.B., the Postdoctoral Associate in the Group); CNPq/MCT Instituto do Milenio Program (to P.A.); and the U.S. Geological Survey (to J.E.K.). Contributions: D.M.J.S.B. conceived of the original idea; J.K.B. and D.M.J.S.B. co-organized the KITP/NCEAS workshop and assumed editorial responsibility; all authors participated in the workshop and/or contributed to manuscript writing; G.R.W., P.A., and I.C.P. developed the radiative forcing figure; C.A.K., C.I.R., and A.C.S. designed the timeline diagram.	Alencar A, 2006, EARTH INTERACT, V10; Allen CD, 2002, ECOL APPL, V12, P1418; Andreae MO, 2004, SCIENCE, V303, P1337, DOI 10.1126/science.1092779; Andreae MO, 2001, GLOBAL BIOGEOCHEM CY, V15, P955, DOI 10.1029/2000GB001382; ARINO O, 1999, EARTH OBS Q, V64, P1; Arora VK, 2005, J GEOPHYS RES-BIOGEO, V110, DOI 10.1029/2005JG000042; Bar-Yosef O, 2002, ANNU REV ANTHROPOL, V31, P363, DOI 10.1146/annurev.anthro.31.040402.085416; Beerling DJ, 2006, GLOBAL CHANGE BIOL, V12, P2023, DOI 10.1111/j.1365-2486.2006.01239.x; Berner RA, 2003, ANNU REV EARTH PL SC, V31, P105, DOI 10.1146/annurev.earth.31.100901.141329; Bond WJ, 2005, TRENDS ECOL EVOL, V20, P387, DOI 10.1016/j.tree.2005.04.025; Bond WJ, 2005, NEW PHYTOL, V165, P525, DOI 10.1111/j.1469-8137.2004.01252.x; Bowman D.M.J.S., 2000, AUSTR RAINFORESTS IS; Cochrane M. A, 2002, SPREAD LIK WILDF TRO; DANTONIO CM, 1992, ANNU REV ECOL SYST, V23, P63, DOI 10.1146/annurev.es.23.110192.000431; Forsyth Greg G., 2008, Koedoe, V50, P3; Giglio L, 2006, J GEOPHYS RES-BIOGEO, V111, DOI 10.1029/2005JG000142; IPCC, 2007, CLIM CHANG 2007 PHYS; Karkanas P, 2007, J HUM EVOL, V53, P197, DOI 10.1016/j.jhevol.2007.04.002; Keeley JE, 2005, ECOL LETT, V8, P683, DOI 10.1111/j.1461-0248.2005.00767.x; Kitzberger T, 2001, GLOBAL ECOL BIOGEOGR, V10, P315, DOI 10.1046/j.1466-822X.2001.00234.x; Kitzberger T, 2007, P NATL ACAD SCI USA, V104, P543, DOI 10.1073/pnas.0606078104; Langenfelds RL, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001466; Lehmann J, 2008, NAT GEOSCI, V1, P832, DOI 10.1038/ngeo358; Lenton TM, 2001, GLOBAL CHANGE BIOL, V7, P613, DOI 10.1046/j.1354-1013.2001.00429.x; Lohman DJ, 2007, SCIENCE, V316, P376, DOI 10.1126/science.1140278; Marlon JR, 2008, NAT GEOSCI, V1, P697, DOI 10.1038/ngeo313; MARSTON JB, 1991, NATURE, V349, P573, DOI 10.1038/349573b0; McGlone MS, 1999, J QUATERNARY SCI, V14, P239, DOI 10.1002/(SICI)1099-1417(199905)14:3<239::AID-JQS438>3.0.CO;2-9; Miller GH, 2005, SCIENCE, V309, P287, DOI 10.1126/science.1111288; Mouillot F, 2005, GLOBAL CHANGE BIOL, V11, P398, DOI 10.1111/j.1365-2486.2005.00920.x; Page SE, 2002, NATURE, V420, P61, DOI 10.1038/nature01131; Platek SM, 2002, MED HYPOTHESES, V58, P1, DOI 10.1054/mehy.2001.1385; Power MJ, 2008, CLIM DYNAM, V30, P887, DOI 10.1007/s00382-007-0334-x; Pyne S., 2001, FIRE BRIEF HIST; Pyne SJ, 2007, INT J WILDLAND FIRE, V16, P271, DOI 10.1071/WF06041; Randerson JT, 2006, SCIENCE, V314, P1130, DOI 10.1126/science.1132075; SCHWEITHELM J, 1999, INDONESIAS FIRE HAZE; Schwilk DW, 2002, OIKOS, V99, P431, DOI 10.1034/j.1600-0706.2002.11730.x; Scott AC, 2006, P NATL ACAD SCI USA, V103, P10861, DOI 10.1073/pnas.0604090103; Segalen L, 2007, J HUM EVOL, V53, P549, DOI 10.1016/j.jhevol.2006.12.010; SWETNAM TW, 1993, SCIENCE, V262, P885, DOI 10.1126/science.262.5135.885; Tansey K, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031567; Theobald DM, 2007, LANDSCAPE URBAN PLAN, V83, P340, DOI 10.1016/j.landurbplan.2007.06.002; van der Werf GR, 2006, ATMOS CHEM PHYS, V6, P3423, DOI 10.5194/acp-6-3423-2006; van der Werf GR, 2004, SCIENCE, V303, P73, DOI 10.1126/science.1090753; van der Werf GR, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003122; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834; Wrangham RW, 1999, CURR ANTHROPOL, V40, P567, DOI 10.1086/300083	48	1781	1851	61	996	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 24	2009	324	5926					481	484		10.1126/science.1163886	http://dx.doi.org/10.1126/science.1163886			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436JU	19390038				2022-12-01	WOS:000265411200037
J	Elsik, CG; Tellam, RL; Worley, KC; Gibbs, RA; Abatepaulo, ARR; Abbey, CA; Adelson, DL; Aerts, J; Ahola, V; Alexander, L; Alioto, T; Almeida, IG; Amadio, AF; Anatriello, E; Antonarakis, SE; Anzola, JM; Astashyn, A; Bahadue, SM; Baldwin, CL; Barris, W; Baxter, R; Bell, SN; Bennett, AK; Bennett, GL; Biase, FH; Boldt, CR; Bradley, DG; Brinkman, FSL; Brinkmeyer-Langford, CL; Brown, WC; Brownstein, MJ; Buhay, C; Caetano, AR; Camara, F; Carroll, JA; Carvalho, WA; Casey, T; Cervelatti, EP; Chack, J; Chacko, E; Chandrabose, MM; Chapin, JE; Chapple, CE; Chen, HC; Chen, L; Cheng, Y; Cheng, Z; Childers, CP; Chitko-McKown, CG; Chiu, R; Choi, JW; Chrast, J; Colley, AJ; Connelley, T; Cree, A; Curry, S; Dalrymple, B; Diep Dao, M; Davis, C; de Oliveira, CJF; de Miranda Santos, IKF; de Campos, TA; Deobald, H; Devinoy, E; Dickens, CM; Ding, Y; Dinh, HH; De Donato, M; Donohue, KE; Donthu, R; Dovc, P; Dugan-Rocha, S; Durbin, KJ; Eberlein, A; Edgar, RC; Egan, A; Eggen, A; Eichler, EE; Elhaik, E; Ellis, SA; Elnitski, L; Ermolaeva, O; Eyras, E; Fitzsimmons, CJ; Fowler, GR; Franzin, AM; Fritz, K; Gabisi, RA; Garcia, GR; Garcia, JF; Genini, S; Gerlach, D; German, JB; Gilbert, JGR; Gill, CA; Gladney, CJ; Glass, EJ; Goodell, J; Grant, JR; Graur, D; Greaser, ML; Green, JA; Green, RD; Guan, L; Guigo, R; Hadsell, DL; Hagen, DE; Hakimov, HA; Halgren, R; Hamernik, DL; Hamilton, C; Harhay, GP; Harrow, JL; Hart, EA; Hastings, N; Havlak, P; Henrichsen, CN; Hernandez, J; Hernandez, M; Herzig, CTA; Hiendleder, SG; Hines, S; Hitchens, ME; Hlavina, W; Hobbs, M; Holder, M; Holt, RA; Hu, ZL; Hume, J; Iivanainen, A; Ingham, A; Iso-Touru, T; Jamis, C; Jann, O; Jensen, K; Jhangiani, SN; Jiang, HY; Johnson, AJ; Jones, SJM; Joshi, V; Junier, T; Kapetis, D; Kappes, SM; Kapustin, Y; Keele, JW; Kent, MP; Kerr, T; Khalil, SS; Khatib, H; Kiryutin, B; Kitts, P; Kokocinski, F; Kolbehdari, D; Kovar, CL; Kriventseva, EV; Kumar, CG; Kumar, D; Lahmers, KK; Landrum, M; Larkin, DM; Lau, LPL; Leach, R; Lee, JCM; Lee, S; Lemay, DG; Lewin, HA; Lewis, LR; Li, CX; Lien, S; Liu, GE; Liu, YS; Liu, Y; Logan, KM; Lopez, J; Lozado, RJ; Lutzow, YS; Lynn, DJ; MacNeil, MD; Maglott, D; Malinverni, R; Maqbool, NJ; Marques, E; Marra, MA; Martin, WF; Martins, NF; Maruyama, SR; Matukumalli, LK; Mazza, R; McEwan, JC; McKay, SD; McLean, KL; McWilliam, S; Medrano, JF; Memili, E; Moen, C; Molenaar, AL; Moore, SS; Moore, R; More, DD; Moreno, BT; Morgan, MB; Muntean, CT; Muzny, DM; Nandakumar, HP; Nazareth, LV; Nguyen, NB; Nicholas, FW; Nogueira, MFG; Okwuonu, GO; Olsaker, I; Pant, SD; Panzitta, F; Pastor, RCP; Patel, BM; Payne, GM; Plass, M; Poli, MA; Poslusny, N; Pruitt, K; Pu, LL; Qin, X; Rachagani, S; Raison, JM; Ranganathan, S; Ratnakumar, A; Razpet, A; Reecy, J; Reese, JT; Ren, Y; Reymond, A; Riggs, PK; Rijnkels, M; Rincon, G; Roberts, A; Rodriguez-Osorio, N; Rodriguez-Zas, SL; Romero, NE; Rosenwald, A; Ruiz, SJ; Sabo, A; Salih, H; Sando, L; Santibanez, J; Sapojnikov, V; Schein, JE; Schmutz, SM; Schnabel, RD; Schook, L; Searle, SM; Seo, SW; Shen, YF; Shen, LB; Sherman, L; Skow, LC; Smith, T; Snelling, WM; Sodergren, E; Solovyev, V; Song, H; Song, JZ; Sonstegard, TS; Southey, BR; Souvorov, A; Spurlock, D; Steffen, D; Stone, RT; Stothard, P; Sugimoto, Y; Sweedler, JV; Takasuga, A; Tammen, I; Taniguchi, M; Taylor, JF; Telugu, BPVL; Ucla, C; Urbanski, JM; Utsunomiya, YT; Van, CP; Vattathil, S; Verschoor, CP; Waardenberg, AJ; Walker, A; Wang, ZQ; Ward, R; Warren, JT; Waterman, RC; Weikard, R; Weinstock, GM; Welsh, TH; Wheeler, DA; Wheeler, TT; White, SN; Whitside, MD; Wilczek-Boney, K; Williams, JL; Williams, RL; Wilming, LG; Womack, J; Wright, RA; Wunderlich, KR; Wyss, C; Yang, MQ; Yang, JQ; Zdobnov, EM; Zhang, JK; Zhao, FQ; Zhu, B				Elsik, Christine G.; Tellam, Ross L.; Worley, Kim C.; Gibbs, Richard A.; Abatepaulo, Antonio R. R.; Abbey, Colette A.; Adelson, David L.; Aerts, Jan; Ahola, Virpi; Alexander, Lee; Alioto, Tyler; Almeida, Iassudara G.; Amadio, Ariel F.; Anatriello, Elen; Antonarakis, Stylianos E.; Anzola, Juan M.; Astashyn, Alex; Bahadue, Suria M.; Baldwin, Cynthia L.; Barris, Wes; Baxter, Rebecca; Bell, Stephanie Nicole; Bennett, Anna K.; Bennett, Gary L.; Biase, Fernando H.; Boldt, Clayton R.; Bradley, Daniel G.; Brinkman, Fiona S. L.; Brinkmeyer-Langford, Candice L.; Brown, Wendy C.; Brownstein, Michael J.; Buhay, Christian; Caetano, Alexandre R.; Camara, Francisco; Carroll, Jeffrey A.; Carvalho, Wanessa A.; Casey, Theresa; Cervelatti, Elaine P.; Chack, Joseph; Chacko, Elsa; Chandrabose, Mimi M.; Chapin, Jennifer E.; Chapple, Charles E.; Chen, Hsiu-Chuan; Chen, Lin; Cheng, Ye; Cheng, Ze; Childers, Christopher P.; Chitko-McKown, Carol G.; Chiu, Readman; Choi, Jungwoo; Chrast, Jacqueline; Colley, Adam J.; Connelley, Tomothy; Cree, Andy; Curry, Stacey; Dalrymple, Brian; Diep Dao, Marvin; Davis, Clay; de Oliveira, Carlo J. F.; de Miranda Santos, Isabel K. F.; de Campos, Tatiana A.; Deobald, Heather; Devinoy, Eve; Dickins, C. Michael; Yan, Ding; Dinh, Huyen H.; De Donato, Marcos; Donohue, Kaitlin E.; Donthu, Ravikiran; Dovc, Peter; Dugan-Rocha, Shannon; Durbin, K. James; Eberlein, Annett; Edgar, Robert C.; Egan, Amy; Eggen, Andre; Eichler, Evan E.; Elhaik, Eran; Ellis, Shirley A.; Elnitski, Laura; Ermolaeva, Olga; Eyras, Eduardo; Fitzsimmons, Carolyn J.; Fowler, Gerald R.; Franzin, Alessandra M.; Fritz, Krista; Gabisi, Ramatu Ayiesha; Garcia, Gustavo R.; Garcia, Jose Fernando; Genini, Sem; Gerlach, Daniel; German, J. Bruce; Gilbert, James G. R.; Gill, Clare A.; Gladney, Cody J.; Glass, Elizabeth J.; Goodell, Jason; Grant, Jason R.; Graur, Dan; Greaser, Marion L.; Green, Jonathan A.; Green, Ronnie D.; Guan, Leluo; Guigo, Roderic; Hadsell, Darryl L.; Hagen, Darren E.; Hakimov, Hatam A.; Halgren, Rob; Hamernik, Debora L.; Hamilton, Cerissa; Harhay, Gregory P.; Harrow, Jennifer L.; Hart, Elizabeth A.; Hastings, Nicola; Havlak, Paul; Henrichsen, Charlotte N.; Hernandez, Judith; Hernandez, Marta; Herzig, Carolyn T. A.; Hiendleder, Stefan G.; Hines, Sandra; Hitchens, Matthew Edward; Hlavina, Wratko; Hobbs, Matthew; Holder, Michael; Holt, Robert A.; Hu, Zhi-Liang; Hume, Jennifer; Iivanainen, Antti; Ingham, Aaron; Iso-Touru, Terhi; Jamis, Catherine; Jann, Oliver; Jensen, Kirsty; Jhangiani, Shalini N.; Jiang, Huaiyang; Johnson, Angela Jolivet; Jones, Steven J. M.; Joshi, Vandita; Junier, Thomas; Kapetis, Dimos; Kappes, Steve M.; Kapustin, Yuri; Keele, John W.; Kent, Matthew P.; Kerr, Tovah; Khalil, Sari S.; Khatib, Hasan; Kiryutin, Boris; Kitts, Paul; Kokocinski, Felix; Kolbehdari, Davood; Kovar, Christie L.; Kriventseva, Evgenia V.; Kumar, Charu G.; Kumar, Dinesh; Lahmers, Kevin K.; Landrum, Melissa; Larkin, Denis M.; Lau, Lilian P. L.; Leach, Richard; Lee, Justin C. M.; Lee, Sandra; Lemay, Danielle G.; Lewin, Harris A.; Lewis, Lora R.; Li, Changxi; Lien, Sigbjorn; Liu, George E.; Liu, Yih-shin; Liu, Yue; Logan, Krystin M.; Lopez, John; Lozado, Ryan J.; Lutzow, Ylva Strandberg; Lynn, David J.; MacNeil, Michael D.; Maglott, Donna; Malinverni, Roberto; Maqbool, Nauman J.; Marques, Elisa; Marra, Marco A.; Martin, William F.; Martins, Natalia F.; Maruyama, Sandra R.; Matukumalli, Lakshmi K.; Mazza, Raffaele; McEwan, John C.; McKay, Stephanie D.; McLean, Kim L.; McWilliam, Sean; Medrano, Juan F.; Memili, Erdogan; Moen, Charles; Molenaar, Adrian J.; Moore, Stephen S.; Moore, Richard; More, Daniela D.; Moreno, Barbara T.; Morgan, Margaret B.; Muntean, Carl T.; Muzny, Donna M.; Nandakumar, Hari P.; Nazareth, Lynne V.; Nguyen, Ngoc Bich; Nicholas, Frank W.; Nogueira, Marcelo F. G.; Okwuonu, Geoffrey O.; Olsaker, Ingrid; Pant, Sameer D.; Panzitta, Francesca; Pastor, Rosemeire C. P.; Patel, Bella Mayurkumar; Payne, Gemma M.; Plass, Mireya; Poli, Mario A.; Poslusny, Nathan; Pruitt, Kim; Pu, Ling-Ling; Qin, Xiang; Rachagani, Satyanarayana; Raison, Joy M.; Ranganathan, Shoba; Ratnakumar, Abhirami; Razpet, Andrej; Reecy, James; Reese, Justin T.; Ren, Yanru; Reymond, Alexandre; Riggs, Penny K.; Rijnkels, Monique; Rincon, Gonzalo; Roberts, Andy; Rodriguez-Osorio, Nelida; Rodriguez-Zas, Sandra L.; Romero, Natasha E.; Rosenwald, Anne; Ruiz, San Juana; Sabo, Aniko; Salih, Hanni; Sando, Lillian; Santibanez, Jireh; Sapojnikov, Victor; Schein, Jacqueline E.; Schmutz, Sheila M.; Schnabel, Robert D.; Schook, Lawrence; Searle, Stephen M.; Seo, Seongwon; Shen, Yufeng; Shen, Libing; Sherman, Laura; Skow, Loren C.; Smith, Timothy; Snelling, Warren M.; Sodergren, Erica; Solovyev, Victor; Song, Henry; Song, Jiuzhou; Sonstegard, Tad S.; Southey, Bruce R.; Souvorov, Alexandre; Spurlock, Diane; Steffen, David; Stone, Roger T.; Stothard, Paul; Sugimoto, Yoshikazu; Sweedler, Jonathan V.; Takasuga, Akiko; Tammen, Imke; Taniguchi, Masaaki; Taylor, Jeremy F.; Telugu, Bhanu Prakash V. L.; Ucla, Catherine; Urbanski, Jennifer M.; Utsunomiya, Yuri T.; Van, Curtis P.; Vattathil, Selina; Verschoor, Chris P.; Waardenberg, Ashley J.; Walker, Angela; Wang, Zhiquan; Ward, Robert; Warren, James T.; Waterman, Richard C.; Weikard, Rosemarie; Weinstock, George M.; Welsh, Thomas H., Jr.; Wheeler, David A.; Wheeler, Thomas T.; White, Stephen N.; Whiteside, Matthew D.; Wilczek-Boney, Katarzyna; Williams, John L.; Williams, Rex Lee, Jr.; Wilming, Laurens G.; Womack, James; Wright, Rita A.; Wunderlich, Kris R.; Wyss, Carine; Yang, Mary Q.; Yang, Jianqi; Zdobnov, Evgeny M.; Zhang, Jingkun; Zhao, Feng-Qi; Zhu, Bin		Bovine Genome Sequencing & Analysi	The Genome Sequence of Taurine Cattle: A Window to Ruminant Biology and Evolution	SCIENCE			English	Article							NEONATAL FC-RECEPTOR; GENE-EXPRESSION; BOVINE; ORGANIZATION; INTERFERON; FAMILY; ROLES; MAP	To understand the biology and evolution of ruminants, the cattle genome was sequenced to about sevenfold coverage. The cattle genome contains a minimum of 22,000 genes, with a core set of 14,345 orthologs shared among seven mammalian species of which 1217 are absent or undetected in noneutherian (marsupial or monotreme) genomes. Cattle-specific evolutionary breakpoint regions in chromosomes have a higher density of segmental duplications, enrichment of repetitive elements, and species-specific variations in genes associated with lactation and immune responsiveness. Genes involved in metabolism are generally highly conserved, although five metabolic genes are deleted or extensively diverged from their human orthologs. The cattle genome sequence thus provides a resource for understanding mammalian evolution and accelerating livestock genetic improvement for milk and meat production.	[Elsik, Christine G.] Georgetown Univ, Dept Biol, 406 Reiss,37th & O St NW, Washington, DC 20057 USA; [Tellam, Ross L.] CSIRO Livestock Ind, St Lucia, Qld 4067, Australia; [Worley, Kim C.] Baylor Coll Med, Dept Mol & Human Genet, Human Genome Sequencing Ctr, Houston, TX 77030 USA; Washington Univ, Sch Med, Genome Ctr, St Louis, MO 63108 USA; Texas A&M Univ, Dept Anim Sci, College Stn, TX 77843 USA; Univ Adelaide, Sch Mol Biomed & Sci, Sch Agr Food & Wine, Adelaide, SA 5005, Australia; Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; Howard Hughes Med Inst, Seattle, WA 98195 USA; Natl Human Genome Res Inst, Natl Inst Hlth, Rockville, MD 20878 USA; Univ Pompeu Fabra, Ctr Genomic Regulation, Grp Recerca Informatica Biomed, Inst Municipal Invest Med, E-08003 Barcelona, Spain; USDA, Cooperative State Res Educ & Extension Serv, Washington, DC 20250 USA; USDA Agr Res Serv, Natl Program Staff, Beltsville, MD 20705 USA; Univ Illinois Urban Champaign, Dept Anim Sci, Urbana, IL 61801 USA; Univ Illinois Urban Champaign, Inst Genomic Biol, Urbana, IL 61801 USA; Simon Fraser Univ, Dept Mol Biol Biochem, Burnaby, BC V5A 1S6, Canada; Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia; Univ Lausanne, Ctr Integrative Genomics, CH-1015 Lausanne, Switzerland; Baylor Coll Med, Dept Pediat Nutr, USDA Agr Res Serv, Childrens Nutr Res Ctr, Houston, TX 77030 USA; Texas A&M Univ, Dept Vet Integrative Biosci, College Stn, TX 77843 USA; Univ Geneva Med Sch, Dept Genetic Med & Dev, CH-1211 Geneva, Switzerland; Swiss Inst Bioinformatics, CH-1211 Geneva, Switzerland; Imperial Coll, S Kensington Campus, Div Mol Biosci, London SW7 2AZ, England; Texas A&M Univ, Dept Vet Pathobiol, College Stn, TX 77843 USA; Natl Inst Hlth, Natl Lib Med, Natl Ctr Biotech Information, Bethesda, MD 20892 USA; Wellcome Trust Sanger Inst Hinxton, Informatics Dept, Cambridge CB10 1HH, England; Univ London, Royal Holloway Egham, Dept Comp Sci, Surrey TW20 0EX, England; Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA; Johns Hopkins Univ Sch Med, McKusick Nathans Inst Genetic Med, Baltimore, MD 21205 USA; 45 Monterey Dr, Tiburon, CA 94920 USA; AgResearch, Anim Genomics, Mosgiel 9053, New Zealand; Univ Adelaide N Terrace, eRes SA, Adelaide, SA 5005, Australia; Univ Geneva Med Sch, Dept Struct Biol Bioinformatics, CH-1211 Geneva, Switzerland; Catalan Inst Res & Adv Studies, E-08010 Barcelona, Spain; Univ Pompeu Fabra, Comp Genomics, E-08003 Barcelona, Spain; Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA; USDA Agr Res Serv, Meat Anim Res Ctr, Clay Ctr, NE 68933 USA; Bovine Functional Genomics Lab, USDA Agr Res Serv, BARC E, Beltsville, MD 20705 USA; George Mason Univ, Dept Bioinformatics & Computational Biol, Manassas, VA 20110 USA; Univ Maryland, Dept Bioengineering, College Pk, MD 20742 USA; Trinity Coll Dublin, Smurfit Inst Genetics, Dublin 2, Ireland; Univ Missouri, Dept Vet Pathobiology, Columbia, MO 65211 USA; Daily Sci & Tech Section, AgRes, Ruakura Res Ctr, Hamilton 3240, New Zealand; Michigan State Univ, Dept Anim Sci, E Lansing, MI 48824 USA; Nestle Res Ctr, CH-1000 Lausanne, Switzerland; Univ Calif Davis, Dept Food Sci & Tech, Davis, CA 95616 USA; Bioinformatics Mathematics Stat, AgRes, Ruakura Res Ctr, Hamilton 3240, New Zealand; Chungnam Natl Univ, Div Anim Sci & Resource, Daejeon 305764, South Korea; Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB T6G 2P5, Canada; Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA; Univ Edinburgh, Roslin Inst & Royal Dick Sch Vet Studies, Midlothian EH25 9PS, Scotland; Washington State Univ, Dept Vet Microbiol & Pathology, Pullman, WA 99164 USA; Univ Edinburgh, Roslin Inst & Royal Dick Sch Vet Sci, Div Infect & Immunity, Midlothian EH25 9RG, Scotland; Inst Anim Hlth, Immunol Div, Compton RG20 7NN, England; Univ Helsinki, Dept Basic Vet Sci, FIN-00014 Helsinki, Finland; Wellcome Trust Sanger Inst, Genome Dynamics & Evolution, Cambridge CB10 1SA, England; Embrapa Recursos Geneticos Biotech, BR-70770900 Brasilia, DF, Brazil; UNESP Sao Paulo State Univ, Anim Prod & Hlth Dept, BR-16050680 Aracatuba, SP, Brazil; Texas AgriLife Res, College Stn, TX 77843 USA; Univ Adelaide, Sch Agr Food & Wine & Res Ctr Reprod Hlth, JS Davies Epigenetics & Genetics Grp, Roseworthy, SA 5371, Australia; Mississippi State Univ, Mississippi Agr & Forestry Expt Stn, Dept Anim & Dairy Sci, Mississippi State, MS 39762 USA; Polo Univ, Parco Tecnol Padano, Via Einstein, I-26900 Lodi, Italy; USDA Agr Res Serv, Fort Keogh Livestock & Range Res Lab, Miles City, MT 59301 USA; NIH, Natl Inst Mental Hlth, Lab Genetics, Bethesda, MD 20892 USA; British Columbia Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z 1L3, Canada; Natl Inst Agrobiol Sci, Div of Anim Sci, Tsukuba, Ibaraki 3058602, Japan; Baylor Coll Med, Bioinfo Res Ctr, Houston, TX 77030 USA; Univ California Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; Univ Houston, Dept Comp Sci, Houston, TX 77204 USA; Columbia Univ, Dept Comp Sci & Ctr Comp Biol & Bioinfo, New York, NY 10032 USA; INRA, Anim Genetics & Integrative Biol, Bovine Genetics & Genomics, F-78350 Jouy En Josas, France; Pfizer Anim Hlth, Pfizer Anim Genetics, New York, NY 10017 USA; Univ Sydney, Fac Vet Sci, Camden, NSW 2570, Australia; Norwegian Univ Life Sci, Ctr Integrative Genetics, Dept Anim & Aquacultural Sci, N-1432 As, Norway; Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA; Uppsala Univ, Dept Med Biochem & Microbiol, S-75123 Uppsala, Sweden; Shirakawa Inst Anim Genetics, Nishigo, Fukushima 9618061, Japan; Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Biochem & Immunol, BR-14049900 Ribeirao Preto, SP, Brazil; MTT Agrifood Res Finland, Biotech & Food Res, FIN-31600 Jokioinen, Finland; INTA, EEA Rafaela, RA-3080 Rafaela, Argentina; USDA Agr Res Serv, Livestock Issues Res Unit, Lubbock, TX 79403 USA; Macquarie Univ, Dept Chem & Biomol Sci, ARC Ctr Excellence Bioinfo, Sydney, NSW 2109, Australia; Univ Guelph, Dept Anim & Poultry Sci, Guelph, ON N1G 2W1, Canada; Univ Oriente, Inst Invest Biomed & Ciencias Aplicadas, Cumana 6101, Sucre, Venezuela; Univ Saskatchewan, Dept Anim & Poultry Sci, Saskatoon, SK S7N 5A8, Canada; INRA UR1196, Genomique Phys Lactation, F-78352 Jouy En Josas, France; Univ Ljubljana, Dept Anim Sci, SI-1230 Domzale, Slovenia; Res Inst Biol Farm Anim FBN, Res Unit Mol Biol, D-18196 Dummerstorf, Germany; Univ Wisconsin Madison, Dept Anim Sci, Madison, WI 53706 USA; Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; EMBL Heidelberg, Cell Biol & Biophys, Heidelberg, Germany; ITACyL, Lab Mol Biol, E-47071 Valladolid, Spain; Univ Wisconsin, Dept Dairy Sci, Madison, WI 53706 USA; Monsanto Co, Ankeny, IA 50021 USA; Natl Bur Anim Genetic Res, Genes & Genetic Res Mol Anal Lab, Karnal 132001, Haryana, India; Agr & Agri-Food Canada, Lacombe Res Ctr, Lacombe, AB T4L 1W1, Canada; Univ Guelph, Biomed Sci, Guelph, ON N1G 2W6, Canada; Univ Cattolica Sacro Cuore, Zootechnics Inst, I-29100 Piacenza, Italy; Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA; UNESP Sao Paulo State Univ, Dept Ciencias Biol, Fac Ciencias Letras, BR-19806900 Assis, SP, Brazil; Norwegian Sch Vet Sci, Dept Basic Sci & Aquatic Med, N-0033 Oslo, Norway; INTA, Inst Genetica Ewald Favret, RA-B1712WAA Buenos Aires, Argentina; Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117597, Singapore; Univ Antioquia, Grp CENTAURO, Medellin, Colombia; Univ Illinois, Dept Chem, Urbana, IL 61801 USA; Griffith Univ, Eskitis Inst Cell & Mol Therapies, Nathan, QLD 4111, Australia; Utah State Univ, Nutr & Food Sci, Logan, UT 84322 USA; USDA Agr Res Serv, Anim Dis Res Unit, Pullman, WA 99164 USA; Univ Iowa, Dept Pharm 2 344 BSB, Iowa City, IA 52242 USA; Univ Vermont, Dept Anim Sci 211 Terrill, Burlington, VT 05405 USA	Georgetown University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Baylor College of Medicine; Washington University (WUSTL); Texas A&M University System; Texas A&M University College Station; University of Adelaide; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Simon Fraser University; University of Sydney; University of Lausanne; Baylor College of Medicine; United States Department of Agriculture (USDA); Texas A&M University System; Texas A&M University College Station; University of Geneva; Swiss Institute of Bioinformatics; Imperial College London; Texas A&M University System; Texas A&M University College Station; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Wellcome Trust Sanger Institute; University of London; Royal Holloway University London; University of Houston System; University of Houston; Johns Hopkins University; AgResearch - New Zealand; University of Adelaide; University of Geneva; ICREA; Pompeu Fabra University; Iowa State University; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); George Mason University; University System of Maryland; University of Maryland College Park; Trinity College Dublin; University of Missouri System; University of Missouri Columbia; AgResearch - New Zealand; Michigan State University; Nestle SA; University of California System; University of California Davis; AgResearch - New Zealand; Chungnam National University; University of Alberta; University of Massachusetts System; University of Massachusetts Amherst; University of Edinburgh; Washington State University; University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; University of Helsinki; Wellcome Trust Sanger Institute; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Estadual Paulista; Texas A&M University System; Texas A&M University College Station; Texas A&M AgriLife Research; University of Adelaide; Mississippi State University; United States Department of Agriculture (USDA); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); British Columbia Cancer Agency; National Institute of Agrobiological Sciences - Japan; Baylor College of Medicine; University of California System; University of California Santa Cruz; University of Houston System; University of Houston; Columbia University; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Pfizer; University of Sydney; Norwegian University of Life Sciences; University of Missouri System; University of Missouri Columbia; Uppsala University; Universidade de Sao Paulo; Natural Resources Institute Finland (Luke); Instituto Nacional de Tecnologia Agropecuaria (INTA); United States Department of Agriculture (USDA); Macquarie University; University of Guelph; University of Saskatchewan; INRAE; University of Ljubljana; Forschungsinstitut fur Nutztierbiologie (FBN); University of Wisconsin System; University of Wisconsin Madison; University of Guelph; European Molecular Biology Laboratory (EMBL); University of Wisconsin System; University of Wisconsin Madison; Monsanto; Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Animal Genetic Resources; Agriculture & Agri Food Canada; University of Guelph; Catholic University of the Sacred Heart; University of California System; University of California Davis; Universidade Estadual Paulista; Norwegian University of Life Sciences; Instituto Nacional de Tecnologia Agropecuaria (INTA); National University of Singapore; Universidad de Antioquia; University of Illinois System; University of Illinois Urbana-Champaign; Griffith University; Utah System of Higher Education; Utah State University; United States Department of Agriculture (USDA); University of Iowa; University of Vermont	Elsik, CG (corresponding author), Georgetown Univ, Dept Biol, 406 Reiss,37th & O St NW, Washington, DC 20057 USA.	ce75@georgetown.edu; ross.tellam@csiro.au; kworley@bcm.edu	Liu, George/K-3371-2019; Malinverni, Roberto/ABF-9644-2021; Marra, Marco A/B-5987-2008; Glass, Elizabeth J/L-4612-2016; Tellam, Ross/T-2423-2019; Utsunomiya, Yuri Tani T/K-5214-2013; Plass, Mireya/B-4240-2010; Weinstock, George M/C-6314-2013; Gasull, Martina/J-4076-2019; Elhaik, Eran/H-6838-2019; Zhu, Bin/E-4911-2010; Nogueira, Marcelo Fábio Gouveia/D-9801-2012; Rodriguez-Osorio, Nelida/AAT-1650-2020; Lahmers, Kevin/E-8272-2017; De Donato, Marcos/I-5307-2012; Hor, Charlotte/H-5908-2015; Elnitski, Laura/AAD-3595-2021; Ferreira, Francisco Câmara/G-9841-2015; Bradley, Daniel G/A-3240-2012; Hor, Charlotte/AAB-4850-2020; Casey, Theresa Marie/F-1171-2015; Guigo, Roderic/D-1303-2010; Ward, Robert E/E-1250-2011; Caetano, Alexandre Rodrigues/B-5227-2017; Waardenberg, Ashley/D-2595-2012; Nicholas, Frank William/AAE-5566-2022; Van Tassell, Curtis P./O-4247-2019; Garcia, Gustavo/E-5182-2013; Wheeler, David A/M-9740-2018; Franzin, Alessandra/D-4545-2013; Hernandez, Marta/I-3276-2016; Antonarakis, Stylianos E/N-8866-2014; Gill, Clare/R-3677-2019; Biase, Fernando/AAB-5132-2020; Adelson, David L/E-5506-2011; McWilliam, Sean M/H-8978-2013; Kumar, Charu/A-1582-2013; Schein, Jacquie E/G-3674-2015; TANIGUCHI, Masaaki/I-2564-2019; Greaser, Marion L/C-6147-2012; de Miranda Santos, Isabel K. F./D-5261-2016; Khatib, Hasan/AAA-2693-2021; Pant, Sameer Dinkar/D-1448-2017; Driemeier, David/H-3461-2012; Eyras, Eduardo/A-1560-2010; Riggs, Penny/AAE-8398-2020; Hadsell, Darryl/GPF-9037-2022; de Miranda Santos, Isabel KF/B-7597-2012; Junier, Thomas/A-6748-2011; BIASE, FERNANDO/A-3994-2010; Nicholas, Frank/AGY-8318-2022; Anatriello, Elen/N-1429-2015; McEwan, John/A-1143-2008; Zdobnov, Evgeny/AAB-2745-2022; Larkin, Denis/AAB-2249-2022; Khaleel, Sari/ABH-2168-2021; Seo, Seongwon/E-9687-2013; Harhay, Gregory/AAC-5411-2022; Alioto, Tyler/K-7267-2015; Malinverni, Roberto/K-2559-2017; Riggs, Penny K/A-8192-2008; Eyras, Eduardo/ABG-7144-2020; Alioto, Tyler/AAF-6342-2020; Holt, Robert A/C-3303-2009; Maruyama, Sandra R/G-1171-2012; Sweedler, Jonathan V/A-9405-2009; Tammen, Imke/AFF-7998-2022; Moore, Stephen S/F-5285-2013; Larkin, Denis/AAB-1633-2022; Brinkman, Fiona/N-3195-2013; Elsik, Christine G/C-4120-2017; Jones, Steven J/C-3621-2009; Eduardo, Eyras/L-1053-2014; Ingham, Aaron/C-1166-2008; Solovyev, Victor/C-4614-2013; Song, Jiuzhou/AAD-6440-2020; Keele, John W/A-5846-2009; Dalrymple, Brian P/F-8721-2010; MacNeil, Michael D/A-6772-2009; Zdobnov, Evgeny M/K-1133-2012; plass, mireya/AAB-7483-2019; KUMAR, DINESH/GRJ-5448-2022; Aerts, Jan/AAQ-6949-2020; martins, natalia florencio/AAE-7875-2019; Memili, Erdogan/AAY-8726-2020; Tellam, Ross/H-2798-2013; Bennett, Gary L/C-1124-2012	Liu, George/0000-0003-0192-6705; Malinverni, Roberto/0000-0002-0113-3417; Marra, Marco A/0000-0001-7146-7175; Glass, Elizabeth J/0000-0002-6183-0185; Utsunomiya, Yuri Tani T/0000-0002-6526-8337; Plass, Mireya/0000-0002-9891-2723; Weinstock, George M/0000-0002-2997-4592; Elhaik, Eran/0000-0003-4795-1084; Nogueira, Marcelo Fábio Gouveia/0000-0002-2239-9652; Rodriguez-Osorio, Nelida/0000-0002-2235-979X; De Donato, Marcos/0000-0001-8860-6020; Hor, Charlotte/0000-0002-5361-2372; Ferreira, Francisco Câmara/0000-0002-1971-5466; Hor, Charlotte/0000-0002-5361-2372; Casey, Theresa Marie/0000-0002-8835-3550; Guigo, Roderic/0000-0002-5738-4477; Ward, Robert E/0000-0002-6981-4040; Caetano, Alexandre Rodrigues/0000-0002-3419-7337; Nicholas, Frank William/0000-0002-9178-3965; Van Tassell, Curtis P./0000-0002-8416-2087; Wheeler, David A/0000-0002-9056-6299; Hernandez, Marta/0000-0001-6914-9987; Antonarakis, Stylianos E/0000-0001-8907-5823; Gill, Clare/0000-0003-2640-1825; Adelson, David L/0000-0003-2404-5636; McWilliam, Sean M/0000-0002-3148-0428; TANIGUCHI, Masaaki/0000-0001-8194-3577; Greaser, Marion L/0000-0002-6583-9566; Pant, Sameer Dinkar/0000-0002-0672-4478; Driemeier, David/0000-0003-3766-0654; Riggs, Penny/0000-0003-3296-320X; Nicholas, Frank/0000-0002-9178-3965; McEwan, John/0000-0003-4801-6207; Zdobnov, Evgeny/0000-0002-5178-1498; Khaleel, Sari/0000-0002-0886-0860; Harhay, Gregory/0000-0002-0129-6822; Alioto, Tyler/0000-0002-2960-5420; Malinverni, Roberto/0000-0002-0113-3417; Riggs, Penny K/0000-0003-3296-320X; Eyras, Eduardo/0000-0003-0793-6218; Alioto, Tyler/0000-0002-2960-5420; Holt, Robert A/0000-0002-7259-1247; Sweedler, Jonathan V/0000-0003-3107-9922; Tammen, Imke/0000-0002-5520-6597; Larkin, Denis/0000-0001-7859-6201; Brinkman, Fiona/0000-0002-0584-4099; Elsik, Christine G/0000-0002-4248-7713; Jones, Steven J/0000-0003-3394-2208; Eduardo, Eyras/0000-0003-0793-6218; Ingham, Aaron/0000-0001-8006-9443; Solovyev, Victor/0000-0001-8885-493X; Dalrymple, Brian P/0000-0003-3891-5233; plass, mireya/0000-0002-9891-2723; KUMAR, DINESH/0000-0002-9641-6662; Aerts, Jan/0000-0002-6416-2717; Memili, Erdogan/0000-0002-8335-5645; Tellam, Ross/0000-0003-2353-1640; Bennett, Gary L/0000-0001-7649-018X; Elnitski, Laura/0000-0003-1065-019X; Pruitt, Kim/0000-0001-7950-1374; Rodriguez-Zas, Sandra/0000-0003-1122-4758; Kokocinski, Felix/0000-0002-8472-9207; carvalho, wanessa/0000-0002-1346-5240; Rincon, Gonzalo/0000-0002-6149-9103; McKay, Stephanie/0000-0003-1434-3111; Molenaar, Adrian J./0000-0001-7347-0714; Lahmers, Kevin/0000-0002-5290-3426; Southey, Bruce/0000-0002-8959-7709; Reecy, James/0000-0003-4602-0990; Green, Jonathan/0000-0003-4968-8187; Hagen, Darren/0000-0001-8295-020X; Waardenberg, Ashley/0000-0002-9382-7490; Iso-Touru, Terhi/0000-0001-8258-9047; Schook, Lawrence/0000-0002-6580-8364; Gerlach, Daniel/0000-0001-9338-3765; Maqbool, Nauman/0000-0002-9404-3647; Amadio, Ariel Fernando/0000-0002-1147-4485; /0000-0001-6807-1452; Wilming, Laurens/0000-0002-4154-7358; Carroll, Jeffery/0000-0002-0202-4888; Moore, Stephen/0000-0002-9758-166X; Reymond, Alexandre/0000-0003-1030-8327; Schnabel, Robert/0000-0001-5018-7641; Williams, John/0000-0001-5188-7957; Kinney Ferreira de Miranda Santos, Isabel/0000-0002-0438-4430; Lemay, Danielle/0000-0003-3318-0485; Worley, Kim/0000-0002-0282-1000; Skow, Loren/0000-0001-8998-359X; Roberts, Andrew/0000-0001-8720-322X; Seo, Seongwon/0000-0002-4131-0545; Childers, Anna/0000-0002-0747-8539; Jensen, Kirsty/0000-0002-0005-6931; martins, natalia florencio/0000-0002-8816-4258; Ranganathan, Shoba/0000-0002-8290-813X; Gilbert, James/0000-0001-8079-3159; Hobbs, Matthew/0000-0002-6879-1369; Harrow, Jennifer/0000-0003-0338-3070; Childers, Chris/0000-0002-1253-5550; Anzola, Juan/0000-0003-2677-6731; Lynn, David/0000-0003-4664-1404; Bradley, Daniel G/0000-0001-7335-7092; White, Stephen N./0000-0001-9255-6054; Ternus, Krista/0000-0003-1138-5308	National Human Genome Research Institute [U54 HG003273]; U.S. Department of Agriculture's Agricultural Research Service [59-0790-3-196]; Cooperative State Research, Education, and Extension Service National Research Initiative [2004-35216-14163]; the state of Texas; Genome British Columbia; Alberta Science and Research Authority; Commonwealth Scientific and Industrial Research Organization of Australia (CSIRO); Agritech Investments Ltd; Dairy Insight, Inc; AgResearch Ltd.; Research Council of Norway; Kleberg Foundation; National, Texas, and South Dakota Beef Check-off Funds; ICREA Funding Source: Custom; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200323, U54HG003273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018310] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BBS/B/13438, BBS/B/13446, BB/D524040/2] Funding Source: researchfish; BBSRC [BB/D524040/2] Funding Source: UKRI	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); U.S. Department of Agriculture's Agricultural Research Service; Cooperative State Research, Education, and Extension Service National Research Initiative; the state of Texas; Genome British Columbia; Alberta Science and Research Authority; Commonwealth Scientific and Industrial Research Organization of Australia (CSIRO)(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Agritech Investments Ltd; Dairy Insight, Inc; AgResearch Ltd.; Research Council of Norway(Research Council of Norway); Kleberg Foundation; National, Texas, and South Dakota Beef Check-off Funds; ICREA(ICREA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funded by the National Human Genome Research Institute (NHGRI U54 HG003273); the U.S. Department of Agriculture's Agricultural Research Service (USDA-ARS agreement no. 59-0790-3-196) and Cooperative State Research, Education, and Extension Service National Research Initiative (grant no. 2004-35216-14163); the state of Texas; Genome Canada through Genome British Columbia; the Alberta Science and Research Authority; the Commonwealth Scientific and Industrial Research Organization of Australia (CSIRO); Agritech Investments Ltd., Dairy Insight, Inc., and AgResearch Ltd., all of New Zealand; the Research Council of Norway; the Kleberg Foundation; and the National, Texas, and South Dakota Beef Check-off Funds. The master accession for this WGS sequencing project is AAFC03000000. The individual WGS sequences are AAFC03000001 to AAFC03131728, and the scaffold records are CM000177 to CM000206 (chromosomes) and DS490632 to DS495890 (unplaced scaffolds).	Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Clawson ML, 2004, MAMM GENOME, V15, P227, DOI 10.1007/s00335-003-2320-x; Everts-van der Wind A, 2005, P NATL ACAD SCI USA, V102, P18526, DOI 10.1073/pnas.0509285102; Hashizume K, 2007, REPROD FERT DEVELOP, V19, P79, DOI 10.1071/RD06118; IRWIN DM, 1995, J MOL EVOL, V41, P299, DOI 10.1007/BF01215177; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; Kordis D, 1999, GENE, V238, P171, DOI 10.1016/S0378-1119(99)00260-7; Larson JH, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-227; Larson JH, 2006, PHYSIOL GENOMICS, V25, P405, DOI 10.1152/physiolgenomics.00307.2005; Liu Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-180; Malik HS, 1998, MOL BIOL EVOL, V15, P1123, DOI 10.1093/oxfordjournals.molbev.a026020; Mayer B, 2005, J DAIRY RES, V72, P107, DOI 10.1017/S0022029905001135; Modrek B, 2003, NAT GENET, V34, P177, DOI 10.1038/ng1159; Murphy WJ, 2005, SCIENCE, V309, P613, DOI 10.1126/science.1111387; Murphy WJ, 2004, TRENDS GENET, V20, P631, DOI 10.1016/j.tig.2004.09.005; NEWBY TJ, 1982, VET IMMUNOL IMMUNOP, V3, P67, DOI 10.1016/0165-2427(82)90032-0; Nilsen H, 2008, ANIM GENET, V39, P97, DOI 10.1111/j.1365-2052.2007.01686.x; Prasad A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-310; Rijnkels M, 2003, GENOMICS, V82, P417, DOI 10.1016/S0888-7543(03)00114-9; Roberts RM, 2008, SEMIN CELL DEV BIOL, V19, P170, DOI 10.1016/j.semcdb.2007.10.007; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; SCHMIDHAUSER C, 1992, MOL BIOL CELL, V3, P699, DOI 10.1091/mbc.3.6.699; Scocchi M, 1997, FEBS LETT, V417, P311, DOI 10.1016/S0014-5793(97)01310-0; Shimamura M, 1999, MOL BIOL EVOL, V16, P1046, DOI 10.1093/oxfordjournals.molbev.a026194; Sorek R, 2004, TRENDS GENET, V20, P68, DOI 10.1016/j.tig.2003.12.004; WILLHAM RL, 1986, J ANIM SCI, V62, P1742, DOI 10.2527/jas1986.6261742x; WU CI, 1985, P NATL ACAD SCI USA, V82, P1741, DOI 10.1073/pnas.82.6.1741; Zhang SY, 2008, IMMUNOL REV, V226, P29, DOI 10.1111/j.1600-065X.2008.00698.x	28	852	1040	5	236	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 24	2009	324	5926					522	528		10.1126/science.1169588	http://dx.doi.org/10.1126/science.1169588			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436JU	19390049	Green Accepted			2022-12-01	WOS:000265411200050
J	Lee, GM; Craik, CS				Lee, Gregory M.; Craik, Charles S.			Trapping Moving Targets with Small Molecules	SCIENCE			English	Editorial Material							PROTEIN-PROTEIN INTERACTIONS; HIGH-AFFINITY LIGANDS; NMR-SPECTROSCOPY; ALLOSTERIC REGULATION; BINDING MODES; IN-VITRO; DYNAMICS; ANTAGONISTS; INHIBITORS; MECHANISM	Structure-based drug design traditionally uses static protein models as inspirations for focusing on "active" site targets. Allosteric regulation of biological macromolecules, however, is affected by both conformational and dynamic properties of the protein or protein complex and can potentially lead to more avenues for therapeutic development. We discuss the advantages of searching for molecules that conformationally trap a macromolecule in its inactive state. Although multiple methodologies exist to probe protein dynamics and ligand binding, our current discussion highlights the use of nuclear magnetic resonance spectroscopy in the drug discovery and design process.	[Lee, Gregory M.; Craik, Charles S.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Craik, CS (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, 600 16th St,Box 2280, San Francisco, CA 94158 USA.	craik@cgl.ucsf.edu			NIH [1R01A1067423]; HIV Accessory and Regulatory Complex Center [P50 GM082250]; UCSF-Gladstone Institute for Virology & Immunology/Center for AIDS Research Clinical Science Pilot Award [P30-AI027763]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763, R01AI067423] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082250] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HIV Accessory and Regulatory Complex Center; UCSF-Gladstone Institute for Virology & Immunology/Center for AIDS Research Clinical Science Pilot Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported in part by grants from the NIH (grant 1R01A1067423) and the HIV Accessory and Regulatory Complex Center (grant P50 GM082250). G.M.L. is a recipient of the 2007 2008 UCSF-Gladstone Institute for Virology & Immunology Center for AIDS Research Clinical Science Pilot Award (grant P30-AI027763). We also thank K. Dill, J. Gross, D. Hostetter, and T. Shahian for discussion and proofreading of this manuscript.	Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Babe LM, 1997, CELL, V91, P427, DOI 10.1016/S0092-8674(00)80426-2; Best JL, 2004, P NATL ACAD SCI USA, V101, P17622, DOI 10.1073/pnas.0406374101; Boehr DD, 2006, CHEM REV, V106, P3055, DOI 10.1021/cr050312q; Caskey CT, 2007, ANNU REV MED, V58, P1, DOI 10.1146/annurev.med.58.042705.124037; D'Silva L, 2005, J AM CHEM SOC, V127, P13220, DOI 10.1021/ja052143x; De Francesco R, 2007, ADV DRUG DELIVER REV, V59, P1242, DOI 10.1016/j.addr.2007.04.016; DILL K, 1R01A1067423 NIH; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Frederick KK, 2007, NATURE, V448, P325, DOI 10.1038/nature05959; Golovanov AP, 2007, J AM CHEM SOC, V129, P6528, DOI 10.1021/ja070505q; Goodey NM, 2008, NAT CHEM BIOL, V4, P474, DOI 10.1038/nchembio.98; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Hornak V, 2007, DRUG DISCOV TODAY, V12, P132, DOI 10.1016/j.drudis.2006.12.011; Hu CQ, 2008, CURR MED CHEM, V15, P1720, DOI 10.2174/092986708784872375; Kern D, 2003, CURR OPIN STRUC BIOL, V13, P748, DOI 10.1016/j.sbi.2003.10.008; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Martinez-Cajas JL, 2008, DRUGS, V68, P43, DOI 10.2165/00003495-200868010-00004; Martins S, 2008, CURR MED CHEM, V15, P1083, DOI 10.2174/092986708784221467; Masterson LR, 2008, J AM CHEM SOC, V130, P7818, DOI 10.1021/ja802701w; MOBLEY DL, STRUCTURE IN PRESS; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Nomura AM, 2005, NAT STRUCT MOL BIOL, V12, P1019, DOI 10.1038/nsmb1006; O'Hare T, 2005, CANCER RES, V65, P4500, DOI 10.1158/0008-5472.CAN-05-0259; Pazgiera M, 2009, P NATL ACAD SCI USA, V106, P4665, DOI 10.1073/pnas.0900947106; Schanda P, 2008, J MOL BIOL, V380, P726, DOI 10.1016/j.jmb.2008.05.040; Scheer JM, 2006, P NATL ACAD SCI USA, V103, P7595, DOI 10.1073/pnas.0602571103; Showalter SA, 2008, J AM CHEM SOC, V130, P6472, DOI 10.1021/ja800201j; Shuker SB, 1996, SCIENCE, V274, P1531, DOI 10.1126/science.274.5292.1531; Sprangers R, 2007, NAT METHODS, V4, P697, DOI 10.1038/NMETH1080; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Tsai CJ, 2008, J MOL BIOL, V378, P1, DOI 10.1016/j.jmb.2008.02.034; Tsai CJ, 1999, PROTEIN SCI, V8, P1181, DOI 10.1110/ps.8.6.1181; Tsai CJ, 1999, P NATL ACAD SCI USA, V96, P9970, DOI 10.1073/pnas.96.18.9970; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Vajpai N, 2008, J BIOL CHEM, V283, P18292, DOI 10.1074/jbc.M801337200; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Verkhivker GM, 2002, CURR OPIN STRUC BIOL, V12, P197, DOI 10.1016/S0959-440X(02)00310-X; Volkman HM, 2005, J AM CHEM SOC, V127, P4649, DOI 10.1021/ja042761y; WEBER G, 1972, BIOCHEMISTRY-US, V11, P864, DOI 10.1021/bi00755a028; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526	41	131	135	2	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 10	2009	324	5924					213	215		10.1126/science.1169378	http://dx.doi.org/10.1126/science.1169378			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430WX	19359579	Green Accepted			2022-12-01	WOS:000265024400035
J	Parati, G; Pickering, TG				Parati, Gianfranco; Pickering, Thomas G.			Home blood-pressure monitoring: US and European consensus	LANCET			English	Editorial Material							HYPERTENSION; SOCIETY		[Parati, Gianfranco] Univ Milan, Dept Clin Med & Prevent, Milan, Italy; [Parati, Gianfranco] IRCCS, Ist Auxol Italiano, S Luca Hosp, Dept Cardiol, I-20149 Milan, Italy; [Pickering, Thomas G.] Columbia Presbyterian Med Ctr, Behav Cardiovasc Hlth & Hypertens Program, New York, NY 10032 USA	University of Milan; IRCCS Istituto Auxologico Italiano; Columbia University; NewYork-Presbyterian Hospital	Parati, G (corresponding author), Univ Milan, Dept Clin Med & Prevent, Milan, Italy.	gianfranco.parati@unimib.it	Parati, Gianfranco/K-7151-2016	Parati, Gianfranco/0000-0001-9402-7439				O'Brien E, 2003, J HYPERTENS, V21, P821, DOI 10.1097/00004872-200305000-00001; Parati G, 2004, CURR OPIN NEPHROL HY, V13, P343, DOI 10.1097/00041552-200405000-00013; Parati G, 2008, J HYPERTENS, V26, P1505, DOI 10.1097/HJH.0b013e328308da66; Pickering TG, 2008, HYPERTENSION, V52, P1, DOI 10.1161/HYPERTENSIONAHA.107.189011; Stergiou G, 2004, BMJ-BRIT MED J, V329, P870, DOI 10.1136/bmj.329.7471.870	5	62	62	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 14	2009	373	9667					876	878		10.1016/S0140-6736(09)60526-2	http://dx.doi.org/10.1016/S0140-6736(09)60526-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	418OU	19286071				2022-12-01	WOS:000264158700009
J	Bayer, M; Nawy, T; Giglione, C; Galli, M; Meinnel, T; Lukowitz, W				Bayer, Martin; Nawy, Tal; Giglione, Carmela; Galli, Mary; Meinnel, Thierry; Lukowitz, Wolfgang			Paternal Control of Embryonic Patterning in Arabidopsis thaliana	SCIENCE			English	Article							RECEPTOR-LIKE KINASES; SEED DEVELOPMENT; STOMATAL DEVELOPMENT; PROTEIN-KINASES; MAPKK KINASE; PLANTS; ELEMENTS	The YODA (YDA) mitogen-activated protein kinase pathway promotes elongation of the Arabidopsis zygote and development of its basal daughter cell into the extra-embryonic suspensor. Here, we show that the interleukin-1 receptor-associated kinase (IRAK)/Pelle-like kinase gene SHORT SUSPENSOR (SSP) regulates this pathway through a previously unknown parent-of-origin effect. SSP transcripts are produced in mature pollen but do not appear to be translated. Instead, they are delivered via the sperm cells to the zygote and the endosperm, where SSP protein transiently accumulates. Ectopic expression of SSP protein in the leaf epidermis is sufficient to activate YDA-dependent signaling. We propose that SSP protein produced from paternal transcripts upon fertilization triggers zygotic YDA activity, providing an essential temporal cue for the regulation of the asymmetric first division.	[Bayer, Martin; Nawy, Tal; Galli, Mary; Lukowitz, Wolfgang] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Giglione, Carmela; Meinnel, Thierry] CNRS, Inst Sci Vegetal, F-91198 Gif Sur Yvette, France; [Lukowitz, Wolfgang] Univ Georgia, Dept Plant Pathol, Athens, GA 30602 USA	Cold Spring Harbor Laboratory; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University System of Georgia; University of Georgia	Lukowitz, W (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	lukowitz@uga.edu	Bayer, Martin/AAP-3372-2020; Meinnel, Thierry/B-9813-2016	Bayer, Martin/0000-0001-5806-2253; Meinnel, Thierry/0000-0001-5642-8637; Giglione, Carmela/0000-0002-7475-1558; Nawy, Tal/0000-0003-3720-3699	NSF [IOB-0446103]; Deutsche Forschungsgemeinschaft; Cold Spring Harbor Laboratory Association; Association pour le Recherche sur le Cancer [4920]	NSF(National Science Foundation (NSF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cold Spring Harbor Laboratory Association; Association pour le Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer)	This work was supported by the NSF (grant IOB-0446103 to W.L.), the Deutsche Forschungsgemeinschaft (M.B.), the Cold Spring Harbor Laboratory Association (T.N.), and the Association pour le Recherche sur le Cancer (grant 4920 to T.M.). Seed of ssp-1 have been deposited with the Arabidopsis stock center. Materials were kindly made available by P. Das (Caltech), F. Besnard and T. Vernoux (Ecole Normale Superieure Lyon, pENTR triple Venus), S. McCormick (University of California Berkeley, GEX2 marker), N. Sauer (Erlangen University, SUC3 marker), A. Schnittger (Strasbourg University, cdc2a;fie1), and K. Slotkin and R. Martienssen (Cold Spring Harbor Laboratory, met1, ddm1, cmt3, drm2, and rdr1; rdr2; rdr6). S. Alabaster and J. A. Traverso provided help in the early phases of the project. We thank T. Berleth (University of Toronto), C. S. Gillmor and M. Willman (University of Pennsylvania), S. Jeong and C. Schulz (University of Georgia), R. Schwab (Cold Spring Harbor Laboratory), and D. Weijers (Wageningen University) for comments on the manuscript.	Adams JA, 2001, CHEM REV, V101, P2271, DOI 10.1021/cr000230w; Bergmann DC, 2004, SCIENCE, V304, P1494, DOI 10.1126/science.1096014; Boisson B, 2003, ANAL BIOCHEM, V322, P116, DOI 10.1016/j.ab.2003.07.007; Borges F, 2008, PLANT PHYSIOL, V148, P1168, DOI 10.1104/pp.108.125229; Castells E, 2007, J EXP BOT, V58, P3503, DOI 10.1093/jxb/erm226; Feil R, 2007, TRENDS GENET, V23, P192, DOI 10.1016/j.tig.2007.02.004; Huh JH, 2007, CURR OPIN GENET DEV, V17, P480, DOI 10.1016/j.gde.2007.08.011; Janssens S, 2003, MOL CELL, V11, P293, DOI 10.1016/S1097-2765(03)00053-4; Jenik PD, 2007, ANNU REV CELL DEV BI, V23, P207, DOI 10.1146/annurev.cellbio.22.011105.102609; Lukowitz W, 2004, CELL, V116, P109, DOI 10.1016/S0092-8674(03)01067-5; Meyer S, 2004, PLANT PHYSIOL, V134, P684, DOI 10.1104/pp.103.033399; Meyer S, 2007, CURR BIOL, V17, P1686, DOI 10.1016/j.cub.2007.08.046; Mukherjee K, 2008, CELL, V133, P328, DOI 10.1016/j.cell.2008.02.036; Nowack MK, 2007, NATURE, V447, P312, DOI 10.1038/nature05770; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Scott RJ, 1998, DEVELOPMENT, V125, P3329; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; Spillane C, 2007, NATURE, V448, P349, DOI 10.1038/nature05984; Wang HC, 2007, PLANT CELL, V19, P63, DOI 10.1105/tpc.106.048298; Wardlaw CW, 1955, EMBRYOGENESIS PLANTS	21	249	260	0	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2009	323	5920					1485	1488		10.1126/science.1167784	http://dx.doi.org/10.1126/science.1167784			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417TP	19286558				2022-12-01	WOS:000264101700043
J	Powers, AF; Franck, AD; Gestaut, DR; Cooper, J; Gracyzk, B; Wei, RR; Wordeman, L; Davis, TN; Asbury, CL				Powers, Andrew F.; Franck, Andrew D.; Gestaut, Daniel R.; Cooper, Jeremy; Gracyzk, Beth; Wei, Ronnie R.; Wordeman, Linda; Davis, Trisha N.; Asbury, Charles L.			The Ndc80 Kinetochore Complex Forms Load-Bearing Attachments to Dynamic Microtubule Tips via Biased Diffusion	CELL			English	Article							CHROMOSOME MOTION; BUDDING YEAST; DAM1 COMPLEX; MITOSIS; DEPOLYMERIZATION; MOVEMENT; DRIVEN; HEC1; ARCHITECTURE; CHECKPOINT	Kinetochores couple chromosomes to the assembling and disassembling tips of microtubules, a dynamic behavior that is fundamental to mitosis in all eukaryotes but poorly understood. Genetic, biochemical, and structural studies implicate the Ndc80 complex as a direct point of contact between kinetochores and microtubules, but these approaches provide only a static view. Here, using techniques for manipulating and tracking individual molecules in vitro, we demonstrate that the Ndc80 complex is capable of forming the dynamic, load-bearing attachments to assembling and disassembling tips required for coupling in vivo. We also establish that Ndc80-based coupling likely occurs through a biased diffusion mechanism and that this activity is conserved from yeast to humans. Our findings demonstrate how an ensemble of Ndc80 complexes may provide the combination of plasticity and strength that allows kinetochores to maintain load-bearing tip attachments during both microtubule assembly and disassembly.	[Powers, Andrew F.; Franck, Andrew D.; Cooper, Jeremy; Wordeman, Linda; Asbury, Charles L.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; [Gestaut, Daniel R.; Gracyzk, Beth; Davis, Trisha N.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Wei, Ronnie R.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Harvard University; Harvard Medical School	Asbury, CL (corresponding author), Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA.	casbury@u.washington.edu	Davis, Trisha/F-8584-2010	Davis, Trisha/0000-0003-4797-3152; Wordeman, Linda/0000-0002-9444-0650	NIH [T32 GM07270]; NSF IGERT [DGE-0504573]; Packard Fellowship for Science and Engineering [2006-30521]; National Institute of General Medical Sciences [R01GM40506, R01GM79373, R01GM69429]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079373, R01GM069429, T32GM007270, R01GM040506] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF IGERT(National Science Foundation (NSF)); Packard Fellowship for Science and Engineering; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Stephen Harrison and Jennifer DeLuca for plasmids, Anthony Azevedo for conducting early experiments with the 2NCC: 2S construct, Ryan Lemke for technical assistance, Jason Stumpff for helpful comments on the manuscript, and all members of the Seattle Mitosis Club for valuable discussion. This work was supported by an NIH traineeship (T32 GM07270 awarded to A. F. P.), an NSF IGERT traineeship (DGE-0504573 to A. D. F.), a Searle Scholar Award (06- L-111 to C. L. A.), a Packard Fellowship for Science and Engineering (2006-30521 to C. L. A.), and by grants R01GM40506, R01GM79373, and R01GM69429 from the National Institute of General Medical Sciences (to T. N. D., C. L. A., and L. W., respectively).	Asbury CL, 2006, P NATL ACAD SCI USA, V103, P9873, DOI 10.1073/pnas.0602249103; Blainey PC, 2006, P NATL ACAD SCI USA, V103, P5752, DOI 10.1073/pnas.0509723103; Brower-Toland BD, 2002, P NATL ACAD SCI USA, V99, P1960, DOI 10.1073/pnas.022638399; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Ciferri C, 2008, CELL, V133, P427, DOI 10.1016/j.cell.2008.03.020; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; DeLuca JG, 2002, J CELL BIOL, V159, P549, DOI 10.1083/jcb.200208159; DeLuca JG, 2005, MOL BIOL CELL, V16, P519, DOI 10.1091/mbc.E04-09-0852; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Emanuele MJ, 2005, MOL BIOL CELL, V16, P4882, DOI 10.1091/mbc.E05-03-0239; Franck AD, 2007, NAT CELL BIOL, V9, P832, DOI 10.1038/ncb1609; Gestaut DR, 2008, NAT CELL BIOL, V10, P407, DOI 10.1038/ncb1702; Grishchuk EL, 2006, EMBO J, V25, P4888, DOI 10.1038/sj.emboj.7601353; Guimaraes GJ, 2008, CURR BIOL, V18, P1778, DOI 10.1016/j.cub.2008.08.012; He XW, 2001, CELL, V106, P195, DOI 10.1016/S0092-8674(01)00438-X; HILL TL, 1985, P NATL ACAD SCI USA, V82, P4404, DOI 10.1073/pnas.82.13.4404; Joglekar AP, 2008, J CELL BIOL, V181, P587, DOI 10.1083/jcb.200803027; Kapoor TM, 2006, SCIENCE, V311, P388, DOI 10.1126/science.1122142; KOSHLAND DE, 1988, NATURE, V331, P499, DOI 10.1038/331499a0; LOMBILLO VA, 1995, NATURE, V373, P161, DOI 10.1038/373161a0; Maddox P, 2003, J CELL BIOL, V162, P377, DOI 10.1083/jcb.200301088; McAinsh AD, 2003, ANNU REV CELL DEV BI, V19, P519, DOI 10.1146/annurev.cellbio.19.111301.155607; McIntosh JR, 2008, CELL, V135, P322, DOI 10.1016/j.cell.2008.08.038; Miller SA, 2008, CURR BIOL, V18, P1785, DOI 10.1016/j.cub.2008.11.007; Miranda JJL, 2005, NAT STRUCT MOL BIOL, V12, P138, DOI 10.1038/nsmb896; NICKLAS RB, 1988, ANNU REV BIOPHYS BIO, V17, P431, DOI 10.1146/annurev.bb.17.060188.002243; Pearson CG, 2001, J CELL BIOL, V152, P1255, DOI 10.1083/jcb.152.6.1255; Rieder CL, 1998, TRENDS CELL BIOL, V8, P310, DOI 10.1016/S0962-8924(98)01299-9; Sharp DJ, 2000, NAT CELL BIOL, V2, P922, DOI 10.1038/35046574; Shimogawa MM, 2006, CURR BIOL, V16, P1489, DOI 10.1016/j.cub.2006.06.063; Stumpff J, 2008, DEV CELL, V14, P252, DOI 10.1016/j.devcel.2007.11.014; Tanaka K, 2007, J CELL BIOL, V178, P269, DOI 10.1083/jcb.200702141; Tanaka TU, 2008, CURR OPIN CELL BIOL, V20, P53, DOI 10.1016/j.ceb.2007.11.005; Weaver BAA, 2003, J CELL BIOL, V162, P551, DOI 10.1083/jcb.200303167; Wei RR, 2007, NAT STRUCT MOL BIOL, V14, P54, DOI 10.1038/nsmb1186; Wei RR, 2006, STRUCTURE, V14, P1003, DOI 10.1016/j.str.2006.04.007; Wei RR, 2005, P NATL ACAD SCI USA, V102, P5363, DOI 10.1073/pnas.0501168102; Westermann S, 2006, NATURE, V440, P565, DOI 10.1038/nature04409; Yang ZY, 2007, CURR BIOL, V17, P973, DOI 10.1016/j.cub.2007.04.056	39	202	203	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 6	2009	136	5					865	875		10.1016/j.cell.2008.12.045	http://dx.doi.org/10.1016/j.cell.2008.12.045			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	415JU	19269365	Green Accepted, Bronze			2022-12-01	WOS:000263930900010
J	Schwenk, J; Harmel, N; Zolles, G; Bildl, W; Kulik, A; Heimrich, B; Chisaka, O; Jonas, P; Schulte, U; Fakler, B; Klocker, N				Schwenk, Jochen; Harmel, Nadine; Zolles, Gerd; Bildl, Wolfgang; Kulik, Akos; Heimrich, Bernd; Chisaka, Osamu; Jonas, Peter; Schulte, Uwe; Fakler, Bernd; Kloecker, Nikolaj			Functional Proteomics Identify Cornichon Proteins as Auxiliary Subunits of AMPA Receptors	SCIENCE			English	Article							EXCITATORY POSTSYNAPTIC CURRENTS; 2 DISTINCT MECHANISMS; GLUTAMATE RECEPTORS; KINETIC-PROPERTIES; CA2+ PERMEABILITY; GAMMA-SUBUNIT; MUTANT MOUSE; ION CHANNELS; TIME-COURSE; STARGAZIN	Glutamate receptors of the AMPA-subtype (AMPARs), together with the transmembrane AMPAR regulatory proteins (TARPs), mediate fast excitatory synaptic transmission in the mammalian brain. Here, we show by proteomic analysis that the majority of AMPARs in the rat brain are coassembled with two members of the cornichon family of transmembrane proteins, rather than with the TARPs. Coassembly with cornichon homologs 2 and 3 affects AMPARs in two ways: Cornichons increase surface expression of AMPARs, and they alter channel gating by markedly slowing deactivation and desensitization kinetics. These results demonstrate that cornichons are intrinsic auxiliary subunits of native AMPARs and provide previously unknown molecular determinants for glutamatergic neurotransmission in the central nervous system.	[Schwenk, Jochen; Harmel, Nadine; Zolles, Gerd; Bildl, Wolfgang; Schulte, Uwe; Fakler, Bernd; Kloecker, Nikolaj] Univ Freiburg, Inst Physiol 2, D-79108 Freiburg, Germany; [Schulte, Uwe] Logopharm GmbH, D-79108 Freiburg, Germany; [Jonas, Peter] Univ Freiburg, Inst Physiol 1, D-79108 Freiburg, Germany; [Kulik, Akos; Heimrich, Bernd] Univ Freiburg, Inst Anat & Cell Biol, D-79104 Freiburg, Germany; [Fakler, Bernd] Ctr Biol Signaling Studies Bioss, D-79104 Freiburg, Germany; [Chisaka, Osamu] Kyoto Univ, Dept Cell & Dev Biol, Kyoto 6068502, Japan	University of Freiburg; University of Freiburg; University of Freiburg; Kyoto University	Fakler, B (corresponding author), Univ Freiburg, Inst Physiol 2, Engesserstr 4, D-79108 Freiburg, Germany.	bernd.fakler@physiologie.uni-freiburg.de; kloecker@physiologie.uni-freiburg.de		Schwenk, Jochen/0000-0003-3664-9795; Jonas, Peter/0000-0001-5001-4804	Deutsche Forschungsgemeinschaft [SFB 746/TP16, SFB780/TPA3, EXC 294, SFB780/TPB4]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank J. P. Adelman for insightful comments and critical reading of the manuscript and A. Haupt for help with bioinformatics. This work was supported by grants of the Deutsche Forschungsgemeinschaft to B.F. (SFB 746/TP16, SFB780/TPA3, EXC 294) and to N.K. (SFB780/TPB4).	Antz C, 1999, NAT STRUCT BIOL, V6, P146; Barbour B, 1997, TRENDS NEUROSCI, V20, P377; Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; Berkefeld H, 2006, SCIENCE, V314, P615, DOI 10.1126/science.1132915; Bokel C, 2006, DEVELOPMENT, V133, P459, DOI 10.1242/dev.02219; BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Chen L, 1999, P NATL ACAD SCI USA, V96, P12132, DOI 10.1073/pnas.96.21.12132; Cho CH, 2007, NEURON, V55, P890, DOI 10.1016/j.neuron.2007.08.024; Collingridge GL, 2009, NEUROPHARMACOLOGY, V56, P2, DOI 10.1016/j.neuropharm.2008.06.063; COLQUHOUN D, 1992, J PHYSIOL-LONDON, V458, P261, DOI 10.1113/jphysiol.1992.sp019417; Conti F, 1999, TRENDS NEUROSCI, V22, P451, DOI 10.1016/S0166-2236(99)01445-9; Dingledine R, 1999, PHARMACOL REV, V51, P7; Fukaya M, 2005, NEUROSCI RES, V53, P376, DOI 10.1016/j.neures.2005.08.009; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Hashimoto K, 1999, J NEUROSCI, V19, P6027, DOI 10.1523/JNEUROSCI.19-14-06027.1999; Hille B., 2001, ION CHANNELS EXCITAB, V3; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; Hoshino H, 2007, MOL BIOL CELL, V18, P1143, DOI 10.1091/mbc.E06-08-0733; Jonas P, 2000, NEWS PHYSIOL SCI, V15, P83; Jonas Peter, 1994, Current Opinion in Neurobiology, V4, P366, DOI 10.1016/0959-4388(94)90098-1; Kato AS, 2008, NEURON, V59, P986, DOI 10.1016/j.neuron.2008.07.034; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; Klugbauer N, 2000, FEBS LETT, V470, P189, DOI 10.1016/S0014-5793(00)01306-5; KOH DS, 1995, J PHYSIOL-LONDON, V485, P383, DOI 10.1113/jphysiol.1995.sp020737; Liu J, 2007, J BIOL CHEM, V282, P18945, DOI 10.1074/jbc.M701083200; LOMELI H, 1994, SCIENCE, V266, P1709, DOI 10.1126/science.7992055; Menuz K, 2008, J NEUROSCI, V28, P8740, DOI 10.1523/JNEUROSCI.1319-08.2008; Menuz K, 2009, NEUROPHARMACOLOGY, V56, P22, DOI 10.1016/j.neuropharm.2008.06.037; Milstein AD, 2007, NEURON, V55, P905, DOI 10.1016/j.neuron.2007.08.022; MOSBACHER J, 1994, SCIENCE, V266, P1059, DOI 10.1126/science.7973663; Nadal MS, 2003, NEURON, V37, P449, DOI 10.1016/S0896-6273(02)01185-6; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; Perez Castro C, 2007, J CELL SCI, V120, P2454, DOI 10.1242/jcs.004200; RAMAN IM, 1992, NEURON, V9, P173, DOI 10.1016/0896-6273(92)90232-3; Rollenhagen A, 2007, J NEUROSCI, V27, P10434, DOI 10.1523/JNEUROSCI.1946-07.2007; ROTH S, 1995, CELL, V81, P967, DOI 10.1016/0092-8674(95)90016-0; SAH P, 1990, J PHYSIOL-LONDON, V430, P605, DOI 10.1113/jphysiol.1990.sp018310; Schulte U, 2006, NEURON, V49, P697, DOI 10.1016/j.neuron.2006.01.033; Seeburg PH, 1998, BRAIN RES REV, V26, P217, DOI 10.1016/S0165-0173(97)00062-3; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; SILVER RA, 1992, NATURE, V355, P163, DOI 10.1038/355163a0; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Soto D, 2007, NAT NEUROSCI, V10, P1260, DOI 10.1038/nn1966; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Tomita S, 2005, NATURE, V435, P1052, DOI 10.1038/nature03624; Turetsky D, 2005, J NEUROSCI, V25, P7438, DOI 10.1523/JNEUROSCI.1108-05.2005; Vandenberghe W, 2005, P NATL ACAD SCI USA, V102, P485, DOI 10.1073/pnas.0408269102	49	287	299	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2009	323	5919					1313	1319		10.1126/science.1167852	http://dx.doi.org/10.1126/science.1167852			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414PC	19265014				2022-12-01	WOS:000263876700034
J	Kim, JH; Woo, HR; Kim, J; Lim, PO; Lee, IC; Choi, SH; Hwang, D; Nam, HG				Kim, Jin Hee; Woo, Hye Ryun; Kim, Jeongsik; Lim, Pyung Ok; Lee, In Chul; Choi, Seung Hee; Hwang, Daehee; Nam, Hong Gil			Trifurcate Feed-Forward Regulation of Age-Dependent Cell Death Involving miR164 in Arabidopsis	SCIENCE			English	Article							LATERAL ROOT DEVELOPMENT; LEAF SENESCENCE; SIGNALING PATHWAYS; STRESS RESPONSES; THALIANA; MICRORNA; ETHYLENE; TRANSCRIPTOME; TARGETS	Aging induces gradual yet massive cell death in higher organisms, including annual plants. Even so, the underlying regulatory mechanisms are barely known, despite the long- standing interest in this topic. Here, we demonstrate that ORE1, which is a NAC ( NAM, ATAF, and CUC) transcription factor, positively regulates aging- induced cell death in Arabidopsis leaves. ORE1 expression is up- regulated concurrently with leaf aging by EIN2 but is negatively regulated by miR164. miR164 expression gradually decreases with aging through negative regulation by EIN2, which leads to the elaborate up- regulation of ORE1 expression. However, EIN2 still contributes to aging- induced cell death in the absence of ORE1. The trifurcate feed- forward pathway involving ORE1, miR164, and EIN2 provides a highly robust regulation to ensure that aging induces cell death in Arabidopsis leaves.	[Kim, Jin Hee; Woo, Hye Ryun; Kim, Jeongsik; Lee, In Chul; Choi, Seung Hee; Nam, Hong Gil] Pohang Univ Sci & Technol, Div Mol Life Sci, Pohang 790784, South Korea; [Lim, Pyung Ok] Cheju Natl Univ, Dept Sci Educ, Cheju, South Korea; [Hwang, Daehee] Pohang Univ Sci & Technol, Dept Chem Engn, Pohang 790784, South Korea; [Hwang, Daehee; Nam, Hong Gil] Pohang Univ Sci & Technol, Sch Interdisciplinary Biosci & Bioengn, Pohang 790784, South Korea	Pohang University of Science & Technology (POSTECH); Jeju National University; Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH)	Nam, HG (corresponding author), Pohang Univ Sci & Technol, Div Mol Life Sci, Pohang 790784, South Korea.	nam@postech.ac.kr	Kim, Jeongsik/I-6184-2019	Kim, Jeongsik/0000-0002-2729-6003	Korea Science and Engineering Foundation National Core Research Center [R15-2004-033-05002-0)]; Crop Functional Genomics Frontier Research Program [CG3132]	Korea Science and Engineering Foundation National Core Research Center(Korea Science and Engineering Foundation); Crop Functional Genomics Frontier Research Program	We thank E. M. Meyerowitz and P. Sieber for the mir164abc triple mutant line; J. Traas for the miR164A- and miR164B-overexpressing lines; and K. H. Suh, B. H. Kim, and Y. S. Park for technical assistance. This research was supported by grants from the Korea Science and Engineering Foundation National Core Research Center (no. R15-2004-033-05002-0) and the Crop Functional Genomics Frontier Research Program (CG3132) from the Korean government (Ministry of Education, Science, and Technology).	Alonso JM, 1999, SCIENCE, V284, P2148, DOI 10.1126/science.284.5423.2148; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Buchanan-Wollaston V, 2005, PLANT J, V42, P567, DOI 10.1111/j.1365-313X.2005.02399.x; Cao WH, 2007, PLANT PHYSIOL, V143, P707, DOI 10.1104/pp.106.094292; Guo HS, 2005, PLANT CELL, V17, P1376, DOI 10.1105/tpc.105.030841; Guo YF, 2005, CURR TOP DEV BIOL, V71, P83, DOI 10.1016/S0070-2153(05)71003-6; He XJ, 2005, PLANT J, V44, P903, DOI 10.1111/j.1365-313X.2005.02575.x; Himelblau E, 2001, J PLANT PHYSIOL, V158, P1317, DOI 10.1078/0176-1617-00608; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Lim PO, 2007, ANNU REV PLANT BIOL, V58, P115, DOI 10.1146/annurev.arplant.57.032905.105316; Mallory AC, 2004, CURR BIOL, V14, P1035, DOI 10.1016/j.cub.2004.06.022; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Oh SA, 1997, PLANT J, V12, P527, DOI 10.1046/j.1365-313X.1997.00527.x; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Sieber P, 2007, DEVELOPMENT, V134, P1051, DOI 10.1242/dev.02817; Torres MA, 2005, NAT GENET, V37, P1130, DOI 10.1038/ng1639; Woo HR, 2001, PLANT CELL, V13, P1779, DOI 10.1105/tpc.13.8.1779; Wu G, 2006, DEVELOPMENT, V133, P3539, DOI 10.1242/dev.02521	20	481	523	8	166	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2009	323	5917					1053	1057		10.1126/science.1166386	http://dx.doi.org/10.1126/science.1166386			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409AK	19229035				2022-12-01	WOS:000263478400040
J	Waldman, SA; Hyslop, T; Schulz, S; Barkun, A; Nielsen, K; Haaf, J; Bonaccorso, C; Li, YY; Weinberg, DS				Waldman, Scott A.; Hyslop, Terry; Schulz, Stephanie; Barkun, Alan; Nielsen, Karl; Haaf, Janis; Bonaccorso, Christine; Li, Yanyan; Weinberg, David S.			Association of GUCY2C Expression in Lymph Nodes With Time to Recurrence and Disease-Free Survival in pN0 Colorectal Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GUANYLYL CYCLASE-C; II COLON-CANCER; STAGE-II; ADJUVANT CHEMOTHERAPY; PREDICT RECURRENCE; MESSENGER-RNA; DUKES-B; MICROMETASTASES; PROGNOSIS; THERAPY	Context The established relationship between lymph node metastasis and prognosis in colorectal cancer suggests that recurrence in 25% of patients with lymph nodes free of tumor cells by histopathology ( pN0) reflects the presence of occult metastases. Guanylyl cyclase 2C ( GUCY2C) is a marker expressed by colorectal tumors that could reveal occult metastases in lymph nodes and better estimate recurrence risk. Objective To examine the association of occult lymph node metastases detected by quantifying GUCY2C messenger RNA, using the reverse transcriptase - polymerase chain reaction, with recurrence and survival in patients with colorectal cancer. Design, Setting, and Participants Prospective study of 257 patients with pN0 colorectal cancer enrolled between March 2002 and June 2007 at 9 US and Canadian centers ( 7 academic medical centers and 2 community hospitals) provided 2570 fresh lymph nodes measuring 5 mm or larger for histopathology and GUCY2C messenger RNA analysis. Patients were followed up for a median of 24 months ( range, 2- 63 months) for disease recurrence or death. Main Outcome Measures Time to recurrence ( primary outcome) and diseasefree survival ( secondary outcome) relative to expression of GUCY2C in lymph nodes. Results Thirty- two patients ( 12.5%) had lymph nodes negative for GUCY2C ( pN0 [ mol-]), and all but 2 remained free of disease during follow- up ( recurrence rate, 6.3%; 95% confidence interval [ CI], 0.8%- 20.8%). Conversely, 225 patients ( 87.5%) had lymph nodes positive for GUCY2C ( pN0 [ mol +]), and 47 developed recurrent disease ( 20.9%; 95% CI, 15.8%- 26.8%) ( P=. 006). Multivariate analyses revealed that GUCY2C in lymph nodes was an independent marker of prognosis. Patients who were pN0 ( mol +) exhibited earlier time to recurrence ( adjusted hazard ratio, 4.66; 95% CI, 1.11- 19.57; P=. 04) and reduced disease- free survival ( adjusted hazard ratio, 3.27; 95% CI, 1.15-9.29; P=. 03). Conclusion Expression of GUCY2C in histologically negative lymph nodes appears to be independently associated with time to recurrence and disease- free survival in patients with pN0 colorectal cancer.	[Waldman, Scott A.; Hyslop, Terry; Schulz, Stephanie; Nielsen, Karl; Haaf, Janis; Bonaccorso, Christine; Li, Yanyan] Thomas Jefferson Univ, Dept Pharmacol & Expt Therapeut, Philadelphia, PA 19107 USA; [Barkun, Alan] McGill Univ, Dept Med, Div Gastroenterol, Montreal, PQ, Canada; [Weinberg, David S.] Fox Chase Canc Ctr, Dept Med, Philadelphia, PA 19111 USA	Jefferson University; McGill University; Fox Chase Cancer Center	Waldman, SA (corresponding author), Thomas Jefferson Univ, Dept Pharmacol & Expt Therapeut, 132 S 10th St, Philadelphia, PA 19107 USA.	Scott.Waldman@jefferson.edu		Waldman, Scott/0000-0001-6619-175X	National Institutes of Health [CA75123, CA95026, CA112147]; Targeted Diagnostic and Therapeutics Inc; NATIONAL CANCER INSTITUTE [R33CA112147, R21CA112147, R01CA075123, R01CA095026] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Targeted Diagnostic and Therapeutics Inc; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Institutes of Health grants CA75123 and CA95026 (to Dr Waldman) and CA112147 (to Dr Hyslop) and by funding from the Targeted Diagnostic and Therapeutics Inc (to Dr Waldman). Dr Waldman is the Samuel M. V. Hamilton Endowed Professor of Thomas Jefferson University.	Andre T, 2004, NEW ENGL J MED, V350, P2343, DOI 10.1056/NEJMoa032709; Benson AB, 2004, J CLIN ONCOL, V22, P3408, DOI 10.1200/JCO.2004.05.063; Bilchik AJ, 2007, ANN SURG, V246, P568, DOI 10.1097/SLA.0b013e318155a9c7; Birbe R, 2005, HUM PATHOL, V36, P170, DOI 10.1016/j.humpath.2004.12.002; Brown HG, 2004, MODERN PATHOL, V17, P402, DOI 10.1038/modpathol.3800071; Cagir B, 1999, ANN INTERN MED, V131, P805, DOI 10.7326/0003-4819-131-11-199912070-00002; Carrithers SL, 1996, P NATL ACAD SCI USA, V93, P14827, DOI 10.1073/pnas.93.25.14827; Chervoneva I, 2007, STAT MED, V26, P5596, DOI 10.1002/sim.3127; Compton CC, 2004, CA-CANCER J CLIN, V54, P295, DOI 10.3322/canjclin.54.6.295; Figueredo A, 2004, J CLIN ONCOL, V22, P3395, DOI 10.1200/JCO.2004.03.087; Frick GS, 2005, EXPERT REV MOL DIAGN, V5, P701, DOI 10.1586/14737159.5.5.701; Frigola J, 2006, NAT GENET, V38, P540, DOI 10.1038/ng1781; Gill S, 2004, J CLIN ONCOL, V22, P1797, DOI 10.1200/JCO.2004.09.059; Gray R, 2007, LANCET, V370, P2020, DOI 10.1016/s0140-6736(07)61866-2; Greene FL., 2002, AJCC CANC STAGING MA, V6, DOI DOI 10.1007/978-1-4757-3656-4; Groner RS, 2005, CANCER-AM CANCER SOC, V104, P395, DOI 10.1002/cncr.21170; HERRERAORNELAS L, 1987, ARCH SURG-CHICAGO, V122, P1253; Hitchcock CL, 1999, DIS COLON RECTUM, V42, P1046, DOI 10.1007/BF02236701; Hosmer DW, 1999, APPL SURVIVAL ANAL R; Iddings D, 2006, ANN SURG ONCOL, V13, P1386, DOI 10.1245/s10434-006-9120-y; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; JEN J, 1994, NEW ENGL J MED, V331, P213, DOI 10.1056/NEJM199407283310401; Le Voyer TE, 2003, J CLIN ONCOL, V21, P2912, DOI 10.1200/JCO.2003.05.062; Li P, 2007, GASTROENTEROLOGY, V133, P599, DOI 10.1053/j.gastro.2007.05.052; Mamounas E, 1999, J CLIN ONCOL, V17, P1349, DOI 10.1200/JCO.1999.17.5.1349; Meyerhardt JA, 2005, NEW ENGL J MED, V352, P476, DOI 10.1056/NEJMra040958; MOERTEL CG, 1986, CANCER, V58, P603, DOI 10.1002/1097-0142(19860801)58:3<603::AID-CNCR2820580302>3.0.CO;2-K; Newcombe RG, 1998, STAT MED, V17, P857, DOI 10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E; Nicastri DG, 2007, J MOL DIAGN, V9, P563, DOI 10.2353/jmoldx.2007.070032; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Pitari GM, 2007, CLIN PHARMACOL THER, V82, P441, DOI 10.1038/sj.clpt.6100325; Pocock SJ, 2002, LANCET, V359, P1686, DOI 10.1016/S0140-6736(02)08594-X; Punt CJA, 2007, JNCI-J NATL CANCER I, V99, P998, DOI 10.1093/jnci/djm024; Ratto C, 1999, DIS COLON RECTUM, V42, P143, DOI 10.1007/BF02237119; Schulz S, 2006, CLIN CANCER RES, V12, P4545, DOI 10.1158/1078-0432.CCR-06-0865; Swanson RS, 2003, ANN SURG ONCOL, V10, P65, DOI 10.1245/ASO.2003.03.058; Waldman SA, 2007, CLIN PHARMACOL THER, V82, P343, DOI 10.1038/sj.clpt.6100360; Waldman SA, 2007, CLIN PHARMACOL THER, V81, P3, DOI 10.1038/sj.clpt.6100032; Wang YX, 2004, J CLIN ONCOL, V22, P1564, DOI 10.1200/JCO.2004.08.186; Witek ME, 2005, CLIN CANCER RES, V11, P8549, DOI 10.1158/1078-0432.CCR-05-1624; Wolpin BM, 2007, CA-CANCER J CLIN, V57, P168, DOI 10.3322/canjclin.57.3.168	42	96	99	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 18	2009	301	7					745	752		10.1001/jama.2009.141	http://dx.doi.org/10.1001/jama.2009.141			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	407MX	19224751	Green Accepted, Bronze, Green Submitted			2022-12-01	WOS:000263370100017
J	Sreekumar, A; Poisson, LM; Rajendiran, TM; Khan, AP; Cao, Q; Yu, JD; Laxman, B; Mehra, R; Lonigro, RJ; Li, Y; Nyati, MK; Ahsan, A; Kalyana-Sundaram, S; Han, B; Cao, XH; Byun, J; Omenn, GS; Ghosh, D; Pennathur, S; Alexander, DC; Berger, A; Shuster, JR; Wei, JT; Varambally, S; Beecher, C; Chinnaiyan, AM				Sreekumar, Arun; Poisson, Laila M.; Rajendiran, Thekkelnaycke M.; Khan, Amjad P.; Cao, Qi; Yu, Jindan; Laxman, Bharathi; Mehra, Rohit; Lonigro, Robert J.; Li, Yong; Nyati, Mukesh K.; Ahsan, Aarif; Kalyana-Sundaram, Shanker; Han, Bo; Cao, Xuhong; Byun, Jaeman; Omenn, Gilbert S.; Ghosh, Debashis; Pennathur, Subramaniam; Alexander, Danny C.; Berger, Alvin; Shuster, Jeffrey R.; Wei, John T.; Varambally, Sooryanarayana; Beecher, Christopher; Chinnaiyan, Arul M.			Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression	NATURE			English	Article							MOLECULAR-GENETICS; POLYCOMB; EZH2; EXPRESSION	Multiple, complex molecular events characterize cancer development and progression(1,2). Deciphering the molecular networks that distinguish organ- confined disease from metastatic disease may lead to the identification of critical biomarkers for cancer invasion and disease aggressiveness. Although gene and protein expression have been extensively profiled in human tumours, little is known about the global metabolomic alterations that characterize neoplastic progression. Using a combination of high- throughput liquid- and- gas- chromatography- based mass spectrometry, we profiled more than 1,126 metabolites across 262 clinical samples related to prostate cancer ( 42 tissues and 110 each of urine and plasma). These unbiased metabolomic profiles were able to distinguish benign prostate, clinically localized prostate cancer and metastatic disease. Sarcosine, an N- methyl derivative of the amino acid glycine, was identified as a differential metabolite that was highly increased during prostate cancer progression to metastasis and can be detected non- invasively in urine. Sarcosine levels were also increased in invasive prostate cancer cell lines relative to benign prostate epithelial cells. Knockdown of glycine- N- methyl transferase, the enzyme that generates sarcosine from glycine, attenuated prostate cancer invasion. Addition of exogenous sarcosine or knockdown of the enzyme that leads to sarcosine degradation, sarcosine dehydrogenase, induced an invasive phenotype in benign prostate epithelial cells. Androgen receptor and the ERG gene fusion product coordinately regulate components of the sarcosine pathway. Here, by profiling the metabolomic alterations of prostate cancer progression, we reveal sarcosine as a potentially important metabolic intermediary of cancer cell invasion and aggressivity.	[Sreekumar, Arun; Rajendiran, Thekkelnaycke M.; Khan, Amjad P.; Cao, Qi; Yu, Jindan; Laxman, Bharathi; Mehra, Rohit; Lonigro, Robert J.; Li, Yong; Kalyana-Sundaram, Shanker; Han, Bo; Cao, Xuhong; Varambally, Sooryanarayana; Beecher, Christopher; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA; [Sreekumar, Arun; Omenn, Gilbert S.; Pennathur, Subramaniam; Beecher, Christopher; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Ctr Computat Med & Biol, Ann Arbor, MI 48109 USA; [Sreekumar, Arun; Rajendiran, Thekkelnaycke M.; Khan, Amjad P.; Cao, Qi; Yu, Jindan; Laxman, Bharathi; Mehra, Rohit; Li, Yong; Kalyana-Sundaram, Shanker; Han, Bo; Cao, Xuhong; Varambally, Sooryanarayana; Beecher, Christopher; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Sreekumar, Arun; Lonigro, Robert J.; Nyati, Mukesh K.; Ghosh, Debashis; Pennathur, Subramaniam; Wei, John T.; Varambally, Sooryanarayana; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Poisson, Laila M.; Ghosh, Debashis] Univ Michigan, Sch Med, Dept Biostat, Ann Arbor, MI 48109 USA; [Nyati, Mukesh K.; Ahsan, Aarif] Univ Michigan, Sch Med, Dept Radiat Oncol, Ann Arbor, MI 48109 USA; [Byun, Jaeman; Omenn, Gilbert S.; Pennathur, Subramaniam] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Omenn, Gilbert S.] Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA; [Wei, John T.; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI 48109 USA; [Varambally, Sooryanarayana] Univ Michigan, Sch Med, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; [Ghosh, Debashis] Penn State Univ, Dept Stat, University Pk, PA 16802 USA; [Ghosh, Debashis] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA; [Alexander, Danny C.; Berger, Alvin; Shuster, Jeffrey R.] Metabolon Inc, Durham, NC 27713 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Metabolon	Chinnaiyan, AM (corresponding author), Univ Michigan, Sch Med, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA.	arul@umich.edu	Cao, Qi/A-5517-2010; Berger, Alvin/AAE-5353-2022; Wei, John T/E-8967-2012; Kalyana-Sundaram, Shanker/F-6860-2012	Cao, Qi/0000-0002-5140-3681; Varambally, Sooryanarayana/0000-0002-2277-1127; Omenn, Gilbert S./0000-0002-8976-6074; Ghosh, Debashis/0000-0001-6618-1316; Kalyana-Sundaram, Shanker/0000-0002-7309-3848	Early Detection Research Network; National Institutes of Health; MTTC; Clinical Translational Science Award; Fund for Discovery of the University of Michigan Comprehensive Cancer Center; University of Michigan Cancer Biostatistics Training Grant; Doris Duke Charitable Foundation; NATIONAL CANCER INSTITUTE [T32CA083654, U01CA111275, R01CA133458, K99CA129565] Funding Source: NIH RePORTER	Early Detection Research Network; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MTTC; Clinical Translational Science Award; Fund for Discovery of the University of Michigan Comprehensive Cancer Center; University of Michigan Cancer Biostatistics Training Grant(University of Michigan System); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank J. Granger for help in manuscript preparation, J. Siddiqui and R. Varambally for help with the clinical database, and A. Vellaichamy and S. Pullela for technical assistance. We thank K. Pienta for access to metastatic prostate cancer samples from the University of Michigan Prostate SPORE rapid autopsy programme. This work is supported in part by the Early Detection Research Network (A.M.C., J.T.W.), National Institutes of Health (A.S., S.P., J.B., T.M.R., D.G., G.S.O. and A.M.C.) and an MTTC grant (G.S.O. and A.S.). A.M.C. is supported by a Clinical Translational Science Award from the Burroughs Welcome Foundation. A. S. is supported by a grant from the Fund for Discovery of the University of Michigan Comprehensive Cancer Center. L. M. P. is supported by the University of Michigan Cancer Biostatistics Training Grant. A. M. C and S. P. are supported by the Doris Duke Charitable Foundation.	Abate-Shen C, 2000, GENE DEV, V14, P2410, DOI 10.1101/gad.819500; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eisen MB, 1999, METHOD ENZYMOL, V303, P179; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Laible G, 1997, EMBO J, V16, P3219, DOI 10.1093/emboj/16.11.3219; Lawton KA, 2008, PHARMACOGENOMICS, V9, P383, DOI 10.2217/14622416.9.4.383; Rhodes DR, 2007, NEOPLASIA, V9, P443, DOI 10.1593/neo.07292; Ruijter E, 1999, ENDOCR REV, V20, P22, DOI 10.1210/er.20.1.22; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; van der Vlag J, 1999, NAT GENET, V23, P474, DOI 10.1038/70602; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Yu J, 2007, CANCER CELL, V12, P419, DOI 10.1016/j.ccr.2007.10.016; Yu J, 2007, CANCER RES, V67, P10657, DOI 10.1158/0008-5472.CAN-07-2498	18	1638	1716	22	792	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2009	457	7231					910	914		10.1038/nature07762	http://dx.doi.org/10.1038/nature07762			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406AF	19212411	Green Published, Green Accepted			2022-12-01	WOS:000263266700051
J	Yun, MH; Hiom, K				Yun, Maximina H.; Hiom, Kevin			CtIP-BRCA1 modulates the choice of DNA double-strand-break repair pathway throughout the cell cycle	NATURE			English	Article							HOMOLOGOUS RECOMBINATION; END RESECTION; MAMMALIAN-CELLS; DAMAGE; BRCA1; CTIP; DOMAINS; PROTEIN; GENE; LINE	The repair of DNA double-strand breaks (DSBs) is tightly regulated during the cell cycle. In G1 phase, the absence of a sister chromatid means that repair of DSBs occurs through non-homologous end-joining or microhomology-mediated end-joining (MMEJ)(1). These pathways often involve loss of DNA sequences at the break site and are therefore error-prone. In late S and G2 phases, even though DNA end-joining pathways remain functional(2), there is an increase in repair of DSBs by homologous recombination, which is mostly error-free(3,4). Consequently, the relative contribution of these different pathways to DSB repair in the cell cycle has a large influence on the maintenance of genetic integrity. It has remained unknown how DSBs are directed for repair by different, potentially competing, repair pathways. Here we identify a role for CtIP (also known as RBBP8) in this process in the avian B-cell line DT40. We establish that CtIP is required not only for repair of DSBs by homologous recombination in S/G2 phase but also for MMEJ in G1. The function of CtIP in homologous recombination, but not MMEJ, is dependent on the phosphorylation of serine residue 327 and recruitment of BRCA1. Cells expressing CtIP protein that cannot be phosphorylated at serine 327 are specifically defective in homologous recombination and have a decreased level of single-stranded DNA after DNA damage, whereas MMEJ remains unaffected. Our data support a model in which phosphorylation of serine 327 of CtIP as cells enter S phase and the recruitment of BRCA1 functions as a molecular switch to shift the balance of DSB repair from error-prone DNA end-joining to error-free homologous recombination.	[Yun, Maximina H.; Hiom, Kevin] MRC, Mol Biol Lab, Div Prot & Nucle Acid Chem, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Hiom, K (corresponding author), MRC, Mol Biol Lab, Div Prot & Nucle Acid Chem, Hills Rd, Cambridge CB2 0QH, England.	hiom@mrc-lmb.cam.ac.uk		Yun, Maximina/0000-0001-9019-2453	Medical Research Council [U.1051.03.005(78826), MC_U105184300] Funding Source: Medline; MRC [MC_U105184300] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Baumann P, 1998, TRENDS BIOCHEM SCI, V23, P247, DOI 10.1016/S0968-0004(98)01232-8; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Bridge WL, 2005, NAT GENET, V37, P953, DOI 10.1038/ng1627; Chen PL, 2005, MOL CELL BIOL, V25, P3535, DOI 10.1128/MCB.25.9.3535-3542.2005; Endicott JA, 1999, CURR OPIN STRUC BIOL, V9, P738, DOI 10.1016/S0959-440X(99)00038-X; Greenberger JS, 2006, EXP HEMATOL, V34, P46; Huertas P, 2008, NATURE, V455, P689, DOI 10.1038/nature07215; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; Kim JS, 2005, J CELL BIOL, V170, P341, DOI 10.1083/jcb.200411083; Ma JL, 2003, MOL CELL BIOL, V23, P8820, DOI 10.1128/MCB.23.23.8820-8828.2003; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Schlegel BP, 2006, CANCER RES, V66, P5181, DOI 10.1158/0008-5472.CAN-05-3209; Simpson LJ, 2003, EMBO J, V22, P1654, DOI 10.1093/emboj/cdg161; Sonoda E, 2001, PHILOS T ROY SOC B, V356, P111, DOI 10.1098/rstb.2000.0755; Stark JM, 2004, MOL CELL BIOL, V24, P9305, DOI 10.1128/MCB.24.21.9305-9316.2004; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; Tauchi H, 2002, ONCOGENE, V21, P8967, DOI 10.1038/sj.onc.1206136; Yu X, 1998, J BIOL CHEM, V273, P25388, DOI 10.1074/jbc.273.39.25388; Yu XC, 2004, MOL CELL BIOL, V24, P9478, DOI 10.1128/MCB.24.21.9478-9486.2004	21	378	386	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2009	459	7245					460	U184		10.1038/nature07955	http://dx.doi.org/10.1038/nature07955			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448DQ	19357644	Green Accepted			2022-12-01	WOS:000266243700053
J	Kelly, JX; Smilkstein, MJ; Brun, R; Wittlin, S; Cooper, RA; Lane, KD; Janowsky, A; Johnson, RA; Dodean, RA; Winter, R; Hinrichs, DJ; Riscoe, MK				Kelly, Jane X.; Smilkstein, Martin J.; Brun, Reto; Wittlin, Sergio; Cooper, Roland A.; Lane, Kristin D.; Janowsky, Aaron; Johnson, Robert A.; Dodean, Rozalia A.; Winter, Rolf; Hinrichs, David J.; Riscoe, Michael K.			Discovery of dual function acridones as a new antimalarial chemotype	NATURE			English	Article							CHLOROQUINE RESISTANCE TRANSPORTER; TRANSMEMBRANE PROTEIN PFCRT; PLASMODIUM-FALCIPARUM; DIGESTIVE VACUOLE; BETA-HEMATIN; IN-VITRO; DRUG; MALARIA; MUTATIONS; MECHANISM	Preventing and delaying the emergence of drug resistance is an essential goal of antimalarial drug development. Monotherapy and highly mutable drug targets have each facilitated resistance, and both are undesirable in effective long-term strategies against multi-drug-resistant malaria. Haem remains an immutable and vulnerable target, because it is not parasite-encoded and its detoxification during haemoglobin degradation, critical to parasite survival, can be subverted by drug-haem interaction as in the case of quinolines and many other drugs(1-5). Here we describe a new antimalarial chemotype that combines the haem-targeting character of acridones, together with a chemosensitizing component that counteracts resistance to quinoline antimalarial drugs. Beyond the essential intrinsic characteristics common to deserving candidate antimalarials ( high potency in vitro against pan-sensitive and multi-drug-resistant Plasmodium falciparum, efficacy and safety in vivo after oral administration, inexpensive synthesis and favourable physicochemical properties), our initial lead, T3.5 (3-chloro-6-(2-diethylamino-ethoxy)-10-(2-diethylamino-ethyl)acridone), demonstrates unique synergistic properties. In addition to 'verapamil-like' chemosensitization to chloroquine and amodiaquine against quinoline-resistant parasites, T3.5 also results in an apparently mechanistically distinct synergism with quinine and with piperaquine. This synergy, evident in both quinoline-sensitive and quinoline-resistant parasites, has been demonstrated both in vitro and in vivo. In summary, this innovative acridone design merges intrinsic potency and resistance-counteracting functions in one molecule, and represents a new strategy to expand, enhance and sustain effective antimalarial drug combinations.	[Kelly, Jane X.; Smilkstein, Martin J.; Janowsky, Aaron; Johnson, Robert A.; Dodean, Rozalia A.; Winter, Rolf; Hinrichs, David J.; Riscoe, Michael K.] Portland VA Med Ctr, Portland, OR 97239 USA; [Kelly, Jane X.; Smilkstein, Martin J.; Dodean, Rozalia A.; Winter, Rolf; Riscoe, Michael K.] Portland State Univ, Dept Chem, Portland, OR 97201 USA; [Smilkstein, Martin J.; Janowsky, Aaron; Johnson, Robert A.; Hinrichs, David J.; Riscoe, Michael K.] Oregon Hlth & Sci Univ, Portland, OR 97239 USA; [Brun, Reto; Wittlin, Sergio] Swiss Trop Inst, CH-4002 Basel, Switzerland; [Cooper, Roland A.; Lane, Kristin D.] Old Dominion Univ, Dept Biol Sci, Norfolk, VA 23529 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; Portland State University; Oregon Health & Science University; University of Basel; Swiss Tropical & Public Health Institute; Old Dominion University	Kelly, JX (corresponding author), Portland VA Med Ctr, Portland, OR 97239 USA.	kellyja@ohsu.edu; riscoem@ohsu.edu	Lane, Kristin D./AAS-3596-2020	Lane, Kristin D./0000-0002-4352-0562; Dodean, Rozalia/0000-0001-5002-4607	Merit Review Program of the Department of Veterans Affairs	Merit Review Program of the Department of Veterans Affairs(US Department of Veterans Affairs)	We thank D. Kyle for the gift of P. falciparum parasite Tm90-C2B, and the Malaria Research and Reference Resource Center for supplying P. falciparum parasites D6, Dd2 and 7G8. We thank A. P. Waters and C. J. Janse for the donation of GFP- labelled P. berghei strain ANKA. We thank L. Jones- Brando and R. Yolken for the cytotoxicity (HFF) data. We are grateful to A. Cornea for the confocal imaging. We thank K. Liebman, C. Hudson, S. Burgess and D. Peyton for compound characterization. We acknowledge financial support from the Merit Review Program of the Department of Veterans Affairs. United States patent applications have been filed by the US Department of Veterans Affairs to protect the intellectual property described in this report.	Bhattacharjee AK, 2002, J CHEM INF COMP SCI, V42, P1212, DOI 10.1021/ci0200265; Bhattacharjee AK, 2001, ANTIMICROB AGENTS CH, V45, P2655, DOI 10.1128/AAC.45.9.2655-2657.2001; Biot Christophe, 2006, Infectious Disorders - Drug Targets, V6, P173, DOI 10.2174/187152606784112155; Biot C, 2005, MOL PHARMACEUT, V2, P185, DOI 10.1021/mp0500061; Burgess SJ, 2006, J MED CHEM, V49, P5623, DOI 10.1021/jm060399n; Cooper RA, 2005, ACTA TROP, V94, P170, DOI 10.1016/j.actatropica.2005.04.004; Cooper RA, 2002, MOL PHARMACOL, V61, P35, DOI 10.1124/mol.61.1.35; Cooper RA, 2007, MOL MICROBIOL, V63, P270, DOI 10.1111/j.1365-2958.2006.05511.x; Egan TJ, 2008, MOL BIOCHEM PARASIT, V157, P127, DOI 10.1016/j.molbiopara.2007.11.005; Egan TJ, 2007, CURR OPIN INFECT DIS, V20, P598, DOI 10.1097/QCO.0b013e3282f1673a; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; FITCH CD, 1969, P NATL ACAD SCI USA, V64, P1181, DOI 10.1073/pnas.64.4.1181; Fivelman QL, 2004, ANTIMICROB AGENTS CH, V48, P4097, DOI 10.1128/AAC.48.11.4097-4102.2004; Foley M, 1997, INT J PARASITOL, V27, P231, DOI 10.1016/S0020-7519(96)00152-X; Kelly JX, 2007, ANTIMICROB AGENTS CH, V51, P4133, DOI 10.1128/AAC.00669-07; KROGSTAD DJ, 1987, SCIENCE, V238, P1283, DOI 10.1126/science.3317830; Krugliak M, 2002, MOL BIOCHEM PARASIT, V119, P249, DOI 10.1016/S0166-6851(01)00427-3; Kumar S, 2007, LIFE SCI, V80, P813, DOI 10.1016/j.lfs.2006.11.008; MARTIN SK, 1987, SCIENCE, V235, P899, DOI 10.1126/science.3544220; OLLIARO PL, 1995, PARASITOL TODAY, V11, P294, DOI 10.1016/0169-4758(95)80042-5; Pagola S, 2000, NATURE, V404, P307, DOI 10.1038/35005132; Smilkstein M, 2004, ANTIMICROB AGENTS CH, V48, P1803, DOI 10.1128/AAC.48.5.1803-1806.2004; Sullivan DJ, 1996, P NATL ACAD SCI USA, V93, P11865, DOI 10.1073/pnas.93.21.11865; van Schalkwyk DA, 2006, DRUG RESIST UPDATE, V9, P211, DOI 10.1016/j.drup.2006.09.002; Waller KL, 2003, J BIOL CHEM, V278, P33593, DOI 10.1074/jbc.M302215200; Wellems TE, 2002, SCIENCE, V298, P124, DOI 10.1126/science.1078167; *WHO, 2006, WHOHTMMAL20061108; YAYON A, 1984, EMBO J, V3, P2695, DOI 10.1002/j.1460-2075.1984.tb02195.x	28	146	150	0	39	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 14	2009	459	7244					270	273		10.1038/nature07937	http://dx.doi.org/10.1038/nature07937			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	445FR	19357645	Green Accepted			2022-12-01	WOS:000266036100045
J	Sato, T; Vries, RG; Snippert, HJ; van de Wetering, M; Barker, N; Stange, DE; van Es, JH; Abo, A; Kujala, P; Peters, PJ; Clevers, H				Sato, Toshiro; Vries, Robert G.; Snippert, Hugo J.; van de Wetering, Marc; Barker, Nick; Stange, Daniel E.; van Es, Johan H.; Abo, Arie; Kujala, Pekka; Peters, Peter J.; Clevers, Hans			Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche	NATURE			English	Article							SMALL-INTESTINE; EPITHELIAL-CELLS; EXPRESSION; DIFFERENTIATION; PROLIFERATION; INHIBITION; CULTURES; GROWTH; COLON; MICE	The intestinal epithelium is the most rapidly self-renewing tissue in adult mammals. We have recently demonstrated the presence of about six cycling Lgr(5+) stem cells at the bottoms of small-intestinal crypts(1). Here we describe the establishment of long-term culture conditions under which single crypts undergo multiple crypt fission events, while simultanously generating villus-like epithelial domains in which all differentiated cell types are present. Single sorted Lgr(5+) stem cells can also initiate these crypt-villus organoids. Tracing experiments indicate that the Lgr(5+) stem-cell hierarchy is maintained in organoids. We conclude that intestinal crypt-villus units are self-organizing structures, which can be built from a single stem cell in the absence of a non-epithelial cellular niche.	[Sato, Toshiro; Vries, Robert G.; Snippert, Hugo J.; van de Wetering, Marc; Barker, Nick; Stange, Daniel E.; van Es, Johan H.; Clevers, Hans] Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Sato, Toshiro; Vries, Robert G.; Snippert, Hugo J.; van de Wetering, Marc; Barker, Nick; Stange, Daniel E.; van Es, Johan H.; Clevers, Hans] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Abo, Arie] Nuvelo Inc, San Carlos, CA 94070 USA; [Kujala, Pekka; Peters, Peter J.] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Netherlands Cancer Institute	Clevers, H (corresponding author), Hubrecht Inst, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	h.clevers@niob.knaw.nl	Stange, Daniel E/O-1837-2015; van+Es, Johan/ABD-5411-2021; Barker, Nick/A-5535-2011; Barker, Nick/AAE-9833-2021; Sato, Toshiro/J-3522-2014; Barker, Nick/AAS-2774-2020	Stange, Daniel E/0000-0003-4246-2230; Barker, Nick/0000-0003-3566-4475; Sato, Toshiro/0000-0001-8353-8137; 				Barker N, 2008, GENE DEV, V22, P1856, DOI 10.1101/gad.1674008; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Bjerknes M, 2006, METHOD ENZYMOL, V419, P337, DOI 10.1016/S0076-6879(06)19014-X; CHENG H, 1974, AM J ANAT, V141, P461, DOI 10.1002/aja.1001410403; Dignass AU, 2001, EUR J GASTROEN HEPAT, V13, P763, DOI 10.1097/00042737-200107000-00002; EVANS GS, 1992, J CELL SCI, V101, P219; FUKAMACHI H, 1992, J CELL SCI, V103, P511; Haramis APG, 2004, SCIENCE, V303, P1684, DOI 10.1126/science.1093587; Hofmann C, 2007, GASTROENTEROLOGY, V132, P587, DOI 10.1053/j.gastro.2006.11.017; Kedinger M, 1998, ANN NY ACAD SCI, V859, P1, DOI 10.1111/j.1749-6632.1998.tb11107.x; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Kuhnert F, 2004, P NATL ACAD SCI USA, V101, P266, DOI 10.1073/pnas.2536800100; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Li LH, 1998, IMMUNITY, V8, P43, DOI 10.1016/S1074-7613(00)80457-4; Perreault N, 1996, EXP CELL RES, V224, P354, DOI 10.1006/excr.1996.0145; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; Powell DW, 1999, AM J PHYSIOL-CELL PH, V277, pC183, DOI 10.1152/ajpcell.1999.277.2.C183; Sasaki T, 2002, EXP CELL RES, V275, P185, DOI 10.1006/excr.2002.5499; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; STCLAIR WH, 1985, CELL TISSUE KINET, V18, P255; Stingl J, 2001, BREAST CANCER RES TR, V67, P93, DOI 10.1023/A:1010615124301; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Whitehead RH, 1999, GASTROENTEROLOGY, V117, P858, DOI 10.1016/S0016-5085(99)70344-6; Yen TH, 2006, STEM CELL REV, V2, P203, DOI 10.1007/s12015-006-0048-1	30	3789	3960	53	583	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 14	2009	459	7244					262	U147		10.1038/nature07935	http://dx.doi.org/10.1038/nature07935			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445FR	19329995				2022-12-01	WOS:000266036100043
J	He, LM; Xue, L; Xu, JH; McNeil, BD; Bai, L; Melicoff, E; Adachi, R; Wu, LG				He, Liming; Xue, Lei; Xu, Jianhua; McNeil, Benjamin D.; Bai, Li; Melicoff, Ernestina; Adachi, Roberto; Wu, Ling-Gang			Compound vesicle fusion increases quantal size and potentiates synaptic transmission	NATURE			English	Article							MULTIVESICULAR RELEASE; POSTTETANIC POTENTIATION; TRANSMITTER RELEASE; RAT CALYX; 2 MODES; EXOCYTOSIS; ENDOCYTOSIS; CAPACITANCE; MEMBRANE; CURRENTS	Exocytosis at synapses involves fusion between vesicles and the plasma membrane(1). Although compound fusion between vesicles(2,3) was proposed to occur at ribbon-type synapses(4,5), whether it exists, how it is mediated, and what role it plays at conventional synapses remain unclear. Here we report the existence of compound fusion, its underlying mechanism, and its role at a nerve terminal containing conventional active zones in rats and mice. We found that high potassium application and high frequency firing induced giant capacitance up-steps, reflecting exocytosis of vesicles larger than regular ones, followed by giant down-steps, reflecting bulk endocytosis. These intense stimuli also induced giant vesicle-like structures, as observed with electron microscopy, and giant miniature excitatory postsynaptic currents (mEPSCs), reflecting more transmitter release. Calcium and its sensor for vesicle fusion, synaptotagmin, were required for these giant events. After high frequency firing, calcium/synaptotagmin-dependent mEPSC size increase was paralleled by calcium/synaptotagmin-dependent post-tetanic potentiation. These results suggest a new route of exocytosis and endocytosis composed of three steps. First, calcium/synaptotagmin mediates compound fusion between vesicles. Second, exocytosis of compound vesicles increases quantal size, which increases synaptic strength and contributes to the generation of post-tetanic potentiation. Third, exocytosed compound vesicles are retrieved via bulk endocytosis. We suggest that this vesicle cycling route be included in models of synapses in which only vesicle fusion with the plasma membrane is considered(1).	[He, Liming; Xue, Lei; Xu, Jianhua; McNeil, Benjamin D.; Bai, Li; Wu, Ling-Gang] NINDS, Bethesda, MD 20892 USA; [Melicoff, Ernestina; Adachi, Roberto] Univ Texas MD Anderson Canc Ctr, Dept Pulm Med, Houston, TX 77030 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Texas System; UTMD Anderson Cancer Center	Wu, LG (corresponding author), NINDS, 35 Convent Dr,Bldg 35,Room 2B 1012, Bethesda, MD 20892 USA.	wul@ninds.nih.gov		Xu, Jianhua/0000-0003-0084-8856; Melicoff, Ernestina/0000-0001-5696-7112; Adachi, Roberto/0000-0002-0146-0768; McNeil, Benjamin/0000-0001-7545-3598	National Institute of Neurological Disorders and Stroke Intramural Research Program; American Heart Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003009] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Diamond and K. Paradiso for comments on the manuscript, and S. Cheng, R. Azzam and V. Crocker for help in EM. This work was supported by the National Institute of Neurological Disorders and Stroke Intramural Research Program (L.-G. W.) and the American Heart Association (R. A.).	ALVAREZ DT, 1990, J GEN PHYSIOL, V95, P397, DOI DOI 10.1085/JGP.95.3.397; Boraud T, 2002, PROG NEUROBIOL, V66, P265, DOI 10.1016/S0301-0082(01)00033-8; Coggins MR, 2007, J PHYSIOL-LONDON, V584, P853, DOI 10.1113/jphysiol.2007.140848; de Lange RPJ, 2003, J NEUROSCI, V23, P10164; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P560, DOI 10.1113/jphysiol.1954.sp005129; Gentet LJ, 2000, BIOPHYS J, V79, P314, DOI 10.1016/S0006-3495(00)76293-X; Habets RLP, 2005, J PHYSIOL-LONDON, V564, P173, DOI 10.1113/jphysiol.2004.079160; He LM, 2006, NATURE, V444, P102, DOI 10.1038/nature05250; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; Henze DA, 2002, J NEUROPHYSIOL, V87, P15, DOI 10.1152/jn.00394.2001; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; HEUSER JE, 1974, J PHYSIOL-LONDON, V239, pP106, DOI 10.1113/jphysiol.1974.sp010593; Korogod N, 2005, J NEUROSCI, V25, P5127, DOI 10.1523/JNEUROSCI.1295-05.2005; Lindau M, 2003, BBA-MOL CELL RES, V1641, P167, DOI 10.1016/S0167-4889(03)00085-5; Llano I, 2000, NAT NEUROSCI, V3, P1256, DOI 10.1038/81781; Matthews G, 2008, J NEUROSCI, V28, P5403, DOI 10.1523/JNEUROSCI.0935-08.2008; Oertel D, 1999, ANNU REV PHYSIOL, V61, P497, DOI 10.1146/annurev.physiol.61.1.497; Paillart C, 2003, J NEUROSCI, V23, P4092; Richards DA, 2000, NEURON, V27, P551, DOI 10.1016/S0896-6273(00)00065-9; Satzler K, 2002, J NEUROSCI, V22, P10567; SCEPEK S, 1993, EMBO J, V12, P1811, DOI 10.1002/j.1460-2075.1993.tb05829.x; Singer JH, 2004, NAT NEUROSCI, V7, P826, DOI 10.1038/nn1280; SPRUCE AE, 1990, NEURON, V4, P643, DOI 10.1016/0896-6273(90)90192-I; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sun J, 2007, NATURE, V450, P676, DOI 10.1038/nature06308; Sun JY, 2001, NEURON, V30, P171, DOI 10.1016/S0896-6273(01)00271-9; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; TONG G, 1994, NEURON, V12, P51, DOI 10.1016/0896-6273(94)90151-1; Wadiche JI, 2001, NEURON, V32, P301, DOI 10.1016/S0896-6273(01)00488-3; Wall MJ, 1998, NAT NEUROSCI, V1, P675, DOI 10.1038/3677; Xu JH, 2005, NEURON, V46, P633, DOI 10.1016/j.neuron.2005.03.024; Xu JH, 2008, NAT NEUROSCI, V11, P45, DOI 10.1038/nn2021; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	33	91	92	1	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 7	2009	459	7243					93	U99		10.1038/nature07860	http://dx.doi.org/10.1038/nature07860			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441WN	19279571	Green Accepted			2022-12-01	WOS:000265801300036
J	Mummery-Widmer, JL; Yamazaki, M; Stoeger, T; Novatchkova, M; Bhalerao, S; Chen, D; Dietzl, G; Dickson, BJ; Knoblich, JA				Mummery-Widmer, Jennifer L.; Yamazaki, Masakazu; Stoeger, Thomas; Novatchkova, Maria; Bhalerao, Sheetal; Chen, Doris; Dietzl, Georg; Dickson, Barry J.; Knoblich, Juergen A.			Genome-wide analysis of Notch signalling in Drosophila by transgenic RNAi	NATURE			English	Article							CELL-FATE; PROTEIN TRAFFICKING; BOUNDARY FORMATION; GENE; HAIRLESS; LOCALIZATION; NUMB; INTEGRATION; SUPPRESSOR; ENDOCYTOSIS	Genome-wide RNA interference (RNAi) screens have identified near-complete sets of genes involved in cellular processes. However, this methodology has not yet been used to study complex developmental processes in a tissue-specific manner. Here we report the use of a library of Drosophila strains expressing inducible hairpin RNAi constructs to study the Notch signalling pathway during external sensory organ development. We assigned putative loss-of-function phenotypes to 21.2% of the protein-coding Drosophila genes. Using secondary assays, we identified 6 new genes involved in asymmetric cell division and 23 novel genes regulating the Notch signalling pathway. By integrating our phenotypic results with protein interaction data, we constructed a genome-wide, functionally validated interaction network governing Notch signalling and asymmetric cell division. We used clustering algorithms to identify nuclear import pathways and the COP9 signallosome as Notch regulators. Our results show that complex developmental processes can be analysed on a genome-wide level and provide a unique resource for functional annotation of the Drosophila genome.	[Mummery-Widmer, Jennifer L.; Yamazaki, Masakazu; Stoeger, Thomas; Novatchkova, Maria; Bhalerao, Sheetal; Knoblich, Juergen A.] Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria; [Novatchkova, Maria; Bhalerao, Sheetal; Dietzl, Georg; Dickson, Barry J.] Res Inst Mol Pathol, A-1030 Vienna, Austria; [Chen, Doris] MFPL, Dept Biochem, A-1030 Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Knoblich, JA (corresponding author), Austrian Acad Sci, Inst Mol Biotechnol, Dr Bohr Gasse 3, A-1030 Vienna, Austria.	juergen.knoblich@imba.oeaw.ac.at	Dickson, Barry/AAE-7632-2019; Knoblich, Juergen A/C-2974-2015	Dickson, Barry/0000-0003-0715-892X; Knoblich, Juergen A/0000-0002-6751-3404; Chen, Doris/0000-0001-8835-0280; Stoeger, Thomas/0000-0002-5540-4278	Austrian Science Fund FWF [P 16629] Funding Source: Medline	Austrian Science Fund FWF(Austrian Science Fund (FWF))		Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; BANG AG, 1991, DEVELOPMENT, V111, P89; Bellaiche Y, 2001, NAT CELL BIOL, V3, P50, DOI 10.1038/35050558; Bettencourt-Dias M, 2004, NATURE, V432, P980, DOI 10.1038/nature03160; Blair SS, 2007, ANNU REV CELL DEV BI, V23, P293, DOI 10.1146/annurev.cellbio.23.090506.123606; Bosu DR, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-7; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; BRAND AH, 1993, DEVELOPMENT, V118, P401; Breitkreutz BJ, 2008, NUCLEIC ACIDS RES, V36, pD637, DOI 10.1093/nar/gkm1001; Calleja M, 2000, DEVELOPMENT, V127, P3971; Cavodeassi F, 2002, DEVELOPMENT, V129, P3815; Crowner D, 2003, CURR BIOL, V13, P967, DOI 10.1016/S0960-9822(03)00325-7; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dove SK, 2002, CURR BIOL, V12, P885, DOI 10.1016/S0960-9822(02)00891-6; Furriols M, 2001, CURR BIOL, V11, P60, DOI 10.1016/S0960-9822(00)00044-0; Gallagher CM, 2006, DEV CELL, V11, P641, DOI 10.1016/j.devcel.2006.09.014; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gho M, 1996, DEVELOPMENT, V122, P1673; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; Goshima G, 2007, SCIENCE, V316, P417, DOI 10.1126/science.1141314; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; HARTENSTEIN V, 1990, DEV BIOL, V142, P13, DOI 10.1016/0012-1606(90)90147-B; Hutterer A, 2005, EMBO REP, V6, P836, DOI 10.1038/sj.embor.7400500; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kiger A A, 2003, J Biol, V2, P27, DOI 10.1186/1475-4924-2-27; Koo EH, 2004, NAT MED, V10, pS26, DOI 10.1038/nm1065; Kulkarni MM, 2006, NAT METHODS, V3, P833, DOI 10.1038/nmeth935; Le Borgne R, 2005, DEVELOPMENT, V132, P1751, DOI 10.1242/dev.01789; Lu BW, 1999, MOL CELL, V4, P883, DOI 10.1016/S1097-2765(00)80218-X; Meshorer E, 2008, J CELL BIOL, V181, P9, DOI 10.1083/jcb.200802155; Milan M, 2005, DEV DYNAM, V233, P804, DOI 10.1002/dvdy.20384; Milan M, 2001, CELL, V106, P785, DOI 10.1016/S0092-8674(01)00489-5; Mistry H, 2004, MECH DEVELOP, V121, P1495, DOI 10.1016/j.mod.2004.07.007; Nagel AC, 2000, MECH DEVELOP, V94, P3, DOI 10.1016/S0925-4773(00)00319-1; O'Connor-Giles KM, 2003, DEV CELL, V5, P231, DOI 10.1016/S1534-5807(03)00226-0; Pi HW, 2004, P NATL ACAD SCI USA, V101, P8378, DOI 10.1073/pnas.0306010101; Reddien PW, 2005, DEV CELL, V8, P635, DOI 10.1016/j.devcel.2005.02.014; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; Rozen S, 2000, Methods Mol Biol, V132, P365; Rusten TE, 2006, MOL BIOL CELL, V17, P3989, DOI 10.1091/mbc.E06-03-0239; Schweisguth F, 2004, CURR BIOL, V14, pR129, DOI 10.1016/j.cub.2004.01.023; SCHWEISGUTH F, 1994, DEVELOPMENT, V120, P1433; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shinza-Kameda M, 2006, NEURON, V49, P205, DOI 10.1016/j.neuron.2005.11.013; Tekotte H, 2002, DEV BIOL, V244, P396, DOI 10.1006/dbio.2002.0612; VAESSIN H, 1991, CELL, V67, P941, DOI 10.1016/0092-8674(91)90367-8; von Mering C, 2007, NUCLEIC ACIDS RES, V35, pD358, DOI 10.1093/nar/gkl825; Wilson RJ, 2008, NUCLEIC ACIDS RES, V36, pD588, DOI 10.1093/nar/gkm930; Wu JT, 2005, NAT CELL BIOL, V7, P1014, DOI 10.1038/ncb1301; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P17518, DOI 10.1073/pnas.0702275104	54	232	243	1	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	2009	458	7241					987	U59		10.1038/nature07936	http://dx.doi.org/10.1038/nature07936			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436KL	19363474	Green Accepted			2022-12-01	WOS:000265412900033
J	Kiser, AK; Pronovost, PJ				Kiser, Ava K.; Pronovost, Peter J.			Management of Diseases Without Current Treatment Options Something Can Be Done	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RESPIRATORY-DISTRESS-SYNDROME; RETINITIS-PIGMENTOSA; SURVIVORS		[Kiser, Ava K.] Johns Hopkins Univ, Wilmer Eye Inst, Dept Ophthalmol, Baltimore, MD 21218 USA; [Pronovost, Peter J.] Johns Hopkins Univ, Dept Anesthesiol & Crit Care, Baltimore, MD 21218 USA; [Pronovost, Peter J.] Johns Hopkins Univ, Dept Surg, Baltimore, MD 21218 USA; [Pronovost, Peter J.] Johns Hopkins Univ, Dept Hlth Policy & Management, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Kiser, AK (corresponding author), 550 N Broadway,6th Floor, Baltimore, MD 21205 USA.	abittne1@jhmi.edu	Bittner, Ava/AAK-8778-2021	Bittner, Ava/0000-0002-9498-2230	NEI NIH HHS [K23 EY018356-02, K23 EY018356] Funding Source: Medline; NINR NIH HHS [P30 NR008995-05, P30 NR008995] Funding Source: Medline; NATIONAL EYE INSTITUTE [K23EY018356] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [P30NR008995] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))		Cohen S, 2007, JAMA-J AM MED ASSOC, V298, P1685, DOI 10.1001/jama.298.14.1685; Davydow DS, 2008, PSYCHOSOM MED, V70, P512, DOI 10.1097/PSY.0b013e31816aa0dd; HECKENLIVELY JR, 1988, AM J OPHTHALMOL, V105, P504, DOI 10.1016/0002-9394(88)90242-5; Herridge MS, 2003, NEW ENGL J MED, V348, P683, DOI 10.1056/NEJMoa022450; Kiser AK, 2008, CLIN EXP OPTOM, V91, P166, DOI 10.1111/j.1444-0938.2007.00224.x; Ormel J, 1997, PSYCHOL MED, V27, P1065, DOI 10.1017/S0033291797005321; Palop JJ, 2006, NATURE, V443, P768, DOI 10.1038/nature05289; Westfall JM, 2007, JAMA-J AM MED ASSOC, V297, P403, DOI 10.1001/jama.297.4.403; Woolf SH, 2008, JAMA-J AM MED ASSOC, V299, P211, DOI 10.1001/jama.2007.26; Zhao X, 2007, P NATL ACAD SCI USA, V104, P12831, DOI 10.1073/pnas.0705803104	10	4	5	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 22	2009	301	16					1708	1709		10.1001/jama.2009.506	http://dx.doi.org/10.1001/jama.2009.506			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	435NN	19383962	Green Accepted			2022-12-01	WOS:000265350700027
J	McWilliams, JM; Meara, E; Zaslavsky, AM; Ayanian, JZ				McWilliams, J. Michael; Meara, Ellen; Zaslavsky, Alan M.; Ayanian, John Z.			Differences in Control of Cardiovascular Disease and Diabetes by Race, Ethnicity, and Education: U. S. Trends From 1999 to 2006 and Effects of Medicare Coverage	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY-OF-CARE; NUTRITION EXAMINATION SURVEY; ACUTE MYOCARDIAL-INFARCTION; PAY-FOR-PERFORMANCE; RACIAL DISPARITIES; NATIONAL-HEALTH; HYPERTENSION PREVALENCE; UNINSURED ADULTS; UNITED-STATES; US ADULTS	Background: Efforts to improve the care of cardiovascular disease and diabetes or expand insurance coverage for adults with these conditions may reduce differences in clinical outcomes. Objective: To assess recent national trends in disease control, trends in sociodemographic differences in control, and changes in sociodemographic differences after age 65 years associated with near-universal Medicare coverage. Design: Observational and quasi-experimental analyses of repeated cross-sectional data. Setting: National Health and Nutrition Examination Survey, 1999 to 2006. Participants: Adults age 40 to 85 years with relevant clinical conditions. Measurements: Blood pressure control (< 140/90 mm Hg) and mean systolic blood pressure among adults with hypertension (n = 4521); glycemic control (hemoglobin A(1c) levels < 7.0%) and mean hemoglobin A1c levels among those with diabetes (n = 1733); and total cholesterol level control (< 5.2 mmol/L [< 200 mg/dL]) and mean total cholesterol levels among those with coronary heart disease, stroke, or diabetes (n = 2928). Temporal trends in these measures were compared by race, ethnicity, and education, and sociodemographic differences were compared above and below eligibility for Medicare at age 65 years. Results: Disease control improved significantly between 1999 and 2006 for all 6 measures ( P < 0.001). These trends did not differ by race or ethnicity or by education ( P >= 0.185 for group-time interactions), except that white-Hispanic differences in glycemic control widened (P = 0.042). Black-white differences in systolic blood pressure were smaller among adults age 65 to 85 years than among adults age 40 to 64 years (reduction in difference, 4.2 mm Hg; P = 0.009). Black-white differences in hemoglobin A(1c) levels were also smaller after age 65 years (reduction in difference, 0.7%; P = 0.005), as were Hispanic-white differences (reduction in difference, 0.7%; P = 0.007) and differences between less and more educated adults (reduction in difference, 0.5%; P = 0.033). Limitation: Data were cross-sectional, and estimates may have been biased by coincidental events at age 65 years, such as retirement, that may affect disease control. Conclusion: Control of blood pressure and glucose and cholesterol levels has improved since 1999 for adults with cardiovascular disease and diabetes, but racial, ethnic, or socioeconomic differences have not narrowed significantly. Medicare coverage after age 65 years is associated with reductions in these differences.	[McWilliams, J. Michael; Meara, Ellen; Zaslavsky, Alan M.; Ayanian, John Z.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Natl Bur Econ Res, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; National Bureau of Economic Research	Ayanian, JZ (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.	ayanian@hcp.med.harvard.edu		Meara, Ellen/0000-0003-0211-1970	Commonwealth Fund [20060485]	Commonwealth Fund	By The Commonwealth Fund (grant no. 20060485).	ABRAIDOLANZA AF, 1999, AM J PUBLIC HEALTH, V89, P1543, DOI DOI 10.2105/AJPH.89.10.1543; Anderson GF, 2005, NEW ENGL J MED, V353, P305, DOI 10.1056/NEJMsb044133; Andrulis DP, 1998, ANN INTERN MED, V129, P412, DOI 10.7326/0003-4819-129-5-199809010-00012; [Anonymous], 2008, NAT DIAB FACT SHEET; [Anonymous], 2004, 10365 NBER; Asch SM, 2004, ANN INTERN MED, V141, P938, DOI 10.7326/0003-4819-141-12-200412210-00010; Ayanian JZ, 2000, JAMA-J AM MED ASSOC, V284, P2061, DOI 10.1001/jama.284.16.2061; Ayanian JZ, 2003, AM J PUBLIC HEALTH, V93, P2051, DOI 10.2105/AJPH.93.12.2051; Bach PB, 2004, NEW ENGL J MED, V351, P575, DOI 10.1056/NEJMsa040609; Barnato AE, 2005, MED CARE, V43, P308, DOI 10.1097/01.mlr.0000156848.62086.06; BINDER DA, 1983, INT STAT REV, V51, P279, DOI 10.2307/1402588; Blumenthal D, 2007, NEW ENGL J MED, V356, P2527, DOI 10.1056/NEJMhpr066212; Blustein J, 2008, JAMA-J AM MED ASSOC, V299, P814, DOI 10.1001/jama.299.7.814; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; CARD D, 2007, 3668 NAT BUR EC RES; Casalino LP, 2007, HEALTH AFFAIR, V26, pW405, DOI 10.1377/hlthaff.26.3.w405; Chaturvedi N, 1997, LANCET, V349, P1787, DOI 10.1016/S0140-6736(96)10244-0; Chernew ME, 2007, HEALTH AFFAIR, V26, pW195, DOI 10.1377/hlthaff.26.2.w195; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Collins R, 2003, LANCET, V361, P2005; Cutler DM, 2006, NEW ENGL J MED, V355, P920, DOI 10.1056/NEJMsa054744; Cutler JA, 2008, HYPERTENSION, V52, P818, DOI 10.1161/HYPERTENSIONAHA.108.113357; Decker SL, 2005, J HUM RESOUR, V40, P948, DOI 10.3368/jhr.XL.4.948; FIHN SD, 1988, J GEN INTERN MED, V3, P356, DOI 10.1007/BF02595794; Fiscella K, 2000, JAMA-J AM MED ASSOC, V283, P2579, DOI 10.1001/jama.283.19.2579; Fiscella K, 2008, ANN FAM MED, V6, P497, DOI 10.1370/afm.873; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Ford ES, 2003, CIRCULATION, V107, P2185, DOI 10.1161/01.CIR.0000066320.27195.B4; Friedberg MW, 2007, J GEN INTERN MED, V22, P1385, DOI 10.1007/s11606-007-0234-0; Hasnain-Wynia R, 2007, ARCH INTERN MED, V167, P1233, DOI 10.1001/archinte.167.12.1233; Hertz RP, 2005, ARCH INTERN MED, V165, P2098, DOI 10.1001/archinte.165.18.2098; Hoerger TJ, 2008, DIABETES CARE, V31, P81, DOI 10.2337/dc07-1572; *I MED, 2002, UN TREATM CONFR RAC; *I MED, 2004, INS AM HLTH PRINC R; Institute of Medicine, 2001, CROSSING QUALITY CHA; Institute of Medicine, 2001, COV MATT INS HLTH CA; Jencks SF, 2003, JAMA-J AM MED ASSOC, V289, P305, DOI 10.1001/jama.289.3.305; Jha AK, 2007, ARCH INTERN MED, V167, P1177, DOI 10.1001/archinte.167.11.1177; Kanjilal S, 2006, ARCH INTERN MED, V166, P2348, DOI 10.1001/archinte.166.21.2348; KEELER EB, 1985, JAMA-J AM MED ASSOC, V254, P1926; Landon BE, 2008, MED CARE RES REV, V65, P167, DOI 10.1177/1077558707310208; Landon BE, 2007, NEW ENGL J MED, V356, P921, DOI 10.1056/NEJMsa062860; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; LURIE N, 1984, NEW ENGL J MED, V311, P480, DOI 10.1056/NEJM198408163110735; Ma J, 2005, ARCH INTERN MED, V165, P1354, DOI 10.1001/archinte.165.12.1354; Margolis KL, 2008, CLIN TRIALS, V5, P240, DOI 10.1177/1740774508091749; Martin LM, 2000, AM J PREV MED, V18, P215, DOI 10.1016/S0749-3797(99)00158-0; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; McGuire TG, 2006, HEALTH SERV RES, V41, P1979, DOI 10.1111/j.1475-6773.2006.00583.x; McWilliams JM, 2007, JAMA-J AM MED ASSOC, V298, P2886, DOI 10.1001/jama.298.24.2886; McWilliams JM, 2007, NEW ENGL J MED, V357, P143, DOI 10.1056/NEJMsa067712; McWilliams JM, 2003, JAMA-J AM MED ASSOC, V290, P757, DOI 10.1001/jama.290.6.757; Mehrotra A, 2006, ANN INTERN MED, V145, P826, DOI 10.7326/0003-4819-145-11-200612050-00007; *NAT CTR HLTH STAT, 2007, DHHS PUBL; *NCHS, 2003, NAT HLTH NUTR EX SUR; [NCHS] National Center for Health Statistics, 1999, NAT HLTH NUTR EX SUR; *NHANES, 2006, AN REP GUID 2006; Ong KL, 2008, ANN EPIDEMIOL, V18, P222, DOI 10.1016/j.annepidem.2007.10.007; Ong KL, 2007, HYPERTENSION, V49, P69, DOI 10.1161/01.HYP.0000252676.46043.18; Rosenthal MB, 2007, JAMA-J AM MED ASSOC, V297, P740, DOI 10.1001/jama.297.7.740; Schneider EC, 2001, JAMA-J AM MED ASSOC, V286, P1455, DOI 10.1001/jama.286.12.1455; Sequist TD, 2006, ARCH INTERN MED, V166, P675, DOI 10.1001/archinte.166.6.675; Simantov E, 2001, HEALTH AFFAIR, V20, P139, DOI 10.1377/hlthaff.20.4.139; Skinner J, 2005, CIRCULATION, V112, P2634, DOI 10.1161/CIRCULATIONAHA.105.543231; Smith DB, 2007, HEALTH AFFAIR, V26, P1448, DOI 10.1377/hlthaff.26.5.1448; Sudano JJ, 2003, AM J PUBLIC HEALTH, V93, P130, DOI 10.2105/AJPH.93.1.130; Tisnado DM, 2006, MED CARE, V44, P132, DOI 10.1097/01.mlr.0000196952.15921.bf; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; Trivedi AN, 2006, JAMA-J AM MED ASSOC, V296, P1998, DOI 10.1001/jama.296.16.1998; Trivedi AN, 2005, NEW ENGL J MED, V353, P692, DOI 10.1056/NEJMsa051207; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; *US PREV SERV TASK, 2007, AHRQ PUBL; Vargas CM, 1997, PREV MED, V26, P678, DOI 10.1006/pmed.1997.0190; Wennberg JE, 2007, HEALTH AFFAIR, V26, P1575, DOI 10.1377/hlthaff.26.6.1575; Werner RM, 2008, JAMA-J AM MED ASSOC, V299, P2180, DOI 10.1001/jama.299.18.2180; Wong MD, 2002, NEW ENGL J MED, V347, P1585, DOI 10.1056/NEJMsa012979; Yusuf S, 2000, NEW ENGL J MED, V342, P145	79	262	263	0	22	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 21	2009	150	8					505	W90		10.7326/0003-4819-150-8-200904210-00005	http://dx.doi.org/10.7326/0003-4819-150-8-200904210-00005			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	437AD	19380852				2022-12-01	WOS:000265457000001
J	Narimatsu, M; Bose, R; Pye, M; Zhang, L; Miller, B; Ching, P; Sakuma, R; Luga, V; Roncari, L; Attisano, L; Wrana, JL				Narimatsu, Masahiro; Bose, Rohit; Pye, Melanie; Zhang, Liang; Miller, Bryan; Ching, Peter; Sakuma, Rui; Luga, Valbona; Roncari, Luba; Attisano, Liliana; Wrana, Jeffrey L.			Regulation of Planar Cell Polarity by Smurf Ubiquitin Ligases	CELL			English	Article							NEURAL-TUBE DEFECTS; INNER-EAR; HAIR-CELLS; LOOP-TAIL; SIGNALING SPECIFICITY; CONVERGENT EXTENSION; STRABISMUS/VAN-GOGH; FLOOR PLATE; PCP PATHWAY; DROSOPHILA	Planar cell polarity (PCP) is critical for morphogenesis in metazoans. PCP in vertebrates regulates stereocilia alignment in neurosensory cells of the cochlea and closure of the neural tube through convergence and extension movements (CE). Noncanonical Wnt morphogens regulate PCP and CE in vertebrates, but the molecular mechanisms remain unclear. Smurfs are ubiquitin ligases that regulate signaling, cell polarity and motility through spatiotemporally restricted ubiquitination of diverse substrates. Here, we report an unexpected role for Smurfs in controlling PCP and CE. Mice mutant for Smurf1 and Smurf2 display PCP defects in the cochlea and CE defects that include a failure to close the neural tube. Further, we show that Smurfs engage in a non-canonical Wnt signaling pathway that targets the core PCP protein Prickle1 for ubiquitin-mediated degradation. Our work thus uncovers ubiquitin ligases in a mechanistic link between noncanonical Wnt signaling and PCP/CE.	[Miller, Bryan; Ching, Peter; Attisano, Liliana] Univ Toronto, Dept Biochem, Toronto, ON M5S 3E1, Canada; [Bose, Rohit; Luga, Valbona; Wrana, Jeffrey L.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 3E1, Canada; [Miller, Bryan; Ching, Peter; Attisano, Liliana] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada; [Narimatsu, Masahiro; Bose, Rohit; Pye, Melanie; Zhang, Liang; Sakuma, Rui; Luga, Valbona; Roncari, Luba; Wrana, Jeffrey L.] Mt Sinai Hosp, Ctr Syst Biol, Samuel Lunenfeld Res Inst, Toronto, ON M5S 1X5, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Attisano, L (corresponding author), Univ Toronto, Dept Biochem, 160 Coll St, Toronto, ON M5S 3E1, Canada.	liliana.attisano@utoronto.ca; wrana@mshri.on.ca	Bose, Rohit/O-9825-2018; Wrana, Jeffrey/F-8857-2013	Bose, Rohit/0000-0002-6785-0697; ZHANG, Liang/0000-0003-3100-8593	Canadian Institutes of Health Research (CIHR) [77690, 74692, 12860]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	We thank Dr. W. Rod Hardy and the ES and transgenic core facilities at Samuel Lunenfeld Research Institute/Toronto Centre for Phenogenomics for supporting generation of ES clones and diploid/tetraploid chimeras. We thank Siyuan Song for technical assistance, Dr. H. McNeill and the members of Drs. Wrana's and Attisano's labs for helpful comments and discussion. This work was supported by grants to L.A. (#77690) and J.L.W. (#74692, #12860) from the Canadian Institutes of Health Research (CIHR). L.A. and J.L.W. hold Canadian Research Chairs, and J.L.W. is an International Scholar of the Howard Hughes Medical Institute.	Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Bastock R, 2003, DEVELOPMENT, V130, P3007, DOI 10.1242/dev.00526; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; Ciruna B, 2006, NATURE, V439, P220, DOI 10.1038/nature04375; Classen AK, 2005, DEV CELL, V9, P805, DOI 10.1016/j.devcel.2005.10.016; Copp AJ, 2003, NAT REV GENET, V4, P784, DOI 10.1038/nrg1181; Curtin JA, 2003, CURR BIOL, V13, P1129, DOI 10.1016/S0960-9822(03)00374-9; Das G, 2004, DEVELOPMENT, V131, P4467, DOI 10.1242/dev.01317; Deans MR, 2007, J NEUROSCI, V27, P3139, DOI 10.1523/JNEUROSCI.5151-06.2007; Greene NDE, 1998, MECH DEVELOP, V73, P59, DOI 10.1016/S0925-4773(98)00029-X; Hyodo-Miura J, 2006, DEV CELL, V11, P69, DOI 10.1016/j.devcel.2006.04.019; Izzi L, 2006, NEOPLASIA, V8, P677, DOI 10.1593/neo.06472; Jenny A, 2005, NAT CELL BIOL, V7, P691, DOI 10.1038/ncb1271; Jiang D, 2005, CURR BIOL, V15, P79; Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478; Kibar Z, 2001, NAT GENET, V28, P251, DOI 10.1038/90081; Lewis J, 2002, J NEUROBIOL, V53, P190, DOI 10.1002/neu.10124; Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618; Montcouquiol M, 2006, J NEUROSCI, V26, P5265, DOI 10.1523/JNEUROSCI.4680-05.2006; Murdoch JN, 2001, HUM MOL GENET, V10, P2593, DOI 10.1093/hmg/10.22.2593; Ogunjimi AA, 2005, MOL CELL, V19, P297, DOI 10.1016/j.molcel.2005.06.028; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Penton A, 2002, GENETICS, V161, P747; Podos SD, 2001, DEV CELL, V1, P567, DOI 10.1016/S1534-5807(01)00057-0; Qian D, 2007, DEV BIOL, V306, P121, DOI 10.1016/j.ydbio.2007.03.011; Sahai E, 2007, J CELL BIOL, V176, P35, DOI 10.1083/jcb.200605135; Schlessinger K, 2007, J CELL BIOL, V178, P355, DOI 10.1083/jcb.200701083; Seifert JRK, 2007, NAT REV GENET, V8, P126, DOI 10.1038/nrg2042; Silvestri C, 2008, DEV CELL, V14, P411, DOI 10.1016/j.devcel.2008.01.004; Strutt DI, 2002, SEMIN CELL DEV BIOL, V13, P225, DOI 10.1016/S1084-9521(02)00041-1; Takeuchi M, 2003, CURR BIOL, V13, P674, DOI 10.1016/S0960-9822(03)00245-8; Torban E, 2004, J BIOL CHEM, V279, P52703, DOI 10.1074/jbc.M408675200; Tree DRP, 2002, CELL, V109, P371, DOI 10.1016/S0092-8674(02)00715-8; Wallingford JB, 2002, DEV CELL, V2, P695, DOI 10.1016/S1534-5807(02)00197-1; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Wang JB, 2006, DEVELOPMENT, V133, P1767, DOI 10.1242/dev.02347; Wang JB, 2005, NAT GENET, V37, P980, DOI 10.1038/ng1622; Wang YS, 2007, DEVELOPMENT, V134, P647, DOI 10.1242/dev.02772; Wang YH, 2006, J NEUROSCI, V26, P2147, DOI 10.1523/JNEUROSCI.4698-05.2005; Wu J, 2008, MECH DEVELOP, V125, P30, DOI 10.1016/j.mod.2007.10.006; Yamashita M, 2005, CELL, V121, P101, DOI 10.1016/j.cell.2005.01.035; Ybot-Gonzalez P, 2007, DEVELOPMENT, V134, P3203, DOI 10.1242/dev.008177; Zallen JA, 2007, CELL, V129, P1051, DOI 10.1016/j.cell.2007.05.050; Zhang X, 2007, NAT CELL BIOL, V9, P743, DOI 10.1038/ncb1603	45	249	255	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 17	2009	137	2					295	307		10.1016/j.cell.2009.02.025	http://dx.doi.org/10.1016/j.cell.2009.02.025			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	437AB	19379695	Bronze			2022-12-01	WOS:000265456800022
J	Nejentsev, S; Walker, N; Riches, D; Egholm, M; Todd, JA				Nejentsev, Sergey; Walker, Neil; Riches, David; Egholm, Michael; Todd, John A.			Rare Variants of IFIH1, a Gene Implicated in Antiviral Responses, Protect Against Type 1 Diabetes	SCIENCE			English	Article							GENOME-WIDE ASSOCIATION; LYMPHOID TYROSINE PHOSPHATASE; COMMON DISEASES; SUSCEPTIBILITY; LOCUS; POLYMORPHISMS; RECOGNITION; CONTRIBUTE; MUTATION; VIRUSES	Genome-wide association studies (GWASs) are regularly used to map genomic regions contributing to common human diseases, but they often do not identify the precise causative genes and sequence variants. To identify causative type 1 diabetes (T1D) variants, we resequenced exons and splice sites of 10 candidate genes in pools of DNA from 480 patients and 480 controls and tested their disease association in over 30,000 participants. We discovered four rare variants that lowered T1D risk independently of each other (odds ratio = 0.51 to 0.74; P = 1.3 x 10(-3) to 2.1 x 10(-16)) in IFIH1 (interferon induced with helicase C domain 1), a gene located in a region previously associated with T1D by GWASs. These variants are predicted to alter the expression and structure of IFIH1 [MDA5 (melanoma differentiation-associated protein 5)], a cytoplasmic helicase that mediates induction of interferon response to viral RNA. This finding firmly establishes the role of IFIH1 in T1D and demonstrates that resequencing studies can pinpoint disease-causing genes in genomic regions initially identified by GWASs.	[Nejentsev, Sergey; Walker, Neil; Todd, John A.] Univ Cambridge, Cambridge Inst Med Res, Wellcome Trust Diabet & Inflammat Lab, Juvenile Diabet Res Fdn, Cambridge CB2 0XY, England; [Nejentsev, Sergey] Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England; [Riches, David; Egholm, Michael] 454 Life Sci, Branford, CT 06405 USA	University of Cambridge; University of Cambridge	Nejentsev, S (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Wellcome Trust Diabet & Inflammat Lab, Juvenile Diabet Res Fdn, Cambridge CB2 0XY, England.	sn262@cam.ac.uk	Todd, John A/A-3542-2010	Todd, John A/0000-0003-2740-8148; Walker, Neil/0000-0001-9796-7688	Diabetes Research and Wellness Foundation Non-Clinical Fellowship; Royal Society University Research Fellowship; Juvenile Diabetes Research Foundation; Wellcome Trust; National Institute for Health Research Biomedical Research Centre; Cambridge Institute for Medical Research [079895]; Medical Research Council [G0000934] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10275] Funding Source: researchfish; MRC [G0000934] Funding Source: UKRI	Diabetes Research and Wellness Foundation Non-Clinical Fellowship; Royal Society University Research Fellowship(Royal Society of London); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research Biomedical Research Centre(National Institute for Health Research (NIHR)); Cambridge Institute for Medical Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the patients, control participants, and family members for participating in the study. S.N. held the Diabetes Research and Wellness Foundation Non-Clinical Fellowship at the early stages of the project and now holds the Royal Society University Research Fellowship. The Juvenile Diabetes Research Foundation/Wellcome Trust Diabetes and Inflammation Laboratory is funded by the Juvenile Diabetes Research Foundation, the Wellcome Trust, and the National Institute for Health Research Biomedical Research Centre. The Cambridge Institute for Medical Research is in receipt of a Wellcome Trust Strategic Award (079895). Full acknowledgements are in the supporting online material. Previously unseen SNPs were submitted to dbSNP database (www.ncbi.nlm.nih.gov/SNP/); their submission numbers are in table S3.	Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Concannon P, 2008, DIABETES, V57, P2858, DOI 10.2337/db08-0753; Cooper JD, 2008, NAT GENET, V40, P1399, DOI 10.1038/ng.249; Cordell HJ, 2002, AM J HUM GENET, V70, P124, DOI 10.1086/338007; Hornum L, 2002, DIABETES, V51, P1972, DOI 10.2337/diabetes.51.6.1972; Hyoty H, 2002, DIABETOLOGIA, V45, P1353, DOI 10.1007/s00125-002-0852-3; Ji WZ, 2008, NAT GENET, V40, P592, DOI 10.1038/ng.118; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Liu S, 2009, HUM MOL GENET, V18, P358, DOI 10.1093/hmg/ddn342; Lowe CE, 2007, NAT GENET, V39, P1074, DOI 10.1038/ng2102; MacMurray AJ, 2002, GENOME RES, V12, P1029, DOI 10.1101/gr.412702; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Murphy R, 2008, NAT CLIN PRACT ENDOC, V4, P200, DOI 10.1038/ncpendmet0778; Nejentsev S, 2007, NATURE, V450, P887, DOI 10.1038/nature06406; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Smyth D, 2004, DIABETES, V53, P3020, DOI 10.2337/diabetes.53.11.3020; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068	25	708	726	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2009	324	5925					387	389		10.1126/science.1167728	http://dx.doi.org/10.1126/science.1167728			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433QT	19264985	Green Accepted			2022-12-01	WOS:000265221600042
J	Jones, S; Hruban, RH; Kamiyama, M; Borges, M; Zhang, XS; Parsons, DW; Lin, JCH; Palmisano, E; Brune, K; Jaffee, EM; Iacobuzio-Donahue, CA; Maitra, A; Parmigiani, G; Kern, SE; Velculescu, VE; Kinzler, KW; Vogelstein, B; Eshleman, JR; Goggins, M; Klein, AP				Jones, Sian; Hruban, Ralph H.; Kamiyama, Mihoko; Borges, Michael; Zhang, Xiaosong; Parsons, D. Williams; Lin, Jimmy Cheng-Ho; Palmisano, Emily; Brune, Kieran; Jaffee, Elizabeth M.; Iacobuzio-Donahue, Christine A.; Maitra, Anirban; Parmigiani, Giovanni; Kern, Scott E.; Velculescu, Victor E.; Kinzler, Kenneth W.; Vogelstein, Bert; Eshleman, James R.; Goggins, Michael; Klein, Alison P.			Exomic Sequencing Identifies PALB2 as a Pancreatic Cancer Susceptibility Gene	SCIENCE			English	Article							BREAST-CANCER; FUTURE		[Jones, Sian; Hruban, Ralph H.; Zhang, Xiaosong; Parsons, D. Williams; Lin, Jimmy Cheng-Ho; Palmisano, Emily; Brune, Kieran; Jaffee, Elizabeth M.; Iacobuzio-Donahue, Christine A.; Maitra, Anirban; Parmigiani, Giovanni; Kern, Scott E.; Vogelstein, Bert; Eshleman, James R.; Goggins, Michael; Klein, Alison P.] Johns Hopkins Med Inst, Sol Goldman Pancreat Canc Res Ctr, Dept Oncol, Baltimore, MD 21231 USA; [Jones, Sian; Zhang, Xiaosong; Parsons, D. Williams; Lin, Jimmy Cheng-Ho; Velculescu, Victor E.; Kinzler, Kenneth W.; Vogelstein, Bert] Howard Hughes Med Inst, Baltimore, MD 21231 USA; [Jones, Sian; Zhang, Xiaosong; Parsons, D. Williams; Lin, Jimmy Cheng-Ho; Velculescu, Victor E.; Kinzler, Kenneth W.; Vogelstein, Bert] Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD 21231 USA; [Hruban, Ralph H.; Kamiyama, Mihoko; Borges, Michael; Jaffee, Elizabeth M.; Iacobuzio-Donahue, Christine A.; Maitra, Anirban; Parmigiani, Giovanni; Kern, Scott E.; Eshleman, James R.; Goggins, Michael; Klein, Alison P.] Johns Hopkins Med Inst, Sol Goldman Pancreat Canc Res Ctr, Dept Pathol, Baltimore, MD 21231 USA; [Goggins, Michael] Johns Hopkins Med Inst, Sol Goldman Pancreat Canc Res Ctr, Dept Med, Baltimore, MD 21231 USA	Johns Hopkins University; Johns Hopkins Medicine; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Eshleman, JR (corresponding author), Johns Hopkins Med Inst, Sol Goldman Pancreat Canc Res Ctr, Dept Oncol, Baltimore, MD 21231 USA.	aklein1@jhmi.edu	Velculescu, Victor/ABF-4846-2020; Iacobuzio-Donahue, Christine/ABF-1295-2020; Jones, Sian/A-5050-2012	Velculescu, Victor/0000-0003-1195-438X; Iacobuzio-Donahue, Christine/0000-0002-4672-3023; Jaffee, Elizabeth/0000-0003-3841-6549; Parsons, Donald/0000-0002-8775-3501	Sol Goldman Pancreatic Cancer Research Center; Lustgarten Foundation for Pancreatic Cancer Research; Virginia and D. K. Ludwig Fund for Cancer Research; NIH [CA62924, CA123483, RO1CA97075]; Michael Rolfe Pancreatic Cancer Foundation; NATIONAL CANCER INSTITUTE [R37CA057345, R01CA121113, R01CA123483, R37CA043460, R01CA097075, P50CA062924] Funding Source: NIH RePORTER	Sol Goldman Pancreatic Cancer Research Center; Lustgarten Foundation for Pancreatic Cancer Research; Virginia and D. K. Ludwig Fund for Cancer Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michael Rolfe Pancreatic Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by the Sol Goldman Pancreatic Cancer Research Center; the Lustgarten Foundation for Pancreatic Cancer Research; the Virginia and D. K. Ludwig Fund for Cancer Research; NIH grants CA62924, CA123483, and RO1CA97075; and the Michael Rolfe Pancreatic Cancer Foundation.	Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; *LUSTG FDN PANCR C, CA62924 NIH LUSTG FD; Maitra A, 2008, ANNU REV PATHOL-MECH, V3, P157, DOI 10.1146/annurev.pathmechdis.3.121806.154305; McGuire AL, 2007, SCIENCE, V317, P1687, DOI 10.1126/science.1147475; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Rahman N, 2007, NAT GENET, V39, P165, DOI 10.1038/ng1959; Turnbull C, 2008, ANNU REV GENOM HUM G, V9, P321, DOI 10.1146/annurev.genom.9.081307.164339; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022	9	559	578	0	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 10	2009	324	5924					217	217		10.1126/science.1171202	http://dx.doi.org/10.1126/science.1171202			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430WX	19264984	Green Accepted			2022-12-01	WOS:000265024400036
J	Campbell, BH				Campbell, Bruce H.			The Code	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												bcampbel@mcw.edu							0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 8	2009	301	14					1415	1416		10.1001/jama.2009.459	http://dx.doi.org/10.1001/jama.2009.459			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	429MN	19351928				2022-12-01	WOS:000264924900001
J	Jung, HW; Tschaplinski, TJ; Wang, L; Glazebrook, J; Greenberg, JT				Jung, Ho Won; Tschaplinski, Timothy J.; Wang, Lin; Glazebrook, Jane; Greenberg, Jean T.			Priming in Systemic Plant Immunity	SCIENCE			English	Article							ACQUIRED-RESISTANCE; ARABIDOPSIS-THALIANA; SALICYLIC-ACID; SIGNAL; ACCUMULATION; PATHOGEN; TOBACCO	Plants possess inducible systemic defense responses when locally infected by pathogens. Bacterial infection results in the increased accumulation of the mobile metabolite azelaic acid, a nine-carbon dicarboxylic acid, in the vascular sap of Arabidopsis that confers local and systemic resistance against the pathogen Pseudomonas syringae. Azelaic acid primes plants to accumulate salicylic acid (SA), a known defense signal, upon infection. Mutation of the AZELAIC ACID INDUCED 1 (AZI1) gene, which is induced by azelaic acid, results in the specific loss of systemic immunity triggered by pathogen or azelaic acid and of the priming of SA induction in plants. Furthermore, the predicted secreted protein AZI1 is also important for generating vascular sap that confers disease resistance. Thus, azelaic acid and AZI1 are components of plant systemic immunity involved in priming defenses.	[Jung, Ho Won; Greenberg, Jean T.] Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; [Tschaplinski, Timothy J.] Oak Ridge Natl Lab, Div Environm Sci, Oak Ridge, TN 37831 USA; [Wang, Lin; Glazebrook, Jane] Univ Minnesota, Dept Plant Biol, Microbial & Plant Genom Inst, St Paul, MN 55108 USA	University of Chicago; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Minnesota System; University of Minnesota Twin Cities	Greenberg, JT (corresponding author), Univ Chicago, Dept Mol Genet & Cell Biol, 1103 E 57th St EBC410, Chicago, IL 60637 USA.	jgreenbe@midway.uchicago.edu	Tschaplinski, Timothy/D-6382-2018; Wang, Lin/D-4021-2009	Tschaplinski, Timothy/0000-0002-9540-6622; Glazebrook, Jane/0000-0001-5167-736X; Greenberg, Jean/0000-0002-7213-7618	NSF [IOB-0450207, IOB-0419648]; Korea Research Foundation fellowship; Office of Biological and Environmental Research of the U.S. Department of Energy; U.S. Department of Energy [DE-AC05-00OR22725]	NSF(National Science Foundation (NSF)); Korea Research Foundation fellowship(National Research Foundation of Korea); Office of Biological and Environmental Research of the U.S. Department of Energy(United States Department of Energy (DOE)); U.S. Department of Energy(United States Department of Energy (DOE))	This work was funded by NSF grants to J.T.G. (IOB-0450207) and J.G. (IOB-0419648) and by a fellowship from Korea Research Foundation to H.W.J., and T.J.T. was supported by the Office of Biological and Environmental Research of the U.S. Department of Energy. Oak Ridge National Laboratory is managed by UT-Battelle for the U.S. Department of Energy under contract DE-AC05-00OR22725. We thank J. Bergelson and L. Mets for the use of their high-performance liquid chromatographys, F. Katagiri and J. Malamy for useful discussions, R. Cameron for sharing her detailed exudate collection protocol, and N. Engle for analysis of exudates. A patent application related to this work has been filed by the University of Chicago and UT-Battelle on behalf of inventors J.T.G., H.W.J., and T.J.T. on the use of azelaic acid to confer protection in crop plants against infection.	Cameron RK, 1999, PHYSIOL MOL PLANT P, V55, P121, DOI 10.1006/pmpp.1999.0214; Chassot C, 2007, PLANT J, V49, P972, DOI 10.1111/j.1365-313X.2006.03017.x; Chaturvedi R, 2008, PLANT J, V54, P106, DOI 10.1111/j.1365-313X.2007.03400.x; DEAN RA, 1986, PHYTOPATHOLOGY, V76, P966, DOI 10.1094/Phyto-76-966; MALAMY J, 1990, SCIENCE, V250, P1002, DOI 10.1126/science.250.4983.1002; Maldonado AM, 2002, NATURE, V419, P399, DOI 10.1038/nature00962; Nandi A, 2004, PLANT CELL, V16, P465, DOI 10.1105/tpc.016907; Park SW, 2007, SCIENCE, V318, P113, DOI 10.1126/science.1147113; Pieterse CMJ, 1998, PLANT CELL, V10, P1571, DOI 10.1105/tpc.10.9.1571; Ryals JA, 1996, PLANT CELL, V8, P1809, DOI 10.1105/tpc.8.10.1809; Sato M, 2007, PLANT J, V49, P565, DOI 10.1111/j.1365-313X.2006.02972.x; Truman W, 2007, P NATL ACAD SCI USA, V104, P1075, DOI 10.1073/pnas.0605423104; Vlot AC, 2008, PLANT J, V56, P445, DOI 10.1111/j.1365-313X.2008.03618.x	13	562	590	8	201	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2009	324	5923					89	91		10.1126/science.1170025	http://dx.doi.org/10.1126/science.1170025			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427TN	19342588				2022-12-01	WOS:000264802100038
J	Jeong, H; Then, F; Melia, TJ; Mazzulli, JR; Cui, L; Savas, JN; Voisine, C; Paganetti, P; Tanese, N; Hart, AC; Yamamoto, A; Krainc, D				Jeong, Hyunkyung; Then, Florian; Melia, Thomas J., Jr.; Mazzulli, Joseph R.; Cui, Libin; Savas, Jeffrey N.; Voisine, Cindy; Paganetti, Paolo; Tanese, Naoko; Hart, Anne C.; Yamamoto, Ai; Krainc, Dimitri			Acetylation Targets Mutant Huntingtin to Autophagosomes for Degradation	CELL			English	Article							INCLUSION-BODY FORMATION; CAENORHABDITIS-ELEGANS; POLYGLUTAMINE EXPANSIONS; IN-VITRO; DISEASE; PROTEIN; DYSFUNCTION; MODEL; AGGREGATION; NEURODEGENERATION	Huntington's disease (HD) is an incurable neurodegenerative disease caused by neuronal accumulation of the mutant protein huntingtin. Improving clearance of the mutant protein is expected to prevent cellular dysfunction and neurodegeneration in HD. We report here that such clearance can be achieved by posttranslational modification of the mutant Huntingtin (Htt) by acetylation at lysine residue 444 (K444). Increased acetylation at K444 facilitates trafficking of mutant Htt into autophagosomes, significantly improves clearance of the mutant protein by macroautophagy, and reverses the toxic effects of mutant huntingtin in primary striatal and cortical neurons and in a transgenic C. elegans model of HD. In contrast, mutant Htt that is rendered resistant to acetylation dramatically accumulates and leads to neurodegeneration in cultured neurons and in mouse brain. These studies identify acetylation as a mechanism for removing accumulated protein in HD, and more broadly for actively targeting proteins for degradation by autophagy.	[Jeong, Hyunkyung; Then, Florian; Mazzulli, Joseph R.; Cui, Libin; Krainc, Dimitri] Harvard Univ, Sch Med, Massachusetts Gen Hosp, MassGen Inst Neurodegenerat,Dept Neurol, Charlestown, MA 02129 USA; [Voisine, Cindy; Hart, Anne C.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, MassGen Inst Neurodegenerat,Ctr Canc Res, Charlestown, MA 02129 USA; [Melia, Thomas J., Jr.] Yale Univ, Dept Cell Biol, New Haven, CT 06519 USA; [Savas, Jeffrey N.; Tanese, Naoko] New York Univ, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Savas, Jeffrey N.] New York Univ, Sch Med, NYU & NIH Grad Partnership Program Struct Biol, New York, NY 10016 USA; [Paganetti, Paolo] Novartis Pharma AG, NIBR Basel, Neurosci Dis, CH-4002 Basel, Switzerland; [Yamamoto, Ai] Columbia Univ, Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Yale University; New York University; National Institutes of Health (NIH) - USA; New York University; Novartis; Columbia University	Krainc, D (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, MassGen Inst Neurodegenerat,Dept Neurol, Charlestown, MA 02129 USA.	krainc@helix.mgh.harvard.edu	Paganetti, Paolo/AAF-8039-2020; Voisine, Cindy/AAG-9045-2019; Yamamoto, Ai/D-1100-2011	Tanese, Naoko/0000-0002-1946-3211; Paganetti, Paolo/0000-0003-1896-6324; Voisine, Cindy/0000-0001-7165-9636	DFG;  [R01NS050352];  [R01 NS051303];  [R01 NS050199]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063973, R01NS051303, R01NS050199, R01NS050352] Funding Source: NIH RePORTER	DFG(German Research Foundation (DFG)); ; ; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to Drs. K. Kegel, M. DiFiglia, C. D. Allis, A. Basu, H. Park, and A.B. Young and members of the Krainc laboratory for helpful suggestions and comments on the manuscript. We also thank Drs. D. Sarracino, B. Krastins, J. Kowalak, S. Markey, and A. Makusky for help with mass spectrometry; B. Hyman, W. Stoothoff, and C. Lill for help with live-cell imaging; E. Regulier for help with lentiviral transductions; A. Weiss and A. Roscic for help with HN10 cells; H. Ischiropoulos for use of HPLC system; N. Mizushima for Atg5-deficient cells; A. Kazantsev for CBP and CBP Delta Q constructs; Y. Yoshimori for GFP-LC3; G.A. Fitzgerald for p300 and P/CAF; P.W. Faber for osm::Htt564-150Q; and the New York Structural Biology Center for the EM facilities. This work was supported by R01NS050352 and R01 NS051303 (to D.K.) and R01 NS050199 (to A.Y.). F.T. is a fellow of the DFG. Author contributions: H.J. and F.T. contributed equally to this work.	Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Bates EA, 2006, J NEUROSCI, V26, P2830, DOI 10.1523/JNEUROSCI.3344-05.2006; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Cuervo AM, 2004, MOL CELL BIOCHEM, V263, P55, DOI 10.1023/B:MCBI.0000041848.57020.57; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; Faber PW, 1999, P NATL ACAD SCI USA, V96, P179, DOI 10.1073/pnas.96.1.179; Graham RK, 2006, NEUROBIOL DIS, V21, P444, DOI 10.1016/j.nbd.2005.08.007; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Hackam AS, 1998, J CELL BIOL, V141, P1097, DOI 10.1083/jcb.141.5.1097; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hart AC, 1999, J NEUROSCI, V19, P1952; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kegel KB, 2000, J NEUROSCI, V20, P7268, DOI 10.1523/jneurosci.20-19-07268.2000; Kegel KB, 2002, J BIOL CHEM, V277, P7466, DOI 10.1074/jbc.M103946200; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; LAWRENCE BP, 1993, J CELL SCI, V105, P473; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lunkes A, 1998, HUM MOL GENET, V7, P1355, DOI 10.1093/hmg/7.9.1355; MARZELLA L, 1982, J CELL BIOL, V93, P144, DOI 10.1083/jcb.93.1.144; Mazzulli JR, 2006, J NEUROSCI, V26, P10068, DOI 10.1523/JNEUROSCI.0896-06.2006; Menalled LB, 2003, J COMP NEUROL, V465, P11, DOI 10.1002/cne.10776; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Nagaoka U, 2004, J NEUROCHEM, V91, P57, DOI 10.1111/j.1471-4159.2004.02692.x; Nixon RA, 2005, NEUROBIOL AGING, V26, P373, DOI 10.1016/j.neurobiolaging.2004.09.018; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Perutz MF, 1999, TRENDS BIOCHEM SCI, V24, P58, DOI 10.1016/S0968-0004(98)01350-4; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Reggiori F, 2002, EUKARYOT CELL, V1, P11, DOI 10.1128/EC.01.1.11-21.2002; Regulier E, 2003, HUM MOL GENET, V12, P2827, DOI 10.1093/hmg/ddg305; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Sapp E, 1997, ANN NEUROL, V42, P604, DOI 10.1002/ana.410420411; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Stromhaug PE, 1998, BIOCHEM J, V335, P217, DOI 10.1042/bj3350217; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Voisine Cindy, 2004, V277, P141; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; Weiss A, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-11; Wheeler VC, 1999, HUM MOL GENET, V8, P115, DOI 10.1093/hmg/8.1.115; Yamamoto A, 2006, J CELL BIOL, V172, P719, DOI 10.1083/jcb.200510065; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6; Zhai WG, 2005, CELL, V123, P1241, DOI 10.1016/j.cell.2005.10.030	48	295	305	1	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 2	2009	137	1					60	72		10.1016/j.cell.2009.03.018	http://dx.doi.org/10.1016/j.cell.2009.03.018			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	427XV	19345187	Green Accepted, Bronze			2022-12-01	WOS:000264813300014
J	Macdonald, S; Dixit, A; Wyatt, MG				Macdonald, S.; Dixit, A.; Wyatt, M. G.			Picture quiz "Brain attack"	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TRANSIENT ISCHEMIC ATTACK; CAROTID STENOSIS; SYMPTOMATIC PATIENTS; ENDARTERECTOMY; STROKE; TRIAL; RISK		[Macdonald, S.; Dixit, A.; Wyatt, M. G.] Newcastle Tyne Hosp NHS Fdn Trust, Newcastle Upon Tyne NE7 7TN, Tyne & Wear, England	Newcastle Upon Tyne Hospitals NHS Foundation Trust	Wyatt, MG (corresponding author), Newcastle Tyne Hosp NHS Fdn Trust, Newcastle Upon Tyne NE7 7TN, Tyne & Wear, England.	mike.wyatt@nuth.nhs.uk		Wyatt, Michael G/0000-0002-9144-4437				[Anonymous], 1994, STROKE, V25, P2523; Corriveau MM, 2004, J VASC SURG, V39, P735, DOI 10.1016/j.jvs.2003.12.017; DEANE C, 2007, SOC VASC TECHN GREAT; Halliday A, 2004, LANCET, V363, P1491; Johnston SC, 2007, LANCET, V369, P283, DOI 10.1016/S0140-6736(07)60150-0; *NAT I HLTH CLIN E, 2007, 233 IPG NAT I HLTH C; National Institutes of Health and Clinical Excellence, 2008, NIC CLIN GUID; OATES CP, 2008, EUR J VASC ENDO 1127; Schulz UG, 2004, STROKE, V35, P2459, DOI 10.1161/01.STR.0000143455.55877.b9; Sen S, 2000, CEREBROVASC DIS, V10, P102, DOI 10.1159/000016038; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; Vidjak V, 2007, COLLEGIUM ANTROPOL, V31, P775; Wardlaw JM, 2006, HEALTH TECHNOL ASSES, V10, P1; WARLOW C, 1991, LANCET, V337, P1235, DOI 10.1016/0140-6736(91)92916-P	14	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 1	2009	338								a3109	10.1136/bmj.a3109	http://dx.doi.org/10.1136/bmj.a3109			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	429AM	19359302				2022-12-01	WOS:000264893200001
J	Aller, SG; Yu, J; Ward, A; Weng, Y; Chittaboina, S; Zhuo, RP; Harrell, PM; Trinh, YT; Zhang, QH; Urbatsch, IL; Chang, G				Aller, Stephen G.; Yu, Jodie; Ward, Andrew; Weng, Yue; Chittaboina, Srinivas; Zhuo, Rupeng; Harrell, Patina M.; Trinh, Yenphuong T.; Zhang, Qinghai; Urbatsch, Ina L.; Chang, Geoffrey			Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding	SCIENCE			English	Article							ABC TRANSPORTER; MULTIDRUG-RESISTANCE; CASSETTE TRANSPORTER; NUCLEOTIDE-BINDING; CRYSTAL-STRUCTURE; PURIFICATION; CONFORMATION; RECOGNITION; MECHANISMS; MICROSCOPY	P-glycoprotein (P-gp) detoxifies cells by exporting hundreds of chemically unrelated toxins but has been implicated in multidrug resistance (MDR) in the treatment of cancers. Substrate promiscuity is a hallmark of P-gp activity, thus a structural description of poly-specific drug-binding is important for the rational design of anticancer drugs and MDR inhibitors. The x-ray structure of apo P-gp at 3.8 angstroms reveals an internal cavity of similar to 6000 angstroms cubed with a 30 angstrom separation of the two nucleotide-binding domains. Two additional P-gp structures with cyclic peptide inhibitors demonstrate distinct drug-binding sites in the internal cavity capable of stereoselectivity that is based on hydrophobic and aromatic interactions. Apo and drug-bound P-gp structures have portals open to the cytoplasm and the inner leaflet of the lipid bilayer for drug entry. The inward-facing conformation represents an initial stage of the transport cycle that is competent for drug binding.	[Aller, Stephen G.; Yu, Jodie; Weng, Yue; Chittaboina, Srinivas; Zhang, Qinghai; Chang, Geoffrey] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Ward, Andrew] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Zhuo, Rupeng; Harrell, Patina M.; Trinh, Yenphuong T.; Urbatsch, Ina L.] Texas Tech Univ, Hlth Sci Ctr, Lubbock, TX 79430 USA; [Weng, Yue] Wuhan Univ, Coll Chem & Mol Sci, Wuhan 430072, Peoples R China	Scripps Research Institute; Scripps Research Institute; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Wuhan University	Chang, G (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd,CB105, La Jolla, CA 92037 USA.	gchang@scripps.edu	Ward, Andrew/ABD-7728-2021; Ward, Andrew B/F-9203-2014	Ward, Andrew/0000-0001-7153-3769; Ward, Andrew B/0000-0001-7153-3769; Aller, Stephen/0000-0003-0379-5534; Weng, Yue/0000-0001-9126-3321	Army [W81XWH-05-1-0316]; NIH [GM61905, GM078914, GM073197]; Beckman Foundation; Skaggs Chemical Biology Foundation; Jasper L. and Jack Denton Wilson Foundation; Southwest Cancer and Treatment Center; Norton B. Gilula Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM073197, R01GM061905, F32GM078914] Funding Source: NIH RePORTER	Army; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beckman Foundation; Skaggs Chemical Biology Foundation; Jasper L. and Jack Denton Wilson Foundation; Southwest Cancer and Treatment Center; Norton B. Gilula Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. C. Rees, I. Wilson, R. H. Spencer, M. B. Stowell, A. Senior, A. Frost, V. M. Unger, C. D. Stout, and P. Wright. Y. Weng was supported by a scholarship from P. R. China. We thank Stanford Synchrotron Radiation Lightsource, Advanced Light Source, and Advanced Photon Source. This work was supported by grants from the Army (W81XWH-05-1-0316), NIH (GM61905, GM078914, and GM073197), the Beckman Foundation, the Skaggs Chemical Biology Foundation, Jasper L. and Jack Denton Wilson Foundation, the Southwest Cancer and Treatment Center, and the Norton B. Gilula Fellowship. Coordinates and structure factors deposited to the Protein DataBank (PDB accession codes 3G5U, 3G60, and 3G61).	*AM CANC SOC HOM, 2007, GLOB CANC FACTS FIG; Bosch I, 1997, BIOCHEMISTRY-US, V36, P5685, DOI 10.1021/bi962728r; Callaghan R, 1997, BBA-BIOMEMBRANES, V1328, P109, DOI 10.1016/S0005-2736(97)00079-5; Chami M, 2002, J MOL BIOL, V315, P1075, DOI 10.1006/jmbi.2001.5309; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Dong JH, 2005, SCIENCE, V308, P1023, DOI 10.1126/science.1106592; Gatlik-Landwojtowicz E, 2006, BIOCHEMISTRY-US, V45, P3020, DOI 10.1021/bi051380+; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; Hofacker M, 2007, J BIOL CHEM, V282, P3951, DOI 10.1074/jbc.M609899200; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; Lam FC, 2001, J NEUROCHEM, V76, P1121, DOI 10.1046/j.1471-4159.2001.00113.x; Lee JY, 2008, J BIOL CHEM, V283, P5769, DOI 10.1074/jbc.M707028200; Lerner-Marmarosh N, 1999, J BIOL CHEM, V274, P34711, DOI 10.1074/jbc.274.49.34711; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Longley DB, 2005, J PATHOL, V205, P275, DOI 10.1002/path.1706; Loo TW, 2006, BIOCHEM J, V399, P351, DOI 10.1042/BJ20060715; Loo TW, 2003, J BIOL CHEM, V278, P39706, DOI 10.1074/jbc.M308559200; Loo TW, 1997, J BIOL CHEM, V272, P31945, DOI 10.1074/jbc.272.51.31945; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Pinkett HW, 2007, SCIENCE, V315, P373, DOI 10.1126/science.1133488; Ramachandra M, 1998, BIOCHEMISTRY-US, V37, P5010, DOI 10.1021/bi973045u; RAVIV Y, 1990, J BIOL CHEM, V265, P3975; Rosenberg MF, 2003, J BIOL CHEM, V278, P8294, DOI 10.1074/jbc.M211758200; Schumacher MA, 2002, MOL MICROBIOL, V45, P885, DOI 10.1046/j.1365-2958.2002.03039.x; Sharom FJ, 2008, PHARMACOGENOMICS, V9, P105, DOI 10.2217/14622416.9.1.105; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Tombline G, 2005, BIOCHEMISTRY-US, V44, P12879, DOI 10.1021/bi0509797; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Watkins RE, 2001, SCIENCE, V292, P2329, DOI 10.1126/science.1060762; Zheleznova EE, 1999, CELL, V96, P353, DOI 10.1016/S0092-8674(00)80548-6	32	1501	1561	8	453	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2009	323	5922					1718	1722		10.1126/science.1168750	http://dx.doi.org/10.1126/science.1168750			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	424IG	19325113	Green Accepted			2022-12-01	WOS:000264559800037
J	Ishii, M; Egen, JG; Klauschen, F; Meier-Schellersheim, M; Saeki, Y; Vacher, J; Proia, RL; Germain, RN				Ishii, Masaru; Egen, Jackson G.; Klauschen, Frederick; Meier-Schellersheim, Martin; Saeki, Yukihiko; Vacher, Jean; Proia, Richard L.; Germain, Ronald N.			Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis	NATURE			English	Article							PROTEIN-COUPLED RECEPTOR; SPHINGOSINE 1-PHOSPHATE; CELL-MIGRATION; VASCULAR MATURATION; LYMPHOID ORGANS; TRANSGENIC MICE; T-CELLS; MARROW; EXPRESSION; COLLAGEN	Osteoclasts are the only somatic cells with bone-resorbing capacity and, as such, they have a critical role not only in normal bone homeostasis (called 'bone remodelling') but also in the pathogenesis of bone destructive disorders such as rheumatoid arthritis and osteoporosis(1). A major focus of research in the field has been on gene regulation by osteoclastogenic cytokines such as receptor activator of NF-kappa B-ligand (RANKL, also known as TNFSF11) and TNF-alpha, both of which have been well documented to contribute to osteoclast terminal differentiation(2,3). A crucial process that has been less well studied is the trafficking of osteoclast precursors to and from the bone surface, where they undergo cell fusion to form the fully differentiated multinucleated cells that mediate bone resorption. Here we report that sphingosine-1-phosphate (S1P), a lipid mediator enriched in blood(4,5), induces chemotaxis and regulates the migration of osteoclast precursors not only in culture but also in vivo, contributing to the dynamic control of bone mineral homeostasis. Cells with the properties of osteoclast precursors express functional S1P(1) receptors and exhibit positive chemotaxis along an S1P gradient in vitro. Intravital two-photon imaging of bone tissues showed that a potent S1P(1) agonist, SEW2871, stimulated motility of osteoclast precursor-containing monocytoid populations in vivo. Osteoclast/monocyte (CD11b, also known as ITGAM) lineage-specific conditional S1P(1) knockout mice showed osteoporotic changes due to increased osteoclast attachment to the bone surface. Furthermore, treatment with the S1P(1) agonist FTY720 relieved ovariectomy-induced osteoporosis in mice by reducing the number of mature osteoclasts attached to the bone surface. Together, these data provide evidence that S1P controls the migratory behaviour of osteoclast precursors, dynamically regulating bone mineral homeostasis, and identifies a critical control point in osteoclastogenesis that may have potential as a therapeutic target.	[Ishii, Masaru; Egen, Jackson G.; Germain, Ronald N.] NIDDK, Lymphocyte Biol Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Klauschen, Frederick; Meier-Schellersheim, Martin; Germain, Ronald N.] NIDDK, Program Syst Immunol & Infect Dis Modeling, NIAID, NIH, Bethesda, MD 20892 USA; [Proia, Richard L.] NIDDK, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA; [Ishii, Masaru] Osaka Univ, WPI Immunol Frontier Res Ctr, Lab Biol Imaging, Suita, Osaka 5650871, Japan; [Ishii, Masaru; Saeki, Yukihiko] Natl Osaka Minami Med Ctr, Dept Clin Res, Osaka 5868521, Japan; [Vacher, Jean] Clin Res Inst Montreal, Montreal, PQ H2W 1R7, Canada	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Osaka University; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Germain, RN (corresponding author), NIDDK, Lymphocyte Biol Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA.	rgermain@niaid.nih.gov	Germain, Ronald/ABE-7090-2020; Ishii, Masaru/D-2361-2009; Germain, Ronald N./Z-1945-2019; Proia, Richard L/A-7908-2012; Klauschen, Frederick/C-5637-2015	Egen, Jackson/0000-0003-2053-0837; Proia, Richard/0000-0003-0456-1270	Intramural Research Program of the National Institute of Allergy and Infectious Diseases; NIH; US Department of Health and Human Services; International Human Frontier Science Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000545] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK056015, ZIADK056014] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Health and Human Services; International Human Frontier Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank U. H. von Andrian and I. B. Mazo for their help with the technique of intravital skull bone imaging. We also thank Y. Takuwa and N. Sugimoto for discussions, and P. M. Murphy and S. Venkatesan for their help in imaging in vitro chemotaxis using the EZ-Taxiscan. This work was supported in part by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, NIH, US Department of Health and Human Services, and by a fellowship grant to M. I. from the International Human Frontier Science Program.	Akbar H, 2006, METHOD ENZYMOL, V406, P554, DOI 10.1016/S0076-6879(06)06043-5; Allende ML, 2003, BLOOD, V102, P3665, DOI 10.1182/blood-2003-02-0460; BOKOCH GM, 1984, J BIOL CHEM, V259, P3560; Burnett SH, 2004, J LEUKOCYTE BIOL, V75, P612, DOI 10.1189/jlb.0903442; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Ferron M, 2005, GENESIS, V41, P138, DOI 10.1002/gene.20108; Filgueira L, 2004, J HISTOCHEM CYTOCHEM, V52, P411, DOI 10.1177/002215540405200312; Ishii M, 2006, J BONE MINER RES, V21, P965, DOI 10.1359/JBMR.060308; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kappos L, 2006, NEW ENGL J MED, V355, P1124, DOI 10.1056/NEJMoa052643; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kobayashi K, 2000, J EXP MED, V191, P275, DOI 10.1084/jem.191.2.275; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Mazo IB, 2005, IMMUNITY, V22, P259, DOI 10.1016/j.immuni.2005.01.008; Mazo IB, 1998, J EXP MED, V188, P465, DOI 10.1084/jem.188.3.465; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Okamoto H, 2000, MOL CELL BIOL, V20, P9247, DOI 10.1128/MCB.20.24.9247-9261.2000; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Sanna MG, 2004, J BIOL CHEM, V279, P13839, DOI 10.1074/jbc.M311743200; Spiegel S, 2002, TRENDS CELL BIOL, V12, P236, DOI 10.1016/S0962-8924(02)02277-8; Stoller P, 2002, BIOPHYS J, V82, P3330, DOI 10.1016/S0006-3495(02)75673-7; Takuwa Y, 2002, BBA-MOL CELL BIOL L, V1582, P112, DOI 10.1016/S1388-1981(02)00145-2; Tedesco-Silva H, 2007, TRANSPLANTATION, V84, P885, DOI 10.1097/01.tp.0000281385.26500.3b; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Wei SH, 2005, NAT IMMUNOL, V6, P1228, DOI 10.1038/ni1269; Yu XF, 2003, J BONE MINER RES, V18, P1404, DOI 10.1359/jbmr.2003.18.8.1404	29	382	403	3	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2009	458	7237					524	U8		10.1038/nature07713	http://dx.doi.org/10.1038/nature07713			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423YJ	19204730	Green Accepted			2022-12-01	WOS:000264532400048
J	O'Rourke, MF				O'Rourke, Michael F.			Should doctors recommend automated external defibrillators for use at home after myocardial infarction? Yes	BRITISH MEDICAL JOURNAL			English	Editorial Material							HOSPITAL CARDIAC-ARREST		[O'Rourke, Michael F.] Univ New S Wales, Darlinghurst, NSW 2010, Australia; [O'Rourke, Michael F.] St Vincents Clin, Darlinghurst, NSW 2010, Australia	University of New South Wales Sydney	O'Rourke, MF (corresponding author), Univ New S Wales, 438 Victoria St, Darlinghurst, NSW 2010, Australia.	m.orourke@unsw.edu.au		Hutchinson, Mathew/0000-0002-8286-0113				Bardy GH, 2008, NEW ENGL J MED, V358, P1793, DOI 10.1056/NEJMoa0801651; Caffrey SL, 2002, NEW ENGL J MED, V347, P1242, DOI 10.1056/NEJMoa020932; EISENBERG MS, 1989, AM J CARDIOL, V63, P443, DOI 10.1016/0002-9149(89)90316-0; HAYES DL, 2008, BRAUNWALDS HEART DIS, P831; Norris RM, 2005, HEART, V91, P1537, DOI 10.1136/hrt.2004.057018; O'Rourke MF, 2005, HEART, V91, P1505, DOI 10.1136/hrt.2005.061572; Weaver WD, 2002, NEW ENGL J MED, V347, P1223, DOI 10.1056/NEJMp020108; Whitfield R, 2005, RESUSCITATION, V64, P269, DOI 10.1016/j.resuscitation.2005.01.003	8	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 23	2009	338								b874	10.1136/bmj.b874	http://dx.doi.org/10.1136/bmj.b874			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	425LO	19307277				2022-12-01	WOS:000264639400018
J	Wood, E; Werb, D; Marshall, BDL; Montaner, JSG; Kerr, T				Wood, Evan; Werb, Daniel; Marshall, Brandon D. L.; Montaner, Julio S. G.; Kerr, Thomas			The war on drugs: a devastating public-policy disaster	LANCET			English	Editorial Material							HIV		[Wood, Evan; Werb, Daniel; Marshall, Brandon D. L.; Montaner, Julio S. G.; Kerr, Thomas] St Pauls Hosp, British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada; [Wood, Evan; Montaner, Julio S. G.; Kerr, Thomas] Univ British Columbia, Fac Med, Div Aids, Dept Med, Vancouver, BC, Canada; [Werb, Daniel; Marshall, Brandon D. L.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada	B.C. Centre for Excellence in HIV/AIDS; St. Paul's Hospital; University of Saskatchewan; University of British Columbia; University of British Columbia	Wood, E (corresponding author), St Pauls Hosp, British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada.	uhri-ew@cfenet.ubc.ca	Montaner, Julio/K-7621-2012; Marshall, Brandon/B-4895-2010	Marshall, Brandon/0000-0002-0134-7052				[Anonymous], 2003, INT J DRUG POLICY, DOI DOI 10.1016/S0955-3959(03)00005-7; Bluthenthal R. N., 1999, International Journal of Drug Policy, V10, P25, DOI 10.1016/S0955-3959(98)00076-0; Degenhardt L, 2008, PLOS MED, V5, P1053, DOI 10.1371/journal.pmed.0050141; *EUR MON CTR DRUGS, 2008, STAT B 2008; FAZEY C, 2003, INT J DRUG POLICY, V14, P159; FELLNER J, 2008, TARGETING BLACKS DRU; HANSON S, 2008, WASHINGTON POST 1125; JELSMA M, 2003, INT J DRUG POLICY, V14, P195; Jurgens R, 2009, LANCET INFECT DIS, V9, P57, DOI 10.1016/S1473-3099(08)70305-0; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; MORRIS SK, 2003, INT J DRUG POLICY, V14, P209; *UN OFF DRUGS CRIM, 2002, 2005 WORLD DRUG REP; Werb D, 2008, J PUBLIC HEALTH POL, V29, P440, DOI 10.1057/jphp.2008.29	13	39	39	0	18	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 21	2009	373	9668					989	990		10.1016/S0140-6736(09)60455-4	http://dx.doi.org/10.1016/S0140-6736(09)60455-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	422AA	19282025				2022-12-01	WOS:000264398200009
J	Brown, CJ; Roth, DL; Allman, RM; Sawyer, P; Ritchie, CS; Roseman, JM				Brown, Cynthia J.; Roth, David L.; Allman, Richard M.; Sawyer, Patricia; Ritchie, Christine S.; Roseman, Jeffrey M.			Trajectories of Life-Space Mobility After Hospitalization	ANNALS OF INTERNAL MEDICINE			English	Article							FUNCTIONAL DECLINE; OLDER-ADULTS; MULTICOMPONENT INTERVENTION; RANDOMIZED-TRIAL; NATURAL-HISTORY; ACUTE-CARE; OUTCOMES; DELIRIUM; PREVALENCE; DISABILITY	Background: Life space is a measure of where a person goes, the frequency of going there, and the dependency in getting there. It may be a more accurate measure of mobility in older adults because it reflects participation in society as well as physical ability. Objective: To assess effects of hospitalization on life space in older adults, and to compare life-space trajectories associated with surgical and nonsurgical hospitalizations. Design: Prospective observational study. Setting: Central Alabama. Participants: 687 community-dwelling Medicare beneficiaries at least 65 years of age with surgical (n = 44), nonsurgical (n = 167), or no (n = 476) hospitalizations. Measurements: Life-Space Assessment (LSA) scores before and after hospitalization (range, 0 to 120; higher scores reflect greater mobility). Results: Mean age of participants was 74.6 years (SD, 6.3). Fifty percent were black, and 46% were male. Before hospitalization, adjusted LSA scores were similar in participants with surgical and nonsurgical admissions. Life-space assessment scores decreased in both groups immediately after hospitalization; however, participants with surgical hospitalizations had a greater decrease in scores (12.1 more points [95% CI, 3.6 to 20.7 points]; P = 0.005) than those with nonsurgical hospitalizations. However, participants with surgical hospitalizations recovered more rapidly over time (gain of 4.7 more points [CI, 2.0 to 7.4 points] per ln [week after discharge]; P < 0.001). Score recovery for participants with nonsurgical hospitalizations did not significantly differ from the null (average recovery, 0.7 points [CI,-0.6 to 1.9 points] per ln [week after discharge]). Limitation: Life space immediately before and after hospitalization was self-reported, often after hospital discharge. Conclusion: Hospitalization decreases life space in older adults. Surgical hospitalizations are associated with immediate marked life-space declines followed by rapid recovery, in contrast to nonsurgical hospitalizations, which are associated with more modest immediate declines and little evidence of recovery after several years of follow-up.	Birmingham & Atlanta Vet Affairs Geriatr Res, Birmingham, AL USA; Ctr Clin, Birmingham, AL USA; Univ Alabama Birmingham, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham	Brown, CJ (corresponding author), Birmingham Vet Affairs Med Ctr, 11G,700 S 19th St, Birmingham, AL 35233 USA.	cbrown@aging.uab.edu; droth@uab.edu	Allman, Richard M./O-1693-2019	Allman, Richard M./0000-0002-1850-6515; Brown, Cynthia J/0000-0002-1629-5507	National Institute on Aging [R01 AG015062]; Veterans Affairs Research Career Development Award [E4-3842VA]; John A. Hartford Foundation; NATIONAL INSTITUTE ON AGING [R01AG015062] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs Research Career Development Award(US Department of Veterans Affairs); John A. Hartford Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Primary Funding Source: National Institute on Aging.; Grant Support: By a Veterans Affairs Research Career Development Award (E4-3842VA) (Dr. Brown) and a John A. Hartford Foundation-funded Southeast Center of Excellence in Geriatric Medicine Special Fellows grant (Dr. Brown). The UAB Study of Aging is funded through a grant from the National Institute on Aging (R01 AG015062).	Ahmed A, 2007, AM J CARDIOL, V99, P549, DOI 10.1016/j.amjcard.2006.08.065; *AL RUR HLTH ASS, 1998, HLTH STAT RUR AL; Baker PS, 2003, J AM GERIATR SOC, V51, P1610, DOI 10.1046/j.1532-5415.2003.51512.x; Brown CJ, 2004, J AM GERIATR SOC, V52, P1263, DOI 10.1111/j.1532-5415.2004.52354.x; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Counsell SR, 2000, J AM GERIATR SOC, V48, P1572, DOI 10.1111/j.1532-5415.2000.tb03866.x; Covinsky KE, 2003, J AM GERIATR SOC, V51, P451, DOI 10.1046/j.1532-5415.2003.51152.x; CREDITOR MC, 1993, ANN INTERN MED, V118, P219, DOI 10.7326/0003-4819-118-3-199302010-00011; Dubois MF, 2007, J CLIN EPIDEMIOL, V60, P1040, DOI 10.1016/j.jclinepi.2006.12.011; HIRSCH CH, 1990, J AM GERIATR SOC, V38, P1296, DOI 10.1111/j.1532-5415.1990.tb03451.x; *I MED, 2006, FUT DIS AM; Incalzi RA, 1996, ARCH INTERN MED, V156, P425, DOI 10.1001/archinte.156.4.425; Inouye SK, 1999, NEW ENGL J MED, V340, P669, DOI 10.1056/NEJM199903043400901; Inouye SK, 1998, J GEN INTERN MED, V13, P234, DOI 10.1046/j.1525-1497.1998.00073.x; INOUYE SK, 1993, J GEN INTERN MED, V8, P645, DOI 10.1007/BF02598279; JETTE AM, 2006, PHYS THER, V86, P726, DOI DOI 10.1093/PTJ/86.5.726; LANDEFELD CS, 1995, NEW ENGL J MED, V332, P1338, DOI 10.1056/NEJM199505183322006; LAZARUS BA, 1991, ARCH INTERN MED, V151, P2452, DOI 10.1001/archinte.151.12.2452; Littell R.C., 2006, SAS SYSTEM MIXED MOD, DOI 10.1017/CBO9781107415324.004; Marcantonio ER, 2003, J AM GERIATR SOC, V51, P4, DOI 10.1034/j.1601-5215.2002.51002.x; MARGITIC SE, 1993, J AM GERIATR SOC, V41, P258, DOI 10.1111/j.1532-5415.1993.tb06703.x; McAvay GJ, 2006, J AM GERIATR SOC, V54, P1245, DOI 10.1111/j.1532-5415.2006.00815.x; McCusker J, 2002, ARCH INTERN MED, V162, P457, DOI 10.1001/archinte.162.4.457; MCVEY LJ, 1989, ANN INTERN MED, V110, P79, DOI 10.7326/0003-4819-110-1-79; MELIN AL, 1992, MED CARE, V30, P1004, DOI 10.1097/00005650-199211000-00004; Nikolaus T, 1999, AGE AGEING, V28, P543, DOI 10.1093/ageing/28.6.543; Parker M, 2002, J GERONTOL NURS, V35, P35, DOI DOI 10.1300/J083V35N04_04; Peak EL, 2005, J BONE JOINT SURG AM, V87A, P247, DOI 10.2106/JBJS.C.01513; Peel C, 2005, PHYS THER, V85, P1008, DOI 10.1093/ptj/85.10.1008; Roseman, 2006, AGING HLTH, V2, P417, DOI [10.2217/1745509x.2.3.417, DOI 10.2217/1745509X.2.3.417]; RUEL M, 2005, SABISTON SPENCER SUR, P1476; Sager MA, 1996, J AM GERIATR SOC, V44, P251, DOI 10.1111/j.1532-5415.1996.tb00910.x; Sager MA, 1998, CLIN GERIATR MED, V14, P669; Shumway-Cook A, 2005, J AM GERIATR SOC, V53, P1217, DOI 10.1111/j.1532-5415.2005.53372.x; Singer JJW., 2003, APPL LONGITUDINAL DA, DOI DOI 10.1093/ACPROF:OSO/9780195152968.001.0001; Smith GL, 2003, J AM COLL CARDIOL, V41, P1510, DOI 10.1016/S0735-1097(03)00185-2; Sullivan DH, 1999, JAMA-J AM MED ASSOC, V281, P2013, DOI 10.1001/jama.281.21.2013; VAITKEVICUS VP, 2003, PRINCIPLES GERIATRIC, P361; WARSHAW GA, 1982, JAMA-J AM MED ASSOC, V248, P847, DOI 10.1001/jama.248.7.847; World Health O, 2001, INT CLASS FUNCT DIS	40	131	131	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 17	2009	150	6					372	W67		10.7326/0003-4819-150-6-200903170-00005	http://dx.doi.org/10.7326/0003-4819-150-6-200903170-00005			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	423AJ	19293070	Green Accepted			2022-12-01	WOS:000264468500002
J	Cooter, R				Cooter, Roger			Historical keyword Crisis	LANCET			English	Editorial Material									UCL, Wellcome Trust Ctr, London, England	University of London; University College London	Cooter, R (corresponding author), UCL, Wellcome Trust Ctr, London, England.	r.cooter@ucl.ac.uk							0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 14	2009	373	9667					887	887		10.1016/S0140-6736(09)60532-8	http://dx.doi.org/10.1016/S0140-6736(09)60532-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	418OU	19286073				2022-12-01	WOS:000264158700013
J	Krum, H; Abraham, WT				Krum, Henry; Abraham, William T.			Heart failure	LANCET			English	Review							LEFT-VENTRICULAR DYSFUNCTION; CARDIAC-RESYNCHRONIZATION THERAPY; CONVERTING-ENZYME INHIBITORS; PRESERVED SYSTOLIC FUNCTION; MYOCARDIAL-INFARCTION; NATRIURETIC PEPTIDE; DIASTOLIC DYSFUNCTION; EJECTION FRACTION; RANDOMIZED-TRIAL; ISOSORBIDE DINITRATE	Despite advances in management of heart failure, the condition remains a major public-health issue, with high prevalence, poor clinical outcomes, and large health-care costs. Risk factors are well known and, thus, preventive strategies should have a positive effect on disease burden. Treatment of established systolic chronic heart failure includes use of agents that block the renin-angiotensin-aldosterone and sympathetic nervous systems to prevent adverse remodelling, to reduce symptoms and prolong survival. Diuretics are used to achieve and maintain euvolaemia. Devices have a key role in management of advanced heart failure and include cardiac resynchronisation in patients with evidence of cardiac dyssynchrony and implantation of a cardioverter defibrillator in individuals with low ejection fraction. Approaches for treatment of acute heart failure and heart failure with preserved ejection fraction are supported by little clinical evidence. Emerging strategies for heart failure management include individualisation of treatment, novel approaches to diagnosis and tracking of therapeutic response, pharmacological agents aimed at new targets, and cell-based and gene-based methods for cardiac regeneration.	[Krum, Henry] Monash Univ, Sch Publ Hlth & Prevent Med, Ctr Cardiovasc Res & Educ Therapeut, Melbourne, Vic 3004, Australia; [Abraham, William T.] Ohio State Univ, Div Cardiovasc Med, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA	Monash University; University System of Ohio; Ohio State University	Krum, H (corresponding author), Monash Univ, Sch Publ Hlth & Prevent Med, Ctr Cardiovasc Res & Educ Therapeut, Melbourne, Vic 3004, Australia.	henry.krum@med.monash.edu.au			National Health and Medical Research Council; National Institutes of Health; Medtronic; Paracor; St Jude Medical	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medtronic(Medtronic); Paracor; St Jude Medical(St. Jude Medical)	H K has received grant and research support within the past 12 months from National Health and Medical Research Council. Medtronic, Scios, BUPA. Pfizer, and GlaxoSmithKline, and consultancy and speaker honoraria from Amgen, AstraZeneca. Medtronic, St Jude Medical, Roche, Novartis, Sanofi-Aventis, Pfizer, Mesoblast, and Gilead. HK is a member of the following advisory boards: Biotronik. Novartis, Sanofi-Aventis, Pfizer, Mesoblast, Apollo Life Sciences, and Gilead. WTA has received grant and research support within the past 12 months from National Institutes of Health, Medtronic, Paracor, and St Jude Medical, and consultancy and speaker honoraria from Amgen, AstraZeneca. Medtronic. Novartis, Pfizer, Respironics, St Jude Medical, and GlaxoSmithKline. WTA is a member of the following advisory boards: BioEnergy, Biotronik, CardioKine, CardioKinetix, CardioMEMS, Department of Veterans Affairs Cooperative Studies Program, Edwards Lifesciences, Inovise, Medtronic, National Institutes of Health, Paracor, St Jude Medical, and Sunshine Heart.	Abraham WT, 2005, J AM COLL CARDIOL, V46, P57, DOI 10.1016/j.jacc.2005.03.051; Abraham WT, 2002, NEW ENGL J MED, V346, P1845, DOI 10.1056/NEJMoa013168; Abraham WT, 2000, J CARD FAIL, V6, P369, DOI 10.1054/jcaf.2000.20841; Ahmed A, 2006, CIRCULATION, V114, P397, DOI 10.1161/CIRCULATIONAHA.106.628347; *AIHW, 1999, AIHW HLTH WELF EXP S, V5; Anker SD, 2004, ANN MED, V36, P518, DOI 10.1080/07853890410017467; Anker SD, 1997, LANCET, V349, P1050, DOI 10.1016/S0140-6736(96)07015-8; Aronow WS, 2005, GERIATRICS, V60, P24; Athanasuleas CL, 2001, J AM COLL CARDIOL, V37, P1199, DOI 10.1016/S0735-1097(01)01119-6; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Belardinelli R, 2006, EUR HEART J, V27, P2675, DOI 10.1093/eurheartj/ehl158; Berg TJ, 1999, DIABETES CARE, V22, P1186, DOI 10.2337/diacare.22.7.1186; Bleumink GS, 2004, EUR HEART J, V25, P1614, DOI 10.1016/j.ehj.2004.06.038; BOLLING SF, 1995, J THORAC CARDIOV SUR, V109, P676, DOI 10.1016/S0022-5223(95)70348-9; BRAUNWALD E, 1986, J AM COLL CARDIOL, V8, P1467, DOI 10.1016/S0735-1097(86)80325-4; Bristow MR, 2004, NEW ENGL J MED, V350, P2140, DOI 10.1056/NEJMoa032423; Bristow MR, 2000, J CARD FAIL, V6, P276, DOI 10.1054/jcaf.2000.9501; BYRNE J, 2004, CARING HEART FAILURE, P75; Carson P, 2005, J CARD FAIL, V11, P576, DOI 10.1016/j.cardfail.2005.06.432; Cazeau S, 2001, NEW ENGL J MED, V344, P873, DOI 10.1056/NEJM200103223441202; Cleland JGF, 2005, NEW ENGL J MED, V352, P1539, DOI 10.1056/NEJMoa050496; Cleland JGF, 2001, EUR J HEART FAIL, V3, P481, DOI 10.1016/S1388-9842(01)00176-3; Cleland JGF, 2006, EUR J HEART FAIL, V8, P764, DOI 10.1016/j.ejheart.2006.10.001; Cleland JGF, 2006, EUR HEART J, V27, P2338, DOI 10.1093/eurheartj/ehl250; Clerico A, 2002, CLIN CHEM LAB MED, V40, P371, DOI 10.1515/CCLM.2002.060; *CLIN GOV, ALD ANT THER AD HEAR; *CLIN GOV, COMP OUTC PAT NYHA C; COHN JN, 1986, NEW ENGL J MED, V314, P1547, DOI 10.1056/NEJM198606123142404; Cohn JN, 1997, CIRCULATION, V96, P856, DOI 10.1161/01.cir.96.3.856; Cohn JN, 2001, NEW ENGL J MED, V345, P1667, DOI 10.1056/NEJMoa010713; COHN JN, 1991, NEW ENGL J MED, V325, P303, DOI 10.1056/NEJM199108013250502; Cohn JN, 2000, J AM COLL CARDIOL, V35, P569, DOI 10.1016/S0735-1097(99)00630-0; Costanzo MR, 2007, J AM COLL CARDIOL, V49, P675, DOI 10.1016/j.jacc.2006.07.073; Cowie MR, 1999, EUR HEART J, V20, P421, DOI 10.1053/euhj.1998.1280; Damasceno A, 2007, J AM COLL CARDIOL, V50, P1688, DOI 10.1016/j.jacc.2007.07.030; Dargie HJ, 2001, LANCET, V357, P1385, DOI 10.1016/s0140-6736(00)04560-8; Davie AP, 1996, BRIT MED J, V312, P222; Davie AP, 1997, QJM-MON J ASSOC PHYS, V90, P335, DOI 10.1093/qjmed/90.5.335; Domanski M, 2006, J CARD FAIL, V12, P327, DOI 10.1016/j.cardfail.2006.03.006; Enck R E, 1999, Am J Hosp Palliat Care, V16, P373, DOI 10.1177/104990919901600102; Erdmann E, 2007, DIABETES CARE, V30, P2773, DOI 10.2337/dc07-0717; Fischer M, 2003, EUR HEART J, V24, P320, DOI 10.1016/S0195-668X(02)00428-1; Flather MD, 2005, EUR HEART J, V26, P215, DOI 10.1093/eurheartj/ehi118; FRANCIS GS, 1990, CIRCULATION, V82, P1724, DOI 10.1161/01.CIR.82.5.1724; Fukuta H, 2005, CIRCULATION, V112, P357, DOI 10.1161/CIRCULATIONAHA.104.519876; Giannuzzi P, 2003, CIRCULATION, V108, P554, DOI 10.1161/01.CIR.0000081780.38477.FA; Goodlin SJ, 1998, J PALLIAT CARE, V14, P30, DOI 10.1177/082585979801400106; Granger CB, 2003, LANCET, V362, P772, DOI 10.1016/S0140-6736(03)14284-5; Gray A, 2008, NEW ENGL J MED, V359, P142, DOI 10.1056/NEJMoa0707992; Haas SJ, 2003, AM HEART J, V146, P848, DOI 10.1016/S0002-8703(03)00403-4; Higgins SL, 2003, J AM COLL CARDIOL, V42, P1454, DOI 10.1016/S0735-1097(03)01042-8; Hjalmarson A, 1999, LANCET, V353, P2001; HO KKL, 1993, CIRCULATION, V88, P107, DOI 10.1161/01.CIR.88.1.107; Hogg K, 2004, J AM COLL CARDIOL, V43, P317, DOI 10.1016/j.jacc.2003.07.046; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Jougasaki M, 2003, PEPTIDES, V24, P889, DOI 10.1016/S0196-9781(03)00163-3; Jourdain P, 2007, J AM COLL CARDIOL, V49, P1733, DOI 10.1016/j.jacc.2006.10.081; Kadish A, 2004, NEW ENGL J MED, V350, P2151, DOI 10.1056/NEJMoa033088; Kaneko Y, 2003, NEW ENGL J MED, V348, P1233, DOI 10.1056/NEJMoa022479; KANNEL WB, 1974, AM J CARDIOL, V34, P29, DOI 10.1016/0002-9149(74)90089-7; Kaye DM, 2007, NAT REV DRUG DISCOV, V6, P127, DOI 10.1038/nrd2219; KILLIP T, 1985, CIRCULATION, V72, P102; Kjekshus J, 2007, NEW ENGL J MED, V357, P2248, DOI 10.1056/NEJMoa0706201; Kober L, 2008, NEW ENGL J MED, V358, P2678, DOI 10.1056/NEJMoa0800456; Kostis JB, 1997, JAMA-J AM MED ASSOC, V278, P212; Krum H, 2003, LANCET, V362, P147, DOI 10.1016/S0140-6736(03)13869-X; Krum H, 2003, EXPERT OPIN INV DRUG, V12, P751, DOI 10.1517/13543784.12.5.751; Krum H, 2002, J AM COLL CARDIOL, V39, P1567, DOI 10.1016/S0735-1097(02)01827-2; Krum H, 2006, J CARD FAIL, V12, P333, DOI 10.1016/j.cardfail.2006.05.001; Krum H, 2006, MED J AUSTRALIA, V185, P549, DOI 10.5694/j.1326-5377.2006.tb00690.x; Lechat P, 1999, LANCET, V353, P9; Leclercq C, 2002, EUR HEART J, V23, P1780, DOI 10.1053/euhj.2002.3232; Levy D, 2002, NEW ENGL J MED, V347, P1397, DOI 10.1056/NEJMoa020265; Lloyd-Jones DM, 2002, CIRCULATION, V106, P3068, DOI 10.1161/01.CIR.0000039105.49749.6F; Lyon AR, 2008, HEART, V94, P89, DOI 10.1136/hrt.2007.116483; MacDonald MR, 2008, EUR HEART J, V29, P1224, DOI 10.1093/eurheartj/ehn156; Maisel AS, 2002, NEW ENGL J MED, V347, P161, DOI 10.1056/NEJMoa020233; Maisel AS, 2003, J AM COLL CARDIOL, V41, P2010, DOI 10.1016/S0735-1097(03)00405-4; Martos R, 2007, CIRCULATION, V115, P888, DOI 10.1161/CIRCULATIONAHA.106.638569; Massad MG, 2004, CARDIOLOGY, V101, P79, DOI 10.1159/000075988; McAlister FA, 2004, J AM COLL CARDIOL, V44, P810, DOI 10.1016/j.jacc.2004.05.055; McDonagh TA, 1997, LANCET, V350, P829, DOI 10.1016/S0140-6736(97)03033-X; McGregor E, 2006, CIRC RES, V98, P309, DOI 10.1161/01.RES.0000201280.20709.26; MCKELVIE RS, 1995, J AM COLL CARDIOL, V25, P789, DOI 10.1016/0735-1097(94)00428-S; McMurray JJV, 2003, LANCET, V362, P767, DOI 10.1016/S0140-6736(03)14283-3; McMurray JJV, 2005, LANCET, V365, P1877, DOI 10.1016/S0140-6736(05)66621-4; McNamara DM, 2008, CURR OPIN CARDIOL, V23, P261, DOI 10.1097/HCO.0b013e3282fcd662; Menasche P, 2007, PROG CARDIOVASC DIS, V50, P7, DOI 10.1016/j.pcad.2007.02.002; Morgan JA, 2003, J THORAC CARDIOV SUR, V126, P1188, DOI 10.1016/S0022-5223(03)00935-8; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Mosterd A, 1999, EUR HEART J, V20, P447, DOI 10.1053/euhj.1998.1239; Mosterd A, 2007, HEART, V93, P1137, DOI 10.1136/hrt.2003.025270; NICKLAS JM, 1992, NEW ENGL J MED, V327, P685; Nieminen MS, 2005, EUR HEART J, V26, P384; Nishimura RA, 1997, J AM COLL CARDIOL, V30, P8, DOI 10.1016/S0735-1097(97)00144-7; Owan TE, 2005, PROG CARDIOVASC DIS, V47, P320, DOI 10.1016/j.pcad.2005.02.010; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Packer M, 1999, CIRCULATION, V100, P2312, DOI 10.1161/01.CIR.100.23.2312; Packer M, 1996, NEW ENGL J MED, V335, P1107, DOI 10.1056/NEJM199610103351504; Packer M, 2001, NEW ENGL J MED, V344, P1651, DOI 10.1056/NEJM200105313442201; Packer M, 2003, CIRCULATION, V108, P2950, DOI 10.1161/01.CIR.0000109205.35813.8E; Packer M, 2006, J AM COLL CARDIOL, V47, P2245, DOI 10.1016/j.jacc.2005.12.071; Parissis JT, 2005, EXPERT OPIN INV DRUG, V14, P567, DOI 10.1517/13543784.14.5.567; Paterna S, 2008, CLIN SCI, V114, P221, DOI 10.1042/CS20070193; Perry G, 1997, NEW ENGL J MED, V336, P525; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Poirier P, 2001, DIABETES CARE, V24, P5, DOI 10.2337/diacare.24.1.5; Poole-Wilson PA, 2003, LANCET, V362, P7, DOI 10.1016/S0140-6736(03)13800-7; Rathore SS, 2003, JAMA-J AM MED ASSOC, V289, P871, DOI 10.1001/jama.289.7.871; Redfield MM, 2003, JAMA-J AM MED ASSOC, V289, P194, DOI 10.1001/jama.289.2.194; Ritzema J, 2007, CIRCULATION, V116, P2952, DOI 10.1161/CIRCULATIONAHA.107.702191; Roger VL, 2004, JAMA-J AM MED ASSOC, V292, P344, DOI 10.1001/jama.292.3.344; Rose EA, 2001, NEW ENGL J MED, V345, P1435, DOI 10.1056/NEJMoa012175; Rothenburger M, 2002, THORAC CARDIOV SURG, V50, P351, DOI 10.1055/s-2002-35746; Roy D, 2008, NEW ENGL J MED, V358, P2667, DOI 10.1056/NEJMoa0708789; Rundqvist B, 1997, CIRCULATION, V95, P169, DOI 10.1161/01.CIR.95.1.169; Sackner-Bernstein JD, 2005, JAMA-J AM MED ASSOC, V293, P1900, DOI 10.1001/jama.293.15.1900; Schuleri K. H., 2007, V180, P195; See F, 2004, J AM COLL CARDIOL, V44, P1679, DOI 10.1016/j.jacc.2004.07.038; Senni M, 2001, J AM COLL CARDIOL, V38, P1277, DOI 10.1016/S0735-1097(01)01567-4; Solomon SD, 2007, LANCET, V369, P2079, DOI 10.1016/S0140-6736(07)60980-5; Starling E. H., 1918, LINACRE LECT LAW HEA; STEVENSON WG, 1993, CIRCULATION, V88, P2953, DOI 10.1161/01.CIR.88.6.2953; Stevenson WG, 1997, CURR OPIN CARDIOL, V12, P242, DOI 10.1097/00001573-199705000-00005; Stewart S, 2002, EUR J HEART FAIL, V4, P361, DOI 10.1016/S1388-9842(01)00198-2; Stewart S, 2001, EUR HEART J, V22, P209, DOI 10.1053/euhj.2000.2291; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429; Swedberg K, 2005, EUR HEART J, V26, P1115, DOI 10.1093/eurheartj/ehi204; Tavazzi L, 2004, EUR J HEART FAIL, V6, P635, DOI 10.1016/j.ejheart.2004.03.001; Taylor AL, 2004, NEW ENGL J MED, V351, P2049, DOI 10.1056/NEJMoa042934; Uretsky BF, 1997, J AM COLL CARDIOL, V30, P1589, DOI 10.1016/S0735-1097(97)00361-6; Vasan RS, 2000, CIRCULATION, V101, P2118, DOI 10.1161/01.CIR.101.17.2118; Vasan RS, 1999, J AM COLL CARDIOL, V33, P1948, DOI 10.1016/S0735-1097(99)00118-7; Vasan RS, 2002, JAMA-J AM MED ASSOC, V288, P1252, DOI 10.1001/jama.288.10.1252; Vitarelli A, 1998, AM J CARDIOL, V81, p115G, DOI 10.1016/S0002-9149(98)00067-8; Wang TJ, 2003, CIRCULATION, V108, P977, DOI 10.1161/01.CIR.0000085166.44904.79; Wexler DJ, 2001, AM HEART J, V142, P350, DOI 10.1067/mhj.2001.116476; Whellan DJ, 2007, AM HEART J, V153, P201, DOI 10.1016/j.ahj.2006.11.007; White JA, 2007, CARDIOL CLIN, V25, P71, DOI 10.1016/j.ccl.2007.02.003; Willenheimer R, 2005, CIRCULATION, V112, P2426, DOI 10.1161/CIRCULATIONAHA.105.582320; Witte KKA, 2001, J AM COLL CARDIOL, V37, P1765, DOI 10.1016/S0735-1097(01)01227-X; Young JB, 2002, JAMA-J AM MED ASSOC, V287, P1531, DOI 10.1001/jama.287.12.1531; Young JB, 2003, JAMA-J AM MED ASSOC, V289, P2685, DOI 10.1001/jama.289.20.2685; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501; Yusuf S, 2003, LANCET, V362, P777, DOI 10.1016/S0140-6736(03)14285-7; Yusuf S, 2000, NEW ENGL J MED, V342, P145	149	127	137	0	28	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 14	2009	373	9667					941	955		10.1016/S0140-6736(09)60236-1	http://dx.doi.org/10.1016/S0140-6736(09)60236-1			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	418OU	19286093				2022-12-01	WOS:000264158700035
J	Hutchins, DCJ; White, SM				Hutchins, David C. J.; White, Stuart M.			Coming round to recycling	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							NATIONAL-HEALTH-SERVICE; CLIMATE-CHANGE; CARE WASTE; CORNWALL; SINGLE; STRATEGIES; MANAGEMENT; DEVICES; NHS		[Hutchins, David C. J.; White, Stuart M.] Royal Sussex Cty Hosp, Brighton Anaesthesia Res Forum, Brighton BN2 5BE, E Sussex, England	University of Brighton	White, SM (corresponding author), Royal Sussex Cty Hosp, Brighton Anaesthesia Res Forum, Brighton BN2 5BE, E Sussex, England.	stuart.white@bsuh.nhs.uk		White, Stuart/0000-0002-0258-8210				BILITEWSKI B, 1996, WASTE MANAGE, P1; Blunt MC, 2003, BRIT J ANAESTH, V90, P1, DOI 10.1093/bja/aeg006; Bogner J, 2008, WASTE MANAGE RES, V26, P11, DOI 10.1177/0734242X07088433; *CARB TRUST, 2007, HOSP HLTH BUDG EN EF; Carey D, 2001, J Contemp Health Law Policy, V17, P657; Coote A, 2008, BRIT MED J, V336, P733, DOI 10.1136/bmj.39538.509456.80; *DEP ENV FOOD RUR, 2003, STUD EST DIS COSTS L; Department of Health, HLTH TECHN MEM 07 01; Elliott P, 2001, BRIT MED J, V323, P363, DOI 10.1136/bmj.323.7309.363; Gaiser RR, 2004, BRIT J ANAESTH, V92, P584, DOI 10.1093/bja/aeh103; Griffiths J, 2008, BRIT MED J, V336, P1507; *HOSP EP STAT, DAT 2003 4; Jacobs P, 2008, INFECT CONT HOSP EP, V29, P297, DOI 10.1086/529587; Laupau W, 2006, ANAESTHESIA, V61, P524, DOI 10.1111/j.1365-2044.2006.04642.x; Lee BK, 2002, WASTE MANAGE, V22, P461, DOI 10.1016/S0956-053X(02)00006-5; *MED HEALTHC PROD, 2006, SINGL US MED DEV IMP; *NHS SUST DEV UN, 2008, SAV CARB IMPR HLTH C; Rowley E, 2007, ANAESTHESIA, V62, P569, DOI 10.1111/j.1365-2044.2007.04995.x; Seidman PA, 1998, ANESTH ANALG, V87, P634, DOI 10.1097/00000539-199809000-00027; Tudor TL, 2008, WASTE MANAGE, V28, P1209, DOI 10.1016/j.wasman.2007.04.004; Tudor TL, 2007, WASTE MANAGE RES, V25, P510, DOI 10.1177/0734242X07082030; Tudor TL, 2005, WASTE MANAGE, V25, P606, DOI 10.1016/j.wasman.2004.10.004; Webster J, 2005, AM J INFECT CONTROL, V33, P348, DOI 10.1016/j.ajic.2004.11.010; [No title captured]	24	42	42	2	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 10	2009	338								b609	10.1136/bmj.b609	http://dx.doi.org/10.1136/bmj.b609			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	419FU	19278971				2022-12-01	WOS:000264205300003
J	Cassidy, J				Cassidy, Jane			Medicine and the Media Jade, class, and cervical cancer	BRITISH MEDICAL JOURNAL			English	Editorial Material												janecassi2@googlemail.com						Brown J, 1997, Popul Trends, P40; Brown J, 1997, POPUL TRENDS, V90, P49; Harris V, 1998, CANC REGISTRATION ST, P182; *NHS CERV SCREEN P, ANN REV 2008	4	3	3	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 18	2009	338								b691	10.1136/bmj.b691	http://dx.doi.org/10.1136/bmj.b691			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417CG	19224973				2022-12-01	WOS:000264052100009
J	Reimer, J; Haasen, C				Reimer, Jens; Haasen, Christian			Need-adapted HCV-treatment setting for injection drug users	LANCET			English	Editorial Material							HEPATITIS-C; PREVENTION; VIRUS; CARE		[Reimer, Jens; Haasen, Christian] Univ Hamburg, Ctr Interdisciplinary Addict Res, D-20246 Hamburg, Germany	University of Hamburg	Reimer, J (corresponding author), Univ Hamburg, Ctr Interdisciplinary Addict Res, Martinistr 52, D-20246 Hamburg, Germany.	reimer@uke.de						Anand BS, 2006, GASTROENTEROLOGY, V130, P1607, DOI 10.1053/j.gastro.2006.02.023; Edlin BR, 2005, CLIN INFECT DIS, V40, pS276, DOI 10.1086/427441; Jack K, 2009, ALIMENT PHARM THER, V29, P38, DOI 10.1111/j.1365-2036.2008.03872.x; Laine C, 2001, JAMA-J AM MED ASSOC, V285, P2355, DOI 10.1001/jama.285.18.2355; Mehta SH, 2008, J COMMUN HEALTH, V33, P126, DOI 10.1007/s10900-007-9083-3; NEUMAN MG, 2003, ALCOHOL CLIN EXP S1, V25, pS215; Paterson BL, 2007, INT J DRUG POLICY, V18, P364, DOI 10.1016/j.drugpo.2007.02.004; Stoove MA, 2005, DRUG ALCOHOL DEPEN, V77, P81, DOI 10.1016/j.drugalcdep.2004.07.002; Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632; Wilkinson M, 2009, ALIMENT PHARM THER, V29, P29, DOI 10.1111/j.1365-2036.2008.03834.x; Wong JB, 2006, PHARMACOECONOMICS, V24, P661, DOI 10.2165/00019053-200624070-00005; Wright C, 2003, BRIT J PSYCHIAT, V183, P132, DOI 10.1192/bjp.183.2.132; Wright TL, 2007, HEPATOL RES, V37, pS294, DOI 10.1111/j.1872-034X.2007.00200.x	13	16	17	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 20	2009	373	9681					2090	2091		10.1016/S0140-6736(09)60347-0	http://dx.doi.org/10.1016/S0140-6736(09)60347-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	460YQ	19376573				2022-12-01	WOS:000267229700007
J	Townsend, JA; Wright, DA; Winfrey, RJ; Fu, FL; Maeder, ML; Joung, JK; Voytas, DF				Townsend, Jeffrey A.; Wright, David A.; Winfrey, Ronnie J.; Fu, Fengli; Maeder, Morgan L.; Joung, J. Keith; Voytas, Daniel F.			High-frequency modification of plant genes using engineered zinc-finger nucleases	NATURE			English	Article							HOMOLOGOUS RECOMBINATION; MAMMALIAN-CELLS; RESISTANCE; TOXICITY	An efficient method for making directed DNA sequence modifications to plant genes (gene targeting) is at present lacking, thereby frustrating efforts to dissect plant gene function and engineer crop plants that better meet the world's burgeoning need for food, fibre and fuel. Zinc-finger nucleases (ZFNs)-enzymes engineered to create DNA double-strand breaks at specific loci-are potent stimulators of gene targeting(1,2); for example, they can be used to precisely modify engineered reporter genes in plants(3,4). Here we demonstrate high-frequency ZFN-stimulated gene targeting at endogenous plant genes, namely the tobacco acetolactate synthase genes (ALS SuRA and SuRB), for which specific mutations are known to confer resistance to imidazolinone and sulphonylurea herbicides(5). Herbicide-resistance mutations were introduced into SuR loci by ZFN-mediated gene targeting at frequencies exceeding 2% of transformed cells for mutations as far as 1.3 kilobases from the ZFN cleavage site. More than 40% of recombinant plants had modifications in multiple SuR alleles. The observed high frequency of gene targeting indicates that it is now possible to efficiently make targeted sequence changes in endogenous plant genes.	[Voytas, Daniel F.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Voytas, Daniel F.] Univ Minnesota, Ctr Genome Engn, Minneapolis, MN 55455 USA; [Townsend, Jeffrey A.; Wright, David A.; Winfrey, Ronnie J.; Fu, Fengli] Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA; [Maeder, Morgan L.; Joung, J. Keith] Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA 02129 USA; [Maeder, Morgan L.; Joung, J. Keith] Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA 02129 USA; [Maeder, Morgan L.; Joung, J. Keith] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Joung, J. Keith] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Iowa State University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Voytas, DF (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA.	voytas@umn.edu		Voytas, Daniel/0000-0002-4944-1224	National Science Foundation; National Institutes of Health; Massachusetts General Hospital Department of Pathology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069906] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006862] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Massachusetts General Hospital Department of Pathology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank M. Eichtinger for help in making ZFA reagents. This work was supported by grants to D. F. V. from the National Science Foundation and to J. K. J. from the National Institutes of Health and the Massachusetts General Hospital Department of Pathology.	Bibikova M, 2003, SCIENCE, V300, P764, DOI 10.1126/science.1079512; Cornu TI, 2008, MOL THER, V16, P352, DOI 10.1038/sj.mt.6300357; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Epinat JC, 2003, NUCLEIC ACIDS RES, V31, P2952, DOI 10.1093/nar/gkg375; Kaeppler SM, 2000, PLANT MOL BIOL, V43, P179, DOI 10.1023/A:1006423110134; LEE KY, 1988, EMBO J, V7, P1241, DOI 10.1002/j.1460-2075.1988.tb02937.x; Lloyd A, 2005, P NATL ACAD SCI USA, V102, P2232, DOI 10.1073/pnas.0409339102; Maeder ML, 2008, MOL CELL, V31, P294, DOI 10.1016/j.molcel.2008.06.016; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Porteus MH, 2003, SCIENCE, V300, P763, DOI 10.1126/science.1078395; Pruett-Miller SM, 2008, MOL THER, V16, P707, DOI 10.1038/mt.2008.20; Ramirez CL, 2008, NAT METHODS, V5, P374, DOI 10.1038/nmeth0508-374; Ronaghi M, 1998, SCIENCE, V281, P363, DOI 10.1126/science.281.5375.363; Segal DJ, 1999, P NATL ACAD SCI USA, V96, P2758, DOI 10.1073/pnas.96.6.2758; Szczepek M, 2007, NAT BIOTECHNOL, V25, P786, DOI 10.1038/nbt1317; Tranel PJ, 2002, WEED SCI, V50, P700, DOI 10.1614/0043-1745(2002)050[0700:RROWTA]2.0.CO;2; Wright DA, 2005, PLANT J, V44, P693, DOI 10.1111/j.1365-313X.2005.02551.x; Wright DA, 2006, NAT PROTOC, V1, P1637, DOI 10.1038/nprot.2006.259	18	456	586	4	127	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2009	459	7245					442	U161		10.1038/nature07845	http://dx.doi.org/10.1038/nature07845			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448DQ	19404258	Green Accepted			2022-12-01	WOS:000266243700049
J	Das, C; Lucia, MS; Hansen, KC; Tyler, JK				Das, Chandrima; Lucia, M. Scott; Hansen, Kirk C.; Tyler, Jessica K.			CBP/p300-mediated acetylation of histone H3 on lysine 56	NATURE			English	Article							IN-GEL DIGESTION; DNA-REPLICATION; S-PHASE; H3K56 ACETYLATION; CHAPERONE ASF1; CELL-CYCLE; PROTEIN; REPAIR; RTT109; ACETYLTRANSFERASE	Acetylation within the globular core domain of histone H3 on lysine 56 (H3K56) has recently been shown to have a critical role in packaging DNA into chromatin following DNA replication and repair in budding yeast(1,2). However, the function or occurrence of this specific histone mark has not been studied in multicellular eukaryotes, mainly because the Rtt109 enzyme that is known to mediate acetylation of H3K56 (H3K56ac) is fungal-specific(3,4). Here we demonstrate that the histone acetyl transferase CBP (also known as Nejire) in flies and CBP and p300 (Ep300) in humans acetylate H3K56, whereas Drosophila Sir2 and human SIRT1 and SIRT2 deacetylate H3K56ac. The histone chaperones ASF1A in humans and Asf1 in Drosophila are required for acetylation of H3K56 in vivo, whereas the histone chaperone CAF-1 (chromatin assembly factor 1) in humans and Caf1 in Drosophila are required for the incorporation of histones bearing this mark into chromatin. We show that, in response to DNA damage, histones bearing acetylated K56 are assembled into chromatin in Drosophila and human cells, forming foci that colocalize with sites of DNA repair. Furthermore, acetylation of H3K56 is increased in multiple types of cancer, correlating with increased levels of ASF1A in these tumours. Our identification of multiple proteins regulating the levels of H3K56 acetylation in metazoans will allow future studies of this critical and unique histone modification that couples chromatin assembly to DNA synthesis, cell proliferation and cancer.	[Das, Chandrima; Tyler, Jessica K.] Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; [Lucia, M. Scott] Univ Colorado, Sch Med, Dept Pathol, Aurora, CO 80045 USA; [Hansen, Kirk C.] Univ Colorado, Sch Med, Canc Ctr Prote Core, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Tyler, JK (corresponding author), Univ Colorado, Sch Med, Dept Biochem & Mol Genet, POB 6511, Aurora, CO 80045 USA.	jessica.tyler@uchsc.edu	Das, Chandrima/AAI-7398-2021	Das, Chandrima/0000-0002-8117-2810; Tyler, Jessica/0000-0001-9765-1659	National Institutes of Health [GM64475, CA95641]; NATIONAL CANCER INSTITUTE [R01CA095641] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064475] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Kadonaga for Drosophila embryos and the Sir2 antibody, A. Mazo for the CBP antisera, and E. Nigg for ASF1A/B antisera. We thank C. Wike and the UC microscope core, and the UCCC flow cytometry core for assistance. This work was supported by funding from the National Institutes of Health (grants GM64475 and CA95641) to J. K. T.	Ait-Si-Ali S, 2000, ONCOGENE, V19, P2430, DOI 10.1038/sj.onc.1203562; Ait-Si-Ali S, 1998, NATURE, V396, P184, DOI 10.1038/24190; Carre C, 2005, MOL CELL BIOL, V25, P8228, DOI 10.1128/MCB.25.18.8228-8238.2005; Celic I, 2006, CURR BIOL, V16, P1280, DOI 10.1016/j.cub.2006.06.023; Chen CC, 2008, CELL, V134, P231, DOI 10.1016/j.cell.2008.06.035; Florence B, 1998, GENETICS, V150, P1497; Francis NJ, 2001, NAT REV MOL CELL BIO, V2, P409, DOI 10.1038/35073039; Frei C, 2000, GENE DEV, V14, P81; Garcia BA, 2007, J BIOL CHEM, V282, P7641, DOI 10.1074/jbc.M607900200; Groth A, 2005, MOL CELL, V17, P301, DOI 10.1016/j.molcel.2004.12.018; Han JH, 2007, SCIENCE, V315, P653, DOI 10.1126/science.1133234; Hasan S, 2001, NATURE, V410, P387, DOI 10.1038/35066610; HELLMAN U, 1995, ANAL BIOCHEM, V224, P451, DOI 10.1006/abio.1995.1070; Hoek M, 2003, P NATL ACAD SCI USA, V100, P12183, DOI 10.1073/pnas.1635158100; Kim EJ, 2007, MOL CELL, V28, P277, DOI 10.1016/j.molcel.2007.08.030; Kuninger D, 2004, HUM GENE THER, V15, P1287, DOI 10.1089/hum.2004.15.1287; Li Q, 2008, CELL, V134, P244, DOI 10.1016/j.cell.2008.06.018; Liu X, 2008, NATURE, V451, P846, DOI 10.1038/nature06546; Maas NL, 2006, MOL CELL, V23, P109, DOI 10.1016/j.molcel.2006.06.006; Madigan JP, 2002, NUCLEIC ACIDS RES, V30, P3698, DOI 10.1093/nar/gkf496; Marcu MG, 2006, MED CHEM, V2, P169, DOI 10.2174/157340606776056133; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Megiorni F, 2005, NEUROSCI LETT, V381, P169, DOI 10.1016/j.neulet.2005.02.027; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Pallier C, 2003, MOL BIOL CELL, V14, P3414, DOI 10.1091/mbc.E02-09-0581; Recht J, 2006, P NATL ACAD SCI USA, V103, P6988, DOI 10.1073/pnas.0601676103; ROSENFELD J, 1992, ANAL BIOCHEM, V203, P173, DOI 10.1016/0003-2697(92)90061-B; Sanematsu F, 2006, J BIOL CHEM, V281, P13817, DOI 10.1074/jbc.M511590200; Schneider J, 2006, J BIOL CHEM, V281, P37270, DOI 10.1074/jbc.C600265200; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Schulz LL, 2006, FASEB J, V20, P488, DOI 10.1096/fj.05-5020fje; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Tamburini BA, 2005, EUKARYOT CELL, V4, P1583, DOI 10.1128/EC.4.9.1583-1590.2005; Tang Y, 2008, NAT STRUCT MOL BIOL, V15, P738, DOI 10.1038/nsmb.1448; Tsubota T, 2007, MOL CELL, V25, P703, DOI 10.1016/j.molcel.2007.02.006; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147; Tyler JK, 2001, MOL CELL BIOL, V21, P6574, DOI 10.1128/MCB.21.19.6574-6584.2001; Williams SK, 2008, P NATL ACAD SCI USA, V105, P9000, DOI 10.1073/pnas.0800057105; Xhemalce B, 2007, J BIOL CHEM, V282, P15040, DOI 10.1074/jbc.M701197200; Xu F, 2005, CELL, V121, P375, DOI 10.1016/j.cell.2005.03.011; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4	41	514	531	1	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 7	2009	459	7243					113	U123		10.1038/nature07861	http://dx.doi.org/10.1038/nature07861			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441WN	19270680	Green Accepted			2022-12-01	WOS:000265801300040
J	Wilson, CW; Nguyen, CT; Chen, MH; Yang, JH; Gacayan, R; Huang, J; Chen, JN; Chuang, PT				Wilson, Christopher W.; Nguyen, Catherine T.; Chen, Miao-Hsueh; Yang, Jehn-Hsiahn; Gacayan, Rhodora; Huang, Jie; Chen, Jau-Nian; Chuang, Pao-Tien			Fused has evolved divergent roles in vertebrate Hedgehog signalling and motile ciliogenesis	NATURE			English	Article							KINESIN-RELATED PROTEIN; TRANSDUCTION; DROSOPHILA; HOMOLOG; MECHANISM; DEFECTS; COSTAL2; PRODUCT; COMPLEX; GROWTH	Hedgehog (Hh) signalling is essential for several aspects of embryogenesis(1,2). In Drosophila, Hh transduction is mediated by a cytoplasmic signalling complex(3-5) that includes the putative serine-threonine kinase Fused (Fu) and the kinesin Costal 2 (Cos2, also known as Cos), yet Fu does not have a conserved role in Hh signalling in mammals(6,7). Mouse Fu (also known as Stk36) mutants are viable and seem to respond normally to Hh signalling. Here we show that mouse Fu is essential for construction of the central pair apparatus of motile, 912 cilia and offers a new model of human primary ciliary dyskinesia. We found that mouse Fu physically interacts with Kif27, a mammalian Cos2 orthologue(8), and linked Fu to known structural components of the central pair apparatus, providing evidence for the first regulatory component involved in central pair construction. We also demonstrated that zebrafish Fu is required both for Hh signalling and cilia biogenesis in Kupffer's vesicle. Mouse Fu rescued both Hh-dependent and-independent defects in zebrafish. Our results delineate a new pathway for central pair apparatus assembly, identify common regulators of Hh signalling and motile ciliogenesis, and provide insights into the evolution of the Hh cascade.	[Wilson, Christopher W.; Chen, Miao-Hsueh; Yang, Jehn-Hsiahn; Gacayan, Rhodora; Chuang, Pao-Tien] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA; [Nguyen, Catherine T.; Huang, Jie; Chen, Jau-Nian] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA	University of California System; University of California San Francisco; University of California System; University of California Los Angeles	Chuang, PT (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA.	pao-tien.chuang@ucsf.edu	Chen, Jau-Nian/AAM-7808-2020	Chen, Jau-Nian/0000-0001-8807-3607; Chen, Miao-Hsueh/0000-0002-9715-3067; YANG, JEHN-HSIAHN/0000-0001-8648-0882	National Institutes of Health; American Lung Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091915] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lung Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank H. Bourne, C. C. Hui, Z. Zhang, J. Strauss III and W. Hwang for constructs, antibodies and sharing of unpublished results; R. Harland and T. Mikawa for X. tropicalis and chicken tissue; K. Thorn and S. Dandekar for assistance with microscopy and ciliary beat frequency analysis; M.-L. Cheong and Y. Nozawa for technical assistance; and D. Casso, S. Coughlin, T. Kornberg, W. Marshall, T. Mikawa, K. Wemmer and members of the Chen and Chuang laboratories for discussion and critical reading of the manuscript. Some data for this study were acquired at the Nikon Imaging Center at UCSF/QB3. This work was supported by grants from the National Institutes of Health to J.-N. C. and P.-T. C., and a Career Investigator Award from the American Lung Association to P.-T. C.	Afzelius BA, 2004, J PATHOL, V204, P470, DOI 10.1002/path.1652; Behringer R., 2003, MANIPULATING MOUSE E; Chen JN, 1996, DEVELOPMENT, V122, P3809; Chen MH, 2005, MOL CELL BIOL, V25, P7042, DOI 10.1128/MCB.25.16.7042-7053.2005; Chen WB, 2001, DEVELOPMENT, V128, P2385; Chilvers MA, 2003, J ALLERGY CLIN IMMUN, V112, P518, DOI 10.1067/mai.2003.1701; Davenport JR, 2005, AM J PHYSIOL-RENAL, V289, pF1159, DOI 10.1152/ajprenal.00118.2005; Davis EE, 2006, DEV CELL, V11, P9, DOI 10.1016/j.devcel.2006.06.009; Dawe HR, 2007, J CELL SCI, V120, P7, DOI 10.1242/jcs.03305; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; FRISCH D, 1968, ANAT REC, V162, P221, DOI 10.1002/ar.1091620209; Huangfu D, 2006, DEVELOPMENT, V133, P3, DOI 10.1242/dev.02169; Katoh Y, 2004, INT J ONCOL, V25, P1875; Kramer-Zucker AG, 2005, DEVELOPMENT, V132, P1907, DOI 10.1242/dev.01772; Lum L, 2003, MOL CELL, V12, P1261, DOI 10.1016/S1097-2765(03)00426-X; Marshall WF, 2008, CURR OPIN CELL BIOL, V20, P48, DOI 10.1016/j.ceb.2007.11.009; McKean PG, 2003, CURR BIOL, V13, P598, DOI 10.1016/S0960-9822(03)00174-X; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; Merchant M, 2005, MOL CELL BIOL, V25, P7054, DOI 10.1128/MCB.25.16.7054-7068.2005; Mitchell B, 2007, NATURE, V447, P97, DOI 10.1038/nature05771; Neilson LI, 1999, GENOMICS, V60, P272, DOI 10.1006/geno.1999.5914; Oh SA, 2005, CURR BIOL, V15, P2107, DOI 10.1016/j.cub.2005.10.044; Robbins DJ, 1997, CELL, V90, P225, DOI 10.1016/S0092-8674(00)80331-1; Sambrook JF., 2001, MOL CLONING LAB MANU; Sapiro R, 2000, BIOL REPROD, V62, P511, DOI 10.1095/biolreprod62.3.511; Shu XD, 2007, DEVELOPMENT, V134, P1921, DOI 10.1242/dev.02851; Sisson JC, 1997, CELL, V90, P235, DOI 10.1016/S0092-8674(00)80332-3; Smith EF, 1997, MOL BIOL CELL, V8, P455, DOI 10.1091/mbc.8.3.455; Tay SY, 2005, DEVELOPMENT, V132, P625, DOI 10.1242/dev.01606; Varjosalo M, 2006, DEV CELL, V10, P177, DOI 10.1016/j.devcel.2005.12.014; Vladar EK, 2007, J CELL BIOL, V178, P31, DOI 10.1083/jcb.200703064; Westerfield M., 1995, ZEBRAFISH BOOK; Wolff C, 2003, CURR BIOL, V13, P1169, DOI 10.1016/S0960-9822(03)00461-5; Yang XZ, 2008, B MATH BIOL, V70, P1192, DOI 10.1007/s11538-008-9296-3; You YJ, 2002, AM J PHYSIOL-LUNG C, V283, pL1315, DOI 10.1152/ajplung.00169.2002; Zariwala MA, 2007, ANNU REV PHYSIOL, V69, P423, DOI 10.1146/annurev.physiol.69.040705.141301; Zhang ZB, 2002, MOL CELL BIOL, V22, P7993, DOI 10.1128/MCB.22.22.7993-8004.2002	37	106	113	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 7	2009	459	7243					98	U105		10.1038/nature07883	http://dx.doi.org/10.1038/nature07883			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441WN	19305393	Green Accepted			2022-12-01	WOS:000265801300037
J	Wolf, D; Goff, SP				Wolf, Daniel; Goff, Stephen P.			Embryonic stem cells use ZFP809 to silence retroviral DNAs	NATURE			English	Article							PRIMER-BINDING-SITE; MURINE LEUKEMIA-VIRUS; CARCINOMA-CELLS; TRANSFER-RNA; HTLV-I; PROTEIN; EXPRESSION; TRIM28; ASSAYS; ZINC	Embryonic stem cells (ESCs) and other primitive stem cells of mice have been known for more than 30 years to potently block retrovirus replication(1). Infection of ESCs by the murine leukaemia viruses (MLVs) results in the normal establishment of integrated proviral DNA, but this DNA is then transcriptionally silenced, preventing further viral spread. The repression is largely mediated by transacting factors that recognize a conserved sequence element termed the primer binding site, an 18-base pair sequence complementary to the 39 end of a cellular transfer RNA(2-6). A specific tRNA is annealed to the primer binding site sequence of the viral genomic RNA, and is used to prime DNA synthesis(7). This same sequence in the context of the integrated proviral DNA is targeted for silencing in ESCs. We have recently shown that a large protein complex binding to the primer binding site in ESCs contains TRIM28 (refs 8, 9), a well-characterized transcriptional co-repressor(10-12). An important question remains as to the identity of the factor that directly recognizes integrated retroviral DNAs and recruits TRIM28 to mediate their specific silencing. Here we identify the zinc finger protein ZFP809 as the recognition molecule that bridges the integrated proviral DNA and TRIM28. We show that expression of ZFP809 is sufficient to render even differentiated cells highly resistant to MLV infection. Furthermore, we demonstrate that ZFP809 is able to potently block transcription from DNA constructs of human T-cell lymphotropic virus-1 (HTLV-1), which use the same primer tRNA. These results identify ZFP809 as a DNA-binding factor that specifically recognizes a large subset of mammalian retroviruses and retroelements, targeting them for transcriptional silencing. We propose that ZFP809 evolved as a stem-cell-specific retroviral restriction factor, and therefore constitutes a new component of the intrinsic immune system of stem cells.	[Wolf, Daniel; Goff, Stephen P.] Columbia Univ, Coll Phys & Surg, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute	Goff, SP (corresponding author), Columbia Univ, Coll Phys & Surg, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, HHSC 1310,701 W 168th St, New York, NY 10032 USA.	spg1@columbia.edu	Goff, Stephen P/K-6337-2014	Goff, Stephen P/0000-0003-0693-5547	National Cancer Institute [R37 CA 30488]; NATIONAL CANCER INSTITUTE [R37CA030488] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Public Health Service grant R37 CA 30488 from the National Cancer Institute. We thank D. Derse, F. Bouamr and E. Barklis for their generosity with reagents. We are grateful to M. de los Santos, H. Nickerson and M. A. Gawinowicz (Protein Core Facility Columbia University) for technical assistance. We would also like to thank P. Adusumilli, M. Banes, M. Bilsky, J. Yamada and co-workers, without whose help this paper would never have been written. D. W. is an Associate, and S. P. G. is an Investigator of the Howard Hughes Medical Institute.	Ayyanathan K, 2003, GENE DEV, V17, P1855, DOI 10.1101/gad.1102803; BARKLIS E, 1986, CELL, V47, P391, DOI 10.1016/0092-8674(86)90596-9; Berg JM, 1996, SCIENCE, V271, P1081, DOI 10.1126/science.271.5252.1081; Bex F, 1998, METHODS, V16, P83, DOI 10.1006/meth.1998.0646; FELBER BK, 1985, SCIENCE, V229, P675, DOI 10.1126/science.2992082; FEUER G, 1989, J VIROL, V63, P2317, DOI 10.1128/JVI.63.5.2317-2324.1989; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Fuks F, 2003, J BIOL CHEM, V278, P4035, DOI 10.1074/jbc.M210256200; HARADA F, 1979, J BIOL CHEM, V254, P979; Kolosha VO, 1997, P NATL ACAD SCI USA, V94, P10155, DOI 10.1073/pnas.94.19.10155; O'Geen H, 2007, PLOS GENET, V3, P916, DOI 10.1371/journal.pgen.0030089; PETERSEN R, 1991, MOL CELL BIOL, V11, P1214, DOI 10.1128/MCB.11.3.1214; TEICH NM, 1977, CELL, V12, P973, DOI 10.1016/0092-8674(77)90162-3; Telesnitsky A, 1995, METHOD ENZYMOL, V262, P347; Tsuruma R, 2008, ONCOGENE, V27, P3054, DOI 10.1038/sj.onc.1210952; Urrutia R, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-231; Wolf D, 2002, J BIOL CHEM, V277, P25562, DOI 10.1074/jbc.M201196200; Wolf D, 2008, ANNU REV GENET, V42, P143, DOI 10.1146/annurev.genet.42.110807.091704; Wolf D, 2008, P NATL ACAD SCI USA, V105, P12521, DOI 10.1073/pnas.0805540105; Wolf D, 2008, J VIROL, V82, P4675, DOI 10.1128/JVI.02445-07; Wolf D, 2007, CELL, V131, P46, DOI 10.1016/j.cell.2007.07.026; YAMAUCHI M, 1995, J VIROL, V69, P1142, DOI 10.1128/JVI.69.2.1142-1149.1995	22	260	265	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2009	458	7242					1201	1204		10.1038/nature07844	http://dx.doi.org/10.1038/nature07844			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441FL	19270682	Green Accepted			2022-12-01	WOS:000265754600053
J	Coumailleau, F; Furthauer, M; Knoblich, JA; Gonzalez-Gaitan, M				Coumailleau, F.; Fuerthauer, M.; Knoblich, J. A.; Gonzalez-Gaitan, M.			Directional Delta and Notch trafficking in Sara endosomes during asymmetric cell division	NATURE			English	Article							RECEPTOR ACTIVATION; DROSOPHILA EMBRYOS; DOMAIN PROTEIN; FYVE DOMAIN; ENDOCYTOSIS; LOCALIZATION; SUPPRESSOR; PRESENILIN; SANPODO; FATE	Endocytosis has a crucial role during Notch signalling after the asymmetric division of fly sensory organ precursors (SOPs): directional signalling is mediated by differential endocytosis of the ligand Delta and the Notch effector Sanpodo in one of the SOP daughters, pIIb(1-3). Here we show a new mechanism of directional signalling on the basis of the trafficking of Delta and Notch molecules already internalized in the SOP and subsequently targeted to the other daughter cell, pIIa. Internalized Delta and Notch traffic to an endosome marked by the protein Sara(4,5). During SOP mitosis, Sara endosomes containing Notch and Delta move to the central spindle and then to pIIa. Subsequently, in pIIa (but not in pIIb) Notch appears cleaved in Sara endosomes in a gamma-secretase-and Delta internalization-dependent manner, indicating that the release of the intracellular Notch tail to activate Notch target genes has occurred. We thus uncover a new mechanism to bias signalling even before asymmetric endocytosis of Sanpodo and Delta takes place in the daughter cells: already during SOP mitosis, asymmetric targeting of Delta and Notch-containing Sara endosomes will increase Notch signalling in pIIa and decrease it in pIIb.	[Coumailleau, F.; Fuerthauer, M.; Gonzalez-Gaitan, M.] Univ Geneva, Dept Biochem, CH-1211 Geneva 4, Switzerland; [Coumailleau, F.; Fuerthauer, M.; Gonzalez-Gaitan, M.] Univ Geneva, Dept Mol Biol, CH-1211 Geneva 4, Switzerland; [Knoblich, J. A.] Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria	University of Geneva; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Furthauer, M (corresponding author), Univ Geneva, Dept Biochem, 30 Quai Ernest Ansermet, CH-1211 Geneva 4, Switzerland.	Maximilian.Fuerthauer@unige.ch; Marcos.Gonzalez@unige.ch	FÃrthauer, Maximilian/AAY-4516-2020; Knoblich, Juergen A/C-2974-2015	FÃrthauer, Maximilian/0000-0001-6344-6585; Knoblich, Juergen A/0000-0002-6751-3404; Gonzalez-Gaitan, Marcos/0000-0002-6295-7321; COUMAILLEAU, Franck/0000-0002-1392-5665	EMBO; Human Frontier Science Program (HFSP); Fondation pour la recherche medicale (FRM); Max Planck Society; Volkswagen; FP6 Strep (ONCASYM); Swiss National Science Foundation (SNF); SystemsX (LipidX); HFSP	EMBO(European Molecular Biology Organization (EMBO)); Human Frontier Science Program (HFSP)(Human Frontier Science Program); Fondation pour la recherche medicale (FRM)(Fondation pour la Recherche Medicale); Max Planck Society(Max Planck SocietyFoundation CELLEX); Volkswagen(Volkswagen); FP6 Strep (ONCASYM)(European Commission); Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); SystemsX (LipidX); HFSP(Human Frontier Science Program)	We thank S. Bray, P. Bryant, D. Glover, C. Gonzalez, E. Lai, C. Micchelli, M. Muskavitch, M. O'Connor, J. Posakony, F. Schweisguth, J. Skeath and A. Wodarz for providing reagents, and the M. G.-G. laboratory members, A. Martinez-Arias and F. Schweisguth for critically reading the manuscript. We thank S. Sigrist and W. Fouquet for providing us the opportunity to perform stimulated emission depletion (STED) microscopy. We thank A. Schwabedissen, D. Backash, C. Alliod and A. Beguin for technical assistance. M. F. thanks M. P. Euzenot for support. M. F. has benefited from EMBO and Human Frontier Science Program (HFSP) long-term postdoctoral fellowships and F. C. from a Fondation pour la recherche medicale (FRM) postdoctoral fellowship. This work was supported by the Max Planck Society, Volkswagen, an FP6 Strep (ONCASYM), the Swiss National Science Foundation (SNF), SystemsX (LipidX) and HFSP.	Andrews R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000493; Bardin AJ, 2006, DEV CELL, V10, P245, DOI 10.1016/j.devcel.2005.12.017; Beckmann J, 2007, BLOOD, V109, P5494, DOI 10.1182/blood-2006-11-055921; Betschinger J, 2003, NATURE, V422, P326, DOI 10.1038/nature01486; Bokel C, 2006, SCIENCE, V314, P1135, DOI 10.1126/science.1132524; Cournailleau F, 2008, CURR OPIN CELL BIOL, V20, P462, DOI 10.1016/j.ceb.2008.03.007; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Emery G, 2005, CELL, V122, P763, DOI 10.1016/j.cell.2005.08.017; Emery G, 2006, CURR OPIN CELL BIOL, V18, P407, DOI 10.1016/j.ceb.2006.06.009; Furriols M, 2001, CURR BIOL, V11, P60, DOI 10.1016/S0960-9822(00)00044-0; Gallagher CM, 2006, DEV CELL, V11, P641, DOI 10.1016/j.devcel.2006.09.014; Gho M, 1999, DEVELOPMENT, V126, P3573; Gupta-Rossi N, 2004, J CELL BIOL, V166, P73, DOI 10.1083/jcb.200310098; Hutterer A, 2005, EMBO REP, V6, P836, DOI 10.1038/sj.embor.7400500; Itoh F, 2002, GENES CELLS, V7, P321, DOI 10.1046/j.1365-2443.2002.00519.x; Langevin J, 2005, CURR BIOL, V15, P955, DOI 10.1016/j.cub.2005.04.054; Le Borgne R, 2003, DEV CELL, V5, P139, DOI 10.1016/S1534-5807(03)00187-4; Minestrini G, 2003, MOL BIOL CELL, V14, P4028, DOI 10.1091/mbc.E03-04-0214; Panopoulou E, 2002, J BIOL CHEM, V277, P18046, DOI 10.1074/jbc.M107983200; Royou A, 2002, J CELL BIOL, V158, P127, DOI 10.1083/jcb.200203148; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; Vaccari T, 2005, DEV CELL, V9, P687, DOI 10.1016/j.devcel.2005.09.019; Vaccari T, 2008, J CELL BIOL, V180, P755, DOI 10.1083/jcb.200708127; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087; Ye YH, 1999, NATURE, V398, P525, DOI 10.1038/19096	28	137	138	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	2009	458	7241					1051	1055		10.1038/nature07854	http://dx.doi.org/10.1038/nature07854			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436KL	19295516				2022-12-01	WOS:000265412900048
J	Goldstein, DB				Goldstein, David B.			Common Genetic Variation and Human Traits	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ASSOCIATION		Duke Univ, Inst Genome Sci & Policy, Ctr Human Genome Variat, Durham, NC 27706 USA	Duke University	Goldstein, DB (corresponding author), Duke Univ, Inst Genome Sci & Policy, Ctr Human Genome Variat, Durham, NC 27706 USA.		Goldstein, David/AAY-8125-2020					Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Mallal S, 2008, NEW ENGL J MED, V358, P568, DOI 10.1056/NEJMoa0706135; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121	5	678	706	0	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 23	2009	360	17					1696	1698		10.1056/NEJMp0806284	http://dx.doi.org/10.1056/NEJMp0806284			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	435XY	19369660				2022-12-01	WOS:000265377800002
J	Mikucki, JA; Pearson, A; Johnston, DT; Turchyn, AV; Farquhar, J; Schrag, DP; Anbar, AD; Priscu, JC; Lee, PA				Mikucki, Jill A.; Pearson, Ann; Johnston, David T.; Turchyn, Alexandra V.; Farquhar, James; Schrag, Daniel P.; Anbar, Ariel D.; Priscu, John C.; Lee, Peter A.			A Contemporary Microbially Maintained Subglacial Ferrous "Ocean"	SCIENCE			English	Article							TAYLOR GLACIER; DRY VALLEYS; SULFUR; OXYGEN; SULFATE; EXCHANGE; REDOX; WATER; MODEL; ICE	An active microbial assemblage cycles sulfur in a sulfate-rich, ancient marine brine beneath Taylor Glacier, an outlet glacier of the East Antarctic Ice Sheet, with Fe(III) serving as the terminal electron acceptor. Isotopic measurements of sulfate, water, carbonate, and ferrous iron and functional gene analyses of adenosine 5'-phosphosulfate reductase imply that a microbial consortium facilitates a catalytic sulfur cycle. These metabolic pathways result from a limited organic carbon supply because of the absence of contemporary photosynthesis, yielding a subglacial ferrous brine that is anoxic but not sulfidic. Coupled biogeochemical processes below the glacier enable subglacial microbes to grow in extended isolation, demonstrating how analogous organic-starved systems, such as Neoproterozoic oceans, accumulated Fe(II) despite the presence of an active sulfur cycle.	[Mikucki, Jill A.; Pearson, Ann; Schrag, Daniel P.] Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA; [Johnston, David T.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Turchyn, Alexandra V.] Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; [Farquhar, James] Univ Maryland, Dept Geol, College Pk, MD 20742 USA; [Anbar, Ariel D.] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA; [Anbar, Ariel D.] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; [Priscu, John C.] Montana State Univ, Dept Land Resources & Environm Sci, Bozeman, MT 59717 USA; [Lee, Peter A.] Coll Charleston, Hollings Marine Lab, Charleston, SC 29412 USA	Harvard University; Harvard University; University of Cambridge; University System of Maryland; University of Maryland College Park; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Montana State University System; Montana State University Bozeman; College of Charleston	Mikucki, JA (corresponding author), Dartmouth Coll, Dept Earth Sci, Hanover, NH 03755 USA.	jill.a.mikucki@dartmouth.edu	Pearson, Ann/A-6723-2009; Johnston, David/A-9796-2010	Pearson, Ann/0000-0003-2785-8405; Johnston, David/0000-0002-2487-1084	NSF Polar postdoctoral fellowship [OPP-0528710]; NSF [EAR-0311937, OPP-432595, OPP-0631494, OPP-0338097, OCE-0728683]; Canadian Institute for Advanced Research; Harvard Microbial Sciences Initiative; NASA [NNX07AV51G]	NSF Polar postdoctoral fellowship; NSF(National Science Foundation (NSF)); Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR)); Harvard Microbial Sciences Initiative; NASA(National Aeronautics & Space Administration (NASA))	G. Eischeld and S. Fawcett assisted with oxygen isotope measurements, A. Masterson assisted with sulfur isotope measurements, and G. Gordon assisted with iron isotope measurements. We are grateful for assistance from the Crary Laboratory, Petroleum Helicopters Incorporated, and S. Carter. We would like to extend a special thanks to McMurdo personnel B. Peace and W. Hayworth. Discussions with H. Keys, M. Tranter, K. Welch, W. B. Lyons, W. Hamilton, F. MacDonald, S. Shah, and A. Knoll were helpful in formulating the ideas presented. The comments of three anonymous reviewers and A. J. Kaufman greatly improved the manuscript. This research was funded by an NSF Polar postdoctoral fellowship (OPP-0528710) to J.A.M. Additional support was provided by NSF grants EAR-0311937 (A.P.), OPP-432595 and OPP-0631494 (J.C.P.), and OPP-0338097 and OCE-0728683 (awarded to G. R. DiTullio) (P.A.L.); Canadian Institute for Advanced Research (A.V.T.); Harvard Microbial Sciences Initiative; and NASA (NNX07AV51G) (D.T.J.). DNA sequences have been submitted to GenBank with accession numbers FJ389341 to FJ389351.	Aciego SM, 2007, QUATERNARY RES, V68, P303, DOI 10.1016/j.yqres.2007.07.013; BETTS RH, 1970, CAN J CHEMISTRY, V48, P2035, DOI 10.1139/v70-339; Bick JA, 2000, J BACTERIOL, V182, P135, DOI 10.1128/JB.182.1.135-142.2000; Black R.F., 1965, J GEOL, V73, P175, DOI [10.1086/627053, DOI 10.1086/627053]; Brunner B, 2005, GEOCHIM COSMOCHIM AC, V69, P4773, DOI 10.1016/j.gca.2005.04.017; Canfield DE, 1998, NATURE, V396, P450, DOI 10.1038/24839; Canfield DE, 2001, REV MINERAL GEOCHEM, V43, P607, DOI 10.2138/gsrmg.43.1.607; Canfield DE, 2008, SCIENCE, V321, P949, DOI 10.1126/science.1154499; CHIBA H, 1985, GEOCHIM COSMOCHIM AC, V49, P993, DOI 10.1016/0016-7037(85)90314-X; COX SC, 1991, ANTARCT SCI, V3, P405, DOI 10.1017/S0954102091000500; ELSTON DP, 1981, ANTARCT RES SER, V33, P413, DOI DOI 10.1029/AR033P0413; Farquhar J, 2002, SCIENCE, V298, P2369, DOI 10.1126/science.1078617; Fountain AG, 1999, BIOSCIENCE, V49, P961, DOI 10.2307/1313730; HAMILTON W, 1965, 456B GEOL SURV; Hattori S, 2000, INT J SYST EVOL MICR, V50, P1601, DOI 10.1099/00207713-50-4-1601; Hoffman PF, 2002, TERRA NOVA, V14, P129, DOI 10.1046/j.1365-3121.2002.00408.x; Hubbard A, 2004, ANN GLACIOL-SER, V39, P79, DOI 10.3189/172756404781813970; Johnson CM, 2008, ANNU REV EARTH PL SC, V36, P457, DOI 10.1146/annurev.earth.36.031207.124139; Kirschvink J.L., 1992, PROTEROZOIC BIOSPHER, P51; Lovley DR, 1996, NATURE, V382, P445, DOI 10.1038/382445a0; Lyons WB, 2005, GEOCHIM COSMOCHIM AC, V69, P305, DOI 10.1016/j.gca.2004.06.040; MIKUCKI JA, 2005, THESIS MONTANA STATE; Mikucki JA, 2007, APPL ENVIRON MICROB, V73, P4029, DOI 10.1128/AEM.01396-06; Newman DK, 2000, NATURE, V405, P94, DOI 10.1038/35011098; Priscu J. C., 2008, POLAR LAKES RIVERS, P119, DOI DOI 10.1093/ACPROF:OSO/9780199213887.003.0007; Priscu JC, 1999, SCIENCE, V286, P2141, DOI 10.1126/science.286.5447.2141; Schink B, 2006, ENG LIFE SCI, V6, P228, DOI 10.1002/elsc.200620130; Straub KL, 2004, APPL ENVIRON MICROB, V70, P5744, DOI 10.1128/AEM.70.10.5744-5749.2004; Tranter M, 2005, HYDROL PROCESS, V19, P995, DOI 10.1002/hyp.5854; Turchyn AV, 2006, GEOBIOLOGY, V4, P191, DOI 10.1111/j.1472-4669.2006.00079.x; Turchyn AV, 2004, SCIENCE, V303, P2004, DOI 10.1126/science.1092296; WILCH TI, 1993, GEOGR ANN A, V75, P331, DOI DOI 10.1080/04353676.1993.11880399	32	175	182	0	126	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2009	324	5925					397	400		10.1126/science.1167350	http://dx.doi.org/10.1126/science.1167350			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433QT	19372431				2022-12-01	WOS:000265221600045
J	Lin, YY; Lu, JY; Zhang, JM; Walter, W; Dang, WW; Wan, J; Tao, SC; Qian, J; Zhao, YM; Boeke, JD; Berger, SL; Zhu, H				Lin, Yu-yi; Lu, Jin-ying; Zhang, Junmei; Walter, Wendy; Dang, Weiwei; Wan, Jun; Tao, Sheng-Ce; Qian, Jiang; Zhao, Yingming; Boeke, Jef D.; Berger, Shelley L.; Zhu, Heng			Protein Acetylation Microarray Reveals that NuA4 Controls Key Metabolic Target Regulating Gluconeogenesis	CELL			English	Article							SISTER-CHROMATID COHESION; LIFE-SPAN EXTENSION; PHOSPHOENOLPYRUVATE CARBOXYKINASE GTP; SACCHAROMYCES-CEREVISIAE; HISTONE ACETYLTRANSFERASE; CALORIE RESTRICTION; MOUSE-LIVER; HEPATIC GLUCONEOGENESIS; FUNCTIONAL DISSECTION; LYSINE ACETYLATION	Histone acetyltransferases (HATs) and histone deacetylases (HDACs) conduct many critical functions through nonhistone substrates in metazoans, but only chromatin-associated nonhistone substrates are known in Saccharomyces cerevisiae. Using yeast proteome microarrays, we identified and validated many nonchromatin substrates of the essential nucleosome acetyltransferase of H4 (NuA4) complex. Among these, acetylation sites (Lys19 and 514) of phosphoenolpyruvate carboxykinase (Pck1p) were determined by tandem mass spectrometry. Acetylation at Lys514 was crucial for enzymatic activity and the ability of yeast cells to grow on nonfermentable carbon sources. Furthermore, Sir2p deacetylated Pck1p both in vitro and in vivo. Loss of Pck1p activity blocked the extension of yeast chronological life span caused by water starvation. In human hepatocellular carcinoma (HepG2) cells, human Pck1 acetylation and glucose production were dependent on TIP60, the human homolog of ESA1. Our findings demonstrate a regulatory function for the NuA4 complex in glucose metabolism and life span by acetylating a critical metabolic enzyme.	[Lin, Yu-yi; Lu, Jin-ying; Tao, Sheng-Ce; Boeke, Jef D.; Zhu, Heng] Johns Hopkins Univ, Sch Med, High Throughput Biol Ctr, Baltimore, MD 21205 USA; [Lu, Jin-ying; Tao, Sheng-Ce; Zhu, Heng] Johns Hopkins Univ, Sch Med, Dept Pharmacol, Baltimore, MD 21205 USA; [Lu, Jin-ying; Tao, Sheng-Ce; Zhu, Heng] Johns Hopkins Univ, Sch Med, Dept Mol Sci, Baltimore, MD 21205 USA; [Wan, Jun; Qian, Jiang] Johns Hopkins Univ, Sch Med, Wilmer Eye Ctr, Baltimore, MD 21205 USA; [Lu, Jin-ying] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei 100, Taiwan; [Zhang, Junmei; Zhao, Yingming] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Walter, Wendy; Dang, Weiwei; Berger, Shelley L.] Wistar Inst Anat & Biol, Gene Express & Regulat Program, Philadelphia, PA 19104 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; National Taiwan University; National Taiwan University Hospital; University of Texas System; University of Texas Southwestern Medical Center Dallas; The Wistar Institute	Boeke, JD (corresponding author), Johns Hopkins Univ, Sch Med, High Throughput Biol Ctr, Baltimore, MD 21205 USA.	jboeke@jhmi.edu; berger@wistar.org; heng.zhu@jhmi.edu	Tao, Sheng-ce/A-5833-2012; Wan, Jun/AAN-1337-2020; Wan, Jun/A-2177-2014; Wan, Jun/H-7132-2013	Tao, Sheng-ce/0000-0002-9210-1823; Wan, Jun/0000-0001-9286-6562; Wan, Jun/0000-0001-9286-6562; Wan, Jun/0000-0001-9286-6562; Berger, Shelley/0000-0001-5398-4400; Dang, Weiwei/0000-0002-6931-4636; Boeke, Jef/0000-0001-5322-4946	National Institutes of Health [U54 RR 020839, R01CA126832, R01EY017589]; Keck Foundation; NATIONAL CANCER INSTITUTE [R01CA126832] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020839] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY017589] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Keck Foundation(W.M. Keck Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank E. M. Cooper, L. Dai, A. Norris, and K. A. O'Donnell for gifts of reagents; J. Liu, J. T. Stivers, H. Takahashi, S. Taverna, J. Zhang, and members of the Zhu and Boeke labs for valuable discussions throughout the course of the work. This work was supported in part by National Institutes of Health Roadmap Grant U54 RR 020839, "Technology Center for Networks and Pathways'' (to J.D.B., S.L.B., and H.Z.); the Keck Foundation (H.Z.); and National Institutes of Health Grants R01CA126832 (to Y.Z.) and R01EY017589 (to J. Q.).	Allard S, 1999, EMBO J, V18, P5108, DOI 10.1093/emboj/18.18.5108; Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Ashrafi K, 2000, GENE DEV, V14, P1872; Auger A, 2008, MOL CELL BIOL, V28, P2257, DOI 10.1128/MCB.01755-07; Babiarz JE, 2006, GENE DEV, V20, P700, DOI 10.1101/gad.1386306; BALY DL, 1985, J NUTR, V115, P872, DOI 10.1093/jn/115.7.872; Beale EG, 2004, TRENDS ENDOCRIN MET, V15, P129, DOI 10.1016/j.tem.2004.02.006; Ben-Shahar TR, 2008, SCIENCE, V321, P563, DOI 10.1126/science.1157774; Boudreault AA, 2003, GENE DEV, V17, P1415, DOI 10.1101/gad.1056603; Burgess SC, 2007, CELL METAB, V5, P313, DOI 10.1016/j.cmet.2007.03.004; Choi JK, 2008, MOL CELL BIOL, V28, P6967, DOI 10.1128/MCB.00570-08; Clarke AS, 1999, MOL CELL BIOL, V19, P2515; Delbaere LTJ, 2004, BBA-PROTEINS PROTEOM, V1697, P271, DOI 10.1016/j.bbapap.2003.11.030; Duvel K, 2003, MOL CELL, V11, P1467, DOI 10.1016/S1097-2765(03)00228-4; Fabrizio P, 2005, CELL, V123, P655, DOI 10.1016/j.cell.2005.08.042; Fabrizio P, 2003, AGING CELL, V2, P73, DOI 10.1046/j.1474-9728.2003.00033.x; Fabrizio Paola, 2007, Methods Mol Biol, V371, P89; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Hagopian K, 2003, EXP GERONTOL, V38, P267, DOI 10.1016/S0531-5565(02)00202-4; Hagopian K, 2008, BIOSCIENCE REP, V28, P107, DOI 10.1042/BSR20080015; Hakimi P, 2007, J BIOL CHEM, V282, P32844, DOI 10.1074/jbc.M706127200; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; Haurie V, 2001, J BIOL CHEM, V276, P76, DOI 10.1074/jbc.M008752200; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Keogh MC, 2006, GENE DEV, V20, P660, DOI 10.1101/gad.1388106; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lardy H, 1972, ENZYMES, P117; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Li Y, 2007, CELL DEATH DIFFER, V14, P2058, DOI 10.1038/sj.cdd.4402219; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Lin YY, 2008, GENE DEV, V22, P2062, DOI 10.1101/gad.1679508; Lu JY, 2008, MOL CELL PROTEOMICS, V7, P35, DOI 10.1074/mcp.M700353-MCP200; Matte A, 1997, J BIOL CHEM, V272, P8105, DOI 10.1074/jbc.272.13.8105; Millar CB, 2006, NAT REV MOL CELL BIO, V7, P657, DOI 10.1038/nrm1986; Millar CB, 2006, GENE DEV, V20, P711, DOI 10.1101/gad.1395506; Mitchell L, 2008, MOL CELL BIOL, V28, P2244, DOI 10.1128/MCB.01653-07; Neugebauer RC, 2008, CURR PHARM DESIGN, V14, P562; Permutt MA, 2000, TRENDS ENDOCRIN MET, V11, P383, DOI 10.1016/S1043-2760(00)00329-5; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Pronk JT, 1996, YEAST, V12, P1607, DOI 10.1002/(SICI)1097-0061(199612)12:16<1607::AID-YEA70>3.0.CO;2-4; Raab RM, 2006, NUTR METAB, V3, DOI 10.1186/1743-7075-3-40; Ravanal MC, 2003, J PROTEIN CHEM, V22, P311, DOI 10.1023/A:1025306105105; Reshef L, 2003, J BIOL CHEM, V278, P30413, DOI 10.1074/jbc.R300017200; Robyr D, 2002, CELL, V109, P437, DOI 10.1016/S0092-8674(02)00746-8; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; ROGNSTAD R, 1979, J BIOL CHEM, V254, P1875; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Scherz-Shouval R, 2007, TRENDS CELL BIOL, V17, P422, DOI 10.1016/j.tcb.2007.07.009; Schuller HJ, 2003, CURR GENET, V43, P139, DOI 10.1007/s00294-003-0381-8; Schwer B, 2008, CELL METAB, V7, P104, DOI 10.1016/j.cmet.2007.11.006; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Smith ER, 1998, P NATL ACAD SCI USA, V95, P3561, DOI 10.1073/pnas.95.7.3561; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Takahashi H, 2006, MOL CELL, V23, P207, DOI 10.1016/j.molcel.2006.05.040; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; Tao SC, 2007, COMB CHEM HIGH T SCR, V10, P706, DOI 10.2174/138620707782507386; Unal E, 2008, SCIENCE, V321, P566, DOI 10.1126/science.1157880; van Voorst F, 2006, YEAST, V23, P351, DOI 10.1002/yea.1359; VanDemark AP, 2007, MOL CELL, V27, P817, DOI 10.1016/j.molcel.2007.08.018; vandenBerg MA, 1996, J BIOL CHEM, V271, P28953, DOI 10.1074/jbc.271.46.28953; Vogelauer M, 2000, NATURE, V408, P495, DOI 10.1038/35044127; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Yin ZK, 2000, MOL MICROBIOL, V35, P553, DOI 10.1046/j.1365-2958.2000.01723.x; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zaman S, 2008, ANNU REV GENET, V42, P27, DOI 10.1146/annurev.genet.41.110306.130206; Zhang HY, 2004, MOL CELL BIOL, V24, P9424, DOI 10.1128/MCB.24.21.9424-9436.2004; Zhang JL, 2008, MOL CELL, V31, P143, DOI 10.1016/j.molcel.2008.06.006; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191	74	239	251	0	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 20	2009	136	6					1073	1084		10.1016/j.cell.2009.01.033	http://dx.doi.org/10.1016/j.cell.2009.01.033			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	422CE	19303850	Green Accepted, Bronze			2022-12-01	WOS:000264403900013
J	Kearney, MK; Weininger, RB; Vachon, MLS; Harrison, RL; Mount, BM				Kearney, Michael K.; Weininger, Radhule B.; Vachon, Mary L. S.; Harrison, Richard L.; Mount, Balfour M.			Self-care of Physicians Caring for Patients at the End of Life "Being Connected ... A Key to My Survival"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							WRITTEN EMOTIONAL EXPRESSION; STRESS REDUCTION; MENTAL-HEALTH; OF-LIFE; SURGICAL ONCOLOGISTS; HOSPITAL CONSULTANTS; PERSONAL WELLNESS; CONTROLLED-TRIAL; PALLIATIVE CARE; IMMUNE FUNCTION	Physicians providing end-of-life care are subject to a variety of stresses that may lead to burnout and compassion fatigue at both individual and team levels. Through the story of an oncologist, we discuss the prodromal symptoms and signs leading to burnout and compassion fatigue and present the evidence for prevention. We define and discuss factors that contribute to burnout and compassion fatigue and consider factors that may mitigate burnout. We explore the practice of empathy and discuss an approach for physicians to maximize wellness through self-awareness in the setting of caring for patients with end-stage illness. Finally, we discuss some practical applications of self-care in the workplace.	[Kearney, Michael K.] Santa Barbara Cottage Hosp, Palliat Care Serv, Santa Barbara, CA 93102 USA; [Kearney, Michael K.] Visiting Nurse & Hosp Care Santa Barbara, Santa Barbara, CA USA; [Weininger, Radhule B.] La Casa de Maria Retreat & Conf Ctr, Santa Barbara, CA USA; [Vachon, Mary L. S.] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Vachon, Mary L. S.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Harrison, Richard L.] Univ British Columbia, Counseling Psychol Program, Vancouver, BC V5Z 1M9, Canada; [Mount, Balfour M.] McGill Univ, Dept Med, Montreal, PQ, Canada	Santa Barbara Cottage Hospital; University of Toronto; University of Toronto; University of British Columbia; McGill University	Kearney, MK (corresponding author), Santa Barbara Cottage Hosp, Palliat Care Serv, POB 689,Pueblo Bath St, Santa Barbara, CA 93102 USA.	mkearney@sbch.org						Allegra CJ, 2005, J ONCOL PRACT, V1, P140, DOI 10.1200/jop.2005.1.4.140; Armstrong J, 2004, J CLIN ONCOL, V22, P4425, DOI 10.1200/JCO.2004.07.138; Arnold D, 2005, J HUMANIST PSYCHOL, V45, P239, DOI 10.1177/0022167805274729; Asai M, 2007, PSYCHO-ONCOLOGY, V16, P421, DOI 10.1002/pon.1066; Balch CM, 2007, ANN SURG ONCOL, V14, P3029, DOI 10.1245/s10434-007-9588-0; BARNARD D, 2000, CROSSING OVER NARRAT; Beddoe AE, 2004, J NURS EDUC, V43, P305; Boston PH, 2006, J PAIN SYMPTOM MANAG, V32, P13, DOI 10.1016/j.jpainsymman.2006.01.009; Brady DW, 2002, ANN INTERN MED, V137, P220, DOI 10.7326/0003-4819-137-3-200208060-00025; Bressi C, 2008, BRIT J CANCER, V98, P1046, DOI 10.1038/sj.bjc.6604270; Calhoun LG, 1998, LEA SER PER CLIN PSY, P215; Calhoun LG, 1999, FACILITATING POSTTRA; Cepeda MS, 2008, J PAIN SYMPTOM MANAG, V35, P623, DOI 10.1016/j.jpainsymman.2007.08.011; Charon R, 2001, JAMA-J AM MED ASSOC, V286, P1897, DOI 10.1001/jama.286.15.1897; CHARON R, 2008, NARRATIVE MED HONORI, P156; Cohen-Katz Joanne, 2004, Holist Nurs Pract, V18, P302; Coster JS, 1997, PROF PSYCHOL-RES PR, V28, P5, DOI 10.1037/0735-7028.28.1.5; Dahlin Marie E, 2007, BMC Med Educ, V7, P6, DOI 10.1186/1472-6920-7-6; Davidson RJ, 2003, PSYCHOSOM MED, V65, P564, DOI 10.1097/01.PSY.0000077505.67574.E3; Desalvo Louise, 1999, WRITING WAY HEALING; Elit L, 2004, GYNECOL ONCOL, V94, P134, DOI 10.1016/j.ygyno.2004.04.014; Epstein RM, 1999, JAMA-J AM MED ASSOC, V282, P833, DOI 10.1001/jama.282.9.833; *EUR COMM, 2004, PROM DEV INT PALL CA; Fallowfield L, 2003, BRIT J CANCER, V89, P1445, DOI 10.1038/sj.bjc.6601309; Fallowfield L, 2002, LANCET, V359, P650, DOI 10.1016/S0140-6736(02)07810-8; Figley C.R., 2002, TREATING COMPASSION; Figley C.R., 1995, COMPASSION FATIGUE C; Fillion L, 2009, PSYCHO-ONCOLOGY, V18, P1300, DOI 10.1002/pon.1513; Frisina PG, 2004, J NERV MENT DIS, V192, P629, DOI 10.1097/01.nmd.0000138317.30764.63; GARFIELD C, 1995, SOMETIMES MY HEART G; Gentry J., 2002, TREATING COMPASSION; Graham J, 1996, PALLIATIVE MED, V10, P185, DOI 10.1177/026921639601000302; Graham J, 2002, EUR J CANCER CARE, V11, P188, DOI 10.1046/j.1365-2354.2002.00338.x; Grossman P, 2004, J PSYCHOSOM RES, V57, P35, DOI 10.1016/S0022-3999(03)00573-7; Grunfeld E, 2000, CAN MED ASSOC J, V163, P166; Halbesleben JRB, 2008, HEALTH CARE MANAGE R, V33, P29, DOI 10.1097/01.HMR.0000304493.87898.72; Harris AHS, 2006, J CONSULT CLIN PSYCH, V74, P243, DOI 10.1037/0022-006X.74.2.243; HARRISON RL, PSYCHOTHERA IN PRESS; Haward R, 2003, BRIT J CANCER, V89, P15, DOI 10.1038/sj.bjc.6601073; Hojat M, 2002, AM J PSYCHIAT, V159, P1563, DOI 10.1176/appi.ajp.159.9.1563; HUGGARD PK, 2008, MANAGING COMPASSION; Jackson VA, 2008, J PALLIAT MED, V11, P893, DOI 10.1089/jpm.2007.2480; Johnson T.A., 2006, PROFESSIONALS WEEP E, P3; Kabat-Zinn J, 2003, CLIN PSYCHOL-SCI PR, V10, P144, DOI 10.1093/clipsy/bpg016; Kash KM, 2000, ONCOLOGY-NY, V14, P1621; Kearney M, 2009, PLACE HEALING WORKIN; Keeton K, 2007, OBSTET GYNECOL, V109, P949, DOI 10.1097/01.AOG.0000258299.45979.37; Kjeldmand D, 2004, PATIENT EDUC COUNS, V55, P230, DOI 10.1016/j.pec.2003.09.009; KOBASA SC, 1982, J PERS SOC PSYCHOL, V42, P168, DOI 10.1037/0022-3514.42.1.168; KOBASA SC, 1979, J PERS SOC PSYCHOL, V37, P1, DOI 10.1037/0022-3514.37.1.1; Kornfield Jack, 2008, WISE HEART GUIDE UNI; Kuerer HM, 2007, ANN SURG ONCOL, V14, P3043, DOI 10.1245/s10434-007-9579-1; Lazar SW, 2005, NEUROREPORT, V16, P1893, DOI 10.1097/01.wnr.0000186598.66243.19; Le Blanc PM, 2007, J APPL PSYCHOL, V92, P213, DOI 10.1037/0021-9010.92.1.213; Leiter MP, 2005, NEW HORIZ MANAG, P544; Linley PA, 2005, PSYCHOTHER PSYCHOSOM, V74, P185, DOI 10.1159/000084004; Mackereth Peter A, 2005, Eur J Oncol Nurs, V9, P147, DOI 10.1016/j.ejon.2004.04.006; Maslach C, 2001, ANNU REV PSYCHOL, V52, P397, DOI 10.1146/annurev.psych.52.1.397; Maslach C, 2003, CURR DIR PSYCHOL SCI, V12, P189, DOI 10.1111/1467-8721.01258; Maslach C., 1996, MASLACH BURNOUT INVE; Maslach C, 2008, J APPL PSYCHOL, V93, P498, DOI 10.1037/0021-9010.93.3.498; Meier DE, 2001, JAMA-J AM MED ASSOC, V286, P3007, DOI 10.1001/jama.286.23.3007; Morgan Nancy P, 2008, Oncologist, V13, P196, DOI 10.1634/theoncologist.2007-0147; Mount BM, 2007, J PAIN SYMPTOM MANAG, V33, P372, DOI 10.1016/j.jpainsymman.2006.09.014; Muscatello MRA, 2006, PSYCHOL REP, V99, P641, DOI 10.2466/PR0.99.2.641-650; Neff KD, 2007, J RES PERS, V41, P139, DOI 10.1016/j.jrp.2006.03.004; Novack DH, 1997, JAMA-J AM MED ASSOC, V278, P502, DOI 10.1001/jama.278.6.502; Novack DH, 1999, ACAD MED, V74, P516, DOI 10.1097/00001888-199905000-00017; O'Cleirigh C, 2008, BRIT J HEALTH PSYCH, V13, P81, DOI 10.1348/135910707X250884; Pearlman L. A., 1999, SECONDARY TRAUMATIC, P51; Pennebaker JW., 1997, OPENING HEALING POWE; Perry Beth, 2008, Can Oncol Nurs J, V18, P87; Petrie KJ, 2004, PSYCHOSOM MED, V66, P272, DOI 10.1097/01.psy.0000116782.49850.d3; Pierce B, 2007, J PALLIAT CARE, V23, P32, DOI 10.1177/082585970702300105; QUILL TE, 1990, ARCH INTERN MED, V150, P1857, DOI 10.1001/archinte.150.9.1857; Rabinowitz S, 1996, AAOHN J, V44, P28; RAMIREZ AJ, 1995, BRIT J CANCER, V71, P1263, DOI 10.1038/bjc.1995.244; Ramirez AJ, 1996, LANCET, V347, P724, DOI 10.1016/S0140-6736(96)90077-X; Robinson Katya, 2004, J Palliat Med, V7, P637, DOI 10.1089/jpm.2004.7.637; ROHAN EA, 2005, EXLPORATION VICARIOU; Saakvitne, 1995, TRAUMA THERAPIST COU, P31; Salston M, 2003, J TRAUMA STRESS, V16, P167, DOI 10.1023/A:1022899207206; Shanafelt T, 2006, J CLIN ONCOL, V24, P4020, DOI 10.1200/JCO.2006.05.8248; Shanafelt TD, 2005, J GEN INTERN MED, V20, P559, DOI 10.1007/s11606-005-0102-8; Shanafelt TD, 2005, ONCOLOGY-BASEL, V68, P23, DOI 10.1159/000084519; SHAPIRO S, 2008, MINDFULNESS THERAPEU; Shapiro S.L., 2005, INT J STRESS MANAGE, V12, P164, DOI [10.1037/1072-5245.12.2.164, DOI 10.1037/1072-5245.12.2.164]; Shapiro SL, 2007, TRAIN EDUC PROF PSYC, V1, P105, DOI 10.1037/1931-3918.1.2.105; Shapiro SL, 1998, J BEHAV MED, V21, P581, DOI 10.1023/A:1018700829825; SHAPIRO SL, CASS SEM JUN 27 2008; Siegal Dan, 2017, DR DAN SIEGALS HAND; Smyth JM, 1999, JAMA-J AM MED ASSOC, V281, P1304, DOI 10.1001/jama.281.14.1304; SPANN C, 2004, POET HEALER CONT POE; Spickard A, 2002, JAMA-J AM MED ASSOC, V288, P1447, DOI 10.1001/jama.288.12.1447; Stamm B.H., 2002, PSYCHOSOCIAL STRESS, P107; Stanton AL, 2002, J CLIN ONCOL, V20, P4160, DOI 10.1200/JCO.2002.08.521; Taylor C, 2005, LANCET, V366, P742, DOI 10.1016/S0140-6736(05)67178-4; TEDESCHI RG, 1995, TRAUMA TRANSFORMATIO, P43; Travado L, 2005, PSYCHO-ONCOLOGY, V14, P661, DOI 10.1002/pon.890; Vachon M., 2007, PRINCIPLES PRACTICE, V3rd, P667; VACHON MLS, 1995, PALLIATIVE MED, V9, P91, DOI 10.1177/026921639500900202; Vachon MLS, 2009, HDB PSYCHIAT PALLIAT; Vachon MLS., 1987, OCCUPATIONAL STRESS; VACHON MLS, 2008, PALLIATIVE MED, P75; VACHON MLS, PSYCHOONCOL IN PRESS; Valent P., 2002, TREATING COMPASSION, P17; Wallace BA, 2006, AM PSYCHOL, V61, P690, DOI 10.1037/0003-066X.61.7.690; West CP, 2006, JAMA-J AM MED ASSOC, V296, P1071, DOI 10.1001/jama.296.9.1071; Whippen DA, 2004, J CLIN ONCOL, V22, p532S; WHIPPEN DA, 1991, J CLIN ONCOL, V9, P1916, DOI 10.1200/JCO.1991.9.10.1916; Wright B, 2004, PALLIATIVE MED, V18, P3, DOI 10.1191/0269216304pm866ed	111	256	261	0	51	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 18	2009	301	11					1155	1164		10.1001/jama.2009.352	http://dx.doi.org/10.1001/jama.2009.352			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	419UC	19293416				2022-12-01	WOS:000264244200021
J	Patel, MR; Shen, K				Patel, Maulik R.; Shen, Kang			RSY-1 Is a Local Inhibitor of Presynaptic Assembly in C. elegans	SCIENCE			English	Article							CORNEAL EPITHELIAL-CELLS; CAENORHABDITIS-ELEGANS; PROTEIN; SYNAPSES; GENE; DIFFERENTIATION; TRANSCRIPTION; BRUCHPILOT; MECHANISMS; COMPONENTS	As fundamental units of neuronal communication, chemical synapses are composed of presynaptic and postsynaptic specializations that form at specific locations with defined shape and size. Synaptic assembly must be tightly regulated to prevent overgrowth of the synapse size and number, but the molecular mechanisms that inhibit synapse assembly are poorly understood. We identified regulator of synaptogenesis-1 (RSY-1) as an evolutionarily conserved molecule that locally antagonized presynaptic assembly. The loss of RSY-1 in Caenorhabditis elegans led to formation of extra synapses and recruitment of excessive synaptic material to presynaptic sites. RSY-1 directly interacted with and negatively regulated SYD-2/liprin-alpha, a master assembly molecule that recruits numerous synaptic components to presynaptic sites. RSY-1 also bound and regulated SYD-1, a synaptic protein required for proper functioning of SYD-2. Thus, local inhibitory mechanisms govern synapse formation.	[Patel, Maulik R.; Shen, Kang] Stanford Univ, Neurosci Program, Herrin Labs, Stanford, CA 94305 USA; [Shen, Kang] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Shen, Kang] Stanford Univ, Dept Biol, Herrin Labs, Stanford, CA 94305 USA; [Shen, Kang] Stanford Univ, Dept Pathol, Herrin Labs, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University	Shen, K (corresponding author), Stanford Univ, Neurosci Program, Herrin Labs, 385 Serra Mall,Room 144, Stanford, CA 94305 USA.	kangshen@stanford.edu			NIH [1R01NS048392, National Research Service Award predoctoral fellowship]; Human Frontier Science Foundation; Howard Hughes Medical Institute; W. M. Keck Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048392] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Foundation(Human Frontier Science Program); Howard Hughes Medical Institute(Howard Hughes Medical Institute); W. M. Keck Foundation(W.M. Keck Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank the Caenorhabditis Genetics Center and the Japanese NBPR for strains; Y. Kohara (National Institute of Genetics, Japan) for Y53H1A.1 cDNAs; J. Audhya (University of California, San Diego) for C. elegans optimized mCherry cDNA; L. Luo (Stanford University) for vertebrate mCherry cDNA; T. Meyer (Stanford University) for eYFP-C3 plasmid; M. Park (Stanford University) for mCerulean-C1 plasmid; C. Gao for technical assistance; and members of the Shen lab, C. Bargmann, T. Clandinin, and L. Luo for critical comments on the manuscript. We would also like to thank B. Grill (Stanford University) for providing protocol and guidance for coimmunoprecipitation experiments. This work was funded by grants awarded to K.S. [from NIH (1R01NS048392), the Human Frontier Science Foundation, the Howard Hughes Medical Institute, and the W. M. Keck Foundation] and by a National Research Service Award predoctoral fellowship awarded to M.R.P. by NIH.	Alpatov R, 2004, MOL CELL BIOL, V24, P10223, DOI 10.1128/MCB.24.23.10223-10235.2004; Baumeister R, 1996, GENE DEV, V10, P1395, DOI 10.1101/gad.10.11.1395; Blanchard D, 2006, MOL CELL PROTEOMICS, V5, P2175, DOI 10.1074/mcp.T600025-MCP200; Chang Q, 2000, NEURON, V26, P287, DOI 10.1016/S0896-6273(00)81161-7; Dai Y, 2006, NAT NEUROSCI, V9, P1479, DOI 10.1038/nn1808; Deken SL, 2005, J NEUROSCI, V25, P5975, DOI 10.1523/JNEUROSCI.0804-05.2005; DEKEN SL, 2005, CELL, P5975; DESAI C, 1989, GENETICS, V121, P703; Ding M, 2007, SCIENCE, V317, P947, DOI 10.1126/science.1145727; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; FULGA TA, 2008, CAENORHABDITIS, P339; Fulga TA, 2008, NEURON, V57, P339, DOI 10.1016/j.neuron.2008.01.016; HALL DH, 1991, CELL, V65, P837, DOI 10.1016/0092-8674(91)90391-B; Joo JH, 2005, MOL VIS, V11, P133; Kittel RJ, 2006, SCIENCE, V312, P1051, DOI 10.1126/science.1126308; Klassen MP, 2007, CELL, V130, P704, DOI 10.1016/j.cell.2007.06.046; Ko J, 2003, J BIOL CHEM, V278, P42377, DOI 10.1074/jbc.M307561200; KO J, E KIM; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nakata K, 2005, CELL, V120, P407, DOI 10.1016/j.cell.2004.12.017; Patel MR, 2006, NAT NEUROSCI, V9, P1488, DOI 10.1038/nn1806; Pin OY, 1999, BIOCHEM BIOPH RES CO, V263, P192, DOI 10.1006/bbrc.1999.1353; Poon VY, 2008, NATURE, V455, P669, DOI 10.1038/nature07291; Shen K, 2003, CELL, V112, P619, DOI 10.1016/S0092-8674(03)00113-2; van Roessel P, 2004, CELL, V119, P707, DOI 10.1016/j.cell.2004.11.028; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Waites CL, 2005, ANNU REV NEUROSCI, V28, P251, DOI 10.1146/annurev.neuro.27.070203.144336; Wang P, 2002, BIOCHEM BIOPH RES CO, V294, P448, DOI 10.1016/S0006-291X(02)00495-3; Zhen M, 2004, CURR OPIN NEUROBIOL, V14, P280, DOI 10.1016/j.conb.2004.05.013; Zhen M, 1999, NATURE, V401, P371, DOI 10.1038/43886; Zimowska G, 2003, INVEST OPHTH VIS SCI, V44, P4715, DOI 10.1167/iovs.03-0240	31	35	40	1	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2009	323	5920					1500	1503		10.1126/science.1169025	http://dx.doi.org/10.1126/science.1169025			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417TP	19286562	Green Accepted			2022-12-01	WOS:000264101700047
J	Buckley, B; Grant, AM				Buckley, Brian; Grant, Adrian M.			Uncertainties Page What is the most effective management of neurogenic bladder dysfunction?	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Grant, Adrian M.] Univ Aberdeen, Coll Life Sci & Med, Inst Appl Hlth Sci, Aberdeen AB25 2ZD, Scotland	University of Aberdeen		bsbuckley@iol.ie	Buckley, Brian/B-4080-2010	Buckley, Brian/0000-0002-6007-9238				Broome Barbara Ann Shelton, 2003, Health Qual Life Outcomes, V1, P35, DOI 10.1186/1477-7525-1-35; Buckley B., 2007, CONTINENCE UK, V1, P76; *CONS SPIN CORD ME, 2006, BLADD MAN AD SPIN CO; Fowler CJ, 2003, J NEUROL NEUROSUR PS, V74, P27; HERBISON GP, 2003, COCHRANE DB SYST REV; Jamison J, 2004, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD004375.PUB2, 10.1002/14651858.CD004375.pub2]; Moore KN, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006008.pub2; NABI G, 2003, COCHRANE DB SYST REV; NIELWEISE BS, 2005, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004201.PUB2; *NIH CLIN EXC ROY, 2006, UR INC MAN UR INC WO; *SOCTT INT GUID NE, 2004, MAN UR INC PRIM CAR; Stohrer M, 2003, GUIDELINES NEUROGENI; *U AB HLTH SERV RE, 2007, OUTC TRANSP INT SEGM	13	4	5	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 12	2009	338								b659	10.1136/bmj.b659	http://dx.doi.org/10.1136/bmj.b659			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	419FV	19282439				2022-12-01	WOS:000264205400004
J	Kuo, Y; Sharma, G; Freeman, JL; Goodwin, JS				Kuo, Yong-Fang; Sharma, Gulshan; Freeman, Jean L.; Goodwin, James S.			Growth in the Care of Older Patients by Hospitalists in the United States.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AMBULATORY-CARE; MEDICINE; SERVICE; PHYSICIANS; OUTCOMES; QUALITY; CANCER; ASSOCIATION; IMPACT; BREAST	Background: National and population-based information on the increase in patient care by hospitalists in the United States is lacking. Methods: Using a 5% sample of Medicare beneficiaries in 1995, 1997, 1999, and the period from 2001 through 2006, we identified 120,226 physicians in general internal medicine who were providing care to older patients in 5800 U.S. hospitals. We defined hospitalists as general internists who derived 90% or more of their Medicare claims for evaluation-and-management services from the care of hospitalized patients. We then calculated the percentage of all inpatient Medicare services provided by hospitalists and identified patient and hospital characteristics associated with the receipt of hospitalist services. Results: The percentage of physicians in general internal medicine who were identified as hospitalists increased from 5.9% in 1995 to 19.0% in 2006, and the percentage of all claims for inpatient evaluation-and-management services by general internists that were attributed to hospitalists increased from 9.1% to 37.1% during this same period. Accompanying the increase in care by hospitalists was an increase in the percentage of all hospitalized Medicare patients who were treated by general internists (both hospitalists and traditional, non-hospital-based general internists), from 46.4% in 1995 to 61.0% in 2006. In a multilevel, multivariable analysis controlling for patient and hospital characteristics, the odds of receiving care from a hospitalist increased by 29.2% per year from 1997 through 2006. In 2006, there was marked geographic variation in the rates of care provided by hospitalists, with rates of more than 70% in some hospital-referral regions. Conclusions: These analyses of data from Medicare claims showed a substantial increase in the care of hospitalized patients by hospitalist physicians from 1995 to 2006. N Engl J Med 2009;360:1102-12.	[Kuo, Yong-Fang] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA; Univ Texas Med Branch, Sealy Ctr Aging, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Kuo, Y (corresponding author), Univ Texas Med Branch, Dept Internal Med, 301 Univ Blvd, Galveston, TX 77555 USA.	yokuo@utmb.edu			Americans Independence Center [5P30AG024832]; Center for Population Health and Health Disparities [5P50CA105631]; University of Texas Medical Branch; NATIONAL CANCER INSTITUTE [P50CA105631, K05CA134923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG033134, P30AG024832] Funding Source: NIH RePORTER	Americans Independence Center; Center for Population Health and Health Disparities; University of Texas Medical Branch; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by grants from the Claude D. Pepper Older Americans Independence Center (5P30AG024832) and the Center for Population Health and Health Disparities (5P50CA105631) at the University of Texas Medical Branch.	Auerbach AD, 2002, ANN INTERN MED, V137, P859, DOI 10.7326/0003-4819-137-11-200212030-00006; Ayanian JZ, 2002, NEW ENGL J MED, V347, P1678, DOI 10.1056/NEJMsa020080; Baldwin LM, 2002, MED CARE, V40, P82; Coffman J, 2005, MED CARE RES REV, V62, P379, DOI 10.1177/1077558705277379; Freed David H, 2004, Health Care Manag (Frederick), V23, P238; Freed GL, 2007, PEDIATRICS, V120, P33, DOI 10.1542/peds.2007-0304; Glasheen JJ, 2007, ARCH INTERN MED, V167, P727, DOI 10.1001/archinte.167.7.727; Greer A L, 1988, Int J Technol Assess Health Care, V4, P5; Kearns PJ, 2001, ARCH INTERN MED, V161, P235, DOI 10.1001/archinte.161.2.235; Keating NL, 2005, J GEN INTERN MED, V20, P38, DOI 10.1111/j.1525-1497.2004.40079.x; Kralovec PD, 2006, J HOSP MED, V1, P75, DOI 10.1002/jhm.82; Lackan NA, 2004, MED CARE, V42, P116, DOI 10.1097/01.mlr.0000108765.86294.1b; Landrigan CP, 2006, PEDIATRICS, V117, P1736, DOI 10.1542/peds.2005-0609; Lindenauer PK, 2007, NEW ENGL J MED, V357, P2589, DOI 10.1056/NEJMsa067735; Lindenauer PK, 1999, ANN INTERN MED, V130, P343, DOI 10.7326/0003-4819-130-4-199902161-00003; Meltzer D, 2002, ANN INTERN MED, V137, P866, DOI 10.7326/0003-4819-137-11-200212030-00007; Palmer HC, 2001, AM J MED, V111, P627, DOI 10.1016/S0002-9343(01)00976-7; Saint S, 2000, Eff Clin Pract, V3, P35; *SHM, 2008, SOC HOSP MED REL RES; Snyder CF, 2008, J GEN INTERN MED, V23, P254, DOI 10.1007/s11606-007-0497-5; *SOC HOSP MED, 2007, HOSP MED SPEC SHOWS; The Dartmouth Atlas of Health Care, ZIP COD CROSSW FIL H; Vansaghi LM, 2008, AM J MED, V121, P349, DOI 10.1016/j.amjmed.2007.11.019; VASILEVSKIS EE, 2007, RISE HOSP CALIFORNIA; Wachter RM, 1998, JAMA-J AM MED ASSOC, V279, P1560, DOI 10.1001/jama.279.19.1560; Wachter RM, 1996, NEW ENGL J MED, V335, P514, DOI 10.1056/NEJM199608153350713; Wachter RM, 2008, MED CLIN N AM, V92, P265, DOI 10.1016/j.mcna.2007.10.008	27	180	180	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 12	2009	360	11					1102	1112		10.1056/NEJMsa0802381	http://dx.doi.org/10.1056/NEJMsa0802381			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417BW	19279342	Bronze, Green Accepted			2022-12-01	WOS:000264051000008
J	Long, YW; Hayashi, N; Saito, T; Azuma, M; Muranaka, S; Shimakawa, Y				Long, Y. W.; Hayashi, N.; Saito, T.; Azuma, M.; Muranaka, S.; Shimakawa, Y.			Temperature-induced A-B intersite charge transfer in an A-site-ordered LaCu3Fe4O12 perovskite	NATURE			English	Article							HIGH-DIELECTRIC-CONSTANT; CRYSTAL-STRUCTURE; PRESSURE; MAGNETORESISTANCE; INSULATOR; PHYSICS	Changes of valence states in transition-metal oxides often cause significant changes in their structural and physical properties(1,2). Chemical doping is the conventional way of modulating these valence states. In ABO(3) perovskite and/or perovskite-like oxides, chemical doping at the A site can introduce holes or electrons at the B site, giving rise to exotic physical properties like high-transition-temperature superconductivity and colossal magneto-resistance(3,4). When valence-variable transition metals at two different atomic sites are involved simultaneously, we expect to be able to induce charge transfer-and, hence, valence changes by using a small external stimulus rather than by introducing a doping element. Materials showing this type of charge transfer are very rare, however, and such externally induced valence changes have been observed only under extreme conditions like high pressure(5,6). Here we report unusual temperature-induced valence changes at the A and B sites in the A-site-ordered double perovskite LaCu3Fe4O12; the underlying intersite charge transfer is accompanied by considerable changes in the material's structural, magnetic and transport properties. When cooled, the compound shows a first-order, reversible transition at 393 K from LaCu32+Fe43.75+O12 with Fe3.75+ ions at the B site to LaCu33+Fe43+O12 with rare Cu3+ ions at the A site. Intersite charge transfer between the A-site Cu and B-site Fe ions leads to paramagnetism-to-antiferromagnetism and metal-to-insulator isostructural phase transitions. What is more interesting in relation to technological applications is that this above-room-temperature transition is associated with a large negative thermal expansion.	[Long, Y. W.; Saito, T.; Azuma, M.; Shimakawa, Y.] Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan; [Hayashi, N.; Muranaka, S.] Kyoto Univ, Grad Sch Human & Environm Studies, Kyoto 6068501, Japan	Kyoto University; Kyoto University	Long, YW (corresponding author), Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan.	ywlong@msk.kuicr.kyoto-u.ac.jp; shimak@scl.kyoto-u.ac.jp	Azuma, Masaki/C-2945-2009; Saito, Takashi/G-9102-2011; Shimakawa, Yuichi/L-3231-2017; Long, Youwen/B-2930-2011	Azuma, Masaki/0000-0002-8378-321X; Saito, Takashi/0000-0002-2565-8795; Shimakawa, Yuichi/0000-0003-1019-2512; Long, Youwen/0000-0002-8587-7818	Global COE Program 'International Center for Integrated Research and Advanced Education in Materials Science' [19GS0207, 18350097, 17038014, 19014010, 19340098]; Ministry of Education, Culture, Sports, Science and Technology of Japan	Global COE Program 'International Center for Integrated Research and Advanced Education in Materials Science'(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank K. Nishimura and K. Oka for help with the high-pressure synthesis and magnetic measurements, and we thank K. Jungeun for help with the SXRD experiments. Thanks are also due to M. Takano for discussions. This work was partly supported by Grants-in-Aid for Scientific Research (19GS0207, 18350097, 17038014, 19014010 and 19340098), by the Global COE Program 'International Center for Integrated Research and Advanced Education in Materials Science' and by a grant for the Joint Project of Chemical Synthesis Core Research Institutions from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Alonso JA, 2003, APPL PHYS LETT, V83, P2623, DOI 10.1063/1.1611647; Azuma M, 2007, J AM CHEM SOC, V129, P14433, DOI 10.1021/ja074880u; BLAAUW C, 1973, J PHYS C SOLID STATE, V6, P1422, DOI 10.1088/0022-3719/6/8/009; BOCQUET AE, 1992, PHYS REV B, V45, P1561, DOI 10.1103/PhysRevB.45.1561; BROWN ID, 1985, ACTA CRYSTALLOGR B, V41, P244, DOI 10.1107/S0108768185002063; Goto T, 2003, ADV PHYS, V52, P67, DOI 10.1080/0001873021000057114; Homes CC, 2001, SCIENCE, V293, P673, DOI 10.1126/science.1061655; Imada M, 1998, REV MOD PHYS, V70, P1039, DOI 10.1103/RevModPhys.70.1039; IMAI K, 1992, J PHYS SOC JPN, V61, P1819, DOI 10.1143/JPSJ.61.1819; Kawasaki S, 1996, J SOLID STATE CHEM, V121, P174, DOI 10.1006/jssc.1996.0025; Larson A.C., 1994, 86748 LAUR LOS AL NA; Lee PA, 2006, REV MOD PHYS, V78, P17, DOI 10.1103/RevModPhys.78.17; LI X, 1991, HYPERFINE INTERACT, V69, P851, DOI 10.1007/BF02401960; Prodi A, 2004, NAT MATER, V3, P48, DOI 10.1038/nmat1038; RIESEMEIER H, 1994, J PHYS CHEM SOLIDS, V55, P613, DOI 10.1016/0022-3697(94)90060-4; Salamon MB, 2001, REV MOD PHYS, V73, P583, DOI 10.1103/RevModPhys.73.583; Sanchez-Benitez J, 2003, CHEM MATER, V15, P2193, DOI 10.1021/cm0212616; Seda T, 2004, J PHYS-CONDENS MAT, V16, P2707, DOI 10.1088/0953-8984/16/15/021; Shimakawa Y, 2008, INORG CHEM, V47, P8562, DOI 10.1021/ic800696u; Sleight AW, 1998, ANNU REV MATER SCI, V28, P29, DOI 10.1146/annurev.matsci.28.1.29; Subramanian MA, 2000, J SOLID STATE CHEM, V151, P323, DOI 10.1006/jssc.2000.8703; TAKANO M, 1977, MATER RES BULL, V12, P923, DOI 10.1016/0025-5408(77)90104-0; TAKANO M, 1981, J SOLID STATE CHEM, V39, P75, DOI 10.1016/0022-4596(81)90304-2; Takata K, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.024429; Takenaka K, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2147726; Takenaka K, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2831715; Yamada I, 2008, ANGEW CHEM INT EDIT, V47, P7032, DOI 10.1002/anie.200801482; Zeng Z, 1999, PHYS REV LETT, V82, P3164, DOI 10.1103/PhysRevLett.82.3164	28	291	296	19	376	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 5	2009	458	7234					60	U3		10.1038/nature07816	http://dx.doi.org/10.1038/nature07816			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414AJ	19262669				2022-12-01	WOS:000263836000032
J	Cech, TR				Cech, Thomas R.			Crawling Out of the RNA World	CELL			English	Article							SIGNAL RECOGNITION PARTICLE; GROUP-II INTRON; RIBOSOMAL-SUBUNIT; TELOMERASE RNA; PROTEINS; EVOLUTION; CATALYSIS; RIBONUCLEOPROTEIN; RIBOZYME; ENZYME	Comparison of phylogenetically diverse ribonucleoprotein (RNP) enzymes and information about their biochemistry have stimulated hypotheses about their evolution. Instead of the canonical view, in which catalysis proceeds from ribozyme to RNP enzyme to protein enzyme, RNP enzymes and proteins are seen to share contemporary catalysis. Furthermore, the RNA components of RNP enzymes show no evidence of fading out but instead, in some cases, have elaborated new functions.	Univ Colorado, Dept Chem & Biochem, Howard Hughes Med Inst, Boulder, CO 80309 USA	Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder	Cech, TR (corresponding author), Univ Colorado, Dept Chem & Biochem, Howard Hughes Med Inst, Campus Box 215, Boulder, CO 80309 USA.	thomas.cech@colorado.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Atsumi S, 2001, EMBO J, V20, P5453, DOI 10.1093/emboj/20.19.5453; Brodersen DE, 2002, J MOL BIOL, V316, P725, DOI 10.1006/jmbi.2001.5359; Cleaves HJ, 2008, ORIGINS LIFE EVOL B, V38, P105, DOI 10.1007/s11084-007-9120-3; Evans D, 2006, TRENDS BIOCHEM SCI, V31, P333, DOI 10.1016/j.tibs.2006.04.007; Helm M, 2005, J AM CHEM SOC, V127, P10492, DOI 10.1021/ja052886i; HERSCHLAG D, 1990, BIOCHEMISTRY-US, V29, P10159, DOI 10.1021/bi00496a003; Holzmann J, 2008, CELL, V135, P462, DOI 10.1016/j.cell.2008.09.013; KASHIWAGI N, 2007, NUCL ACIDS S SER, V51, P387; Klein DJ, 2004, J MOL BIOL, V340, P141, DOI 10.1016/j.jmb.2004.03.076; Miller MC, 2002, P NATL ACAD SCI USA, V99, P6585, DOI 10.1073/pnas.102024699; Noller HF, 2006, COLD SPRING HARB MON, V43, P287; Noller HF, 2004, RNA, V10, P1833, DOI 10.1261/rna.7142404; Paukstelis PJ, 2008, NATURE, V451, P94, DOI 10.1038/nature06413; Poole AM, 1998, J MOL EVOL, V46, P1, DOI 10.1007/PL00006275; PORITZ MA, 1990, SCIENCE, V250, P1111, DOI 10.1126/science.1701272; Qiao F, 2008, NAT STRUCT MOL BIOL, V15, P634, DOI 10.1038/nsmb.1420; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Schuenemann D, 1998, P NATL ACAD SCI USA, V95, P10312, DOI 10.1073/pnas.95.17.10312; Toor N, 2001, RNA, V7, P1142, DOI 10.1017/S1355838201010251; Toor N, 2008, NAT STRUCT MOL BIOL, V15, P1221, DOI 10.1038/nsmb.1509; Villa T, 2002, CELL, V109, P149, DOI 10.1016/S0092-8674(02)00726-2; Walker SC, 2006, CRIT REV BIOCHEM MOL, V41, P77, DOI 10.1080/10409230600602634; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; Zappulla DC, 2004, P NATL ACAD SCI USA, V101, P10024, DOI 10.1073/pnas.0403641101	24	77	79	1	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 20	2009	136	4					599	602		10.1016/j.cell.2009.02.002	http://dx.doi.org/10.1016/j.cell.2009.02.002			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	411XX	19239881	Green Published, Bronze			2022-12-01	WOS:000263688200011
J	Cullen, BR				Cullen, Bryan R.			Viral RNAs: Lessons from the Enemy	CELL			English	Article							MESSENGER-RNA; NUCLEAR EXPORT; GENE-EXPRESSION; VIRUS GENOME; ENTRY SITE; HIV-1; TRANSLATION; INITIATION; MICRORNAS; CYTOPLASM	Viruses are adept at evolving or co-opting genomic elements that allow them to maximize their replication potential in the infected host. This evolutionary plasticity makes viruses an invaluable system to identify new mechanisms used not only by viruses but also by vertebrate cells to modulate gene expression. Here, I discuss the identification and characterization of viral mRNA structures and noncoding RNAs that have led to important insights into the molecular mechanisms of eukaryotic cells.	Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Ctr Virol, Durham, NC 27710 USA	Duke University	Cullen, BR (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Ctr Virol, Durham, NC 27710 USA.	bryan.cullen@duke.edu						Atanasiu D, 2007, J VIROL, V81, P7695, DOI 10.1128/JVI.00282-07; Barboric M, 2005, PLOS BIOL, V3, P200, DOI 10.1371/journal.pbio.0030076; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BERGET SM, 1977, P NATL ACAD SCI USA, V74, P3171, DOI 10.1073/pnas.74.8.3171; BRAY M, 1994, P NATL ACAD SCI USA, V91, P1256, DOI 10.1073/pnas.91.4.1256; Brierley I, 2006, VIRUS RES, V119, P29, DOI 10.1016/j.virusres.2005.10.008; Bushell M, 2006, MOL CELL, V23, P401, DOI 10.1016/j.molcel.2006.06.012; CHOW LT, 1977, CELL, V12, P1, DOI 10.1016/0092-8674(77)90180-5; Conrad NK, 2006, MOL CELL, V24, P943, DOI 10.1016/j.molcel.2006.10.029; Cullen BR, 2003, TRENDS BIOCHEM SCI, V28, P419, DOI 10.1016/S0968-0004(03)00142-7; Cullen BR, 2006, NAT IMMUNOL, V7, P563, DOI 10.1038/ni1352; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; FISCHER U, 1995, CELL, V82, P475, DOI 10.1016/0092-8674(95)90436-0; FISHER AG, 1986, NATURE, V320, P367, DOI 10.1038/320367a0; FURUICHI Y, 1975, P NATL ACAD SCI USA, V72, P362, DOI 10.1073/pnas.72.1.362; Gottwein E, 2008, CELL HOST MICROBE, V3, P375, DOI 10.1016/j.chom.2008.05.002; Gruter P, 1998, MOL CELL, V1, P649, DOI 10.1016/S1097-2765(00)80065-9; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; JACKS T, 1988, NATURE, V331, P280, DOI 10.1038/331280a0; Jan E, 2003, P NATL ACAD SCI USA, V100, P15410, DOI 10.1073/pnas.2535183100; JANG SK, 1988, J VIROL, V62, P2636, DOI 10.1128/JVI.62.8.2636-2643.1988; KAO SY, 1987, NATURE, V330, P489, DOI 10.1038/330489a0; KATES J, 1970, COLD SPRING HARB SYM, V35, P743, DOI 10.1101/SQB.1970.035.01.090; Kohler A, 2007, NAT REV MOL CELL BIO, V8, P761, DOI 10.1038/nrm2255; Komar AA, 2005, J BIOL CHEM, V280, P23425, DOI 10.1074/jbc.R400041200; LeBlanc JJ, 2007, VIROLOGY, V363, P376, DOI 10.1016/j.virol.2007.01.026; LEGRAIN P, 1989, CELL, V57, P573, DOI 10.1016/0092-8674(89)90127-X; MALIM MH, 1989, NATURE, V338, P254, DOI 10.1038/338254a0; Martinez-Salas E, 2008, J GEN VIROL, V89, P611, DOI 10.1099/vir.0.83426-0; MATHEWS MB, 1991, J VIROL, V65, P5657, DOI 10.1128/JVI.65.11.5657-5662.1991; PELLETIER J, 1988, NATURE, V334, P320, DOI 10.1038/334320a0; Pestova TV, 2003, GENE DEV, V17, P181, DOI 10.1101/gad.1040803; Reeves MB, 2007, SCIENCE, V316, P1345, DOI 10.1126/science.1142984; Shigemoto K, 2001, NUCLEIC ACIDS RES, V29, P4079, DOI 10.1093/nar/29.19.4079; Sullivan Christopher S., 2009, P645, DOI 10.1007/978-0-387-68945-6_25; TSUCHIHASHI Z, 1990, P NATL ACAD SCI USA, V87, P2516, DOI 10.1073/pnas.87.7.2516; Umbach JL, 2008, NATURE, V454, P780, DOI 10.1038/nature07103; WEI CM, 1975, P NATL ACAD SCI USA, V72, P318, DOI 10.1073/pnas.72.1.318; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3	39	31	31	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 20	2009	136	4					592	597		10.1016/j.cell.2009.01.048	http://dx.doi.org/10.1016/j.cell.2009.01.048			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	411XX	19239880	Bronze, Green Published			2022-12-01	WOS:000263688200010
J	Nikolaev, A; McLaughlin, T; O'Leary, DDM; Tessier-Lavigne, M				Nikolaev, Anatoly; McLaughlin, Todd; O'Leary, Dennis D. M.; Tessier-Lavigne, Marc			APP binds DR6 to trigger axon pruning and neuron death via distinct caspases	NATURE			English	Article							AMYLOID PRECURSOR PROTEIN; PROGRAMMED CELL-DEATH; BAX-DEFICIENT MICE; ALZHEIMERS-DISEASE; NERVOUS-SYSTEM; COMMISSURAL AXONS; GENE-EXPRESSION; FAMILY-MEMBERS; TNF RECEPTOR; DEGENERATION	Naturally occurring axonal pruning and neuronal cell death help to sculpt neuronal connections during development, but their mechanistic basis remains poorly understood. Here we report that beta-amyloid precursor protein ( APP) and death receptor 6 ( DR6, also known as TNFRSF21) activate a widespread caspase- dependent self- destruction program. DR6 is broadly expressed by developing neurons, and is required for normal cell body death and axonal pruning both in vivo and after trophic- factor deprivation in vitro. Unlike neuronal cell body apoptosis, which requires caspase 3, we show that axonal degeneration requires caspase 6, which is activated in a punctate pattern that parallels the pattern of axonal fragmentation. DR6 is activated locally by an inactive surface ligand( s) that is released in an active form after trophic- factor deprivation, and we identify APP as a DR6 ligand. Trophic- factor deprivation triggers the shedding of surface APP in a beta-secretase ( BACE)- dependent manner. Loss- and gain- of- function studies support a model in which a cleaved amino- terminal fragment of APP ( N- APP) binds DR6 and triggers degeneration. Genetic support is provided by a common neuromuscular junction phenotype in mutant mice. Our results indicate that APP and DR6 are components of a neuronal self- destruction pathway, and suggest that an extracellular fragment of APP, acting via DR6 and caspase 6, contributes to Alzheimer's disease.	[Nikolaev, Anatoly; Tessier-Lavigne, Marc] Genentech Inc, Div Res, San Francisco, CA 94080 USA; [McLaughlin, Todd; O'Leary, Dennis D. M.] Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA	Roche Holding; Genentech; Salk Institute	Tessier-Lavigne, M (corresponding author), Genentech Inc, Div Res, 1 DNA Way, San Francisco, CA 94080 USA.	marctl@gene.com		Nikolaev, Anatoly/0000-0003-2818-5839	Genentech; National Eye Institute [R01 EY07025]; NATIONAL EYE INSTITUTE [R01EY007025] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025970] Funding Source: NIH RePORTER	Genentech(Roche HoldingGenentech); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank R. Axel, C. Bargmann, B. de Strooper, V. Dixit, C. Henderson, J. Lewcock, R. Scheller, R. Vassar, R. Watts, and members of the M. T.- L. laboratory for helpful discussions and suggestions, and critical reading of the manuscript, and A. Bruce for making the diagrams. We thank P. Hass and members of his laboratory (Genentech) for generation and purification of the DR6 ectodomain and APP(1-286), and W.-C. Liang and Y. Wu (Genentech) for binding experiments with purified proteins. Supported by Genentech (A.N. and M.T.-L.) and National Eye Institute grant R01 EY07025 (D.D.M.O.'L.).	Albrecht S, 2007, AM J PATHOL, V170, P1200, DOI 10.2353/ajpath.2007.060974; Atwal JK, 2008, SCIENCE, V322, P967, DOI 10.1126/science.1161151; Bertram L, 2004, HUM MOL GENET, V13, pR135, DOI 10.1093/hmg/ddh077; Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; Bossen C, 2006, J BIOL CHEM, V281, P13964, DOI 10.1074/jbc.M601553200; Buss RR, 2006, ANNU REV NEUROSCI, V29, P1, DOI 10.1146/annurev.neuro.29.051605.112800; CAMPENOT RB, 1991, J NEUROSCI, V11, P1126; Chen Z, 2008, NEURON, V58, P325, DOI 10.1016/j.neuron.2008.02.016; Chiang LW, 2001, P NATL ACAD SCI USA, V98, P2814, DOI 10.1073/pnas.051630598; Cole SL, 2008, CURR ALZHEIMER RES, V5, P100, DOI 10.2174/156720508783954758; Deppmann CD, 2008, SCIENCE, V320, P369, DOI 10.1126/science.1152677; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Edwards PD, 2007, J MED CHEM, V50, P5912, DOI 10.1021/jm070829p; Finn JT, 2000, J NEUROSCI, V20, P1333; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Guo HS, 2004, AM J PATHOL, V165, P523, DOI 10.1016/S0002-9440(10)63317-2; Haase G, 2008, CURR OPIN NEUROBIOL, V18, P284, DOI 10.1016/j.conb.2008.07.013; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Han P, 2005, J NEUROSCI, V25, P11542, DOI 10.1523/JNEUROSCI.3831-05.2005; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Heber S, 2000, J NEUROSCI, V20, P7951; Higuchi H, 2003, BIOCHEM BIOPH RES CO, V301, P804, DOI 10.1016/S0006-291X(03)00029-9; HILBICH C, 1993, J BIOL CHEM, V268, P26571; Horowitz PM, 2004, J NEUROSCI, V24, P7895, DOI 10.1523/JNEUROSCI.1988-04.2004; Klaiman G, 2008, MOL CELL PROTEOMICS, V7, P1541, DOI 10.1074/mcp.M800007-MCP200; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Kuo CT, 2006, NEURON, V51, P283, DOI 10.1016/j.neuron.2006.07.014; LeBlanc A, 1999, J BIOL CHEM, V274, P23426, DOI 10.1074/jbc.274.33.23426; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; Matrone C, 2008, P NATL ACAD SCI USA, V105, P13139, DOI 10.1073/pnas.0806133105; Matrone C, 2008, J ALZHEIMERS DIS, V13, P81; McLaughlin T, 2003, NEURON, V40, P1147, DOI 10.1016/S0896-6273(03)00790-6; Medana IM, 2003, BRAIN, V126, P515, DOI 10.1093/brain/awg061; Muller T, 2008, PROG NEUROBIOL, V85, P393, DOI 10.1016/j.pneurobio.2008.05.002; Okada A, 2006, NATURE, V444, P369, DOI 10.1038/nature05246; PALMERT MR, 1988, BIOCHEM BIOPH RES CO, V156, P432, DOI 10.1016/S0006-291X(88)80859-3; Pan GH, 1998, FEBS LETT, V431, P351, DOI 10.1016/S0014-5793(98)00791-1; Perez RG, 1997, J NEUROSCI, V17, P9407; PETTMANN B, 1988, J NEUROSCI, V8, P3624; Plachta N, 2007, NAT NEUROSCI, V10, P712, DOI 10.1038/nn1897; Raff MC, 2002, SCIENCE, V296, P868, DOI 10.1126/science.1068613; Reinhard C, 2005, EMBO J, V24, P3996, DOI 10.1038/sj.emboj.7600860; Sabatier C, 2004, CELL, V117, P157, DOI 10.1016/S0092-8674(04)00303-4; SAGOT Y, 1995, J NEUROSCI, V15, P7727; Saxena S, 2007, PROG NEUROBIOL, V83, P174, DOI 10.1016/j.pneurobio.2007.07.007; Schmidt CS, 2003, J EXP MED, V197, P51, DOI 10.1084/jem.20020617; Singh KK, 2008, NAT NEUROSCI, V11, P649, DOI 10.1038/nn.2114; SLUNT HH, 1994, J BIOL CHEM, V269, P2637; VANGOOL D, 1995, DEMENTIA, V6, P63, DOI 10.1159/000106923; Walsh DM, 2007, BIOCHEM SOC T, V35, P416, DOI 10.1042/BST0350416; Wang H, 1999, NATURE, V401, P765, DOI 10.1038/44521; Wang P, 2005, J NEUROSCI, V25, P1219, DOI 10.1523/JNEUROSCI.4660-04.2005; Watts RJ, 2003, NEURON, V38, P871, DOI 10.1016/S0896-6273(03)00295-2; White FA, 1998, J NEUROSCI, V18, P1428; Williams DW, 2006, NAT NEUROSCI, V9, P1234, DOI 10.1038/nn1774; Young-Pearse TL, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-15; Zhao HR, 2001, J EXP MED, V194, P1441, DOI 10.1084/jem.194.10.1441	59	794	842	0	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2009	457	7232					981	U1		10.1038/nature07767	http://dx.doi.org/10.1038/nature07767			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HF	19225519	Green Accepted			2022-12-01	WOS:000263425400036
J	Hafed, ZM; Goffart, L; Krauzlis, RJ				Hafed, Ziad M.; Goffart, Laurent; Krauzlis, Richard J.			A Neural Mechanism for Microsaccade Generation in the Primate Superior Colliculus	SCIENCE			English	Article							SACCADIC EYE-MOVEMENTS; COVERT ATTENTION; TARGET SELECTION; VISUAL-CORTEX; NEURONS; INACTIVATION; FIXATION; TRACKING; STRIATE; PURSUIT	During fixation, the eyes are not still but often exhibit microsaccadic movements. The function of microsaccades is controversial, largely because the neural mechanisms responsible for their generation are unknown. Here, we show that the superior colliculus ( SC), a retinotopically organized structure involved in voluntary- saccade target selection, plays a causal role in microsaccade generation. Neurons in the foveal portion of the SC increase their activity before and during microsaccades with sizes of only a few minutes of arc and exhibit selectivity for the direction and amplitude of these movements. Reversible inactivation of these neurons significantly reduces microsaccade rate without otherwise compromising fixation. These results, coupled with computational modeling of SC activity, demonstrate that microsaccades are controlled by the SC and explain the link between microsaccades and visual attention.	[Hafed, Ziad M.; Krauzlis, Richard J.] Salk Inst Biol Studies, Syst Neurobiol Lab, La Jolla, CA 92037 USA; [Goffart, Laurent] Univ Aix Marseille 1, CNRS, Inst Neurosci Cognit Mediterranee, UMR 6193, F-13402 Marseille, France	Salk Institute; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Hafed, ZM (corresponding author), Salk Inst Biol Studies, Syst Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	zhafed@salk.edu	Goffart, Laurent/AEX-7821-2022	Goffart, Laurent/0000-0001-8767-1867; Richard, Krauzlis/0000-0002-1826-0447	NIH [EY12212]; Agence Nationale de la Recherche; RETINAE; NATIONAL EYE INSTITUTE [R01EY012212] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agence Nationale de la Recherche(French National Research Agency (ANR)); RETINAE; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding provided by NIH grant EY12212 and Agence Nationale de la Recherche grant RETINAE. We thank K. Nielsen and V. Ciaramitaro for helpful comments.	Bair W, 1998, VISUAL NEUROSCI, V15, P779, DOI 10.1017/S0952523898154160; BARLOW HB, 1952, J PHYSIOL-LONDON, V116, P290, DOI 10.1113/jphysiol.1952.sp004706; BRIDGEMAN B, 1980, VISION RES, V20, P813, DOI 10.1016/0042-6989(80)90013-9; Carello CD, 2004, NEURON, V43, P575, DOI 10.1016/j.neuron.2004.07.026; CORNSWEET TN, 1956, J OPT SOC AM, V46, P987, DOI 10.1364/JOSA.46.000987; Engbert R, 2003, VISION RES, V43, P1035, DOI 10.1016/S0042-6989(03)00084-1; Hafed ZM, 2008, J NEUROSCI, V28, P9426, DOI 10.1523/JNEUROSCI.1313-08.2008; Hafed ZM, 2008, J NEUROSCI, V28, P8124, DOI 10.1523/JNEUROSCI.1317-08.2008; Hafed ZM, 2002, VISION RES, V42, P2533, DOI 10.1016/S0042-6989(02)00263-8; Ignashchenkova A, 2004, NAT NEUROSCI, V7, P56, DOI 10.1038/nn1169; KINGSTONE A, 1995, PERCEPT PSYCHOPHYS, V57, P796, DOI 10.3758/BF03206795; KOWLER E, 1980, VISION RES, V20, P273, DOI 10.1016/0042-6989(80)90113-3; Krauzlis RJ, 2003, J NEUROSCI, V23, P4333; Krauzlis RJ, 2000, J NEUROPHYSIOL, V84, P876, DOI 10.1152/jn.2000.84.2.876; Leopold DA, 1998, EXP BRAIN RES, V123, P341, DOI 10.1007/s002210050577; Martinez-Conde S, 2006, NEURON, V49, P297, DOI 10.1016/j.neuron.2005.11.033; Martinez-Conde S, 2004, NAT REV NEUROSCI, V5, P229, DOI 10.1038/nrn1348; Martinez-Conde S, 2000, NAT NEUROSCI, V3, P251, DOI 10.1038/72961; McPeek RM, 2004, NAT NEUROSCI, V7, P757, DOI 10.1038/nn1269; MUNOZ DP, 1995, J NEUROPHYSIOL, V73, P2313, DOI 10.1152/jn.1995.73.6.2313; RATLIFF F, 1950, J EXP PSYCHOL, V40, P687, DOI 10.1037/h0057754; Snodderly DM, 2001, VISUAL NEUROSCI, V18, P259, DOI 10.1017/S0952523801182118; STEINMAN RM, 1967, SCIENCE, V155, P1577, DOI 10.1126/science.155.3769.1577; STEINMAN RM, 1973, SCIENCE, V181, P810, DOI 10.1126/science.181.4102.810; VANGISBERGEN JAM, 1981, J NEUROPHYSIOL, V45, P417, DOI 10.1152/jn.1981.45.3.417; WINTERSON BJ, 1976, VISION RES, V16, P1387, DOI 10.1016/0042-6989(76)90156-5; ZUBER BL, 1965, SCIENCE, V150, P1459, DOI 10.1126/science.150.3702.1459	27	278	281	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 13	2009	323	5916					940	943		10.1126/science.1166112	http://dx.doi.org/10.1126/science.1166112			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406KW	19213919	Green Accepted			2022-12-01	WOS:000263295400044
J	Yu, JY; Hu, KJ; Smuga-Otto, K; Tian, SL; Stewart, R; Slukvin, II; Thomson, JA				Yu, Junying; Hu, Kejin; Smuga-Otto, Kim; Tian, Shulan; Stewart, Ron; Slukvin, Igor I.; Thomson, James A.			Human Induced Pluripotent Stem Cells Free of Vector and Transgene Sequences	SCIENCE			English	Article							EPSTEIN-BARR-VIRUS; STABLE REPLICATION; INDUCTION; FIBROBLASTS; GENERATION; PLASMIDS; REPLICON	Reprogramming differentiated human cells to induced pluripotent stem (iPS) cells has applications in basic biology, drug development, and transplantation. Human iPS cell derivation previously required vectors that integrate into the genome, which can create mutations and limit the utility of the cells in both research and clinical applications. We describe the derivation of human iPS cells with the use of nonintegrating episomal vectors. After removal of the episome, iPS cells completely free of vector and transgene sequences are derived that are similar to human embryonic stem (ES) cells in proliferative and developmental potential. These results demonstrate that reprogramming human somatic cells does not require genomic integration or the continued presence of exogenous reprogramming factors and removes one obstacle to the clinical application of human iPS cells.	[Yu, Junying; Smuga-Otto, Kim; Tian, Shulan; Stewart, Ron; Thomson, James A.] Morgridge Inst Res, Madison, WI 53707 USA; [Yu, Junying; Smuga-Otto, Kim; Tian, Shulan; Stewart, Ron; Thomson, James A.] Genome Ctr Wisconsin, Madison, WI 53706 USA; [Yu, Junying; Hu, Kejin; Smuga-Otto, Kim; Slukvin, Igor I.; Thomson, James A.] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53715 USA; [Slukvin, Igor I.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA; [Thomson, James A.] Univ Wisconsin, Dept Anat, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; The Morgridge Institute for Research, Inc.; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Yu, JY (corresponding author), Morgridge Inst Res, Madison, WI 53707 USA.	jyyu2008@gmail.com; thomson@primate.wisc.edu	Hu, Kejin/AAQ-8862-2021; wang, baocheng/B-7805-2008	Hu, Kejin/0000-0003-3111-4054; wang, baocheng/0000-0002-8236-8014	Charlotte Geyer Foundation; NIH [P51 RR000167, P01 GM081629]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000167] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM081629] Funding Source: NIH RePORTER	Charlotte Geyer Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by the Charlotte Geyer Foundation and NIH (grants P51 RR000167 and P01 GM081629). We thank A. Griep, P. Powers, B. Sugden, M. Probasco, A. Elwell, C. Glennon, V. Ruotti, and D. J. Faupel for assistance and advice. The authors declare competing financial interests: J.A.T. is a founder, stock owner, consultant, and board member of Cellular Dynamics International (CDI). He also serves as a scientific adviser to and has financial interests in Tactics II Stem Cell Ventures. I.I.S. is a founder, stock owner, and consultant for CDI. The authors are filing a patent based on the results reported in this paper. Combination 6 and 19 episomal vectors are deposited in Addgene (Cambridge, MA), and vector-free human iPS cell subclones are deposited in the WiCell International Stem Cell (WISC) Bank (Madison, WI). Microarray data are deposited in the Gene Expression Omnibus (GEO) database (accession number GSE15148 [NCBI GEO] ).	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Leight ER, 2001, MOL CELL BIOL, V21, P4149, DOI 10.1128/MCB.21.13.4149-4161.2001; Liao J, 2008, CELL RES, V18, P600, DOI 10.1038/cr.2008.51; Nanbo A, 2007, EMBO J, V26, P4252, DOI 10.1038/sj.emboj.7601853; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; YATES J, 1984, P NATL ACAD SCI-BIOL, V81, P3806, DOI 10.1073/pnas.81.12.3806; YATES JL, 1985, NATURE, V313, P812, DOI 10.1038/313812a0; YATES JL, 1991, J VIROL, V65, P483, DOI 10.1128/JVI.65.1.483-488.1991; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	22	1611	1882	5	325	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	2009	324	5928					797	801		10.1126/science.1172482	http://dx.doi.org/10.1126/science.1172482			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442HN	19325077	Green Accepted			2022-12-01	WOS:000265832400050
J	Harmon, LJ; Matthews, B; Des Roches, S; Chase, JM; Shurin, JB; Schluter, D				Harmon, Luke J.; Matthews, Blake; Des Roches, Simone; Chase, Jonathan M.; Shurin, Jonathan B.; Schluter, Dolph			Evolutionary diversification in stickleback affects ecosystem functioning	NATURE			English	Article							DISSOLVED ORGANIC-MATTER; RAPID EVOLUTION; SYMPATRIC STICKLEBACKS; BIODIVERSITY; PREY; SPECIATION; PREDATORS; DIVERSITY; SELECTION; DYNAMICS	Explaining the ecological causes of evolutionary diversification is a major focus of biology, but surprisingly little has been said about the effects of evolutionary diversification on ecosystems(1-3). The number of species in an ecosystem and their traits are key predictors of many ecosystem-level processes, such as rates of productivity, biomass sequestration and decomposition(4,5). Here we demonstrate short-term ecosystem-level effects of adaptive radiation in the threespine stickleback (Gasterosteus aculeatus) over the past 10,000 years. These fish have undergone recent parallel diversification in several lakes in coastal British Columbia, resulting in the formation of two specialized species (benthic and limnetic) from a generalist ancestor(6). Using a mesocosm experiment, we demonstrate that this diversification has strong effects on ecosystems, affecting prey community structure, total primary production, and the nature of dissolved organic materials that regulate the spectral properties of light transmission in the system. However, these ecosystem effects do not simply increase in their relative strength with increasing specialization and species richness; instead, they reflect the complex and indirect consequences of ecosystem engineering by sticklebacks. It is well known that ecological factors influence adaptive radiation(7,8). We demonstrate that adaptive radiation, even over short timescales, can have profound effects on ecosystems.	[Harmon, Luke J.; Des Roches, Simone] Univ Idaho, Dept Biol Sci, Moscow, ID 83844 USA; [Harmon, Luke J.; Matthews, Blake; Shurin, Jonathan B.; Schluter, Dolph] Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V6T 1Z4, Canada; [Harmon, Luke J.; Matthews, Blake; Shurin, Jonathan B.; Schluter, Dolph] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; [Matthews, Blake] EAWAG, CH-6047 Kastanienbaum, Switzerland; [Chase, Jonathan M.] Washington Univ, Dept Biol, St Louis, MO 63130 USA	Idaho; University of Idaho; University of British Columbia; University of British Columbia; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Washington University (WUSTL)	Harmon, LJ (corresponding author), Univ Idaho, Dept Biol Sci, Moscow, ID 83844 USA.	lukeh@uidaho.edu	Matthews, Blake/B-5608-2009; Des Roches, Simone/A-4814-2011; Harmon, Luke/A-8225-2012; B, A/AHB-5155-2022	Matthews, Blake/0000-0001-9089-704X; Harmon, Luke/0000-0002-4985-5750; Des Roches, Simone/0000-0002-5360-8197; Shurin, Jonathan/0000-0001-7870-1972; Schluter, Dolph/0000-0003-1683-7836				Abrams PA, 2000, ANNU REV ECOL SYST, V31, P79, DOI 10.1146/annurev.ecolsys.31.1.79; Bell T, 2003, OECOLOGIA, V134, P578, DOI 10.1007/s00442-002-1135-x; Boughman JW, 2001, NATURE, V411, P944, DOI 10.1038/35082064; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Erwin DH, 2008, TRENDS ECOL EVOL, V23, P304, DOI 10.1016/j.tree.2008.01.013; Fussmann GF, 2007, FUNCT ECOL, V21, P465, DOI 10.1111/j.1365-2435.2007.01275.x; Ghan D, 1998, CAN J FISH AQUAT SCI, V55, P1350, DOI 10.1139/cjfas-55-6-1350; Goudard A, 2008, AM NAT, V171, P91, DOI 10.1086/523945; Grant, 2008, WHY SPECIES MULTIPLY; Jones CG, 1997, ECOLOGY, V78, P1946, DOI 10.1890/0012-9658(1997)078[1946:PANEOO]2.0.CO;2; Lennon JT, 2008, ECOL LETT, V11, P1178, DOI 10.1111/j.1461-0248.2008.01225.x; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; LOSOS JB, 2009, PORTRAIT ADAPTIVE RA; MAZUMDER A, 1990, SCIENCE, V247, P312, DOI 10.1126/science.247.4940.312; McKnight DM, 2001, LIMNOL OCEANOGR, V46, P38, DOI 10.4319/lo.2001.46.1.0038; MCPHAIL JD, 1993, CAN J ZOOL, V71, P515, DOI 10.1139/z93-072; Obernosterer I, 2004, LIMNOL OCEANOGR, V49, P117, DOI 10.4319/lo.2004.49.1.0117; Palkovacs EP, 2009, ECOLOGY, V90, P300, DOI 10.1890/08-1673.1; Pienitz R, 2000, NATURE, V404, P484, DOI 10.1038/35006616; Retamal L, 2007, ESTUAR COAST SHELF S, V72, P261, DOI 10.1016/j.ecss.2006.10.022; Rundle HD, 2000, SCIENCE, V287, P306, DOI 10.1126/science.287.5451.306; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Schmitz OJ, 2008, SCIENCE, V319, P952, DOI 10.1126/science.1152355; Schmitz OJ, 2006, ECOLOGY, V87, P1432, DOI 10.1890/0012-9658(2006)87[1432:PHLEOE]2.0.CO;2; Seehausen O, 2008, NATURE, V455, P620, DOI 10.1038/nature07285; Snyder WE, 2006, ECOL LETT, V9, P789, DOI 10.1111/j.1461-0248.2006.00922.x; Stibor H, 2004, ECOL LETT, V7, P321, DOI 10.1111/j.1461-0248.2004.00580.x; Thompson JN, 1998, TRENDS ECOL EVOL, V13, P329, DOI 10.1016/S0169-5347(98)01378-0; Williamson CE, 1999, LIMNOL OCEANOGR, V44, P795, DOI 10.4319/lo.1999.44.3_part_2.0795; Yoshida T, 2003, NATURE, V424, P303, DOI 10.1038/nature01767	30	263	265	4	209	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2009	458	7242					1167	1170		10.1038/nature07974	http://dx.doi.org/10.1038/nature07974			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441FL	19339968				2022-12-01	WOS:000265754600047
J	Hothorn, M; Neumann, H; Lenherr, ED; Wehner, M; Rybin, V; Hassa, PO; Uttenweiler, A; Reinhardt, M; Schmidt, A; Seiler, J; Ladurner, AG; Herrmann, C; Scheffzek, K; Mayer, A				Hothorn, Michael; Neumann, Heinz; Lenherr, Esther D.; Wehner, Mark; Rybin, Vladimir; Hassa, Paul O.; Uttenweiler, Andreas; Reinhardt, Monique; Schmidt, Andrea; Seiler, Jeanette; Ladurner, Andreas G.; Herrmann, Christian; Scheffzek, Klaus; Mayer, Andreas			Catalytic Core of a Membrane-Associated Eukaryotic Polyphosphate Polymerase	SCIENCE			English	Article							INORGANIC POLYPHOSPHATE; MYCORRHIZAL SYMBIOSIS; VTC PROTEINS; V-ATPASE; POLY-P; YEAST; METABOLISM; PHOSPHATE; TRIPHOSPHATASE; INSIGHTS	Polyphosphate (polyP) occurs ubiquitously in cells, but its functions are poorly understood and its synthesis has only been characterized in bacteria. Using x-ray crystallography, we identified a eukaryotic polyphosphate polymerase within the membrane-integral vacuolar transporter chaperone (VTC) complex. A 2.6 angstrom crystal structure of the catalytic domain grown in the presence of adenosine triphosphate (ATP) reveals polyP winding through a tunnel-shaped pocket. Nucleotide-and phosphate-bound structures suggest that the enzyme functions by metal-assisted cleavage of the ATP gamma-phosphate, which is then in-line transferred to an acceptor phosphate to form polyP chains. Mutational analysis of the transmembrane domain indicates that VTC may integrate cytoplasmic polymer synthesis with polyP membrane translocation. Identification of the polyP-synthesizing enzyme opens the way to determine the functions of polyP in lower eukaryotes.	[Hothorn, Michael; Lenherr, Esther D.; Rybin, Vladimir; Hassa, Paul O.; Seiler, Jeanette; Ladurner, Andreas G.; Scheffzek, Klaus] European Mol Biol Lab, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany; [Hothorn, Michael] Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; [Neumann, Heinz; Uttenweiler, Andreas; Reinhardt, Monique; Schmidt, Andrea; Mayer, Andreas] Univ Lausanne, Dept Biochim, CH-1066 Epalinges, Switzerland; [Wehner, Mark; Herrmann, Christian] Ruhr Univ Bochum, D-44780 Bochum, Germany; [Mayer, Andreas] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA	European Molecular Biology Laboratory (EMBL); Salk Institute; University of Lausanne; Ruhr University Bochum; Baylor College of Medicine	Scheffzek, K (corresponding author), European Mol Biol Lab, Struct & Computat Biol Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany.	scheffzek@embl.de	Neumann, Heinz/ABC-7323-2021; Hothorn, Michael/C-6807-2011; Mayer, Andreas/AAE-4315-2020; Neumann, Heinz/F-7875-2014	Mayer, Andreas/0000-0001-6131-313X; Neumann, Heinz/0000-0001-9657-1913; Ladurner, Andreas/0000-0003-3835-232X; Hothorn, Michael/0000-0002-3597-5698	Peter and Traudl Engelhorn Foundation (Penzberg, Germany); European Molecular Biology Organization long-term fellowship; Boehringer Ingelheim Fonds; German Science Foundation; Landesstiftung Baden-Wurttemberg; Swiss National Science Foundation; National Science Foundation [IOS-0649389]; Medical Research Council [G0500367] Funding Source: researchfish; MRC [G0500367] Funding Source: UKRI	Peter and Traudl Engelhorn Foundation (Penzberg, Germany); European Molecular Biology Organization long-term fellowship(European Molecular Biology Organization (EMBO)); Boehringer Ingelheim Fonds(Boehringer Ingelheim); German Science Foundation(German Research Foundation (DFG)); Landesstiftung Baden-Wurttemberg; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Science Foundation(National Science Foundation (NSF)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	With the exception of the AppNHp-Mn2+ and PPi complexes (determined at the Salk Institute), all crystallographic work was carried out at the European Molecular Biology Laboratory. We thank J. Noel, T. Gibson, and T. A. Steitz for discussion and J. Chory for generous support. This work was funded by the Peter and Traudl Engelhorn Foundation (Penzberg, Germany) and a European Molecular Biology Organization long-term fellowship (M.H), the Boehringer Ingelheim Fonds (A.U.), the German Science Foundation and the Landesstiftung Baden-Wurttemberg (K.S.), the Swiss National Science Foundation (A.M, P.O.H), and the National Science Foundation (IOS-0649389 to J. Chory). We thank the staff at the European Synchrotron Radiation Facility, Grenoble, France, at the Deutsches Elektronen Synchrotron, Hamburg, Germany, and at the Advanced Light Source, Berkeley, for technical support; and C. Muller and S. Cusack for sharing beam time. Coordinates and structure factors for Vtc2p183-553 (PDB-ID 3g3o), Vtc4p*-polyP (3g3q), Vtc4p*-AppNHp-Mn2+ (3g3r), Vtc4p*-Pi (3g3t), and Vtc4p*- PPi (3g3u) have been deposited with the Protein DataBank (www.rcsb.org).	AHN KH, 1990, J BIOL CHEM, V265, P11734; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Brown MRW, 2008, TRENDS BIOCHEM SCI, V33, P284, DOI 10.1016/j.tibs.2008.04.005; Cohen A, 1999, J BIOL CHEM, V274, P26885, DOI 10.1074/jbc.274.38.26885; Diaz J, 2008, SCIENCE, V320, P652, DOI 10.1126/science.1151751; Docampo R, 2005, NAT REV MICROBIOL, V3, P251, DOI 10.1038/nrmicro1097; Fang JM, 2007, BIOCHEM J, V407, P161, DOI 10.1042/BJ20070612; Freimoser FM, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r109; Ho CK, 1998, J BIOL CHEM, V273, P34151, DOI 10.1074/jbc.273.51.34151; Javot H, 2007, PLANT CELL ENVIRON, V30, P310, DOI 10.1111/j.1365-3040.2006.01617.x; Keppetipola N, 2007, J BIOL CHEM, V282, P11941, DOI 10.1074/jbc.M611328200; Lima CD, 1999, CELL, V99, P533, DOI 10.1016/S0092-8674(00)81541-X; Martin F, 2008, NATURE, V452, P88, DOI 10.1038/nature06556; Muller O, 2003, J CELL SCI, V116, P1107, DOI 10.1242/jcs.00328; Muller O, 2002, EMBO J, V21, P259, DOI 10.1093/emboj/21.3.259; Murray JM, 2000, GENETICS, V154, P155; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Ogawa N, 2000, MOL BIOL CELL, V11, P4309, DOI 10.1091/mbc.11.12.4309; Omelon SJ, 2008, CHEM REV, V108, P4694, DOI 10.1021/cr0782527; Thomas MR, 2005, P NATL ACAD SCI USA, V102, P9565, DOI 10.1073/pnas.0501122102; Werner TP, 2007, FUNGAL GENET BIOL, V44, P845, DOI 10.1016/j.fgb.2007.01.008; Zhang HY, 2005, P NATL ACAD SCI USA, V102, P2731, DOI 10.1073/pnas.0500023102	22	192	198	4	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 24	2009	324	5926					513	516		10.1126/science.1168120	http://dx.doi.org/10.1126/science.1168120			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436JU	19390046				2022-12-01	WOS:000265411200047
J	Lee, SM; Pippel, E; Gosele, U; Dresbach, C; Qin, Y; Chandran, CV; Brauniger, T; Hause, G; Knez, M				Lee, Seung-Mo; Pippel, Eckhard; Goesele, Ulrich; Dresbach, Christian; Qin, Yong; Chandran, C. Vinod; Braeuniger, Thomas; Hause, Gerd; Knez, Mato			Greatly Increased Toughness of Infiltrated Spider Silk	SCIENCE			English	Article							MECHANICAL-PROPERTIES; MOLECULAR-ORIENTATION; INSECT MANDIBLES; POLYCHAETE JAWS; ZINC; PROTEIN; METAL; MANGANESE; COMPLEX; DESIGN	In nature, tiny amounts of inorganic impurities, such as metals, are incorporated in the protein structures of some biomaterials and lead to unusual mechanical properties of those materials. A desire to produce these biomimicking new materials has stimulated materials scientists, and diverse approaches have been attempted. In contrast, research to improve the mechanical properties of biomaterials themselves by direct metal incorporation into inner protein structures has rarely been tried because of the difficulty of developing a method that can infiltrate metals into biomaterials, resulting in a metal-incorporated protein matrix. We demonstrated that metals can be intentionally infiltrated into inner protein structures of biomaterials through multiple pulsed vapor-phase infiltration performed with equipment conventionally used for atomic layer deposition (ALD). We infiltrated zinc (Zn), titanium (Ti), or aluminum (Al), combined with water from corresponding ALD precursors, into spider dragline silks and observed greatly improved toughness of the resulting silks. The presence of the infiltrated metals such as Al or Ti was verified by energy-dispersive x-ray (EDX) and nuclear magnetic resonance spectra measured inside the treated silks. This result of enhanced toughness of spider silk could potentially serve as a model for a more general approach to enhance the strength and toughness of other biomaterials.	[Lee, Seung-Mo; Pippel, Eckhard; Goesele, Ulrich; Qin, Yong; Knez, Mato] Max Planck Inst Microstruct Phys, D-06120 Halle, Germany; [Dresbach, Christian] Fraunhofer Inst Mech Mat, D-06120 Halle, Germany; [Chandran, C. Vinod; Braeuniger, Thomas] Univ Halle Wittenberg, Inst Phys, Nucl Magnet Resonance Grp, D-06108 Halle, Germany; [Hause, Gerd] Univ Halle Wittenberg, Microscopy Unit Bioctr, D-06120 Halle, Germany	Max Planck Society; Fraunhofer Gesellschaft; Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg	Lee, SM (corresponding author), Max Planck Inst Microstruct Phys, Weinberg 2, D-06120 Halle, Germany.	smlee@mpi-halle.de; mknez@mpi-halle.de	Knez, Mato/F-9287-2014; Qin, Yong/D-9716-2011	Knez, Mato/0000-0002-9850-1035; Chandran, C. Vinod/0000-0003-4074-8833	Bundesministerium fur Bildung und Forschung [FKZ 03X5507]; Deutsche Forschungsgemeinschaft [BR 3370/3-1, Mi 390/17-1]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank W. Lee from the Korea Research Institute of Standards and Science in Daejeon, Korea; H. Han from the Department of Material Science and Engineering, Pohang University of Science and Technology in Pohang, Korea; and G.-M. Kim from the Department of Physics, Martin-Luther-University Halle-Wittenberg in Merseburg, Germany, for their helpful discussions on physical and chemical interpretations of mechanical properties, WAXS, NMR spectra, Raman spectra, energy-filtered TEM (EFTEM), and time-of-flight secondary ion mass spectroscopy (TOF-SIMS) data. We also thank J. Woltersdorf, M. Becker, and J. Liu from the Max Planck Institute of Microstructure Physics in Halle, Germany, for EFTEM and Raman measurements. We appreciate TOF-SIMS measurement by M. Krause and help and support in arranging the mechanical properties measurements and TOF-SIMS measurement by M. Petzold from the Fraunhofer Institute for Mechanics of Materials in Halle, Germany. This work has received financial support from the Bundesministerium fur Bildung und Forschung (grant FKZ 03X5507) and Deutsche Forschungsgemeinschaft (grants BR 3370/3-1 and Mi 390/17-1).	ARNOLD FH, 1991, SCIENCE, V252, P1796, DOI 10.1126/science.1648261; Broomell CC, 2008, ACTA BIOMATER, V4, P2045, DOI 10.1016/j.actbio.2008.06.017; Broomell CC, 2006, J EXP BIOL, V209, P3219, DOI 10.1242/jeb.02373; BRYAN GW, 1979, J MAR BIOL ASSOC UK, V59, P969, DOI 10.1017/S0025315400036961; Chang CY, 2008, ORG ELECTRON, V9, P667, DOI 10.1016/j.orgel.2008.04.009; Cordier F, 2002, J MOL BIOL, V317, P739, DOI 10.1006/jmbi.2002.5446; Cribb BW, 2008, NATURWISSENSCHAFTEN, V95, P17, DOI 10.1007/s00114-007-0288-1; Du N, 2006, BIOPHYS J, V91, P4528, DOI 10.1529/biophysj.106.089144; Edwards Ashley J., 1993, Cell Biology International, V17, P697, DOI 10.1006/cbir.1993.1125; Fernandez A, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.018102; FORNES RE, 1983, J POLYM SCI POL PHYS, V21, P1163, DOI 10.1002/pol.1983.180210715; GIBBS PE, 1980, J MAR BIOL ASSOC UK, V60, P205, DOI 10.1017/S0025315400024267; Gosline JM, 1999, J EXP BIOL, V202, P3295; GROSSKREUTZ JC, 1969, J ELECTROCHEM SOC, V116, P1232, DOI 10.1149/1.2412286; Guinea GV, 2005, J EXP BIOL, V208, P25, DOI 10.1242/jeb.01344; GURD FRN, 1956, ADV PROTEIN CHEM, V11, P311, DOI 10.1016/S0065-3233(08)60424-6; GUSTAVSON KH, 1958, NATURE, V182, P1125, DOI 10.1038/1821125a0; HANDEL T, 1990, J AM CHEM SOC, V112, P6710, DOI 10.1021/ja00174a039; HILLERTON JE, 1982, J EXP BIOL, V101, P333; HILLERTON JE, 1984, J STORED PROD RES, V20, P133, DOI 10.1016/0022-474X(84)90020-1; KELLIS JT, 1991, BIO-TECHNOL, V9, P994, DOI 10.1038/nbt1091-994; Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780; Lefevre T, 2007, BIOPHYS J, V92, P2885, DOI 10.1529/biophysj.106.100339; Let AL, 2008, J NON-CRYST SOLIDS, V354, P1801, DOI 10.1016/j.jnoncrysol.2007.09.005; Lichtenegger HC, 2002, SCIENCE, V298, P389, DOI 10.1126/science.1075433; Lichtenegger HC, 2003, P NATL ACAD SCI USA, V100, P9144, DOI 10.1073/pnas.1632658100; Liu Y, 2005, NAT MATER, V4, P901, DOI 10.1038/nmat1534; Morgan TD, 2003, J STORED PROD RES, V39, P65, DOI 10.1016/S0022-474X(02)00019-X; Pontin MG, 2007, P NATL ACAD SCI USA, V104, P13559, DOI 10.1073/pnas.0702034104; Quicke DLJ, 1998, ZOOL J LINN SOC-LOND, V124, P387, DOI 10.1111/j.1096-3642.1998.tb00583.x; RAO KSJ, 1994, MOL CELL BIOCHEM, V137, P61; SCHOFIELD R, 1989, J EXP BIOL, V144, P577; Schofield RMS, 2002, NATURWISSENSCHAFTEN, V89, P579, DOI 10.1007/s00114-002-0381-4; Shao ZZ, 1999, INT J BIOL MACROMOL, V24, P295, DOI 10.1016/S0141-8130(98)00093-2; Simmons AH, 1996, SCIENCE, V271, P84, DOI 10.1126/science.271.5245.84; Sun HZ, 1998, ANGEW CHEM INT EDIT, V37, P1577, DOI 10.1002/(SICI)1521-3773(19980619)37:11<1577::AID-ANIE1577>3.0.CO;2-M; TERMONIA Y, 1994, MACROMOLECULES, V27, P7378, DOI 10.1021/ma00103a018; Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000; Wilson CA, 2005, CHEM MATER, V17, P5625, DOI 10.1021/cm050704d	39	287	290	8	273	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 24	2009	324	5926					488	492		10.1126/science.1168162	http://dx.doi.org/10.1126/science.1168162			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436JU	19390040				2022-12-01	WOS:000265411200040
J	Canto, C; Gerhart-Hines, Z; Feige, JN; Lagouge, M; Noriega, L; Milne, JC; Elliott, PJ; Puigserver, P; Auwerx, J				Canto, Carles; Gerhart-Hines, Zachary; Feige, Jerome N.; Lagouge, Marie; Noriega, Lilia; Milne, Jill C.; Elliott, Peter J.; Puigserver, Pere; Auwerx, Johan			AMPK regulates energy expenditure by modulating NAD(+) metabolism and SIRT1 activity	NATURE			English	Article							ACTIVATED PROTEIN-KINASE; GENE-EXPRESSION; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; MITOCHONDRIAL-FUNCTION; GLUCOSE-HOMEOSTASIS; SKELETAL-MUSCLE; RECEPTOR-GAMMA; PGC-1-ALPHA; MECHANISM; OXIDATION	AMP-activated protein kinase (AMPK) is a metabolic fuel gauge conserved along the evolutionary scale in eukaryotes that senses changes in the intracellular AMP/ATP ratio(1). Recent evidence indicated an important role for AMPK in the therapeutic benefits of metformin(2,3), thiazolidinediones(4) and exercise(5), which form the cornerstones of the clinical management of type 2 diabetes and associated metabolic disorders. In general, activation of AMPK acts to maintain cellular energy stores, switching on catabolic pathways that produce ATP, mostly by enhancing oxidative metabolism and mitochondrial biogenesis, while switching off anabolic pathways that consume ATP(1). This regulation can take place acutely, through the regulation of fast post-translational events, but also by transcriptionally reprogramming the cell to meet energetic needs. Here we demonstrate that AMPK controls the expression of genes involved in energy metabolism in mouse skeletal muscle by acting in coordination with another metabolic sensor, the NAD(+)-dependent type III deacetylase SIRT1. AMPK enhances SIRT1 activity by increasing cellular NAD(+) levels, resulting in the deacetylation and modulation of the activity of downstream SIRT1 targets that include the peroxisome proliferator-activated receptor-gamma coactivator 1 alpha and the forkhead box O1 (FOXO1) and O3 (FOXO3a) transcription factors. The AMPK-induced SIRT1-mediated deacetylation of these targets explains many of the convergent biological effects of AMPK and SIRT1 on energy metabolism.	[Canto, Carles; Feige, Jerome N.; Lagouge, Marie; Noriega, Lilia; Auwerx, Johan] CNRS INSERM ULP, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France; [Canto, Carles; Noriega, Lilia; Auwerx, Johan] Ecole Polytech Fed Lausanne, CH-1015 Lausanne, Switzerland; [Gerhart-Hines, Zachary; Puigserver, Pere] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Gerhart-Hines, Zachary; Puigserver, Pere] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Milne, Jill C.; Elliott, Peter J.] Sirtris Pharmaceut Inc, Cambridge, MA 02139 USA; [Auwerx, Johan] Inst Clin Souris, F-67404 Illkirch Graffenstaden, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School	Auwerx, J (corresponding author), CNRS INSERM ULP, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France.	admin.auwerx@epfl.ch	Noriega, Lilia G./ABF-4876-2020; Auwerx, Johan/ABE-9307-2021	Noriega, Lilia G./0000-0003-2156-9872; Auwerx, Johan/0000-0002-5065-5393; Canto, Carles/0000-0002-5167-7922	CNRS; Ecole Polytechnique Federale de Lausanne; INSERM; ULP; NIH [DK59820, DK069966]; EU [LSHM-CT-2004-512013, ERC-2008-AdG-23118]; Fondation de la Recherche Medicale (FRM); EMBO; FEBS; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK059820, R01DK069966] Funding Source: NIH RePORTER	CNRS(Centre National de la Recherche Scientifique (CNRS)); Ecole Polytechnique Federale de Lausanne; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); ULP; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EU(European Commission); Fondation de la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); EMBO(European Molecular Biology Organization (EMBO)); FEBS; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants of CNRS, Ecole Polytechnique Federale de Lausanne, INSERM, ULP, NIH (DK59820 and DK069966), EU FP6 (EUGENE2; LSHM-CT-2004-512013) and EU Ideas programme (sirtuins; ERC-2008-AdG-23118). C. C. has been supported by grants of Fondation de la Recherche Medicale (FRM) and EMBO. J. N. F. was supported by a FEBS grant. The authors thank F. Foufelle and P. Ferre, B. Spiegelman, D. P. Kelly, S.-i. Imai, G. Hardie, C. Ammann (Topotarget) and F. Alt for providing materials, and members of the Auwerx and Puigserver laboratories for discussion.	Barnes BR, 2005, DIABETES, V54, P3484, DOI 10.2337/diabetes.54.12.3484; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Chua KF, 2005, CELL METAB, V2, P67, DOI 10.1016/j.cmet.2005.06.007; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; Dasgupta B, 2007, P NATL ACAD SCI USA, V104, P7217, DOI 10.1073/pnas.0610068104; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hasmann M, 2003, CANCER RES, V63, P7436; Hayashi T, 2000, DIABETES, V49, P527, DOI 10.2337/diabetes.49.4.527; Huss JM, 2002, J BIOL CHEM, V277, P40265, DOI 10.1074/jbc.M206324200; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lin SS, 2001, J BIOL CHEM, V276, P36000, DOI 10.1074/jbc.M103509200; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Pich S, 2005, HUM MOL GENET, V14, P1405, DOI 10.1093/hmg/ddi149; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Suwa M, 2003, J APPL PHYSIOL, V95, P960, DOI 10.1152/japplphysiol.00349.2003; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Wende AR, 2005, MOL CELL BIOL, V25, P10684, DOI 10.1128/MCB.25.24.10684-10694.2005; Woods A, 2000, MOL CELL BIOL, V20, P6704, DOI 10.1128/MCB.20.18.6704-6711.2000; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599	33	2196	2293	17	490	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 23	2009	458	7241					1056	U140		10.1038/nature07813	http://dx.doi.org/10.1038/nature07813			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436KL	19262508	Green Accepted			2022-12-01	WOS:000265412900049
J	Kraft, P; Hunter, DJ				Kraft, Peter; Hunter, David J.			Genetic Risk Prediction - Are We There Yet?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DISEASE		[Kraft, Peter; Hunter, David J.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Hunter, David J.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Kraft, P (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.							Couzin J, 2008, SCIENCE, V322, P357, DOI 10.1126/science.322.5900.357; Janssens ACJW, 2008, HUM MOL GENET, V17, pR166, DOI 10.1093/hmg/ddn250; Katsanis SH, 2008, SCIENCE, V320, P316; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; Wray NR, 2007, GENOME RES, V17, P1520, DOI 10.1101/gr.6665407	5	307	317	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 23	2009	360	17					1701	1703		10.1056/NEJMp0810107	http://dx.doi.org/10.1056/NEJMp0810107			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	435XY	19369656				2022-12-01	WOS:000265377800004
J	Scott-Browne, JP; White, J; Kappler, JW; Gapin, L; Marrack, P				Scott-Browne, James P.; White, Janice; Kappler, John W.; Gapin, Laurent; Marrack, Philippa			Germline-encoded amino acids in the alpha beta T-cell receptor control thymic selection	NATURE			English	Article							POSITIVE SELECTION; MHC; ANTIGEN; RECOGNITION; REPERTOIRE; H-2-ANTIGENS; HYBRIDOMAS; PEPTIDE	An alpha beta T-cell response depends on the recognition of antigen plus major histocompatibility complex (MHC) proteins(1) by its antigen receptor (TCR). The ability of peripheral alpha beta T cells to recognize MHC is at least partly determined by MHC-dependent thymic selection, by which an immature T cell survives only if its TCR can recognize self MHC2-7. This process may allow MHC-reactive TCRs to be selected from a repertoire with completely random and unbiased specificities. However, analysis of thymocytes before positive selection indicated that TCR proteins might have a predetermined ability to bind MHC8-11. Here we show that specific germline-encoded amino acids in the TCR promote 'generic' MHC recognition and control thymic selection. In mice expressing single, rearranged TCR beta-chains, individual mutation of amino acids in the complementarity-determining region (CDR) 2 beta to Ala reduced development of the entire TCR repertoire. Altogether, these results show that thymic selection is controlled by germline-encoded MHC contact points in the alpha beta TCR and indicate that the diversity of the peripheral T-cell repertoire is enhanced by this 'built-in' specificity.	[Scott-Browne, James P.; White, Janice; Kappler, John W.; Gapin, Laurent; Marrack, Philippa] Natl Jewish Hlth & Univ Colorado Denver, Integrated Dept Immunol, Denver, CO 80206 USA; [Kappler, John W.; Marrack, Philippa] Univ Colorado Denver, Howard Hughes Med Inst, Aurora, CO 80220 USA; [Kappler, John W.; Marrack, Philippa] Univ Colorado Denver, Dept Med, Aurora, CO 80220 USA; [Kappler, John W.] Univ Colorado Denver, Dept Pharmacol, Aurora, CO 80220 USA; [Kappler, John W.] Univ Colorado Denver, Program Biomol Struct, Aurora, CO 80220 USA; [Marrack, Philippa] Univ Colorado Denver, Dept Biochem & Mol Genet, Aurora, CO 80220 USA	National Jewish Health; Children's Hospital Colorado; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Marrack, P (corresponding author), Natl Jewish Hlth & Univ Colorado Denver, Integrated Dept Immunol, Denver, CO 80206 USA.	james.scott-browne@ucdenver.edu; marrackp@njhealth.org	Marrack, Philippa/AHE-6316-2022	Marrack, Philippa/0000-0003-1883-3687	National Institutes of Health [AI18785, AI22295, AI057485]; NIH [T32 AI07405]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI018785, R56AI018785, R56AI017134, T32AI007405, R01AI057485, R21AI076463, R37AI018785, P01AI022295] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Acknowledgements We thank E. Huseby, K. Urdahl, C. Hsieh, G. Hernandez-Hoyos and members of the Kappler/Marrack and Gapin laboratories for discussion. We thank the flow cytometry facilities at NJH and UCD for technical assistance with cell sorting and E. Kushnir for assistance with generating bone marrow chimaeras. We thank R. O'Brien and W. Born for providing Tcrb<SUP>-/-</SUP> Tcrd<SUP>-/-</SUP> mice and Y. Refaeli for providing stem cell cytokines. This work was supported by grants from the National Institutes of Health (AI18785 and AI22295 to P. M. and J. W. K. and AI057485 to L. G.). P. M. and J. W. K. are investigators of the Howard Hughes Medical Institute. J. P. S.-B. was supported by an NIH training grant (T32 AI07405).	Arden Bernhard, 1995, Immunogenetics, V42, P501; BEVAN MJ, 1977, NATURE, V269, P417, DOI 10.1038/269417a0; BLACKMAN M, 1986, CELL, V47, P349, DOI 10.1016/0092-8674(86)90591-X; Dai S, 2008, IMMUNITY, V28, P324, DOI 10.1016/j.immuni.2008.01.008; Feng D, 2007, NAT IMMUNOL, V8, P975, DOI 10.1038/ni1502; FINK PJ, 1978, J EXP MED, V148, P766, DOI 10.1084/jem.148.3.766; Grubin CE, 1997, IMMUNITY, V7, P197, DOI 10.1016/S1074-7613(00)80523-3; Huseby ES, 2005, CELL, V122, P247, DOI 10.1016/j.cell.2005.05.013; Jameson SC, 2002, NAT REV IMMUNOL, V2, P547, DOI 10.1038/nri853; JAMESON SC, 1995, ANNU REV IMMUNOL, V13, P93, DOI 10.1146/annurev.immunol.13.1.93; JERNE N K, 1971, European Journal of Immunology, V1, P1, DOI 10.1002/eji.1830010102; KAPPLER JW, 1981, J EXP MED, V153, P1198, DOI 10.1084/jem.153.5.1198; KISIELOW P, 1988, NATURE, V335, P730, DOI 10.1038/335730a0; Lee PUY, 2000, J EXP MED, V191, P1355, DOI 10.1084/jem.191.8.1355; Manning TC, 1998, IMMUNITY, V8, P413, DOI 10.1016/S1074-7613(00)80547-6; MARCIN P, 2006, BMC BIOINFORMATICS, V7, P225; Marrack P, 2008, ANNU REV IMMUNOL, V26, P171, DOI 10.1146/annurev.immunol.26.021607.090421; Maynard J, 2005, IMMUNITY, V22, P81, DOI 10.1016/j.immuni.2004.11.015; Merkenschlager M, 1997, J EXP MED, V186, P1149, DOI 10.1084/jem.186.7.1149; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Scott-Browne JP, 2007, NAT IMMUNOL, V8, P1105, DOI 10.1038/ni1510; SHA WC, 1988, NATURE, V336, P73, DOI 10.1038/336073a0; WHITE J, 1993, J EXP MED, V177, P119, DOI 10.1084/jem.177.1.119; WHITE J, 1989, J IMMUNOL, V143, P1822; Wong P, 2000, J IMMUNOL, V164, P6252, DOI 10.4049/jimmunol.164.12.6252; YAGUE J, 1985, CELL, V42, P81, DOI 10.1016/S0092-8674(85)80103-3; Zerrahn J, 1997, CELL, V88, P627, DOI 10.1016/S0092-8674(00)81905-4; ZINKERNA.RM, 1974, NATURE, V248, P701, DOI 10.1038/248701a0; ZINKERNAGEL RM, 1978, J EXP MED, V147, P882, DOI 10.1084/jem.147.3.882	29	123	124	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	2009	458	7241					1043	U124		10.1038/nature07812	http://dx.doi.org/10.1038/nature07812			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436KL	19262510	Green Accepted			2022-12-01	WOS:000265412900046
J	Caggiano, V; Fogassi, L; Rizzolatti, G; Thier, P; Casile, A				Caggiano, Vittorio; Fogassi, Leonardo; Rizzolatti, Giacomo; Thier, Peter; Casile, Antonino			Mirror Neurons Differentially Encode the Peripersonal and Extrapersonal Space of Monkeys	SCIENCE			English	Article							PREMOTOR CORTEX; BODY SCHEMA; AREA-6	Actions performed by others may have different relevance for the observer, and thus lead to different behavioral responses, depending on the regions of space in which they are executed. We found that in rhesus monkeys, the premotor cortex neurons activated by both the execution and the observation of motor acts (mirror neurons) are differentially modulated by the location in space of the observed motor acts relative to the monkey, with about half of them preferring either the monkey's peripersonal or extrapersonal space. A portion of these spatially selective mirror neurons encode space according to a metric representation, whereas other neurons encode space in operational terms, changing their properties according to the possibility that the monkey will interact with the object. These results suggest that a set of mirror neurons encodes the observed motor acts not only for action understanding, but also to analyze such acts in terms of features that are relevant to generating appropriate behaviors.	[Caggiano, Vittorio; Thier, Peter; Casile, Antonino] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Cognit Neurol, D-72076 Tubingen, Germany; [Fogassi, Leonardo] Univ Parma, Dipartimento Psicol, I-43100 Parma, Italy; [Fogassi, Leonardo; Rizzolatti, Giacomo] Univ Parma, Dipartimento Neurosci, I-43100 Parma, Italy; [Fogassi, Leonardo; Rizzolatti, Giacomo] Univ Parma, Ist Italiano Tecnol, I-43100 Parma, Italy	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Parma; University of Parma; Istituto Italiano di Tecnologia - IIT; University of Parma	Casile, A (corresponding author), Univ Tubingen, Hertie Inst Clin Brain Res, Dept Cognit Neurol, D-72076 Tubingen, Germany.	antonino.casile@uni-tuebingen.de	Caggiano, Vittorio/E-5623-2012; FOGASSI, Leonardo/K-3541-2018	Caggiano, Vittorio/0000-0002-2186-1550; Thier, Peter/0000-0001-5909-4222; FOGASSI, Leonardo/0000-0003-3348-039X	Deutsche Forschungsgemeinschaft [SFB550-C10]; Hermann and Lilly Schilling Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Hermann and Lilly Schilling Foundation	We thank P. Dicke for many decisive technical contributions, two anonymous reviewers for helpful comments, and M. Giese for stimulating discussions. Supported by Deutsche Forschungsgemeinschaft grant SFB550-C10 and by the Hermann and Lilly Schilling Foundation.	Fogassi L, 1996, J NEUROPHYSIOL, V76, P141, DOI 10.1152/jn.1996.76.1.141; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; GENTILUCCI M, 1983, EXP BRAIN RES, V50, P464; GRAZIANO MSA, 1994, SCIENCE, V266, P1054, DOI 10.1126/science.7973661; Graziano MSA, 1997, J NEUROPHYSIOL, V77, P2268, DOI 10.1152/jn.1997.77.5.2268; Iriki A, 1996, NEUROREPORT, V7, P2325; Maravita A, 2004, TRENDS COGN SCI, V8, P79, DOI 10.1016/j.tics.2003.12.008; Rizzolatti G, 1997, SCIENCE, V277, P190, DOI 10.1126/science.277.5323.190; RIZZOLATTI G, 1983, BRAIN, V106, P655, DOI 10.1093/brain/106.3.655; RIZZOLATTI G, 1996, BRAIN RES COGN BRAIN, V3, P131, DOI DOI 10.1016/0926-6410(95)00038-0	10	191	196	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2009	324	5925					403	406		10.1126/science.1166818	http://dx.doi.org/10.1126/science.1166818			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433QT	19372433				2022-12-01	WOS:000265221600047
J	Solovei, I; Kreysing, M; Lanctot, C; Kosem, S; Peichl, L; Cremer, T; Guck, J; Joffe, B				Solovei, Irina; Kreysing, Moritz; Lanctot, Christian; Koesem, Sueleyman; Peichl, Leo; Cremer, Thomas; Guck, Jochen; Joffe, Boris			Nuclear Architecture of Rod Photoreceptor Cells Adapts to Vision in Mammalian Evolution	CELL			English	Article							CHROMOSOME TERRITORIES; GENE-EXPRESSION; MOUSE RETINA; INACTIVE-X; ORGANIZATION; GENOME; LOCUS; TRANSCRIPTION; REPRESSION; LAMINA	We show that the nuclear architecture of rod photoreceptor cells differs fundamentally in nocturnal and diurnal mammals. The rods of diurnal retinas possess the conventional architecture found in nearly all eukaryotic cells, with most heterochromatin situated at the nuclear periphery and euchromatin residing toward the nuclear interior. The rods of nocturnal retinas have a unique inverted pattern, where heterochromatin localizes in the nuclear center, whereas euchromatin, as well as nascent transcripts and splicing machinery, line the nuclear border. The inverted pattern forms by remodeling of the conventional one during terminal differentiation of rods. The inverted rod nuclei act as collecting lenses, and computer simulations indicate that columns of such nuclei channel light efficiently toward the light-sensing rod outer segments. Comparison of the two patterns suggests that the conventional architecture prevails in eukaryotic nuclei because it results in more flexible chromosome arrangements, facilitating positional regulation of nuclear functions.	[Kreysing, Moritz; Guck, Jochen] Univ Cambridge, Dept Phys, Cavendish Lab, Cambridge CB3 0HE, England; [Solovei, Irina; Lanctot, Christian; Koesem, Sueleyman; Cremer, Thomas; Joffe, Boris] Univ Munich, Div Anthropol & Human Genet, Bioctr, D-82152 Planegg Martinsried, Germany; [Peichl, Leo] Max Planck Inst Brain Res, D-60528 Frankfurt, Germany; [Cremer, Thomas] CiPSM, D-81377 Munich, Germany	University of Cambridge; University of Munich; Max Planck Society	Guck, J (corresponding author), Univ Cambridge, Dept Phys, Cavendish Lab, JJ Thomson Ave, Cambridge CB3 0HE, England.	jg473@cam.ac.uk; boris.joffe@lrz.uni-muenchen.de	Cremer, Thomas/D-7979-2011; Solovei, Irina/K-1191-2014; Kreysing, Moritz/B-3751-2017; Guck, Jochen/B-4412-2014	Cremer, Thomas/0000-0002-1830-9589; Kreysing, Moritz/0000-0001-7432-3871; Guck, Jochen/0000-0002-1453-6119; Peichl, Leo/0000-0002-8141-0911; Cremer, Thomas/0000-0001-7135-7216; Solovei, Irina/0000-0002-6813-7279; Lanctot, Christian/0000-0003-3211-3061	Deutsche Forschungsgemeinschaft [Cr59/ 20]; Bundesministerium fur Bildung und Forschung NGFN II-EP [0213377A]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung NGFN II-EP	We thank A. H. F. M. Peters (FMI for Biomedical Research, Basel) for antibodies against H3K9me3 and H4K20me3, M. Hess (University of Munich) for initial help with mouse retina, S. Heynck (MPI for Brain Research, Frankfurt) for perfect sectioning, all colleagues who kindly supplied us mammal retina material (see Table S2), S. Haverkamp (MPI for Brain Research) for a TEM image of mouse rod perykarion, B. Amos (MRC LMB, Cambridge, UK) for help with the Jamin-Lebedev microscope, and M. Gerard (Abattoir Haverhill) for the provision of pig eyes. We are grateful to D. Sheer (Queen Mary's School of Medicine and Dentistry, London), A. Reichenbach (University of Leipzig), W. Stephan (University of Munich), and T. D. Lamb (Australian National University, Canberra) for reading of the manuscript and/or critical comments. The study was supported by Deutsche Forschungsgemeinschaft grant Cr59/ 20 and Bundesministerium fur Bildung und Forschung NGFN II-EP grant 0213377A to T. C., fellowships from the Instituts de recherche en sante du Canada and the Humboldt Stiftung to C. L., and Engineering and Physical Sciences Research Council and Cambridge European Trust scholarships to M. K.	Acosta ML, 2008, J COMP NEUROL, V506, P506, DOI 10.1002/cne.21561; Ahnelt PK, 2000, PROG RETIN EYE RES, V19, P711, DOI 10.1016/S1350-9462(00)00012-4; Akhtar A, 2007, NAT REV GENET, V8, P507, DOI 10.1038/nrg2122; Blackshaw S, 2001, CELL, V107, P579, DOI 10.1016/S0092-8674(01)00574-8; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; Chadwick BP, 2004, P NATL ACAD SCI USA, V101, P17450, DOI 10.1073/pnas.0408021101; Chuang CH, 2006, CURR BIOL, V16, P825, DOI 10.1016/j.cub.2006.03.059; Corbo JC, 2005, PLOS GENET, V1, P140, DOI 10.1371/journal.pgen.0010011; Cremer Marion, 2007, CSH Protoc, V2007, DOI 10.1101/pdb.prot4723; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Cremer T, 2006, CURR OPIN CELL BIOL, V18, P307, DOI 10.1016/j.ceb.2006.04.007; Dundr M, 2007, J CELL BIOL, V179, P1095, DOI 10.1083/jcb.200710058; Farjadpour A, 2006, OPT LETT, V31, P2972, DOI 10.1364/OL.31.002972; Ferreira J, 1997, J CELL BIOL, V139, P1597, DOI 10.1083/jcb.139.7.1597; Finlan LE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000039; Franze K, 2007, P NATL ACAD SCI USA, V104, P8287, DOI 10.1073/pnas.0611180104; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Gartenberg MR, 2004, CELL, V119, P955, DOI 10.1016/j.cell.2004.11.008; Gregory TR, 2007, NUCLEIC ACIDS RES, V35, pD332, DOI 10.1093/nar/gkl828; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Helmlinger D, 2006, PLOS BIOL, V4, P432, DOI 10.1371/journal.pbio.0040067; Knabe W, 1997, VISION RES, V37, P267, DOI 10.1016/S0042-6989(96)00199-X; Kosak ST, 2007, PLOS BIOL, V5, P2602, DOI 10.1371/journal.pbio.0050309; Kupper K, 2007, CHROMOSOMA, V116, P285, DOI 10.1007/s00412-007-0098-4; Kumaran RI, 2008, J CELL BIOL, V180, P51, DOI 10.1083/jcb.200706060; Lanctot C, 2007, NAT REV GENET, V8, P104, DOI 10.1038/nrg2041; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; Peichl L, 2005, ANAT REC PART A, V287A, P1001, DOI 10.1002/ar.a.20262; Postberg J, 2005, J CELL SCI, V118, P3973, DOI 10.1242/jcs.02497; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Ragoczy T, 2006, GENE DEV, V20, P1447, DOI 10.1101/gad.1419506; Reddy KL, 2008, NATURE, V452, P243, DOI 10.1038/nature06727; REESE BE, 1995, P NATL ACAD SCI USA, V92, P2494, DOI 10.1073/pnas.92.7.2494; Ronneberger O, 2008, CHROMOSOME RES, V16, P523, DOI 10.1007/s10577-008-1236-4; Sadoni N, 1999, J CELL BIOL, V146, P1211, DOI 10.1083/jcb.146.6.1211; Sexton T, 2007, NAT STRUCT MOL BIOL, V14, P1049, DOI 10.1038/nsmb1324; SOLOVEI I, 2007, COLD SPRING HARBOR P, DOI DOI 10.1101/PDB.PR0T4729; Sterling P, 2003, VISUAL NEUROSCIENCES, V1, P234; Takizawa T, 2008, GENE DEV, V22, P489, DOI 10.1101/gad.1634608; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; WILLIAMS RW, 2003, VISUAL NEUROSCIENCES, P65; Zhang LF, 2007, CELL, V129, P693, DOI 10.1016/j.cell.2007.03.036	44	512	532	1	55	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 17	2009	137	2					356	368		10.1016/j.cell.2009.01.052	http://dx.doi.org/10.1016/j.cell.2009.01.052			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	437AB	19379699	Bronze			2022-12-01	WOS:000265456800027
J	Sanghavi, P; Bhalla, K; Das, V				Sanghavi, Prachi; Bhalla, Kavi; Das, Veena			Fire-related deaths in India in 2001: a retrospective analysis of data	LANCET			English	Article							BURN MORTALITY; EPIDEMIOLOGY; SUICIDE; AUTOPSY; RATES	Background Hospital-based studies have suggested that fire-related deaths might be a neglected public-health issue in India. However, no national estimates of these deaths exist and the only numbers reported in published literature come from the Indian police. We combined multiple health datasets to assess the extent of the problem. Methods We computed age-sex-specific fire-related mortality fractions nationally using a death registration system based on medically certified causes of death in urban areas and a verbal autopsy based sample survey for rural populations. We combined these data with all-cause mortality estimates based on the sample registration system and the population census. We adjusted for ill-defined injury categories that might contain misclassified fire-related deaths, and estimated the proportion of suicides due to self-immolation when deaths were reported by external causes. Findings We estimated over 163 000 fire-related deaths in 2001 in India, which is about 2% of all deaths. This number was six times that reported by police. About 106 000 of these deaths occurred in women, mostly between 15 and 34 years of age. This age-sex pattern was consistent across multiple local studies, and the average ratio of fire-related deaths of young women to young men was 3:1. Interpretation The high frequency of fire-related deaths in young women suggests that these deaths share common causes, including kitchen accidents, self-immolation, and different forms of domestic violence. Identification of populations at risk and description of structural determinants from existing data sources are urgently needed so that interventions can be rapidly implemented.	[Bhalla, Kavi] Harvard Univ, Initiat Global Hlth, Cambridge, MA 02138 USA; [Das, Veena] Johns Hopkins Univ, Dept Anthropol, Baltimore, MD USA	Harvard University; Johns Hopkins University	Sanghavi, P (corresponding author), 15-42 Everett St, Cambridge, MA 02138 USA.	prachi.sanghavi@gmail.com						Ahuja RB, 2002, BURNS, V28, P555, DOI 10.1016/S0305-4179(02)00069-4; Alexandrescu R, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-80; Ambade VN, 2006, BURNS, V32, P902, DOI 10.1016/j.burns.2006.03.001; Amoros E, 2007, ACCIDENT ANAL PREV, V39, P483, DOI 10.1016/j.aap.2006.09.006; Batra AK, 2003, BURNS, V29, P270, DOI 10.1016/S0305-4179(02)00306-6; BAWABHALLA KS, 2000, ACCIDENT ANAL PREV, V32, P407; Eddleston M, 2006, INJURY PREV, V12, P333, DOI 10.1136/ip.2006.012641; Gajalakshmi V, 2007, INT J EPIDEMIOL, V36, P203, DOI 10.1093/ije/dyl308; GUPTA M, 1993, BURNS, V19, P47, DOI 10.1016/0305-4179(93)90100-M; GUPTA RK, 1988, FORENSIC SCI INT, V37, P81, DOI 10.1016/0379-0738(88)90096-5; GURURAJ G, 2005, INJURIES INDIA NATL; HADDON W, 1972, J TRAUM, V12, P193, DOI 10.1097/00005373-197203000-00002; Hill K, 2007, LANCET, V370, P1311, DOI 10.1016/S0140-6736(07)61572-4; *INT I POP STUD, 1999, NAT FAM HLTH SURV, V2; JAYARAMAN V, 1993, BURNS, V19, P339, DOI 10.1016/0305-4179(93)90124-Q; Kumar V, 2004, LANCET, V364, P18, DOI 10.1016/S0140-6736(04)17625-3; Lester D, 1999, ARCH SUICIDE RES, V5, P91, DOI 10.1080/13811119908258320; MAHAPATRA P, 2001, ESTIMATING NATL BURD; *MIN HOM AFF REG G, 2001, SAMPL REG SYST; *MIN HOM AFF REG G, 1999, CIV REG SYST; *MIN HOM AFF REG G, 2001, CENS IND; *MIN HOM AFF REG G, 2001, MED CERT CAUS DEATH; *MIN HOM NAT CRIM, 2005, CRIM IND; Murray CJL, 2007, PLOS MED, V4, P1739, DOI 10.1371/journal.pmed.0040327; Murray CJL, 2007, PLOS MED, V4, P1754, DOI 10.1371/journal.pmed.0040326; Oldenburg V.T., 2002, DOWRY MURDER IMPERIA; Prasad S, 1999, Violence Against Women, V5, P478, DOI 10.1177/10778019922181338; Runyan C W, 1998, Inj Prev, V4, P302; SAWHNEY CP, 1989, BURNS, V15, P362, DOI 10.1016/0305-4179(89)90099-5; Sharma BR, 2002, BURNS, V28, P250, DOI 10.1016/S0305-4179(02)00003-7; Singh D, 1998, BURNS, V24, P150, DOI 10.1016/S0305-4179(97)00106-X; Subrahmanyam M, 1996, BURNS, V22, P439, DOI 10.1016/0305-4179(96)00001-0; SUBRAHMANYAM M, 2003, ANN BURNS FIRE DISAS, V16, P74; *VIT STAT DIV REG, 1998, SURV CAUS DEATH; *WHO, 2005, WORLD HLTH SURV	35	72	72	3	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 11	2009	373	9671					1282	1288		10.1016/S0140-6736(09)60235-X	http://dx.doi.org/10.1016/S0140-6736(09)60235-X			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	432PN	19250664				2022-12-01	WOS:000265146300031
J	Wallace, GG; Moulton, SE; Clark, GM				Wallace, G. G.; Moulton, S. E.; Clark, G. M.			Electrode-Cellular Interface	SCIENCE			English	Editorial Material							NEURAL STIMULATION; CONDUCTING POLYMER; POLYPYRROLE; BIOCOMPATIBILITY; OSTEOBLASTS; COMPOSITE; RELEASE; CELLS		[Wallace, G. G.; Moulton, S. E.; Clark, G. M.] Univ Wollongong, Australian Res Council Ctr Excellence Electromat, Intelligent Polymer Res Inst, Wollongong, NSW 2522, Australia	University of Wollongong	Wallace, GG (corresponding author), Univ Wollongong, Australian Res Council Ctr Excellence Electromat, Intelligent Polymer Res Inst, Wollongong, NSW 2522, Australia.	gwallace@uow.edu.au	Wallace, Gordon G/H-1123-2011; Moulton, Simon E/G-1031-2011; Moulton, Simon/AAS-1452-2021	Wallace, Gordon G/0000-0002-0381-7273; Moulton, Simon E/0000-0002-8320-3852; Moulton, Simon/0000-0002-8320-3852				Boockvar JA, 2000, J NEUROSURG, V93, P140, DOI 10.3171/jns.2000.93.1.0140; Campbell TE, 1999, ELECTROANAL, V11, P215, DOI 10.1002/(SICI)1521-4109(199904)11:4<215::AID-ELAN215>3.0.CO;2-#; Chen H, 2008, ADV MATER, V20, P3557, DOI 10.1002/adma.200800757; Clark GM, 2006, PHILOS T R SOC B, V361, P791, DOI 10.1098/rstb.2005.1782; Cogan SF, 2008, ANNU REV BIOMED ENG, V10, P275, DOI 10.1146/annurev.bioeng.10.061807.160518; Czarnecki JS, 2008, TISSUE ENG PT A, V14, P255, DOI 10.1089/tea.2007.0169; Dhillon GS, 2004, J HAND SURG-AM, V29A, P605, DOI 10.1016/j.jhsa.2004.02.006; Gerard M, 2002, BIOSENS BIOELECTRON, V17, P345, DOI 10.1016/S0956-5663(01)00312-8; Hodgson A. J., 1994, SUPRAMOL SCI, V1, P77; Kam NWS, 2009, NANO LETT, V9, P273, DOI 10.1021/nl802859a; LIN Y, 1994, J CONTROL RELEASE, V30, P137, DOI 10.1016/0168-3659(94)90260-7; Newbold C, 2004, J NEURAL ENG, V1, P218, DOI 10.1088/1741-2560/1/4/005; Richardson-Burns SM, 2007, BIOMATERIALS, V28, P1539, DOI 10.1016/j.biomaterials.2006.11.026; Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948; Supronowicz PR, 2002, J BIOMED MATER RES, V59, P499, DOI 10.1002/jbm.10015; Thompson BC, 2006, J CONTROL RELEASE, V116, P285, DOI 10.1016/j.jconrel.2006.09.004; Wang K, 2006, NANO LETT, V6, P2043, DOI 10.1021/nl061241t; Wang XD, 2004, J BIOMED MATER RES A, V68A, P411, DOI 10.1002/jbm.a.20065; Widge AS, 2007, BIOSENS BIOELECTRON, V22, P1723, DOI 10.1016/j.bios.2006.08.011; Wong YT, 2007, IEEE T NEUR SYS REH, V15, P425, DOI 10.1109/TNSRE.2007.903958	20	84	86	1	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 10	2009	324	5924					185	186		10.1126/science.1168346	http://dx.doi.org/10.1126/science.1168346			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430WX	19359568	Green Submitted			2022-12-01	WOS:000265024400024
J	Gilestro, GF; Tononi, G; Cirelli, C				Gilestro, Giorgio F.; Tononi, Giulio; Cirelli, Chiara			Widespread Changes in Synaptic Markers as a Function of Sleep and Wakefulness in Drosophila	SCIENCE			English	Article							TUMOR-SUPPRESSOR GENE; DEPENDENT PLASTICITY; PROTEIN; POTENTIATION; WAKING; NEED; DLG	Sleep is universal, strictly regulated, and necessary for cognition. Why this is so remains a mystery, although recent work suggests that sleep, memory, and plasticity are linked. However, little is known about how wakefulness and sleep affect synapses. Using Western blots and confocal microscopy in Drosophila, we found that protein levels of key components of central synapses were high after waking and low after sleep. These changes were related to behavioral state rather than time of day and occurred in all major areas of the Drosophila brain. The decrease of synaptic markers during sleep was progressive, and sleep was necessary for their decline. Thus, sleep may be involved in maintaining synaptic homeostasis altered by waking activities.	[Gilestro, Giorgio F.; Tononi, Giulio; Cirelli, Chiara] Univ Wisconsin, Dept Psychiat, Madison, WI 53719 USA	University of Wisconsin System; University of Wisconsin Madison	Tononi, G (corresponding author), Univ Wisconsin, Dept Psychiat, Madison, WI 53719 USA.	gtononi@wisc.edu; ccirelli@wisc.edu	Tononi, Giulio/B-8387-2009; Gilestro, Giorgio/A-8721-2010	Gilestro, Giorgio/0000-0001-7512-8541	National Institute of General Medical Sciences [R01 GM075315]; NIH Director's Pioneer award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075315] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000579] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH Director's Pioneer award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Authors' contributions: G.F.G. performed the experiments; G.F.G., G.T., and C.C. designed the experiments; G.T. and C.C. conceived and coordinated the project. All authors wrote the manuscript and read and approved the final version. We thank D. Paasch, D. Denucci, and M. Uy for technical assistance with fly work; M. Pfister-Genskow for help with Western blot analysis; L. Rodenkirch and the UW Keck Laboratory for Biological Imaging for assistance in confocal microscopy; and D. Bushey for discussion and comments on the manuscript. Supported by National Institute of General Medical Sciences grant R01 GM075315 (C.C.) and an NIH Director's Pioneer award (G.T.).	Albornoz V, 2008, GENE EXPR PATTERNS, V8, P443, DOI 10.1016/j.gep.2008.04.001; Budnik V, 1996, NEURON, V17, P627, DOI 10.1016/S0896-6273(00)80196-8; Chen KY, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-1; Cirelli C, 2008, PLOS BIOL, V6, P1605, DOI 10.1371/journal.pbio.0060216; Donlea JM, 2009, SCIENCE, V324, P105, DOI 10.1126/science.1166657; Ehrlich I, 2004, J NEUROSCI, V24, P916, DOI 10.1523/JNEUROSCI.4733-03.2004; El-Hussein AE, 2000, SCIENCE, V290, P1364; Fernandez MP, 2008, PLOS BIOL, V6, P518, DOI 10.1371/journal.pbio.0060069; Ganguly-Fitzgerald I, 2006, SCIENCE, V313, P1775, DOI 10.1126/science.1130408; Gorska-Andrzejak J, 2005, PHOTOCH PHOTOBIO SCI, V4, P721, DOI 10.1039/b417023g; Guan Z, 2005, NEURON, V48, P91, DOI 10.1016/j.neuron.2005.08.036; HEISENBERG M, 1995, J NEUROSCI, V15, P1951, DOI 10.1523/JNEUROSCI.15-03-01951.1995; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Kazama H, 2007, NEUROSCIENCE, V145, P1007, DOI 10.1016/j.neuroscience.2006.12.066; Klagges BRE, 1996, J NEUROSCI, V16, P3154; LAHEY T, 1994, NEURON, V13, P823, DOI 10.1016/0896-6273(94)90249-6; Margulies C, 2005, CURR BIOL, V15, pR700, DOI 10.1016/j.cub.2005.08.024; Mehnert KI, 2007, DEV NEUROBIOL, V67, P415, DOI 10.1002/dneu.20332; Pyza E, 1999, J NEUROBIOL, V40, P77, DOI 10.1002/(SICI)1097-4695(199907)40:1<77::AID-NEU7>3.0.CO;2-0; Sachse S, 2007, NEURON, V56, P838, DOI 10.1016/j.neuron.2007.10.035; SCHULZE KL, 1995, CELL, V80, P311, DOI 10.1016/0092-8674(95)90414-X; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Vyazovskiy VV, 2008, NAT NEUROSCI, V11, P200, DOI 10.1038/nn2035; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X; ZINSMAIER KE, 1994, SCIENCE, V263, P977, DOI 10.1126/science.8310297	28	232	235	0	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2009	324	5923					109	112		10.1126/science.1166673	http://dx.doi.org/10.1126/science.1166673			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427TN	19342593	Green Accepted			2022-12-01	WOS:000264802100044
J	Di Sabatino, A; Corazza, GR				Di Sabatino, Antonio; Corazza, Gino Roberto			Coeliac disease	LANCET			English	Review							STEM-CELL TRANSPLANTATION; INTESTINAL T-CELLS; GLUTEN-FREE DIET; TERM-FOLLOW-UP; TISSUE TRANSGLUTAMINASE; VILLOUS ATROPHY; INTRAEPITHELIAL LYMPHOCYTES; CLINICAL PRESENTATION; SPLENIC HYPOFUNCTION; GLIADIN PEPTIDES	Coeliac disease is a chronic inflammatory disorder of the small bowel induced in genetically susceptible people by the irritant gluten and possibly other environmental cofactors. The disorder is characterised by a diverse clinical heterogeneity that ranges from asymptomatic to severely symptomatic, and it manifests with frank malabsorption, an increased morbidity attributable to the frequent association with autoimmune disorders and increased mortality resulting from the emergence of T-cell clonal proliferations that predispose the patient to enteropathy-type T-cell lymphoma. Our understanding of the molecular basis for this disorder has improved and enabled the identification of targets for new therapies, although a strict gluten-free diet remains the mainstay of safe and effective treatment. In this Seminar we critically reassess the clinical and diagnostic aspects of this disease and new perspectives in its pathogenesis and treatment.	[Corazza, Gino Roberto] Univ Pavia, Fdn IRCCS Policlin San Matteo, Med Clin 1, Dept Med 1,Ctr Studio & Cura Malattia Celiaca, I-27100 Pavia, Italy	IRCCS Fondazione San Matteo; University of Pavia	Corazza, GR (corresponding author), Univ Pavia, Fdn IRCCS Policlin San Matteo, Med Clin 1, Dept Med 1,Ctr Studio & Cura Malattia Celiaca, Piazzale Golgi 5, I-27100 Pavia, Italy.	gr.corazza@smatteo.pv.it	Di Sabatino, Antonio/K-8015-2016; CORAZZA, GINO ROBERTO/K-8500-2016	Di Sabatino, Antonio/0000-0002-0302-8645; CORAZZA, GINO ROBERTO/0000-0001-9532-0573				Al-Toma A, 2007, GUT, V56, P1373, DOI 10.1136/gut.2006.114512; Al-Toma A, 2007, BLOOD, V109, P2243, DOI 10.1182/blood-2006-08-042820; Al-Toma A, 2006, CLIN GASTROENTEROL H, V4, P1322, DOI 10.1016/j.cgh.2006.07.007; Arentz-Hansen H, 2004, PLOS MED, V1, P84, DOI 10.1371/journal.pmed.0010001; AshtonKey M, 1997, AM J PATHOL, V151, P493; Bardella MT, 2000, GASTROINTEST ENDOSC, V51, P714, DOI 10.1067/mge.2000.104653; Barone MV, 2007, GASTROENTEROLOGY, V132, P1245, DOI 10.1053/j.gastro.2007.01.030; Benahmed M, 2007, GASTROENTEROLOGY, V132, P994, DOI 10.1053/j.gastro.2006.12.025; Bethune MT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001614; Bishton MJ, 2007, BRIT J HAEMATOL, V136, P111, DOI 10.1111/j.1365-2141.2006.06371.x; Bonamico M, 2008, J PEDIATR GASTR NUTR, V47, P618, DOI 10.1097/MPG.0b013e3181677d6e; Brar P, 2007, DIGEST LIVER DIS, V39, P26, DOI 10.1016/j.dld.2006.07.014; BROCCHI E, 1988, NEW ENGL J MED, V319, P741, DOI 10.1056/NEJM198809223191202; Brown I, 2006, ARCH PATHOL LAB MED, V130, P1020; Bushara KO, 2005, GASTROENTEROLOGY, V128, pS92, DOI 10.1053/j.gastro.2005.02.018; Cammarota G, 2000, LANCET, V356, P1494, DOI 10.1016/S0140-6736(00)02880-4; Cammarota G, 2006, ALIMENT PHARM THER, V23, P61, DOI 10.1111/j.1365-2036.2006.02732.x; Carroccio A, 2002, CLIN CHEM, V48, P1546; Cataldo F, 2000, GUT, V47, P366, DOI 10.1136/gut.47.3.366; Catassi C, 1999, LANCET, V354, P647, DOI 10.1016/S0140-6736(99)02609-4; Catassi C, 2007, AM J CLIN NUTR, V85, P160, DOI 10.1093/ajcn/85.1.160; Cellier C, 1998, GASTROENTEROLOGY, V114, P471, DOI 10.1016/S0016-5085(98)70530-X; Cellier C, 2000, LANCET, V356, P203, DOI 10.1016/S0140-6736(00)02481-8; Ciccocioppo R, 2006, AM J CLIN PATHOL, V125, P502, DOI 10.1309/DTYRA91G8R0KTM8M; Ciccocioppo R, 2005, LAB INVEST, V85, P397, DOI 10.1038/labinvest.3700225; COLLIN P, 1993, SCAND J GASTROENTERO, V28, P595, DOI 10.3109/00365529309096094; CORAZZA G, 1992, GASTROENTEROLOGY, V103, P1517, DOI 10.1016/0016-5085(92)91172-Z; Corazza GR, 2007, CLIN GASTROENTEROL H, V5, P838, DOI 10.1016/j.cgh.2007.03.019; Corazza GR, 1997, LANCET, V350, P106, DOI 10.1016/S0140-6736(97)01042-8; CORAZZA GR, 1993, J CLIN GASTROENTEROL, V16, P16, DOI 10.1097/00004836-199301000-00006; Corazza GR, 1999, AM J GASTROENTEROL, V94, P391; CORAZZA GR, 1995, GASTROENTEROLOGY, V109, P122, DOI 10.1016/0016-5085(95)90276-7; Corrao G, 2001, LANCET, V358, P356, DOI 10.1016/S0140-6736(01)05554-4; Dewar DH, 2006, EUR J GASTROEN HEPAT, V18, P483, DOI 10.1097/00042737-200605000-00005; Dewar DH, 2005, GASTROENTEROLOGY, V128, pS19, DOI 10.1053/j.gastro.2005.02.010; Di Cagno R, 2004, APPL ENVIRON MICROB, V70, P1088, DOI 10.1128/AEM.70.2.1088-1096.2004; Di Sabatino A, 2006, GUT, V55, P469, DOI 10.1136/gut.2005.068684; Di Sabatino A, 2006, CLIN GASTROENTEROL H, V4, P179, DOI 10.1016/S1542-3565(05)00982-1; Di Sabatino A, 2001, GUT, V49, P380, DOI 10.1136/gut.49.3.380; Di Sabatino A, 2007, J ALLERGY CLIN IMMUN, V120, P1461, DOI 10.1016/j.jaci.2007.07.054; Di Sabatino A, 2007, GASTROENTEROLOGY, V133, P1175, DOI 10.1053/j.gastro.2007.08.018; Dieterich W, 2006, GUT, V55, P478, DOI 10.1136/gut.2005.069385; Dieterich W, 1997, NAT MED, V3, P797, DOI 10.1038/nm0797-797; Esposito C, 2003, AM J GASTROENTEROL, V98, P1813, DOI [10.1016/S0002-9270(03)00431-3, 10.1111/j.1572-0241.2003.07582.x]; Esposito C, 2002, GUT, V51, P177, DOI 10.1136/gut.51.2.177; Fabbro E, 2008, CLIN CHIM ACTA, V390, P134, DOI 10.1016/j.cca.2008.01.015; Fabiani E, 2000, J PEDIATR-US, V136, P841, DOI 10.1016/S0022-3476(00)35904-2; Fasano A, 2003, ARCH INTERN MED, V163, P286, DOI 10.1001/archinte.163.3.286; Fasano A, 2001, GASTROENTEROLOGY, V120, P636, DOI 10.1053/gast.2001.22123; FERGUSON A, 1993, GUT, V34, P150, DOI 10.1136/gut.34.2.150; Fina D, 2008, GUT, V57, P887, DOI 10.1136/gut.2007.129882; Fine KD, 1997, GASTROENTEROLOGY, V112, P1830, DOI 10.1053/gast.1997.v112.pm9178673; Forsberg G, 2004, AM J GASTROENTEROL, V99, P894, DOI 10.1111/j.1572-0241.2004.04157.x; Forsberg G, 2002, GASTROENTEROLOGY, V123, P667, DOI 10.1053/gast.2002.35355; Gass J, 2007, GASTROENTEROLOGY, V133, P472, DOI 10.1053/j.gastro.2007.05.028; Gianfrani C, 2007, GASTROENTEROLOGY, V133, P780, DOI 10.1053/j.gastro.2007.06.023; Greco L, 1998, AM J HUM GENET, V62, P669, DOI 10.1086/301754; Green PHR, 2001, AM J GASTROENTEROL, V96, P126, DOI 10.1111/j.1572-0241.2001.03462.x; Guidetti CS, 2001, GUT, V49, P502, DOI 10.1136/gut.49.4.502; Halttunen T, 1999, GASTROENTEROLOGY, V116, P566, DOI 10.1016/S0016-5085(99)70178-2; Hill ID, 2005, GASTROENTEROLOGY, V128, pS25, DOI 10.1053/j.gastro.2005.02.012; Hin H, 1999, BMJ-BRIT MED J, V318, P164, DOI 10.1136/bmj.318.7177.164; Hoffenberg EJ, 2003, J PEDIATR-US, V143, P308, DOI 10.1067/S0022-3476(03)00282-8; Holopainen P, 2004, TISSUE ANTIGENS, V63, P212, DOI 10.1111/j.1399-0039.2004.00189.x; Hue S, 2004, IMMUNITY, V21, P367, DOI 10.1016/j.immuni.2004.06.018; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Ivarsson A, 2002, AM J CLIN NUTR, V75, P914, DOI 10.1093/ajcn/75.5.914; JABBARI M, 1988, GASTROENTEROLOGY, V95, P1518, DOI 10.1016/S0016-5085(88)80071-4; Jabri B, 2000, GASTROENTEROLOGY, V118, P867, DOI 10.1016/S0016-5085(00)70173-9; Jafri MR, 2008, DIGEST DIS SCI, V53, P964, DOI 10.1007/s10620-007-9976-0; Jantunen E, 2003, LEUKEMIA LYMPHOMA, V44, P2163, DOI 10.1080/1042819031000123456; Johnston SD, 1998, QJM-MON J ASSOC PHYS, V91, P853, DOI 10.1093/qjmed/91.12.853; Kagnoff MF, 2007, J CLIN INVEST, V117, P41, DOI 10.1172/JCI30253; Karell K, 2003, HUM IMMUNOL, V64, P469, DOI 10.1016/S0198-8859(03)00027-2; Kaukinen K, 2007, SCAND J GASTROENTERO, V42, P1428, DOI 10.1080/00365520701452217; Kemppainen T, 1999, BONE, V24, P249, DOI 10.1016/S8756-3282(98)00178-1; Kemppainen T, 2007, SCAND J GASTROENTERO, V42, P54, DOI 10.1080/00365520600842245; Kim CY, 2004, P NATL ACAD SCI USA, V101, P4175, DOI 10.1073/pnas.0306885101; Kiraly R, 2006, J AUTOIMMUN, V26, P278, DOI 10.1016/j.jaut.2006.03.002; Korponay-Szabo IR, 2007, BMJ-BRIT MED J, V335, P1244, DOI 10.1136/bmj.39405.472975.80; KUMAR PJ, 1988, ARCH DIS CHILD, V63, P916, DOI 10.1136/adc.63.8.916; Lammers KM, 2008, GASTROENTEROLOGY, V135, P194, DOI 10.1053/j.gastro.2008.03.023; Lee A, 2003, J AM DIET ASSOC, V103, P1533, DOI 10.1016/j.jada.2003.08.027; Lewis NR, 2008, ALIMENT PHARM THER, V27, P1140, DOI 10.1111/j.1365-2036.2008.03660.x; Lewis NR, 2005, EUR J GASTROEN HEPAT, V17, P1065, DOI 10.1097/00042737-200510000-00009; Losowsky MS, 2008, DIGEST DIS, V26, P112, DOI 10.1159/000116768; Ludvigsson JF, 2008, GUT, V57, P1074, DOI 10.1136/gut.2007.133868; Ludvigsson JF, 2007, ALIMENT PHARM THER, V25, P273, DOI 10.1111/j.1365-2036.2006.03203.x; Lundin KEA, 2003, GUT, V52, P1649, DOI 10.1136/gut.52.11.1649; Maiuri L, 2003, LANCET, V362, P30, DOI 10.1016/S0140-6736(03)13803-2; MAKI M, 1990, ARCH DIS CHILD, V65, P1137, DOI 10.1136/adc.65.10.1137; Maki M, 2003, NEW ENGL J MED, V348, P2517, DOI 10.1056/NEJMoa021687; Malamut G, 2009, GASTROENTEROLOGY, V136, P81, DOI 10.1053/j.gastro.2008.09.069; MANN NS, 2006, INTERN MED J, V13, P3; Matysiak-Budnik T, 2008, J EXP MED, V205, P143, DOI 10.1084/jem.20071204; Matysiak-Budnik T, 2007, GUT, V56, P1379, DOI 10.1136/gut.2006.100511; Mention JJ, 2003, GASTROENTEROLOGY, V125, P730, DOI 10.1016/S0016-5085(03)01047-3; Mitea C, 2008, GUT, V57, P25, DOI 10.1136/gut.2006.111609; Molberg O, 1998, NAT MED, V4, P713, DOI 10.1038/nm0698-713; Molberg O, 2005, GASTROENTEROLOGY, V128, P393, DOI 10.1053/j.gastro.2004.11.003; Molberg O, 2003, GASTROENTEROLOGY, V125, P337, DOI 10.1016/S0016-5085(03)00890-4; Monsuur AJ, 2005, NAT GENET, V37, P1341, DOI 10.1038/ng1680; Monteleone G, 2001, EUR J IMMUNOL, V31, P2247, DOI 10.1002/1521-4141(200108)31:8<2247::AID-IMMU2247>3.0.CO;2-4; Monteleone I, 2004, GUT, V53, P1090, DOI 10.1136/gut.2003.030551; Mora S, 2001, J PEDIATR-US, V139, P516, DOI 10.1067/mpd.2001.116298; MORTIMER PE, 1968, BRIT MED J, V3, P7, DOI 10.1136/bmj.3.5609.7; Mulder CJJ, 2005, BEST PRACT RES CL GA, V19, P479, DOI 10.1016/j.bpg.2005.01.007; Murray JA, 2008, CLIN GASTROENTEROL H, V6, P186, DOI 10.1016/j.cgh.2007.10.012; Murray JA, 2003, CLIN GASTROENTEROL H, V1, P19, DOI 10.1053/jcgh.2003.50004; Nilsen EM, 1998, GASTROENTEROLOGY, V115, P551, DOI 10.1016/S0016-5085(98)70134-9; Nistico L, 2006, GUT, V55, P803, DOI 10.1136/gut.2005.083964; Norris JM, 2005, JAMA-J AM MED ASSOC, V293, P2343, DOI 10.1001/jama.293.19.2343; O'Leary C, 2004, AM J GASTROENTEROL, V99, P2437, DOI 10.1111/j.1572-0241.2004.40182.x; Oberhuber G, 1999, EUR J GASTROEN HEPAT, V11, P1185, DOI 10.1097/00042737-199910000-00019; Obermann EC, 2004, J PATHOL, V202, P252, DOI 10.1002/path.1506; Pais WP, 2008, GASTROINTEST ENDOSC, V67, P1082, DOI 10.1016/j.gie.2007.10.015; Peters U, 2003, ARCH INTERN MED, V163, P1566, DOI 10.1001/archinte.163.13.1566; Pietzak MM, 2005, GASTROENTEROLOGY, V128, pS135, DOI 10.1053/j.gastro.2005.02.025; PRZEMIOSLO RT, 1994, GUT, V35, P1398, DOI 10.1136/gut.35.10.1398; Pyle GG, 2005, CLIN GASTROENTEROL H, V3, P687, DOI 10.1016/S1542-3565(05)00366-6; Qiao SW, 2005, J IMMUNOL, V174, P1657, DOI 10.4049/jimmunol.174.3.1657; Qiao SW, 2004, J IMMUNOL, V173, P1757, DOI 10.4049/jimmunol.173.3.1757; Rashtak S, 2007, ANN INTERN MED, V147, P339, DOI 10.7326/0003-4819-147-5-200709040-00009; Rostami K, 2001, EUR J OBSTET GYN R B, V96, P146, DOI 10.1016/S0301-2115(00)00457-7; Rubio-Tapia A, 2007, HEPATOLOGY, V46, P1650, DOI 10.1002/hep.21949; Rubio-Tapia A, 2009, GASTROENTEROLOGY, V136, P99, DOI 10.1053/j.gastro.2008.10.013; Salvati VM, 2002, GUT, V50, P186, DOI 10.1136/gut.50.2.186; SategnaGuidetti C, 1996, J CLIN GASTROENTEROL, V23, P101, DOI 10.1097/00004836-199609000-00006; Schumann M, 2008, GUT, V57, P747, DOI 10.1136/gut.2007.136366; Shah VH, 2000, GASTROINTEST ENDOSC, V51, P717, DOI 10.1067/mge.2000.104977; Shan L, 2002, SCIENCE, V297, P2275, DOI 10.1126/science.1074129; Solaymani-Dodaran M, 2007, AM J GASTROENTEROL, V102, P864, DOI 10.1111/j.1572-0241.2007.01111.x; Sollid LM, 2005, CLIN GASTROENTEROL H, V3, P843, DOI 10.1016/S1542-3565(05)00532-X; SOLLID LM, 1989, J EXP MED, V169, P345, DOI 10.1084/jem.169.1.345; Spaenij-Dekking L, 2005, GASTROENTEROLOGY, V129, P797, DOI 10.1053/j.gastro.2005.06.017; Stene LC, 2006, AM J GASTROENTEROL, V101, P2333, DOI 10.1111/j.1572-0241.2006.00741.x; STURGESS R, 1994, LANCET, V343, P758, DOI 10.1016/S0140-6736(94)91837-6; Thomas HJ, 2008, EUR J GASTROEN HEPAT, V20, P624, DOI 10.1097/MEG.0b013e3282f45764; Tommasini A, 2004, ARCH DIS CHILD, V89, P512, DOI 10.1136/adc.2003.029603; Vader LW, 2003, GASTROENTEROLOGY, V125, P1105, DOI 10.1016/S0016-5085(03)01204-6; Vader W, 2002, GASTROENTEROLOGY, V122, P1729, DOI 10.1053/gast.2002.33606; Vahedi K, 2003, AM J GASTROENTEROL, V98, P1079, DOI 10.1111/j.1572-0241.2003.07284.x; van de Wal Y, 1998, J IMMUNOL, V161, P1585; van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058; Ventura A, 1999, GASTROENTEROLOGY, V117, P297, DOI 10.1053/gast.1999.0029900297; Verkarre V, 2003, GASTROENTEROLOGY, V125, P40, DOI 10.1016/S0016-5085(03)00692-9; Vivas S, 2006, NEW ENGL J MED, V354, P2514, DOI 10.1056/NEJMc053129; Wapenaar MC, 2008, GUT, V57, P463, DOI 10.1136/gut.2007.133132; West J, 2004, BRIT MED J, V329, P716, DOI 10.1136/bmj.38169.486701.7C; West J, 2003, GUT, V52, P960, DOI 10.1136/gut.52.7.960; WIESER H, 1995, BAILLIERE CLIN GASTR, V9, P191, DOI 10.1016/0950-3528(95)90027-6; Wieser H, 2007, FOOD MICROBIOL, V24, P115, DOI 10.1016/j.fm.2006.07.004; Wolters VM, 2008, AM J GASTROENTEROL, V103, P190, DOI 10.1111/j.1572-0241.2007.01471.x; Zanoni G, 2006, PLOS MED, V3, P1637, DOI 10.1371/journal.pmed.0030358	155	464	492	0	83	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR-MAY	2009	373	9673					1480	1493		10.1016/S0140-6736(09)60254-3	http://dx.doi.org/10.1016/S0140-6736(09)60254-3			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437QL	19394538				2022-12-01	WOS:000265501900037
J	Gilman, M; Gilman, SL; Johns, MM				Gilman, Marina; Gilman, Sander L.; Johns, Michael M., III			The art of medicine Human papillomavirus, abstinence, and the other risks	LANCET			English	Editorial Material									[Gilman, Sander L.] Emory Univ, Grad Inst Liberal Arts, Atlanta, GA 30322 USA; [Gilman, Sander L.] Emory Univ, Dept Psychiat, Atlanta, GA 30322 USA; [Gilman, Marina; Johns, Michael M., III] Emory Univ, Emory Voice Clin, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University	Gilman, SL (corresponding author), Emory Univ, Grad Inst Liberal Arts, Atlanta, GA 30322 USA.	sander.gilman@emory.edu	Gilman, Marina/AAI-8144-2021					[Anonymous], 2006, Lancet, V368, P1212; Chan JK, 2007, J CLIN ONCOL, V25, P2975, DOI 10.1200/JCO.2007.10.8662; Chaturvedi AK, 2008, J CLIN ONCOL, V26, P612, DOI 10.1200/JCO.2007.14.1713; Trenholm C, 2008, J POLICY ANAL MANAG, V27, P255, DOI 10.1002/pam.20324; Winer RL, 2008, J INFECT DIS, V197, P279, DOI 10.1086/524875	5	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR-MAY	2009	373	9673					1420	1421		10.1016/S0140-6736(09)60810-2	http://dx.doi.org/10.1016/S0140-6736(09)60810-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	437QL	19400001				2022-12-01	WOS:000265501900016
J	Chen, M; Briscoe, WH; Armes, SP; Klein, J				Chen, Meng; Briscoe, Wuge H.; Armes, Steven P.; Klein, Jacob			Lubrication at Physiological Pressures by Polyzwitterionic Brushes	SCIENCE			English	Article							BOUNDARY LUBRICATION; FRICTIONAL FORCES; POLYMER; SURFACE; LAYERS; HYDRATION; QUALITY; CHAINS	The very low sliding friction at natural synovial joints, which have friction coefficients of mu < 0.002 at pressures up to 5 megapascals or more, has to date not been attained in any human-made joints or between model surfaces in aqueous environments. We found that surfaces in water bearing polyzwitterionic brushes that were polymerized directly from the surface can have m values as low as 0.0004 at pressures as high as 7.5 megapascals. This extreme lubrication is attributed primarily to the strong hydration of the phosphorylcholine-like monomers that make up the robustly attached brushes, and may have relevance to a wide range of human-made aqueous lubrication situations.	[Chen, Meng; Briscoe, Wuge H.; Klein, Jacob] Univ Oxford, Phys & Theoret Chem Lab, Oxford OX1 3QZ, England; [Armes, Steven P.] Univ Sheffield, Dept Chem, Sheffield S3 7HF, S Yorkshire, England; [Klein, Jacob] Weizmann Inst Sci, IL-76100 Rehovot, Israel	University of Oxford; University of Sheffield; Weizmann Institute of Science	Klein, J (corresponding author), Univ Oxford, Phys & Theoret Chem Lab, Oxford OX1 3QZ, England.	jacob.klein@weizmann.ac.il	Briscoe, Wuge H/H-5435-2018	Briscoe, Wuge H/0000-0001-8025-960X; Armes, Steven/0000-0002-8289-6351; Chen, Meng/0000-0001-6553-0799	Engineering and Physical Sciences Research Council; Petroleum Research Fund [45694-AC7]; Charles McCutchen Foundation; Minerva Foundation at the Weizmann Institute; Engineering and Physical Sciences Research Council [EP/C535421/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Petroleum Research Fund(American Chemical Society); Charles McCutchen Foundation; Minerva Foundation at the Weizmann Institute; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank A. L. Lewis (Biocompatibles Ltd.) for kind donation of the MPC monomer; X. Y. Chen for synthesis of the macroinitiator; I. E. Dunlop, S. Perkin, and W. Feng for help and advice; and P. Pincus for a discussion. S.P.A. is the recipient of a Royal Society Research Merit Award. W.H.B. thanks the Taiho Kogyo Tribology Research Foundation for support. This work was supported by the Engineering and Physical Sciences Research Council, the Petroleum Research Fund (grant 45694-AC7), the Charles McCutchen Foundation, and the Minerva Foundation at the Weizmann Institute.	Briscoe WH, 2006, NATURE, V444, P191, DOI 10.1038/nature05196; CHAN DYC, 1980, J COLLOID INTERF SCI, V77, P283, DOI 10.1016/0021-9797(80)90445-2; Chen M, 2007, CHEMPHYSCHEM, V8, P1303, DOI 10.1002/cphc.200700131; COTTON FA, 1998, ADV INORG CHEM, P1288; Feng W, 2007, BIOINTERPHASES, V2, P34, DOI 10.1116/1.2711705; Forster AM, 2006, J POLYM SCI POL PHYS, V44, P649, DOI 10.1002/polb.20701; Gong JP, 2001, J AM CHEM SOC, V123, P5582, DOI 10.1021/ja003794q; Gourdon D, 2008, LANGMUIR, V24, P1534, DOI 10.1021/la702259c; Hills BA, 2002, J RHEUMATOL, V29, P200; Ishihara K, 1998, J BIOMED MATER RES, V39, P323, DOI 10.1002/(SICI)1097-4636(199802)39:2<323::AID-JBM21>3.0.CO;2-C; Klein J, 2006, P I MECH ENG J-J ENG, V220, P691, DOI 10.1243/13506501JET143; KLEIN J, 1994, NATURE, V370, P634, DOI 10.1038/370634a0; Kobayashi M, 2007, SOFT MATTER, V3, P740, DOI 10.1039/b615780g; Lee S, 2008, SCIENCE, V319, P575, DOI 10.1126/science.1153273; LIS LJ, 1982, BIOPHYS J, V37, P657; MCCUTCHEN CW, 1966, FED PROC, V25, P1061; Moro T, 2004, NAT MATER, V3, P829, DOI 10.1038/nmat1233; Pabst G, 2000, PHYS REV E, V62, P4000, DOI 10.1103/PhysRevE.62.4000; Park S, 2004, J BIOMECH, V37, P1679, DOI 10.1016/j.jbiomech.2004.02.017; Rappolt M, 2001, COLLOID SURFACE A, V183, P171, DOI 10.1016/S0927-7757(01)00568-4; Raviv U, 2003, NATURE, V425, P163, DOI 10.1038/nature01970; Raviv U, 2002, SCIENCE, V297, P1540, DOI 10.1126/science.1074481; Schorr PA, 2003, MACROMOLECULES, V36, P389, DOI 10.1021/ma011207v; SWANN DA, 1984, ARTHRITIS RHEUM, V27, P552, DOI 10.1002/art.1780270511; Tadmor R, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.115503; WITTEN TA, 1990, MACROMOLECULES, V23, P824, DOI 10.1021/ma00205a022; Yaseen M, 2006, LANGMUIR, V22, P5825, DOI 10.1021/la053316z; [No title captured]	28	509	537	21	462	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2009	323	5922					1698	1701		10.1126/science.1169399	http://dx.doi.org/10.1126/science.1169399			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	424IG	19325108	Green Accepted			2022-12-01	WOS:000264559800031
J	Hill, MN; Gorzalka, BB				Hill, Matthew N.; Gorzalka, Boris B.			Impairments in Endocannabinoid Signaling and Depressive Illness	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							STRESS-INDUCED ACTIVATION; PITUITARY-ADRENAL AXIS; ANANDAMIDE HYDROLYSIS; HIPPOCAMPUS; MODULATION; BLOCKADE; SYSTEM; BRAIN		[Hill, Matthew N.] Rockefeller Univ, Neuroendocrinol Lab, New York, NY 10021 USA; [Gorzalka, Boris B.] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada	Rockefeller University; University of British Columbia	Hill, MN (corresponding author), Rockefeller Univ, Neuroendocrinol Lab, 1230 York Ave, New York, NY 10021 USA.	mhill@rockefeller.edu	Hill, Matthew N/J-4610-2013					Aso E, 2008, J NEUROCHEM, V105, P565, DOI 10.1111/j.1471-4159.2007.05149.x; Gobbi G, 2005, P NATL ACAD SCI USA, V102, P18620, DOI 10.1073/pnas.0509591102; Hill MN, 2008, PHARMACOPSYCHIATRY, V41, P48, DOI 10.1055/s-2007-993211; Hill MN, 2007, J NEUROCHEM, V103, P47, DOI 10.1111/j.1471-4159.2007.04688.x; Hill MN, 2006, NEUROPSYCHOPHARMACOL, V31, P2591, DOI 10.1038/sj.npp.1301092; Hill MN, 2005, BEHAV PHARMACOL, V16, P333, DOI 10.1097/00008877-200509000-00006; Hill MN, 2005, NEUROPSYCHOPHARMACOL, V30, P508, DOI 10.1038/sj.npp.1300601; Justinova Z, 2008, BIOL PSYCHIAT, V64, P930, DOI 10.1016/j.biopsych.2008.08.008; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; Patel S, 2004, ENDOCRINOLOGY, V145, P5431, DOI 10.1210/en.2004-0638; Pertwee RG, 2008, ADDICT BIOL, V13, P147, DOI 10.1111/j.1369-1600.2008.00108.x; *WHO, DEPR; *ZIM AC REP, PFIZ KILLS DIET DRUG	13	53	53	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 18	2009	301	11					1165	1166		10.1001/jama.2009.369	http://dx.doi.org/10.1001/jama.2009.369			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	419UC	19293417				2022-12-01	WOS:000264244200022
J	Wilson, JF				Wilson, Jennifer Fisher			More Cases of Drug-Resistant Tuberculosis Complicate Care but Spur Global Research and Innovation	ANNALS OF INTERNAL MEDICINE			English	News Item												jenwilson@acponline.org	Wilson, Jennifer/Q-3623-2019	Wilson, Jennifer/0000-0003-4025-3136				Anonymous, 2007, Morbidity and Mortality Weekly Report, V56, P245; FRIEDEN TR, 1995, NEW ENGL J MED, V333, P229, DOI 10.1056/NEJM199507273330406; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Loveday M, 2008, INT J TUBERC LUNG D, V12, P1042; Mitnick C, 2003, NEW ENGL J MED, V348, P119, DOI 10.1056/NEJMoa022928; Resch SC, 2006, PLOS MED, V3, P1048, DOI 10.1371/journal.pmed.0030241; Shin SS, 2008, EMERG INFECT DIS, V14, P701, DOI 10.3201/eid1405.070721	7	1	1	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 17	2009	150	6					433	436		10.7326/0003-4819-150-6-200903170-00031	http://dx.doi.org/10.7326/0003-4819-150-6-200903170-00031			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	423AJ	19293087				2022-12-01	WOS:000264468500025
J	Vance, C; Rogelj, B; Hortobagyi, T; De Vos, KJ; Nishimura, AL; Sreedharan, J; Hu, X; Smith, B; Ruddy, D; Wright, P; Ganesalingam, J; Williams, KL; Tripathi, V; Al-Saraj, S; Al-Chalabi, A; Leigh, PN; Blair, IP; Nicholson, G; de Belleroche, J; Gallo, JM; Miller, CC; Shaw, CE				Vance, Caroline; Rogelj, Boris; Hortobagyi, Tibor; De Vos, Kurt J.; Nishimura, Agnes Lumi; Sreedharan, Jemeen; Hu, Xun; Smith, Bradley; Ruddy, Deborah; Wright, Paul; Ganesalingam, Jeban; Williams, Kelly L.; Tripathi, Vineeta; Al-Saraj, Safa; Al-Chalabi, Ammar; Leigh, P. Nigel; Blair, Ian P.; Nicholson, Garth; de Belleroche, Jackie; Gallo, Jean-Marc; Miller, Christopher C.; Shaw, Christopher E.			Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6	SCIENCE			English	Article							FRONTOTEMPORAL DEMENTIA; TARDBP MUTATIONS; CHROMOSOME 9P; TDP-43; LOCUS; ALS; ACCUMULATION; DEGENERATION; PATIENT; LINKAGE	Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that is familial in 10% of cases. We have identified a missense mutation in the gene encoding fused in sarcoma (FUS) in a British kindred, linked to ALS6. In a survey of 197 familial ALS index cases, we identified two further missense mutations in eight families. Postmortem analysis of three cases with FUS mutations showed FUS-immunoreactive cytoplasmic inclusions and predominantly lower motor neuron degeneration. Cellular expression studies revealed aberrant localization of mutant FUS protein. FUS is involved in the regulation of transcription and RNA splicing and transport, and it has functional homology to another ALS gene, TARDBP, which suggests that a common mechanism may underlie motor neuron degeneration.	[Vance, Caroline; Rogelj, Boris; Hortobagyi, Tibor; Nishimura, Agnes Lumi; Sreedharan, Jemeen; Hu, Xun; Smith, Bradley; Ruddy, Deborah; Wright, Paul; Ganesalingam, Jeban; Tripathi, Vineeta; Al-Saraj, Safa; Al-Chalabi, Ammar; Leigh, P. Nigel; Gallo, Jean-Marc; Miller, Christopher C.; Shaw, Christopher E.] Kings Coll London, Inst Psychiat, Ctr Neurodegenerat Res, Dept Clin Neurosci,MRC, London SE5 8AF, England; [De Vos, Kurt J.; Miller, Christopher C.] Kings Coll London, Inst Psychiat, Ctr Neurodegenerat Res, Dept Neurosci,MRC, London SE5 8AF, England; [Williams, Kelly L.; Blair, Ian P.; Nicholson, Garth] ANSAC Res Inst, Northcott Neurosci Lab, Concord, NSW 2139, Australia; [Nicholson, Garth] Concord Hosp, Mol Med Lab, Sydney, NSW 2139, Australia; [Blair, Ian P.; Nicholson, Garth] Univ Sydney, Fac Med, Sydney, NSW 2139, Australia; [de Belleroche, Jackie] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Fac Med, Div Neurosci & Mental Hlth, London W12 0NN, England	University of London; King's College London; University of London; King's College London; Concord Repatriation General Hospital; University of Sydney; Imperial College London	Shaw, CE (corresponding author), Kings Coll London, Inst Psychiat, Ctr Neurodegenerat Res, Dept Clin Neurosci,MRC, London SE5 8AF, England.	chris.shaw@iop.kcl.ac.uk	Nishimura, Agnes L/B-2905-2011; Wright, Paul/K-9171-2013; Vance, Caroline/Q-2633-2019; Vance, Caroline/C-3047-2012; De Vos, Kurt/D-8380-2011; Leigh, Peter/AAD-5638-2019; Al-Chalabi, Ammar/E-5361-2010; Williams, Kelly L/A-5545-2010; Smith, Bradley/H-6107-2013; Rogelj, Boris/G-9252-2011; Miller, Christopher/H-5733-2012; sreedharan, jemeen/E-7327-2016	Wright, Paul/0000-0002-0359-9683; Vance, Caroline/0000-0001-5780-6951; Vance, Caroline/0000-0001-5780-6951; De Vos, Kurt/0000-0003-2161-6309; Al-Chalabi, Ammar/0000-0002-4924-7712; Williams, Kelly L/0000-0001-6319-9473; Rogelj, Boris/0000-0003-3898-1943; Nishimura, Agnes/0000-0001-5295-797X; Blair, Ian/0000-0003-3083-0075; Gallo, Jean-Marc/0000-0003-0214-4545; Smith, Bradley/0000-0002-6980-2453; Shaw, Christopher/0000-0003-0251-0146; Nicholson, Garth/0000-0001-9694-066X; Miller, Christopher/0000-0002-5130-1845; Wright, Paul/0000-0001-8367-5529; sreedharan, jemeen/0000-0002-8682-6844	American ALS Association; Lady Edith Wolfson Trust; Motor Neurone Disease Association UK; The Wellcome Trust; European Union [LSHM-CT-2003-503330]; National Institute for Health Research Biomedical Research Centre for Mental Health; The South London and Maudsley National Health Service Foundation Trust; Medical Research Council UK; King's College Hospital Charity [Jack Cigman]; The Heaton-Ellis Trust; The Psychiatry Research Trust of the Institute of Psychiatry; Australian National Health and Medical Research Council [CDA 511941]; Motor Neuron Disease Research Institute of Australia [Peter Stearne]; MRC [G0500289, G0501573, G0900688, G0300329, G0600676, MC_G1000733, G0600974] Funding Source: UKRI; Medical Research Council [G0500289, G0501573, G0900688, MC_G1000733, G0600676, G0500289B, G0600974, G0300329] Funding Source: researchfish	American ALS Association; Lady Edith Wolfson Trust; Motor Neurone Disease Association UK; The Wellcome Trust(Wellcome TrustEuropean Commission); European Union(European Commission); National Institute for Health Research Biomedical Research Centre for Mental Health(National Institute for Health Research (NIHR)); The South London and Maudsley National Health Service Foundation Trust; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); King's College Hospital Charity; The Heaton-Ellis Trust; The Psychiatry Research Trust of the Institute of Psychiatry; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Motor Neuron Disease Research Institute of Australia; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This publication is dedicated to the patients and families who have contributed to this project and to B. Coote and C. Cecere for blood sample collection. Postmortem tissues were provided by MRC Neurodegenerative Diseases Brain Bank. This work was supported in the United Kingdom by grants from the American ALS Association, the Middlemass family, Lady Edith Wolfson Trust, Motor Neurone Disease Association UK, The Wellcome Trust, European Union (APOPIS consortium, contract LSHM-CT-2003-503330, and NeuroNE Consortium), National Institute for Health Research Biomedical Research Centre for Mental Health, The South London and Maudsley National Health Service Foundation Trust, Medical Research Council UK, a Jack Cigman grant from King's College Hospital Charity, The Heaton-Ellis Trust, and The Psychiatry Research Trust of the Institute of Psychiatry. In Australia the work was supported by the Australian National Health and Medical Research Council (CDA 511941) and a Peter Stearne grant from the Motor Neuron Disease Research Institute of Australia.	Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Conforti FL, 2008, NEUROMUSCULAR DISORD, V18, P68, DOI 10.1016/j.nmd.2007.07.003; De Vos KJ, 2008, ANNU REV NEUROSCI, V31, P151, DOI 10.1146/annurev.neuro.31.061307.090711; Gitcho MA, 2008, ANN NEUROL, V63, P535, DOI 10.1002/ana.21344; Greenway MJ, 2006, NAT GENET, V38, P411, DOI 10.1038/ng1742; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hand CK, 2002, AM J HUM GENET, V70, P251, DOI 10.1086/337945; Hosler BA, 2000, JAMA-J AM MED ASSOC, V284, P1664, DOI 10.1001/jama.284.13.1664; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Law Warren J., 2006, Briefings in Functional Genomics & Proteomics, V5, P8, DOI 10.1093/bfgp/ell015; Mackenzie IRA, 2007, ANN NEUROL, V61, P427, DOI 10.1002/ana.21147; Morita M, 2006, NEUROLOGY, V66, P839, DOI 10.1212/01.wnl.0000200048.53766.b4; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Paubel A, 2008, ARCH NEUROL-CHICAGO, V65, P1333, DOI 10.1001/archneur.65.10.1333; ROSEN DR, 1993, NATURE, V364, P362, DOI 10.1038/364362c0; Ruddy DM, 2003, AM J HUM GENET, V73, P390, DOI 10.1086/377157; Sapp PC, 2003, AM J HUM GENET, V73, P397, DOI 10.1086/377158; Shaw C E, 2001, Curr Neurol Neurosci Rep, V1, P69, DOI 10.1007/s11910-001-0078-7; Shaw CE, 1998, ANN NEUROL, V43, P390, DOI 10.1002/ana.410430319; Shaw CE, 1997, NEUROLOGY, V49, P1612, DOI 10.1212/WNL.49.6.1612; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Valdmanis PN, 2007, ARCH NEUROL-CHICAGO, V64, P240, DOI 10.1001/archneur.64.2.240; Van Deerlin VM, 2008, LANCET NEUROL, V7, P409, DOI 10.1016/S1474-4422(08)70071-1; Vance C, 2006, BRAIN, V129, P868, DOI 10.1093/brain/awl030; Wang J, 2002, NEUROBIOL DIS, V9, P139, DOI 10.1006/nbdi.2001.0471; Yoshimura A, 2006, CURR BIOL, V16, P2345, DOI 10.1016/j.cub.2006.10.024	27	1834	1883	8	141	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2009	323	5918					1208	1211		10.1126/science.1165942	http://dx.doi.org/10.1126/science.1165942			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411XT	19251628	Green Accepted			2022-12-01	WOS:000263687600037
J	Licht, JD				Licht, Jonathan D.			Acute Promyelocytic Leukemia -- Weapons of Mass Differentiation.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							GENES		Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Div Hematol & Oncol, Chicago, IL 60611 USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center	Licht, JD (corresponding author), Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Div Hematol & Oncol, Chicago, IL 60611 USA.		Licht, Jonathan/AAL-9184-2020; Licht, Jonathan/L-4239-2019	Licht, Jonathan/0000-0002-3942-1369; 	NATIONAL CANCER INSTITUTE [R01CA059936] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA059936] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alcalay M, 2003, J CLIN INVEST, V112, P1751, DOI 10.1172/JCI17595; Mathews V, 2006, BLOOD, V107, P2627, DOI 10.1182/blood-2005-08-3532; Nasr R, 2008, NAT MED, V14, P1333, DOI 10.1038/nm.1891; Yuan W, 2007, BLOOD, V109, P961, DOI 10.1182/blood-2006-07-036640; Zheng XM, 2007, HAEMATOLOGICA, V92, P323, DOI 10.3324/haematol.10541	5	37	40	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 26	2009	360	9					928	930		10.1056/NEJMcibr0810371	http://dx.doi.org/10.1056/NEJMcibr0810371			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	411CD	19246367				2022-12-01	WOS:000263624700015
J	Bar-Yam, Y; Harmon, D; de Bivort, B				Bar-Yam, Yaneer; Harmon, Dion; de Bivort, Benjamin			SYSTEMS BIOLOGY Attractors and Democratic Dynamics	SCIENCE			English	Editorial Material							TRANSCRIPTIONAL REGULATORY NETWORK; ESCHERICHIA-COLI; CELL FATE; EVOLUTION		[Bar-Yam, Yaneer; Harmon, Dion; de Bivort, Benjamin] New England Complex Syst Inst, Cambridge, MA 02138 USA; [de Bivort, Benjamin] Harvard Univ, Roland Inst, Cambridge, MA 02139 USA	Harvard University	Bar-Yam, Y (corresponding author), New England Complex Syst Inst, 24 Mt Auburn St, Cambridge, MA 02138 USA.	yaneer@necsi.edu						Ao P, 2008, MED HYPOTHESES, V70, P678, DOI 10.1016/j.mehy.2007.03.043; Balazsi G, 2005, P NATL ACAD SCI USA, V102, P7841, DOI 10.1073/pnas.0500365102; Bang AG, 2008, SCIENCE, V320, P58, DOI 10.1126/science.1157042; Bar-Yam Y, 2004, P NATL ACAD SCI USA, V101, P4341, DOI 10.1073/pnas.0400673101; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; de Visser JAGM, 2003, EVOLUTION, V57, P1959, DOI 10.1554/02-750R; Dobrin R, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-10; Huang S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.128701; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Losick R, 2008, SCIENCE, V320, P65, DOI 10.1126/science.1147888; Medina KL, 2004, DEV CELL, V7, P607, DOI 10.1016/j.devcel.2004.08.006; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Waddington C.H., 1956, PRINCIPLES EMBRYOLOG	14	70	73	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 20	2009	323	5917					1016	1017		10.1126/science.1163225	http://dx.doi.org/10.1126/science.1163225			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	409AK	19229023				2022-12-01	WOS:000263478400025
J	Stutchbury, BJM; Tarof, SA; Done, T; Gow, E; Kramer, PM; Tautin, J; Fox, JW; Afanasyev, V				Stutchbury, Bridget J. M.; Tarof, Scott A.; Done, Tyler; Gow, Elizabeth; Kramer, Patrick M.; Tautin, John; Fox, James W.; Afanasyev, Vsevolod			Tracking Long-Distance Songbird Migration by Using Geolocators	SCIENCE			English	Article							STABLE-ISOTOPES; RANGES		[Stutchbury, Bridget J. M.; Tarof, Scott A.; Done, Tyler; Gow, Elizabeth; Kramer, Patrick M.] York Univ, Dept Biol, N York, ON M3J 1P3, Canada; [Tautin, John] Tom Ridge Environm Ctr, Purple Martin Conservat Assoc, Erie, PA 16505 USA; [Fox, James W.; Afanasyev, Vsevolod] British Antarctic Survey, NERC, Cambridge CB3 0ET, England	York University - Canada; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Stutchbury, BJM (corresponding author), York Univ, Dept Biol, 4700 Keele St, N York, ON M3J 1P3, Canada.	bstutch@yorku.ca			Natural Sciences and Engineering Research Council of Canada; National Geographic Society; Purple Martin Conservation Association; NERC [bas010013] Funding Source: UKRI; Natural Environment Research Council [bas010013] Funding Source: researchfish	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Geographic Society(National Geographic Society); Purple Martin Conservation Association; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank C. Graziano, R. Kresnik, T. MacIntosh, M. MacPherson, E. Pifer, T. Piraino, S. Puppi, C. Silverio, and C. Stanley for field assistance. For funding, we thank the Natural Sciences and Engineering Research Council of Canada, the National Geographic Society, the Purple Martin Conservation Association, and proceeds from (10).	Croxall JP, 2005, SCIENCE, V307, P249, DOI 10.1126/science.1106042; Gauthreaux SA, 2003, AUK, V120, P266, DOI 10.1642/0004-8038(2003)120[0266:ROABC]2.0.CO;2; Hobson KA, 2005, AUK, V122, P1037, DOI 10.1642/0004-8038(2005)122[1037:SIATDO]2.0.CO;2; Rubenstein DR, 2002, SCIENCE, V295, P1062, DOI 10.1126/science.1067124; Ruegg KC, 2002, P ROY SOC B-BIOL SCI, V269, P1375, DOI 10.1098/rspb.2002.2032; Shaffer SA, 2006, P NATL ACAD SCI USA, V103, P12799, DOI 10.1073/pnas.0603715103; Sillett TS, 2000, SCIENCE, V288, P2040, DOI 10.1126/science.288.5473.2040; Stutchbury B., 2007, SILENCE SONGBIRDS; Wikelski M, 2003, NATURE, V423, P704, DOI 10.1038/423704a; Yong W, 1997, AUK, V114, P263, DOI 10.2307/4089167	10	337	365	2	135	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 13	2009	323	5916					896	896		10.1126/science.1166664	http://dx.doi.org/10.1126/science.1166664			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406KW	19213909				2022-12-01	WOS:000263295400031
J	Takahashi, H; Kato, M; Matsuura, M; Mobbs, D; Suhara, T; Okubo, Y				Takahashi, Hidehiko; Kato, Motoichiro; Matsuura, Masato; Mobbs, Dean; Suhara, Tetsuya; Okubo, Yoshiro			When Your Gain Is My Pain and Your Pain Is My Gain: Neural Correlates of Envy and Schadenfreude	SCIENCE			English	Article							BRAIN ACTIVITY; FMRI; BIAS	We often evaluate the self and others from social comparisons. We feel envy when the target person has superior and self- relevant characteristics. Schadenfreude occurs when envied persons fall from grace. To elucidate the neurocognitive mechanisms of envy and schadenfreude, we conducted two functional magnetic resonance imaging studies. In study one, the participants read information concerning target persons characterized by levels of possession and self- relevance of comparison domains. When the target person's possession was superior and self- relevant, stronger envy and stronger anterior cingulate cortex ( ACC) activation were induced. In study two, stronger schadenfreude and stronger striatum activation were induced when misfortunes happened to envied persons. ACC activation in study one predicted ventral striatum activation in study two. Our findings document mechanisms of painful emotion, envy, and a rewarding reaction, schadenfreude.	[Takahashi, Hidehiko; Suhara, Tetsuya] Natl Inst Radiol Sci, Dept Mol Neuroimaging, Inage Ku, Chiba 2638555, Japan; [Takahashi, Hidehiko; Matsuura, Masato] Tokyo Med & Dent Univ, Dept Life Sci & Bioinformat, Grad Sch Hlth Sci, Bunkyo Ku, Tokyo 1138549, Japan; [Takahashi, Hidehiko] Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan; [Kato, Motoichiro] Keio Univ, Sch Med, Dept Neuropsychiat, Shinjuku Ku, Tokyo 1608582, Japan; [Mobbs, Dean] Univ Cambridge, MRC, Cognit & Brain Sci Unit, Cambridge CB2 7EF, England; [Okubo, Yoshiro] Nippon Med Sch, Dept Neuropsychiat, Bunkyo Ku, Tokyo 1138603, Japan	National Institutes for Quantum Science & Technology; Tokyo Medical & Dental University (TMDU); Japan Science & Technology Agency (JST); Keio University; University of Cambridge; Nippon Medical School	Takahashi, H (corresponding author), Natl Inst Radiol Sci, Dept Mol Neuroimaging, Inage Ku, 9-1, 4 Chome Anagawa, Chiba 2638555, Japan.	hidehiko@nirs.go.jp		Takahashi, Hidehiko/0000-0002-5102-1982	Health and Labor Sciences Research Grant for Comprehensive Research on Disability, Health, and Welfare [H20-SYOGAI-011]; Japanese Ministry of Health, Labor, and Welfare; Health and Labor Sciences Research Grant for Research on Psychiatric and Neurological Diseases and Mental Health [H20-KOKORO-025]; MRC (UK)	Health and Labor Sciences Research Grant for Comprehensive Research on Disability, Health, and Welfare; Japanese Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Health and Labor Sciences Research Grant for Research on Psychiatric and Neurological Diseases and Mental Health; MRC (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We gratefully thank C. Frith for his valuable comments. This study was supported by a Health and Labor Sciences Research Grant for Comprehensive Research on Disability, Health, and Welfare (H20-SYOGAI-011) from the Japanese Ministry of Health, Labor, and Welfare, and a Health and Labor Sciences Research Grant for Research on Psychiatric and Neurological Diseases and Mental Health (H20-KOKORO-025) from the Japanese Ministry of Health, Labor, and Welfare. D.M. is support by MRC (UK).	Amodio DM, 2004, PSYCHOL SCI, V15, P88, DOI 10.1111/j.0963-7214.2004.01502003.x; Aristotle, 1981, ART RHETORIC; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; de Spinoza B., 2006, ETHICS; Eisenberg Nancy, 2007, Novartis Found Symp, V278, P71; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Fehr E, 2007, TRENDS COGN SCI, V11, P419, DOI 10.1016/j.tics.2007.09.002; Festinger L, 1954, HUM RELAT, V7, P117, DOI 10.1177/001872675400700202; Fliessbach K, 2007, SCIENCE, V318, P1305, DOI 10.1126/science.1145876; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Harmon-Jones E, 2004, BIOL PSYCHOL, V67, P51, DOI 10.1016/j.biopsycho.2004.03.003; Heider F., 1958, PSYCHOL INTERPERSONA, DOI [10.1037/10628-000, DOI 10.1037/14200-000]; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; LAZEAR EP, 1989, J POLIT ECON, V97, P561, DOI 10.1086/261616; Mcclure SM, 2004, NEUROSCIENTIST, V10, P260, DOI 10.1177/1073858404263526; Mora Gonzalo Fernandez de la, 1987, EGALITARIAN ENVY POL; Nozick Robert, 1974, ANARCHY STATE UTOPIA; PARROTT WG, 1993, J PERS SOC PSYCHOL, V64, P906, DOI 10.1037/0022-3514.64.6.906; Rawls John, 1999, THEORY JUSTICE, DOI DOI 10.4159/9780674042605; Russell Bertrand., 1930, CONQUEST HAPPINESS; Sharot T, 2007, NATURE, V450, P102, DOI 10.1038/nature06280; Shelby-Bigge L. A., 1978, TREATISE HUMAN NATUR, V2; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Singer T, 2006, NATURE, V439, P466, DOI 10.1038/nature04271; Smith RH, 1999, PERS SOC PSYCHOL B, V25, P1007, DOI 10.1177/01461672992511008; TESSER A, 1991, J EXP SOC PSYCHOL, V27, P501, DOI 10.1016/0022-1031(91)90023-Y; Tesser A., 1988, ADV EXP SOC PSYCHOL, V21, P181, DOI [10.1016/S0065-2601(08)60227-0, DOI 10.1016/S0065-2601(08)60227-0]; van Dijk WW, 2006, EMOTION, V6, P156, DOI 10.1037/1528-3542.6.1.156	28	312	332	9	179	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 13	2009	323	5916					937	939		10.1126/science.1165604	http://dx.doi.org/10.1126/science.1165604			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	406KW	19213918				2022-12-01	WOS:000263295400043
J	Bendavid, E; Bhattacharya, J				Bendavid, Eran; Bhattacharya, Jayanta			The President's Emergency Plan for AIDS Relief in Africa: An Evaluation of Outcomes	ANNALS OF INTERNAL MEDICINE			English	Article							HIV/AIDS	Background: Since 2003, the President's Emergency Plan for AIDS Relief (PEPFAR) has been the most ambitious initiative to address the global HIV epidemic. However, the effect of PEPFAR on HIV-related outcomes is unknown. Objective: To assess the effect of PEPFAR on HIV-related deaths, the number of people living with HIV, and HIV prevalence in sub-Saharan Africa. Design: Comparison of trends before and after the initiation of PEPFAR's activities. Setting: 12 African focus countries and 29 control countries with a generalized HIV epidemic from 1997 to 2007 ( 451 country-year observations). Intervention: A 5-year, $15 billion program for HIV treatment, prevention, and care that started in late 2003. Measurements: HIV-related deaths, the number of people living with HIV, and HIV prevalence. Results: Between 2004 and 2007, the difference in the annual change in the number of HIV-related deaths was 10.5% lower in the focus countries than in the control countries ( P = 0.001). The difference in trends between the groups before 2003 was not significant. The annual growth in the number of people living with HIV was 3.7% slower in the focus countries than in the control countries from 1997 to 2002 ( P = 0.05), but during PEPFAR's activities, the difference was no longer significant. The difference in the change in HIV prevalence did not significantly differ throughout the study period. These estimates were stable after sensitivity analysis. Limitation: The selection of the focus countries was not random, which limits the generalizability of the results. Conclusion: After 4 years of PEPFAR activity, HIV-related deaths decreased in sub-Saharan African focus countries compared with control countries, but trends in adult prevalence did not differ. Assessment of epidemiologic effectiveness should be part of PEPFAR's evaluation programs. Primary Funding Source: Agency for Healthcare Research and Quality.			Bendavid, E (corresponding author), 117 Encina Commons, Stanford, CA 94305 USA.	ebd@stanford.edu			Agency for Healthcare Research and Quality; National Institute on Aging; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K01AI084582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG017253, K02AG024237, R21AG041112] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	By a training grant from the Agency for Healthcare Research and Quality ( Dr. Bendavid) and the National Institute on Aging ( Dr. Bhattacharya).	ANDERSON RM, 1988, NATURE, V333, P514, DOI 10.1038/333514a0; Bertrand M, 2004, Q J ECON, V119, P249, DOI 10.1162/003355304772839588; Bristol N, 2008, LANCET, V372, P277, DOI 10.1016/S0140-6736(08)61093-4; COHEN C, 2008, DESIGN CONSIDERATION; Cole TJ, 2000, STAT MED, V19, P3109, DOI 10.1002/1097-0258(20001130)19:22<3109::AID-SIM558>3.0.CO;2-F; Creese A, 2002, LANCET, V359, P1635, DOI 10.1016/S0140-6736(02)08595-1; Duflo Esther, 2005, EVALUATING DEV EFFEC; Easterly W, 2007, J DEV ECON, V84, P755, DOI 10.1016/j.jdeveco.2006.11.002; El-Sadr WM, 2008, NEW ENGL J MED, V359, P553, DOI 10.1056/NEJMp0803762; Ghys PD, 2008, SEX TRANSM INFECT, V84, pI1, DOI 10.1136/sti.2008.032573; Ghys PD, 2004, SEX TRANSM INFECT, V80, DOI 10.1136/sti.2004.010199; *GLOB FUND, 2008, PLEDG CONTR; GORGENSALBINO M, 2000, INT BANK RECONSTRUCT; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Joint United Nations Programme on HIV/AIDS (UNAIDS), JOINT UN PROGR HIV A; *OFF US GLOB AIDS, POW PARTN PRES EM PL; Piot P, 2001, NATURE, V410, P968, DOI 10.1038/35073639; *PRES EM PLAN AIDS, US 5 YEAR GLOB HIV A; Sachs JD, 2004, BROOKINGS PAP ECO AC, P117; SEPULVEDA J, 2007, PEPFAR IMPLEMENTATIO; Singer JJW., 2003, APPL LONGITUDINAL DA, DOI DOI 10.1093/ACPROF:OSO/9780195152968.001.0001; STOLBERG SG, 2008, NY TIMES        0105; *UN, 2001, DECL COMM HIV AIDS P; *UNAIDS, 2008, REP GLOB AIDS EP EP; UNAIDS, MON DECL COMM HIV AI; UNAIDS, 2007, FIN RES REQ ACH UN A; *US CENS BUR, INT DAT BAS POP PYR; *US DEP STAT, PRES EM PLAN AIDS RE; *US PRES EM PLAN A, MAK DIFF FUND; *WORLD BANK, GOV MATT 2008 WORLDW	30	110	112	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 19	2009	150	10					688	U5		10.7326/0003-4819-150-10-200905190-00117	http://dx.doi.org/10.7326/0003-4819-150-10-200905190-00117			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	448TQ	19349625	Green Accepted			2022-12-01	WOS:000266285300004
J	Wilson, JF				Wilson, Jennifer Fisher			Cancer Care: A Microcosm of the Problems Facing All of Health Care	ANNALS OF INTERNAL MEDICINE			English	News Item							LIFE; END; CHEMOTHERAPY; DEATH					jenwilson@acponline.org	Wilson, Jennifer/Q-3623-2019	Wilson, Jennifer/0000-0003-4025-3136				Avorn J, 2009, ANN INTERN MED, V150, P563, DOI 10.7326/0003-4819-150-8-200904210-00012; Earle CC, 2004, J CLIN ONCOL, V22, P315, DOI 10.1200/JCO.2004.08.136; Emanuel EJ, 2003, ANN INTERN MED, V138, P639, DOI 10.7326/0003-4819-138-8-200304150-00011; Matsuyama R, 2006, J CLIN ONCOL, V24, P3490, DOI 10.1200/JCO.2005.03.6236; *MED PAYM ADV COMM, 2003, REP C VAR INN MED JU; Meropol NJ, 2007, J CLIN ONCOL, V25, P180, DOI 10.1200/JCO.2006.09.6081; Miksad RA, 2007, J CLIN ONCOL, V25, P4506, DOI 10.1200/JCO.2007.13.0401; Nadler E, 2006, ONCOLOGIST, V11, P90, DOI 10.1634/theoncologist.11-2-90; OGLESBY P, 1991, CARING PHYS LIFE FRA; Pollak KI, 2007, J CLIN ONCOL, V25, P5748, DOI 10.1200/JCO.2007.12.4180; Schrag D, 2007, J CLIN ONCOL, V25, P233, DOI 10.1200/JCO.2006.09.2437; Schwartz LM, 2009, ANN INTERN MED, V150, P516, DOI 10.7326/0003-4819-150-8-200904210-00106; Wright AA, 2008, JAMA-J AM MED ASSOC, V300, P1665, DOI 10.1001/jama.300.14.1665	13	8	8	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 21	2009	150	8					573	576		10.7326/0003-4819-150-8-200904210-00024	http://dx.doi.org/10.7326/0003-4819-150-8-200904210-00024			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437AD	19380865				2022-12-01	WOS:000265457000017
J	Doksani, Y; Bermejo, R; Fiorani, S; Haber, JE; Foiani, M				Doksani, Ylli; Bermejo, Rodrigo; Fiorani, Simona; Haber, James E.; Foiani, Marco			Replicon Dynamics, Dormant Origin Firing, and Terminal Fork Integrity after Double-Strand Break Formation	CELL			English	Article							DNA-DAMAGE RESPONSE; STALLED REPLICATION FORKS; HUMAN-CELLS; CHECKPOINT ACTIVATION; GENOMIC INSTABILITY; CHROMOSOME-III; YEAST; ATR; COMPLEX; ARREST	In response to replication stress, the Mec1/ATR and SUMO pathways control stalled-and damaged-fork stability. We investigated the S phase response at forks encountering a broken template (termed the terminal fork). We show that double-strand break (DSB) formation can locally trigger dormant origin firing. Irreversible fork resolution at the break does not impede progression of the other fork in the same replicon (termed the sister fork). The Mre11-Tel1/ATM response acts at terminal forks, preventing accumulation of cruciform DNA intermediates that tether sister chromatids and can undergo nucleolytic processing. We conclude that sister forks can be uncoupled during replication and that, after DSB-induced fork termination, replication is rescued by dormant origin firing or adjacent replicons. We have uncovered a Tel1/ATM- and Mre11-dependent response controlling terminal fork integrity. Our findings have implications for those genome instability syndromes that accumulate DNA breaks during S phase and for forks encountering eroding telomeres.	[Doksani, Ylli; Bermejo, Rodrigo; Fiorani, Simona; Foiani, Marco] Univ Milan, FIRC Inst Mol Oncol Fdn, IFOM, IEO Campus, I-20139 Milan, Italy; [Doksani, Ylli; Bermejo, Rodrigo; Fiorani, Simona; Foiani, Marco] Univ Milan, DSBB, I-20139 Milan, Italy; [Haber, James E.] Brandeis Univ, Rosenstiel Ctr, Waltham, MA 02254 USA; [Haber, James E.] Brandeis Univ, Dept Biol, Waltham, MA 02254 USA	IFOM - FIRC Institute of Molecular Oncology; IRCCS European Institute of Oncology (IEO); University of Milan; University of Milan; Brandeis University; Brandeis University	Foiani, M (corresponding author), Univ Milan, FIRC Inst Mol Oncol Fdn, IFOM, IEO Campus, Via Adamello 16, I-20139 Milan, Italy.	marco.foiani@ifom-ieo-campus.it	Bermejo, Rodrigo/AAG-7830-2019; Bermejo, Rodrigo/S-2445-2019; Foiani, Marco/M-8234-2014; Bermejo, Rodrigo/K-6613-2014	Foiani, Marco/0000-0003-4795-834X; Bermejo, Rodrigo/0000-0002-2692-7045; Doksani, Ylli/0000-0002-2392-5722; Haber, James/0000-0002-1878-0610	Italian Association for Cancer Research; Telethon-Italy; European Community; Italian Ministry of Health; Regione Lombardia; National Institutes of Health [GM20056, 61766]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076020, R01GM061766, R37GM020056, R01GM020056] Funding Source: NIH RePORTER	Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Telethon-Italy(Fondazione Telethon); European Community(European Commission); Italian Ministry of Health(Ministry of Health, Italy); Regione Lombardia(Regione Lombardia); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We wish to thank D. Branzei, F. d'Adda di Fagagna, A. Pellicioli, D. Sherratt, and all members of our laboratories for helpful comments and F. Vanoli for technical suggestions. We are grateful to D. Agostini, E. Nezi, and R. Zonda for artwork. Work in the M. F. laboratory is supported by grants from Italian Association for Cancer Research, Telethon-Italy, European Community, Italian Ministry of Health, and Regione Lombardia. Work in the J.E.H. laboratory is supported by National Institutes of Health grants GM20056 and 61766.	Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bermejo R, 2008, GENE DEV, V22, P2297, DOI 10.1101/gad.1719308; Bianchi A, 2007, CELL, V128, P1051, DOI 10.1016/j.cell.2007.01.041; Branzei D, 2005, CURR OPIN CELL BIOL, V17, P568, DOI 10.1016/j.ceb.2005.09.003; Branzei D, 2006, CELL, V127, P509, DOI 10.1016/j.cell.2006.08.050; Branzei D, 2008, NATURE, V456, P915, DOI 10.1038/nature07587; BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8; BREWER BJ, 1993, SCIENCE, V262, P1728, DOI 10.1126/science.8259517; BREWER BJ, 1992, CELL, V71, P267, DOI 10.1016/0092-8674(92)90355-G; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; Casper AM, 2002, CELL, V111, P779, DOI 10.1016/S0092-8674(02)01113-3; Cha RS, 2002, SCIENCE, V297, P602, DOI 10.1126/science.1071398; Ciapponi L, 2004, CURR BIOL, V14, P1360, DOI 10.1016/j.cub.2004.07.019; CONNOLLY B, 1988, MOL CELL BIOL, V8, P2342, DOI 10.1128/MCB.8.6.2342; Cortez D, 2004, P NATL ACAD SCI USA, V101, P10078, DOI 10.1073/pnas.0403410101; Cotta-Ramusino C, 2005, MOL CELL, V17, P153, DOI 10.1016/j.molcel.2004.11.032; Cuadrado M, 2006, J EXP MED, V203, P297, DOI 10.1084/jem.20051923; d'Adda di Fagagna F, 2003, NATURE, V426, P194, DOI [DOI 10.1038/NATURE02118, 10.1038/nature02118]; D'Amours D, 2001, GENE DEV, V15, P2238, DOI 10.1101/gad.208701; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Diede SJ, 2001, CURR BIOL, V11, P1336, DOI 10.1016/S0960-9822(01)00400-6; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Fiorani S, 2008, CELL CYCLE, V7, P493, DOI 10.4161/cc.7.4.5323; FISHMANLOBELL J, 1992, MOL CELL BIOL, V12, P1292, DOI 10.1128/MCB.12.3.1292; Flott S, 2007, MOL CELL BIOL, V27, P6433, DOI 10.1128/MCB.00135-07; Friedman KL, 1995, METHOD ENZYMOL, V262, P613; Gasser R, 1996, J MOL BIOL, V258, P224, DOI 10.1006/jmbi.1996.0245; Ge XQ, 2007, GENE DEV, V21, P3331, DOI 10.1101/gad.457807; Glover TW, 2005, HUM MOL GENET, V14, pR197, DOI 10.1093/hmg/ddi265; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.0.CO;2-K; GREENFEDER SA, 1992, MOL BIOL CELL, V3, P999, DOI 10.1091/mbc.3.9.999; Grenon M, 2006, FEMS YEAST RES, V6, P836, DOI 10.1111/j.1567-1364.2006.00076.x; Haber JE, 2006, DNA REPAIR, V5, P998, DOI 10.1016/j.dnarep.2006.05.025; Haber JE, 1998, ANNU REV GENET, V32, P561, DOI 10.1146/annurev.genet.32.1.561; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Heller RC, 2006, NATURE, V439, P557, DOI 10.1038/nature04329; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Ibarra A, 2008, P NATL ACAD SCI USA, V105, P8956, DOI 10.1073/pnas.0803978105; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Kaplun L, 2000, P NATL ACAD SCI USA, V97, P10077, DOI 10.1073/pnas.97.18.10077; Kaye JA, 2004, CURR BIOL, V14, P2096, DOI 10.1016/j.cub.2004.10.051; Kim JA, 2007, J CELL BIOL, V178, P209, DOI 10.1083/jcb.200612031; Kitamura E, 2006, CELL, V125, P1297, DOI 10.1016/j.cell.2006.04.041; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; KOSTRIKEN R, 1984, COLD SPRING HARB SYM, V49, P89, DOI 10.1101/SQB.1984.049.01.012; KRYSAN PJ, 1991, MOL CELL BIOL, V11, P1464, DOI 10.1128/MCB.11.3.1464; Lee K, 2008, NATURE, V454, P543, DOI 10.1038/nature07054; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Lee SE, 2000, COLD SPRING HARB SYM, V65, P303, DOI 10.1101/sqb.2000.65.303; Lengronne A, 2002, MOL CELL, V9, P1067, DOI 10.1016/S1097-2765(02)00513-0; Lengsfeld BM, 2007, MOL CELL, V28, P638, DOI 10.1016/j.molcel.2007.11.001; Lobachev K, 2004, CURR BIOL, V14, P2107, DOI 10.1016/j.cub.2004.11.051; Lopes M, 2006, MOL CELL, V21, P15, DOI 10.1016/j.molcel.2005.11.015; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Lopes M, 2003, MOL CELL, V12, P1499, DOI 10.1016/S1097-2765(03)00473-8; Lucas I, 2001, EMBO J, V20, P6509, DOI 10.1093/emboj/20.22.6509; Makovets S, 2004, MOL CELL BIOL, V24, P4019, DOI 10.1128/MCB.24.9.4019-4031.2004; Marheineke K, 2005, NUCLEIC ACIDS RES, V33, P6931, DOI 10.1093/nar/gki994; Moreau S, 2001, GENETICS, V159, P1423; Morrison AJ, 2007, CELL, V130, P499, DOI 10.1016/j.cell.2007.06.010; Nakada D, 2003, GENE DEV, V17, P1957, DOI 10.1101/gad.1099003; Nakada D, 2004, MOL CELL BIOL, V24, P10016, DOI 10.1128/MCB.24.22.10016-10025.2004; NEWLON CS, 1993, COLD SPRING HARB SYM, V58, P415, DOI 10.1101/SQB.1993.058.01.048; Pellicioli A, 2001, MOL CELL, V7, P293, DOI 10.1016/S1097-2765(01)00177-0; Pellicioli A, 1999, EMBO J, V18, P6561, DOI 10.1093/emboj/18.22.6561; Peterson CL, 2004, GENE DEV, V18, P602, DOI 10.1101/gad.1182704; Poloumienko A, 2001, MOL BIOL CELL, V12, P3317, DOI 10.1091/mbc.12.11.3317; Postow L, 2001, J BIOL CHEM, V276, P2790, DOI 10.1074/jbc.M006736200; Raghuraman MK, 2001, SCIENCE, V294, P115, DOI 10.1126/science.294.5540.115; RAGHURAMAN MK, 1994, GENE DEV, V8, P554, DOI 10.1101/gad.8.5.554; Rao VA, 2007, MOL CANCER RES, V5, P713, DOI 10.1158/1541-7786.MCR-07-0028; Reyes-Lamothe R, 2008, CELL, V133, P90, DOI 10.1016/j.cell.2008.01.044; SANDELL LL, 1993, CELL, V75, P729, DOI 10.1016/0092-8674(93)90493-A; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Shirahige K, 1998, NATURE, V395, P618, DOI 10.1038/27007; Shroff R, 2004, CURR BIOL, V14, P1703, DOI 10.1016/j.cub.2004.09.047; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Tsubouchi H, 1998, MOL CELL BIOL, V18, P260, DOI 10.1128/MCB.18.1.260; Usui T, 2001, MOL CELL, V7, P1255, DOI 10.1016/S1097-2765(01)00270-2; Vaze MB, 2002, MOL CELL, V10, P373, DOI 10.1016/S1097-2765(02)00593-2; Vogelauer M, 2002, MOL CELL, V10, P1223, DOI 10.1016/S1097-2765(02)00702-5; Wach A, 1996, YEAST, V12, P259, DOI 10.1002/(SICI)1097-0061(19960315)12:3<259::AID-YEA901>3.0.CO;2-C; Wang XD, 2008, GENE DEV, V22, P2426, DOI 10.1101/gad.487508; WHITE CI, 1990, EMBO J, V9, P663, DOI 10.1002/j.1460-2075.1990.tb08158.x; Williams RS, 2007, BIOCHEM CELL BIOL, V85, P509, DOI 10.1139/O07-069; ZHU JG, 1992, MOL CELL BIOL, V12, P4733, DOI 10.1128/MCB.12.10.4733; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037; Zierhut C, 2008, EMBO J, V27, P1875, DOI 10.1038/emboj.2008.111; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	93	81	83	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 17	2009	137	2					247	258		10.1016/j.cell.2009.02.016	http://dx.doi.org/10.1016/j.cell.2009.02.016			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	437AB	19361851	Green Accepted, Bronze			2022-12-01	WOS:000265456800018
J	Koehn, EM; Fleischmann, T; Conrad, JA; Palfey, BA; Lesley, SA; Mathews, II; Kohen, A				Koehn, Eric M.; Fleischmann, Todd; Conrad, John A.; Palfey, Bruce A.; Lesley, Scott A.; Mathews, Irimpan I.; Kohen, Amnon			An unusual mechanism of thymidylate biosynthesis in organisms containing the thyX gene	NATURE			English	Article							CATALYTIC MECHANISM; ESCHERICHIA-COLI; ACTIVE-SITE; SYNTHASE-X; FLAVIN; ENZYME; DNA	Biosynthesis of the DNA base thymine depends on activity of the enzyme thymidylate synthase to catalyse the methylation of the uracil moiety of 2'-deoxyuridine-5'-monophosphate. All known thymidylate synthases rely on an active site residue of the enzyme to activate 2'-deoxyuridine-5'-monophosphate(1,2). This functionality has been demonstrated for classical thymidylate synthases, including human thymidylate synthase, and is instrumental in mechanism-based inhibition of these enzymes. Here we report an example of thymidylate biosynthesis that occurs without an enzymatic nucleophile. This unusual biosynthetic pathway occurs in organisms containing the thyX gene, which codes for a flavin-dependent thymidylate synthase (FDTS), and is present in several human pathogens(3-5). Our findings indicate that the putative active site nucleophile is not required for FDTS catalysis, and no alternative nucleophilic residues capable of serving this function can be identified. Instead, our findings suggest that a hydride equivalent (that is, a proton and two electrons) is transferred from the reduced flavin cofactor directly to the uracil ring, followed by an isomerization of the intermediate to form the product, 2'-deoxythymidine-5'-monophosphate. These observations indicate a very different chemical cascade than that of classical thymidylate synthases or any other known biological methylation. The findings and chemical mechanism proposed here, together with available structural data, suggest that selective inhibition of FDTSs, with little effect on human thymine biosynthesis, should be feasible. Because several human pathogens depend on FDTS for DNA biosynthesis, its unique mechanism makes it an attractive target for antibiotic drugs.	[Koehn, Eric M.; Fleischmann, Todd; Kohen, Amnon] Univ Iowa, Dept Chem, Iowa City, IA 52242 USA; [Conrad, John A.; Palfey, Bruce A.] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Lesley, Scott A.] Novartis Res Fdn, Genom Inst, Joint Ctr Struct Genom, San Diego, CA 92121 USA; [Mathews, Irimpan I.] Stanford Univ, Stanford Synchrotron Radiat Lab, Menlo Pk, CA 94025 USA	University of Iowa; University of Michigan System; University of Michigan; Novartis; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Kohen, A (corresponding author), Univ Iowa, Dept Chem, Iowa City, IA 52242 USA.	amnon-kohen@uiowa.edu		Palfey, Bruce/0000-0001-5098-259X; Koehn, Eric/0000-0001-8195-9595	NIH [R01 GM065368, R01 GM61087, GM08270]; NSF [CHE 0715448]; JCSG [U54GM074898]; DOE; OBER; NCRR; NIGMS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061087, T32GM008270, U54GM074898, R01GM065368] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); JCSG; DOE(United States Department of Energy (DOE)); OBER; NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH R01 GM065368 and NSF CHE 0715448 to A. K., the Iowa Center for Biocatalysis and Bioprocessing to E. M. K., NIH R01 GM61087 to B. A. P., NIH training grant GM08270 to J.A.C., and JCSG grant U54GM074898 to S. A. L. Portions of this research were carried out at the Stanford Synchrotron Radiation Laboratory (SSRL), a national user facility operated by Stanford University on behalf of DOE, OBER. The SSRL Structural Molecular Biology Program is supported by DOE, OBER and by NIH, NCRR, Biomedical Technology Program and NIGMS.	Agrawal N, 2004, BIOCHEMISTRY-US, V43, P10295, DOI 10.1021/bi0490439; Brown BJ, 1998, J BIOL CHEM, V273, P32753, DOI 10.1074/jbc.273.49.32753; Burdzy A, 2002, NUCLEIC ACIDS RES, V30, P4068, DOI 10.1093/nar/gkf520; CARRERAS CW, 1995, ANNU REV BIOCHEM, V64, P721, DOI 10.1146/annurev.bi.64.070195.003445; Chernyshev A, 2007, APPL MICROBIOL BIOT, V74, P282, DOI 10.1007/s00253-006-0763-1; Escartin F, 2008, P NATL ACAD SCI USA, V105, P9948, DOI 10.1073/pnas.0801356105; Fagan RL, 2006, BIOCHEMISTRY-US, V45, P14926, DOI 10.1021/bi060919g; Finer-Moore JS, 2003, BIOCHEMISTRY-US, V42, P248, DOI 10.1021/bi020599a; Gattis SG, 2005, J AM CHEM SOC, V127, P832, DOI 10.1021/ja0432214; Graziani S, 2006, J BIOL CHEM, V281, P24048, DOI 10.1074/jbc.M600745200; Hong B, 2005, J LABELLED COMPD RAD, V48, P759, DOI 10.1002/jlcr.993; Hong BY, 2007, BIOCHEMISTRY-US, V46, P14188, DOI 10.1021/bi701363s; Hyatt DC, 1997, BIOCHEMISTRY-US, V36, P4585, DOI 10.1021/bi962936j; KLOTZER W, 1973, MONATSH CHEM, V104, P415, DOI 10.1007/BF00903105; Leduc D, 2004, BIOCHEM SOC T, V32, P231, DOI 10.1042/BST0320231; Leduc D, 2004, P NATL ACAD SCI USA, V101, P7252, DOI 10.1073/pnas.0401365101; Lesley SA, 2002, P NATL ACAD SCI USA, V99, P11664, DOI 10.1073/pnas.142413399; Mathews II, 2003, STRUCTURE, V11, P677, DOI 10.1016/S0969-2126(03)00097-2; Myllykallio H, 2002, SCIENCE, V297, P105, DOI 10.1126/science.1072113; Myllykallio H, 2003, TRENDS MICROBIOL, V11, P220, DOI 10.1016/S0966-842X(03)00101-X; Sampathkumar P, 2005, J MOL BIOL, V352, P1091, DOI 10.1016/j.jmb.2005.07.071; Sundberg R, 2000, ADV ORGANIC CHEM; WALDMAN AS, 1983, J BIOL CHEM, V258, P1571; WATAYA Y, 1975, BIOCHEM BIOPH RES CO, V67, P818, DOI 10.1016/0006-291X(75)90886-4	24	65	66	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 16	2009	458	7240					919	U13		10.1038/nature07973	http://dx.doi.org/10.1038/nature07973			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433CS	19370033	Green Accepted			2022-12-01	WOS:000265182500049
J	Sakuno, T; Tada, K; Watanabe, Y				Sakuno, Takeshi; Tada, Kenji; Watanabe, Yoshinori			Kinetochore geometry defined by cohesion within the centromere	NATURE			English	Article							REDUCTIONAL CHROMOSOME SEGREGATION; FISSION YEAST CENTROMERE; 1ST MEIOTIC DIVISION; MEIOSIS-I; MITOTIC SPINDLE; PRECOCIOUS SEPARATION; MONOPOLAR ATTACHMENT; SISTER KINETOCHORES; BI-ORIENTATION; BUDDING YEAST	During cell division microtubules capture chromosomes by binding to the kinetochore assembled in the centromeric region of chromosomes. In mitosis sister chromatids are captured by microtubules emanating from both spindle poles, a process called bipolar attachment, whereas in meiosis I sisters are attached to microtubules originating from one spindle pole, called monopolar attachment. For determining chromosome orientation, kinetochore geometry or structure might be an important target of regulation. However, the molecular basis of this regulation has remained elusive. Here we show the link between kinetochore orientation and cohesion within the centromere in fission yeast Schizosaccharomyces pombe by strategies developed to visualize the concealed cohesion within the centromere, and to introduce artificial tethers that can influence kinetochore geometry. Our data imply that cohesion at the core centromere induces the mono-orientation of kinetochores whereas cohesion at the peri-centromeric region promotes bi-orientation. Our study may reveal a general mechanism for the geometric regulation of kinetochores, which collaborates with previously defined tension-dependent reorientation machinery.	[Sakuno, Takeshi; Tada, Kenji; Watanabe, Yoshinori] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Chromosome Dynam, Tokyo 1130032, Japan; [Tada, Kenji; Watanabe, Yoshinori] Univ Tokyo, Grad Sch Sci, Grad Program Biophys & Biochem, Tokyo GRAD SCH SC, Japan	University of Tokyo; University of Tokyo	Watanabe, Y (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Lab Chromosome Dynam, Tokyo 1130032, Japan.	ywatanab@iam.u-tokyo.ac.jp	Sakuno, Takeshi/Y-9478-2019	Watanabe, Yoshinori/0000-0002-5488-4812	Special Coordination Funds for Promoting Science and Technology; MEXT, Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [21000010] Funding Source: KAKEN	Special Coordination Funds for Promoting Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank S. Hauf for critically reading the manuscript. We thank H. Matsuzaki, A. Yamamoto, R. Allshire, K. Nasmyth and the Yeast Genetic Resource Center (YGRC) for yeast strains. We also thank all the members of our laboratory for their support and discussion, especially S. Yokobayashi for materials and assistance in the initial stage of this project. This work was supported in part by Special Coordination Funds for Promoting Science and Technology (to T. S.), the Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms), MEXT, Japan, and a Grant- in- Aid for Specially Promoted Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to Y. W.).	ALLSHIRE RC, 1995, GENE DEV, V9, P218, DOI 10.1101/gad.9.2.218; Amor DJ, 2004, TRENDS CELL BIOL, V14, P359, DOI 10.1016/j.tcb.2004.05.009; ARAKI H, 1992, J MOL BIOL, V225, P25, DOI 10.1016/0022-2836(92)91023-I; Bernard P, 2001, SCIENCE, V294, P2539, DOI 10.1126/science.1064027; Blower MD, 2002, DEV CELL, V2, P319, DOI 10.1016/S1534-5807(02)00135-1; BRENNER S, 1981, J CELL BIOL, V91, P95, DOI 10.1083/jcb.91.1.95; Chang CR, 2005, GENE DEV, V19, P3031, DOI 10.1101/gad.1356305; Chelysheva L, 2005, J CELL SCI, V118, P4621, DOI 10.1242/jcs.02583; Cimini D, 2006, CURR BIOL, V16, P1711, DOI 10.1016/j.cub.2006.07.022; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Dewar H, 2004, NATURE, V428, P93, DOI 10.1038/nature02328; Eckert CA, 2007, GENE DEV, V21, P278, DOI 10.1101/gad.1498707; GOLDSTEIN LSB, 1981, CELL, V25, P591, DOI 10.1016/0092-8674(81)90167-7; Goshima G, 2000, CELL, V100, P619, DOI 10.1016/S0092-8674(00)80699-6; Gruber S, 2006, CELL, V127, P523, DOI 10.1016/j.cell.2006.08.048; Hauf S, 2004, CELL, V119, P317, DOI 10.1016/j.cell.2004.10.014; He XW, 2000, CELL, V101, P763, DOI 10.1016/S0092-8674(00)80888-0; Horie S, 1998, MOL CELL BIOL, V18, P2118, DOI 10.1128/MCB.18.4.2118; Izawa D, 2005, NATURE, V434, P529, DOI 10.1038/nature03406; Kawashima SA, 2007, GENE DEV, V21, P420, DOI 10.1101/gad.1497307; Kitajima TS, 2004, NATURE, V427, P510, DOI 10.1038/nature02312; Kurzbauer R, 2004, P NATL ACAD SCI USA, V101, P10984, DOI 10.1073/pnas.0403435101; Lee J, 2000, MOL REPROD DEV, V56, P51, DOI 10.1002/(SICI)1098-2795(200005)56:1&lt;51::AID-MRD7&gt;3.0.CO;2-N; Monje-Casas F, 2007, CELL, V128, P477, DOI 10.1016/j.cell.2006.12.040; Moore DP, 1998, CURR TOP DEV BIOL, V37, P263; Nabeshima K, 1998, MOL BIOL CELL, V9, P3211, DOI 10.1091/mbc.9.11.3211; Nicklas RB, 1997, SCIENCE, V275, P632, DOI 10.1126/science.275.5300.632; Nonaka N, 2002, NAT CELL BIOL, V4, P89, DOI 10.1038/ncb739; Ocampo-Hafalla MT, 2007, CHROMOSOMA, V116, P531, DOI 10.1007/s00412-007-0118-4; OSTERGREN G, 1951, HEREDITAS, V37, P85; Parra MT, 2004, J CELL SCI, V117, P1221, DOI 10.1242/jcs.00947; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Pidoux AL, 2004, CHROMOSOME RES, V12, P521, DOI 10.1023/B:CHRO.0000036586.81775.8b; Rabitsch KP, 2004, CURR BIOL, V14, P287, DOI 10.1016/j.cub.2004.01.051; RIEDER CL, 1994, J CELL BIOL, V124, P223, DOI 10.1083/jcb.124.3.223; Sullivan BA, 2004, NAT STRUCT MOL BIOL, V11, P1076, DOI 10.1038/nsmb845; TAKAHASHI K, 1992, MOL BIOL CELL, V3, P819, DOI 10.1091/mbc.3.7.819; Tanaka TU, 2000, NAT CELL BIOL, V2, P492, DOI 10.1038/35019529; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; Tanaka TU, 2002, CURR OPIN CELL BIOL, V14, P365, DOI 10.1016/S0955-0674(02)00328-9; Tomonaga T, 2000, GENE DEV, V14, P2757, DOI 10.1101/gad.832000; Toth A, 2000, CELL, V103, P1155, DOI 10.1016/S0092-8674(00)00217-8; Watanabe Y, 1999, NATURE, V400, P461, DOI 10.1038/22774; Watanabe Y, 2001, NATURE, V409, P359, DOI 10.1038/35053103; Winey M, 2005, MOL BIOL CELL, V16, P1178, DOI 10.1091/mbc.E04-09-0765; Yamamoto A, 2003, EMBO J, V22, P2284, DOI 10.1093/emboj/cdg222; Yamamoto A, 2008, J CELL BIOL, V182, P277, DOI 10.1083/jcb.200802053; Yokobayashi S, 2003, MOL CELL BIOL, V23, P3965, DOI 10.1128/MCB.23.11.3965-3973.2003; Yokobayashi S, 2005, CELL, V123, P803, DOI 10.1016/j.cell.2005.09.013; Yu HG, 2000, J CELL BIOL, V151, P131, DOI 10.1083/jcb.151.1.131	50	126	126	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 16	2009	458	7240					852	U1		10.1038/nature07876	http://dx.doi.org/10.1038/nature07876			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433CS	19370027				2022-12-01	WOS:000265182500035
J	Christakis, NA				Christakis, Nicholas A.			Observations Only Connect The anthroposphere is changing	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Christakis, Nicholas A.] Harvard Univ, Sch Med, Cambridge, MA 02138 USA; [Christakis, Nicholas A.] Mt Auburn Hosp, Cambridge, MA USA	Harvard University; Harvard University; Mount Auburn Hospital	Christakis, NA (corresponding author), Harvard Univ, Sch Med, Cambridge, MA 02138 USA.	christak@hcp.med.harvard.edu	Christakis, Nicholas A/C-3205-2009						0	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 15	2009	338								b1534	10.1136/bmj.b1534	http://dx.doi.org/10.1136/bmj.b1534			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	434TJ	19369280				2022-12-01	WOS:000265296700006
J	Eichler, HG; Abadie, E; Raine, JM; Salmonson, T				Eichler, Hans-Georg; Abadie, Eric; Raine, June M.; Salmonson, Tomas			Safe Drugs and the Cost of Good Intentions	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Eichler, Hans-Georg; Abadie, Eric] EMEA, Comm Med Prod Human Use CHMP, London, England; [Abadie, Eric] Agence Francaise Secur Sanitaire Prod Sante, St Denis, France; [Raine, June M.] Med Healthcare Prod Regulatory Agcy, Vigilance & Risk Management Med, London, England; [Salmonson, Tomas] Lakemedelsverket Med Prod Agcy, Uppsala, Sweden	The Medicines & Healthcare Products Regulatory Agency; Medical Products Agency	Eichler, HG (corresponding author), EMEA, Comm Med Prod Human Use CHMP, London, England.							Calfee J., 2006, REPRESENTATIVE SURVE; FISCHHOFF B, OXFORD TXB IN PRESS; Gazarian M, 2006, MED J AUSTRALIA, V185, P544, DOI 10.5694/j.1326-5377.2006.tb00689.x; Thompson JP, 2008, NEUROLOGY, V71, P357, DOI 10.1212/01.wnl.0000319648.65173.7a; Vandenbroucke JP, 2008, PLOS MED, V5, P339, DOI 10.1371/journal.pmed.0050067	5	50	50	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 2	2009	360	14					1378	1380		10.1056/NEJMp0900092	http://dx.doi.org/10.1056/NEJMp0900092			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427AL	19339718				2022-12-01	WOS:000264751800002
J	Pan, DN; Fujimoto, M; Lopes, A; Wang, YX				Pan, Dongning; Fujimoto, Masaki; Lopes, Andrea; Wang, Yong-Xu			Twist-1 Is a PPAR delta-Inducible, Negative-Feedback Regulator of PGC-1 alpha in Brown Fat Metabolism	CELL			English	Article							ACTIVATED RECEPTOR-DELTA; ADIPOSE-TISSUE; MITOCHONDRIAL BIOGENESIS; ADAPTIVE THERMOGENESIS; GAMMA COACTIVATOR-1; UNCOUPLING PROTEIN; INSULIN-RESISTANCE; GENE-EXPRESSION; ADULT HUMANS; ERR-ALPHA	Brown fat is specialized for energy expenditure, a process that is principally controlled by the transcriptional coactivator PGC-1 alpha. Here, we describe a molecular network important for PGC-1 alpha function and brown fat metabolism. We find that twist-1 is selectively expressed in adipose tissue, interacts with PGC-1 alpha, and is recruited to the promoters of PGC-1 alpha's target genes to suppress mitochondrial metabolism and uncoupling. In vivo, transgenic mice expressing twist-1 in the adipose tissue are prone to high-fat-diet-induced obesity, whereas twist-1 heterozygous knockout mice are obesity resistant. These phenotypes are attributed to their altered mitochondrial metabolism in the brown fat. Interestingly, the nuclear receptor PPAR delta not only mediates the actions of PGC-1 alpha but also regulates twist-1 expression, suggesting a negative-feedback regulatory mechanism. These findings reveal an unexpected physiological role for twist-1 in the maintenance of energy homeostasis and have important implications for understanding metabolic control and metabolic diseases.	[Pan, Dongning; Fujimoto, Masaki; Lopes, Andrea; Wang, Yong-Xu] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA; [Pan, Dongning; Fujimoto, Masaki; Lopes, Andrea; Wang, Yong-Xu] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Wang, YX (corresponding author), Univ Massachusetts, Sch Med, Program Gene Funct & Express, 364 Plantat St, Worcester, MA 01605 USA.	yongxu.wang@umassmed.edu	Pan, Dongning/P-6523-2019	Pan, Dongning/0000-0001-5463-8155	American Diabetes Association; Smith Family Foundation; National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases [R56DK076118, R01DK076118]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK076118, R01DK076118] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); Smith Family Foundation; National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Drs. Michael Green, Michael Czech, and Silvia Corvera for insightful comments on this work; Drs. Ron Evans, Marc Montminy, Heonjoong Kang, and Brian Lewis for reagents; Drs. Hong-Ping Guan, Yasuyuki Okawa, and Claude Gazin for help on CHIP assays; Dr. Greg Hendricks and Tracy Levin for electron microscopy; Alison Burkart for help on oxygen consumption, Drs. Matthew Paul and Robert Dallmann for help on the use of iButtons; and Sue Wheeler, Heidi Chandler, and Dr. Denice Godfrey for animal surgery. These studies were funded by grants from the American Diabetes Association, the Smith Family Foundation, and National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases (R56DK076118 and R01DK076118).	Almind K, 2007, P NATL ACAD SCI USA, V104, P2366, DOI 10.1073/pnas.0610416104; Ansieau S, 2008, CANCER CELL, V14, P79, DOI 10.1016/j.ccr.2008.06.005; Atchley WR, 1997, P NATL ACAD SCI USA, V94, P5172, DOI 10.1073/pnas.94.10.5172; Barak Y, 2002, P NATL ACAD SCI USA, V99, P303, DOI 10.1073/pnas.012610299; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bialek P, 2004, DEV CELL, V6, P423, DOI 10.1016/S1534-5807(04)00058-9; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Chawla A, 2003, P NATL ACAD SCI USA, V100, P1268, DOI 10.1073/pnas.0337331100; CHEN ZF, 1995, GENE DEV, V9, P686, DOI 10.1101/gad.9.6.686; Collins S, 2004, MOL ENDOCRINOL, V18, P2123, DOI 10.1210/me.2004-0193; Cooper MP, 2006, GENE DEV, V20, P2996, DOI 10.1101/gad.1483906; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Davidson AJ, 2003, J BIOL RHYTHM, V18, P430, DOI 10.1177/0748730403256066; Fan M, 2004, GENE DEV, V18, P278, DOI 10.1101/gad.1152204; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; GARRUTI G, 1992, INT J OBESITY, V16, P383; Hamamori Y, 1999, CELL, V96, P405, DOI 10.1016/S0092-8674(00)80553-X; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; HUTTUNEN P, 1981, EUR J APPL PHYSIOL O, V46, P339, DOI 10.1007/BF00422121; Kakuma T, 2000, ENDOCRINOLOGY, V141, P4576, DOI 10.1210/en.141.12.4576; Kontani Y, 2005, AGING CELL, V4, P147, DOI 10.1111/j.1474-9726.2005.00157.x; Koo SH, 2004, NAT MED, V10, P530, DOI 10.1038/nm1044; Kopecky J, 1995, J CLIN INVEST, V96, P2914, DOI 10.1172/JCI118363; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; LEAN MEJ, 1986, INT J OBESITY, V10, P219; Lerin C, 2006, CELL METAB, V3, P429, DOI 10.1016/j.cmet.2006.04.013; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Picard F, 2002, CELL, V111, P931, DOI 10.1016/S0092-8674(02)01169-8; Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; Scime A, 2005, CELL METAB, V2, P283, DOI 10.1016/j.cmet.2005.10.002; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Sosic D, 2003, CELL, V112, P169, DOI 10.1016/S0092-8674(03)00002-3; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Tiraby C, 2003, TRENDS ENDOCRIN MET, V14, P439, DOI 10.1016/j.tem.2003.10.001; Tseng YH, 2004, MOL CELL BIOL, V24, P1918, DOI 10.1128/MCB.24.5.1918-1929.2004; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Villavicencio EH, 2002, GENESIS, V32, P247, DOI 10.1002/gene.10078; Villena JA, 2007, P NATL ACAD SCI USA, V104, P1418, DOI 10.1073/pnas.0607696104; Wang XJ, 2005, MOL CELL ENDOCRINOL, V238, P1, DOI 10.1016/j.mce.2005.04.009; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006	50	167	174	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 2	2009	137	1					73	86		10.1016/j.cell.2009.01.051	http://dx.doi.org/10.1016/j.cell.2009.01.051			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	427XV	19345188	Green Accepted, Bronze			2022-12-01	WOS:000264813300015
J	Teis, D; Saksena, S; Emr, SD				Teis, David; Saksena, Suraj; Emr, Scott D.			SnapShot: The ESCRT Machinery	CELL			English	Editorial Material							III COMPLEX		[Teis, David; Saksena, Suraj; Emr, Scott D.] Cornell Univ, Ithaca, NY 14853 USA; [Teis, David] Innsbruck Med Univ, Innsbruck, Austria	Cornell University; Medical University of Innsbruck	Teis, D (corresponding author), Cornell Univ, Ithaca, NY 14853 USA.			Teis, David/0000-0002-8181-0253	HFSP [LT00634/2006-L]; American Heart Association [AHA 0826060D]; Weill Institute for Cell and Molecular Biology	HFSP(Human Frontier Science Program); American Heart Association(American Heart Association); Weill Institute for Cell and Molecular Biology	D.T. is funded by HFSP (LT00634/2006-L). S.S. is supported by a fellowship of the American Heart Association (AHA 0826060D). We are grateful to E.V. MacGurn for assistance with graphics. S.D.E. is supported by funds from the Weill Institute for Cell and Molecular Biology. We also thank Z. Yu and G. Jensen for providing the image of the Vps/Vta1 complex.	Kostelansky MS, 2007, CELL, V129, P485, DOI 10.1016/j.cell.2007.03.016; Muziol T, 2006, DEV CELL, V10, P821, DOI 10.1016/j.devcel.2006.03.013; Prag G, 2007, DEV CELL, V12, P973, DOI 10.1016/j.devcel.2007.04.013; Saksena S, 2007, TRENDS BIOCHEM SCI, V32, P561, DOI 10.1016/j.tibs.2007.09.010; Saksena S, 2009, CELL, V136, P97, DOI 10.1016/j.cell.2008.11.013; Teis D, 2008, DEV CELL, V15, P578, DOI 10.1016/j.devcel.2008.08.013; Teo H, 2004, DEV CELL, V7, P559, DOI 10.1016/j.devcel.2004.09.003; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836; Yu ZH, 2008, J MOL BIOL, V377, P364, DOI 10.1016/j.jmb.2008.01.009	10	31	31	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 2	2009	137	1							182.e1	10.1016/j.cell.2009.03.027	http://dx.doi.org/10.1016/j.cell.2009.03.027			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	427XV	19345195	Bronze			2022-12-01	WOS:000264813300024
J	Guerrini, I; Jackson, S; Keaney, F				Guerrini, Irene; Jackson, Siobhan; Keaney, Francis			Practice Pregnancy Plus Pregnancy and alcohol misuse	BRITISH MEDICAL JOURNAL			English	Article							BRIEF INTERVENTION; YOUNG-WOMEN; BRAIN; WITHDRAWAL; RISK		[Guerrini, Irene] S London & Maudsley NHS Fdn Trust, Bexley Substance Misuse Serv, London DA8 1RQ, Kent, England; [Jackson, Siobhan] S London & Maudsley NHS Fdn Trust, Queen Elizabeth Hosp Woolwich, Greenwich & Antenatal Clin, Beresford Project, London SE18 6LZ, England; [Keaney, Francis] Maudsley Hosp & Inst Psychiat, S London & Maudsley NHS Fdn Trust, London SE5 8AZ, England	South London & Maudsley NHS Trust; South London & Maudsley NHS Trust; South London & Maudsley NHS Trust; University of London; King's College London	Guerrini, I (corresponding author), S London & Maudsley NHS Fdn Trust, Bexley Substance Misuse Serv, London DA8 1RQ, Kent, England.	irene.guerrini@slam.nhs.uk						Chang G, 2005, OBSTET GYNECOL, V105, P991, DOI 10.1097/01.AOG.0000157109.05453.84; Chang G, 2001, ALCOHOL RES HEALTH, V25, P204; Crome IB, 2007, SEMIN FETAL NEONAT M, V12, P98, DOI 10.1016/j.siny.2006.12.002; Department of Health, 2007, UPD ALC ADV PREGN WO; Gilmore IT, 2008, BRIT MED J, V336, P952, DOI 10.1136/bmj.39520.716863.94; Goransson M, 2003, ADDICTION, V98, P1513, DOI 10.1046/j.1360-0443.2003.00498.x; Guerrini I, 2007, NEUROSCI BIOBEHAV R, V31, P212, DOI 10.1016/j.neubiorev.2006.06.022; HENDERSON J, 2006, BJOG, V114, P243; Maconochie N, 2007, BJOG-INT J OBSTET GY, V114, P170, DOI 10.1111/j.1471-0528.2006.01193.x; Myrick H, 1998, ALCOHOL HEALTH RES W, V22, P38; *NAT I HLTH CLIN E, 2005, PREV RED ALC MIS ED; *NAT TREATM AG SUB, 2006, REV EFF TREATM ALC P; *NAT TREATM AG SUB, 2007, GUID CLIN MAN DRUG M; National Institute for Health and Clincial Excellence, 2008, ANT CAR; NORA AH, 1977, LANCET, V2, P664; O'Connor MJ, 2007, AM J PUBLIC HEALTH, V97, P252, DOI 10.2105/AJPH.2005.077222; Riley EP, 2005, EXP BIOL MED, V230, P357, DOI 10.1177/15353702-0323006-03; *ROYAL COLL OBST G, 2006, RCOG STAT, V5; RUSSELL M, 1988, ALCOHOL CLIN EXP RES, V12, P824, DOI 10.1111/j.1530-0277.1988.tb01354.x; Thomas JD, 1998, ALCOHOL HEALTH RES W, V22, P47; *US DEP HLTH, TIP SER US DEP HLTH, V2; *WHO, 2001, BRIEF INT HAZ HARMF; Young C, 2006, NEUROBIOL DIS, V22, P548, DOI 10.1016/j.nbd.2005.12.015	24	1	1	0	8	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 30	2009	338								b845	10.1136/bmj.b845	http://dx.doi.org/10.1136/bmj.b845			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	429AK	19332453				2022-12-01	WOS:000264893000012
J	Li, QS; Skinner, PJ; Ha, SJ; Duan, LJ; Mattila, TL; Hage, A; White, C; Barber, DL; O'Mara, L; Southern, PJ; Reilly, CS; Carlis, JV; Miller, CJ; Ahmed, R; Haase, AT				Li, Qingsheng; Skinner, Pamela J.; Ha, Sang-Jun; Duan, Lijie; Mattila, Teresa L.; Hage, Aaron; White, Cara; Barber, Daniel L.; O'Mara, Leigh; Southern, Peter J.; Reilly, Cavan S.; Carlis, John V.; Miller, Christopher J.; Ahmed, Rafi; Haase, Ashley T.			Visualizing Antigen-Specific and Infected Cells in Situ Predicts Outcomes in Early Viral Infection	SCIENCE			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; SIMIAN IMMUNODEFICIENCY VIRUS; CD8(+) T-CELLS; SIV INFECTION; PERSISTENCE; TRANSMISSION; GLYCOPROTEIN; REPLICATION; RESPONSES; EPITOPES	In the early stages of viral infection, outcomes depend on a race between expansion of infection and the immune response generated to contain it. We combined in situ tetramer staining with in situ hybridization to visualize, map, and quantify relationships between immune effector cells and their targets in tissues. In simian immunodeficiency virus infections in macaques and lymphocytic choriomeningitis virus infections in mice, the magnitude and timing of the establishment of an excess of effector cells versus targets were found to correlate with the extent of control and the infection outcome (i.e., control and clearance versus partial or poor control and persistent infection). This method highlights the importance of the location, timing, and magnitude of the immune response needed for a vaccine to be effective against agents of persistent infection, such as HIV-1.	[Li, Qingsheng; Duan, Lijie; Southern, Peter J.; Haase, Ashley T.] Univ Minnesota, Sch Med, Dept Microbiol, Minneapolis, MN 55455 USA; [Skinner, Pamela J.; Mattila, Teresa L.; Hage, Aaron; White, Cara] Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA; [Ha, Sang-Jun; O'Mara, Leigh; Ahmed, Rafi] Emory Univ, Sch Med, Emory Vaccine Ctr, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Barber, Daniel L.] NIAID, Immunobiol Sect, Bethesda, MD 20892 USA; [Reilly, Cavan S.] Univ Minnesota, Sch Publ Hlth, Div Biostat, Minneapolis, MN 55455 USA; [Carlis, John V.] Univ Minnesota, Inst Technol, Dept Comp Sci & Engn, Minneapolis, MN 55455 USA; [Miller, Christopher J.] Univ Calif Davis, Calif Natl Primate Res Ctr, Ctr Comparat Med, Davis, CA 95616 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Emory University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Davis	Haase, AT (corresponding author), Univ Minnesota, Sch Med, Dept Microbiol, Minneapolis, MN 55455 USA.	haase001@umn.edu	Barber, Daniel L./V-1190-2019	Skinner, Pamela/0000-0003-3388-1687; Ha, Sang-Jun/0000-0002-1192-6031	NIH [AI48484, AI20048, AI066314]; National Center for Research Resources [RR00169]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI066314, R01AI048484] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the Immunology Core Laboratory and Primate Services Unit of the California National Primate Research Center (CNPRC); D. Lu, T. Rourke, R. Dizon, and B. Vang for technical assistance; J. Sedgewick for assistance in setting up the confocal microscope to capture images of silver grains; D. Masopust for helpful discussion; and C. O'Neill and T. Leonard for help in preparing the manuscript and figures. Supported in part by NIH research grants AI48484 (A.T.H.), AI20048 (R.A.), and AI066314 (C.J.M.); National Center for Research Resources grant RR00169 (CNPRC, University of California, Davis); and a gift from the James B. Pendleton Charitable Trust (C.J.M.).	AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Davenport MP, 2004, J VIROL, V78, P10096, DOI 10.1128/JVI.78.18.10096-10103.2004; Doherty PC, 1998, SCIENCE, V280, P227, DOI 10.1126/science.280.5361.227; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Kuroda MJ, 1999, J IMMUNOL, V162, P5127; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; MATLOUBIAN M, 1990, J EXP MED, V172, P1043, DOI 10.1084/jem.172.4.1043; MATLOUBIAN M, 1993, J VIROL, V67, P7340, DOI 10.1128/JVI.67.12.7340-7349.1993; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Miller CJ, 2005, J VIROL, V79, P9217, DOI 10.1128/JVI.79.14.9217-9227.2005; Mothe BR, 2002, J VIROL, V76, P875, DOI 10.1128/JVI.76.2.875-884.2002; Mueller SN, 2007, P NATL ACAD SCI USA, V104, P15430, DOI 10.1073/pnas.0702579104; Pope M, 2003, NAT MED, V9, P847, DOI 10.1038/nm0703-847; Reynolds MR, 2005, J VIROL, V79, P9228, DOI 10.1128/JVI.79.14.9228-9235.2005; Skinner PJ, 2000, J IMMUNOL, V165, P613, DOI 10.4049/jimmunol.165.2.613; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003	18	155	169	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2009	323	5922					1726	1729		10.1126/science.1168676	http://dx.doi.org/10.1126/science.1168676			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	424IG	19325114	Green Submitted, Green Accepted			2022-12-01	WOS:000264559800039
J	Kamerow, D				Kamerow, Douglas			Yankee Doodling The papal position on condoms and HIV	BRITISH MEDICAL JOURNAL			English	Editorial Material												dkamerow@rti.org		Kamerow, Douglas/0000-0001-7000-9957					0	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 25	2009	338								b1217	10.1136/bmj.b1217	http://dx.doi.org/10.1136/bmj.b1217			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	425LQ	19321547				2022-12-01	WOS:000264639600004
J	Daley, AC; Budd, GE; Caron, JB; Edgecombe, GD; Collins, D				Daley, Allison C.; Budd, Graham E.; Caron, Jean-Bernard; Edgecombe, Gregory D.; Collins, Desmond			The Burgess Shale Anomalocaridid Hurdia and Its Significance for Early Euarthropod Evolution	SCIENCE			English	Article							GREAT-APPENDAGE ARTHROPOD; OPABINIA; FAUNA	As the largest predators of the Cambrian seas, the anomalocaridids had an important impact in structuring the first complex marine animal communities, but many aspects of morphology, diversity, ecology, and affinity remain unclear owing to a paucity of specimens. Here we describe the anomalocaridid Hurdia, based on several hundred specimens from the Burgess Shale in Canada. Hurdia possesses a general body architecture similar to those of Anomalocaris and Laggania, including the presence of exceptionally well-preserved gills, but differs from those anomalocaridids by possessing a prominent anterior carapace structure. These features amplify and clarify the diversity of known anomalocaridid morphology and provide insight into the origins of important arthropod features, such as the head shield and respiratory exites.	[Daley, Allison C.; Budd, Graham E.] Uppsala Univ, Dept Earth Sci, SE-75236 Uppsala, Sweden; [Caron, Jean-Bernard] Royal Ontario Museum, Dept Nat Hist, Toronto, ON M5S 2C6, Canada; [Edgecombe, Gregory D.] Nat Hist Museum, Dept Palaeontol, London SW7 5BD, England	Uppsala University; Royal Ontario Museum; Natural History Museum London	Daley, AC (corresponding author), Uppsala Univ, Dept Earth Sci, Villavagen 16, SE-75236 Uppsala, Sweden.	allison.daley@geo.uu.se	Daley, Allison/A-3117-2015	Daley, Allison/0000-0001-5369-5879; Edgecombe, Gregory/0000-0002-9591-8011; Caron, Jean-Bernard/0000-0002-1670-5502	European Union Marie Curie Research Training Network ZOONET [MRTN-CT-2004-005624]; Swedish Research Council (Vetenskapsradet)	European Union Marie Curie Research Training Network ZOONET(European Commission); Swedish Research Council (Vetenskapsradet)(Swedish Research Council)	We thank J. Bergstrom for discussion. Comments from D. E. G. Briggs, B. S. Lieberman, and anonymous reviewers improved the manuscript. J. Dougherty and F. Collier provided access to specimens at GSC and MCZ, respectively, and D. Erwin and J. Thompson provided access to specimens at NMNH. Permission to collect Burgess Shale specimens was given by Parks Canada to D.C. Funding was provided by European Union Marie Curie Research Training Network ZOONET (grant MRTN-CT-2004-005624) to G.E.B. and A.C.D. and the Swedish Research Council (Vetenskapsradet) to G.E.B. This is ROM Burgess Shale Project number 8.	BERGSTROM J, 1987, LETHAIA, V20, P187, DOI 10.1111/j.1502-3931.1987.tb00777.x; Boxshall GA, 2004, BIOL REV, V79, P253, DOI 10.1017/S1464793103006274; Briggs D.E.G., 1979, Palaeontology (Oxford), V22, P631; Briggs DEG, 2008, J PALEONTOL, V82, P238, DOI 10.1666/06-086.1; Budd GE, 2002, NATURE, V417, P271, DOI 10.1038/417271a; Budd GE, 1996, LETHAIA, V29, P1, DOI 10.1111/j.1502-3931.1996.tb01831.x; Caron JB, 2008, PALAEOGEOGR PALAEOCL, V258, P222, DOI 10.1016/j.palaeo.2007.05.023; Chen JY, 2004, LETHAIA, V37, P3, DOI 10.1080/00241160410004764; CHLUPAC I, 2002, B CZECH GEOLOGICAL S, V77, P167; Collins D, 1996, J PALEONTOL, V70, P280, DOI 10.1017/S0022336000023362; COLLINS D, 1999, ROTUNDA, V32, P25; COLLINS D, 1992, PALEONTOLOGICAL SOC, V6, P66; CUI Z, 1990, ACTA PALAEONTOL SIN, V29, P328; Dewel R.A., 1998, Systematics Association Special Volume Series, V55, P109; Fletcher TP, 1998, CAN J EARTH SCI, V35, P413, DOI 10.1139/e97-120; HOU XG, 1995, GFF, V117, P163, DOI 10.1080/11035899509546213; Hou XG, 2006, GEOL J, V41, P259, DOI 10.1002/gj.1050; Kuhl G, 2009, SCIENCE, V323, P771, DOI 10.1126/science.1166586; Lieberman BS, 2003, J PALEONTOL, V77, P674, DOI 10.1666/0022-3360(2003)077<0674:ANSFTP>2.0.CO;2; Maas A, 2004, PROG NAT SCI-MATER, V14, P158, DOI 10.1080/10020070412331343301; ROLFE W. D. IAN, 1962, BREVIORA MUS COMP ZOOL [HARVARD], V160, P1; Simonetta A.M, 1975, Palaeontographia Italica, V69, P1; Walcott Charles D., 1912, Smithsonian Institution Miscellaneous Collection, V57; Walcott Charles D., 1911, Smithsonian Institution Miscellaneous Collection, V57; Walcott Charles Doolittle, 1911, Smithsonian Institution Miscellaneous Collection, V57; Whiteaves J. F., 1892, CANADIAN RECORD SCI, V5, P205; WHITTINGTON HB, 1985, PHILOS T R SOC B, V309, P569, DOI 10.1098/rstb.1985.0096; Wills MA, 1998, ARTHROPOD FOSSILS AND PHYLOGENY, P33; Wolff C, 2008, P ROY SOC B-BIOL SCI, V275, P1023, DOI 10.1098/rspb.2007.1327; Zhang XL, 2007, LETHAIA, V40, P161, DOI 10.1111/j.1502-3931.2007.00013.x	30	137	137	0	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2009	323	5921					1597	1600		10.1126/science.1169514	http://dx.doi.org/10.1126/science.1169514			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421EN	19299617				2022-12-01	WOS:000264342300036
J	Koder, RL; Anderson, JLR; Solomon, LA; Reddy, KS; Moser, CC; Dutton, PL				Koder, Ronald L.; Anderson, J. L. Ross; Solomon, Lee A.; Reddy, Konda S.; Moser, Christopher C.; Dutton, P. Leslie			Design and engineering of an O-2 transport protein	NATURE			English	Article							CYTOCHROME-C-OXIDASE; HEME-PROTEINS; LIGAND-BINDING; COMPUTATIONAL DESIGN; ELECTRON-TRANSFER; ENZYME CATALYSIS; 4-HELIX BUNDLE; HEMOGLOBIN; MAQUETTE; MECHANISM	The principles of natural protein engineering are obscured by overlapping functions and complexity accumulated through natural selection and evolution. Completely artificial proteins offer a clean slate on which to define and test these protein engineering principles, while recreating and extending natural functions. Here we introduce this method with the design of an oxygen transport protein, akin to human neuroglobin. Beginning with a simple and unnatural helix-forming sequence with just three different amino acids, we assembled a four-helix bundle, positioned histidines to bis-histidine ligate haems, and exploited helical rotation and glutamate burial on haem binding to introduce distal histidine strain and facilitate O-2 binding. For stable oxygen binding without haem oxidation, water is excluded by simple packing of the protein interior and loops that reduce helical-interface mobility. O-2 affinities and exchange timescales match natural globins with distal histidines, with the remarkable exception that O-2 binds tighter than CO.	[Koder, Ronald L.; Anderson, J. L. Ross; Solomon, Lee A.; Reddy, Konda S.; Moser, Christopher C.; Dutton, P. Leslie] Univ Penn, Dept Biochem & Biophys, Johnson Res Fdn, Philadelphia, PA 19104 USA	University of Pennsylvania	Dutton, PL (corresponding author), Univ Penn, Dept Biochem & Biophys, Johnson Res Fdn, Philadelphia, PA 19104 USA.	dutton@mail.med.upenn.edu	Koder, Ronald L/A-6089-2008; Moser, Christopher C/O-6559-2014	Moser, Christopher C/0000-0003-4814-8568; Solomon, Lee/0000-0003-1471-9510; Anderson, Ross/0000-0002-6796-0482; Koder, Ronald/0000-0003-0868-4972	US Department of Energy; US National Institute of Health; US National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041048] Funding Source: NIH RePORTER	US Department of Energy(United States Department of Energy (DOE)); US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. J. Wand for assistance in NMR measurements, P. R. Rich for FTIR measurements, M. S. Hargrove for neuroglobin reference spectra and discussions, and D. Hilvert for suggestions. This work was supported by grants from US Department of Energy, US National Institute of Health and US National Science Foundation as detailed in Supplementary Information.	ANSARI A, 1992, SCIENCE, V256, P1796, DOI 10.1126/science.1615323; Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; Bolon DN, 2001, P NATL ACAD SCI USA, V98, P14274, DOI 10.1073/pnas.251555398; Borovik AS, 2005, ACCOUNTS CHEM RES, V38, P54, DOI 10.1021/ar030160q; Brannigan JA, 2002, NAT REV MOL CELL BIO, V3, P964, DOI 10.1038/nrm975; Carbone MN, 2007, CURR OPIN STRUC BIOL, V17, P454, DOI 10.1016/j.sbi.2007.08.005; CHANCE B, 1975, P NATL ACAD SCI USA, V72, P1635, DOI 10.1073/pnas.72.4.1635; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; Collman JP, 2004, CHEM REV, V104, P561, DOI 10.1021/cr0206059; Csete ME, 2002, SCIENCE, V295, P1664, DOI 10.1126/science.1069981; Darwin C., 1872, ORIGIN SPECIES MEANS, V144, P971; Dewilde S, 2001, J BIOL CHEM, V276, P38949, DOI 10.1074/jbc.M106438200; ENGELS WR, 1993, TRENDS BIOCHEM SCI, V18, P448, DOI 10.1016/0968-0004(93)90148-G; Frauenfelder H, 2003, P NATL ACAD SCI USA, V100, P8615, DOI 10.1073/pnas.1633688100; Gibney BR, 1999, J AM CHEM SOC, V121, P4952, DOI 10.1021/ja9833117; Gibney BR, 2000, BIOCHEMISTRY-US, V39, P11041, DOI 10.1021/bi000925r; Goldberg DE, 1999, CHEM REV, V99, P3371, DOI 10.1021/cr970152l; Grosset AM, 2001, BIOCHEMISTRY-US, V40, P5474, DOI 10.1021/bi002504f; Hargrove MS, 2000, BIOPHYS J, V79, P2733, DOI 10.1016/S0006-3495(00)76512-X; Hilvert D, 2000, ANNU REV BIOCHEM, V69, P751, DOI 10.1146/annurev.biochem.69.1.751; Huang SS, 2004, P NATL ACAD SCI USA, V101, P5536, DOI 10.1073/pnas.0306676101; Huang SS, 2003, J MOL BIOL, V326, P1219, DOI 10.1016/S0022-2836(02)01441-9; Isogai Y, 1999, BIOCHEMISTRY-US, V38, P7431, DOI 10.1021/bi983006y; JENCKS WP, 1975, ADV ENZYMOL RAMB, V43, P219; Jiang L, 2008, SCIENCE, V319, P1387, DOI 10.1126/science.1152692; Kaplan J, 2004, P NATL ACAD SCI USA, V101, P11566, DOI 10.1073/pnas.0404387101; Koder RL, 2006, J AM CHEM SOC, V128, P14450, DOI 10.1021/ja064883r; Kraut DA, 2003, ANNU REV BIOCHEM, V72, P517, DOI 10.1146/annurev.biochem.72.121801.161617; Marshall SA, 2001, J MOL BIOL, V305, P619, DOI 10.1006/jmbi.2000.4319; MATHEWS AJ, 1989, J BIOL CHEM, V264, P16573; MCLENDON G, 1991, STRUCT BOND, V75, P159; Moffet DA, 2001, J AM CHEM SOC, V123, P2109, DOI 10.1021/ja0036007; Moffet DA, 2000, J AM CHEM SOC, V122, P7612, DOI 10.1021/ja001198q; Monien BH, 2007, J MOL BIOL, V371, P739, DOI 10.1016/j.jmb.2007.05.047; MOORE JT, 1993, PROTEIN EXPRES PURIF, V4, P160, DOI 10.1006/prep.1993.1022; MOSER CC, 1992, NATURE, V355, P796, DOI 10.1038/355796a0; MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8; Page CC, 2003, CURR OPIN CHEM BIOL, V7, P551, DOI 10.1016/j.cbpa.2003.08.005; Pesce A, 2003, STRUCTURE, V11, P1087, DOI 10.1016/S0969-2126(03)00166-7; Peterson ES, 1997, BIOCHEMISTRY-US, V36, P13110, DOI 10.1021/bi971156n; REGAN L, 1988, SCIENCE, V241, P976, DOI 10.1126/science.3043666; ROBERTSON DE, 1994, NATURE, V368, P425, DOI 10.1038/368425a0; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; SHARMA VS, 1976, J BIOL CHEM, V251, P4267; Shifman JM, 1998, BIOCHEMISTRY-US, V37, P16815, DOI 10.1021/bi9816857; Shikama K, 1998, CHEM REV, V98, P1357, DOI 10.1021/cr970042e; SMITH KM, 1986, J ORG CHEM, V51, P666, DOI 10.1021/jo00355a016; SPRINGER BA, 1994, CHEM REV, V94, P699, DOI 10.1021/cr00027a007; STEMMER WPC, 1995, GENE, V164, P49, DOI 10.1016/0378-1119(95)00511-4; Trent JT, 2001, BIOCHEMISTRY-US, V40, P6155, DOI 10.1021/bi0100790; VALLEE BL, 1968, P NATL ACAD SCI USA, V59, P498, DOI 10.1073/pnas.59.2.498; WANG JH, 1958, J AM CHEM SOC, V80, P3168, DOI 10.1021/ja01545a072; Warshel A, 2003, ANNU REV BIOPH BIOM, V32, P425, DOI 10.1146/annurev.biophys.32.110601.141807; Zhuang JY, 2004, INORG CHEM, V43, P8218, DOI 10.1021/ic048502r	54	184	195	0	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 19	2009	458	7236					305	U64		10.1038/nature07841	http://dx.doi.org/10.1038/nature07841			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420JH	19295603	Green Accepted			2022-12-01	WOS:000264285600034
J	Gooskens, J; Jonges, M; Claas, ECJ; Meijer, A; van den Broek, PJ; Kroes, ACM				Gooskens, Jairo; Jonges, Marcel; Claas, Eric C. J.; Meijer, Adam; van den Broek, Peterhans J.; Kroes, Aloys C. M.			Morbidity and Mortality Associated With Nosocomial Transmission of Oseltamivir-Resistant Influenza A(H1N1) Virus	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IN-VITRO; NEURAMINIDASE; VIVO	Context The sudden emergence and rapid spread of oseltamivir-resistant influenza A(H1N1) viruses with neuraminidase (NA) gene H274Y amino acid substitution is the hallmark of global seasonal influenza since January 2008. Viruses carrying this mutation are widely presumed to exhibit attenuated pathogenicity, compromised transmission, and reduced lethality. Objective To investigate nosocomial viral transmission in a cluster of patients with influenza A(H1N1) virus infection. Design, Setting, and Patients Descriptive outbreak investigation of 2 hematopoietic stem cell transplant recipients and an elderly patient who developed hospital-acquired influenza A virus infection following exposure to an index patient with community-acquired H274Y-mutated influenza A(H1N1) virus infection in a medical ward at a Dutch university hospital in February 2008. The investigation included a review of the medical records, influenza virus polymerase chain reaction and culture, phenotypic oseltamivir and zanamivir susceptibility determination, and hemagglutinin chain 1(HA(1)) gene and NA gene sequence analysis. Main Outcome Measure Phylogenetic relationship of patient cluster influenza A(H1N1) viruses and other 2007-2008 seasonal influenza A(H1N1) viruses. Results Viral HA1 and NA gene sequence analysis from the 4 patients revealed indistinguishable nucleotide sequences and phylogenetic clustering of H274Y-mutated, oseltamivir-resistant influenza A(H1N1) virus, confirming nosocomial transmission. Influenza virus pneumonia (3 patients) and attributable mortality (2 patients) during active infection was observed in patients with lymphocytopenia at onset. Conclusion Seasonal oseltamivir-resistant influenza A(H1N1) viruses with NA gene H274Y mutation are transmitted and retain significant pathogenicity and lethality in high-risk patients.	[Gooskens, Jairo; Claas, Eric C. J.; Kroes, Aloys C. M.] Leiden Univ, Med Ctr, Dept Med Microbiol, Ctr Infect Dis, NL-2300 RC Leiden, Netherlands; [van den Broek, Peterhans J.] Leiden Univ, Med Ctr, Dept Infect Dis, Ctr Infect Dis, NL-2300 RC Leiden, Netherlands; [Jonges, Marcel; Meijer, Adam] Natl Inst Publ Hlth & Environm, Virol Sect, NL-3720 BA Bilthoven, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Netherlands National Institute for Public Health & the Environment	Gooskens, J (corresponding author), Leiden Univ, Med Ctr, Dept Med Microbiol, Ctr Infect Dis, E4-65,POB 9600, NL-2300 RC Leiden, Netherlands.	j.gooskens@lumc.nl	Gooskens, Jairo/A-6634-2009	Gooskens, Jairo/0000-0002-8381-7870; Kroes, Aloysius/0000-0002-9866-2461				*CDCP, 2008, CDC ISS INT REC US I; Gooskens J, 2007, J CLIN VIROL, V39, P136, DOI 10.1016/j.jcv.2007.03.010; Hayden F, 2009, CLIN INFECT DIS, V48, pS3, DOI 10.1086/591851; Herlocher ML, 2004, J INFECT DIS, V190, P1627, DOI 10.1086/424572; Ives JAL, 2002, ANTIVIR RES, V55, P307, DOI 10.1016/S0166-3542(02)00053-0; Lackenby A., 2008, Eurosurveillance, V13, P8026; Nicoll A., 2008, EUROSURVEILLANCE, V13, P8025, DOI [10.2807/ese.13.05.08025-en, DOI 10.2807/ESE.13.05.08025-EN]; POTIER M, 1979, ANAL BIOCHEM, V94, P287, DOI 10.1016/0003-2697(79)90362-2; Templeton KE, 2004, J CLIN MICROBIOL, V42, P1564, DOI 10.1128/JCM.42.4.1564-1569.2004; van der Vries E, 2008, NEW ENGL J MED, V359, P1074, DOI 10.1056/NEJMc0803120; *WHO, 2008, EP PAND AL RESP INFL; Yen HL, 2007, J VIROL, V81, P12418, DOI 10.1128/JVI.01067-07	12	80	88	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 11	2009	301	10					1042	1046		10.1001/jama.2009.297	http://dx.doi.org/10.1001/jama.2009.297			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	416OQ	19255111	Bronze			2022-12-01	WOS:000264015800028
J	Erhard, KF; Stonaker, JL; Parkinson, SE; Lim, JP; Hale, CJ; Hollick, JB				Erhard, Karl F., Jr.; Stonaker, Jennifer L.; Parkinson, Susan E.; Lim, Jana P.; Hale, Christopher J.; Hollick, Jay B.			RNA Polymerase IV Functions in Paramutation in Zea mays	SCIENCE			English	Article							ALPHA-AMANITIN; MAIZE; DNA; TRANSCRIPTION; STATES; REPRESSION; PATHWAY; PLANTS; GENES	Plants have distinct RNA polymerase complexes (Pol IV and Pol V) with largely unknown roles in maintaining small RNA-associated gene silencing. Curiously, the eudicot Arabidopsis thaliana is not affected when either function is lost. By use of mutation selection and positional cloning, we showed that the largest subunit of the presumed maize Pol IV is involved in paramutation, an inherited epigenetic change facilitated by an interaction between two alleles, as well as normal maize development. Bioinformatics analyses and nuclear run-on transcription assays indicate that Pol IV does not engage in the efficient RNA synthesis typical of the three major eukaryotic DNA-dependent RNA polymerases. These results indicate that Pol IV employs abnormal RNA polymerase activities to achieve genome-wide silencing and that its absence affects both maize development and heritable epigenetic changes.	[Erhard, Karl F., Jr.; Stonaker, Jennifer L.; Parkinson, Susan E.; Lim, Jana P.; Hale, Christopher J.; Hollick, Jay B.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Hollick, JB (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, 111 Koshland Hall, Berkeley, CA 94720 USA.	hollick@nature.berkeley.edu			National Research Initiative of the U.S. Department of Agriculture Cooperative State Research, Education and Extension Service [99-35301-7753, 2001-35301-10641, 2006-35304-17399]; NSF [MCB-0419909]	National Research Initiative of the U.S. Department of Agriculture Cooperative State Research, Education and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); NSF(National Science Foundation (NSF))	We thank X. Parisky for technical assistance; N. Bolduc for providing nucleic acid samples; S. McCormick and D. Zilberman for comments; and the maize, Sorghum bicolor, and Brachypodium genome-sequencing projects for providing sequence information before publication. Brachypodium and Sorghum bicolor sequences were produced by the U.S. Department of Energy Joint Genome Institute (www.jgi.doe.gov/). cDNA sequences for Rmr6-A619, rmr6-1, rmr6-7, rmr6-8, and rmr6-14 are archived under GenBank accession numbers FJ426107 to FJ426111, respectively. Germ plasm containing mutations in the rmr6 gene is covered by U.S. patent 07264970 awarded to the Regents of the University of California. Supported by the National Research Initiative of the U.S. Department of Agriculture Cooperative State Research, Education and Extension Service (grants 99-35301-7753, 2001-35301-10641, and 2006-35304-17399) and NSF (grant MCB-0419909).	Alleman M, 2006, NATURE, V442, P295, DOI 10.1038/nature04884; BRINK RA, 1964, AM NAT, V98, P193, DOI 10.1086/282320; Bushnell DA, 2002, P NATL ACAD SCI USA, V99, P1218, DOI 10.1073/pnas.251664698; Calderon-Urrea A, 1999, DEVELOPMENT, V126, P435; Chandler VL, 2007, CELL, V128, P641, DOI 10.1016/j.cell.2007.02.007; CONE KC, 1993, PLANT CELL, V5, P1807, DOI 10.1105/tpc.5.12.1807; Dorweiler JE, 2000, PLANT CELL, V12, P2101, DOI 10.1105/tpc.12.11.2101; Hale CJ, 2007, PLOS BIOL, V5, P2156, DOI 10.1371/journal.pbio.0050275; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; Hollick JB, 2005, GENETICS, V171, P725, DOI 10.1534/genetics.105.045260; Hollick JB, 2001, GENETICS, V157, P369; Huettel B, 2007, BBA-GENE STRUCT EXPR, V1769, P358, DOI 10.1016/j.bbaexp.2007.03.001; JOKERST RS, 1989, MOL GEN GENET, V215, P266, DOI 10.1007/BF00339727; Kaplan CD, 2008, MOL CELL, V30, P547, DOI 10.1016/j.molcel.2008.04.023; KERMICLE JL, 1990, DEVELOPMENT, P9; LINDELL TJ, 1970, SCIENCE, V170, P447, DOI 10.1126/science.170.3956.447; Liu RY, 2007, P NATL ACAD SCI USA, V104, P7116, DOI 10.1073/pnas.0700266104; Luo J, 2007, J MOL EVOL, V64, P101, DOI 10.1007/s00239-006-0093-z; MCCLINTOCK B, 1951, COLD SPRING HARB SYM, V16, P13, DOI 10.1101/SQB.1951.016.01.004; MCMULLEN MD, 1986, NUCLEIC ACIDS RES, V14, P4953, DOI 10.1093/nar/14.12.4953; Mosher RA, 2008, P NATL ACAD SCI USA, V105, P3145, DOI 10.1073/pnas.0709632105; Mroczek RJ, 2003, GENETICS, V165, P809; Parkinson SE, 2007, DEV BIOL, V308, P462, DOI 10.1016/j.ydbio.2007.06.004; Pikaard CS, 2008, TRENDS PLANT SCI, V13, P390, DOI 10.1016/j.tplants.2008.04.008; Pontes O, 2006, CELL, V126, P79, DOI 10.1016/j.cell.2006.05.031; Ream TS, 2009, MOL CELL, V33, P192, DOI 10.1016/j.molcel.2008.12.015; SOBELL HM, 1985, P NATL ACAD SCI USA, V82, P5328, DOI 10.1073/pnas.82.16.5328; Wierzbicki AT, 2008, CELL, V135, P635, DOI 10.1016/j.cell.2008.09.035; Woodhouse MR, 2006, PLOS BIOL, V4, P1678, DOI 10.1371/journal.pbio.0040339; Zaratiegui M, 2007, CELL, V128, P763, DOI 10.1016/j.cell.2007.02.016; Zhang XY, 2007, P NATL ACAD SCI USA, V104, P4536, DOI 10.1073/pnas.0611456104	31	109	110	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2009	323	5918					1201	1205		10.1126/science.1164508	http://dx.doi.org/10.1126/science.1164508			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411XT	19251626				2022-12-01	WOS:000263687600035
J	Kuchibhotla, KV; Lattarulo, CR; Hyman, BT; Bacskai, BJ				Kuchibhotla, Kishore V.; Lattarulo, Carli R.; Hyman, Bradley T.; Bacskai, Brian J.			Synchronous Hyperactivity and Intercellular Calcium Waves in Astrocytes in Alzheimer Mice	SCIENCE			English	Article							MOUSE MODEL; AMYLOID DEPOSITION; BETA-PLAQUES; IN-VIVO; DISEASE; PROPAGATION	Although senile plaques focally disrupt neuronal health, the functional response of astrocytes to Alzheimer's disease pathology is unknown. Using multiphoton fluorescence lifetime imaging microscopy in vivo, we quantitatively imaged astrocytic calcium homeostasis in a mouse model of Alzheimer's disease. Resting calcium was globally elevated in the astrocytic network, but was independent of proximity to individual plaques. Time-lapse imaging revealed that calcium transients in astrocytes were more frequent, synchronously coordinated across long distances, and uncoupled from neuronal activity. Furthermore, rare intercellular calcium waves were observed, but only in mice with amyloid-beta plaques, originating near plaques and spreading radially at least 200 micrometers. Thus, although neurotoxicity is observed near amyloid-beta deposits, there exists a more general astrocyte-based network response to focal pathology.	[Kuchibhotla, Kishore V.; Lattarulo, Carli R.; Hyman, Bradley T.; Bacskai, Brian J.] Massachusetts Gen Hosp, Dept Neurol, Alzheimers Dis Res Lab, Charlestown, MA 02129 USA; [Kuchibhotla, Kishore V.] Harvard Univ, Program Biophys, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University	Bacskai, BJ (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Alzheimers Dis Res Lab, 114 16th St, Charlestown, MA 02129 USA.	bbacskai@partners.org	Bacskai, Brian/AAE-9583-2021		NIH [EB000768, AG08487, NS580752]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS058075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG008487, P50AG005134] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank K. O. Ohki and R. C. Reid for assistance with the multicell bolus loading technique. This work was supported by NIH grants EB000768 (B.J.B.), AG08487 (B.T.H.), and NS580752 (K.V.K.).	Abramov AY, 2003, J NEUROSCI, V23, P5088; Agulhon C, 2008, NEURON, V59, P932, DOI 10.1016/j.neuron.2008.09.004; BOITANO S, 1992, SCIENCE, V258, P292, DOI 10.1126/science.1411526; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Busche MA, 2008, SCIENCE, V321, P1686, DOI 10.1126/science.1162844; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; Cotrina ML, 2000, J NEUROSCI, V20, P2835; Fiacco TA, 2006, GLIA, V54, P676, DOI 10.1002/glia.20396; Garcia-Alloza M, 2006, J NEUROPATH EXP NEUR, V65, P1082, DOI 10.1097/01.jnen.0000240468.12543.af; Garcia-Alloza M, 2006, NEUROBIOL DIS, V24, P516, DOI 10.1016/j.nbd.2006.08.017; Guthrie PB, 1999, J NEUROSCI, V19, P520, DOI 10.1523/jneurosci.19-02-00520.1999; Hirase H, 2004, PLOS BIOL, V2, P494, DOI 10.1371/journal.pbio.0020096; Kuchibhotla KV, 2008, NEURON, V59, P214, DOI 10.1016/j.neuron.2008.06.008; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Meyer-Luehmann M, 2008, NATURE, V451, P720, DOI 10.1038/nature06616; Petravicz J, 2008, J NEUROSCI, V28, P4967, DOI 10.1523/JNEUROSCI.5572-07.2008; Scemes E, 2006, GLIA, V54, P716, DOI 10.1002/glia.20374; Schummers J, 2008, SCIENCE, V320, P1638, DOI 10.1126/science.1156120; Spires TL, 2005, J NEUROSCI, V25, P7278, DOI 10.1523/JNEUROSCI.1879-05.2005; Takano T, 2007, ANN NY ACAD SCI, V1097, P40, DOI 10.1196/annals.1379.004; Wang XH, 2006, NAT NEUROSCI, V9, P816, DOI 10.1038/nn1703; Wegiel J, 2001, NEUROBIOL AGING, V22, P49, DOI 10.1016/S0197-4580(00)00181-0; Wilms CD, 2006, CELL CALCIUM, V40, P73, DOI 10.1016/j.ceca.2006.03.006; Wyss-Coray T, 2003, NAT MED, V9, P453, DOI 10.1038/nm838	24	485	496	0	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2009	323	5918					1211	1215		10.1126/science.1169096	http://dx.doi.org/10.1126/science.1169096			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411XT	19251629	Green Accepted			2022-12-01	WOS:000263687600038
J	Marintchev, A; Edmonds, KA; Marintcheva, B; Hendrickson, E; Oberer, M; Suzuki, C; Herdy, B; Sonenberg, N; Wagner, G				Marintchev, Assen; Edmonds, Katherine A.; Marintcheva, Boriana; Hendrickson, Elthea; Oberer, Monika; Suzuki, Chikako; Herdy, Barbara; Sonenberg, Nahum; Wagner, Gerhard			Topology and Regulation of the Human eIF4A/4G/4H Helicase Complex in Translation Initiation	CELL			English	Article							BOX PROTEIN EIF4A; FACTOR 4G EIF4G; MESSENGER-RNA; CRYSTAL-STRUCTURE; BINDING; CAP; DOMAINS; FRAMEWORK; SITES	The RNA helicase eIF4A plays a key role in unwinding of mRNA and scanning during translation initiation. Free eIF4A is a poor helicase and requires the accessory proteins eIF4G and eIF4H. However, the structure of the helicase complex and the mechanisms of stimulation of eIF4A activity have remained elusive. Here we report the topology of the eIF4A/4G/4H helicase complex, which is built from multiple experimentally observed domain-domain contacts. Remarkably, some of the interactions are continuously rearranged during the ATP binding/hydrolysis cycle of the helicase. We show that the accessory proteins modulate the affinity of eIF4A for ATP by interacting simultaneously with both helicase domains and promoting either the closed, ATP-bound conformation or the open, nucleotide-free conformation. The topology of the complex and the spatial arrangement of the RNA-binding surfaces offer insights into their roles in stimulation of helicase activity and the mechanisms of mRNA unwinding and scanning.	[Oberer, Monika] Graz Univ, Inst Mol Biosci, Graz, Austria; [Herdy, Barbara; Sonenberg, Nahum] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Marintchev, Assen; Edmonds, Katherine A.; Hendrickson, Elthea; Suzuki, Chikako; Wagner, Gerhard] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	University of Graz; McGill University; Harvard University; Harvard Medical School	Marintchev, A (corresponding author), Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA.	amarint@bu.edu; gerhard_wagner@hms.harvard.edu		Marintchev, Assen/0000-0002-9901-3500; Oberer, Monika/0000-0003-2525-9513	NATIONAL CANCER INSTITUTE [K01CA119107, R01CA068262, R01CA127990] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000995, S10RR015742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM066360, P01GM047467, R01GM038608] Funding Source: NIH RePORTER; NCI NIH HHS [K01CA119107, R01 CA127990, R01 CA068262-14, R01 CA068262-11, R01 CA068262, R01 CA068262-12, K01 CA119107, CA68262, R01 CA127990-03, R01 CA068262-13] Funding Source: Medline; NCRR NIH HHS [P41 RR000995-27, S10 RR015742-01, P41 RR000995-26] Funding Source: Medline; NIBIB NIH HHS [P41 EB002026] Funding Source: Medline; NIGMS NIH HHS [P01 GM047467-179002, P41 GM066360-05, GM47467, R01 GM038608-13, P41 GM066360-04, P01 GM047467-170010, P41 GM066360, R01 GM038608-12, R01 GM038608-11A2, R01 GM038608, P01 GM047467-179001, P01 GM047467, P01 GM047467-170011] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andersen CBF, 2006, SCIENCE, V313, P1968, DOI 10.1126/science.1131981; Bellsolell L, 2006, STRUCTURE, V14, P913, DOI 10.1016/j.str.2006.03.012; Caruthers JM, 2000, P NATL ACAD SCI USA, V97, P13080, DOI 10.1073/pnas.97.24.13080; Feng PH, 2005, J VIROL, V79, P9651, DOI 10.1128/JVI.79.15.9651-9664.2005; Fersht A., 1999, STRUCTURE MECH PROTE, P125; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; GRIFO JA, 1984, J BIOL CHEM, V259, P8648; Gross JD, 2003, CELL, V115, P739, DOI 10.1016/S0092-8674(03)00975-9; Imataka H, 1997, MOL CELL BIOL, V17, P6940, DOI 10.1128/MCB.17.12.6940; Jackson RJ, 2000, COLD SPRING HARBOR M, V39, P127; Korneeva NL, 2001, J BIOL CHEM, V276, P2872, DOI 10.1074/jbc.M006345200; Korneeva NL, 2000, J BIOL CHEM, V275, P41369, DOI 10.1074/jbc.M007525200; LAMPHEAR BJ, 1995, J BIOL CHEM, V270, P21975, DOI 10.1074/jbc.270.37.21975; Lorsch JR, 1998, BIOCHEMISTRY-US, V37, P2180, DOI 10.1021/bi972430g; Lorsch JR, 1998, BIOCHEMISTRY-US, V37, P2194, DOI 10.1021/bi9724319; Marcotrigiano J, 2001, MOL CELL, V7, P193, DOI 10.1016/S1097-2765(01)00167-8; Marintchev A, 2004, Q REV BIOPHYS, V37, P197, DOI 10.1017/S0033583505004026; Marintchev A, 2005, BIOCHEMISTRY-US, V44, P12265, DOI 10.1021/bi051271v; Marintchev A, 2007, METHOD ENZYMOL, V430, P283, DOI 10.1016/S0076-6879(07)30012-8; Mazza C, 2002, EMBO J, V21, P5548, DOI 10.1093/emboj/cdf538; Morino S, 2000, MOL CELL BIOL, V20, P468, DOI 10.1128/MCB.20.2.468-477.2000; Oberer M, 2005, GENE DEV, V19, P2212, DOI 10.1101/gad.1335305; PAUSE A, 1994, EMBO J, V13, P1205, DOI 10.1002/j.1460-2075.1994.tb06370.x; Pisarev AV, 2008, EMBO J, V27, P1609, DOI 10.1038/emboj.2008.90; Prevot D, 2003, EMBO J, V22, P1909, DOI 10.1093/emboj/cdg175; Richter-Cook NJ, 1998, J BIOL CHEM, V273, P7579, DOI 10.1074/jbc.273.13.7579; Roehrl MHA, 2004, BIOCHEMISTRY-US, V43, P16056, DOI 10.1021/bi048233g; Rogers GW, 2002, PROG NUCLEIC ACID RE, V72, P307, DOI 10.1016/S0079-6603(02)72073-4; Rozovsky N, 2008, RNA, V14, P2136, DOI 10.1261/rna.1049608; Schutz P, 2008, P NATL ACAD SCI USA, V105, P9564, DOI 10.1073/pnas.0800418105; Siridechadilok B, 2005, SCIENCE, V310, P1513, DOI 10.1126/science.1118977; Yang HS, 2004, MOL CELL BIOL, V24, P3894, DOI 10.1128/MCB.24.9.3894-3906.2004; Yusupova GZ, 2001, CELL, V106, P233, DOI 10.1016/S0092-8674(01)00435-4	33	172	175	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 6	2009	136	3					447	460		10.1016/j.cell.2009.01.014	http://dx.doi.org/10.1016/j.cell.2009.01.014			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	403ZN	19203580	Green Submitted, Green Accepted, Bronze			2022-12-01	WOS:000263120600015
J	Monecke, T; Guttler, T; Neumann, P; Dickmanns, A; Gorlich, D; Ficner, R				Monecke, Thomas; Guettler, Thomas; Neumann, Piotr; Dickmanns, Achim; Goerlich, Dirk; Ficner, Ralf			Crystal Structure of the Nuclear Export Receptor CRM1 in Complex with Snurportin1 and RanGTP	SCIENCE			English	Article							IMPORTIN-BETA; RIBOSOMAL-SUBUNITS; TRANSPORT; CYTOPLASM; BINDING; DOMAIN; ALPHA; IDENTIFICATION; RECOGNITION; PROTEINS	CRM1 mediates nuclear export of numerous unrelated cargoes, which may carry a short leucine-rich nuclear export signal or export signatures that include folded domains. How CRM1 recognizes such a variety of cargoes has been unknown up to this point. Here we present the crystal structure of the SPN1.CRM1.RanGTP export complex at 2.5 angstrom resolution (where SPN1 is snurportin1 and RanGTP is guanosine 5' triphosphate-bound Ran). SPN1 is a nuclear import adapter for cytoplasmically assembled, m(3)G-capped spliceosomal U snRNPs (small nuclear ribonucleoproteins). The structure shows how CRM1 can specifically return the cargo-free form of SPN1 to the cytoplasm. The extensive contact area includes five hydrophobic residues at the SPN1 amino terminus that dock into a hydrophobic cleft of CRM1, as well as numerous hydrophilic contacts of CRM1 to m3G cap-binding domain and carboxyl-terminal residues of SPN1. The structure suggests that RanGTP promotes cargo-binding to CRM1 solely through long-range conformational changes in the exportin.	[Guettler, Thomas; Goerlich, Dirk] Max Planck Inst Biophys Chem, Abt Zellulare Logist, D-37077 Gottingen, Germany; [Monecke, Thomas; Neumann, Piotr; Dickmanns, Achim; Ficner, Ralf] Univ Gottingen, Abt Mol Strukturbiol, Inst Mikrobiol & Genet, GZMB, D-37077 Gottingen, Germany	Max Planck Society; University of Gottingen	Gorlich, D (corresponding author), Max Planck Inst Biophys Chem, Abt Zellulare Logist, Fassberg 11, D-37077 Gottingen, Germany.	goerlich@mpibpc.mpg.de	Görlich, Dirk/B-8296-2017; Güttler, Thomas/O-4851-2016	Görlich, Dirk/0000-0002-4343-5210; Güttler, Thomas/0000-0002-1456-7310	Deutsche Forschungsgemeinschaft [SFB523]; Max-Planck-Gesellschaft; Alfried Krupp-Foundation; Boehringer Ingelheim Fonds	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max-Planck-Gesellschaft(Max Planck Society); Alfried Krupp-Foundation; Boehringer Ingelheim Fonds(Boehringer Ingelheim)	We thank the staff of synchrotron beamlines at BESSY (Berlin), the European Molecular Biology Laboratory/Deutsches Elektronen-Synchrotron (Hamburg), and the European Synchotron Radiation Facility (Grenoble) for assistance during data collection; D. Deichsel for excellent technical help; and S. Frey and S. Guttler for comments on the manuscript. We received funding from the Deutsche Forschungsgemeinschaft (grant SFB523 to R.F. and T.M.), the Max-Planck-Gesellschaft (to D.G. and T.G.), the Alfried Krupp-Foundation (to D.G. and T.G.), and the Boehringer Ingelheim Fonds (to T.G.). Coordinates and structure factors have been deposited in the Protein Data Bank with accession code 3GJX.	Andrade MA, 2001, J MOL BIOL, V309, P1, DOI 10.1006/jmbi.2001.4624; Bohnsack MT, 2002, EMBO J, V21, P6205, DOI 10.1093/emboj/cdf613; Chook YM, 1999, NATURE, V399, P230, DOI 10.1038/20375; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Cook A, 2005, MOL CELL, V18, P355, DOI 10.1016/j.molcel.2005.03.021; Cook A, 2007, ANNU REV BIOCHEM, V76, P647, DOI 10.1146/annurev.biochem.76.052705.161529; FISCHER U, 1995, CELL, V82, P475, DOI 10.1016/0092-8674(95)90436-0; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fornerod M, 1997, EMBO J, V16, P807, DOI 10.1093/emboj/16.4.807; Gadal O, 2001, MOL CELL BIOL, V21, P3405, DOI 10.1128/MCB.21.10.3405-3415.2001; Gorlich D, 1996, EMBO J, V15, P1810, DOI 10.1002/j.1460-2075.1996.tb00530.x; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Gorlich D, 1997, J CELL BIOL, V138, P65, DOI 10.1083/jcb.138.1.65; Gorlich D, 1996, EMBO J, V15, P5584, DOI 10.1002/j.1460-2075.1996.tb00943.x; Huber J, 1998, EMBO J, V17, P4114, DOI 10.1093/emboj/17.14.4114; Johnson AW, 2002, TRENDS BIOCHEM SCI, V27, P580, DOI 10.1016/S0968-0004(02)02208-9; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Kutay U, 2005, TRENDS CELL BIOL, V15, P121, DOI 10.1016/j.tcb.2005.01.005; Kutay U, 1997, CELL, V90, P1061, DOI 10.1016/S0092-8674(00)80372-4; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Matsuura Y, 2004, NATURE, V432, P872, DOI 10.1038/nature03144; Mitrousis G, 2008, J BIOL CHEM, V283, P7877, DOI 10.1074/jbc.M709093200; Moy TI, 2002, J CELL SCI, V115, P2985; Ohno M, 2000, CELL, V101, P187, DOI 10.1016/S0092-8674(00)80829-6; Paraskeva E, 1999, J CELL BIOL, V145, P255, DOI 10.1083/jcb.145.2.255; Petosa C, 2004, MOL CELL, V16, P761, DOI 10.1016/j.molcel.2004.11.018; SCHEFFZEK K, 1995, NATURE, V374, P378, DOI 10.1038/374378a0; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Stewart M, 1998, J MOL BIOL, V284, P1517, DOI 10.1006/jmbi.1998.2204; Strasser A, 2005, EMBO J, V24, P2235, DOI 10.1038/sj.emboj.7600701; Vetter IR, 1999, CELL, V97, P635, DOI 10.1016/S0092-8674(00)80774-6; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; Wohlwend D, 2007, J MOL BIOL, V374, P1129, DOI 10.1016/j.jmb.2007.09.065	33	163	175	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2009	324	5930					1087	1091		10.1126/science.1173388	http://dx.doi.org/10.1126/science.1173388			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448EU	19389996				2022-12-01	WOS:000266246700046
J	Andrew, TL; Tsai, HY; Menon, R				Andrew, Trisha L.; Tsai, Hsin-Yu; Menon, Rajesh			Confining Light to Deep Subwavelength Dimensions to Enable Optical Nanopatterning	SCIENCE			English	Article							MICROSCOPY; RESOLUTION; MEMORIES	In the past, the formation of microscale patterns in the far field by light has been diffractively limited in resolution to roughly half the wavelength of the radiation used. Here, we demonstrate lines with an average width of 36 nanometers (nm), about one-tenth the illuminating wavelength lambda(1) = 325 nm, made by applying a film of thermally stable photochromic molecules above the photoresist. Simultaneous irradiation of a second wavelength, lambda(2) = 633 nm, renders the film opaque to the writing beam except at nodal sites, which let through a spatially constrained segment of incident lambda(1) light, allowing subdiffractional patterning. The same experiment also demonstrates a patterning of periodic lines whose widths are about one-tenth their period, which is far smaller than what has been thought to be lithographically possible.	[Tsai, Hsin-Yu; Menon, Rajesh] MIT, Elect Res Lab, Cambridge, MA 02139 USA; [Menon, Rajesh] LumArray, Somerville, MA 02143 USA; [Tsai, Hsin-Yu] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Andrew, Trisha L.] MIT, Dept Chem, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Menon, R (corresponding author), MIT, Elect Res Lab, Cambridge, MA 02139 USA.	rmenon@mit.edu			LumArray [6916866]; MIT Deshpande Center for Technological Innovation; Defense Advanced Research Projects Agency Small Business Innovation Research award [W31P4Q-05-C-R156]	LumArray; MIT Deshpande Center for Technological Innovation; Defense Advanced Research Projects Agency Small Business Innovation Research award(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	We thank F. Stellacci and T. Swager for advice on synthesis of the photochromic molecules, H. Koh for the ellipsometric measurements, T. OReilly for assistance with the Lloyds-mirror interferometer, and H. Smith for suggestions on the manuscript. T.L.A. was partially funded by a subcontract (6916866) from LumArray. H.Y.T. was partially funded by an ignition grant from the MIT Deshpande Center for Technological Innovation. R.M. was partially funded by a Defense Advanced Research Projects Agency Small Business Innovation Research award (W31P4Q-05-C-R156). Three patents have been filed through MIT based on the work presented herein.	Abbe E., 1873, ARCH MIKROSK ANAT, V9, P413, DOI [10.1007/BF02956173, DOI 10.1007/BF02956173]; ASH EA, 1972, NATURE, V237, P510, DOI 10.1038/237510a0; BETZIG E, 1991, SCIENCE, V251, P1468, DOI 10.1126/science.251.5000.1468; Chovin A, 2004, NANO LETT, V4, P1965, DOI 10.1021/nl048824s; Crano JC, 1999, T APPL CHEM, P1; DARCY PJ, 1981, J CHEM SOC PERK T 1, P202, DOI 10.1039/p19810000202; Fang N, 2005, SCIENCE, V308, P534, DOI 10.1126/science.1108759; Frey HG, 2002, APPL PHYS LETT, V81, P5030, DOI 10.1063/1.1530736; Hell SW, 2003, NAT BIOTECHNOL, V21, P1347, DOI 10.1038/nbt895; Irie M, 2000, CHEM REV, V100, P1685, DOI 10.1021/cr980069d; Ito T, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2227633; Jacob Z, 2006, OPT EXPRESS, V14, P8247, DOI 10.1364/OE.14.008247; Menon R, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.043905; Menon R, 2006, J OPT SOC AM A, V23, P2290, DOI 10.1364/JOSAA.23.002290; Menon R, 2009, J OPT SOC AM A, V26, P297, DOI 10.1364/JOSAA.26.000297; Murooka K, 2003, J VAC SCI TECHNOL B, V21, P2668, DOI 10.1116/1.1627803; Novotny L, 1998, ULTRAMICROSCOPY, V71, P341, DOI 10.1016/S0304-3991(97)00066-1; Ozbay E, 2006, SCIENCE, V311, P189, DOI 10.1126/science.1114849; Pease RF, 2005, MICROELECTRON ENG, V78-79, P381, DOI 10.1016/j.mee.2005.01.009; TAFLOVE A, 2000, COPUTATION ELECTRODY; Tsai HY, 2008, OPT LETT, V33, P2916, DOI 10.1364/OL.33.002916; Tsai HY, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2775092; Yin XB, 2002, APPL PHYS LETT, V81, P3663, DOI 10.1063/1.1519329; Yokoyama Y, 2000, CHEM REV, V100, P1717, DOI 10.1021/cr980070c	24	191	211	5	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 15	2009	324	5929					917	921		10.1126/science.1167704	http://dx.doi.org/10.1126/science.1167704			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	19359545				2022-12-01	WOS:000266048800032
J	Sharma, G; Fletcher, KE; Zhang, D; Kuo, YF; Freeman, JL; Goodwin, JS				Sharma, Gulshan; Fletcher, Kathlyn E.; Zhang, Dong; Kuo, Yong-Fang; Freeman, Jean L.; Goodwin, James S.			Continuity of Outpatient and Inpatient Care by Primary Care Physicians for Hospitalized Older Adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PROVIDER CONTINUITY; UNITED-STATES; INFORMATION-TECHNOLOGY; PATIENT RELATIONSHIP; PREVENTIVE SERVICES; FAMILY PHYSICIANS; HEALTH-CARE; CLAIMS DATA; QUALITY; CANCER	Context Little is known about the extent of continuity of care across the transition from outpatient care to hospitalization. Objectives To describe continuity of care in older hospitalized patients, change in continuity over time, and factors associated with discontinuity. Design, Setting, and Participants A retrospective cohort study of 3 020 770 hospital admissions between 1996 and 2006 using enrollment and claims data for a 5% national sample of Medicare beneficiaries older than 66 years. Data files were constructed to include the patients' demographic and enrollment information (denominator file) and claims for hospital stays (MEDPAR file) and physician services (carrier claims file). Characteristics of the hospitals were included in annual provider of services files. Being seen by a physician was defined as when a physician had submitted a bill for evaluation and management services for that patient. Main Outcome Measures Percentage of patients who during hospitalization were seen by any outpatient physician they had visited in the year before hospitalization ( continuity with any outpatient physician) or by their primary care physician (PCP) (continuity with a PCP). Results In 1996, 50.5% (95% confidence interval [CI], 50.3%-50.7%) of hospitalized patients were seen by at least 1 physician that they had visited in an outpatient setting in the prior year, and 44.3% (95% CI, 44.1%-44.6%) of patients with an identifiable PCP were seen by that physician while hospitalized. These percentages decreased to 39.8% ( 95% CI, 39.6%-40.0%) and 31.9% (95% CI, 31.6%-32.1%), respectively, in 2006. Greater absolute decreases in continuity with any outpatient physician between 1996 and 2006 occurred in patients admitted on weekends (13.9%; 95% CI, 12.9%-14.7%) and those living in large metropolitan areas (11.7%; 95% CI, 11.1%12.3%) and in New England (16.2%; 95% CI, 14.4%-18.0%). In multivariable multilevel models, increasing involvement of hospitalists was associated with approximately one-third of the decrease in continuity of care between 1996 and 2006. Conclusion Between 1996 and 2006, physician continuity from outpatient to inpatient settings decreased in the Medicare population.	[Sharma, Gulshan; Kuo, Yong-Fang; Freeman, Jean L.; Goodwin, James S.] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA; [Sharma, Gulshan; Zhang, Dong; Kuo, Yong-Fang; Freeman, Jean L.; Goodwin, James S.] Univ Texas Med Branch, Sealy Ctr Aging, Galveston, TX 77555 USA; [Fletcher, Kathlyn E.] Med Coll Wisconsin, Clement J Zablocki Vet Affairs Med Ctr, Milwaukee, WI 53226 USA; [Fletcher, Kathlyn E.] Med Coll Wisconsin, Dept Gen Internal Med, Milwaukee, WI 53226 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Medical College of Wisconsin; Medical College of Wisconsin	Sharma, G (corresponding author), Univ Texas Med Branch, Dept Internal Med, 301 Univ Blvd,JSA 5-112, Galveston, TX 77555 USA.	gulshan.sharma@utmb.edu			National Cancer Institute [P50 CA 105631]; National Institute on Aging [K-08 AG 031583, P60 AG 17231]; NATIONAL CANCER INSTITUTE [P50CA105631, K05CA134923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG024832, K08AG031583, P60AG017231] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grant P50 CA 105631 from the National Cancer Institute and grants K-08 AG 031583 and P60 AG 17231 from the National Institute on Aging.	Arday SL, 2000, HEALTH CARE FINANC R, V21, P107; Arora V, 2009, ARCH INTERN MED, V169, P199, DOI 10.1001/archinternmed.2008.565; Atlas SJ, 2006, J GEN INTERN MED, V21, P973, DOI 10.1007/BF02743147; Atlas SJ, 2009, ANN INTERN MED, V150, P325, DOI 10.7326/0003-4819-150-5-200903030-00008; Bach PB, 2002, MED CARE, V40, P19; Baldwin LM, 2002, MED CARE, V40, P82; Bates DW, 2005, HEALTH AFFAIR, V24, P1180, DOI 10.1377/hlthaff.24.5.1180; BICE TW, 1977, MED CARE, V15, P347, DOI 10.1097/00005650-197704000-00010; BRESLAU N, 1976, J HEALTH SOC BEHAV, V17, P339, DOI 10.2307/2136712; Burge F, 2003, MED CARE, V41, P992, DOI 10.1097/00005650-200308000-00012; Burge Frederick, 2003, J Palliat Med, V6, P911, DOI 10.1089/109662103322654794; Centers for Medicare & Medicaid Services, STAND AN FIL; Christakis DA, 2001, PEDIATRICS, V107, P524, DOI 10.1542/peds.107.3.524; Citro R, 1997, IEEE Trans Inf Technol Biomed, V1, P189, DOI 10.1109/4233.654862; Coleman EA, 2004, HEALTH SERV RES, V39, P1449, DOI 10.1111/j.1475-6773.2004.00298.x; Coleman EA, 2004, ANN INTERN MED, V141, P533, DOI 10.7326/0003-4819-141-7-200410050-00009; *COMM FUT PRIM CAR, 1996, PRIM CAR AM HLTH NEW; *CTR MED MED SERV, NON DAT FIL PROV SER; EJLERTSSON G, 1984, MED CARE, V22, P231, DOI 10.1097/00005650-198403000-00006; Ettner SL, 1999, MED CARE, V37, P547, DOI 10.1097/00005650-199906000-00004; Ettner SL, 1996, AM J PUBLIC HEALTH, V86, P1748, DOI 10.2105/AJPH.86.12.1748; Finison K S, 1999, Eff Clin Pract, V2, P120; Freese RB, 1999, ANN INTERN MED, V130, P350, DOI 10.7326/0003-4819-130-4-199902161-00004; Gallagher TC, 2001, MED CARE, V39, P1086, DOI 10.1097/00005650-200110000-00006; Gill JM, 1998, ARCH FAM MED, V7, P352, DOI 10.1001/archfami.7.4.352; Guthrie B, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a867; Haggerty JL, 2003, BRIT MED J, V327, P1219, DOI 10.1136/bmj.327.7425.1219; Kerse N, 2004, ANN FAM MED, V2, P455, DOI 10.1370/afm.139; Klabunde CN, 2000, J CLIN EPIDEMIOL, V53, P1258, DOI 10.1016/S0895-4356(00)00256-0; Kripalani S, 2007, JAMA-J AM MED ASSOC, V297, P831, DOI 10.1001/jama.297.8.831; Kuo Y, 2009, NEW ENGL J MED, V360, P1102, DOI 10.1056/NEJMsa0802381; Lambrew JM, 1996, MED CARE, V34, P138, DOI 10.1097/00005650-199602000-00006; Landon BE, 2003, JAMA-J AM MED ASSOC, V290, P1183, DOI 10.1001/jama.290.9.1183; Lindenauer PK, 2007, NEW ENGL J MED, V357, P2589, DOI 10.1056/NEJMsa067735; Love MM, 2000, J FAM PRACTICE, V49, P998; Mainous AG, 2001, FAM MED, V33, P22; Mainous AG, 2004, ANN FAM MED, V2, P452, DOI 10.1370/afm.84; Mainous AG, 2004, FAM MED, V36, P35; Mainous AG, 1998, AM J PUBLIC HEALTH, V88, P1539, DOI 10.2105/AJPH.88.10.1539; Moore Kent J, 2005, Fam Pract Manag, V12, P29; OMalley AS, 1997, ARCH INTERN MED, V157, P1462, DOI 10.1001/archinte.157.13.1462; Pantilat SZ, 2001, AM J MED, V111, P15, DOI 10.1016/S0002-9343(01)00964-0; Parchman ML, 2004, FAM MED, V36, P22; Pham HH, 2008, HEALTH AFFAIR, V27, P1315, DOI 10.1377/hlthaff.27.5.1315; Pham HH, 2007, NEW ENGL J MED, V356, P1130, DOI 10.1056/NEJMsa063979; *RES DAT ASS CTR, MED DAT FIL DESCR; Riall TS, 2007, J GASTROINTEST SURG, V11, P1242, DOI 10.1007/s11605-007-0245-5; Rodriguez HP, 2008, J GEN INTERN MED, V23, P1499, DOI 10.1007/s11606-008-0692-z; Rosenblatt RA, 1998, JAMA-J AM MED ASSOC, V279, P1364, DOI 10.1001/jama.279.17.1364; Saultz JW, 2004, ANN FAM MED, V2, P445, DOI 10.1370/afm.91; Scholle SH, 2009, AM J MANAG CARE, V15, P67; Shah BR, 2007, HEALTH SERV RES, V42, P1783, DOI 10.1111/j.1475-6773.2006.00681.x; Shahinian VB, 2007, J CLIN ONCOL, V25, P5359, DOI 10.1200/JCO.2006.09.9580; Sharma G, 2009, ARCH INTERN MED, V169, P81, DOI 10.1001/archinternmed.2008.514; SHEAR CL, 1983, MED CARE, V21, P1204, DOI 10.1097/00005650-198312000-00007; Slater B, 1996, Int J Health Care Qual Assur, V9, P34, DOI 10.1108/09526869610109143; SMEDBY O, 1986, MED CARE, V24, P511; Sobel M. E., 1982, SOCIOL METHODOL, P290, DOI [10.2307/270723, DOI 10.2307/270723]; STEINWACHS DM, 1979, MED CARE, V17, P551, DOI 10.1097/00005650-197906000-00001; Stokes T, 2005, ANN FAM MED, V3, P353, DOI 10.1370/afm.351; US Census Bureau, CENS REG DIV US; Weiner M, 2006, J GEN INTERN MED, V21, pS35, DOI 10.1111/j.1525-1497.2006.00307.x; Weiner M, 2003, ANN INTERN MED, V139, P430, DOI 10.7326/0003-4819-139-5_Part_2-200309021-00010; Weiss LJ, 1996, AM J PUBLIC HEALTH, V86, P1742, DOI 10.2105/AJPH.86.12.1742	64	85	85	0	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 22	2009	301	16					1671	1680		10.1001/jama.2009.517	http://dx.doi.org/10.1001/jama.2009.517			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	435NN	19383958	Green Accepted, Bronze			2022-12-01	WOS:000265350700023
J	Essers, MAG; Offner, S; Blanco-Bose, WE; Waibler, Z; Kalinke, U; Duchosal, MA; Trumpp, A				Essers, Marieke A. G.; Offner, Sandra; Blanco-Bose, William E.; Waibler, Zoe; Kalinke, Ulrich; Duchosal, Michel A.; Trumpp, Andreas			IFN alpha activates dormant haematopoietic stem cells in vivo	NATURE			English	Article							CHRONIC MYELOID-LEUKEMIA; SELF-RENEWAL; INTERFERONS; NICHES; EXPRESSION; THERAPY; DISEASE; MICE	Maintenance of the blood system is dependent on dormant haematopoietic stem cells (HSCs) with long-term self-renewal capacity. After injury these cells are induced to proliferate to quickly reestablish homeostasis(1). The signalling molecules promoting the exit of HSCs out of the dormant stage remain largely unknown. Here we show that in response to treatment of mice with interferon-alpha (IFN alpha), HSCs efficiently exit G(0) and enter an active cell cycle. HSCs respond to IFN alpha treatment by the increased phosphorylation of STAT1 and PKB/Akt (also known as AKT1), the expression of IFN alpha target genes, and the upregulation of stem cell antigen-1 (Sca-1, also known as LY6A). HSCs lacking the IFN alpha/beta receptor (IFNAR)(2), STAT1 (ref. 3) or Sca-1 (ref. 4) are insensitive to IFN alpha stimulation, demonstrating that STAT1 and Sca-1 mediate IFN alpha-induced HSC proliferation. Although dormant HSCs are resistant to the anti-proliferative chemotherapeutic agent 5-fluoro-uracil(1,5), HSCs pre-treated (primed) with IFN alpha and thus induced to proliferate are efficiently eliminated by 5-fluoro-uracil exposure in vivo. Conversely, HSCs chronically activated by IFN alpha are functionally compromised and are rapidly out-competed by non-activatable Ifnar(-/-) cells in competitive repopulation assays. Whereas chronic activation of the IFN alpha pathway in HSCs impairs their function, acute IFN alpha treatment promotes the proliferation of dormant HSCs in vivo. These data may help to clarify the so far unexplained clinical effects of IFN alpha on leukaemic cells(6,7), and raise the possibility for new applications of type I interferons to target cancer stem cells(8).	[Essers, Marieke A. G.; Trumpp, Andreas] DKFZ ZMBH Alliance, Deutsch Krebsforschungszentrum, Div Stem Cells & Canc, D-69120 Heidelberg, Germany; [Essers, Marieke A. G.; Trumpp, Andreas] Heidelberg Inst Stem Cell Technol & Expt Med HI S, D-69120 Heidelberg, Germany; [Offner, Sandra; Blanco-Bose, William E.; Trumpp, Andreas] Ecole Polytech Fed Lausanne, Swiss Inst Expt Canc Res, Sch Life Sci, CH-1015 Lausanne, Switzerland; [Waibler, Zoe; Kalinke, Ulrich] Paul Ehrlich Inst, Div Immunol, D-63225 Langen, Germany; [Kalinke, Ulrich] TWINCORE Ctr Expt & Clin Infect Res, D-30625 Hannover, Germany; [Duchosal, Michel A.] Univ Lausanne Hosp, CHUV, Serv & Cent Lab Hematol, CH-1011 Lausanne, Switzerland	Helmholtz Association; German Cancer Research Center (DKFZ); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; Paul Ehrlich Institute; Helmholtz Association; Helmholtz-Center for Infection Research; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Trumpp, A (corresponding author), DKFZ ZMBH Alliance, Deutsch Krebsforschungszentrum, Div Stem Cells & Canc, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	a.trumpp@dkfz-heidelberg.de	Essers, Marieke A.G./B-7758-2017; Trumpp, Andreas/Z-2141-2019	Essers, Marieke A.G./0000-0003-3117-1809; Trumpp, Andreas/0000-0002-6212-3466; Kalinke, Ulrich/0000-0003-0503-9564	Swiss National Science Foundation; Swiss Cancer League; EU; Deutsche Forschungsgemeinschaft [SFB432.B15]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Cancer League; EU(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We are grateful to M. Aguet for discussions and advice throughout the project, and for providing mouse strains. We thank D. Tough for providing mouse recombinant IFN alpha 4, T. Pedrazzini, W. Stanford and M. Muller for mouse strains, K. Harshman and O. Hagenbuchle and the DAFL team for excellent service and help with the DNA microarrays. We thank C. Dubey and D. Aubry for animal husbandry, genetic screening and technical help, and J. Roberts for FACS sorting. We are grateful to A. Wilson for comments on the manuscript. M. A. G. E. is the recipient of an EMBO long-term fellowship. This work was supported by grants to A. T. from the Swiss National Science Foundation, the Swiss Cancer League, the EU-FP6 Program 'INTACT', the EU-FP7 Program 'EuroSyStem' and to UK from the Deutsche Forschungsgemeinschaft (SFB432.B15).	Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Atallah E, 2007, CURR OPIN HEMATOL, V14, P138; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Heaney NCB, 2007, HEMATOL ONCOL, V25, P66, DOI 10.1002/hon.813; Hehlmann R, 2007, LANCET, V370, P342, DOI 10.1016/S0140-6736(07)61165-9; Hochhaus Andreas, 2008, J Natl Compr Canc Netw, V6 Suppl 2, pS1; Holmes C, 2007, STEM CELLS, V25, P1339, DOI 10.1634/stemcells.2006-0644; Ito CY, 2003, BLOOD, V101, P517, DOI 10.1182/blood-2002-06-1918; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Kujawski LA, 2007, CYTOKINE GROWTH F R, V18, P459, DOI 10.1016/j.cytogfr.2007.06.015; LERNER C, 1990, EXP HEMATOL, V18, P114; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; O'Hare T, 2006, CURR OPIN GENET DEV, V16, P92, DOI 10.1016/j.gde.2005.11.002; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012; Randall TD, 1997, BLOOD, V89, P3596, DOI 10.1182/blood.V89.10.3596.3596_3596_3606; Rousselot P, 2007, BLOOD, V109, P58, DOI 10.1182/blood-2006-03-011239; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Trumpp A, 2008, NAT CLIN PRACT ONCOL, V5, P337, DOI 10.1038/ncponc1110; van Boxel-Dezaire AHH, 2006, IMMUNITY, V25, P361, DOI 10.1016/j.immuni.2006.08.014; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Wilson A, 2007, ANN NY ACAD SCI, V1106, P64, DOI 10.1196/annals.1392.021; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Yang XL, 2004, J BIOL CHEM, V279, P49298, DOI 10.1074/jbc.M407535200	30	924	945	2	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 16	2009	458	7240					904	U11		10.1038/nature07815	http://dx.doi.org/10.1038/nature07815			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433CS	19212321				2022-12-01	WOS:000265182500046
J	Reithinger, R; Tarleton, RL; Urbina, JA; Kitron, U; Gurtler, RE				Reithinger, Richard; Tarleton, Rick L.; Urbina, Julio A.; Kitron, Uriel; Guertler, Ricardo E.			Eliminating Chagas disease: challenges and a roadmap	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TRYPANOSOMA-CRUZI; TRANSMISSION		[Reithinger, Richard] Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, Dis Control & Vector Biol Unit, London WC1E 7HT, England; [Tarleton, Rick L.] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; [Urbina, Julio A.] Inst Venezolano Invest Cient, Caracas, Venezuela; [Kitron, Uriel] Emory Univ, Dept Environm Studies, Atlanta, GA 30322 USA; [Guertler, Ricardo E.] Univ Buenos Aires, Dept Ecol Genet & Evolut, Buenos Aires, DF, Argentina	University of London; London School of Hygiene & Tropical Medicine; University System of Georgia; University of Georgia; Venezuelan Institute Science Research; Emory University; University of Buenos Aires	Reithinger, R (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, Dis Control & Vector Biol Unit, Keppel St, London WC1E 7HT, England.	rreithinger@yahoo.co.uk		Reithinger, Richard/0000-0001-5710-1556; Tarleton, Rick/0000-0002-9589-5243; Kitron, Uriel/0000-0003-0493-2043	FIC NIH HHS [R01 TW005836, R01 TW005836-01] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [R01TW005836] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		Attaran A, 2006, LANCET, V368, P1768, DOI 10.1016/S0140-6736(06)69730-4; Beard CB, 2003, EMERG INFECT DIS, V9, P103, DOI 10.3201/eid0901.020217; Bowman NM, 2008, CLIN INFECT DIS, V46, P1822, DOI 10.1086/588299; *CAMP ACC ESS MED, 2008, REV SOC BREAS MED TR, V41, P315; *COMM DIS CTR, PAR HLTH TRYP; Dias JCP, 2002, MEM I OSWALDO CRUZ, V97, P603, DOI 10.1590/S0074-02762002000500002; Diaz JH, 2008, J TRAVEL MED, V15, P184, DOI 10.1111/j.1708-8305.2008.00205.x; Dorn PL, 2007, EMERG INFECT DIS, V13, P605, DOI 10.3201/eid1304.061002; Hotez P, 2006, ADV EXP MED BIOL, V582, P23; Kroeger A, 2003, AM J TROP MED HYG, V68, P307, DOI 10.4269/ajtmh.2003.68.307; Leiby DA, 2008, J INFECT DIS, V198, P609, DOI 10.1086/590159; Lescure FX, 2008, EMERG INFECT DIS, V14, P644, DOI 10.3201/eid1404.070489; *MIN SAL, 2006, GUIAS AT PAC INF TRY; Pirard M, 2005, TRANSFUSION, V45, P554, DOI 10.1111/j.0041-1132.2005.04214.x; Prata A, 2001, Lancet Infect Dis, V1, P92, DOI 10.1016/S1473-3099(01)00065-2; Rassi A, 2006, NEW ENGL J MED, V355, P799, DOI 10.1056/NEJMoa053241; Reithinger R, 2006, AM J TROP MED HYG, V74, P766, DOI 10.4269/ajtmh.2006.74.766; Roll Back Malaria Monitoring and Evaluation Reference Group, 2005, MAL IND SURV BAS DOC; *SCR SAL, INF EP MOB 2005 VERS; Stramer S. L., 2007, Morbidity and Mortality Weekly Report, V56, P141; Tarleton RL, 2007, PLOS MED, V4, P1852, DOI 10.1371/journal.pmed.0040332; *WHO, NEW GLOB EFF EL CHAN; *WHO, STRAT DIR RES DIS BU; *WHO, 2004, WHO REP 2004 CHANG H; WHO Expert Committee, 2002, CONTR CHAG DIS; World Health Organization, 2007, WHO CONS INT BIOL RE; Yabsley MJ, 2002, J WILDLIFE DIS, V38, P75, DOI 10.7589/0090-3558-38.1.75; YADON ZE, 2006, DECENTRALIZACION GES; [No title captured]; [No title captured]	30	39	39	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 14	2009	338								b1283	10.1136/bmj.b1283	http://dx.doi.org/10.1136/bmj.b1283			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	434TI	19366739	Green Accepted, Green Published			2022-12-01	WOS:000265296600003
J	Konhauser, KO; Pecoits, E; Lalonde, SV; Papineau, D; Nisbet, EG; Barley, ME; Arndt, NT; Zahnle, K; Kamber, BS				Konhauser, Kurt O.; Pecoits, Ernesto; Lalonde, Stefan V.; Papineau, Dominic; Nisbet, Euan G.; Barley, Mark E.; Arndt, Nicholas T.; Zahnle, Kevin; Kamber, Balz S.			Oceanic nickel depletion and a methanogen famine before the Great Oxidation Event	NATURE			English	Article							RISE; NI; GEOCHEMISTRY; TECTONICS; CHEMISTRY; SULFUR; GROWTH; CRUST; IRON; PB	It has been suggested that a decrease in atmospheric methane levels triggered the progressive rise of atmospheric oxygen, the so-called Great Oxidation Event, about 2.4 Gyr ago(1). Oxidative weathering of terrestrial sulphides, increased oceanic sulphate, and the ecological success of sulphate-reducing microorganisms over methanogens has been proposed as a possible cause for the methane collapse(1), but this explanation is difficult to reconcile with the rock record(2,3). Banded iron formations preserve a history of Precambrian oceanic elemental abundance and can provide insights into our understanding of early microbial life and its influence on the evolution of the Earth system(4,5). Here we report a decline in the molar nickel to iron ratio recorded in banded iron formations about 2.7 Gyr ago, which we attribute to a reduced flux of nickel to the oceans, a consequence of cooling upper-mantle temperatures and decreased eruption of nickel-rich ultramafic rocks at the time. We measured nickel partition coefficients between simulated Precambrian sea water and diverse iron hydroxides, and subsequently determined that dissolved nickel concentrations may have reached similar to 400nM throughout much of the Archaean eon, but dropped below similar to 200nM by 2.5 Gyr ago and to modern day values(6) (similar to 9 nM) by similar to 550 Myr ago. Nickel is a key metal cofactor in several enzymes of methanogens(7) and we propose that its decline would have stifled their activity in the ancient oceans and disrupted the supply of biogenic methane. A decline in biogenic methane production therefore could have occurred before increasing environmental oxygenation and not necessarily be related to it. The enzymatic reliance of methanogens on a diminishing supply of volcanic nickel links mantle evolution to the redox state of the atmosphere.	[Konhauser, Kurt O.; Pecoits, Ernesto; Lalonde, Stefan V.] Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB T6G 2E3, Canada; [Papineau, Dominic] Carnegie Inst Sci, Geophys Lab, Washington, DC 20015 USA; [Nisbet, Euan G.] Royal Holloway Univ London, Dept Earth Sci, Egham TW20 0EX, Surrey, England; [Barley, Mark E.] Univ Western Australia, Sch Earth & Environm, Crawley, WA 6009, Australia; [Arndt, Nicholas T.] Univ Grenoble 1, Lab Geodynam Chaine Alpines Maison Geosci, F-38041 Grenoble, France; [Zahnle, Kevin] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Kamber, Balz S.] Laurentian Univ, Dept Earth Sci, Sudbury, ON P3E 2C6, Canada	University of Alberta; Carnegie Institution for Science; University of London; Royal Holloway University London; University of Western Australia; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Laurentian University	Konhauser, KO (corresponding author), Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB T6G 2E3, Canada.	kurtk@ualberta.ca	Papineau, Dominic/AAD-6366-2019; Kamber, Balz/A-1823-2008	Konhauser, Kurt/0000-0001-7722-7068; Kamber, Balz/0000-0002-8720-0608; Papineau, Dominic/0000-0003-0063-7514	Natural Science and Engineering Research Council of Canada (NSERC); Australian Research Council (ARC)	Natural Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Australian Research Council (ARC)(Australian Research Council)	We thank M. Labbe for sample preparation, G. Chen and A. Simonetti for assistance with LA-ICP-MS analyses in the Radiogenic Isotope Facility at the University of Alberta, and S. Matveev for assistance with electron microprobe analyses. Field assistance by W. Mueller is acknowledged for Hunter Mine Group samples. Samples from the Loch Maree Group were provided by A. Wright. Funding was provided by the Natural Science and Engineering Research Council of Canada (NSERC) to K. O. K., the Canada Research Chairs Program to B. S. K., the Australian Research Council (ARC) to M. E. B., and NASA Exobiology and Evolutionary Biology Program individually to D. P. and K. Z. This manuscript was improved by discussions with R. Buick, J. Kasting and M. Lesher, and reviews by R. Frei and M. Saito.	Arndt N, 2008, KOMATIITE, P1, DOI 10.1017/CBO9780511535550; ARNDT NT, 1991, TECTONOPHYSICS, V187, P411, DOI 10.1016/0040-1951(91)90479-C; Barley ME, 1998, PRECAMBRIAN RES, V91, P65, DOI 10.1016/S0301-9268(98)00039-4; Barley ME, 2005, EARTH PLANET SC LETT, V238, P156, DOI 10.1016/j.epsl.2005.06.062; Basiliko N, 2001, BIOGEOCHEMISTRY, V52, P133, DOI 10.1023/A:1006461803585; Berry AJ, 2008, NATURE, V455, P960, DOI 10.1038/nature07377; Bjerrum CJ, 2002, NATURE, V417, P159, DOI 10.1038/417159a; Catling DC, 2007, PHILOS T R SOC A, V365, P1867, DOI 10.1098/rsta.2007.2047; Chester R., 2000, MARINE GEOCHEMISTRY; CONDIE KC, 1993, CHEM GEOL, V104, P1, DOI 10.1016/0009-2541(93)90140-E; DIEKERT G, 1980, ARCH MICROBIOL, V127, P273, DOI 10.1007/BF00427204; Drever J.I., 1988, GEOCHEMISTRY NATURAL; Frausto da Silva J.J.R., 1991, BIOL CHEM ELEMENTS I; Hannington MD, 2003, MINER DEPOSITA, V38, P393, DOI 10.1007/s00126-002-0298-z; Hausrath EM, 2007, GEOBIOLOGY, V5, P49, DOI 10.1111/j.1472-4669.2007.00095.x; JARRELL KF, 1982, J BACTERIOL, V149, P346, DOI 10.1128/JB.149.1.346-353.1982; JAUN B, 2007, METAL IONS LIFE SCI, V0002, P00323; Kamber BS, 2005, EARTH PLANET SC LETT, V240, P276, DOI 10.1016/j.epsl.2005.09.037; Kamber BS, 2001, GEOCHIM COSMOCHIM AC, V65, P2509, DOI 10.1016/S0016-7037(01)00613-5; KEAYS RR, 1995, LITHOS, V34, P1; Kharecha P, 2005, GEOBIOLOGY, V3, P53, DOI 10.1111/j.1472-4669.2005.00049.x; Kida K, 2001, J BIOSCI BIOENG, V91, P590, DOI 10.1263/jbb.91.590; Konhauser KO, 2007, SCIENCE, V315, P1234, DOI 10.1126/science.1136328; Kruger M, 2003, NATURE, V426, P878, DOI 10.1038/nature02207; Kump LR, 2007, NATURE, V448, P1033, DOI 10.1038/nature06058; Maliva RG, 2005, GEOL SOC AM BULL, V117, P835, DOI 10.1130/B25555.1; MCLENNAN SM, 1989, REV MINERAL, V21, P169; MCLENNAN SM, 1983, GEOCHIM COSMOCHIM AC, V47, P1211, DOI 10.1016/0016-7037(83)90063-7; Nisbet E. G, 1982, KOMATIITES, P501; OZTURK M, 1995, MAR CHEM, V48, P329, DOI 10.1016/0304-4203(95)92785-Q; Papineau D, 2007, EARTH PLANET SC LETT, V255, P188, DOI 10.1016/j.epsl.2006.12.015; Saito MA, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002216; Saito MA, 2003, INORG CHIM ACTA, V356, P308, DOI 10.1016/S0020-1693(03)00442-0; SCHONHEIT P, 1979, ARCH MICROBIOL, V123, P105, DOI 10.1007/BF00403508; Scott C, 2008, NATURE, V452, P456, DOI 10.1038/nature06811; Shima S, 2007, CHEM REC, V7, P37, DOI 10.1002/tcr.20111; Taylor S.R., 1985, CONTINENTAL CRUST IT, P1, DOI DOI 10.1002/GJ.3350210116; TREGUER P, 1995, SCIENCE, V268, P375, DOI 10.1126/science.268.5209.375; TRENDALL AF, 2002, SPECIAL PUBLICATION, V33, P33, DOI DOI 10.1016/J.PRECAMRES.2016.04.016; Zahnle K., 2006, GEOBIOLOGY, V4, P271, DOI 10.1111/j.1472-4669.2006.00085.x	40	303	322	8	197	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 9	2009	458	7239					750	U85		10.1038/nature07858	http://dx.doi.org/10.1038/nature07858			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433GZ	19360085				2022-12-01	WOS:000265193600038
J	TaufiqUrRahman; Skupin, A; Falcke, M; Taylor, CW				TaufiqUrRahman; Skupin, Alexander; Falcke, Martin; Taylor, Colin W.			Clustering of InsP(3) receptors by InsP(3) retunes their regulation by InsP(3) and Ca2+	NATURE			English	Article							INOSITOL TRISPHOSPHATE RECEPTOR; CHANNELS RYANODINE RECEPTORS; CALCIUM-RELEASE CHANNELS; IP3 RECEPTORS; SPATIAL-DISTRIBUTION; XENOPUS OOCYTES; INACTIVATION; MEMBRANE; PATTERNS; KINETICS	The versatility of Ca2+ signals derives from their spatio-temporal organization(1,2). For Ca2+ signals initiated by inositol-1,4,5-trisphosphate (InsP(3)), this requires local interactions between InsP(3) receptors (InsP(3)Rs)(3,4) mediated by their rapid stimulation and slower inhibition(4) by cytosolic Ca2+. This allows hierarchical recruitment of Ca2+ release events as the InsP(3) concentration increases(5). Single InsP(3)Rs respond first, then clustered InsP(3)Rs open together giving a local 'Ca2+ puff', and as puffs become more frequent they ignite regenerative Ca2+ waves(1,5-9). Using nuclear patch-clamp recording(10), here we demonstrate that InsP(3)Rs are initially randomly distributed with an estimated separation of similar to 1 mu m. Low concentrations of InsP(3) cause InsP(3)Rs to aggregate rapidly and reversibly into small clusters of about four closely associated InsP(3)Rs. At resting cytosolic [Ca2+], clustered InsP(3)Rs open independently, but with lower open probability, shorter open time, and less InsP(3) sensitivity than lone InsP(3)Rs. Increasing cytosolic [Ca2+] reverses the inhibition caused by clustering, InsP(3)R gating becomes coupled, and the duration of multiple openings is prolonged. Clustering both exposes InsP(3)Rs to local Ca2+ rises and increases the effects of Ca2+. Dynamic regulation of clustering by InsP(3) retunes InsP(3)R sensitivity to InsP(3) and Ca2+, facilitating hierarchical recruitment of the elementary events that underlie all InsP(3)-evoked Ca2+ signals(3,5).	[TaufiqUrRahman; Taylor, Colin W.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England; [Skupin, Alexander; Falcke, Martin] Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany; [Falcke, Martin] Helmholtz Ctr Berlin Mat & Energy, D-14109 Berlin, Germany	University of Cambridge; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB)	Taylor, CW (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1PD, England.	cwt1000@cam.ac.uk	Falcke, Martin/I-2966-2012	Falcke, Martin/0000-0001-7137-1114; SKUPIN, Alexander/0000-0002-8955-8304	The Wellcome Trust; The Biotechnology and Biological Sciences Research Council; Jameel Family Trust; IRTG 'Genomics and Systems Biology of Molecular Networks' of the Deutsche Forschungsgemeinschaft	The Wellcome Trust(Wellcome TrustEuropean Commission); The Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Jameel Family Trust; IRTG 'Genomics and Systems Biology of Molecular Networks' of the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by The Wellcome Trust ( C. W. T.), The Biotechnology and Biological Sciences Research Council ( C. W. T.), a scholarship from the Jameel Family Trust (T.-U.-R.), and the IRTG 'Genomics and Systems Biology of Molecular Networks' of the Deutsche Forschungsgemeinschaft ( A. S.). We thank S. Dedos for help with DT40 cells, D. Prole and B. Billups for advice, and T. Kurosaki for providing DT40-KO cells.	Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Boehning D, 2001, BIOPHYS J, V81, P117, DOI 10.1016/S0006-3495(01)75685-8; Bootman MD, 1997, CELL, V91, P367, DOI 10.1016/S0092-8674(00)80420-1; BOURGUIGNON LYW, 1993, CELL BIOL INT, V17, P751, DOI 10.1006/cbir.1993.1136; Dargan SL, 2003, J PHYSIOL-LONDON, V553, P775, DOI 10.1113/jphysiol.2003.054247; Dellis O, 2006, SCIENCE, V313, P229, DOI 10.1126/science.1125203; Falcke M, 2004, ADV PHYS, V53, P255, DOI 10.1080/00018730410001703159; Ferreri-Jacobia M, 2005, J BIOL CHEM, V280, P3824, DOI 10.1074/jbc.M409462200; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Fukatsu K, 2004, J BIOL CHEM, V279, P48976, DOI 10.1074/jbc.M408364200; Horne JH, 1997, SCIENCE, V276, P1690, DOI 10.1126/science.276.5319.1690; Ionescu L, 2006, J PHYSIOL-LONDON, V573, P645, DOI 10.1113/jphysiol.2006.109504; Katayama E, 1996, EMBO J, V15, P4844, DOI 10.1002/j.1460-2075.1996.tb00865.x; Mak DOD, 1998, AM J PHYSIOL-CELL PH, V275, pC179, DOI 10.1152/ajpcell.1998.275.1.C179; Mak DOD, 1997, J GEN PHYSIOL, V109, P571, DOI 10.1085/jgp.109.5.571; Marchant J, 1999, EMBO J, V18, P5285, DOI 10.1093/emboj/18.19.5285; Marchant JS, 2001, EMBO J, V20, P65, DOI 10.1093/emboj/20.1.65; Marx SO, 1998, SCIENCE, V281, P818, DOI 10.1126/science.281.5378.818; Marx SO, 2001, CIRC RES, V88, P1151, DOI 10.1161/hh1101.091268; Prole DL, 2003, J GEN PHYSIOL, V122, P775, DOI 10.1085/jgp.200308897; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Shuai JW, 2006, BIOPHYS J, V91, P4033, DOI 10.1529/biophysj.106.088880; Sneyd J, 2005, PROG BIOPHYS MOL BIO, V89, P207, DOI 10.1016/j.pbiomolbio.2004.11.001; Sun XP, 1998, J PHYSIOL-LONDON, V509, P67, DOI 10.1111/j.1469-7793.1998.067bo.x; Tateishi Y, 2005, J BIOL CHEM, V280, P6816, DOI 10.1074/jbc.M405469200; Yin CC, 2005, J MOL BIOL, V349, P538, DOI 10.1016/j.jmb.2005.04.002	26	107	108	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 2	2009	458	7238					655	659		10.1038/nature07763	http://dx.doi.org/10.1038/nature07763			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RK	19348050	Green Accepted			2022-12-01	WOS:000264796200046
J	Moorthy, V; Smith, PG; Kieny, MP				Moorthy, Vasee; Smith, Peter G.; Kieny, Marie-Paule			A vaccine against malaria: a substantial step forward	LANCET			English	Editorial Material							PLASMODIUM-FALCIPARUM INFECTION; RANDOMIZED CONTROLLED-TRIAL; EFFICACY; CHILDREN; PROTECTION; DISEASE		[Moorthy, Vasee; Kieny, Marie-Paule] WHO, Dept Immunizat Vaccines & Biol, Initiat Vaccine Res, CH-1211 Geneva 27, Switzerland; [Moorthy, Vasee] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England; [Smith, Peter G.] London Sch Hyg & Trop Med, London WC1, England	World Health Organization; University of Oxford; University of London; London School of Hygiene & Tropical Medicine	Moorthy, V (corresponding author), WHO, Dept Immunizat Vaccines & Biol, Initiat Vaccine Res, CH-1211 Geneva 27, Switzerland.	vasee.moorthy@gmail.com	Kieny, Marie-Paule/Q-1238-2019; smith, peter/ABH-9627-2020; Kieny, Marie-Paule/N-3914-2017	smith, peter/0000-0003-0080-7560; Kieny, Marie-Paule/0000-0002-5943-6488; Moorthy, Vasee/0000-0002-6535-2854	MRC [G0700837] Funding Source: UKRI; Medical Research Council [G0700837] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abdulla S, 2008, NEW ENGL J MED, V359, P2533, DOI 10.1056/NEJMoa0807773; Alonso PL, 2005, LANCET, V366, P2012, DOI 10.1016/S0140-6736(05)67669-6; Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; Bejon P, 2008, NEW ENGL J MED, V359, P2521, DOI 10.1056/NEJMoa0807381; Bojang KA, 2001, LANCET, V358, P1927, DOI 10.1016/S0140-6736(01)06957-4; Epstein JE, 2007, LANCET, V370, P1523, DOI 10.1016/S0140-6736(07)61642-0; Epstein JE, 2007, CURR OPIN MOL THER, V9, P12; Moorthy Vasee, 2007, Vaccine, V25, P5115, DOI 10.1016/j.vaccine.2007.01.085; Moorthy VS, 2009, VACCINE, V27, P624, DOI 10.1016/j.vaccine.2008.11.034; Smith PG, 2005, LANCET, V365, P472	10	4	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR-MAY	2009	373	9673					1411	1412		10.1016/S0140-6736(09)60802-3	http://dx.doi.org/10.1016/S0140-6736(09)60802-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437QL	19394521				2022-12-01	WOS:000265501900010
J	Hubner, W; McNerney, GP; Chen, P; Dale, BM; Gordon, RE; Chuang, FYS; Li, XD; Asmuth, DM; Huser, T; Chen, BK				Huebner, Wolfgang; McNerney, Gregory P.; Chen, Ping; Dale, Benjamin M.; Gordon, Ronald E.; Chuang, Frank Y. S.; Li, Xiao-Dong; Asmuth, David M.; Huser, Thomas; Chen, Benjamin K.			Quantitative 3D Video Microscopy of HIV Transfer Across T Cell Virological Synapses	SCIENCE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; GP41 CYTOPLASMIC TAIL; LYMPHOCYTES; FUSION; SPREAD; ENTRY; CYTOSKELETON; REPLICATION; ENDOCYTOSIS; INFECTION	The spread of HIV between immune cells is greatly enhanced by cell-cell adhesions called virological synapses, although the underlying mechanisms have been unclear. With use of an infectious, fluorescent clone of HIV, we tracked the movement of Gag in live CD4 T cells and captured the direct translocation of HIV across the virological synapse. Quantitative, high-speed three-dimensional (3D) video microscopy revealed the rapid formation of micrometer-sized "buttons" containing oligomerized viral Gag protein. Electron microscopy showed that these buttons were packed with budding viral crescents. Viral transfer events were observed to form virus-laden internal compartments within target cells. Continuous time-lapse monitoring showed preferential infection through synapses. Thus, HIV dissemination may be enhanced by virological synapse-mediated cell adhesion coupled to viral endocytosis.	[Huebner, Wolfgang; Chen, Ping; Dale, Benjamin M.; Chen, Benjamin K.] Mt Sinai Sch Med, Dept Med, Inst Immunol, Div Infect Dis, New York, NY 10029 USA; [Gordon, Ronald E.] Mt Sinai Sch Med, Dept Pathol, New York, NY 10029 USA; [McNerney, Gregory P.; Chuang, Frank Y. S.; Huser, Thomas] Univ Calif Davis, NSF Ctr Biophoton Sci & Technol, Sacramento, CA 95817 USA; [Li, Xiao-Dong; Asmuth, David M.; Huser, Thomas] Univ Calif Davis, Med Ctr, Dept Internal Med, Sacramento, CA 95817 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; National Science Foundation (NSF); University of California System; University of California Davis; University of California System; University of California Davis	Chen, BK (corresponding author), Mt Sinai Sch Med, Dept Med, Inst Immunol, Div Infect Dis, New York, NY 10029 USA.	ben.chen@mssm.edu	Huser, Thomas/K-7291-2019; Hubner, Wolfgang/O-7907-2016	Huser, Thomas/0000-0003-2348-7416; Chen, Benjamin K/0000-0002-5404-1997; Asmuth, David/0000-0003-0916-7950; Hubner, Wolfgang/0000-0002-1128-6468	NIH [AI074420-02]; Burroughs Wellcome Fund Investigator Award; Hirschl Weill Caulier Career Scientist Award; Mount Sinai School of Medicine Microscopy Shared Resource Facility [NIH-NCI 5R24 CA095823-04, NSF-DBI-9724504, NIH-S10RR09145-01]; NSF Center for Biophotonics Science and Technology [PHY012099]; UCD Health System Research Award; UCD Clinical and Translational Science Center [NIH-NCRR ULRR024146]; NATIONAL CANCER INSTITUTE [R24CA095823] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR009145] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074420] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA028866] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund Investigator Award(Burroughs Wellcome Fund); Hirschl Weill Caulier Career Scientist Award; Mount Sinai School of Medicine Microscopy Shared Resource Facility; NSF Center for Biophotonics Science and Technology; UCD Health System Research Award; UCD Clinical and Translational Science Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank R. H. Cheng, V. Simon, M. Klotman, R. Iyengar, and A. Del Portillo for critiques and discussions; R. Huq for microscopy support; S. Izadmehr for image analysis; M. Grisotto and V. Sahi for cell sorting; H. Bell for electron microscopy support; and S. Lira for imaging support. Work was supported by NIH grant AI074420-02, Burroughs Wellcome Fund Investigator Award, and Hirschl Weill Caulier Career Scientist Award to B.K.C. Imaging was supported by Mount Sinai School of Medicine Microscopy Shared Resource Facility grants NIH-NCI 5R24 CA095823-04, NSF-DBI-9724504, and NIH-S10RR09145-01; by the NSF Center for Biophotonics Science and Technology (cooperative agreement PHY012099); a UCD Health System Research Award to T.H.; and the UCD Clinical and Translational Science Center grant NIH-NCRR ULRR024146 (T.H. and D.M.A.).	Blanco J, 2004, J BIOL CHEM, V279, P51305, DOI 10.1074/jbc.M408547200; CAMERON PU, 1992, SCIENCE, V257, P383, DOI 10.1126/science.1352913; Chen P, 2007, J VIROL, V81, P12582, DOI 10.1128/JVI.00381-07; Cohen GB, 1999, IMMUNITY, V10, P661, DOI 10.1016/S1074-7613(00)80065-5; Derdowski A, 2004, J VIROL, V78, P1230, DOI 10.1128/JVI.78.3.1230-1242.2004; DIMITROV DS, 1993, J VIROL, V67, P2182, DOI 10.1128/JVI.67.4.2182-2190.1993; Fackler OT, 2000, CURR BIOL, V10, P1005, DOI 10.1016/S0960-9822(00)00654-0; Germain RN, 2006, NAT REV IMMUNOL, V6, P497, DOI 10.1038/nri1884; Haase AT, 2005, NAT REV IMMUNOL, V5, P783, DOI 10.1038/nri1706; Hubner W, 2007, J VIROL, V81, P12596, DOI 10.1128/JVI.01088-07; Igakura T, 2003, SCIENCE, V299, P1713, DOI 10.1126/science.1080115; Jolly C, 2005, J VIROL, V79, P12088, DOI 10.1128/JVI.79.18.12088-12094.2005; Jolly C, 2004, J EXP MED, V199, P283, DOI 10.1084/jem.20030648; Jolly C, 2007, J VIROL, V81, P13916, DOI 10.1128/JVI.01585-07; Jolly C, 2007, J VIROL, V81, P5547, DOI 10.1128/JVI.01469-06; Lakadamyali M, 2006, CELL, V124, P997, DOI 10.1016/j.cell.2005.12.038; Larson DR, 2003, J CELL BIOL, V162, P1233, DOI 10.1083/jcb.200303200; Marechal V, 2001, J VIROL, V75, P11166, DOI 10.1128/JVI.75.22.11166-11177.2001; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; McDonald D, 2003, SCIENCE, V300, P1295, DOI 10.1126/science.1084238; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Schaeffer E, 2004, J VIROL, V78, P1375, DOI 10.1128/JVI.78.3.1375-1383.2004; Sol-Foulon N, 2007, EMBO J, V26, P516, DOI 10.1038/sj.emboj.7601509; Sourisseau M, 2007, J VIROL, V81, P1000, DOI 10.1128/JVI.01629-06; Wyma DJ, 2004, J VIROL, V78, P3429, DOI 10.1128/JVI.78.7.3429-3435.2004; Wyss S, 2005, J VIROL, V79, P12231, DOI 10.1128/JVI.79.19.12231-12241.2005	26	359	363	0	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2009	323	5922					1743	1747		10.1126/science.1167525	http://dx.doi.org/10.1126/science.1167525			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	424IG	19325119	Green Accepted			2022-12-01	WOS:000264559800044
J	Song, AH; Wang, D; Chen, G; Li, Y; Luo, J; Duan, SM; Poo, MM				Song, Ai-hong; Wang, Dong; Chen, Gang; Li, Yuju; Luo, Jianhong; Duan, Shumin; Poo, Mu-ming			A Selective Filter for Cytoplasmic Transport at the Axon Initial Segment	CELL			English	Article							HIPPOCAMPAL-NEURONS; ANKYRIN-G; MEMBRANE-PROTEINS; GLUTAMATE RECEPTORS; DIFFUSION BARRIER; LATERAL DIFFUSION; KINESIN; TRAFFICKING; MECHANISMS; CHANNELS	Distinct molecules are segregated into somatodendritic and axonal compartments of polarized neurons, but mechanisms underlying the development and maintenance of such segregation remain largely unclear. In cultured hippocampal neurons, we observed an ankyrin G-and F-actin-dependent structure that emerged in the cytoplasm of the axon initial segment (AIS) within 2 days after axon/dendrite differentiation, imposing a selective filter for diffusion of macromolecules and transport of vesicular carriers into the axon. Axonal entry was allowed for KIF5-driven carriers of synaptic vesicle protein VAMP2, but not for KIF17-driven carriers of dendrite-targeting NMDA receptor subunit NR2B. Comparisons of transport rates between chimeric forms of KIF17 and KIF5B, with the motor and cargo-binding domains switched, and between KIF5 loaded with VAMP2 versus GluR2 suggest that axonal entry of vesicular carriers depends on the transport efficacy of KIF-cargo complexes. This selective AIS filtering may contribute to preferential trafficking and segregation of cellular components in polarized neurons.	[Song, Ai-hong; Wang, Dong; Chen, Gang; Li, Yuju; Duan, Shumin; Poo, Mu-ming] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, State Key Lab Neurobiol, Shanghai 200031, Peoples R China; [Luo, Jianhong] Zhejiang Univ, Dept Neurobiol, Sch Med, Hangzhou 310031, Zhejiang, Peoples R China; [Poo, Mu-ming] Univ Calif Berkeley, Div Neurobiol, Dept Mol & Cell Biol, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Zhejiang University; University of California System; University of California Berkeley	Duan, SM (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, State Key Lab Neurobiol, Shanghai 200031, Peoples R China.	shumin@ion.ac.cn; mpoo@berkeley.edu		Chen, Gang/0000-0003-3669-5687	Major State Basic Research Program of China [2006CB806600]; National Natural Science Foundation of China [30730037]	Major State Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank J.G. Chen, V. Bennett, C. Gu, and D. B. Arnold for providing cDNA clones and J.Y. Shen for technical assistance with siRNA constructs. This work was supported by grants from the Major State Basic Research Program of China (2006CB806600) and the National Natural Science Foundation of China (30730037).	Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; Bennett V, 2001, CURR OPIN CELL BIOL, V13, P61, DOI 10.1016/S0955-0674(00)00175-7; BENSHALOM G, 1985, J NEUROCYTOL, V14, P943, DOI 10.1007/BF01224806; Boiko T, 2007, J NEUROSCI, V27, P590, DOI 10.1523/JNEUROSCI.4302-06.2007; Brown MD, 1997, BRAIN RES, V747, P313, DOI 10.1016/S0006-8993(96)01321-2; Burack MA, 2000, NEURON, V26, P465, DOI 10.1016/S0896-6273(00)81178-2; Chu PJ, 2006, J BIOL CHEM, V281, P365, DOI 10.1074/jbc.M508897200; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.neuro.17.1.267; CRAIG AM, 1993, NEURON, V10, P1055, DOI 10.1016/0896-6273(93)90054-U; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Guillaud L, 2003, J NEUROSCI, V23, P131; Harata NC, 2006, J NEUROCHEM, V97, P1546, DOI 10.1111/j.1471-4159.2006.03987.x; Hemar A, 1997, J NEUROSCI, V17, P9026; HIROKAWA N, 1982, J CELL BIOL, V94, P129, DOI 10.1083/jcb.94.1.129; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; Horton AC, 2003, NEURON, V40, P277, DOI 10.1016/S0896-6273(03)00629-9; Jenkins SM, 2001, J CELL BIOL, V155, P739, DOI 10.1083/jcb.200109026; Kamal A, 2000, NEURON, V28, P449, DOI 10.1016/S0896-6273(00)00124-0; KILLISCH I, 1991, NEURON, V7, P927, DOI 10.1016/0896-6273(91)90338-Z; Kizhatil K, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703158200; LUBYPHELPS K, 1986, J CELL BIOL, V102, P2015, DOI 10.1083/jcb.102.6.2015; Nakada C, 2003, NAT CELL BIOL, V5, P626, DOI 10.1038/ncb1009; Nakata T, 2003, J CELL BIOL, V162, P1045, DOI 10.1083/jcb.200302175; Nishimura K, 2007, MOL CELL NEUROSCI, V34, P422, DOI 10.1016/j.mcn.2006.11.017; PALAY SL, 1968, J CELL BIOL, V38, P193, DOI 10.1083/jcb.38.1.193; Pan ZM, 2006, J NEUROSCI, V26, P2599, DOI 10.1523/JNEUROSCI.4314-05.2006; POO MM, 1974, NATURE, V247, P438, DOI 10.1038/247438a0; POO MM, 1982, NATURE, V295, P332, DOI 10.1038/295332a0; POPOV S, 1992, J NEUROSCI, V12, P77; PROVANCE DW, 1993, J CELL SCI, V106, P565; Sampo B, 2003, NEURON, V37, P611, DOI 10.1016/S0896-6273(03)00058-8; Setou M, 2002, NATURE, V417, P83, DOI 10.1038/nature743; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Stowell JN, 1999, NEURON, V22, P525, DOI 10.1016/S0896-6273(00)80707-2; Triller A, 2008, NEURON, V59, P359, DOI 10.1016/j.neuron.2008.06.022; Winckler B, 1999, NATURE, V397, P698, DOI 10.1038/17789; Wisco D, 2003, J CELL BIOL, V162, P1317, DOI 10.1083/jcb.200307069; Xu MX, 2007, J NEUROSCI, V27, P14158, DOI 10.1523/JNEUROSCI.3675-07.2007; Yap CC, 2008, J CELL BIOL, V180, P827, DOI 10.1083/jcb.200707143	40	243	250	1	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 20	2009	136	6					1148	1160		10.1016/j.cell.2009.01.016	http://dx.doi.org/10.1016/j.cell.2009.01.016			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	422CE	19268344	Bronze			2022-12-01	WOS:000264403900019
J	Jerrett, M; Burnett, RT; Pope, CA; Ito, K; Thurston, G; Krewski, D; Shi, YL; Calle, E; Thun, M				Jerrett, Michael; Burnett, Richard T.; Pope, C. Arden, II; Ito, Kazuhiko; Thurston, George; Krewski, Daniel; Shi, Yuanli; Calle, Eugenia; Thun, Michael			Long-Term Ozone Exposure and Mortality.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AIR-POLLUTION; LUNG-FUNCTION; CANCER PREVENTION; SPATIAL-ANALYSIS; AMBIENT OZONE; CHILDREN; ASSOCIATION; POLLUTANTS; HEALTH; FEV1	Background: Although many studies have linked elevations in tropospheric ozone to adverse health outcomes, the effect of long-term exposure to ozone on air pollution-related mortality remains uncertain. We examined the potential contribution of exposure to ozone to the risk of death from cardiopulmonary causes and specifically to death from respiratory causes. Methods: Data from the study cohort of the American Cancer Society Cancer Prevention Study II were correlated with air-pollution data from 96 metropolitan statistical areas in the United States. Data were analyzed from 448,850 subjects, with 118,777 deaths in an 18-year follow-up period. Data on daily maximum ozone concentrations were obtained from April 1 to September 30 for the years 1977 through 2000. Data on concentrations of fine particulate matter (particles that are lessthan/equal 2.5 microm in aerodynamic diameter [PM(sub 2.5)]) were obtained for the years 1999 and 2000. Associations between ozone concentrations and the risk of death were evaluated with the use of standard and multilevel Cox regression models. Results: In single-pollutant models, increased concentrations of either PM(sub 2.5) or ozone were significantly associated with an increased risk of death from cardiopulmonary causes. In two-pollutant models, PM(sub 2.5) was associated with the risk of death from cardiovascular causes, whereas ozone was associated with the risk of death from respiratory causes. The estimated relative risk of death from respiratory causes that was associated with an increment in ozone concentration of 10 ppb was 1.040 (95% confidence interval, 1.010 to 1.067). The association of ozone with the risk of death from respiratory causes was insensitive to adjustment for confounders and to the type of statistical model used. Conclusions: In this large study, we were not able to detect an effect of ozone on the risk of death from cardiovascular causes when the concentration of PM(sub 2.5) was taken into account. We did, however, demonstrate a significant increase in the risk of death from respiratory causes in association with an increase in ozone concentration. N Engl J Med 2009;360:1085-95.	[Jerrett, Michael] Univ Calif Berkeley, Sch Publ Hlth, Div Environm Hlth Sci, Berkeley, CA 94720 USA; [Burnett, Richard T.] Hlth Canada, Ottawa, ON K1A 0L2, Canada; [Pope, C. Arden, II] Brigham Young Univ, Provo, UT 84602 USA; [Ito, Kazuhiko; Thurston, George] NYU, Sch Med, New York, NY USA; [Krewski, Daniel; Shi, Yuanli] Univ Ottawa, Ottawa, ON, Canada; [Calle, Eugenia; Thun, Michael] Amer Canc Soc, Atlanta, GA 30329 USA	University of California System; University of California Berkeley; Health Canada; Brigham Young University; New York University; University of Ottawa; American Cancer Society	Jerrett, M (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Environm Hlth Sci, 710 Univ Hall, Berkeley, CA 94720 USA.	jerrett@berkeley.edu	Thurston, George/ABB-1359-2021; Pope, C. Arden/ABD-5522-2021; Jerrett, Michael/CAA-2482-2022		Health Effects Institute; Natural Sciences and Engineering Research Council of Canada; National Institute of Environmental Health Sciences [ES00260]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000260] Funding Source: NIH RePORTER	Health Effects Institute; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Supported by the Health Effects Institute. Dr. Krewski reports receiving grant support from the Natural Sciences and Engineering Research Council of Canada as holder of the Industrial Research Chair in Risk Science. This chair is funded by a peer- reviewed university- industry partnership program. No other potential conflict of interest relevant to this article was reported. We thank the National Institute of Environmental Health Sciences for providing grant support ( ES00260) to the New York University School of Medicine.	Abbey DE, 1999, AM J RESP CRIT CARE, V159, P373, DOI 10.1164/ajrccm.159.2.9806020; AckermannLiebrich U, 1997, AM J RESP CRIT CARE, V155, P122, DOI 10.1164/ajrccm.155.1.9001300; *AM CANC SOC, 2009, CANC PREV STUD OV; Bell ML, 2005, EPIDEMIOLOGY, V16, P436, DOI 10.1097/01.ede.0000165817.40152.85; Brook RD, 2004, CIRCULATION, V109, P2655, DOI 10.1161/01.CIR.0000128587.30041.C8; Brown JS, 2008, ENVIRON HEALTH PERSP, V116, P1023, DOI 10.1289/ehp.11396; CALLE EE, 1993, AM J EPIDEMIOL, V137, P235, DOI 10.1093/oxfordjournals.aje.a116664; Chao A, 2000, JNCI-J NATL CANCER I, V92, P1888, DOI 10.1093/jnci/92.23.1888; Chen C, 2007, ENVIRON HEALTH PERSP, V115, P1732, DOI 10.1289/ehp.10294; Chow JC, 2006, J AIR WASTE MANAGE, V56, P1368, DOI 10.1080/10473289.2006.10464545; *COMM MED EFF AIR, 2007, EFF HLTH LONG TERM E; Committee on Estimating Mortality Risk Reduction Benefits from Decreasing Tropospheric Ozone Exposure, 2008, EST MORT RISK RED EC; Delfino RJ, 2004, ENVIRON HEALTH PERSP, V112, P932, DOI 10.1289/ehp.6815; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; *ENV PROT AG, 2007, EPA452R07007; Galizia A, 1999, ENVIRON HEALTH PERSP, V107, P675, DOI 10.2307/3434461; Ito K, 2005, EPIDEMIOLOGY, V16, P446, DOI 10.1097/01.ede.0000165821.90114.7f; Jerrett M, 2005, EPIDEMIOLOGY, V16, P727, DOI 10.1097/01.ede.0000181630.15826.7d; Jerrett M, 2003, J TOXICOL ENV HEAL A, V66, P1735, DOI 10.1080/15287390306438; KREWSKI D, EXTENDED FO IN PRESS; Krewski D, 2000, REANALYSIS HARVARD 2; Levy JI, 2005, EPIDEMIOLOGY, V16, P458, DOI 10.1097/01.ede.0000165820.08301.b3; Ma RJ, 2003, BIOMETRIKA, V90, P157, DOI 10.1093/biomet/90.1.157; McConnell R, 2002, LANCET, V359, P386, DOI 10.1016/S0140-6736(02)07597-9; McConnell R, 2002, LANCET, V359, P896; McConnell R, 2006, SCI TOTAL ENVIRON, V363, P166, DOI 10.1016/j.scitotenv.2005.06.028; Miller KA, 2007, NEW ENGL J MED, V356, P447, DOI 10.1056/NEJMoa054409; Mudway IS, 2004, AM J RESP CRIT CARE, V169, P1089, DOI 10.1164/rccm.200309-1325PP; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; Rojas-Martinez R, 2007, AM J RESP CRIT CARE, V176, P377, DOI 10.1164/rccm.200510-1678OC; Schachter J., 2001, GEOGRAPHICAL MOBILIT; Siemiatycki J, 2003, J TOXICOL ENV HEAL A, V66, P1591, DOI 10.1080/15287390306428; SPEKTOR DM, 1988, AM REV RESPIR DIS, V137, P313, DOI 10.1164/ajrccm/137.2.313; Tager IB, 2005, EPIDEMIOLOGY, V16, P751, DOI 10.1097/01.ede.0000183166.68809.b0; THUN MJ, 1992, JNCI-J NATL CANCER I, V84, P1491, DOI 10.1093/jnci/84.19.1491; Thurston GD, 1997, AM J RESP CRIT CARE, V155, P654, DOI 10.1164/ajrccm.155.2.9032209; Willis A, 2003, J TOXICOL ENV HEAL A, V66, P1563, DOI 10.1080/15287390306425; Yang QY, 2003, INHAL TOXICOL, V15, P1297, DOI 10.1080/08958370390241768; Zidek JV, 1996, ENVIRONMETRICS, V7, P441, DOI 10.1002/(SICI)1099-095X(199607)7:4<441::AID-ENV226>3.0.CO;2-V	39	925	957	20	408	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 12	2009	360	11					1085	1095		10.1056/NEJMoa0803894	http://dx.doi.org/10.1056/NEJMoa0803894			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417BW	19279340	Bronze, Green Accepted			2022-12-01	WOS:000264051000006
J	Park, CY; Hoover, PJ; Mullins, FM; Bachhawat, P; Covington, ED; Raunser, S; Walz, T; Garcia, KC; Dolmetsch, RE; Lewis, RS				Park, Chan Young; Hoover, Paul J.; Mullins, Franklin M.; Bachhawat, Priti; Covington, Elizabeth D.; Raunser, Stefan; Walz, Thomas; Garcia, K. Christopher; Dolmetsch, Ricardo E.; Lewis, Richard S.			STIM1 Clusters and Activates CRAC Channels via Direct Binding of a Cytosolic Domain to Orai1	CELL			English	Article							STROMAL INTERACTION MOLECULE-1; OPERATED CA2+ ENTRY; STORE DEPLETION; PORE SUBUNIT; I-CRAC; OLIGOMERIZATION; TERMINUS; RECEPTOR; SENSOR	Store-operated Ca2+ channels activated by the depletion of Ca2+ from the endoplasmic reticulum (ER) are a major Ca2+ entry pathway in nonexcitable cells and are essential for T cell activation and adaptive immunity. After store depletion, the ER Ca2+ sensor STIM1 and the CRAC channel protein Orai1 redistribute to ER-plasma membrane (PM) junctions, but the fundamental issue of how STIM1 activates the CRAC channel at these sites is unresolved. Here, we identify a minimal, highly conserved 107-aa CRAC activation domain (CAD) of STIM1 that binds directly to the N and C termini of Orai1 to open the CRAC channel. Purified CAD forms a tetramer that clusters CRAC channels, but analysis of STIM1 mutants reveals that channel clustering is not sufficient for channel activation. These studies establish a molecular mechanism for store-operated Ca2+ entry in which the direct binding of STIM1 to Orai1 drives the accumulation and the activation of CRAC channels at ER-PM junctions.	[Park, Chan Young; Dolmetsch, Ricardo E.] Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA; [Hoover, Paul J.; Mullins, Franklin M.; Bachhawat, Priti; Covington, Elizabeth D.; Garcia, K. Christopher; Lewis, Richard S.] Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA; [Mullins, Franklin M.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Bachhawat, Priti; Garcia, K. Christopher] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Walz, Thomas] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Raunser, Stefan; Walz, Thomas] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Dolmetsch, RE (corresponding author), Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA.	ricardo.dolmetsch@stanford.edu; rslewis@stanford.edu	Raunser, Stefan/AHE-1573-2022; Park, Chan Young/F-5696-2010	Park, Chan Young/0000-0002-5183-3665; Raunser, Stefan/0000-0001-9373-3016; Lewis, Richard/0000-0002-6010-7403; Walz, Thomas/0000-0003-2606-2835	National Science Foundation and Stanford University; NIH Medical Scientist Training Program; Korea Research Foundation [KRF-2005-214-C00222]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048564] Funding Source: NIH RePORTER	National Science Foundation and Stanford University(National Science Foundation (NSF)); NIH Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korea Research Foundation(National Research Foundation of Korea); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank M. Wu for early Ca<SUP>2+</SUP> imaging experiments on CT- STIM1, D. Oh for helpful comments, and M. Cahalan, S. Feske, T. Meyer, S. Muallem, C. Romanin, and T. Xu for cDNA constructs. This work was supported by grants from the National Institutes of Health (NIH; R. E. D. and R. S. L.) and the Mathers Charitable Foundation (R. S. L.), graduate fellowships from the National Science Foundation and Stanford University (E.D.C.), an NIH Medical Scientist Training Program Grant (P.J.H.), and the Korea Research Foundation (KRF-2005-214-C00222) and the SPARK program (C.Y.P.). T. W. and K. C. G. are Investigators of the Howard Hughes Medical Institute.	Baba Y, 2006, P NATL ACAD SCI USA, V103, P16704, DOI 10.1073/pnas.0608358103; Bautista DM, 2002, J PHYSIOL-LONDON, V541, P877, DOI 10.1113/jphysiol.2001.016154; BERRIDGE MJ, 1995, BIOCHEM J, V312, P1, DOI 10.1042/bj3120001; Bolotina VM, 2008, J PHYSIOL-LONDON, V586, P3035, DOI 10.1113/jphysiol.2008.154997; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Feske S, 2001, NAT IMMUNOL, V2, P316, DOI 10.1038/86318; Feske S, 2005, J EXP MED, V202, P651, DOI 10.1084/jem.20050687; Gwack Y, 2007, J BIOL CHEM, V282, P16232, DOI 10.1074/jbc.M609630200; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Ji W, 2008, P NATL ACAD SCI USA, V105, P13668, DOI 10.1073/pnas.0806499105; Li ZZ, 2007, J BIOL CHEM, V282, P29448, DOI 10.1074/jbc.M703573200; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Navarro-Borelly L, 2008, J PHYSIOL-LONDON, V586, P5383, DOI 10.1113/jphysiol.2008.162503; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; PARTISETI M, 1994, J BIOL CHEM, V269, P32327; Penna A, 2008, NATURE, V456, P116, DOI 10.1038/nature07338; Prakriya M, 2001, J PHYSIOL-LONDON, V536, P3, DOI 10.1111/j.1469-7793.2001.t01-1-00003.x; PRAKRIYA M, 2004, MOL CELLULAR INSIGHT, P121; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Stathopulos PB, 2006, J BIOL CHEM, V281, P35855, DOI 10.1074/jbc.M608247200; Takahashi Y, 2007, BIOCHEM BIOPH RES CO, V356, P45, DOI 10.1016/j.bbrc.2007.02.107; Thaminy Safia, 2004, Methods Mol Biol, V261, P297; Varnai P, 2007, J BIOL CHEM, V282, P29678, DOI 10.1074/jbc.M704339200; Vig M, 2008, NAT IMMUNOL, V9, P89, DOI 10.1038/ni1550; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Xu PY, 2006, BIOCHEM BIOPH RES CO, V350, P969, DOI 10.1016/j.bbrc.2006.09.134; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Zhang SYL, 2008, J BIOL CHEM, V283, P17662, DOI 10.1074/jbc.M801536200; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; ZWEIFACH A, 1995, J GEN PHYSIOL, V105, P209, DOI 10.1085/jgp.105.2.209	38	711	736	3	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 6	2009	136	5					876	890		10.1016/j.cell.2009.02.014	http://dx.doi.org/10.1016/j.cell.2009.02.014			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	415JU	19249086	Green Accepted, Bronze			2022-12-01	WOS:000263930900011
J	Zhang, ZY; Lan, Y; Chai, Y; Jiang, RL				Zhang, Zunyi; Lan, Yu; Chai, Yang; Jiang, Rulang			Antagonistic Actions of Msx1 and Osr2 Pattern Mammalian Teeth into a Single Row	SCIENCE			English	Article							EARLY TOOTH DEVELOPMENT; MORPHOGENESIS; EXPRESSION; DIVERSITY; DENTITION; ECTODIN; SIGNALS; GENES; MODEL; CUSP	Mammals have single-rowed dentitions, whereas many nonmammalian vertebrates have teeth in multiple rows. Neither the molecular mechanism regulating iterative tooth initiation nor that restricting mammalian tooth development in one row is known. We found that mice lacking the transcription factor odd-skipped related-2 (Osr2) develop supernumerary teeth lingual to their molars because of expansion of the odontogenic field. Osr2 was expressed in a lingual-to-buccal gradient and restricted expression of bone morphogenetic protein 4 (Bmp4), an essential odontogenic signal, in the developing tooth mesenchyme. Expansion of odontogenic field in Osr2-deficient mice required Msx1, a feedback activator of Bmp4 expression. These findings suggest that the Bmp4-Msx1 pathway propagates mesenchymal activation for sequential tooth induction and that spatial modulation of this pathway provides a mechanism for patterning vertebrate dentition.	[Zhang, Zunyi; Lan, Yu; Jiang, Rulang] Univ Rochester, Med Ctr, Ctr Oral Biol, Rochester, NY 14642 USA; [Zhang, Zunyi; Lan, Yu; Jiang, Rulang] Univ Rochester, Med Ctr, Dept Biomed Genet, Rochester, NY 14642 USA; [Chai, Yang] Univ So Calif, Sch Dent, Ctr Craniofacial Mol Biol, Los Angeles, CA 90033 USA	University of Rochester; University of Rochester; University of Southern California	Jiang, RL (corresponding author), Univ Rochester, Med Ctr, Ctr Oral Biol, Rochester, NY 14642 USA.	Rulang_Jiang@urmc.rochester.edu		Jiang, Rulang/0000-0001-7842-4696	NIH [R01DE013681, T32DE007202]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013681] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE007202] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by NIH grants R01DE013681 (R.J.) and T32DE007202 (Z.Z.). We thank K. Maltby for technical assistance and K. Ackerman, C. E. Ovitt, and M. Dixon for comments.	Bei M, 1998, DEVELOPMENT, V125, P4325; Chen YP, 1996, DEVELOPMENT, V122, P3035; Dassule HR, 1998, DEV BIOL, V202, P215, DOI 10.1006/dbio.1998.8992; Fraser GJ, 2006, J EXP ZOOL PART B, V306B, P183, DOI 10.1002/jez.b.21097; Fraser GJ, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-32; Jung HS, 1998, DEV BIOL, V196, P11, DOI 10.1006/dbio.1998.8850; Kassai Y, 2005, SCIENCE, V309, P2067, DOI 10.1126/science.1116848; Kavanagh KD, 2007, NATURE, V449, P427, DOI 10.1038/nature06153; Keranen SVE, 1998, DEV GENES EVOL, V208, P477, DOI 10.1007/s004270050206; Klein OD, 2006, DEV CELL, V11, P181, DOI 10.1016/j.devcel.2006.05.014; Kulesa PM, 1996, J THEOR BIOL, V180, P287, DOI 10.1006/jtbi.1996.0103; Lan Y, 2001, MECH DEVELOP, V107, P175, DOI 10.1016/S0925-4773(01)00457-9; Laurikkala J, 2003, DEV BIOL, V264, P91, DOI 10.1016/j.ydbio.2003.08.011; Maas R, 1997, CRIT REV ORAL BIOL M, V8, P4, DOI 10.1177/10454411970080010101; Mucchielli ML, 1997, DEV BIOL, V189, P275, DOI 10.1006/dbio.1997.8672; Mustonen T, 2003, DEV BIOL, V259, P123, DOI 10.1016/S0012-1606(03)00157-X; Peterkova R, 2006, J EXP ZOOL PART B, V306B, P234, DOI 10.1002/jez.b.21093; Pispa J, 2003, DEV BIOL, V262, P195, DOI 10.1016/S0012-1606(03)00325-7; Streelman JT, 2003, EVOL DEV, V5, P600, DOI 10.1046/j.1525-142X.2003.03065.x; Tucker A, 2004, NAT REV GENET, V5, P499, DOI 10.1038/nrg1380; Vastardis H, 1996, NAT GENET, V13, P417, DOI 10.1038/ng0896-417; Zhang QH, 2003, DEV DYNAM, V227, P78, DOI 10.1002/dvdy.10289	22	90	95	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2009	323	5918					1232	1234		10.1126/science.1167418	http://dx.doi.org/10.1126/science.1167418			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411XT	19251632	Green Accepted			2022-12-01	WOS:000263687600044
J	Buller, HR; ten Cate-Hoek, AJ; Hoes, AW; Joore, MA; Moons, KGM; Oudega, R; Prins, MH; Stoffers, HEJH; Toll, DB; van der Velde, EF; van Weert, HCPM				Buller, Harry R.; ten Cate-Hoek, Arina J.; Hoes, Arno W.; Joore, Manuela A.; Moons, Karel G. M.; Oudega, Ruud; Prins, Martin H.; Stoffers, Henri E. J. H.; Toll, Diane B.; van der Velde, Eit F.; van Weert, Henk C. P. M.		AMUSE	Safely Ruling Out Deep Venous Thrombosis in Primary Care	ANNALS OF INTERNAL MEDICINE			English	Article							SUSPECTED PULMONARY-EMBOLISM; DIAGNOSTIC WORK-UP; D-DIMER CONCENTRATION; SIMPLIFY D-DIMER; VEIN THROMBOSIS; CLINICAL PROBABILITY; EMERGENCY-DEPARTMENT; COMPUTED-TOMOGRAPHY; DECISION RULE; MANAGEMENT	Background: Up to 90% of patients referred for ultrasonography with suspected deep venous thrombosis (DVT) of the leg do not have the disease. Objective: To evaluate the safety and efficiency of using a clinical decision rule that includes a point-of-care D-dimer assay at initial presentation in primary care to exclude DVT. Design: A prospective management study. Setting: Approximately 300 primary care practices in 3 regions of the Netherlands ( Amsterdam, Maastricht, and Utrecht). Patients: 1028 consecutive patients with clinically suspected DVT. Intervention: Patients were managed on the basis of the result of the clinical decision rule, which included a D-dimer result. Patients with a score of 3 or less were not referred for ultrasonography and received no anticoagulant treatment; patients with a score of 4 or more were referred for ultrasonography. Measurements: The primary outcome was symptomatic, objectively confirmed, venous thromboembolism during 3-month follow-up. Results: The mean age of the 1028 study patients was 58 years, and 37% of patients were men. A valid score was obtained in 1002 patients (98%). In 500 patients (49%), with a score of 3 or less, 7 developed venous thromboembolism within 3 months ( incidence, 1.4% [95% CI, 0.6% to 2.9%]). A total of 502 patients ( 49%) had a score of 4 or more; 3 did not have ultrasonography. Ultrasonography showed DVT in 125 patients (25%), for an overall prevalence in evaluable patients of 13% ( 125 of 1002). Of the 374 patients who had normal ultrasonography results, 4 developed venous thromboembolism within 3 months (1.1% [ CI, 0.3% to 2.7%]). Limitation: The study lacked a randomized design and relied on clinical follow-up to detect missed thrombotic disease. Conclusion: A diagnostic management strategy in primary care by using a simple clinical decision rule and a point-of-care D-dimer assay reduces the need for referral to secondary care of patients with clinically suspected DVT by almost 50% and is associated with a low risk for subsequent venous thromboembolic events.	Univ Amsterdam, Amsterdam, Netherlands; Univ Med Ctr Utrecht, Utrecht, Netherlands	University of Amsterdam; Utrecht University; Utrecht University Medical Center	Prins, MH (corresponding author), Univ Limburg, Dept Epidemiol, P Debyepl 1, NL-6200 MD Maastricht, Netherlands.	mh.prins@epid.unimaas.nl	Stoffers, Henri E.J.H./N-3785-2019	Stoffers, Henri E.J.H./0000-0002-7908-5101	Netherlands Organization for Scientific Research.	Netherlands Organization for Scientific Research.(Netherlands Organization for Scientific Research (NWO))	The Netherlands Organization for Scientific Research.	Anderson DR, 2003, J THROMB HAEMOST, V1, P645, DOI 10.1046/j.1538-7836.2003.00131.x; Bates SM, 2003, ANN INTERN MED, V138, P787, DOI 10.7326/0003-4819-138-10-200305200-00006; Buller HR, 2003, NEW ENGL J MED, V349, P1695; Cini M, 2003, J THROMB HAEMOST, V1, P2681, DOI 10.1111/j.1538-7836.2003.0543d.x; ELF JL, 2008, THROMB RES; Goekoop RJ, 2007, THROMB HAEMOSTASIS, V97, P146, DOI 10.1160/TH06-09-0529; Huerta C, 2007, ARCH INTERN MED, V167, P935, DOI 10.1001/archinte.167.9.935; Janes S, 2001, BRIT J HAEMATOL, V112, P1079, DOI 10.1046/j.1365-2141.2001.02607.x; Kearon C, 2001, ANN INTERN MED, V135, P108, DOI 10.7326/0003-4819-135-2-200107170-00011; Kilroy DA, 2003, EMERG MED J, V20, P29, DOI 10.1136/emj.20.1.29; Kraaijenhagen R A, 1997, Curr Opin Pulm Med, V3, P268, DOI 10.1097/00063198-199707000-00006; Kruip MJHA, 2002, ARCH INTERN MED, V162, P1631, DOI 10.1001/archinte.162.14.1631; Leclercq MGL, 2003, THROMB HAEMOSTASIS, V89, P97; Lensing AWA, 1999, LANCET, V353, P479, DOI 10.1016/S0140-6736(98)04298-6; Ljungqvist M, 2008, EUR J INTERN MED, V19, P285, DOI 10.1016/j.ejim.2007.08.007; Neale D, 2004, EMERG MED J, V21, P663, DOI 10.1136/emj.2003.011049; Oudega R, 2005, THROMB HAEMOSTASIS, V94, P200, DOI 10.1160/TH04-12-0829; Oudega R, 2005, ANN INTERN MED, V143, P100, DOI 10.7326/0003-4819-143-2-200507190-00008; Parent F, 2007, THROMB RES, V120, P195, DOI 10.1016/j.thromres.2006.09.012; Perrier A, 2004, AM J MED, V116, P291, DOI 10.1016/j.amjmed.2003.09.041; Reilly BM, 2006, ANN INTERN MED, V144, P201, DOI 10.7326/0003-4819-144-3-200602070-00009; Schutgens REG, 2003, CIRCULATION, V107, P593, DOI 10.1161/01.CIR.0000045670.12988.1E; Subramaniam Rathan M, 2006, Emerg Med Australas, V18, P457, DOI 10.1111/j.1742-6723.2006.00866.x; Ten Cate-Hoek AJ, 2005, J THROMB HAEMOST, V3, P2465, DOI 10.1111/j.1538-7836.2005.01556.x; Ten Wolde M, 2004, J THROMB HAEMOST, V2, P1110, DOI 10.1111/j.1538-7836.2004.00769.x; Toll DB, 2006, J FAM PRACTICE, V55, P613; van Belle A, 2006, JAMA-J AM MED ASSOC, V295, P172; Velde EF, 2007, J THROMB HAEMOST, V5, P1327, DOI 10.1111/j.1538-7836.2007.02567.x; Wells PS, 2003, NEW ENGL J MED, V349, P1227, DOI 10.1056/NEJMoa023153; Wells PS, 2006, JAMA-J AM MED ASSOC, V295, P199, DOI 10.1001/jama.295.2.199; Wells PS, 2001, ANN INTERN MED, V135, P98, DOI 10.7326/0003-4819-135-2-200107170-00010	31	74	79	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 17	2009	150	4					229	U13		10.7326/0003-4819-150-4-200902170-00003	http://dx.doi.org/10.7326/0003-4819-150-4-200902170-00003			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	410FI	19221374				2022-12-01	WOS:000263562500001
J	Nicklin, P; Bergman, P; Zhang, BL; Triantafellow, E; Wang, H; Nyfeler, B; Yang, HD; Hild, M; Kung, C; Wilson, C; Myer, VE; MacKeigan, JP; Porter, JA; Wang, YK; Cantley, LC; Finan, PM; Murphy, LO				Nicklin, Paul; Bergman, Philip; Zhang, Bailin; Triantafellow, Ellen; Wang, Henry; Nyfeler, Beat; Yang, Haidi; Hild, Marc; Kung, Charles; Wilson, Christopher; Myer, Vic E.; MacKeigan, Jeffrey P.; Porter, Jeffrey A.; Wang, Y. Karen; Cantley, Lewis C.; Finan, Peter M.; Murphy, Leon O.			Bidirectional Transport of Amino Acids Regulates mTOR and Autophagy	CELL			English	Article							P70 S6 KINASE; FUNCTIONAL-CHARACTERIZATION; GLUTAMINE-METABOLISM; GENE-EXPRESSION; RAG GTPASES; CELL-SIZE; SYSTEM L; PROTEIN; RAPAMYCIN; MUSCLE	Amino acids are required for activation of the mammalian target of rapamycin ( mTOR) kinase which regulates protein translation, cell growth, and autophagy. Cell surface transporters that allow amino acids to enter the cell and signal to mTOR are unknown. We show that cellular uptake of L-glutamine and its subsequent rapid efflux in the presence of essential amino acids (EAA) is the rate-limiting step that activates mTOR. L-glutamine uptake is regulated by SLC1A5 and loss of SLC1A5 function inhibits cell growth and activates autophagy. The molecular basis for L-glutamine sensitivity is due to SLC7A5/SLC3A2, a bidirectional transporter that regulates the simultaneous efflux of L-glutamine out of cells and transport of L-leucine/EAA into cells. Certain tumor cell lines with high basal cellular levels of L-glutamine bypass the need for L-glutamine uptake and are primed for mTOR activation. Thus, L-glutamine flux regulates mTOR, translation and autophagy to coordinate cell growth and proliferation.	Novartis Inst BioMed Res, Dev & Mol Pathways, Cambridge, MA 02139 USA; [Cantley, Lewis C.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Cantley, Lewis C.] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02115 USA; [Zhang, Bailin; Wang, Y. Karen] Novartis Inst BioMed Res, Analyt Sci, Cambridge, MA 02139 USA	Novartis; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Novartis	Murphy, LO (corresponding author), Novartis Inst BioMed Res, Dev & Mol Pathways, 250 Massachusetts Ave, Cambridge, MA 02139 USA.	leon.murphy@novartis.com	Cantley, Lewis C/D-1800-2014	Cantley, Lewis C/0000-0002-1298-7653; MacKeigan, Jeffrey/0000-0002-0198-5679; Wilson, Christopher/0000-0002-9146-522X	Novartis Pharmaceuticals; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041890] Funding Source: NIH RePORTER	Novartis Pharmaceuticals(Novartis); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank Stephen Helliwell, Dan Garza, Dmitri Wiederschain, Greg Michaud, Alex Huang, Leslie Pond, and John Westwick for support, comments, and advice; and to Alan Abrams for help with graphics; and Akos Szilvasi for help with confocal imaging. All authors ( except L. C. C.) are employees of Novartis Pharmaceuticals.	Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Arsham AM, 2006, CURR OPIN CELL BIOL, V18, P589, DOI 10.1016/j.ceb.2006.09.005; BLOMMAART EFC, 1995, J BIOL CHEM, V270, P2320, DOI 10.1074/jbc.270.5.2320; Boado RJ, 1999, P NATL ACAD SCI USA, V96, P12079, DOI 10.1073/pnas.96.21.12079; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Cardenas ME, 1999, GENE DEV, V13, P3271, DOI 10.1101/gad.13.24.3271; CHRISTA L, 1994, GASTROENTEROLOGY, V106, P1312, DOI 10.1016/0016-5085(94)90024-8; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; Crespo JL, 2002, MICROBIOL MOL BIOL R, V66, P579, DOI 10.1128/MMBR.66.4.579-591.2002; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; Dann SG, 2006, FEBS LETT, V580, P2821, DOI 10.1016/j.febslet.2006.04.068; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; DECHELOTTE P, 1991, AM J PHYSIOL, V260, pG677, DOI 10.1152/ajpgi.1991.260.5.G677; EAGLE H, 1956, J BIOL CHEM, V218, P607; Edinger AL, 2002, MOL BIOL CELL, V13, P2276, DOI 10.1091/mbc.01-12-0584; Esslinger CS, 2005, BIOORGAN MED CHEM, V13, P1111, DOI 10.1016/j.bmc.2004.11.028; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Fuchs BC, 2006, J SURG RES, V131, P26, DOI 10.1016/j.jss.2005.07.013; Fuchs BC, 2005, SEMIN CANCER BIOL, V15, P254, DOI 10.1016/j.semcancer.2005.04.005; GAUGITSCH HW, 1992, J BIOL CHEM, V267, P11267; GEBHARDT R, 1995, CARCINOGENESIS, V16, P1673; Gingras AC, 2003, CURR TOP MICROBIOL, V279, P169; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Hardwick JS, 1999, P NATL ACAD SCI USA, V96, P14866, DOI 10.1073/pnas.96.26.14866; Holecek M, 2002, NUTRITION, V18, P130, DOI 10.1016/S0899-9007(01)00767-5; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jacinto E, 2008, BIOCHEM J, V410, P19, DOI 10.1042/BJ20071518; Kanai Y, 1998, J BIOL CHEM, V273, P23629, DOI 10.1074/jbc.273.37.23629; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; KOVACEVIC Z, 1972, CANCER RES, V32, P326; Liu XM, 2004, FASEB J, V18, P768, DOI 10.1096/fj.03-0886fje; Martin JF, 2000, MECH DEVELOP, V92, P155, DOI 10.1016/S0925-4773(99)00338-X; Martin KA, 2002, ADV CANCER RES, V86, P1, DOI 10.1016/S0065-230X(02)86001-8; Mastroberardino L, 1998, NATURE, V395, P288, DOI 10.1038/26246; Max X, 2008, CELL, V133, P303, DOI 10.1016/j.cell.2008.02.031; McGivan JD, 2007, FRONT BIOSCI, V12, P874, DOI 10.2741/2109; Meier C, 2002, EMBO J, V21, P580, DOI 10.1093/emboj/21.4.580; Mittendorfer B, 2001, AM J PHYSIOL-ENDOC M, V280, pE323, DOI 10.1152/ajpendo.2001.280.2.E323; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Nii T, 2001, BIOCHEM J, V358, P693, DOI 10.1042/0264-6021:3580693; Ohanna M, 2005, NAT CELL BIOL, V7, P286, DOI 10.1038/ncb1231; REITZER LJ, 1979, J BIOL CHEM, V254, P2669; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Segawa H, 1999, J BIOL CHEM, V274, P19745, DOI 10.1074/jbc.274.28.19745; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Smith EM, 2005, J BIOL CHEM, V280, P18717, DOI 10.1074/jbc.M414499200; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; UtsunomiyaTate N, 1996, J BIOL CHEM, V271, P14883, DOI 10.1074/jbc.271.25.14883; Verrey F, 2003, PFLUG ARCH EUR J PHY, V445, P529, DOI 10.1007/S00424-002-0973-Z; Wang XM, 1998, BIOCHEM J, V334, P261, DOI 10.1042/bj3340261; Wolf DA, 1996, CANCER RES, V56, P5012; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yanagida O, 2001, BBA-BIOMEMBRANES, V1514, P291, DOI 10.1016/S0005-2736(01)00384-4	59	1169	1230	10	147	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 6	2009	136	3					521	534		10.1016/j.cell.2008.11.044	http://dx.doi.org/10.1016/j.cell.2008.11.044			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	403ZN	19203585	Green Accepted, Bronze			2022-12-01	WOS:000263120600021
J	Glessner, JT; Wang, K; Cai, GQ; Korvatska, O; Kim, CE; Wood, S; Zhang, HT; Estes, A; Brune, CW; Bradfield, JP; Imielinski, M; Frackelton, EC; Reichert, J; Crawford, EL; Munson, J; Sleiman, PMA; Chiavacci, R; Annaiah, K; Thomas, K; Hou, CP; Glaberson, W; Flory, J; Otieno, F; Garris, M; Soorya, L; Klei, L; Piven, J; Meyer, KJ; Anagnostou, E; Sakurai, T; Game, RM; Rudd, DS; Zurawiecki, D; McDougle, CJ; Davis, LK; Miller, J; Posey, DJ; Michaels, S; Kolevzon, A; Silverman, JM; Bernier, R; Levy, SE; Schultz, RT; Dawson, G; Owley, T; McMahon, WM; Wassink, TH; Sweeney, JA; Nurnberger, JI; Coon, H; Sutcliffe, JS; Minshew, NJ; Grant, SFA; Bucan, M; Cook, EH; Buxbaum, JD; Devlin, B; Schellenberg, GD; Hakonarson, H				Glessner, Joseph T.; Wang, Kai; Cai, Guiqing; Korvatska, Olena; Kim, Cecilia E.; Wood, Shawn; Zhang, Haitao; Estes, Annette; Brune, Camille W.; Bradfield, Jonathan P.; Imielinski, Marcin; Frackelton, Edward C.; Reichert, Jennifer; Crawford, Emily L.; Munson, Jeffrey; Sleiman, Patrick M. A.; Chiavacci, Rosetta; Annaiah, Kiran; Thomas, Kelly; Hou, Cuiping; Glaberson, Wendy; Flory, James; Otieno, Frederick; Garris, Maria; Soorya, Latha; Klei, Lambertus; Piven, Joseph; Meyer, Kacie J.; Anagnostou, Evdokia; Sakurai, Takeshi; Game, Rachel M.; Rudd, Danielle S.; Zurawiecki, Danielle; McDougle, Christopher J.; Davis, Lea K.; Miller, Judith; Posey, David J.; Michaels, Shana; Kolevzon, Alexander; Silverman, Jeremy M.; Bernier, Raphael; Levy, Susan E.; Schultz, Robert T.; Dawson, Geraldine; Owley, Thomas; McMahon, William M.; Wassink, Thomas H.; Sweeney, John A.; Nurnberger, John I., Jr.; Coon, Hilary; Sutcliffe, James S.; Minshew, Nancy J.; Grant, Struan F. A.; Bucan, Maja; Cook, Edwin H., Jr.; Buxbaum, Joseph D.; Devlin, Bernie; Schellenberg, Gerard D.; Hakonarson, Hakon			Autism genome-wide copy number variation reveals ubiquitin and neuronal genes	NATURE			English	Article							SPECTRUM DISORDER; SUSCEPTIBILITY GENE; MUTATIONS; ASSOCIATION; NEUROLIGINS; MIGRATION; LINKAGE	Autism spectrum disorders (ASDs) are childhood neurodevelopmental disorders with complex genetic origins(1-4). Previous studies focusing on candidate genes or genomic regions have identified several copy number variations (CNVs) that are associated with an increased risk of ASDs(5-9). Here we present the results from a whole-genome CNV study on a cohort of 859 ASD cases and 1,409 healthy children of European ancestry who were genotyped with similar to 550,000 single nucleotide polymorphism markers, in an attempt to comprehensively identify CNVs conferring susceptibility to ASDs. Positive findings were evaluated in an independent cohort of 1,336 ASD cases and 1,110 controls of European ancestry. Besides previously reported ASD candidate genes, such as NRXN1 (ref. 10) and CNTN4 (refs 11, 12), several new susceptibility genes encoding neuronal cell-adhesion molecules, including NLGN1 and ASTN2, were enriched with CNVs in ASD cases compared to controls (P = 9.5 x 10(-3)). Furthermore, CNVs within or surrounding genes involved in the ubiquitin pathways, including UBE3A, PARK2, RFWD2 and FBXO40, were affected by CNVs not observed in controls (P = 3.3 x 10(-3)). We also identified duplications 55 kilobases upstream of complementary DNA AK123120 (P = 3.6 x 10(-6)). Although these variants may be individually rare, they target genes involved in neuronal cell-adhesion or ubiquitin degradation, indicating that these two important gene networks expressed within the central nervous system may contribute to the genetic susceptibility of ASD.	[Glessner, Joseph T.; Wang, Kai; Kim, Cecilia E.; Zhang, Haitao; Bradfield, Jonathan P.; Imielinski, Marcin; Frackelton, Edward C.; Sleiman, Patrick M. A.; Chiavacci, Rosetta; Annaiah, Kiran; Thomas, Kelly; Hou, Cuiping; Glaberson, Wendy; Flory, James; Otieno, Frederick; Garris, Maria; Grant, Struan F. A.; Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Cai, Guiqing; Reichert, Jennifer; Soorya, Latha; Anagnostou, Evdokia; Sakurai, Takeshi; Zurawiecki, Danielle; Kolevzon, Alexander; Silverman, Jeremy M.; Buxbaum, Joseph D.] Mt Sinai Sch Med, Dept Psychiat, Seaver Autism Ctr Res & Treatment, New York, NY 10029 USA; [Korvatska, Olena; Estes, Annette; Munson, Jeffrey; Bernier, Raphael; Dawson, Geraldine] Univ Washington, Seattle, WA 98105 USA; [Wood, Shawn; Klei, Lambertus; Michaels, Shana; Devlin, Bernie] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15260 USA; [Wood, Shawn; Klei, Lambertus; Michaels, Shana; Devlin, Bernie] Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA 15260 USA; [Brune, Camille W.; Owley, Thomas; Sweeney, John A.; Cook, Edwin H., Jr.] Univ Illinois, Inst Juvenile Res, Chicago, IL 60608 USA; [Brune, Camille W.; Owley, Thomas; Sweeney, John A.; Cook, Edwin H., Jr.] Univ Illinois, Dept Psychiat, Chicago, IL 60608 USA; [Crawford, Emily L.; Game, Rachel M.; Sutcliffe, James S.] Vanderbilt Univ, Ctr Mol Neurosci, Nashville, TN 37235 USA; [Crawford, Emily L.; Game, Rachel M.; Sutcliffe, James S.] Vanderbilt Univ, Vanderbilt Kennedy Ctr, Nashville, TN 37235 USA; [Piven, Joseph] Univ N Carolina, Neurodev Disorders Res Ctr, Greensboro, NC 27412 USA; [Piven, Joseph] Univ N Carolina, Dept Psychiat, Greensboro, NC 27412 USA; [Meyer, Kacie J.; Rudd, Danielle S.; Davis, Lea K.; Wassink, Thomas H.] Univ Iowa, Iowa City, IA 52242 USA; [Miller, Judith; McMahon, William M.; Coon, Hilary] Univ Utah, Salt Lake City, UT 84112 USA; [McDougle, Christopher J.; Posey, David J.; Nurnberger, John I., Jr.] Indiana Univ, Indianapolis, IN 46202 USA; [Levy, Susan E.; Schultz, Robert T.; Grant, Struan F. A.; Hakonarson, Hakon] Univ Penn, Sch Med, Dept Pediat, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Minshew, Nancy J.] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA 15260 USA; [Minshew, Nancy J.] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15260 USA; [Bucan, Maja] Univ Penn, Sch Med, Dept Genet Biol & Biostat, Philadelphia, PA 19104 USA; [Buxbaum, Joseph D.] Mt Sinai Sch Med, Dept Neurosci, New York, NY 10029 USA; [Buxbaum, Joseph D.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA; [Schellenberg, Gerard D.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Icahn School of Medicine at Mount Sinai; University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Vanderbilt University; Vanderbilt University; University of North Carolina; University of North Carolina Greensboro; University of North Carolina; University of North Carolina Greensboro; University of Iowa; Utah System of Higher Education; University of Utah; Indiana University System; Indiana University-Purdue University Indianapolis; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Pennsylvania; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Pennsylvania	Hakonarson, H (corresponding author), Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA.	gerardsc@mail.med.upenn.edu; hakonarson@chop.edu	Sutcliffe, James S/C-1348-2012; Buxbaum, Joseph D/G-6001-2010; Silverman, Jeremy M./AAO-4268-2020	Sutcliffe, James S/0000-0001-5200-6007; Estes, Annette/0000-0003-2687-4155; Nurnberger, John/0000-0002-7674-1767; Munson, Jeffrey A/0000-0003-1798-8927; Sweeney, John/0000-0003-1752-2828; Dawson, Geraldine/0000-0003-1410-2764; Buxbaum, Joseph/0000-0001-8898-8313; Grant, Struan/0000-0003-2025-5302; Glessner, Joseph/0000-0001-5131-2811; Wassink, Thomas/0000-0002-0952-8333	Children's Hospital of Philadelphia, Autism Speaks; NICHD [HD35476]; National Institute of Mental Health [1U24MH081810]; Margaret Q. Landenberger Foundation [UL1-RR024134-03]; Cotswold Foundation; Beatrice and Stanley A. Seaver Foundation; Department of Veterans Affairs; National Institute of Health [HD055782-01]; Utah Autism Foundation [MH0666730, MH061009, NS049261, HD055751, U10MH66766-02S1, MH69359, M01-RR00064]; Institutional Development Award to the Center for Applied Genomics; Children's Hospital of Philadelphia; Medical Research Council (UK); Health Research Board (Ireland);  [MH64547]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD035476, U19HD035476, P50HD055751, P50HD055782] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000064, UL1RR024134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057881, R01MH061009, R01MH064547, U54MH066673, U10MH066766, R01MH069359, U24MH081810] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049261] Funding Source: NIH RePORTER	Children's Hospital of Philadelphia, Autism Speaks; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Margaret Q. Landenberger Foundation; Cotswold Foundation; Beatrice and Stanley A. Seaver Foundation; Department of Veterans Affairs(US Department of Veterans Affairs); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Utah Autism Foundation; Institutional Development Award to the Center for Applied Genomics; Children's Hospital of Philadelphia; Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Health Research Board (Ireland); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We gratefully thank all the ASD children and their families at the participating study sites who were enrolled in this study and all the control subjects who donated blood samples to Children's Hospital of Philadelphia for genetic research purposes. We thank the technical staff in the Center for Applied Genomics, Children's Hospital of Philadelphia for generating the genotypes used in this study. We thank S. Diskin for her contribution to the discussion on the effect of wave artifacts on CNV calling. We also thank S. Kristinsson, L. A. Hermannsson and A. Krisbjornsson for their software design and contribution. This research was financially supported by The Children's Hospital of Philadelphia, Autism Speaks, and NICHD (HD35476). We also gratefully acknowledge the resources provided by the AGRE Consortium (D. H. Geschwind, M. Bucan, W. T. Brown, J. D. Buxbaum, R. M. Cantor, J. N. Constantino, T. C. Gilliam, C. M. Lajonchere, D. H. Ledbetter, C. Lese-Martin, J. Miller, S. F. Nelson, G. D. Schellenberg, C. A. Samango-Sprouse, S. Spence, M. State, R. E. Tanzi) and the participating families. AGRE is a program of Autism Speaks and is at present supported, in part, by grant 1U24MH081810 from the National Institute of Mental Health to C. M. Lajonchere (PI), and formerly by grant MH64547 to D. H. Geschwind (PI). The AGRE data set was genotyped by the Center for Applied Genomics at the Children's Hospital of Philadelphia, which funded all genotyping for this study, and the complete sets of genotyping data have been released to the public domain. AGRE-approved academic researchers can acquire the data sets from AGRE (http://www.agre.org). The study is supported in part by Research Award from the Margaret Q. Landenberger Foundation (H. H.), UL1-RR024134-03 (H. H.), a Research Development Award from the Cotswold Foundation (H. H. and S. F. A. G.), the Beatrice and Stanley A. Seaver Foundation (J. D. B.), the Department of Veterans Affairs (G. D. S.), and National Institute of Health grants HD055782-01 (J. Munson, A. E., O. K., G. D. and G. D. S.), MH0666730 (J. D. B.), MH061009 and NS049261 (J. S. S.), HD055751 (E. H. C.), U10MH66766-02S1 (C. J. M.), MH69359, M01-RR00064 and the Utah Autism Foundation (H. C., J. Miller, and W. M. M.). All genotyping for this study was supported by an Institutional Development Award to the Center for Applied Genomics (H. H.) from the Children's Hospital of Philadelphia. We acknowledge the Autism Genome Project Consortium (J. P., C. W. B., T. H. W., W. M. M., H. C., J. I. N., J. S. S., E. H. C., J. Munson, A. E., O. K., J. D. B., B. D. and G. D. S.) funded by Autism Speaks, the Medical Research Council (UK) and the Health Research Board (Ireland). We are grateful for the public access to the Affymetrix 5.0 data available for a subset of AGRE families (http://www.agre.org), which served as important validation of CNV calls made.	Alarcon M, 2008, AM J HUM GENET, V82, P150, DOI 10.1016/j.ajhg.2007.09.005; [Anonymous], 2007, AUTISM DEV DISABILIT; Chubykin AA, 2005, J BIOL CHEM, V280, P22365, DOI 10.1074/jbc.M410723200; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Diskin SJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn556; Fernandez T, 2008, AM J HUM GENET, V82, P1385, DOI 10.1016/j.ajhg.2008.04.021; Geschwind DH, 2001, AM J HUM GENET, V69, P463, DOI 10.1086/321292; Gupta AR, 2007, BIOL PSYCHIAT, V61, P429, DOI 10.1016/j.biopsych.2006.06.020; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Kahler AK, 2008, AM J MED GENET B, V147B, P1089, DOI 10.1002/ajmg.b.30726; Kalscheuer VM, 2007, HUM GENET, V121, P501, DOI 10.1007/s00439-006-0284-0; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim HG, 2008, AM J HUM GENET, V82, P199, DOI 10.1016/j.ajhg.2007.09.011; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Klauck SM, 2006, EUR J HUM GENET, V14, P714, DOI 10.1038/sj.ejhg.5201610; Le Couteur A, 2008, J AUTISM DEV DISORD, V38, P362, DOI 10.1007/s10803-007-0403-3; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Moessner R, 2007, AM J HUM GENET, V81, P1289, DOI 10.1086/522590; Newschaffer CJ, 2007, ANNU REV PUBL HEALTH, V28, P235, DOI 10.1146/annurev.publhealth.28.021406.144007; Roohi J, 2009, J MED GENET, V46, P176, DOI 10.1136/jmg.2008.057505; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Tai HC, 2008, NAT REV NEUROSCI, V9, P826, DOI 10.1038/nrn2499; Vorstman JAS, 2006, MOL PSYCHIATR, V11, P18, DOI 10.1038/sj.mp.4001757; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Yi JJ, 2005, NEURON, V47, P629, DOI 10.1016/j.neuron.2005.07.008; Zheng C, 1996, SCIENCE, V272, P417, DOI 10.1126/science.272.5260.417	29	969	1015	1	124	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2009	459	7246					569	573		10.1038/nature07953	http://dx.doi.org/10.1038/nature07953			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449ZS	19404257	Green Accepted, hybrid, Green Published			2022-12-01	WOS:000266370500039
J	Mukhtasimova, N; Lee, WY; Wang, HL; Sine, SM				Mukhtasimova, Nuriya; Lee, Won Yong; Wang, Hai-Long; Sine, Steven M.			Detection and trapping of intermediate states priming nicotinic receptor channel opening	NATURE			English	Article							SINGLE-CHANNEL; AGONIST BINDING; ACETYLCHOLINE-RECEPTORS; BC3H-1 CELLS; ION CHANNELS; END-PLATE; ACTIVATION; KINETICS; MUTATION; SUBUNIT	In the course of synaptic transmission in the brain and periphery, acetylcholine receptors (AChRs) rapidly transduce a chemical signal into an electrical impulse. The speed of transduction is facilitated by rapid ACh association and dissociation, suggesting a binding site relatively non-selective for small cations. Selective transduction has been thought to originate from the ability of ACh, over that of other organic cations, to trigger the subsequent channel-opening step. However, transitions to and from the open state were shown to be similar for agonists with widely different efficacies(1-3). By studying mutant AChRs, we show here that the ultimate closed-to-open transition is agonist-independent and preceded by two primed closed states; the first primed state elicits brief openings, whereas the second elicits long-lived openings. Long-lived openings and the associated primed state are detected in the absence and presence of an agonist, and exhibit the same kinetic signatures under both conditions. By covalently locking the agonist-binding sites in the bound conformation, we find that each site initiates a priming step. Thus, a change in binding-site conformation primes the AChR for channel opening in a process that enables selective activation by ACh while maximizing the speed and efficiency of the biological response.	[Mukhtasimova, Nuriya; Lee, Won Yong; Wang, Hai-Long; Sine, Steven M.] Mayo Clin, Coll Med, Dept Physiol & Biomed Engn, Receptor Biol Lab, Rochester, MN 55905 USA; [Sine, Steven M.] Mayo Clin, Coll Med, Dept Neurol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Sine, SM (corresponding author), Mayo Clin, Coll Med, Dept Physiol & Biomed Engn, Receptor Biol Lab, Rochester, MN 55905 USA.	sine@mayo.edu		Lee, Won Yong/0000-0001-7915-1829	National Institutes of Health [NS031744]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031744, R37NS031744] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Johnson for computer programming, and C. Free for technical contributions. This work was supported by National Institutes of Health grant NS031744 (S. M. S.).	Burzomato V, 2004, J NEUROSCI, V24, P10924, DOI 10.1523/JNEUROSCI.3424-04.2004; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; COLQUHOUN D, 1981, NATURE, V294, P464, DOI 10.1038/294464a0; COLQUHOUN D, 1985, J PHYSIOL-LONDON, V369, P501, DOI 10.1113/jphysiol.1985.sp015912; COLQUHOUN D, 1981, PROC R SOC SER B-BIO, V211, P205, DOI 10.1098/rspb.1981.0003; Colquhoun D, 1983, SINGLE CHANNEL RECOR, P191; DELCASTILLO J, 1957, PROC R SOC SER B-BIO, V146, P369; Grosman C, 2000, J GEN PHYSIOL, V115, P621, DOI 10.1085/jgp.115.5.621; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Lape R, 2008, NATURE, V454, P722, DOI 10.1038/nature07139; LEE BS, 1991, J BIOL CHEM, V266, P11448; Lee WY, 2008, J GEN PHYSIOL, V132, P265, DOI 10.1085/jgp.200810014; Lee WY, 2004, J GEN PHYSIOL, V124, P555, DOI 10.1085/jgp.200409077; LIU Y, 1991, BIOPHYS J, V60, P424, DOI 10.1016/S0006-3495(91)82068-9; Maconochie DJ, 1998, J PHYSIOL-LONDON, V506, P53, DOI 10.1111/j.1469-7793.1998.053bx.x; Mukhtasimova N, 2005, J GEN PHYSIOL, V126, P23, DOI 10.1085/jgp.200509283; Mukhtasimova N, 2007, J NEUROSCI, V27, P4110, DOI 10.1523/JNEUROSCI.0025-07.2007; Ohno K, 1996, NEURON, V17, P157, DOI 10.1016/S0896-6273(00)80289-5; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Qin F, 1996, BIOPHYS J, V70, P264, DOI 10.1016/S0006-3495(96)79568-1; SINE SM, 1986, J PHYSIOL-LONDON, V373, P129, DOI 10.1113/jphysiol.1986.sp016039; SINE SM, 1990, J GEN PHYSIOL, V96, P395, DOI 10.1085/jgp.96.2.395; SINE SM, 1986, J PHYSIOL-LONDON, V370, P357, DOI 10.1113/jphysiol.1986.sp015939; Wang HL, 1997, J GEN PHYSIOL, V109, P757, DOI 10.1085/jgp.109.6.757	25	166	166	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2009	459	7245					451	U172		10.1038/nature07923	http://dx.doi.org/10.1038/nature07923			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448DQ	19339970	Green Accepted			2022-12-01	WOS:000266243700051
J	Trivedi, V; Boire, A; Tchemychev, B; Kaneider, NC; Leger, AJ; O'Callaghan, K; Covic, L; Kuliopulos, A				Trivedi, Vishal; Boire, Adrienne; Tchemychev, Boris; Kaneider, Nicole C.; Leger, Andrew J.; O'Callaghan, Katie; Covic, Lidija; Kuliopulos, Athan			Platelet Matrix Metalloprotease-1 Mediates Thrombogenesis by Activating PAR1 at a Cryptic Ligand Site	CELL			English	Article							TISSUE FACTOR; THROMBIN RECEPTOR; CLEAVAGE SITE; INHIBITION; COLLAGEN; RELEASE; HEMOSTASIS; FAMILY; GROWTH; BLOOD	Matrix metalloproteases (MMPs) play important roles in normal and pathological remodeling processes including atherothrombotic disease, inflammation, angiogenesis, and cancer. MMPs have been viewed as matrix-degrading enzymes, but recent studies have shown that they possess direct signaling capabilities. Platelets harbor several MMPs that modulate hemostatic function and platelet survival; however their mode of action remains unknown. We show that platelet MMP-1 activates protease-activated receptor-1 (PAR1) on the surface of platelets. Exposure of platelets to fibrillar collagen converts the surface-bound proMMP-1 zymogen to active MMP-1, which promotes aggregation through PAR1. Unexpectedly, MMP-1 cleaves PAR1 at a distinct site that strongly activates Rho-GTP pathways, cell shape change and motility, and MAPK signaling. Blockade of MMP1-PAR1 curtails thrombogenesis under arterial flow conditions and inhibits thrombosis in animals. These studies provide a link between matrix-dependent activation of metalloproteases and platelet-G protein signaling and identify MMP1-PAR1 as a potential target for the prevention of arterial thrombosis.	[Trivedi, Vishal; Boire, Adrienne; Tchemychev, Boris; Kaneider, Nicole C.; Leger, Andrew J.; O'Callaghan, Katie; Covic, Lidija; Kuliopulos, Athan] Tufts Univ, Sch Med, Mol Oncol Res Inst, Dept Med,Tufts Med Ctr, Boston, MA 02111 USA; [Trivedi, Vishal; Boire, Adrienne; Tchemychev, Boris; Kaneider, Nicole C.; Leger, Andrew J.; O'Callaghan, Katie; Covic, Lidija; Kuliopulos, Athan] Tufts Univ, Sch Med, Mol Oncol Res Inst, Dept Biochem,Tufts Med Ctr, Boston, MA 02111 USA	Tufts Medical Center; Tufts University; Tufts Medical Center; Tufts University	Kuliopulos, A (corresponding author), Tufts Univ, Sch Med, Mol Oncol Res Inst, Dept Med,Tufts Med Ctr, 800 Washington St, Boston, MA 02111 USA.	athan.kuliopulos@tufts.edu	Boire, Adrienne/AAA-3578-2022; Boire, Adrienne/AAJ-9352-2021	Boire, Adrienne/0000-0002-9029-1248; 	NIH [R01 HL-57905, R01 HL-64701, R01 CA-122992]; NATIONAL CANCER INSTITUTE [R01CA122992] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057905, R01HL064701] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Support from NIH R01 HL-57905, R01 HL-64701, and R01 CA-122992 (to A. K.) is gratefully acknowledged. A. K. and L. C. are founders of Ascent Therapeutics and are members of its scientific advisory board. Ascent Therapeutics has licensed the pepducins used in this study.	Bergmeier W, 2003, BLOOD, V102, P4229, DOI 10.1182/blood-2003-04-1305; BERMAN J, 1992, J BIOL CHEM, V267, P1434; Bhatt DL, 2003, NAT REV DRUG DISCOV, V2, P15, DOI 10.1038/nrd985; Boire A, 2005, CELL, V120, P303, DOI 10.1016/j.cell.2004.12.018; CHANG JY, 1985, EUR J BIOCHEM, V151, P217, DOI 10.1111/j.1432-1033.1985.tb09091.x; CHESNEY CM, 1974, J CLIN INVEST, V53, P1647, DOI 10.1172/JCI107715; Conant K, 2004, J BIOL CHEM, V279, P8056, DOI 10.1074/jbc.M307051200; Covic L, 2002, P NATL ACAD SCI USA, V99, P643, DOI 10.1073/pnas.022460899; Dollery CM, 2006, CARDIOVASC RES, V69, P625, DOI 10.1016/j.cardiores.2005.11.003; Dumin JA, 2001, J BIOL CHEM, V276, P29368, DOI 10.1074/jbc.M104179200; FRESSINAUD E, 1992, BLOOD, V80, P988; Galt SW, 2002, CIRC RES, V90, P1093, DOI 10.1161/01.RES.0000019241.12929.EB; GAST A, 1994, ARTERIOSCLER THROMB, V14, P1466, DOI 10.1161/01.ATV.14.9.1466; Giesen PLA, 1999, P NATL ACAD SCI USA, V96, P2311, DOI 10.1073/pnas.96.5.2311; Gogly B, 1998, ANAL BIOCHEM, V255, P211, DOI 10.1006/abio.1997.2318; Huang JS, 2007, J BIOL CHEM, V282, P10210, DOI 10.1074/jbc.M605678200; Huebner JL, 1998, ARTHRITIS RHEUM-US, V41, P877, DOI 10.1002/1529-0131(199805)41:5<877::AID-ART16>3.0.CO;2-#; INAUEN W, 1990, ARTERIOSCLEROSIS, V10, P607, DOI 10.1161/01.ATV.10.4.607; Jackson SP, 2003, J THROMB HAEMOST, V1, P1602, DOI 10.1046/j.1538-7836.2003.00267.x; Kaneider NC, 2007, NAT IMMUNOL, V8, P1303, DOI 10.1038/ni1525; Kazes I, 2000, BLOOD, V96, P3064, DOI 10.1182/blood.V96.9.3064.h8003064_3064_3069; Kuliopulos A, 2004, THROMB HAEMOSTASIS, V92, P1387, DOI 10.1160/TH04-03-0187; Kuliopulos A, 1999, BIOCHEMISTRY-US, V38, P4572, DOI 10.1021/bi9824792; Leger AJ, 2006, CIRCULATION, V113, P1244, DOI 10.1161/CIRCULATIONAHA.105.587758; Leger AJ, 2006, CIRCULATION, V114, P1070, DOI 10.1161/CIRCULATIONAHA.105.574830; Levy GG, 2001, NATURE, V413, P488, DOI 10.1038/35097008; Mackman N, 2004, ARTERIOSCL THROM VAS, V24, P1015, DOI 10.1161/01.ATV.0000130465.23430.74; Mann KG, 2007, J THROMB HAEMOST, V5, P2055, DOI 10.1111/j.1538-7836.2007.02710.x; Moers A, 2003, NAT MED, V9, P1418, DOI 10.1038/nm943; NETZELARNETT S, 1991, J BIOL CHEM, V266, P6747; Nieswandt B, 2003, BLOOD, V102, P449, DOI 10.1182/blood-2002-12-3882; OFFERMANNS S, 1994, P NATL ACAD SCI USA, V91, P504, DOI 10.1073/pnas.91.2.504; Okorie UM, 2008, BLOOD, V111, P3507, DOI 10.1182/blood-2007-08-106229; Pearce E, 2005, CIRC RES, V97, P1070, DOI 10.1161/01.RES.0000189302.03303.11; Ruggeri ZM, 2002, NAT MED, V8, P1227, DOI 10.1038/nm1102-1227; Sawicki G, 1997, NATURE, V386, P616, DOI 10.1038/386616a0; Seeley S, 2003, CHEM BIOL, V10, P1033, DOI 10.1016/j.chembiol.2003.10.014; Stephens G, 2005, BLOOD, V105, P186, DOI 10.1182/blood-2004-07-2842; Sukhova GK, 1999, CIRCULATION, V99, P2503, DOI 10.1161/01.CIR.99.19.2503; Suzuki H, 2008, EUR J CLIN INVEST, V38, P166, DOI 10.1111/j.1365-2362.2007.01919.x; Turk BE, 2001, NAT BIOTECHNOL, V19, P661, DOI 10.1038/90273; VEEN G, 1993, J AM COLL CARDIOL, V22, P1755, DOI 10.1016/0735-1097(93)90754-O; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V	43	195	201	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 17	2009	137	2					332	343		10.1016/j.cell.2009.02.018	http://dx.doi.org/10.1016/j.cell.2009.02.018			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	437AB	19379698	Green Accepted, Bronze			2022-12-01	WOS:000265456800025
J	Whitehouse, PJ; George, D				Whitehouse, Peter J.; George, Daniel			The art of medicine Banking on stories for healthier cognitive ageing	LANCET			English	Editorial Material									[Whitehouse, Peter J.] Case Western Reserve Univ, Fairhill Ctr, Cleveland, OH 44120 USA; Univ Oxford Hertford Coll, Oxford, England	Case Western Reserve University; University of Oxford	Whitehouse, PJ (corresponding author), Case Western Reserve Univ, Fairhill Ctr, Cleveland, OH 44120 USA.	peter.whitehouse@case.edu						Ballenger J.F., 2006, SELF SENILITY ALZHEI; Kleinman A., 1988, ILLNESS NARRATIVES S; Stein J, 2008, ENV THREATS HLTH AGI; WHITEHOUSE PJ, 1997, CONCEPTS ALZHEIMER D; Whitehouse PJ, 2008, MYTH ALZHEIMERS WHAT	5	11	11	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 4	2009	373	9670					1166	1167		10.1016/S0140-6736(09)60672-3	http://dx.doi.org/10.1016/S0140-6736(09)60672-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	429SO	19350706				2022-12-01	WOS:000264940600014
J	Adorno, M; Cordenonsi, M; Montagner, M; Dupont, S; Wong, C; Hann, B; Solari, A; Bobisse, S; Rondina, MB; Guzzardo, V; Parenti, AR; Rosato, A; Bicciato, S; Balmain, A; Piccolo, S				Adorno, Maddalena; Cordenonsi, Michelangelo; Montagner, Marco; Dupont, Sirio; Wong, Christine; Hann, Byron; Solari, Aldo; Bobisse, Sara; Rondina, Maria Beatrice; Guzzardo, Vincenza; Parenti, Anna R.; Rosato, Antonio; Bicciato, Silvio; Balmain, Allan; Piccolo, Stefano			A Mutant-p53/Smad Complex Opposes p63 to Empower TGF beta-Induced Metastasis	CELL			English	Article							LI-FRAUMENI-SYNDROME; BREAST-CANCER; HISTOLOGIC GRADE; MOUSE MODEL; P53; PROGRESSION; MUTANT; GAIN; MICE; P73	TGF beta ligands act as tumor suppressors in early stage tumors but are paradoxically diverted into potent prometastatic factors in advanced cancers. The molecular nature of this switch remains enigmatic. Here, we show that TGF beta-dependent cell migration, invasion and metastasis are empowered by mutant-p53 and opposed by p63. Mechanistically, TGF beta acts in concert with oncogenic Ras and mutant-p53 to induce the assembly of a mutant-p53/p63 protein complex in which Smads serve as essential platforms. Within this ternary complex, p63 functions are antagonized. Downstream of p63, we identified two candidate metastasis suppressor genes associated with metastasis risk in a large cohort of breast cancer patients. Thus, two common oncogenic lesions, mutant-p53 and Ras, selected in early neoplasms to promote growth and survival, also prefigure a cellular set-up with particular metastasis proclivity by TGF beta-dependent inhibition of p63 function.	[Adorno, Maddalena; Cordenonsi, Michelangelo; Montagner, Marco; Dupont, Sirio; Piccolo, Stefano] Univ Padua, Sch Med, Dept Histol Microbiol & Med Biotechnol, I-35100 Padua, Italy; [Wong, Christine; Hann, Byron; Balmain, Allan] Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94115 USA; [Solari, Aldo] Univ Padua, Dept Chem Engn Proc, I-35131 Padua, Italy; [Bobisse, Sara; Rondina, Maria Beatrice; Rosato, Antonio] Univ Padua, Dept Oncol & Surg Sci, I-35126 Padua, Italy; [Bobisse, Sara; Rondina, Maria Beatrice; Rosato, Antonio] Univ Padua, Ist Oncol Veneto, I-35126 Padua, Italy; [Guzzardo, Vincenza; Parenti, Anna R.] Univ Padua, Sect Pathol, Dept Med Diagnost Sci & Special Therapies, I-35126 Padua, Italy; [Bicciato, Silvio] Univ Modena & Reggio Emilia, Dept Biomed Sci, I-41100 Modena, Italy	University of Padua; University of California System; University of California San Francisco; University of Padua; IRCCS Istituto Oncologico Veneto (IOV); University of Padua; IRCCS Istituto Oncologico Veneto (IOV); University of Padua; University of Padua; Universita di Modena e Reggio Emilia	Piccolo, S (corresponding author), Univ Padua, Sch Med, Dept Histol Microbiol & Med Biotechnol, Viale Colombo 3, I-35100 Padua, Italy.	piccolo@civ.bio.unipd.it	Montagner, Marco/AAY-3236-2020; Cordenonsi, Michelangelo/K-7692-2016; Bicciato, Silvio/C-9825-2009; Rosato, Antonio/E-8626-2010; BICCIATO, Silvio/J-4466-2019; Dupont, Sirio/AAP-8133-2021	Montagner, Marco/0000-0003-3080-2138; Cordenonsi, Michelangelo/0000-0002-8253-5724; Bicciato, Silvio/0000-0002-1944-7078; Rosato, Antonio/0000-0002-5263-8386; BICCIATO, Silvio/0000-0002-1944-7078; SOLARI, ALDO/0000-0003-1243-0385; Dupont, Sirio/0000-0002-6869-1966; PICCOLO, STEFANO/0000-0002-2037-0004	Swiss National Science Foundation; Cariparo; NCI [U01 CA84244]; Italian Association on Cancer Research (AIRC); Fondazione Cariparo; NATIONAL CANCER INSTITUTE [U01CA084244] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Cariparo(Fondazione Cariparo); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Italian Association on Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Fondazione Cariparo(Fondazione Cariparo); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is dedicated to the memory of Stefano Ferrari. We thank O. Wessely, G. Bressan, D. Volpin, G. Del Sal, and all members of the Piccolo group for invaluable discussions and comments on the manuscript; G. Del Sal and J. Girardini for transgenic MEFs; L. Morsut for data-mining; A. Colombatti and P. Spessotto for training with transwell and invasion assays; G. Gallina for microarrays; and G. Blandino, L. W. Ellisen, M. Tripodi, and L. Naldini for gifts of reagents. C.W. is a Swiss National Science Foundation fellow. This work is supported by grants from Cariparo (Excellence grant) to S.B., from NCI (U01 CA84244) to A.B. and from the Italian Association on Cancer Research (AIRC) and Fondazione Cariparo (Excellence grant) to S.P.	Bernards R, 2002, NATURE, V418, P823, DOI 10.1038/418823a; Caulin C, 2007, J CLIN INVEST, V117, P1893, DOI 10.1172/JCI31721; Cordenonsi M, 2003, CELL, V113, P301, DOI 10.1016/S0092-8674(03)00308-8; Cordenonsi M, 2007, SCIENCE, V315, P840, DOI 10.1126/science.1135961; Cui W, 1996, CELL, V86, P531, DOI 10.1016/S0092-8674(00)80127-0; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; DeYoung MP, 2007, ONCOGENE, V26, P5169, DOI 10.1038/sj.onc.1210337; Dupont S, 2009, CELL, V136, P123, DOI 10.1016/j.cell.2008.10.051; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Flores ER, 2005, CANCER CELL, V7, P363, DOI 10.1016/j.ccr.2005.02.019; Gaiddon C, 2001, MOL CELL BIOL, V21, P1874, DOI 10.1128/MCB.21.5.1874-1887.2001; Grunert S, 2003, NAT REV MOL CELL BIO, V4, P657, DOI 10.1038/nrm1175; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Oft M, 2002, NAT CELL BIOL, V4, P487, DOI 10.1038/ncb807; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Sobin LH, 2009, UICC TNM CLASSIFICAT; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Soussi T, 2001, NAT REV CANCER, V1, P233, DOI 10.1038/35106009; Strano S, 2002, J BIOL CHEM, V277, P18817, DOI 10.1074/jbc.M201405200	22	613	632	2	48	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 2	2009	137	1					87	98		10.1016/j.cell.2009.01.039	http://dx.doi.org/10.1016/j.cell.2009.01.039			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	427XV	19345189	Bronze			2022-12-01	WOS:000264813300016
J	Kawashima, Y; Pfafferott, K; Frater, J; Matthews, P; Payne, R; Addo, M; Gatanaga, H; Fujiwara, M; Hachiya, A; Koizumi, H; Kuse, N; Oka, S; Duda, A; Prendergast, A; Crawford, H; Leslie, A; Brumme, Z; Brumme, C; Allen, T; Brander, C; Kaslow, R; Tang, J; Hunter, E; Allen, S; Mulenga, J; Branch, S; Roach, T; John, M; Mallal, S; Ogwu, A; Shapiro, R; Prado, JG; Fidler, S; Weber, J; Pybus, OG; Klenerman, P; Ndung'u, T; Phillips, R; Heckerman, D; Harrigan, PR; Walker, BD; Takiguchi, M; Goulder, P				Kawashima, Yuka; Pfafferott, Katja; Frater, John; Matthews, Philippa; Payne, Rebecca; Addo, Marylyn; Gatanaga, Hiroyuki; Fujiwara, Mamoru; Hachiya, Atsuko; Koizumi, Hirokazu; Kuse, Nozomi; Oka, Shinichi; Duda, Anna; Prendergast, Andrew; Crawford, Hayley; Leslie, Alasdair; Brumme, Zabrina; Brumme, Chanson; Allen, Todd; Brander, Christian; Kaslow, Richard; Tang, James; Hunter, Eric; Allen, Susan; Mulenga, Joseph; Branch, Songee; Roach, Tim; John, Mina; Mallal, Simon; Ogwu, Anthony; Shapiro, Roger; Prado, Julia G.; Fidler, Sarah; Weber, Jonathan; Pybus, Oliver G.; Klenerman, Paul; Ndung'u, Thumbi; Phillips, Rodney; Heckerman, David; Harrigan, P. Richard; Walker, Bruce D.; Takiguchi, Masafumi; Goulder, Philip			Adaptation of HIV-1 to human leukocyte antigen class I	NATURE			English	Article							T-LYMPHOCYTE RESPONSE; MHC-CLASS-I; ESCAPE MUTATIONS; CELL RESPONSES; VIRAL LOAD; HLA-B; GAG; TRANSMISSION; POLYMORPHISMS; ASSOCIATIONS	The rapid and extensive spread of the human immunodeficiency virus (HIV) epidemic provides a rare opportunity to witness host-pathogen co-evolution involving humans. A focal point is the interaction between genes encoding human leukocyte antigen (HLA) and those encoding HIV proteins. HLA molecules present fragments (epitopes) of HIV proteins on the surface of infected cells to enable immune recognition and killing by CD8(+) T cells; particular HLA molecules, such as HLA-B*57, HLA-B*27 and HLA-B*51, are more likely to mediate successful control of HIV infection(1). Mutation within these epitopes can allow viral escape from CD8(+) T-cell recognition. Here we analysed viral sequences and HLA alleles from. 2,800 subjects, drawn from 9 distinct study cohorts spanning 5 continents. Initial analysis of the HLA-B*51-restricted epitope, TAFTIPSI (reverse transcriptase residues 128135), showed a strong correlation between the frequency of the escape mutation I135X and HLA-B*51 prevalence in the 9 study cohorts (P=0.0001). Extending these analyses to incorporate other well-defined CD8(+) T-cell epitopes, including those restricted by HLA-B*57 and HLA-B*27, showed that the frequency of these epitope variants (n=14) was consistently correlated with the prevalence of the restricting HLA allele in the different cohorts (together, P < 0.0001), demonstrating strong evidence of HIV adaptation to HLA at a population level. This process of viral adaptation may dismantle the well-established HLA associations with control of HIV infection that are linked to the availability of key epitopes, and highlights the challenge for a vaccine to keep pace with the changing immunological landscape presented by HIV.	[Pfafferott, Katja; Matthews, Philippa; Payne, Rebecca; Prendergast, Andrew; Crawford, Hayley; Leslie, Alasdair; Prado, Julia G.; Goulder, Philip] Dept Paediat, Oxford OX1 3SY, England; [Frater, John; Duda, Anna; Klenerman, Paul; Phillips, Rodney] Nuffield Dept Clin Med, Oxford OX1 3SY, England; [Frater, John; Duda, Anna; Klenerman, Paul; Phillips, Rodney] James Martin 21st Century Sch, Oxford OX1 3SY, England; [Kawashima, Yuka; Fujiwara, Mamoru; Hachiya, Atsuko; Koizumi, Hirokazu; Kuse, Nozomi; Takiguchi, Masafumi] Kumamoto Univ, Div Viral Immunol, Kumamoto 8600811, Japan; [Gatanaga, Hiroyuki; Oka, Shinichi] Kumamoto Univ, Div Infect Dis, Ctr AIDS Res, Kumamoto 8600811, Japan; [Pfafferott, Katja; John, Mina; Mallal, Simon; Goulder, Philip] Royal Perth Hosp, Ctr Clin Immunol & Biomed Stat, Perth, WA 6000, Australia; [Pfafferott, Katja; John, Mina; Mallal, Simon; Goulder, Philip] Murdoch Univ, Murdoch, WA 6000, Australia; [Addo, Marylyn; Brumme, Zabrina; Brumme, Chanson; Allen, Todd; Brander, Christian; Walker, Bruce D.] Massachusetts Gen Hosp, Partners AIDS Res Ctr, Boston, MA 02129 USA; [Gatanaga, Hiroyuki; Hachiya, Atsuko; Oka, Shinichi] Int Med Ctr Japan, AIDS Clin Ctr, Shinjuku Ku, Tokyo 1628655, Japan; [Brander, Christian] Hosp Badalona Germans Trias & Pujol, Fundacio IrsiCaixa HIVACAT, Badalona, Spain; [Brander, Christian] ICREA, Barcelona 08916, Spain; [Kaslow, Richard; Tang, James] Univ Alabama Birmingham, Birmingham, AL 35294 USA; [Hunter, Eric] Emory Univ, Vaccine Ctr, Atlanta, GA 30329 USA; [Hunter, Eric] Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA; [Allen, Susan; Mulenga, Joseph] Zambia Emory HIV Res Project, Lusaka, Zambia; [Allen, Susan; Mulenga, Joseph] Zambia Blood Transfus Serv, Lusaka, Zambia; [Branch, Songee; Roach, Tim] Univ W Indies, Ladymeade Reference Unit, BB-11156 Bridgetown, Barbados; [Ogwu, Anthony; Shapiro, Roger] Botswana Harvard Sch Publ Hlth, AIDS Initiat Partnership, Gaborone, Botswana; [Fidler, Sarah; Weber, Jonathan] Univ London Imperial Coll Sci Technol & Med, St Marys Hosp, Wright Fleming Inst, Div Med, London W2 1PG, England; [Pybus, Oliver G.] Univ Oxford, Dept Zool, Oxford OX1 3SY, England; [Ndung'u, Thumbi; Walker, Bruce D.; Goulder, Philip] Univ KwaZulu Natal, Doris Duke Med Res Inst, HIV Pathogenesis Programme, ZA-4013 Durban, South Africa; [Harrigan, P. Richard] Miscrosoft Res, Redmond, WA USA; [Heckerman, David] BC Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada; [Walker, Bruce D.] Howard Hughes Med Inst, Chevy Chase, MD 20185 USA	University of Oxford; University of Oxford; Kumamoto University; Kumamoto University; Royal Perth Hospital; University of Western Australia; Murdoch University; Harvard University; Massachusetts General Hospital; National Center for Global Health & Medicine - Japan; Hospital Germans Trias i Pujol; Institut de Recerca de la Sida - IrsiCaixa; ICREA; University of Alabama System; University of Alabama Birmingham; Emory University; University West Indies Mona Jamaica; University of the West Indies Open Campus; Imperial College London; University of Oxford; University of Kwazulu Natal; B.C. Centre for Excellence in HIV/AIDS; Howard Hughes Medical Institute	Goulder, P (corresponding author), Dept Paediat, Peter Medawar Bldg Pathogen Res,S Parks Rd, Oxford OX1 3SY, England.	philip.goulder@paediatrics.ox.ac.uk	Tang, Jianming "James"/O-4980-2019; Matthews, Philippa/P-7810-2019; Mallal, Simon Alexander/HDM-9561-2022; Pybus, Oliver G/B-2640-2012; Takiguchi, Masafumi/E-7468-2013; Prado, Julia Garcia/R-7177-2019; Allen, Todd/F-5473-2011; Addo, Marylyn M./GNP-2548-2022; Payne, Rebecca/AAC-4783-2022	Tang, Jianming "James"/0000-0003-0137-7486; Matthews, Philippa/0000-0002-4036-4269; Mallal, Simon Alexander/0000-0002-7036-1309; Pybus, Oliver G/0000-0002-8797-2667; Prado, Julia Garcia/0000-0002-5439-4645; Allen, Todd/0000-0002-6609-1318; Payne, Rebecca/0000-0002-9037-7367; klenerman, paul/0000-0003-4307-9161; Brumme, Chanson/0000-0003-2722-5288; Oka, Shinichi/0000-0002-9283-2167; Frater, John/0000-0001-7163-7277; Ndung'u, Thumbi/0000-0003-2962-3992; Fidler, Sarah/0000-0003-1676-7583; Addo, Marylyn/0000-0003-2836-9224; Prendergast, Andrew/0000-0001-7904-7992; Brumme, Zabrina/0000-0002-8157-1037; Brander, Christian/0000-0002-0548-5778	National Institutes of Health [RO1AI46995, 1 R01 AI067073, R01AI64060]; Wellcome Trust; UK Medical Research Council; Mark and Lisa Schwartz Foundation; Ministry of Health, Labour and Welfare [012]; Ministry of Education, Science, Sports and Culture [18390141]; NIHR Biomedical Research Centre Programme; Elizabeth Glaser Pediatric AIDS Foundation Scientist; Marie Curie Fellow [IEF-041811]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067073, R01AI046995, R01AI060460, R01AI064060] Funding Source: NIH RePORTER; ICREA Funding Source: Custom; MRC [G108/626, G0501777, G0500384] Funding Source: UKRI; Medical Research Council [G108/626, G0500384, G0501777] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10313] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Mark and Lisa Schwartz Foundation; Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NIHR Biomedical Research Centre Programme(National Institute for Health Research (NIHR)); Elizabeth Glaser Pediatric AIDS Foundation Scientist; Marie Curie Fellow(European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ICREA(ICREA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work is funded by grants from the National Institutes of Health (RO1AI46995 ( P. G.), 1 R01 AI067073 ( B. D. W.), R01AI64060 ( E. H.)), the Wellcome Trust ( P. G., P. K.), the UK Medical Research Council (J.F., A. P. and P. M.), and the Mark and Lisa Schwartz Foundation, the Ministry of Health, Labour and Welfare (Health and Labour HIV/AIDS Research Grants 012), the NIHR Biomedical Research Centre Programme and the Ministry of Education, Science, Sports and Culture ( number 18390141), Japan ( M. T.). P. G. is an Elizabeth Glaser Pediatric AIDS Foundation Scientist; J.G.P. is a Marie Curie Fellow (contract number IEF-041811). The authors are also grateful to A. McLean and H. Fryer for discussions of the manuscript.	Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Bhattacharya T, 2007, SCIENCE, V315, P1583, DOI 10.1126/science.1131528; Brumme ZL, 2008, J VIROL, V82, P9216, DOI 10.1128/JVI.01041-08; Brumme ZL, 2008, AIDS, V22, P1277, DOI 10.1097/QAD.0b013e3283021a8c; Crawford H, 2007, J VIROL, V81, P8346, DOI 10.1128/JVI.00465-07; Draenert R, 2004, J EXP MED, V199, P905, DOI 10.1084/jem.20031982; Feeney ME, 2004, J VIROL, V78, P8927, DOI 10.1128/JVI.78.16.8927-8930.2004; Gallimore A, 1998, J EXP MED, V187, P1647; Gatanaga H, 2006, VIROLOGY, V344, P354, DOI 10.1016/j.virol.2005.09.005; Goepfert PA, 2008, J EXP MED, V205, P1009, DOI 10.1084/jem.20072457; Goulder PJR, 2008, NAT REV IMMUNOL, V8, P619, DOI 10.1038/nri2357; Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212; Goulder PJR, 2001, NATURE, V412, P334, DOI 10.1038/35085576; Holtappels R, 2008, J VIROL, V82, P5781, DOI 10.1128/JVI.00155-08; Itoh Y, 2005, IMMUNOGENETICS, V57, P717, DOI 10.1007/s00251-005-0048-3; Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Leslie A, 2005, J EXP MED, V201, P891, DOI 10.1084/jem.20041455; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; Martinez-Picado J, 2006, J VIROL, V80, P3617, DOI 10.1128/JVI.80.7.3617-3623.2006; Matthews PC, 2008, J VIROL, V82, P8548, DOI 10.1128/JVI.00580-08; McKiernan SM, 2004, HEPATOLOGY, V40, P108, DOI 10.1002/hep.20261; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; O'Brien SJ, 2001, TRENDS MOL MED, V7, P379, DOI 10.1016/S1471-4914(01)02131-1; Schneidewind A, 2007, J VIROL, V81, P12382, DOI 10.1128/JVI.01543-07; Seki S, 2008, J VIROL, V82, P5093, DOI 10.1128/JVI.02607-07; Tang JM, 2002, J VIROL, V76, P8276, DOI 10.1128/JVI.76.16.8276-8284.2002; Tomiyama H, 2002, J VIROL, V76, P7535, DOI 10.1128/JVI.76.15.7535-7543.2002; Tomiyama H, 1999, HUM IMMUNOL, V60, P177, DOI 10.1016/S0198-8859(98)00113-X	30	344	360	1	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 2	2009	458	7238					641	U108		10.1038/nature07746	http://dx.doi.org/10.1038/nature07746			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RK	19242411	Green Accepted			2022-12-01	WOS:000264796200043
J	Matsumoto-Miyai, K; Sokolowska, E; Zurlinden, A; Gee, CE; Luscher, D; Hettwer, S; Wolfel, J; Ladner, AP; Ster, J; Gerber, U; Rulicke, T; Kunz, B; Sonderegger, P				Matsumoto-Miyai, Kazumasa; Sokolowska, Ewa; Zurlinden, Andreas; Gee, Christine E.; Luescher, Daniel; Hettwer, Stefan; Woelfel, Jens; Ladner, Ana Paula; Ster, Jeanne; Gerber, Urs; Ruelicke, Thomas; Kunz, Beat; Sonderegger, Peter			Coincident Pre- and Postsynaptic Activation Induces Dendritic Filopodia via Neurotrypsin-Dependent Agrin Cleavage	CELL			English	Article							LONG-TERM POTENTIATION; NEOCORTEX IN-VIVO; HIPPOCAMPAL-NEURONS; SPINE FORMATION; NEUROMUSCULAR-JUNCTION; SYNAPTIC-TRANSMISSION; MENTAL-RETARDATION; NERVOUS-SYSTEM; AREA CA1; GROWTH	The synaptic serine protease neurotrypsin is essential for cognitive function, as its deficiency in humans results in severe mental retardation. Recently, we demonstrated the activity-dependent release of neurotrypsin from presynaptic terminals and proteolytical cleavage of agrin at the synapse. Here we show that the activity-dependent formation of dendritic filopodia is abolished in hippocampal neurons from neurotrypsin-deficient mice. Administration of the neurotrypsin-dependent 22 kDa fragment of agrin rescues the filopodial response. Detailed analyses indicated that presynaptic action potential firing is necessary for the release of neurotrypsin, whereas postsynaptic NMDA receptor activation is necessary for the neurotrypsin-dependent cleavage of agrin. This contingency characterizes the neurotrypsinagrin system as a coincidence detector of pre-and postsynaptic activation. As the resulting dendritic filopodia are thought to represent precursors of synapses, the neurotrypsin-dependent cleavage of agrin at the synapse may be instrumental for a Hebbian organization and remodeling of synaptic circuits in the CNS.	[Matsumoto-Miyai, Kazumasa; Sokolowska, Ewa; Zurlinden, Andreas; Luescher, Daniel; Woelfel, Jens; Ladner, Ana Paula; Kunz, Beat; Sonderegger, Peter] Univ Zurich, Dept Biochem, CH-8057 Zurich, Switzerland; [Gee, Christine E.; Ster, Jeanne; Gerber, Urs] Univ Zurich, Brain Res Inst, CH-8057 Zurich, Switzerland; [Ruelicke, Thomas] Univ Zurich, Inst Lab Anim Sci, CH-8057 Zurich, Switzerland; [Hettwer, Stefan] Neurotune AG, CH-8952 Schlieren, Switzerland	University of Zurich; University of Zurich; University of Zurich	Sonderegger, P (corresponding author), Univ Zurich, Dept Biochem, CH-8057 Zurich, Switzerland.	peter.sonderegger@bioc.uzh.ch	Gee, Christine E/E-9241-2013	Gee, Christine E/0000-0003-0345-3665; Ster, Jeanne/0000-0002-7277-9135	Swiss National Science Foundation; Olga Mayenfisch Stiftung; Neurotune AG	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Olga Mayenfisch Stiftung; Neurotune AG	We thank P. Caroni for the mouse line L15 expressing membrane-targeted GFP in sparse neurons, G. Miesenbock for the cDNA of superecliptic pHluorin, D. Blaser for mouse husbandry, and B. Gahwiler for critical reading of the manuscript. This work was supported by grants of the Swiss National Science Foundation, the National Center of Competence in Research "Brain Plasticity and Repair'' of the Swiss National Science Foundation, and the Olga Mayenfisch Stiftung. P. S. is a cofounder and minor shareholder (<1%) of Neurotune AG. Part of this work (<10%) was financially supported by Neurotune AG.	Annies M, 2006, MOL CELL NEUROSCI, V31, P515, DOI 10.1016/j.mcn.2005.11.005; BOURNE HR, 1993, CELL, V72, P65, DOI 10.1016/S0092-8674(05)80029-7; Burgess RW, 1999, NEURON, V23, P33, DOI 10.1016/S0896-6273(00)80751-5; Caroni P, 1997, J NEUROSCI METH, V71, P3, DOI 10.1016/S0165-0270(96)00121-5; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; De Paola V, 2003, NAT NEUROSCI, V6, P491, DOI 10.1038/nn1046; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fiala JC, 1998, J NEUROSCI, V18, P8900; Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X; Frischknecht R, 2008, J NEUROSCI, V28, P1568, DOI 10.1523/JNEUROSCI.3398-07.2008; Glass DJ, 1996, CELL, V85, P513, DOI 10.1016/S0092-8674(00)81252-0; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Gschwend TP, 1997, MOL CELL NEUROSCI, V9, P207, DOI 10.1006/mcne.1997.0616; HANSE E, 1994, J NEUROSCI, V14, P5028; Hebb D.O., 2002, CLIN PSYCHOL; Hilgenberg LGW, 2006, CELL, V125, P359, DOI 10.1016/j.cell.2006.01.052; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Holtmaat A, 2006, NATURE, V441, P979, DOI 10.1038/nature04783; HUANG YY, 1993, J NEUROSCI, V13, P568; HUBER KM, 1995, J NEUROPHYSIOL, V73, P270, DOI 10.1152/jn.1995.73.1.270; Jontes JD, 2000, NEURON, V27, P11, DOI 10.1016/S0896-6273(00)00003-9; Jourdain P, 2003, J NEUROSCI, V23, P10645; Khalilov I, 1997, NEURON, V19, P743, DOI 10.1016/S0896-6273(00)80956-3; Knott G, 2008, BRAIN RES REV, V58, P282, DOI 10.1016/j.brainresrev.2008.01.002; Knott GW, 2006, NAT NEUROSCI, V9, P1117, DOI 10.1038/nn1747; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; Koulen P, 1999, EUR J NEUROSCI, V11, P4188, DOI 10.1046/j.1460-9568.1999.00848.x; Ksiazek I, 2007, J NEUROSCI, V27, P7183, DOI 10.1523/JNEUROSCI.1609-07.2007; Kummer TT, 2006, CURR OPIN NEUROBIOL, V16, P74, DOI 10.1016/j.conb.2005.12.003; Li J, 2001, NEUROSCIENCE, V105, P589, DOI 10.1016/S0306-4522(01)00204-4; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Marrs GS, 2001, NAT NEUROSCI, V4, P1006, DOI 10.1038/nn717; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; McCroskery S, 2006, MOL CELL NEUROSCI, V33, P15, DOI 10.1016/j.mcn.2006.06.004; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Molinari F, 2002, SCIENCE, V298, P1779, DOI 10.1126/science.1076521; Nagerl UV, 2007, J NEUROSCI, V27, P8149, DOI 10.1523/JNEUROSCI.0511-07.2007; Nagerl UV, 2004, NEURON, V44, P759, DOI 10.1016/j.neuron.2004.11.016; Nikonenko I, 2002, HIPPOCAMPUS, V12, P585, DOI 10.1002/hipo.10095; Nyberg P, 2005, CANCER RES, V65, P3967, DOI 10.1158/0008-5472.CAN-04-2427; Okabe S, 2001, J NEUROSCI, V21, P6105, DOI 10.1523/JNEUROSCI.21-16-06105.2001; Otmakhov N, 2004, J NEUROPHYSIOL, V91, P1955, DOI 10.1152/jn.00941.2003; Reif R, 2007, FASEB J, V21, P3468, DOI 10.1096/fj.07-8800com; Saito Y, 1997, J NEUROSCI, V17, P8792; Stepanyants A, 2002, NEURON, V34, P275, DOI 10.1016/S0896-6273(02)00652-9; Stephan A, 2008, FASEB J, V22, P1861, DOI 10.1096/fj.07-100008; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Toni N, 2007, NAT NEUROSCI, V10, P727, DOI 10.1038/nn1908; Tsien JZ, 2000, CURR OPIN NEUROBIOL, V10, P266, DOI 10.1016/S0959-4388(00)00070-2; VAUGHN JE, 1974, J CELL BIOL, V60, P664, DOI 10.1083/jcb.60.3.664; Wolfer DP, 2001, MOL CELL NEUROSCI, V18, P407, DOI 10.1006/mcne.2001.1029; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	54	83	87	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 20	2009	136	6					1161	1171		10.1016/j.cell.2009.02.034	http://dx.doi.org/10.1016/j.cell.2009.02.034			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	422CE	19303856	Bronze, Green Accepted			2022-12-01	WOS:000264403900020
J	Katz, PR; Karuza, J; Intrator, O; Mor, V				Katz, Paul R.; Karuza, Jurgis; Intrator, Orna; Mor, Vincent			Nursing Home Physician Specialists: A Response to the Workforce Crisis in Long-Term Care	ANNALS OF INTERNAL MEDICINE			English	Article							HOSPITAL MEDICINE; INTERNAL-MEDICINE; RESIDENTS; QUALITY; PATTERNS; STATE; STAFF	Marginalization of physicians in the nursing home threatens the overall care of increasingly frail nursing home residents who have medically complex illnesses. The authors propose that creating a nursing home medicine specialty, which recognizes the nursing home as a unique practice site, would go a long way toward remedying existing problems with care in skilled nursing facilities and would best serve the needs of the 1.6 million nursing home residents in the United States. Reviewing what is known about physician practice in nursing homes and hospitals, and taking a lead from the hospitalist movement, the specialty would be characterized in 3 dimensions: the degree of physicians' commitment, physicians' practice competencies, and the structure of the medical staff organization in which they practice. Challenges to the adoption of a nursing home specialist model include mainstream medicine's failure to recognize the nursing home as a legitimate medical practice, the need for the nursing home industry and policymakers to appreciate the links between physician practice and quality, and assurance of financial viability. Implications for quality of care, health policy, and research needs are discussed in this article.	[Katz, Paul R.] Univ Rochester, Sch Med & Dent, Rochester, NY 14620 USA; SUNY Buffalo, Buffalo, NY 14260 USA; Brown Univ, Providence, RI 02912 USA	University of Rochester; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Brown University	Katz, PR (corresponding author), Univ Rochester, Sch Med & Dent, 435 E Henrietta Rd, Rochester, NY 14620 USA.	Paul_Katz@urmc.rochester.edu			National Institute on Aging [R21 AG025246]; NATIONAL INSTITUTE ON AGING [R21AG025246] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Grant Support: Dr. Katz was supported by the National Institute on Aging (grant R21 AG025246).	*AM MED DIR ASS, CMS IMPL REV SURV GU; Baron RJ, 2008, JAMA-J AM MED ASSOC, V299, P1595, DOI 10.1001/jama.299.13.1595; Blumenthal D, 2001, JAMA-J AM MED ASSOC, V286, P1027, DOI 10.1001/jama.286.9.1027; Borger C, 2006, HEALTH AFFAIR, V25, pW61, DOI 10.1377/hlthaff.25.w61; Caprio T. V., 2006, ANNALS OF LONG TERM, V14, P17; Caprio TV, 2009, J AM MED DIR ASSOC, V10, P93, DOI 10.1016/j.jamda.2008.07.007; DeFrances C. J, 2007, 2005 NATL HOSP DISCH, V385; FLOOD AB, 1978, J HEALTH SOC BEHAV, V19, P240, DOI 10.2307/2136557; Glasheen JJ, 2008, J GEN INTERN MED, V23, P1110, DOI 10.1007/s11606-008-0646-5; Gruneir A, 2007, MED CARE RES REV, V64, P351, DOI 10.1177/1077558707301810; Iglehart JK, 2008, NEW ENGL J MED, V358, P1741, DOI 10.1056/NEJMhpr0800058; Institute of Medicine, 2008, RET AG AM BUILD HLTH; Intrator O, 1999, MED CARE, V37, P228, DOI 10.1097/00005650-199903000-00003; Jones Adrienne, 2002, Vital Health Stat 13, P1; KARUZA J, 1994, J AM GERIATR SOC, V42, P787, DOI 10.1111/j.1532-5415.1994.tb06543.x; Kasper J, 2007, CHANGES CHARACTERIST; Katz PR, 2006, J AM MED DIR ASSOC, V7, P394, DOI 10.1016/j.jamda.2006.05.003; Katz Paul R, 2003, J Am Med Dir Assoc, V4, P115, DOI 10.1016/S1525-8610(04)70288-1; Katz PR, 1997, J AM GERIATR SOC, V45, P911, DOI 10.1111/j.1532-5415.1997.tb02958.x; KATZ PR, 1993, J GEN INTERN MED, V8, P691, DOI 10.1007/BF02598291; Katz PR, 2005, J AM GERIATR SOC, V53, P1826, DOI 10.1111/j.1532-5415.2005.53509.x; Kirch DG, 2008, JAMA-J AM MED ASSOC, V299, P2680, DOI 10.1001/jama.299.22.2680; Landrigan CP, 2006, PEDIATRICS, V117, P1736, DOI 10.1542/peds.2005-0609; Leibovitz A, 2004, AGING CLIN EXP RES, V16, P314; *MED PAYM ADV COMM, 2008, DAT BOOK HLTH CAR SP; Medina-Walpole A, 2002, J AM GERIATR SOC, V50, P949, DOI 10.1046/j.1532-5415.2002.50225.x; Roemer M., 1971, DOCTORS HOSP MED STA; Schmidt IK, 2002, SOC SCI MED, V54, P1767, DOI 10.1016/S0277-9536(01)00146-0; Schols J M G A, 2004, J Am Med Dir Assoc, V5, P207, DOI 10.1097/01.JAM.0000123031.43619.60; SHORTELL S, 1976, ORG RES HOSP; SHORTELL SM, 1981, MED CARE, V19, P1041, DOI 10.1097/00005650-198110000-00006; Shortell SM, 2005, MED CARE RES REV, V62, P407, DOI 10.1177/1077558705277389; Sloane PD, 2003, J AM GERIATR SOC, V51, P1587, DOI 10.1046/j.1532-5415.2003.51511.x; Spillman BC, 2000, NEW ENGL J MED, V342, P1409, DOI 10.1056/NEJM200005113421906; Spillman BC, 2002, MED CARE, V40, P965, DOI 10.1097/00005650-200210000-00013; *US, 1987, ANN REV POPUL LAW, V14, P473; Wachter RM, 2008, MED CLIN N AM, V92, P265, DOI 10.1016/j.mcna.2007.10.008; Zimmerman S, 2002, J AM GERIATR SOC, V50, P1987, DOI 10.1046/j.1532-5415.2002.50610.x; CERTIFIED MED DIRECT	39	81	81	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 17	2009	150	6					411	W73		10.7326/0003-4819-150-6-200903170-00010	http://dx.doi.org/10.7326/0003-4819-150-6-200903170-00010			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	423AJ	19293074	Green Accepted			2022-12-01	WOS:000264468500007
J	Inomata, K; Ohno, A; Tochio, H; Isogai, S; Tenno, T; Nakase, I; Takeuchi, T; Futaki, S; Ito, Y; Hiroaki, H; Shirakawa, M				Inomata, Kohsuke; Ohno, Ayako; Tochio, Hidehito; Isogai, Shin; Tenno, Takeshi; Nakase, Ikuhiko; Takeuchi, Toshihide; Futaki, Shiroh; Ito, Yutaka; Hiroaki, Hidekazu; Shirakawa, Masahiro			High-resolution multi-dimensional NMR spectroscopy of proteins in human cells	NATURE			English	Article							INTERNALIZATION MECHANISMS; PENETRATING PEPTIDES; LIVING CELLS; UBIQUITIN; DELIVERY; TRANSDUCTION; DOMAINS; OOCYTES; DESIGN; FK506	In-cell NMR is an isotope-aided multi-dimensional NMR technique that enables observations of conformations and functions of proteins in living cells at the atomic level(1). This method has been successfully applied to proteins overexpressed in bacteria, providing information on protein-ligand interactions(2) and conformations(3,4). However, the application of in-cell NMR to eukaryotic cells has been limited to Xenopus laevis oocytes(5-7). Wider application of the technique is hampered by inefficient delivery of isotope-labelled proteins into eukaryote somatic cells. Here we describe a method to obtain high-resolution two-dimensional (2D) heteronuclear NMR spectra of proteins inside living human cells. Proteins were delivered to the cytosol by the pyrenebutyrate-mediated action of cell-penetrating peptides(8) linked covalently to the proteins. The proteins were subsequently released from cell-penetrating peptides by endogenous enzymatic activity or by autonomous reductive cleavage. The heteronuclear 2D spectra of three different proteins inside human cells demonstrate the broad application of this technique to studying interactions and protein processing. The in-cell NMR spectra of FKBP12 (also known as FKBP1A) show the formation of specific complexes between the protein and extracellularly administered immunosuppressants, demonstrating the utility of this technique in drug screening programs. Moreover, in-cell NMRspectroscopy demonstrates that ubiquitin has much higher hydrogen exchange rates in the intracellular environment, possibly due to multiple interactions with endogenous proteins.	[Inomata, Kohsuke; Ohno, Ayako; Tochio, Hidehito; Isogai, Shin; Shirakawa, Masahiro] Kyoto Univ, Grad Sch Engn, Dept Mol Engn, Nishikyo Ku, Kyoto 6158510, Japan; [Inomata, Kohsuke; Tochio, Hidehito; Tenno, Takeshi; Ito, Yutaka; Hiroaki, Hidekazu; Shirakawa, Masahiro] JST, CREST, Kawaguchi, Saitama 3320012, Japan; [Futaki, Shiroh] JST, SORST, Kawaguchi, Saitama 3320012, Japan; [Tenno, Takeshi; Hiroaki, Hidekazu] Kobe Univ, Grad Sch Med, Div Struct Biol, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Nakase, Ikuhiko; Takeuchi, Toshihide; Futaki, Shiroh] Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan; [Ito, Yutaka] Tokyo Metropolitan Univ, Dept Chem, Tokyo 1920397, Japan; [Shirakawa, Masahiro] RIKEN, Yokohama Inst, Yokohama, Kanagawa 2300045, Japan	Kyoto University; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); Kobe University; Kyoto University; Tokyo Metropolitan University; RIKEN	Shirakawa, M (corresponding author), Kyoto Univ, Grad Sch Engn, Dept Mol Engn, Nishikyo Ku, Kyoto 6158510, Japan.	tochio@moleng.kyoto-u.ac.jp; shirakawa@moleng.kyoto-u.ac.jp	Tochio, Hidehito/GWV-0429-2022; Hiroaki, Hidekazu/G-9564-2012; Tochio, Hidehito/F-6109-2011; Ito, Yutaka/P-2604-2015; Inomata, Kohsuke/H-9189-2017; HIROAKI, HIDEKAZU/N-1658-2019	Tochio, Hidehito/0000-0003-3843-3330; Ito, Yutaka/0000-0002-1030-4660; Inomata, Kohsuke/0000-0002-6816-7961; HIROAKI, HIDEKAZU/0000-0003-1621-5893; Isogai, Shin/0000-0002-3768-6427; Futaki, Shiroh/0000-0002-0124-4002	Japan Science and Technology Agency and the Ministry of Education, Culture, Sports, Science and Technology-Japan (MEXT); Global COE Program 'International Center for Integrated Research and Advanced Education in Materials Science' [B-09]; Japan Society for the Promotion of Science; Innovative Techno-Hub for Integrated Medical Bio-imaging Project of the Special Coordination Funds for Promoting Science and Technology, from MEXT; MEXT;  [FKBP12]	Japan Science and Technology Agency and the Ministry of Education, Culture, Sports, Science and Technology-Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global COE Program 'International Center for Integrated Research and Advanced Education in Materials Science'(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Innovative Techno-Hub for Integrated Medical Bio-imaging Project of the Special Coordination Funds for Promoting Science and Technology, from MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 	We thank M. Waelchli, A. Kidera and H. Akutsu for discussion, T. Kokubo for monkey COS-7 cells, H. Ohnishi for the plasmid for production of FKBP12 and M. Imanishi for taking gel fluorimaging. This work was supported by grants to M. S. from Japan Science and Technology Agency and the Ministry of Education, Culture, Sports, Science and Technology-Japan (MEXT), and also in part by the Global COE Program 'International Center for Integrated Research and Advanced Education in Materials Science' ( No. B-09) of MEXT, administered by the Japan Society for the Promotion of Science. This work was partly supported by the Innovative Techno-Hub for Integrated Medical Bio-imaging Project of the Special Coordination Funds for Promoting Science and Technology, from MEXT to A. O. and M. S., and by grants from MEXT to S. F. and H. T.	Bai YW, 1995, METHOD ENZYMOL, V259, P344; Burz DS, 2006, NAT METHODS, V3, P91, DOI 10.1038/NMETH851; CARLSON N, 1987, J CELL BIOL, V104, P537, DOI 10.1083/jcb.104.3.537; Dedmon MM, 2002, P NATL ACAD SCI USA, V99, P12681, DOI 10.1073/pnas.202331299; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Delom F, 2007, BIOCHEM BIOPH RES CO, V352, P587, DOI 10.1016/j.bbrc.2006.11.046; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; Futaki S, 2006, BIOPOLYMERS, V84, P241, DOI 10.1002/bip.20421; Giriat I, 2003, J AM CHEM SOC, V125, P7180, DOI 10.1021/ja034736i; Goddard T. D., 1999, SPARKY 3; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; ITOH S, 1995, PROTEIN SCI, V4, P2261, DOI 10.1002/pro.5560041103; Lange OF, 2008, SCIENCE, V320, P1471, DOI 10.1126/science.1157092; LAUE ED, 1986, J MAGN RESON, V68, P14, DOI 10.1016/0022-2364(86)90312-4; Loison F, 2005, MOL THER, V11, P205, DOI 10.1016/j.ymthe.2004.10.010; Mezo G, 2000, BIOCONJUGATE CHEM, V11, P484, DOI 10.1021/bc990116o; Nakase I, 2008, ADV DRUG DELIVER REV, V60, P598, DOI 10.1016/j.addr.2007.10.006; OBRIEN R, 1970, J HISTOCHEM CYTOCHEM, V18, P581, DOI 10.1177/18.8.581; ROSEN MK, 1991, BIOCHEMISTRY-US, V30, P4774, DOI 10.1021/bi00233a020; Sakai T, 2006, J BIOMOL NMR, V36, P179, DOI 10.1007/s10858-006-9079-9; Schanda P, 2005, J AM CHEM SOC, V127, P8014, DOI 10.1021/ja051306e; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Selenko P, 2008, NAT STRUCT MOL BIOL, V15, P321, DOI 10.1038/nsmb.1395; Selenko P, 2006, P NATL ACAD SCI USA, V103, P11904, DOI 10.1073/pnas.0604667103; Serber Z, 2001, BIOCHEMISTRY-US, V40, P14317, DOI 10.1021/bi011751w; Takeuchi T, 2006, ACS CHEM BIOL, V1, P299, DOI 10.1021/cb600127m; Tenno T, 2004, GENES CELLS, V9, P865, DOI 10.1111/j.1365-2443.2004.00780.x; Wender PA, 2008, ADV DRUG DELIVER REV, V60, P452, DOI 10.1016/j.addr.2007.10.016	28	334	336	3	147	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 5	2009	458	7234					106	U11		10.1038/nature07839	http://dx.doi.org/10.1038/nature07839			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414AJ	19262675				2022-12-01	WOS:000263836000042
J	Eisenberg, MS; Psaty, BM				Eisenberg, Mickey S.; Psaty, Bruce M.			Defining and Improving Survival Rates From Cardiac Arrest in US Communities	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							AMERICAN-HEART-ASSOCIATION; HEALTH-PROFESSIONALS; CARE COMMITTEE; RESUSCITATION; STATEMENT; CARDIOPULMONARY; OUTCOMES; COUNCIL		[Eisenberg, Mickey S.] Seattle King Cty Dept Publ Hlth, King Cty Emergency Med Serv Div, Seattle, WA USA; [Eisenberg, Mickey S.; Psaty, Bruce M.] Univ Washington, Dept Med, Seattle, WA USA; [Psaty, Bruce M.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Psaty, Bruce M.] Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Seattle, WA 98101 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Group Health Cooperative	Psaty, BM (corresponding author), Cardiovasc Hlth Res Unit, 1730 Minor Ave,Suite 1360, Seattle, WA 98101 USA.	psaty@u.washington.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL080295, R01HL074745, R01HL085251, R01HL080295, R01HL087652] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL080295, HL74745, HL085251, HL087652] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], 2017, SEER CANC STAT REV; BECKER LB, 1991, ANN EMERG MED, V20, P355, DOI 10.1016/S0196-0644(05)81654-3; CUMMINS RO, 1991, CIRCULATION, V84, P960, DOI 10.1161/01.CIR.84.2.960; CUMMINS RO, 1991, CIRCULATION, V83, P1832, DOI 10.1161/01.CIR.83.5.1832; Dunne RB, 2007, RESUSCITATION, V72, P59, DOI 10.1016/j.resuscitation.2006.04.017; EISENBERG MS, 1990, ANN EMERG MED, V19, P179, DOI 10.1016/S0196-0644(05)81805-0; Holzer M, 2002, NEW ENGL J MED, V346, P549; Institute of Medicine, EM MED SERV CROSSR; LARSEN MP, 1993, ANN EMERG MED, V22, P1652, DOI 10.1016/S0196-0644(05)81302-2; Lombardi Gary, 1994, JAMA (Journal of the American Medical Association), V271, P678, DOI 10.1001/jama.271.9.678; Nichol G, 2008, JAMA-J AM MED ASSOC, V300, P1423, DOI 10.1001/jama.300.12.1423; Nichol G, 2008, CIRCULATION, V117, P2299, DOI 10.1161/CIRCULATIONAHA.107.189472; Rea TD, 2004, RESUSCITATION, V63, P17, DOI 10.1016/j.resuscitation.2004.03.025; Rea TD, 2006, CIRCULATION, V114, P2760, DOI 10.1161/CIRCULATIONAHA.106.654715; White RD, 2005, RESUSCITATION, V65, P279, DOI 10.1016/j.resuscitation.2004.10.018	15	12	12	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 25	2009	301	8					860	862		10.1001/jama.2009.193	http://dx.doi.org/10.1001/jama.2009.193			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	410WV	19244194				2022-12-01	WOS:000263609900028
J	Bruix, J; Llovet, JM				Bruix, Jordi; Llovet, Josep M.			Major achievements in hepato cellular carcinoma	LANCET			English	Editorial Material							HEPATOCELLULAR-CARCINOMA; GENE-EXPRESSION; CLASSIFICATION; CIRRHOSIS; COHORT; NODULES; CANCER; RISK; HCC		[Bruix, Jordi; Llovet, Josep M.] Univ Barcelona, Barcelona Clin Liver Canc Grp, Liver Unit, Hosp Clin,IDIBAPS,CIBEREHD, E-08036 Barcelona, Spain; [Llovet, Josep M.] Mt Sinai Sch Med, Mt Sinai Liver Canc Program, New York, NY USA; [Llovet, Josep M.] ICREA, Catalonia, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Icahn School of Medicine at Mount Sinai; ICREA	Bruix, J (corresponding author), Univ Barcelona, Barcelona Clin Liver Canc Grp, Liver Unit, Hosp Clin,IDIBAPS,CIBEREHD, E-08036 Barcelona, Spain.	jbruix@clinic.ub.es	Llovet, Josep M/D-4340-2014; Llovet, Josep M/ABB-6264-2021	Llovet, Josep M/0000-0003-0547-2667; Llovet, Josep M/0000-0003-0547-2667; Bruix, Jordi/0000-0002-9826-0753	ICREA Funding Source: Custom	ICREA(ICREA)		Boyault S, 2007, HEPATOLOGY, V45, P42, DOI 10.1002/hep.21467; Bruix J, 2004, GASTROENTEROLOGY, V127, pS179, DOI 10.1053/j.gastro.2004.09.032; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Bruno S, 2007, HEPATOLOGY, V46, P1350, DOI 10.1002/hep.21826; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Calvisi DF, 2006, GASTROENTEROLOGY, V130, P1117, DOI 10.1053/j.gastro.2006.01.006; Chiang DY, 2008, CANCER RES, V68, P6779, DOI 10.1158/0008-5472.CAN-08-0742; Forner A, 2008, HEPATOLOGY, V47, P97, DOI 10.1002/hep.21966; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Lee JS, 2004, HEPATOLOGY, V40, P667, DOI 10.1002/hep.20375; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Llovet JM, 2008, HEPATOLOGY, V48, P1312, DOI 10.1002/hep.22506; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Llovet JM, 2006, GASTROENTEROLOGY, V131, P1758, DOI 10.1053/j.gastro.2006.09.014; Llovet JM, 2008, JNCI-J NATL CANCER I, V100, P698, DOI 10.1093/jnci/djn134; Marrero JA, 2005, HEPATOLOGY, V41, P707, DOI 10.1002/hep.20636; Mazzaferro V, 2009, LANCET ONCOL, V10, P35, DOI 10.1016/S1470-2045(08)70284-5; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Villanueva A, 2008, GASTROENTEROLOGY, V135, P1972, DOI 10.1053/j.gastro.2008.08.008; Yang HI, 2008, JNCI-J NATL CANCER I, V100, P1134, DOI 10.1093/jnci/djn243	20	247	264	0	22	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 21	2009	373	9664					614	616		10.1016/S0140-6736(09)60381-0	http://dx.doi.org/10.1016/S0140-6736(09)60381-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	410FS	19231618				2022-12-01	WOS:000263563500009
J	Gros, J; Feistel, K; Viebahn, C; Blum, M; Tabin, CJ				Gros, Jerome; Feistel, Kerstin; Viebahn, Christoph; Blum, Martin; Tabin, Clifford J.			Cell Movements at Hensen's Node Establish Left/Right Asymmetric Gene Expression in the Chick	SCIENCE			English	Article							EMBRYO; CILIA	In vertebrates, the readily apparent left/right (L/R) anatomical asymmetries of the internal organs can be traced to molecular events initiated at or near the time of gastrulation. However, the earliest steps of this process do not seem to be universally conserved. In particular, how this axis is first defined in chicks has remained problematic. Here we show that asymmetric cell rearrangements take place within chick embryos, creating a leftward movement of cells around the node. It is the relative displacement of cells expressing sonic hedgehog (Shh) and fibroblast growth factor 8 (Fgf8) that is responsible for establishing their asymmetric expression patterns. The creation of asymmetric expression domains as a passive effect of cell movements represents an alternative strategy for breaking L/R symmetry in gene activity.	[Gros, Jerome; Tabin, Clifford J.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Feistel, Kerstin; Blum, Martin] Univ Hohenheim, Inst Zool, D-70953 Stuttgart, Germany; [Viebahn, Christoph] Univ Gottingen, Dept Anat & Embryol, D-37079 Gottingen, Germany	Harvard University; Harvard Medical School; University Hohenheim; University of Gottingen	Tabin, CJ (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	tabin@genetics.med.harvard.edu		Feistel, Kerstin/0000-0003-3397-8972; Gros, Jerome/0000-0002-2264-2851	Human Frontier Science Program fellowship; Ph.D. fellowship from the Boehringer Ingelheim Fonds; Deutsche Forschungsgemeinschaft (DFG) [VI 151-8-1]; NIH [R01-HD045499]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD045499] Funding Source: NIH RePORTER	Human Frontier Science Program fellowship(Human Frontier Science Program); Ph.D. fellowship from the Boehringer Ingelheim Fonds(Boehringer Ingelheim); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank M. Levin for helpful suggestions for addressing the role of ion channels, R. ORahilly for providing information regarding human embryos, D. Rath and P. Schwarts for provision of pig embros and assistance with electron microscopy; and C. Cui, C. Little, and B. Rongish for discussing data before publication. This work was supported by a Human Frontier Science Program fellowship to J.G., a Ph.D. fellowship from the Boehringer Ingelheim Fonds to K.F., a grant from the Deutsche Forschungsgemeinschaft (DFG) to M.B., a grant from the DFG (VI 151-8-1) to C.V., and grant R01-HD045499 from NIH to C.J.T.	Cui C, 2009, ANAT REC, V292, P557, DOI 10.1002/ar.20872; Dathe V, 2002, ANAT EMBRYOL, V205, P343, DOI 10.1007/s00429-002-0269-2; Essner JJ, 2002, NATURE, V418, P37, DOI 10.1038/418037a; HERTWIG O, 1910, LEHRBUCH ENGWICKLUNG; Kirby ML, 2003, DEV BIOL, V253, P175, DOI 10.1016/S0012-1606(02)00024-6; Kolliker A, 1879, ENTWICKLUNGSGESCHICH; Lee JD, 2008, DEV DYNAM, V237, P3464, DOI 10.1002/dvdy.21598; Levin M, 2005, MECH DEVELOP, V122, P3, DOI 10.1016/j.mod.2004.08.006; Levin M, 2002, CELL, V111, P77, DOI 10.1016/S0092-8674(02)00939-X; LEVIN M, 1995, CELL, V82, P803, DOI 10.1016/0092-8674(95)90477-8; Marlow F, 2002, CURR BIOL, V12, P876, DOI 10.1016/S0960-9822(02)00864-3; O'Rahilly R. R, 2006, EMBRYONIC HUMAN BRAI; Raya A, 2006, NAT REV GENET, V7, P283, DOI 10.1038/nrg1830; Wei L, 2001, DEVELOPMENT, V128, P2953; Yin YL, 2009, DEVELOPMENT, V136, P655, DOI 10.1242/dev.028464	15	126	128	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 15	2009	324	5929					941	944		10.1126/science.1172478	http://dx.doi.org/10.1126/science.1172478			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	19359542	Green Accepted			2022-12-01	WOS:000266048800040
J	Zebker, HA; Stiles, B; Hensley, S; Lorenz, R; Kirk, RL; Lunine, J				Zebker, Howard A.; Stiles, Bryan; Hensley, Scott; Lorenz, Ralph; Kirk, Randolph L.; Lunine, Jonathan			Size and Shape of Saturn's Moon Titan	SCIENCE			English	Article							RADAR; ORIGIN; PLANETS; LAKES	Cassini observations show that Saturn's moon Titan is slightly oblate. A fourth-order spherical harmonic expansion yields north polar, south polar, and mean equatorial radii of 2574.32 +/- 0.05 kilometers (km), 2574.36 +/- 0.03 km, and 2574.91 +/- 0.11 km, respectively; its mean radius is 2574.73 +/- 0.09 km. Titan's shape approximates a hydrostatic, synchronously rotating triaxial ellipsoid but is best fit by such a body orbiting closer to Saturn than Titan presently does. Titan's lack of high relief implies that most-but not all-of the surface features observed with the Cassini imaging subsystem and synthetic aperture radar are uncorrelated with topography and elevation. Titan's depressed polar radii suggest that a constant geopotential hydrocarbon table could explain the confinement of the hydrocarbon lakes to high latitudes.	[Zebker, Howard A.] Stanford Univ, Dept Geophys, Stanford, CA 94305 USA; [Zebker, Howard A.] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; [Stiles, Bryan; Hensley, Scott] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Lorenz, Ralph] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Kirk, Randolph L.] US Geol Survey, Flagstaff, AZ 86001 USA; [Lunine, Jonathan] Univ Arizona, Dept Planetary Sci, Tucson, AZ 85721 USA; [Lunine, Jonathan] Univ Arizona, Dept Phys, Tucson, AZ 85721 USA	Stanford University; Stanford University; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; United States Department of the Interior; United States Geological Survey; University of Arizona; University of Arizona	Zebker, HA (corresponding author), Stanford Univ, Dept Geophys, Stanford, CA 94305 USA.	zebker@stanford.edu	Lorenz, Ralph D/B-8759-2016	Lorenz, Ralph D/0000-0001-8528-4644; zebker, howard/0000-0001-9931-5237; Lunine, Jonathan/0000-0003-2279-4131	Cassini Project; NASA	Cassini Project; NASA(National Aeronautics & Space Administration (NASA))	We thank the Cassini Radar Team for detailed planning of these observations. This work was supported by the Cassini Project and by NASA as part of the Cassini Data Analysis Program. We also thank the reviewers for many constructive comments on our error analysis and data interpretation. The Cassini Project is a joint endeavor of NASA, the European Space Agency, and the Italian Space Agency. Cassini is managed by JPL, California Institute of Technology, under a contract with NASA.	ALBERS S, MAP TITAN DERIVED IM; ANTREASIAN PG, 2008, AM I AER ASTR AAS AS; Barnes JW, 2008, ICARUS, V195, P400, DOI 10.1016/j.icarus.2007.12.006; Castillo-Rogez JC, 2007, ICARUS, V190, P179, DOI 10.1016/j.icarus.2007.02.018; DERMOTT SF, 1979, ICARUS, V37, P310, DOI 10.1016/0019-1035(79)90137-4; DERMOTT SF, 1988, ICARUS, V73, P25, DOI 10.1016/0019-1035(88)90084-X; ELACHI C, 1991, P IEEE, V79, P867, DOI 10.1109/5.90164; Elachi C, 2005, SCIENCE, V308, P970, DOI 10.1126/science.1109919; Fortes AD, 2007, ICARUS, V188, P139, DOI 10.1016/j.icarus.2006.11.002; Mitri G, 2007, ICARUS, V186, P385, DOI 10.1016/j.icarus.2006.09.004; MOORE RK, 1981, IEEE T AERO ELEC SYS, V17, P410, DOI 10.1109/TAES.1981.309069; OJAKANGAS GW, 1989, ICARUS, V81, P220, DOI 10.1016/0019-1035(89)90052-3; Porco CC, 2005, NATURE, V434, P159, DOI 10.1038/nature03436; Rhodes Donald R., 1959, INTRO MONOPULSE; Stiles BW, 2009, ICARUS, V202, P584, DOI 10.1016/j.icarus.2009.03.032; Stofan ER, 2007, NATURE, V445, P61, DOI 10.1038/nature05438; Tobie G, 2006, NATURE, V440, P61, DOI 10.1038/nature04497; Tsiganis K, 2005, NATURE, V435, P459, DOI 10.1038/nature03539; Zebker HA, 2009, ICARUS, V200, P240, DOI 10.1016/j.icarus.2008.10.023	19	80	80	2	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 15	2009	324	5929					921	923		10.1126/science.1168905	http://dx.doi.org/10.1126/science.1168905			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	19342551				2022-12-01	WOS:000266048800033
J	Smith, KF; Behrens, M; Schloegel, LM; Marano, N; Burgiel, S; Daszak, P				Smith, Katherine F.; Behrens, Michael; Schloegel, Lisa M.; Marano, Nina; Burgiel, Stas; Daszak, Peter			Reducing the Risks of the Wildlife Trade	SCIENCE			English	Editorial Material							MONKEYPOX		[Smith, Katherine F.] Brown Univ, Providence, RI 02912 USA; [Smith, Katherine F.; Schloegel, Lisa M.; Daszak, Peter] Wildlife Trust, New York, NY 10001 USA; [Behrens, Michael] Pacific Lutheran Univ, Tacoma, WA 98447 USA; [Schloegel, Lisa M.] Kingston Univ, Sch Life Sci, Kingston upon Thames KT1 2EE, Surrey, England; [Marano, Nina] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [Burgiel, Stas] Global Invas Species Programme, Alexandria, VA 22301 USA	Brown University; Pacific Lutheran University; Kingston University; Centers for Disease Control & Prevention - USA	Smith, KF (corresponding author), Brown Univ, Providence, RI 02912 USA.	katherine_smith@brown.edu; daszak@wildlifetrust.org	daszak, peter/U-4588-2017	daszak, peter/0000-0002-2046-5695				Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P561; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Defenders of Wildlife, 2007, BROK SCREENS REG LIV; DEPOORTER M, 2008, IN DEPTH REV ONGOING; Di Giulio DB, 2004, LANCET INFECT DIS, V4, P15, DOI 10.1016/S1473-3099(03)00856-9; Fowler AJ, 2007, FRONT ECOL ENVIRON, V5, P353, DOI 10.1890/1540-9295(2007)5[353:FOTLAT]2.0.CO;2; Hutson CL, 2007, AM J TROP MED HYG, V76, P757, DOI 10.4269/ajtmh.2007.76.757; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Karesh WB, 2005, EMERG INFECT DIS, V11, P1000; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Reed KD, 2004, NEW ENGL J MED, V350, P342, DOI 10.1056/NEJMoa032299; Schloegel LM, 2006, ECOHEALTH, V3, P35, DOI 10.1007/s10393-005-0012-6; SCHLOEGEL LM, BIOL CONSER IN PRESS; Vitousek PM, 1996, AM SCI, V84, P468; 2003, FED REG, V68, P36566	15	171	178	0	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 1	2009	324	5927					594	595		10.1126/science.1174460	http://dx.doi.org/10.1126/science.1174460			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	439DW	19407185				2022-12-01	WOS:000265608800025
J	Dong, XH; Biswas, A; Suel, KE; Jackson, LK; Martinez, R; Gu, HM; Chook, YM				Dong, Xiuhua; Biswas, Anindita; Sueel, Katherine E.; Jackson, Laurie K.; Martinez, Rita; Gu, Hongmei; Chook, Yuh Min			Structural basis for leucine-rich nuclear export signal recognition by CRM1	NATURE			English	Article							PROTEIN EXPORT; NUCLEOCYTOPLASMIC TRANSPORT; SEQUENCE REQUIREMENTS; IMPORTIN-BETA; T-ANTIGEN; LOCALIZATION; PREDICTION; PATHWAY; COMPLEX; SYSTEM	CRM1 (also known as XPO1 and exportin 1) mediates nuclear export of hundreds of proteins through the recognition of the leucine-rich nuclear export signal (LR-NES). Here we present the 2.9 angstrom structure of CRM1 bound to snurportin 1 (SNUPN). Snurportin 1 binds CRM1 in a bipartite manner by means of an amino-terminal LR-NES and its nucleotide-binding domain. The LR-NES is a combined alpha-helical-extended structure that occupies a hydrophobic groove between two CRM1 outer helices. The LR-NES interface explains the consensus hydrophobic pattern, preference for intervening electronegative residues and inhibition by leptomycin B. The second nuclear export signal epitope is a basic surface on the snurportin 1 nucleotide-binding domain, which binds an acidic patch on CRM1 adjacent to the LR-NES site. Multipartite recognition of individually weak nuclear export signal epitopes may be common to CRM1 substrates, enhancing CRM1 binding beyond the generally low affinity LR-NES. Similar energetic construction is also used in multipartite nuclear localization signals to provide broad substrate specificity and rapid evolution in nuclear transport.	[Dong, Xiuhua; Biswas, Anindita; Sueel, Katherine E.; Jackson, Laurie K.; Martinez, Rita; Gu, Hongmei; Chook, Yuh Min] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Chook, YM (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, 6001 Forest Pk, Dallas, TX 75390 USA.	yuhmin.chook@utsouthwestern.edu	Chook, Yuh Min/AAA-9549-2019		National Institute of Health (NIH) [R01GM069909, R01GM069909-03S1, 5-T32-GM008297]; Welch Foundation [I-1532]; UT Southwestern Endowed Scholars Program; US Department of Energy; Office of Energy Research [W-31-109-ENG-38]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069909, T32GM008297] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); UT Southwestern Endowed Scholars Program; US Department of Energy(United States Department of Energy (DOE)); Office of Energy Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Y. Sheng, C. Kong, D. Tomchick and C. Dann for assistance during data collection and structure determination, S. Padrick for advice on fluorescence binding assays, G. Suel and T. Cagatay for help with microscopy, K. Weis for yeast strains and constructs, X. Zhang, L. Rice and M. Rosen for discussion. This work is funded by National Institute of Health (NIH) grants R01GM069909, R01GM069909-03S1, 5-T32-GM008297, Welch Foundation grant I-1532 and the UT Southwestern Endowed Scholars Program. Use of the Argonne National Laboratory Stuctural Biology Center beamlines at the Advanced Photon Source, was supported by the US Department of Energy, Office of Energy Research, under contract no. W-31-109-ENG-38.	Askjaer P, 1998, J BIOL CHEM, V273, P33414, DOI 10.1074/jbc.273.50.33414; Bogerd HP, 1996, MOL CELL BIOL, V16, P4207; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cansizoglu AE, 2007, NAT STRUCT MOL BIOL, V14, P452, DOI 10.1038/nsmb1229; Conti E, 2001, CURR OPIN CELL BIOL, V13, P310, DOI 10.1016/S0955-0674(00)00213-1; DINGWALL C, 1982, CELL, V30, P449, DOI 10.1016/0092-8674(82)90242-2; DONG X, NATURE STRU IN PRESS, DOI DOI 10.1038/NSMB.1585; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engelsma D, 2004, EMBO J, V23, P3643, DOI 10.1038/sj.emboj.7600370; Englmeier L, 2001, EMBO REP, V2, P926, DOI 10.1093/embo-reports/kve200; FISCHER U, 1995, CELL, V82, P475, DOI 10.1016/0092-8674(95)90436-0; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Henderson BR, 2000, EXP CELL RES, V256, P213, DOI 10.1006/excr.2000.4825; Huber J, 1998, EMBO J, V17, P4114, DOI 10.1093/emboj/17.14.4114; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KALDERON D, 1984, NATURE, V311, P33, DOI 10.1038/311033a0; Kosugi S, 2008, TRAFFIC, V9, P2053, DOI 10.1111/j.1600-0854.2008.00825.x; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Kutay U, 2005, TRENDS CELL BIOL, V15, P121, DOI 10.1016/j.tcb.2005.01.005; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; LANFORD RE, 1984, CELL, V37, P801, DOI 10.1016/0092-8674(84)90415-X; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Mancias JD, 2005, TRAFFIC, V6, P278, DOI 10.1111/j.1600-0854.2005.00279.x; Matsuura Y, 2004, NATURE, V432, P872, DOI 10.1038/nature03144; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; Meiler J, 2003, P NATL ACAD SCI USA, V100, P12105, DOI 10.1073/pnas.1831973100; Mitrousis G, 2008, J BIOL CHEM, V283, P7877, DOI 10.1074/jbc.M709093200; Neville M, 1997, CURR BIOL, V7, P767, DOI 10.1016/S0960-9822(06)00335-6; NISHI K, 1994, J BIOL CHEM, V269, P6320; OssarehNazari B, 1997, SCIENCE, V278, P141, DOI 10.1126/science.278.5335.141; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paraskeva E, 1999, J CELL BIOL, V145, P255, DOI 10.1083/jcb.145.2.255; Petosa C, 2004, MOL CELL, V16, P761, DOI 10.1016/j.molcel.2004.11.018; Richards SA, 1997, SCIENCE, V276, P1842, DOI 10.1126/science.276.5320.1842; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; SIKORSKI RS, 1989, GENETICS, V122, P19; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Strasser A, 2005, EMBO J, V24, P2235, DOI 10.1038/sj.emboj.7600701; Suel KE, 2006, METHODS, V39, P342, DOI 10.1016/j.ymeth.2006.06.015; Suel KE, 2008, PLOS BIOL, V6, P1253, DOI 10.1371/journal.pbio.0060137; Swanton E, 2006, CELL, V127, P877, DOI 10.1016/j.cell.2006.11.018; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Thomas F, 2003, J CELL SCI, V116, P2409, DOI 10.1242/jcs.00464; Tran EJ, 2007, CELL, V131, DOI 10.1016/j.cell.2007.10.015; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736	50	238	243	3	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2009	458	7242					1136	U71		10.1038/nature07975	http://dx.doi.org/10.1038/nature07975			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441FL	19339969	Green Accepted			2022-12-01	WOS:000265754600040
J	Singh, R; Kaushik, S; Wang, YJ; Xiang, YQ; Novak, I; Komatsu, M; Tanaka, K; Cuervo, AM; Czaja, MJ				Singh, Rajat; Kaushik, Susmita; Wang, Yongjun; Xiang, Youqing; Novak, Inna; Komatsu, Masaaki; Tanaka, Keiji; Cuervo, Ana Maria; Czaja, Mark J.			Autophagy regulates lipid metabolism	NATURE			English	Article							LOW-DENSITY-LIPOPROTEIN; PHOSPHATIDYLINOSITOL 3-KINASE; TRIACYLGLYCEROL; LIPOLYSIS; DISEASE; STRESS; CYP2E1; ROLES; LIVER	The intracellular storage and utilization of lipids are critical to maintain cellular energy homeostasis. During nutrient deprivation, cellular lipids stored as triglycerides in lipid droplets are hydrolysed into fatty acids for energy. A second cellular response to starvation is the induction of autophagy, which delivers intracellular proteins and organelles sequestered in double-membrane vesicles (autophagosomes) to lysosomes for degradation and use as an energy source. Lipolysis and autophagy share similarities in regulation and function but are not known to be interrelated. Here we show a previously unknown function for autophagy in regulating intracellular lipid stores (macrolipophagy). Lipid droplets and autophagic components associated during nutrient deprivation, and inhibition of autophagy in cultured hepatocytes and mouse liver increased triglyceride storage in lipid droplets. This study identifies a critical function for autophagy in lipid metabolism that could have important implications for human diseases with lipid over-accumulation such as those that comprise the metabolic syndrome.	[Singh, Rajat; Kaushik, Susmita; Wang, Yongjun; Xiang, Youqing; Cuervo, Ana Maria; Czaja, Mark J.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; [Singh, Rajat; Kaushik, Susmita; Wang, Yongjun; Xiang, Youqing; Novak, Inna; Cuervo, Ana Maria; Czaja, Mark J.] Albert Einstein Coll Med, Marion Bessin Liver Res Ctr, Bronx, NY 10461 USA; [Kaushik, Susmita; Cuervo, Ana Maria] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA; [Kaushik, Susmita; Cuervo, Ana Maria] Albert Einstein Coll Med, Inst Aging Studies, Bronx, NY 10461 USA; [Novak, Inna] Albert Einstein Coll Med, Dept Pediat, Bronx, NY 10461 USA; [Komatsu, Masaaki; Tanaka, Keiji] Tokyo Metropolitan Inst Med Sci, Lab Frontier Sci, Bunkyo Ku, Tokyo 1138613, Japan	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Tokyo Metropolitan Institute of Medical Science	Czaja, MJ (corresponding author), Albert Einstein Coll Med, Dept Med, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	amcuervo@aecom.yu.edu; czaja@aecom.yu.edu	Komatsu, Masaaki/B-8321-2011; Kaushik, Susmita/GVS-3186-2022; Novak, Inna/ABF-9575-2020	Komatsu, Masaaki/0000-0001-7672-7722; Kaushik, Susmita/0000-0002-6096-5387; Cuervo, Ana Maria/0000-0002-0771-700X	National Institute of Diabetes and Digestive and Kidney Diseases; National Institute on Aging; American Liver Foundation Postdoctoral Research Fellowship Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061498, K01DK087776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021904, P01AG031782] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Liver Foundation Postdoctoral Research Fellowship Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank D. Silver for his discussions, N. Mizushima for providing the Atg5<SUP>-/-</SUP> mouse embryonic fibroblasts, R. Stockert for the protein disulphide isomerase antibody and the personnel at the Analytical Imaging Facility for their technical assistance. This work was supported by National Institutes of Health grants from the National Institute of Diabetes and Digestive and Kidney Diseases and National Institute on Aging, a Glenn Award and an American Liver Foundation Postdoctoral Research Fellowship Award (R.S.).	Andersson L, 2006, J CELL SCI, V119, P2246, DOI 10.1242/jcs.02941; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Brasaemle DL, 2000, J BIOL CHEM, V275, P38486, DOI 10.1074/jbc.M007322200; Brasaemle DL, 2006, CURR PROTOC CELL BIO, DOI DOI 10.1002/0471143030.CB0315S29; CUERVO AM, 1995, EUR J BIOCHEM, V227, P792, DOI 10.1111/j.1432-1033.1995.tb20203.x; Cuervo AM, 2005, AUTOPHAGY, V1, P131, DOI 10.4161/auto.1.3.2017; DUNN WA, 1990, J CELL BIOL, V110, P1935, DOI 10.1083/jcb.110.6.1935; Finn PF, 2006, NUTRITION, V22, P830, DOI 10.1016/j.nut.2006.04.008; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; GOCZE PM, 1994, CYTOMETRY, V17, P151, DOI 10.1002/cyto.990170207; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; HOPPEL C, 1979, J BIOL CHEM, V254, P4164; Kaushik S, 2006, EMBO J, V25, P3921, DOI 10.1038/sj.emboj.7601283; Kellner-Weibel G, 2001, J LIPID RES, V42, P768; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Leclercq IA, 2000, J CLIN INVEST, V105, P1067, DOI 10.1172/JCI8814; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; MARZELLA L, 1982, J CELL BIOL, V93, P144, DOI 10.1083/jcb.93.1.144; Millar JS, 2005, J LIPID RES, V46, P2023, DOI 10.1194/jlr.D500019-JLR200; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, ANNU REV NUTR, V27, P19, DOI 10.1146/annurev.nutr.27.061406.093749; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Owen O E, 1979, Adv Exp Med Biol, V111, P169; Piva R, 2006, BLOOD, V107, P689, DOI 10.1182/blood-2005-05-2125; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Roberts P, 2003, MOL BIOL CELL, V14, P129, DOI 10.1091/mbc.E02-08-0483; Sahai A, 2006, AM J PHYSIOL-GASTR L, V291, pG55, DOI 10.1152/ajpgi.00360.2005; Schattenberg JRM, 2005, J BIOL CHEM, V280, P9887, DOI 10.1074/jbc.M410310200; Wang YJ, 2004, J BIOL CHEM, V279, P31089, DOI 10.1074/jbc.M404170200; Wang YJ, 2008, J BIOL CHEM, V283, P4766, DOI 10.1074/jbc.M706666200; WIGGINS D, 1992, BIOCHEM J, V284, P457, DOI 10.1042/bj2840457; Yorimitsu T, 2006, J BIOL CHEM, V281, P30299, DOI 10.1074/jbc.M607007200; Zechner R, 2005, CURR OPIN LIPIDOL, V16, P333, DOI 10.1097/01.mol.0000169354.20395.1c	35	2507	2623	22	533	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2009	458	7242					1131	U64		10.1038/nature07976	http://dx.doi.org/10.1038/nature07976			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441FL	19339967	Green Accepted, Green Submitted			2022-12-01	WOS:000265754600039
J	Subramanian, SV; Ackerson, LK; Smith, GD; John, NA				Subramanian, S. V.; Ackerson, Leland K.; Smith, George Davey; John, Neetu A.			Association of Maternal Height With Child Mortality, Anthropometric Failure, and Anemia in India	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BIRTH-WEIGHT; RISK-FACTORS; NUTRITIONAL-STATUS; MALNUTRITION; DETERMINANTS; GROWTH; OLD	Context Prior research on the determinants of child health has focused on contemporaneous risk factors such as maternal behaviors, dietary factors, and immediate environmental conditions. Research on intergenerational factors that might also predispose a child to increased health adversity remains limited. Objective To examine the association between maternal height and child mortality, anthropometric failure, and anemia. Design, Setting, and Population We retrieved data from the 2005-2006 National Family Health Survey in India ( released in 2008). The study population constitutes a nationally representative cross-sectional sample of singleton children aged 0 to 59 months and born after January 2000 or January 2001 (n=50 750) to mothers aged 15 to 49 years from all 29 states of India. Information on children was obtained by a face-to-face interview with mothers, with a response rate of 94.5%. Height was measured with an adjustable measuring board calibrated in millimeters. Demographic and socioeconomic variables were considered as covariates. Modified Poisson regression models that account for multistage survey design and sampling weights were estimated. Main Outcome Measures Mortality was the primary end point; underweight, stunting, wasting, and anemia were included as secondary outcomes. Results In adjusted models, a 1-cm increase in maternal height was associated with a decreased risk of child mortality (relative risk [RR], 0.978; 95% confidence interval [CI], 0.970-0.987; P < .001), underweight (RR, 0.971; 95% CI, 0.968-0.974; P < .001), stunting (RR, 0.971; 95% CI, 0.968-0.0973; P < .001), wasting (RR, 0.989; 95% CI, 0.984-0.994; P < .001), and anemia (RR, 0.998; 95% CI, 0.997-0.999; P=.02). Children born to mothers who were less than 145 cm in height were 1.71 times more likely to die (95% CI, 1.37-2.13) (absolute probability, 0.09; 95% CI, 0.07-0.12) compared with mothers who were at least 160 cm in height (absolute probability, 0.05; 95% CI, 0.04-0.07). Similar patterns were observed for anthropometric failure related to underweight and stunting. Paternal height was not associated with child mortality or anemia but was associated with child anthropometric failure. Conclusion In a nationally representative sample of households in India, maternal height was inversely associated with child mortality and anthropometric failure.	[Subramanian, S. V.; John, Neetu A.] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA; [Ackerson, Leland K.] Univ Massachusetts, Sch Hlth & Environm, Dept Community Hlth & Sustainabil, Lowell, MA USA; [Smith, George Davey] Univ Bristol, MRC Ctr Causal Anal Translat Epidemiol, Bristol, Avon, England	Harvard University; Harvard T.H. Chan School of Public Health; University of Massachusetts System; University of Massachusetts Lowell; University of Bristol	Subramanian, SV (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, 677 Huntington Ave, Boston, MA 02115 USA.	svsubram@hsph.harvard.edu	Davey Smith, George/A-7407-2013	Davey Smith, George/0000-0002-1407-8314; John, Neetu/0000-0001-8983-1211; s, hema/0000-0002-3440-9475; Venkatasubramanian, Siddharth/0000-0002-5860-0768	National Institutes of Health Career Development Award [NHLBI K25 HL081275]; Medical Research Council [G0600705] Funding Source: researchfish; MRC [G0600705] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K25HL081275] Funding Source: NIH RePORTER	National Institutes of Health Career Development Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr Subramanian is supported by a National Institutes of Health Career Development Award (NHLBI K25 HL081275).	Alasfoor D, 2007, J HEALTH POPUL NUTR, V25, P359; Amin Nurul, 1993, Indian Journal of Pediatrics, V60, P269, DOI 10.1007/BF02822189; [Anonymous], 1995, Bull World Health Organ, V73 Suppl, P1; Back S, 2004, POINT CARE, V3, P60, DOI DOI 10.1097/01.poc.0000127152.03809.87; BAQUI AH, 1994, EUR J CLIN NUTR, V48, P349; Bhalotra S, 2008, J ECONOMETRICS, V143, P274, DOI 10.1016/j.jeconom.2007.10.005; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; BLOSSNER M, 2007, WHO ANTHRO PERSONAL; Casapia M, 2007, BRIT J NUTR, V98, P1259, DOI 10.1017/S0007114507795272; Cohen JC, 2008, THEOR BIOL MED MODEL, V5, DOI 10.1186/1742-4682-5-1; Faber M, 2007, J HEALTH POPUL NUTR, V25, P285; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.1353/dem.2001.0003; Gwatkin DR, 2000, SOCIOECONOMIC DIFFER; Hirve S S, 1994, Indian Pediatr, V31, P1221; Huntsman AC, 2007, ANN HUM BIOL, V34, P411, DOI 10.1080/03014460701366373; International Institute for Population Sciences, 2006, ANTHR AN HIV TEST FI; International Institute for Population Sciences (IIPS), 2007, NAT FAM HLTH SURV NF; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Malik Sushma, 1997, Indian Journal of Pediatrics, V64, P373, DOI 10.1007/BF02845207; Mamiro PS, 2005, J HEALTH POPUL NUTR, V23, P222; Martin RM, 2004, EPIDEMIOLOGY, V15, P308, DOI 10.1097/01.ede.0000120042.16363.e3; Mavalankar D V, 1994, Indian Pediatr, V31, P1205; Mohanty C, 2006, J TROP PEDIATRICS, V52, P24, DOI 10.1093/tropej/fmi059; *ORC MACR, 2005, HIV TEST LAB MAN DEM; PANANDIKER VAP, 1997, POLITICS BACKWARDNES, P88; Rikimaru T, 1998, J NUTR SCI VITAMINOL, V44, P391, DOI 10.3177/jnsv.44.391; Seckler D., 1982, NEWER CONCEPTS NUTR, P127; Silventoinen K, 2003, J BIOSOC SCI, V35, P263, DOI 10.1017/S0021932003002633; Smith GD, 2008, BASIC CLIN PHARMACOL, V102, P245, DOI 10.1111/j.1742-7843.2007.00191.x; Steckel RH, 2008, J ECON PERSPECT, V22, P129, DOI 10.1257/jep.22.1.129; Subramanian SV, 2006, PLOS MED, V3, P1794, DOI 10.1371/journal.pmed.0030421; Uchimura TT, 2003, REV SAUDE PUBL, V37, P397, DOI 10.1590/S0034-89102003000400002; United Nations Children's Fund, 2008, STAT WORLDS CHILDR 2; Veena SR, 2004, PAEDIATR PERINAT EP, V18, P361, DOI 10.1111/j.1365-3016.2004.00579.x; Vitolo MR, 2008, J PEDIAT-BRAZIL, V84, P251, DOI [10.2223/JPED.1776, 10.1590/S0021-75572008000300011]; WATERLOW JC, 1972, BRIT MED J, V3, P566, DOI 10.1136/bmj.3.5826.566; Webb E, 2008, J EPIDEMIOL COMMUN H, V62, P351, DOI 10.1136/jech.2006.056457; WHO, 2008, WORLDW PREV AN 1993; World Health Organization. Multicentre growth reference study group, 2006, WHO CHILD GROWTH STA; Zhang X, 2007, J PEDIATR-US, V150, P603, DOI 10.1016/j.jpeds.2007.01.048; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	41	163	164	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 22	2009	301	16					1691	1701		10.1001/jama.2009.548	http://dx.doi.org/10.1001/jama.2009.548			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	435NN	19383960	Bronze, Green Published, Green Accepted			2022-12-01	WOS:000265350700025
J	Gradinaru, V; Mogri, M; Thompson, KR; Henderson, JM; Deisseroth, K				Gradinaru, Viviana; Mogri, Murtaza; Thompson, Kimberly R.; Henderson, Jaimie M.; Deisseroth, Karl			Optical Deconstruction of Parkinsonian Neural Circuitry	SCIENCE			English	Article							DEEP-BRAIN-STIMULATION; MOTOR CORTEX STIMULATION; SUBTHALAMIC NUCLEUS STIMULATION; TREATMENT-RESISTANT DEPRESSION; TRANSCRANIAL MAGNETIC STIMULATION; BASAL GANGLIA; MOVEMENT-DISORDERS; IN-VIVO; TRANSGENIC MICE; DISEASE	Deep brain stimulation (DBS) is a therapeutic option for intractable neurological and psychiatric disorders, including Parkinson's disease and major depression. Because of the heterogeneity of brain tissues where electrodes are placed, it has been challenging to elucidate the relevant target cell types or underlying mechanisms of DBS. We used optogenetics and solid-state optics to systematically drive or inhibit an array of distinct circuit elements in freely moving parkinsonian rodents and found that therapeutic effects within the subthalamic nucleus can be accounted for by direct selective stimulation of afferent axons projecting to this region. In addition to providing insight into DBS mechanisms, these results demonstrate an optical approach for dissection of disease circuitry and define the technological toolbox needed for systematic deconstruction of disease circuits by selectively controlling individual components.	[Gradinaru, Viviana; Mogri, Murtaza; Thompson, Kimberly R.; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Gradinaru, Viviana] Stanford Univ, Program Neurosci, Stanford, CA 94305 USA; [Henderson, Jaimie M.] Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Deisseroth, K (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	deissero@stanford.edu		Henderson, Jaimie/0000-0002-3276-2267	Kinetics Foundation; William M. Keck Foundation; Snyder Foundation; Albert Yu and Mary Bechmann Foundation; Wallace Coulter Foundation; California Institute for Regenerative Medicine; McKnight Foundation; Esther A. and Joseph Klingenstein Fund; NSF; National Institute of Mental Health; National Institute on Drug Abuse; NIH Pioneer Award; SGF; SIGF; Bio-X; NARSAD; John Blume Foundation; Davis Phinney Foundation	Kinetics Foundation; William M. Keck Foundation(W.M. Keck Foundation); Snyder Foundation; Albert Yu and Mary Bechmann Foundation; Wallace Coulter Foundation; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); McKnight Foundation; Esther A. and Joseph Klingenstein Fund; NSF(National Science Foundation (NSF)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIH Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SGF; SIGF; Bio-X; NARSAD(NARSAD); John Blume Foundation; Davis Phinney Foundation	K.D. is supported by the Kinetics Foundation, the William M. Keck Foundation, the Snyder Foundation, the Albert Yu and Mary Bechmann Foundation, and the Wallace Coulter Foundation, as well as by California Institute for Regenerative Medicine, the McKnight Foundation, the Esther A. and Joseph Klingenstein Fund, NSF, National Institute of Mental Health, National Institute on Drug Abuse, and the NIH Pioneer Award. V.G. is supported by SGF and SIGF (Stanford Graduate Fellowships). M.M is supported by Bio-X and SGF Fellowships. K.R.T. is supported by NARSAD. J.M.H is supported by the Coulter Foundation, the John Blume Foundation and the Davis Phinney Foundation. We especially thank A. M. Aravanis for mentoring and advice on animal surgery and in vivo recordings, F. Zhang and H. C. Tsai for assistance with Cre-dependent opsin targeting, L. Meltzer for useful discussion, advice and help on immunohistochemistry, G. Feng and G. Augustine for collaboration on generation of the Thy-1 mice (available at the Jackson Laboratory), and V. Sohal for help with power spectra analysis. We also thank the entire Deisseroth lab for useful discussions. The materials and methods described herein are freely distributed and supported by the authors (www.stanford.edu/group/dlab).	Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; Airan RD, 2007, SCIENCE, V317, P819, DOI 10.1126/science.1144400; ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Arle JE, 2008, J NEUROSURG, V109, P133, DOI 10.3171/JNS/2008/109/7/0133; Bekar L, 2008, NAT MED, V14, P75, DOI 10.1038/nm1693; BENABID AL, 1994, STEREOT FUNCT NEUROS, V62, P76, DOI 10.1159/000098600; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Bronte-Stewart H, 2009, EXP NEUROL, V215, P20, DOI 10.1016/j.expneurol.2008.09.008; Brown P, 2001, J NEUROSCI, V21, P1033, DOI 10.1523/JNEUROSCI.21-03-01033.2001; Canavero S, 2002, J NEUROSURG, V97, P1208, DOI 10.3171/jns.2002.97.5.1208; Canavero S, 2000, MOVEMENT DISORD, V15, P169, DOI 10.1002/1531-8257(200001)15:1<169::AID-MDS1030>3.0.CO;2-W; Cilia R, 2007, MOVEMENT DISORD, V22, P111, DOI 10.1002/mds.21207; Degos B, 2008, EUR J NEUROSCI, V27, P2599, DOI 10.1111/j.1460-9568.2008.06229.x; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; Dostrovsky JO, 2002, MOVEMENT DISORD, V17, pS63, DOI 10.1002/mds.10143; Drouot' X, 2004, NEURON, V44, P769, DOI 10.1016/j.neuron.2004.11.023; Fregni F, 2005, J NEUROL NEUROSUR PS, V76, P1614, DOI 10.1136/jnnp.2005.069849; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; Gradinaru V, 2008, BRAIN CELL BIOL, V36, P129, DOI 10.1007/s11068-008-9027-6; Gross RE, 2008, CLIN NEUROPHYSIOL, V119, P1947, DOI 10.1016/j.clinph.2008.06.003; Hamani C, 2004, BRAIN, V127, P4, DOI 10.1093/brain/awh029; Khedr EM, 2006, MOVEMENT DISORD, V21, P2201, DOI 10.1002/mds.21089; Kringelbach ML, 2007, NAT REV NEUROSCI, V8, P623, DOI 10.1038/nrn2196; Lefaucheur JP, 2004, CLIN NEUROPHYSIOL, V115, P2530, DOI 10.1016/j.clinph.2004.05.025; Levy R, 2001, BRAIN, V124, P2105, DOI 10.1093/brain/124.10.2105; Li S, 2007, J NEUROPHYSIOL, V98, P3525, DOI 10.1152/jn.00808.2007; LIMOUSIN P, 1995, LANCET, V345, P91, DOI 10.1016/S0140-6736(95)90062-4; Liu Y, 2008, NEUROSCI BIOBEHAV R, V32, P343, DOI 10.1016/j.neubiorev.2006.10.007; Lozano AM, 2008, BIOL PSYCHIAT, V64, P461, DOI 10.1016/j.biopsych.2008.05.034; Matsuya T, 2007, J PHARMACOL SCI, V103, P329, DOI 10.1254/jphs.SCZ070058; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; McIntyre CC, 2004, J NEUROPHYSIOL, V91, P1457, DOI 10.1152/jn.00989.2003; McIntyre CC, 2004, CLIN NEUROPHYSIOL, V115, P1239, DOI 10.1016/j.clinph.2003.12.024; McIntyre CC, 2002, J NEUROPHYSIOL, V88, P1592, DOI 10.1152/jn.2002.88.4.1592; McNeely HE, 2008, J NERV MENT DIS, V196, P405, DOI 10.1097/NMD.0b013e3181710927; Metz GA, 2005, EUR J NEUROSCI, V22, P735, DOI 10.1111/j.1460-9568.2005.04238.x; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Pagni C A, 2003, J Neurosurg Sci, V47, P189; Payoux P, 2004, ARCH NEUROL-CHICAGO, V61, P1307, DOI 10.1001/archneur.61.8.1307; Ressler KJ, 2007, NAT NEUROSCI, V10, P1116, DOI 10.1038/nn1944; Rezai AR, 2008, NEUROSURGERY, V62, P809, DOI [10.1227/01.NEU.0000297003.12598.89, 10.1227/01.neu.0000316285.52865.53]; RIDDING MC, 1995, ANN NEUROL, V37, P181, DOI 10.1002/ana.410370208; RIVKEES SA, 1995, BRAIN RES, V677, P193, DOI 10.1016/0006-8993(95)00062-U; Shen KZ, 2003, NEUROSCIENCE, V116, P99, DOI 10.1016/S0306-4522(02)00656-5; SMITH Y, 1988, BRAIN RES, V453, P353, DOI 10.1016/0006-8993(88)90177-1; Strafella AP, 2007, MOVEMENT DISORD, V22, P2113, DOI 10.1002/mds.21691; Tabar V, 2008, NAT MED, V14, P379, DOI 10.1038/nm1732; Vitek JL, 2002, MOVEMENT DISORD, V17, pS69, DOI 10.1002/mds.10144; Wang H, 2007, P NATL ACAD SCI USA, V104, P8143, DOI 10.1073/pnas.0700384104; Wang L., UNPUB; Wingeier B, 2006, EXP NEUROL, V197, P244, DOI 10.1016/j.expneurol.2005.09.016; Zhang F, 2008, NAT NEUROSCI, V11, P631, DOI 10.1038/nn.2120; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhang YP, 2007, NAT METHODS, V4, P139, DOI 10.1038/nmeth988	58	1080	1136	10	397	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2009	324	5925					354	359		10.1126/science.1167093	http://dx.doi.org/10.1126/science.1167093			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433QT	19299587	Green Accepted			2022-12-01	WOS:000265221600033
J	Scheid, JF; Mouquet, H; Feldhahn, N; Seaman, MS; Velinzon, K; Pietzsch, J; Ott, RG; Anthony, RM; Zebroski, H; Hurley, A; Phogat, A; Chakrabarti, B; Li, YX; Connors, M; Pereyra, F; Walker, BD; Wardemann, H; Ho, D; Wyatt, RT; Mascola, JR; Ravetch, JV; Nussenzweig, MC				Scheid, Johannes F.; Mouquet, Hugo; Feldhahn, Niklas; Seaman, Michael S.; Velinzon, Klara; Pietzsch, John; Ott, Rene G.; Anthony, Robert M.; Zebroski, Henry; Hurley, Arlene; Phogat, Adhuna; Chakrabarti, Bimal; Li, Yuxing; Connors, Mark; Pereyra, Florencia; Walker, Bruce D.; Wardemann, Hedda; Ho, David; Wyatt, Richard T.; Mascola, John R.; Ravetch, Jeffrey V.; Nussenzweig, Michel C.			Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals	NATURE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN MONOCLONAL-ANTIBODIES; PASSIVE TRANSFER; BINDING-SITE; TYPE-1; EPITOPE; GLYCOPROTEIN; GENERATION; GP41	Antibodies to conserved epitopes on the human immunodeficiency virus (HIV) surface protein gp140 can protect against infection in non-human primates, and some infected individuals show high titres of broadly neutralizing immunoglobulin (Ig)G antibodies in their serum. However, little is known about the specificity and activity of these antibodies(1-3). To characterize the memory antibody responses to HIV, we cloned 502 antibodies from HIV envelope-binding memory B cells from six HIV-infected patients with broadly neutralizing antibodies and low to intermediate viral loads. We show that in these patients, the B-cell memory response to gp140 is composed of up to 50 independent clones expressing high affinity neutralizing antibodies to the gp120 variable loops, the CD4-binding site, the co-receptor-binding site, and to a new neutralizing epitope that is in the same region of gp120 as the CD4-binding site. Thus, the IgG memory B-cell compartment in the selected group of patients with broad serum neutralizing activity to HIV is comprised of multiple clonal responses with neutralizing activity directed against several epitopes on gp120.	[Scheid, Johannes F.; Mouquet, Hugo; Feldhahn, Niklas; Velinzon, Klara; Pietzsch, John; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Ott, Rene G.; Anthony, Robert M.; Ravetch, Jeffrey V.] Rockefeller Univ, Lab Mol Genet & Immunol, New York, NY 10065 USA; [Zebroski, Henry] Rockefeller Univ, Prote Resource Ctr, New York, NY 10065 USA; [Hurley, Arlene] Rockefeller Univ, Rockefeller Univ Hosp, New York, NY 10065 USA; [Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA; [Scheid, Johannes F.] Charite, D-10117 Berlin, Germany; [Seaman, Michael S.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Pietzsch, John] Free Univ Berlin, Inst Chem & Biochem, D-14195 Berlin, Germany; [Phogat, Adhuna; Chakrabarti, Bimal; Li, Yuxing; Wyatt, Richard T.; Mascola, John R.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Connors, Mark] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA; [Pereyra, Florencia; Walker, Bruce D.] Mass Gen Hosp, Partners AIDS Res Ctr, Charlestown, MA 02129 USA; [Wardemann, Hedda] Max Planck Inst Infect Biol, D-10117 Berlin, Germany; [Pereyra, Florencia; Walker, Bruce D.] Harvard Univ, Sch Med, Charlestown, MA 02129 USA; [Ho, David] Aaron Diamond AIDS Res Ctr, New York, NY 10065 USA	Rockefeller University; Rockefeller University; Rockefeller University; Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Harvard University; Beth Israel Deaconess Medical Center; Free University of Berlin; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Max Planck Society; Harvard University	Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA.	nussen@mail.rockefeller.edu	Ravetch, Jeffrey/Z-1596-2019; Mascola, John/AAI-7193-2021; Mouquet, Hugo/M-2750-2014; Nussenzweig, Michel/AAE-7292-2019	Ravetch, Jeffrey/0000-0003-2024-9041; Mouquet, Hugo/0000-0002-4230-610X; Wardemann, Hedda/0000-0003-3921-5933	Rockefeller University; International Aids Vaccine Initiative; Bill and Melinda Gates Foundation; Intramural Research Program of the Vaccine Research Center; Division of Intramural Research; National Institute of Allergy and Infectious Diseases; National Institutes of Health; Deutscher Akademischer Austauschdienst; Fondation Recherche Medicale; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI005089, Z01AI005095, ZIAAI005095, ZIAAI005089, ZIAAI005010, Z01AI005069, ZIAAI001090, ZIAAI005069] Funding Source: NIH RePORTER	Rockefeller University; International Aids Vaccine Initiative; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Intramural Research Program of the Vaccine Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutscher Akademischer Austauschdienst(Deutscher Akademischer Austausch Dienst (DAAD)); Fondation Recherche Medicale; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank D. Wycuff, E. Lybarger and B. Dey for supplying gp120 proteins for mapping studies, K. McKee for serum adsorption studies and N. Doria- Rose for her work with patient material from patients 4 and 6. This research was supported by the Rockefeller University, the International Aids Vaccine Initiative, the Bill and Melinda Gates Foundation, the Intramural Research Program of the Vaccine Research Center ( R. T. W., J. R. M.), and the Division of Intramural Research ( M. C.), National Institute of Allergy and Infectious Diseases, National Institutes of Health. J. F. S. was supported by the Deutscher Akademischer Austauschdienst, H. M. was supported by the Fondation Recherche Medicale. M. C. N. is a Howard Hughes Medical Institute investigator.	BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; BURTON DR, 1991, P NATL ACAD SCI USA, V88, P10134, DOI 10.1073/pnas.88.22.10134; GORNY MK, 1992, J VIROL, V66, P7538, DOI 10.1128/JVI.66.12.7538-7542.1992; Hedestam GBK, 2008, NAT REV MICROBIOL, V6, P143, DOI 10.1038/nrmicro1819; Huang CC, 2004, P NATL ACAD SCI USA, V101, P2706, DOI 10.1073/pnas.0308527100; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Mascola JR, 2007, NATURE, V449, P29, DOI 10.1038/449029a; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Mietzner B, 2008, P NATL ACAD SCI USA, V105, P9727, DOI 10.1073/pnas.0803644105; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; OLSHEVSKY U, 1990, J VIROL, V64, P5701, DOI 10.1128/JVI.64.12.5701-5707.1990; Pantophlet R, 2003, J VIROL, V77, P642, DOI 10.1128/JVI.77.1.642-658.2003; Scheid JF, 2009, J IMMUNOL METHODS, V343, P65, DOI 10.1016/j.jim.2008.11.012; Shibata R, 1999, NAT MED, V5, P204, DOI 10.1038/5568; THALI M, 1991, J VIROL, V65, P6188, DOI 10.1128/JVI.65.11.6188-6193.1991; THALI M, 1993, J VIROL, V67, P3978, DOI 10.1128/JVI.67.7.3978-3988.1993; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Tiller T, 2007, IMMUNITY, V26, P205, DOI 10.1016/j.immuni.2007.01.009; Trkola A, 2005, NAT MED, V11, P615, DOI 10.1038/nm1244; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; XU JY, 1991, J VIROL, V65, P4832, DOI 10.1128/JVI.65.9.4832-4838.1991; Yang XZ, 2000, J VIROL, V74, P5716, DOI 10.1128/JVI.74.12.5716-5725.2000; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zolla-Pazner S, 2004, NAT REV IMMUNOL, V4, P199, DOI 10.1038/nri1307; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	29	680	758	0	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 2	2009	458	7238					636	640		10.1038/nature07930	http://dx.doi.org/10.1038/nature07930			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RK	19287373				2022-12-01	WOS:000264796200042
J	Chen, GY; Tang, J; Zheng, P; Liu, Y				Chen, Guo-Yun; Tang, Jie; Zheng, Pan; Liu, Yang			CD24 and Siglec-10 Selectively Repress Tissue Damage-Induced Immune Responses	SCIENCE			English	Article							MOBILITY GROUP BOX-1; HEAT-STABLE ANTIGEN; T-CELL GROWTH; ISCHEMIA-REPERFUSION; PROTEIN; HMGB1; ACTIVATION; SYSTEM; AUTOIMMUNITY; INFLAMMATION	Patten recognition receptors, which recognize pathogens or components of injured cells (danger), trigger activation of the innate immune system. Whether and how the host distinguishes between danger-versus pathogen-associated molecular patterns remains unresolved. We report that CD24-deficient mice exhibit increased susceptibility to danger- but not pathogen-associated molecular patterns. CD24 associates with high mobility group box 1, heat shock protein 70, and heat shock protein 90; negatively regulates their stimulatory activity; and inhibits nuclear factor kappa B (NF-kappa B) activation. This occurs at least in part through CD24 association with Siglec-10 in humans or Siglec-G in mice. Our results reveal that the CD24-Siglec G pathway protects the host against a lethal response to pathological cell death and discriminates danger-versus pathogen-associated molecular patterns.	[Chen, Guo-Yun; Zheng, Pan; Liu, Yang] Univ Michigan, Sch Med, Dept Surg, Div Immunotherapy, Ann Arbor, MI 48109 USA; [Zheng, Pan] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Liu, Yang] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Tang, Jie] Chinese Acad Sci, Inst Biophys, Beijing 100080, Peoples R China	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Chinese Academy of Sciences; Institute of Biophysics, CAS	Zheng, P (corresponding author), Univ Michigan, Sch Med, Dept Surg, Div Immunotherapy, Ann Arbor, MI 48109 USA.	panz@umich.edu; yangl@umich.edu	Zheng, Pan/E-8691-2011; Chen, Guo-yun/C-2436-2011	Zheng, Pan/0000-0003-2598-3544; Liu, Yang/0000-0002-9442-700X	NIH [AI064350, CA58033, CA112001]; U.S. department of Defense [W81XWH-08-1-0036]; Natural Science Foundation of China [30640420558]; Ministry of Science and Technology of China [2006CB910901]; NATIONAL CANCER INSTITUTE [R01CA058033, R01CA112001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064350] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. department of Defense(United States Department of Defense); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by grants from the NIH (AI064350, CA58033, and CA112001), U.S. department of Defense (W81XWH-08-1-0036), and Natural Science Foundation of China (30640420558) and Ministry of Science and Technology of China (2006CB910901). The authors have no conflicts of interest. We dedicate this study to Dr. Charles A. Janeway Jr.	Abraham E, 2000, J IMMUNOL, V165, P2950, DOI 10.4049/jimmunol.165.6.2950; Andrassy M, 2008, CIRCULATION, V117, P3216, DOI 10.1161/CIRCULATIONAHA.108.769331; Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Bai XF, 2000, J CLIN INVEST, V105, P1227, DOI 10.1172/JCI9012; Cavassani KA, 2008, J EXP MED, V205, P2609, DOI 10.1084/jem.20081370; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Ding C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000997; Harris HE, 2006, EMBO REP, V7, P774, DOI 10.1038/sj.embor.7400759; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Li O, 2006, J EXP MED, V203, P1713, DOI 10.1084/jem.20052293; LIU Y, 1992, J EXP MED, V175, P437, DOI 10.1084/jem.175.2.437; LIU Y, 1991, INT IMMUNOL, V3, P323, DOI 10.1093/intimm/3.4.323; Liu Y, 2007, TRENDS IMMUNOL, V28, P315, DOI 10.1016/j.it.2007.05.001; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Millar DG, 2003, NAT MED, V9, P1469, DOI 10.1038/nm962; Ochsner SA, 2007, STEM CELLS, V25, P2476, DOI 10.1634/stemcells.2007-0101; Pao LI, 2007, IMMUNITY, V27, P35, DOI 10.1016/j.immuni.2007.04.016; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; Tsung A, 2005, J EXP MED, V201, P1135, DOI 10.1084/jem.20042614; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Wang Y, 2007, MICROW OPT TECHN LET, V49, P100, DOI 10.1002/mop.22056; Whitney G, 2001, EUR J BIOCHEM, V268, P6083, DOI 10.1046/j.0014-2956.2001.02543.x; Yang H, 2004, P NATL ACAD SCI USA, V101, P296, DOI 10.1073/pnas.2434651100	26	521	553	3	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2009	323	5922					1722	1725		10.1126/science.1168988	http://dx.doi.org/10.1126/science.1168988			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	424IG	19264983	Green Accepted			2022-12-01	WOS:000264559800038
J	Gelbart, WM; Knobler, CM				Gelbart, William M.; Knobler, Charles M.			Pressurized Viruses	SCIENCE			English	Editorial Material							EJECTION FORCES; DNA EJECTION; MOTOR		[Gelbart, William M.; Knobler, Charles M.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Gelbart, WM (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA.	gelbart@chem.ucla.edu						EARNSHAW WC, 1977, NATURE, V268, P598, DOI 10.1038/268598a0; Evilevitch A, 2003, P NATL ACAD SCI USA, V100, P9292, DOI 10.1073/pnas.1233721100; Fuller DN, 2007, J MOL BIOL, V373, P1113, DOI 10.1016/j.jmb.2007.09.011; Fuller DN, 2007, P NATL ACAD SCI USA, V104, P16868, DOI 10.1073/pnas.0704008104; Gaussier H, 2006, J MOL BIOL, V357, P1154, DOI 10.1016/j.jmb.2006.01.013; Grayson P, 2006, VIROLOGY, V348, P430, DOI 10.1016/j.virol.2006.01.003; Grayson P, 2007, CURR OPIN MICROBIOL, V10, P401, DOI 10.1016/j.mib.2007.04.004; Kindt J, 2001, P NATL ACAD SCI USA, V98, P13671, DOI 10.1073/pnas.241486298; Lander GC, 2006, SCIENCE, V312, P1791, DOI 10.1126/science.1127981; Mangenot S, 2005, CURR BIOL, V15, P430, DOI 10.1016/j.cub.2004.12.080; Michel JP, 2006, P NATL ACAD SCI USA, V103, P6184, DOI 10.1073/pnas.0601744103; Raoult D, 2004, SCIENCE, V306, P1344, DOI 10.1126/science.1101485; RAU DC, 1992, BIOPHYS J, V61, P246, DOI 10.1016/S0006-3495(92)81831-3; Smith DE, 2001, NATURE, V413, P748, DOI 10.1038/35099581; Tzlil S, 2003, BIOPHYS J, V84, P1616, DOI 10.1016/S0006-3495(03)74971-6	15	75	75	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2009	323	5922					1682	1683		10.1126/science.1170645	http://dx.doi.org/10.1126/science.1170645			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	424IG	19325104				2022-12-01	WOS:000264559800026
J	Rahighi, S; Ikeda, F; Kawasaki, M; Akutsu, M; Suzuki, N; Kato, R; Kensche, T; Uejima, T; Bloor, S; Komander, D; Randow, F; Wakatsuki, S; Dikic, I				Rahighi, Simin; Ikeda, Fumiyo; Kawasaki, Masato; Akutsu, Masato; Suzuki, Nobuhiro; Kato, Ryuichi; Kensche, Tobias; Uejima, Tamami; Bloor, Stuart; Komander, David; Randow, Felix; Wakatsuki, Soichi; Dikic, Ivan			Specific Recognition of Linear Ubiquitin Chains by NEMO Is Important for NF-kappa B Activation	CELL			English	Article							ANHIDROTIC ECTODERMAL DYSPLASIA; POLYUBIQUITIN CHAINS; CONJUGATING ENZYME; BINDING DOMAINS; IKK-GAMMA; COMPLEX; IMMUNODEFICIENCY; TURNOVER; REQUIRES; REVEALS	Activation of nuclear factor-kappa B (NF-kappa B), a key mediator of inducible transcription in immunity, requires binding of NF-kappa B essential modulator (NEMO) to ubiquitinated substrates. Here, we report that the UBAN (ubiquitin binding in ABIN and NEMO) motif of NEMO selectively binds linear (head-to-tail) ubiquitin chains. Crystal structures of the UBAN motif revealed a parallel coiled-coil dimer that formed a heterotetrameric complex with two linear diubiquitin molecules. The UBAN dimer contacted all four ubiquitin moieties, and the integrity of each binding site was required for efficient NF-kappa B activation. Binding occurred via a surface on the proximal ubiquitin moiety and the canonical Ile44 surface on the distal one, thereby providing specificity for linear chain recognition. Residues of NEMO involved in binding linear ubiquitin chains are required for NF-kappa B activation by TNF-alpha and other agonists, providing an explanation for the detrimental effect of NEMO mutations in patients suffering from X-linked ectodermal dysplasia and immunodeficiency.	[Rahighi, Simin; Kawasaki, Masato; Akutsu, Masato; Suzuki, Nobuhiro; Kato, Ryuichi; Uejima, Tamami; Wakatsuki, Soichi] High Energy Accelerator Res Org KEK, Struct Biol Res Ctr, Photon Factory, Inst Mat Struct Sci, Tsukuba, Ibaraki 3050801, Japan; [Rahighi, Simin; Kawasaki, Masato; Akutsu, Masato; Kato, Ryuichi; Wakatsuki, Soichi] Grad Univ Adv Studies, Kanagawa 2400193, Japan; [Ikeda, Fumiyo; Kensche, Tobias; Dikic, Ivan] Univ Frankfurt, Inst Biochem & Cluster Excellence Frankfurt 2, Sch Med, D-60590 Frankfurt, Main, Germany; [Ikeda, Fumiyo; Dikic, Ivan] Mediterranean Inst Life Sci, Tumor Biol Program, Split 21000, Croatia; [Akutsu, Masato; Bloor, Stuart; Komander, David; Randow, Felix] MRC, Mol Biol Lab, Div Prot & Nucle Acid Chem, Cambridge CB2 0QH, England; [Dikic, Ivan] Univ Split, Dept Immunol, Sch Med, Split 21000, Croatia	High Energy Accelerator Research Organization (KEK); Graduate University for Advanced Studies - Japan; Goethe University Frankfurt; MRC Laboratory Molecular Biology; University of Split	Wakatsuki, S (corresponding author), High Energy Accelerator Res Org KEK, Struct Biol Res Ctr, Photon Factory, Inst Mat Struct Sci, Tsukuba, Ibaraki 3050801, Japan.	soichi.wakatsuki@kek.jp; ivan.dikic@biochem2.de	Suzuki, Nobuhiro/M-7238-2015; akutsu, masato/L-4095-2016; Uejima, Tamami/C-4128-2017; Ikeda, Fumiyo/AAD-3770-2020; Dikic, Ivan/O-4650-2015	Suzuki, Nobuhiro/0000-0001-8420-5852; akutsu, masato/0000-0002-9839-3345; Ikeda, Fumiyo/0000-0003-0407-2768; Dikic, Ivan/0000-0001-8156-9511; Kato, Ryuichi/0000-0003-2087-2896; Wakatsuki, Soichi/0000-0001-5896-7968	Deutsche Forschungsgemeinschaft [EXC115]; Ministry of Education, Culture, Sports, Science, and Technology (MEXT); MRC [MC_U105170648, MC_U105192732] Funding Source: UKRI; Medical Research Council [MC_U105170648, MC_U105192732] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to Marc Schmidt-Supprian for the NEMO-KOMEFs used in this study. We are thankful to Kazuhiro Iwai for sharing results prior to publication of the manuscripts. We thank Caroline Grabbe, Daniela Hoeller, and the members of our labs for discussions, constructive comments, and critical reading of the manuscript. I. F. is a postdoctoral fellow of the Japan Society for the Promotion of Science. This work was supported by grants from Deutsche Forschungsgemeinschaft, the Cluster of Excellence "Macromolecular Complexes'' of the Goethe University Frankfurt (EXC115) to I. D., and partly by Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) to M. K. and Target Protein Research Program of the MEXT to S. W.	Bagneris C, 2008, MOL CELL, V30, P620, DOI 10.1016/j.molcel.2008.04.029; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Blankenship JW, 2009, BIOCHEM J, V417, P149, DOI 10.1042/BJ20081885; Bloor S, 2008, P NATL ACAD SCI USA, V105, P1279, DOI 10.1073/pnas.0706552105; Boyault C, 2006, EMBO J, V25, P3357, DOI 10.1038/sj.emboj.7601210; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Cordier F, 2008, J MOL BIOL, V377, P1419, DOI 10.1016/j.jmb.2008.01.048; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Doffinger R, 2001, NAT GENET, V27, P277, DOI 10.1038/85837; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Filipe-Santos O, 2006, J EXP MED, V203, P1745, DOI 10.1084/jem.20060085; Gyrd-Hansen M, 2008, NAT CELL BIOL, V10, P1309, DOI 10.1038/ncb1789; HACKER H, 2006, SCI STKE, pRE13, DOI DOI 10.1126/STKE.3572006RE13; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Komander D, 2008, MOL CELL, V29, P451, DOI 10.1016/j.molcel.2007.12.018; Lo YC, 2009, MOL CELL, V33, P602, DOI 10.1016/j.molcel.2009.01.012; Matsuzawa A, 2008, SCIENCE, V321, P663, DOI 10.1126/science.1157340; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Ordureau A, 2008, BIOCHEM J, V409, P43, DOI 10.1042/BJ20071365; Oshima S, 2009, NATURE, V457, P906, DOI 10.1038/nature07575; Puel A, 2004, CURR OPIN IMMUNOL, V16, P34, DOI 10.1016/j.coi.2003.11.013; Rushe M, 2008, STRUCTURE, V16, P798, DOI 10.1016/j.str.2008.02.012; Schmidt-Supprian M, 2000, MOL CELL, V5, P981, DOI 10.1016/S1097-2765(00)80263-4; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Varfolomeev E, 2008, J BIOL CHEM, V283, P24295, DOI 10.1074/jbc.C800128200; Wagner S, 2008, ONCOGENE, V27, P3739, DOI 10.1038/sj.onc.1211042; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Yamamoto M, 2006, NAT IMMUNOL, V7, P962, DOI 10.1038/ni1367; Zhu G, 2007, CURR BIOL, V17, P1438, DOI 10.1016/j.cub.2007.07.041	35	541	561	0	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 20	2009	136	6					1098	1109		10.1016/j.cell.2009.03.007	http://dx.doi.org/10.1016/j.cell.2009.03.007			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	422CE	19303852	Bronze			2022-12-01	WOS:000264403900015
J	Lerner, BH				Lerner, Barron H.			The art of medicine Complicated lessons: Lorenzo Odone and medical miracles	LANCET			English	Editorial Material							OIL		Columbia Univ, Ctr Hist & Eth Publ Hlth, New York, NY 10032 USA	Columbia University	Lerner, BH (corresponding author), Columbia Univ, Ctr Hist & Eth Publ Hlth, New York, NY 10032 USA.	bhl5@columbia.edu						Jones AH, 2000, ANN INTERN MED, V133, P567, DOI 10.7326/0003-4819-133-7-200010030-00030; Lerner B.H., 2006, ILLNESS GOES PUBLIC; Moser HW, 2005, ARCH NEUROL-CHICAGO, V62, P1073, DOI 10.1001/archneur.62.7.1073; ODONE C, 2008, DAILY MAIL      0601; Rettig R. A., 2007, FALSE HOPE BONE MARR	5	7	7	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 14	2009	373	9667					888	889		10.1016/S0140-6736(09)60534-1	http://dx.doi.org/10.1016/S0140-6736(09)60534-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	418OU	19291841				2022-12-01	WOS:000264158700014
J	Serruys, PW; Ormiston, JA; Onuma, Y; Regar, E; Gonzalo, N; Garcia-Garcia, HM; Nieman, K; Bruining, N; Dorange, C; Miquel-Hebert, K; Veldhof, S; Webster, M; Thuesen, L; Dudek, D				Serruys, Patrick W.; Ormiston, John A.; Onuma, Yoshinobu; Regar, Evelyn; Gonzalo, Nieves; Garcia-Garcia, Hector M.; Nieman, Koen; Bruining, Nico; Dorange, Cecile; Miquel-Hebert, Karine; Veldhof, Susan; Webster, Mark; Thuesen, Leif; Dudek, Dariusz			A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods	LANCET			English	Article							ATHEROSCLEROTIC PLAQUE COMPOSITION; INTRAVASCULAR ULTRASOUND; ARTERY LESIONS; ANGIOPLASTY; TOMOGRAPHY; COVERAGE	Background Drug-eluting metallic coronary stents predispose to late stent thrombosis, prevent late lumen vessel enlargement, hinder surgical revascularisation, and impair imaging with multislice CT. We assessed the safety of the bioabsorbable everolimus-eluting stent (BVS). Methods 30 patients with a single de-novo coronary artery lesion were followed up for 2 years clinically and with multiple imaging methods: multislice CT, angiography, intravascular ultrasound, derived morphology parameters (virtual histology, palpography, and echogenicity), and optical coherence tomography (OCT). Findings Clinical data were obtained from 29 of 30 patients. At 2 years, the device was safe with no cardiac deaths, ischaemia-driven target lesion revascularisations, or stent thromboses recorded, and only one myocardial infarction (non-Q wave). 18-month multislice CT (assessed in 25 patients) showed a mean diameter stenosis of 19% (SD 9). At 2-year angiography, the in-stent late loss of 0.48 mm (SD 0.28) and the diameter stenosis of 27% (11) did not differ from the findings at 6 months. The luminal area enlargement on OCT and intravascular ultrasound between 6 months and 2 years was due to a decrease in plaque size without change in vessel size. At 2 years, 34.5% of strut locations presented no discernible features by OCT, confirming decreases in echogenicity and in radiofrequency backscattering; the remaining apparent struts were fully apposed. Additionally, vasomotion occurred at the stented site and adjacent coronary artery in response to vasoactive agents. Interpretation At 2 years after implantation the stent was bioabsorbed, had vasomotion restored and restenosis prevented, and was clinically safe, suggesting freedom from late thrombosis. Late luminal enlargement due to plaque reduction without vessel remodelling needs confirmation.	[Serruys, Patrick W.; Onuma, Yoshinobu; Regar, Evelyn; Gonzalo, Nieves; Nieman, Koen; Bruining, Nico] Erasmus MC, Ctr Thorax, Rotterdam, Netherlands; [Nieman, Koen] Erasmus MC, Dept Radiol, Rotterdam, Netherlands; [Ormiston, John A.; Webster, Mark] Auckland City Hosp, Auckland, New Zealand; [Garcia-Garcia, Hector M.] Cardialysis BV, Rotterdam, Netherlands; [Dorange, Cecile; Miquel-Hebert, Karine; Veldhof, Susan] Abbott Vasc, Diegem, Belgium; [Thuesen, Leif] Aarhus Univ Hosp, Skejby Sygehus, Skejby, Denmark; [Dudek, Dariusz] Jagiellonian Univ, Krakow, Poland	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Auckland City Hospital; Cardialysis; Aarhus University; Jagiellonian University	Serruys, PW (corresponding author), SGravendijkwal 230, NL-3015 CE Rotterdam, Netherlands.	p.w.j.c.serruys@erasmusmc.nl	Regar, E/ABA-3301-2020; Bruining, Nico/ABG-5155-2020; Garcia-Garcia, Hector Manuel/AAG-7471-2020; Onuma, Yoshinobu/AHB-6273-2022; Regar, Evelyn/AAD-8201-2019	Bruining, Nico/0000-0002-0272-5617; Garcia-Garcia, Hector Manuel/0000-0001-5100-0471; Onuma, Yoshinobu/0000-0001-7702-0649; 	Abbott Vascular (Santa Clara, CA, USA)	Abbott Vascular (Santa Clara, CA, USA)(Abbott Laboratories)	This study was sponsored by Abbott Vascular (Santa Clara, CA, USA). We thank Wai-Fung Cheong, Krishnankutty Sudhir, and Robert McGreevy for their intellectual input in writing the report.	American College of Cardiology, 2006, J Am Coll Cardiol, V48, pe1, DOI 10.1016/j.jacc.2006.05.021; Aoki J, 2005, J AM COLL CARDIOL, V46, P1670, DOI 10.1016/j.jacc.2005.06.076; Bruining N, 1998, CATHETER CARDIO DIAG, V43, P254, DOI 10.1002/(SICI)1097-0304(199803)43:3<254::AID-CCD3>3.0.CO;2-8; Bruining N, 1999, CATHETER CARDIO INTE, V48, P133, DOI 10.1002/(SICI)1522-726X(199910)48:2<133::AID-CCD3>3.0.CO;2-H; BRUINING N, 2008, EUROINTERVENTION, V4, P1; Bruining N, 2007, CATHETER CARDIO INTE, V70, P968, DOI 10.1002/ccd.21310; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; de Winter SA, 2003, COMPUT CARDIOL, V30, P73, DOI 10.1109/CIC.2003.1291093; Eggebrecht H, 2005, CIRCULATION, V112, pE303, DOI 10.1161/CIRCULATIONAHA.104.521641; Erbel R, 2007, LANCET, V369, P1869, DOI 10.1016/S0140-6736(07)60853-8; Finn AV, 2007, CIRCULATION, V115, P2435, DOI 10.1161/CIRCULATIONAHA.107.693739; FOLEY DP, 1994, PROG CARDIOVASC DIS, V36, P363, DOI 10.1016/S0033-0620(05)80027-1; Fujimoto J.G.S.J., 2007, OPTICAL COHERENCE TO, V1st, DOI [10.3109/9780203931561, DOI 10.3109/9780203931561]; Garcia-Garcia HM, 2009, EUROINTERVENTION, V4, P443, DOI 10.4244/EIJV4I4A77; HAASE J, 1995, EUR HEART J, V16, P112, DOI 10.1093/eurheartj/16.1.112; Hofma SH, 2006, EUR HEART J, V27, P166, DOI 10.1093/eurheartj/ehi571; Jang IK, 2002, J AM COLL CARDIOL, V39, P604, DOI 10.1016/S0735-1097(01)01799-5; Kotani J, 2006, J AM COLL CARDIOL, V47, P2108, DOI 10.1016/j.jacc.2005.11.092; KURNIK PB, 1984, CATHETER CARDIO DIAG, V10, P353, DOI 10.1002/ccd.1810100408; Lind A Y, 2005, Heart, V91, P1604, DOI 10.1136/hrt.2005.064113; Meijboom WB, 2008, J AM COLL CARDIOL, V52, P2135, DOI 10.1016/j.jacc.2008.08.058; Mintz GS, 1996, CIRCULATION, V94, P35, DOI 10.1161/01.CIR.94.1.35; Nair A, 2002, CIRCULATION, V106, P2200, DOI 10.1161/01.CIR.0000035654.18341.5E; Nair A, 2001, ULTRASOUND MED BIOL, V27, P1319, DOI 10.1016/S0301-5629(01)00436-7; Nair Anuja, 2007, EuroIntervention, V3, P113; NISSEN SE, 1991, CIRCULATION, V84, P1087, DOI 10.1161/01.CIR.84.3.1087; Ormiston JA, 2008, LANCET, V371, P899, DOI 10.1016/S0140-6736(08)60415-8; Sabate M, 1999, CIRCULATION, V100, P1623, DOI 10.1161/01.CIR.100.15.1623; Schaar JA, 2004, CIRCULATION, V109, P2716, DOI 10.1161/01.CIR.0000131887.65955.3B; Schaar JA, 2003, CIRCULATION, V108, P2636, DOI 10.1161/01.CIR.0000097067.96619.1F; Serruys P W, 1983, Z Kardiol, V72 Suppl 3, P116; Serruys PW, 2008, CIRCULATION, V118, P1172, DOI 10.1161/CIRCULATIONAHA.108.771899; Silber S, 2005, EUR HEART J, V26, P804, DOI 10.1093/eurheartj/ehi138; Tamai H, 2000, CIRCULATION, V102, P399; TAMAI H, 2004, BIODEGRADABLE STENTS; Tanigawa Jun, 2007, EuroIntervention, V3, P128; Tsuchida K, 2007, AM J CARDIOL, V99, P607, DOI 10.1016/j.amjcard.2006.09.107; Van Mieghem CAG, 2006, J AM COLL CARDIOL, V47, P1134, DOI 10.1016/j.jacc.2005.09.075; Verheye S, 2007, J AM COLL CARDIOL, V49, P706, DOI 10.1016/j.jacc.2006.09.047; vonBirgelen C, 1996, AM J CARDIOL, V78, P520, DOI 10.1016/S0002-9149(96)00356-6; vonBirgelen C, 1997, CIRCULATION, V96, P2944, DOI 10.1161/01.CIR.96.9.2944	41	632	681	3	81	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 14	2009	373	9667					897	910		10.1016/S0140-6736(09)60325-1	http://dx.doi.org/10.1016/S0140-6736(09)60325-1			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	418OU	19286089				2022-12-01	WOS:000264158700031
J	Pruneda-Paz, JL; Breton, G; Para, A; Kay, SA				Pruneda-Paz, Jose L.; Breton, Ghislain; Para, Alessia; Kay, Steve A.			A Functional Genomics Approach Reveals CHE as a Component of the Arabidopsis Circadian Clock	SCIENCE			English	Article							GENE-EXPRESSION; RHYTHMS; TOC1; PLANTS; REGULATOR; GROWTH	Transcriptional feedback loops constitute the molecular circuitry of the plant circadian clock. In Arabidopsis, a core loop is established between CCA1 and TOC1. Although CCA1 directly represses TOC1, the TOC1 protein has no DNA binding domains, which suggests that it cannot directly regulate CCA1. We established a functional genomic strategy that led to the identification of CHE, a TCP transcription factor that binds specifically to the CCA1 promoter. CHE is a clock component partially redundant with LHY in the repression of CCA1. The expression of CHE is regulated by CCA1, thus adding a CCA1/CHE feedback loop to the Arabidopsis circadian network. Because CHE and TOC1 interact, and CHE binds to the CCA1 promoter, a molecular linkage between TOC1 and CCA1 gene regulation is established.	[Pruneda-Paz, Jose L.; Breton, Ghislain; Para, Alessia; Kay, Steve A.] Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Kay, SA (corresponding author), Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA.	skay@ucsd.edu	Breton, Ghislain/F-7266-2016; Kay, Steve A/F-6025-2011	Breton, Ghislain/0000-0001-6400-3858; Kay, Steve A/0000-0002-0402-2878	NIH [GM56006, GM67837]; Fundacion Antorchas [postdoctoral fellowships]; National Sciences and Engineering Research Council of Canada; Wenner-Gren Stiftelserna; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056006, R01GM067837] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacion Antorchas; National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Wenner-Gren Stiftelserna; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Imaizumi, E. Hamilton, E. Farre, B. Chow, D. A. Nusinow, and M. Sawa for critical reading of the manuscript; K. Yamada for providing the YM187 yeast strain; Y. Zhao for microscopy assistance; and A. Schopke, R. Sawaya, and S. Asbaghi for technical assistance. This work was supported by NIH grants GM56006 and GM67837 to S.A.K. and partially by postdoctoral fellowships from Fundacion Antorchas to J.L.P.-P., the National Sciences and Engineering Research Council of Canada to G.B., and Wenner-Gren Stiftelserna to A.P.	Alabadi D, 2001, SCIENCE, V293, P880, DOI 10.1126/science.1061320; Baudry A, 2008, ADV BOT RES, V48, P69, DOI 10.1016/S0065-2296(08)00402-3; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; Cubas P, 1999, PLANT J, V18, P215, DOI 10.1046/j.1365-313X.1999.00444.x; Dobi KC, 2007, MOL CELL BIOL, V27, P5575, DOI 10.1128/MCB.00459-07; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Gardner MJ, 2006, BIOCHEM J, V397, P15, DOI 10.1042/BJ20060484; Green RM, 1999, P NATL ACAD SCI USA, V96, P4176, DOI 10.1073/pnas.96.7.4176; Green RM, 2002, PLANT PHYSIOL, V129, P576, DOI 10.1104/pp.004374; Kosugi S, 2002, PLANT J, V30, P337, DOI 10.1046/j.1365-313X.2002.01294.x; Makino S, 2002, PLANT CELL PHYSIOL, V43, P58, DOI 10.1093/pcp/pcf005; Mas P, 2003, PLANT CELL, V15, P223, DOI 10.1105/tpc.006734; McClung CR, 2006, PLANT CELL, V18, P792, DOI 10.1105/tpc.106.040980; Para A, 2007, PLANT CELL, V19, P3462, DOI 10.1105/tpc.107.054775; Perales M, 2007, PLANT CELL, V19, P2111, DOI 10.1105/tpc.107.050807; Schaffer R, 1998, CELL, V93, P1219, DOI 10.1016/S0092-8674(00)81465-8; Strayer C, 2000, SCIENCE, V289, P768, DOI 10.1126/science.289.5480.768; Wang ZY, 1997, PLANT CELL, V9, P491, DOI 10.1105/tpc.9.4.491; Wang ZY, 1998, CELL, V93, P1207, DOI 10.1016/S0092-8674(00)81464-6; Wijnen H, 2006, ANNU REV GENET, V40, P409, DOI 10.1146/annurev.genet.40.110405.090603	20	327	357	6	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2009	323	5920					1481	1485		10.1126/science.1167206	http://dx.doi.org/10.1126/science.1167206			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417TP	19286557	Green Accepted			2022-12-01	WOS:000264101700042
J	Curtiss, LK				Curtiss, Linda K.			Reversing Atherosclerosis?.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA	Scripps Research Institute	Curtiss, LK (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.							Fan EG, 2008, J MED FOOD, V11, P610, DOI 10.1089/jmf.2007.0091; Park YM, 2009, J CLIN INVEST, V119, P136, DOI 10.1172/JCI35535; Rahaman SO, 2006, CELL METAB, V4, P211, DOI 10.1016/j.cmet.2006.06.007; Witztum JL, 2005, J CLIN INVEST, V115, P2072, DOI 10.1172/JCI26130	4	38	46	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 12	2009	360	11					1144	1146		10.1056/NEJMcibr0810383	http://dx.doi.org/10.1056/NEJMcibr0810383			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417BW	19279347				2022-12-01	WOS:000264051000015
J	Ressl, S; van Scheltinga, ACT; Vonrhein, C; Ott, V; Ziegler, C				Ressl, Susanne; van Scheltinga, Anke C. Terwisscha; Vonrhein, Clemens; Ott, Vera; Ziegler, Christine			Molecular basis of transport and regulation in the Na+/betaine symporter BetP	NATURE			English	Article							SOLUTES GLYCINE BETAINE; RENAL MEDULLARY CELLS; CORYNEBACTERIUM-GLUTAMICUM; COMPATIBLE SOLUTES; ORGANIC OSMOLYTES; NEUROTRANSMITTER TRANSPORTERS; SEROTONIN TRANSPORTER; OSMOTIC REGULATION; CRYSTAL-STRUCTURE; VOLUME REGULATION	Osmoregulated transporters sense intracellular osmotic pressure and respond to hyperosmotic stress by accumulation of osmolytes to restore normal hydration levels. Here we report the determination of the X-ray structure of a member of the family of betaine/choline/carnitine transporters, the Na+-coupled symporter BetP from Corynebacterium glutamicum, which is a highly effective osmoregulated uptake system for glycine betaine. Glycine betaine is bound in a tryptophan box occluded from both sides of the membrane with aromatic side chains lining the transport pathway. BetP has the same overall fold as three unrelated Na+-coupled symporters. Whereas these are crystallized in either the outward-facing or the inward-facing conformation, the BetP structure reveals a unique intermediate conformation in the Na+-coupled transport cycle. The trimeric architecture of BetP and the break in three-fold symmetry by the osmosensing C-terminal helices suggest a regulatory mechanism of Na+-coupled osmolyte transport to counteract osmotic stress.	[Ressl, Susanne; van Scheltinga, Anke C. Terwisscha; Ziegler, Christine] Max Planck Inst Biophys, Dept Biol Struct, D-60438 Frankfurt, Germany; [Vonrhein, Clemens] Global Phasing Ltd, Sheraton House, Cambridge CB3 0AX, England; [Ott, Vera] Univ Cologne, Inst Biochem, D-50937 Cologne, Germany	Max Planck Society; Global Phasing Limited; University of Cologne	Ziegler, C (corresponding author), Max Planck Inst Biophys, Dept Biol Struct, D-60438 Frankfurt, Germany.	christine.ziegler@mpibp-frankfurt.mpg.de	Ressl, Susanne/AAT-2517-2021	Ziegler, Christine Maria/0000-0003-3439-7213	German Research Foundation; Collaborative Research Centre 807 'Transport and Communication across Biological Membranes'	German Research Foundation(German Research Foundation (DFG)); Collaborative Research Centre 807 'Transport and Communication across Biological Membranes'	The authors thank W. Kuhlbrandt and R. Kramer for support and comments on the manuscript; J. StandfuB for contributions in the early stages of the project; O. Yildiz, T. Barros and R. Wouts for computational support; S. Schulze, S. Morbach, S. Nicklisch and L. Forrest for discussions; J. Hakulinen and J. Carrera for cloning, C. Perez for the reconstitution and freeze fracture experiments; and H. Volk for help with the figures. Special thanks are due to E. Pohl and the X10SA beamline staff at the Swiss Light Source, as well as the European Synchrotron Radiation Facility. This work is supported by the German Research Foundation, Collaborative Research Centre 807 'Transport and Communication across Biological Membranes'.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Athawale MV, 2005, BIOPHYS J, V89, P858, DOI 10.1529/biophysj.104.056671; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Blomberg A, 1997, ELECTROPHORESIS, V18, P1429, DOI 10.1002/elps.1150180818; Bolen DW, 2008, ANNU REV BIOCHEM, V77, P339, DOI 10.1146/annurev.biochem.77.061306.131357; Borden LA, 1996, NEUROCHEM INT, V29, P335, DOI 10.1016/0197-0186(95)00158-1; Burg MB, 2008, J BIOL CHEM, V283, P7309, DOI 10.1074/jbc.R700042200; BURG MB, 1995, AM J PHYSIOL-RENAL, V268, pF983, DOI 10.1152/ajprenal.1995.268.6.F983; Chang AB, 2004, MOL MEMBR BIOL, V21, P171, DOI 10.1080/09687680410001720830; Cowtan K., 1994, JT CCP4 ESF EACBM NE, V31, P34; da Costa M. S., 1998, V61, P117; Empadinhas N, 2006, INT MICROBIOL, V9, P199; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; FARWICK M, 1995, J BACTERIOL, V177, P4690, DOI 10.1128/jb.177.16.4690-4695.1995; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; GARCIAPEREZ A, 1990, HYPERTENSION, V16, P595, DOI 10.1161/01.HYP.16.6.595; Horn C, 2006, J MOL BIOL, V357, P592, DOI 10.1016/j.jmb.2005.12.085; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kappes RM, 1996, J BACTERIOL, V178, P5071, DOI 10.1128/jb.178.17.5071-5079.1996; Kempf B, 1998, ARCH MICROBIOL, V170, P319, DOI 10.1007/s002030050649; Kempson SA, 2004, PFLUG ARCH EUR J PHY, V449, P227, DOI 10.1007/s00424-004-1338-6; KINNE RKH, 1993, J EXP ZOOL, V265, P346, DOI 10.1002/jez.1402650403; Kuhlmann SI, 2008, BIOCHEMISTRY-US, V47, P9475, DOI 10.1021/bi8006719; Lang F, 2007, J AM COLL NUTR, V26, p613S, DOI 10.1080/07315724.2007.10719667; Lim CH, 2007, METHOD ENZYMOL, V428, P325, DOI 10.1016/S0076-6879(07)28019-x; Lolkema JS, 2008, MOL MEMBR BIOL, V25, P567, DOI 10.1080/09687680802541177; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Neuhofer W, 2005, CONTRIB NEPHROL, V148, P21, DOI 10.1159/000086041; Ott V, 2008, BIOCHEMISTRY-US, V47, P12208, DOI 10.1021/bi801325r; Palsdottir H, 2004, BBA-BIOMEMBRANES, V1666, P2, DOI 10.1016/j.bbamem.2004.06.012; Peter H, 1998, J BIOL CHEM, V273, P2567, DOI 10.1074/jbc.273.5.2567; Peter H, 1996, J BACTERIOL, V178, P5229, DOI 10.1128/jb.178.17.5229-5234.1996; Pfluger K, 2004, J BIOENERG BIOMEMBR, V36, P17, DOI 10.1023/B:JOBB.0000019594.43450.c5; Rapp M, 2006, NAT STRUCT MOL BIOL, V13, P112, DOI 10.1038/nsmb1057; Roberts MF, 2000, FRONT BIOSCI-LANDMRK, V5, pD796, DOI 10.2741/roberts; Rosgen J, 2007, METHOD ENZYMOL, V428, P459, DOI 10.1016/S0076-6879(07)28026-7; Saier MH, 2000, MOL MICROBIOL, V35, P699, DOI 10.1046/j.1365-2958.2000.01759.x; Schiefner A, 2004, J BIOL CHEM, V279, P48270, DOI 10.1074/jbc.M403540200; Schiefner A, 2004, J BIOL CHEM, V279, P5588, DOI 10.1074/jbc.M309771200; Schiller D, 2004, BIOCHEMISTRY-US, V43, P5583, DOI 10.1021/bi0359628; Schiller D, 2004, FEBS LETT, V563, P108, DOI 10.1016/S0014-5793(04)00279-0; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Smicun Y, 1999, J BIOL CHEM, V274, P36058, DOI 10.1074/jbc.274.51.36058; Stephan MM, 1997, BIOCHEMISTRY-US, V36, P1322, DOI 10.1021/bi962150l; Tanford C, 1970, Adv Protein Chem, V24, P1, DOI 10.1016/S0065-3233(08)60241-7; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Tuteja N, 2007, METHOD ENZYMOL, V428, P419, DOI 10.1016/S0076-6879(07)28024-3; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Wood JM, 2007, METHOD ENZYMOL, V428, P77, DOI 10.1016/S0076-6879(07)28005-X; Wood JM, 2001, COMP BIOCHEM PHYS A, V130, P437, DOI 10.1016/S1095-6433(01)00442-1; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yancey PH, 2005, J EXP BIOL, V208, P2819, DOI 10.1242/jeb.01730; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Ziegler C, 2004, J MOL BIOL, V337, P1137, DOI 10.1016/j.jmb.2004.02.026	59	257	258	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 5	2009	458	7234					47	U1		10.1038/nature07819	http://dx.doi.org/10.1038/nature07819			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414AJ	19262666	Green Published, Green Submitted			2022-12-01	WOS:000263836000029
J	Lyle, K; Kumar, P; Wittmann, T				Lyle, Karen; Kumar, Praveen; Wittmann, Torsten			SnapShot: Microtubule Regulators II	CELL			English	Editorial Material							PROTEINS; FAMILY		[Lyle, Karen; Kumar, Praveen; Wittmann, Torsten] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Lyle, K (corresponding author), Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA.		Wittmann, Torsten/F-9833-2013	Wittmann, Torsten/0000-0001-9134-691X	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE007306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079139] Funding Source: NIH RePORTER; NIDCR NIH HHS [5T32DE007306, T32 DE007306] Funding Source: Medline; NIGMS NIH HHS [R01 GM079139, R01GM079139] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Amos LA, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-229; Bosc C, 2003, BIOCHEMISTRY-US, V42, P12125, DOI 10.1021/bi0352163; Clarke PR, 2008, NAT REV MOL CELL BIO, V9, P464, DOI 10.1038/nrm2410; Davis TN, 2007, TRENDS CELL BIOL, V17, P377, DOI 10.1016/j.tcb.2007.08.001; Dehmelt L, 2005, GENOME BIOL, V6; DeWard AD, 2008, CURR BIOL, V18, pR605, DOI 10.1016/j.cub.2008.06.001; Halpain S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-224; Manning AL, 2008, CURR OPIN CELL BIOL, V20, P101, DOI 10.1016/j.ceb.2007.11.004; Peset I, 2008, TRENDS CELL BIOL, V18, P379, DOI 10.1016/j.tcb.2008.06.005	10	12	12	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 6	2009	136	3							566.e1	10.1016/j.cell.2009.01.011	http://dx.doi.org/10.1016/j.cell.2009.01.011			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	403ZN	19203588	Green Accepted, Bronze			2022-12-01	WOS:000263120600025
J	Bastolla, U; Fortuna, MA; Pascual-Garcia, A; Ferrera, A; Luque, B; Bascompte, J				Bastolla, Ugo; Fortuna, Miguel A.; Pascual-Garcia, Alberto; Ferrera, Antonio; Luque, Bartolo; Bascompte, Jordi			The architecture of mutualistic networks minimizes competition and increases biodiversity	NATURE			English	Article							COEVOLUTIONARY NETWORKS; POLLINATION NETWORKS; MODEL-ECOSYSTEMS; MAINTENANCE; DIVERSITY; STABILITY; COMPLEX	The main theories of biodiversity either neglect species interactions(1,2) or assume that species interact randomly with each other(3,4). However, recent empirical work has revealed that ecological networks are highly structured(5-7), and the lack of a theory that takes into account the structure of interactions precludes further assessment of the implications of such network patterns for biodiversity. Here we use a combination of analytical and empirical approaches to quantify the influence of network architecture on the number of coexisting species. As a case study we consider mutualistic networks between plants and their animal pollinators or seed dispersers(5,8-11). These networks have been found to be highly nested(5), with the more specialist species interacting only with proper subsets of the species that interact with the more generalist. We show that nestedness reduces effective interspecific competition and enhances the number of coexisting species. Furthermore, we show that a nested network will naturally emerge if new species are more likely to enter the community where they have minimal competitive load. Nested networks seem to occur in many biological and social contexts(12-14), suggesting that our results are relevant in a wide range of fields.	[Fortuna, Miguel A.; Bascompte, Jordi] CSIC, Estac Biol Donana, Integrat Ecol Grp, Seville 41092, Spain; [Bastolla, Ugo; Pascual-Garcia, Alberto] Univ Autonoma Madrid, CSIC, Ctr Mol Biol, E-28049 Madrid, Spain; [Ferrera, Antonio; Luque, Bartolo] Univ Politecn Madrid, Dept Matemat Aplicada & Estadist, ETSI Aeronaut, E-28040 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Politecnica de Madrid	Bascompte, J (corresponding author), CSIC, Estac Biol Donana, Integrat Ecol Grp, C Amer Vespucio S-N, Seville 41092, Spain.	bascompte@ebd.csic.es	Bascompte, Jordi/B-7596-2008; Bastolla, Ugo/H-6330-2015; Luque, Bartolo/B-3646-2018; Fortuna, Miguel A/D-4154-2013	Bascompte, Jordi/0000-0002-0108-6411; Bastolla, Ugo/0000-0001-9342-4678; Luque, Bartolo/0000-0002-0396-4396; Fortuna, Miguel A/0000-0002-8374-1941; Pascual Garcia, Alberto/0000-0002-8444-3196	Spanish Ministry of Science and Technology; European Heads of Research Councils; European Science Foundation; EC; Ramon Areces Foundation	Spanish Ministry of Science and Technology(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Heads of Research Councils; European Science Foundation(European Science Foundation (ESF)European Commission); EC(European CommissionEuropean Commission Joint Research Centre); Ramon Areces Foundation	We thank P. Jordano and J. Olesen for providing data and insight, A. Ramirez Ortiz for discussions and P. Buston and D. Stouffer for comments on a previous draft. J. Olesen provided the drawings in Fig. 1. Funding was provided by the Spanish Ministry of Science and Technology (through a Ramon y Cajal Contract and a Consolider Ingenio Project to U. B., a PhD Fellowship to M. A. F. and a grant to B. L.) and by the European Heads of Research Councils, the European Science Foundation, and the EC Sixth Framework Programme through a European Young Investigator Award (J. B.). Research at the Centro de Biologia Molecular Severo Ochoa is facilitated by an institutional grant from the Ramon Areces Foundation.	Alonso D, 2006, TRENDS ECOL EVOL, V21, P451, DOI 10.1016/j.tree.2006.03.019; ATMAR W, 1993, OECOLOGIA, V96, P373, DOI 10.1007/BF00317508; Bascompte J, 2006, SCIENCE, V312, P431, DOI 10.1126/science.1123412; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bastolla U, 2005, J THEOR BIOL, V235, P531, DOI 10.1016/j.jtbi.2005.02.006; Bastolla U, 2005, J THEOR BIOL, V235, P521, DOI 10.1016/j.jtbi.2005.02.005; Burgos E, 2007, J THEOR BIOL, V249, P307, DOI 10.1016/j.jtbi.2007.07.030; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Fortuna MA, 2006, ECOL LETT, V9, P278, DOI 10.1111/j.1461-0248.2005.00868.x; Guimaraes PR, 2007, BIOL LETTERS, V3, P51, DOI 10.1098/rsbl.2006.0562; Holland JN, 2006, SCIENCE, V313, P1887, DOI 10.1126/science.1129547; Jordano P, 2003, ECOL LETT, V6, P69, DOI 10.1046/j.1461-0248.2003.00403.x; Lieberman E, 2005, NATURE, V433, P312, DOI 10.1038/nature03204; May RM, 1974, SYST MAN CYBERN, DOI 10.2307/j.ctvs32rq4; May RM, 2008, NATURE, V451, P893, DOI 10.1038/451893a; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Montoya JM, 2006, NATURE, V442, P259, DOI 10.1038/nature04927; Okuyama T, 2008, ECOL LETT, V11, P208, DOI 10.1111/j.1461-0248.2007.01137.x; Olesen JM, 2007, P NATL ACAD SCI USA, V104, P19891, DOI 10.1073/pnas.0706375104; Pachepsky E, 2002, ARTIF LIFE, V8, P5, DOI 10.1162/106454602753694747; Pascual M., 2006, ECOLOGICAL NETWORKS; Rezende EL, 2007, NATURE, V448, P925, DOI 10.1038/nature05956; Rikvold PA, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.031913; Saavedra S, 2009, NATURE, V457, P463, DOI 10.1038/nature07532; Sugihara G., 1984, P S APPL MATH, V30, P83, DOI DOI 10.1090/PSAPM/030/738641; SUGIHARA G, 1982, THESIS PRINCETON U; Tokita K, 2003, THEOR POPUL BIOL, V63, P131, DOI 10.1016/S0040-5809(02)00038-2; Vazquez DP, 2004, ECOLOGY, V85, P1251, DOI 10.1890/03-3112; Volkov I, 2007, NATURE, V450, P45, DOI 10.1038/nature06197; WRIGHT DH, 1989, AM NAT, V134, P664, DOI 10.1086/285003	30	652	665	16	371	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	2009	458	7241					1018	U91		10.1038/nature07950	http://dx.doi.org/10.1038/nature07950			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436KL	19396144				2022-12-01	WOS:000265412900040
J	Hara, K; Shiga, A; Fukutake, T; Nozaki, H; Miyashita, A; Yokoseki, A; Kawata, H; Koyama, A; Arima, K; Takahashi, T; Ikeda, M; Shiota, H; Tamura, M; Shimoe, Y; Hirayama, M; Arisato, T; Yanagawa, S; Tanaka, A; Nakano, I; Ikeda, S; Yoshida, Y; Yamamoto, T; Ikeuchi, T; Kuwano, R; Nishizawa, M; Tsuji, S; Onodera, O				Hara, Kenju; Shiga, Atsushi; Fukutake, Toshio; Nozaki, Hiroaki; Miyashita, Akinori; Yokoseki, Akio; Kawata, Hirotoshi; Koyama, Akihide; Arima, Kunimasa; Takahashi, Toshiaki; Ikeda, Mari; Shiota, Hiroshi; Tamura, Masato; Shimoe, Yutaka; Hirayama, Mikio; Arisato, Takayo; Yanagawa, Sohei; Tanaka, Akira; Nakano, Imaharu; Ikeda, Shu-ichi; Yoshida, Yutaka; Yamamoto, Tadashi; Ikeuchi, Takeshi; Kuwano, Ryozo; Nishizawa, Masatoyo; Tsuji, Shoji; Onodera, Osamu			Association of HTRA1 Mutations and Familial Ischemic Cerebral Small-Vessel Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SMOOTH-MUSCLE-CELLS; AUTOSOMAL RECESSIVE ARTERIOPATHY; BONE MORPHOGENETIC PROTEINS; SERINE-PROTEASE HTRA1; GROWTH-FACTOR; MACULAR DEGENERATION; EXTRACELLULAR-MATRIX; SUBCORTICAL INFARCTS; BETA; EXPRESSION	BACKGROUND The genetic cause of cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL), which is characterized by ischemic, non-hypertensive, cerebral small-vessel disease with associated alopecia and spondylosis, is unclear. METHODS In five families with CARASIL, we carried out linkage analysis, fine mapping of the region implicated in the disease, and sequence analysis of a candidate gene. We also conducted functional analysis of wild-type and mutant gene products and measured the signaling by members of the transforming growth factor beta (TGF-beta) family and gene and protein expression in the small arteries in the cerebrum of two patients with CARASIL. RESULTS We found linkage of the disease to the 2.4-Mb region on chromosome 10q, which contains the HtrA serine protease 1 (HTRA1) gene. HTRA1 is a serine protease that represses signaling by TGF-beta family members. Sequence analysis revealed two nonsense mutations and two missense mutations in HTRA1. The missense mutations and one of the nonsense mutations resulted in protein products that had comparatively low levels of protease activity and did not repress signaling by the TGF-beta family. The other nonsense mutation resulted in the loss of HTRA1 protein by nonsense-mediated decay of messenger RNA. Immunohistochemical analysis of the cerebral small arteries in affected persons showed increased expression of the extra domain-A region of fibronectin and versican in the thickened tunica intima and of TGF-beta 1 in the tunica media. CONCLUSIONS CARASIL is associated with mutations in the HTRA1 gene. Our findings indicate a link between repressed inhibition of signaling by the TGF-beta family and ischemic cerebral small-vessel disease, alopecia, and spondylosis.	[Hara, Kenju; Shiga, Atsushi; Nozaki, Hiroaki; Miyashita, Akinori; Yokoseki, Akio; Koyama, Akihide; Takahashi, Toshiaki; Ikeda, Mari; Yoshida, Yutaka; Yamamoto, Tadashi; Ikeuchi, Takeshi; Kuwano, Ryozo; Nishizawa, Masatoyo; Onodera, Osamu] Niigata Univ, Niigata, Japan; [Fukutake, Toshio] Kameda Med Ctr, Kamogawa City, Chiba, Japan; [Kawata, Hirotoshi; Tanaka, Akira; Nakano, Imaharu] Jichi Med Univ, Shimotsuke, Tochigi, Japan; [Arima, Kunimasa] Natl Ctr Neurol & Psychiat, Tokyo, Japan; [Shiota, Hiroshi] Nihon Univ, Sch Med, Tokyo, Japan; [Tamura, Masato] Nagaoka Nishi Hosp, Nagaoka, Niigata, Japan; [Shimoe, Yutaka] Kashima Rosai Hosp, Kashima, Japan; [Hirayama, Mikio] Kasugai Municipal Hosp, Kasugai, Aichi, Japan; [Arisato, Takayo] Minamikyushu Natl Hosp, Kagoshima, Japan; [Yanagawa, Sohei] Iida Municipal Hosp, Iida, Japan; [Ikeda, Shu-ichi] Shinshu Univ, Sch Med, Matsumoto, Nagano 390, Japan; [Tsuji, Shoji] Univ Tokyo, Tokyo, Japan	Niigata University; Jichi Medical University; National Center for Neurology & Psychiatry - Japan; Nihon University; Shinshu University; University of Tokyo	Onodera, O (corresponding author), Brain Res Inst, Niigata 9518585, Japan.	onodera@bri.niigata-u.ac.jp	Onodera, Osamu/K-7327-2013	Onodera, Osamu/0000-0003-3354-5472; Dichgans, Martin/0000-0002-0654-387X	Advanced Brain Science Project and Applied Genomics; Center for Integrated Brain Medical Science; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science, and Niigata University	Advanced Brain Science Project and Applied Genomics; Center for Integrated Brain Medical Science; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science, and Niigata University(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Supported in part by grants from the Advanced Brain Science Project and Applied Genomics, the Center for Integrated Brain Medical Science, the Ministry of Education, Culture, Sports, Science, and Technology of Japan, the Japan Society for the Promotion of Science, and Niigata University.	Botchkarev VA, 2003, J INVEST DERMATOL, V120, P36, DOI 10.1046/j.1523-1747.2003.12002.x; BRUNNER AM, 1989, J BIOL CHEM, V264, P13660; Chui HC, 2007, NEUROL CLIN, V25, P717, DOI 10.1016/j.ncl.2007.04.003; Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; De Luca A, 2003, J HISTOCHEM CYTOCHEM, V51, P1279, DOI 10.1177/002215540305101004; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; FUKUTAKE T, 1995, EUR NEUROL, V35, P69, DOI 10.1159/000117096; Gazzerro E, 1998, J CLIN INVEST, V102, P2106, DOI 10.1172/JCI3459; Gilicze A, 2007, MOL IMMUNOL, V44, P2961, DOI 10.1016/j.molimm.2007.01.004; GLUKHOVA MA, 1989, J CELL BIOL, V109, P357, DOI 10.1083/jcb.109.1.357; Gould DB, 2006, NEW ENGL J MED, V354, P1489, DOI 10.1056/NEJMoa053727; Grainger DJ, 2004, ARTERIOSCL THROM VAS, V24, P399, DOI 10.1161/01.ATV.0000114567.76772.33; Grau S, 2005, P NATL ACAD SCI USA, V102, P6021, DOI 10.1073/pnas.0501823102; Hadfield KD, 2008, J BIOL CHEM, V283, P5928, DOI 10.1074/jbc.M709299200; Hillger F, 2005, J BIOL CHEM, V280, P14974, DOI 10.1074/jbc.M414413200; Hu SI, 1998, J BIOL CHEM, V273, P34406, DOI 10.1074/jbc.273.51.34406; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Katagiri T, 2002, GENES CELLS, V7, P949, DOI 10.1046/j.1365-2443.2002.00573.x; Kuzmiak HA, 2006, TRENDS MOL MED, V12, P306, DOI 10.1016/j.molmed.2006.05.005; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Launay S, 2008, CELL DEATH DIFFER, V15, P1408, DOI 10.1038/cdd.2008.82; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Liu X, 2001, P NATL ACAD SCI USA, V98, P9139, DOI 10.1073/pnas.161016098; MAEDA S, 1976, Folia Psychiatrica et Neurologica Japonica, V30, P165; O'Callaghan CJ, 2000, HYPERTENSION, V36, P319, DOI 10.1161/01.HYP.36.3.319; Oide T, 2008, NEUROPATHOLOGY, V28, P132, DOI 10.1111/j.1440-1789.2007.00864.x; Oka C, 2004, DEVELOPMENT, V131, P1041, DOI 10.1242/dev.00999; Okeda R, 2004, NEUROPATHOLOGY, V24, P21, DOI 10.1111/j.1440-1789.2003.00534.x; Revesz T, 2003, J NEUROPATH EXP NEUR, V62, P885, DOI 10.1093/jnen/62.9.885; Richards A, 2007, NAT GENET, V39, P1068, DOI 10.1038/ng2082; SCHONHERR E, 1991, J BIOL CHEM, V266, P17640; Tanoi Y, 2000, ACTA NEUROPATHOL, V100, P347, DOI 10.1007/s004010000203; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; Tsuchiya A, 2005, BONE, V37, P323, DOI 10.1016/j.bone.2005.03.015; Yanagawa S, 2002, NEUROLOGY, V58, P817, DOI 10.1212/WNL.58.5.817; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811; Yoon BS, 2004, J CELL BIOCHEM, V93, P93, DOI 10.1002/jcb.20211; Zacchigna L, 2006, CELL, V124, P929, DOI 10.1016/j.cell.2005.12.035	39	306	330	1	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 23	2009	360	17					1729	1739		10.1056/NEJMoa0801560	http://dx.doi.org/10.1056/NEJMoa0801560			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	435XY	19387015	Bronze			2022-12-01	WOS:000265377800007
J	Cornelis, MC; Qi, L; Zhang, CL; Kraft, P; Manson, J; Cai, TX; Hunter, DJ; Hu, FB				Cornelis, Marilyn C.; Qi, Lu; Zhang, Cuilin; Kraft, Peter; Manson, JoAnn; Cai, Tianxi; Hunter, David J.; Hu, Frank B.			Joint Effects of Common Genetic Variants on the Risk for Type 2 Diabetes in U. S. Men and Women of European Ancestry	ANNALS OF INTERNAL MEDICINE			English	Article							GENOME-WIDE ASSOCIATION; PHYSICAL-ACTIVITY; NURSES HEALTH; LIFE-STYLE; FAT MASS; MELLITUS; LOCI; REPRODUCIBILITY; DISCRIMINATION; REPLICATION	Background: Genome-wide association studies have identified novel type 2 diabetes loci, each of which has a modest impact on risk. Objective: To examine the joint effects of several type 2 diabetes risk variants and their combination with conventional risk factors on type 2 diabetes risk in 2 prospective cohorts. Design: Nested case-control study. Setting: United States. Participants: 2809 patients with type 2 diabetes and 3501 healthy control participants of European ancestry from the Health Professionals Follow-up Study and Nurses' Health Study. Measurements: A genetic risk score (GRS) was calculated on the basis of 10 polymorphisms in 9 loci. Results: After adjustment for age and body mass index (BMI), the odds ratio for type 2 diabetes with each point of GRS, corresponding to 1 risk allele, was 1.19 ( 95% CI, 1.14 to 1.24) and 1.16 (CI, 1.12 to 1.20) for men and women, respectively. Persons with a BMI of 30 kg/m(2) or greater and a GRS in the highest quintile had an odds ratio of 14.06 (CI, 8.90 to 22.18) compared with persons with a BMI less than 25 kg/m(2) and a GRS in the lowest quintile after adjustment for age and sex. Persons with a positive family history of diabetes and a GRS in the highest quintile had an odds ratio of 9.20 (CI, 5.50 to 15.40) compared with persons without a family history of diabetes and with a GRS in the lowest quintile. The addition of the GRS to a model of conventional risk factors improved discrimination by 1% ( P < 0.001). Limitation: The study focused only on persons of European ancestry; whether GRS is associated with type 2 diabetes in other ethnic groups remains unknown. Conclusion: Although its discriminatory value is currently limited, a GRS that combines information from multiple genetic variants might be useful for identifying subgroups with a particularly high risk for type 2 diabetes.	[Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Channing Lab, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA 02115 USA; Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Rockville, MD USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Hu, FB (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, Channing Lab, Bldg 2,665 Huntington Ave, Boston, MA 02115 USA.	frank.hu@channing.harvard.edu	Hu, Frank/C-1919-2013	Zhang, Cuilin/0000-0002-8014-2708	National Institutes of Health [DK58845, CA87969]; Canadian Institutes of Health Research Fellowship; American Heart Association Scientist Development; Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008888] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA087969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058845] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research Fellowship(Canadian Institutes of Health Research (CIHR)); American Heart Association Scientist Development(American Heart Association); Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	By the National Institutes of Health (grants DK58845 and CA87969). Dr. Cornelis is a recipient of a Canadian Institutes of Health Research Fellowship. Dr. Qi is a recipient of the American Heart Association Scientist Development Award. Dr. Zhang is supported by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development.	Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cauchi S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002031; Cauchi S, 2007, J MOL MED, V85, P777, DOI 10.1007/s00109-007-0203-4; Colditz GA, 2005, NAT REV CANCER, V5, P388, DOI 10.1038/nrc1608; Colditz GA, 1997, J WOMENS HEALTH, V6, P49, DOI 10.1089/jwh.1997.6.49; Field AE, 2001, ARCH INTERN MED, V161, P1581, DOI 10.1001/archinte.161.13.1581; Frayling TM, 2007, NAT REV GENET, V8, P657, DOI 10.1038/nrg2178; Gavin JR, 1997, DIABETES CARE, V20, P1183; Gregg EW, 2004, DIABETES CARE, V27, P2806, DOI 10.2337/diacare.27.12.2806; HARRIS M, 1979, DIABETES, V28, P1039; Hu FB, 2004, DIABETES, V53, P209, DOI 10.2337/diabetes.53.1.209; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Hu FB, 2001, ARCH INTERN MED, V161, P1542, DOI 10.1001/archinte.161.12.1542; KAPRIO J, 1992, DIABETOLOGIA, V35, P1060, DOI 10.1007/BF02221682; Lango H, 2008, DIABETES, V57, P3129, DOI 10.2337/db08-0504; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Ludovico O, 2007, OBESITY, V15, P1076, DOI 10.1038/oby.2007.617; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; MANSON JE, 1991, LANCET, V338, P774, DOI 10.1016/0140-6736(91)90664-B; Meigs JB, 2008, NEW ENGL J MED, V359, P2208, DOI 10.1056/NEJMoa0804742; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Petersen M, 2003, DIABETES CARE, V26, P917; Qi L, 2008, DIABETES, V57, P3145, DOI 10.2337/db08-0006; Qi L, 2006, HUM MOL GENET, V15, P1914, DOI 10.1093/hmg/ddl113; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; RIMM EB, 1991, LANCET, V338, P464, DOI 10.1016/0140-6736(91)90542-W; Rimm EB, 1992, AM J EPIDEMIOL, V135, P1127, DOI DOI 10.1093/OXFORDJOURNALS.AJE.A116211; RISCH N, 1990, AM J HUM GENET, V46, P222; Sandhu MS, 2007, NAT GENET, V39, P951, DOI 10.1038/ng2067; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schulze MB, 2005, ANNU REV PUBL HEALTH, V26, P445, DOI 10.1146/annurev.publhealth.26.021304.144532; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; van Dam RM, 2005, DIABETIC MED, V22, P590, DOI 10.1111/j.1464-5491.2005.01465.x; van Hoek M, 2008, DIABETES, V57, P3122, DOI 10.2337/db08-0425; Weedon MN, 2006, PLOS MED, V3, P1877, DOI 10.1371/journal.pmed.0030374; WILLETT W, 1983, AM J EPIDEMIOL, V117, P651, DOI 10.1093/oxfordjournals.aje.a113598; Willett W., 2013, NUTR EPIDEMIOLOGY, V3rd; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	45	179	189	1	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 21	2009	150	8					541	W98		10.7326/0003-4819-150-8-200904210-00008	http://dx.doi.org/10.7326/0003-4819-150-8-200904210-00008			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437AD	19380854	Green Accepted			2022-12-01	WOS:000265457000004
J	Fletcher, CM; Coyne, MJ; Villa, OF; Chatzidaki-Livanis, M; Comstock, LE				Fletcher, C. Mark; Coyne, Michael J.; Villa, Otto F.; Chatzidaki-Livanis, Maria; Comstock, Laurie E.			A General O-Glycosylation System Important to the Physiology of a Major Human Intestinal Symbiont	CELL			English	Article							HOST-MICROBIAL INTERACTIONS; PROTEIN GLYCOSYLATION; DNA INVERSIONS; DIVERSITY; SURFACE; BIOSYNTHESIS; LIPOPROTEIN; EXPRESSION; BACTERIA; GLYCOPROTEINS	The Bacteroides are a numerically dominant genus of the human intestinal microbiota. These organisms harbor a rare bacterial pathway for incorporation of exogenous fucose into capsular polysaccharides and glycoproteins. The infrequency of glycoprotein synthesis by bacteria prompted a more detailed analysis of this process. Here, we demonstrate that Bacteroides fragilis has a general O-glycosylation system. The proteins targeted for glycosylation include those predicted to be involved in protein folding, protein-protein interactions, peptide degradation as well as surface lipoproteins. Protein glycosylation is central to the physiology of B. fragilis and is necessary for the organism to competitively colonize the mammalian intestine. We provide evidence that general O-glycosylation systems are conserved among intestinal Bacteroides species and likely contribute to the predominance of Bacteroides in the human intestine.	[Fletcher, C. Mark; Coyne, Michael J.; Chatzidaki-Livanis, Maria; Comstock, Laurie E.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA; [Villa, Otto F.] Mt Sinai Sch Med, Dept Med, Pulm Crit Care & Sleep Div, New York, NY 10029 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Icahn School of Medicine at Mount Sinai	Comstock, LE (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Channing Lab, 181 Longwood Ave, Boston, MA 02115 USA.	lcomstock@rics.bwh.harvard.edu			NCRR [RR018502]; NIH/NIAID [AI067711]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR018502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067711] Funding Source: NIH RePORTER	NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank P. Azadi and S. Park of the Complex Carbohydrate Research Center (CCRC) for glycan release and Z. Waldon of Children's Hospital Boston for MS. This work was supported in part by NCRR grant RR018502 to the CCRC and mostly by NIH/NIAID grant AI067711.	Bayley DP, 2000, FEMS MICROBIOL LETT, V193, P149, DOI 10.1016/S0378-1097(00)00472-9; Benz I, 2002, MOL MICROBIOL, V45, P267, DOI 10.1046/j.1365-2958.2002.03030.x; Bry L, 1996, SCIENCE, V273, P1380, DOI 10.1126/science.273.5280.1380; Cerdeno-Tarraga AM, 2005, SCIENCE, V307, P1463, DOI 10.1126/science.1107008; Comstock LE, 2000, INFECT IMMUN, V68, P6182, DOI 10.1128/IAI.68.11.6182-6188.2000; Coyne MJ, 2008, P NATL ACAD SCI USA, V105, P13099, DOI 10.1073/pnas.0804220105; Coyne MJ, 2008, J BACTERIOL, V190, P736, DOI 10.1128/JB.01559-07; Coyne MJ, 2005, SCIENCE, V307, P1778, DOI 10.1126/science.1106469; Coyne MJ, 2001, INFECT IMMUN, V69, P4342, DOI 10.1128/IAI.69.7.4342-4350.2001; Duguay AR, 2004, BBA-MOL CELL RES, V1694, P121, DOI 10.1016/j.bbamcr.2004.04.012; Dutton RJ, 2008, P NATL ACAD SCI USA, V105, P11933, DOI 10.1073/pnas.0804621105; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Faridmoayer A, 2007, J BACTERIOL, V189, P8088, DOI 10.1128/JB.01318-07; Fletcher CM, 2007, P NATL ACAD SCI USA, V104, P2413, DOI 10.1073/pnas.0608797104; GAREN A, 1960, BIOCHIM BIOPHYS ACTA, V38, P470, DOI 10.1016/0006-3002(60)91282-8; Haltiwanger RS, 2004, ANNU REV BIOCHEM, V73, P491, DOI 10.1146/annurev.biochem.73.011303.074043; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hooper LV, 2003, NAT IMMUNOL, V4, P269, DOI 10.1038/ni888; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Krinos CM, 2001, NATURE, V414, P555, DOI 10.1038/35107092; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; LANGSFORD ML, 1987, FEBS LETT, V225, P163, DOI 10.1016/0014-5793(87)81150-X; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; MELDGAARD M, 1994, MICROBIOL-UK, V140, P159, DOI 10.1099/13500872-140-1-159; MIDTVEDT T, 1974, AM J CLIN NUTR, V27, P1341, DOI 10.1093/ajcn/27.11.1341; Nakatsukasa K, 2004, J BIOL CHEM, V279, P49762, DOI 10.1074/jbc.M403234200; NOLTMANN EA, 1966, METHOD ENZYMOL, V9, P557; Nsofor MN, 2006, BBA-GEN SUBJECTS, V1760, P1160, DOI 10.1016/j.bbagen.2006.03.004; O'Keefe SJD, 2008, CURR OPIN GASTROEN, V24, P51, DOI 10.1097/MOG.0b013e3282f323f3; Penders J, 2007, ALLERGY, V62, P1223, DOI 10.1111/j.1398-9995.2007.01462.x; PLUMMER TH, 1995, J BIOL CHEM, V270, P13192, DOI 10.1074/jbc.270.22.13192; Reilly TJ, 1999, J BACTERIOL, V181, P6797, DOI 10.1128/JB.181.21.6797-6805.1999; Salyers AA, 2004, TRENDS MICROBIOL, V12, P412, DOI 10.1016/j.tim.2004.07.004; SALYERS AA, 1980, J BACTERIOL, V143, P781, DOI 10.1128/JB.143.2.781-788.1980; Santos-Silva T, 2007, J MOL BIOL, V370, P659, DOI 10.1016/j.jmb.2007.04.055; Schaffer C, 2001, PROTEOMICS, V1, P248; Shipman JA, 1999, J BACTERIOL, V181, P7206, DOI 10.1128/JB.181.23.7206-7211.1999; Sijbrandi R, 2008, MICROBES INFECT, V10, P514, DOI 10.1016/j.micinf.2008.01.015; SMITH CJ, 1992, PLASMID, V27, P141, DOI 10.1016/0147-619X(92)90014-2; Steiner K, 2008, J BIOL CHEM, V283, P21120, DOI 10.1074/jbc.M801833200; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Sund CJ, 2008, MOL MICROBIOL, V67, P129, DOI 10.1111/j.1365-2958.2007.06031.x; Szymanski CM, 2005, NAT REV MICROBIOL, V3, P225, DOI 10.1038/nrmicro1100; Szymanski CM, 1999, MOL MICROBIOL, V32, P1022, DOI 10.1046/j.1365-2958.1999.01415.x; THOMPSON JS, 1990, J BACTERIOL, V172, P2584, DOI 10.1128/jb.172.5.2584-2593.1990; TOKUDA H, 2004, BIOCHIM BIOPHYS ACTA, V1694, pN1; Vik A, 2009, P NATL ACAD SCI USA, V106, P4447, DOI 10.1073/pnas.0809504106; Wacker M, 2002, SCIENCE, V298, P1790, DOI 10.1126/science.298.5599.1790; Weinacht KG, 2004, MOL MICROBIOL, V53, P1319, DOI 10.1111/j.1365-2958.2004.04219.x; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; Xu J, 2007, PLOS BIOL, V5, P1574, DOI 10.1371/journal.pbio.0050156; YAMAGUCHI K, 1988, CELL, V53, P423, DOI 10.1016/0092-8674(88)90162-6; Young NM, 2002, J BIOL CHEM, V277, P42530, DOI 10.1074/jbc.M206114200	57	126	134	4	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 17	2009	137	2					321	331		10.1016/j.cell.2009.02.041	http://dx.doi.org/10.1016/j.cell.2009.02.041			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	437AB	19379697	Green Accepted, Bronze			2022-12-01	WOS:000265456800024
J	Kramer, JM				Kramer, Judith M.			Balancing the Benefits and Risks of Inhaled Long-Acting Beta-Agonists - The Influence of Values	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Duke Univ, Med Ctr, Duke Translat Med Inst, Clin Trials Transformat Initiat, Durham, NC 27710 USA	Duke University	Kramer, JM (corresponding author), Duke Univ, Med Ctr, Duke Translat Med Inst, Clin Trials Transformat Initiat, Durham, NC 27710 USA.							[Anonymous], [No title captured]; Martinez FD, 2005, NEW ENGL J MED, V353, P2637, DOI 10.1056/NEJMp058299; Nelson HS, 2006, CHEST, V129, P15, DOI 10.1378/chest.129.1.15	3	84	86	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 16	2009	360	16					1592	1595		10.1056/NEJMp0810561	http://dx.doi.org/10.1056/NEJMp0810561			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	433BH	19369665				2022-12-01	WOS:000265178000003
J	Cook, PJ; Ju, BG; Telese, F; Wang, XT; Glass, CK; Rosenfeld, MG				Cook, Peter J.; Ju, Bong Gun; Telese, Francesca; Wang, Xiangting; Glass, Christopher K.; Rosenfeld, Michael G.			Tyrosine dephosphorylation of H2AX modulates apoptosis and survival decisions	NATURE			English	Article							DOUBLE-STRAND BREAKS; DNA-DAMAGE RESPONSE; HISTONE H2AX; EYES ABSENT; GENOMIC INSTABILITY; SIGNALING PATHWAYS; CELLULAR-RESPONSE; DROSOPHILA EYE; IN-VIVO; PROTEIN	Life and death fate decisions allow cells to avoid massive apoptotic death in response to genotoxic stress. Although the regulatory mechanisms and signalling pathways controlling DNA repair and apoptosis are well characterized, the precise molecular strategies that determine the ultimate choice of DNA repair and survival or apoptotic cell death remain incompletely understood. Here we report that a protein tyrosine phosphatase, EYA, is involved in promoting efficient DNA repair rather than apoptosis in response to genotoxic stress in mammalian embryonic kidney cells by executing a damage-signal-dependent dephosphorylation of an H2AX carboxy-terminal tyrosine phosphate (Y142). This post-translational modification determines the relative recruitment of either DNA repair or pro-apoptotic factors to the tail of serine phosphorylated histone H2AX (gamma-H2AX) and allows it to function as an active determinant of repair/survival versus apoptotic responses to DNA damage, revealing an additional phosphorylation-dependent mechanism that modulates survival/apoptotic decisions during mammalian organogenesis.	[Cook, Peter J.; Ju, Bong Gun; Telese, Francesca; Wang, Xiangting; Rosenfeld, Michael G.] Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Cook, Peter J.] Univ Calif San Diego, Sch Med, Dept Biol Grad Program, La Jolla, CA 92093 USA; [Ju, Bong Gun] Sogang Univ, Dept Life Sci, Seoul 121742, South Korea; [Glass, Christopher K.] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; Sogang University; University of California System; University of California San Diego	Rosenfeld, MG (corresponding author), Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, La Jolla, CA 92037 USA.	mrosenfeld@ucsd.edu	Glass, Christopher/AAI-3933-2021; xiangting, wang/P-1010-2014	Glass, Christopher/0000-0003-4344-3592; xiangting, wang/0000-0003-2106-3425; Telese, Francesca/0000-0003-3877-0628	NIH; NCI; Sogang University Research Grant of 2008; USAMRAA; NATIONAL CANCER INSTITUTE [R01CA097134] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034934] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Sogang University Research Grant of 2008; USAMRAA; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Kastan for providing reagents/technical assistance for the I-PpoI system. We thank V. Lunyak, J. Dixon and R. Koladner for review and discussions. We thank the laboratory of R. S. Johnson for use of equipment and advice on hypoxia incubations, as well as H. Taylor for animal care assistance and C. Nelson for cell culture assistance. We thank A. Nussenzweig, Y. Xu and H. Song for H2ax 2/2 MEFs. We thank J. Hightower and M. Fisher for assistance with figure and manuscript preparation. We additionally thank X. Li and W. Liu. M. G. R. is an HHMI Investigator. This work was supported by grants from NIH and NCI to M. G. R. and C. K. G. This work also was supported by the Sogang University Research Grant of 2008 to B. G. J and PCF and USAMRAA grants to M. G. R.	Bassing CH, 2002, P NATL ACAD SCI USA, V99, P8173, DOI 10.1073/pnas.122228699; Bassing CH, 2004, DNA REPAIR, V3, P781, DOI 10.1016/j.dnarep.2004.06.001; Berkovich E, 2008, NAT PROTOC, V3, P915, DOI 10.1038/nprot.2008.54; Berkovich E, 2007, NAT CELL BIOL, V9, P683, DOI 10.1038/ncb1599; BONINI NM, 1993, CELL, V72, P379, DOI 10.1016/0092-8674(93)90115-7; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; DUILIO A, 1991, NUCLEIC ACIDS RES, V19, P5269, DOI 10.1093/nar/19.19.5269; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Haase VH, 2006, AM J PHYSIOL-RENAL, V291, pF271, DOI 10.1152/ajprenal.00071.2006; Jemc J, 2007, DEV BIOL, V310, P416, DOI 10.1016/j.ydbio.2007.07.024; Karagiannis TC, 2007, LEUKEMIA, V21, P195, DOI 10.1038/sj.leu.2404478; Kim JE, 2006, MOL CARCINOGEN, V45, P403, DOI 10.1002/mc.20221; Kumar JP, 2001, NAT REV GENET, V2, P846, DOI 10.1038/35098564; Lavin MF, 2007, CELL CYCLE, V6, P931, DOI 10.4161/cc.6.8.4180; Lee MS, 2005, J BIOL CHEM, V280, P32053, DOI 10.1074/jbc.C500273200; Lee YM, 2001, DEV DYNAM, V220, P175, DOI 10.1002/1097-0177(20010201)220:2<175::AID-DVDY1101>3.0.CO;2-F; Li X, 2003, NATURE, V426, P247, DOI 10.1038/nature02083; Lu CR, 2006, MOL CELL, V23, P121, DOI 10.1016/j.molcel.2006.05.023; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Minopoli G, 2007, J BIOL CHEM, V282, P831, DOI 10.1074/jbc.C600276200; Nakaya T, 2008, J BIOL CHEM, V283, P19119, DOI 10.1074/jbc.M801827200; Pignoni F, 1997, CELL, V91, P881, DOI 10.1016/S0092-8674(00)80480-8; Rayapureddi JP, 2005, BIOCHEMISTRY-US, V44, P751, DOI 10.1021/bi0481794; Rayapureddi JP, 2003, NATURE, V426, P295, DOI 10.1038/nature02093; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Sambrook JF., 2001, MOL CLONING LAB MANU; Silver SJ, 2005, DEVELOPMENT, V132, P3, DOI 10.1242/dev.01539; Stokes MP, 2007, P NATL ACAD SCI USA, V104, P19855, DOI 10.1073/pnas.0707579104; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Tootle TL, 2003, NATURE, V426, P299, DOI 10.1038/nature02097; van Attikum H, 2005, NAT REV MOL CELL BIO, V6, P757, DOI 10.1038/nrm1737; Wu XH, 2000, NATURE, V405, P477, DOI 10.1038/35013089; Xiao A, 2009, NATURE, V457, P57, DOI 10.1038/nature07668; Xu PX, 1999, NAT GENET, V23, P113, DOI 10.1038/12722	35	387	413	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 2	2009	458	7238					591	U53		10.1038/nature07849	http://dx.doi.org/10.1038/nature07849			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RK	19234442	Green Accepted, Green Submitted			2022-12-01	WOS:000264796200032
J	Maron, BJ; Roberts, WC; Arad, M; Haas, TS; Spirito, P; Wright, GB; Almquist, AK; Baffa, JM; Saul, JP; Ho, CY; Seidman, J; Seidman, CE				Maron, Barry J.; Roberts, William C.; Arad, Michael; Haas, Tammy S.; Spirito, Paolo; Wright, Gregory B.; Almquist, Adrian K.; Baffa, Jeanne M.; Saul, J. Philip; Ho, Carolyn Y.; Seidman, Jonathan; Seidman, Christine E.			Clinical Outcome and Phenotypic Expression in LAMP2 Cardiomyopathy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MYOSIN HEAVY-CHAIN; HYPERTROPHIC CARDIOMYOPATHY; DANON DISEASE; TROPONIN-T; PREVALENCE; MUTATIONS; GENE	Context Mutations in X-linked lysosome-associated membrane protein gene (LAMP2; Danon disease) produce a cardiomyopathy in young patients that clinically mimics severe hypertrophic cardiomyopathy (HCM) due to sarcomere protein mutations. However, the natural history and phenotypic expression of this newly recognized disease is incompletely resolved and its identification may have important clinical implications. Objectives To determine the clinical consequences, outcome, and phenotypic expression of LAMP2 cardiomyopathy associated with diagnostic and management strategies. Design, Setting, and Patients Clinical course and outcome were assessed prospectively in 7 young patients (6 boys) with defined LAMP2 mutations from the time of diagnosis (age 7-17 years; median, 14 years) to October 2008. Phenotypic expression of this disease was assessed both clinically and at autopsy. Main Outcome Measures Progressive heart failure, cardiac death, and transplant. Results Over a mean (SD) follow-up of 8.6 (2.6) years, and by age 14 to 24 years, the study patients developed left ventricular systolic dysfunction (mean [SD] ejection fraction, 25% [7%]) and cavity enlargement, as well as particularly adverse clinical consequences, including progressive refractory heart failure and death (n= 4), sudden death (n= 1), aborted cardiac arrest (n= 1), or heart transplantation (n= 1). Left ventricular hypertrophy was particularly marked (maximum thickness, 29-65 mm; mean [SD], 44 [15] mm), including 2 patients with massive ventricular septal thickness of 60 mm and 65 mm at ages 23 and 14 years, respectively. In 6 patients, a ventricular pre-excitation pattern at study entry was associated with markedly increased voltages of R-wave or S-wave (15-145 mm; mean [SD], 69 [39] mm), and deeply inverted T-waves. Autopsy findings included a combination of histopathologic features that were consistent with a lysosomal storage disease (ie, clusters of vacuolated myocytes) but also typical of HCM due to sarcomere protein mutations (ie, myocyte disarray, small vessel disease, myocardial scarring). Conclusions LAMP2 cardiomyopathy is a profound disease process characterized by progressive clinical deterioration leading rapidly to cardiac death in young patients (<25 years). These observations underscore the importance of timely molecular diagnosis for predicting prognosis and early consideration of heart transplantation.	[Maron, Barry J.; Haas, Tammy S.; Almquist, Adrian K.] Minneapolis Heart Inst Fdn, Hypertroph Cardiomyopathy Ctr, Minneapolis, MN 55407 USA; [Roberts, William C.] Baylor Cardiovasc Res Inst, Dallas, TX USA; [Arad, Michael] Chaim Sheba Med Ctr, Inst Heart, Tal Hashomer, Israel; [Arad, Michael] Chaim Sheba Med Ctr, Heart Failure Serv, Tal Hashomer, Israel; [Spirito, Paolo] Osped Osped Galliera, Div Cardiol, Genoa, Italy; [Wright, Gregory B.] Childrens Heart Clin, Minneapolis, MN USA; [Baffa, Jeanne M.] Alfred I Dupont Hosp Children, Nemours Cardiac Ctr, Wilmington, DE USA; [Saul, J. Philip] Med Univ S Carolina, Dept Pediat, Charleston, SC 29425 USA; [Ho, Carolyn Y.] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; [Seidman, Jonathan; Seidman, Christine E.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA	Minneapolis Heart Institute Foundation; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Ente Ospedaliero Ospedali Galliera; Nemours Alfred I. duPont Hospital for Children; Medical University of South Carolina; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Maron, BJ (corresponding author), Minneapolis Heart Inst Fdn, Hypertroph Cardiomyopathy Ctr, 920 E 28th St,Ste 620, Minneapolis, MN 55407 USA.	hcm.maron@mhif.org		Ho, Carolyn/0000-0002-7334-7924	Howard Hughes Medical Institute; National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084553] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding/Support: This study was supported in part by grants from the Howard Hughes Medical Institute and National Institutes of Health.	Ackerman MJ, 2002, J AM COLL CARDIOL, V39, P2042, DOI 10.1016/S0735-1097(02)01900-9; Arad M, 2005, NEW ENGL J MED, V352, P362, DOI 10.1056/NEJMoa033349; Bertini E, 2005, NEUROPEDIATRICS, V36, P309, DOI 10.1055/s-2005-872844; Charron P, 2004, HEART, V90, P842, DOI 10.1136/hrt.2003.029504; Echaniz-Laguna A, 2006, MUSCLE NERVE, V33, P393, DOI 10.1002/mus.20471; Fanin M, 2006, AM J PATHOL, V168, P1309, DOI 10.2353/ajpath.2006.050646; Harris KM, 2006, CIRCULATION, V114, P216, DOI 10.1161/CIRCULATIONAHA.105.583500; Maron BJ, 2007, JAMA-J AM MED ASSOC, V298, P405, DOI 10.1001/jama.298.4.405; Maron BJ, 2003, J AM COLL CARDIOL, V42, P882, DOI 10.1016/S0735-1097(03)00855-6; MARON BJ, 1995, CIRCULATION, V92, P2748, DOI 10.1161/01.CIR.92.9.2748; MARON BJ, 1979, CIRCULATION, V59, P689, DOI 10.1161/01.CIR.59.4.689; MARON BJ, 1986, J AM COLL CARDIOL, V8, P545, DOI 10.1016/S0735-1097(86)80181-4; Niimura H, 1998, NEW ENGL J MED, V338, P1248, DOI 10.1056/NEJM199804303381802; Nishino I, 2000, NATURE, V406, P906, DOI 10.1038/35022604; ROBERTS CS, 1989, PROGR CARDIOLOGY, V2, P3; ROBERTS WC, 1985, AM J CARDIOL, V55, P485, DOI 10.1016/0002-9149(85)90399-6; Sugie K, 2002, NEUROLOGY, V58, P1773, DOI 10.1212/WNL.58.12.1773; Tanaka Y, 2000, NATURE, V406, P902, DOI 10.1038/35022595; Taylor MRG, 2007, J HUM GENET, V52, P830, DOI 10.1007/s10038-007-0184-8; Van Driest SL, 2002, CIRCULATION, V106, P3085, DOI 10.1161/01.CIR.0000042675.59901.14; Varnava AM, 2001, AM J CARDIOL, V88, P275, DOI 10.1016/S0002-9149(01)01640-X; Yang Z, 2005, CIRCULATION, V112, P1612, DOI 10.1161/CIRCULATIONAHA.105.546481	22	223	240	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 25	2009	301	12					1253	1259		10.1001/jama.2009.371	http://dx.doi.org/10.1001/jama.2009.371			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	423JO	19318653	Bronze, Green Accepted			2022-12-01	WOS:000264492800025
J	Ezhkova, E; Pasolli, HA; Parker, JS; Stokes, N; Su, IH; Hannon, G; Tarakhovsky, A; Fuchs, E				Ezhkova, Elena; Pasolli, H. Amalia; Parker, Joel S.; Stokes, Nicole; Su, I-hsin; Hannon, Gregory; Tarakhovsky, Alexander; Fuchs, Elaine			Ezh2 Orchestrates Gene Expression for the Stepwise Differentiation of Tissue-Specific Stem Cells	CELL			English	Article							POLYCOMB GROUP PROTEINS; SELF-RENEWAL; DEVELOPMENTAL REGULATORS; CORNIFIED ENVELOPE; PROXIMAL PROMOTER; BMI-1; SKIN; METHYLATION; CHROMATIN; BARRIER	Although in vitro studies of embryonic stem cells have identified polycomb repressor complexes (PRCs) as key regulators of differentiation, it remains unclear as to how PRC-mediated mechanisms control fates of multipotent progenitors in developing tissues. Here, we show that an essential PRC component, Ezh2, is expressed in epidermal progenitors but diminishes concomitant with embryonic differentiation and with postnatal decline in proliferative activity. We show that Ezh2 controls proliferative potential of basal progenitors by repressing the Ink4A-Ink4B locus and tempers the developmental rate of differentiation by preventing premature recruitment of AP1 transcriptional activator to the structural genes that are required for epidermal differentiation. Together, our studies reveal that PRCs control epigenetic modifications temporally and spatially in tissue-restricted stem cells. They maintain their proliferative potential and globally repressing undesirable differentiation programs while selectively establishing a specific terminal differentiation program in a stepwise fashion.	[Ezhkova, Elena; Pasolli, H. Amalia; Stokes, Nicole; Fuchs, Elaine] Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA; [Su, I-hsin; Tarakhovsky, Alexander] Rockefeller Univ, Lab Lymphocyte Signaling, New York, NY 10065 USA; [Parker, Joel S.] Express Anal Inc, Durham, NC 27502 USA; [Su, I-hsin] Nanyang Technol Univ, Div Genom & Genet, Sch Biol Sci, Singapore 637551, Singapore; [Hannon, Gregory] Cold Spring Harbor Lab, Watson Sch Biol Sci, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA	Howard Hughes Medical Institute; Rockefeller University; Rockefeller University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA.	fuchslb@rockefeller.edu	Su, I-hsin/A-2207-2011; Fuchs, Elaine/G-1565-2016; Hannon, Gregory/AAB-3568-2019; Parker, Joel/AAG-1108-2019	Su, I-hsin/0000-0002-5894-9580; Pasolli, Hilda Amalia/0000-0003-3899-3530; Ezhkova, Elena/0000-0003-4154-1615	Life Sciences Research Foundation; NIH; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050452] Funding Source: NIH RePORTER	Life Sciences Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank Markus Schober, Scott Williams, Greg Wang (Allis's lab), Maria Nikolova, June Racelis, Svetlana Mazel, Christopher Bare, Xiaoxuan Fan, and Agnes Viale for technical assistance and our colleagues in the Fuchs laboratory, especially Jonathan Nowak, Rui Yi, and Valerie Horsley, for constructive discussion and criticisms. E. E. is a NY Stem Cell Foundation postdoctoral fellow of the Life Sciences Research Foundation. E. F. is an HHMI Investigator. This work was supported by a grant (E. F.) from the NIH.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Bruggeman SWM, 2007, CANCER CELL, V12, P328, DOI 10.1016/j.ccr.2007.08.032; Bruggeman SWM, 2005, GENE DEV, V19, P1438, DOI 10.1101/gad.1299305; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Chamberlain SJ, 2008, STEM CELLS, V26, P1496, DOI 10.1634/stemcells.2008-0102; DILLON N, 1993, TRENDS GENET, V9, P134, DOI 10.1016/0168-9525(93)90208-Y; DISEPIO D, 1995, J BIOL CHEM, V270, P10792, DOI 10.1074/jbc.270.18.10792; Eckert RL, 1997, J INVEST DERMATOL, V109, P501, DOI 10.1111/1523-1747.ep12336477; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Frye M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000763; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Hardman MJ, 1998, DEVELOPMENT, V125, P1541; HENNINGS H, 1980, CELL, V19, P245, DOI 10.1016/0092-8674(80)90406-7; Jackson B, 2005, J INVEST DERMATOL, V124, P1062, DOI 10.1111/j.0022-202X.2005.23699.x; Jang SI, 1996, J BIOL CHEM, V271, P24105, DOI 10.1074/jbc.271.39.24105; Jaubert J, 2003, DEVELOPMENT, V130, P2767, DOI 10.1242/dev.00477; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Laible G, 1997, EMBO J, V16, P3219, DOI 10.1093/emboj/16.11.3219; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Margueron R, 2008, MOL CELL, V32, P503, DOI 10.1016/j.molcel.2008.11.004; Marshall D, 2001, P NATL ACAD SCI USA, V98, P13031, DOI 10.1073/pnas.231489198; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Patel S, 2006, P NATL ACAD SCI USA, V103, P18668, DOI 10.1073/pnas.0608658103; Pietersen AM, 2008, CURR OPIN CELL BIOL, V20, P201, DOI 10.1016/j.ceb.2008.01.004; RASTELLI L, 1993, EMBO J, V12, P1513, DOI 10.1002/j.1460-2075.1993.tb05795.x; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Sarma K, 2008, MOL CELL BIOL, V28, P2718, DOI 10.1128/MCB.02017-07; Sauvageau M, 2008, PLOS BIOL, V6, P678, DOI 10.1371/journal.pbio.0060113; Sen GL, 2008, GENE DEV, V22, P1865, DOI 10.1101/gad.1673508; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Spivakov M, 2007, NAT REV GENET, V8, P263, DOI 10.1038/nrg2046; STEVEN AC, 1990, J STRUCT BIOL, V104, P150, DOI 10.1016/1047-8477(90)90071-J; Su I, 2005, CELL, V121, P425, DOI 10.1016/j.cell.2005.02.029; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Watt FM, 2006, CURR OPIN GENET DEV, V16, P518, DOI 10.1016/j.gde.2006.08.006	49	447	455	2	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 20	2009	136	6					1122	1135		10.1016/j.cell.2008.12.043	http://dx.doi.org/10.1016/j.cell.2008.12.043			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	422CE	19303854	Green Accepted, Bronze			2022-12-01	WOS:000264403900017
J	Wilson, TJ; Lilley, DMJ				Wilson, Timothy J.; Lilley, David M. J.			The Evolution of Ribozyme Chemistry	SCIENCE			English	Editorial Material							DELTA VIRUS RIBOZYME; ACTIVE-SITE; CRYSTAL-STRUCTURE; TRANSITION-STATE; CATALYTIC RNA; SPLICEOSOME; MECHANISM; GUANINE; INTRON; DOMAIN		[Wilson, Timothy J.; Lilley, David M. J.] Univ Dundee, Canc Res UK Nucle Acid Struct Res Grp, Dundee DD1 5EH, Scotland	University of Dundee	Wilson, TJ (corresponding author), Univ Dundee, Canc Res UK Nucle Acid Struct Res Grp, MSI WTB Complex,Dow St, Dundee DD1 5EH, Scotland.	d.m.j.lilley@dundee.ac.uk			Biotechnology and Biological Sciences Research Council [B17092] Funding Source: Medline; Cancer Research UK [11722] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK)		Adams PL, 2004, NATURE, V430, P45, DOI 10.1038/nature02642; Das SR, 2005, NAT CHEM BIOL, V1, P45, DOI 10.1038/nchembio703; Forconi M, 2008, BIOCHEMISTRY-US, V47, P6883, DOI 10.1021/bi800519a; Kingery DA, 2008, CHEM BIOL, V15, P493, DOI 10.1016/j.chembiol.2008.04.005; Klein DJ, 2007, J AM CHEM SOC, V129, P14858, DOI 10.1021/ja0768441; Lee TS, 2008, J AM CHEM SOC, V130, P3053, DOI 10.1021/ja076529e; LILLEY DMJ, 2008, RIBOYZMES RNA CATALY; Lincoln TA, 2009, SCIENCE, V323, P1229, DOI 10.1126/science.1167856; Martick M, 2006, CELL, V126, P309, DOI 10.1016/j.cell.2006.06.036; Nakano S, 2000, SCIENCE, V287, P1493, DOI 10.1126/science.287.5457.1493; Nowotny M, 2005, CELL, V121, P1005, DOI 10.1016/j.cell.2005.04.024; Pena V, 2008, EMBO J, V27, P2929, DOI 10.1038/emboj.2008.209; Ritchie DB, 2008, NAT STRUCT MOL BIOL, V15, P1199, DOI 10.1038/nsmb.1505; Rupert PB, 2002, SCIENCE, V298, P1421, DOI 10.1126/science.1076093; Schmeing TM, 2005, MOL CELL, V20, P437, DOI 10.1016/j.molcel.2005.09.006; Shan SO, 1999, P NATL ACAD SCI USA, V96, P12299, DOI 10.1073/pnas.96.22.12299; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Toor N, 2008, SCIENCE, V320, P77, DOI 10.1126/science.1153803; Weinger JS, 2004, NAT STRUCT MOL BIOL, V11, P1101, DOI 10.1038/nsmb841; Wilson TJ, 2007, EMBO J, V26, P2489, DOI 10.1038/sj.emboj.7601698	20	29	29	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 13	2009	323	5920					1436	1438		10.1126/science.1169231	http://dx.doi.org/10.1126/science.1169231			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417TP	19286542				2022-12-01	WOS:000264101700026
J	Kamikouchi, A; Inagaki, HK; Effertz, T; Hendrich, O; Fiala, A; Gopfert, MC; Ito, K				Kamikouchi, Azusa; Inagaki, Hidehiko K.; Effertz, Thomas; Hendrich, Oliver; Fiala, Andre; Goepfert, Martin C.; Ito, Kei			The neural basis of Drosophila gravity-sensing and hearing	NATURE			English	Article							TRANSDUCTION CHANNEL; TRP CHANNELS; MELANOGASTER; EXPRESSION; MUTATIONS; PATHWAYS; CEREBELLUM; AUDITION; NEURONS; NUCLEI	The neural substrates that the fruitfly Drosophila uses to sense smell, taste and light share marked structural and functional similarities with ours, providing attractive models to dissect sensory stimulus processing. Here we focus on two of the remaining and less understood prime sensory modalities: graviception and hearing. We show that the fly has implemented both sensory modalities into a single system, Johnston's organ, which houses specialized clusters of mechanosensory neurons, each of which monitors specific movements of the antenna. Gravity- and sound-sensitive neurons differ in their response characteristics, and only the latter express the candidate mechanotransducer channel NompC. The two neural subsets also differ in their central projections, feeding into neural pathways that are reminiscent of the vestibular and auditory pathways in our brain. By establishing the Drosophila counterparts of these sensory systems, our findings provide the basis for a systematic functional and molecular dissection of how different mechanosensory stimuli are detected and processed.	[Kamikouchi, Azusa; Inagaki, Hidehiko K.; Ito, Kei] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; [Kamikouchi, Azusa; Effertz, Thomas; Hendrich, Oliver; Goepfert, Martin C.] Univ Cologne, Inst Zool, Sensory Syst Lab, D-50923 Cologne, Germany; [Kamikouchi, Azusa] Tokyo Univ Pharm & Life Sci, Sch Life Sci, Tokyo 1920392, Japan; [Effertz, Thomas; Hendrich, Oliver; Fiala, Andre; Goepfert, Martin C.] Univ Gottingen, Johann Friedrich Blumenbach Inst, D-37073 Gottingen, Germany; [Fiala, Andre] Univ Wurzburg, Dept Genet & Neurobiol, Theodor Boveri Inst, D-97074 Wurzburg, Germany	University of Tokyo; University of Cologne; Tokyo University of Pharmacy & Life Sciences; University of Gottingen; University of Wurzburg	Ito, K (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan.	mgoepfe@gwdg.de; itokei@iam.u-tokyo.ac.jp	Fiala, André/AAA-3852-2019; Effertz, Thomas/E-2930-2010	Fiala, André/0000-0002-9745-5145; Hendrich, Oliver/0000-0003-1185-520X; Inagaki, Hidehiko/0000-0003-4580-2763; Kamikouchi, Azusa/0000-0003-1552-6892; Gopfert, Martin/0000-0001-8201-5334	Japanese Cell Science Research Foundation; Alexander von Humboldt Foundation; Japan Society for the Promotion of Science; DFG Collaborative Research Centre 554; Volkswagen Foundation; BMBF Bernstein Network for Computational Neuroscience; DFG Research Centre Molecular Physiology of the Brain; Human Frontier Science Program Organisation; BIRD/Japan Science and Technology Agency	Japanese Cell Science Research Foundation; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); DFG Collaborative Research Centre 554(German Research Foundation (DFG)); Volkswagen Foundation(Volkswagen); BMBF Bernstein Network for Computational Neuroscience(Federal Ministry of Education & Research (BMBF)); DFG Research Centre Molecular Physiology of the Brain(German Research Foundation (DFG)); Human Frontier Science Program Organisation(Human Frontier Science Program); BIRD/Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by the Japanese Cell Science Research Foundation, the Alexander von Humboldt Foundation, and the Japan Society for the Promotion of Science ( to A. K.), the DFG Collaborative Research Centre 554 ( to A. F.), the Volkswagen Foundation, the BMBF Bernstein Network for Computational Neuroscience, and the DFG Research Centre Molecular Physiology of the Brain ( to M. C. G.), and the Human Frontier Science Program Organisation, BIRD/Japan Science and Technology Agency, and the Japan Society for the Promotion of Science ( to K. I.).	Albert JT, 2007, CURR BIOL, V17, P1000, DOI 10.1016/j.cub.2007.05.004; ALBERT JT, 2006, NATURE PROTOCOLS, DOI DOI 10.1038/NPROT.2006.364; BACON JP, 1986, J COMP PHYSIOL A, V158, P529, DOI 10.1007/BF00603798; Baker DA, 2007, J COMP NEUROL, V501, P756, DOI 10.1002/cne.21257; Barmack NH, 2003, BRAIN RES BULL, V60, P511, DOI 10.1016/S0361-9230(03)00055-8; Beckingham KM, 2005, ADV GENET, V55, P105, DOI 10.1016/S0065-2660(05)55004-1; BENZER S, 1967, P NATL ACAD SCI USA, V58, P1112, DOI 10.1073/pnas.58.3.1112; BRAND AH, 1993, DEVELOPMENT, V118, P401; Buttner-Ennever JA, 1999, ANN NY ACAD SCI, V871, P51, DOI 10.1111/j.1749-6632.1999.tb09175.x; Caldwell JC, 2002, J NEUROBIOL, V53, P172, DOI 10.1002/neu.10126; Cant NB, 2003, BRAIN RES BULL, V60, P457, DOI 10.1016/S0361-9230(03)00050-9; Dickson BJ, 2008, SCIENCE, V322, P904, DOI 10.1126/science.1159276; Eberl DF, 1997, P NATL ACAD SCI USA, V94, P14837, DOI 10.1073/pnas.94.26.14837; Eberl DF, 2000, J NEUROSCI, V20, P5981, DOI 10.1523/JNEUROSCI.20-16-05981.2000; FIALA A, 2003, SCI STKE, pP16; Gopfert MC, 2006, NAT NEUROSCI, V9, P999, DOI 10.1038/nn1735; GOLDBERG ME, 2000, PRINCIPLES NEURAL SC, P801; Gopfert MC, 2002, J EXP BIOL, V205, P1199; Gopfert MC, 2001, NATURE, V411, P908, DOI 10.1038/35082144; HORN E, 1978, J COMP PHYSIOL, V126, P137, DOI 10.1007/BF00666366; Kamikouchi A, 2006, J COMP NEUROL, V499, P317, DOI 10.1002/cne.21075; Kandel E. R., 2000, PRINCIPLES NEURAL SC, V4, P590; Keppel G., 2004, DESIGN ANAL RES HDB; Kernan MJ, 2007, PFLUG ARCH EUR J PHY, V454, P703, DOI 10.1007/s00424-007-0263-x; Kim J, 2003, NATURE, V424, P81, DOI 10.1038/nature01733; Liu L, 2007, NATURE, V450, P294, DOI 10.1038/nature06223; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Miyawaki A, 1999, P NATL ACAD SCI USA, V96, P2135, DOI 10.1073/pnas.96.5.2135; Nadrowski B, 2008, CURR BIOL, V18, P1365, DOI 10.1016/j.cub.2008.07.095; Newsome TP, 2000, DEVELOPMENT, V127, P851; Otsuna H, 2006, J COMP NEUROL, V497, P928, DOI 10.1002/cne.21015; Phelan P, 1996, J NEUROSCI, V16, P1101; Ricci AJ, 2005, J NEUROSCI, V25, P7831, DOI 10.1523/JNEUROSCI.1127-05.2005; Sharma Y, 2002, GENESIS, V34, P115, DOI 10.1002/gene.10127; Smith HK, 1996, DEV GENES EVOL, V206, P14, DOI 10.1007/s004270050026; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Tauber E, 2003, BEHAV PROCESS, V64, P197, DOI 10.1016/S0376-6357(03)00135-9; TEMPEL BL, 1984, P NATL ACAD SCI-BIOL, V81, P3577, DOI 10.1073/pnas.81.11.3577; Thum AS, 2006, J COMP NEUROL, V498, P194, DOI 10.1002/cne.21022; Todi SV, 2004, MICROSC RES TECHNIQ, V63, P388, DOI 10.1002/jemt.20053; Toma DP, 2002, NAT GENET, V31, P349, DOI 10.1038/ng893; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9	43	248	254	1	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 12	2009	458	7235					165	U1		10.1038/nature07810	http://dx.doi.org/10.1038/nature07810			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417EQ	19279630				2022-12-01	WOS:000264059700035
J	Streiff, MB; Haut, ER				Streiff, Michael B.; Haut, Elliott R.			The CMS Ruling on Venous Thromboembolism After Total Knee or Hip Arthroplasty Weighing Risks and Benefits	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DIRECT THROMBIN INHIBITOR; DOUBLE-BLIND; DABIGATRAN ETEXILATE; PREVENTION; ENOXAPARIN; REPLACEMENT; XIMELAGATRAN; PROPHYLAXIS; TRIAL; THROMBOPROPHYLAXIS		[Streiff, Michael B.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Streiff, Michael B.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Haut, Elliott R.] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Streiff, MB (corresponding author), Johns Hopkins Med Inst, Dept Med, 1830 E Monument St,Ste 7300, Baltimore, MD 21205 USA.	mstreif@jhmi.edu	Haut, Elliott R./J-3948-2019	Haut, Elliott/0000-0001-7075-771X				Cohen AT, 2008, LANCET, V371, P387, DOI 10.1016/S0140-6736(08)60202-0; Cohen AT, 2007, THROMB HAEMOSTASIS, V98, P756, DOI 10.1160/TH07-03-0212; Colwell CW, 2003, J THROMB HAEMOST, V1, P2119, DOI 10.1046/j.1538-7836.2003.00368.x; Colwell CW, 2005, J BONE JOINT SURG AM, V87A, P2169, DOI 10.2106/JBJS.D.02184; Deep vein thrombosis (DVT)/pulmonary embolism (PE), 2008, FED REG, V73, P48480; Eriksson BI, 2007, J THROMB HAEMOST, V5, P2178, DOI 10.1111/j.1538-7836.2007.02748.x; Eriksson BI, 2008, NEW ENGL J MED, V358, P2765, DOI 10.1056/NEJMoa0800374; Eriksson BI, 2007, LANCET, V370, P949, DOI 10.1016/S0140-6736(07)61445-7; Francis CW, 2003, NEW ENGL J MED, V349, P1703, DOI 10.1056/NEJMoa035162; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Goldhaber SZ, 2000, CHEST, V118, P1680, DOI 10.1378/chest.118.6.1680; Larson DM, 2007, JAMA-J AM MED ASSOC, V298, P2754, DOI 10.1001/jama.298.23.2754; Lassen MR, 2008, NEW ENGL J MED, V358, P2776, DOI 10.1056/NEJMoa076016; Michota FA, 2007, J GEN INTERN MED, V22, P1762, DOI 10.1007/s11606-007-0369-z; Turpie AGG, 2002, LANCET, V359, P1721, DOI 10.1016/S0140-6736(02)08648-8	15	62	66	1	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 11	2009	301	10					1063	1065		10.1001/jama.301.10.1063	http://dx.doi.org/10.1001/jama.301.10.1063			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	416OQ	19278950				2022-12-01	WOS:000264015800032
J	Fiedler, D; Braberg, H; Mehta, M; Chechik, G; Cagney, G; Mukherjee, P; Silva, AC; Shales, M; Collins, SR; van Wageningen, S; Kemmeren, P; Holstege, FCP; Weissman, JS; Keogh, MC; Koller, D; Shokat, KM; Krogan, NJ				Fiedler, Dorothea; Braberg, Hannes; Mehta, Monika; Chechik, Gal; Cagney, Gerard; Mukherjee, Paromita; Silva, Andrea C.; Shales, Michael; Collins, Sean R.; van Wageningen, Sake; Kemmeren, Patrick; Holstege, Frank C. P.; Weissman, Jonathan S.; Keogh, Michael-Christopher; Koller, Daphne; Shokat, Kevan M.; Krogan, Nevan J.			Functional Organization of the S-cerevisiae Phosphorylation Network	CELL			English	Article							H2A VARIANT HTZ1; PROTEIN-KINASES; TRANSCRIPTION ELONGATION; SIGNALING PATHWAYS; GENETIC-ANALYSIS; IN-VIVO; YEAST; PHOSPHATASE; COMPLEX; ROLES	Reversible protein phosphorylation is a signaling mechanism involved in all cellular processes. To create a systems view of the signaling apparatus in budding yeast, we generated an epistatic miniarray profile (E-MAP) comprised of 100,000 pairwise, quantitative genetic interactions, including virtually all protein and small-molecule kinases and phosphatases as well as key cellular regulators. Quantitative genetic interaction mapping reveals factors working in compensatory pathways (negative genetic interactions) or those operating in linear pathways (positive genetic interactions). We found an enrichment of positive genetic interactions between kinases, phosphatases, and their substrates. In addition, we assembled a higher-order map from sets of three genes that display strong interactions with one another: triplets enriched for functional connectivity. The resulting network view provides insights into signaling pathway regulation and reveals a link between the cell-cycle kinase, Cak1, the Fus3 MAP kinase, and a pathway that regulates chromatin integrity during transcription by RNA polymerase II.	[Fiedler, Dorothea; Braberg, Hannes; Cagney, Gerard; Shales, Michael; Collins, Sean R.; Weissman, Jonathan S.; Shokat, Kevan M.; Krogan, Nevan J.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Fiedler, Dorothea; Collins, Sean R.; Weissman, Jonathan S.; Shokat, Kevan M.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Braberg, Hannes; Cagney, Gerard; Shales, Michael; Collins, Sean R.; Weissman, Jonathan S.; Krogan, Nevan J.] Univ Calif San Francisco, Calif Inst Quantitat Biomed Res, San Francisco, CA 94158 USA; [Mehta, Monika; Mukherjee, Paromita; Silva, Andrea C.; Keogh, Michael-Christopher] Yeshiva Univ Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; [Chechik, Gal; Koller, Daphne] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Cagney, Gerard] Univ Coll Dublin, Conway Inst, Dublin 4, Ireland; [van Wageningen, Sake; Kemmeren, Patrick; Holstege, Frank C. P.] Univ Med Ctr Utrect, Dept Physiol Chem, Utrecht, Netherlands	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Yeshiva University; Albert Einstein College of Medicine; Stanford University; University College Dublin; Utrecht University; Utrecht University Medical Center	Shokat, KM (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA.	shokat@cmp.ucsf.edu; krogan@cmp.ucsf.edu	Silva, Andrea Cristina/K-8837-2014; Holstege, Frank/AAM-9944-2021; Silva, Andrea/O-8852-2019	Silva, Andrea Cristina/0000-0001-5248-5511; Weissman, Jonathan/0000-0003-2445-670X; Chechik, Gal/0000-0001-9164-5303; Kemmeren, Patrick/0000-0003-2237-7354; Mehta, Monika/0000-0003-3928-3733; Cagney, Gerard/0000-0001-7189-9496; Collins, Sean/0000-0002-4276-5840	Ernst Schering Postdoctoral Fellowship; Biophysics Graduate Group at UCSF; National Science Foundation; New York Speakers Fund for Biomedical Research; Howard Hughes Medical Institute; NIH; Sandler Family Funding; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084448] Funding Source: NIH RePORTER	Ernst Schering Postdoctoral Fellowship; Biophysics Graduate Group at UCSF; National Science Foundation(National Science Foundation (NSF)); New York Speakers Fund for Biomedical Research; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sandler Family Funding; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank A. Roguev, C. Kaplan, C. J. Ingles, P. Aguilar, T. Walther, J. H. Morris, and members of the Krogan, Shokat, and Keogh labs for advice and comments. We also thank W. A. Lim for discussion on MAP kinase cascades. We are grateful to A. Chan, E. Cheng, Y. Nijati, and Li Jieying for technical assistance. We thank F. Winston and S. Buratowski for providing yeast strains and B. Strahl, S. Hahn, and D. Morgan for sharing unpublished data. The work was supported by an Ernst Schering Postdoctoral Fellowship (D.F.), the Biophysics Graduate Group at UCSF (H.B.), the National Science Foundation (G.C. and D. K.), the New York Speakers Fund for Biomedical Research (M.-C.K.), the Howard Hughes Medical Institute (K.M.S.), the NIH (N.J.K. and K. M. S.), and Sandler Family Funding (N.J.K.).	Alcazar-Roman AR, 2008, CHROMOSOMA, V117, P1, DOI 10.1007/s00412-007-0126-4; Babiarz JE, 2006, GENE DEV, V20, P700, DOI 10.1101/gad.1386306; Bakal C, 2008, SCIENCE, V322, P453, DOI 10.1126/science.1158739; Bertram PG, 2002, MOL CELL BIOL, V22, P1246, DOI 10.1128/MCB.22.4.1246-1252.2002; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Chechik G, 2008, NAT BIOTECHNOL, V26, P1251, DOI 10.1038/nbt.1499; Chen RE, 2007, BBA-MOL CELL RES, V1773, P1311, DOI 10.1016/j.bbamcr.2007.05.003; Cherkasova VA, 2003, GENE DEV, V17, P859, DOI 10.1101/gad.1069003; Cheung V, 2008, PLOS BIOL, V6, P2550, DOI 10.1371/journal.pbio.0060277; Cho EJ, 2001, GENE DEV, V15, P3319, DOI 10.1101/gad.935901; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Collins SR, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r63; Cullen PJ, 2002, EUKARYOT CELL, V1, P884, DOI 10.1128/EC.1.6.884-894.2002; Dhillon N, 2006, MOL CELL BIOL, V26, P489, DOI 10.1128/MCB.26.2.489-501.2006; Diella F, 2008, NUCLEIC ACIDS RES, V36, pD240, DOI 10.1093/nar/gkm772; Espinoza FH, 1998, MOL CELL BIOL, V18, P6365, DOI 10.1128/MCB.18.11.6365; Ficarro SB, 2002, NAT BIOTECHNOL, V20, P301, DOI 10.1038/nbt0302-301; Goossens A, 2000, MOL CELL BIOL, V20, P7654, DOI 10.1128/MCB.20.20.7654-7661.2000; Green KD, 2007, J AM CHEM SOC, V129, P10, DOI 10.1021/ja066828o; Hampsey M, 2003, CELL, V113, P429, DOI 10.1016/S0092-8674(03)00360-X; Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Johnson SA, 2005, NAT METHODS, V2, P17, DOI 10.1038/NMETH731; Joshi AA, 2005, MOL CELL, V20, P971, DOI 10.1016/j.molcel.2005.11.021; Kannan N, 2007, PLOS BIOL, V5, P467, DOI 10.1371/journal.pbio.0050017; Kaplan CD, 2003, SCIENCE, V301, P1096, DOI 10.1126/science.1087374; Kelley R, 2005, NAT BIOTECHNOL, V23, P561, DOI 10.1038/nbt1096; Keogh MC, 2006, GENE DEV, V20, P660, DOI 10.1101/gad.1388106; Keogh MC, 2006, NATURE, V439, P497, DOI 10.1038/nature04384; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Korber P, 2004, CELL, V117, P5, DOI 10.1016/S0092-8674(04)00296-X; Krogan NJ, 2004, P NATL ACAD SCI USA, V101, P13513, DOI 10.1073/pnas.0405753101; Lee TY, 2006, NUCLEIC ACIDS RES, V34, pD622, DOI 10.1093/nar/gkj083; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; Luke MM, 1996, MOL CELL BIOL, V16, P2744; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Millar CB, 2006, GENE DEV, V20, P711, DOI 10.1101/gad.1395506; Mulet JM, 1999, MOL CELL BIOL, V19, P3328; Mulugu S, 2007, SCIENCE, V316, P106, DOI 10.1126/science.1139099; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Nourani A, 2006, MOL CELL BIOL, V26, P1496, DOI 10.1128/MCB.26.4.1496-1509.2006; O'Rourke SM, 2004, MOL BIOL CELL, V15, P532, DOI 10.1091/mbc.E03-07-0521; Oficjalska-Pham D, 2006, MOL CELL, V22, P623, DOI 10.1016/j.molcel.2006.04.008; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Ostapenko D, 2005, MOL CELL BIOL, V25, P3906, DOI 10.1128/MCB.25.10.3906-3913.2005; Pan XW, 2004, MOL CELL, V16, P487, DOI 10.1016/j.molcel.2004.09.035; Pokholok DK, 2006, SCIENCE, V313, P533, DOI 10.1126/science.1127677; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Roguev A, 2008, SCIENCE, V322, P405, DOI 10.1126/science.1162609; Rua D, 2001, CURR OPIN MICROBIOL, V4, P720, DOI 10.1016/S1369-5274(01)00274-0; Saiardi A, 2004, SCIENCE, V306, P2101, DOI 10.1126/science.1103344; Schaber M, 2002, MOL CELL BIOL, V22, P57, DOI 10.1128/MCB.22.1.57-68.2002; Schuldiner M, 2006, METHODS, V40, P344, DOI 10.1016/j.ymeth.2006.07.034; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Sopko R, 2006, MOL CELL, V21, P319, DOI 10.1016/j.molcel.2005.12.011; St Onge RP, 2007, NAT GENET, V39, P199, DOI 10.1038/ng1948; Svejstrup JQ, 2007, CURR OPIN CELL BIOL, V19, P331, DOI 10.1016/j.ceb.2007.04.005; Tate JJ, 2006, J BIOL CHEM, V281, P37980, DOI 10.1074/jbc.M606973200; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; van de Peppel J, 2005, MOL CELL, V19, P511, DOI 10.1016/j.molcel.2005.06.033; Wang HM, 2003, MOL BIOL CELL, V14, P4342, DOI 10.1091/mbc.E03-02-0072; Wilmes GM, 2008, MOL CELL, V32, P735, DOI 10.1016/j.molcel.2008.11.012; Wu C, 1997, J BIOL CHEM, V272, P30623, DOI 10.1074/jbc.272.49.30623; Yao S, 2002, MOL CELL BIOL, V22, P6750, DOI 10.1128/MCB.22.19.6750-6758.2002; Youdell ML, 2008, MOL CELL BIOL, V28, P4915, DOI 10.1128/MCB.00001-08; Zanzoni A, 2007, NUCLEIC ACIDS RES, V35, pD229, DOI 10.1093/nar/gkl922	68	198	202	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 6	2009	136	5					952	963		10.1016/j.cell.2008.12.039	http://dx.doi.org/10.1016/j.cell.2008.12.039			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	415JU	19269370	Bronze, Green Accepted			2022-12-01	WOS:000263930900017
J	Gago, S; Elena, SF; Flores, R; Sanjuan, R				Gago, Selma; Elena, Santiago F.; Flores, Ricardo; Sanjuan, Rafael			Extremely High Mutation Rate of a Hammerhead Viroid	SCIENCE			English	Article							EVOLUTION		[Gago, Selma; Elena, Santiago F.; Flores, Ricardo; Sanjuan, Rafael] Univ Politecn Valencia, Inst Biol Mol & Celular Plantas, CSIC, Valencia 46022, Spain; [Sanjuan, Rafael] Univ Valencia, Inst Cavanilles Biodiversitat & Biol Evolut, Valencia 46980, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institute of Molecular & Cellular Biology of Plants (IBMCP); Universitat Politecnica de Valencia; University of Valencia	Sanjuan, R (corresponding author), Univ Politecn Valencia, Inst Biol Mol & Celular Plantas, CSIC, Valencia 46022, Spain.	rafael.sanjuan@uv.es	Elena, Santiago F./A-4191-2011; Flores, Ricardo/K-2788-2014; Gago Zachert, Selma/N-2902-2017	Elena, Santiago F./0000-0001-8249-5593; Flores, Ricardo/0000-0002-3033-5077; Gago Zachert, Selma/0000-0002-1084-2119; Sanjuan, Rafael/0000-0002-1844-545X	Spanish Ministerio de Ciencia e Innovacion [BFU2006-14819-C02-01/BMC, BFU2008-03154/BMC, BFU2008-03978/BMC]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was supported by grants from the Spanish Ministerio de Ciencia e Innovacion: BFU2006-14819-C02-01/BMC to S.F.E., BFU2008-03154/BMC to R.F., and BFU2008-03978/BMC to R.S. GenBank sequence accession numbers are FJ647228 to FJ647553.	DIENER TO, 1989, P NATL ACAD SCI USA, V86, P9370, DOI 10.1073/pnas.86.23.9370; Drake JW, 1998, GENETICS, V148, P1667; Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323; Duran-Vila N, 2008, ORIGIN AND EVOLUTION OF VIRUSES, 2ND EDITION, P43, DOI 10.1016/B978-0-12-374153-0.00002-3; EIGEN M, 1971, NATURWISSENSCHAFTEN, V58, P465, DOI 10.1007/BF00623322; Flores R, 2005, ANNU REV PHYTOPATHOL, V43, P117, DOI 10.1146/annurev.phyto.43.040204.140243; Martick M, 2006, CELL, V126, P309, DOI 10.1016/j.cell.2006.06.036; Sniegowski PD, 2000, BIOESSAYS, V22, P1057, DOI 10.1002/1521-1878(200012)22:12&lt;1057::AID-BIES3&gt;3.0.CO;2-W	8	154	162	3	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2009	323	5919					1308	1308		10.1126/science.1169202	http://dx.doi.org/10.1126/science.1169202			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414PC	19265013				2022-12-01	WOS:000263876700032
J	Conley, DJ; Paerl, HW; Howarth, RW; Boesch, DF; Seitzinger, SP; Havens, KE; Lancelot, C; Likens, GE				Conley, Daniel J.; Paerl, Hans W.; Howarth, Robert W.; Boesch, Donald F.; Seitzinger, Sybil P.; Havens, Karl E.; Lancelot, Christiane; Likens, Gene E.			ECOLOGY Controlling Eutrophication: Nitrogen and Phosphorus	SCIENCE			English	Editorial Material							LIMITING NUTRIENT; MANAGEMENT; LAKES; ECOSYSTEM; HYPOXIA; SEA		[Conley, Daniel J.] Lund Univ, Dept Geol, GeoBiosphere Sci Ctr, SE-22362 Lund, Sweden; [Paerl, Hans W.] Univ N Carolina, Inst Marine Sci, Morehead City, NC 28557 USA; [Howarth, Robert W.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14873 USA; [Boesch, Donald F.] Univ Maryland, Ctr Environm Sci, Cambridge, MD 21613 USA; [Havens, Karl E.] Royal Swedish Acad Sci, Int Geosphere Biosphere Programme, SE-10405 Stockholm, Sweden; [Havens, Karl E.] Univ Florida, Florida Sea Grant, Gainesville, FL 32611 USA; [Lancelot, Christiane] Univ Libre Bruxelles, B-1050 Brussels, Belgium; [Likens, Gene E.] Cary Inst Ecosyst Studies, Millbrook, NY 12545 USA	Lund University; University of North Carolina; University of North Carolina Chapel Hill; Cornell University; University System of Maryland; University of Maryland Center for Environmental Science; Royal Swedish Academy of Sciences; State University System of Florida; University of Florida; Universite Libre de Bruxelles; Cary Institute of Ecosystem Studies	Conley, DJ (corresponding author), Lund Univ, Dept Geol, GeoBiosphere Sci Ctr, Solvegatan 12, SE-22362 Lund, Sweden.	daniel.conley@geol.lu.se; hpaerl@email.unc.edu; rwh2@cornell.edu; boesch@umces.edu; sybil.seitzinger@igpb.kva.se; khavens@ufl.edu; lancelot@ulb.ac.be; likensg@ecostudies.org		Conley, Daniel Joseph/0000-0001-9668-9284; Howarth, Robert/0000-0001-9531-4288; Boesch, Donald/0000-0002-8154-133X				Arrigo KR, 2005, NATURE, V437, P349, DOI 10.1038/nature04159; Blomqvist S, 2004, LIMNOL OCEANOGR, V49, P2236, DOI 10.4319/lo.2004.49.6.2236; Conley DJ, 2002, ENVIRON SCI TECHNOL, V36, P5315, DOI 10.1021/es025763w; Conley DJ, 1999, HYDROBIOLOGIA, V410, P87, DOI 10.1023/A:1003784504005; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Havens KE, 2001, ENVIRON POLLUT, V111, P263, DOI 10.1016/S0269-7491(00)00074-9; Howarth RW, 2006, LIMNOL OCEANOGR, V51, P364, DOI 10.4319/lo.2006.51.1_part_2.0364; Howarth RW, 2005, MILLENNIUM ECOSYSTEM, P295; LIKENS GE, 1972, LIMNOLOGY OCEANOGRAP, V1, P328; Malone TC, 1996, ESTUARIES, V19, P371, DOI 10.2307/1352457; Marino R, 2006, MAR ECOL PROG SER, V309, P25, DOI 10.3354/meps309025; National Research Council, 2000, CLEAN COAST WAT UND, DOI 10.17226/9812; National Research Council, 1992, REST AQ EC; Paerl HW, 2006, ECOL STU AN, V189, P95, DOI 10.1007/978-3-540-32210-8_8; Paerl HW, 2004, ENVIRON SCI TECHNOL, V38, P3068, DOI 10.1021/es0352350; RYTHER JH, 1971, SCIENCE, V171, P1008, DOI 10.1126/science.171.3975.1008; Scavia D, 2007, ENVIRON SCI TECHNOL, V41, P8111, DOI 10.1021/es0714235; Schindler DW, 2008, P NATL ACAD SCI USA, V105, P11254, DOI 10.1073/pnas.0805108105; SCHINDLER DW, 1974, SCIENCE, V184, P897, DOI 10.1126/science.184.4139.897; Skogen MD, 2004, J MARINE SYST, V46, P23, DOI 10.1016/j.jmarsys.2003.11.013; Sylvan JB, 2007, LIMNOL OCEANOGR, V52, P2679, DOI 10.4319/lo.2007.52.6.2679; Vahtera E, 2007, AMBIO, V36, P186, DOI 10.1579/0044-7447(2007)36[186:IEFENC]2.0.CO;2; van Beusekom JEE, 2005, HELGOLAND MAR RES, V59, P45, DOI 10.1007/s10152-004-0206-2; Visser PM., 2005, HARMFUL CYANOBACTERI, V3; Vitousek PM, 2002, BIOGEOCHEMISTRY, V57, P1, DOI 10.1023/A:1015798428743; Wulff F, 2007, AMBIO, V36, P243, DOI 10.1579/0044-7447(2007)36[243:MOAEOA]2.0.CO;2	27	2351	2626	126	2425	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2009	323	5917					1014	1015		10.1126/science.1167755	http://dx.doi.org/10.1126/science.1167755			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409AK	19229022				2022-12-01	WOS:000263478400024
J	Lewis, SL; Lopez-Gonzalez, G; Sonke, B; Affum-Baffoe, K; Baker, TR; Ojo, LO; Phillips, OL; Reitsma, JM; White, L; Comiskey, JA; Djuikouo, MN; Ewango, CEN; Feldpausch, TR; Hamilton, AC; Gloor, M; Hart, T; Hladik, A; Lloyd, J; Lovett, JC; Makana, JR; Malhi, Y; Mbago, FM; Ndangalasi, HJ; Peacock, J; Peh, KSH; Sheil, D; Sunderland, T; Swaine, MD; Taplin, J; Taylor, D; Thomas, SC; Votere, R; Woll, H				Lewis, Simon L.; Lopez-Gonzalez, Gabriela; Sonke, Bonaventure; Affum-Baffoe, Kofi; Baker, Timothy R.; Ojo, Lucas O.; Phillips, Oliver L.; Reitsma, Jan M.; White, Lee; Comiskey, James A.; Djuikouo K., Marie-Noel; Ewango, Corneille E. N.; Feldpausch, Ted R.; Hamilton, Alan C.; Gloor, Manuel; Hart, Terese; Hladik, Annette; Lloyd, Jon; Lovett, Jon C.; Makana, Jean-Remy; Malhi, Yadvinder; Mbago, Frank M.; Ndangalasi, Henry J.; Peacock, Julie; Peh, Kelvin S. -H.; Sheil, Douglas; Sunderland, Terry; Swaine, Michael D.; Taplin, James; Taylor, David; Thomas, Sean C.; Votere, Raymond; Woell, Hannsjoerg			Increasing carbon storage in intact African tropical forests	NATURE			English	Article							CLIMATE; BIOMASS; IMPACTS; BALANCE; CYCLE	The response of terrestrial vegetation to a globally changing environment is central to predictions of future levels of atmospheric carbon dioxide(1,2). The role of tropical forests is critical because they are carbon- dense and highly productive(3,4). Inventory plots across Amazonia show that old- growth forests have increased in carbon storage over recent decades(5-7), but the response of one- third of the world's tropical forests in Africa(8) is largely unknown owing to an absence of spatially extensive observation networks(9,10). Here we report data from a ten- country network of long- term monitoring plots in African tropical forests. We find that across 79 plots ( 163 ha) above- ground carbon storage in live trees increased by 0.63 Mg C ha(-1) yr(-1) between 1968 and 2007 ( 95% confidence interval ( CI), 0.22 - 0.94; mean interval, 1987 - 96). Extrapolation to unmeasured forest components ( live roots, small trees, necromass) and scaling to the continent implies a total increase in carbon storage in African tropical forest trees of 0.34 Pg C yr(-1) ( CI, 0.15 - 0.43). These reported changes in carbon storage are similar to those reported for Amazonian forests per unit area(6,7), providing evidence that increasing carbon storage in old- growth forests is a pan- tropical phenomenon. Indeed, combining all standardized inventory data from this study and from tropical America and Asia(5,6,11) together yields a comparable figure of 0.49 Mg C ha(-1) yr(-1) (n = 156; 562 ha; CI, 0.29 - 0.66; mean interval, 1987 - 97). This indicates a carbon sink of 1.3 Pg C yr(-1) ( CI, 0.8 - 1.6) across all tropical forests during recent decades. Taxon- specific analyses of African inventory and other data(12) suggest that widespread changes in resource availability, such as increasing atmospheric carbon dioxide concentrations, may be the cause of the increase in carbon stocks(13), as some theory(14) and models(2,10,15) predict.	[Lewis, Simon L.; Lopez-Gonzalez, Gabriela; Baker, Timothy R.; Phillips, Oliver L.; Feldpausch, Ted R.; Gloor, Manuel; Lloyd, Jon; Peacock, Julie; Peh, Kelvin S. -H.] Univ Leeds, Earth & Biosphere Inst, Sch Geog, Leeds LS2 9JT, W Yorkshire, England; [Sonke, Bonaventure; Djuikouo K., Marie-Noel] Univ Yaounde I, Plant Systemat & Ecol Lab, Yaounde, Cameroon; [Affum-Baffoe, Kofi; Votere, Raymond] Forestry Commiss Ghana, Resource Management Support Ctr, Kumasi, Ghana; [Ojo, Lucas O.] Univ Agr, Dept Environm Management & Toxicol, Abeokuta, Ogun, Nigeria; [Reitsma, Jan M.] Bur Waardenburg BV, NL-4100 AJ Culemborg, Netherlands; [White, Lee] IRET, Libreville, Gabon; [Comiskey, James A.; Sunderland, Terry] Smithsonian Inst, SI MAB Biodivers Program, Washington, DC 20560 USA; [Ewango, Corneille E. N.] Univ Wageningen & Res Ctr, Dept Environm Sci, Forest Ecol & Management Grp, NL-6700 Wageningen, Netherlands; [Hamilton, Alan C.] Plantlife Int, Salisbury SP1 1DX, Wilts, England; [Hart, Terese; Makana, Jean-Remy] Wildlife Conservat Soc DRC, Kinshasa, DEM REP CONGO; [Hladik, Annette] MNHN, Dept Hommes Nat Soc, F-91800 Brunoy, France; [Lovett, Jon C.; Taplin, James] Univ York, Dept Environm, Ctr Ecol Law & Policy, York YO10 5DD, N Yorkshire, England; [Malhi, Yadvinder] Univ Oxford, Environm Change Inst, Sch Geog & Environm, Oxford OX1 3QY, England; [Mbago, Frank M.; Ndangalasi, Henry J.] Univ Dar Es Salaam, Dept Bot, Dar Es Salaam, Tanzania; [Sheil, Douglas] Ctr Int Forestry Res, Bogor 16000, Indonesia; [Swaine, Michael D.] Univ Aberdeen, Dept Plant & Soil Sci, Sch Biol Sci, Aberdeen AB24 3UU, Scotland; [Taylor, David] Univ Dublin Trinity Coll, Sch Nat Sci, Dept Geog, Dublin 2, Ireland; [Thomas, Sean C.] Univ Toronto, Fac Forestry, Toronto, ON M5S 3B3, Canada	University of Leeds; University of Yaounde I; University of Agriculture, Abeokuta; Smithsonian Institution; Wageningen University & Research; Museum National d'Histoire Naturelle (MNHN); University of York - UK; University of Oxford; University of Dar es Salaam; CGIAR; Center for International Forestry Research (CIFOR); University of Aberdeen; Trinity College Dublin; University of Toronto	Lewis, SL (corresponding author), Univ Leeds, Earth & Biosphere Inst, Sch Geog, Leeds LS2 9JT, W Yorkshire, England.	s.l.lewis@leeds.ac.uk	THOMAS, Sean C./B-6089-2008; Ndangalasi, Henry Joseph/ABD-8651-2020; Lloyd, Jonathan J/F-8893-2010; Sheil, Douglas/A-3867-2015; Feldpausch, Ted/D-3436-2009; Peh, Kelvin/C-3408-2013; Sheil, Douglas/H-1466-2012; Sunderland, Terence/AAE-7851-2019; Feldpausch, Ted/ABH-3123-2020; Mitchard, Edward T A/C-6346-2009; Phillips, Oliver L/A-1523-2011; Sheil, Douglas/N-3291-2019	THOMAS, Sean C./0000-0002-0686-2483; Ndangalasi, Henry Joseph/0000-0003-3738-6405; Lloyd, Jonathan J/0000-0002-5458-9960; Sheil, Douglas/0000-0002-1166-6591; Feldpausch, Ted/0000-0002-6631-7962; Peh, Kelvin/0000-0002-2921-1341; Sunderland, Terence/0000-0002-1985-9849; Feldpausch, Ted/0000-0002-6631-7962; Mitchard, Edward T A/0000-0002-5690-4055; Phillips, Oliver L/0000-0002-8993-6168; Comiskey, James/0000-0001-6710-1269; Lopez-Gonzalez, Gabriela/0000-0002-0814-8830; Lewis, Simon/0000-0002-8066-6851; Taylor, David/0000-0002-6098-5636; Makana, Jean-Remy/0000-0002-6006-2938	Royal Society and the Natural Environment Research Council (UK); Natural Environment Research Council [NE/B504630/1, NE/B503384/1, NE/D005590/1, NE/D000300/1] Funding Source: researchfish; NERC [NE/D005590/1] Funding Source: UKRI	Royal Society and the Natural Environment Research Council (UK); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank the villagers from Oban (Nigeria), Prince Town, Baneekurom and Dadieso (Ghana), Somolomo, Mekas, Lomie and Alat Makay (Cameroon) and Ekobakoba (Gabon) for hosting our fieldwork, and A. Moungazi, S. Mbadinga, H. Bourobou, L. N. Banak, T. Nzebi, K. Jeffery, SEGC/CIRMF/WCS Research Station Lope, K. Ntim, K. Opoku, Forestry Commission of Ghana, T. Tafoek, Federal University of Agriculture, Abeokuta, Nigeria, ECOFAC- Cameroon, Cameroon Ministry Scientific Research and Innovation, Cameroon Ministry of Forests and Fauna (MINFOF), Forest Development Authority (Liberia), S. Grahame, R. Lowe, L. Banin and K. C. Nguembou for field assistance and logistical support. We thank R. Condit for helping access the Edoro and Lenda data sets, C. Chatelain for providing data from the African Flowering Plants database to standardize our species identifications, J. Chave for providing allometric data, L. Poorter for providing gap size- frequency data, B. Nelson for providing large- scale blow- down data, D. Appleyard for assistance with the plot map, and the Network for Vegetation Function (Nation Evolutionary Synthesis Center and ARC-NZ) for providing some wood mass density data. This work was supported by the Royal Society and the Natural Environment Research Council ( UK).	Achard F, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002142; Baker TR, 2004, PHILOS T R SOC B, V359, P353, DOI 10.1098/rstb.2003.1422; Brncic TM, 2007, PHILOS T R SOC B, V362, P229, DOI 10.1098/rstb.2006.1982; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; Chave J, 2008, PLOS BIOL, V6, P455, DOI 10.1371/journal.pbio.0060045; Ciais P, 2008, BIOGEOSCIENCES, V5, P1259, DOI 10.5194/bg-5-1259-2008; Cramer W, 2004, PHILOS T R SOC B, V359, P331, DOI 10.1098/rstb.2003.1428; Deans JD, 1996, FOREST ECOL MANAG, V88, P215, DOI 10.1016/S0378-1127(96)03843-1; Fisher JI, 2008, ECOL LETT, V11, P554, DOI 10.1111/j.1461-0248.2008.01169.x; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Gurney KR, 2002, NATURE, V415, P626, DOI 10.1038/415626a; Houghton RA, 2006, J GEOPHYS RES-BIOGEO, V111, DOI 10.1029/2005JG000076; Katz RW, 2005, ECOLOGY, V86, P1124, DOI 10.1890/04-0606; Lewis SL, 2004, PHILOS T ROY SOC B, V359, P421, DOI 10.1098/rstb.2003.1431; Lewis SL, 2006, PHILOS T R SOC B, V361, P195, DOI 10.1098/rstb.2005.1711; Lewis SL, 2004, PHILOS T R SOC B, V359, P437, DOI 10.1098/rstb.2003.1432; Lloyd J, 1996, FUNCT ECOL, V10, P4, DOI 10.2307/2390258; Malhi Y, 2004, GLOBAL CHANGE BIOL, V10, P563, DOI 10.1111/j.1529-8817.2003.00778.x; Malhi Y, 2000, TRENDS ECOL EVOL, V15, P332, DOI 10.1016/S0169-5347(00)01906-6; Mayaux P, 2005, PHILOS T R SOC B, V360, P373, DOI 10.1098/rstb.2004.1590; NELSON BW, 1994, ECOLOGY, V75, P853, DOI 10.2307/1941742; Ngomanda A, 2007, QUATERNARY RES, V67, P411, DOI 10.1016/j.yqres.2007.01.006; Phillips OL, 1998, SCIENCE, V282, P439, DOI 10.1126/science.282.5388.439; Phillips OL, 2008, PHILOS T R SOC B, V363, P1819, DOI 10.1098/rstb.2007.0033; Rodenbeck C, 2003, ATMOS CHEM PHYS, V3, P1919; Smith P, 2007, AR4 CLIMATE CHANGE 2007: MITIGATION OF CLIMATE CHANGE, P497; Stephens BB, 2007, SCIENCE, V316, P1732, DOI 10.1126/science.1137004; Urquiza-Haas T, 2007, FOREST ECOL MANAG, V247, P80, DOI 10.1016/j.foreco.2007.04.015; Wild M, 2005, SCIENCE, V308, P847, DOI 10.1126/science.1103215; Williams Christopher A, 2007, Carbon Balance Manag, V2, P3, DOI 10.1186/1750-0680-2-3	30	647	683	13	351	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 19	2009	457	7232					1003	U3		10.1038/nature07771	http://dx.doi.org/10.1038/nature07771			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HF	19225523				2022-12-01	WOS:000263425400040
J	Post, R				Post, Robert			Prescribing Records and the First Amendment-New Hampshire's Data-Mining Statute	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Post, Robert] Yale Univ, Sch Law, New Haven, CT 06520 USA	Yale University	Post, R (corresponding author), Yale Univ, Sch Law, New Haven, CT 06520 USA.							Post R, 2000, UCLA LAW REV, V48, P1; Post R, 2007, U ILLINOIS LAW REV, P939	2	5	5	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 19	2009	360	8					745	747		10.1056/NEJMp0810339	http://dx.doi.org/10.1056/NEJMp0810339			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	408CN	19228615				2022-12-01	WOS:000263411300001
J	Yan, H; Parsons, DW; Jin, GL; McLendon, R; Rasheed, BA; Yuan, WS; Kos, I; Batinic-Haberle, I; Jones, S; Riggins, GJ; Friedman, H; Friedman, A; Reardon, D; Herndon, J; Kinzler, KW; Velculescu, VE; Vogelstein, B; Bigner, DD				Yan, Hai; Parsons, D. Williams; Jin, Genglin; McLendon, Roger; Rasheed, B. Ahmed; Yuan, Weishi; Kos, Ivan; Batinic-Haberle, Ines; Jones, Sian; Riggins, Gregory J.; Friedman, Henry; Friedman, Allan; Reardon, David; Herndon, James; Kinzler, Kenneth W.; Velculescu, Victor E.; Vogelstein, Bert; Bigner, Darell D.			IDH1 and IDH2 Mutations in Gliomas	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DEPENDENT ISOCITRATE DEHYDROGENASE; COMPARATIVE GENOMIC HYBRIDIZATION; FACTOR RECEPTOR GENE; MALIGNANT GLIOMAS; GLIOBLASTOMA; PATHWAYS; AMPLIFICATION; EXPRESSION; MECHANISM; MAJORITY	Background A recent genomewide mutational analysis of glioblastomas ( World Health Organization [ WHO] grade IV glioma) revealed somatic mutations of the isocitrate dehydrogenase 1 gene ( IDH1) in a fraction of such tumors, most frequently in tumors that were known to have evolved from lower- grade gliomas ( secondary glioblastomas). Methods We determined the sequence of the IDH1 gene and the related IDH2 gene in 445 central nervous system ( CNS) tumors and 494 non- CNS tumors. The enzymatic activity of the proteins that were produced from normal and mutant IDH1 and IDH2 genes was determined in cultured glioma cells that were transfected with these genes. Results We identified mutations that affected amino acid 132 of IDH1 in more than 70% of WHO grade II and III astrocytomas and oligodendrogliomas and in glioblastomas that developed from these lower- grade lesions. Tumors without mutations in IDH1 often had mutations affecting the analogous amino acid ( R172) of the IDH2 gene. Tumors with IDH1 or IDH2 mutations had distinctive genetic and clinical characteristics, and patients with such tumors had a better outcome than those with wild- type IDH genes. Each of four tested IDH1 and IDH2 mutations reduced the enzymatic activity of the encoded protein. Conclusions Mutations of NADP(+)-dependent isocitrate dehydrogenases encoded by IDH1 and IDH2 occur in a majority of several types of malignant gliomas.	[Yan, Hai; Jin, Genglin; McLendon, Roger; Rasheed, B. Ahmed; Bigner, Darell D.] Duke Univ, Med Ctr, Dept Pathol, Pediat Brain Tumor Fdn Inst, Durham, NC 27710 USA; [Kos, Ivan; Batinic-Haberle, Ines] Duke Univ, Med Ctr, Dept Radiat Oncol, Pediat Brain Tumor Fdn Inst, Durham, NC 27710 USA; [Friedman, Henry] Duke Univ, Med Ctr, Dept Neurooncol, Pediat Brain Tumor Fdn Inst, Durham, NC 27710 USA; [Friedman, Allan; Reardon, David] Duke Univ, Med Ctr, Dept Surg, Pediat Brain Tumor Fdn Inst, Durham, NC 27710 USA; [Yan, Hai; Jin, Genglin; McLendon, Roger; Rasheed, B. Ahmed; Kos, Ivan; Batinic-Haberle, Ines; Friedman, Henry; Friedman, Allan; Reardon, David; Bigner, Darell D.] Duke Univ, Med Ctr, Preston Robert Tisch Brain Tumor Ctr, Durham, NC 27710 USA; [Herndon, James] Duke Univ, Med Ctr, Canc Stat Ctr, Durham, NC 27710 USA; [Parsons, D. Williams; Jones, Sian; Kinzler, Kenneth W.; Velculescu, Victor E.; Vogelstein, Bert] Johns Hopkins Kimmel Canc Ctr, Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD USA; [Parsons, D. Williams; Jones, Sian; Kinzler, Kenneth W.; Velculescu, Victor E.; Vogelstein, Bert] Johns Hopkins Kimmel Canc Ctr, Howard Hughes Med Inst, Baltimore, MD USA; [Riggins, Gregory J.] Johns Hopkins Med Inst, Baltimore, MD 21205 USA; [Parsons, D. Williams] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Yuan, Weishi] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA	Duke University; Duke University; Duke University; Duke University; Duke University; Duke University; Johns Hopkins University; Johns Hopkins Medicine; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Baylor College of Medicine; US Food & Drug Administration (FDA)	Yan, H (corresponding author), Duke Univ, Med Ctr, Dept Pathol, Pediat Brain Tumor Fdn Inst, Durham, NC 27710 USA.	yan00002@mc.duke.edu; dwparson@txccc.org	Velculescu, Victor/ABF-4846-2020; Jones, Sian/A-5050-2012; Jin, Genglin/F-6868-2011	Velculescu, Victor/0000-0003-1195-438X; Parsons, Donald/0000-0002-8775-3501	Pediatric Brain Tumor Foundation Institute; Damon Runyon Foundation Scholar Award; Southeastern Brain Tumor Foundation; Alex's Lemonade Stand Foundation; V Foundation for Cancer Research; Virginia and D. K. Ludwig Fund for Cancer Research; Pew Charitable Trusts; American Brain Tumor Association; Brain Tumor Research Fund at Johns Hopkins [R01CA118822, NS20023-21, R37CA11898-34, CA121113, CA43460, CA57345, 5P50-CA-108786, 5P50-NS-20023, 5R37CA-11898, 2P30-CA-14236]; Beckman Coulter; Accelerate Brain Cancer Cure Foundation; Johns Hopkins University; NATIONAL CANCER INSTITUTE [R37CA043460, P30CA014236, R37CA011898, R01CA043460, R01CA121113, P50CA108786, R01CA118822, R37CA057345, R01CA140316, P50CA062924, R01CA057345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS020023] Funding Source: NIH RePORTER	Pediatric Brain Tumor Foundation Institute; Damon Runyon Foundation Scholar Award; Southeastern Brain Tumor Foundation; Alex's Lemonade Stand Foundation; V Foundation for Cancer Research; Virginia and D. K. Ludwig Fund for Cancer Research; Pew Charitable Trusts; American Brain Tumor Association; Brain Tumor Research Fund at Johns Hopkins; Beckman Coulter; Accelerate Brain Cancer Cure Foundation; Johns Hopkins University(Johns Hopkins University); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by a grant from the Pediatric Brain Tumor Foundation Institute, a Damon Runyon Foundation Scholar Award, a grant from the Southeastern Brain Tumor Foundation, Alex's Lemonade Stand Foundation, a grant from the V Foundation for Cancer Research, the Virginia and D. K. Ludwig Fund for Cancer Research, the Pew Charitable Trusts, the American Brain Tumor Association, the Brain Tumor Research Fund at Johns Hopkins, grants (R01CA118822, NS20023-21, R37CA11898-34, CA121113, CA43460, CA57345, 5P50-CA-108786, 5P50-NS-20023, 5R37CA-11898, and 2P30-CA-14236) from Beckman Coulter, and grants from the Accelerate Brain Cancer Cure Foundation.; Drs. Yan, Parsons, Jones, Kinzler, Velculescu, Vogelstein, and Bigner report being eligible for royalties received by Johns Hopkins University on sales of products related to research described in this article, under licensing agreements between the university and Beckman Coulter. No other potential conflict of interest relevant to this article was reported.; The views expressed in this article are those of the authors and do not necessarily represent the official views of the Food and Drug Administration.; We thank Melissa J. Ehinger, Diane L. Satterfield, Eric Lipp, Michael Leonard, Jennifer D. Funkhouser, and Patrick Killela for their assistance with the clinical information; P. Buckhaults, S. Powell, S. Kern, J. Eshleman, C. Civin, I.- M. Shih, and A. Gazdar for providing DNA from non-central nervous system cancers; and Dr. A. T. Campagnoni at the University of California, Los Angeles, for donating the human oligodendroglioma cell line.	Batinic-Haberle I, 2008, FREE RADICAL RES, V42, P618, DOI 10.1080/10715760802209639; Bigner SH, 1999, AM J PATHOL, V155, P375, DOI 10.1016/S0002-9440(10)65134-6; Burger PC, 2000, PATHOLOGY GENETICS T, P45; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Jennings GT, 1997, BIOCHEMISTRY-US, V36, P13743, DOI 10.1021/bi970916r; Jones DTW, 2008, CANCER RES, V68, P8673, DOI 10.1158/0008-5472.CAN-08-2097; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Louis D. N., 2007, WHO CLASSIFICATION T; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; Ohgaki H, 2004, CANCER RES, V64, P6892, DOI 10.1158/0008-5472.CAN-04-1337; Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; RIEFENBERGER J, 1994, AM J PATHOL, V145, P1175; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Ueki K, 1996, CANCER RES, V56, P150; Wang TL, 2004, P NATL ACAD SCI USA, V101, P3089, DOI 10.1073/pnas.0308716101; Weber RG, 1996, ONCOGENE, V13, P983; Wen PY, 2008, NEW ENGL J MED, V359, P877; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; WONG AJ, 1992, P NATL ACAD SCI USA, V89, P2965, DOI 10.1073/pnas.89.7.2965; WONG AJ, 1987, P NATL ACAD SCI USA, V84, P6899, DOI 10.1073/pnas.84.19.6899; Xu X, 2004, J BIOL CHEM, V279, P33946, DOI 10.1074/jbc.M404298200	24	3898	4071	11	298	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 19	2009	360	8					765	773		10.1056/NEJMoa0808710	http://dx.doi.org/10.1056/NEJMoa0808710			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	408CN	19228619	Green Accepted			2022-12-01	WOS:000263411300006
J	Rousseau, P				Rousseau, Paul			Southern Comfort	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												palliativedoctor@aol.com							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 18	2009	301	7					704	704		10.1001/jama.2009.142	http://dx.doi.org/10.1001/jama.2009.142			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	407MX	19224740				2022-12-01	WOS:000263370100001
J	Marques-Bonet, T; Kidd, JM; Ventura, M; Graves, TA; Cheng, Z; Hillier, LW; Jiang, ZS; Baker, C; Malfavon-Borja, R; Fulton, LA; Alkan, C; Aksay, G; Girirajan, S; Siswara, P; Chen, L; Cardone, MF; Navarro, A; Mardis, ER; Wilson, RK; Eichler, EE				Marques-Bonet, Tomas; Kidd, Jeffrey M.; Ventura, Mario; Graves, Tina A.; Cheng, Ze; Hillier, LaDeana W.; Jiang, Zhaoshi; Baker, Carl; Malfavon-Borja, Ray; Fulton, Lucinda A.; Alkan, Can; Aksay, Gozde; Girirajan, Santhosh; Siswara, Priscillia; Chen, Lin; Cardone, Maria Francesca; Navarro, Arcadi; Mardis, Elaine R.; Wilson, Richard K.; Eichler, Evan E.			A burst of segmental duplications in the genome of the African great ape ancestor	NATURE			English	Article							COPY NUMBER VARIATION; STRUCTURAL VARIATION; EVOLUTION	It is generally accepted that the extent of phenotypic change between human and great apes is dissonant with the rate of molecular change(1). Between these two groups, proteins are virtually identical(1,2), cytogenetically there are few rearrangements that distinguish ape - human chromosomes(3), and rates of single- base- pair change(4-7) and retrotransposon activity(8-10) have slowed particularly within hominid lineages when compared to rodents or monkeys. Studies of gene family evolution indicate that gene loss and gain are enriched within the primate lineage(11,12). Here, we perform a systematic analysis of duplication content of four primate genomes ( macaque, orang- utan, chimpanzee and human) in an effort to understand the pattern and rates of genomic duplication during hominid evolution. We find that the ancestral branch leading to human and African great apes shows the most significant increase in duplication activity both in terms of base pairs and in terms of events. This duplication acceleration within the ancestral species is significant when compared to lineage- specific rate estimates even after accounting for copy- number polymorphism and homoplasy. We discover striking examples of recurrent and independent gene- containing duplications within the gorilla and chimpanzee that are absent in the human lineage. Our results suggest that the evolutionary properties of copy- number mutation differ significantly from other forms of genetic mutation and, in contrast to the hominid slowdown of single- base- pair mutations, there has been a genomic burst of duplication activity at this period during human evolution.	[Marques-Bonet, Tomas; Kidd, Jeffrey M.; Cheng, Ze; Jiang, Zhaoshi; Baker, Carl; Malfavon-Borja, Ray; Alkan, Can; Aksay, Gozde; Girirajan, Santhosh; Siswara, Priscillia; Chen, Lin; Eichler, Evan E.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Marques-Bonet, Tomas; Kidd, Jeffrey M.; Cheng, Ze; Jiang, Zhaoshi; Baker, Carl; Malfavon-Borja, Ray; Alkan, Can; Aksay, Gozde; Girirajan, Santhosh; Siswara, Priscillia; Chen, Lin; Eichler, Evan E.] Howard Hughes Med Inst, Seattle, WA 98195 USA; [Marques-Bonet, Tomas; Navarro, Arcadi] UPF CSIC, Inst Biol Evolut, Barcelona 08003, Spain; [Ventura, Mario; Cardone, Maria Francesca] Univ Bari, Sez Genet, Dipartimento Anat Patol & Genet, I-70125 Bari, Italy; [Graves, Tina A.; Hillier, LaDeana W.; Fulton, Lucinda A.; Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Sch Med, Genome Sequencing Ctr, St Louis, MO 63108 USA; [Navarro, Arcadi] ICREA, Barcelona 08003, Spain; [Navarro, Arcadi] INB, Barcelona 08003, Spain	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; Universita degli Studi di Bari Aldo Moro; Washington University (WUSTL); ICREA	Eichler, EE (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	eee@gs.washington.edu	Wilson, Richard K./AAF-4139-2019; Girirajan, Santhosh/A-5280-2010; Cardone, Maria Francesca/G-8818-2012; Alkan, Can/D-2982-2009; Navarro, Arcadi/F-1592-2011; Marques-Bonet, Tomas/I-4618-2014; Ventura, Mario/E-6420-2011; Marques-Bonet, Tomas/ABF-3734-2020; Mardis, Elaine/W-2202-2019	Wilson, Richard K./0000-0002-1992-1358; Cardone, Maria Francesca/0000-0002-7597-7313; Alkan, Can/0000-0002-5443-0706; Navarro, Arcadi/0000-0003-2162-8246; Marques-Bonet, Tomas/0000-0002-5597-3075; Ventura, Mario/0000-0001-7762-8777; Marques-Bonet, Tomas/0000-0002-5597-3075; Kidd, Jeffrey/0000-0002-9631-1465	NIH [HG002385, U54 HG003079]; Marie Curie fellowship; Departament d'Educacio i Universitats de la Generalitat de Catalunya; ICREA Funding Source: Custom; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR013986] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003079, R01HG002385] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marie Curie fellowship(European Commission); Departament d'Educacio i Universitats de la Generalitat de Catalunya(Generalitat de Catalunya); ICREA(ICREA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank H. Mefford, A. Itsara, G. Cooper, T. Brown and G. McVicker for comments during the preparation of this manuscript. The authors are also grateful to J. Sikela and L. Dumas for assistance with the comparison to cDNA microarray data sets. We are grateful to L. Faust, J. Rogers, Southwest National Primate Research Center (P51- RR013986) and P. Parham for providing some of the primate material used in this study and to M. Adams for providing the alignments for the positive selection analysis. We also thank the large genome sequencing centres for early access to the whole genome sequence data for targeted analysis of segmental duplications. This work was supported, in part, by an NIH grant HG002385 to E.E.E. and NIH grant U54 HG003079 to R.K.W. and E.R.M. INB is a platform of Genoma Espana. T.M.-B. is supported by a Marie Curie fellowship and by Departament d'Educacio i Universitats de la Generalitat de Catalunya. E.E.E. is an investigator of the Howard Hughes Medical Institute.	Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Cheng Z, 2005, NATURE, V437, P88, DOI 10.1038/nature04000; *CHIMP SEQ AN CONS, 2005, NATURE, V0437; Dumas L, 2007, GENOME RES, V17, P1266, DOI 10.1101/gr.6557307; Elango N, 2006, P NATL ACAD SCI USA, V103, P1370, DOI 10.1073/pnas.0510716103; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; GOODMAN M, 1961, HUM BIOL, V33, P131; Hahn MW, 2007, GENETICS, V177, P1941, DOI 10.1534/genetics.107.080077; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Jiang ZS, 2008, GENOME RES, V18, P1362, DOI 10.1101/gr.078477.108; Jiang Z, 2007, NAT GENET, V39, P1361, DOI 10.1038/ng.2007.9; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Lee AS, 2008, HUM MOL GENET, V17, P1127, DOI 10.1093/hmg/ddn002; Lee JA, 2006, NEURON, V52, P103, DOI 10.1016/j.neuron.2006.09.027; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; LI WH, 1987, NATURE, V326, P93, DOI 10.1038/326093a0; Newman TL, 2005, GENOME RES, V15, P1344, DOI 10.1101/gr.4338005; Perry GH, 2006, P NATL ACAD SCI USA, V103, P8006, DOI 10.1073/pnas.0602318103; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sharp AJ, 2006, NAT GENET, V38, P1038, DOI 10.1038/ng1862; Stankiewicz P, 2004, GENOME RES, V14, P2209, DOI 10.1101/gr.2746604; Steiper ME, 2004, P NATL ACAD SCI USA, V101, P17021, DOI 10.1073/pnas.0407270101; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; WU CI, 1985, P NATL ACAD SCI USA, V82, P1741, DOI 10.1073/pnas.82.6.1741; YUNIS JJ, 1982, SCIENCE, V215, P1525, DOI 10.1126/science.7063861	30	167	169	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2009	457	7231					877	881		10.1038/nature07744	http://dx.doi.org/10.1038/nature07744			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406AF	19212409	Green Accepted			2022-12-01	WOS:000263266700044
J	Malone, CD; Brennecke, J; Dus, M; Stark, A; McCombie, WR; Sachidanandam, R; Hannon, GJ				Malone, Colin D.; Brennecke, Julius; Dus, Monica; Stark, Alexander; McCombie, W. Richard; Sachidanandam, Ravi; Hannon, Gregory J.			Specialized piRNA Pathways Act in Germline and Somatic Tissues of the Drosophila Ovary	CELL			English	Article							GYPSY ENDOGENOUS RETROVIRUS; SELFISH GENETIC ELEMENTS; MELANOGASTER GERMLINE; INFECTIOUS RETROVIRUS; TRANSPOSABLE ELEMENTS; CELL MAINTENANCE; FEMALE GERMLINE; POLAR GRANULES; STEM-CELLS; PIWI	In Drosophila gonads, Piwi proteins and associated piRNAs collaborate with additional factors to form a small RNA-based immune system that silences mobile elements. Here, we analyzed nine Drosophila piRNA pathway mutants for their impacts on both small RNA populations and the subcellular localization patterns of Piwi proteins. We find that distinct piRNA pathways with differing components function in ovarian germ and somatic cells. In the soma, Piwi acts singularly with the conserved flamenco piRNA cluster to enforce silencing of retroviral elements that may propagate by infecting neighboring germ cells. In the germline, silencing programs encoded within piRNA clusters are optimized via a slicer-dependent amplification loop to suppress a broad spectrum of elements. The classes of transposons targeted by germline and somatic piRNA clusters, though not the precise elements, are conserved among Drosophilids, demonstrating that the architecture of piRNA clusters has coevolved with the transposons that they are tasked to control.	[Malone, Colin D.; Brennecke, Julius; Dus, Monica; McCombie, W. Richard; Sachidanandam, Ravi; Hannon, Gregory J.] Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Malone, Colin D.; Brennecke, Julius; Dus, Monica; Hannon, Gregory J.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; [Stark, Alexander] MIT, Broad Inst, Cambridge, MA 02141 USA; [Stark, Alexander] Harvard Univ, Cambridge, MA 02141 USA; [Stark, Alexander] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA	Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT)	Hannon, GJ (corresponding author), Cold Spring Harbor Lab, Watson Sch Biol Sci, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	hannon@cshl.edu	Brennecke, Julius/T-5883-2019; Hannon, Gregory/AAB-3568-2019; Stark, Alexander/D-1473-2012; Brennecke, Julius/C-1626-2015; sachidanandam, ravi/Q-6916-2019	Brennecke, Julius/0000-0002-5141-0814; Stark, Alexander/0000-0003-2611-0841; Brennecke, Julius/0000-0002-5141-0814; sachidanandam, ravi/0000-0001-9844-4459; McCombie, W. Richard/0000-0003-1899-0682	Watson School of Biological Sciences; National Science Foundation Graduate Research Fellowship; Ernst Schering foundation; Human Frontier Science Program; National Institutes of Health; NATIONAL CANCER INSTITUTE [P01CA013106] Funding Source: NIH RePORTER	Watson School of Biological Sciences(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Ernst Schering foundation; Human Frontier Science Program(Human Frontier Science Program); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank members of the Hannon laboratory for helpful discussions and Oliver Tam for computational assistance. We are grateful to Michelle Rooks, Emily Hodges, Danea Rebolini, Laura Cardone, and Mike Regulski ( Cold Spring Harbor Laboratory) for help with deep sequencing. We also thank Attilio Pane and Trudi Schupbach for providing the zuc and squ fly stocks. C. D. M. is a Beckman fellow of the Watson School of Biological Sciences and is supported by a National Science Foundation Graduate Research Fellowship. J.B. is supported by a fellowship from the Ernst Schering foundation. M. D. is an Engelhorn fellow of the Watson School of Biological Sciences. A. S. is supported by a Human Frontier Science Program postdoctoral fellowship. This work was supported in part from grants from the National Institutes of Health to G.J.H. and W.R.M. and a kind gift from Kathryn W. Davis ( G.J.H.).	ALMUKHTAR KA, 1971, J EMBRYOL EXP MORPH, V26, P195; Aravin AA, 2001, CURR BIOL, V11, P1017, DOI 10.1016/S0960-9822(01)00299-8; Aravin AA, 2004, MOL CELL BIOL, V24, P6742, DOI 10.1128/MCB.24.15.6742-6750.2004; Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Barbosa V, 2007, GENETICS, V176, P1967, DOI 10.1534/genetics.106.069575; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Chalvet F, 1999, EMBO J, V18, P2659, DOI 10.1093/emboj/18.9.2659; Chambeyron S, 2008, P NATL ACAD SCI USA, V105, P14964, DOI 10.1073/pnas.0805943105; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Cook HA, 2004, CELL, V116, P817, DOI 10.1016/S0092-8674(04)00250-8; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Cox DN, 2000, DEVELOPMENT, V127, P503; Desset S, 2003, GENETICS, V164, P501; Desset S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001526; EDDY EM, 1974, ANAT REC, V178, P731, DOI 10.1002/ar.1091780406; Findley SD, 2003, DEVELOPMENT, V130, P859, DOI 10.1242/dev.00310; GILLESPIE DE, 1995, GENE DEV, V9, P2495, DOI 10.1101/gad.9.20.2495; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Harris AN, 2001, DEVELOPMENT, V128, P2823; HAZELRIGG T, 1984, CELL, V36, P469, DOI 10.1016/0092-8674(84)90240-X; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kennerdell JR, 2002, GENE DEV, V16, P1884, DOI 10.1101/gad.990802; KIM A, 1994, P NATL ACAD SCI USA, V91, P1285, DOI 10.1073/pnas.91.4.1285; Klattenhoff C, 2008, DEVELOPMENT, V135, P3, DOI 10.1242/dev.006486; Klenov MS, 2007, NUCLEIC ACIDS RES, V35, P5430, DOI 10.1093/nar/gkm576; Lecher P, 1997, J GEN VIROL, V78, P2379; LI C, 2009, CELL IN PRESS, V137, DOI DOI 10.1016/J.CELL.2009.04.027; LIANG L, 1994, DEVELOPMENT, V120, P1201; Lim AK, 2007, P NATL ACAD SCI USA, V104, P6714, DOI 10.1073/pnas.0701920104; Lin HF, 1997, DEVELOPMENT, V124, P2463; LUNING KG, 1981, HEREDITAS, V95, P181; MAHOWALD AP, 1968, J EXP ZOOL, V167, P237, DOI 10.1002/jez.1401670211; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Mevel-Ninio M, 2007, GENETICS, V175, P1615, DOI 10.1534/genetics.106.068106; Murchison EP, 2008, GENOME RES, V18, P995, DOI 10.1101/gr.073056.107; Pane A, 2007, DEV CELL, V12, P851, DOI 10.1016/j.devcel.2007.03.022; Pelisson A, 2007, MOL BIOL EVOL, V24, P498, DOI 10.1093/molbev/msl176; PRUDHOMME N, 1995, GENETICS, V139, P697; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Sarot E, 2004, GENETICS, V166, P1313, DOI 10.1534/genetics.166.3.1313; SCHUPBACH T, 1991, GENETICS, V129, P1119; Shpiz S, 2007, MOL BIOL EVOL, V24, P2535, DOI 10.1093/molbev/msm205; Shpiz S, 2009, NUCLEIC ACIDS RES, V37, P268, DOI 10.1093/nar/gkn960; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Snee MJ, 2004, J CELL SCI, V117, P2109, DOI 10.1242/jcs.01059; Song SU, 1997, DEVELOPMENT, V124, P2789; SONG SU, 1994, GENE DEV, V8, P2046, DOI 10.1101/gad.8.17.2046; SPRADLING AC, 1993, CELL, V72, P649, DOI 10.1016/0092-8674(93)90393-5; Styhler S, 1998, DEVELOPMENT, V125, P1569; Tomari Y, 2004, CELL, V116, P831, DOI 10.1016/S0092-8674(04)00218-1; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Vagin Vasily V, 2004, RNA Biol, V1, P54; WilschBrauninger M, 1997, J CELL BIOL, V139, P817, DOI 10.1083/jcb.139.3.817; Wilson JE, 1996, DEVELOPMENT, V122, P1631	58	592	611	4	71	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 1	2009	137	3					522	535		10.1016/j.cell.2009.03.040	http://dx.doi.org/10.1016/j.cell.2009.03.040			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	440CV	19395010	Green Accepted, Bronze			2022-12-01	WOS:000265677200021
J	Nakahata, Y; Sahar, S; Astarita, G; Kaluzova, M; Sassone-Corsi, P				Nakahata, Yasukazu; Sahar, Saurabh; Astarita, Giuseppe; Kaluzova, Milota; Sassone-Corsi, Paolo			Circadian Control of the NAD(+) Salvage Pathway by CLOCK-SIRT1	SCIENCE			English	Article							NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PROTEIN SIR2; CLOCK; DEACETYLASE; BIOSYNTHESIS; MECHANISM	Many metabolic and physiological processes display circadian oscillations. We have shown that the core circadian regulator, CLOCK, is a histone acetyltransferase whose activity is counterbalanced by the nicotinamide adenine dinucleotide (NAD(+))-dependent histone deacetylase SIRT1. Here we show that intracellular NAD(+) levels cycle with a 24-hour rhythm, an oscillation driven by the circadian clock. CLOCK: BMAL1 regulates the circadian expression of NAMPT (nicotinamide phosphoribosyltransferase), an enzyme that provides a rate-limiting step in the NAD(+) salvage pathway. SIRT1 is recruited to the Nampt promoter and contributes to the circadian synthesis of its own coenzyme. Using the specific inhibitor FK866, we demonstrated that NAMPT is required to modulate circadian gene expression. Our findings in mouse embryo fibroblasts reveal an interlocked transcriptional-enzymatic feedback loop that governs the molecular interplay between cellular metabolism and circadian rhythms.	[Nakahata, Yasukazu; Sahar, Saurabh; Astarita, Giuseppe; Kaluzova, Milota; Sassone-Corsi, Paolo] Univ Calif Irvine, Dept Pharmacol, Sch Med, Irvine, CA 92697 USA	University of California System; University of California Irvine	Sassone-Corsi, P (corresponding author), Univ Calif Irvine, Dept Pharmacol, Sch Med, Irvine, CA 92697 USA.	psc@uci.edu	Astarita, Giuseppe/AAD-1239-2019; Sassone-Corsi, Paolo/H-6182-2011; Astarita, Giuseppe/N-7346-2014	Astarita, Giuseppe/0000-0001-6700-301X; Nakahata, Yasukazu/0000-0003-3814-5822	Japan Society for the Promotion of Science Postdoctoral Fellowships for Research Abroad; postdoctoral fellowship from the American Heart Association, Western States Affiliate; Cancer Research Coordinating Committee of the University of California; NIH [R01-GM081634]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081634] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science Postdoctoral Fellowships for Research Abroad(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); postdoctoral fellowship from the American Heart Association, Western States Affiliate(American Heart Association); Cancer Research Coordinating Committee of the University of California(University of California System); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Thanks to D. Piomelli for insightful discussions and help. Thanks also to L. Guarente, K. Yamagata, and members of the Sassone-Corsi's laboratory for help, reagents, and support. Y.N. was supported by the Japan Society for the Promotion of Science Postdoctoral Fellowships for Research Abroad. S.S. was supported by a postdoctoral fellowship from the American Heart Association, Western States Affiliate. Work supported by the Cancer Research Coordinating Committee of the University of California and NIH (R01-GM081634 [GenBank] -01).	Anderson RM, 2002, J BIOL CHEM, V277, P18881, DOI 10.1074/jbc.M111773200; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Belden WJ, 2008, CELL, V134, P212, DOI 10.1016/j.cell.2008.07.010; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; ECKELMAHAN K, NAT STRUCT IN PRESS; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Hasmann M, 2003, CANCER RES, V63, P7436; Hirayama J, 2007, NATURE, V450, P1086, DOI 10.1038/nature06394; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kaasik K, 2004, NATURE, V430, P467, DOI 10.1038/nature02724; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Olesen UH, 2008, BIOCHEM BIOPH RES CO, V367, P799, DOI 10.1016/j.bbrc.2008.01.019; Revollo JR, 2007, CELL METAB, V6, P363, DOI 10.1016/j.cmet.2007.09.003; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Rongvaux A, 2003, BIOESSAYS, V25, P683, DOI 10.1002/bies.10297; Rongvaux A, 2008, J IMMUNOL, V181, P4685, DOI 10.4049/jimmunol.181.7.4685; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; van der Veer E, 2007, J BIOL CHEM, V282, P10841, DOI 10.1074/jbc.C700018200; Wang J, 2005, J CELL BIOL, V170, P349, DOI 10.1083/jcb.200504028; Wijnen H, 2006, ANNU REV GENET, V40, P409, DOI 10.1146/annurev.genet.40.110405.090603; Yamada K, 2006, ANAL BIOCHEM, V352, P282, DOI 10.1016/j.ab.2006.02.017; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035	27	842	877	3	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 1	2009	324	5927					654	657		10.1126/science.1170803	http://dx.doi.org/10.1126/science.1170803			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439DW	19286518	Green Accepted			2022-12-01	WOS:000265608800048
J	Ford, N; Mills, E; Calmy, A				Ford, Nathan; Mills, Edward; Calmy, Alexandra			GLOBAL HEALTH Rationing Antiretroviral Therapy in Africa - Treating Too Few, Too Late	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SUB-SAHARAN AFRICA		[Ford, Nathan] MSF, Med Unit, Cape Town, South Africa; [Ford, Nathan] Univ Cape Town, Sch Publ Hlth & Family Med, ZA-7925 Cape Town, South Africa; [Mills, Edward] Univ Ottawa, Canada Res Chair Global Hlth, Ottawa, ON, Canada; [Calmy, Alexandra] Univ Hosp Geneva, Infect Dis Serv, HIV Unit, Geneva, Switzerland; [Calmy, Alexandra] MSF Int, MSF Access Campaign, Geneva, Switzerland	Doctors Without Borders; University of Cape Town; University of Ottawa; University of Geneva; Doctors Without Borders	Ford, N (corresponding author), MSF, Med Unit, Cape Town, South Africa.							Auvert B, 2004, JAIDS-J ACQ IMM DEF, V36, P613, DOI 10.1097/00126334-200405010-00010; Keiser O, 2008, TROP MED INT HEALTH, V13, P870, DOI 10.1111/j.1365-3156.2008.02078.x; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Moreno S, 2009, INT J TUBERC LUNG D, V13, P150; Persad G, 2009, LANCET, V373, P423, DOI 10.1016/S0140-6736(09)60137-9	5	21	22	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 30	2009	360	18					1808	1810		10.1056/NEJMp0902820	http://dx.doi.org/10.1056/NEJMp0902820			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	438MU	19403900				2022-12-01	WOS:000265560300002
J	Barraclough, K				Barraclough, Kevin			Diagnosis in General Practice Chronic cough in adults	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PERTUSSIS; ASTHMA; MANAGEMENT; DISEASE				Barraclough, K (corresponding author), Hoyland House, Painswick GL6 6RD, Stroud, England.	k.barraclough@btinternet.com						Cherry JD, 2005, PEDIATRICS, V115, P1422, DOI 10.1542/peds.2004-2648; Cockcroft DW, 1997, ANN ALLERG ASTHMA IM, V79, P226, DOI 10.1016/S1081-1206(10)63006-2; CULLINAN P, 1992, RESP MED, V86, P143, DOI 10.1016/S0954-6111(06)80231-3; Dicpinigaitis PV, 2006, CHEST, V129, p169S, DOI 10.1378/chest.129.1_suppl.169S; Dicpinigaitis PV, 2004, THORAX, V59, P71; Glasziou P, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1312; Hewlett EL, 2005, NEW ENGL J MED, V352, P1215, DOI 10.1056/NEJMcp041025; IRWIN RS, 1989, AM REV RESPIR DIS, V140, P1294, DOI 10.1164/ajrccm/140.5.1294; Irwin RS, 2006, CHEST, V129, P1, DOI 10.1378/chest.129.1.1; Kardos P, 1996, Pneumologie, V50, P437; Kastelik JA, 2005, EUR RESPIR J, V25, P235, DOI 10.1183/09031936.05.00140803; Morice AH, 2004, EUR RESPIR J, V24, P481, DOI 10.1183/09031936.04.00027804; Morice AH, 2003, THORAX, V58, P901, DOI 10.1136/thorax.58.10.901; Numans ME, 2004, ANN INTERN MED, V140, P518, DOI 10.7326/0003-4819-140-7-200404060-00011; Palombini BC, 1999, CHEST, V116, P279, DOI 10.1378/chest.116.2.279; Thomas PF, 2000, MED J AUSTRALIA, V173, P74, DOI 10.5694/j.1326-5377.2000.tb139246.x; *WHO, 2008, ALL RH ITS IMP ASTHM; Willemse BWM, 2004, EUR RESPIR J, V23, P464, DOI 10.1183/09031936.04.00012704	18	3	4	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 24	2009	338								b1218	10.1136/bmj.b1218	http://dx.doi.org/10.1136/bmj.b1218			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437OR	19395418				2022-12-01	WOS:000265497300002
J	Justman, QA; Serber, Z; Ferrell, JE; El-Samad, H; Shokat, KM				Justman, Quincey A.; Serber, Zach; Ferrell, James E., Jr.; El-Samad, Hana; Shokat, Kevan M.			Tuning the Activation Threshold of a Kinase Network by Nested Feedback Loops	SCIENCE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; CELL-CYCLE; SWITCH; MATURATION; OOCYTES; MODULE; MEMORY	Determining proper responsiveness to incoming signals is fundamental to all biological systems. We demonstrate that intracellular signaling nodes can tune a signaling network's response threshold away from the basal median effective concentration established by ligand-receptor interactions. Focusing on the bistable kinase network that governs progesterone-induced meiotic entry in Xenopus oocytes, we characterized glycogen synthase kinase-3b (GSK-3 beta) as a dampener of progesterone responsiveness. GSK-3 beta engages the meiotic kinase network through a double-negative feedback loop; this specific feedback architecture raises the progesterone threshold in correspondence with the strength of double-negative signaling. We also identified a marker of nutritional status, L-leucine, which lowers the progesterone threshold, indicating that oocytes integrate additional signals into their cell-fate decisions by modulating progesterone responsiveness.	[El-Samad, Hana] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Justman, Quincey A.] Univ Calif San Francisco, Grad Grp Biophys, San Francisco, CA 94158 USA; [Justman, Quincey A.; Shokat, Kevan M.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Justman, Quincey A.; Shokat, Kevan M.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Serber, Zach; Ferrell, James E., Jr.] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Stanford University	El-Samad, H (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA.	helsamad@biochem.ucsf.edu; shokat@cmp.ucsf.edu			NIH [AI49006, GM46383]; Sandler Family Supporting Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044009, R43AI049006] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046383] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sandler Family Supporting Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Yue for providing Mos and cyclin protein; N. L. Salimi for help with statistics; J. J. Fleming and P. M. England for help with oocytes; and A. W. Murray, R. D. Mullins, J. A. Blair, and E. C. Garner for critical reading of the manuscript. Funding from NIH grant AI49006 (to K.M.S.), the Sandler Family Supporting Foundation (to H.E.), and NIH grant GM46383 (to J.E.F.).	Acar M, 2005, NATURE, V435, P228, DOI 10.1038/nature03524; Amonlirdviman K, 2005, SCIENCE, V307, P423, DOI 10.1126/science.1105471; Brandman O, 2005, SCIENCE, V310, P496, DOI 10.1126/science.1113834; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Fisher DL, 1999, DEVELOPMENT, V126, P567; FORTUNE JE, 1983, DEV BIOL, V99, P502, DOI 10.1016/0012-1606(83)90299-3; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gebauer F, 1997, BIOESSAYS, V19, P23, DOI 10.1002/bies.950190106; Ingolia NT, 2007, CURR BIOL, V17, P668, DOI 10.1016/j.cub.2007.03.016; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kishimoto T, 2003, CURR OPIN CELL BIOL, V15, P654, DOI 10.1016/j.ceb.2003.10.010; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Lutz LB, 2001, P NATL ACAD SCI USA, V98, P13728, DOI 10.1073/pnas.241471598; Nebreda AR, 2000, CURR OPIN CELL BIOL, V12, P666, DOI 10.1016/S0955-0674(00)00150-2; O'Neill DJ, 2004, BIOORGAN MED CHEM, V12, P3167, DOI 10.1016/j.bmc.2004.04.010; Peyrollier K, 2000, BIOCHEM J, V350, P361, DOI 10.1042/0264-6021:3500361; Pomerening JR, 2005, CELL, V122, P565, DOI 10.1016/j.cell.2005.06.016; Sarkissian M, 2004, GENE DEV, V18, P48, DOI 10.1101/gad.1136004; Suel GM, 2006, NATURE, V440, P545, DOI 10.1038/nature04588; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089	21	40	40	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 24	2009	324	5926					509	512		10.1126/science.1169498	http://dx.doi.org/10.1126/science.1169498			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436JU	19390045	Green Accepted			2022-12-01	WOS:000265411200046
J	Soucy, TA; Smith, PG; Milhollen, MA; Berger, AJ; Gavin, JM; Adhikari, S; Brownell, JE; Burke, KE; Cardin, DP; Critchley, S; Cullis, CA; Doucette, A; Garnsey, JJ; Gaulin, JL; Gershman, RE; Lublinsky, AR; McDonald, A; Mizutani, H; Narayanan, U; Olhava, EJ; Peluso, S; Rezaei, M; Sintchak, MD; Talreja, T; Thomas, MP; Traore, T; Vyskocil, S; Weatherhead, GS; Yu, J; Zhang, J; Dick, LR; Claiborne, CF; Rolfe, M; Bolen, JB; Langston, SP				Soucy, Teresa A.; Smith, Peter G.; Milhollen, Michael A.; Berger, Allison J.; Gavin, James M.; Adhikari, Sharmila; Brownell, James E.; Burke, Kristine E.; Cardin, David P.; Critchley, Stephen; Cullis, Courtney A.; Doucette, Amanda; Garnsey, James J.; Gaulin, Jeffrey L.; Gershman, Rachel E.; Lublinsky, Anna R.; McDonald, Alice; Mizutani, Hirotake; Narayanan, Usha; Olhava, Edward J.; Peluso, Stephane; Rezaei, Mansoureh; Sintchak, Michael D.; Talreja, Tina; Thomas, Michael P.; Traore, Tary; Vyskocil, Stepan; Weatherhead, Gabriel S.; Yu, Jie; Zhang, Julie; Dick, Lawrence R.; Claiborne, Christopher F.; Rolfe, Mark; Bolen, Joseph B.; Langston, Steven P.			An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer	NATURE			English	Article							NEDD8 CONJUGATION PATHWAY; KAPPA-B-ALPHA; UBIQUITIN LIGASE; DNA-DAMAGE; G(2)/M CHECKPOINT; ACTIVATING ENZYME; CELL-CYCLE; DEGRADATION; CDT1; COMPLEX	The clinical development of an inhibitor of cellular proteasome function suggests that compounds targeting other components of the ubiquitin-proteasome system might prove useful for the treatment of human malignancies. NEDD8-activating enzyme (NAE) is an essential component of the NEDD8 conjugation pathway that controls the activity of the cullin-RING subtype of ubiquitin ligases, thereby regulating the turnover of a subset of proteins upstream of the proteasome. Substrates of cullin-RING ligases have important roles in cellular processes associated with cancer cell growth and survival pathways. Here we describe MLN4924, a potent and selective inhibitor of NAE. MLN4924 disrupts cullin-RING ligase-mediated protein turnover leading to apoptotic death in human tumour cells by a new mechanism of action, the deregulation of S-phase DNA synthesis. MLN4924 suppressed the growth of human tumour xenografts in mice at compound exposures that were well tolerated. Our data suggest that NAE inhibitors may hold promise for the treatment of cancer.	[Soucy, Teresa A.; Smith, Peter G.; Milhollen, Michael A.; Berger, Allison J.; Gavin, James M.; Adhikari, Sharmila; Brownell, James E.; Burke, Kristine E.; Cardin, David P.; Critchley, Stephen; Cullis, Courtney A.; Doucette, Amanda; Garnsey, James J.; Gaulin, Jeffrey L.; Gershman, Rachel E.; Lublinsky, Anna R.; McDonald, Alice; Mizutani, Hirotake; Narayanan, Usha; Olhava, Edward J.; Peluso, Stephane; Rezaei, Mansoureh; Sintchak, Michael D.; Talreja, Tina; Thomas, Michael P.; Traore, Tary; Vyskocil, Stepan; Weatherhead, Gabriel S.; Yu, Jie; Zhang, Julie; Dick, Lawrence R.; Claiborne, Christopher F.; Rolfe, Mark; Bolen, Joseph B.; Langston, Steven P.] Millennium Pharmaceut Inc, Cambridge, MA 02139 USA	Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals	Soucy, TA (corresponding author), Millennium Pharmaceut Inc, 40 Landsdowne St, Cambridge, MA 02139 USA.	teresa.soucy@mpi.com	Dick, Lawrence/ABA-8831-2021; Zhang, Julie/GQH-2525-2022	Dick, Larry/0000-0002-6880-0405				Archambault V, 2005, MOL CELL BIOL, V25, P6707, DOI 10.1128/MCB.25.15.6707-6721.2005; Arias EE, 2005, GENE DEV, V19, P114, DOI 10.1101/gad.1255805; BLOCH A, 1971, BIOCHEMISTRY-US, V10, P4394, DOI 10.1021/bi00800a007; Bohnsack RN, 2003, J BIOL CHEM, V278, P26823, DOI 10.1074/jbc.M303177200; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Chen YZ, 2000, J BIOL CHEM, V275, P8929, DOI 10.1074/jbc.275.12.8929; Chiba T, 2004, CURR PROTEIN PEPT SC, V5, P177, DOI 10.2174/1389203043379783; Donzelli M, 2002, EMBO J, V21, P4875, DOI 10.1093/emboj/cdf491; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Gong LM, 1999, J BIOL CHEM, V274, P12036, DOI 10.1074/jbc.274.17.12036; HAAS AL, 1982, J BIOL CHEM, V257, P329; HANDELI S, 1992, CELL, V71, P599, DOI 10.1016/0092-8674(92)90594-3; Hershko A, 2005, CELL DEATH DIFFER, V12, P1191, DOI 10.1038/sj.cdd.4401702; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Higa LAA, 2003, NAT CELL BIOL, V5, P1008, DOI 10.1038/ncb1061; Hu J, 2004, NAT CELL BIOL, V6, P1003, DOI 10.1038/ncb1172; Kamura T, 2000, P NATL ACAD SCI USA, V97, P10430, DOI 10.1073/pnas.190332597; Kane RC, 2003, ONCOLOGIST, V8, P508, DOI 10.1634/theoncologist.8-6-508; Kane RC, 2007, CLIN CANCER RES, V13, P5291, DOI 10.1158/1078-0432.CCR-07-0871; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kim Y, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-18; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kondo T, 2004, J BIOL CHEM, V279, P27315, DOI 10.1074/jbc.M314023200; Li XH, 2003, J BIOL CHEM, V278, P30854, DOI 10.1074/jbc.C300251200; Lin JJ, 2007, J BIOL CHEM, V282, P30357, DOI 10.1074/jbc.M705178200; Lovejoy CA, 2006, MOL CELL BIOL, V26, P7977, DOI 10.1128/MCB.00819-06; Machida YJ, 2005, CELL, V123, P13, DOI 10.1016/j.cell.2005.09.019; Margottin-Goguet F, 2003, DEV CELL, V4, P813, DOI 10.1016/S1534-5807(03)00153-9; Melixetian M, 2004, J CELL BIOL, V165, P473, DOI 10.1083/jcb.200403106; Nalepa G, 2006, NAT REV DRUG DISCOV, V5, P596, DOI 10.1038/nrd2056; Nateri AS, 2004, SCIENCE, V303, P1374, DOI 10.1126/science.1092880; Nishitani H, 2006, EMBO J, V25, P1126, DOI 10.1038/sj.emboj.7601002; Pan ZQ, 2004, ONCOGENE, V23, P1985, DOI 10.1038/sj.onc.1207414; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Podust VN, 2000, P NATL ACAD SCI USA, V97, P4579, DOI 10.1073/pnas.090465597; Read MA, 2000, MOL CELL BIOL, V20, P2326, DOI 10.1128/MCB.20.7.2326-2333.2000; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Saxena S, 2003, CELL CYCLE, V2, P283, DOI 10.4161/cc.2.4.443; Vaziri C, 2003, MOL CELL, V11, P997, DOI 10.1016/S1097-2765(03)00099-6; Walden H, 2003, MOL CELL, V12, P1427, DOI 10.1016/S1097-2765(03)00452-0; Walden H, 2003, NATURE, V422, P330, DOI 10.1038/nature01456; Wilkinson KD, 2005, P NATL ACAD SCI USA, V102, P15280, DOI 10.1073/pnas.0504842102; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Ye X, 2004, J BIOL CHEM, V279, P50110, DOI 10.1074/jbc.M409226200; Zhu WG, 2004, MOL CELL BIOL, V24, P7140, DOI 10.1128/MCB.24.16.7140-7150.2004	46	1318	1373	8	139	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 9	2009	458	7239					732	U67		10.1038/nature07884	http://dx.doi.org/10.1038/nature07884			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	433GZ	19360080				2022-12-01	WOS:000265193600033
J	Harrison, SA; Tong, F				Harrison, Stephenie A.; Tong, Frank			Decoding reveals the contents of visual working memory in early visual areas	NATURE			English	Article							SHORT-TERM-MEMORY; PREFRONTAL CORTEX; PERSISTENT ACTIVITY; NEURAL MECHANISMS; TEMPORAL CORTEX; MOTION TASK; CAPACITY; PERFORMANCE; CORRELATE; NEURONS	Visual working memory provides an essential link between perception and higher cognitive functions, allowing for the active maintenance of information about stimuli no longer in view(1,2). Research suggests that sustained activity in higher-order prefrontal, parietal, inferotemporal and lateral occipital areas supports visual maintenance(3-11), and may account for the limited capacity of working memory to hold up to 3-4 items(9-11). Because higher-order areas lack the visual selectivity of early sensory areas, it has remained unclear how observers can remember specific visual features, such as the precise orientation of a grating, with minimal decay in performance over delays of many seconds(12). One proposal is that sensory areas serve to maintain fine-tuned feature information(13), but early visual areas show little to no sustained activity over prolonged delays(14-16). Here we show that orientations held in working memory can be decoded from activity patterns in the human visual cortex, even when overall levels of activity are low. Using functional magnetic resonance imaging and pattern classification methods, we found that activity patterns in visual areas V1-V4 could predict which of two oriented gratings was held in memory with mean accuracy levels upwards of 80%, even in participants whose activity fell to baseline levels after a prolonged delay. These orientation-selective activity patterns were sustained throughout the delay period, evident in individual visual areas, and similar to the responses evoked by unattended, task-irrelevant gratings. Our results demonstrate that early visual areas can retain specific information about visual features held in working memory, over periods of many seconds when no physical stimulus is present.	[Tong, Frank] Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA; Vanderbilt Univ, Vanderbilt Vis Res Ctr, Nashville, TN 37240 USA	Vanderbilt University; Vanderbilt University	Tong, F (corresponding author), Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA.	frank.tong@vanderbilt.edu			National Eye Institute; National Institutes of Health; Natural Sciences and Engineering Research Council of Canada; NATIONAL EYE INSTITUTE [R01EY017082] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank D. Brady and B. Wolfe for technical support, and J. Gore and the Vanderbilt University Institute of Imaging Science for MRI support. This work was supported by a grant from the National Eye Institute, National Institutes of Health to F. T. and a postgraduate fellowship from the Natural Sciences and Engineering Research Council of Canada to S. A. H.	Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Bisley JW, 2004, J NEUROPHYSIOL, V91, P286, DOI 10.1152/jn.00870.2003; Courtney SM, 1997, NATURE, V386, P608, DOI 10.1038/386608a0; Curtis CE, 2003, TRENDS COGN SCI, V7, P415, DOI 10.1016/S1364-6613(03)00197-9; FUSTER JM, 1971, SCIENCE, V173, P652, DOI 10.1126/science.173.3997.652; Geng JJ, 2009, J COGNITIVE NEUROSCI, V21, P230, DOI 10.1162/jocn.2008.21025; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Kosslyn SM, 2001, NAT REV NEUROSCI, V2, P635, DOI 10.1038/35090055; Lee H, 2005, NEURON, V45, P147, DOI 10.1016/j.neuron.2004.12.025; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; Magnussen S, 1999, PSYCHOL RES-PSYCH FO, V62, P81, DOI 10.1007/s004260050043; MILLER EK, 1993, J NEUROSCI, V13, P1460; Miller EK, 1996, J NEUROSCI, V16, P5154; MIYASHITA Y, 1988, NATURE, V331, P68, DOI 10.1038/331068a0; Offen S, 2009, VISION RES, V49, P1352, DOI 10.1016/j.visres.2007.12.022; Pasternak T, 2005, NAT REV NEUROSCI, V6, DOI 10.1038/nrn1637; Pessoa L, 2002, NEURON, V35, P975, DOI 10.1016/S0896-6273(02)00817-6; Ress D, 2000, NAT NEUROSCI, V3, P940, DOI 10.1038/78856; Roelfsema PR, 2005, TRENDS COGN SCI, V9, P226, DOI 10.1016/j.tics.2005.03.012; Sasaki Y, 2006, NEURON, V51, P661, DOI 10.1016/j.neuron.2006.07.021; Super H, 2001, SCIENCE, V293, P120, DOI 10.1126/science.1060496; Todd JJ, 2004, NATURE, V428, P751, DOI 10.1038/nature02466; Tong F, 2003, NAT REV NEUROSCI, V4, P219, DOI 10.1038/nrn1055; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; Wang XJ, 2001, TRENDS NEUROSCI, V24, P455, DOI 10.1016/S0166-2236(00)01868-3; Xu YD, 2006, NATURE, V440, P91, DOI 10.1038/nature04262; Zaksas D, 2006, J NEUROSCI, V26, P11726, DOI 10.1523/JNEUROSCI.3420-06.2006	30	785	805	8	145	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 2	2009	458	7238					632	635		10.1038/nature07832	http://dx.doi.org/10.1038/nature07832			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RK	19225460	Green Accepted			2022-12-01	WOS:000264796200041
J	Bostrom, J; Yu, SF; Kan, D; Appleton, BA; Lee, CV; Billeci, K; Man, W; Peale, F; Ross, S; Wiesmann, C; Fuh, G				Bostrom, Jenny; Yu, Shang-Fan; Kan, David; Appleton, Brent A.; Lee, Chingwei V.; Billeci, Karen; Man, Wenyan; Peale, Franklin; Ross, Sarajane; Wiesmann, Christian; Fuh, Germaine			Variants of the Antibody Herceptin That Interact with HER2 and VEGF at the Antigen Binding Site	SCIENCE			English	Article							ENDOTHELIAL GROWTH-FACTOR; SOMATIC HYPERMUTATION; BREAST-CANCER; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; MOLECULAR-BASIS; RECEPTOR; COMPLEX; XENOGRAFTS; DIVERSITY	The interface between antibody and antigen is often depicted as a lock and key, suggesting that an antibody surface can accommodate only one antigen. Here, we describe an antibody with an antigen binding site that binds two distinct proteins with high affinity. We isolated a variant of Herceptin, a therapeutic monoclonal antibody that binds the human epidermal growth factor receptor 2 (HER2), on the basis of its ability to simultaneously interact with vascular endothelial growth factor (VEGF). Crystallographic and mutagenesis studies revealed that distinct amino acids of this antibody, called bH1, engage HER2 and VEGF energetically, but there is extensive overlap between the antibody surface areas contacting the two antigens. An affinity-improved version of bH1 inhibits both HER2-and VEGF-mediated cell proliferation in vitro and tumor progression in mouse models. Such "two-in-one" antibodies challenge the monoclonal antibody paradigm of one binding site, one antigen. They could also provide new opportunities for antibody-based therapy.	[Bostrom, Jenny; Appleton, Brent A.; Lee, Chingwei V.; Man, Wenyan; Wiesmann, Christian; Fuh, Germaine] Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA; [Yu, Shang-Fan; Kan, David; Ross, Sarajane] Genentech Inc, Dept Translat Oncol, San Francisco, CA 94080 USA; [Billeci, Karen] Genentech Inc, Dept Assay & Automat Technol, San Francisco, CA 94080 USA; [Peale, Franklin] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Fuh, G (corresponding author), Genentech Inc, Dept Prot Engn, 1 DNA Way, San Francisco, CA 94080 USA.	gml@gene.com		Appleton, Brent/0000-0003-1136-5649; Wiesmann, Christian/0000-0002-4092-9880	Chalmers University of Technology, Sweden; Director, Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy [DE-AC02-05CH11231]	Chalmers University of Technology, Sweden; Director, Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy(United States Department of Energy (DOE))	We thank the Protein Engineering structure group, L. Haber, and D. McMahon for technical consultation and C. Eigenbrot for helpful advice. We also thank members of the DNA synthesis, DNA sequencing, in vivo cell culture, and protein chemistry groups at Genentech. We are grateful for the support of R. Neutze and Chalmers University of Technology, Sweden. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy under contract no. DE-AC02-05CH11231. The atomic coordinates of the bH1/HER2 and bH1/VEGF were deposited in the Protein Data Bank with accession numbers 3BDY and 3BE1, respectively. G.F. and J.B. are inventors of the patent application "Multispecific Antibodies" (Pub. App. No. 20080069820), which relates to this work. All authors are or were under the employment of Genentech and declare competing financial interests.	Baselga J, 1998, CANCER RES, V58, P2825; Bernard-Marty C, 2006, DRUGS, V66, P1577, DOI 10.2165/00003495-200666120-00004; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; Clark LA, 2006, J IMMUNOL, V177, P333, DOI 10.4049/jimmunol.177.1.333; Colf LA, 2007, CELL, V129, P135, DOI 10.1016/j.cell.2007.01.048; DallAcqua W, 1996, BIOCHEMISTRY-US, V35, P9667, DOI 10.1021/bi960819i; FIELDS BA, 1995, NATURE, V374, P739, DOI 10.1038/374739a0; Foote J, 2003, SCIENCE, V299, P1327, DOI 10.1126/science.1082717; Fuh G, 2006, J BIOL CHEM, V281, P6625, DOI 10.1074/jbc.M507783200; James LC, 2003, SCIENCE, V299, P1362, DOI 10.1126/science.1079731; Jimenez R, 2003, P NATL ACAD SCI USA, V100, P92, DOI 10.1073/pnas.262411399; KELLEY RF, 1993, BIOCHEMISTRY-US, V32, P6828, DOI 10.1021/bi00078a005; Kufer P, 2004, TRENDS BIOTECHNOL, V22, P238, DOI 10.1016/j.tibtech.2004.03.006; Liang WC, 2006, J BIOL CHEM, V281, P951, DOI 10.1074/jbc.M508199200; Muller YA, 1997, P NATL ACAD SCI USA, V94, P7192, DOI 10.1073/pnas.94.14.7192; Mylvaganam SE, 1998, J MOL BIOL, V281, P301, DOI 10.1006/jmbi.1998.1942; Nemazee D, 2006, NAT REV IMMUNOL, V6, P728, DOI 10.1038/nri1939; Neuberger MS, 2008, IMMUNOL CELL BIOL, V86, P124, DOI 10.1038/sj.icb.7100160; NEUBERGER MS, 1995, CURR OPIN IMMUNOL, V7, P248, DOI 10.1016/0952-7915(95)80010-7; Pauling L, 1940, J AM CHEM SOC, V62, P2643, DOI 10.1021/ja01867a018; Pegram MD, 2002, SEMIN ONCOL, V29, P29, DOI 10.1053/sonc.2002.34053; Reichert JM, 2005, NAT BIOTECHNOL, V23, P1073, DOI 10.1038/nbt0905-1073; Senn BM, 2003, EUR J IMMUNOL, V33, P950, DOI 10.1002/eji.200323340; Sethi DK, 2006, IMMUNITY, V24, P429, DOI 10.1016/j.immuni.2006.02.010; Tomlinson IM, 1996, J MOL BIOL, V256, P813, DOI 10.1006/jmbi.1996.0127; WELLS JA, 1993, RECENT PROG HORM RES, V48, P253; Wiesmann C, 1997, CELL, V91, P695, DOI 10.1016/S0092-8674(00)80456-0	27	265	379	1	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2009	323	5921					1610	1614		10.1126/science.1165480	http://dx.doi.org/10.1126/science.1165480			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421EN	19299620				2022-12-01	WOS:000264342300040
J	Carreira, A; Hilario, J; Amitani, I; Baskin, RJ; Shivji, MKK; Venkitaraman, AR; Kowalczykowski, SC				Carreira, Aura; Hilario, Jovencio; Amitani, Ichiro; Baskin, Ronald J.; Shivji, Mahmud K. K.; Venkitaraman, Ashok R.; Kowalczykowski, Stephen C.			The BRC Repeats of BRCA2 Modulate the DNA-Binding Selectivity of RAD51	CELL			English	Article							HOMOLOGY-DIRECTED REPAIR; REPLICATION PROTEIN-A; FILAMENT FORMATION; STRAND EXCHANGE; RECOMBINATION; PROMOTES; COMPLEX; CANCER; STABILIZATION; MEDIATOR	The breast cancer susceptibility protein, BRCA2, is essential for recombinational DNA repair. BRCA2 delivers RAD51 to double-stranded DNA (dsDNA) breaks through interaction with eight conserved, similar to 35 amino acid motifs, the BRC repeats. Here we show that the solitary BRC4 promotes assembly of RAD51 onto single-stranded DNA (ssDNA), but not dsDNA, to stimulate DNA strand exchange. BRC4 acts by blocking ATP hydrolysis and thereby maintaining the active ATP-bound form of the RAD51-ssDNA filament. Single-molecule visualization shows that BRC4 does not disassemble RAD51-dsDNA filaments but rather blocks nucleation of RAD51 onto dsDNA. Furthermore, this behavior is manifested by a domain of BRCA2 comprising all eight BRC repeats. These results establish that the BRC repeats modulate RAD51-DNA interaction in two opposing but functionally reinforcing ways: targeting active RAD51 to ssDNA and prohibiting RAD51 nucleation onto dsDNA. Thus, BRCA2 recruits RAD51 to DNA breaks and, we propose, the BRC repeats regulate DNA-binding selectivity.	[Carreira, Aura; Hilario, Jovencio; Amitani, Ichiro; Kowalczykowski, Stephen C.] Univ Calif Davis, Dept Microbiol, Davis, CA 95616 USA; [Carreira, Aura; Hilario, Jovencio; Amitani, Ichiro; Baskin, Ronald J.; Kowalczykowski, Stephen C.] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Shivji, Mahmud K. K.; Venkitaraman, Ashok R.] Hutchison MRC Res Ctr, MRC, Canc Cell Unit, Cambridge CB2 0XZ, England	University of California System; University of California Davis; University of California System; University of California Davis	Kowalczykowski, SC (corresponding author), Univ Calif Davis, Dept Microbiol, Davis, CA 95616 USA.	sckowalczykowski@ucdavis.edu		Carreira, Aura/0000-0001-5489-4343	NIH [GM-62653, GM-64745]; Ministerio de Educacion y Ciencia (Spain); Susan G. Komen postdoctoral fellowship [PDF0707927]; U. K. Medical Research Council; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062653, R01GM064745, R37GM062653] Funding Source: NIH RePORTER; Medical Research Council [MC_U105359877, G0700651, G9900064, G0600332] Funding Source: researchfish; MRC [G0700651, MC_U105359877, G9900064, G0600332] Funding Source: UKRI	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministerio de Educacion y Ciencia (Spain)(Spanish Government); Susan G. Komen postdoctoral fellowship(Susan G. Komen Breast Cancer Foundation); U. K. Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to Dr. Ryan Jensen for providing us with the full-length BRCA2 construct and to all the members of the Kowalczykowski lab (Jason Bell, Petr Cejka, Anthony Forget, Ryan Jensen, Taeho Kim, Edgar Valencia-Morales, Amitabh Nimonkar, Jody Plank, Katsumi Morimatsu, Behzad Rad, Jason Wong, Rebecca Wright, and Liang Yang) for insightful comments on the manuscript. This work was supported by NIH grants (GM-62653 and GM-64745) to S. C. K., a postdoctoral fellowship from Ministerio de Educacion y Ciencia (Spain) to A. C., a Susan G. Komen postdoctoral fellowship (PDF0707927) to J. H., and funds from the U. K. Medical Research Council to M. K. K. S. and A. R. V. We thank Owen Davies and Luca Pellegrini for BRCA2BRC1-8 purification.	Baumann P, 1996, CELL, V87, P757, DOI 10.1016/S0092-8674(00)81394-X; Benson FE, 1998, NATURE, V391, P401, DOI 10.1038/34937; BENSON FE, 1994, EMBO J, V13, P5764, DOI 10.1002/j.1460-2075.1994.tb06914.x; Bianco PR, 2001, NATURE, V409, P374, DOI 10.1038/35053131; Bugreev DV, 2004, P NATL ACAD SCI USA, V101, P9988, DOI 10.1073/pnas.0402105101; Chen CF, 1999, J BIOL CHEM, V274, P32931, DOI 10.1074/jbc.274.46.32931; Chen PL, 1998, P NATL ACAD SCI USA, V95, P5287, DOI 10.1073/pnas.95.9.5287; Davies AA, 2001, MOL CELL, V7, P273, DOI 10.1016/S1097-2765(01)00175-7; Davies OR, 2007, NAT STRUCT MOL BIOL, V14, P475, DOI 10.1038/nsmb1251; Esashi F, 2007, NAT STRUCT MOL BIOL, V14, P468, DOI 10.1038/nsmb1245; Galkin VE, 2005, P NATL ACAD SCI USA, V102, P8537, DOI 10.1073/pnas.0407266102; Galletto R, 2006, NATURE, V443, P875, DOI 10.1038/nature05197; Hilario J, 2009, P NATL ACAD SCI USA, V106, P361, DOI 10.1073/pnas.0811965106; Kim HK, 2002, GENES CELLS, V7, P1125, DOI 10.1046/j.1365-2443.2002.00588.x; Kowalczykowski SC, 2005, NATURE, V433, P591, DOI 10.1038/433591a; Mazin AV, 2000, EMBO J, V19, P1148, DOI 10.1093/emboj/19.5.1148; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; New JH, 1998, NATURE, V391, P407, DOI 10.1038/34950; Nomme J, 2008, GENES CELLS, V13, P471, DOI 10.1111/j.1365-2443.2008.01180.x; Pellegrini L, 2002, NATURE, V420, P287, DOI 10.1038/nature01230; Petalcorin MIR, 2007, P NATL ACAD SCI USA, V104, P8299, DOI [10.1073/pnas.0702805104, 10.1073/pnas.0702808104]; Saeki H, 2006, P NATL ACAD SCI USA, V103, P8768, DOI 10.1073/pnas.0600298103; San Filippo J, 2006, J BIOL CHEM, V281, P11649, DOI 10.1074/jbc.M601249200; Shin DS, 2003, EMBO J, V22, P4566, DOI 10.1093/emboj/cdg429; Shinohara A, 1998, NATURE, V391, P404, DOI 10.1038/34943; Shivji MKK, 2006, NUCLEIC ACIDS RES, V34, P4000, DOI 10.1093/nar/gkl505; Sugiyama T, 2002, J BIOL CHEM, V277, P31663, DOI 10.1074/jbc.M203494200; Sung P, 2003, J BIOL CHEM, V278, P42729, DOI 10.1074/jbc.R300027200; SUNG P, 1995, CELL, V82, P453, DOI 10.1016/0092-8674(95)90434-4; Sung P, 1997, J BIOL CHEM, V272, P28194, DOI 10.1074/jbc.272.45.28194; Tutt A, 2001, EMBO J, V20, P4704, DOI 10.1093/emboj/20.17.4704; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Yang HJ, 2002, SCIENCE, V297, P1837, DOI 10.1126/science.297.5588.1837; Yang HJ, 2005, NATURE, V433, P653, DOI 10.1038/nature03234	34	167	176	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 20	2009	136	6					1032	1043		10.1016/j.cell.2009.02.019	http://dx.doi.org/10.1016/j.cell.2009.02.019			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	422CE	19303847	Green Submitted, Bronze, Green Accepted			2022-12-01	WOS:000264403900010
J	Volkow, ND; Fowler, JS; Logan, J; Alexoff, D; Zhu, W; Telang, F; Wang, GJ; Jayne, M; Hooker, JM; Wong, C; Hubbard, B; Carter, P; Warner, D; King, P; Shea, C; Xu, YW; Muench, L; Apelskog-Torres, K				Volkow, Nora D.; Fowler, Joanna S.; Logan, Jean; Alexoff, David; Zhu, Wei; Telang, Frank; Wang, Gene-Jack; Jayne, Millard; Hooker, Jacob M.; Wong, Christopher; Hubbard, Barbara; Carter, Pauline; Warner, Donald; King, Payton; Shea, Colleen; Xu, Youwen; Muench, Lisa; Apelskog-Torres, Karen			Effects of Modafinil on Dopamine and Dopamine Transporters in the Male Human Brain Clinical Implications	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INDUCED WAKEFULNESS; DOUBLE-BLIND; ORAL METHYLPHENIDATE; C-11 RACLOPRIDE; BLOOD-FLOW; BINDING; DRUG; PET; AMPHETAMINE; INCREASES	Context Modafinil, a wake-promoting drug used to treat narcolepsy, is increasingly being used as a cognitive enhancer. Although initially launched as distinct from stimulants that increase extracellular dopamine by targeting dopamine transporters, recent preclinical studies suggest otherwise. Objective To measure the acute effects of modafinil at doses used therapeutically (200 mg and 400 mg given orally) on extracellular dopamine and on dopamine transporters in the male human brain. Design, Setting, and Participants Positron emission tomography with [C-11] raclopride (D-2/D-3 radioligand sensitive to changes in endogenous dopamine) and [C-11] cocaine (dopamine transporter radioligand) was used to measure the effects of modafinil on extracellular dopamine and on dopamine transporters in 10 healthy male participants. The study took place over an 8-month period (2007-2008) at Brookhaven National Laboratory. Main Outcome Measures Primary outcomes were changes in dopamine D-2/D-3 receptor and dopamine transporter availability (measured by changes in binding potential) after modafinil when compared with after placebo. Results Modafinil decreased mean (SD) [C-11] raclopride binding potential in caudate (6.1% [6.5%]; 95% confidence interval [CI], 1.5% to 10.8%; P = .02), putamen (6.7% [4.9%]; 95% CI, 3.2% to 10.3%; P = .002), and nucleus accumbens (19.4% [20%]; 95% CI, 5% to 35%; P = .02), reflecting increases in extracellular dopamine. Modafinil also decreased [C-11] cocaine binding potential in caudate (53.8% [13.8%]; 95% CI, 43.9% to 63.6%; P < .001), putamen (47.2% [11.4%]; 95% CI, 39.1% to 55.4%; P < .001), and nucleus accumbens (39.3% [10%]; 95% CI, 30% to 49%; P = .001), reflecting occupancy of dopamine transporters. Conclusions In this pilot study, modafinil blocked dopamine transporters and increased dopamine in the human brain ( including the nucleus accumbens). Because drugs that increase dopamine in the nucleus accumbens have the potential for abuse, and considering the increasing use of modafinil, these results highlight the need for heightened awareness for potential abuse of and dependence on modafinil in vulnerable populations.	[Volkow, Nora D.] Natl Inst Drug Abuse, Bethesda, MD 20892 USA; [Volkow, Nora D.; Telang, Frank; Jayne, Millard; Muench, Lisa] NIAAA, Bethesda, MD USA; [Fowler, Joanna S.; Logan, Jean; Alexoff, David; Wang, Gene-Jack; Hooker, Jacob M.; Wong, Christopher; Hubbard, Barbara; Carter, Pauline; Warner, Donald; King, Payton; Shea, Colleen; Xu, Youwen; Apelskog-Torres, Karen] Brookhaven Natl Lab, Upton, NY 11973 USA; [Fowler, Joanna S.; Wang, Gene-Jack] Mt Sinai Sch Med, New York, NY USA; [Fowler, Joanna S.] SUNY Stony Brook, Dept Chem, Stony Brook, NY USA; [Zhu, Wei] SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); United States Department of Energy (DOE); Brookhaven National Laboratory; Icahn School of Medicine at Mount Sinai; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook	Volkow, ND (corresponding author), Natl Inst Drug Abuse, 6001 Execut Blvd,Room 5274,MSC 9581, Bethesda, MD 20892 USA.	nvolkow@nida.nih.gov	Hooker, Jacob M/P-5716-2018	Hooker, Jacob M/0000-0002-9394-7708; Logan, Jean/0000-0002-6993-9994	Brookhaven National Laboratory [DE-AC02-98CH10886]; Office of Biological and Environmental Research; National Institutes of Health [K05DA020001]; National Institute on Alcohol Abuse; Alcoholism Intramural research program [F32EB997320]; National Institute of Biomedical Imaging and Bioengineering; General Research Clinical Centers [MO1RR10710]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR010710] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA020001] Funding Source: NIH RePORTER	Brookhaven National Laboratory(United States Department of Energy (DOE)); Office of Biological and Environmental Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Alcohol Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Alcoholism Intramural research program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); General Research Clinical Centers; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was carried out at Brookhaven National Laboratory under contract DE-AC02-98CH10886 with the US Department of Energy with infrastructure support from its Office of Biological and Environmental Research. Support was also provided by grant K05DA020001 (J.S.F.) from the National Institutes of Health, the National Institute on Alcohol Abuse and Alcoholism Intramural research program, grant F32EB997320 (J.M.H.) from the National Institute of Biomedical Imaging and Bioengineering, and grant MO1RR10710 from the General Research Clinical Centers. A Goldhaber distinguished fellowship provided support for Dr Hooker.	ALEXOFF DL, 1995, NUCL MED BIOL, V22, P893, DOI 10.1016/0969-8051(95)00042-V; [Anonymous], 2007, NATURE, V450, P320, DOI 10.1038/450320a; [Anonymous], SAS STAT 9 2 US GUID; Biederman J, 2006, J CLIN PSYCHIAT, V67, P727, DOI 10.4088/JCP.v67n0506; CRONE C, 1963, ACTA PHYSIOL SCAND, V58, P292, DOI 10.1111/j.1748-1716.1963.tb02652.x; Dackis CA, 2005, NEUROPSYCHOPHARMACOL, V30, P205, DOI 10.1038/sj.npp.1300600; EHRIN E, 1987, J LABELLED COMPD RAD, V24, P931, DOI 10.1002/jlcr.2580240808; Ferraro L, 1997, BIOL PSYCHIAT, V42, P1181, DOI 10.1016/S0006-3223(97)00353-3; FOWLER JS, 1989, SYNAPSE, V4, P371, DOI 10.1002/syn.890040412; Gjedde A, 2005, INT REV NEUROBIOL, V63, P1, DOI 10.1016/S0074-7742(05)63001-2; Gold LH, 1996, PSYCHOPHARMACOLOGY, V126, P286, DOI 10.1007/BF02247379; Greenhill LL, 2006, PEDIATR ANN, V35, P552, DOI 10.3928/0090-4481-20060801-07; Hart CL, 2008, NEUROPSYCHOPHARMACOL, V33, P761, DOI 10.1038/sj.npp.1301472; Hilaire ZD, 2001, NEUROREPORT, V12, P3533, DOI 10.1097/00001756-200111160-00032; Jasinski DR, 2000, CLIN NEUROPHARMACOL, V23, P149, DOI 10.1097/00002826-200005000-00004; Joo EP, 2008, J SLEEP RES, V17, P82, DOI 10.1111/j.1365-2869.2008.00624.x; Kruszewski SP, 2006, AM J PSYCHIAT, V163, P549, DOI 10.1176/appi.ajp.163.3.549; Kruszewski SP, 2007, J CLIN PSYCHIAT, V68, P970, DOI 10.4088/JCP.v68n0624b; Lin JS, 1996, P NATL ACAD SCI USA, V93, P14128, DOI 10.1073/pnas.93.24.14128; LOGAN J, 1990, J CEREBR BLOOD F MET, V10, P740, DOI 10.1038/jcbfm.1990.127; LOGAN J, 1994, J CEREBR BLOOD F MET, V14, P995, DOI 10.1038/jcbfm.1994.132; MACNAIR DM, 1971, EDITS MANUAL PROFILE; Madras BK, 2006, J PHARMACOL EXP THER, V319, P561, DOI 10.1124/jpet.106.106583; Minzenberg MJ, 2008, NEUROPSYCHOPHARMACOL, V33, P1477, DOI 10.1038/sj.npp.1301534; Minzenberg MJ, 2008, SCIENCE, V322, P1700, DOI 10.1126/science.1164908; Murillo-Rodriguez E, 2007, BEHAV BRAIN RES, V176, P353, DOI 10.1016/j.bbr.2006.10.016; Myrick Hugh, 2004, Ann Clin Psychiatry, V16, P101, DOI 10.1080/10401230490453743; Qu WM, 2008, J NEUROSCI, V28, P8462, DOI 10.1523/JNEUROSCI.1819-08.2008; Scammell TE, 2000, J NEUROSCI, V20, P8620, DOI 10.1523/JNEUROSCI.20-22-08620.2000; Stoops WW, 2005, PSYCHOPHARMACOLOGY, V182, P186, DOI 10.1007/s00213-005-0044-1; Volkow N, 2005, NAT NEUROSCI, V8, P1429, DOI 10.1038/nn1105-1429; VOLKOW ND, 1994, SYNAPSE, V16, P255, DOI 10.1002/syn.890160402; Volkow ND, 2002, SYNAPSE, V44, P175, DOI 10.1002/syn.10075; Volkow ND, 2002, SYNAPSE, V43, P181, DOI 10.1002/syn.10038; Volkow ND, 1998, AM J PSYCHIAT, V155, P1325, DOI 10.1176/ajp.155.10.1325; Wang GJ, 1997, EUR ADDICT RES, V3, P49, DOI 10.1159/000259147; Wisor JP, 2001, J NEUROSCI, V21, P1787, DOI 10.1523/JNEUROSCI.21-05-01787.2001; 2006, 2006 PHYS DESK REFER, P1002	38	372	377	0	33	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 18	2009	301	11					1148	1154		10.1001/jama.2009.351	http://dx.doi.org/10.1001/jama.2009.351			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	419UC	19293415	Green Accepted, Green Published			2022-12-01	WOS:000264244200020
J	Brinster, S; Lamberet, G; Staels, B; Trieu-Cuot, P; Gruss, A; Poyart, C				Brinster, Sophie; Lamberet, Gilles; Staels, Bart; Trieu-Cuot, Patrick; Gruss, Alexandra; Poyart, Claire			Type II fatty acid synthesis is not a suitable antibiotic target for Gram-positive pathogens	NATURE			English	Article							GROUP-B STREPTOCOCCUS; BIOSYNTHESIS; VIRULENCE; BACTERIA; DISEASE; MUTANS; GROWTH; CONTRIBUTES; INHIBITOR; DISCOVERY	Antimicrobial drugs targeting the reportedly essential type II fatty acid synthesis (FASII) pathway(1-5) have been recently acclaimed for their efficacy against infections caused by multiresistant Gram-positive bacteria(6-8). Our findings show that the strategy for antibiotic development based on FASII pathway targets is fundamentally flawed by the fact that exogenous fatty acids fully bypass inhibition of this pathway in both in vitro and in vivo conditions. We demonstrate that major Gram-positive pathogens-such as streptococci, pneumococci, enterococci and staphylococci-overcome drug-induced FASII pathway inhibition when supplied with exogenous fatty acids, and human serum proves to be a highly effective source of fatty acids. For opportunist pathogen Streptococcus agalactiae, growth in serum leads to an overall decrease of FASII gene expression. No antibiotic inhibitor could have a stronger effect than the inactivation of the target gene, so we challenged the role of FASII using deletion mutants. Our results unequivocally show that the FASII target enzymes are dispensable in vivo during S. agalactiae infection. The results of this study largely compromise the use of FASII-based antimicrobials for treating sepsis caused by Gram-positive pathogens.	[Brinster, Sophie; Poyart, Claire] Univ Paris 05, Inst Cochin, CNRS, UMR 8104, Paris, France; [Brinster, Sophie; Poyart, Claire] INSERM, U567, Paris, France; [Lamberet, Gilles; Gruss, Alexandra] INRA, Unite Bacteries Lact & Pathogenes Opportunistes, UR888, F-78350 Jouy En Josas, France; [Staels, Bart] Univ Lille 2, Inst Pasteur Lille, UMR545, Lille, France; [Trieu-Cuot, Patrick; Poyart, Claire] Inst Pasteur, CNRS, URA 2172, Unite Biol Bacteries Pathogenes Gram Posi, Paris, France; [Poyart, Claire] Hop Cochin, Ctr Natl Reference Streptocoques, AP HP, F-75674 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Poyart, C (corresponding author), Univ Paris 05, Inst Cochin, CNRS, UMR 8104, Paris, France.	Alexandra.gruss@jouy.inra.fr; claire.poyart@cch.aphp.fr	Staels, Bart/N-9497-2016; POYART, Claire/P-4225-2017	Staels, Bart/0000-0002-3784-1503; POYART, Claire/0000-0003-2158-6293; TRIEU-CUOT, Patrick/0000-0002-2768-9587; Gruss, Alexandra/0000-0001-7426-5229	French Agence Nationale de la Recherche; INSERM; INRA; Universite Paris Descartes; Institut Pasteur; ANR StrepRespire Project	French Agence Nationale de la Recherche(French National Research Agency (ANR)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); INRA; Universite Paris Descartes; Institut Pasteur(European Commission); ANR StrepRespire Project(French National Research Agency (ANR))	We are grateful to I. Tardieux, P. Bouloc and L. Gutmann for critical reading and discussion of the manuscript, and P. Gaudu and Y. Yamamoto for discussion. We thank A. Bouaboud for technical assistance, and C. Fievet and N. Hennuye for mouse serum fatty acid analyses and advice. This work was supported by research funding from the French Agence Nationale de la Recherche (ANR, StrepRespire Project), INSERM, INRA, Universite Paris Descartes, and the Institut Pasteur. S. B. was a recipient of a post-doctoral fellowship from the ANR StrepRespire Project.	Altabe S, 2007, J BACTERIOL, V189, P8139, DOI 10.1128/JB.01275-07; ALTENBERN RA, 1977, ANTIMICROB AGENTS CH, V11, P574, DOI 10.1128/AAC.11.3.574; Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Bhargava HN, 1996, AM J INFECT CONTROL, V24, P209, DOI 10.1016/S0196-6553(96)90017-6; Campbell JW, 2001, J BACTERIOL, V183, P5982, DOI 10.1128/JB.183.20.5982-5990.2001; Campbell JW, 2001, ANNU REV MICROBIOL, V55, P305, DOI 10.1146/annurev.micro.55.1.305; Dramsi S, 2006, MOL MICROBIOL, V60, P1401, DOI 10.1111/j.1365-2958.2006.05190.x; Fozo EM, 2007, INFECT IMMUN, V75, P1537, DOI 10.1128/IAI.01938-06; Fozo EM, 2004, J BACTERIOL, V186, P4152, DOI 10.1128/JB.186.13.4152-4158.2004; Gill CJ, 1998, ANTIMICROB AGENTS CH, V42, P1996, DOI 10.1128/AAC.42.8.1996; Glaser P, 2002, MOL MICROBIOL, V45, P1499, DOI 10.1046/j.1365-2958.2002.03126.x; Hamilton JA, 2002, PROSTAG LEUKOTR ESS, V67, P65, DOI 10.1054/plef.2002.0400; JOHNSSON T, 1995, APPL ENVIRON MICROB, V61, P4497, DOI 10.1128/AEM.61.12.4497-4499.1995; Kankaanpaa P, 2004, APPL ENVIRON MICROB, V70, P129, DOI 10.1128/AEM.70.1.129-136.2004; Lai CY, 2003, J BIOL CHEM, V278, P51494, DOI 10.1074/jbc.M308638200; Maguin E, 1996, J BACTERIOL, V178, P931, DOI 10.1128/jb.178.3.931-935.1996; Marrakchi H, 2002, BIOCHEM SOC T, V30, P1050, DOI 10.1042/bst0301050; MOELLERI.RC, 1971, J CLIN INVEST, V50, P2580, DOI 10.1172/JCI106758; Nakamura T, 2003, BRIT J NUTR, V89, P267, DOI 10.1079/BJN2002747; Price AC, 2001, J BIOL CHEM, V276, P6551, DOI 10.1074/jbc.M007101200; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Scortti M, 2006, NAT MED, V12, P515, DOI 10.1038/nm1396; Staels B, 2008, NAT CLIN PRACT CARD, V5, P542, DOI 10.1038/ncpcardio1278; Tomita Y, 2008, J OLEO SCI, V57, P115, DOI 10.5650/jos.57.115; Wang J, 2006, NATURE, V441, P358, DOI 10.1038/nature04784; Wang J, 2007, P NATL ACAD SCI USA, V104, P7612, DOI 10.1073/pnas.0700746104; Wright HT, 2007, CURR OPIN MICROBIOL, V10, P447, DOI 10.1016/j.mib.2007.07.001; Yamamoto Y, 2005, MOL MICROBIOL, V56, P525, DOI 10.1111/j.1365-2958.2005.04555.x; Yamamoto Y, 2006, MOL MICROBIOL, V62, P772, DOI 10.1111/j.1365-2958.2006.05406.x; Zhang YM, 2008, NAT REV MICROBIOL, V6, P222, DOI 10.1038/nrmicro1839; Zhang YM, 2006, J BIOL CHEM, V281, P17541, DOI 10.1074/jbc.R600004200	31	233	236	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 5	2009	458	7234					83	U5		10.1038/nature07772	http://dx.doi.org/10.1038/nature07772			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414AJ	19262672				2022-12-01	WOS:000263836000037
J	Silvester, JA; Rashid, M				Silvester, Jocelyn Anne; Rashid, Mohsin			A Patient's Journey Coeliac disease and a gluten-free diet	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Rashid, Mohsin] Dalhousie Univ, Fac Med, Dept Paediat, Div Gastroenterol,IWK Hlth Ctr, Halifax, NS B3K 6R8, Canada	Dalhousie University	Rashid, M (corresponding author), Dalhousie Univ, Fac Med, Dept Paediat, Div Gastroenterol,IWK Hlth Ctr, Halifax, NS B3K 6R8, Canada.	mohsin.rashid@iwk.nshealth.ca	Silvester, Jocelyn/T-2680-2019	Silvester, Jocelyn/0000-0002-3615-1666				GODLEE F, 2009, BRIT MED J, V338, pB821; Harnden A, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b491; Jones R, 2009, BRIT MED J, V338, DOI 10.1136/bmj.a3058; Willis HWM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3066	4	5	5	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 19	2009	338								b380	10.1136/bmj.b380	http://dx.doi.org/10.1136/bmj.b380			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417CH	19228765				2022-12-01	WOS:000264052200003
J	Kuiken, TA; Li, GL; Lock, BA; Lipschutz, RD; Miller, LA; Stubblefield, KA; Englehart, KB				Kuiken, Todd A.; Li, Guanglin; Lock, Blair A.; Lipschutz, Robert D.; Miller, Laura A.; Stubblefield, Kathy A.; Englehart, Kevin B.			Targeted Muscle Reinnervation for Real-time Myoelectric Control of Multifunction Artificial Arms	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NEURAL-MACHINE INTERFACE; PROSTHESIS CONTROL; AMPUTEES; NERVE; EMG; ELECTROMYOGRAM; STIMULATION; SCHEME	Context Improving the function of prosthetic arms remains a challenge, because access to the neural- control information for the arm is lost during amputation. A surgical technique called targeted muscle reinnervation ( TMR) transfers residual arm nerves to alternative-muscle sites. After reinnervation, these target muscles produce electromyogram( EMG) signals on the surface of the skin that can be measured and used to control prosthetic arms. Objective To assess the performance of patients with upper- limb amputation who had undergone TMR surgery, using a pattern- recognition algorithm to decode EMG signals and control prosthetic- arm motions. Design, Setting, and Participants Study conducted between January 2007 and January 2008 at the Rehabilitation Institute of Chicago among 5 patients with shoulder-disarticulation or transhumeral amputations who underwent TMR surgery between February 2002 and October 2006 and 5 control participants without amputation. Surface EMG signals were recorded from all participants and decoded using a pattern-recognition algorithm. The decoding program controlled the movement of a virtual prosthetic arm. All participants were instructed to perform various arm movements, and their abilities to control the virtual prosthetic arm were measured. In addition, TMR patients used the same control system to operate advanced arm prosthesis prototypes. Main Outcome Measure Performance metrics measured during virtual arm movements included motion selection time, motion completion time, and motion completion ("success") rate. Results The TMR patients were able to repeatedly perform 10 different elbow, wrist, and hand motions with the virtual prosthetic arm. For these patients, the mean motion selection and motion completion times for elbow and wrist movements were 0.22 seconds ( SD, 0.06) and 1.29 seconds ( SD, 0.15), respectively. These times were 0.06 seconds and 0.21 seconds longer than the mean times for control participants. For TMR patients, the mean motion selection and motion completion times for hand-grasp patterns were 0.38 seconds ( SD, 0.12) and 1.54 seconds ( SD, 0.27), respectively. These patients successfully completed a mean of 96.3% ( SD, 3.8) of elbow and wrist movements and 86.9% ( SD, 13.9) of hand movements within 5 seconds, compared with 100% ( SD, 0) and 96.7% ( SD, 4.7) completed by controls. Three of the patients were able to demonstrate the use of this control system in advanced prostheses, including motorized shoulders, elbows, wrists, and hands. Conclusion These results suggest that reinnervated muscles can produce sufficient EMG information for real- time control of advanced artificial arms.	[Kuiken, Todd A.; Li, Guanglin; Lock, Blair A.; Lipschutz, Robert D.; Miller, Laura A.; Stubblefield, Kathy A.] Rehabil Inst Chicago, Neural Engn Ctr Artificial Limbs, Chicago, IL 60611 USA; [Kuiken, Todd A.; Li, Guanglin; Miller, Laura A.] Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Kuiken, Todd A.] Northwestern Univ, Dept Biomed Engn, Chicago, IL 60611 USA; [Englehart, Kevin B.] Univ New Brunswick, Inst Biomed Engn, Fredericton, NB, Canada	Shirley Ryan AbilityLab; Northwestern University; Northwestern University; University of New Brunswick	Kuiken, TA (corresponding author), Rehabil Inst Chicago, Neural Engn Ctr Artificial Limbs, 345 E Super St,Room 1309, Chicago, IL 60611 USA.	tkuiken@northwestern.edu	Miller, Laura A/E-1110-2011	Miller, Laura A/0000-0002-7271-6214; Englehart, Kevin/0000-0003-4525-1121; Li, Guanglin/0000-0001-9016-2617	Defense Advanced Research Projects Agency; Army Research Office; DEKA Integrated Solution Corp Prime [W911NF-06-C-001]; National Institute of Child Health and Human Development [R01 HD-043137, JHU-APL-DARPA 908090, N66001-06-C8006R01 HD0-044798]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD044798, R01HD043137] Funding Source: NIH RePORTER	Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Army Research Office; DEKA Integrated Solution Corp Prime; National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by the Defense Advanced Research Projects Agency, Army Research Office, DEKA Integrated Solution Corp Prime contract W911NF-06-C-001, the National Institute of Child Health and Human Development grant R01 HD-043137, JHU-APL-DARPA contract 908090 under Prime Contract N66001-06-C8006R01 HD0-044798, and National Institute of Child Health and Human Development grant R01 HD-043137.	Ajiboye AB, 2005, IEEE T NEUR SYS REH, V13, P280, DOI 10.1109/TNSRE.2005.847357; Branner A, 2004, IEEE T BIO-MED ENG, V51, P146, DOI 10.1109/TBME.2003.820321; Duda R.O., 2000, PATTERN CLASSIFICATI; EDELL DJ, 1986, IEEE T BIO-MED ENG, V33, P203, DOI 10.1109/TBME.1986.325892; Englehart K, 2003, IEEE T BIO-MED ENG, V50, P848, DOI 10.1109/TBME.2003.813539; Englehart K., 2003, TECHNOL DISAB, V15, P95; Farina D, 2006, EXERC SPORT SCI REV, V34, P121, DOI 10.1249/00003677-200607000-00006; FARREL TR, 2007, THESIS NW U EVANSTON; HEFFTNER G, 1988, IEEE T BIO-MED ENG, V35, P230, DOI 10.1109/10.1370; Hijjawi JB, 2006, PLAST RECONSTR SURG, V118, P1573, DOI 10.1097/01.prs.0000242487.62487.fb; Huang H, 2008, IEEE T NEUR SYS REH, V16, P37, DOI 10.1109/TNSRE.2007.910282; Huang YH, 2005, IEEE T BIO-MED ENG, V52, P1801, DOI 10.1109/TBME.2005.856295; HUDGINS B, 1993, IEEE T BIO-MED ENG, V40, P82, DOI 10.1109/10.204774; Kuiken TA, 2004, PROSTHET ORTHOT INT, V28, P245; Kuiken TA., 2003, TECHNOL DISABIL, V15, P105, DOI [10.3233/TAD-2003-15206, DOI 10.3233/TAD-2003-15206]; Kuiken Todd, 2006, Phys Med Rehabil Clin N Am, V17, P1, DOI 10.1016/j.pmr.2005.10.001; Kuiken TA, 2007, P NATL ACAD SCI USA, V104, P20061, DOI 10.1073/pnas.0706525104; Kuiken TA, 2007, LANCET, V369, P371, DOI 10.1016/S0140-6736(07)60193-7; LOCK BA, 2005, MYOEL CONTR S AUG 15; O'Shaughnessy KD, 2008, J BONE JOINT SURG AM, V90A, P393, DOI 10.2106/JBJS.G.00268; PARKER PA, 1986, CRIT REV BIOMED ENG, V13, P283; Sears H., 1992, ATLAS LIMB PROSTHETI; Strange K D, 1999, IEEE Trans Rehabil Eng, V7, P289, DOI 10.1109/86.788466; WEIR RF, 2003, P 25 SILV ANN INT C; Zhou P, 2007, J NEUROPHYSIOL, V98, P2974, DOI 10.1152/jn.00178.2007	25	649	690	7	162	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 11	2009	301	6					619	628		10.1001/jama.2009.116	http://dx.doi.org/10.1001/jama.2009.116			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	405MN	19211469	Bronze, Green Accepted			2022-12-01	WOS:000263229000026
J	Smirnov, DA; Morley, M; Shin, E; Spielman, RS; Cheung, VG				Smirnov, Denis A.; Morley, Michael; Shin, Eunice; Spielman, Richard S.; Cheung, Vivian G.			Genetic analysis of radiation-induced changes in human gene expression	NATURE			English	Article							GENOME-WIDE ASSOCIATION; CELLS; LINKAGE; DISSECTION; APOPTOSIS; TRAITS; GROWTH	Humans are exposed to radiation through the environment and in medical settings. To deal with radiation-induced damage, cells mount complex responses that rely on changes in gene expression. These gene expression responses differ greatly between individuals(1) and contribute to individual differences in response to radiation(2). Here we identify regulators that influence expression levels of radiation-responsive genes. We treated radiation-induced changes in gene expression as quantitative phenotypes(3,4), and conducted genetic linkage and association studies to map their regulators. For more than 1,200 of these phenotypes there was significant evidence of linkage to specific chromosomal regions. Nearly all of the regulators act in trans to influence the expression of their target genes; there are very few cis-acting regulators. Some of the transacting regulators are transcription factors, but others are genes that were not known to have a regulatory function in radiation response. These results have implications for our basic and clinical understanding of how human cells respond to radiation.	[Smirnov, Denis A.; Cheung, Vivian G.] Univ Penn, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; [Morley, Michael; Shin, Eunice; Cheung, Vivian G.] Univ Penn, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Spielman, Richard S.; Cheung, Vivian G.] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA; [Cheung, Vivian G.] Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA	Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania	Cheung, VG (corresponding author), Univ Penn, Howard Hughes Med Inst, Philadelphia, PA 19104 USA.	vcheung@mail.med.upenn.edu	Cheung, Vivian G./AAT-3115-2020	Morley, Michael/0000-0002-0958-7376	National Center for Research Resources; National Institutes of Health; University of Pennsylvania Center for Excellence in Environmental Toxicology; W. W. Smith Endowed Chair; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081930] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pennsylvania Center for Excellence in Environmental Toxicology; W. W. Smith Endowed Chair; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. George and W. Ewens for advice and discussion, A. Bruzel, S. Solomon, T. Weber and K. Halasa for technical help, and C. McGarry for manuscript preparation. Some analyses for this paper were performed by using the program package S. A. G. E., which is supported by a grant from the National Center for Research Resources. This work is supported by grants from the National Institutes of Health (to V. G. C. and R. S. S.), by seed grants from the University of Pennsylvania Center for Excellence in Environmental Toxicology (to V. G. C.), by the W. W. Smith Endowed Chair (to V. G. C.) and the Howard Hughes Medical Institute (to V. G. C.).	Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Amundson SA, 2008, CANCER RES, V68, P415, DOI 10.1158/0008-5472.CAN-07-2120; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Burdick JT, 2006, NAT GENET, V38, P1002, DOI 10.1038/ng1863; Chen H, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-147; Chen ZH, 2002, DEV CELL, V3, P339, DOI 10.1016/S1534-5807(02)00258-7; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Cheung VG, 2003, NAT GENET, V33, P422, DOI 10.1038/ng1094; Correa CR, 2004, AM J HUM GENET, V75, P885, DOI 10.1086/425221; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Li Y, 2006, PLOS GENET, V2, P2155, DOI 10.1371/journal.pgen.0020222; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Myers Jason W, 2006, J RNAi Gene Silencing, V2, P181; Pan DN, 2006, CANCER LETT, V235, P26, DOI 10.1016/j.canlet.2005.03.045; Pant PVK, 2006, GENOME RES, V16, P331, DOI 10.1101/gr.4559106; Price AL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000294; Rockman MV, 2006, NAT REV GENET, V7, P862, DOI 10.1038/nrg1964; Samuels-Lev Y, 2001, MOL CELL, V8, P781, DOI 10.1016/S1097-2765(01)00367-7; Sato N, 2000, EXP CELL RES, V255, P321, DOI 10.1006/excr.1999.4797; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; SELVAKUMARAN M, 1994, MOL CELL BIOL, V14, P2352, DOI 10.1128/MCB.14.4.2352; Shete S, 2003, HUM HERED, V55, P79, DOI 10.1159/000072312; Smith EN, 2008, PLOS BIOL, V6, P810, DOI 10.1371/journal.pbio.0060083; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Vairapandi M, 2002, J CELL PHYSIOL, V192, P327, DOI 10.1002/jcp.10140; Wigginton JE, 2005, BIOINFORMATICS, V21, P3445, DOI 10.1093/bioinformatics/bti529	30	154	157	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2009	459	7246					587	U120		10.1038/nature07940	http://dx.doi.org/10.1038/nature07940			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449ZS	19349959	Green Accepted			2022-12-01	WOS:000266370500043
J	Lee, YJ; Yi, H; Kim, WJ; Kang, K; Yun, DS; Strano, MS; Ceder, G; Belcher, AM				Lee, Yun Jung; Yi, Hyunjung; Kim, Woo-Jae; Kang, Kisuk; Yun, Dong Soo; Strano, Michael S.; Ceder, Gerbrand; Belcher, Angela M.			Fabricating Genetically Engineered High-Power Lithium-Ion Batteries Using Multiple Virus Genes	SCIENCE			English	Article							CARBON NANOTUBE; ELECTRODE PERFORMANCE; HIGH-CAPACITY; PEPTIDES; CATHODE; FEPO4	Development of materials that deliver more energy at high rates is important for high-power applications, including portable electronic devices and hybrid electric vehicles. For lithium-ion (Li+) batteries, reducing material dimensions can boost Li+ ion and electron transfer in nanostructured electrodes. By manipulating two genes, we equipped viruses with peptide groups having affinity for single-walled carbon nanotubes (SWNTs) on one end and peptides capable of nucleating amorphous iron phosphate (a-FePO4) fused to the viral major coat protein. The virus clone with the greatest affinity toward SWNTs enabled power performance of a-FePO4 comparable to that of crystalline lithium iron phosphate (c-LiFePO4) and showed excellent capacity retention upon cycling at 1C. This environmentally benign low-temperature biological scaffold could facilitate fabrication of electrodes from materials previously excluded because of extremely low electronic conductivity.	[Lee, Yun Jung; Yi, Hyunjung; Yun, Dong Soo; Ceder, Gerbrand; Belcher, Angela M.] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Kim, Woo-Jae; Strano, Michael S.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Kang, Kisuk] Korea Adv Inst Sci & Technol, Dept Mat Sci & Engn, Taejon 305701, South Korea; [Kang, Kisuk] Korea Adv Inst Sci & Technol, Inst Ecoenergy, Taejon 305701, South Korea; [Belcher, Angela M.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Massachusetts Institute of Technology (MIT)	Belcher, AM (corresponding author), MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA.	belcher@mit.edu	Yi, Hyunjung/C-8672-2012; Kang, Kisuk/B-5776-2011; Kim, Woo-Jae/F-8036-2013; Ceder, Gerbrand/Y-2544-2019	Yi, Hyunjung/0000-0001-8812-497X; Kim, Woo-Jae/0000-0001-8761-6809; Kang, Kisuk/0000-0002-8696-1886	Army Research Office Institute of the Institute of Collaborative Biotechnologies (ICB); U.S. NSF through the Materials Research Science and Engineering Centers program; Korean Government [KRF-2005-214-D00260]; Korea Science and Engineering Foundation of the Ministry of Education, Science and Technology [R01-2008-000-10913-0]; Energy Resource Technology Development program by the Ministry of Knowledge Economy [2008-E-EL11-P-08-3-010]; Office of Naval Research; EPSRC [EP/C01197X/2, EP/C01197X/1] Funding Source: UKRI	Army Research Office Institute of the Institute of Collaborative Biotechnologies (ICB); U.S. NSF through the Materials Research Science and Engineering Centers program(National Science Foundation (NSF)); Korean Government(Korean Government); Korea Science and Engineering Foundation of the Ministry of Education, Science and Technology; Energy Resource Technology Development program by the Ministry of Knowledge Economy; Office of Naval Research(Office of Naval Research); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the Army Research Office Institute of the Institute of Collaborative Biotechnologies (ICB) and U.S. NSF through the Materials Research Science and Engineering Centers program. H.Y. is grateful for Korean Government Overseas Scholarship. W.-J.K. is grateful for support from the Korea Research Foundation Grant funded by the Korean Government (MOEHRD) (KRF-2005-214-D00260). K.K is grateful for funding support from Korea Science and Engineering Foundation of the Ministry of Education, Science and Technology (No. R01-2008-000-10913-0) and Energy Resource Technology Development program by the Ministry of Knowledge Economy (No. 2008-E-EL11-P-08-3-010). M.S.S. is grateful for funding from the NSF and the Office of Naval Research Young Investigator Grant.	Ahn S, 1998, ELECTROCHEM SOLID ST, V1, P111; Armand M, 2008, NATURE, V451, P652, DOI 10.1038/451652a; Bruce PG, 2008, ANGEW CHEM INT EDIT, V47, P2930, DOI 10.1002/anie.200702505; Chung SY, 2002, NAT MATER, V1, P123, DOI 10.1038/nmat732; Croce F, 2002, ELECTROCHEM SOLID ST, V5, pA47, DOI 10.1149/1.1449302; Delacourt C, 2006, ELECTROCHEM SOLID ST, V9, pA352, DOI 10.1149/1.2201987; Hu YS, 2007, ADV MATER, V19, P1963, DOI 10.1002/adma.200700697; Huang Y, 2005, NANO LETT, V5, P1429, DOI 10.1021/nl050795d; Kang KS, 2006, SCIENCE, V311, P977, DOI 10.1126/science.1122152; Kavan L, 2007, CHEM MATER, V19, P4716, DOI 10.1021/cm071107p; Khalil AS, 2007, P NATL ACAD SCI USA, V104, P4892, DOI 10.1073/pnas.0605727104; Kim DH, 2006, ELECTROCHEM SOLID ST, V9, pA439, DOI 10.1149/1.2218308; Moore VC, 2003, NANO LETT, V3, P1379, DOI 10.1021/nl034524j; Nam KT, 2008, P NATL ACAD SCI USA, V105, P17227, DOI 10.1073/pnas.0711620105; Nam KT, 2008, ACS NANO, V2, P1480, DOI 10.1021/nn800018n; Nam KT, 2004, NANO LETT, V4, P23, DOI 10.1021/nl0347536; Prosini PP, 2002, J ELECTROCHEM SOC, V149, pA297, DOI 10.1149/1.1435359; Sakamoto JS, 2002, J ELECTROCHEM SOC, V149, pA26, DOI 10.1149/1.1425791; Shi ZC, 2008, ELECTROCHIM ACTA, V53, P2665, DOI 10.1016/j.electacta.2007.06.079; Tarascon JM, 2004, DALTON T, P2988, DOI 10.1039/b408442j; Wang Q, 2007, J AM CHEM SOC, V129, P3163, DOI 10.1021/ja066260j; Wang SQ, 2003, NAT MATER, V2, P196, DOI 10.1038/nmat833; Whaley SR, 2000, NATURE, V405, P665, DOI 10.1038/35015043; Zheng M, 2003, SCIENCE, V302, P1545, DOI 10.1126/science.1091911	24	622	650	9	668	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2009	324	5930					1051	1055		10.1126/science.1171541	http://dx.doi.org/10.1126/science.1171541			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448EU	19342549				2022-12-01	WOS:000266246700036
J	Kriaucionis, S; Heintz, N				Kriaucionis, Skirmantas; Heintz, Nathaniel			The Nuclear DNA Base 5-Hydroxymethylcytosine Is Present in Purkinje Neurons and the Brain	SCIENCE			English	Article							TRANSLATIONAL PROFILING APPROACH; CNS CELL-TYPES; OXIDATIVE DAMAGE; 5-METHYLCYTOSINE	Despite the importance of epigenetic regulation in neurological disorders, little is known about neuronal chromatin. Cerebellar Purkinje neurons have large and euchromatic nuclei, whereas granule cell nuclei are small and have a more typical heterochromatin distribution. While comparing the abundance of 5-methylcytosine in Purkinje and granule cell nuclei, we detected the presence of an unusual DNA nucleotide. Using thin-layer chromatography, high-pressure liquid chromatography, and mass spectrometry, we identified the nucleotide as 5-hydroxymethyl-2'-deoxycytidine (hmdC). hmdC constitutes 0.6% of total nucleotides in Purkinje cells, 0.2% in granule cells, and is not present in cancer cell lines. hmdC is a constituent of nuclear DNA that is highly abundant in the brain, suggesting a role in epigenetic control of neuronal function.	[Kriaucionis, Skirmantas; Heintz, Nathaniel] Rockefeller Univ, Mol Biol Lab, Howard Hughes Med Inst, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University	Heintz, N (corresponding author), Rockefeller Univ, Mol Biol Lab, Howard Hughes Med Inst, New York, NY 10065 USA.	heintz@mail.rockefeller.edu	Kriaucionis, Skirmantas/A-2986-2015; jia, xu/A-8386-2016	Kriaucionis, Skirmantas/0000-0002-2273-5994; 	Howard Hughes Medical Institute; Simons Foundation Autism Research Initiative	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Simons Foundation Autism Research Initiative	We thank B. Gauthier for technical assistance; S. Mazel, C. Bare, and X. Fan for flow cytometry advice and nuclei sorts; and H. Deng and J. Fernandez for acquirement of MS data and help with HPLC. We are grateful to members of the Heintz laboratory for discussions and support. This work was supported by the Howard Hughes Medical Institute and the Simons Foundation Autism Research Initiative.	Burdzy A, 2002, NUCLEIC ACIDS RES, V30, P4068, DOI 10.1093/nar/gkf520; Cadet J, 2006, NAT CHEM BIOL, V2, P348, DOI 10.1038/nchembio0706-348; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; GOMMERSAMPT JH, 1995, FASEB J, V9, P1034, DOI 10.1096/fasebj.9.11.7649402; HAYATSU H, 1979, BIOCHEMISTRY-US, V18, P632, DOI 10.1021/bi00571a013; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; KOTHARI RM, 1976, J MOL EVOL, V7, P325, DOI 10.1007/BF01743628; Ooi SKT, 2008, CELL, V133, P1145, DOI 10.1016/j.cell.2008.06.009; PENN NW, 1972, BIOCHEM J, V126, P781, DOI 10.1042/bj1260781; Ramsahoye Bernard H, 2002, Methods Mol Biol, V200, P9; TardyPlanechaud S, 1997, NUCLEIC ACIDS RES, V25, P553, DOI 10.1093/nar/25.3.553; Valinluck V, 2004, NUCLEIC ACIDS RES, V32, P4100, DOI 10.1093/nar/gkh739; WYATT GR, 1953, BIOCHEM J, V55, P774, DOI 10.1042/bj0550774; ZUO SJ, 1995, NUCLEIC ACIDS RES, V23, P3239, DOI 10.1093/nar/23.16.3239	14	1922	2011	1	246	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 15	2009	324	5929					929	930		10.1126/science.1169786	http://dx.doi.org/10.1126/science.1169786			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	19372393	Green Accepted			2022-12-01	WOS:000266048800036
J	Livingston, DM				Livingston, David M.			Complicated Supercomplexes	SCIENCE			English	Editorial Material							CANCER SUSCEPTIBILITY GENE; BREAST-CANCER; FANCONI-ANEMIA; PALB2; MUTATIONS; PARTNER		[Livingston, David M.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Genet, Boston, MA 02115 USA; [Livingston, David M.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Livingston, DM (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Genet, Boston, MA 02115 USA.	david_livingston@dfci.harvard.edu						Campeau PM, 2008, HUM GENET, V124, P31, DOI 10.1007/s00439-008-0529-1; Chen JJ, 1998, MOL CELL, V2, P317, DOI 10.1016/S1097-2765(00)80276-2; Erkko H, 2007, NATURE, V446, P316, DOI 10.1038/nature05609; Goggins M, 1996, CANCER RES, V56, P5360; Greenberg RA, 2006, GENE DEV, V20, P34, DOI 10.1101/gad.1381306; Jones S, 2009, SCIENCE, V324, P217, DOI 10.1126/science.1171202; Rahman N, 2007, NAT GENET, V39, P165, DOI 10.1038/ng1959; Reid S, 2007, NAT GENET, V39, P162, DOI 10.1038/ng1947; Sy SMH, 2009, P NATL ACAD SCI USA, V106, P7155, DOI 10.1073/pnas.0811159106; Tischkowitz M, 2007, P NATL ACAD SCI USA, V104, P6788, DOI 10.1073/pnas.0701724104; Walsh T, 2007, CANCER CELL, V11, P103, DOI 10.1016/j.ccr.2007.01.010; Xia B, 2007, NAT GENET, V39, P159, DOI 10.1038/ng1942; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022; Zhang F, 2009, CURR BIOL, V19, P524, DOI 10.1016/j.cub.2009.02.018	14	14	14	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 1	2009	324	5927					602	603		10.1126/science.1174839	http://dx.doi.org/10.1126/science.1174839			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439DW	19407191				2022-12-01	WOS:000265608800031
J	Raj, A; Saggurti, N; Balaiah, D; Silverman, JG				Raj, Anita; Saggurti, Niranjan; Balaiah, Donta; Silverman, Jay G.			Prevalence of child marriage and its effect on fertility and fertility-control outcomes of young women in India: a cross-sectional, observational study	LANCET			English	Article							HEALTH	Background Child marriage is a substantial barrier to social and economic development in India, and a primary concern for women's health. We assessed the prevalence of child marriage-ie, before 18 years of age-in young adult women in India, and the associations between child marriage and women's fertility and fertility-control outcomes. Methods Data from the National Family Health Survey-3 (2005-06) were limited to a sample of Indian women aged 20-24 years (n=22807), of whom 14813 had been or were presently married (ever-married). Prevalence of child marriage was estimated for the whole sample. We used regression models adjusted for demographics, and models adjusted for demographics and duration of marriage to estimate odds ratios (ORs) for the associations between child marriage and both fertility and fertility-control outcomes, in the ever-married subsample. Findings 44.5% of women aged 20-24 years were married before age 18 years, 22.6% were married before age 16 years, and 2.6% were married before age 13 years. Child marriage was significantly associated with no contraceptive use before first childbirth (adjusted OR 1.37 [95% CI 1.22-1.54]), high fertility (three or more births) (7.40 [6.45-8.50]), a repeat childbirth in less than 24 months (3.00 [2.74-3.29]), multiple unwanted pregnancies (2.36 [1.90-2.94]), pregnancy termination (1.48 [1.34-1.63]), and female sterilisation (6.68 [5.78-7.60]). The association between child marriage and high fertility, a repeat childbirth in less than 24 months, multiple unwanted pregnancies, pregnancy termination, and sterilisation all remained significant after controlling for duration of marriage. Interpretation Increased enforcement of existing policies is crucial for prevention of child marriage. improved family-planning education, access, and support are urgently needed for women married as children, their husbands, and their families to reduce the high fertility and poor fertility-control outcomes of this practice. Funding US National Institutes of Health and Indian Council of Medical Research.	[Raj, Anita] Boston Univ, Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02118 USA; [Saggurti, Niranjan] Populat Council, New Delhi, India; [Balaiah, Donta] Indian Council Med Res, Natl Inst Res Reprod Hlth, Bombay, Maharashtra, India; [Silverman, Jay G.] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA	Boston University; Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Reproductive Health (NIRRH); Harvard University; Harvard T.H. Chan School of Public Health	Raj, A (corresponding author), Boston Univ, Sch Publ Hlth, Dept Social & Behav Sci, 801 Massachusetts Ave,C-O 715 Albany St, Boston, MA 02118 USA.	anitaraj@bu.edu		Saggurti, Niranjan/0000-0002-5267-8425	US National Institutes of Health; Indian Council of Medical Research Indo-US Program on Maternal and Child Health and Human Development [1 R03 HD055120-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD055120] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indian Council of Medical Research Indo-US Program on Maternal and Child Health and Human Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was funded by a grant from the US National Institutes of Health and the Indian Council of Medical Research Indo-US Program on Maternal and Child Health and Human Development to JGS (grant number 1 R03 HD055120-01).	AUDINARAYANA N, 1993, DEMOGRAPHY INDIA, V22, P169; AUDINARAYANA N, 1986, J FAM WELFARE, V31, P56; BHAGAT RB, 2002, EARLY MARRIAGES INDI; Bhattacharya G, 2004, HEALTH EDUC BEHAV, V31, P101, DOI 10.1177/1090198103259204; Bhutta ZA, 2004, BMJ-BRIT MED J, V328, P816, DOI 10.1136/bmj.328.7443.816; Chatterjee P, 2007, LANCET, V370, P1023, DOI 10.1016/S0140-6736(07)61460-3; Chatterjee P, 2006, LANCET, V368, P1483, DOI 10.1016/S0140-6736(06)69620-7; DATT G, 2846 WPS; *GOV IND MIN HUM R, 2007, SEL ED STAT; *I SOC STUD TRUST, 2007, PROGR WOM S AS; *INT CTR RES WOM, NEW INS PREV CHILD M; *INT I POP SCI MAC, 2007, NAT FAM HLTH SURV NF; KROLL L, 2008, FORBES MAGAZINE 0305; Mensch B., 2003, TRENDS TIMING 1 MARR; Ministry of Health and Family Welfare (MOHFW), NAT RUR HLTH MISS 20; PANAGARIYA A, 2008, BROOKINGS WASHI 0124; PATIL PA, 2002, J 3 WORLD STUD, V19, P195; RAO GR, 1998, DEMOGRAPHY INDIA, V27, P401; RICHARD J, 1997, DEMOGRAPHY INDIA, V24, P81; Rigsby D C, 1998, J Pediatr Adolesc Gynecol, V11, P115; Saardchom N, 2005, MARRIAGE FAM REV, V37, P73, DOI 10.1300/J002v37n03_05; SIVARAM M, 1995, J BIOSOC SCI, V27, P325, DOI 10.1017/S0021932000022847; SUREENDER S, 1993, NEW TIMES BOMBAY, P5; THENMOZHI N, 1992, INDIAN J PUBL ADMIN, V38, P341; *UN, MILL DEV GOALS; *UNFPA, STAT WORLD POP 2005; UNICEF, 2001, EARL MARR CHILD SPOU; United Nations Children's Fund (UNICEF), PROGR CHILDR WORLD F; *WOLD BANK, IND COUNTR OV 2008	29	201	201	1	37	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY-JUN	2009	373	9678					1883	1889		10.1016/S0140-6736(09)60246-4	http://dx.doi.org/10.1016/S0140-6736(09)60246-4			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	453ND	19278721	Green Accepted			2022-12-01	WOS:000266616400031
J	Frost, A; Unger, VM; De Camilli, P				Frost, Adam; Unger, Vinzenz M.; De Camilli, Pietro			The BAR Domain Superfamily: Membrane-Molding Macromolecules	CELL			English	Article							SYNAPTIC VESICLE ENDOCYTOSIS; MEDIATED ENDOCYTOSIS; ACTIN CYTOSKELETON; AMPHIPHYSIN-2 BIN1; STRUCTURAL BASIS; FISSION YEAST; PROTEINS; CURVATURE; FAMILY; INVAGINATION	Membrane-shaping proteins of the BAR domain superfamily are determinants of organelle biogenesis, membrane trafficking, cell division, and cell migration. An upsurge of research now reveals new principles of BAR domain-mediated membrane remodeling, enhancing our understanding of membrane curvature-mediated information processing.	[Frost, Adam; Unger, Vinzenz M.] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06510 USA; [De Camilli, Pietro] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; [De Camilli, Pietro] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA; [Frost, Adam; Unger, Vinzenz M.; De Camilli, Pietro] Yale Univ, Sch Med, Interdepartmental Neurosci Program, New Haven, CT 06510 USA; [Frost, Adam; De Camilli, Pietro] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [De Camilli, Pietro] Yale Univ, Sch Med, Kavli Inst Neurosci, New Haven, CT 06510 USA; [De Camilli, Pietro] Yale Univ, Sch Med, Program Cellular Neurosci Neurodegenerat & Repair, New Haven, CT 06510 USA	Yale University; Yale University; Yale University; Yale University; Howard Hughes Medical Institute; Yale University; Yale University; Yale University	Unger, VM (corresponding author), Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06510 USA.	vinzenz.unger@yale.edu; pietro.decamilli@yale.edu		Frost, Adam/0000-0003-2231-2577	NATIONAL INSTITUTE ON DRUG ABUSE [R21DA024101, P30DA018343] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIDA NIH HHS [R21 DA024101, P30 DA018343] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Ayton GS, 2007, BIOPHYS J, V92, P3595, DOI 10.1529/biophysj.106.101709; Bonifacino JS, 2008, CURR OPIN CELL BIOL, V20, P427, DOI 10.1016/j.ceb.2008.03.009; Butler MH, 1997, J CELL BIOL, V137, P1355, DOI 10.1083/jcb.137.6.1355; Cullen PJ, 2008, NAT REV MOL CELL BIO, V9, P574, DOI 10.1038/nrm2427; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Ferguson SM, 2007, SCIENCE, V316, P570, DOI 10.1126/science.1140621; Frost A, 2008, CELL, V132, P807, DOI 10.1016/j.cell.2007.12.041; Frost A, 2007, STRUCTURE, V15, P751, DOI 10.1016/j.str.2007.06.006; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; GOLDENTHAL KL, 1984, EXP CELL RES, V152, P558, DOI 10.1016/0014-4827(84)90658-X; Habermann B, 2004, EMBO REP, V5, P250, DOI 10.1038/sj.embor.7400105; Ho HYH, 2004, CELL, V118, P203, DOI 10.1016/j.cell.2004.06.027; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Itoh T, 2006, BBA-MOL CELL BIOL L, V1761, P897, DOI 10.1016/j.bbalip.2006.06.015; Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024; KANBE T, 1989, J CELL SCI, V94, P647; Karbowski M, 2004, J CELL BIOL, V166, P1027, DOI 10.1083/jcb.200407046; Kumar V, 2009, MOL BIOL CELL, V20, P2254, DOI 10.1091/mbc.E08-10-1072; Kusumi N, 2007, CELL STRUCT FUNCT, V32, P101, DOI 10.1247/csf.07024; Lee EY, 2002, SCIENCE, V297, P1193, DOI 10.1126/science.1071362; Lippincott J, 1998, J CELL BIOL, V143, P1947, DOI 10.1083/jcb.143.7.1947; Lundmark R, 2008, CURR BIOL, V18, P1802, DOI 10.1016/j.cub.2008.10.044; Mattila PK, 2007, J CELL BIOL, V176, P953, DOI 10.1083/jcb.200609176; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; McBride HM, 2008, J CELL BIOL, V183, P757, DOI 10.1083/jcb.200810184; Miaczynska M, 2004, CELL, V116, P445, DOI 10.1016/S0092-8674(04)00117-5; Miki H, 2000, NATURE, V408, P732, DOI 10.1038/35047107; Nicot AS, 2007, NAT GENET, V39, P1134, DOI 10.1038/ng2086; Ochoa GC, 2000, J CELL BIOL, V150, P377, DOI 10.1083/jcb.150.2.377; Padrick SB, 2008, MOL CELL, V32, P426, DOI 10.1016/j.molcel.2008.10.012; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Razzaq A, 2001, GENE DEV, V15, P2967, DOI 10.1101/gad.207801; ROBERTSGALBRAIT.RH, 2008, POMBE CDC15 HOMOLOGY; Rodal AA, 2008, J NEUROSCI, V28, P8316, DOI 10.1523/JNEUROSCI.2304-08.2008; Saarikangas J, 2009, CURR BIOL, V19, P95, DOI 10.1016/j.cub.2008.12.029; Shimada A, 2007, CELL, V129, P761, DOI 10.1016/j.cell.2007.03.040; Spencer S, 1997, J CELL BIOL, V138, P845, DOI 10.1083/jcb.138.4.845; Takahashi Y, 2005, MOL CELL BIOL, V25, P9369, DOI 10.1128/MCB.25.21.9369-9382.2005; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Tarricone C, 2001, NATURE, V411, P215, DOI 10.1038/35075620; Wu JQ, 2006, J CELL BIOL, V174, P391, DOI 10.1083/jcb.200602032; Yarar D, 2007, DEV CELL, V13, P43, DOI 10.1016/j.devcel.2007.04.014	45	414	421	1	55	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 17	2009	137	2					191	196		10.1016/j.cell.2009.04.010	http://dx.doi.org/10.1016/j.cell.2009.04.010			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	437AB	19379681	Green Accepted, Bronze			2022-12-01	WOS:000265456800006
J	Grigoryan, G; Reinke, AW; Keating, AE				Grigoryan, Gevorg; Reinke, Aaron W.; Keating, Amy E.			Design of protein-interaction specificity gives selective bZIP-binding peptides	NATURE			English	Article							COILED-COIL; PDZ DOMAIN; COMPUTATIONAL REDESIGN; PREDICTION; STABILITY; INTERFACES; AFFINITY; ENERGY	Interaction specificity is a required feature of biological networks and a necessary characteristic of protein or small-molecule reagents and therapeutics. The ability to alter or inhibit protein interactions selectively would advance basic and applied molecular science. Assessing or modelling interaction specificity requires treating multiple competing complexes, which presents computational and experimental challenges. Here we present a computational framework for designing protein-interaction specificity and use it to identify specific peptide partners for human basic-region leucine zipper (bZIP) transcription factors. Protein microarrays were used to characterize designed, synthetic ligands for all but one of 20 bZIP families. The bZIP proteins share strong sequence and structural similarities and thus are challenging targets to bind specifically. Nevertheless, many of the designs, including examples that bind the oncoproteins c-Jun, c-Fos and c-Maf (also called JUN, FOS and MAF, respectively), were selective for their targets over all 19 other families. Collectively, the designs exhibit a wide range of interaction profiles and demonstrate that human bZIPs have only sparsely sampled the possible interaction space accessible to them. Our computational method provides a way to systematically analyse trade-offs between stability and specificity and is suitable for use with many types of structure-scoring functions; thus, it may prove broadly useful as a tool for protein design.	[Grigoryan, Gevorg; Reinke, Aaron W.; Keating, Amy E.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Keating, AE (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	keating@mit.edu		Reinke, Aaron/0000-0001-7612-5342; Keating, Amy/0000-0003-4074-8980	NIH [GM67681]; NSF [0216437]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067681] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NIH award GM67681 and used computer equipment purchased under the NSF award 0216437. We thank the MIT BioMicro center for arraying instrumentation and R. T. Sauer, M. Singh, B. Tidor, M. Laub, T. A. Baker, J. H. Davis, M. S. Kay, J. R. S. Newman, W. F. DeGrado and members of the Keating laboratory, especially O. Ashenberg and T. C. S. Chen, for comments on the manuscript.	Acharya A, 2006, BIOCHEMISTRY-US, V45, P11324, DOI 10.1021/bi060822u; Ali MH, 2005, STRUCTURE, V13, P225, DOI 10.1016/j.str.2004.12.009; APGAR JR, J COMPUT CH IN PRESS; Boas FE, 2007, CURR OPIN STRUC BIOL, V17, P199, DOI 10.1016/j.sbi.2007.03.006; Bolon DN, 2005, P NATL ACAD SCI USA, V102, P12724, DOI 10.1073/pnas.0506124102; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; Deutsch JM, 1996, PHYS REV LETT, V76, P323, DOI 10.1103/PhysRevLett.76.323; Fong JH, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r11; Fu XR, 2007, J MOL BIOL, V371, P1099, DOI 10.1016/j.jmb.2007.04.069; Gerdes MJ, 2006, CANCER RES, V66, P7578, DOI 10.1158/0008-5472.CAN-06-1247; Grigoryan G, 2006, J MOL BIOL, V355, P1125, DOI 10.1016/j.jmb.2005.11.036; Grigoryan G, 2006, PLOS COMPUT BIOL, V2, P551, DOI 10.1371/journal.pcbi.0020063; Hadley EB, 2008, P NATL ACAD SCI USA, V105, P530, DOI 10.1073/pnas.0709068105; Havranek JJ, 2003, NAT STRUCT BIOL, V10, P45, DOI 10.1038/nsb877; Hoover DM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e43; Jones RB, 2006, NATURE, V439, P168, DOI 10.1038/nature04177; Kangas E, 2000, J CHEM PHYS, V112, P9120, DOI 10.1063/1.481522; Kaplan T, 2005, PLOS COMPUT BIOL, V1, P5, DOI 10.1371/journal.pcbi.0010001; Kingsford CL, 2005, BIOINFORMATICS, V21, P1028, DOI 10.1093/bioinformatics/bti144; Kortemme T, 2004, NAT STRUCT MOL BIOL, V11, P371, DOI 10.1038/nsmb749; KRYLOV D, 1995, EMBO J, V14, P5329, DOI 10.1002/j.1460-2075.1995.tb00217.x; Krylov D, 1998, J MOL BIOL, V279, P959, DOI 10.1006/jmbi.1998.1762; Landgraf C, 2004, PLOS BIOL, V2, P94, DOI 10.1371/journal.pbio.0020014; Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0; Mason JM, 2007, BIOCHEMISTRY-US, V46, P4804, DOI 10.1021/bi602506p; Mason JM, 2006, P NATL ACAD SCI USA, V103, P8989, DOI 10.1073/pnas.0509880103; Newman JRS, 2003, SCIENCE, V300, P2097, DOI 10.1126/science.1084648; Reina J, 2002, NAT STRUCT BIOL, V9, P621, DOI 10.1038/nsb815; Sanchez IE, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000052; Shifman JM, 2003, P NATL ACAD SCI USA, V100, P13274, DOI 10.1073/pnas.2234277100; Skerker JM, 2005, PLOS BIOL, V3, P1770, DOI 10.1371/journal.pbio.0030334; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Van der Sloot AM, 2006, P NATL ACAD SCI USA, V103, P8634, DOI 10.1073/pnas.0510187103; Vinson C, 2006, BBA-GENE STRUCT EXPR, V1759, P4, DOI 10.1016/j.bbaexp.2005.12.005; Wiedemann U, 2004, J MOL BIOL, V343, P703, DOI 10.1016/j.jmb.2004.08.064; Yin H, 2007, SCIENCE, V315, P1817, DOI 10.1126/science.1136782; Zhou F, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.148103; Zhou HY, 2002, PROTEIN SCI, V11, P2714, DOI 10.1110/ps.0217002	38	275	281	2	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 16	2009	458	7240					859	U2		10.1038/nature07885	http://dx.doi.org/10.1038/nature07885			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433CS	19370028	Green Accepted			2022-12-01	WOS:000265182500036
J	Kudla, G; Murray, AW; Tollervey, D; Plotkin, JB				Kudla, Grzegorz; Murray, Andrew W.; Tollervey, David; Plotkin, Joshua B.			Coding-Sequence Determinants of Gene Expression in Escherichia coli	SCIENCE			English	Article							SYNONYMOUS CODON USAGE; RNA SECONDARY STRUCTURE; MESSENGER-RNA; TRANSLATION INITIATION; PROTEIN EXPRESSION; BIAS; DOWNSTREAM; MUTATIONS; STABILITY; SELECTION	Synonymous mutations do not alter the encoded protein, but they can influence gene expression. To investigate how, we engineered a synthetic library of 154 genes that varied randomly at synonymous sites, but all encoded the same green fluorescent protein (GFP). When expressed in Escherichia coli, GFP protein levels varied 250-fold across the library. GFP messenger RNA (mRNA) levels, mRNA degradation patterns, and bacterial growth rates also varied, but codon bias did not correlate with gene expression. Rather, the stability of mRNA folding near the ribosomal binding site explained more than half the variation in protein levels. In our analysis, mRNA folding and associated rates of translation initiation play a predominant role in shaping expression levels of individual genes, whereas codon bias influences global translation efficiency and cellular fitness.	[Kudla, Grzegorz; Plotkin, Joshua B.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Kudla, Grzegorz; Plotkin, Joshua B.] Univ Penn, Program Appl Math & Computat Sci, Philadelphia, PA 19104 USA; [Murray, Andrew W.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Tollervey, David] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland; [Tollervey, David] Univ Edinburgh, Ctr Syst Biol, Edinburgh EH9 3JR, Midlothian, Scotland	University of Pennsylvania; University of Pennsylvania; Harvard University; University of Edinburgh; University of Edinburgh	Plotkin, JB (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	jplotkin@sas.upenn.edu	Plotkin, Joshua B/E-6947-2013; Tollervey, David/AAR-6662-2020	Tollervey, David/0000-0003-2894-2772; Kudla, Grzegorz/0000-0002-7924-2744	Burroughs Wellcome Fund; James S. McDonnell Foundation; Penn Genome Frontiers Institute; Defense Advanced Research Projects Agency [HR0011-05-1-0057]; Foundation for Polish Science; European Molecular Biology Organization; Wellcome Trust/BBSRC [BB/DO19621/1]; Biotechnology and Biological Sciences Research Council [BB/D019621/1] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068763] Funding Source: NIH RePORTER; BBSRC [BB/D019621/1] Funding Source: UKRI	Burroughs Wellcome Fund(Burroughs Wellcome Fund); James S. McDonnell Foundation; Penn Genome Frontiers Institute; Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Wellcome Trust/BBSRC(Wellcome TrustUK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank A. Helwak, J. Lucks, P. Sharp, L. Hurst, and members of the Plotkin and Tollervey laboratories for conceptual input; and A. Heath (Sigma), A. Aitken, J. Skerker, T. Shimizu, I. Iost, and J. Han for reagents, protocols, and equipment. Support provided by the Burroughs Wellcome Fund, James S. McDonnell Foundation, Penn Genome Frontiers Institute, and Defense Advanced Research Projects Agency "FunBio Program" HR0011-05-1-0057 (J.B.P.); Foundation for Polish Science and European Molecular Biology Organization (G.K.); Wellcome Trust/BBSRC grant BB/DO19621/1 (D.T.).	AKASHI H, 1994, GENETICS, V136, P927; ANDERSSON SGE, 1990, MICROBIOL REV, V54, P198, DOI 10.1128/MMBR.54.2.198-210.1990; Boycheva S, 2003, BIOINFORMATICS, V19, P987, DOI 10.1093/bioinformatics/btg082; Coleman JR, 2008, SCIENCE, V320, P1784, DOI 10.1126/science.1155761; de Valdivia EIG, 2004, NUCLEIC ACIDS RES, V32, P5198, DOI 10.1093/nar/gkh857; DESMIT MH, 1990, P NATL ACAD SCI USA, V87, P7668, DOI 10.1073/pnas.87.19.7668; Drummond DA, 2005, P NATL ACAD SCI USA, V102, P14338, DOI 10.1073/pnas.0504070102; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; EYREWALKER A, 1993, NUCLEIC ACIDS RES, V21, P4599, DOI 10.1093/nar/21.19.4599; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Griswold KE, 2003, PROTEIN EXPRES PURIF, V27, P134, DOI 10.1016/S1046-5928(02)00578-8; Gustafsson C, 2004, TRENDS BIOTECHNOL, V22, P346, DOI 10.1016/j.tibtech.2004.04.006; HALL MN, 1982, NATURE, V295, P616, DOI 10.1038/295616a0; IKEMURA T, 1981, J MOL BIOL, V151, P389, DOI 10.1016/0022-2836(81)90003-6; IKEMURA T, 1985, MOL BIOL EVOL, V2, P13; IOST I, 1995, EMBO J, V14, P3252, DOI 10.1002/j.1460-2075.1995.tb07328.x; JACQUES N, 1990, MOL MICROBIOL, V4, P1063, DOI 10.1111/j.1365-2958.1990.tb00679.x; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Kozak M, 2005, GENE, V361, P13, DOI 10.1016/j.gene.2005.06.037; Lithwick G, 2003, GENOME RES, V13, P2665, DOI 10.1101/gr.1485203; MUDD EA, 1990, MOL MICROBIOL, V4, P2127, DOI 10.1111/j.1365-2958.1990.tb00574.x; Nackley AG, 2006, SCIENCE, V314, P1930, DOI 10.1126/science.1131262; Parmley JL, 2007, BIOESSAYS, V29, P515, DOI 10.1002/bies.20592; Qing GL, 2003, J MOL MICROB BIOTECH, V6, P133, DOI 10.1159/000077244; ROSENBERG AH, 1993, J BACTERIOL, V175, P716, DOI 10.1128/JB.175.3.716-722.1993; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Stoletzki N, 2007, MOL BIOL EVOL, V24, P374, DOI 10.1093/molbev/msl166; ZUCKERKANDL E, 1965, J THEOR BIOL, V8, P357, DOI 10.1016/0022-5193(65)90083-4	28	966	999	11	193	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 10	2009	324	5924					255	258		10.1126/science.1170160	http://dx.doi.org/10.1126/science.1170160			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430WX	19359587	Green Accepted			2022-12-01	WOS:000265024400047
J	Wittebolle, L; Marzorati, M; Clement, L; Balloi, A; Daffonchio, D; Heylen, K; De Vos, P; Verstraete, W; Boon, N				Wittebolle, Lieven; Marzorati, Massimo; Clement, Lieven; Balloi, Annalisa; Daffonchio, Daniele; Heylen, Kim; De Vos, Paul; Verstraete, Willy; Boon, Nico			Initial community evenness favours functionality under selective stress	NATURE			English	Article							CURRENT KNOWLEDGE; SPECIES RICHNESS; BIODIVERSITY; DIVERSITY; STABILITY; ECOLOGY; PRODUCTIVITY; REDUNDANCY; SYSTEMS	Owing to the present global biodiversity crisis, the biodiversity-stability relationship and the effect of biodiversity on ecosystem functioning have become major topics in ecology(1-3). Biodiversity is a complex term that includes taxonomic, functional, spatial and temporal aspects of organismic diversity, with species richness (the number of species) and evenness (the relative abundance of species) considered among the most important measures(4,5). With few exceptions (see, for example, ref. 6), the majority of studies of biodiversity-functioning and biodiversity-stability theory have predominantly examined richness(7-11). Here we show, using microbial microcosms, that initial community evenness is a key factor in preserving the functional stability of an ecosystem. Using experimental manipulations of both richness and initial evenness in microcosms with denitrifying bacterial communities, we found that the stability of the net ecosystem denitrification in the face of salinity stress was strongly influenced by the initial evenness of the community. Therefore, when communities are highly uneven, or there is extreme dominance by one or a few species, their functioning is less resistant to environmental stress. Further unravelling how evenness influences ecosystem processes in natural and humanized environments constitutes a major future conceptual challenge.	[Wittebolle, Lieven; Marzorati, Massimo; Verstraete, Willy; Boon, Nico] Univ Ghent, Lab Microbial Ecol & Technol, LabMET, B-9000 Ghent, Belgium; [Clement, Lieven] Univ Ghent, BIOSTAT, Dept Appl Math Biometr & Proc Control, B-9000 Ghent, Belgium; [Heylen, Kim; De Vos, Paul] Univ Ghent, Microbiol Lab, Dept Biochem Physiol & Microbiol, LM UGent, B-9000 Ghent, Belgium; [Balloi, Annalisa; Daffonchio, Daniele] Univ Milan, Dipartimento Sci & Tecnol Alimentari & Microbiol, DISTAM, I-20133 Milan, Italy	Ghent University; Ghent University; Ghent University; University of Milan	Boon, N (corresponding author), Univ Ghent, Lab Microbial Ecol & Technol, LabMET, B-9000 Ghent, Belgium.	nico.boon@ugent.be	Clement, Lieven/G-5143-2012; Boon, Nico/B-4083-2011; Daffonchio, Daniele/AAF-4922-2019; Marzorati, Massimo/A-3419-2013; Heylen, Kim/G-4085-2011; De Vos, Paul/J-5392-2013	Boon, Nico/0000-0002-7734-3103; Daffonchio, Daniele/0000-0003-0947-925X; clement, lieven/0000-0002-9050-4370	Institute for the Promotion of Innovation through Science and Technology in Flanders; Interuniversity Attraction Pole research network grant of the Belgian government, Belgian Science Policy; 'Program Master and Back' from Regione Sardegna; 'Programma dell'Universita' per la Ricerca,; Geconcerteerde Onderzoeksactie of Ghent University; Ministerie van de Vlaamse Gemeenschap; Bestuur Wetenschappelijk Onderzoek	Institute for the Promotion of Innovation through Science and Technology in Flanders(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Interuniversity Attraction Pole research network grant of the Belgian government, Belgian Science Policy(Belgian Federal Science Policy Office); 'Program Master and Back' from Regione Sardegna; 'Programma dell'Universita' per la Ricerca,; Geconcerteerde Onderzoeksactie of Ghent University(Ghent University); Ministerie van de Vlaamse Gemeenschap; Bestuur Wetenschappelijk Onderzoek	We are grateful to R. Amann for comments on the original manuscript and to P. Van Damme for practical assistance. This work was supported by the Institute for the Promotion of Innovation through Science and Technology in Flanders ( IWT- Vlaanderen) ( to L. W.), by an Interuniversity Attraction Pole research network grant of the Belgian government, Belgian Science Policy ( to L. C.), by 'Program Master and Back' from Regione Sardegna ( Italy; to A. B.), by 'Programma dell'Universita' per la Ricerca, PUR 2008' (ex FIRST) of the University of Milan ( to D. D.), and by the Geconcerteerde Onderzoeksactie of Ghent University contract grant of the Ministerie van de Vlaamse Gemeenschap, Bestuur Wetenschappelijk Onderzoek ( Belgium; to K. H., P. D. V., W. V. and N. B.). Author Contributions L. W., M. M. and N. B. had the original idea for the experiment.	Balvanera P, 2005, ECOL APPL, V15, P360, DOI 10.1890/03-5192; Bell T, 2005, NATURE, V436, P1157, DOI 10.1038/nature03891; Cardinale BJ, 2002, NATURE, V415, P426, DOI 10.1038/415426a; Caron JB, 2008, PALAEOGEOGR PALAEOCL, V258, P222, DOI 10.1016/j.palaeo.2007.05.023; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Decho AW, 2000, CONT SHELF RES, V20, P1257, DOI 10.1016/S0278-4343(00)00022-4; Gitay H, 1996, J ECOL, V84, P121, DOI 10.2307/2261706; Griffiths BS, 2001, APPL SOIL ECOL, V16, P49, DOI 10.1016/S0929-1393(00)00081-0; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Horner-Devine MC, 2004, P ROY SOC B-BIOL SCI, V271, P113, DOI 10.1098/rspb.2003.2549; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Jessup CM, 2004, TRENDS ECOL EVOL, V19, P189, DOI 10.1016/j.tree.2004.01.008; Kassen R, 2000, NATURE, V406, P508, DOI 10.1038/35020060; Kutner MH., 2004, APPL LINEAR STAT MOD, P481; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; MONTGOMERY H, 1961, ANALYST, V86, P414; Naeem S, 1997, NATURE, V390, P507, DOI 10.1038/37348; Philippot L, 2005, CURR OPIN MICROBIOL, V8, P234, DOI 10.1016/j.mib.2005.04.003; Prosser JI, 2007, NAT REV MICROBIOL, V5, P384, DOI 10.1038/nrmicro1643; Purvis A, 2000, NATURE, V405, P212, DOI 10.1038/35012221; Sankaran M, 1999, NATURE, V401, P691, DOI 10.1038/44368; Symonds MRE, 2008, AM NAT, V171, P480, DOI 10.1086/528960; WALKER BH, 1992, CONSERV BIOL, V6, P18, DOI 10.1046/j.1523-1739.1992.610018.x; Wilsey BJ, 2000, ECOLOGY, V81, P887, DOI 10.1890/0012-9658(2000)081[0887:BAEFIO]2.0.CO;2; Wilsey BJ, 2002, ECOL LETT, V5, P676, DOI 10.1046/j.1461-0248.2002.00372.x; Wu T, 2008, MICROB ECOL, V55, P293, DOI 10.1007/s00248-007-9276-4; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463; Yang DR, 2008, SYMBIOSIS, V45, P153	30	673	701	16	387	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 2	2009	458	7238					623	626		10.1038/nature07840	http://dx.doi.org/10.1038/nature07840			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RK	19270679				2022-12-01	WOS:000264796200039
J	MacGregor, GA; de Wardener, HE				MacGregor, Graham A.; de Wardener, Hugh E.			The French salt industry in court	LANCET			English	Editorial Material							RISK		[MacGregor, Graham A.] Univ London, St Georges Hosp, Blood Pressure Unit, Div Cardiac & Vasc Med, London SW17 0RE, England; [de Wardener, Hugh E.] Univ London Imperial Coll Sci Technol & Med, London, England	St Georges University London; University of London; Imperial College London	MacGregor, GA (corresponding author), Univ London, St Georges Hosp, Blood Pressure Unit, Div Cardiac & Vasc Med, London SW17 0RE, England.	g.macgregor@sgul.ac.uk						ALDERMAN MH, 1995, HYPERTENSION, V25, P1144, DOI 10.1161/01.HYP.25.6.1144; de Wardener HE, 1999, J HUM HYPERTENS, V13, P1, DOI 10.1038/sj.jhh.1000759; *FDN SCI CIT, 2008, NOT LIB ACT BROUGHT; *FRENCH FOOD SAF A, 2002, REP SALT EV REC; *NAT AC MED, 2004, REP SALT INT BLOOD P; 2008, LIBERATION FR   0313; 2006, SALT SKIP NEWS, V140, P4	7	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 21	2009	373	9668					990	992		10.1016/S0140-6736(09)60589-4	http://dx.doi.org/10.1016/S0140-6736(09)60589-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	422AA	19304002				2022-12-01	WOS:000264398200010
J	Slade, D; Lindner, AB; Paul, G; Radman, M				Slade, Dea; Lindner, Ariel B.; Paul, Gregory; Radman, Miroslav			Recombination and Replication in DNA Repair of Heavily Irradiated Deinococcus radiodurans	CELL			English	Article							BREAK-INDUCED REPLICATION; DOUBLE-STRAND BREAKS; ESCHERICHIA-COLI; TARGETED MUTAGENESIS; MICROCOCCUS; POLYMERASE; RADIATION; PROTEIN; DAMAGE; RADIORESISTANCE	Deinococcus radiodurans' extreme resistance to ionizing radiation, desiccation, and DNA-damaging chemicals involves a robust DNA repair that reassembles its shattered genome. The repair process requires diploidy and commences with an extensive exonucleolytic erosion of DNA fragments. Liberated single-stranded overhangs prime strand elongation on overlapping fragments and the elongated complementary strands reestablish chromosomal contiguity by annealing. We explored the interdependence of the DNA recombination and replication processes in the reconstitution of the D. radiodurans genome disintegrated by ionizing radiation. The priming of extensive DNA repair synthesis involves RecA and RadA proteins. DNA polymerase III is essential for the initiation of repair synthesis, whereas efficient elongation requires DNA polymerases I and III. Inactivation of both polymerases leads to degradation of DNA fragments and rapid cell death. The present in vivo characterization of key recombination and replication processes dissects the mechanism of DNA repair in heavily irradiated D. radiodurans.	[Slade, Dea; Lindner, Ariel B.; Paul, Gregory; Radman, Miroslav] Univ Paris 05, Fac Med, INSERM, U571, F-75015 Paris, France; [Radman, Miroslav] Mediterranean Inst Life Sci, Split 21000, Croatia	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Franche-Comte	Radman, M (corresponding author), Univ Paris 05, Fac Med, INSERM, U571, 156 Rue Vaugirard, F-75015 Paris, France.	miroslav.radman@inserm.fr	Lindner, Ariel/K-9247-2019; Lindner, Ariel B/I-8503-2016; Radman, Miroslav/HDM-5955-2022	Lindner, Ariel/0000-0001-5015-6511; Lindner, Ariel B/0000-0001-5015-6511; Slade, Dea/0000-0002-0052-5910; Radman, Miroslav/0000-0002-7034-4365; Radman, Miroslav/0000-0003-0216-3148	Institut National de la Sante et de la Recherche Medicale (INSERM); Boehringer Ingelheim Fonds	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Boehringer Ingelheim Fonds(Boehringer Ingelheim)	D. S. wishes to thank Dragana Ahel and Rupert Thorough for revision and editing of the manuscript. We thank Marina Elez and Dennis R. Harris for comments pertaining to the manuscript. We acknowledge generous gifts: Mary E. Lidstrom for pRAD1, John R. Battista for the polA mutant, and Suzanne Sommer for the recA mutant. We also thank Sophie Viel at Institut Curie in Paris for using <SUP>137</SUP>Cs gamma-ray source, Kathleen Smith of Eucodis for lending the PFGE equipment, and Gely Chantal of INSERM unit 876 for using the scintillation counter. This work was funded by Institut National de la Sante et de la Recherche Medicale (INSERM). D. S. is a Boehringer Ingelheim Fonds Ph. D. fellow. D. S. carried out all the experiments. D. S. and M. R. designed the experiments. D. S., A. B. L., and M. R. interpreted the results. G. P. computed an algorithm for quantitative analysis of PFGE gels. D. S. and M. R. wrote the manuscript.	ANDERSON AW, 1956, FOOD TECHNOL-CHICAGO, V10, P575; Battista JR, 1997, ANNU REV MICROBIOL, V51, P203, DOI 10.1146/annurev.micro.51.1.203; BIANCHI ME, 1983, CELL, V35, P511, DOI 10.1016/0092-8674(83)90185-X; Blasius M, 2006, MOL MICROBIOL, V60, P165, DOI 10.1111/j.1365-2958.2006.05077.x; Blasius M, 2008, CRIT REV BIOCHEM MOL, V43, P221, DOI [10.1080/10409230802122274, 10.1080/10409230802122274 ]; Cox MM, 2005, NAT REV MICROBIOL, V3, P882, DOI 10.1038/nrmicro1264; Cox MM, 2003, ANNU REV MICROBIOL, V57, P551, DOI 10.1146/annurev.micro.57.030502.090953; Daly MJ, 2007, PLOS BIOL, V5, P769, DOI 10.1371/journal.pbio.0050092; Daly MJ, 2004, SCIENCE, V306, P1025, DOI 10.1126/science.1103185; Daly MJ, 1996, J BACTERIOL, V178, P4461, DOI 10.1128/jb.178.15.4461-4471.1996; DRIEDGER A A, 1970, Radiation Research, V44, P835, DOI 10.2307/3573160; FORMOSA T, 1986, CELL, V47, P793, DOI 10.1016/0092-8674(86)90522-2; Gladyshev E, 2008, P NATL ACAD SCI USA, V105, P5139, DOI 10.1073/pnas.0800966105; GUTMAN PD, 1993, J BACTERIOL, V175, P3581, DOI 10.1128/jb.175.11.3581-3590.1993; HANSEN MT, 1978, J BACTERIOL, V134, P71, DOI 10.1128/JB.134.1.71-75.1978; Harris DR, 2004, PLOS BIOL, V2, P1629, DOI 10.1371/journal.pbio.0020304; HARSOJO KS, 1981, J BIOCH, V90, P877; Holmes AM, 1999, CELL, V96, P415, DOI 10.1016/S0092-8674(00)80554-1; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Jolivet E, 2006, MOL MICROBIOL, V59, P338, DOI 10.1111/j.1365-2958.2005.04946.x; Kim JI, 2002, P NATL ACAD SCI USA, V99, P7917, DOI 10.1073/pnas.122218499; Kornberg A., 1992, DNA REPLICATION; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; Kraus E, 2001, P NATL ACAD SCI USA, V98, P8255, DOI 10.1073/pnas.151008198; Lecointe F, 2004, MOL MICROBIOL, V53, P1721, DOI 10.1111/j.1365-2958.2004.04233.x; LETT JT, 1970, J MOL BIOL, V48, P395, DOI 10.1016/0022-2836(70)90053-7; Levin-Zaidman S, 2003, SCIENCE, V299, P254, DOI 10.1126/science.1077865; Lydeard JR, 2007, NATURE, V448, P820, DOI 10.1038/nature06047; Mattimore V, 1996, J BACTERIOL, V178, P633, DOI 10.1128/jb.178.3.633-637.1996; MINTON KW, 1995, BIOESSAYS, V17, P457, DOI 10.1002/bies.950170514; MOSELEY BEB, 1975, J BACTERIOL, V121, P422, DOI 10.1128/JB.121.2.422-428.1975; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; SINHA NK, 1972, J BACTERIOL, V112, P1321, DOI 10.1128/JB.112.3.1321-1334.1972; Smith CE, 2007, NATURE, V447, P102, DOI 10.1038/nature05723; Tian B, 2007, BBA-GEN SUBJECTS, V1770, P902, DOI 10.1016/j.bbagen.2007.01.016; Vandewiele D, 2002, MUTAT RES-FUND MOL M, V499, P85, DOI 10.1016/S0027-5107(01)00268-8; VUKOVICNAGY B, 1974, INT J RADIAT BIOL, V25, P329, DOI 10.1080/09553007414550401; Wang X, 2004, MOL CELL BIOL, V24, P6891, DOI 10.1128/MCB.24.16.6891-6899.2004; WHITE CI, 1990, EMBO J, V9, P663, DOI 10.1002/j.1460-2075.1990.tb08158.x; Xu WL, 2001, MOL MICROBIOL, V39, P286, DOI 10.1046/j.1365-2958.2001.02267.x; Zahradka K, 2006, NATURE, V443, P569, DOI 10.1038/nature05160; Zhou Q, 2006, CHINESE SCI BULL, V51, P2993, DOI 10.1007/s11434-006-2209-7	42	176	190	1	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 20	2009	136	6					1044	1055		10.1016/j.cell.2009.01.018	http://dx.doi.org/10.1016/j.cell.2009.01.018			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	422CE	19303848	Bronze			2022-12-01	WOS:000264403900011
J	Zoncu, R; Perera, RM; Balkin, DM; Pirruccello, M; Toomre, D; De Camilli, P				Zoncu, Roberto; Perera, Rushika M.; Balkin, Daniel M.; Pirruccello, Michelle; Toomre, Derek; De Camilli, Pietro			A Phosphoinositide Switch Controls the Maturation and Signaling Properties of APPL Endosomes	CELL			English	Article							CLATHRIN-COATED PITS; ENDOCYTIC PATHWAY; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; INDEPENDENT ENDOCYTOSIS; MEDIATED ENDOCYTOSIS; BAR-PH; RECEPTOR; PROTEIN; MEMBRANE; RAB5	The recent identification of several novel endocytic compartments has challenged our current understanding of the topological and functional organization of the endocytic pathway. Using quantitative single vesicle imaging and acute manipulation of phosphoinositides we show that APPL endosomes, which participate in growth factor receptor trafficking and signaling, represent an early endocytic intermediate common to a subset of clathrin derived endocytic vesicles and macropinosomes. Most APPL endosomes are precursors of classical PI3P positive endosomes, and PI3P plays a critical role in promoting this conversion. Depletion of PI3P causes a striking reversion of Rab5 positive endosomes to the APPL stage, and results in enhanced growth factor signaling. These findings reveal a surprising plasticity of the early endocytic pathway. Importantly, PI3P functions as a switch to dynamically regulate maturation and signaling of APPL endosomes.	[Zoncu, Roberto; Perera, Rushika M.; Balkin, Daniel M.; Pirruccello, Michelle; Toomre, Derek; De Camilli, Pietro] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; [Zoncu, Roberto; Balkin, Daniel M.; Pirruccello, Michelle; De Camilli, Pietro] Yale Univ, Sch Med, Howard Hughes Med Inst, Kavli Inst Neurosci, New Haven, CT 06510 USA; [Zoncu, Roberto; Balkin, Daniel M.; Pirruccello, Michelle; De Camilli, Pietro] Yale Univ, Sch Med, Program Cellular Neurosci Neurodegenerat & Repair, New Haven, CT 06510 USA	Yale University; Howard Hughes Medical Institute; Yale University; Yale University	Toomre, D (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA.	derek.toomre@yale.edu; pietro.decamilli@yale.edu		Pirruccello-Straub, Michelle/0000-0002-7996-857X	NIH [CA46128, DK45735, NS36251, DA018343]; New Innovator award [1DP20D002980-01]; MSTP TG [5T32GM07205]; Mathers Charitable Foundation; Keck Foundation; Kavli Foundation; Yale Cancer Center; NATIONAL CANCER INSTITUTE [P01CA046128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK045735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS036251, R01NS036251] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018343] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002980] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Innovator award; MSTP TG; Mathers Charitable Foundation; Keck Foundation(W.M. Keck Foundation); Kavli Foundation; Yale Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank P. P. Di Fiore and S. Ferguson for critical reading of the manuscript; Ariad Pharmaceuticals for generously providing us with the rapalogue AP021967; J, Keen, B. Larijani, N. Fili, S. Corvera, and S. Grinstein for valuable reagents; A. Karpikov for help with the TIRF calibration; D. Sabatini and J. Settleman for support. This work was supported by grants from the NIH (CA46128, DK45735, NS36251, and DA018343 to P. D. C., New Innovator award 1DP20D002980-01 to D. T., and MSTP TG 5T32GM07205 to D. M. B.), the G. Harold and Leila Y. Mathers Charitable Foundation, the Keck Foundation and the Kavli Foundation to P. D. C., and the Yale Cancer Center ASC-IRG grant to D. T.	Behnia R, 2005, NATURE, V438, P597, DOI 10.1038/nature04397; Colaluca IN, 2008, NATURE, V451, P76, DOI 10.1038/nature06412; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; De Matteis MA, 2005, BBA-MOL CELL RES, V1744, P396, DOI 10.1016/j.bbamcr.2005.04.013; Di Fiore PP, 2001, CELL, V106, P1, DOI 10.1016/S0092-8674(01)00428-7; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; Erdmann KS, 2007, DEV CELL, V13, P377, DOI 10.1016/j.devcel.2007.08.004; Fili N, 2006, P NATL ACAD SCI USA, V103, P15473, DOI 10.1073/pnas.0607040103; Gaullier JM, 2000, J BIOL CHEM, V275, P24595, DOI 10.1074/jbc.M906554199; Gruenberg J, 2001, NAT REV MOL CELL BIO, V2, P721, DOI 10.1038/35096054; Haglund Kaisa, 2007, Critical Reviews in Oncogenesis, V13, P39; Hayakawa A, 2006, P NATL ACAD SCI USA, V103, P11928, DOI 10.1073/pnas.0508832103; Hu LYA, 2003, J BIOL CHEM, V278, P26295, DOI 10.1074/jbc.M212352200; Ivetac I, 2005, MOL BIOL CELL, V16, P2218, DOI 10.1091/mbc.e04-09-0799; Jiang XJ, 2003, MOL BIOL CELL, V14, P858, DOI 10.1091/mbc.E02-08-0532; Jones RB, 2006, NATURE, V439, P168, DOI 10.1038/nature04177; Lakadamyali M, 2006, CELL, V124, P997, DOI 10.1016/j.cell.2005.12.038; Lee JA, 2008, AUTOPHAGY, V4, P230, DOI 10.4161/auto.5384; Li J, 2007, STRUCTURE, V15, P525, DOI 10.1016/j.str.2007.03.011; Lidke DS, 2004, NAT BIOTECHNOL, V22, P198, DOI 10.1038/nbt929; Lin DC, 2006, MOL CELL BIOL, V26, P8928, DOI 10.1128/MCB.00228-06; Lowe M, 2005, TRAFFIC, V6, P711, DOI 10.1111/j.1600-0854.2005.00311.x; Lu C, 2007, TRAFFIC, V8, P1246, DOI 10.1111/j.1600-0854.2007.00602.x; Mao XM, 2006, NAT CELL BIOL, V8, P516, DOI 10.1038/ncb1404; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.biochem.55.1.663; Merithew E, 2003, J BIOL CHEM, V278, P8494, DOI 10.1074/jbc.M211514200; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; Miaczynska M, 2004, CELL, V116, P445, DOI 10.1016/S0092-8674(04)00117-5; Odorizzi G, 2000, TRENDS BIOCHEM SCI, V25, P229, DOI 10.1016/S0968-0004(00)01543-7; Patki V, 1997, P NATL ACAD SCI USA, V94, P7326, DOI 10.1073/pnas.94.14.7326; Perera RM, 2006, P NATL ACAD SCI USA, V103, P19332, DOI 10.1073/pnas.0609795104; Porat-Shliom N, 2008, MOL BIOL CELL, V19, P765, DOI 10.1091/mbc.E07-08-0841; Puthenveedu MA, 2006, CELL, V127, P113, DOI 10.1016/j.cell.2006.08.035; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Schenck A, 2008, CELL, V133, P486, DOI 10.1016/j.cell.2008.02.044; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Shin HW, 2005, J CELL BIOL, V170, P607, DOI 10.1083/jcb.200505128; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Slessareva JE, 2006, CELL, V126, P191, DOI 10.1016/j.cell.2006.04.045; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; Tosoni D, 2005, CELL, V123, P875, DOI 10.1016/j.cell.2005.10.021; Varnai P, 2006, J CELL BIOL, V175, P377, DOI 10.1083/jcb.200607116; Varsano T, 2006, MOL CELL BIOL, V26, P8942, DOI 10.1128/MCB.00305-06; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; von Zastrow M, 2007, CURR OPIN CELL BIOL, V19, P436, DOI 10.1016/j.ceb.2007.04.021; Wu JL, 2006, DEVELOPMENT, V133, P3651, DOI 10.1242/dev.02547; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhu GY, 2007, EMBO J, V26, P3484, DOI 10.1038/sj.emboj.7601771; Zoncu R, 2007, P NATL ACAD SCI USA, V104, P3793, DOI 10.1073/pnas.0611733104	51	254	261	1	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 20	2009	136	6					1110	1121		10.1016/j.cell.2009.01.032	http://dx.doi.org/10.1016/j.cell.2009.01.032			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	422CE	19303853	Bronze, Green Accepted			2022-12-01	WOS:000264403900016
J	Fu, DL; Uauy, C; Distelfeld, A; Blechl, A; Epstein, L; Chen, XM; Sela, HA; Fahima, T; Dubcovsky, J				Fu, Daolin; Uauy, Cristobal; Distelfeld, Assaf; Blechl, Ann; Epstein, Lynn; Chen, Xianming; Sela, Hanan; Fahima, Tzion; Dubcovsky, Jorge			A Kinase-START Gene Confers Temperature-Dependent Resistance to Wheat Stripe Rust	SCIENCE			English	Article								Stripe rust is a devastating fungal disease that afflicts wheat in many regions of the world. New races of Puccinia striiformis, the pathogen responsible for this disease, have overcome most of the known race-specific resistance genes. We report the map-based cloning of the gene Yr36 (WKS1), which confers resistance to a broad spectrum of stripe rust races at relatively high temperatures (25 degrees to 35 degrees C). This gene includes a kinase and a putative START lipid-binding domain. Five independent mutations and transgenic complementation confirmed that both domains are necessary to confer resistance. Yr36 is present in wild wheat but is absent in modern pasta and bread wheat varieties, and therefore it can now be used to improve resistance to stripe rust in a broad set of varieties.	[Fu, Daolin; Uauy, Cristobal; Distelfeld, Assaf; Dubcovsky, Jorge] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Distelfeld, Assaf; Sela, Hanan; Fahima, Tzion] Univ Haifa, Dept Evolutionary & Environm Biol, IL-31905 Haifa, Israel; [Blechl, Ann] USDA ARS, Western Reg Res Ctr, Albany, CA 94710 USA; [Epstein, Lynn] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA; [Chen, Xianming] Washington State Univ, Dept Plant Pathol, Pullman, WA 99164 USA; [Chen, Xianming] Washington State Univ, USDA ARS, Pullman, WA 99164 USA	University of California System; University of California Davis; University of Haifa; United States Department of Agriculture (USDA); University of California System; University of California Davis; Washington State University; United States Department of Agriculture (USDA); Washington State University	Dubcovsky, J (corresponding author), Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA.	jdubcovsky@ucdavis.edu	Distelfeld, Assaf/D-4951-2014; Dubcovsky, Jorge/T-5214-2019; Uauy, Cristobal/B-3879-2011; Uauy, Cristobal/B-7912-2014; Uauy, Cristobal/T-4382-2019; Dubcovsky, Jorge/A-4969-2008; Epstein, Lynn/F-1251-2013	Distelfeld, Assaf/0000-0003-1777-3053; Uauy, Cristobal/0000-0002-9814-1770; Uauy, Cristobal/0000-0002-9814-1770; Dubcovsky, Jorge/0000-0002-7571-4345; Fahima, Tzion/0000-0001-5555-0040; Sela, Hanan/0000-0002-4218-4376	USDA-CSREES [2005-00975, 2006-55606-16629]; U.S. and Israel BARD Fund [US-4024-07]; Biotechnology and Biological Sciences Research Council [BBS/E/J/000C0628] Funding Source: researchfish	USDA-CSREES(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); U.S. and Israel BARD Fund; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Supported by USDA-CSREES grants 2005-00975 and 2006-55606-16629 and by U.S. and Israel BARD Fund grant US-4024-07. We thank C. Li, F. Paraiso, L. Penman, K. L. Richardson, S. Bassein, M.R. Paddy, Q. Lam, and M. Jindal for technical assistance and R. Thilmony and M. Whalen for critical reading of the manuscript. Gene sequences have been deposited in GenBank with accession numbers EU835198-EU835200, FJ154103-FJ154118, and FJ155069-FJ155070.	ALPY F, 2005, PLANT PHYSIOL, V2791, P129; Cenci A, 2003, THEOR APPL GENET, V107, P931, DOI 10.1007/s00122-003-1331-z; Chen XM, 2007, AUST J AGR RES, V58, P648, DOI 10.1071/AR07045; Dardick C, 2006, PLOS PATHOG, V2, P14, DOI 10.1371/journal.ppat.0020002; Distelfeld Assaf, 2004, Functional & Integrative Genomics, V4, P59, DOI 10.1007/s10142-003-0097-3; Krattinger SG, 2009, SCIENCE, V323, P1360, DOI 10.1126/science.1166453; Line RF, 2002, ANNU REV PHYTOPATHOL, V40, P75, DOI 10.1146/annurev.phyto.40.020102.111645; Ma Q, 2004, J PLANT PATHOL, V86, P19; McCallum CM, 2000, NAT BIOTECHNOL, V18, P455, DOI 10.1038/74542; QAYOUM A, 1985, PHYTOPATHOLOGY, V75, P1121, DOI 10.1094/Phyto-75-1121; Shang HongSheng, 1998, Scientia Agricultura Sinica, V31, P46; Singh R.P., 2004, 4 INT CROP SCI C BRI; Tang DZ, 2005, PLANT J, V44, P245, DOI 10.1111/j.1365-313X.2005.02523.x; Uauy C, 2005, THEOR APPL GENET, V112, P97, DOI 10.1007/s00122-005-0109-x; Verica JA, 2002, PLANT PHYSIOL, V129, P455, DOI 10.1104/pp.011028; Vorwerk S, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-35; Wan AM, 2007, AUST J AGR RES, V58, P605, DOI 10.1071/AR06142	17	461	508	5	188	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2009	323	5919					1357	1360		10.1126/science.1166289	http://dx.doi.org/10.1126/science.1166289			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414PC	19228999	Green Accepted			2022-12-01	WOS:000263876700046
J	Torchinsky, MB; Garaude, J; Martin, AP; Blander, JM				Torchinsky, Miriam Beer; Garaude, Johan; Martin, Andrea P.; Blander, J. Magarian			Innate immune recognition of infected apoptotic cells directs T(H)17 cell differentiation	NATURE			English	Article							ESCHERICHIA-COLI ESPF; T-HELPER-CELLS; TGF-BETA; INTERLEUKIN-22; IL-17; MITOCHONDRIA; INFLAMMATION; CYTOKINE	Adaptive immune responses rely on differentiation of CD4 Thelper cells into subsets with distinct effector functions best suited for host defence against the invading pathogen. Interleukin (IL)-17 producing T helper cells (T(H)17) are a recently identified subset, separate from the T helper type 1 (T(H)1) and T helper type 2 (T(H)2) subsets(1). Synergy between the cytokines transforming growth factor-beta and IL-6 in vitro induces development of TH17 cells in mouse(1-5) and human(6) systems, whereas IL-23 supports expansion of these cells(2,4,5). However, it is not known which conditions in vivo would induce this combination of cytokines. Furthermore, it is enigmatic that a combination of pro-inflammatory and anti-inflammatory cytokines would be required to generate an effector TH17 response. Here we show that the relevant physiological stimulus triggering this combination of cytokines is the recognition and phagocytosis of infected apoptotic cells by dendritic cells. Phagocytosis of infected apoptotic cells uniquely triggers the combination of IL-6 and transforming growth factor-beta through recognition of pathogen-associated molecular patterns(7) and phosphatidylserine exposed on apoptotic cells(8), respectively. Conversely, phagocytosis of apoptotic cells in the absence of microbial signals induces differentiation of the closely related regulatory T cells, which are important for controlling autoimmunity(9). Blocking apoptosis during infection of the mouse intestinal epithelium with the rodent pathogen Citrobacter rodentium(10), which models human infections with the attaching and effacing enteropathogenic and enterohaemorrhagic Escherichia coli, impairs the characteristic TH17 response in the lamina propria. Our results demonstrate that infected apoptotic cells are a critical component of the innate immune signals instructing TH17 differentiation, and point to pathogens particularly adept at triggering apoptosis that might preferentially induce T(H)17-mediated immunity. Because TH17 cells have been correlated with autoimmune diseases(1), investigation of the pathways of innate recognition of infected apoptotic cells might lead to improved understanding of the causative defects in autoimmunity.	[Torchinsky, Miriam Beer; Garaude, Johan; Martin, Andrea P.; Blander, J. Magarian] Mt Sinai Sch Med, Dept Med, Inst Immunol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Blander, JM (corresponding author), Mt Sinai Sch Med, Dept Med, Inst Immunol, 1425 Madison Ave, New York, NY 10029 USA.	julie.blander@mssm.edu		Blander, Julie Magarian/0000-0001-9207-1700; Garaude, Johan/0000-0001-7789-7715	NIH [AI073899]; Kinship Foundation Searle Scholar Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI123284, R56AI073899, R01AI073899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK072201] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kinship Foundation Searle Scholar Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to R. Medzhitov, L. Mayer and D. Amsen for advice and critical reading of the manuscript, S. Lira for use of cryostat and microscope, B. B. Finlay and W. Deng for Citrobacter mutants, former Blander laboratory members H. Peche and B. Trinite for technical assistance and discussions, S. Mehrotra for advice with caspase inhibitors, and I. George and M. Grisotto for cell sorting. We are indebted to B. Brown, H. Xiong, G. Frankel, C. Dong, K. Schluns, M. Kamanaka, S. Yu, P. Arnaboldi, M. Bogunovic, B. M. Baker, S. L. Fishman, M. Blander and S. J. Blander for technical advice, assistance and support. J. G. is supported by the Fondation pour la Recherche Medicale, and J. M. B. is supported by NIH grant AI073899 and the Kinship Foundation Searle Scholar Award.	Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Betti M, 2006, ANN ONCOL, V17, P235; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; Deng WY, 2004, P NATL ACAD SCI USA, V101, P3597, DOI 10.1073/pnas.0400326101; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Laurence A, 2008, NAT MED, V14, P247, DOI 10.1038/nm0308-247; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Nagai T, 2005, J BIOL CHEM, V280, P2998, DOI 10.1074/jbc.M411550200; Nougayrede JP, 2004, CELL MICROBIOL, V6, P1097, DOI 10.1111/j.1462-5822.2004.00421.x; O'Garra A, 2008, NAT IMMUNOL, V9, P588, DOI 10.1038/ni0608-588; Pappu BP, 2008, J EXP MED, V205, P1049, DOI 10.1084/jem.20071364; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622; Vallance BA, 2003, INFECT IMMUN, V71, P3443, DOI 10.1128/IAI.71.6.3443-3453.2003; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Viswanathan VK, 2008, AM J PHYSIOL-GASTR L, V294, pG1165, DOI 10.1152/ajpgi.00596.2007; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zitvogel L, 2008, CURR OPIN IMMUNOL, V20, P501, DOI 10.1016/j.coi.2008.07.009	30	260	268	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 5	2009	458	7234					78	82		10.1038/nature07781	http://dx.doi.org/10.1038/nature07781			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414AJ	19262671				2022-12-01	WOS:000263836000036
J	Tillman, K; Burton, B; Jacques, LB; Phurrough, SE				Tillman, Katherine; Burton, Brijet; Jacques, Louis B.; Phurrough, Steve E.			Compendia and Anticancer Therapy Under Medicare	ANNALS OF INTERNAL MEDICINE			English	Article							INVESTIGATIONAL THERAPY	In 1993, Congress directed the Medicare program to refer to 3 existing published compendia, American Medical Association Drug Evaluations (AMA-DE), United States Pharmacopoeia Drug Information for the Health Professional (USP-DI), and American Hospital Formulary Service Drug Information (AHFS-DI), to identify unlabeled but medically accepted uses of drugs and biologicals in anticancer chemotherapy regimens. Public discussion during the preceding years had centered on whether to designate unlabeled uses of anticancer treatments as experimental and thus outside the scope of Medicare benefits. American Medical Association Drug Evaluations and USP-DI subsequently ceased publication, and the Medicare program faced increasing calls to revise the list of acceptable compendia, as authorized in the statute. In 2007, the Centers for Medicare & Medicaid Services used its regulatory authority to establish a publicly transparent process to revise the list. The Centers for Medicare & Medicaid Services considered 5 requests in 2008 and added National Comprehensive Cancer Network Drugs and Biologics Compendium, DRUGDEX, and Clinical Pharmacology to the list of compendia. DrugPoints was not added, and AMA-DE was removed. Because of the potential for conflicts of interest to lead to biased judgments, the 2008 Medicare Improvements for Patients and Providers Act has a provision that explicitly prohibits inclusion of compendia that do not have a publicly transparent process for evaluating therapies and identifying potential conflicts of interest.	[Tillman, Katherine; Burton, Brijet; Jacques, Louis B.; Phurrough, Steve E.] Ctr Medicare & Medicaid Serv, Baltimore, MD 21244 USA	Centers for Medicare & Medicaid Services	Tillman, K (corresponding author), Ctr Medicare & Medicaid Serv, Mailstop C1-09-06,7500 Secur Blvd, Baltimore, MD 21244 USA.	katherine.tillman@cms.hhs.gov						Abernethy AP, 2009, ANN INTERN MED, V150, P336, DOI 10.7326/0003-4819-150-5-200903030-00107; ARONSON FR, 1990, J NATL CANCER I, V82, P1434, DOI 10.1093/jnci/82.17.1434; *CLIN PHARM, ED POL SUMM; *CTR MED MED SERV, THOMS MICR DRUGPOINT; *CTR MED MED SERV, CLIN PHARM COMP REV; *CTR MED MED SERV, THOMS MICR DRUGDEX C; *CTR MED MED SERV, NCCN COMP REV REQ; *CTR MED MED SERV, AMA DE COMP REV REQ; MCINTOSH H, 1990, J NATL CANCER I, V82, P996, DOI 10.1093/jnci/82.12.996; *NAT COMP CANC NET, NCCN EXP DISCL POL; *THOMS REUT HEALTH, THOMS MICR CONFL INT	11	24	24	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 3	2009	150	5					348	+		10.7326/0003-4819-150-5-200903030-00109	http://dx.doi.org/10.7326/0003-4819-150-5-200903030-00109			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417CC	19221368				2022-12-01	WOS:000264051700007
J	Caplan, AL; Patrizio, P				Caplan, Arthur L.; Patrizio, Pasquale			The beginning of the end of the embryo wars	LANCET			English	Editorial Material									[Caplan, Arthur L.] Univ Penn, Ctr Bioeth, Philadelphia, PA 19104 USA; [Patrizio, Pasquale] Yale Univ, Fertil Ctr, New Haven, CT USA	University of Pennsylvania; Yale University	Caplan, AL (corresponding author), Univ Penn, Ctr Bioeth, Philadelphia, PA 19104 USA.	caplan@mail.med.upenn.edu	Patrizio, Pasquale/AGO-0674-2022					Caplan AL, 2007, SOCIETY, V44, P26, DOI 10.1007/BF02919513; George RP., 2008, EMBRYO DEFENSE HUMAN; Gottweis H, 2009, HEALTH TECHNOL SOC, P1, DOI 10.1057/9780230594364; Guenin LM, 2008, MORALITY OF EMBRYO USE, P1; Kovalevsky G, 2005, FERTIL STERIL, V84, P325, DOI 10.1016/j.fertnstert.2005.04.020; Ord T, 2008, AM J BIOETHICS, V8, P12, DOI 10.1080/15265160802248146; Quinn B., 2009, GUARDIAN	7	4	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR-APR	2009	373	9669					1074	1075		10.1016/S0140-6736(09)60638-3	http://dx.doi.org/10.1016/S0140-6736(09)60638-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	427IS	19338071				2022-12-01	WOS:000264773600015
J	Molyneux, DH				Molyneux, David H.			10 years of success in addressing lymphatic filariasis	LANCET			English	Editorial Material							DISEASES; ACHIEVE		[Molyneux, David H.] Univ Liverpool, Liverpool Sch Trop Med, Ctr Neglected Trop Dis, Liverpool L3 5QA, Merseyside, England	Liverpool School of Tropical Medicine; University of Liverpool	Molyneux, DH (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Ctr Neglected Trop Dis, Liverpool L3 5QA, Merseyside, England.	david.molyneux@liv.ac.uk						Blackburn BG, 2006, AM J TROP MED HYG, V75, P650, DOI 10.4269/ajtmh.2006.75.650; Goldman AS, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000067; Hotez PJ, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000270; Laxminarayan R, 2006, LANCET, V367, P1193, DOI 10.1016/S0140-6736(06)68440-7; Molyneux DH, 2008, T ROY SOC TROP MED H, V102, P509, DOI 10.1016/j.trstmh.2008.02.024; Molyneux DH, 2009, LANCET, V373, P296, DOI 10.1016/S0140-6736(09)60089-1; Ottesen EA, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000317; Ramaiah KD, 2000, PARASITOL TODAY, V16, P251, DOI 10.1016/S0169-4758(00)01643-4; *WHO, 2008, 61 WORLD HLTH ASS MA; World Health Organization, 2008, Weekly Epidemiological Record, V83, P333; World Health Organization, 2006, PREV CHEM HUM HELM	11	11	11	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 14	2009	373	9663					529	530		10.1016/S0140-6736(09)60181-1	http://dx.doi.org/10.1016/S0140-6736(09)60181-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	406ZO	19217976				2022-12-01	WOS:000263333600011
J	Gibbs, RA; Taylor, JF; Van Tassell, CP; Barendse, W; Eversoie, KA; Gill, CA; Green, RD; Hamernik, DL; Kappes, SM; Lien, S; Matukumalli, LK; McEwan, JC; Nazareth, LV; Schnabel, RD; Taylor, JF; Weinstock, GM; Wheeler, DA; Ajmone-Marsan, P; Barendse, W; Boettcher, PJ; Caetano, AR; Garcia, JF; Hanotte, O; Mariani, P; Skow, LC; Williams, JL; Caetano, AR; Diallo, B; Green, RD; Hailemariam, L; Hanotte, O; Martinez, ML; Morris, CA; Silva, LOC; Spelman, RJ; Taylor, JF; Mulatu, W; Zhao, KY; Abbey, CA; Agaba, M; Araujo, FR; Bunch, RJ; Burton, J; Gill, CA; Gorni, C; Olivier, H; Harrison, BE; Luff, B; Machado, MA; Mariani, P; Morris, CA; Mwakaya, J; Plastow, G; Sim, W; Skow, LC; Smith, T; Sonstegard, TS; Spelman, RJ; Taylor, JF; Thomas, MB; Valentini, A; Williams, P; Womack, J; Wooliams, JA; Liu, Y; Qin, X; Worley, KC; Gao, C; Gill, CA; Jiang, HY; Liu, Y; Moore, SS; Nazareth, LV; Ren, YR; Song, XZ; Bustamante, CD; Hernandez, RD; Muzny, DM; Nazareth, LV; Patil, S; Lucas, AS; Fu, Q; Kent, MP; Moore, SS; Vega, R; Abbey, CA; Gao, C; Gill, CA; Green, RD; Matukumalli, LK; Matukumalli, A; McWilliam, S; Schnabel, RD; Sclep, G; Ajmone-Marsan, P; Bryc, K; Bustamante, CD; Choi, J; Gao, H; Grefenstette, JJ; Murdoch, B; Stella, A; Villa-Angulo, R; Wright, M; Aerts, J; Jann, O; Negrini, R; Sonstegard, TS; Williams, JL; Taylor, JF; Villa-Angulo, R; Goddard, ME; Hayes, BJ; Barendse, W; Bradley, DG; Boettcher, PJ; Bustamante, CD; da Silva, MB; Lau, LPL; Liu, GE; Lynn, DJ; Panzitta, F; Sclep, G; Wright, M; Dodds, KG				Gibbs, Richard A.; Taylor, Jeremy F.; Van Tassell, Curtis P.; Barendse, William; Eversoie, Kallye A.; Gill, Clare A.; Green, Ronnie D.; Hamernik, Debora L.; Kappes, Steven M.; Lien, Sigbjorn; Matukumalli, Lakshmi K.; McEwan, John C.; Nazareth, Lynne V.; Schnabel, Robert D.; Taylor, Jeremy F.; Weinstock, George M.; Wheeler, David A.; Ajmone-Marsan, Paolo; Barendse, William; Boettcher, Paul J.; Caetano, Alexandre R.; Garcia, Jose Fernando; Hanotte, Olivier; Mariani, Paola; Skow, Loren C.; Williams, John L.; Caetano, Alexandre R.; Diallo, Boubacar; Green, Ronnie D.; Hailemariam, Lemecha; Hanotte, Olivier; Martinez, Mario L.; Morris, Chris A.; Silva, Luiz O. C.; Spelman, Richard J.; Taylor, Jeremy F.; Mulatu, Woudyalew; Zhao, Keyan; Abbey, Colette A.; Agaba, Morris; Araujo, Flabio R.; Bunch, Rowan J.; Burton, James; Gill, Clare A.; Gorni, Chiara; Olivier, Hanotte; Harrison, Blair E.; Luff, Bill; Machado, Marco A.; Mariani, Paola; Morris, Chris A.; Mwakaya, Joel; Plastow, Graham; Sim, Warren; Skow, Loren C.; Smith, Timothy; Sonstegard, Tad S.; Spelman, Richard J.; Taylor, Jeremy F.; Thomas, Merle B.; Valentini, Alessio; Williams, Paul; Womack, James; Wooliams, John A.; Liu, Yue; Qin, Xiang; Worley, Kim C.; Gao, Chuan; Gill, Clare A.; Jiang, Huaiyang; Liu, Yue; Moore, Stephen S.; Nazareth, Lynne V.; Ren, Yanru; Song, Xing-Zhi; Bustamante, Carlos D.; Hernandez, Ryan D.; Muzny, Donna M.; Nazareth, Lynne V.; Patil, Shobha; Lucas, Anthony San; Fu, Qing; Kent, Matthew P.; Moore, Stephen S.; Vega, Richard; Abbey, Colette A.; Gao, Chuan; Gill, Clare A.; Green, Ronnie D.; Matukumalli, Lakshmi K.; Matukumalli, Aruna; McWilliam, Sean; Schnabel, Robert D.; Sclep, Gert; Ajmone-Marsan, Paolo; Bryc, Katarzyna; Bustamante, Carlos D.; Choi, Jungwoo; Gao, Hong; Grefenstette, John J.; Murdoch, Brenda; Stella, Alessandra; Villa-Angulo, Rafael; Wright, Mark; Aerts, Jan; Jann, Oliver; Negrini, Riccardo; Sonstegard, Tad S.; Williams, John L.; Taylor, Jeremy F.; Villa-Angulo, Rafael; Goddard, Mike E.; Hayes, Ben J.; Barendse, William; Bradley, Daniel G.; Boettcher, Paul J.; Bustamante, Carlos D.; da Silva, Marcos Barbosa; Lau, Lilian P. L.; Liu, George E.; Lynn, David J.; Panzitta, Francesca; Sclep, Gert; Wright, Mark; Dodds, Ken G.			Genome-Wide Survey of SNP Variation Uncovers the Genetic Structure of Cattle Breeds	SCIENCE			English	Article							MISSENSE MUTATION; MILK-YIELD; IDENTIFICATION; SELECTION; ORIGIN; SCANS; QTL	The imprints of domestication and breed development on the genomes of livestock likely differ from those of companion animals. A deep draft sequence assembly of shotgun reads from a single Hereford female and comparative sequences sampled from six additional breeds were used to develop probes to interrogate 37,470 single-nucleotide polymorphisms (SNPs) in 497 cattle from 19 geographically and biologically diverse breeds. These data show that cattle have undergone a rapid recent decrease in effective population size from a very large ancestral population, possibly due to bottlenecks associated with domestication, selection, and breed formation. Domestication and artificial selection appear to have left detectable signatures of selection within the cattle genome, yet the current levels of diversity within breeds are at least as great as exists within humans.	[Van Tassell, Curtis P.; Matukumalli, Lakshmi K.; Sonstegard, Tad S.; Matukumalli, Lakshmi K.; Matukumalli, Aruna; Sonstegard, Tad S.; da Silva, Marcos Barbosa; Liu, George E.] ARS, USDA, Bovine Funct Genom Lab, BARC E, Beltsville, MD 20705 USA; [Gibbs, Richard A.; Nazareth, Lynne V.; Weinstock, George M.; Wheeler, David A.; Liu, Yue; Qin, Xiang; Worley, Kim C.; Jiang, Huaiyang; Liu, Yue; Nazareth, Lynne V.; Ren, Yanru; Song, Xing-Zhi; Muzny, Donna M.; Nazareth, Lynne V.; Patil, Shobha; Lucas, Anthony San; Fu, Qing; Vega, Richard] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Gibbs, Richard A.; Nazareth, Lynne V.; Weinstock, George M.; Wheeler, David A.; Liu, Yue; Qin, Xiang; Worley, Kim C.; Jiang, Huaiyang; Liu, Yue; Nazareth, Lynne V.; Ren, Yanru; Song, Xing-Zhi; Muzny, Donna M.; Nazareth, Lynne V.; Patil, Shobha; Lucas, Anthony San; Fu, Qing; Vega, Richard] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Taylor, Jeremy F.; Schnabel, Robert D.; Taylor, Jeremy F.; Taylor, Jeremy F.; Taylor, Jeremy F.; Schnabel, Robert D.; Taylor, Jeremy F.] Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA; [Barendse, William; Barendse, William; Bunch, Rowan J.; Harrison, Blair E.; Sim, Warren; Thomas, Merle B.; Williams, Paul; McWilliam, Sean; Barendse, William] CSIRO, Livestock Ind, St Lucia, Qld 4067, Australia; [Barendse, William; Barendse, William; Bunch, Rowan J.; Harrison, Blair E.; Sim, Warren; Thomas, Merle B.; McWilliam, Sean; Barendse, William] Univ New England, CRC, Beef Genet Technol, Armidale, NSW 2351, Australia; [Eversoie, Kallye A.] Alliance Anim Genome Res, Bethesda, MD 20816 USA; [Gill, Clare A.; Abbey, Colette A.; Gill, Clare A.; Gao, Chuan; Gill, Clare A.; Abbey, Colette A.; Gao, Chuan; Gill, Clare A.; Choi, Jungwoo] Texas A&M Univ, Dept Anim Sci, College Stn, TX 77843 USA; [Green, Ronnie D.; Kappes, Steven M.; Green, Ronnie D.; Olivier, Hanotte; Green, Ronnie D.] ARS, USDA, Natl Program Staff, Beltsville, MD 20705 USA; [Hamernik, Debora L.] USDA Cooperat State Res Educ & Extens Serv, Washington, DC 20250 USA; [Lien, Sigbjorn; Kent, Matthew P.] Norwegian Univ Life Sci, Ctr Integrat Genet, N-1432 As, Norway; [Lien, Sigbjorn; Kent, Matthew P.] Norwegian Univ Life Sci, Dept Anim & Aquacultural Sci, N-1432 As, Norway; [Matukumalli, Lakshmi K.; Matukumalli, Lakshmi K.; Grefenstette, John J.; Villa-Angulo, Rafael; Villa-Angulo, Rafael] George Mason Univ, Dept Bioinformat & Computat Biol, Manassas, VA USA; [McEwan, John C.; Dodds, Ken G.] AgResearch, Anim Genom, Invermay 9053, Mosgiel, New Zealand; [Ajmone-Marsan, Paolo; Ajmone-Marsan, Paolo; Negrini, Riccardo] Univ Cattolica Sacro Cuore, Ist Zootecn, I-29100 Piacenza, Italy; [Boettcher, Paul J.; Garcia, Jose Fernando; Boettcher, Paul J.] IAEA, Joint United Nations FAO, Div Nucl Tech Food & Agr, A-1400 Vienna, Austria; [Caetano, Alexandre R.; Caetano, Alexandre R.] Embrapa Genet Resources & Biotechnol Ctr, BR-70770900 Brasilia, DF, Brazil; [Garcia, Jose Fernando] UNESP, Dept Anim Prod & Hlth, IAEA, Collaborat Ctr Anim Genom & Bioinformat, BR-16050680 Aracatuba, SP, Brazil; [Hanotte, Olivier; Hanotte, Olivier; Agaba, Morris] Int Livestock Res Inst, Nairobi 00100, Kenya; [Skow, Loren C.; Skow, Loren C.] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Integrat Biol Sci, College Stn, TX 77843 USA; [Williams, John L.; Wooliams, John A.; Aerts, Jan; Jann, Oliver; Williams, John L.] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin Inst, Roslin E25 9PS, Midlothian, Scotland; [Diallo, Boubacar] Direct Natl Elevage, Conakry, Guinea; [Hailemariam, Lemecha] Ethiopian Inst Agr Res, Addis Ababa, Ethiopia; [Martinez, Mario L.; Machado, Marco A.; da Silva, Marcos Barbosa] Embrapa Dairy Cattle Ctr, BR-36038330 Juiz De Fora, MG, Brazil; [Morris, Chris A.; Morris, Chris A.] AgResearch, Anim Genom, Hamilton 3240, New Zealand; [Silva, Luiz O. C.; Araujo, Flabio R.] Embrapa Beef Cattle Ctr, BR-79002970 Campo Grande, MS, Brazil; [Spelman, Richard J.; Spelman, Richard J.] LIC, Res & Dev, Hamilton 3240, New Zealand; [Mulatu, Woudyalew] Int Livestock Res Inst, Addis Ababa, Ethiopia; [Zhao, Keyan; Bustamante, Carlos D.; Hernandez, Ryan D.; Bryc, Katarzyna; Bustamante, Carlos D.; Gao, Hong; Wright, Mark; Bustamante, Carlos D.; Wright, Mark] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA; [Burton, James] Univ Edinburgh Summerhall, Royal Dick Sch Vet Studies, Edinburgh EH9 1QH, Midlothian, Scotland; [Plastow, Graham; Moore, Stephen S.; Moore, Stephen S.; Murdoch, Brenda] Univ Alberta, AgFor Ctr 410, Edmonton, AB T6G 2P5, Canada; [Smith, Timothy] ARS, USDA, US Meat Anim Res Ctr, Mol Genet Res Unit, Clay Ctr, NE 68933 USA; [Valentini, Alessio] Univ Tuscia, Dipartimento Prod Anim, I-01100 Viterbo, Italy; [Womack, James] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Pathobiol, College Stn, TX 77843 USA; [Aerts, Jan] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; [Goddard, Mike E.] Univ Melbourne, Fac Land & Food Resources, Parkville, Vic 3010, Australia; [Bradley, Daniel G.; Lau, Lilian P. L.; Lynn, David J.] Trinity Coll Dublin, Smurfit Inst Genet, Dublin 2, Ireland; [Lynn, David J.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada	United States Department of Agriculture (USDA); Baylor College of Medicine; Baylor College of Medicine; University of Missouri System; University of Missouri Columbia; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of New England; Texas A&M University System; Texas A&M University College Station; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Norwegian University of Life Sciences; Norwegian University of Life Sciences; George Mason University; AgResearch - New Zealand; Catholic University of the Sacred Heart; Food & Agriculture Organization of the United Nations (FAO); International Atomic Energy Agency; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Estadual Paulista; CGIAR; International Livestock Research Institute (ILRI); Texas A&M University System; Texas A&M University College Station; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; Ethiopian Institute of Agricultural Research (EIAR); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); AgResearch - New Zealand; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); CGIAR; International Livestock Research Institute (ILRI); Cornell University; University of Edinburgh; University of Alberta; United States Department of Agriculture (USDA); Tuscia University; Texas A&M University System; Texas A&M University College Station; Wellcome Trust Sanger Institute; University of Melbourne; Trinity College Dublin; Simon Fraser University	Van Tassell, CP (corresponding author), ARS, USDA, Bovine Funct Genom Lab, BARC E, Beltsville, MD 20705 USA.	agibbs@bcm.tmc.edu; taylorjerr@missouri.edu; curt.vantassell@ars.usda.gov	stella, Alessandra/AAG-6401-2021; Caetano, Alexandre Rodrigues/B-5227-2017; stella, Alessandra/ABB-1952-2021; Gao, Chuan/A-8808-2015; Wheeler, David A/M-9740-2018; Gill, Clare/R-3677-2019; Moore, Stephen S/F-5285-2013; Weinstock, George M/C-6314-2013; valentini, alessio/L-3970-2013; Hanotte, Olivier/B-4669-2013; Stella, Alessandra/AAY-7322-2020; Eversole, Kellye/AAN-6141-2020; Hayes, Ben J/L-3308-2016; McWilliam, Sean M/H-8978-2013; Liu, George/K-3371-2019; Van Tassell, Curtis P./O-4247-2019; Aerts, Jan/AAQ-6949-2020; Bradley, Daniel G/A-3240-2012; McEwan, John/A-1143-2008; Villa-Angulo, Rafael/I-5937-2015; Barendse, William J/D-8608-2011; AJMONE MARSAN, Paolo/M-2466-2018	stella, Alessandra/0000-0003-2850-3964; Caetano, Alexandre Rodrigues/0000-0002-3419-7337; stella, Alessandra/0000-0003-2850-3964; Gao, Chuan/0000-0002-1399-8450; Wheeler, David A/0000-0002-9056-6299; Gill, Clare/0000-0003-2640-1825; Weinstock, George M/0000-0002-2997-4592; valentini, alessio/0000-0003-4733-7519; Eversole, Kellye/0000-0002-8784-4913; Hayes, Ben J/0000-0002-5606-3970; McWilliam, Sean M/0000-0002-3148-0428; Liu, George/0000-0003-0192-6705; Van Tassell, Curtis P./0000-0002-8416-2087; Aerts, Jan/0000-0002-6416-2717; McEwan, John/0000-0003-4801-6207; Villa-Angulo, Rafael/0000-0002-7698-6617; Barendse, William J/0000-0002-5464-0658; Worley, Kim/0000-0002-0282-1000; AJMONE MARSAN, Paolo/0000-0003-3165-4579; Goddard, Michael/0000-0001-9917-7946; Williams, John/0000-0001-5188-7957; Wright, Mark/0000-0001-8036-1161; Zhao, Keyan/0000-0002-8800-2304; Moore, Stephen/0000-0002-9758-166X; Dodds, Ken/0000-0002-9347-6379; Bradley, Daniel G/0000-0001-7335-7092; mariani, paola/0000-0002-5604-4550; Hanotte, Olivier/0000-0002-2877-4767; Skow, Loren/0000-0001-8998-359X; Lynn, David/0000-0003-4664-1404; Schnabel, Robert/0000-0001-5018-7641; NEGRINI, Riccardo/0000-0002-8735-0286; Bustamante, Carlos D./0000-0002-4187-7920; Plastow, Graham/0000-0002-3774-3110	National Human Genome Research Institute of the National Institutes of Health; U.S. Department of Agricultures Agricultural Research Service (USDA-ARS); Cooperative State Research, Education and Extension Service (USDA CSREES); Research Council of Norway; American Angus Association; American Hereford Association; American Jersey Cattle Association; AgResearch (New Zealand); Australian Brahman Breeders Association; Beefmaster Breeders United; The Brazilian Agricultural Research Corporation (Embrapa); Brown Swiss Association; Commonwealth Scientific and Industrial Research Organization; Dairy InSight; GENO Breeding and Artificial Insemination Association-Norway; Herd Book/France Limousin Selection; Holstein Association USA; International Atomic Energy Agency (IAEA)-United Nations Food and Agriculture Organization (FAO)/IAEA Vienna; International Livestock Research Institute-Kenya; Italian Piedmontese Breeders-Parco Tecnologico Padano; Italian Romagnola Society-Universita Cattolica del Sacro Cuore; Livestock Improvement Corporation; Meat and Wool New Zealand; North American Limousin Foundation; Red Angus Association of America; Roslin Institute for UK Guernsey; Sygen (now Genus); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083606] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BBS/B/05710, BBS/E/R/00000673, BBS/E/R/00001618, BBS/E/R/00001610, BBS/E/D/05191130] Funding Source: researchfish; BBSRC [BBS/E/R/00001610, BBS/E/R/00001618, BBS/E/D/05191130] Funding Source: UKRI	National Human Genome Research Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); U.S. Department of Agricultures Agricultural Research Service (USDA-ARS)(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Cooperative State Research, Education and Extension Service (USDA CSREES)(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Research Council of Norway(Research Council of Norway); American Angus Association; American Hereford Association; American Jersey Cattle Association; AgResearch (New Zealand); Australian Brahman Breeders Association; Beefmaster Breeders United; The Brazilian Agricultural Research Corporation (Embrapa); Brown Swiss Association; Commonwealth Scientific and Industrial Research Organization; Dairy InSight; GENO Breeding and Artificial Insemination Association-Norway; Herd Book/France Limousin Selection; Holstein Association USA; International Atomic Energy Agency (IAEA)-United Nations Food and Agriculture Organization (FAO)/IAEA Vienna(International Atomic Energy Agency); International Livestock Research Institute-Kenya(CGIAR); Italian Piedmontese Breeders-Parco Tecnologico Padano; Italian Romagnola Society-Universita Cattolica del Sacro Cuore; Livestock Improvement Corporation(Livestock Improvement Corporation); Meat and Wool New Zealand; North American Limousin Foundation; Red Angus Association of America; Roslin Institute for UK Guernsey; Sygen (now Genus); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The Bovine Hapmap Consortium funded by the National Human Genome Research Institute of the National Institutes of Health, U.S. Department of Agricultures Agricultural Research Service (USDA-ARS) and Cooperative State Research, Education and Extension Service (USDA CSREES), the Research Council of Norway, as well as: American Angus Association, American Hereford Association, American Jersey Cattle Association, AgResearch (New Zealand), Beef CRC and Meat and Livestock Australia for the Australian Brahman Breeders Association, Beefmaster Breeders United, The Brazilian Agricultural Research Corporation (Embrapa), Brown Swiss Association, Commonwealth Scientific and Industrial Research Organization, Dairy InSight, GENO Breeding and Artificial Insemination Association-Norway, Herd Book/France Limousin Selection, Holstein Association USA, International Atomic Energy Agency (IAEA)-United Nations Food and Agriculture Organization (FAO)/IAEA Vienna, International Livestock Research Institute-Kenya, Italian Piedmontese Breeders-Parco Tecnologico Padano, Italian Romagnola Society-Universita Cattolica del Sacro Cuore, Livestock Improvement Corporation, Meat and Wool New Zealand. North American Limousin Foundation, Red Angus Association of America, Roslin Institute for UK Guernsey, and Sygen (now Genus). See SOM for additional acknowledgements. The genome sequence (AAFC03000000) and SNPs (SOM) are available from NCBI.	Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Barendse W, 2007, GENETICS, V176, P2601, DOI 10.1534/genetics.107.074328; Barendse W, 2007, GENETICS, V176, P1893, DOI 10.1534/genetics.107.072637; Barendse W, 2004, AUST J EXP AGR, V44, P669, DOI 10.1071/EA02156; Bradley DG, 1996, P NATL ACAD SCI USA, V93, P5131, DOI 10.1073/pnas.93.10.5131; Clutton-Brock J., 1999, NATURAL HIST DOMESTI, V2nd ed.; Cohen-Zinder M, 2005, GENOME RES, V15, P936, DOI 10.1101/gr.3806705; Edwards CJ, 2007, P ROY SOC B-BIOL SCI, V274, P1377, DOI 10.1098/rspb.2007.0020; Gao H, 2007, GENETICS, V176, P1635, DOI 10.1534/genetics.107.072371; Grisart B, 2002, GENOME RES, V12, P222, DOI 10.1101/gr.224202; Grobet L, 1997, NAT GENET, V17, P71, DOI 10.1038/ng0997-71; Kappes SM, 2000, J ANIM SCI, V78, P3053; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Loftus RT, 1999, MOL ECOL, V8, P2015, DOI 10.1046/j.1365-294x.1999.00805.x; Nielsen R, 2005, GENOME RES, V15, P1566, DOI 10.1101/gr.4252305; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Schreiber A, 1999, J HERED, V90, P165, DOI 10.1093/jhered/90.1.165; SVED J A, 1971, Theoretical Population Biology, V2, P125; Tenesa A, 2007, GENOME RES, V17, P520, DOI 10.1101/gr.6023607; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072	22	599	637	2	131	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 24	2009	324	5926					528	532		10.1126/science.1167936	http://dx.doi.org/10.1126/science.1167936			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436JU	19390050	Green Accepted, Green Published			2022-12-01	WOS:000265411200051
J	Klionsky, DJ				Klionsky, Daniel J.			Crohn's Disease, Autophagy, and the Paneth Cell	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ATG16L1		Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Klionsky, DJ (corresponding author), Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053396] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM053396, R01 GM053396-19] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Cadwell K, 2009, AUTOPHAGY, V5, P250, DOI 10.4161/auto.5.2.7560; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Kuballa P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003391; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383	5	38	39	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 23	2009	360	17					1785	1786		10.1056/NEJMcibr0810347	http://dx.doi.org/10.1056/NEJMcibr0810347			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	435XY	19369659	Green Accepted			2022-12-01	WOS:000265377800015
J	Tonelli, M; Klarenbach, S; Rose, C; Wiebe, N; Gill, J				Tonelli, Marcello; Klarenbach, Scott; Rose, Caren; Wiebe, Natasha; Gill, John			Access to Kidney Transplantation Among Remote- and Rural-Dwelling Patients With Kidney Failure in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARDIAC REVASCULARIZATION SERVICES; ACUTE MYOCARDIAL-INFARCTION; QUALITY-OF-CARE; URBAN AREAS; INDICATORS; HOSPITALS; RESIDENCE; LOCATION; SCOTLAND; CANADA	Context US residents with end-stage renal disease ( ESRD) may live far away from the closest transplant center, which could compromise their access to kidney transplantation. Objective To assess access to kidney transplantation as a function of distance from the closest transplant center or as a function of rural rather than urban residence. Design, Setting, and Participants Observational study of 699 751 adult patients with kidney failure who had initiated renal replacement in the United States between 1995 and 2007 and were thus placed on a prospective mandatory registry list. Main Outcome Measures Time to placement on the kidney transplant waiting list and time to kidney transplantation, both measured at the start of renal replacement. Results During a median follow-up of 2.0 years (range, 0.0-12.5 years), 122 785 (17.5%) patients received a kidney transplant. Median distance to the closest transplant center was 15 miles. Participants were classified into distance categories by miles from a transplant center with 0 to 15 miles serving as the referent category. Compared with the referent category, the adjusted hazard ratios of deceased or living donor transplantation within each category follows: 16 to 50 miles, 1.03 (95% CI, 1.02-1.05); 51 to 100 miles, 1.11 (95% CI, 1.09-1.12); 101 to 136 miles, 1.14 (95% CI, 1.11-1.17); 137 to 231 miles, 1.16 (95% CI, 1.13-1.20); 232 to 310 miles, 1.20 (95% CI, 1.12-1.28); and more than 310 miles, 1.16 (95% CI, 1.09-1.23). When residence location was classified using rural-urban commuter areas, 79.6% of patients lived in urban; 10.3%, micropolitan; and 10.0%, rural areas. Compared with those living in metropolitan areas, the adjusted hazard ratios of deceased or living donor transplantation among patients residing in micropolitan communities was 1.13 (95% CI, 1.11-1.15) and 1.15 (95% CI, 1.13-1.18) for rural areas. Results were similar for both deceased donor and living donor transplantation and were consistent in multiple sensitivity analyses. Conclusion Remote or rural residence was not associated with increased time to kidney transplantation among people treated for ESRD in the United States.	[Tonelli, Marcello; Klarenbach, Scott; Wiebe, Natasha] Univ Alberta, Dept Med, Edmonton, AB T6B 2B7, Canada; [Tonelli, Marcello] Univ Alberta, Div Crit Care Med, Edmonton, AB T6B 2B7, Canada; [Tonelli, Marcello] Univ Alberta, Dept Publ Hlth Sci, Edmonton, AB T6B 2B7, Canada; [Tonelli, Marcello; Klarenbach, Scott] Inst Hlth Econ, Edmonton, AB, Canada; [Rose, Caren; Gill, John] St Pauls Hosp, Div Nephrol, Vancouver, BC V6Z 1Y6, Canada; [Gill, John] Tufts Univ New England Med Ctr, Div Nephrol, Boston, MA USA	University of Alberta; University of Alberta; University of Alberta; St. Paul's Hospital; University of Saskatchewan; Tufts Medical Center	Tonelli, M (corresponding author), Univ Alberta, Dept Med, 7-129 Clin Sci Bldg,8440 112 St, Edmonton, AB T6B 2B7, Canada.	mtonelli-admin@med.ualberta.ca	Wiebe, Natasha/V-7803-2019; Tonelli, Marcello/B-3028-2009	Wiebe, Natasha/0000-0002-5613-1582; Tonelli, Marcello/0000-0002-0846-3187	Alberta Heritage Foundation for Medical Research; Alberta Health and Wellness and the University of Alberta; Canadian Institutes of Health Research; Michael Smith Foundation for Medical Research	Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); Alberta Health and Wellness and the University of Alberta(University of Alberta); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Medical Research(Michael Smith Foundation for Health Research)	Funding/Support: Drs Tonelli and Klarenbach were supported by Population Health Investigator Awards from the Alberta Heritage Foundation for Medical Research and by a joint initiative between Alberta Health and Wellness and the University of Alberta. Dr Tonelli was also supported by a New Investigator Award from the Canadian Institutes of Health Research. Dr Gill was supported by the Michael Smith Foundation for Medical Research.	Alexander GC, 2001, AM J KIDNEY DIS, V37, P321, DOI 10.1053/ajkd.2001.21297; Axelrod DA, 2008, JAMA-J AM MED ASSOC, V299, P202, DOI 10.1001/jama.2007.50; Baldwin LM, 2004, J RURAL HEALTH, V20, P99, DOI 10.1111/j.1748-0361.2004.tb00015.x; BLACK N, 1995, J EPIDEMIOL COMMUN H, V49, P408, DOI 10.1136/jech.49.4.408; Booth GL, 2005, DIABETES CARE, V28, P1045, DOI 10.2337/diacare.28.5.1045; Brabyn L., 2004, CARTOGRAPHICA, V39, P41, DOI [10.3138/TH62-2668-3273-3344, DOI 10.3138/TH62-2668-3273-3344]; Brabyn Lars, 2002, Int J Health Geogr, V1, P3, DOI 10.1186/1476-072X-1-3; Ellison MD, 2003, TRANSPLANTATION, V76, P1389, DOI 10.1097/01.TP.0000090332.30050.BA; Gamm LD, 2003, RURAL HLTH PEOPLE 20; Gregory PM, 2000, MED CARE, V38, P45, DOI 10.1097/00005650-200001000-00006; Grubesic Tony H, 2006, Int J Health Geogr, V5, P58, DOI 10.1186/1476-072X-5-58; Hall SA, 2006, J URBAN HEALTH, V83, P162, DOI 10.1007/s11524-005-9016-3; Kasiske BL, 2008, AM J TRANSPLANT, V8, P647, DOI 10.1111/j.1600-6143.2007.02130.x; KASISKE BL, 1995, J AM SOC NEPHROL, V6, P1; Larson R. C., 1981, URBAN OPERATIONS RES; LEESE GP, 1993, BRIT MED J, V306, P187, DOI 10.1136/bmj.306.6871.187; Leira EC, 2008, ARCH NEUROL-CHICAGO, V65, P887, DOI 10.1001/archneur.65.7.887; Levin KA, 2006, AM J PUBLIC HEALTH, V96, P145, DOI 10.2105/AJPH.2004.051193; Loubeau P R, 2001, Prog Transplant, V11, P291; Lutfiyya MN, 2007, INT J QUAL HEALTH C, V19, P141, DOI 10.1093/intqhc/mzm010; Neylan JF, 1999, J AM SOC NEPHROL, V10, P2237; Oniscu GC, 2003, BRIT MED J, V327, P1261, DOI 10.1136/bmj.327.7426.1261; Pong RW, 2002, CAN J PUBLIC HEALTH, V93, pS52, DOI 10.1007/BF03405119; Seidel JE, 2004, CAN J CARDIOL, V20, P517; Sheikh K, 2001, ARCH INTERN MED, V161, P737, DOI 10.1001/archinte.161.5.737; Tonelli M, 2006, CAN MED ASSOC J, V175, P478, DOI 10.1503/cmaj.051356; Turnbull J, 2008, BRIT J GEN PRACT, V58, P471, DOI 10.3399/bjgp08X319431; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303	28	68	68	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 22	2009	301	16					1681	1690		10.1001/jama.2009.545	http://dx.doi.org/10.1001/jama.2009.545			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	435NN	19383959	Bronze			2022-12-01	WOS:000265350700024
J	Kaddis, JS; Olack, BJ; Sowinski, J; Cravens, J; Contreras, JL; Niland, JC				Kaddis, John S.; Olack, Barbara J.; Sowinski, Janice; Cravens, James; Contreras, Juan L.; Niland, Joyce C.			Human Pancreatic Islets and Diabetes Research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ENDOTHELIAL GROWTH-FACTOR; QUALITY-OF-LIFE; BETA-CELL; TRANSPLANTATION; LANGERHANS; XENOTRANSPLANTATION; INFLAMMATION; APOPTOSIS; VARIABLES; MODELS	Human islet research is crucial to understanding the cellular biology of the pancreas in developing therapeutic options for diabetes patients and in attempting to prevent the development of this disease. The national Islet Cell Resource Center Consortium provides human pancreatic islets for diabetes research while simultaneously addressing the need to improve islet isolation and transplantation technologies. Since its inception in 2001, the consortium has supplied 297.6 million islet equivalents to 151 national and international scientists for use in clinical and laboratory projects. Data on the volume, quality, and frequency of shipments substantiate the importance of human islets for diabetes research, as do the number of funded grants for beta-cell projects and publications produced as a direct result of islets supplied by this resource. Limitations in using human islets are discussed, along with the future of islet distribution centers. The information presented here is instructive to clinicians, basic science investigators, and policy makers who determine the availability of funding for such work. Organ procurement coordinators also may find the information useful in explaining to donor families why research consent is so valuable.	[Kaddis, John S.; Olack, Barbara J.; Sowinski, Janice; Cravens, James; Niland, Joyce C.] City Hope Natl Med Ctr, Dept Informat Sci, Duarte, CA 91010 USA; [Contreras, Juan L.] Univ Alabama Birmingham, Dept Surg, Birmingham, AL USA	City of Hope; University of Alabama System; University of Alabama Birmingham	Kaddis, JS (corresponding author), City Hope Natl Med Ctr, Dept Informat Sci, 1500 E Duarte Rd, Duarte, CA 91010 USA.	jkaddis@coh.org		Kaddis, John/0000-0002-6752-7670; Olack, Barbara/0000-0001-6645-8215	National Center for Research Resources (NCRR); National Institute of Diabetes and Digestive and Kidney Diseases; US National Institutes of Health (NIH); NCRR [U42 RR 017673, U42 RR 023246]; NATIONAL CENTER FOR RESEARCH RESOURCES [U42RR017673, U42RR023246] Funding Source: NIH RePORTER	National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funding/Support: This work was funded by the cooperative efforts of the National Center for Research Resources (NCRR) and the National Institute of Diabetes and Digestive and Kidney Diseases, a component of the US National Institutes of Health (NIH), in conjunction with the generous contributions of the Juvenile Diabetes Research Foundation. Messrs Kaddis and Cravens, Mss Olack and Sowinski, and Dr Niland are supported by grants U42 RR 017673 (J.C.N.) and U42 RR 023246 (J.L.C.) from the NCRR.	Alejandro R, 2008, TRANSPLANTATION, V86, P1783, DOI 10.1097/TP.0b013e3181913f6a; Ballian N, 2007, WORLD J SURG, V31, P705, DOI 10.1007/s00268-006-0719-8; BALLINGER WF, 1972, SURGERY, V72, P175; Barshes NR, 2005, J LEUKOCYTE BIOL, V77, P587, DOI 10.1189/jlb.1104649; Bhonde R, 2007, INDIAN J MED RES, V125, P425; Bonner-Weir S, 2005, NAT BIOTECHNOL, V23, P857, DOI 10.1038/nbt1115; Brissova M, 2005, J HISTOCHEM CYTOCHEM, V53, P1087, DOI 10.1369/jhc.5C6684.2005; Brissova M, 2006, DIABETES, V55, P2974, DOI 10.2337/db06-0690; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103; Cure P, 2008, TRANSPLANTATION, V85, P801, DOI 10.1097/TP.0b013e318166a27b; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Dufrane D, 2006, XENOTRANSPLANTATION, V13, P204, DOI 10.1111/j.1399-3089.2006.00275.x; Eftat S, 2008, ADV DRUG DELIVER REV, V60, P114, DOI 10.1016/j.addr.2007.08.033; EIZIRIK DL, 1994, P NATL ACAD SCI USA, V91, P9253, DOI 10.1073/pnas.91.20.9253; Elliott RB, 2000, CELL TRANSPLANT, V9, P895, DOI 10.1177/096368970000900616; Goss JA, 2004, TRANSPLANTATION, V77, P462, DOI 10.1097/01.TP.0000100397.86756.A3; GROTH CG, 1994, LANCET, V344, P1402, DOI 10.1016/S0140-6736(94)90570-3; Hanley NA, 2008, MOL CELL ENDOCRINOL, V288, P79, DOI 10.1016/j.mce.2008.03.001; Hanley SC, 2008, TRANSPLANTATION, V85, P950, DOI 10.1097/TP.0b013e3181683df5; Hering BJ, 2007, AM J TRANSPLANT, V7, P205; Hohmeier HE, 2005, NAT BIOTECHNOL, V23, P1231, DOI 10.1038/nbt1005-1231; Hohmeier HE, 2004, MOL CELL ENDOCRINOL, V228, P121, DOI 10.1016/j.mce.2004.04.017; Huang XL, 2008, ENDOCR REV, V29, P603, DOI 10.1210/er.2008-0006; Ichii H, 2007, AM J TRANSPLANT, V7, P1010, DOI 10.1111/j.1600-6143.2006.01687.x; *INT SOC CELL THER, RISK BOV SPONG ENC B; *ISI WEB KNOWL, WEB SCI J IMP REP TO; *JUV DIAB RES FDN, JUV DIAB RES FDN INT; Knazek Richard A, 2002, Diabetes Technol Ther, V4, P551, DOI 10.1089/152091502760306652; Korsgren O, 2008, DIABETOLOGIA, V51, P227, DOI 10.1007/s00125-007-0868-9; LAKEY JR, 2006, HUM ISL IS TRANSP TE; Lakey JRT, 1996, TRANSPLANTATION, V61, P1047, DOI 10.1097/00007890-199604150-00010; Markmann JF, 2008, AM J TRANSPLANT, V8, P1588, DOI 10.1111/j.1600-6143.2008.02305.x; Meivar-Levy I, 2003, TRENDS ENDOCRIN MET, V14, P460, DOI 10.1016/j.tem.2003.10.006; Movahedi B, 2008, DIABETES, V57, P2128, DOI 10.2337/db07-1705; Narushima M, 2005, NAT BIOTECHNOL, V23, P1274, DOI 10.1038/nbt1145; *NAT SCI FDN, NAT SCI FDN AW SEARC; NIH RePORTER, NIH RES PORTF ONL RE; O'Neil JJ, 2003, CELL TRANSPLANT, V12, P883, DOI 10.3727/000000003771000110; Oliver-Krasinski JM, 2008, GENE DEV, V22, P1998, DOI 10.1101/gad.1670808; *OPTN, OPTN NAT DAT REP; Parnaud G, 2008, DIABETOLOGIA, V51, P91, DOI 10.1007/s00125-007-0855-1; Pileggi A, 2006, ANN NY ACAD SCI, V1079, P383, DOI 10.1196/annals.1375.059; Qian D, 2007, COMPUT STAT DATA AN, V51, P5494, DOI 10.1016/j.csda.2007.02.030; Rees DA, 2005, DIABETIC MED, V22, P359, DOI 10.1111/j.1464-5491.2005.01499.x; RICORDI C, 1988, DIABETES, V37, P413, DOI 10.2337/diabetes.37.4.413; RICORDI C, 1991, PANCREAS, V6, P242, DOI 10.1097/00006676-199103000-00018; Ryan EA, 2004, DIABETES, V53, P955, DOI 10.2337/diabetes.53.4.955; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Sorenson RL, 1997, HORM METAB RES, V29, P301, DOI 10.1055/s-2007-979040; Toso C, 2007, TRANSPLANTATION, V84, P664, DOI 10.1097/01.tp.0000280550.01028.89; Valdes-Gonzalez RA, 2005, EUR J ENDOCRINOL, V153, P419, DOI 10.1530/eje.1.01982; Westermark GT, 2008, NEW ENGL J MED, V359, P977, DOI 10.1056/NEJMc0802893; Yang Z, 2004, TRANSPL P, V36, P1532, DOI 10.1016/j.transproceed.2004.04.075; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314; ZOON KC, LETT TRANSPLANT CTR	56	44	46	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 15	2009	301	15					1580	1587		10.1001/jama.2009.482	http://dx.doi.org/10.1001/jama.2009.482			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	432MH	19366778	Green Accepted			2022-12-01	WOS:000265137900029
J	Zhao, SM; Lin, Y; Xu, W; Jiang, WQ; Zha, ZY; Wang, P; Yu, W; Li, ZQ; Gong, LL; Peng, YJ; Ding, JP; Lei, QY; Guan, KL; Xiong, Y				Zhao, Shimin; Lin, Yan; Xu, Wei; Jiang, Wenqing; Zha, Zhengyu; Wang, Pu; Yu, Wei; Li, Zhiqiang; Gong, Lingling; Peng, Yingjie; Ding, Jianping; Lei, Qunying; Guan, Kun-Liang; Xiong, Yue			Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1 alpha	SCIENCE			English	Article							DEPENDENT ISOCITRATE DEHYDROGENASE; MECHANISM; TUMORS	Heterozygous mutations in the gene encoding isocitrate dehydrogenase-1 (IDH1) occur in certain human brain tumors, but their mechanistic role in tumor development is unknown. We have shown that tumor-derived IDH1 mutations impair the enzyme's affinity for its substrate and dominantly inhibit wild-type IDH1 activity through the formation of catalytically inactive heterodimers. Forced expression of mutant IDH1 in cultured cells reduces formation of the enzyme product, alpha-ketoglutarate (alpha-KG), and increases the levels of hypoxia-inducible factor subunit HIF-1 alpha, a transcription factor that facilitates tumor growth when oxygen is low and whose stability is regulated by alpha-KG. The rise in HIF-1 alpha levels was reversible by an alpha-KG derivative. HIF-1 alpha levels were higher in human gliomas harboring an IDH1 mutation than in tumors without a mutation. Thus, IDH1 appears to function as a tumor suppressor that, when mutationally inactivated, contributes to tumorigenesis in part through induction of the HIF-1 pathway.	[Zhao, Shimin; Lin, Yan; Xu, Wei; Jiang, Wenqing; Zha, Zhengyu; Wang, Pu; Yu, Wei; Lei, Qunying; Guan, Kun-Liang; Xiong, Yue] Fudan Univ, Inst Biomed Sci, Mol & Cell Biol Lab, Shanghai 200032, Peoples R China; [Zhao, Shimin; Xu, Wei; Jiang, Wenqing; Wang, Pu; Yu, Wei; Xiong, Yue] Fudan Univ, Sch Life Sci, Shanghai 200433, Peoples R China; [Lei, Qunying; Guan, Kun-Liang] Fudan Univ, Sch Med, Dept Biol Chem, Shanghai 200032, Peoples R China; [Li, Zhiqiang] Wuhan Univ, Dept Neurosurg, Zhongnan Hosp, Wuhan 430071, Peoples R China; [Gong, Lingling] Wuhan Univ, Dept Pathol, Zhongnan Hosp, Wuhan 430071, Peoples R China; [Peng, Yingjie; Ding, Jianping] Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Mol Biol, Shanghai 200031, Peoples R China; [Guan, Kun-Liang] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Guan, Kun-Liang] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Xiong, Yue] Univ N Carolina, Dept Biochem & Biophys, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	Fudan University; Fudan University; Fudan University; Wuhan University; Wuhan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of California System; University of California San Diego; University of California System; University of California San Diego; University of North Carolina; University of North Carolina Chapel Hill	Guan, KL (corresponding author), Fudan Univ, Inst Biomed Sci, Mol & Cell Biol Lab, 130 Dong An Rd, Shanghai 200032, Peoples R China.	kuguan@ucsd.edu; yxiong@email.unc.edu	Peng, Yingjie/B-1280-2013; Guan, Kun-Liang/ADK-7088-2022; Lei, Qun-Ying/J-1390-2017; YU, WEI/G-6710-2013; YU, WEI/C-3822-2012	Lei, Qun-Ying/0000-0002-8547-8518; Zhiqiang, LI/0000-0002-4148-780X; YU, WEI/0000-0001-9898-4607; ding, jian ping/0000-0001-7029-7346	Chinese Ministry of Education; State Key Development Programs of China [2009CB918401, 2006CB806700]; National 863 Program of China [2006AA02A308]; China NSF [30600112, 30871255]; Shanghai Key Basic Research Projects [06JC14086, 07PJ14011, 08JC1400900]; NIH; NATIONAL CANCER INSTITUTE [R01CA068377] Funding Source: NIH RePORTER	Chinese Ministry of Education(Ministry of Education, China); State Key Development Programs of China; National 863 Program of China(National High Technology Research and Development Program of China); China NSF(National Natural Science Foundation of China (NSFC)); Shanghai Key Basic Research Projects; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank members of the Fudan Molecular and Cell Biology Laboratory for valuable input; Y. Liu, X. Liu, and H. Zhu for assistance with histology; Z. Bao, L. Yang, Q. Shi, and G. Zhao for clinical samples; and S. Jackson for reading the manuscript. This work is supported by the 985 program from the Chinese Ministry of Education, State Key Development Programs of China (2009CB918401, 2006CB806700), National 863 Program of China (2006AA02A308), China NSF grants (30600112 and 30871255) and Shanghai Key Basic Research Projects (06JC14086, 07PJ14011, and 08JC1400900), and NIH grants (to K.-L.G. and Y.X.). Y. Xiong, K.-L. Guan, and S. Zhao are applying for a patent related to the work on permeable alpha-ketogluterate.	ALBE KR, 1990, J THEOR BIOL, V143, P163, DOI 10.1016/S0022-5193(05)80266-8; Balss J, 2008, ACTA NEUROPATHOL, V116, P597, DOI 10.1007/s00401-008-0455-2; Bleeker FE, 2009, HUM MUTAT, V30, P7, DOI 10.1002/humu.20937; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; INGEBRETSEN OC, 1976, BIOCHIM BIOPHYS ACTA, V452, P302, DOI 10.1016/0005-2744(76)90180-7; MacKenzie ED, 2007, MOL CELL BIOL, V27, P3282, DOI 10.1128/MCB.01927-06; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Semenza GL, 2007, DRUG DISCOV TODAY, V12, P853, DOI 10.1016/j.drudis.2007.08.006; Soundar S, 2000, J BIOL CHEM, V275, P5606, DOI 10.1074/jbc.275.8.5606; WINKLER BS, 1986, EXP EYE RES, V43, P829, DOI 10.1016/S0014-4835(86)80013-6; Xu X, 2004, J BIOL CHEM, V279, P33946, DOI 10.1074/jbc.M404298200; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	12	867	964	5	183	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 10	2009	324	5924					261	265		10.1126/science.1170944	http://dx.doi.org/10.1126/science.1170944			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430WX	19359588	Green Accepted			2022-12-01	WOS:000265024400049
J	Ritz, E; Bakris, G				Ritz, E.; Bakris, G.			World Kidney Day: hypertension and chronic kidney disease	LANCET			English	Editorial Material							CKD		[Ritz, E.] Nierenzentrum, Dept Internal Med, Organising Comm, D-69100 Heidelberg, Germany; [Bakris, G.] Univ Chicago, Med Ctr, Chicago, IL 60637 USA	University of Chicago; University of Chicago Medical Center	Ritz, E (corresponding author), Nierenzentrum, Dept Internal Med, Organising Comm, D-69100 Heidelberg, Germany.	prof.e.ritz@t-online.de						Alebiosu CO, 2005, ETHNIC DIS, V15, P418; Atkins RC, 2005, KIDNEY INT, V67, pS14, DOI 10.1111/j.1523-1755.2005.09403.x; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Khosla N, 2006, CLIN J AM SOC NEPHRO, V1, P229, DOI 10.2215/CJN.00840805; KLAHR S, 1989, NEW ENGL J MED, V320, P731, DOI 10.1056/NEJM198903163201110; Lea JP, 2006, AM J KIDNEY DIS, V47, P72, DOI 10.1053/j.ajkd.2005.09.027; Perico N, 2005, KIDNEY INT, V68, pS87, DOI 10.1111/j.1523-1755.2005.09715.x; Rao MV, 2008, AM J KIDNEY DIS, V51, pS30, DOI 10.1053/j.ajkd.2007.12.012; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415	9	33	36	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 4	2009	373	9670					1157	1158		10.1016/S0140-6736(09)60355-X	http://dx.doi.org/10.1016/S0140-6736(09)60355-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	429SO	19282027				2022-12-01	WOS:000264940600009
J	Matsuura, K; Vargo, EL; Kawatsu, K; Labadie, PE; Nakano, H; Yashiro, T; Tsuji, K				Matsuura, Kenji; Vargo, Edward L.; Kawatsu, Kazutaka; Labadie, Paul E.; Nakano, Hiroko; Yashiro, Toshihisa; Tsuji, Kazuki			Queen Succession Through Asexual Reproduction in Termites	SCIENCE			English	Article							CLONAL REPRODUCTION; COLONY FOUNDATION; RHINOTERMITIDAE; PARTHENOGENESIS; ISOPTERA; ANT		[Matsuura, Kenji; Nakano, Hiroko; Yashiro, Toshihisa] Okayama Univ, Grad Sch Environm Sci, Lab Insect Ecol, Okayama 7008530, Japan; [Vargo, Edward L.; Labadie, Paul E.] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; [Vargo, Edward L.; Labadie, Paul E.] N Carolina State Univ, WM Keck Ctr Behav Biol, Raleigh, NC 27695 USA; [Kawatsu, Kazutaka] Kyoto Univ, Grad Sch Agr, Lab Insect Ecol, Kyoto 6068502, Japan; [Tsuji, Kazuki] Univ Ryukyus, Fac Agr, Okinawa 9000213, Japan	Okayama University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; Kyoto University; University of Ryukyus	Matsuura, K (corresponding author), Okayama Univ, Grad Sch Environm Sci, Lab Insect Ecol, Okayama 7008530, Japan.	kenjijpn@cc.okayama-u.ac.jp	Tsuji, Kazuki/D-6607-2014; Vargo, Edward/D-1097-2010; Matsuura, Kenji/H-8364-2019; Kawtasu, Kazutaka/B-1066-2010; Yashiro, Toshihisa/J-3120-2015	Tsuji, Kazuki/0000-0002-2027-8582; Vargo, Edward/0000-0002-8712-1248; Matsuura, Kenji/0000-0002-9099-6694; Kawtasu, Kazutaka/0000-0003-4447-4761; Yashiro, Toshihisa/0000-0002-9582-4605	Japan Society for the Promotion of Science; Program for Promotion of Basic Research Activities for Innovative Biosciences	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Program for Promotion of Basic Research Activities for Innovative Biosciences	We are grateful to K. Shimizu, E. Hasegawa, S. Dobata, and N. E. Pierce for discussion and to W. Booth, D. R. Tarpy, K. Ross, L. Keller, and C. Schal for comments on the manuscript. Funded by the Japan Society for the Promotion of Science (K.M., K.T.) and the Program for Promotion of Basic Research Activities for Innovative Biosciences (K.M.).	Fournier D, 2005, NATURE, V435, P1230, DOI 10.1038/nature03705; Matsuura K, 2004, INSECT SOC, V51, P325, DOI 10.1007/s00040-004-0746-0; Matsuura K, 2001, POPUL ECOL, V43, P119, DOI 10.1007/PL00012022; Ohkawara K, 2006, BIOL LETTERS, V2, P359, DOI 10.1098/rsbl.2006.0491; Pearcy M, 2004, SCIENCE, V306, P1780, DOI 10.1126/science.1105453; Shellman-Reeve JS, 1999, P ROY SOC B-BIOL SCI, V266, P137, DOI 10.1098/rspb.1999.0613; Thorne BL, 1999, ETHOL ECOL EVOL, V11, P149, DOI 10.1080/08927014.1999.9522833	7	106	113	2	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 27	2009	323	5922					1687	1687		10.1126/science.1169702	http://dx.doi.org/10.1126/science.1169702			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	424IG	19325106				2022-12-01	WOS:000264559800028
J	Zaghloul, KA; Blanco, JA; Weidemann, CT; McGill, K; Jaggi, JL; Baltuch, GH; Kahana, MJ				Zaghloul, Kareem A.; Blanco, Justin A.; Weidemann, Christoph T.; McGill, Kathryn; Jaggi, Jurg L.; Baltuch, Gordon H.; Kahana, Michael J.			Human Substantia Nigra Neurons Encode Unexpected Financial Rewards	SCIENCE			English	Article							MIDBRAIN DOPAMINE NEURONS; BASAL GANGLIA; PARKINSONS-DISEASE; AVERSIVE STIMULI; PREDICTION ERROR; MONKEY; MEDICATION; ACTIVATION; RESPONSES; TASK	The brain's sensitivity to unexpected outcomes plays a fundamental role in an organism's ability to adapt and learn new behaviors. Emerging research suggests that midbrain dopaminergic neurons encode these unexpected outcomes. We used microelectrode recordings during deep brain stimulation surgery to study neuronal activity in the human substantia nigra (SN) while patients with Parkinson's disease engaged in a probabilistic learning task motivated by virtual financial rewards. Based on a model of the participants' expected reward, we divided trial outcomes into expected and unexpected gains and losses. SN neurons exhibited significantly higher firing rates after unexpected gains than unexpected losses. No such differences were observed after expected gains and losses. This result provides critical support for the hypothesized role of the SN in human reinforcement learning.	[Zaghloul, Kareem A.; McGill, Kathryn; Jaggi, Jurg L.; Baltuch, Gordon H.] Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA; [Blanco, Justin A.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Weidemann, Christoph T.; Kahana, Michael J.] Univ Penn, Dept Psychol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Zaghloul, KA (corresponding author), Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA.	zaghlouk@uphs.upenn.edu; kahana@psych.upenn.edu	Weidemann, Christoph T./E-8857-2011; Zaghloul, Kareem/AAV-4208-2020	Weidemann, Christoph T./0000-0002-4280-2744; 	NIH [MH61975]; Conte Center [MH062196]; Dana Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH062196, R01MH061975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048598] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Conte Center; Dana Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is partially supported by NIH grant MH61975, Conte Center grant MH062196, and the Dana Foundation. We thank the staff of the Pennsylvania Neurological Institute for their assistance. We also thank J. Wachter and A. Krieger for statistical advice, A. Geller for cognitive task programming, and M. Kilpatrick and P. Connolly for assistance with DBS surgery.	Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Cools R, 2001, CEREB CORTEX, V11, P1136, DOI 10.1093/cercor/11.12.1136; Cools R, 2003, NEUROPSYCHOLOGIA, V41, P1431, DOI 10.1016/S0028-3932(03)00117-9; Daw ND, 2006, CURR OPIN NEUROBIOL, V16, P199, DOI 10.1016/j.conb.2006.03.006; Frank MJ, 2004, SCIENCE, V306, P1940, DOI 10.1126/science.1102941; Frank MJ, 2005, J COGNITIVE NEUROSCI, V17, P51, DOI 10.1162/0898929052880093; Graybiel AM, 2005, CURR OPIN NEUROBIOL, V15, P638, DOI 10.1016/j.conb.2005.10.006; Hardman CD, 2002, J COMP NEUROL, V445, P238, DOI 10.1002/cne.10165; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Knowlton BJ, 1996, SCIENCE, V273, P1399, DOI 10.1126/science.273.5280.1399; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; Mirenowicz J, 1996, NATURE, V379, P449, DOI 10.1038/379449a0; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Morris G, 2006, NAT NEUROSCI, V9, P1057, DOI 10.1038/nn1743; Nakahara H, 2004, NEURON, V41, P269, DOI 10.1016/S0896-6273(03)00869-9; Rescorla R.A., 1972, CLASSICAL CONDITION, P64, DOI [10.1177/0269881120954052, DOI 10.1177/0269881120954052, DOI 10.1101/GR.110528.110]; Rubin DC, 1996, PSYCHOL REV, V103, P734, DOI 10.1037/0033-295X.103.4.734; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; SCHULTZ W, 1983, EXP BRAIN RES, V51, P377; SCHULTZ W, 1993, J NEUROSCI, V13, P900; SCHULTZ W, 1986, J NEUROPHYSIOL, V56, P1439, DOI 10.1152/jn.1986.56.5.1439; Sutton R.S., 1990, LEARNING COMPUTATION, P497; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; WIXTED JT, 1991, PSYCHOL SCI, V2, P409, DOI 10.1111/j.1467-9280.1991.tb00175.x	26	147	149	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 13	2009	323	5920					1496	1499		10.1126/science.1167342	http://dx.doi.org/10.1126/science.1167342			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417TP	19286561	Green Accepted			2022-12-01	WOS:000264101700046
J	Saito, T; Fujii, T; Kanatani, Y; Saijo, M; Morikawa, S; Yokote, H; Takeuchi, T; Kuwabara, N				Saito, Tomoya; Fujii, Tatsuya; Kanatani, Yasuhiro; Saijo, Masayuki; Morikawa, Shigeru; Yokote, Hiroyuki; Takeuchi, Tsutomu; Kuwabara, Noriyuki			Clinical and Immunological Response to Attenuated Tissue-Cultured Smallpox Vaccine LC16m8	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNITED-STATES; ANTIVIRAL IMMUNITY; REVACCINATION; DURATION; PROTECTION; STRAIN	Context The attenuated, tissue-cultured, third-generation smallpox vaccine LC16m8 was administered to vaccinia-naive infants in Japan during the 1970s without serious adverse events. It is a good candidate for use as part of a prevention plan for bio-terrorism. Objective To assess the immunogenicity and frequency of adverse events of LC16m8 vaccine in unvaccinated and previously vaccinated adults. Design, Setting, and Participants Between 2002 and 2005 we vaccinated and revaccinated 1529 and 1692 adults, respectively, in the Japan Self-Defense Forces with LC16m8 vaccine, given intraepidermally using a bifurcated needle. Vaccinees were examined 10 to 14 days after vaccination to determine if they had developed a major skin reaction ("take"). Neutralizing antibody responses among 200 participants were assessed using a plaque-reduction neutralization test 30 days postvaccination. We monitored vaccinees for adverse events for 30 days postvaccination. Main Outcome Measures Documentation of a vaccine take, presence of neutralizing antibody response, and frequency of adverse events. Results The proportions of take in vaccinia-naive and previously vaccinated individuals were 1443 of 1529 (94.4% [95% confidence interval {CI}, 93.2%-95.9%] and 1465 of 1692 (86.6% [95% CI, 85.0%-88.2%]), respectively. Seroconversion or an effective booster response among the individuals with take was elicited in 37 of 41 (90.2% [95% CI, 81.2%-99.3%]) vaccinia-naive participants and in 93 of 155 (60.0% [95% CI, 52.3%-67.7%]) previously vaccinated participants. One case of allergic dermatitis and another of erythema multiforme, both of which were mild and self-limited, were suspected to be caused by vaccination. No severe adverse events were observed. Conclusion Administration of an attenuated tissue-cultured smallpox vaccine (LC16m8) to healthy adults was associated with high levels of vaccine take and seroconversion in those who were vaccinia-naive and yielded an effective booster response in some previously vaccinated individuals.	[Kanatani, Yasuhiro] Natl Def Med Coll, Res Inst, Tokorozawa, Saitama 3598513, Japan; [Saito, Tomoya; Takeuchi, Tsutomu] Keio Univ, Dept Trop Med & Parasitol, Sch Med, Biopreparedness Res Lab, Tokyo, Japan; [Fujii, Tatsuya] Japan Self Def Forces Cen Hosp, Dept Internal Med, Tokyo, Japan; [Kuwabara, Noriyuki] Japan Self Def Forces Cen Hosp, Ctr Hlth Management, Tokyo, Japan; [Saijo, Masayuki; Morikawa, Shigeru] Natl Inst Infect Dis, Dept Virol 1, Tokyo, Japan; [Yokote, Hiroyuki] Chemosero Therapeut Res Inst Kaketsuken, Kumamoto, Japan	National Defense Medical College - Japan; Keio University; National Institute of Infectious Diseases (NIID)	Kanatani, Y (corresponding author), Natl Def Med Coll, Res Inst, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan.	ykanatan@ndmc.ac.jp	Kanatani, Yasuhiro/AAE-5551-2019; Saijo, Masayuki/L-2697-2019; 金谷, 泰宏/GQZ-8179-2022	Kanatani, Yasuhiro/0000-0001-5790-4084; MORIKAWA, SHIGERU/0000-0001-6249-6716; Saito, Tomoya/0000-0001-6250-4464	Japan Ministry of Health, Labour and Welfare	Japan Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan)	This study was supported by research funding from the Japan Ministry of Health, Labour and Welfare in fiscal year 2004-2006.	*AC INC, VACC REL BIOL PROD A; Centers of Disease Control and Prevention, 2001, MMWR Recomm Rep, V50, P1; Arita I, 2005, LANCET INFECT DIS, V5, P647, DOI 10.1016/S1473-3099(05)70242-5; Arita I, 2002, JPN J INFECT DIS, V55, P112; Balicer RD, 2005, HUM VACCINES, V1, P224, DOI 10.4161/hv.1.6.2279; Belyakov IM, 2003, P NATL ACAD SCI USA, V100, P9458, DOI 10.1073/pnas.1233578100; Casey CG, 2005, JAMA-J AM MED ASSOC, V294, P2734, DOI 10.1001/jama.294.21.2734; Edghill-Smith Y, 2005, NAT MED, V11, P740, DOI 10.1038/nm1261; Empig C, 2006, VACCINE, V24, P3686, DOI 10.1016/j.vaccine.2005.03.029; Fenner F., 1988, SMALLPOX ITS ERADICA; Fulginiti VA, 2003, CLIN INFECT DIS, V37, P241, DOI 10.1086/375824; Halsell JS, 2003, JAMA-J AM MED ASSOC, V289, P3283, DOI 10.1001/jama.289.24.3283; Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917; Hashizume S., 1985, VACCINIA VIRUSES VEC, P87; Hatakeyama S, 2005, CLIN DIAGN LAB IMMUN, V12, P520, DOI 10.1128/CDLI.12.4.520-524.2005; Henderson DA, 1999, JAMA-J AM MED ASSOC, V281, P2127, DOI 10.1001/jama.281.22.2127; HIRAYAMA M, 1975, SMALLPOX VACCINATION; *JAP DEF AG, 2002, GUID SMALLP VACC; *JAP DEF AG, 2005, DEF JAP 2005; Kidokoro M, 2005, P NATL ACAD SCI USA, V102, P4152, DOI 10.1073/pnas.0406671102; Manischewitz J, 2003, J INFECT DIS, V188, P440, DOI 10.1086/376557; Morikawa S, 2005, J VIROL, V79, P11873, DOI 10.1128/JVI.79.18.11873-11891.2005; NEFF JM, 1967, NEW ENGL J MED, V276, P125, DOI 10.1056/NEJM196701192760301; Neff J, 2008, CLIN INFECT DIS, V46, pS258, DOI 10.1086/524749; Nishiura H, 2006, EPIDEMIOLOGY, V17, P576, DOI 10.1097/01.ede.0000229196.41862.c2; Orr N, 2004, J INFECT DIS, V190, P1295, DOI 10.1086/423851; Saijo M, 2006, J VIROL, V80, P5179, DOI 10.1128/JVI.02642-05; Sejvar JJ, 2005, JAMA-J AM MED ASSOC, V294, P2744, DOI 10.1001/jama.294.21.2744; SHINMURA Y, 2007, 55 ANN M JAP SOC VIR; *WHO ADV COMM VAR, 2007, REP 9 M NOV 29 30 GE; Yamaguchi M, 1975, RINSHO UIRUSU, V3, P269	31	47	48	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 11	2009	301	10					1025	1033		10.1001/jama.2009.289	http://dx.doi.org/10.1001/jama.2009.289			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	416OQ	19278946	Bronze			2022-12-01	WOS:000264015800026
J	Christensen, J; Pedersen, MG; Pedersen, CB; Sidenius, P; Olsen, J; Vestergaard, M				Christensen, Jakob; Pedersen, Marianne G.; Pedersen, Carsten B.; Sidenius, Per; Olsen, Jorn; Vestergaard, Mogens			Long-term risk of epilepsy after traumatic brain injury in children and young adults: a population-based cohort study	LANCET			English	Article							POSTTRAUMATIC EPILEPSY; PUBLIC-HEALTH; SEIZURES; EPIDEMIOLOGY; PREVENTION; DENMARK; DRUGS	Background The risk of epilepsy shortly after traumatic brain injury is high, but how long this high risk lasts is unknown. We aimed to assess the risk of epilepsy up to 10 years or longer after traumatic brain injury, taking into account sex, age, severity and family history. Methods We identified 1605 216 people born in Denmark (1977-2002) from the Civil Registration System. We obtained information on traumatic brain injury and epilepsy from the National Hospital Register and estimated relative risks (RR) with Poisson analyses. Findings Risk of epilepsy was increased after a mild brain injury (RR 2.22, 95% CI 2.07-2.38), severe brain injury (7.40, 6.16-8.89), and skull fracture (2.17, 1.73-2.71). The risk was increased more than 10 years after mild brain injury (1.51, 1.24-1.85), severe brain injury (4.29, 2.04-9.00), and skull fracture (2.06, 1.37-3.11). RR increased with age at mild and severe injury and was especially high among people older than 15 years of age with mild (3.51, 2.90-4.26) and severe (12.24, 8.52-17.57) injury. The risk was slightly higher in women (2.49, 2.25-2.76) than in men (2.01, 1.83-2.22). Patients with a family history of epilepsy had a notably high risk of epilepsy after mild (5.75, 4.56-7.27) and severe brain injury (10.09, 4.20-24.26). Interpretation The longlasting high risk of epilepsy after brain injury might provide a window for prevention of post-traumatic epilepsy. Funding Danish Research Agency, P A Messerschmidt and Wife's Foundation, Mrs Grethe Bonnelycke's Foundation.	[Christensen, Jakob; Sidenius, Per] Aarhus Univ Hosp, Dept Neurol, DK-8000 Aarhus C, Denmark; [Christensen, Jakob] Univ Aarhus, Dept Clin Pharmacol, DK-8000 Aarhus C, Denmark; [Pedersen, Marianne G.; Pedersen, Carsten B.] Univ Aarhus, Natl Ctr Register Based Res, DK-8000 Aarhus C, Denmark; [Olsen, Jorn] Univ Calif Los Angeles, Sch Publ Hlth, So Calif Injury Prevent Res Ctr, Los Angeles, CA 90024 USA; [Olsen, Jorn] Univ Aarhus, Inst Publ Hlth, Dept Epidemiol, Aarhus, Denmark; [Vestergaard, Mogens] Univ Aarhus, Inst Publ Hlth, Dept Gen Practice, Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University; University of California System; University of California Los Angeles; Aarhus University; Aarhus University	Christensen, J (corresponding author), Aarhus Univ Hosp, Dept Neurol, Norrebrogade 44, DK-8000 Aarhus C, Denmark.	jakob@farm.au.dk	Vestergaard, Mogens/M-9333-2014; Pedersen, Carsten Bøcker/B-8441-2013	Vestergaard, Mogens/0000-0001-8830-2174; Pedersen, Carsten Bøcker/0000-0003-2077-8533; Christensen, Jakob/0000-0002-9385-6435				Agrawal A, 2006, CLIN NEUROL NEUROSUR, V108, P433, DOI 10.1016/j.clineuro.2005.09.001; Andersen TF, 1999, DAN MED BULL, V46, P263; Angeleri F, 1999, EPILEPSIA, V40, P1222, DOI 10.1111/j.1528-1157.1999.tb00850.x; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; [Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; [Anonymous], 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1093/arclin/acp006, DOI 10.1097/00001199-199309000-00010]; Benardo LS, 2003, EPILEPSIA, V44, P27, DOI 10.1046/j.1528-1157.44.s10.2.x; Berkovic SF, 2006, TRENDS NEUROSCI, V29, P391, DOI 10.1016/j.tins.2006.05.009; Breslow N E, 1987, IARC Sci Publ, P1; BRESLOW NE, 1996, STAT APPL, V8, P23; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Christensen J, 2005, EPILEPSIA, V46, P956, DOI 10.1111/j.1528-1167.2005.51204.x; Christensen J, 2007, EPILEPSY RES, V76, P60, DOI 10.1016/j.eplepsyres.2007.06.012; Christensen J, 2007, EPILEPSY RES, V75, P162, DOI 10.1016/j.eplepsyres.2007.05.009; Clayton D., 1993, STAT MODELS EPIDEMIO; D'Ambrosio R, 2004, CURR OPIN NEUROL, V17, P731, DOI 10.1097/00019052-200412000-00014; *DAN NAT BOARD HLT, 1997, 1208 DAN NAT BOARD H; Engberg A, 1998, EUR J EPIDEMIOL, V14, P165, DOI 10.1023/A:1007492025190; Engberg A, 1995, Acta Neurol Scand Suppl, V164, P1; Engberg Aase Worsaae, 2007, Ugeskr Laeger, V169, P199; Engberg AW, 2001, EUR J EPIDEMIOL, V17, P437, DOI 10.1023/A:1013733107520; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Hewson Paul J, 2005, Traffic Inj Prev, V6, P127, DOI 10.1080/15389580590931590; Kjeldsen MJ, 2003, EPILEPSY RES, V55, P137, DOI 10.1016/S0920-1211(03)00117-7; Macpherson A., 2008, COCHRANE DB SYST REV, V3; Metting Z, 2007, LANCET NEUROL, V6, P699, DOI 10.1016/S1474-4422(07)70191-6; Pedersen CB, 2006, DAN MED BULL, V53, P441; PINNER M, KONSENSUSRAPPORT COM; Pitkanen A, 2006, J NEUROTRAUM, V23, P241, DOI 10.1089/neu.2006.23.241; ROBINSON DL, 2006, BRIT MED J, V332, P722; Rothman KJ, 1986, MODERN EPIDEMIOLOGY; Sun YL, 2006, EPIDEMIOLOGY, V17, P296, DOI 10.1097/01.ede.0000208478.47401.b6; Temkin NR, 2001, EPILEPSIA, V42, P515, DOI 10.1046/j.1528-1157.2001.28900.x; Thompson DC, 2000, COCHRANE DB SYST REV, V2; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Vestergaard M, 2007, AM J EPIDEMIOL, V165, P911, DOI 10.1093/aje/kwk086	37	228	237	2	33	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR-APR	2009	373	9669					1105	1110		10.1016/S0140-6736(09)60214-2	http://dx.doi.org/10.1016/S0140-6736(09)60214-2			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427IS	19233461				2022-12-01	WOS:000264773600031
J	Clevers, H				Clevers, Hans			Inflammatory Bowel Disease, Stress, and the Endoplasmic Reticulum	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							LINKS		[Clevers, Hans] Hubrecht Inst, Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	Clevers, H (corresponding author), Hubrecht Inst, Utrecht, Netherlands.				Agamyxis	Agamyxis	Dr. Clevers reports having an equity interest in Agamyxis. No potential conflict of interest relevant to this article was reported.	Bertolotti A, 2001, J CLIN INVEST, V107, P585, DOI 10.1172/JCI11476; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Lee AH, 2005, EMBO J, V24, P4368, DOI 10.1038/sj.emboj.7600903; Mathew CG, 2008, NAT REV GENET, V9, P9, DOI 10.1038/nrg2203; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199	5	13	15	1	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 12	2009	360	7					726	727		10.1056/NEJMcibr0809591	http://dx.doi.org/10.1056/NEJMcibr0809591			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	405YQ	19213688				2022-12-01	WOS:000263260500013
J	Leaver, M; Dominguez-Cuevas, P; Coxhead, JM; Daniel, RA; Errington, J				Leaver, M.; Dominguez-Cuevas, P.; Coxhead, J. M.; Daniel, R. A.; Errington, J.			Life without a wall or division machine in Bacillus subtilis	NATURE			English	Article							DIPHOSPHATE SYNTHASE ACTIVITY; STABLE L-FORM; ESCHERICHIA-COLI; CELL-DIVISION; PEPTIDOGLYCAN SYNTHESIS; GROWTH; SEQUENCE; GENOME; MREB; LICHENIFORMIS	The cell wall is an essential structure for virtually all bacteria, forming a tough outer shell that protects the cell from damage and osmotic lysis. It is the target of our best antibiotics. L- form strains are wall- deficient derivatives of common bacteria that have been studied for decades. However, they are difficult to generate and typically require growth for many generations on osmotically protective media with antibiotics or enzymes that kill walled forms. Despite their potential importance for understanding antibiotic resistance and pathogenesis, little is known about their basic cell biology or their means of propagation. We have developed a controllable system for generating L- forms in the highly tractable model bacterium Bacillus subtilis. Here, using genome sequencing, we identify a single point mutation that predisposes cells to grow without a wall. We show that propagation of L- forms does not require the normal FtsZ- dependent division machine but occurs by a remarkable extrusion- resolution mechanism. This novel form of propagation provides insights into how early forms of cellular life may have proliferated.	[Leaver, M.; Dominguez-Cuevas, P.; Daniel, R. A.; Errington, J.] Univ Newcastle, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Coxhead, J. M.] Univ Newcastle, Int Ctr Life, Inst Human Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Errington, J (corresponding author), Univ Newcastle, Inst Cell & Mol Biosci, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	jeff.errington@newcastle.ac.uk	Errington, Jeff/G-1832-2011; Daniel, Richard A./I-2850-2019; Leaver, Mark/GLR-0282-2022; Dominguez-Cuevas, Patricia/D-6608-2017	Errington, Jeff/0000-0002-6977-9388; Daniel, Richard A./0000-0002-6483-5897; Dominguez-Cuevas, Patricia/0000-0002-9343-091X	UK Biotechnology and Biological Sciences Research Council; EMBO Long-Term Fellowship	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO))	We thank D. Swan for assistance with bioinformatics; A. Danchin for providing unpublished sequence data; E. J. Allan for providing the L- form strain that sparked our interest; T. Davey and V. Thompson of the Electron Microscopy Research Service of Newcastle University for technical assistance with electron microscopy; S. Gruber for help with quantitative real time PCR; J.-W. Veening and H. Murray for supplying strains and advice; and D. Claessen, K. Gerdes, H. Murray and W. Vollmer for critical reading of the manuscript. M. L. was supported by the UK Biotechnology and Biological Sciences Research Council. P.D.-C. was supported by an EMBO Long-Term Fellowship.	ABHAYAWARDHANE Y, 1995, J BACTERIOL, V177, P765, DOI 10.1128/jb.177.3.765-773.1995; ALLAN EJ, 1991, J APPL BACTERIOL, V70, P339, DOI 10.1111/j.1365-2672.1991.tb02946.x; ALLAN EJ, ADV APPL MI IN PRESS; BEALL B, 1991, GENE DEV, V5, P447, DOI 10.1101/gad.5.3.447; BURMEISTER HR, 1968, J BACTERIOL, V95, P1857, DOI 10.1128/JB.95.5.1857-1861.1968; Claessen D, 2008, MOL MICROBIOL, V68, P1029, DOI 10.1111/j.1365-2958.2008.06210.x; DANIEL RA, 1993, J GEN MICROBIOL, V139, P361, DOI 10.1099/00221287-139-2-361; Domingue GJ, 1997, CLIN MICROBIOL REV, V10, P320, DOI 10.1128/CMR.10.2.320; Formstone A, 2005, MOL MICROBIOL, V55, P1646, DOI 10.1111/j.1365-2958.2005.04506.x; FUJISAKI S, 1990, J BIOCHEM-TOKYO, V108, P995, DOI 10.1093/oxfordjournals.jbchem.a123327; GILPIN RW, 1973, J BACTERIOL, V113, P486, DOI 10.1128/JB.113.1.486-499.1973; GILPIN RW, 1976, J BACTERIOL, V127, P1018, DOI 10.1128/JB.127.2.1018-1021.1976; Glockner FO, 2003, P NATL ACAD SCI USA, V100, P8298, DOI 10.1073/pnas.1431443100; Hanczyc MM, 2003, SCIENCE, V302, P618, DOI 10.1126/science.1089904; Holtje JV, 1998, MICROBIOL MOL BIOL R, V62, P181; Hosfield DJ, 2004, J BIOL CHEM, V279, P8526, DOI 10.1074/jbc.C300511200; JOLY A, 1993, J BIOL CHEM, V268, P26983; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; Joseleau-Petit D, 2007, J BACTERIOL, V189, P6512, DOI 10.1128/JB.00273-07; Kandler O, 1998, CELL MOL LIFE SCI, V54, P305, DOI 10.1007/s000180050156; King J R, 1970, J Bacteriol, V102, P196; Klieneberger E, 1935, J PATHOL BACTERIOL, V40, P93, DOI 10.1002/path.1700400108; Leaver M, 2005, MOL MICROBIOL, V57, P1196, DOI 10.1111/j.1365-2958.2005.04736.x; Margolin W, 2000, FEMS MICROBIOL REV, V24, P531, DOI 10.1016/S0168-6445(00)00038-3; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Moszer I, 2002, NUCLEIC ACIDS RES, V30, P62, DOI 10.1093/nar/30.1.62; Murray T, 1998, J BACTERIOL, V180, P4555, DOI 10.1128/JB.180.17.4555-4563.1998; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; ROGERS HJ, 1976, J BACTERIOL, V125, P556, DOI 10.1128/JB.125.2.556-564.1976; Rothfield L, 2005, NAT REV MICROBIOL, V3, P959, DOI 10.1038/nrmicro1290; Soufo HJD, 2003, CURR BIOL, V13, P1916, DOI 10.1016/j.cub.2003.10.024; Vicente M, 1998, CELL MOL LIFE SCI, V54, P317, DOI 10.1007/s000180050158; WARD JB, 1975, J BACTERIOL, V124, P668, DOI 10.1128/JB.124.2.668-678.1975; Weiss DS, 2004, MOL MICROBIOL, V54, P588, DOI 10.1111/j.1365-2958.2004.04283.x; WYRICK PB, 1973, J BACTERIOL, V116, P456, DOI 10.1128/JB.116.1.456-465.1973	35	193	195	2	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2009	457	7231					849	853		10.1038/nature07742	http://dx.doi.org/10.1038/nature07742			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406AF	19212404				2022-12-01	WOS:000263266700038
J	Losos, JB; Ricklefs, RE				Losos, Jonathan B.; Ricklefs, Robert E.			Adaptation and diversification on islands	NATURE			English	Review							SPECIES-AREA RELATIONSHIP; ADAPTIVE RADIATION; CHARACTER DISPLACEMENT; OCEANIC ISLAND; ECOLOGICAL SPECIATION; SYMPATRIC SPECIATION; MOLECULAR EVIDENCE; TERRESTRIAL FAUNA; DARWINS FINCHES; CANARY-ISLANDS	Charles Darwin's travels on HMS Beagle taught him that islands are an important source of evidence for evolution. Because many islands are young and have relatively few species, evolutionary adaptation and species proliferation are obvious and easy to study. In addition, the geographical isolation of many islands has allowed evolution to take its own course, free of influence from other areas, resulting in unusual faunas and floras, often unlike those found anywhere else. For these reasons, island research provides valuable insights into speciation and adaptive radiation, and into the relative importance of contingency and determinism in evolutionary diversification.	[Losos, Jonathan B.] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA; [Ricklefs, Robert E.] Univ Missouri, Dept Biol, St Louis, MO 63121 USA	Harvard University; University of Missouri System; University of Missouri Saint Louis	Losos, JB (corresponding author), Harvard Univ, Museum Comparat Zool, 26 Oxford St, Cambridge, MA 02138 USA.	jlosos@oeb.harvard.edu			National Science Foundation; National Geographic Society; Smithsonian Institution	National Science Foundation(National Science Foundation (NSF)); National Geographic Society(National Geographic Society); Smithsonian Institution(Smithsonian Institution)	For comments on drafts, we thank A. Berry, R. Gillespie, R. Glor, P. Grant, L. Harmon, C. Parent, T. Price, D. Schluter and R. Whittaker. The National Science Foundation, the National Geographic Society and the Smithsonian Institution have supported our research on island faunas. We are also grateful to numerous individuals and governmental institutions throughout the West Indies for logistical and other support in the field.	[Anonymous], NATURAL HIST MADAGAS; Berry A, 2008, NATURE, V453, P1188, DOI 10.1038/4531188a; BROWN JH, 1993, AM NAT, V142, P573, DOI 10.1086/285558; Brown P, 2004, NATURE, V431, P1055, DOI 10.1038/nature02999; Carlquist S., 2003, TARWEEDS SILVERSWORD; Carlquist S., 1974, ISLAND BIOL, DOI [10.5962/bhl.title.63768, DOI 10.5962/BHL.TITLE.63768]; CARSON HL, 1984, ANNU REV ECOL SYST, V15, P97, DOI 10.1146/annurev.es.15.110184.000525; Chiba S, 2004, J EVOLUTION BIOL, V17, P131, DOI 10.1046/j.1420-9101.2004.00639.x; Coyne JA, 2000, EVOLUTION, V54, P2166; DAMUTH J, 1993, NATURE, V365, P748, DOI 10.1038/365748a0; Darwin C., 1859, ORIGIN SPECIES MEANS; Darwin Charles, 1845, J RESEARCHES NATURAL, V2nd; DAUGHERTY CH, 1993, TRENDS ECOL EVOL, V8, P437, DOI 10.1016/0169-5347(93)90006-B; Dayan T, 2005, ECOL LETT, V8, P875, DOI 10.1111/j.1461-0248.2005.00791.x; DIAMOND JM, 1977, SYST ZOOL, V26, P263, DOI 10.2307/2412673; DIAMOND JM, 1990, ECOLOGICAL RESTORATI, P3; Douglas Pratt H., 2005, HAWAIIAN HONEYCREEPE; Emerson BC, 2005, EVOLUTION, V59, P586; FranciscoOrtega J, 1996, P NATL ACAD SCI USA, V93, P4085, DOI 10.1073/pnas.93.9.4085; Fryer G, 1996, ENVIRON BIOL FISH, V45, P109, DOI 10.1007/BF00005225; Gavrilets S, 2005, P NATL ACAD SCI USA, V102, P18040, DOI 10.1073/pnas.0506330102; Gavrilets S, 2007, MOL ECOL, V16, P2910, DOI 10.1111/j.1365-294X.2007.03304.x; Gifford ME, 2008, MOL PHYLOGENET EVOL, V49, P277, DOI 10.1016/j.ympev.2008.06.003; Gillespie R, 2004, SCIENCE, V303, P356, DOI 10.1126/science.1091875; Gillespie RG, 2008, PHILOS T R SOC B, V363, P3335, DOI 10.1098/rstb.2008.0124; Givnish Thomas J., 1997, P1; Givnish TJ, 2004, AM J BOT, V91, P228, DOI 10.3732/ajb.91.2.228; Goldberg J, 2008, PHILOS T R SOC B, V363, P3319, DOI 10.1098/rstb.2008.0114; Gould S.J., 1989, WONDERFUL LIFE; Grant, 2008, WHY SPECIES MULTIPLY; Grant PR, 2006, SCIENCE, V313, P224, DOI 10.1126/science.1128374; Grant PR, 2002, SCIENCE, V296, P707, DOI 10.1126/science.1070315; GRANT PR, THEORY ISLA IN PRESS; Heaney LR, 2000, GLOBAL ECOL BIOGEOGR, V9, P59, DOI 10.1046/j.1365-2699.2000.00163.x; Kambysellis Michael P., 1997, P475; Kirkendall LR, 2006, BIOL J LINN SOC, V89, P729, DOI 10.1111/j.1095-8312.2006.00698.x; Lack D., 1947, DARWINS FINCHES; Leigh EG, 2007, REV ECOL-TERRE VIE, V62, P105; Lomolino MV, 2005, J BIOGEOGR, V32, P1683, DOI 10.1111/j.1365-2699.2005.01314.x; Losos JB, 1998, SCIENCE, V279, P2115, DOI 10.1126/science.279.5359.2115; Losos JB, 2000, NATURE, V408, P847, DOI 10.1038/35048558; Losos JB, 2009, ORGANISM ENVIRON, V10, P1; LOSOS JB, THEORY ISLA IN PRESS; Losos JB, 2006, SCIENCE, V314, P1111, DOI 10.1126/science.1133584; Lovette IJ, 2002, P ROY SOC B-BIOL SCI, V269, P37, DOI 10.1098/rspb.2001.1789; MAC ARTHUR ROBERT H., 1967; Mayr E., 2001, BIRDS NO MELANESIA S; Mayr E, 1963, ANIMAL SPECIES EVOLU; Meimberg H, 2006, MOL PHYLOGENET EVOL, V41, P566, DOI 10.1016/j.ympev.2006.05.037; Meiri S, 2008, P ROY SOC B-BIOL SCI, V275, P141, DOI 10.1098/rspb.2007.1056; Morris SC, 2003, LIFES SOLUTION INEVI; Nicholson KE, 2005, J BIOGEOGR, V32, P929, DOI 10.1111/j.1365-2699.2004.01222.x; Otte D., 1989, P482; Parent CE, 2008, PHILOS T R SOC B, V363, P3347, DOI 10.1098/rstb.2008.0118; Parent CE, 2006, EVOLUTION, V60, P2311, DOI 10.1554/06-366.1; Rand A. S., 1969, Breviora, VNo. 319, P1; Ricklefs RE, 2004, AM NAT, V163, P227, DOI 10.1086/381002; Ricklefs RE, 2002, GLOBAL ECOL BIOGEOGR, V11, P353, DOI 10.1046/j.1466-822x.2002.00300.x; RICKLEFS RE, 1980, AUK, V97, P321; Rubinoff D, 2008, PHILOS T R SOC B, V363, P3459, DOI 10.1098/rstb.2008.0115; Ryan PG, 2007, SCIENCE, V315, P1420, DOI 10.1126/science.1138829; Savolainen V, 2006, NATURE, V441, P210, DOI 10.1038/nature04566; SCHLUTER D, 1990, AM NAT, V136, P560, DOI 10.1086/285115; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Shaw Kerry L., 1995, P39; SIMBERLOFF D, 1981, EVOLUTION, V35, P1206, DOI 10.1111/j.1558-5646.1981.tb04990.x; SLATKIN M, 1980, ECOLOGY, V61, P163, DOI 10.2307/1937166; Thorpe RS, 2008, PHILOS T R SOC B, V363, P3071, DOI 10.1098/rstb.2008.0077; WALLACE AR, 1881, ISLAND LIFE OR PHENO; Whittaker R.J., 2007, ISLAND BIOGEOGRAPHY; Whittaker RJ, 2008, J BIOGEOGR, V35, P977, DOI 10.1111/j.1365-2699.2008.01892.x; WIENS JA, 1991, ECOLOGY, V72, P479, DOI 10.2307/2937189; Williams E.E., 1983, P326; WILSON EO, 1959, EVOLUTION, V13, P122, DOI 10.2307/2405948; WILSON EO, 1961, AM NAT, V95, P169, DOI 10.1086/282174	75	594	610	11	372	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2009	457	7231					830	836		10.1038/nature07893	http://dx.doi.org/10.1038/nature07893			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406AF	19212401				2022-12-01	WOS:000263266700033
J	Scott, TF; Kowalski, BA; Sullivan, AC; Bowman, CN; McLeod, RR				Scott, Timothy F.; Kowalski, Benjamin A.; Sullivan, Amy C.; Bowman, Christopher N.; McLeod, Robert R.			Two-Color Single-Photon Photoinitiation and Photoinhibition for Subdiffraction Photolithography	SCIENCE			English	Article							2-PHOTON RADICAL-PHOTOINITIATOR; POLYMERIZATION; SYSTEM; PHOTOPOLYMERIZATION; BENZOSPIROPYRANS; MICROFABRICATION; LITHOGRAPHY; WAVELENGTH; RESOLUTION	Controlling and reducing the developed region initiated by photoexposure is one of the fundamental goals of optical lithography. Here, we demonstrate a two-color irradiation scheme whereby initiating species are generated by single-photon absorption at one wavelength while inhibiting species are generated by single-photon absorption at a second, independent wavelength. Co-irradiation at the second wavelength thus reduces the polymerization rate, delaying gelation of the material and facilitating enhanced spatial control over the polymerization. Appropriate overlapping of the two beams produces structures with both feature sizes and monomer conversions otherwise unobtainable with use of single- or two-photon absorption photopolymerization. Additionally, the generated inhibiting species rapidly recombine when irradiation with the second wavelength ceases, allowing for fast sequential exposures not limited by memory effects in the material and thus enabling fabrication of complex two- or three-dimensional structures.	[Kowalski, Benjamin A.; Sullivan, Amy C.; McLeod, Robert R.] Univ Colorado, Dept Elect & Comp Engn, Boulder, CO 80309 USA; [Scott, Timothy F.; Bowman, Christopher N.] Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	McLeod, RR (corresponding author), Univ Colorado, Dept Elect & Comp Engn, Boulder, CO 80309 USA.	robert.mcleod@colorado.edu	Scott, Timothy/AAV-5819-2021; Bowman, Christopher N/B-1490-2008; McLeod, Robert R/R-2569-2019	Scott, Timothy/0000-0002-5893-3140; Bowman, Christopher N/0000-0001-8458-7723; MCLEOD, ROBERT/0000-0001-6354-0168	NSF [IIP-0750506, IIP-0822695, ECS-0636650]; NIH [DE10959]; University of Colorado; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE010959, R29DE010959] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Colorado; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Supported by NSF programs IIP-0750506, IIP-0822695, and ECS-0636650, NIH grant DE10959, and the University of Colorado Innovative Seed Grant Program. A preliminary patent based on this technology has been filed by T.F.S., A.C.S., C.N.B., and R.R.M.	Arlt J, 2000, OPT LETT, V25, P191, DOI 10.1364/OL.25.000191; Cumpston BH, 1999, NATURE, V398, P51, DOI 10.1038/17989; Donnert G, 2006, P NATL ACAD SCI USA, V103, P11440, DOI 10.1073/pnas.0604965103; Flory PJ., 1953, PRINCIPLES POLYM CHE; Haske W, 2007, OPT EXPRESS, V15, P3426, DOI 10.1364/OE.15.003426; ICHIMURA K, 1988, J POLYM SCI POL LETT, V26, P185, DOI 10.1002/pol.1988.140260403; Kawata S, 2001, NATURE, V412, P697, DOI 10.1038/35089130; LEE SK, 1991, CHEM MATER, V3, P852, DOI 10.1021/cm00017a021; LEE SK, 1991, CHEM MATER, V3, P858, DOI 10.1021/cm00017a022; LOUGNOT DJ, 1988, J APPL PHYS, V63, P4841, DOI 10.1063/1.340477; Lovell LG, 2001, POLYMER, V42, P421, DOI 10.1016/S0032-3861(00)00386-4; SOH SK, 1982, J POLYM SCI POL CHEM, V20, P1299, DOI 10.1002/pol.1982.170200513; Strandwitz NC, 2008, J AM CHEM SOC, V130, P8280, DOI 10.1021/ja711295k; Sullivan AC, 2007, APPL OPTICS, V46, P295, DOI 10.1364/AO.46.000295; Sun HB, 2000, OPT LETT, V25, P1110, DOI 10.1364/OL.25.001110; Sun HB, 2004, ADV POLYM SCI, V170, P169, DOI 10.1007/b94405; Tanaka T, 2002, APPL PHYS LETT, V80, P312, DOI 10.1063/1.1432450	17	318	338	10	211	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 15	2009	324	5929					913	917		10.1126/science.1167610	http://dx.doi.org/10.1126/science.1167610			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	19359546				2022-12-01	WOS:000266048800031
J	Gao, B; Hu, JX; Stricker, S; Cheung, M; Ma, G; Law, KF; Witte, F; Briscoe, J; Mundlos, S; He, L; Cheah, KSE; Chan, D				Gao, Bo; Hu, Jianxin; Stricker, Sigmar; Cheung, Martin; Ma, Gang; Law, Kit Fong; Witte, Florian; Briscoe, James; Mundlos, Stefan; He, Lin; Cheah, Kathryn S. E.; Chan, Danny			A mutation in Ihh that causes digit abnormalities alters its signalling capacity and range	NATURE			English	Article							SONIC HEDGEHOG; INDIAN HEDGEHOG; ENDOCHONDRAL BONE; GROWTH-PLATE; EXPRESSION; GENE; DIFFERENTIATION; CARTILAGE; PROTEIN; EMBRYO	Brachydactyly type A1 (BDA1) was the first recorded disorder of the autosomal dominant Mendelian trait in humans, characterized by shortened or absent middle phalanges in digits. It is associated with heterozygous missense mutations in indian hedgehog (IHH)(1,2). Hedgehog proteins are important morphogens for a wide range of developmental processes(3,4). The capacity and range of signalling is thought to be regulated by its interaction with the receptor PTCH1 and antagonist HIP1. Here we show that a BDA1 mutation (E95K) in Ihh impairs the interaction of IHH with PTCH1 and HIP1. This is consistent with a recent paper showing that BDA1 mutations cluster in a calcium-binding site essential for the interaction with its receptor and cell-surface partners(5). Furthermore, we show that in a mouse model that recapitulates the E95K mutation, there is a change in the potency and range of signalling. The mice have digit abnormalities consistent with the human disorder.	[Gao, Bo; Hu, Jianxin; Cheung, Martin; Law, Kit Fong; Cheah, Kathryn S. E.; Chan, Danny] Univ Hong Kong, Dept Biochem, Hong Kong, Hong Kong, Peoples R China; [Gao, Bo; Hu, Jianxin; Ma, Gang; He, Lin] Shanghai Jiao Tong Univ, BioX Ctr, Shanghai 200030, Peoples R China; [Stricker, Sigmar; Witte, Florian; Mundlos, Stefan] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Stricker, Sigmar; Witte, Florian; Mundlos, Stefan] Charite Univ Med Berlin, Inst Med Genet, D-13353 Berlin, Germany; [Cheah, Kathryn S. E.; Chan, Danny] Univ Hong Kong, LKS Fac Med, Ctr Reprod Dev & Growth, Hong Kong, Hong Kong, Peoples R China; [Witte, Florian] Free Univ Berlin, Inst Chem Biochem, D-14195 Berlin, Germany; [Briscoe, James] Natl Inst Med Res, London NW7 1AA, England; [He, Lin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Shanghai 200031, Peoples R China; [He, Lin] Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China	University of Hong Kong; Shanghai Jiao Tong University; Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Hong Kong; Free University of Berlin; MRC National Institute for Medical Research; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Fudan University	Chan, D (corresponding author), Univ Hong Kong, Dept Biochem, Hong Kong, Hong Kong, Peoples R China.	helinhelin@gmail.com; chand@hkusua.hku.hk	Stricker, Sigmar/B-9169-2009; Gao, Bo/F-4688-2013; Mundlos, Stefan/ABH-9585-2020; Chan, Danny/C-4203-2009	Stricker, Sigmar/0000-0002-7174-5363; Chan, Danny/0000-0003-3824-5778; Gao, Bo/0000-0002-8684-5199; Mundlos, Stefan/0000-0002-9788-3166; Briscoe, James/0000-0002-1020-5240	Research Grants Council [N_HKU705/02, HKU2/02C]; University Grants Council of Hong Kong [AoE/M-04/04]; National Key Scientific Program [2007CB947300]; Medical Research Council [MC_U117560541] Funding Source: researchfish; MRC [MC_U117560541] Funding Source: UKRI	Research Grants Council(Hong Kong Research Grants Council); University Grants Council of Hong Kong; National Key Scientific Program; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the Research Grants Council and University Grants Council of Hong Kong (N_HKU705/02, HKU2/02C and AoE/M-04/04), and The National Key Scientific Program (2007CB947300). We thank P. Tam for suggestions and comments, P. Beachy and D. Leahy for sharing unpublished data, and K. Leung for blastocyst injections.	ADRA CN, 1987, GENE, V60, P65, DOI 10.1016/0378-1119(87)90214-9; Behringer R., 2003, MANIPULATING MOUSE E; BITGOOD MJ, 1995, DEV BIOL, V172, P126, DOI 10.1006/dbio.1995.0010; Briscoe J, 2001, MOL CELL, V7, P1279, DOI 10.1016/S1097-2765(01)00271-4; Cheung M, 2003, DEVELOPMENT, V130, P5681, DOI 10.1242/dev.00808; Chuang PT, 1999, NATURE, V397, P617, DOI 10.1038/17611; CROSSLEY PH, 1995, DEVELOPMENT, V121, P439; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Fuse N, 1999, P NATL ACAD SCI USA, V96, P10992, DOI 10.1073/pnas.96.20.10992; Gao B, 2001, NAT GENET, V28, P386, DOI 10.1038/ng577; Gong YQ, 1999, NAT GENET, V21, P302, DOI 10.1038/6821; Haaf T, 1996, BIOTECHNIQUES, V21, P1050; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Hellemans J, 2003, AM J HUM GENET, V72, P1040, DOI 10.1086/374318; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Mak KK, 2006, DEVELOPMENT, V133, P3695, DOI 10.1242/dev.02546; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lee K, 1996, ENDOCRINOLOGY, V137, P5109, DOI 10.1210/en.137.11.5109; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Logan M, 1998, METHODS, V14, P407, DOI 10.1006/meth.1998.0595; McCready ME, 2005, HUM GENET, V117, P285, DOI 10.1007/s00439-005-1289-9; McLellan JS, 2008, NATURE, V455, P979, DOI 10.1038/nature07358; MCLEOD MJ, 1980, TERATOLOGY, V22, P299, DOI 10.1002/tera.1420220306; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Mundlos S, 2000, METH MOL B, V136, P61; Niedermaier M, 2005, J CLIN INVEST, V115, P900, DOI 10.1172/JCI200523675; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Polinkovsky A, 1997, NAT GENET, V17, P18, DOI 10.1038/ng0997-18; Saha K, 2006, DEVELOPMENT, V133, P889, DOI 10.1242/dev.02254; Sanz-Ezquerro JJ, 2003, CURR BIOL, V13, P1830, DOI 10.1016/j.cub.2003.09.040; Schmahl J, 2000, DEVELOPMENT, V127, P65; Seemann P, 2005, J CLIN INVEST, V115, P2373, DOI 10.1172/JCI25118; Spater D, 2006, DEVELOPMENT, V133, P3039, DOI 10.1242/dev.02471; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; St-Jacques B, 1999, GENE DEV, V13, P2617; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Tenzen T, 2006, DEV CELL, V10, P647, DOI 10.1016/j.devcel.2006.04.004; Tsang KY, 2007, PLOS BIOL, V5, P568, DOI 10.1371/journal.pbio.0050044; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Wai AWK, 1998, DEV GENET, V22, P349, DOI 10.1002/(SICI)1520-6408(1998)22:4<349::AID-DVG5>3.0.CO;2-6; Wallis D, 2000, HUM MUTAT, V16, P99, DOI 10.1002/1098-1004(200008)16:2<99::AID-HUMU2>3.0.CO;2-0; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Zhu JJ, 2008, DEV CELL, V14, P624, DOI 10.1016/j.devcel.2008.01.008	44	70	78	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2009	458	7242					1196	U136		10.1038/nature07862	http://dx.doi.org/10.1038/nature07862			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441FL	19252479				2022-12-01	WOS:000265754600052
J	Lyras, D; O'Connor, JR; Howarth, PM; Sambol, SP; Carter, GP; Phumoonna, T; Poon, R; Adams, V; Vedantam, G; Johnson, S; Gerding, DN; Rood, JI				Lyras, Dena; O'Connor, Jennifer R.; Howarth, Pauline M.; Sambol, Susan P.; Carter, Glen P.; Phumoonna, Tongted; Poon, Rachael; Adams, Vicki; Vedantam, Gayatri; Johnson, Stuart; Gerding, Dale N.; Rood, Julian I.			Toxin B is essential for virulence of Clostridium difficile	NATURE			English	Article							ESCHERICHIA-COLI; EXPRESSION; HAMSTERS; DISEASE; SYSTEM; STRAIN; INFECTION; EPIDEMIC	Clostridium difficile is the leading cause of infectious diarrhoea in hospitals worldwide, because of its virulence, spore-forming ability and persistence(1,2). C. difficile-associated diseases are induced by antibiotic treatment or disruption of the normal gastrointestinal flora(3,4). Recently, morbidity and mortality resulting from C. difficile-associated diseases have increased significantly due to changes in the virulence of the causative strains and antibiotic usage patterns(1,2,5,6). Since 2002, epidemic toxinotype III NAP1/027 strains(1,2), which produce high levels of the major virulence factors, toxin A and toxin B, have emerged. These toxins have 63 % amino acid sequence similarity(7) and are members of the large clostridial glucosylating toxin family, which are monoglucosyltransferases that are pro-inflammatory, cytotoxic and enterotoxic in the human colon(8-10). Inside host cells, both toxins catalyse the transfer of glucose onto the Rho family of GTPases, leading to cell death(8,11). However, the role of these toxins in the context of a C. difficile infection is unknown. Here we describe the construction of isogenic tcdA and tcdB (encoding toxin A and B, respectively) mutants of a virulent C. difficile strain and their use in the hamster disease model to show that toxin B is a key virulence determinant. Previous studies showed that purified toxin A alone can induce most of the pathology observed after infection of hamsters with C. difficile(8,9,12) and that toxin B is not toxic in animals unless it is co-administered with toxin A, suggesting that the toxins act synergistically(12). Our work provides evidence that toxin B, not toxin A, is essential for virulence. Furthermore, it is clear that the importance of these toxins in the context of infection cannot be predicted exclusively from studies using purified toxins, reinforcing the importance of using the natural infection process to dissect the role of toxins in disease.	[Lyras, Dena; O'Connor, Jennifer R.; Howarth, Pauline M.; Carter, Glen P.; Phumoonna, Tongted; Poon, Rachael; Adams, Vicki; Rood, Julian I.] Monash Univ, Dept Microbiol, Australian Bacterial Pathogenesis Program, Clayton, Vic 3800, Australia; [Poon, Rachael; Rood, Julian I.] Monash Univ, Dept Microbiol, Australian Res Council, Ctr Excellence Struct & Funct Microbial Genom, Clayton, Vic 3800, Australia; [O'Connor, Jennifer R.; Sambol, Susan P.; Vedantam, Gayatri; Johnson, Stuart; Gerding, Dale N.] Hines VA Hosp, Med Serv, Hines, IL 60141 USA; [O'Connor, Jennifer R.; Sambol, Susan P.; Vedantam, Gayatri; Johnson, Stuart; Gerding, Dale N.] Hines VA Hosp, Res Serv, Hines, IL 60141 USA; Loyola Univ, Stritch Sch Med, Infect Dis Sect, Maywood, IL 60153 USA	Monash University; Monash University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; Loyola University Chicago	Rood, JI (corresponding author), Monash Univ, Dept Microbiol, Australian Bacterial Pathogenesis Program, Clayton, Vic 3800, Australia.	julian.rood@med.monash.edu.au	Adams, Vicki/V-7077-2019; Rood, Julian I/A-4858-2008	Adams, Vicki/0000-0002-1506-1864; Rood, Julian I/0000-0003-2126-7209; Das, Tongted/0000-0002-5331-4420; Lyras, Dena/0000-0003-2345-9271; Carter, Glen/0000-0002-7306-9362; Johnson, Stuart/0000-0001-9548-229X	Australian National Health and Medical Research Council [284214]; ARC Centre of Excellence in Structural and Functional Microbial Genomics; United States National Institute of Allergy and Infectious Diseases [AIO57637]; United States Department of Veterans Affairs Research Service; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057637] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); ARC Centre of Excellence in Structural and Functional Microbial Genomics(Australian Research Council); United States National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); United States Department of Veterans Affairs Research Service(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research at Monash University was supported by Program Grant 284214 from the Australian National Health and Medical Research Council, funding from the ARC Centre of Excellence in Structural and Functional Microbial Genomics and grant AIO57637 from the United States National Institute of Allergy and Infectious Diseases. S.J., D.N.G., and G.V. were supported by Merit Review Grants from the United States Department of Veterans Affairs Research Service. We thank D. Lyerly, K. Aktories and C. von-Eichel Streiber for providing toxin-A-specific and toxin-B-specific antibodies, K. Nagaro and A. Cheknis for assistance with the hamster experiments, V.K. Viswanathan for providing intestinal epithelial cell lines, E. Hartland for providing the HT29 cell line, and M. Merrigan for adherence assays.	Bartlett JG, 2002, NEW ENGL J MED, V346, P334, DOI 10.1056/NEJMcp011603; BARTLETT JG, 1978, GASTROENTEROLOGY, V75, P778; Benson L, 2007, INFECT CONT HOSP EP, V28, P1233, DOI 10.1086/520732; Burger S, 2003, BIOCHEM BIOPH RES CO, V307, P584, DOI 10.1016/S0006-291X(03)01234-8; Carter GP, 2007, J BACTERIOL, V189, P7290, DOI 10.1128/JB.00731-07; CLABOTS CR, 1993, J CLIN MICROBIOL, V31, P1870, DOI 10.1128/JCM.31.7.1870-1875.1993; Dineen SS, 2007, MOL MICROBIOL, V66, P206, DOI 10.1111/j.1365-2958.2007.05906.x; Drudy D, 2007, INT J INFECT DIS, V11, P5, DOI 10.1016/j.ijid.2006.04.003; Du Tim, 2004, Can J Infect Dis, V15, P83; Giesemann T, 2006, J BIOL CHEM, V281, P10808, DOI 10.1074/jbc.M512720200; Heap JT, 2007, J MICROBIOL METH, V70, P452, DOI 10.1016/j.mimet.2007.05.021; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; Jank T, 2008, TRENDS MICROBIOL, V16, P222, DOI 10.1016/j.tim.2008.01.011; Johnson S, 2001, ANN INTERN MED, V135, P434, DOI 10.7326/0003-4819-135-6-200109180-00012; Just I, 2005, REV PHYSIOL BIOCH P, V152, P23, DOI 10.1007/s10254-004-0033-5; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; KIM PH, 1987, INFECT IMMUN, V55, P2984, DOI 10.1128/IAI.55.12.2984-2992.1987; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LYERLY DM, 1985, INFECT IMMUN, V47, P349, DOI 10.1128/IAI.47.2.349-352.1985; Lyras D, 2000, MOL MICROBIOL, V38, P588, DOI 10.1046/j.1365-2958.2000.02154.x; Lyras D, 1998, PLASMID, V39, P160, DOI 10.1006/plas.1997.1325; Mani N, 2002, J BACTERIOL, V184, P5971, DOI 10.1128/JB.184.21.5971-5978.2002; Matamouros S, 2007, MOL MICROBIOL, V64, P1274, DOI 10.1111/j.1365-2958.2007.05739.x; McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590; O'Brien JA, 2007, INFECT CONT HOSP EP, V28, P1219, DOI 10.1086/522676; O'Connor JR, 2006, MOL MICROBIOL, V61, P1335, DOI 10.1111/j.1365-2958.2006.05315.x; Razaq N, 2007, J INFECT DIS, V196, P1813, DOI 10.1086/523106; Redelings MD, 2007, EMERG INFECT DIS, V13, P1417, DOI 10.3201/eid1309.061116; Sambol SP, 2001, J INFECT DIS, V183, P1760, DOI 10.1086/320736; Sambrook JF., 2001, MOL CLONING LAB MANU; Schirmer J, 2004, BBA-GEN SUBJECTS, V1673, P66, DOI 10.1016/j.bbagen.2004.03.014; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; SMITH CJ, 1981, ANTIMICROB AGENTS CH, V19, P997, DOI 10.1128/AAC.19.6.997; Tang-Feldman YJ, 2002, MOL CELL PROBE, V16, P179, DOI 10.1006/mcpr.2002.0409; TORRES J, 1992, TOXICON, V30, P419, DOI 10.1016/0041-0101(92)90538-G; VONEICHELSTREIBER C, 1992, MOL GEN GENET, V233, P260, DOI 10.1007/BF00587587; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; Warny M, 2005, LANCET, V366, P1079, DOI 10.1016/S0140-6736(05)67420-X	38	534	572	2	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2009	458	7242					1176	1181		10.1038/nature07822	http://dx.doi.org/10.1038/nature07822			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441FL	19252482	Green Accepted			2022-12-01	WOS:000265754600055
J	Matsushita, K; Takeuchi, O; Standley, DM; Kumagai, Y; Kawagoe, T; Miyake, T; Satoh, T; Kato, H; Tsujimura, T; Nakamura, H; Akira, S				Matsushita, Kazufumi; Takeuchi, Osamu; Standley, Daron M.; Kumagai, Yutaro; Kawagoe, Tatsukata; Miyake, Tohru; Satoh, Takashi; Kato, Hiroki; Tsujimura, Tohru; Nakamura, Haruki; Akira, Shizuo			Zc3h12a is an RNase essential for controlling immune responses by regulating mRNA decay	NATURE			English	Article							AUTOIMMUNITY; RECOGNITION; ACTIVATION; CLEAVAGE; INNATE	Toll-like receptors (TLRs) recognize microbial components, and evoke inflammation and immune responses(1-3). TLR stimulation activates complex gene expression networks that regulate the magnitude and duration of the immune reaction. Here we identify the TLR-inducible gene Zc3h12a as an immune response modifier that has an essential role in preventing immune disorders. Zc3h12a-deficient mice suffered from severe anaemia, and most died within 12 weeks. Zc3h12a(-/-) mice also showed augmented serum immunoglobulin levels and autoantibody production, together with a greatly increased number of plasma cells, as well as infiltration of plasma cells to the lung. Most Zc3h12a(-/-) splenic T cells showed effector/memory characteristics and produced interferon-gamma in response to T-cell receptor stimulation. Macrophages from Zc3h12a (-/-) mice showed highly increased production of interleukin (IL)-6 and IL-12p40 (also known as IL12b), but not TNF, in response to TLR ligands. Although the activation of TLR signalling pathways was normal, Il6 messenger RNA decay was severely impaired in Zc3h12a (-/-) macrophages. Overexpression of Zc3h12a accelerated Il6 mRNA degradation via its 3'-untranslated region (UTR), and destabilized RNAs with 3'-UTRs for genes including Il6, Il12p40 and the calcitonin receptor gene Calcr. Zc3h12a contains a putative amino-terminal nuclease domain, and the expressed protein had RNase activity, consistent with a role in the decay of Il6 mRNA. Together, these results indicate that Zc3h12a is an essential RNase that prevents immune disorders by directly controlling the stability of a set of inflammatory genes.	[Matsushita, Kazufumi; Takeuchi, Osamu; Kumagai, Yutaro; Kawagoe, Tatsukata; Miyake, Tohru; Satoh, Takashi; Kato, Hiroki; Akira, Shizuo] Osaka Univ, Host Def Lab, Suita, Osaka 5650871, Japan; [Standley, Daron M.] Osaka Univ, Lab Syst Immunol, WPI Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan; [Matsushita, Kazufumi; Takeuchi, Osamu; Kumagai, Yutaro; Kawagoe, Tatsukata; Miyake, Tohru; Satoh, Takashi; Kato, Hiroki; Akira, Shizuo] Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; [Tsujimura, Tohru] Hyogo Coll Med, Dept Pathol, Nishinomiya, Hyogo 6638501, Japan; [Nakamura, Haruki] Osaka Univ, Inst Prot Res, Res Ctr Struct & Funct Prote, Suita, Osaka 5650871, Japan	Osaka University; Osaka University; Osaka University; Hyogo College of Medicine; Osaka University	Akira, S (corresponding author), Osaka Univ, Host Def Lab, 3-1 Yamada Oka, Suita, Osaka 5650871, Japan.	sakira@biken.osaka-u.ac.jp	Takeuchi, Osamu/AAG-9359-2019; Standley, Daron/D-2343-2009; Kumagai, Yutaro/L-7732-2018; Akira, Shizuo/C-3134-2009; Takeuchi, Osamu/D-6007-2011	Takeuchi, Osamu/0000-0002-1260-6232; Kumagai, Yutaro/0000-0002-5039-3979; Miyake, Toru/0000-0003-0947-0116	Japanese Ministry of Education, Culture, Sports, Science and Technology; Ministry of Health, Labour and Welfare in Japan; Global Center of Excellence Program of Japan; NIH [P01 AI070167]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI070167] Funding Source: NIH RePORTER	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare in Japan(Ministry of Health, Labour and Welfare, Japan); Global Center of Excellence Program of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank all colleagues in our laboratory, E. Kamada for secretarial assistance, and Y. Fujiwara, M. Kumagai and R. Abe for technical assistance. We thank S. Sato for discussions and W. Zhao and K. Kirkwood for plasmids. This work was supported by the Special Coordination Funds of the Japanese Ministry of Education, Culture, Sports, Science and Technology, grants from the Ministry of Health, Labour and Welfare in Japan, the Global Center of Excellence Program of Japan, and the NIH (P01 AI070167).	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Anderson P, 2008, NAT IMMUNOL, V9, P353, DOI 10.1038/ni1584; Barabino SML, 1997, GENE DEV, V11, P1703, DOI 10.1101/gad.11.13.1703; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Datta S, 2008, J IMMUNOL, V180, P2545, DOI 10.4049/jimmunol.180.4.2545; Feng M, 2004, NAT STRUCT MOL BIOL, V11, P450, DOI 10.1038/nsmb754; Fukuyama H, 2005, NAT IMMUNOL, V6, P99, DOI 10.1038/ni1151; Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583; Kawagoe T, 2008, NAT IMMUNOL, V9, P684, DOI 10.1038/ni.1606; Kinoshita K, 2004, BIOINFORMATICS, V20, P1329, DOI 10.1093/bioinformatics/bth073; Liang J, 2008, J BIOL CHEM, V283, P6337, DOI 10.1074/jbc.M707861200; Liang J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002880; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Miyoshi Keita, 2008, V442, P29, DOI 10.1007/978-1-59745-191-8_3; Paschoud S, 2006, MOL CELL BIOL, V26, P8228, DOI 10.1128/MCB.01155-06; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpps.20, 10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Yu D, 2007, NATURE, V450, P299, DOI 10.1038/nature06253; Zhao W, 2008, J BIOL CHEM, V283, P1778, DOI 10.1074/jbc.M707573200; Zhou LM, 2006, CIRC RES, V98, P1177, DOI 10.1161/01.RES.0000220106.64661.71	22	449	466	2	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2009	458	7242					1185	U124		10.1038/nature07924	http://dx.doi.org/10.1038/nature07924			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441FL	19322177				2022-12-01	WOS:000265754600050
J	Li, X; Cassidy, JJ; Reinke, CA; Fischboeck, S; Carthew, RW				Li, Xin; Cassidy, Justin J.; Reinke, Catherine A.; Fischboeck, Stephen; Carthew, Richard W.			A MicroRNA Imparts Robustness against Environmental Fluctuation during Development	CELL			English	Article							TRANSCRIPTIONAL REPRESSOR; SIGNAL INTEGRATION; NETWORK MOTIFS; TARGET GENES; NOTCH; CANALIZATION; EXPRESSION; FEEDBACK; RECEPTOR; DIFFERENTIATION	The microRNA miR-7 is perfectly conserved from annelids to humans, and yet some of the genes that it regulates in Drosophila are not regulated in mammals. We have explored the role of lineage restricted targets, using Drosophila, in order to better understand the evolutionary significance of microRNA-target relationships. From studies of two well characterized developmental regulatory networks, we find that miR-7 functions in several interlocking feedback and feedforward loops, and propose that its role in these networks is to buffer them against perturbation. To directly demonstrate this function for miR-7, we subjected the networks to temperature fluctuation and found that miR-7 is essential for the maintenance of regulatory stability under conditions of environmental flux. We suggest that some conserved microRNAs like miR-7 may enter into novel genetic relationships to buffer developmental programs against variation and impart robustness to diverse regulatory networks.	[Li, Xin; Cassidy, Justin J.; Reinke, Catherine A.; Fischboeck, Stephen; Carthew, Richard W.] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA	Northwestern University	Carthew, RW (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, 2205 Tech Dr, Evanston, IL 60208 USA.	r-carthew@northwestern.edu	Li, Xin/D-3421-2013	Li, Xin/0000-0002-3428-3569	Chicago Biomedical Consortium; Chicago Community Trust; NIH [GM077581]; Northwestern Vision Training Grant; CMDB Training; Malkin Scholars program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077581] Funding Source: NIH RePORTER	Chicago Biomedical Consortium; Chicago Community Trust; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Northwestern Vision Training Grant; CMDB Training; Malkin Scholars program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Bellen, S. Bray, C. Delidakis, S. Cohen, T. Hayashi, G. Mardon, and the Bloomington stock center for fly strains; N. Baker, H. Bellen, T. Hayashi, Z.C. Lai, and the Developmental Studies Hybridoma Bank for antibodies; T. Hayashi for sharing unpublished data; R. Gejman for advice and help with all stages of the informatic analysis; Carthew lab members and C. Labonne for discussions; the Biology Imaging Facility at Northwestern University for imaging. This work was supported by the by the Chicago Biomedical Consortium with support from The Searle Funds at The Chicago Community Trust, the NIH (GM077581), the Northwestern Vision Training Grant (C.A.R.), the CMDB Training Grant (J.J.C.), and the Malkin Scholars program.	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Barolo S, 2004, BIOTECHNIQUES, V36, P436, DOI 10.2144/04363ST03; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Cave JW, 2005, CURR BIOL, V15, P94, DOI 10.1016/j.cub.2004.12.070; Cooper MTD, 2000, DEV BIOL, V221, P390, DOI 10.1006/dbio.2000.9691; Correa-Medina M, 2009, GENE EXPR PATTERNS, V9, P193, DOI 10.1016/j.gep.2008.12.003; Flores GV, 2000, CELL, V103, P75, DOI 10.1016/S0092-8674(00)00106-9; Freeman M, 2000, NATURE, V408, P313, DOI 10.1038/35042500; Gibson G, 1996, SCIENCE, V271, P200, DOI 10.1126/science.271.5246.200; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; Hobert O, 2006, COLD SPRING HARB SYM, V71, P181, DOI 10.1101/sqb.2006.71.006; Hornstein E, 2006, NAT GENET, V38, pS20, DOI 10.1038/ng1803; Jafar-Nejad H, 2003, GENE DEV, V17, P2966, DOI 10.1101/gad.1122403; Jander U, 2002, ARTHROPOD STRUCT DEV, V30, P179, DOI 10.1016/S1467-8039(01)00035-4; JARMAN AP, 1994, NATURE, V369, P398, DOI 10.1038/369398a0; Joglekar MV, 2009, GENE EXPR PATTERNS, V9, P109, DOI 10.1016/j.gep.2008.10.001; Kefas B, 2008, CANCER RES, V68, P3566, DOI 10.1158/0008-5472.CAN-07-6639; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Lai EC, 2005, GENE DEV, V19, P1067, DOI 10.1101/gad.1291905; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Leaman D, 2005, CELL, V121, P1097, DOI 10.1016/j.cell.2005.04.016; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Li SH, 1997, CELL, V90, P469, DOI 10.1016/S0092-8674(00)80507-3; Li X, 2005, CELL, V123, P1267, DOI 10.1016/j.cell.2005.10.040; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Mangan S, 2003, J MOL BIOL, V334, P197, DOI 10.1016/j.jmb.2003.09.049; Martinez NJ, 2008, GENE DEV, V22, P2535, DOI 10.1101/gad.1678608; Meiklejohn CD, 2002, TRENDS ECOL EVOL, V17, P468, DOI 10.1016/S0169-5347(02)02596-X; Meir E, 2002, CURR BIOL, V12, P778, DOI 10.1016/S0960-9822(02)00839-4; Melen GJ, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100036; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Miska EA, 2007, PLOS GENET, V3, P2395, DOI 10.1371/journal.pgen.0030215; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Nakahara K, 2005, P NATL ACAD SCI USA, V102, P12023, DOI 10.1073/pnas.0500053102; Nellesen DT, 1999, DEV BIOL, V213, P33, DOI 10.1006/dbio.1999.9324; Powell LM, 2004, MOL CELL BIOL, V24, P9517, DOI 10.1128/MCB.24.21.9517-9526.2004; Prochnik SE, 2007, DEV GENES EVOL, V217, P73, DOI 10.1007/s00427-006-0116-1; Proulx SR, 2005, AM NAT, V165, P147, DOI 10.1086/426873; RENDEL J. M., 1960, AUSTRALIAN JOUR BIOL SCI, V13, P36; RENDEL JM, 1959, EVOLUTION, V13, P425, DOI 10.2307/2406126; Rohrbaugh M, 2002, CURR BIOL, V12, P576, DOI 10.1016/S0960-9822(02)00743-1; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Siegal ML, 2002, P NATL ACAD SCI USA, V99, P10528, DOI 10.1073/pnas.102303999; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Strausfeld N. J., 1981, HDB SENSORY PHYSL, VVII, P1; Tang AH, 1997, CELL, V90, P459, DOI 10.1016/S0092-8674(00)80506-1; Tessmar-Raible K, 2007, CELL, V129, P1389, DOI 10.1016/j.cell.2007.04.041; TREIER M, 1995, CELL, V83, P753, DOI 10.1016/0092-8674(95)90188-4; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; Voas MG, 2004, DEV DYNAM, V229, P162, DOI 10.1002/dvdy.10449; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; WADDINGTON CH, 1953, EVOLUTION, V7, P118, DOI 10.2307/2405747; Webster RJ, 2009, J BIOL CHEM, V284, P5731, DOI 10.1074/jbc.M804280200; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Xu CY, 2000, CELL, V103, P87, DOI 10.1016/S0092-8674(00)00107-0	60	349	364	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 17	2009	137	2					273	282		10.1016/j.cell.2009.01.058	http://dx.doi.org/10.1016/j.cell.2009.01.058			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	437AB	19379693	Green Accepted, Bronze, Green Submitted			2022-12-01	WOS:000265456800020
J	Armstrong, N; Vale, L; Deverill, M; Nabi, G; McClinton, S; N'Dow, J; Pickard, R				Armstrong, Nigel; Vale, Luke; Deverill, Mark; Nabi, Ghulam; McClinton, Samuel; N'Dow, James; Pickard, Robert		BPE Study Grp	Surgical treatments for men with benign prostatic enlargement: cost effectiveness study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TRANSURETHRAL MICROWAVE THERMOTHERAPY; URINARY-TRACT SYMPTOMS; PHOTOSELECTIVE VAPORIZATION; RANDOMIZED-TRIAL; HYPERPLASIA; PROSTATECTOMY; RESECTION; MORTALITY	Objective To determine which surgical treatment for lower urinary tract symptoms suggestive of benign prostate enlargement is cost effective. Design Care pathways describing credible treatment strategies were decided by consensus. Cost-utility analysis used Markov modelling and Monte Carlo simulation. Data sources Clinical effectiveness data came from a systematic review and an individual level dataset. Utility values came from previous economic evaluations. Costs were calculated from National Health Service (NHS) and commercial sources. Methods The Markov model included parameters with associated measures of uncertainty describing health states between which individuals might move at three monthly intervals over 10 years. Successive annual cohorts of 25 000 men were entered into the model and the probability that treatment strategies were cost effective was assessed with Monte Carlo simulation with 10 000 iterations. Results A treatment strategy of initial diathermy vaporisation of the prostate followed by endoscopic holmium laser enucleation of the prostate in case of failure to benefit or subsequent relapse had an 85% probability of being cost effective at a willingness to pay value of 20 pound 000 ((sic)21 595, $28 686)/quality adjusted life year (QALY) gained. Other strategies with diathermy vaporisation as the initial treatment were generally cheaper and more effective than the current standard of transurethral resection repeated once if necessary. The use of potassium titanyl phosphate laser vaporisation incurred higher costs and was less effective than transurethral resection, and strategies involving initial minimally invasive treatment with microwave thermotherapy were not cost effective. Findings were unchanged by wide ranging sensitivity analyses. Conclusion The outcome of this economic model should be interpreted cautiously because of the limitations of the data used. The finding that initial vaporisation followed by holmium laser enucleation for failure or relapse might be advantageous both to men with lower urinary tract symptoms and to healthcare providers requires confirmation in a good quality prospective clinical trial before any change in current practice. Potassium titanyl phosphate laser vaporisation was unlikely to be cost effective in our model, which argues against its unrestricted use until further evidence of effectiveness and cost reduction is obtained.	[Pickard, Robert] Univ Newcastle, Inst Cellular Med, Urol Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Armstrong, Nigel] Univ Newcastle, Inst Hlth & Soc, Newcastle Upon Tyne, Tyne & Wear, England; [Vale, Luke] Univ Aberdeen, Inst Appl Hlth Sci, Hlth Econ Res Unit, Aberdeen AB25 2ZD, Scotland; [Vale, Luke] Univ Aberdeen, Hlth Serv Res Unit, Aberdeen AB25 2ZD, Scotland; [Nabi, Ghulam; McClinton, Samuel; N'Dow, James] Univ Aberdeen, Inst Appl Hlth Sci, Acad Urol Unit, Aberdeen AB25 2ZD, Scotland	Newcastle University - UK; Newcastle University - UK; University of Aberdeen; University of Aberdeen; University of Aberdeen	Pickard, R (corresponding author), Univ Newcastle, Inst Cellular Med, Urol Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	r.s.pickard@ncl.ac.uk		Vale, Luke/0000-0001-8574-8429; Nabi, Ghulam/0000-0002-4864-9445	Health Technology Assessment Programme [04/38/03]; National Institute for Health Research [04/38/03] Funding Source: researchfish; Chief Scientist Office [HERU2, HSRU1, HERU1] Funding Source: researchfish	Health Technology Assessment Programme(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR)); Chief Scientist Office	This study was funded by the Health Technology Assessment Programme (project No 04/38/03). The views expressed in this paper are those of the authors not the institutions providing funding. An extensive monograph describing the whole project of which this analysis is a part is available for open access (Lourenco T, Armstrong N, N'Dow J, Nabi G, Deverill M, Pickard R, et al. Systematic review and economic modelling of effectiveness and cost utility of surgical treatments for men with benign prostatic enlargement. Health Technol Assess 2008; 12: 1516).	Ackerman SJ, 2000, UROLOGY, V56, P972, DOI 10.1016/S0090-4295(00)00828-1; Ades AE, 2004, MED DECIS MAKING, V24, P207, DOI 10.1177/0272989X04263162; *AM UR ASS, 2003, GUID MAN BEN PROST H; BARRY MJ, 1995, J UROLOGY, V154, P1770, DOI 10.1016/S0022-5347(01)66780-6; Blute M, 2000, UROLOGY, V56, P981, DOI 10.1016/S0090-4295(00)00829-3; Boyle P, 2003, BJU INT, V92, P409, DOI 10.1046/j.1464-410X.2003.04369.x; Briggs A., 2001, EC EVALUATION HLTH C; *DEP HLTH, 2005, NHS REF COSTS NHS TR; DiSantostefano RL, 2006, PHARMACOECONOMICS, V24, P171, DOI 10.2165/00019053-200624020-00006; Emberton M, 2003, UROLOGY, V61, P267, DOI 10.1016/S0090-4295(02)02371-3; Francisca EAE, 1999, J UROLOGY, V161, P486, DOI 10.1016/S0022-5347(01)61930-X; Harding C, 2007, EUR UROL, V52, P186, DOI 10.1016/j.eururo.2006.11.009; Horasanli K, 2008, UROLOGY, V71, P247, DOI 10.1016/j.urology.2007.09.017; HOWARD K, 2002, MSAC APPL, V1014; Kok ET, 2002, EUR UROL, V42, P491, DOI 10.1016/S0302-2838(02)00403-7; Lourenco T, 2008, HEALTH TECHNOL ASSES, V12, P1; Lourenco Tania, 2008, BMJ, V337, pa449, DOI 10.1136/bmj.39575.517674.BE; Lourenco T, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1662; Madersbacher S, 2005, EUR UROL, V47, P499, DOI 10.1016/j.eururo.2004.12.010; MEBUST WK, 1989, J UROLOGY, V141, P243, DOI 10.1016/S0022-5347(17)40731-2; *NIH CLIN EXC, GUID MAN 2007; Noble SM, 2002, J UROLOGY, V168, P2476, DOI 10.1016/S0022-5347(05)64172-9; Norby B, 2002, SCAND J UROL NEPHROL, V36, P286, DOI 10.1080/003655902320248263; SEAGROATT V, 1995, LANCET, V346, P1521, DOI 10.1016/S0140-6736(95)92052-8; Stafinski T, 2008, CUAJ-CAN UROL ASSOC, V2, P124; Stovsky MD, 2006, J UROLOGY, V176, P1500, DOI 10.1016/j.juro.2006.06.064; Tooher R, 2004, J UROLOGY, V171, P1773, DOI 10.1097/01.ju.0000113494.03668.6d; WASSON JH, 1995, NEW ENGL J MED, V332, P75, DOI 10.1056/NEJM199501123320202; Watson V, 2004, J UROLOGY, V172, P2321, DOI 10.1097/01.ju.0000140957.31325.7f	29	16	17	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 16	2009	338								b1288	10.1136/bmj.b1288	http://dx.doi.org/10.1136/bmj.b1288			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	434TK	19372131	Green Published, Green Submitted, hybrid			2022-12-01	WOS:000265296800003
J	Hoge, CW; Goldberg, HM; Castro, CA				Hoge, Charles W.; Goldberg, Herb M.; Castro, Carl A.			Care of War Veterans with Mild Traumatic Brain Injury - Flawed Perspectives	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Hoge, Charles W.] Walter Reed Army Inst Res, Div Psychiat & Neurosci, Silver Spring, MD USA; [Goldberg, Herb M.] Walter Reed Army Inst Res, Battlemind Training Off, Silver Spring, MD USA; [Castro, Carl A.] USA, Med Res & Mat Command, Mil Operat Med Res Program, Ft Detrick, MD USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Hoge, CW (corresponding author), Walter Reed Army Inst Res, Div Psychiat & Neurosci, Silver Spring, MD USA.							Cernak I, 1999, J TRAUMA, V47, P96, DOI 10.1097/00005373-199907000-00021; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; McCrea M., 2008, MILD TRAUMATIC BRAIN; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8	5	200	202	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 16	2009	360	16					1588	1591		10.1056/NEJMp0810606	http://dx.doi.org/10.1056/NEJMp0810606			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	433BH	19369664				2022-12-01	WOS:000265178000002
J	Schneider, MC; Prosser, BE; Caesar, JJE; Kugelberg, E; Li, S; Zhang, Q; Quoraishi, S; Lovett, JE; Deane, JE; Sim, RB; Roversi, P; Johnson, S; Tang, CM; Lea, SM				Schneider, Muriel C.; Prosser, Beverly E.; Caesar, Joseph J. E.; Kugelberg, Elisabeth; Li, Su; Zhang, Qian; Quoraishi, Sadik; Lovett, Janet E.; Deane, Janet E.; Sim, Robert B.; Roversi, Pietro; Johnson, Steven; Tang, Christoph M.; Lea, Susan M.			Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates	NATURE			English	Article							MACULAR DEGENERATION; MENINGOCOCCAL DISEASE; ALTERNATIVE PATHWAY; MAXIMUM-LIKELIHOOD; COMPLEMENT; BINDING; LIPOPROTEIN; ANTIBODIES; GNA1870; REFINEMENT	The complement system is an essential component of the innate and acquired immune system(1), and consists of a series of proteolytic cascades that are initiated by the presence of microorganisms. In health, activation of complement is precisely controlled through membrane-bound and soluble plasma-regulatory proteins including complement factor H (fH; ref.2), a 155 kDa protein composed of 20 domains (termed complement control protein repeats). Many pathogens have evolved the ability to avoid immune-killing by recruiting host complement regulators(3) and several pathogens have adapted to avoid complement-mediated killing by sequestering fH to their surface(4). Here we present the structure of a complement regulator in complex with its pathogen surface-protein ligand. This reveals how the important human pathogen Neisseria meningitidis subverts immune responses by mimicking the host, using protein instead of charged-carbohydrate chemistry to recruit the host complement regulator, fH. The structure also indicates the molecular basis of the host-specificity of the interaction between fH and the meningococcus, and informs attempts to develop novel therapeutics and vaccines.	[Prosser, Beverly E.; Caesar, Joseph J. E.; Quoraishi, Sadik; Lovett, Janet E.; Deane, Janet E.; Roversi, Pietro; Johnson, Steven; Lea, Susan M.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Schneider, Muriel C.; Kugelberg, Elisabeth; Li, Su; Zhang, Qian; Tang, Christoph M.] Univ London Imperial Coll Sci Technol & Med, Ctr Mol Microbiol & Infect, London SW7 2AZ, England; [Sim, Robert B.] Univ Oxford, Dept Biochem, MRC, Immunochem Unit, Oxford OX1 3QU, England	University of Oxford; Imperial College London; University of Oxford	Lea, SM (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	c.tang@imperial.ac.uk; susan.lea@path.ox.ac.uk	Roversi, Pietro/AAK-4241-2021; Johnson, Steven J/F-9182-2016; Sim, Bob/A-1354-2008; Tuluc, Petronel/C-2527-2011; Roversi, Pietro/F-8925-2011; Lea, Susan M/B-7678-2009	Roversi, Pietro/0000-0001-9280-9437; Johnson, Steven J/0000-0002-7877-3543; Sim, Bob/0000-0002-2855-7455; Roversi, Pietro/0000-0001-9280-9437; Lea, Susan M/0000-0001-9287-8053; Lovett, Janet Eleanor/0000-0002-3561-450X; Kugelberg, Elisabeth/0000-0002-8302-3595; Deane, Janet/0000-0002-4863-0330	Wellcome Trust; Medical Research Council; Engineering and Physical Sciences Research; EMBO; MRC [G0601195, G0500367, G0400775] Funding Source: UKRI; Medical Research Council [G0601195, G0400775, G0500367] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EMBO(European Molecular Biology Organization (EMBO)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Thanks are due to G. Bricogne and the Global Phasing Consortium for access to a beta version of autoSHARP and autoBUSTER, to the beamline staff of the European Synchrotron Radiation Source (particularly G. Leonard) and DIAMOND (UK), and to many members of the Laboratory of Molecular Biophysics, Oxford, and the Lea group for help with X-ray data collection. B. E. P. was funded by a Wellcome Trust studentship; P. R. and S. J. by Medical Research Council grants to S. M. L.; J. E. D. by a Wellcome Trust grant to SM.L.; and J. E. L. by an Engineering and Physical Sciences Research Grant to S. M. L. Work in C. M. T.'s laboratory is funded by the Wellcome Trust and the Medical Research Council. E. K. is an EMBO fellow.	Bahar M, 2006, ACTA CRYSTALLOGR D, V62, P1170, DOI 10.1107/S0907444906032197; Beernink PT, 2008, INFECT IMMUN, V76, P2568, DOI 10.1128/IAI.00033-08; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Cantini F, 2006, J BIOL CHEM, V281, P7220, DOI 10.1074/jbc.M508595200; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P487, DOI 10.1107/S0907444997011980; DAVIES DR, 1990, ANNU REV BIOCHEM, V59, P439, DOI 10.1146/annurev.biochem.59.1.439; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P. R., 1993, P CCP4 STUD WEEK DAT, P114; Feavers IM, 2000, NATURE, V404, P451, DOI 10.1038/35006546; Fedtke I, 2004, INT J MED MICROBIOL, V294, P189, DOI 10.1016/j.ijmm.2004.06.016; Fletcher LD, 2004, INFECT IMMUN, V72, P2088, DOI 10.1128/IAI.72.4.2088-2100.2004; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Giuliani MM, 2005, INFECT IMMUN, V73, P1151, DOI 10.1128/IAI.73.2.1151-1160.2005; Granoff DM, 2009, INFECT IMMUN, V77, P764, DOI 10.1128/IAI.01191-08; Gray SJ, 2006, J MED MICROBIOL, V55, P887, DOI 10.1099/jmm.0.46288-0; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Haralambous E, 2006, SCAND J INFECT DIS, V38, P764, DOI 10.1080/00365540600643203; Harrison LH, 2006, CLIN MICROBIOL REV, V19, P142, DOI 10.1128/CMR.19.1.142-164.2006; Heckenberg SGB, 2008, MEDICINE, V87, P185, DOI 10.1097/MD.0b013e318180a6b4; Jokiranta TS, 1996, FEBS LETT, V393, P297; Jozsi M, 2008, TRENDS IMMUNOL, V29, P380, DOI 10.1016/j.it.2008.04.008; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; LACHMANN PJ, 1990, BIOCHEM SOC T, V18, P1143, DOI 10.1042/bst0181143; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; Madico G, 2006, J IMMUNOL, V177, P501, DOI 10.4049/jimmunol.177.1.501; Masignani V, 2003, J EXP MED, V197, P789, DOI 10.1084/jem.20021911; MERI S, 1990, P NATL ACAD SCI USA, V87, P3982, DOI 10.1073/pnas.87.10.3982; Prosser BE, 2007, J EXP MED, V204, P2277, DOI 10.1084/jem.20071069; Prosser BE, 2007, ACTA CRYSTALLOGR F, V63, P480, DOI 10.1107/S1744309107020052; Schmidt CQ, 2008, J IMMUNOL, V181, P2610, DOI 10.4049/jimmunol.181.4.2610; Schneider MC, 2006, J IMMUNOL, V176, P7566, DOI 10.4049/jimmunol.176.12.7566; SIM E, 1983, BIOSCIENCE REP, V3, P1119, DOI 10.1007/BF01120205; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; Vagin AA, 2001, ACTA CRYSTALLOGR D, V57, P1451, DOI 10.1107/S0907444901012409; Winn MD, 2003, J SYNCHROTRON RADIAT, V10, P23, DOI 10.1107/S0909049502017235; Zipfel PF, 1999, IMMUNOPHARMACOLOGY, V42, P53, DOI 10.1016/S0162-3109(99)00015-6	40	252	285	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 16	2009	458	7240					890	U9		10.1038/nature07769	http://dx.doi.org/10.1038/nature07769			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433CS	19225461	Green Accepted			2022-12-01	WOS:000265182500043
J	Worden, AZ; Lee, JH; Mock, T; Rouze, P; Simmons, MP; Aerts, AL; Allen, AE; Cuvelier, ML; Derelle, E; Everett, MV; Foulon, E; Grimwood, J; Gundlach, H; Henrissat, B; Napoli, C; McDonald, SM; Parker, MS; Rombauts, S; Salamov, A; Von Dassow, P; Badger, JH; Coutinho, PM; Demir, E; Dubchak, I; Gentemann, C; Eikrem, W; Gready, JE; John, U; Lanier, W; Lindquist, EA; Lucas, S; Mayer, KFX; Moreau, H; Not, F; Otillar, R; Panaud, O; Pangilinan, J; Paulsen, I; Piegu, B; Poliakov, A; Robbens, S; Schmutz, J; Toulza, E; Wyss, T; Zelensky, A; Zhou, K; Armbrust, EV; Bhattacharya, D; Goodenough, UW; Van de Peer, Y; Grigoriev, IV				Worden, Alexandra Z.; Lee, Jae-Hyeok; Mock, Thomas; Rouze, Pierre; Simmons, Melinda P.; Aerts, Andrea L.; Allen, Andrew E.; Cuvelier, Marie L.; Derelle, Evelyne; Everett, Meredith V.; Foulon, Elodie; Grimwood, Jane; Gundlach, Heidrun; Henrissat, Bernard; Napoli, Carolyn; McDonald, Sarah M.; Parker, Micaela S.; Rombauts, Stephane; Salamov, Aasf; Von Dassow, Peter; Badger, Jonathan H.; Coutinho, Pedro M.; Demir, Elif; Dubchak, Inna; Gentemann, Chelle; Eikrem, Wenche; Gready, Jill E.; John, Uwe; Lanier, William; Lindquist, Erika A.; Lucas, Susan; Mayer, Klaus F. X.; Moreau, Herve; Not, Fabrice; Otillar, Robert; Panaud, Olivier; Pangilinan, Jasmyn; Paulsen, Ian; Piegu, Benoit; Poliakov, Aaron; Robbens, Steven; Schmutz, Jeremy; Toulza, Eve; Wyss, Tania; Zelensky, Alexander; Zhou, Kemin; Armbrust, E. Virginia; Bhattacharya, Debashish; Goodenough, Ursula W.; Van de Peer, Yves; Grigoriev, Igor V.			Green Evolution and Dynamic Adaptations Revealed by Genomes of the Marine Picoeukaryotes Micromonas	SCIENCE			English	Article							GENE-EXPRESSION; LAND PLANTS; ALGAE; CHLAMYDOMONAS; ENDOSYMBIOSIS; RIBOSWITCHES; PERSPECTIVE; METABOLISM; PROVIDES; ORIGIN	Picoeukaryotes are a taxonomically diverse group of organisms less than 2 micrometers in diameter. Photosynthetic marine picoeukaryotes in the genus Micromonas thrive in ecosystems ranging from tropical to polar and could serve as sentinel organisms for biogeochemical fluxes of modern oceans during climate change. These broadly distributed primary producers belong to an anciently diverged sister clade to land plants. Although Micromonas isolates have high 18S ribosomal RNA gene identity, we found that genomes from two isolates shared only 90% of their predicted genes. Their independent evolutionary paths were emphasized by distinct riboswitch arrangements as well as the discovery of intronic repeat elements in one isolate, and in metagenomic data, but not in other genomes. Divergence appears to have been facilitated by selection and acquisition processes that actively shape the repertoire of genes that are mutually exclusive between the two isolates differently than the core genes. Analyses of the Micromonas genomes offer valuable insights into ecological differentiation and the dynamic nature of early plant evolution.	[Worden, Alexandra Z.; Simmons, Melinda P.; Cuvelier, Marie L.; McDonald, Sarah M.; Demir, Elif] Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA; [Lee, Jae-Hyeok; Goodenough, Ursula W.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Mock, Thomas; Parker, Micaela S.; Armbrust, E. Virginia] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; [Rouze, Pierre; Rombauts, Stephane; Robbens, Steven; Van de Peer, Yves] Univ Ghent, Dept Plant Syst Biol, Flanders Inst Biotechnol VIB, B-9052 Ghent, Belgium; [Rouze, Pierre; Rombauts, Stephane; Robbens, Steven; Van de Peer, Yves] Univ Ghent, Dept Mol Genet, B-9052 Ghent, Belgium; [Aerts, Andrea L.; Grimwood, Jane; Salamov, Aasf; Dubchak, Inna; Lindquist, Erika A.; Lucas, Susan; Otillar, Robert; Pangilinan, Jasmyn; Poliakov, Aaron; Schmutz, Jeremy; Zhou, Kemin; Grigoriev, Igor V.] US DOE, JGI, Walnut Creek, CA 94598 USA; [Allen, Andrew E.; Badger, Jonathan H.] J Craig Venter Inst, San Diego, CA 92121 USA; [Cuvelier, Marie L.; Everett, Meredith V.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA; [Derelle, Evelyne] Univ Paris 06, CNRS, Observ Oceanol, F-66651 Banyuls Sur Mer, France; [Foulon, Elodie; Von Dassow, Peter; Not, Fabrice] Univ Paris 06, CNRS, Stn Biol Roscoff, Roscoff, France; [Grimwood, Jane; Mayer, Klaus F. X.; Schmutz, Jeremy] Stanford Univ, Sch Med, Stanford Human Genome Ctr, Palo Alto, CA 94304 USA; [Gundlach, Heidrun; Coutinho, Pedro M.] German Res Ctr Environm Hlth, Inst Bioinformat & Syst Biol, D-85764 Neuherberg, Germany; [Henrissat, Bernard] Univ Aix Marseille 1, F-13288 Marseille, France; [Henrissat, Bernard] Univ Aix Marseille 2, F-13288 Marseille, France; [Napoli, Carolyn] Univ Arizona, Inst Biol, Tucson, AZ 85719 USA; [Gentemann, Chelle] Remote Sensing Syst, Santa Rosa, CA 95401 USA; [Eikrem, Wenche] Univ Oslo, N-0316 Oslo, Norway; [Gready, Jill E.] Australian Natl Univ, Coll Med Biol & Environm, Div Mol Biosci, Canberra, ACT 2601, Australia; [John, Uwe] Alfred Wegener Inst Polar & Marine Res, D-27570 Bremerhaven, Germany; [Lanier, William; Bhattacharya, Debashish] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA; [Panaud, Olivier; Piegu, Benoit] Univ Perpignan, Lab Genome & Dev Plantes, F-66860 Perpignan, France; [Paulsen, Ian] Macquarie Univ, Dept Chem & Biomol Sci, N Ryde, NSW 2109, Australia; [Toulza, Eve] Univ Montpellier 2, F-34095 Montpellier 05, France; [Wyss, Tania] Univ Miami, Dept Biol, Miami, FL 33149 USA; [Zelensky, Alexander] Erasmus MC, Dept Genet, NL-3015 CE Rotterdam, Netherlands	Monterey Bay Aquarium Research Institute; Washington University (WUSTL); University of Washington; University of Washington Seattle; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; United States Department of Energy (DOE); Joint Genome Institute - JGI; J. Craig Venter Institute; University of Miami; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Stanford University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; University of Arizona; University of Oslo; Australian National University; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Iowa; Universite Perpignan Via Domitia; Macquarie University; Universite de Montpellier; University of Miami; Erasmus University Rotterdam; Erasmus MC	Worden, AZ (corresponding author), Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA.	azworden@mbari.org	Zelensky, Alexander/Y-7734-2018; Rombauts, Stephane M/D-7640-2014; Mock, Thomas/A-3127-2008; Allen, Andrew E/C-4896-2012; Grimwood, Jane/ABD-5737-2021; Zelensky, Alex/S-3162-2019; Schmutz, Jeremy/N-3173-2013; Van de Peer, Yves/AAE-7666-2019; Worden, Alexandra Z./AAD-6567-2019; Rombauts, Stephane/P-2420-2019; john, uwe/S-3009-2016; Paulsen, Ian T/K-3832-2012; Toulza, Eve/A-9919-2012; Mayer, Klaus FX/M-7941-2015; Van de Peer, Yves/D-4388-2009; Henrissat, Bernard/J-2475-2012; Zelensky, Alex/G-1201-2012; von Dassow, Peter/A-5399-2012	Zelensky, Alexander/0000-0003-3387-7346; Rombauts, Stephane M/0000-0002-3985-4981; Mock, Thomas/0000-0001-9604-0362; Allen, Andrew E/0000-0001-5911-6081; Zelensky, Alex/0000-0002-2664-271X; Schmutz, Jeremy/0000-0001-8062-9172; Van de Peer, Yves/0000-0003-4327-3730; Rombauts, Stephane/0000-0002-3985-4981; john, uwe/0000-0002-1297-4086; Paulsen, Ian T/0000-0001-9015-9418; Toulza, Eve/0000-0003-2049-2279; Mayer, Klaus FX/0000-0001-6484-1077; Van de Peer, Yves/0000-0003-4327-3730; Henrissat, Bernard/0000-0002-3434-8588; Zelensky, Alex/0000-0002-2664-271X; Grigoriev, Igor/0000-0002-3136-8903; Derelle, Evelyne/0000-0002-1499-4240; Gundlach, Heidrun/0000-0002-6757-0943; Gentemann, Chelle/0000-0002-2250-3106; Parker, Micaela/0000-0003-1007-4612; Worden, Alexandra/0000-0002-9888-9324; von Dassow, Peter/0000-0002-1858-1953	DOE Biological and Environmental Research Program [DE-AC02-05CH11231, DE-AC52-07NA27344, DE-AC02-06NA25396, DEFC02-99ER62873]; NSF Molecular and Cellular Biosciences (MCB) [0326829, 0429359]; Gordon and Betty Moore Foundation; Lucille and David Packard Foundation	DOE Biological and Environmental Research Program; NSF Molecular and Cellular Biosciences (MCB); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Lucille and David Packard Foundation	We thank the Culture Collection for Marine Phytoplankton and Roscoff Culture Collection for providing isolates, in particular F. LeGall, A. Houdan, and D. Vaulot. We also thank R. Gausling, C. Perle, Q. Ren, D. Root, L. Stal, J. Van Wye, T. Weissman, R.M. Welsh, and U. Wollenzien. F. Partensky, N. Simon, P. Deschamps, and S. Ball facilitated chloroplast and starch (29) annotations; C. Rancurel and B. Cantarel assisted with carbohydrate-active enzymes (with CNRS funding). We are grateful to S. Giovannoni for thoughtful criticism of the manuscript and overall enthusiasm. Genome sequencing was performed under the DOE Biological and Environmental Research Program contracts DE-AC02-05CH11231, DE-AC52-07NA27344, DE-AC02-06NA25396, and DEFC02-99ER62873. U.W.G. and J.-H.L. were funded by NSF Molecular and Cellular Biosciences (MCB) grant 0326829. Funding carrying the project from inception to completion was provided by a Young Investigator in Marine Microbiology award to A.Z.W. from the Gordon and Betty Moore Foundation with additional funds from NSF MCB grant 0429359 and the Lucille and David Packard Foundation. A.Z.W. coordinated the project and annotation; A.Z.W. and U.W.G. wrote the manuscript with input and sections from J.-H.L., T.M., P.R., and M.P.S. (joint second authors are listed in alphabetical order), and Y.V.P. and D.B. performed intellectually based editing to which S. Rombauts and M.S.P. contributed; I.V.G. coordinated the sequencing and analysis at JGI. A.L.A., A.E.A., M.L.C., E. Derelle, M.V.E., E.F., J.G., H.G., B.H., C.N., S.M.M., M.S.P., S. Rombauts, A.S., and P.V.D. also made substantial contributions (listed in alphabetical order). J.H.B. and A.E.A. constructed the phylogenomic analysis tool. A.Z.W., E.V.A., K.F.X.M., U.W.G., and Y.V.P. supervised analyses; A.Z.W. conceived the study with input from D.B., H.M., and E.V.A. All others contributed as members of the Micromonas genome consortium or JGI sequencing and are listed in alphabetical order. RCC299 and CCMP1545 assemblies and annotations are available at www.jgi.doe.gov/MicromonasRCC299 and www.jgi.doe.gov/MicromonasCCMP1545, respectively. Genome assemblies together with predicted gene models and annotations were deposited at DNA Data Bank of Japan/European Molecular Biology Laboratory/GenBank under the project accession numbers ACCO00000000 and ACCP00000000 for RCC299 and CCMP1545, respectively.	Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Cavalier-Smith T, 2000, TRENDS PLANT SCI, V5, P174, DOI 10.1016/S1360-1385(00)01598-3; Cheah MT, 2007, NATURE, V447, P497, DOI 10.1038/nature05769; Croft MT, 2007, P NATL ACAD SCI USA, V104, P20770, DOI 10.1073/pnas.0705786105; DellaPenna D, 2008, SCIENCE, V320, P479, DOI 10.1126/science.1153715; Derelle E, 2006, P NATL ACAD SCI USA, V103, P11647, DOI 10.1073/pnas.0604795103; Deschamps P, 2008, GENETICS, V178, P2373, DOI 10.1534/genetics.108.087205; Floyd SK, 2007, INT J PLANT SCI, V168, P1, DOI 10.1086/509079; Gaut BS, 2008, SCIENCE, V320, P484, DOI 10.1126/science.1153586; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; Goodenough U, 2007, SEMIN CELL DEV BIOL, V18, P350, DOI 10.1016/j.semcdb.2007.02.006; Hackett JD, 2007, MOL BIOL EVOL, V24, P1702, DOI 10.1093/molbev/msm089; Hall C, 2005, EUKARYOT CELL, V4, P1102, DOI 10.1128/EC.4.6.1102-1115.2005; KNIGHTJONES EW, 1951, NATURE, V167, P445, DOI 10.1038/167445a0; Lane CE, 2008, TRENDS ECOL EVOL, V23, P268, DOI 10.1016/j.tree.2008.02.004; Lee JH, 2007, PLANT PHYSIOL, V144, P1813, DOI 10.1104/pp.107.100891; Lewis LA, 2004, AM J BOT, V91, P1535, DOI 10.3732/ajb.91.10.1535; Lynch M., 2007, ORIGINS GENOME ARCHI; McFadden GI, 1999, CURR OPIN PLANT BIOL, V2, P513, DOI 10.1016/S1369-5266(99)00025-4; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Palenik B, 2007, P NATL ACAD SCI USA, V104, P7705, DOI 10.1073/pnas.0611046104; Reyes-Prieto A, 2007, ANNU REV GENET, V41, P147, DOI 10.1146/annurev.genet.41.110306.130134; Rocap G, 2003, NATURE, V424, P1042, DOI 10.1038/nature01947; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Wachter A, 2007, PLANT CELL, V19, P3437, DOI 10.1105/tpc.107.053645; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Worden A Z, 2008, MICROECOL OCEANS, V2, P159, DOI [10.1002/9780470281840.ch6, DOI 10.1002/9780470281840.CH6]; Worden AZ, 2006, AQUAT MICROB ECOL, V43, P165, DOI 10.3354/ame043165	28	470	774	3	163	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 10	2009	324	5924					268	272		10.1126/science.1167222	http://dx.doi.org/10.1126/science.1167222			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430WX	19359590	Green Submitted			2022-12-01	WOS:000265024400051
J	Jugdutt, BI				Jugdutt, Bodh I.			Limiting Fibrosis after Myocardial Infarction.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							FRIZZLED-RELATED PROTEIN-2		[Jugdutt, Bodh I.] Univ Alberta, Div Cardiol, Dept Med, Edmonton, AB, Canada; [Jugdutt, Bodh I.] Univ Alberta, Fac Med, Cardiovasc Res Grp, Edmonton, AB, Canada	University of Alberta; University of Alberta	Jugdutt, BI (corresponding author), Univ Alberta, Div Cardiol, Dept Med, Edmonton, AB, Canada.							Blankesteijn WM, 2001, ACTA PHYSIOL SCAND, V173, P75, DOI 10.1046/j.1365-201X.2001.00887.x; Frangogiannis NG, 2006, CURR MED CHEM, V13, P1877, DOI 10.2174/092986706777585086; Jugdutt BI, 2003, CIRCULATION, V108, P1395, DOI 10.1161/01.CIR.0000085658.98621.49; Kobayashi K, 2009, NAT CELL BIOL, V11, P46, DOI 10.1038/ncb1811; Mirotsou M, 2007, P NATL ACAD SCI USA, V104, P1643, DOI 10.1073/pnas.0610024104	5	21	24	1	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 9	2009	360	15					1567	1569		10.1056/NEJMcibr0810801	http://dx.doi.org/10.1056/NEJMcibr0810801			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	430GL	19357414				2022-12-01	WOS:000264976800017
J	Hagedorn, M; Rohde, KH; Russell, DG; Soldati, T				Hagedorn, Monica; Rohde, Kyle H.; Russell, David G.; Soldati, Thierry			Infection by Tubercular Mycobacteria Is Spread by Nonlytic Ejection from Their Amoeba Hosts	SCIENCE			English	Article							MARINUM; MACROPHAGES; VISUALIZATION; SECRETION; GRANULOMA; VIRULENCE	To generate efficient vaccines and cures for Mycobacterium tuberculosis, we need a far better understanding of its modes of infection, persistence, and spreading. Host cell entry and the establishment of a replication niche are well understood, but little is known about how tubercular mycobacteria exit host cells and disseminate the infection. Using the social amoeba Dictyostelium as a genetically tractable host for pathogenic mycobacteria, we discovered that M. tuberculosis and M. marinum, but not M. avium, are ejected from the cell through an actin-based structure, the ejectosome. This conserved nonlytic spreading mechanism requires a cytoskeleton regulator from the host and an intact mycobacterial ESX-1 secretion system. This insight offers new directions for research into the spreading of tubercular mycobacteria infections in mammalian cells.	[Hagedorn, Monica; Soldati, Thierry] Univ Geneva, Fac Sci, Dept Biochim, CH-1211 Geneva 4, Switzerland; [Rohde, Kyle H.; Russell, David G.] Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA	University of Geneva; Cornell University	Soldati, T (corresponding author), Univ Geneva, Fac Sci, Dept Biochim, Sci 2,30 Quai Ernest Ansermet, CH-1211 Geneva 4, Switzerland.	thierry.soldati@unige.ch	SOLDATI, Thierry/A-2902-2009; Russell, David G/N-5280-2019; SOLDATI, Thierry/U-6494-2019; Russell, David G/D-4533-2009	SOLDATI, Thierry/0000-0002-2056-7931; Russell, David G/0000-0002-9748-750X; SOLDATI, Thierry/0000-0002-2056-7931; Russell, David G/0000-0002-9748-750X	Swiss National Science Foundation; Swiss 3R Foundation; U.S. NIH [AI 067027, HL 055936]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055936] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067027] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss 3R Foundation; U.S. NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We gratefully acknowledge L. Ramakrishnan and C. Cosma for providing strains of M. marinum, various GFP expression vectors, and advice; G. Griffiths for GFP-expressing M. avium; B. C. VanderVen for providing GFP-expressing M. tuberculosis; F. Rivero and M. Maniak for providing Dictyostelium mutant strains; C. Bauer of the National Center of Competence in Research imaging platform for his help with microscopy; P. Walther and E. Schmid for their expert help with the SEM; and D. Soldati for critical reading of the manuscript. The work was supported by the Swiss National Science Foundation in the form of a grant to T.S. and an individual short-term fellowship to M.H. The T.S. group participates in the NEMO (nonmammalian experimental models for the study of bacterial infections) network supported by the Swiss 3R Foundation. D.G.R. and K.H.R. are supported by grants AI 067027 and HL 055936 from the U.S. NIH.	Abdallah AM, 2007, NAT REV MICROBIOL, V5, P883, DOI 10.1038/nrmicro1773; Boyer L, 2006, J CELL BIOL, V173, P809, DOI 10.1083/jcb.200509009; Byrd TF, 1998, INFECT IMMUN, V66, P5132, DOI 10.1128/IAI.66.11.5132-5139.1998; Carlsson F, 2006, J CELL PHYSIOL, V209, P288, DOI 10.1002/jcp.20721; Castro-Garza J, 2002, FEMS MICROBIOL LETT, V212, P145, DOI 10.1016/S0378-1097(02)00707-3; Chen GK, 2007, SCIENCE, V317, P678, DOI 10.1126/science.1143991; Chen MJ, 2006, J IMMUNOL, V176, P3707, DOI 10.4049/jimmunol.176.6.3707; Cosma CL, 2003, ANNU REV MICROBIOL, V57, P641, DOI 10.1146/annurev.micro.57.030502.091033; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; Davis JM, 2002, IMMUNITY, V17, P693, DOI 10.1016/S1074-7613(02)00475-2; Derrick SC, 2007, CELL MICROBIOL, V9, P1547, DOI 10.1111/j.1462-5822.2007.00892.x; Gao LY, 2004, MOL MICROBIOL, V53, P1677, DOI 10.1111/j.1365-2958.2004.04261.x; Lee E, 2002, TRAFFIC, V3, P186, DOI 10.1034/j.1600-0854.2002.030304.x; Mandato CA, 2001, J CELL BIOL, V154, P785, DOI 10.1083/jcb.200103105; Rohde KH, 2007, CELL HOST MICROBE, V2, P352, DOI 10.1016/j.chom.2007.09.006; Russell DG, 2007, NAT REV MICROBIOL, V5, P39, DOI 10.1038/nrmicro1538; Smith J, 2008, INFECT IMMUN, V76, P5478, DOI 10.1128/IAI.00614-08; Somesh BP, 2006, TRAFFIC, V7, P1194, DOI 10.1111/j.1600-0854.2006.00455.x; Stamm LA, 2004, MICROBES INFECT, V6, P1418, DOI 10.1016/j.micinf.2004.10.003; Stamm LM, 2005, P NATL ACAD SCI USA, V102, P14837, DOI 10.1073/pnas.0504663102; Stamm LM, 2003, J EXP MED, V198, P1361, DOI 10.1084/jem.20031072; Stinear TP, 2008, GENOME RES, V18, P729, DOI 10.1101/gr.075069.107; Tan T, 2006, CELL MICROBIOL, V8, P1417, DOI 10.1111/j.1462-5822.2006.00721.x; Tobin DM, 2008, CELL MICROBIOL, V10, P1027, DOI 10.1111/j.1462-5822.2008.01133.x; van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059; Volkman HE, 2004, PLOS BIOL, V2, P1946, DOI 10.1371/journal.pbio.0020367; ZIGMOND SH, 1993, CELL MOTIL CYTOSKEL, V25, P309, DOI 10.1002/cm.970250402	27	157	159	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2009	323	5922					1729	1733		10.1126/science.1169381	http://dx.doi.org/10.1126/science.1169381			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	424IG	19325115	Green Published, Green Accepted			2022-12-01	WOS:000264559800040
J	Shimoyama, T; Kato, S; Ishii, S; Watanabe, K				Shimoyama, Takefumi; Kato, Souichiro; Ishii, Shun'ichi; Watanabe, Kazuya			Flagellum Mediates Symbiosis	SCIENCE			English	Article									[Shimoyama, Takefumi; Kato, Souichiro; Ishii, Shun'ichi; Watanabe, Kazuya] Marine Biotechnol Inst, Lab Appl Microbiol, Kamaishi, Iwate 0260001, Japan; [Shimoyama, Takefumi; Watanabe, Kazuya] Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, Tokyo 1538904, Japan; [Kato, Souichiro; Watanabe, Kazuya] Japan Sci & Technol Agcy, Exploratory Res Adv Technol, Hashimoto Light Energy Convers Project, Bunkyo Ku, Tokyo 1138656, Japan; [Ishii, Shun'ichi] J Craig Venter Inst, San Diego, CA 92121 USA	University of Tokyo; Japan Science & Technology Agency (JST); J. Craig Venter Institute	Watanabe, K (corresponding author), Marine Biotechnol Inst, Lab Appl Microbiol, 3-75-1 Heita, Kamaishi, Iwate 0260001, Japan.	watanabe@light.t.u-tokyo.ac.jp	Albers, Pieter/I-2563-2017; Kato, Souichiro/M-4151-2018	Kato, Souichiro/0000-0002-2527-7730; Ishii, Shun'ichi/0000-0002-0203-8569	New Energy Development Organization of Japan; JST; Japan Society for Promotion of Science	New Energy Development Organization of Japan; JST(Japan Science & Technology Agency (JST)); Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank K. Nealson for the critical reading of the manuscript, T. Kosaka for microarray setup, and F. Numazaki and M. Sato for technical assistance. This work was supported by the New Energy Development Organization of Japan, JST, and the Japan Society for Promotion of Science.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Ishii S, 2005, APPL ENVIRON MICROB, V71, P7838, DOI 10.1128/AEM.71.12.7838-7845.2005; Keller L, 2006, NAT REV MICROBIOL, V4, P249, DOI 10.1038/nrmicro1383; Schink B, 1997, MICROBIOL MOL BIOL R, V61, P262, DOI 10.1128/.61.2.262-280.1997	4	88	97	1	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2009	323	5921					1574	1574		10.1126/science.1170086	http://dx.doi.org/10.1126/science.1170086			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421EN	19299611				2022-12-01	WOS:000264342300029
J	Meguid, T				Meguid, Tarek			Lack of political will is a clinical issue	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MATERNAL MORTALITY; SAFE MOTHERHOOD; HUMAN-RIGHTS; HEALTH; CARE; ACCESS		[Meguid, Tarek] Kamuzu Cent Hosp, Lilongwe, Malawi; [Meguid, Tarek] Bwaila Hosp, Lilongwe, Malawi		Meguid, T (corresponding author), Kamuzu Cent Hosp, Lilongwe, Malawi.	meguid@globemw.net		McAuliffe, Eilish/0000-0002-9714-5040				5Daniels N., 2008, JUST HLTH M HLTH NEE; AbouZahr C, 2003, BRIT MED BULL, V67, P13, DOI 10.1093/bmb/ldg014; ANDERSON T, 2005, ACTA OBSTET GYNECOL, V70, P679; BERGSTROM S, 2007, ACTA OBSTET GYNECOL, V84, P105; Bhutta ZA, 2000, BRIT MED J, V321, P809, DOI 10.1136/bmj.321.7264.809; Bristol N, 2008, LANCET, V371, P2162, DOI 10.1016/S0140-6736(08)60937-X; *BRIT MED ASS, 2001, MED PROF HUM RIGHTS; Centre on Housing Rights and Evictions, 2003, LIT EC SOC CULT RIGH; Cook RJ, 2006, INT J GYNECOL OBSTET, V94, P216, DOI 10.1016/j.ijgo.2006.04.009; EISENBERG L, 1984, AM J MED, V77, P524, DOI 10.1016/0002-9343(84)90114-1; Farmer Paul, 2008, Health Hum Rights, V10, P5; FATHALLA MF, 1997, OBSTET GYNECOLOGY WO; Filippi V, 2006, LANCET, V368, P1535, DOI 10.1016/S0140-6736(06)69384-7; Freedman LP, 2003, INT J GYNECOL OBSTET, V82, P111, DOI 10.1016/S0020-7292(03)00147-4; HELLMAN H, 2002, GREAT FEUDS MED; HERRING J, 2008, MED LAW ETHICS; Hogerzeil HV, 2006, LANCET, V368, P305, DOI 10.1016/S0140-6736(06)69076-4; Hurwitz B, 1997, BRIT MED J, V315, P1671, DOI 10.1136/bmj.315.7123.1671; Kassirer JP, 1998, NEW ENGL J MED, V339, P397, DOI 10.1056/NEJM199808063390608; Marmot M.W.R, 2006, SOCIAL DETERMINANTS; Meguid Tarek, 2007, Malawi Med J, V19, P9; Meguid Tarek, 2008, Health Hum Rights, V10, P105; Nour Nawal M, 2008, Rev Obstet Gynecol, V1, P77; Pond B, 2006, LANCET, V367, P1448, DOI 10.1016/S0140-6736(06)68346-3; Record R, 2006, GLOBALIZATION HEALTH, V2, DOI 10.1186/1744-8603-2-12; Rosato M, 2008, LANCET, V372, P962, DOI 10.1016/S0140-6736(08)61406-3; Rosenfield A, 2007, NEW ENGL J MED, V356, P1395, DOI 10.1056/NEJMp078026; Shiffman J, 2007, LANCET, V370, P1370, DOI 10.1016/S0140-6736(07)61579-7; Singer Peter, 2004, ETHICS ASSISTANCE MO; Starrs AM, 2006, LANCET, V368, P1130, DOI 10.1016/S0140-6736(06)69385-9; Tita ATN, 2007, OBSTET GYNECOL, V110, P972, DOI 10.1097/01.AOG.0000281668.71111.ea; UDOMBANA NJ, 2007, CASTING NET WIDER HU; Van Dillen J, 2006, ACTA OBSTET GYN SCAN, V85, P499, DOI 10.1080/00016340600555884; VANROOSMALEN J, 2008, ORATIE HOOGLERAARSCH; Weise S, 2007, AM J PHYS ANTHROPOL, P246; *WHO, MAT MORT RAT FALL TO; Winterton W R, 1980, Hist Med, V8, P11; WYKLICKY H, 1983, Infection Control (Thorofare), V4, P367; Yamin AE, 2005, HUM RIGHTS QUART, V27, P1200, DOI 10.1353/hrq.2005.0056; YAMIN AE, 2005, LEARNING DANCE ADV W	40	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 11	2009	338								b1013	10.1136/bmj.b1013	http://dx.doi.org/10.1136/bmj.b1013			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	419GA	19279055				2022-12-01	WOS:000264206100006
J	Ramamurthi, KS; Lecuyer, S; Stone, HA; Losick, R				Ramamurthi, Kumaran S.; Lecuyer, Sigolene; Stone, Howard A.; Losick, Richard			Geometric Cue for Protein Localization in a Bacterium	SCIENCE			English	Article							BACILLUS-SUBTILIS; SUBCELLULAR-LOCALIZATION; MEMBRANE; CURVATURE; SPORULATION; INHIBITOR	Proteins in bacteria often deploy to particular places within the cell, but the cues for localization are frequently mysterious. We found that the peripheral membrane protein SpoVM (VM) recognizes a geometric cue when localizing to a particular membrane during sporulation in Bacillus subtilis. Sporulation involves an inner cell maturing into a spore and an outer cell nurturing the developing spore. VM is produced in the outer cell, where it embeds in the membrane that surrounds the inner cell but not in the cytoplasmic membrane of the outer cell. We found that VM localized by discriminating between the positive curvature of the membrane surrounding the inner cell and the negative curvature of the cytoplasmic membrane. Membrane curvature could be a general cue for protein localization in bacteria.	[Ramamurthi, Kumaran S.; Losick, Richard] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Lecuyer, Sigolene; Stone, Howard A.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University	Losick, R (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	losick@mcb.harvard.edu	Ramamurthi, Kumaran/P-3516-2015; lecuyer, sigolene/E-7626-2012	lecuyer, sigolene/0000-0001-7393-2667	arvard Nanoscale Science and Engineering Center [Fulbright grant]; NIH [GM18568]; NATIONAL CANCER INSTITUTE [ZIABC011211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM018568, R01GM018568] Funding Source: NIH RePORTER	arvard Nanoscale Science and Engineering Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Gaudet, D. Rudner, C. Schmidt, L. Shapiro, R. Schekman, D. Weitz, and N. Wingreen for discussions and S. Lacefield, B. Scheid, and P. de Boer for advice. This work was supported by the Harvard Nanoscale Science and Engineering Center, a Fulbright grant to S.L., and NIH grant GM18568 to R.L.	BARLOW DJ, 1988, J MOL BIOL, V201, P601, DOI 10.1016/0022-2836(88)90641-9; Bendezu FO, 2008, J BACTERIOL, V190, P1792, DOI 10.1128/JB.01322-07; Bigay J, 2005, EMBO J, V24, P2244, DOI 10.1038/sj.emboj.7600714; Blaylock B, 2004, GENE DEV, V18, P2916, DOI 10.1101/gad.1252704; Eichenberger P, 2001, MOL MICROBIOL, V42, P1147, DOI 10.1046/j.1365-2958.2001.02660.x; GOULIAN M, 1993, EUROPHYS LETT, V22, P145, DOI 10.1209/0295-5075/22/2/012; Henriques AO, 2007, ANNU REV MICROBIOL, V61, P555, DOI 10.1146/annurev.micro.61.080706.093224; Huang KC, 2006, PLOS COMPUT BIOL, V2, P1357, DOI 10.1371/journal.pcbi.0020151; Kim KS, 1998, BIOPHYS J, V75, P2274, DOI 10.1016/S0006-3495(98)77672-6; Komeili A, 2006, SCIENCE, V311, P242, DOI 10.1126/science.1123231; Mackenzie C, 2007, ANNU REV MICROBIOL, V61, P283, DOI 10.1146/annurev.micro.61.080706.093402; Parthasarathy R, 2007, SOFT MATTER, V3, P24, DOI 10.1039/b608631d; Prajapati RS, 2000, BBA-GEN SUBJECTS, V1475, P353, DOI 10.1016/S0304-4165(00)00089-1; Ramamurthi KS, 2006, MOL MICROBIOL, V62, P1547, DOI 10.1111/j.1365-2958.2006.05468.x; Rudner DZ, 2002, P NATL ACAD SCI USA, V99, P8701, DOI 10.1073/pnas.132235899; Seeley ES, 2002, MOL BIOL CELL, V13, P782, DOI 10.1091/mbc.01-10-0512; van Ooij C, 2003, J BACTERIOL, V185, P1391, DOI 10.1128/JB.185.4.1391-1398.2003	17	162	163	2	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2009	323	5919					1354	1357		10.1126/science.1169218	http://dx.doi.org/10.1126/science.1169218			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414PC	19265022	Green Accepted			2022-12-01	WOS:000263876700045
J	Bennett, MR; Harris, JWK; Richmond, BG; Braun, DR; Mbua, E; Kiura, P; Olago, D; Kibunjia, M; Omuombo, C; Behrensmeyer, AK; Huddart, D; Gonzalez, S				Bennett, Matthew R.; Harris, John W. K.; Richmond, Brian G.; Braun, David R.; Mbua, Emma; Kiura, Purity; Olago, Daniel; Kibunjia, Mzalendo; Omuombo, Christine; Behrensmeyer, Anna K.; Huddart, David; Gonzalez, Silvia			Early Hominin Foot Morphology Based on 1.5-Million-Year-Old Footprints from Ileret, Kenya	SCIENCE			English	Article							TURKANA-BASIN; PLIOPLEISTOCENE HOMINIDS; LAKE TURKANA; KOOBI FORA; LAETOLI; AUSTRALOPITHECUS; CHIMPANZEE; BIPEDALISM; ETHIOPIA; WALKING	Hominin footprints offer evidence about gait and foot shape, but their scarcity, combined with an inadequate hominin fossil record, hampers research on the evolution of the human gait. Here, we report hominin footprints in two sedimentary layers dated at 1.51 to 1.53 million years ago (Ma) at Ileret, Kenya, providing the oldest evidence of an essentially modern human-like foot anatomy, with a relatively adducted hallux, medial longitudinal arch, and medial weight transfer before push-off. The size of the Ileret footprints is consistent with stature and body mass estimates for Homo ergaster/erectus, and these prints are also morphologically distinct from the 3.75-million-year-old footprints at Laetoli, Tanzania. The Ileret prints show that by 1.5 Ma, hominins had evolved an essentially modern human foot function and style of bipedal locomotion.	[Bennett, Matthew R.] Bournemouth Univ, Sch Conservat Sci, Poole BH12 5BB, Dorset, England; [Harris, John W. K.] Rutgers State Univ, Dept Anthropol, New Brunswick, NJ 08901 USA; [Richmond, Brian G.] George Washington Univ, Dept Anthropol, Ctr Adv Study Hominid Paleobiol, Washington, DC 20052 USA; [Richmond, Brian G.] Smithsonian Inst, Natl Museum Nat Hist, Human Origins Program, Washington, DC 20013 USA; [Braun, David R.] Univ Cape Town, Dept Archaeol, ZA-7701 Rondebosch, South Africa; [Mbua, Emma; Kiura, Purity; Kibunjia, Mzalendo] Natl Museums Kenya, Nairobi, Kenya; [Olago, Daniel; Omuombo, Christine] Univ Nairobi, Dept Geol, Nairobi, Kenya; [Behrensmeyer, Anna K.] Smithsonian Inst, Natl Museum Nat Hist, Dept Paleobiol, MRC 121, Washington, DC 20013 USA; [Huddart, David; Gonzalez, Silvia] Liverpool John Moores Univ, Sch Biol & Earth Sci, Liverpool L3 3AF, Merseyside, England	Bournemouth University; Rutgers State University New Brunswick; George Washington University; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Cape Town; University of Nairobi; Smithsonian Institution; Smithsonian National Museum of Natural History; Liverpool John Moores University	Bennett, MR (corresponding author), Bournemouth Univ, Sch Conservat Sci, Poole BH12 5BB, Dorset, England.	mbennett@bmth.ac.uk	Braun, David/C-9680-2009	Bennett, Matthew/0000-0002-3063-8844; Omuombo, Christine Atieno/0000-0003-3966-2610	Holt Family Foundation; Wenner-Gren Foundation for Anthropological Research; Natural Environment Research Council [NE/C519446/1] Funding Source: researchfish	Holt Family Foundation; Wenner-Gren Foundation for Anthropological Research; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This project is part of the Koobi Fora Research and Training Program, which is jointly run by the National Museum of Kenya and Rutgers University and supported by the Holt Family Foundation, M. Weiss, B. Mortenson, G. Noland, C. Chip, and the Wenner-Gren Foundation for Anthropological Research. B. Wood provided valuable comments on a draft of the paper, and the dating was undertaken by F. Brown. The field assistance of H. Manley, S. A. Morse, and M. J. Steele is acknowledged.	Allen JRL, 1997, PHILOS T ROY SOC B, V352, P481, DOI 10.1098/rstb.1997.0035; Anton SC, 2002, J HUM EVOL, V43, P773, DOI 10.1006/jhev.2002.0602; BEHRENSMEYER AK, 1981, NATURE, V289, P167, DOI 10.1038/289167a0; BRAUN DR, 2008, ARCHAEOMETRY, DOI DOI 10.1111/J.1475-4754.2008.00399; Brown FH, 2006, J GEOL SOC LONDON, V163, P185, DOI 10.1144/0016-764904-165; CHARTERIS J, 1982, AM J PHYS ANTHROPOL, V58, P133, DOI 10.1002/ajpa.1330580205; Elftman H, 1935, AM J PHYS ANTHROPOL, V20, P69, DOI 10.1002/ajpa.1330200109; FEIBEL CS, 1989, AM J PHYS ANTHROPOL, V78, P595, DOI 10.1002/ajpa.1330780412; Griffin N., 2006, HUMAN FOOT COMPANION, P27; Harris JWK, 2002, J HUM EVOL, V42, pA15; LEAKEY MD, 1979, NATURE, V278, P317, DOI 10.1038/278317a0; McHenry HM, 2000, ANNU REV ANTHROPOL, V29, P125, DOI 10.1146/annurev.anthro.29.1.125; Meldrum DJ, 2004, FROM BIPED TO STRIDER, P63; Morag E, 1999, J BIOMECH, V32, P359, DOI 10.1016/S0021-9290(98)00188-2; Pobiner BL, 2008, J HUM EVOL, V55, P103, DOI 10.1016/j.jhevol.2008.02.001; Pontzer H, 2007, J EXP BIOL, V210, P1752, DOI 10.1242/jeb.002246; Richmond BG, 2002, J HUM EVOL, V43, P529, DOI 10.1006/jhev.2002.0594; Richmond BG, 2008, SCIENCE, V319, P1662, DOI 10.1126/science.1154197; ROGERS MJ, 1994, J HUM EVOL, V27, P139, DOI 10.1006/jhev.1994.1039; Ruff Christopher B., 1993, P234; Sockol MD, 2007, P NATL ACAD SCI USA, V104, P12265, DOI 10.1073/pnas.0703267104; Spoor F, 2007, NATURE, V448, P688, DOI 10.1038/nature05986; STERN JT, 1983, AM J PHYS ANTHROPOL, V60, P279, DOI 10.1002/ajpa.1330600302; TUTTLE R, 1990, J ARCHAEOL SCI, V17, P347, DOI 10.1016/0305-4403(90)90028-4; Vereecke E, 2003, AM J PHYS ANTHROPOL, V120, P373, DOI 10.1002/ajpa.10163; Webb S, 2006, J HUM EVOL, V50, P405, DOI 10.1016/j.jhevol.2005.10.002; WHITE TD, 1987, AM J PHYS ANTHROPOL, V72, P485, DOI 10.1002/ajpa.1330720409	27	150	152	2	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 27	2009	323	5918					1197	1201		10.1126/science.1168132	http://dx.doi.org/10.1126/science.1168132			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	411XT	19251625				2022-12-01	WOS:000263687600034
J	Ventura, A; Jacks, T				Ventura, Andrea; Jacks, Tyler			MicroRNAs and Cancer: Short RNAs Go a Long Way	CELL			English	Article							MIR-17-92 CLUSTER; MIR-200 FAMILY; LET-7; EXPRESSION; GENE; MYC; ACTIVATION; SUPPRESSOR; PROFILES; PROLIFERATION	MicroRNAs (miRNAs) may be important regulators of gene expression. By modulating oncogenic and tumor suppressor pathways they could, in principle, contribute to tumorigenesis. Consistent with this hypothesis, recurrent genetic and epigenetic alterations of individual miRNAs are found in some tumors. Functional studies are now elucidating the mechanism of action of putative oncogenic and tumor suppressor miRNAs.	[Jacks, Tyler] MIT, Dept Biol, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Jacks, Tyler] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Ventura, Andrea] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA	Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Memorial Sloan Kettering Cancer Center	Jacks, T (corresponding author), MIT, Dept Biol, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	tjacks@mit.edu	Ventura, Andrea/F-1789-2011	Ventura, Andrea/0000-0003-4320-9907	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bonci D, 2008, NAT MED, V14, P1271, DOI 10.1038/nm.1880; Calin GA, 2006, ONCOGENE, V25, P6202, DOI 10.1038/sj.onc.1209910; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Dorsett Y, 2008, IMMUNITY, V28, P630, DOI 10.1016/j.immuni.2008.04.002; Egle A, 2004, P NATL ACAD SCI USA, V101, P6164, DOI 10.1073/pnas.0401471101; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; He L, 2007, NAT REV CANCER, V7, P819, DOI 10.1038/nrc2232; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kluiver J, 2006, LEUKEMIA, V20, P1931, DOI 10.1038/sj.leu.2404387; Kumar MS, 2008, P NATL ACAD SCI USA, V105, P3903, DOI 10.1073/pnas.0712321105; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu Y, 2007, DEV BIOL, V310, P442, DOI 10.1016/j.ydbio.2007.08.007; Ma L, 2008, TRENDS GENET, V24, P448, DOI 10.1016/j.tig.2008.06.004; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Medina PP, 2008, CELL CYCLE, V7, P2485, DOI 10.4161/cc.7.16.6453; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; O'Connell RM, 2008, J EXP MED, V205, P585, DOI 10.1084/jem.20072108; Ota A, 2004, CANCER RES, V64, P3087, DOI 10.1158/0008-5472.CAN-03-3773; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Raveche ES, 2007, BLOOD, V109, P5079, DOI 10.1182/blood-2007-02-071225; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Rosenfeld N, 2008, NAT BIOTECHNOL, V26, P462, DOI 10.1038/nbt1392; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Saito Y, 2006, CELL CYCLE, V5, P2220, DOI 10.4161/cc.5.19.3340; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Tam W, 1997, MOL CELL BIOL, V17, P1490, DOI 10.1128/MCB.17.3.1490; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Teng G, 2008, IMMUNITY, V28, P621, DOI 10.1016/j.immuni.2008.03.015; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054	50	750	794	0	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 20	2009	136	4					586	591		10.1016/j.cell.2009.02.005	http://dx.doi.org/10.1016/j.cell.2009.02.005			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	411XX	19239879	Bronze, Green Accepted, Green Published			2022-12-01	WOS:000263688200009
J	Gregg, EW; Albright, AL				Gregg, Edward W.; Albright, Ann L.			The Public Health Response to Diabetes-Two Steps Forward, One Step Back	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							UNITED-STATES; US; PREVENTION; DISEASE; ADULTS; TRENDS		[Gregg, Edward W.; Albright, Ann L.] Ctr Dis Control & Prevent, Div Diabet Translat, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA	Centers for Disease Control & Prevention - USA	Gregg, EW (corresponding author), Ctr Dis Control & Prevent, Div Diabet Translat, Natl Ctr Chron Dis Prevent & Hlth Promot, 4770 Buford Hwy NE,Mailstop K-10, Atlanta, GA 30341 USA.	edg7@cdc.gov		Gregg, Edward/0000-0003-2381-6822				Ackermann RT, 2008, AM J PREV MED, V35, P357, DOI 10.1016/j.amepre.2008.06.035; Anonymous, 2008, Morbidity and Mortality Weekly Report, V57, P1169; Burrows NR, 2008, ADV CHRONIC KIDNEY D, V15, P147, DOI 10.1053/j.ackd.2008.01.002; *CDCP, 2008, COUNT LEV EST DIAGN; *CDCP, 2009, DAT TRENDS DIAB SURV; Centers for Disease Control and Prevention, 2008, NAT DIAB SURV SYST; Colagiuri R, 2006, AM J PUBLIC HEALTH, V96, P1562, DOI 10.2105/AJPH.2005.067587; Cowie CC, 2009, DIABETES CARE, V32, P287, DOI 10.2337/dc08-1296; Hoerger TJ, 2008, DIABETES CARE, V31, P81, DOI 10.2337/dc07-1572; Imperatore G, 2004, AM J EPIDEMIOL, V160, P531, DOI 10.1093/aje/kwh232; KRUGER H, 2007, HLTH IMPACT SMOKING; Norris SL, 2002, AM J PREV MED, V22, P15, DOI 10.1016/S0749-3797(02)00423-3; Saaddine JB, 2006, ANN INTERN MED, V144, P465, DOI 10.7326/0003-4819-144-7-200604040-00005; Wang J, 2006, DIABETES CARE, V29, P2018, DOI 10.2337/dc06-0311; Wells H.F., 2008, EC INFORM B	15	24	25	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 15	2009	301	15					1596	1598		10.1001/jama.2009.519	http://dx.doi.org/10.1001/jama.2009.519			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	432MH	19366782				2022-12-01	WOS:000265137900033
J	Whitmer, RA; Karter, AJ; Yaffe, K; Quesenberry, CP; Selby, JV				Whitmer, Rachel A.; Karter, Andrew J.; Yaffe, Kristine; Quesenberry, Charles P., Jr.; Selby, Joseph V.			Hypoglycemic Episodes and Risk of Dementia in Older Patients With Type 2 Diabetes Mellitus	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							AMYLOID PRECURSOR PROTEIN; INSULIN-DEGRADING ENZYME; COGNITIVE FUNCTION; ALZHEIMERS-DISEASE; SYNAPTIC PLASTICITY; GLYCEMIC CONTROL; BLOOD-GLUCOSE; ET-AL; POPULATION; BRAIN	Context Although acute hypoglycemia may be associated with cognitive impairment in children with type 1 diabetes, no studies to date have evaluated whether hypoglycemia is a risk factor for dementia in older patients with type 2 diabetes. Objective To determine if hypoglycemic episodes severe enough to require hospitalization are associated with an increased risk of dementia in a population of older patients with type 2 diabetes followed up for 27 years. Design, Setting, and Patients A longitudinal cohort study from 1980-2007 of 16 667 patients with a mean age of 65 years and type 2 diabetes who are members of an integrated health care delivery system in northern California. Main Outcome Measure Hypoglycemic events from 1980-2002 were collected and reviewed using hospital discharge and emergency department diagnoses. Cohort members with no prior diagnoses of dementia, mild cognitive impairment, or general memory complaints as of January 1, 2003, were followed up for a dementia diagnosis through January 15, 2007. Dementia risk was examined using Cox proportional hazard regression models, adjusted for age, sex, race/ethnicity, education, body mass index, duration of diabetes, 7-year mean glycated hemoglobin, diabetes treatment, duration of insulin use, hyperlipidemia, hypertension, cardiovascular disease, stroke, transient cerebral ischemia, and end-stage renal disease. Results At least 1 episode of hypoglycemia was diagnosed in 1465 patients (8.8%) and dementia was diagnosed in 1822 patients (11%) during follow-up; 250 patients had both dementia and at least 1 episode of hypoglycemia (16.95%). Compared with patients with no hypoglycemia, patients with single or multiple episodes had a graded increase in risk with fully adjusted hazard ratios (HRs): for 1 episode (HR, 1.26; 95% confidence interval [CI], 1.10-1.49); 2 episodes (HR, 1.80; 95% CI, 1.37-2.36); and 3 or more episodes (HR, 1.94; 95% CI, 1.42-2.64). The attributable risk of dementia between individuals with and without a history of hypoglycemia was 2.39% per year (95% CI, 1.72%-3.01%). Results were not attenuated when medical utilization rates, length of health plan membership, or time since initial diabetes diagnosis were added to the model. When examining emergency department admissions for hypoglycemia for association with risk of dementia (535 episodes), results were similar (compared with patients with 0 episodes) with fully adjusted HRs: for 1 episode (HR, 1.42; 95% CI, 1.12-1.78) and for 2 or more episodes (HR, 2.36; 95% CI, 1.57-3.55). Conclusions Among older patients with type 2 diabetes, a history of severe hypoglycemic episodes was associated with a greater risk of dementia. Whether minor hypoglycemic episodes increase risk of dementia is unknown.	[Whitmer, Rachel A.; Karter, Andrew J.; Quesenberry, Charles P., Jr.; Selby, Joseph V.] Kaiser Permanente, Div Res, Sect Etiol & Prevent, Oakland, CA 94612 USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Neurol & Epidemiol, San Francisco, CA 94143 USA	Kaiser Permanente; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Whitmer, RA (corresponding author), Kaiser Permanente, Div Res, Sect Etiol & Prevent, 2000 Broadway, Oakland, CA 94612 USA.	raw@dor.kaiser.org			National Institutes of Health [DK066308, DK081796]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081796, K01DK066308] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K24AG031155] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding/Support: Dr Whitmer receives funding from the National Institutes of Health grants DK066308 and DK081796.	Allen KV, 2004, EUR J PHARMACOL, V490, P169, DOI 10.1016/j.ejphar.2004.02.054; Artola A, 2002, PROG BRAIN RES, V138, P305, DOI 10.1016/S0079-6123(02)38084-1; Biessels GJ, 2008, LANCET NEUROL, V7, P184, DOI 10.1016/S1474-4422(08)70021-8; Biessels GJ, 2006, LANCET NEUROL, V5, P64, DOI 10.1016/S1474-4422(05)70284-2; Chalmers J, 2007, J HYPERTENS, V25, pS23, DOI 10.1097/01.hjh.0000271506.69949.46; Cosway R, 2001, DIABETIC MED, V18, P803, DOI 10.1046/j.1464-5491.2001.00577.x; Craft S, 2005, NEUROBIOL AGING, V26, pS65, DOI 10.1016/j.neurobiolaging.2005.08.021; Craft S, 2000, ANN NY ACAD SCI, V903, P222, DOI 10.1111/j.1749-6632.2000.tb06371.x; Craft S, 2004, LANCET NEUROL, V3, P169, DOI 10.1016/S1474-4422(04)00681-7; Cryer PE, 2007, J CLIN INVEST, V117, P868, DOI 10.1172/JCI31669; Cryer PE, 2007, DIABETES CARE, V30, P190, DOI 10.2337/dc-06-1670; Cryer PE, 2009, J CLIN ENDOCR METAB, V94, P709, DOI 10.1210/jc.2008-1410; Cryer PE, 2008, DIABETES, V57, P3169, DOI 10.2337/db08-1084; Cukierman T, 2005, DIABETOLOGIA, V48, P2460, DOI 10.1007/s00125-005-0023-4; de la Monte SM, 2006, J ALZHEIMERS DIS, V10, P89; DEARY IJ, 1993, DIABETES, V42, P341, DOI 10.2337/diabetes.42.2.341; Deary IJ, 1996, BMJ-BRIT MED J, V313, P767; DRAELOS MT, 1995, AM J MED, V98, P135, DOI 10.1016/S0002-9343(99)80397-0; Ettner SL, 2009, HEALTH ECON, V18, P645, DOI 10.1002/hec.1394; Fanelli CG, 2004, DIABETES-METAB RES, V20, pS32, DOI 10.1002/dmrr.514; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Ginde Adit A, 2008, BMC Endocr Disord, V8, P4, DOI 10.1186/1472-6823-8-4; Gispen WH, 2000, TRENDS NEUROSCI, V23, P542, DOI 10.1016/S0166-2236(00)01656-8; Gordon N P, 1991, Adv Health Econ Health Serv Res, V12, P19; Haan MN, 2003, J AM GERIATR SOC, V51, P169, DOI 10.1046/j.1532-5415.2003.51054.x; HIATT RA, 1982, AM J PUBLIC HEALTH, V72, P829, DOI 10.2105/AJPH.72.8.829; Jacobson AM, 2007, NEW ENGL J MED, V356, P1842; JARJOUR IT, 1995, DIABETOLOGIA, V38, P1090, DOI 10.1007/s001250050396; Karter AJ, 2002, JAMA-J AM MED ASSOC, V287, P2519, DOI 10.1001/jama.287.19.2519; Karter AJ, 2004, DIABETES CARE, V27, P850, DOI 10.2337/diacare.27.3.850-a; Karter AJ, 2001, AM J MED, V111, P1, DOI 10.1016/S0002-9343(01)00742-2; KARTER AJ, 1997, DIABETES; Karter AJ, 1998, J REGISTRY MANAGEMEN, V25, P7; Karter AJ, 2008, AM J PUBLIC HEALTH, V98, P365, DOI 10.2105/AJPH.2005.083501; Karter Andrew J, 2006, Endocr Pract, V12 Suppl 1, P110; Karter AJ, 2006, DIABETES CARE, V29, P1757, DOI 10.2337/dc06-2073; Kaufman FR, 1999, J DIABETES COMPLICAT, V13, P31, DOI 10.1016/S1056-8727(98)00029-4; Klein JP, 2003, LANCET NEUROL, V2, P548, DOI 10.1016/S1474-4422(03)00503-9; KRIEGER N, 1992, AM J PUBLIC HEALTH, V82, P703, DOI 10.2105/AJPH.82.5.703; Kulstad JJ, 2005, J NEUROPATH EXP NEUR, V64, P139, DOI 10.1093/jnen/64.2.139; Launer Lenore J, 2005, Curr Diab Rep, V5, P59, DOI 10.1007/s11892-005-0069-1; McNay EC, 2005, NEUROBIOL AGING, V26, pS76, DOI 10.1016/j.neurobiolaging.2005.08.014; Messier C, 2003, EXP GERONTOL, V38, P941, DOI 10.1016/S0531-5565(03)00153-0; RYAN CM, 1993, DIABETOLOGIA, V36, P329, DOI 10.1007/BF00400236; Schmittdiel JA, 2008, J GEN INTERN MED, V23, P588, DOI 10.1007/s11606-008-0554-8; Selby JV, 1997, DIABETES CARE, V20, P1396, DOI 10.2337/diacare.20.9.1396; Selby JV, 2001, DIABETES CARE, V24, P1547, DOI 10.2337/diacare.24.9.1547; Selby JV, 1997, ANN INTERN MED, V127, P719, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00056; Skyler JS, 2009, CIRCULATION, V119, P351, DOI 10.1161/CIRCULATIONAHA.108.191305; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Suh SW, 2007, GLIA, V55, P1280, DOI 10.1002/glia.20440; Warren RE, 2005, DIABETES OBES METAB, V7, P493, DOI 10.1111/j.1463-1326.2004.00421.x; Whitmer RA, 2008, NEUROLOGY, V71, P1057, DOI 10.1212/01.wnl.0000306313.89165.ef; Whitmer RA, 2005, NEUROLOGY, V64, P277, DOI 10.1212/01.WNL.0000149519.47454.F2; Whitmer RA, 2005, BMJ-BRIT MED J, V330, P1360, DOI 10.1136/bmj.38446.466238.E0; Whitmer RA, 2007, CURR NEUROL NEUROSCI, V7, P373, DOI 10.1007/s11910-007-0058-7; Whitmer RA, 2007, CURR ALZHEIMER RES, V4, P103, DOI 10.2174/156720507780362047; WREDLING R, 1990, DIABETOLOGIA, V33, P152, DOI 10.1007/BF00404042; Wright RJ, 2008, DIABETES-METAB RES, V24, P353, DOI 10.1002/dmrr.865	59	683	716	3	53	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 15	2009	301	15					1565	1572		10.1001/jama.2009.460	http://dx.doi.org/10.1001/jama.2009.460			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	432MH	19366776	Bronze, Green Accepted			2022-12-01	WOS:000265137900027
J	Bergmann, O; Bhardwaj, RD; Bernard, S; Zdunek, S; Barnabe-Heider, F; Walsh, S; Zupicich, J; Alkass, K; Buchholz, BA; Druid, H; Jovinge, S; Frisen, J				Bergmann, Olaf; Bhardwaj, Ratan D.; Bernard, Samuel; Zdunek, Sofia; Barnabe-Heider, Fanie; Walsh, Stuart; Zupicich, Joel; Alkass, Kanar; Buchholz, Bruce A.; Druid, Henrik; Jovinge, Stefan; Frisen, Jonas			Evidence for Cardiomyocyte Renewal in Humans	SCIENCE			English	Article							CARDIAC MYOCYTES; NUCLEAR TESTS; HUMAN HEARTS; CELLS; HYPERTROPHY; PROGENITORS; ORIGINS; C-14	It has been difficult to establish whether we are limited to the heart muscle cells we are born with or if cardiomyocytes are generated also later in life. We have taken advantage of the integration of carbon-14, generated by nuclear bomb tests during the Cold War, into DNA to establish the age of cardiomyocytes in humans. We report that cardiomyocytes renew, with a gradual decrease from 1% turning over annually at the age of 25 to 0.45% at the age of 75. Fewer than 50% of cardiomyocytes are exchanged during a normal life span. The capacity to generate cardiomyocytes in the adult human heart suggests that it may be rational to work toward the development of therapeutic strategies aimed at stimulating this process in cardiac pathologies.	[Bergmann, Olaf; Bhardwaj, Ratan D.; Zdunek, Sofia; Barnabe-Heider, Fanie; Zupicich, Joel; Frisen, Jonas] Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden; [Bernard, Samuel] Univ Lyon 1, Inst Camille Jordan, CNRS, UMR5208, F-69622 Villeurbanne, France; [Walsh, Stuart; Jovinge, Stefan] Lund Univ, Lund Strateg Res Ctr Stem Cell Biol & Cell Therap, SE-22184 Lund, Sweden; [Alkass, Kanar; Druid, Henrik] Karolinska Inst, Dept Forens Med, SE-17177 Stockholm, Sweden; [Buchholz, Bruce A.] Lawrence Livermore Natl Lab, Ctr Accelerator Mass Spectrometry, Livermore, CA 94551 USA; [Jovinge, Stefan] Univ Lund Hosp, Dept Cardiol, SE-22185 Lund, Sweden	Karolinska Institutet; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Ecole Centrale de Lyon; Institut National des Sciences Appliquees de Lyon - INSA Lyon; Universite Jean Monnet; Lund University; Karolinska Institutet; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Lund University; Skane University Hospital	Frisen, J (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden.	jonas.frisen@ki.se	Bergmann, Olaf/A-5706-2009; Buchholz, Bruce A/G-1356-2011; Schick, Joel/ABA-3728-2021; Bernard, Samuel/A-5623-2009	Bergmann, Olaf/0000-0003-1065-4107; Buchholz, Bruce A/0000-0002-9531-551X; Schick, Joel/0000-0002-8623-4910; Bernard, Samuel/0000-0002-8442-9968; alkass, kanar/0000-0002-9154-5393; Druid, Henrik/0000-0002-9198-023X	Swedish Heart-Lung Foundation; Swedish Research Council; Knut och Alice Wallenbergs Stiftelse; Human Frontiers Science Program; Swedish Cancer Society; Foundation for Strategic Research; Karolinska Institutet; Juvenile Diabetes Research Foundation; NIH/NCRR [RR13461]; European Commission; Tobias Foundation; Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; Canadian Institutes of Health Research fellowships; Christopher and Dana Reeve Foundation fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR013461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103483] Funding Source: NIH RePORTER	Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut och Alice Wallenbergs Stiftelse(Knut & Alice Wallenberg Foundation); Human Frontiers Science Program(Human Frontier Science Program); Swedish Cancer Society(Swedish Cancer Society); Foundation for Strategic Research; Karolinska Institutet(Karolinska Institutet); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); European Commission(European CommissionEuropean Commission Joint Research Centre); Tobias Foundation; Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); Canadian Institutes of Health Research fellowships(Canadian Institutes of Health Research (CIHR)); Christopher and Dana Reeve Foundation fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Lee, K. Spalding, and members of the Frisen lab for valuable discussions; M. Toro and K. Hamrin for help with flow cytometry; P. Reimer for assistance with radiocarbon interpretation; R. Cassidy, M. Muller, and E. Klaile for technical advice; M. Stahlberg and T. Bergman for help with high-performance liquid chromatography; and D. Kurdyla and P. Zermeno for producing graphite. This study was supported by grants from the Swedish Heart-Lung Foundation, the Swedish Research Council, Knut och Alice Wallenbergs Stiftelse, Human Frontiers Science Program, the Swedish Cancer Society, the Foundation for Strategic Research, the Karolinska Institutet, the Juvenile Diabetes Research Foundation, NIH/NCRR (RR13461), European Commission FP7 CardioCell, and the Tobias Foundation. This work was performed in part under the auspices of the U.S. Department of Energy by Lawrence Livermore National Laboratory under contract DE-AC52-07NA27344. R.D.B. and F.B.-H. were supported by fellowships from the Canadian Institutes of Health Research, and F.B.-H. was also supported by a fellowship from the Christopher and Dana Reeve Foundation.	Adler C, 1991, DEV REGENERATIVE POT, P227; Anversa P, 2002, NATURE, V415, P240, DOI 10.1038/415240a; Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303; Bhardwaj RD, 2006, P NATL ACAD SCI USA, V103, P12564, DOI 10.1073/pnas.0605177103; BRODSKY VY, 1994, VIRCHOWS ARCH, V424, P429; Butany J, 2005, LANCET ONCOL, V6, P219, DOI 10.1016/S1470-2045(05)70093-0; DEVRIES H, 1958, SCIENCE, V128, P1550, DOI 10.1126/science.128.3338.1550; HARKNESS DD, 1972, NATURE, V240, P302, DOI 10.1038/240302a0; Hsieh PCH, 2007, NAT MED, V13, P970, DOI 10.1038/nm1618; Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117; Laflamme MA, 2002, CIRC RES, V90, P634, DOI 10.1161/01.RES.0000014822.62629.EB; Levin I, 2004, RADIOCARBON, V46, P1261, DOI 10.1017/S0033822200033130; LIBBY WF, 1964, SCIENCE, V146, P1171; Martin-Puig S, 2008, CELL STEM CELL, V2, P320, DOI 10.1016/j.stem.2008.03.010; Nouspikel T, 2002, DNA REPAIR, V1, P59, DOI 10.1016/S1568-7864(01)00005-2; NYDAL R, 1965, NATURE, V206, P1029, DOI 10.1038/2061029a0; Olivetti G, 1996, J MOL CELL CARDIOL, V28, P1463, DOI 10.1006/jmcc.1996.0137; OLIVETTI G, 1991, CIRC RES, V68, P1560, DOI 10.1161/01.RES.68.6.1560; Parmacek MS, 2004, PROG CARDIOVASC DIS, V47, P159, DOI 10.1016/j.pcad.2004.07.003; Passier R, 2008, NATURE, V453, P322, DOI 10.1038/nature07040; PFITZER P, 1971, CURR TOP PATHOL, V54, P125; Rubart M, 2006, ANNU REV PHYSIOL, V68, P29, DOI 10.1146/annurev.physiol.68.040104.124530; Soonpaa MH, 1998, CIRC RES, V83, P15, DOI 10.1161/01.RES.83.1.15; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Spalding KL, 2005, NATURE, V437, P333, DOI 10.1038/437333a; Spalding KL, 2005, CELL, V122, P133, DOI 10.1016/j.cell.2005.04.028; Wild EM, 2000, NUCL INSTRUM METH B, V172, P944, DOI 10.1016/S0168-583X(00)00227-5; Wu SM, 2008, CELL, V132, P537, DOI 10.1016/j.cell.2008.02.002	28	2034	2138	12	250	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2009	324	5923					98	102		10.1126/science.1164680	http://dx.doi.org/10.1126/science.1164680			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427TN	19342590	Green Accepted, Green Submitted			2022-12-01	WOS:000264802100041
J	Palmenberg, AC; Spiro, D; Kuzmickas, R; Wang, S; Djikeng, A; Rathe, JA; Fraser-Liggett, CM; Liggett, SB				Palmenberg, Ann C.; Spiro, David; Kuzmickas, Ryan; Wang, Shiliang; Djikeng, Appolinaire; Rathe, Jennifer A.; Fraser-Liggett, Claire M.; Liggett, Stephen B.			Sequencing and Analyses of All Known Human Rhinovirus Genomes Reveal Structure and Evolution	SCIENCE			English	Article							ASTHMA; RECOMBINATION; INFECTIONS; FEATURES; VIRUSES; TRACT	Infection by human rhinovirus (HRV) is a major cause of upper and lower respiratory tract disease worldwide and displays considerable phenotypic variation. We examined diversity by completing the genome sequences for all known serotypes (n = 99). Superimposition of capsid crystal structure and optimal-energy RNA configurations established alignments and phylogeny. These revealed conserved motifs; clade-specific diversity, including a potential newly identified species (HRV-D); mutations in field isolates; and recombination. In analogy with poliovirus, a hypervariable 5' untranslated region tract may affect virulence. A configuration consistent with nonscanning internal ribosome entry was found in all HRVs and may account for rapid translation. The data density from complete sequences of the reference HRVs provided high resolution for this degree of modeling and serves as a platform for full genome-based epidemiologic studies and antiviral or vaccine development.	[Rathe, Jennifer A.; Liggett, Stephen B.] Univ Maryland, Sch Med, Cardiopulm Genom Program, Baltimore, MD 21201 USA; [Palmenberg, Ann C.] Univ Wisconsin, Inst Mol Virol, Madison, WI 53706 USA; [Spiro, David; Kuzmickas, Ryan; Wang, Shiliang; Djikeng, Appolinaire] J Craig Venter Inst, Rockville, MD 20850 USA; [Fraser-Liggett, Claire M.] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University of Wisconsin System; University of Wisconsin Madison; J. Craig Venter Institute; University System of Maryland; University of Maryland Baltimore	Liggett, SB (corresponding author), Univ Maryland, Sch Med, Cardiopulm Genom Program, Baltimore, MD 21201 USA.	sligg001@umaryland.edu	liggett, stephen b/E-7453-2012	Liggett, Stephen B./0000-0002-0128-3669; Fraser, Claire/0000-0003-1462-2428; Djikeng, Appolinaire/0000-0001-9271-3419	University of Maryland School of Medicine; NIH [U19-AI070503]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI070503] Funding Source: NIH RePORTER	University of Maryland School of Medicine; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by the University of Maryland School of Medicine internal funds and by NIH grant U19-AI070503. We thank A. Wolf and J.-Y. Sgro for implementation of the tree topology tests. The accession numbers for the hrv strains are FJ445111 to FJ445190 (see table S1).	ANDRIES K, 1990, J VIROL, V64, P1117, DOI 10.1128/JVI.64.3.1117-1123.1990; Barnard DL, 2006, CURR PHARM DESIGN, V12, P1379, DOI 10.2174/138161206776361129; Djikeng A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-5; Dominguez SR, 2008, J CLIN VIROL, V43, P219, DOI 10.1016/j.jcv.2008.06.007; Fendrick AM, 2003, ARCH INTERN MED, V163, P487, DOI 10.1001/archinte.163.4.487; Fleischer R, 2003, CLIN INFECT DIS, V37, P1722; GWALTNEY JM, 1966, NEW ENGL J MED, V275, P1261, DOI 10.1056/NEJM196612082752301; Jackson DJ, 2008, AM J RESP CRIT CARE, V178, P667, DOI 10.1164/rccm.200802-309OC; JACKSON RJ, 1996, TRANSLATIONAL CONTRO; Johnston SL, 1996, AM J RESP CRIT CARE, V154, P654, DOI 10.1164/ajrccm.154.3.8810601; Kistler AL, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-40; KNOWLES N, COMMUNICATION; Lau SKP, 2007, J CLIN MICROBIOL, V45, P3655, DOI 10.1128/JCM.01254-07; Ledford RM, 2004, J VIROL, V78, P3663, DOI 10.1128/JVI.78.7.3663-3674.2004; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin LR, 1996, J VIROL, V70, P2027, DOI 10.1128/JVI.70.3.2027-2031.1996; McErlean P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001847; NICHOLSON KG, 1993, BRIT MED J, V307, P982, DOI 10.1136/bmj.307.6910.982; Palmenberg AC, 1997, SEMIN VIROL, V8, P231, DOI 10.1006/smvy.1997.0126; PALMENBERG AC, 2001, MOL BIOL PICORNAVIRU; Savolainen C, 2002, VIRUS RES, V85, P41, DOI 10.1016/S0168-1702(02)00016-3; Savolainen C, 2002, J GEN VIROL, V83, P333, DOI 10.1099/0022-1317-83-2-333; Simmonds P, 2006, J VIROL, V80, P11124, DOI 10.1128/JVI.01076-06; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Vlasak M, 2005, J VIROL, V79, P7389, DOI 10.1128/JVI.79.12.7389-7395.2005; Weiss KB, 2001, J ALLERGY CLIN IMMUN, V107, P3, DOI 10.1067/mai.2001.112262	26	327	347	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2009	324	5923					55	59		10.1126/science.1165557	http://dx.doi.org/10.1126/science.1165557			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427TN	19213880	Green Accepted			2022-12-01	WOS:000264802100029
J	Adams, RW; Aguilar, JA; Atkinson, KD; Cowley, MJ; Elliott, PIP; Duckett, SB; Green, GGR; Khazal, IG; Lopez-Serrano, J; Williamson, DC				Adams, Ralph W.; Aguilar, Juan A.; Atkinson, Kevin D.; Cowley, Michael J.; Elliott, Paul I. P.; Duckett, Simon B.; Green, Gary G. R.; Khazal, Iman G.; Lopez-Serrano, Joaqun; Williamson, David C.			Reversible Interactions with para-Hydrogen Enhance NMR Sensitivity by Polarization Transfer	SCIENCE			English	Article							NOBEL LECTURE; SPECTROSCOPY; CHEMISTRY	The sensitivity of both nuclear magnetic resonance spectroscopy and magnetic resonance imaging is very low because the detected signal strength depends on the small population difference between spin states even in high magnetic fields. Hyperpolarization methods can be used to increase this difference and thereby enhance signal strength. This has been achieved previously by incorporating the molecular spin singlet para-hydrogen into hydrogenation reaction products. We show here that a metal complex can facilitate the reversible interaction of para-hydrogen with a suitable organic substrate such that up to an 800-fold increase in proton, carbon, and nitrogen signal strengths are seen for the substrate without its hydrogenation. These polarized signals can be selectively detected when combined with methods that suppress background signals.	[Adams, Ralph W.; Aguilar, Juan A.; Atkinson, Kevin D.; Cowley, Michael J.; Elliott, Paul I. P.; Duckett, Simon B.; Khazal, Iman G.; Lopez-Serrano, Joaqun; Williamson, David C.] Univ York, Dept Chem, York YO10 5DD, N Yorkshire, England; [Green, Gary G. R.] Univ York, York Neuroimaging Ctr, Bioctr York Sci Pk, York YO10 5DG, N Yorkshire, England	University of York - UK; University of York - UK	Duckett, SB (corresponding author), Univ York, Dept Chem, York YO10 5DD, N Yorkshire, England.	sbd3@york.ac.uk	Adams, Ralph/H-9205-2012; Cowley, Michael/AAQ-5067-2020; Cowley, Michael J/C-5169-2014; Lopez-Serrano, Joaquin/A-2267-2011; Green, Gary GR/D-3543-2009; Cowley, Michael J/H-8512-2012; Aguilar, Juan A./B-5315-2015; Duckett, Simon/M-1790-2016	Adams, Ralph/0000-0001-8009-5334; Cowley, Michael/0000-0003-0664-2891; Cowley, Michael J/0000-0003-0664-2891; Lopez-Serrano, Joaquin/0000-0003-3999-0155; Green, Gary GR/0000-0003-1977-7509; Aguilar, Juan A./0000-0001-9181-8892; Elliott, Paul/0000-0003-1570-3289; Duckett, Simon/0000-0002-9788-6615	University of York; White-Rose Health Innovation Partnership; Engineering and Physical Sciences Research Council; Medical Research Council; Biotechnology and Biological Sciences Research Council; Spanish Ministry of Education and Science [CSD 2007-00006]; Engineering and Physical Sciences Research Council [EP/F022530/1] Funding Source: researchfish; EPSRC [EP/F022530/1] Funding Source: UKRI	University of York(European Commission); White-Rose Health Innovation Partnership; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Spanish Ministry of Education and Science(Spanish Government); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the University of York, the White-Rose Health Innovation Partnership, the Engineering and Physical Sciences Research Council, the Medical Research Council, Biotechnology and Biological Sciences Research Council, the Spanish Ministry of Education and Science [Project Consolider ORFEO (CSD 2007-00006)], and Bruker Bio-Spin. We thank Bruker Bio-Spin, R. Perutz, P. Walton, M. Hymers, S. Johnson, M. Mortimer, and K. Armour for advice and helpful discussions. We have filed a patent application, P115707GB, based on this work	Aguilar JA, 2007, CHEM COMMUN, P1183, DOI 10.1039/b616307f; Anwar MS, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.040501; Ardenkjaer-Larsen JH, 2003, P NATL ACAD SCI USA, V100, P10158, DOI 10.1073/pnas.1733835100; Blazina D, 2004, DALTON T, P2601, DOI 10.1039/b409606a; Bouchard LS, 2008, SCIENCE, V319, P442, DOI 10.1126/science.1151787; BOWERS CR, 1987, J AM CHEM SOC, V109, P5541, DOI 10.1021/ja00252a049; Carravetta M, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1893983; CRABTREE RH, 1986, J AM CHEM SOC, V108, P4032, DOI 10.1021/ja00274a030; Driehuys B, 2006, SCIENCE, V314, P432, DOI 10.1126/science.1134532; ERNST RR, 1992, ANGEW CHEM INT EDIT, V31, P805, DOI 10.1002/anie.199208053; Frydman L, 2007, NAT PHYS, V3, P415, DOI 10.1038/nphys597; Golman K, 2003, P NATL ACAD SCI USA, V100, P10435, DOI 10.1073/pnas.1733836100; Kemsley J, 2008, CHEM ENG NEWS, V86, P12, DOI 10.1021/cen-v086n043.p012; Kuhn LT, 2007, TOP CURR CHEM, V276, P25, DOI 10.1007/128_064; Merritt ME, 2007, P NATL ACAD SCI USA, V104, P19773, DOI 10.1073/pnas.0706235104; Morris P.G., 1986, NUCL MAGNETIC RESONA; OPPELT A, 1986, Electromedica (English Edition), V54, P15; Schroder L, 2006, SCIENCE, V314, P446, DOI 10.1126/science.1131847; Wood NJ, 2007, J AM CHEM SOC, V129, P11012, DOI 10.1021/ja074286k; Wuthrich K, 2003, ANGEW CHEM INT EDIT, V42, P3340, DOI 10.1002/anie.200300595; Zeeman P, 1908, NATURE, V78, P369, DOI 10.1038/078369a0	21	609	617	8	258	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2009	323	5922					1708	1711		10.1126/science.1168877	http://dx.doi.org/10.1126/science.1168877			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	424IG	19325111	Green Accepted			2022-12-01	WOS:000264559800034
J	Carpenter, LM; Linsell, L; Brooks, C; Keegan, TJ; Langdon, T; Doyle, P; Maconochie, NES; Fletcher, T; Nieuwenhuijsen, MJ; Beral, V; Venables, KM				Carpenter, L. M.; Linsell, L.; Brooks, C.; Keegan, T. J.; Langdon, T.; Doyle, P.; Maconochie, N. E. S.; Fletcher, T.; Nieuwenhuijsen, M. J.; Beral, V.; Venables, K. M.			Cancer morbidity in British military veterans included in chemical warfare agent experiments at Porton Down: cohort study	BRITISH MEDICAL JOURNAL			English	Article							MUSTARD GAS; EXPOSURES	Objective To determine cancer morbidity in members of the armed forces who took part in tests of chemical warfare agents from 1941 to 1989. Design Historical cohort study, with cohort members followed up to December 2004. Data source Archive of UK government research facility at Porton Down, UK military personnel records, and national death and cancer records. Participants All veterans included in the cohort study of mortality, excluding those known to have died or been lost to follow-up before 1 January 1971 when the UK cancer registration system commenced. 17 013 male members of the UK armed forces who took part in tests (Porton Down veterans) and a similar group of 16 520 who did not (non-Porton Down veterans). Main outcome measures Cancer morbidity in each group of veterans; rate ratios, with 95% confidence intervals, adjusted for age group and calendar period. Results 3457 cancers were reported in the Porton Down veterans compared with 3380 cancers in the non-Porton Down veterans. While overall cancer morbidity was the same in both groups (rate ratio 1.00, 95% confidence interval 0.95 to 1.05), Porton Down veterans had higher rates of ill defined malignant neoplasms (1.12, 1.02 to 1.22), in situ neoplasms (1.45, 1.06 to 2.00), and those of uncertain or unknown behaviour (1.32, 1.01 to 1.73). Conclusion Overall cancer morbidity in Porton Down veterans was no different from that in non-Porton Down veterans.	[Carpenter, L. M.; Linsell, L.; Brooks, C.; Keegan, T. J.; Langdon, T.; Venables, K. M.] Univ Oxford, Dept Publ Hlth, Oxford OX3 7LF, England; [Doyle, P.; Maconochie, N. E. S.] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England; [Fletcher, T.] London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1, England; [Nieuwenhuijsen, M. J.] IMIM, Ctr Res Environm Epidemiol, Barcelona 08003, Spain; [Nieuwenhuijsen, M. J.] CIBERESP, Barcelona 08003, Spain; [Nieuwenhuijsen, M. J.] Univ London Imperial Coll Sci Technol & Med, Div Epidemiol Publ Hlth & Primary Care, London SW7 2AZ, England; [Beral, V.] Univ Oxford, Canc Epidemiol Unit, Oxford OX3 7LF, England	University of Oxford; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Institut Hospital del Mar d'Investigacions Mediques (IMIM); CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Imperial College London; University of Oxford	Carpenter, LM (corresponding author), Univ Oxford, Dept Publ Hlth, Oxford OX3 7LF, England.	lucy.carpenter@dphpc.ox.ac.uk; kate.venables@dphpc.ox.ac.uk	Fletcher, Tony/D-2394-2011; Nieuwenhuijsen, Mark J/C-3914-2017	Fletcher, Tony/0000-0003-3385-200X; Nieuwenhuijsen, Mark J/0000-0001-9461-7981; Keegan, Thomas/0000-0003-3691-953X; Brooks, Claire/0000-0002-3410-8971	MRC; Department of Public Health; Nuffield College, University of Oxford; MRC [G0200288] Funding Source: UKRI; Medical Research Council [G0200288] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Public Health; Nuffield College, University of Oxford; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding: This study was funded by the MRC with funds provided to it by the MoD. Additional funds were provided by the Department of Public Health and Nuffield College, University of Oxford. The MRC set up a liaison group to oversee the progress of the study. The MoD had no role in study design, analysis, and interpretation of data. The MoD facilitated access to its archives but had no role in deciding which data were abstracted. The MoD was sent a copy of the paper for factual comment but had no role in writing the paper or in the decision to submit for publication. The Universities of Oxford and London are independent of both the MRC and the MoD.	Clayton D., 1993, STAT MODELS EPIDEMIO; EASTON DF, 1988, BRIT J IND MED, V45, P652; EVANS R, 2000, GASSED; International Agency for Research on Cancer, IARC MON EV CARC RIS; Keegan TJ, 2007, ANN OCCUP HYG, V51, P441, DOI 10.1093/annhyg/mem017; Keegan TJ, 2009, ANN OCCUP HYG, V53, P83, DOI 10.1093/annhyg/men040; MANTEL N, 1959, J NATL CANCER I, V22, P719; Ministry of Defence, 2006, HIST SURV PORT SERV; Pechura C., 1993, VETERANS RISK HLTH E; VENABLES KM, 2009, BRIT MED J, pB613; WADA S, 1968, LANCET, V1, P1161	11	5	5	1	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 24	2009	338								b655	10.1136/bmj.b655	http://dx.doi.org/10.1136/bmj.b655			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	425LP	19318700	hybrid, Green Accepted, Green Published			2022-12-01	WOS:000264639500010
J	Goessling, W; North, TE; Loewer, S; Lord, AM; Lee, S; Stoick-Cooper, CL; Weidinger, G; Puder, M; Daley, GQ; Moon, RT; Zon, LI				Goessling, Wolfram; North, Trista E.; Loewer, Sabine; Lord, Allegra M.; Lee, Sang; Stoick-Cooper, Cristi L.; Weidinger, Gilbert; Puder, Mark; Daley, George Q.; Moon, Randall T.; Zon, Leonard I.			Genetic Interaction of PGE2 and Wnt Signaling Regulates Developmental Specification of Stem Cells and Regeneration	CELL			English	Article							FAMILIAL ADENOMATOUS POLYPOSIS; GLYCOGEN-SYNTHASE KINASE-3; BETA-CATENIN; WNT/BETA-CATENIN; COLON-CANCER; LONG-TERM; PROSTAGLANDIN E-2; GAMMA-CATENIN; ZEBRAFISH; PHOSPHORYLATION	Interactions between developmental signaling pathways govern the formation and function of stem cells. Prostaglandin (PG) E2 regulates vertebrate hematopoietic stem cells (HSC). Similarly, the Wnt signaling pathway controls HSC self-renewal and bone marrow repopulation. Here, we show that wnt reporter activity in zebrafish HSCs is responsive to PGE2 modulation, demonstrating a direct interaction in vivo. Inhibition of PGE2 synthesis blocked wnt-induced alterations in HSC formation. PGE2 modified the wnt signaling cascade at the level of beta-catenin degradation through cAMP/PKA-mediated stabilizing phosphorylation events. The PGE2/Wnt interaction regulated murine stem and progenitor populations in vitro in hematopoietic ES cell assays and in vivo following transplantation. The relationship between PGE2 and Wnt was also conserved during regeneration of other organ systems. Our work provides in vivo evidence that Wnt activation in stem cells requires PGE2, and suggests the PGE2/Wnt interaction is a master regulator of vertebrate regeneration and recovery.	[Goessling, Wolfram; North, Trista E.; Daley, George Q.; Zon, Leonard I.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Goessling, Wolfram; North, Trista E.; Loewer, Sabine; Lord, Allegra M.; Lee, Sang; Puder, Mark; Daley, George Q.; Zon, Leonard I.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Goessling, Wolfram; North, Trista E.; Loewer, Sabine; Lord, Allegra M.; Daley, George Q.; Zon, Leonard I.] Childrens Hosp, Howard Hughes Med Inst, Stem Cell Program, Boston, MA 02115 USA; [Lee, Sang; Puder, Mark] Childrens Hosp, Dept Surg, Boston, MA 02115 USA; [Stoick-Cooper, Cristi L.; Weidinger, Gilbert; Moon, Randall T.] Univ Washington, Howard Hughes Med Inst, Inst Stem Cell & Regenerat Med, Sch Med, Seattle, WA 98195 USA	Harvard University; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Zon, LI (corresponding author), Harvard Stem Cell Inst, Cambridge, MA 02138 USA.	zon@enders.tch.harvard.edu	North, Trista/ABG-4789-2020; Moon, Randall T/B-1743-2014; Moon, Randall/M-5605-2019; Weidinger, Gilbert/A-8342-2010	North, Trista/0000-0003-1249-563X; Moon, Randall T/0000-0002-9352-1408; Moon, Randall/0000-0002-9352-1408; Weidinger, Gilbert/0000-0003-3599-6760; Goessling, Wolfram/0000-0001-9972-1569	National Institutes of Health; American Gastroenterological Association; American Cancer Society; Human Frontier Science Program; NATIONAL CANCER INSTITUTE [R01CA103846] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048801] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Gastroenterological Association; American Cancer Society(American Cancer Society); Human Frontier Science Program(Human Frontier Science Program); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank: D. Langenau and C. Ceol for critical reading of the manuscript; C. R. Walkley and L. Purton for advice on HSC transplants; and J. Harris and C. C. Cutting for technical assistance. This work was supported by the National Institutes of Health (W. G., G. Q. D., R. T. M., and L. I. Z.), the American Gastroenterological Association (W. G.), the American Cancer Society (T. E. N.), and the Human Frontier Science Program (S. L.). G. Q. D., R. T. M., L. I. Z. are Howard Hughes Medical Institute investigators.	Barker N, 2006, NAT REV DRUG DISCOV, V5, P997, DOI 10.1038/nrd2154; Boolbol SK, 1996, CANCER RES, V56, P2556; Buchanan FG, 2006, CANCER CELL, V9, P6, DOI 10.1016/j.ccr.2005.12.029; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Clevers H, 2006, NEW ENGL J MED, V354, P761, DOI 10.1056/NEJMcibr055457; Congdon KL, 2008, STEM CELLS, V26, P1202, DOI 10.1634/stemcells.2007-0768; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; Dorsky RI, 2002, DEV BIOL, V241, P229, DOI 10.1006/dbio.2001.0515; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Fevr T, 2007, MOL CELL BIOL, V27, P7551, DOI 10.1128/MCB.01034-07; FISHER JW, 1984, BLOOD CELLS, V10, P241; Fujino H, 2002, J BIOL CHEM, V277, P2614, DOI 10.1074/jbc.M109440200; GIARDIELLO FM, 1993, NEW ENGL J MED, V328, P1313, DOI 10.1056/NEJM199305063281805; Giardiello FM, 2002, NEW ENGL J MED, V346, P1054, DOI 10.1056/NEJMoa012015; Goessling W, 2008, DEV BIOL, V320, P161, DOI 10.1016/j.ydbio.2008.05.526; GOLDSTEIN IM, 1997, INFLAMMATION, V2, P309; Greene AK, 2003, J INVEST SURG, V16, P99, DOI 10.1080/08941930390194424; Hino S, 2005, MOL CELL BIOL, V25, P9063, DOI 10.1128/MCB.25.20.9063-9072.2005; Hirabayashi Y, 2004, DEVELOPMENT, V131, P2791, DOI 10.1242/dev.01165; Hurlstone AFL, 2003, NATURE, V425, P633, DOI 10.1038/nature02028; Jeannet G, 2008, BLOOD, V111, P142, DOI 10.1182/blood-2007-07-102558; Koch U, 2008, BLOOD, V111, P160, DOI 10.1182/blood-2007-07-099754; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; Lewis JL, 2004, DEVELOPMENT, V131, P1299, DOI 10.1242/dev.01007; Lorenz M, 1999, EXP HEMATOL, V27, P1494, DOI 10.1016/S0301-472X(99)00087-9; Meijer L, 2003, CHEM BIOL, V10, P1255, DOI 10.1016/j.chembiol.2003.11.010; Nakanishi M, 2008, CANCER RES, V68, P3251, DOI 10.1158/0008-5472.CAN-07-6100; Nguyen H, 2006, CELL, V127, P171, DOI 10.1016/j.cell.2006.07.036; NOCKA KH, 1989, LEUKEMIA RES, V13, P527, DOI 10.1016/0145-2126(89)90119-7; North TE, 2002, IMMUNITY, V16, P661, DOI 10.1016/S1074-7613(02)00296-0; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Oshima M, 1996, CELL, V87, P803, DOI 10.1016/S0092-8674(00)81988-1; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Scheller M, 2006, NAT IMMUNOL, V7, P1037, DOI 10.1038/ni1387; Shao JY, 2005, J BIOL CHEM, V280, P26565, DOI 10.1074/jbc.M413056200; Shepard JL, 2005, P NATL ACAD SCI USA, V102, P13194, DOI 10.1073/pnas.0506583102; Stoick-Cooper CL, 2007, DEVELOPMENT, V134, P479, DOI 10.1242/dev.001123; Tan XP, 2006, GASTROENTEROLOGY, V131, P1561, DOI 10.1053/j.gastro.2006.08.042; Trowbridge JJ, 2006, NAT MED, V12, P89, DOI 10.1038/nm1339; Weidinger G, 2005, CURR BIOL, V15, P489, DOI 10.1016/j.cub.2005.01.041; WILLIAMS N, 1980, J CELL PHYSIOL, V103, P239, DOI 10.1002/jcp.1041030208; Zhu H, 2005, DEV BIOL, V281, P256, DOI 10.1016/j.ydbio.2005.01.034	44	533	579	2	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 20	2009	136	6					1136	1147		10.1016/j.cell.2009.01.015	http://dx.doi.org/10.1016/j.cell.2009.01.015			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	422CE	19303855	Bronze, Green Accepted			2022-12-01	WOS:000264403900018
J	Garber, AM				Garber, Alan M.			An Uncertain Future for Cardiovascular Drug Development?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Garber, Alan M.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Garber, Alan M.] Stanford Univ, Ctr Primary Care & Outcomes Res, Stanford, CA 94305 USA; [Garber, Alan M.] Stanford Univ, Ctr Hlth Policy, Stanford, CA 94305 USA; [Garber, Alan M.] Natl Bur Econ Res, Hlth Care Program, Cambridge, MA 02138 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Stanford University; National Bureau of Economic Research	Garber, AM (corresponding author), Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA.		Garber, Alan M/F-1476-2010					Kung Hsiang-Ching, 2008, Natl Vital Stat Rep, V56, P1; *PHARM RES MAN AM, 2009 REP MED DEV HEA; *US DRUG SAF SYST, 2007, FUT DRUG SAF PROM PR; Wald NJ, 2003, BRIT MED J, V327, P586; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419; WALD NJ, 2006, BMJ-BRIT MED J, V60, P823; Wang S.S., 2008, WALL STREET J   0930	7	18	19	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 19	2009	360	12					1169	1171		10.1056/NEJMp0808414	http://dx.doi.org/10.1056/NEJMp0808414			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	420IU	19297568	Green Published, Green Submitted			2022-12-01	WOS:000264283400001
J	Steinhubl, SR; Bhatt, DL; Brennan, DM; Montalescot, G; Hankey, GJ; Eikelboom, JW; Berger, PB; Topol, EJ				Steinhubl, Steven R.; Bhatt, Deepak L.; Brennan, Danielle M.; Montalescot, Gilles; Hankey, Graeme J.; Eikelboom, John W.; Berger, Peter B.; Topol, Eric J.		CHARISMA Investigators	Aspirin to Prevent Cardiovascular Disease: The Association of Aspirin Dose and Clopidogrel With Thrombosis and Bleeding	ANNALS OF INTERNAL MEDICINE			English	Article							PLATELET-FUNCTION; CORONARY; RISK; BIOSYNTHESIS; PROSTACYCLIN; EVENTS; ANGINA	Background: The optimal aspirin dose for the prevention of cardiovascular events remains controversial. Objective: To assess the incidence of and risk factors for adverse clinical outcomes by investigator-determined aspirin dose in a primary prevention trial. Design: Post hoc observational analyses of data from a doubleblind, placebo-controlled, randomized trial. Setting: Outpatient. Patients: 15 595 patients with cardiovascular disease or multiple risk factors. Intervention: Clopidogrel, 75 mg/d, or placebo, with aspirin, 75 to 162 mg/d, as selected by the investigators. Measurements: Incidence of the composite outcome of myocardial infarction, stroke, or cardiovascular death (efficacy end point), and incidence of severe or life-threatening bleeding (safety end point), at a median of 28 months (interquartile range, 23 to 31 months) of follow-up. Results: Daily aspirin doses were categorized as less than 100 mg (75 or 81 mg) (n = 7180), 100 mg (n = 4961), and greater than 100 mg (150 or 162 mg) (n = 3454). The hazard of the primary efficacy end point was the same regardless of dose (adjusted hazard ratio, 0.95 [95% CI, 0.80 to 1.13] for 100 mg vs. less than 100 mg, and 1.0 [CI, 0.85 to 1.18] for greater than 100 mg vs. less than 100 mg). The hazard of the primary safety end point also did not depend on dose (adjusted hazard ratio, 0.85 [CI, 0.57 to 1.26] for 100 mg vs. less than 100 mg and 1.05 [CI, 0.74 to 1.48] for greater than 100 mg vs. less than 100 mg). In patients also receiving clopidogrel, daily aspirin doses greater than 100 mg seemed to be non- statistically significantly associated with reduced efficacy (adjusted hazard ratio, 1.16 [CI, 0.93 to 1.44]) and increased harm (adjusted hazard ratio, 1.30 [CI, 0.83 to 2.04]). Limitation: The analysis was post hoc, and aspirin use was not randomized or blinded. Conclusion: Daily aspirin doses of 100 mg or greater were associated with no clear benefit in patients taking aspirin only and possibly with harm in patients taking clopidogrel. Daily doses of 75 to 81 mg may optimize efficacy and safety for patients requiring aspirin for long-term prevention, especially for those receiving dual antiplatelet therapy.	[Steinhubl, Steven R.] Medicines Co, CH-8058 Zurich, Switzerland; Weis Ctr Res, Geisinger Clin, Danville, PA 17822 USA; Vet Affairs Boston Healthcare Syst, Boston, MA USA; Brigham & Womens Hosp, Boston, MA 02115 USA; Cleveland Clin Fdn, Cleveland, OH 44195 USA; CHU Pitie Salpetriere, Inst Cardiol, Paris, France; Royal Perth Hosp, Perth, WA, Australia; McMaster Univ, Hamilton, ON, Canada; Scripps Clin, Scripps Translat Sci Inst, La Jolla, CA 92037 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Brigham & Women's Hospital; Cleveland Clinic Foundation; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Royal Perth Hospital; University of Western Australia; McMaster University; Scripps Research Institute	Steinhubl, SR (corresponding author), Medicines Co, CH-8058 Zurich, Switzerland.	steven.steinhubl@themedco.com	Eikelboom, John/AAG-6117-2019; Hankey, Graeme J/H-4968-2014; Walker, Philip J/F-3034-2010	Eikelboom, John/0000-0003-4126-1285; Hankey, Graeme J/0000-0002-6044-7328; Topol, Eric/0000-0002-1478-4729	Sanofi-Aventis; Bristol-Myers Squibb	Sanofi-Aventis(Sanofi-Aventis); Bristol-Myers Squibb(Bristol-Myers Squibb)	Grant Support: The CHARISMA study was funded by Sanofi-Aventis and Bristol-Myers Squibb.	Ajani UA, 2006, AM J PREV MED, V30, P74, DOI 10.1016/j.amepre.2005.08.042; Alberts MJ, 2004, STROKE, V35, P175, DOI 10.1161/01.STR.0000106763.46123.F6; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Belton O, 2000, CIRCULATION, V102, P840; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Campbell CL, 2007, JAMA-J AM MED ASSOC, V297, P2018, DOI 10.1001/jama.297.18.2018; Cox D, 2006, STROKE, V37, P2153, DOI 10.1161/01.STR.0000231683.43347.ec; DiChiara J, 2007, DIABETES, V56, P3014, DOI 10.2337/db07-0707; Eikelboom JW, 2008, CIRCULATION, V118, P1705, DOI 10.1161/CIRCULATIONAHA.108.768283; Eikelboom JW, 2002, CIRCULATION, V105, P1650, DOI 10.1161/01.CIR.0000013777.21160.07; FITZGERALD GA, 1983, J CLIN INVEST, V71, P676, DOI 10.1172/JCI110814; GIBSON PC, 1949, LANCET, V257, P1172; Hernandez-Diaz S, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-22; Hovens MMC, 2007, AM HEART J, V153, P175, DOI 10.1016/j.ahj.2006.10.040; LEE M, 1994, ANN INTERN MED, V120, P184, DOI 10.7326/0003-4819-120-3-199402010-00002; MONTALESCOT G, 1991, CIRCULATION, V84, P2054, DOI 10.1161/01.CIR.84.5.2054; Ng W, 2006, WORLD J GASTROENTERO, V12, P2923, DOI 10.3748/wjg.v12.i18.2923; PATRONO C, 1985, CIRCULATION, V72, P1177, DOI 10.1161/01.CIR.72.6.1177; Peters RJG, 2003, CIRCULATION, V108, P1682, DOI 10.1161/01.CIR.0000091201.39590.CB; Pirmohamed M, 2004, BMJ-BRIT MED J, V329, P15, DOI 10.1136/bmj.329.7456.15; Quinn MJ, 2004, J AM COLL CARDIOL, V43, P972, DOI 10.1016/j.jacc.2003.09.059; Rao SV, 2006, REV CARDIOVASC MED, V7, pS12; Serebruany VL, 2005, AM J CARDIOL, V95, P1218, DOI 10.1016/j.amjcard.2005.01.049; Smith SC, 2006, CIRCULATION, V113, pE166, DOI 10.1161/CIRCULATIONAHA.106.173220; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001; Topol EJ, 2003, CIRCULATION, V108, P399, DOI 10.1161/01.CIR.0000084501.48570.F6; *US FDA, FIN RUL PROF LAB ASP; WEIL J, 1995, BMJ-BRIT MED J, V310, P827, DOI 10.1136/bmj.310.6983.827	28	124	131	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 17	2009	150	6					379	W68		10.7326/0003-4819-150-6-200903170-00006	http://dx.doi.org/10.7326/0003-4819-150-6-200903170-00006			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	423AJ	19293071				2022-12-01	WOS:000264468500003
J	Maki, DG				Maki, Dennis G.			Coming to Grips with Foodborne Infection - Peanut Butter, Peppers, and Nationwide Salmonella Outbreaks	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Maki, Dennis G.] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Maki, Dennis G.] Univ Wisconsin Hosp & Clin, Madison, WI 53792 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Maki, DG (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53706 USA.							Centers for Disease Control and Prevention (CDC), 2008, INV OUTBR INF CAUS S; Centers for Disease Control and Prevention (CDC), 2009, INV UPD OUTBR SALM T; DuPont HL, 2007, CLIN INFECT DIS, V45, P1353, DOI 10.1086/522662; Maki DG, 2006, NEW ENGL J MED, V355, P1952, DOI 10.1056/NEJMp068225; Osterholm MT, 2004, NEW ENGL J MED, V350, P1898, DOI 10.1056/NEJMsb032657	5	48	48	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 5	2009	360	10					949	953		10.1056/NEJMp0806575	http://dx.doi.org/10.1056/NEJMp0806575			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	413WX	19213675	Bronze			2022-12-01	WOS:000263824500001
J	Sakakibara, D; Sasaki, A; Ikeya, T; Hamatsu, J; Hanashima, T; Mishima, M; Yoshimasu, M; Hayashi, N; Mikawa, T; Walchli, M; Smith, BO; Shirakawa, M; Guntert, P; Ito, Y				Sakakibara, Daisuke; Sasaki, Atsuko; Ikeya, Teppei; Hamatsu, Junpei; Hanashima, Tomomi; Mishima, Masaki; Yoshimasu, Masatoshi; Hayashi, Nobuhiro; Mikawa, Tsutomu; Waelchli, Markus; Smith, Brian O.; Shirakawa, Masahiro; Guentert, Peter; Ito, Yutaka			Protein structure determination in living cells by in-cell NMR spectroscopy	NATURE			English	Article							TRIPLE-RESONANCE SPECTRA; TORSION ANGLE DYNAMICS; SUBCELLULAR-LOCALIZATION; ESCHERICHIA-COLI; SIGNAL PEPTIDES; PREDICTION; ASSIGNMENT; RESOLUTION; PROGRAM; DOMAIN	Investigating proteins 'at work' in a living environment at atomic resolution is a major goal of molecular biology, which has not been achieved even though methods for the three-dimensional (3D) structure determination of purified proteins in single crystals or in solution are widely used. Recent developments in NMR hardware and methodology have enabled the measurement of high-resolution heteronuclear multi-dimensional NMR spectra of macromolecules in living cells (in-cell NMR)(1-5). Various intracellular events such as conformational changes, dynamics and binding events have been investigated by this method. However, the low sensitivity and the short lifetime of the samples have so far prevented the acquisition of sufficient structural information to determine protein structures by in-cell NMR. Here we show the first, to our knowledge, 3D protein structure calculated exclusively on the basis of information obtained in living cells. The structure of the putative heavy-metal binding protein TTHA1718 from Thermus thermophilus HB8 overexpressed in Escherichia coli cells was solved by in-cell NMR. Rapid measurement of the 3D NMR spectra by nonlinear sampling of the indirectly acquired dimensions was used to overcome problems caused by the instability and low sensitivity of living E. coli samples. Almost all of the expected backbone NMR resonances and most of the side-chain NMR resonances were observed and assigned, enabling high quality (0.96 angstrom backbone root mean squared deviation) structures to be calculated that are very similar to the in vitro structure of TTHA1718 determined independently. The in-cell NMR approach can thus provide accurate high-resolution structures of proteins in living environments.	[Sakakibara, Daisuke; Sasaki, Atsuko; Ikeya, Teppei; Hamatsu, Junpei; Hanashima, Tomomi; Mishima, Masaki; Guentert, Peter; Ito, Yutaka] Tokyo Metropolitan Univ, Dept Chem, Tokyo 1920397, Japan; [Sakakibara, Daisuke; Sasaki, Atsuko; Hamatsu, Junpei; Mishima, Masaki; Shirakawa, Masahiro; Ito, Yutaka] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan; [Ikeya, Teppei; Guentert, Peter] Goethe Univ Frankfurt, Inst Biophys Chem, D-60438 Frankfurt, Germany; [Ikeya, Teppei; Guentert, Peter] Goethe Univ Frankfurt, Ctr Biomol Magnet Resonance, D-60438 Frankfurt, Germany; [Yoshimasu, Masatoshi] RIKEN, Cellular & Mol Biol Lab, Wako, Saitama 3510198, Japan; [Hayashi, Nobuhiro] Fujita Hlth Univ, Inst Comprehens Med Sci, Div Biomed Polymer Sci, Toyoake, Aichi 4701192, Japan; [Mikawa, Tsutomu; Ito, Yutaka] RIKEN, Res Grp Biosupramol Struct Funct, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Waelchli, Markus] Bruker BioSpin, Tsukuba, Ibaraki 3050051, Japan; [Smith, Brian O.] Univ Glasgow, Fac Biomed & Life Sci, Div Mol & Cellular Biol, Glasgow G12 8QQ, Lanark, Scotland; [Shirakawa, Masahiro] Kyoto Univ, Grad Sch Engn, Dept Mol Engn, Nishikyo Ku, Kyoto 6158510, Japan; [Guentert, Peter] Frankfurt Inst Adv Studies, D-60438 Frankfurt, Germany	Tokyo Metropolitan University; Japan Science & Technology Agency (JST); Goethe University Frankfurt; Goethe University Frankfurt; RIKEN; Fujita Health University; RIKEN; Bruker Corporation; Bruker BioSpin GmbH; University of Glasgow; Kyoto University	Ito, Y (corresponding author), Tokyo Metropolitan Univ, Dept Chem, 1-1 Minami Osawa, Tokyo 1920397, Japan.	ito-yutaka@tmu.ac.jp	Ito, Yutaka/P-2604-2015; Mikawa, Tsutomu/E-6510-2013; Smith, Brian/AAJ-9393-2020; Hayashi, Nobuhiro/F-6088-2011; Smith, Brian O/J-1899-2015; Güntert, Peter/L-5577-2013	Ito, Yutaka/0000-0002-1030-4660; Mikawa, Tsutomu/0000-0003-2325-5084; Smith, Brian/0000-0003-3363-4168; Hayashi, Nobuhiro/0000-0002-9950-094X; Smith, Brian O/0000-0003-3363-4168; Güntert, Peter/0000-0002-2911-7574	CREST, Japan Science and Technology Agency (JST); Molecular Ensemble Program, RIKEN; Japanese Ministry of Education, Sports, Culture, Science, and Technology; Volkswagen Foundation;  [TTHA1718]	CREST, Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Molecular Ensemble Program, RIKEN; Japanese Ministry of Education, Sports, Culture, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Volkswagen Foundation(Volkswagen); 	The authors thank S. Kuramitsu for providing the plasmid encoding TTHA1718, and D. Nietlispach for setting up 3D NMR experiments with nonlinear sampling schemes and <SUP>15</SUP>N relaxation experiments, T. Anzai for assistance with NMR measurements, and H. Koyama and A. Iwasaki for sample preparations. This work was supported in part by CREST, Japan Science and Technology Agency (JST), the Molecular Ensemble Program, RIKEN, Grants-in-Aid for Scientific Research of Priority Areas from the Japanese Ministry of Education, Sports, Culture, Science, and Technology on 'Molecular Soft Interactions Regulating Membrane Interface of Biological Systems' and 'Molecular Science for Supra Functional Systems - Development of Advanced Methods for Exploring Elementary Process', and by the Volkswagen Foundation.	BARNA JCJ, 1987, J MAGN RESON, V73, P69, DOI 10.1016/0022-2364(87)90225-3; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Burz DS, 2006, NAT METHODS, V3, P91, DOI 10.1038/NMETH851; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Dedmon MM, 2002, P NATL ACAD SCI USA, V99, P12681, DOI 10.1073/pnas.202331299; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; Gardy JL, 2005, BIOINFORMATICS, V21, P617, DOI 10.1093/bioinformatics/bti057; Gardy JL, 2003, NUCLEIC ACIDS RES, V31, P3613, DOI 10.1093/nar/gkg602; Guntert P, 2003, PROG NUCL MAG RES SP, V43, P105, DOI 10.1016/S0079-6565(03)00021-9; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hayashi N, 1998, PROTEIN EXPRES PURIF, V12, P25, DOI 10.1006/prep.1997.0807; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Kainosho M, 2006, NATURE, V440, P52, DOI 10.1038/nature04525; Koradi R, 2000, COMPUT PHYS COMMUN, V124, P139, DOI 10.1016/S0010-4655(99)00436-1; KRAULIS PJ, 1989, J MAGN RESON, V84, P627, DOI 10.1016/0022-2364(89)90130-3; KRAULIS PJ, 1994, BIOCHEMISTRY-US, V33, P3515, DOI 10.1021/bi00178a008; LAUE ED, 1986, J MAGN RESON, V68, P14, DOI 10.1016/0022-2364(86)90312-4; Li CG, 2008, J AM CHEM SOC, V130, P6310, DOI 10.1021/ja801020z; McNulty BC, 2006, J MOL BIOL, V355, P893, DOI 10.1016/j.jmb.2005.11.033; Mueller GA, 2000, J MOL BIOL, V300, P197, DOI 10.1006/jmbi.2000.3842; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Reardon PN, 2005, J AM CHEM SOC, V127, P10848, DOI 10.1021/ja053145k; Reckel S, 2007, PROG NUCL MAG RES SP, V51, P91, DOI 10.1016/j.pnmrs.2007.02.002; Rosen MK, 1996, J MOL BIOL, V263, P627, DOI 10.1006/jmbi.1996.0603; Rovnyak D, 2004, J MAGN RESON, V170, P15, DOI 10.1016/j.jmr.2004.05.016; Sakai T, 2006, J BIOMOL NMR, V36, P179, DOI 10.1007/s10858-006-9079-9; SCHMEIDER P, 1994, J BIOMOL NMR, V4, P483, DOI 10.1007/BF00156615; Selenko P, 2007, J STRUCT BIOL, V158, P244, DOI 10.1016/j.jsb.2007.04.001; Selenko P, 2006, P NATL ACAD SCI USA, V103, P11904, DOI 10.1073/pnas.0604667103; Serber Z, 2005, METHOD ENZYMOL, V394, P17, DOI 10.1016/S0076-6879(05)94002-0; Serber Z, 2004, J AM CHEM SOC, V126, P7119, DOI 10.1021/ja049977k; Serber Z, 2001, J AM CHEM SOC, V123, P8895, DOI 10.1021/ja0112846; Serber Z, 2001, J AM CHEM SOC, V123, P2446, DOI 10.1021/ja0057528; Serber Z, 2006, NAT PROTOC, V1, P2701, DOI 10.1038/nprot.2006.181; Thorstenson YR, 1997, J BACTERIOL, V179, P5333, DOI 10.1128/jb.179.17.5333-5339.1997; Wuthrich K., 1986, NMR PROTEINS NUCL AC	37	271	276	2	132	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 5	2009	458	7234					102	U10		10.1038/nature07814	http://dx.doi.org/10.1038/nature07814			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414AJ	19262674				2022-12-01	WOS:000263836000041
J	Bokov, K; Steinberg, SV				Bokov, Konstantin; Steinberg, Sergey V.			A hierarchical model for evolution of 23S ribosomal RNA	NATURE			English	Article							PEPTIDYL TRANSFERASE CENTER; ANGSTROM RESOLUTION; BOND FORMATION; SUBUNIT; BASE; SITE; ORIGIN	The emergence of the ribosome constituted a pivotal step in the evolution of life. This event happened nearly four billion years ago, and any traces of early stages of ribosome evolution are generally thought to have completely eroded away. Surprisingly, a detailed analysis of the structure of the modern ribosome reveals a concerted and modular scheme of its early evolution.	[Bokov, Konstantin; Steinberg, Sergey V.] Univ Montreal, Dept Biochim, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Steinberg, SV (corresponding author), Univ Montreal, Dept Biochim, Montreal, PQ H3C 3J7, Canada.	serguei.chteinberg@umontreal.ca			NSERC	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	We thank L. Brakier-Gingras, A. Mankin, S. Michnick and I. Ponomarenko for advice and comments. This work was supported by a grant from NSERC.	Agmon F, 2005, BIOL CHEM, V386, P833, DOI 10.1515/BC.2005.098; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-2; CRICK FHC, 1968, J MOL BIOL, V38, P367, DOI 10.1016/0022-2836(68)90392-6; Doherty EA, 2001, NAT STRUCT BIOL, V8, P339, DOI 10.1038/86221; Doudna JA, 2002, CELL, V109, P153, DOI 10.1016/S0092-8674(02)00725-0; GILBERT W, 1986, NATURE, V319, P618, DOI 10.1038/319618a0; GUTELL RR, 1994, MICROBIOL REV, V58, P10, DOI 10.1128/MMBR.58.1.10-26.1994; Hansen JL, 2002, P NATL ACAD SCI USA, V99, P11670, DOI 10.1073/pnas.172404099; Harms J, 2001, CELL, V107, P679, DOI 10.1016/S0092-8674(01)00546-3; Kavran JM, 2007, J MOL BIOL, V371, P1047, DOI 10.1016/j.jmb.2007.05.091; Kim DF, 1999, MOL CELL, V4, P859, DOI 10.1016/S1097-2765(00)80395-0; Nikulin A, 2003, NAT STRUCT BIOL, V10, P104, DOI 10.1038/nsb886; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; Nissen P, 2001, P NATL ACAD SCI USA, V98, P4899, DOI 10.1073/pnas.081082398; NOLLER HF, 1992, SCIENCE, V256, P1416, DOI 10.1126/science.1604315; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Polacek N, 2005, CRIT REV BIOCHEM MOL, V40, P285, DOI 10.1080/10409230500326334; SAMAHA RR, 1995, NATURE, V377, P309, DOI 10.1038/377309a0; Savelsbergh A, 2000, J BIOL CHEM, V275, P890, DOI 10.1074/jbc.275.2.890; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; STILLMAN B, 2001, RIBOSOME; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Zhang BL, 1997, NATURE, V390, P96, DOI 10.1038/36375	25	153	159	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2009	457	7232					977	980		10.1038/nature07749	http://dx.doi.org/10.1038/nature07749			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HF	19225518				2022-12-01	WOS:000263425400035
J	Willis, HWM; Willis, NM; Willis, GW; Ali, FR; Ball, C				Willis, Henry W. M.; Willis, Nichola M.; Willis, George W.; Ali, Faisal R.; Ball, Colin			A Patient's Journey Coeliac disease in childhood	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Ali, Faisal R.; Ball, Colin] Kings Coll Hosp London, Dept Child Hlth, London SE5 9RS, England	King's College Hospital NHS Foundation Trust; King's College Hospital	Ali, FR (corresponding author), Kings Coll Hosp London, Dept Child Hlth, London SE5 9RS, England.	f.r.ali.01@cantab.net		Ali, Faisal/0000-0002-8588-791X				GODLEE F, 2009, BRIT MED J, V338, pB821; Harnden A, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b491; Jones R, 2009, BRIT MED J, V338, DOI 10.1136/bmj.a3058; Silvester JA, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b380	4	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 19	2009	338								a3066	10.1136/bmj.a3066	http://dx.doi.org/10.1136/bmj.a3066			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417CH	19228764				2022-12-01	WOS:000264052200004
J	Gross, O; Poeck, H; Bscheider, M; Dostert, C; Hannesschlager, N; Endres, S; Hartmann, G; Tardivel, A; Schweighoffer, E; Tybulewicz, V; Mocsai, A; Tschopp, J; Ruland, J				Gross, Olaf; Poeck, Hendrik; Bscheider, Michael; Dostert, Catherine; Hannesschlaeger, Nicole; Endres, Stefan; Hartmann, Gunther; Tardivel, Aubry; Schweighoffer, Edina; Tybulewicz, Victor; Mocsai, Attila; Tschopp, Juerg; Ruland, Juergen			Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence	NATURE			English	Article							NALP3 INFLAMMASOME; RHEUMATOID-ARTHRITIS; TYROSINE KINASE; ACTIVATION; RECEPTOR; IL-1-BETA; INHIBITOR; DEFICIENT; CRYSTALS; IMMUNITY	Fungal infections represent a serious threat, particularly in immunocompromised patients(1). Interleukin-1 beta (IL-1 beta) is a key pro-inflammatory factor in innate antifungal immunity(2). The mechanism by which the mammalian immune system regulates IL-1 beta production after fungal recognition is unclear. Two signals are generally required for IL-1 beta production: an NF-kappa B-dependent signal that induces the synthesis of pro-IL-1 beta (p35), and a second signal that triggers proteolytic pro-IL-1 beta processing to produce bioactive IL-1 beta (p17) via Caspase-1-containing multiprotein complexes called inflammasomes(3). Here we demonstrate that the tyrosine kinase Syk, operating downstream of several immunoreceptor tyrosine-based activation motif (ITAM)-coupled fungal pattern recognition receptors, controls both pro-IL-1 beta synthesis and inflammasome activation after cell stimulation with Candida albicans. Whereas Syk signalling for pro-IL-1 beta synthesis selectively uses the Card9 pathway, inflammasome activation by the fungus involves reactive oxygen species production and potassium efflux. Genetic deletion or pharmalogical inhibition of Syk selectively abrogated inflammasome activation by C. albicans but not by inflammasome activators such as Salmonella typhimurium or the bacterial toxin nigericin. Nlrp3 (also known as NALP3) was identified as the critical NOD-like receptor family member that transduces the fungal recognition signal to the inflammasome adaptor Asc (Pycard) for Caspase-1 (Casp1) activation and pro-IL-1 beta processing. Consistent with an essential role for Nlrp3 inflammasomes in antifungal immunity, we show that Nlrp3-deficient mice are hypersusceptible to Candida albicans infection. Thus, our results demonstrate the molecular basis for IL-1 beta production after fungal infection and identify a crucial function for the Nlrp3 inflammasome in mammalian host defence in vivo.	[Gross, Olaf; Poeck, Hendrik; Hannesschlaeger, Nicole; Ruland, Juergen] Tech Univ Munich, Klinikum Rechts Isar, Med Klin 3, D-81675 Munich, Germany; [Gross, Olaf; Dostert, Catherine; Tardivel, Aubry; Tschopp, Juerg] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; [Bscheider, Michael; Endres, Stefan] Univ Munich, Dept Internal Med, Div Clin Pharmacol, D-80539 Munich, Germany; [Hartmann, Gunther] Univ Klinikum Bonn, Inst Clin Chem & Pharmacol, D-53127 Bonn, Germany; [Schweighoffer, Edina; Tybulewicz, Victor] Natl Inst Med Res, London NW7 1AA, England; [Mocsai, Attila] Semmelweis Univ, Sch Med, Budapest, Hungary	Technical University of Munich; University of Lausanne; University of Munich; University of Bonn; MRC National Institute for Medical Research; Semmelweis University	Ruland, J (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Med Klin 3, Ismaninger Str 22, D-81675 Munich, Germany.	jruland@lrz.tum.de	Hartmann, Gunther/P-7492-2017; Mocsai, Attila/B-2792-2008; Dostert, Catherine/AAJ-5473-2020; Gross, Olaf/E-4570-2010; Ruland, Jürgen/Q-6680-2018	Hartmann, Gunther/0000-0003-1021-2018; Gross, Olaf/0000-0001-8660-3619; Ruland, Jürgen/0000-0002-8381-3597; Mocsai, Attila/0000-0002-0512-1157; Tybulewicz, Victor/0000-0003-2439-0798	Marie Curie RTN ApopTrain Fellowship; Swiss National Science Foundation; Deutsche Krebshilfe; Sonderforschungsbereich; Deutsche Forschungsgemeinschaft; Medical Research Council [MC_U117527252] Funding Source: researchfish; MRC [MC_U117527252] Funding Source: UKRI	Marie Curie RTN ApopTrain Fellowship(European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Deutsche Krebshilfe(Deutsche Krebshilfe); Sonderforschungsbereich(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank C. Peschel for helpful conversations, K. Schroder for critically reading the manuscript, RIGEL Inc. for providing the Syk inhibitor R406, P. Vandenabeele for the anti-Caspase-1 antibody and V. Dixit for Nlrc4 2/2 mice. O. G. is supported by a Marie Curie RTN ApopTrain Fellowship. This work was supported by Swiss National Science Foundation National Center of Competence in Research molecular oncology and Mugen grants to J. T., an EMBO long-term fellowship to C. D. and a Max-Eder-Program grant from Deutsche Krebshilfe and Sonderforschungsbereich grants from Deutsche Forschungsgemeinschaft to J. R.	Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Braselmann S, 2006, J PHARMACOL EXP THER, V319, P998, DOI 10.1124/jpet.106.109058; Bugarcic A, 2008, GLYCOBIOLOGY, V18, P679, DOI 10.1093/glycob/cwn046; Chen ST, 2008, NATURE, V453, P672, DOI 10.1038/nature07013; Cruz CM, 2007, J BIOL CHEM, V282, P2871, DOI 10.1074/jbc.M608083200; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hara H, 2007, NAT IMMUNOL, V8, P619, DOI 10.1038/ni1466; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Mencacci A, 2000, INFECT IMMUN, V68, P5126, DOI 10.1128/IAI.68.9.5126-5131.2000; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Ng G, 2008, IMMUNITY, V29, P807, DOI 10.1016/j.immuni.2008.09.013; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Pine PR, 2007, CLIN IMMUNOL, V124, P244, DOI 10.1016/j.clim.2007.03.543; Robinson MJ, 2006, NAT IMMUNOL, V7, P1258, DOI 10.1038/ni1417; Romani L, 2004, NAT REV IMMUNOL, V4, P11, DOI 10.1038/nri1255; Underhill DM, 2005, BLOOD, V106, P2543, DOI 10.1182/blood-2005-03-1239; Vasiljeva O, 2008, ONCOGENE, V27, P4191, DOI 10.1038/onc.2008.59; Vonk AG, 2006, J INFECT DIS, V193, P1419, DOI 10.1086/503363; Weinblatt ME, 2008, ARTHRITIS RHEUM-US, V58, P3309, DOI 10.1002/art.23992; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651; Yu HB, 2008, CELL HOST MICROBE, V4, P198, DOI 10.1016/j.chom.2008.08.007	29	663	695	2	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2009	459	7245					433	U149		10.1038/nature07965	http://dx.doi.org/10.1038/nature07965			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448DQ	19339971				2022-12-01	WOS:000266243700047
J	Adams, GB; Alley, IR; Chung, U; Chabner, KT; Jeanson, NT; Lo Celso, C; Marsters, ES; Chen, M; Weinstein, LS; Lin, CP; Kronenberg, HM; Scadden, DT				Adams, Gregor B.; Alley, Ian R.; Chung, Ung-il; Chabner, Karissa T.; Jeanson, Nathaniel T.; Lo Celso, Cristina; Marsters, Emily S.; Chen, Min; Weinstein, Lee S.; Lin, Charles P.; Kronenberg, Henry M.; Scadden, David T.			Haematopoietic stem cells depend on G alpha(s)-mediated signalling to engraft bone marrow	NATURE			English	Article							IN-VIVO; CHOLERA-TOXIN; MICE; DIFFERENTIATION; LYMPHOPOIESIS; MYELOPOIESIS; MIGRATION; SELECTINS; CXCR4	Haematopoietic stem and progenitor cells (HSPCs) change location during development(1) and circulate in mammals throughout life(2), moving into and out of the bloodstream to engage bone marrow niches in sequential steps of homing, engraftment and retention(3-5). Here we show that HSPC engraftment of bone marrow in fetal development is dependent on the guanine-nucleotide-binding protein stimulatory a subunit (G alpha(s)). HSPCs from adult mice deficient in G alpha(s) (G alpha(-/-)(s)) differentiate and undergo chemotaxis, but also do not home to or engraft in the bone marrow in adult mice and demonstrate a marked inability to engage the marrow microvasculature. If deleted after engraftment, G alpha(s) deficiency did not lead to lack of retention in the marrow, rather cytokine-induced mobilization into the blood was impaired. Testing whether activation of G alpha(s) affects HSPCs, pharmacological activators enhanced homing and engraftment in vivo. G alpha(s) governs specific aspects of HSPC localization under physiological conditions in vivo and may be pharmacologically targeted to improve transplantation efficiency.	[Adams, Gregor B.; Alley, Ian R.; Chabner, Karissa T.; Jeanson, Nathaniel T.; Lo Celso, Cristina; Marsters, Emily S.; Scadden, David T.] Harvard Univ, Sch Med, Ctr Regenerat Med, Boston, MA 02114 USA; [Chung, Ung-il; Kronenberg, Henry M.] Harvard Univ, Sch Med, Endocrine Unit, Boston, MA 02114 USA; [Lin, Charles P.] Harvard Univ, Sch Med, Adv Microscopy Program, Ctr Syst Biol, Boston, MA 02114 USA; [Lin, Charles P.] Harvard Univ, Sch Med, Wellman Ctr Photomed, Massachusetts Gen Hosp, Boston, MA 02114 USA; [Adams, Gregor B.; Lo Celso, Cristina; Scadden, David T.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Scadden, David T.] Harvard Univ, Sch Med, Dept Stem Cell & Regenerat Biol, Boston, MA 02114 USA; [Chen, Min; Weinstein, Lee S.] NIDDKD, Bethesda, MD 20892 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Scadden, DT (corresponding author), Harvard Univ, Sch Med, Ctr Regenerat Med, Boston, MA 02114 USA.	dscadden@mgh.harvard.edu	Weinstein, Lee S/I-5575-2015	Weinstein, Lee/0000-0002-1899-5152; Lo Celso, Cristina/0000-0002-1163-4207	Burroughs Wellcome Fund, Doris Duke Charitable Trust; Harvard Stem Cell Institute; National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL081030] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK043313] Funding Source: NIH RePORTER	Burroughs Wellcome Fund, Doris Duke Charitable Trust(Burroughs Wellcome FundDoris Duke Charitable Foundation (DDCF)); Harvard Stem Cell Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Financial support for this work was provided by the Burroughs Wellcome Fund, Doris Duke Charitable Trust (D. T. S.), the Harvard Stem Cell Institute (C. P. L.) and the National Institutes of Health (G. B. A., C. P. L., H. M. K., D. T. S.).	Bastepe M, 2004, P NATL ACAD SCI USA, V101, P14794, DOI 10.1073/pnas.0405091101; Broxmeyer HE, 2007, ANN NY ACAD SCI, V1106, P1, DOI 10.1196/annals.1392.013; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; DEXTER TM, 1985, BLOOD, V65, P1544, DOI 10.1182/blood.V65.6.1544.bloodjournal6561544; Foudi A, 2006, BLOOD, V107, P2243, DOI 10.1182/blood-2005-02-0581; Kawabata T, 1999, P NATL ACAD SCI USA, V96, P5663, DOI 10.1073/pnas.96.10.5663; Lapidot T, 2005, BLOOD, V106, P1901, DOI 10.1182/blood-2005-04-1417; LONG MW, 1988, EXP HEMATOL, V16, P195; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Mazo IB, 1998, J EXP MED, V188, P465, DOI 10.1084/jem.188.3.465; Mikkola HKA, 2006, DEVELOPMENT, V133, P3733, DOI 10.1242/dev.02568; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Papayannopoulou T, 2001, BLOOD, V98, P2403, DOI 10.1182/blood.V98.8.2403; PLOEMACHER RE, 1991, BLOOD, V78, P2527; Sipkins DA, 2005, NATURE, V435, P969, DOI 10.1038/nature03703; Stier S, 2002, BLOOD, V99, P2369, DOI 10.1182/blood.V99.7.2369; Wright DE, 2002, J EXP MED, V195, P1145, DOI 10.1084/jem.20011284; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Yu SH, 1998, P NATL ACAD SCI USA, V95, P8715, DOI 10.1073/pnas.95.15.8715	21	53	59	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 7	2009	459	7243					103	U111		10.1038/nature07859	http://dx.doi.org/10.1038/nature07859			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441WN	19322176	Green Accepted			2022-12-01	WOS:000265801300038
J	Woltjen, K; Michael, IP; Mohseni, P; Desai, R; Mileikovsky, M; Hamalainen, R; Cowling, R; Wang, W; Liu, PT; Gertsenstein, M; Kaji, K; Sung, HK; Nagy, A				Woltjen, Knut; Michael, Iacovos P.; Mohseni, Paria; Desai, Ridham; Mileikovsky, Maria; Haemaelaeinen, Riikka; Cowling, Rebecca; Wang, Wei; Liu, Pentao; Gertsenstein, Marina; Kaji, Keisuke; Sung, Hoon-Ki; Nagy, Andras			piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells	NATURE			English	Article							MAMMALIAN-CELLS; MOUSE; EXPRESSION; GENERATION; INDUCTION; MICE; INSERTIONS; VECTORS; GENE	Transgenic expression of just four defined transcription factors (c-Myc, Klf4, Oct4 and Sox2) is sufficient to reprogram somatic cells to a pluripotent state(1-4). The resulting induced pluripotent stem (iPS) cells resemble embryonic stem cells in their properties and potential to differentiate into a spectrum of adult cell types. Current reprogramming strategies involve retroviral(1), lentiviral(5), adenoviral(6) and plasmid(7) transfection to deliver reprogramming factor transgenes. Although the latter two methods are transient and minimize the potential for insertion mutagenesis, they are currently limited by diminished reprogramming efficiencies. piggyBac (PB) transposition is host-factor independent, and has recently been demonstrated to be functional in various human and mouse cell lines(8-11). The PB transposon/transposase system requires only the inverted terminal repeats flanking a transgene and transient expression of the transposase enzyme to catalyse insertion or excision events(12). Here we demonstrate successful and efficient reprogramming of murine and human embryonic fibroblasts using doxycycline-inducible transcription factors delivered by PB transposition(13). Stable iPS cells thus generated express characteristic pluripotency markers and succeed in a series of rigorous differentiation assays. By taking advantage of the natural propensity of the PB system for seamless excision(12), we show that the individual PB insertions can be removed from established iPS cell lines, providing an invaluable tool for discovery. In addition, we have demonstrated the traceless removal of reprogramming factors joined with viral 2A sequences(14) delivered by a single transposon from murine iPS lines. We anticipate that the unique properties of this virus-independent simplification of iPS cell production will accelerate this field further towards full exploration of the reprogramming process and future cell-based therapies.	[Woltjen, Knut; Michael, Iacovos P.; Mohseni, Paria; Desai, Ridham; Mileikovsky, Maria; Haemaelaeinen, Riikka; Cowling, Rebecca; Gertsenstein, Marina; Sung, Hoon-Ki; Nagy, Andras] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Michael, Iacovos P.; Mohseni, Paria; Desai, Ridham; Nagy, Andras] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Wang, Wei; Liu, Pentao] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, Cambs, England; [Kaji, Keisuke] Univ Edinburgh, Inst Stem Cell Res, Ctr Regenerat Med, MRC, Edinburgh EH9 3JQ, Midlothian, Scotland	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; Wellcome Trust Sanger Institute; University of Edinburgh	Nagy, A (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	nagy@lunenfeld.ca	Sung, Hoon-Ki/G-3049-2013; Sung, Hoon-Ki/A-1922-2016; Nagy, Andras/G-6465-2013; Michael, Iacovos P/C-8695-2016; Wilson, Matthew H/K-3193-2013; Martikainen, Riikka/AAR-8397-2020	Sung, Hoon-Ki/0000-0001-6677-9385; Nagy, Andras/0000-0003-4311-0413; Michael, Iacovos P/0000-0001-7674-1233; Martikainen, Riikka/0000-0002-5102-0672; Kaji, Keisuke/0000-0001-5946-8415; Woltjen, Knut/0000-0003-2293-1183	Wellcome Trust; Canadian Stem Cell Network; JDRF; MRC [G0700672] Funding Source: UKRI; Medical Research Council [G0700711B, G0700672] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Canadian Stem Cell Network; JDRF(Juvenile Diabetes Research Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank J. Moffat for time-lapse image acquisition, P.-A. Pentilla for cell sorting, M.-S. Eiymo for assisting with initial PB test vector construction, J. Ure and M. Kownacka for technical assistance, M. Kibschull for establishing human embryonic fibroblasts, A. Cheung for discussions, and K. Vintersten for critical reading of the manuscript. This work was supported by the Wellcome Trust to P. L., and grants awarded to A. N. from the Canadian Stem Cell Network and JDRF.	Agha-Mohammadi S, 2004, J GENE MED, V6, P817, DOI 10.1002/jgm.566; Behringer R., 2003, MANIPULATING MOUSE E; Belteki G, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni051; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Cadinanos J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm446; CARY LC, 1989, VIROLOGY, V172, P156, DOI 10.1016/0042-6822(89)90117-7; Dafa'alla TH, 2006, NAT BIOTECHNOL, V24, P820, DOI 10.1038/nbt1221; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Ellis J, 2005, HUM GENE THER, V16, P1241, DOI 10.1089/hum.2005.16.1241; Fraser MJ, 1996, INSECT MOL BIOL, V5, P141, DOI 10.1111/j.1365-2583.1996.tb00048.x; FUJIWARA Y, 1994, P NATL ACAD SCI USA, V91, P12258, DOI 10.1073/pnas.91.25.12258; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Mitra R, 2008, EMBO J, V27, P1097, DOI 10.1038/emboj.2008.41; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wang W, 2008, P NATL ACAD SCI USA, V105, P9290, DOI 10.1073/pnas.0801017105; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Wilson MH, 2007, MOL THER, V15, P139, DOI 10.1038/sj.mt.6300028; Wu SCY, 2006, P NATL ACAD SCI USA, V103, P15008, DOI 10.1073/pnas.0606979103	29	1297	1538	5	340	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 9	2009	458	7239					766	U106		10.1038/nature07863	http://dx.doi.org/10.1038/nature07863			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433GZ	19252478	Green Accepted			2022-12-01	WOS:000265193600042
J	Donlea, JM; Ramanan, N; Shaw, PJ				Donlea, Jeffrey M.; Ramanan, Narendrakumar; Shaw, Paul J.			Use-Dependent Plasticity in Clock Neurons Regulates Sleep Need in Drosophila	SCIENCE			English	Article							PDF CELLS; GENE; DEPRIVATION; MEMORY; SRF; CONSOLIDATION; MELANOGASTER; MUTANTS; CIRCUIT; AROUSAL	Sleep is important for memory consolidation and is responsive to waking experience. Clock circuitry is uniquely positioned to coordinate interactions between processes underlying memory and sleep need. Flies increase sleep both after exposure to an enriched social environment and after protocols that induce long-term memory. We found that flies mutant for rutabaga, period, and blistered were deficient for experience-dependent increases in sleep. Rescue of each of these genes within the ventral lateral neurons (LN(V)s) restores increased sleep after social enrichment. Social experiences that induce increased sleep were associated with an increase in the number of synaptic terminals in the LNV projections into the medulla. The number of synaptic terminals was reduced during sleep and this decline was prevented by sleep deprivation.	[Donlea, Jeffrey M.; Ramanan, Narendrakumar; Shaw, Paul J.] Washington Univ, Dept Anat & Neurobiol, St Louis, MO 63130 USA	Washington University (WUSTL)	Shaw, PJ (corresponding author), Washington Univ, Dept Anat & Neurobiol, 660 S Euclid Ave, St Louis, MO 63130 USA.	shawp@pcg.wustl.edu	RAMANAN, NARENDRAKUMAR/L-7487-2018		NIH [R01-NS051305-01A1, T32-GM008151]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS063514, R01NS051305] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Thimgan, W. Vanderheyden, P. Gray, and P. Taghert for comments. This study was funded by NIH grants R01-NS051305-01A1 and T32-GM008151.	AFFOLTER M, 1994, DEVELOPMENT, V120, P743; Barth M, 1997, LEARN MEMORY, V4, P219, DOI 10.1101/lm.4.2.219; Decker S, 2007, P NATL ACAD SCI USA, V104, P15905, DOI 10.1073/pnas.0702082104; Etkin A, 2006, NEURON, V50, P127, DOI 10.1016/j.neuron.2006.03.013; Fernandez MP, 2008, PLOS BIOL, V6, P518, DOI 10.1371/journal.pbio.0060069; Foltenyi K, 2007, NAT NEUROSCI, V10, P1160, DOI 10.1038/nn1957; FRISTROM D, 1994, DEVELOPMENT, V120, P2661; Ganguly-Fitzgerald I, 2006, SCIENCE, V313, P1775, DOI 10.1126/science.1130408; GAUTHIERROUVIERE C, 1993, EXP CELL RES, V209, P208, DOI 10.1006/excr.1993.1303; Graves LA, 2003, LEARN MEMORY, V10, P168, DOI 10.1101/lm.48803; HELFRICHFORSTER C, 1993, J COMP NEUROL, V337, P177, DOI 10.1002/cne.903370202; Knoll B, 2006, NAT NEUROSCI, V9, P195, DOI 10.1038/nn1627; Montagne J, 1996, DEVELOPMENT, V122, P2589; Parisky KM, 2008, NEURON, V60, P672, DOI 10.1016/j.neuron.2008.10.042; RECHTSCHAFFEN A, 1983, SCIENCE, V221, P182, DOI 10.1126/science.6857280; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Roch F, 1998, DEVELOPMENT, V125, P1823; Sakai T, 2004, P NATL ACAD SCI USA, V101, P16058, DOI 10.1073/pnas.0401472101; Shang YH, 2008, P NATL ACAD SCI USA, V105, P19587, DOI 10.1073/pnas.0809577105; Shaw PJ, 2002, NATURE, V417, P287, DOI 10.1038/417287a; Sheeba V, 2008, CURR BIOL, V18, P1537, DOI 10.1016/j.cub.2008.08.033; Tononi G, 2003, BRAIN RES BULL, V62, P143, DOI 10.1016/j.brainresbull.2003.09.004; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8; Zhang YL, 2007, NEURON, V53, P201, DOI 10.1016/j.neuron.2006.12.016	24	171	172	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2009	324	5923					105	108		10.1126/science.1166657	http://dx.doi.org/10.1126/science.1166657			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427TN	19342592	Green Accepted			2022-12-01	WOS:000264802100043
J	Saijo, K; Winner, B; Carson, CT; Collier, JG; Boyer, L; Rosenfeld, MG; Gage, FH; Glass, CK				Saijo, Kaoru; Winner, Beate; Carson, Christian T.; Collier, Jana G.; Boyer, Leah; Rosenfeld, Michael G.; Gage, Fred H.; Glass, Christopher K.			A Nurr1/CoREST Pathway in Microglia and Astrocytes Protects Dopaminergic Neurons from Inflammation-Induced Death	CELL			English	Article							ORPHAN NUCLEAR RECEPTOR; PARKINSONS-DISEASE; GENE-EXPRESSION; ALPHA-SYNUCLEIN; ACTIVATION; NEURODEGENERATION; CELLS; NURR1; HETERODIMERIZATION; PHOSPHORYLATION	Nurr1, an orphan nuclear receptor, plays an essential role in the generation and maintenance of dopaminergic neurons in the brain. Rare mutations in Nurr1 are associated with familial Parkinson's disease, but the underlying basis for this relationship has not been established. Here, we demonstrate that Nurr1 unexpectedly functions to inhibit expression of pro-inflammatory neurotoxic mediators in both microglia and astrocytes. Reduced Nurr1 expression results in exaggerated inflammatory responses in microglia that are further amplified by astrocytes, leading to the production of factors that cause death of tyrosine hydroxylase-expressing neurons. Nurr1 exerts anti-inflammatory effects by docking to NF-kappa B-p65 on target inflammatory gene promoters in a signal-dependent manner. Subsequently, Nurr1 recruits the CoREST corepressor complex, resulting in clearance of NF-kappa B-p65 and transcriptional repression. These studies suggest that Nurr1 protects against loss of dopaminergic neurons in Parkinson's disease in part by limiting the production of neurotoxic mediators by microglia and astrocytes.	[Saijo, Kaoru; Collier, Jana G.; Glass, Christopher K.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Rosenfeld, Michael G.; Glass, Christopher K.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Rosenfeld, Michael G.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Boyer, Leah] Univ Calif San Diego, Sch Med, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Winner, Beate; Carson, Christian T.; Boyer, Leah; Gage, Fred H.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; Salk Institute	Saijo, K (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.	ksaijo@ucsd.edu; ckg@ucsd.edu	Winner, Beate/K-3730-2012; Winner, Beate/O-8213-2019; Glass, Christopher/AAI-3933-2021	Winner, Beate/0000-0002-6909-0564; Winner, Beate/0000-0002-6909-0564; Glass, Christopher/0000-0003-4344-3592; Boyer, Leah/0000-0002-0546-4344	NIH [CA52599, DK39949, NS34934, DK1877]; Fondation Leducq; CIRM, ISPEN/Biomeasure; Picower Foundation; Alexander von Humboldt Foundation; NATIONAL CANCER INSTITUTE [R01CA052599] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088129, R01HL059694] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039949, K11DK001877, R01DK018477, R37DK039949, R01DK091183] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034934] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation Leducq(Leducq Foundation); CIRM, ISPEN/Biomeasure(California Institute for Regenerative Medicine); Picower Foundation; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors are grateful to Christian Schmedt, Amy Sullivan, and Mary Lynn Gage for critical reading of the manuscript. We thank Katerina Akassoglou for BV2 cells; Alexander Mata de Urquiza for the NBRE-luciferase construct; Inder Verma for the lentivirus vector; Amir Gamliel for the Myc-SUMO1, 2, and 3 constructs; Roberto Jappelli and Roland Riek for the lentivirus encoding A30P alpha-Synuclein; Richard Mulligan and Jeng-Shin Lee for pHAGE vector. We thank Chris Benner for statistical analysis; Eunice Meija, Robert Aigner, and Rosa Luna for technical assistance; and Lynn Bautista for help with preparing figures. KS, JGC, and CKG are supported by grants from the NIH (CA52599) and Fondation Leducq. F.H.G., B.W., L.B., and C.C. are supported by grants from CIRM, ISPEN/Biomeasure and the Picower Foundation. B.W. is a Feodor-Lynen fellow of the Alexander von Humboldt Foundation. MGR is supported by grants from NIH (DK39949, NS34934, and DK1877) and is an investigator of Howard Hughes Medical Institute.	Aarnisalo P, 2002, J BIOL CHEM, V277, P35118, DOI 10.1074/jbc.M201707200; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Ashburner BP, 2001, MOL CELL BIOL, V21, P7065, DOI 10.1128/MCB.21.20.7065-7077.2001; Atkinson TJ, 2008, INT REV IMMUNOL, V27, P255, DOI 10.1080/08830180801959072; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Barish GD, 2005, MOL ENDOCRINOL, V19, P2466, DOI 10.1210/me.2004-0529; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Bonta PI, 2006, ARTERIOSCL THROM VAS, V26, P2288, DOI 10.1161/01.ATV.0000238346.84458.5d; Brown GC, 2007, BIOCHEM SOC T, V35, P1119, DOI 10.1042/BST0351119; Brundin P, 2008, NAT REV NEUROSCI, V9, P741, DOI 10.1038/nrn2477; Buss H, 2004, J BIOL CHEM, V279, P49571, DOI 10.1074/jbc.C400442200; Di Virgilio F, 2007, TRENDS PHARMACOL SCI, V28, P465, DOI 10.1016/j.tips.2007.07.002; Doi Y, 2008, P NATL ACAD SCI USA, V105, P8381, DOI 10.1073/pnas.0803454105; Farrer MJ, 2006, NAT REV GENET, V7, P306, DOI 10.1038/nrg1831; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Frank-Cannon TC, 2008, J NEUROSCI, V28, P10825, DOI 10.1523/JNEUROSCI.3001-08.2008; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA, V3rd ed.; Galleguillos D, 2004, J BIOL CHEM, V279, P2005, DOI 10.1074/jbc.M308113200; Gao HM, 2008, J NEUROSCI, V28, P7687, DOI 10.1523/JNEUROSCI.0143-07.2008; Glass CK, 2006, NAT REV IMMUNOL, V6, P44, DOI 10.1038/nri1748; GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x; Hartmann A, 2003, EXP NEUROL, V184, P561, DOI 10.1016/j.expneurol.2003.08.004; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Kanei-Ishii C, 2004, GENE DEV, V18, P816, DOI 10.1101/gad.1170604; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Le WD, 2003, NAT GENET, V33, P85, DOI 10.1038/ng1066; Lehnardt S, 2003, P NATL ACAD SCI USA, V100, P8514, DOI 10.1073/pnas.1432609100; Lehnardt S, 2008, J NEUROSCI, V28, P2320, DOI 10.1523/JNEUROSCI.4760-07.2008; Maira M, 1999, MOL CELL BIOL, V19, P7549; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; McGeer PL, 2008, MOVEMENT DISORD, V23, P474, DOI 10.1002/mds.21751; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Meredith GE, 2008, ACTA NEUROPATHOL, V115, P385, DOI 10.1007/s00401-008-0350-x; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Nagatsu T, 2005, CURR PHARM DESIGN, V11, P999, DOI 10.2174/1381612053381620; Nordzell M, 2004, BIOCHEM BIOPH RES CO, V313, P205, DOI 10.1016/j.bbrc.2003.11.079; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Pei LM, 2006, MOL ENDOCRINOL, V20, P786, DOI 10.1210/me.2005-0331; Pei LM, 2005, J BIOL CHEM, V280, P29256, DOI 10.1074/jbc.M502606200; Sakurada K, 1999, DEVELOPMENT, V126, P4017; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Tansey MG, 2007, EXP NEUROL, V208, P1, DOI 10.1016/j.expneurol.2007.07.004; Teismann P, 2004, CELL TISSUE RES, V318, P149, DOI 10.1007/s00441-004-0944-0; THERY C, 1992, J NEUROCHEM, V59, P1183, DOI 10.1111/j.1471-4159.1992.tb08366.x; Verstrepen L, 2008, CELL MOL LIFE SCI, V65, P2964, DOI 10.1007/s00018-008-8064-8; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; Wang ZL, 2003, NATURE, V423, P555, DOI 10.1038/nature01645; Whitton PS, 2007, BRIT J PHARMACOL, V150, P963, DOI 10.1038/sj.bjp.0707167; Yasuda J, 2004, CANCER SCI, V95, P52, DOI 10.1111/j.1349-7006.2004.tb03170.x; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248	52	660	687	1	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 2	2009	137	1					47	59		10.1016/j.cell.2009.01.038	http://dx.doi.org/10.1016/j.cell.2009.01.038			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	427XV	19345186	Green Accepted, Bronze			2022-12-01	WOS:000264813300013
J	Makris, NC; Ratilal, P; Jagannathan, S; Gong, Z; Andrews, M; Bertsatos, I; Godo, OR; Nero, RW; Jech, JM				Makris, Nicholas C.; Ratilal, Purnima; Jagannathan, Srinivasan; Gong, Zheng; Andrews, Mark; Bertsatos, Ioannis; Godo, Olav Rune; Nero, Redwood W.; Jech, J. Michael			Critical Population Density Triggers Rapid Formation of Vast Oceanic Fish Shoals	SCIENCE			English	Article							HERRING CLUPEA-HARENGUS; FISHERIES ACOUSTICS; BEHAVIOR; SCHOOLS; DYNAMICS; COMPLEX; GULF	Similarities in the behavior of diverse animal species that form large groups have motivated attempts to establish general principles governing animal group behavior. It has been difficult, however, to make quantitative measurements of the temporal and spatial behavior of extensive animal groups in the wild, such as bird flocks, fish shoals, and locust swarms. By quantifying the formation processes of vast oceanic fish shoals during spawning, we show that (i) a rapid transition from disordered to highly synchronized behavior occurs as population density reaches a critical value; (ii) organized group migration occurs after this transition; and (iii) small sets of leaders significantly influence the actions of much larger groups. Each of these findings confirms general theoretical predictions believed to apply in nature irrespective of animal species.	[Makris, Nicholas C.; Jagannathan, Srinivasan; Bertsatos, Ioannis] MIT, Cambridge, MA 02139 USA; [Ratilal, Purnima; Gong, Zheng; Andrews, Mark] Northeastern Univ, Boston, MA 02115 USA; [Godo, Olav Rune] Inst Marine Res, N-5817 Bergen, Norway; [Nero, Redwood W.] SE Fisheries Sci Ctr, Pascagoula, MS 39568 USA; [Jech, J. Michael] NE Fisheries Sci Ctr, Woods Hole, MA 02543 USA	Massachusetts Institute of Technology (MIT); Northeastern University; Institute of Marine Research - Norway; National Oceanic Atmospheric Admin (NOAA) - USA	Makris, NC (corresponding author), MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	makris@mit.edu	Gong, Zheng/K-5808-2012	Godo, Olav Rune/0000-0001-8826-8068	National Oceanographic Partnership Program; Office of Naval Research; Alfred P. Sloan Foundation	National Oceanographic Partnership Program; Office of Naval Research(Office of Naval Research); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation)	This research was supported by the National Oceanographic Partnership Program, the Office of Naval Research, and the Alfred P. Sloan Foundation and is a contribution to the Census of Marine Life. We would like to thank the science parties, officers, and crew of the research vessels Oceanus, Endeavor, Delaware II, and Hugh Sharp	Blaxter J.H.S., 1982, Advances in Marine Biology, V20, P1, DOI 10.1016/S0065-2881(08)60140-6; Buhl J, 2006, SCIENCE, V312, P1402, DOI 10.1126/science.1125142; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Croft DP, 2003, FISH FISH, V4, P138, DOI 10.1046/j.1467-2979.2003.00113.x; Godo OR, 2004, ICES J MAR SCI, V61, P1093, DOI 10.1016/j.icesjms.2004.06.009; Gregoire G, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.025702; Hoare DJ, 2000, OIKOS, V89, P546, DOI 10.1034/j.1600-0706.2000.890314.x; Huse I, 1996, ICES J MAR SCI, V53, P863, DOI 10.1006/jmsc.1996.9999; Jech JM, 2006, CAN J FISH AQUAT SCI, V63, P2225, DOI 10.1139/F06-126; Link JS, 2001, J FISH BIOL, V59, P783, DOI 10.1111/j.1095-8649.2001.tb00149.x; Mackinson S, 1999, J FISH BIOL, V55, P972, DOI 10.1111/j.1095-8649.1999.tb00733.x; MacLennan D.N., 1992, SPRINGER SCI BUS MED, V5, P54; MacLennan DN, 2002, ICES J MAR SCI, V59, P365, DOI 10.1006/jmsc.2001.1158; Makris NC, 2006, SCIENCE, V311, P660, DOI 10.1126/science.1121756; MILINSKI M, 1993, PREDATION RISK FEEDI, P285; Nottestad L, 1996, SARSIA, V80, P277, DOI 10.1080/00364827.1996.10413601; Overholtz WJ, 2007, ICES J MAR SCI, V64, P83, DOI 10.1093/icesjms/fsl009; Overholtz W.J., 2006, J NW ATLANTIC FISHER, V36, P127; Overholtz WJ, 2002, FISH RES, V57, P237, DOI 10.1016/S0165-7836(01)00359-9; PITCHER TJ, 2001, ENCY OCEAN SCI, P978; Pitcher TJ., 1993, Behaviour of teleost fishes, P363, DOI 10.1007/978-94-011-1578-0_12; RAY C, 1999, PETERSON FIELD GUIDE; RAYLEIGH JWS, 1976, THEORY SOUND, V2, P1; Reebs SG, 2000, ANIM BEHAV, V59, P403, DOI 10.1006/anbe.1999.1314; Skaret G, 2003, AQUAT LIVING RESOUR, V16, P299, DOI 10.1016/S0990-7440(03)00006-8; Sumpter DJT, 2006, PHILOS T R SOC B, V361, P5, DOI 10.1098/rstb.2005.1733; Toner J, 1998, PHYS REV E, V58, P4828, DOI 10.1103/PhysRevE.58.4828; TORESEN R, 1991, ICES J MAR SCI, V48, P15, DOI 10.1093/icesjms/48.1.15; Urick RJ., 1983, PRINCIPLES UNDERWATE, V3; Vabo R, 2008, ECOL MODEL, V214, P125, DOI 10.1016/j.ecolmodel.2008.01.026; VICSEK T, 1995, PHYS REV LETT, V75, P1226, DOI 10.1103/PhysRevLett.75.1226; Viscido SV, 2005, ECOL MODEL, V183, P347, DOI 10.1016/j.ecolmodel.2004.08.019; ZINKENVICH VN, 1967, ICNAF RES B, V4, P101	33	140	145	3	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 27	2009	323	5922					1734	1737		10.1126/science.1169441	http://dx.doi.org/10.1126/science.1169441			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	424IG	19325116				2022-12-01	WOS:000264559800041
J	Lowther, SA; Curriero, FC; Kalish, BT; Shields, TM; Monze, M; Moss, WJ				Lowther, Sara A.; Curriero, Frank C.; Kalish, Brian T.; Shields, Timothy M.; Monze, Mwaka; Moss, William J.			Population immunity to measles virus and the effect of HIV-1 infection after a mass measles vaccination campaign in Lusaka, Zambia: a cross-sectional survey	LANCET			English	Article							ORAL-FLUID; ETHIOPIA; HETEROSKEDASTICITY; ELIMINATION; EPIDEMIC; OUTBREAK; RUBELLA; IMPACT	Background Measles control efforts are hindered by challenges in sustaining high vaccination coverage, waning immunity in HIV-1-infected children, and clustering of susceptible individuals. Our aim was to assess population immunity to measles virus after a mass vaccination campaign in a region with high HIV prevalence. Methods 3 years after a measles supplemental immunisation activity (SIA), we undertook a cross-sectional survey in Lusaka, Zambia. Households were randomly selected from a satellite image. Children aged 9 months to 5 years from selected households were eligible for enrolment. A questionnaire was administered to the children's caregivers to obtain information about measles vaccination history and history of measles. Oral fluid samples were obtained from children and tested for antibodies to measles virus and HIV-1 by EIA. Findings 1015 children from 668 residences provided adequate specimens. 853 (84%) children had a history of measles vaccination according to either caregiver report or immunisation card. 679 children (67%) had antibodies to measles virus, and 64 (6%) children had antibodies to HIV-1. Children with antibodies to HIV-1 were as likely to have no history of measles vaccination as those without antibodies to HIV-1 (odds ratio [OR] 1.17, 95% CI 0.57-2.41). Children without measles antibodies were more likely to have never received measles vaccine than those with antibodies (adjusted OR 2.50, 1.69-3.71). In vaccinated children, 33 (61%) of 54 children with antibodies to HIV-1 also had antibodies to measles virus, compared with 568 (71%) of 796 children without antibodies to HIV-1 (p=0.1). Interpretation 3 years after an SIA, population immunity to measles was insufficient to interrupt measles virus transmission. The use of oral fluid and satellite images for sampling are potential methods to assess population immunity and the timing of SIAs. Funding Thrasher Research Fund.	[Lowther, Sara A.; Moss, William J.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Curriero, Frank C.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD 21205 USA; [Curriero, Frank C.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA; [Shields, Timothy M.; Moss, William J.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; [Monze, Mwaka] Univ Teaching Hosp, Virol Lab, Lusaka, Zambia	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Zambia	Moss, WJ (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, 615 N Wolfe St, Baltimore, MD 21205 USA.	wmoss@jhsph.edu			Thrasher Research Fund [02829-9]; National Eye Institute Training Grant [EY 07127]; National Institutes of Health; Department of Health and Human Services; pre-doctoral Clinical Trials Training Program in Vision Research	Thrasher Research Fund; National Eye Institute Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Health and Human Services; pre-doctoral Clinical Trials Training Program in Vision Research	This work was supported by the Thrasher Research Fund (02829-9). SAL was supported by the National Eye Institute Training Grant (EY 07127), pre-doctoral Clinical Trials Training Program in Vision Research, National Institutes of Health, Department of Health and Human Services. We thank Cliansa Nkojiga-Mwangilwa for administrative assistance, the students and community health workers for assistance in undertaking the survey, the Tianjane Community Theater Group for creative and motivational performances as part ofthe community scusitisation activities, Felicity Cutts for contributions to die early conception of the study, and Greg Glass for expertise and support of the spatial analyses.	*CDC, 2003, MMWR-MORBID MORTAL W, V52, P1044; *CDC, 2005, MMWR-MORBID MORTAL W, V54, P581; Centers for Disease Control and Prevention (CDC), 2007, MMWR Morb Mortal Wkly Rep, V56, P1237; Cressie N.A., 1993, STAT SPATIAL DATA; DIGGLE PJ, 2006, STAT ANAL SPATIAL PO; Enquselassie F, 2003, EPIDEMIOL INFECT, V130, P507, DOI 10.1017/S0950268803008446; FROOT KA, 1989, J FINANC QUANT ANAL, V24, P333, DOI 10.2307/2330815; Grais RF, 2006, T ROY SOC TROP MED H, V100, P867, DOI 10.1016/j.trstmh.2005.10.014; Hassidim A., 2008, Morbidity and Mortality Weekly Report, V57, P203; Helfand RF, 2005, B WORLD HEALTH ORGAN, V83, P329; Helfand RF, 2004, EPIDEMIOL INFECT, V132, P7, DOI 10.1017/S0950268803001547; Huber P. J., 1967, P 5 BERK S MATH STAT, V1, P221; Kleinschmidt I, 2007, AM J TROP MED HYG, V77, P1163, DOI 10.4269/ajtmh.2007.77.1163; Kremer JR, 2005, CLIN DIAGN LAB IMMUN, V12, P668, DOI 10.1128/CDLI.12.5.668-670.2005; Lowther SA, 2009, TROP MED INT HEALTH, V14, P70, DOI 10.1111/j.1365-3156.2008.02185.x; Moss WJ, 2007, J INFECT DIS, V196, P347, DOI 10.1086/519169; Muller CP, 2007, VACCINE, V25, P1, DOI 10.1016/j.vaccine.2006.07.039; Nigatu W, 2008, VACCINE, V26, P4769, DOI 10.1016/j.vaccine.2008.07.005; Nokes DJ, 2001, B WORLD HEALTH ORGAN, V79, P588; Ohuma EO, 2009, EPIDEMIOL INFECT, V137, P227, DOI 10.1017/S0950268808000848; Orenstein WA, 2000, AM J PUBLIC HEALTH, V90, P1521, DOI 10.2105/AJPH.90.10.1521; Parker AA, 2006, NEW ENGL J MED, V355, P447, DOI 10.1056/NEJMoa060775; Ray Sandip Kumar, 2004, Indian Journal of Pediatrics, V71, P583, DOI 10.1007/BF02724116; Scott S, 2008, INT J EPIDEMIOL, V37, P356, DOI 10.1093/ije/dyn007; Setse RW, 2006, J TROP PEDIATRICS, V52, P324, DOI 10.1093/tropej/fmk002; van den Hof S, 2001, EMERG INFECT DIS, V7, P593; Waller L.A., 2004, APPL SPATIAL STAT PU; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; *WHO, IMM SURV ASS MON ZAM; WHO, 2008, MMWR-MORBID MORTAL W, V57, P657; Wolfson LJ, 2007, LANCET, V369, P191, DOI 10.1016/S0140-6736(07)60107-X; World Health Organization United Nations Children's Fund, 2001, MEASL MORT RED REG E; World Health Organization & United Nations Children's Fund, 2005, GLOB IMM VIS STRAT 2	33	19	19	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 21	2009	373	9668					1025	1032		10.1016/S0140-6736(09)60142-2	http://dx.doi.org/10.1016/S0140-6736(09)60142-2			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	422AA	19211140				2022-12-01	WOS:000264398200030
J	Saleh, MC; Tassetto, M; van Rij, RP; Goic, B; Gausson, V; Berry, B; Jacquier, C; Antoniewski, C; Andino, R				Saleh, Maria-Carla; Tassetto, Michel; van Rij, Ronald P.; Goic, Bertsy; Gausson, Valerie; Berry, Bassam; Jacquier, Caroline; Antoniewski, Christophe; Andino, Raul			Antiviral immunity in Drosophila requires systemic RNA interference spread	NATURE			English	Article							DOUBLE-STRANDED-RNA; DISTINCT ROLES; PATHWAY; DSRNA; GENE; MELANOGASTER; VIRUSES; DICER-2; ENTRY	Multicellular organisms evolved sophisticated defence systems to confer protection against pathogens. An important characteristic of these immune systems is their ability to act both locally at the site of infection and at distal uninfected locations(1-4). In insects, such as Drosophila melanogaster, RNA interference (RNAi) mediates antiviral immunity(5-7). However, the antiviral RNAi defence in flies seems to be a local, cell-autonomous process, as flies are thought to be unable to generate a systemic RNAi response(8). Here we show that a recently defined double-stranded RNA(dsRNA) uptake pathway(9) is essential for effective antiviral RNAi immunity in adult flies. Mutant flies defective in this dsRNA uptake pathway were hypersensitive to infection with Drosophila C virus and Sindbis virus. Mortality in dsRNA-uptake-defective flies was accompanied by 100-to 10(5)-fold increases in viral titres and higher levels of viral RNA. Furthermore, inoculating naked dsRNA into flies elicited a sequence-specific antiviral immune response that required an intact dsRNA uptake pathway. These findings suggest that spread of dsRNA to uninfected sites is essential for effective antiviral immunity. Notably, infection with green fluorescent protein (GFP)-tagged Sindbis virus suppressed expression of host-encoded GFP at a distal site. Thus, similar to protein-based immunity in vertebrates, the antiviral RNAi response in flies also relies on the systemic spread of a virus-specific immunity signal.	[Saleh, Maria-Carla; Tassetto, Michel; van Rij, Ronald P.; Andino, Raul] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94122 USA; [Goic, Bertsy; Gausson, Valerie; Berry, Bassam; Jacquier, Caroline; Antoniewski, Christophe] Inst Pasteur, F-75015 Paris, France; [Berry, Bassam; Jacquier, Caroline; Antoniewski, Christophe] CNRS, URA 2578, F-75015 Paris, France	University of California System; University of California San Francisco; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS)	Andino, R (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94122 USA.	raul.andino@ucsf.edu	Saleh, Maria-Carla/ABC-2527-2021; Antoniewski, Christophe/G-4519-2011; Van Rij, Ronald/I-7073-2012; BERRY, Bassam/D-1666-2009	Saleh, Maria-Carla/0000-0001-8593-4117; Antoniewski, Christophe/0000-0001-7709-2116; Van Rij, Ronald/0000-0003-0221-4689; Dorey, valerie/0000-0002-9727-3448	NIH [AI40085, AI064738]; Institut Pasteur; CNRS; ANR; ARC; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040085, R21AI040085, R01AI064738] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institut Pasteur(European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); ANR(French National Research Agency (ANR)); ARC(Australian Research Council); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	d We are grateful to members of the Andino and the O'Farrell laboratories for discussion, technical support and advice on fly work. We thank J. Frydman, P. O'Farrell and M. Vignuzzi for discussions and comments on the manuscript. We also thank T. Cook for advice on the IR EcR eye phenotype, R. Carthew for providing the GMR. IR[white] and Dcr2 fly stocks and M. Siomi for the Ago2 fly stock. B. G. is a Manlio Cantarini fellow. B. B. is a Lebanese CNRSL Fellow. C. J. is a University of Paris VI and Ministere de la Recherche fellow. This work was financially supported by NIH grants AI40085 and AI064738 to R. A., the Institut Pasteur to M.-C. S. and C. A., and CNRS, ANR and ARC grants to C.	Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Cherry S, 2004, NAT IMMUNOL, V5, P81, DOI 10.1038/ni1019; Dorner T, 2007, IMMUNITY, V27, P384, DOI 10.1016/j.immuni.2007.09.002; Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237; Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335; Goto A, 2003, NUCLEIC ACIDS RES, V31, P6619, DOI 10.1093/nar/gkg852; HAHN CS, 1992, P NATL ACAD SCI USA, V89, P2679, DOI 10.1073/pnas.89.7.2679; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; PORTER JA, 1995, EMBO J, V14, P4450, DOI 10.1002/j.1460-2075.1995.tb00124.x; REED L. J., 1938, AMER JOUR HYG, V27, P493; Roignant JY, 2003, RNA, V9, P299, DOI 10.1261/rna.2154103; Roitt I., 2001, IMMUNOLOGY; Saleh MC, 2006, NAT CELL BIOL, V8, P793, DOI 10.1038/ncb1439; Schubiger M, 2005, DEVELOPMENT, V132, P5239, DOI 10.1242/dev.02093; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Ulvila J, 2006, J BIOL CHEM, V281, P14370, DOI 10.1074/jbc.M513868200; Vaistij FE, 2002, PLANT CELL, V14, P857, DOI 10.1105/tpc.010480; van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006; Voinnet O, 2005, FEBS LETT, V579, P5858, DOI 10.1016/j.febslet.2005.09.039; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694	24	205	220	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 19	2009	458	7236					346	U109		10.1038/nature07712	http://dx.doi.org/10.1038/nature07712			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420JH	19204732	Green Accepted			2022-12-01	WOS:000264285600043
J	Srivastava, R				Srivastava, Ranjana			Denial	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																			0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 19	2009	360	12					1174	1177		10.1056/NEJMp0809399	http://dx.doi.org/10.1056/NEJMp0809399			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	420IU	19297570				2022-12-01	WOS:000264283400003
J	Yorozu, S; Wong, A; Fischer, BJ; Dankert, H; Kernan, MJ; Kamikouchi, A; Ito, K; Anderson, DJ				Yorozu, Suzuko; Wong, Allan; Fischer, Brian J.; Dankert, Heiko; Kernan, Maurice J.; Kamikouchi, Azusa; Ito, Kei; Anderson, David J.			Distinct sensory representations of wind and near-field sound in the Drosophila brain	NATURE			English	Article							GREEN FLUORESCENT PROTEIN; MELANOGASTER; HEARING; TRANSDUCTION; DISPERSAL; SONG; MAP	Behavioural responses to wind are thought to have a critical role in controlling the dispersal and population genetics of wild Drosophila species(1,2), as well as their navigation in flight(3), but their underlying neurobiological basis is unknown. We show that Drosophila melanogaster, like wild-caught Drosophila strains(4), exhibits robust wind-induced suppression of locomotion in response to air currents delivered at speeds normally encountered in nature(1,2). Here we identify wind-sensitive neurons in Johnston's organ, an antennal mechanosensory structure previously implicated in near-field sound detection (reviewed in refs 5 and 6). Using enhancer trap lines targeted to different subsets of Johnston's organ neurons(7), and a genetically encoded calcium indicator(8), we show that wind and near-field sound (courtship song) activate distinct populations of Johnston's organ neurons, which project to different regions of the antennal and mechanosensory motor centre in the central brain. Selective genetic ablation of wind-sensitive Johnston's organ neurons in the antenna abolishes wind-induced suppression of locomotion behaviour, without impairing hearing. Moreover, different neuronal subsets within the wind-sensitive population respond to different directions of arista deflection caused by air flow and project to different regions of the antennal and mechanosensory motor centre, providing a rudimentary map of wind direction in the brain. Importantly, sound- and wind-sensitive Johnston's organ neurons exhibit different intrinsic response properties: the former are phasically activated by small, bi-directional, displacements of the aristae, whereas the latter are tonically activated by unidirectional, static deflections of larger magnitude. These different intrinsic properties are well suited to the detection of oscillatory pulses of near-field sound and laminar air flow, respectively. These data identify wind-sensitive neurons in Johnston's organ, a structure that has been primarily associated with hearing, and reveal how the brain can distinguish different types of air particle movements using a common sensory organ.	[Yorozu, Suzuko; Wong, Allan; Fischer, Brian J.; Dankert, Heiko; Anderson, David J.] CALTECH, Div Biol 216 76, Pasadena, CA 91125 USA; [Yorozu, Suzuko; Wong, Allan; Anderson, David J.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Dankert, Heiko] CALTECH, Div Engn & Appl Sci 136 93, Pasadena, CA 91125 USA; [Kernan, Maurice J.] SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA; [Kamikouchi, Azusa; Ito, Kei] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; [Kamikouchi, Azusa] Univ Cologne, Inst Zool, Sensory Syst Lab, D-50923 Cologne, Germany	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; University of Tokyo; University of Cologne	Anderson, DJ (corresponding author), CALTECH, Div Biol 216 76, Pasadena, CA 91125 USA.	yorozu@caltech.edu; mancusog@caltech.edu		Kamikouchi, Azusa/0000-0003-1552-6892; Kernan, Maurice/0000-0002-1546-6159; Dankert, Heiko/0000-0002-0096-8455	NSF [EF-0623527]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002780] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank U. Heberlein and F. Wolf for hosting a sabbatical that led to the discovery of WISL; J. S. Johnson for helpful discussions; L. Zelnik, M. Reiser and P. Perona for creating locomotor tracking software; D. Eberl and J. Hall for D. melanogaster courtship song recordings; G. Maimon for making fly holders for imaging experiments; M. Roy for building behavioral chambers for WISL and female receptivity assays; H. Inagaki for JO-CE-GAL4; eyFLP flies; B. Hay for UAS-hid flies; D. Berdnik for UAS-FRT-STOP-FRT-Ricin flies; M. Dickinson for anemometers and discussions; J. L. Anderson for advice on fluid mechanics; M. Gopfert for providing a pressure gradient microphone; M. Konishi for advice and use of laboratory facilities; and G. Mosconi for laboratory management. D. J. A. is an Investigator of the Howard Hughes Medical Institute. This work was supported in part by NSF grant EF-0623527.	BENNETCLARK HC, 1971, NATURE, V234, P255, DOI 10.1038/234255a0; Berdnik D, 2006, J NEUROSCI, V26, P3367, DOI 10.1523/JNEUROSCI.4941-05.2006; Budick SA, 2007, J EXP BIOL, V210, P4092, DOI 10.1242/jeb.006502; Caldwell JC, 2002, J NEUROBIOL, V53, P172, DOI 10.1002/neu.10126; Eberl DF, 2000, J NEUROSCI, V20, P5981, DOI 10.1523/JNEUROSCI.20-16-05981.2000; EWING AW, 1978, PHYSIOL ENTOMOL, V3, P33, DOI 10.1111/j.1365-3032.1978.tb00129.x; Gopfert MC, 2002, J EXP BIOL, V205, P1199; Hoffmann JN, 2004, ANAT REC PART A, V281A, P1138, DOI 10.1002/ar.a.20119; IKEDA I, 1994, J PHYSIOL-LONDON, V479, P247, DOI 10.1113/jphysiol.1994.sp020292; Johnston J.S., 1982, P241; JOHNSTON JS, 1976, AM NAT, V110, P629, DOI 10.1086/283095; Kamikouchi A, 2006, J COMP NEUROL, V499, P317, DOI 10.1002/cne.21075; Kernan MJ, 2007, PFLUG ARCH EUR J PHY, V454, P703, DOI 10.1007/s00424-007-0263-x; Kim J, 2003, NATURE, V424, P81, DOI 10.1038/nature01733; Mamiya A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004063; MANNING A, 1967, SCIENCE, V158, P136, DOI 10.1126/science.158.3797.136; MOFFAT KG, 1992, DEVELOPMENT, V114, P681; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; RICHARDSON RH, 1975, OECOLOGIA, V20, P287, DOI 10.1007/BF00345519; TANOUYE MA, 1980, J NEUROPHYSIOL, V44, P405, DOI 10.1152/jn.1980.44.2.405; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wang SL, 1999, CELL, V98, P453, DOI 10.1016/S0092-8674(00)81974-1; Wang YL, 2004, J NEUROSCI, V24, P6507, DOI 10.1523/JNEUROSCI.3727-03.2004; WHEELER DA, 1988, BEHAV GENET, V18, P675, DOI 10.1007/BF01066850; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9	25	167	170	1	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 12	2009	458	7235					201	U4		10.1038/nature07843	http://dx.doi.org/10.1038/nature07843			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417EQ	19279637	Green Accepted			2022-12-01	WOS:000264059700043
J	Luo, J; Solimini, NL; Elledge, SJ				Luo, Ji; Solimini, Nicole L.; Elledge, Stephen J.			Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction	CELL			English	Review							DNA-DAMAGE RESPONSE; GROWTH-FACTOR RECEPTOR; HUMAN BREAST; NEOPLASTIC PHENOTYPE; GENOMIC INSTABILITY; SIGNALING PATHWAYS; MITOTIC CHECKPOINT; INDUCED SENESCENCE; RNA INTERFERENCE; P53 RESTORATION	Cancer is a complex collection of distinct genetic diseases united by common hallmarks. Here, we expand upon the classic hallmarks to include the stress phenotypes of tumorigenesis. We describe a conceptual framework of how oncogene and non-oncogene addictions contribute to these hallmarks and how they can be exploited through stress sensitization and stress overload to selectively kill cancer cells. In particular, we present evidence for a large class of non-oncogenes that are essential for cancer cell survival and present attractive drug targets. Finally, we discuss the path ahead to therapeutic discovery and provide theoretical considerations for combining orthogonal cancer therapies.	[Luo, Ji; Solimini, Nicole L.; Elledge, Stephen J.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Howard Hughes Med Inst,Dept Med,Div Genet,Dept Ge, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute	Elledge, SJ (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Howard Hughes Med Inst,Dept Med,Div Genet,Dept Ge, Boston, MA 02115 USA.	selledge@genetics.med.harvard.edu			NIH; HHMI; NATIONAL CANCER INSTITUTE [R33CA140039] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank O.Cohen-Fix, J. Glaven, S. M. Lewis, W. G. Kaelin, and G. M. Wahl for critical reading of the manuscript. J. L. is supported by a fellowship from the American Association of Cancer Research. N. L. S. is a fellow of the Susan G. Komen for the Cure Foundation. This work is supported by grants from the NIH and the U.S. Department of Defense to S. J. E. S. J. E. is an investigator with HHMI. We dedicate this review to I. Bernard Weinstein for his contributions to cancer biology.	Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Ashwell S, 2008, CLIN CANCER RES, V14, P4032, DOI 10.1158/1078-0432.CCR-07-5138; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Carlo-Stella C, 2007, CLIN CANCER RES, V13, P2313, DOI 10.1158/1078-0432.CCR-06-2774; Carpinelli P, 2008, ADV EXP MED BIOL, V610, P54, DOI 10.1007/978-0-387-73898-7_5; Chen ZH, 2006, INT J CANCER, V119, P2784, DOI 10.1002/ijc.22198; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chin L, 1999, NATURE, V400, P468, DOI 10.1038/22788; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Conde C, 2001, EMBO J, V20, P3535, DOI 10.1093/emboj/20.13.3535; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; DENKO NC, 1994, P NATL ACAD SCI USA, V91, P5124, DOI 10.1073/pnas.91.11.5124; Denoyelle C, 2006, NAT CELL BIOL, V8, P1053, DOI 10.1038/ncb1471; Dewhirst MW, 2008, NAT REV CANCER, V8, P425, DOI 10.1038/nrc2397; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Dickins RA, 2007, NAT GENET, V39, P914, DOI 10.1038/ng2045; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Dikmen ZG, 2005, CANCER RES, V65, P7866, DOI 10.1158/0008-5472.CAN-05-1215; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Druker BJ, 2002, ONCOGENE, V21, P8541, DOI 10.1038/sj.onc.1206081; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; Fiorentini Giammaria, 2006, J Cancer Res Ther, V2, P41; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; Garrido F, 2001, ADV CANCER RES, V83, P117, DOI 10.1016/S0065-230X(01)83005-0; Gogvadze V, 2008, TRENDS CELL BIOL, V18, P165, DOI 10.1016/j.tcb.2008.01.006; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hahn WC, 2002, NAT REV CANCER, V2, P331, DOI 10.1038/nrc795; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harley CB, 2008, NAT REV CANCER, V8, P167, DOI 10.1038/nrc2275; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; Hu M, 2008, CURR OPIN GENET DEV, V18, P27, DOI 10.1016/j.gde.2007.12.006; Huettner CS, 2000, NAT GENET, V24, P57, DOI 10.1038/71691; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Iida S, 1997, NAT GENET, V17, P226, DOI 10.1038/ng1097-226; Jain M, 2002, SCIENCE, V297, P102, DOI 10.1126/science.1071489; Jin SK, 2007, AUTOPHAGY, V3, P28, DOI 10.4161/auto.3269; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kennedy RD, 2007, J CLIN INVEST, V117, P1440, DOI 10.1172/JCI31245; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; Komarova NL, 2002, CANCER BIOL THER, V1, P685, DOI 10.4161/cbt.321; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936; Lee YM, 2006, CELL CYCLE, V5, P2110, DOI 10.4161/cc.5.18.3218; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; MACDONALD C, 2005, NATURE, V438, P820; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; Maser RS, 2002, SCIENCE, V297, P565, DOI 10.1126/science.297.5581.565; Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107; McGuire JJ, 2003, CURR PHARM DESIGN, V9, P2593, DOI 10.2174/1381612033453712; Moreira JN, 2006, REV RECENT CLIN TRIA, V1, P217, DOI 10.2174/157488706778250050; Motzer RJ, 2006, J CLIN ONCOL, V24, P16, DOI 10.1200/JCO.2005.02.2574; Muller AJ, 2006, NAT REV CANCER, V6, P613, DOI 10.1038/nrc1929; Nava-Parada P, 2007, CURR OPIN MOL THER, V9, P490; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Papp B, 2003, NATURE, V424, P194, DOI 10.1038/nature01771; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Peggs KS, 2008, IMMUNOL REV, V224, P141, DOI 10.1111/j.1600-065X.2008.00649.x; Pelengaris S, 1999, MOL CELL, V3, P565, DOI 10.1016/S1097-2765(00)80350-0; Pollack JR, 2002, P NATL ACAD SCI USA, V99, P12963, DOI 10.1073/pnas.162471999; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Qiu W, 2008, NAT GENET, V40, P650, DOI 10.1038/ng.117; Quintas-Cardama A, 2007, NAT REV DRUG DISCOV, V6, P834, DOI 10.1038/nrd2324; Richardson PG, 2006, ANNU REV MED, V57, P33, DOI 10.1146/annurev.med.57.042905.122625; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Roccaro AM, 2006, CURR PHARM BIOTECHNO, V7, P441, DOI 10.2174/138920106779116865; Sakai W, 2008, NATURE, V451, P1116, DOI 10.1038/nature06633; Schlabach MR, 2008, SCIENCE, V319, P620, DOI 10.1126/science.1149200; Selivanova G, 2007, ONCOGENE, V26, P2243, DOI 10.1038/sj.onc.1210295; Shaffer AL, 2008, NATURE, V454, P226, DOI 10.1038/nature07064; Sharma S, 2005, CANCER RES, V65, P5211, DOI 10.1158/0008-5472.CAN-05-0141; Sharma SV, 2007, GENE DEV, V21, P3214, DOI 10.1101/gad.1609907; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; SHIRASAWA S, 1993, SCIENCE, V260, P85, DOI 10.1126/science.8465203; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Silva JM, 2008, SCIENCE, V319, P617, DOI 10.1126/science.1149185; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Solimini NL, 2007, CELL, V130, P986, DOI 10.1016/j.cell.2007.09.007; Spira AI, 2003, CURR OPIN PHARMACOL, V3, P338, DOI 10.1016/S1471-4892(03)00081-X; Stauffer SR, 2007, CURR TOP MED CHEM, V7, P961, DOI 10.2174/156802607780906843; Stolina M, 2000, J IMMUNOL, V164, P361, DOI 10.4049/jimmunol.164.1.361; Storchova Z, 2006, NATURE, V443, P541, DOI 10.1038/nature05178; Strebhardt K, 2006, NAT REV CANCER, V6, P321, DOI 10.1038/nrc1841; Su Z, 2005, J IMMUNOL, V174, P3798, DOI 10.4049/jimmunol.174.6.3798; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Torres EM, 2008, GENETICS, V179, P737, DOI 10.1534/genetics.108.090878; Torres EM, 2007, SCIENCE, V317, P916, DOI 10.1126/science.1142210; Tsafrir D, 2006, CANCER RES, V66, P2129, DOI 10.1158/0008-5472.CAN-05-2569; Vander Heiden MG, 2001, MOL CELL BIOL, V21, P5899, DOI 10.1128/MCB.21.17.5899-5912.2001; Vassilev LT, 2007, TRENDS MOL MED, V13, P23, DOI 10.1016/j.molmed.2006.11.002; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Verdine GL, 2007, CLIN CANCER RES, V13, P7264, DOI 10.1158/1078-0432.CCR-07-2184; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Weaver BAA, 2005, CANCER CELL, V8, P7, DOI 10.1016/j.ccr.2005.06.011; Weinstein IB, 2008, CANCER RES, V68, P3077, DOI 10.1158/0008-5472.CAN-07-3293; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Williams BR, 2008, SCIENCE, V322, P703, DOI 10.1126/science.1160058; WINDLE B, 1991, GENE DEV, V5, P160, DOI 10.1101/gad.5.2.160; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yang FC, 2008, CELL, V135, P437, DOI 10.1016/j.cell.2008.08.041; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586	124	1284	1450	3	200	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 6	2009	136	5					823	837		10.1016/j.cell.2009.02.024	http://dx.doi.org/10.1016/j.cell.2009.02.024			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	415JU	19269363	Green Accepted, Bronze			2022-12-01	WOS:000263930900007
J	Sokol, DK				Sokol, Daniel K.			Observations Ethics Man Rethinking ward rounds	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London, London WC1E 7HU, England	University of London	Sokol, DK (corresponding author), Univ London, London WC1E 7HU, England.	daniel.sokol@talk21.com						GODLEE F, 2009, BRIT MED J, V338, pB913; Soar J, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b220	2	7	7	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 4	2009	338								b879	10.1136/bmj.b879	http://dx.doi.org/10.1136/bmj.b879			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	417EC	19261674				2022-12-01	WOS:000264058300005
J	Whitlock, G; Lewington, S; Sherliker, P; Clarke, R; Emberson, J; Halsey, J; Qizilbash, N; Collins, R; Peto, R; Lewington, S; MacMahon, S; Peto, R; Aromaa, A; Baigent, C; Carstensen, J; Chen, Z; Clarke, R; Collins, R; Duffy, S; Kromhout, D; Neaton, J; Qizilbash, N; Rodgers, A; Tominaga, S; Tornberg, S; Tunstall-Pedoe, H; Whitlock, G; Chambless, L; De Backer, G; De Bacquer, D; Kornitzer, M; Whincup, P; Wannamethee, SG; Morris, R; Wald, N; Morris, J; Law, M; Knuiman, M; Bartholomew, H; Smith, GD; Sweetnam, P; Elwood, P; Yarnell, J; Kronmal, R; Kromhout, D; Sutherland, S; Keil, J; Jensen, G; Schnohr, P; Hames, C; Tyroler, A; Aromaa, A; Knekt, P; Reunanen, A; Tuomilehto, J; Jousilahti, P; VArtiainen, E; Puska, P; Kuznetsova, T; Richart, T; Staessen, J; Thijs, L; Jorgensen, T; Thomsen, T; Sharp, D; Curb, JD; Qizilbash, N; Iso, H; Sato, S; Kitamura, A; Naito, Y; Benetos, A; Guize, L; Goldbourt, U; Tomita, M; Nishimoto, Y; Murayama, T; Criqui, M; Davis, C; Hart, C; Smith, GD; Hole, D; Gillis, C; Jacobs, D; Blackburn, H; Luepker, R; Neaton, J; Eberly, L; Cox, C; Levy, D; D'Agostino, R; Silbershatz, H; Tverdal, A; Selmer, R; Meade, T; Garrow, K; Cooper, J; Speizer, F; Stampfer, M; Menotti, A; Spagnolo, A; Tsuji, I; Imai, Y; Ohkubo, T; Hisamichi, S; Haheim, L; Holme, I; Hjermann, I; Leren, P; Ducimetiere, P; Empana, J; Jamrozik, K; Broadhurst, R; Assmann, G; Schulte, H; Bengtsson, C; Bjorkelund, C; Lissner, L; Sorlie, P; Garcia-Palmieri, M; Barrett-Conner, E; Criqui, M; Langer, R; Hart, C; Smith, GD; Hole, D; Nakachi, K; Imai, K; Fang, X; Li, S; Buzina, R; Nissinen, A; Aravanis, C; Dontas, A; Kafatos, A; Menotti, A; Adachi, H; Toshima, H; Imaizumi, T; Kromhout, D; Nedeljkovic, S; Ostojic, M; Chen, Z; Tunstall-Pedoe, H; Nakayama, T; Yoshiike, N; Yokoyama, T; Date, C; Tanaka, H; Keller, J; Bonaa, K; Arnesen, E; Tunstall-Pedoe, H; Rimm, E; Gaziano, M; Buring, JE; Hennekens, C; Tornberg, S; Carstensen, J; Shipley, M; Leon, D; Marmot, M; Clarke, R; Collins, R; Emberson, J; Halsey, J; Lewington, S; Palmer, A; Parish, S; Peto, R; Sherliker, P; Whitlock, G				Whitlock, Gary; Lewington, Sarah; Sherliker, Paul; Clarke, Robert; Emberson, Jonathan; Halsey, Jim; Qizilbash, Nawab; Collins, Rory; Peto, Richard; Lewington, S.; MacMahon, S.; Peto, R.; Aromaa, A.; Baigent, C.; Carstensen, J.; Chen, Z.; Clarke, R.; Collins, R.; Duffy, S.; Kromhout, D.; Neaton, J.; Qizilbash, N.; Rodgers, A.; Tominaga, S.; Toernberg, S.; Tunstall-Pedoe, H.; Whitlock, G.; Chambless, L.; De Backer, G.; De Bacquer, D.; Kornitzer, M.; Whincup, P.; Wannamethee, S. G.; Morris, R.; Wald, N.; Morris, J.; Law, M.; Knuiman, M.; Bartholomew, H.; Smith, G. Davey; Sweetnam, P.; Elwood, P.; Yarnell, J.; Kronmal, R.; Kromhout, D.; Sutherland, S.; Keil, J.; Jensen, G.; Schnohr, P.; Hames, C.; Tyroler, A.; Aromaa, A.; Knekt, P.; Reunanen, A.; Tuomilehto, J.; Jousilahti, P.; VArtiainen, E.; Puska, P.; Kuznetsova, T.; Richart, T.; Staessen, J.; Thijs, L.; Jorgensen, T.; Thomsen, T.; Sharp, D.; Curb, J. D.; Qizilbash, N.; Iso, H.; Sato, S.; Kitamura, A.; Naito, Y.; Benetos, A.; Guize, L.; Goldbourt, U.; Tomita, M.; Nishimoto, Y.; Murayama, T.; Criqui, M.; Davis, C.; Hart, C.; Smith, G. Davey; Hole, D.; Gillis, C.; Jacobs, D.; Blackburn, H.; Luepker, R.; Neaton, J.; Eberly, L.; Cox, C.; Levy, D.; D'Agostino, R.; Silbershatz, H.; Tverdal, A.; Selmer, R.; Meade, T.; Garrow, K.; Cooper, J.; Speizer, F.; Stampfer, M.; Menotti, A.; Spagnolo, A.; Tsuji, I.; Imai, Y.; Ohkubo, T.; Hisamichi, S.; Haheim, L.; Holme, I.; Hjermann, I.; Leren, P.; Ducimetiere, P.; Empana, J.; Jamrozik, K.; Broadhurst, R.; Assmann, G.; Schulte, H.; Bengtsson, C.; Bjoerkelund, C.; Lissner, L.; Sorlie, P.; Garcia-Palmieri, M.; Barrett-Conner, E.; Criqui, M.; Langer, R.; Hart, C.; Smith, G. Davey; Hole, D.; Nakachi, K.; Imai, K.; Fang, X.; Li, S.; Buzina, R.; Nissinen, A.; Aravanis, C.; Dontas, A.; Kafatos, A.; Menotti, A.; Adachi, H.; Toshima, H.; Imaizumi, T.; Kromhout, D.; Nedeljkovic, S.; Ostojic, M.; CHen, Z.; Tunstall-Pedoe, H.; Nakayama, T.; Yoshiike, N.; Yokoyama, T.; Date, C.; Tanaka, H.; Keller, J.; Bonaa, K.; Arnesen, E.; Tunstall-Pedoe, H.; Rimm, E.; Gaziano, M.; Buring, J. E.; Hennekens, C.; Tornberg, S.; Carstensen, J.; Shipley, M.; Leon, D.; Marmot, M.; Clarke, R.; Collins, R.; Emberson, J.; Halsey, J.; Lewington, S.; Palmer, A.; Parish, S.; Peto, R.; Sherliker, P.; Whitlock, G.		PSC Collaborator ARIC	Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies	LANCET			English	Article							CORONARY-HEART-DISEASE; ABDOMINAL ADIPOSITY; BLOOD-PRESSURE; RISK; OBESITY; OVERWEIGHT; STROKE; CANCER; ASSOCIATION; SMOKING	Background The main associations of body-mass index (BMI) with overall and-cause-specific mortality can best be assessed by long-term prospective follow-up of large numbers of people. The Prospective Studies Collaboration aimed to investigate these associations by sharing data from many studies. Methods Collaborative analyses were undertaken of baseline BMI versus mortality in 57 prospective studies with 894576 participants, mostly in western Europe and North America (61% [n=541452] male, mean recruitment age 46 [SD 11] years, median recruitment year 1,979 [IQR 1975-85], mean BMI 25 [SD 4] kg/m(2)). The analyses were adjusted for age, sex, smoking status, and study. To limit reverse causality, the first 5 years of follow up were excluded, leaving 66 552 deaths of known cause during a mean of 8 (SD 6) further years of follow-up (mean age at death 67 [SD 10] years): 30 416 vascular; 2070 diabetic, renal or hepatic; 22 592 neoplastic; 3770 respiratory; 7704 other. Findings In both sexes, mortality was lowest at about 22.5-25 kg/m(2). Above this range, positive associations were recorded for several specific causes and inverse associations for none, the absolute excess risks for higher BMI and smoking were roughly additive, and each 5 kg/m2 higher BMI was on average associated with about 30% higher overall mortality (hazard ratio per 5 kg/m(2) [HR] 1.29 [95% CI 1.27-1.32]): 40% for vascular mortality (HR 1.41 [1.37-1.45]); 60-120% for diabetic, renal, and hepatic mortality (HRs 2.16 [1.89-2.46], 1.59 [1.27-1.99], and 1.82 [1.59-2.09], respectively); 10% for neoplastic mortality (HR 1.10 [1.06-1.15]); and 20% for respiratory and for all other mortality (HRs 1.20 [1.07-1.34] and 1.20 [1.16-1.25], respectively). Below the range 22.5-25 kg/m(2), BMI was associated inversely with overall mortality, mainly because of strong inverse associations with respiratory disease and lung cancer. These inverse associations were much stronger for smokers than for non-smokers, despite cigarette consumption per smoker varying little with BMI. Interpretation Although other anthropometric measures (eg, waist circumference, waist-to-hip ratio) could well add extra information to BMI, and BMI to them, BMI is in itself a strong predictor of overall mortality both above and below the apparent optimum of about 22.5-25 kg/m(2). The progressive excess mortality above this range is due mainly to vascular disease and is probably largely causal. At 30 35 kg/m(2), median survival is reduced by 2-4 years; at 40-45 kg/m(2), it is reduced by 8-10 years (which is comparable with the effects of smoking). The definite excess mortality below 22.5 kg/m(2) is due mainly to smoking-related diseases, and is not fully explained. Funding UK Medical Research Council, British Heart Foundation, Cancer Research UK, EU BIOMED programme, US National Institute on Aging, and Clinical Trial Service Unit (Oxford, UK).	[Whitlock, Gary] Univ Oxford, Clin Trial Serv Unit, Oxford OX3 7LF, England; [Jensen, G.; Schnohr, P.] Copenhagen City Heart Study, Copenhagen, Denmark; [Sharp, D.; Curb, J. D.] Honolulu Heart Program, Honolulu, HI USA; [Iso, H.; Sato, S.; Kitamura, A.; Naito, Y.] Ikawa Noichi & Kyowa, Kyowa, Hokkaido, Japan; [Benetos, A.; Guize, L.] Ctr Invest Prevent & Clin IPC, Paris, France; [Levy, D.; D'Agostino, R.; Silbershatz, H.] NHLBI Framingham Heart Study, Framingham, MA USA; [Menotti, A.; Spagnolo, A.] Occupat Grp, Rome, Italy; [Ducimetiere, P.; Empana, J.] Paris Prospect Study, Paris, France; [Bengtsson, C.; Bjoerkelund, C.; Lissner, L.] Prospect Study Women, Gothenburg, Sweden; [Nakachi, K.; Imai, K.] Saitama Cohort Study, Saitama, Japan	University of Oxford; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Whitlock, G (corresponding author), Univ Oxford, Clin Trial Serv Unit, Richard Doll Bldg, Oxford OX3 7LF, England.	psc@ctsu.ox.ac.uk	Kuznetsova, Tatiana/ABI-5662-2020; NAKAYAMA, Takeo/HCH-0537-2022; Wald, Nicholas/AAY-8924-2021; Wald, Nicholas/AAY-2814-2021; Jørgensen, Torben/Z-1335-2018; Staessen, Jan A/A-1065-2011; Lennon, Lucy/ABB-9433-2020; Empana, Jean-Philippe/AAF-6923-2021; Davey Smith, George/A-7407-2013; Marmot, M G/Y-3920-2019; De Backer, Guy/AAI-4607-2021; Leon, David A/G-2195-2010; Kromhout, Daan/A-8566-2014; Morris, Joan/AAT-9211-2020; Knuiman, Matthew W/I-5549-2013	Kuznetsova, Tatiana/0000-0003-4293-4576; Staessen, Jan A/0000-0002-3026-1637; Lennon, Lucy/0000-0002-1738-1351; Empana, Jean-Philippe/0000-0002-1469-7772; Davey Smith, George/0000-0002-1407-8314; Marmot, M G/0000-0002-2431-6419; Leon, David A/0000-0001-9747-1762; Morris, Joan/0000-0002-7164-612X; s, hema/0000-0002-3440-9475; Thijs, Lutgarde/0000-0002-8108-2356; Morris, Richard/0000-0001-7240-4563; Whincup, Peter/0000-0002-5589-4107; Jorgensen, Torben/0000-0001-9453-2830; Lewington, Sarah/0000-0002-4496-4771; Jacobs, David/0000-0002-7232-0543; MacMahon, Stephen/0000-0003-2064-7699; Rodgers, Anthony/0000-0003-1282-1896; Nakayama, Takeo/0000-0002-7918-6252; Eberly, Lynn/0000-0003-4763-330X; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Tverdal, Aage/0000-0002-2909-5678; Emberson, Jonathan/0000-0001-7792-9422; De Bacquer, Dirk/0000-0002-3202-7238; Carstensen, John/0000-0003-2256-8089	UK Medical Research Council; British Heart Foundation; Cancer Research UK; EU BIOMED; NIA [P01 AG17625-01]; CTSU; Girdlers' Health Research Council of New Zealand Fellowship; Sarah Lewington had a British Heart Foundation Fellowship; British Heart Foundation [RG/07/008/23674, RG/08/013/25942] Funding Source: researchfish; Economic and Social Research Council [ES/G007438/1] Funding Source: researchfish; Medical Research Council [G8802774, G0600705, G0100222, MC_U137686857, G19/35] Funding Source: researchfish; ESRC [ES/G007438/1] Funding Source: UKRI; MRC [MC_U137686857, G0600705] Funding Source: UKRI; NATIONAL INSTITUTE ON AGING [P01AG017625] Funding Source: NIH RePORTER	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); EU BIOMED; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); CTSU; Girdlers' Health Research Council of New Zealand Fellowship; Sarah Lewington had a British Heart Foundation Fellowship; British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Prospective Studies Collaboration has been supported by the UK Medical Research Council, British Heart Foundation, Cancer Research UK, EU BIOMED programme, NIA grant P01 AG17625-01, and CTSU overheads. Merck (F Walker) helped support the 1996 meeting of collaborators. Gary Whitlock was supported by a Girdlers' Health Research Council of New Zealand Fellowship, Sarah Lewington had a British Heart Foundation Fellowship to coordinate the project. Sarah Parish supplied unpublished analyses of BMI and cotinine (webappendix).	[Anonymous], 2 WHO GLOB INFOBASE; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Bogers RP, 2007, ARCH INTERN MED, V167, P1720, DOI 10.1001/archinte.167.16.1720; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Clarke R, 1999, AM J EPIDEMIOL, V150, P341; Curtis JP, 2005, ARCH INTERN MED, V165, P55, DOI 10.1001/archinte.165.1.55; Devesa SS, 1998, CANCER, V83, P2049, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2049::AID-CNCR1>3.3.CO;2-U; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Gaemers IC, 2006, CURR OPIN LIPIDOL, V17, P268, DOI 10.1097/01.mol.0000226118.43178.98; Gallagher D, 1996, AM J EPIDEMIOL, V143, P228, DOI 10.1093/oxfordjournals.aje.a008733; Hu F.B., 2008, OBESITY EPIDEMIOLOGY; Janssen I, 2007, OBES REV, V8, P41, DOI 10.1111/j.1467-789X.2006.00248.x; Jee SH, 2006, NEW ENGL J MED, V355, P779, DOI 10.1056/NEJMoa054017; Kurth T, 2005, CIRCULATION, V111, P1992, DOI 10.1161/01.CIR.0000161822.83163.B6; Landbo C, 1999, AM J RESP CRIT CARE, V160, P1856, DOI 10.1164/ajrccm.160.6.9902115; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Li TY, 2006, CIRCULATION, V113, P499, DOI 10.1161/CIRCULATIONAHA.105.574087; MANSON JAE, 1990, NEW ENGL J MED, V322, P882, DOI 10.1056/NEJM199003293221303; Mhurchu CN, 2004, INT J EPIDEMIOL, V33, P751, DOI 10.1093/ije/dyh163; MICOZZI MS, 1990, AM J PHYS ANTHROPOL, V81, P375, DOI 10.1002/ajpa.1330810307; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; PETO R, 2006, DEATHS SMOKING; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Plummer M, 2004, STAT MED, V23, P93, DOI 10.1002/sim.1485; Reeves GK, 2007, BRIT MED J, V335, P1134, DOI 10.1136/bmj.39367.495995.AE; Rexrode KM, 1998, JAMA-J AM MED ASSOC, V280, P1843, DOI 10.1001/jama.280.21.1843; Rexrode KM, 1997, JAMA-J AM MED ASSOC, V277, P1539, DOI 10.1001/jama.277.19.1539; Smith M, 2008, INT J CANCER, V122, P1604, DOI 10.1002/ijc.23198; Song YM, 2004, STROKE, V35, P831, DOI 10.1161/01.STR.0000119386.22691.1C; Turnbull F, 2003, LANCET, V362, P1527; Wang Y, 2008, KIDNEY INT, V73, P19, DOI 10.1038/sj.ki.5002586; WILLIAMSON DF, 1991, NEW ENGL J MED, V324, P739, DOI 10.1056/NEJM199103143241106; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5; Zhou M, 2008, STROKE, V39, P753, DOI 10.1161/STROKEAHA.107.495374; 2004, HLTH SURVEY ENGLAND	38	2931	3048	5	306	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR-APR	2009	373	9669					1083	1096		10.1016/S0140-6736(09)60318-4	http://dx.doi.org/10.1016/S0140-6736(09)60318-4			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427IS	19299006	Green Accepted, Green Published, Bronze			2022-12-01	WOS:000264773600029
J	Lowman, M; D'Avanzo, C; Brewer, C				Lowman, Margaret; D'Avanzo, Charlene; Brewer, Carol			A National Ecological Network for Research and Education	SCIENCE			English	Editorial Material							OBSERVATORY NETWORK; NEON		[Lowman, Margaret] New Coll Florida, Dept Biol, Sarasota, FL 34243 USA; [Lowman, Margaret] New Coll Florida, Dept Environm Studies, Sarasota, FL 34243 USA; [D'Avanzo, Charlene] Hampshire Coll, Sch Nat Sci, Amherst, MA 01002 USA; [Brewer, Carol] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA	State University System of Florida; New College Florida; State University System of Florida; New College Florida; University of Montana System; University of Montana	Lowman, M (corresponding author), New Coll Florida, Dept Biol, Sarasota, FL 34243 USA.	canopymeg@gmail.com						American Association for the Advancement of Science (AAAS), 1993, 2061 AAAS; BOTKIN D, 1995, OUR NATL HIST LESSON; Brewer C, 2006, CONSERV BIOL, V20, P689, DOI 10.1111/j.1523-1739.2006.00467.x; D'Avanzo C, 2003, FRONT ECOL ENVIRON, V1, P533, DOI 10.2307/3868164; DAVANZO C, 2008, NEON ED OUTREACH STR; Keller M, 2008, FRONT ECOL ENVIRON, V6, P282, DOI 10.1890/1540-9295(2008)6[282:ACSFTN]2.0.CO;2; Mervis J, 2003, SCIENCE, V300, P1869, DOI 10.1126/science.300.5627.1869; National Research Council, 2001, GRAND CHALL ENV SCI; National Research Council (NRC), 1996, NAT SCI ED STAND; *NEON, NEON INT SCI ED PLAN; NRC, 2000, INQUIRY NATL SCI ED, DOI 10.17226/9596; Senkowsky S, 2005, BIOSCIENCE, V55, P106, DOI 10.1641/0006-3568(2005)055[0106:PONMA]2.0.CO;2; Teeri JA, 2002, SCIENCE, V298, P1893, DOI 10.1126/science.298.5600.1893; THOREAU HD, 1865, W POND	14	20	24	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2009	323	5918					1172	1173		10.1126/science.1166945	http://dx.doi.org/10.1126/science.1166945			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	411XT	19251614				2022-12-01	WOS:000263687600022
J	Long, JA; Trinajstic, K; Johanson, Z				Long, John A.; Trinajstic, Kate; Johanson, Zerina			Devonian arthrodire embryos and the origin of internal fertilization in vertebrates	NATURE			English	Article							LIVE BIRTH; FISHES; VIVIPARITY; PHYLOGENY; AUSTRALIA; EVOLUTION; FOSSIL	Evidence of reproductive biology is extremely rare in the fossil record. Recently the first known embryos were discovered within the Placodermi(1), an extinct class of armoured fish, indicating a viviparous mode of reproduction in a vertebrate group outside the crown-group Gnathostomata (Chondrichthyes and Osteichthyes). These embryos were found in ptyctodontids, a small group of placoderms phylogenetically basal to the largest group, the Arthrodira(2,3). Here we report the discovery of embryos in the Arthrodira inside specimens of Incisoscutum ritchiei from the Upper Devonian Gogo Formation of Western Australia(4) (approximately 380 million years ago), providing the first evidence, to our knowledge, for reproduction using internal fertilization in this diverse group. We show that Incisoscutum and some phyllolepid arthrodires possessed pelvic girdles with long basipterygia that articulated distally with an additional cartilaginous element or series, as in chondrichthyans, indicating that the pelvic fin was used in copulation. As homology between similar pelvic girdle skeletal structures in ptyctodontids, arthrodires and chondrichthyans is difficult to reconcile in the light of current phylogenies of lower gnathostomes(2,3,5), we explain these similarities as being most likely due to convergence (homoplasy). These new finds confirm that reproduction by internal fertilization and viviparity was much more widespread in the earliest gnathostomes than had been previously appreciated.	[Long, John A.] Victoria & Albert Museum, Melbourne, Vic 3001, Australia; [Long, John A.] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 2600, Australia; [Long, John A.] Monash Univ, Sch Geosci, Clayton, Vic 3800, Australia; [Trinajstic, Kate] Univ Western Australia, Sch Earth & Geog Sci, Perth, WA 6009, Australia; [Johanson, Zerina] Nat Hist Museum, London SW7 5BD, England	Australian National University; Monash University; University of Western Australia; Natural History Museum London	Long, JA (corresponding author), Victoria & Albert Museum, POB 666, Melbourne, Vic 3001, Australia.	jlong@museum.vic.gov.au	Trinajstic, Kate/B-2537-2009	Long, John/0000-0001-8012-0114; Johanson, Zerina/0000-0002-8444-6776; Trinajstic, Kate/0000-0002-6519-6396	Australian Research Council	Australian Research Council(Australian Research Council)	We thank M. Brazeau for access to his manuscript before publication, A. Ritchie for discussions, and G. Young and G. Edgecombe for reviewing the manuscript. We also thank K. Bifield for the photograph of WAM 04.10.02, and the Centre for Microscopy, Characterisation and Analysis, UWA, for microscopy assistance. J.A.L. and K.T. are supported by Australian Research Council Discovery grants.	Blackburn D.G., 2005, VIVIPAROUS FISHES, P287; Brazeau MD, 2009, NATURE, V457, P305, DOI 10.1038/nature07436; BURGIN T, 1990, ZOOL J LINN SOC-LOND, V100, P379, DOI 10.1111/j.1096-3642.1990.tb01866.x; Chiappe LM, 2004, NATURE, V432, P571, DOI 10.1038/432571a; Davidson RG, 2005, SCOT J GEOL, V41, P129, DOI 10.1144/sjg41020129; DENNIS K, 1981, ZOOL J LINN SOC-LOND, V73, P213, DOI 10.1111/j.1096-3642.1981.tb01594.x; Goujet D, 2004, RECENT ADV ORIGIN EA, P109; Janvier P, 2001, SYST ASSOC SPEC VOL, V61, P172; LEE MYS, 1998, HERPETOLOGICA, V55, P538; Long J.A., 1984, Proceedings of the Linnean Society of New South Wales, V107, P263; LONG JA, 2006, SWIMMING STONE AMAZI, P320; Long JA, 2008, NATURE, V453, P650, DOI 10.1038/nature06966; Lopez JA, 2006, MOL PHYLOGENET EVOL, V40, P50, DOI 10.1016/j.ympev.2006.02.011; LUND R, 1980, SCIENCE, V209, P697, DOI 10.1126/science.209.4457.697; Mank JE, 2006, J EVOLUTION BIOL, V19, P734, DOI 10.1111/j.1420-9101.2005.01060.x; Maxwell EE, 2003, P ROY SOC B-BIOL SCI, V270, pS104, DOI 10.1098/rsbl.2003.0029; Miles R. S., 1967, ZOOLOGICAL J LINNEAN, V47, P99; Ritchie A, 2005, P LINN SOC N S W, V126, P215; SCHULTZE HP, 1972, NATURE-NEW BIOL, V236, P90, DOI 10.1038/newbio236090a0; Sewertzoff AN, 1926, J MORPHOL PHYSIOL, V41, P547, DOI 10.1002/jmor.1050410208; Stensio E., 1963, Kungliga Svenska Vetenskapsakademiens Handlingar (4), V9, P1; TREWIN N H, 1986, Transactions of the Royal Society of Edinburgh Earth Sciences, V77, P21; Upeniece Ieva, 2001, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V4, P101; Webb SA, 2004, MOL PHYLOGENET EVOL, V30, P527, DOI 10.1016/S1055-7903(03)00257-4; WOURMS JP, 1981, AM ZOOL, V21, P473; YOUNG G C, 1988, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V202, P1; YOUNG GC, 1986, ZOOL J LINN SOC-LOND, V88, P1, DOI 10.1111/j.1096-3642.1986.tb00876.x	27	54	56	2	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 26	2009	457	7233					1124	1127		10.1038/nature07732	http://dx.doi.org/10.1038/nature07732			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411VI	19242474				2022-12-01	WOS:000263680100039
J	Pham, HH; O'Malley, AS; Bach, PB; Saiontz-Martinez, C; Schrag, D				Pham, Hoangmai H.; O'Malley, Ann S.; Bach, Peter B.; Saiontz-Martinez, Cynthia; Schrag, Deborah			Primary Care Physicians' Links to Other Physicians Through Medicare Patients: The Scope of Care Coordination	ANNALS OF INTERNAL MEDICINE			English	Article							PERFORMANCE	Background: Primary care physicians are expected to coordinate care for their patients. Objective: To assess the number of physician peers providing care to the Medicare patients of a primary care physician. Design: Cross-sectional analysis of claims data. Setting: Fee-for-service Medicare in 2005. Participants: 2284 primary care physicians who responded to the 2004 to 2005 Community Tracking Study Physician Survey. Measurements: Primary patients for each physician were defined as beneficiaries for whom the physician billed for more evaluation and management visits than any other physician in 2005. The number of physician peers for each physician was the sum of other unique physicians that the index physician's primary patients visited plus other unique physicians who served as the primary physician for each of the index physician's nonprimary patients during 2005. Results: The typical primary care physician has 229 (interquartile range, 125 to 340) other physicians working in 117 ( interquartile range, 66 to 175) practices with which care must be coordinated, equivalent to an additional 99 physicians and 53 practices for every 100 Medicare beneficiaries managed by the primary care physician. When only the 31% of a primary care physician's primary patients who had 4 or more chronic conditions was considered, the median number of peers involved was still substantial ( 86 physicians in 36 practices). The number of peers varied with geographic region, practice type, and reliance on Medicaid revenues. Limitations: Estimates are based only on fee-for-service Medicare patients and physician peers, and the number of peers is therefore probably an underestimate. The modest response rate of the Community Tracking Study Physician Survey may bias results in unpredictable directions. Conclusion: In caring for his or her own primary and nonprimary patients during a single year, each primary care physician potentially must coordinate with a large number of individual physician colleagues who also provide care to these patients.	[Pham, Hoangmai H.] Ctr Studying Hlth Syst Change, Washington, DC 20024 USA; Mem Sloan Kettering Canc Ctr, Hlth Outcomes Res Grp, New York, NY 10021 USA; Social & Sci Syst, Silver Spring, MD USA; Dana Farber Canc Inst, Boston, MA 02115 USA	Memorial Sloan Kettering Cancer Center; Social & Scientific Systems; Harvard University; Dana-Farber Cancer Institute	Pham, HH (corresponding author), Ctr Studying Hlth Syst Change, 600 Maryland Ave SW,Suite 550, Washington, DC 20024 USA.	mpham@hschange.org			National Institute on Aging; American Medical Group Association; Robert Wood Johnson Foundation; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025687] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Medical Group Association; Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	National Institute on Aging, American Medical Group Association, and the Robert Wood Johnson Foundation.	*AG HEALTHC RES QU, PUBL AG HEALTHC RES; Agency for Healthcare Research and Quality R MD, CAHPS CLIN GROUP SUR; Asch DA, 1997, J CLIN EPIDEMIOL, V50, P1129, DOI 10.1016/S0895-4356(97)00126-1; Bach PB, 2004, NEW ENGL J MED, V351, P575, DOI 10.1056/NEJMsa040609; Barr M, 2008, ADV MED HOME PATIENT; Bartschat Wanda, 2006, J AHIMA, V77, p64A; BERENSON RA, 2003, HLTH AFF MILLWOOD S; Bynum JPW, 2007, HEALTH SERV RES, V42, P45, DOI 10.1111/j.1475-6773.2006.00633.x; *CTR STUD HLTH SYS, TECHN PUBL CTR STUD, V38; Druss BG, 2003, NEW ENGL J MED, V348, P130, DOI 10.1056/NEJMsa020993; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Hwang W, 2001, HEALTH AFFAIR, V20, P267, DOI 10.1377/hlthaff.20.6.267; Institute of Medicine, 2001, CROSSING QUALITY CHA; Institute of Medicine, 1996, PRIM CAR AM HLTH NEW; Kwait J, 2001, J URBAN HEALTH, V78, P468, DOI 10.1093/jurban/78.3.468; Pham HH, 2007, NEW ENGL J MED, V356, P1130, DOI 10.1056/NEJMsa063979; Schrag D, 2006, MED CARE, V44, P560, DOI 10.1097/01.mlr.0000215811.68308.ae; Starfield B., 1998, PRIMARY CARE BALANCI; US Census Bureau, CENS REG DIV US; WEINER JP, 1995, JAMA-J AM MED ASSOC, V273, P1503, DOI 10.1001/jama.273.19.1503	20	162	162	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 17	2009	150	4					236	U23		10.7326/0003-4819-150-4-200902170-00004	http://dx.doi.org/10.7326/0003-4819-150-4-200902170-00004			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	410FI	19221375	Green Accepted			2022-12-01	WOS:000263562500002
J	Roberts, AJ; Numata, N; Walker, ML; Kato, YS; Malkova, B; Kon, T; Ohkura, R; Arisaka, F; Knight, PJ; Sutoh, K; Burgess, SA				Roberts, Anthony J.; Numata, Naoki; Walker, Matt L.; Kato, Yusuke S.; Malkova, Bara; Kon, Takahide; Ohkura, Reiko; Arisaka, Fumio; Knight, Peter J.; Sutoh, Kazuo; Burgess, Stan A.			AAA plus Ring and Linker Swing Mechanism in the Dynein Motor	CELL			English	Article							DICTYOSTELIUM CYTOPLASMIC DYNEIN; ARMS IN-SITU; MOLECULAR MOTOR; ELECTRON-MICROSCOPY; NEGATIVE STAIN; RESOLUTION; FAMILY; DOMAIN; COORDINATION; MICROTUBULES	Dynein ATPases power diverse microtubule-based motilities. Each dynein motor domain comprises a ring-like head containing six AAA+ modules and N- and C-terminal regions, together with a stalk that binds microtubules. How these subdomains are arranged and generate force remains poorly understood. Here, using electron microscopy and image processing of tagged and truncated Dictyostelium cytoplasmic dynein constructs, we show that the heart of the motor is a hexameric ring of AAA+ modules, with the stalk emerging opposite the primary ATPase site (AAA1). The C-terminal region is not an integral part of the ring but spans between AAA6 and near the stalk base. The N- terminal region includes a lever-like linker whose N terminus swings by similar to 17 nm during the ATPase cycle between AAA2 and the stalk base. Together with evidence of stalk tilting, which may communicate changes in microtubule binding affinity, these findings suggest a model for dynein's structure and mechanism.	[Roberts, Anthony J.; Kato, Yusuke S.; Malkova, Bara; Knight, Peter J.; Burgess, Stan A.] Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England; [Roberts, Anthony J.; Kato, Yusuke S.; Malkova, Bara; Knight, Peter J.; Burgess, Stan A.] Univ Leeds, Inst Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England; [Numata, Naoki; Kon, Takahide; Ohkura, Reiko; Sutoh, Kazuo] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo 1538902, Japan; [Walker, Matt L.] MLW Consulting, Launceston PL15 9BB, Cornwall, England; [Arisaka, Fumio] Tokyo Inst Technol, Grad Sch, Yokohama, Kanagawa 2268501, Japan; [Arisaka, Fumio] Tokyo Inst Technol, Sch Biosci & Biotechnol, Yokohama, Kanagawa 2268501, Japan	University of Leeds; University of Leeds; University of Tokyo; Tokyo Institute of Technology; Tokyo Institute of Technology	Burgess, SA (corresponding author), Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England.	sutoh@bio.c.u-tokyo.ac.jp; s.a.burgess@leeds.ac.uk	Kon, Takahide/AAG-6975-2021	Kon, Takahide/0000-0002-1231-7609	Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; BBSRC (UK) [24/B19478, BB/E00928X/1]; BBSRC Japan Partnering Award; Wellcome Trust [078115/Z/05/Z, 080709/Z/06/Z]; BBSRC [BB/E00928X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E00928X/1] Funding Source: researchfish	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); BBSRC (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC Japan Partnering Award(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We are grateful to Dr. N. A. Ranson, Dr. D. P. Mulvihill, and Dr. T. A. Edwards for comments on an earlier draft. This work was supported by a Grant-in-Aid for Scientific Research ( S) from the Japan Society for the Promotion of Science (JSPS); a Grant-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan to K. S.; by the BBSRC (UK) to P. J. K. (24/B19478) and to S. A. B. (BB/E00928X/1); a BBSRC Japan Partnering Award to P. J. K. and S. A. B.; and the Wellcome Trust to A. J. R. (078115/Z/05/Z) and B. M. (080709/Z/06/Z).	Burgess SA, 2004, J STRUCT BIOL, V146, P205, DOI 10.1016/j.jsb.2003.10.005; Burgess SA, 2004, J STRUCT BIOL, V147, P247, DOI 10.1016/j.jsb.2004.04.004; Burgess SA, 2004, CURR OPIN STRUC BIOL, V14, P138, DOI 10.1016/j.sbi.2004.03.013; Burgess SA, 2003, NATURE, V421, P715, DOI 10.1038/nature01377; Cavalier-Smith T, 2006, PHILOS T R SOC B, V361, P969, DOI 10.1098/rstb.2006.1842; DiBella LM, 2001, INT REV CYTOL, V210, P227; ELLIOTT A, 1976, PROC R SOC SER B-BIO, V193, P45, DOI 10.1098/rspb.1976.0030; Frank J, 2006, 3 DIMENSIONAL ELECT; Gee MA, 1997, NATURE, V390, P636, DOI 10.1038/37663; Gennerich A, 2007, CELL, V131, P952, DOI 10.1016/j.cell.2007.10.016; Gibbons IR, 2005, J BIOL CHEM, V280, P23960, DOI 10.1074/jbc.M501636200; Hook P, 2006, J CELL SCI, V119, P4369, DOI 10.1242/jcs.03176; Imamula K, 2007, P NATL ACAD SCI USA, V104, P16134, DOI 10.1073/pnas.0702370104; Ishikawa T, 2007, J MOL BIOL, V368, P1249, DOI 10.1016/j.jmb.2007.02.072; Karki S, 1999, CURR OPIN CELL BIOL, V11, P45, DOI 10.1016/S0955-0674(99)80006-4; King SM, 2000, J CELL SCI, V113, P2521; Kon T, 2005, NAT STRUCT MOL BIOL, V12, P513, DOI 10.1038/nsmb930; Kon T, 2004, BIOCHEMISTRY-US, V43, P11266, DOI 10.1021/bi048985a; Koonce MP, 2004, TRENDS CELL BIOL, V14, P612, DOI 10.1016/j.tcb.2004.09.013; Koonce MP, 1996, MOL BIOL CELL, V7, P935, DOI 10.1091/mbc.7.6.935; Kotani N, 2007, BIOPHYS J, V93, P886, DOI 10.1529/biophysj.106.101964; Kurzawa SE, 1997, BIOCHEMISTRY-US, V36, P317, DOI 10.1021/bi962166b; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Lupetti P, 2005, CELL MOTIL CYTOSKEL, V62, P69, DOI 10.1002/cm.20084; Meng X, 2006, J MOL BIOL, V357, P701, DOI 10.1016/j.jmb.2006.01.028; Mizuno N, 2007, P NATL ACAD SCI USA, V104, P20832, DOI 10.1073/pnas.0710406105; Mocz G, 2001, STRUCTURE, V9, P93, DOI 10.1016/S0969-2126(00)00557-8; Mogami T, 2007, J BIOL CHEM, V282, P21639, DOI 10.1074/jbc.M701914200; Neuwald AF, 1999, GENOME RES, V9, P27; Nicastro D, 2006, SCIENCE, V313, P944, DOI 10.1126/science.1128618; Nishiura M, 2004, J BIOL CHEM, V279, P22799, DOI 10.1074/jbc.M313362200; Numata N, 2008, BIOCHEM SOC T, V36, P131, DOI 10.1042/BST0360131; Oda T, 2007, J CELL BIOL, V177, P243, DOI 10.1083/jcb.200609038; Oiwa K, 2005, CURR OPIN CELL BIOL, V17, P98, DOI 10.1016/j.ceb.2004.12.006; Pfister KK, 2006, PLOS GENET, V2, P11, DOI 10.1371/journal.pgen.0020001; Reck-Peterson SL, 2006, CELL, V126, P335, DOI 10.1016/j.cell.2006.05.046; Samso M, 2004, J MOL BIOL, V340, P1059, DOI 10.1016/j.jmb.2004.05.063; Samso M, 1998, J MOL BIOL, V276, P927, DOI 10.1006/jmbi.1997.1584; Serohijos AWR, 2006, P NATL ACAD SCI USA, V103, P18540, DOI 10.1073/pnas.0602867103; Shima T, 2006, P NATL ACAD SCI USA, V103, P17736, DOI 10.1073/pnas.0606794103; Shima T, 2006, J STRUCT BIOL, V156, P182, DOI 10.1016/j.jsb.2006.03.014; Takahashi Y, 2004, P NATL ACAD SCI USA, V101, P12865, DOI 10.1073/pnas.0403429101; Toba S, 2006, P NATL ACAD SCI USA, V103, P5741, DOI 10.1073/pnas.0508511103; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; van Heel M, 2000, Q REV BIOPHYS, V33, P307, DOI 10.1017/S0033583500003644; Yagi T, 2005, J BIOL CHEM, V280, P41412, DOI 10.1074/jbc.M509072200; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246; Zhao L, 2003, J BACTERIOL, V185, P1693, DOI 10.1128/JB.185.5.1693-1700.2003	48	162	163	0	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 6	2009	136	3					485	495		10.1016/j.cell.2008.11.049	http://dx.doi.org/10.1016/j.cell.2008.11.049			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	403ZN	19203583	Green Published, hybrid			2022-12-01	WOS:000263120600018
J	Woodcock, A				Woodcock, Ashley			The Montreal Protocol: getting over the finishing line?	LANCET			English	Editorial Material							OZONE DEPLETION		Univ Manchester, Sch Translat Med, Univ S Manchester Hosp, Manchester M23 9LT, Lancs, England	University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital	Woodcock, A (corresponding author), Univ Manchester, Sch Translat Med, Univ S Manchester Hosp, Manchester M23 9LT, Lancs, England.	ashley.woodcock@manchester.ac.uk		Woodcock, Ashley/0000-0002-5428-8578				Anderson SO, 2007, TECHNOLOGY TRANSFER, P23; FARMAN JC, 1985, NATURE, V315, P207, DOI 10.1038/315207a0; Hendeles L, 2007, NEW ENGL J MED, V356, P1344, DOI 10.1056/NEJMra050380; LePrestre P, 1998, PROTECTING OZONE LAY; LLOYD SA, 1993, LANCET, V342, P1156, DOI 10.1016/0140-6736(93)92130-L; MOLINA MJ, 1974, NATURE, V249, P810, DOI 10.1038/249810a0; Slaper H, 1996, NATURE, V384, P256, DOI 10.1038/384256a0; Velders GJM, 2007, P NATL ACAD SCI USA, V104, P4814, DOI 10.1073/pnas.0610328104	8	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB-MAR	2009	373	9665					705	706		10.1016/S0140-6736(09)60418-9	http://dx.doi.org/10.1016/S0140-6736(09)60418-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	412LD	19249618	Green Submitted			2022-12-01	WOS:000263725400010
J	Liu, J; Cao, L; Chen, JC; Song, SW; Lee, IH; Quijano, C; Liu, HJ; Keyvanfar, K; Chen, HQ; Cao, LY; Ahn, BH; Kumar, NG; Rovira, II; Xu, XL; van Lohuizen, M; Motoyama, N; Deng, CX; Finkel, T				Liu, Jie; Cao, Liu; Chen, Jichun; Song, Shiwei; Lee, In Hye; Quijano, Celia; Liu, Hongjun; Keyvanfar, Keyvan; Chen, Haoqian; Cao, Long-Yue; Ahn, Bong-Hyun; Kumar, Neil G.; Rovira, Ilsa I.; Xu, Xiao-Ling; van Lohuizen, Maarten; Motoyama, Noboru; Deng, Chu-Xia; Finkel, Toren			Bmi1 regulates mitochondrial function and the DNA damage response pathway	NATURE			English	Article							HEMATOPOIETIC STEM-CELLS; SELF-RENEWAL; REPAIR; PROLIFERATION; SENESCENCE; INK4A; MICE; P16(INK4A); TARGET; GROWTH	Mice deficient in the Polycomb repressor Bmi1 develop numerous abnormalities including a severe defect in stem cell self-renewal, alterations in thymocyte maturation and a shortened lifespan. Previous work has implicated de-repression of the Ink4a/Arf (also known as Cdkn2a) locus as mediating many of the aspects of the Bmi1(-/-) phenotype. Here we demonstrate that cells derived from Bmi1(-/-) mice also have impaired mitochondrial function, a marked increase in the intracellular levels of reactive oxygen species and subsequent engagement of the DNA damage response pathway. Furthermore, many of the deficiencies normally observed in Bmi1(-/-) mice improve after either pharmacological treatment with the antioxidant N-acetylcysteine or genetic disruption of the DNA damage response pathway by Chk2 (also known as Chek2) deletion. These results demonstrate that Bmi1 has an unexpected role in maintaining mitochondrial function and redox homeostasis and indicate that the Polycomb family of proteins can coordinately regulate cellular metabolism with stem and progenitor cell function.	[Liu, Jie; Cao, Liu; Song, Shiwei; Lee, In Hye; Quijano, Celia; Liu, Hongjun; Chen, Haoqian; Cao, Long-Yue; Ahn, Bong-Hyun; Kumar, Neil G.; Rovira, Ilsa I.; Finkel, Toren] NHLBI, Translat Med Branch, NIH, Bethesda, MD 20892 USA; [Cao, Liu; Keyvanfar, Keyvan] NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA; [Kumar, Neil G.] NIH, Howard Hughes Med Inst, Res Scholar Program, Bethesda, MD 20892 USA; [Xu, Xiao-Ling; Deng, Chu-Xia] NIDDKD, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA; [van Lohuizen, Maarten] Netherlands Canc Inst, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands; [Motoyama, Noboru] Natl Ctr Geriatr & Gerontol, Natl Inst Longev Sci, Dept Geriatr Med, Aichi 4748522, Japan	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Netherlands Cancer Institute; National Center for Geriatrics & Gerontology	Finkel, T (corresponding author), NHLBI, Translat Med Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	Liu.Cao@nih.gov; finkelt@nih.gov	deng, chuxia/N-6713-2016; LEE, IN HYE/T-2714-2019	LEE, IN HYE/0000-0003-2334-3594	Howard Hughes Medical Institute Funding Source: Medline; Intramural NIH HHS [Z01 HL005012-11] Funding Source: Medline; NIA NIH HHS [R00 AG032356] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006037, ZIAHL005012, ZICHL005906] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK056009, ZIADK056011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R00AG032356] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Adams James David, 2006, Chin Med, V1, P3, DOI 10.1186/1749-8546-1-3; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Bruggeman SWM, 2005, GENE DEV, V19, P1438, DOI 10.1101/gad.1299305; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Fasano CA, 2007, CELL STEM CELL, V1, P87, DOI 10.1016/j.stem.2007.04.001; Ferrick DA, 2008, DRUG DISCOV TODAY, V13, P268, DOI 10.1016/j.drudis.2007.12.008; Finkel T, 2007, NATURE, V448, P767, DOI 10.1038/nature05985; Hirao A, 2002, MOL CELL BIOL, V22, P6521, DOI 10.1128/MCB.22.18.6521-6532.2002; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Neumann CA, 2003, NATURE, V424, P561, DOI 10.1038/nature01819; Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875; Oguro H, 2006, J EXP MED, V203, P2247, DOI 10.1084/jem.20052477; Okada H, 2004, J EXP MED, V199, P399, DOI 10.1084/jem.20032092; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Reese JS, 2003, BLOOD, V102, P1626, DOI 10.1182/blood-2002-10-3035; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Smith AL, 2005, J GERONTOL A-BIOL, V60, P448, DOI 10.1093/gerona/60.4.448; Struthers L, 1998, ANAL BIOCHEM, V255, P20, DOI 10.1006/abio.1997.2354; Takahashi A, 2006, NAT CELL BIOL, V8, P1291, DOI 10.1038/ncb1491; Takai H, 2002, EMBO J, V21, P5195, DOI 10.1093/emboj/cdf506; TeKippe M, 2003, EXP HEMATOL, V31, P521, DOI 10.1016/S0301-472X(03)00072-9; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; Viale A, 2009, NATURE, V457, P51, DOI 10.1038/nature07618; Zaugg K, 2007, P NATL ACAD SCI USA, V104, P3805, DOI 10.1073/pnas.0611584104	38	368	381	2	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2009	459	7245					387	U100		10.1038/nature08040	http://dx.doi.org/10.1038/nature08040			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448DQ	19404261	Green Accepted			2022-12-01	WOS:000266243700037
J	Boothroyd, CE; Dreesen, O; Leonova, T; Ly, KI; Figueiredo, LM; Cross, GAM; Papavasiliou, FN				Boothroyd, Catharine E.; Dreesen, Oliver; Leonova, Tatyana; Ly, K. Ina; Figueiredo, Luisa M.; Cross, George A. M.; Papavasiliou, F. Nina			A yeast-endonuclease-generated DNA break induces antigenic switching in Trypanosoma brucei	NATURE			English	Article							VSG EXPRESSION SITE; AFRICAN TRYPANOSOMES; SURFACE-ANTIGENS; GENE-EXPRESSION; TRANSCRIPTION; ACTIVATION; SEQUENCES; COPIES; END	Trypanosoma brucei is the causative agent of African sleeping sickness in humans and one of the causes of nagana in cattle. This protozoan parasite evades the host immune system by antigenic variation, a periodic switching of its variant surface glycoprotein (VSG) coat. VSG switching is spontaneous and occurs at a rate of about 10(-2)-10(-3) per population doubling in recent isolates from nature, but at a markedly reduced rate (10(-5)-10(-6)) in laboratory-adapted strains(1-3). VSG switching is thought to occur predominantly through gene conversion, a form of homologous recombination initiated by a DNA lesion that is used by other pathogens (for example, Candida albicans, Borrelia sp. and Neisseria gonorrhoeae) to generate surface protein diversity, and by B lymphocytes of the vertebrate immune system to generate antibody diversity. Very little is known about the molecular mechanism of VSG switching in T. brucei. Here we demonstrate that the introduction of a DNA double-stranded break (DSB) adjacent to the similar to 70-base-pair ( bp) repeats upstream of the transcribed VSG gene increases switching in vitro similar to 250-fold, producing switched clones with a frequency and features similar to those generated early in an infection. We were also able to detect spontaneous DSBs within the 70-bp repeats upstream of the actively transcribed VSG gene, indicating that a DSB is a natural intermediate of VSG gene conversion and that VSG switching is the result of the resolution of this DSB by break-induced replication.	[Boothroyd, Catharine E.; Leonova, Tatyana; Ly, K. Ina; Papavasiliou, F. Nina] Rockefeller Univ, Lab Lymphocyte Biol, New York, NY 10065 USA; [Dreesen, Oliver; Figueiredo, Luisa M.; Cross, George A. M.] Rockefeller Univ, Mol Parasitol Lab, New York, NY 10065 USA	Rockefeller University; Rockefeller University	Papavasiliou, FN (corresponding author), Rockefeller Univ, Lab Lymphocyte Biol, New York, NY 10065 USA.	papavas@rockefeller.edu	Cross, George A M/B-7444-2011; Dreesen, Oliver/AAJ-2132-2020; Figueiredo, Luisa Miranda/C-3908-2018	Cross, George A M/0000-0003-1374-6955; Figueiredo, Luisa Miranda/0000-0002-5752-6586	the National Institute of Allergy and Infectious Diseases of the US National Institutes of Health [R01AI021729]; C. H. Revson Foundation; German National Academic Foundation; Otto Ritter Foundation; W. M. Keck Foundation; Irma T. Hirschl Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI085973, R01AI021729] Funding Source: NIH RePORTER	the National Institute of Allergy and Infectious Diseases of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); C. H. Revson Foundation; German National Academic Foundation; Otto Ritter Foundation; W. M. Keck Foundation(W.M. Keck Foundation); Irma T. Hirschl Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by awards from the C. H. Revson Foundation ( to C. E. B.), the German National Academic Foundation ( to K. I. L.), the Otto Ritter Foundation ( to K. I. L.), the W. M. Keck Foundation ( to F. N. P.), the Irma T. Hirschl Foundation ( to F. N. P.) and by grant number R01AI021729 from the National Institute of Allergy and Infectious Diseases of the US National Institutes of Health ( to G. A. M. C.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIAID or the NIH.	Barry JD, 2001, ADV PARASIT, V49, P1, DOI 10.1016/S0065-308X(01)49037-3; Barzel A, 2008, NAT REV GENET, V9, P27, DOI 10.1038/nrg2224; BERNARDS A, 1981, CELL, V27, P497, DOI 10.1016/0092-8674(81)90391-3; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Borst P, 2001, MOL BIOCHEM PARASIT, V114, P17, DOI 10.1016/S0166-6851(01)00243-2; DELANGE T, 1985, EMBO J, V4, P3299, DOI 10.1002/j.1460-2075.1985.tb04080.x; DELANGE T, 1982, NATURE, V299, P451, DOI 10.1038/299451a0; Dreesen O, 2007, NAT REV MICROBIOL, V5, P70, DOI 10.1038/nrmicro1577; Dreesen O, 2006, EUKARYOT CELL, V5, P2114, DOI 10.1128/EC.00059-06; Dreesen O, 2006, MOL CELL BIOL, V26, P4911, DOI 10.1128/MCB.00212-06; Glover L, 2008, NUCLEIC ACIDS RES, V36, P2608, DOI 10.1093/nar/gkn104; Glover L, 2007, NUCLEIC ACIDS RES, V35, P872, DOI 10.1093/nar/gkl1100; Haber JE, 2006, DNA REPAIR, V5, P998, DOI 10.1016/j.dnarep.2006.05.025; Hertz-Fowler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003527; HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883; HOEIJMAKERS JHJ, 1980, NATURE, V284, P78, DOI 10.1038/284078a0; Horn D, 1997, MOL BIOCHEM PARASIT, V84, P189, DOI 10.1016/S0166-6851(96)02794-6; Horn D, 2004, CURR MOL MED, V4, P563, DOI 10.2174/1566524043360078; Llorente B, 2008, CELL CYCLE, V7, P859, DOI 10.4161/cc.7.7.5613; Marcello L, 2007, GENOME RES, V17, P1344, DOI 10.1101/gr.6421207; McCulloch R, 1997, MOL CELL BIOL, V17, P833, DOI 10.1128/MCB.17.2.833; Morrison LJ, 2005, INT J PARASITOL, V35, P961, DOI 10.1016/j.ijpara.2005.05.004; Ohshima K, 1996, J BIOL CHEM, V271, P16784, DOI 10.1074/jbc.271.28.16784; Robinson NP, 1999, MOL CELL BIOL, V19, P5839; SCHLISSEL MS, 1989, CELL, V58, P1001, DOI 10.1016/0092-8674(89)90951-3; Schrader CE, 2005, J EXP MED, V202, P561, DOI 10.1084/jem.20050872; Taylor JE, 2006, TRENDS GENET, V22, P614, DOI 10.1016/j.tig.2006.08.003; Turner CMR, 1997, FEMS MICROBIOL LETT, V153, P227, DOI 10.1111/j.1574-6968.1997.tb10486.x; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Zarrin AA, 2007, SCIENCE, V315, P377, DOI 10.1126/science.1136386	30	107	108	0	9	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 14	2009	459	7244					278	U168		10.1038/nature07982	http://dx.doi.org/10.1038/nature07982			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445FR	19369939	Green Accepted			2022-12-01	WOS:000266036100047
J	Esslinger, C; Walter, H; Kirsch, P; Erk, S; Schnell, K; Arnold, C; Haddad, L; Mier, D; von Boberfeld, CO; Raab, K; Witt, SH; Rietschel, M; Cichon, S; Meyer-Lindenberg, A				Esslinger, Christine; Walter, Henrik; Kirsch, Peter; Erk, Susanne; Schnell, Knut; Arnold, Claudia; Haddad, Leila; Mier, Daniela; von Boberfeld, Carola Opitz; Raab, Kyeon; Witt, Stephanie H.; Rietschel, Marcella; Cichon, Sven; Meyer-Lindenberg, Andreas			Neural Mechanisms of a Genome-Wide Supported Psychosis Variant	SCIENCE			English	Article							SCHIZOPHRENIA		[Esslinger, Christine; Kirsch, Peter; Haddad, Leila; Mier, Daniela; Raab, Kyeon; Meyer-Lindenberg, Andreas] Univ Heidelberg, Dept Psychiat & Psychotherapy, Cent Inst Mental Hlth, D-68159 Mannheim, Germany; [Walter, Henrik; Schnell, Knut] Univ Bonn, Div Med Psychol, D-53105 Bonn, Germany; [Walter, Henrik; Erk, Susanne; Schnell, Knut; Arnold, Claudia; von Boberfeld, Carola Opitz] Univ Bonn, Dept Psychiat & Psychotherapy, D-53105 Bonn, Germany; [Witt, Stephanie H.; Rietschel, Marcella] Univ Heidelberg, Dept Genet Epidemiol Psychiat, Cent Inst Mental Hlth, D-68159 Mannheim, Germany; [Cichon, Sven] Univ Bonn, Life & Brain Ctr, Dept Genom, D-53105 Bonn, Germany; [Cichon, Sven] Univ Bonn, Inst Human Genet, D-53105 Bonn, Germany	Central Institute of Mental Health; Ruprecht Karls University Heidelberg; University of Bonn; University of Bonn; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; University of Bonn; University of Bonn	Meyer-Lindenberg, A (corresponding author), Univ Heidelberg, Dept Psychiat & Psychotherapy, Cent Inst Mental Hlth, J5, D-68159 Mannheim, Germany.	a.meyer-lindenberg@zi-mannheim.de	Cichon, Sven/H-8803-2013; Walter, Henrik/O-2612-2013; Cichon, Sven/B-9618-2014; Kirsch, Peter/C-2499-2008; Meyer-Lindenberg, Andreas/H-1076-2011	Cichon, Sven/0000-0002-9475-086X; Cichon, Sven/0000-0002-9475-086X; Kirsch, Peter/0000-0002-0817-1248; Erk, Susanne/0000-0003-0961-3543; Walter, Henrik/0000-0002-9403-6121; Meyer-Lindenberg, Andreas/0000-0001-5619-1123; Mier, Daniela/0000-0003-2518-7492	Bundesministerium fur Bildung und Forschung; Deutsche Forschungemeinschaft [SFB 636-B7]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungemeinschaft(German Research Foundation (DFG))	Funding was provided by Bundesministerium fur Bildung und Forschung (Nationales Genomforschungsnetz plus MooDs) and Deutsche Forschungemeinschaft (SFB 636-B7). We thank T. Paul, B. Newport, D. Gass, O. Grimm, and C. Sauer for data acquisition; T. Demirakca and M. Ruf for technical support; and T. Schulze and M. Nothen for helpful discussion.	Meyer-Lindenberg A, 2006, NAT REV NEUROSCI, V7, P818, DOI 10.1038/nrn1993; Meyer-Lindenberg A, 2008, NEUROIMAGE, V40, P655, DOI 10.1016/j.neuroimage.2007.11.058; Meyer-Lindenberg AS, 2005, ARCH GEN PSYCHIAT, V62, P379, DOI 10.1001/archpsyc.62.4.379; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; Rasetti R, 2009, AM J PSYCHIAT, V166, P216, DOI 10.1176/appi.ajp.2008.08020261; Stephan KE, 2006, BIOL PSYCHIAT, V59, P929, DOI 10.1016/j.biopsych.2005.10.005	6	320	339	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 1	2009	324	5927					605	605		10.1126/science.1167768	http://dx.doi.org/10.1126/science.1167768			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439DW	19407193				2022-12-01	WOS:000265608800033
J	Sessions, OM; Barrows, NJ; Souza-Neto, JA; Robinson, TJ; Hershey, CL; Rodgers, MA; Ramirez, JL; Dimopoulos, G; Yang, PL; Pearson, JL; Garcia-Blanco, MA				Sessions, October M.; Barrows, Nicholas J.; Souza-Neto, Jayme A.; Robinson, Timothy J.; Hershey, Christine L.; Rodgers, Mary A.; Ramirez, Jose L.; Dimopoulos, George; Yang, Priscilla L.; Pearson, James L.; Garcia-Blanco, Mariano A.			Discovery of insect and human dengue virus host factors	NATURE			English	Article							WEST-NILE-VIRUS; ALPHA-GLUCOSIDASE INHIBITORS; JAPANESE ENCEPHALITIS-VIRUS; UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM; NUCLEAR-LOCALIZATION; ENDOCYTIC PATHWAY; BAFILOMYCIN A1; INFECTED-CELLS; AEDES-AEGYPTI	Dengue fever is the most frequent arthropod-borne viral disease of humans, with almost half of the world's population at risk of infection(1). The high prevalence, lack of an effective vaccine, and absence of specific treatment conspire to make dengue fever a global public health threat(1,2). Given their compact genomes, dengue viruses (DENV-1-4) and other flaviviruses probably require an extensive number of host factors; however, only a limited number of human, and an even smaller number of insect host factors, have been identified(3-10). Here we identify insect host factors required for DENV-2 propagation, by carrying out a genome-wide RNA interference screen in Drosophila melanogaster cells using a well-established 22,632 double-stranded RNA library. This screen identified 116 candidate dengue virus host factors (DVHFs). Although some were previously associated with flaviviruses (for example, V-ATPases and alpha-glucosidases)(3-5,7,9,10), most of the DVHFs were newly implicated in dengue virus propagation. The dipteran DVHFs had 82 readily recognizable human homologues and, using a targeted short-interfering-RNA screen, we showed that 42 of these are human DVHFs. This indicates notable conservation of required factors between dipteran and human hosts. This work suggests new approaches to control infection in the insect vector and the mammalian host.	[Sessions, October M.; Robinson, Timothy J.; Pearson, James L.; Garcia-Blanco, Mariano A.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Sessions, October M.; Barrows, Nicholas J.; Pearson, James L.; Garcia-Blanco, Mariano A.] Duke Univ, Med Ctr, Ctr RNA Biol, Durham, NC 27710 USA; [Barrows, Nicholas J.; Pearson, James L.; Garcia-Blanco, Mariano A.] Duke Univ, Med Ctr, Duke RNAi Facil, Durham, NC 27710 USA; [Barrows, Nicholas J.] Duke Univ, Med Ctr, Inst Genome Sci & Policy, Durham, NC 27710 USA; [Robinson, Timothy J.] Duke Univ, Med Ctr, Med Scientist Training Program, Durham, NC 27710 USA; [Robinson, Timothy J.] Duke Univ, Med Ctr, Program Mol Canc Biol, Durham, NC 27710 USA; [Souza-Neto, Jayme A.; Ramirez, Jose L.; Dimopoulos, George] Johns Hopkins Univ, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; [Souza-Neto, Jayme A.; Ramirez, Jose L.; Dimopoulos, George] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Malaria Res Inst, Baltimore, MD 21205 USA; [Hershey, Christine L.; Rodgers, Mary A.; Yang, Priscilla L.] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; [Garcia-Blanco, Mariano A.] Duke NUS Grad Med Sch, Programin Emerging Infect Dis, Singapore 169547, Singapore	Duke University; Duke University; Duke University; Duke University; Duke University; Duke University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Harvard University; Harvard Medical School; National University of Singapore	Pearson, JL (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA.	pears016@mc.duke.edu; garci001@mc.duke.edu	Souza-Neto, Jayme A/E-7841-2010	Souza-Neto, Jayme A/0000-0001-9281-894X; Rodgers, Mary/0000-0001-8815-8651; Dimopoulos, George/0000-0001-6755-8111; Ramirez, Jose Luis/0000-0001-9607-1097	National Institutes of Health (NIH) [RO1 GM067761, R21-AI64925, 5U54-AI057157-05S, 1RO1AI076442, 1R01AI061576-01, 1SA0RR024572-1]; American Society of Microbiology; Johns Hopkins Malaria Research Institute; North Carolina Biotechnology Center; Duke Center for RNA Biology; Duke University School of Medicine; Institute of Genome Sciences and Policy; Duke Comprehensive Cancer Center [5P30-CA14236]; NATIONAL CANCER INSTITUTE [P30CA014236] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061576, R21AI090188, R01AI078997, U54AI057157, R21AI064925, U54AI057159, R01AI076442, T32AI007417] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067761] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS063845] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society of Microbiology; Johns Hopkins Malaria Research Institute; North Carolina Biotechnology Center; Duke Center for RNA Biology; Duke University School of Medicine; Institute of Genome Sciences and Policy; Duke Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. de Silva, C. Lambeth, E. Wagner, F. Scholle, P. Florez de Sessions, J. Umbach, S. Braderick, B. Cullen, J. Nevins, M. Marengo, M. Gromeier, R. Wharton, D. Gubler, E. E. Ooi and S. Vasudevan, and members of the Triangle Flavivirology Group for reagents, time and insights. M. A. G.-B. thanks the late R. Shope for his inspiration and mentorship. We thank the Drosophila RNAi Screening Center (Harvard Medical School), which is funded by National Institutes of Health (NIH) grant RO1 GM067761, for expert assistance. We give special thanks to B. Mathey-Prevot for his support, advice and expertise, and for pointing out the important overlap of our screen with others previously published. We acknowledge funding from the NIH (R21-AI64925 and 5U54-AI057157-05S to M. A. G.-B., 1RO1AI076442 to P. L. Y., and 1R01AI061576-01 to G. D.); the American Society of Microbiology (to J. L. R.); and Johns Hopkins Malaria Research Institute (to J. A. S.-N.). M. A. R. is a Karnovsky Fellow. P. L. Y. acknowledges an award from the Giovanni Armenise-Harvard Foundation. We also acknowledge funding from the North Carolina Biotechnology Center, NIH (1SA0RR024572-1 to M. A. G.-B.), Duke Center for RNA Biology, Duke University School of Medicine, Institute of Genome Sciences and Policy, and Duke Comprehensive Cancer Center (5P30-CA14236) in support of the RNAi facility.	Ahlquist P, 2006, NAT REV MICROBIOL, V4, P371, DOI 10.1038/nrmicro1389; Andoh T, 1998, J NEUROVIROL, V4, P627, DOI 10.3109/13550289809114229; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; Chapel C, 2006, J GEN VIROL, V87, P861, DOI 10.1099/vir.0.81503-0; Chu JJH, 2004, J VIROL, V78, P10543, DOI 10.1128/JVI.78.19.10543-10555.2004; Courageot MP, 2000, J VIROL, V74, P564, DOI 10.1128/JVI.74.1.564-572.2000; Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052; Emara MM, 2007, P NATL ACAD SCI USA, V104, P9041, DOI 10.1073/pnas.0703348104; Franz AWE, 2006, P NATL ACAD SCI USA, V103, P4198, DOI 10.1073/pnas.0600479103; HEINZ FX, 1994, VIROLOGY, V198, P109, DOI 10.1006/viro.1994.1013; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; KAPOOR M, 1995, J BIOL CHEM, V270, P19100, DOI 10.1074/jbc.270.32.19100; Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207; Krishnan MN, 2007, J VIROL, V81, P4881, DOI 10.1128/JVI.02210-06; Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005; Lawson D, 2007, NUCLEIC ACIDS RES, V35, pD503, DOI 10.1093/nar/gkl960; Littleton JT, 2000, J CELL BIOL, V150, pF77, DOI 10.1083/jcb.150.2.F77; Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144; Mosso C, 2008, VIROLOGY, V378, P193, DOI 10.1016/j.virol.2008.05.012; Nawa M, 1998, ARCH VIROL, V143, P1555, DOI 10.1007/s007050050398; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Pelchen-Matthews A, 2004, TRENDS MICROBIOL, V12, P310, DOI 10.1016/j.tim.2004.05.004; Potter LR, 2006, ENDOCR REV, V27, P47, DOI 10.1210/er.2005-0014; Pryor MJ, 2007, TRAFFIC, V8, P795, DOI 10.1111/j.1600-0854.2007.00579.x; Uchil PD, 2006, J VIROL, V80, P5451, DOI 10.1128/JVI.01982-05; Umareddy I, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-91; Wang SH, 2004, J GEN VIROL, V85, P2307, DOI 10.1099/vir.0.80067-0; Whitby K, 2005, J VIROL, V79, P8698, DOI 10.1128/JVI.79.14.8698-8706.2005; Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098; Yu CY, 2006, J VIROL, V80, P11868, DOI 10.1128/JVI.00879-06	30	288	295	0	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	2009	458	7241					1047	1050		10.1038/nature07967	http://dx.doi.org/10.1038/nature07967			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436KL	19396146	Green Accepted, Green Submitted			2022-12-01	WOS:000265412900047
J	Nishikimi, A; Fukuhara, H; Su, WJ; Hongu, T; Takasuga, S; Mihara, H; Cao, QH; Sanematsu, F; Kanai, M; Hasegawa, H; Tanaka, Y; Shibasaki, M; Kanaho, Y; Sasaki, T; Frohman, MA; Fukui, Y				Nishikimi, Akihiko; Fukuhara, Hideo; Su, Wenjuan; Hongu, Tsunaki; Takasuga, Shunsuke; Mihara, Hisashi; Cao, Qinhong; Sanematsu, Fumiyuki; Kanai, Motomu; Hasegawa, Hiroshi; Tanaka, Yoshihiko; Shibasaki, Masakatsu; Kanaho, Yasunori; Sasaki, Takehiko; Frohman, Michael A.; Fukui, Yoshinori			Sequential Regulation of DOCK2 Dynamics by Two Phospholipids During Neutrophil Chemotaxis	SCIENCE			English	Article							PHOSPHATIDIC-ACID; CELL-MIGRATION; DOWNSTREAM ACTIVATION; RAC ACTIVATION; MOTILITY; POLARITY; PROTEINS; COMPLEX; ROLES; ARF6	During chemotaxis, activation of the small guanosine triphosphatase Rac is spatially regulated to organize the extension of membrane protrusions in the direction of migration. In neutrophils, Rac activation is primarily mediated by DOCK2, an atypical guanine nucleotide exchange factor. Upon stimulation, we found that DOCK2 rapidly translocated to the plasma membrane in a phosphatidylinositol 3,4,5-trisphosphate-dependent manner. However, subsequent accumulation of DOCK2 at the leading edge required phospholipase D-mediated synthesis of phosphatidic acid, which stabilized DOCK2 there by means of interaction with a polybasic amino acid cluster, resulting in increased local actin polymerization. When this interaction was blocked, neutrophils failed to form leading edges properly and exhibited defects in chemotaxis. Thus, intracellular DOCK2 dynamics are sequentially regulated by distinct phospholipids to localize Rac activation during neutrophil chemotaxis.	[Nishikimi, Akihiko; Fukuhara, Hideo; Cao, Qinhong; Sanematsu, Fumiyuki; Tanaka, Yoshihiko; Fukui, Yoshinori] Kyushu Univ, Med Inst Bioregulat, Dept Neurosci & Immunol, Div Immunogenet, Fukuoka 8128582, Japan; [Nishikimi, Akihiko; Tanaka, Yoshihiko; Fukui, Yoshinori] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Tokyo 1020075, Japan; [Su, Wenjuan; Frohman, Michael A.] SUNY Stony Brook, Dept Pharmacol, Ctr Dev Genet, Stony Brook, NY 11794 USA; [Hongu, Tsunaki; Hasegawa, Hiroshi; Kanaho, Yasunori] Univ Tsukuba, Inst Basic Med Sci, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058575, Japan; [Takasuga, Shunsuke; Sasaki, Takehiko] Akita Univ, Sch Med, Dept Pathol & Immunol, Div Microbiol, Akita 0108543, Japan; [Mihara, Hisashi; Kanai, Motomu; Shibasaki, Masakatsu] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo 1130033, Japan	Kyushu University; Japan Science & Technology Agency (JST); State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; University of Tsukuba; Akita University; University of Tokyo	Fukui, Y (corresponding author), Kyushu Univ, Med Inst Bioregulat, Dept Neurosci & Immunol, Div Immunogenet, Fukuoka 8128582, Japan.	fukui@bioreg.kyushu-u.ac.jp	Nishikimi, Akihiko/I-4692-2018; Kanai, Motomu/J-6807-2016	Nishikimi, Akihiko/0000-0001-9497-7557; Kanai, Motomu/0000-0003-1977-7648; Fukui, Yoshinori/0000-0003-2335-8745; Sasaki, Takehiko/0000-0003-1837-3748; TANAKA, Yoshihiko/0000-0002-6458-5082	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Toray Science Foundation; CREST program of Japan Science and Technology Agency; Global Center of Excellence program of the Japan Society for the Promotion of Science; NIH [R01GM71520]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084251, R01GM071520] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Toray Science Foundation(Toray Industries, Inc.); CREST program of Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Global Center of Excellence program of the Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants for Targeted Proteins Research Project, Genome Network Project, Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; Toray Science Foundation; CREST program of Japan Science and Technology Agency; the Global Center of Excellence program of the Japan Society for the Promotion of Science; and NIH award R01GM71520.	ALA A, 2009, MOL PHARM, V75, P437; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Cote JF, 2005, NAT CELL BIOL, V7, P797, DOI 10.1038/ncb1280; Cote JF, 2002, J CELL SCI, V115, P4901, DOI 10.1242/jcs.00219; Du GW, 2004, MOL BIOL CELL, V15, P1024, DOI 10.1091/mbc.E03-09-0673; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Fergus GJ, 2007, NAT CELL BIOL, V9, P86, DOI 10.1038/ncb1517; Fukui Y, 2001, NATURE, V412, P826, DOI 10.1038/35090591; Gardiner EM, 2002, CURR BIOL, V12, P2029, DOI 10.1016/S0960-9822(02)01334-9; Kraynov VS, 2000, SCIENCE, V290, P333, DOI 10.1126/science.290.5490.333; Kunisaki Y, 2006, J CELL BIOL, V174, P647, DOI 10.1083/jcb.200602142; Lehman N, 2006, BLOOD, V108, P3564, DOI 10.1182/blood-2006-02-005959; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; McDermott M, 2004, BIOCHEM CELL BIOL, V82, P225, DOI 10.1139/o03-079; Nishio M, 2007, NAT CELL BIOL, V9, P36, DOI 10.1038/ncb1515; Rickert P, 2000, TRENDS CELL BIOL, V10, P466, DOI 10.1016/S0962-8924(00)01841-9; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; Santy LC, 2005, CURR BIOL, V15, P1749, DOI 10.1016/j.cub.2005.08.052; Srinivasan S, 2003, J CELL BIOL, V160, P375, DOI 10.1083/jcb.200208179; Stace CL, 2006, BBA-MOL CELL BIOL L, V1761, P913, DOI 10.1016/j.bbalip.2006.03.006; Su W, 2009, MOL PHARMACOL, V75, P437, DOI 10.1124/mol.108.053298; Zhao C, 2007, NAT CELL BIOL, V9, P706, DOI 10.1038/ncb1594; Zouwail S, 2005, BIOCHEM J, V389, P207, DOI 10.1042/BJ20050085	24	204	211	2	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2009	324	5925					384	387		10.1126/science.1170179	http://dx.doi.org/10.1126/science.1170179			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433QT	19325080	Green Accepted			2022-12-01	WOS:000265221600041
J	King, RD; Rowland, J; Oliver, SG; Young, M; Aubrey, W; Byrne, E; Liakata, M; Markham, M; Pir, P; Soldatova, LN; Sparkes, A; Whelan, KE; Clare, A				King, Ross D.; Rowland, Jem; Oliver, Stephen G.; Young, Michael; Aubrey, Wayne; Byrne, Emma; Liakata, Maria; Markham, Magdalena; Pir, Pinar; Soldatova, Larisa N.; Sparkes, Andrew; Whelan, Kenneth E.; Clare, Amanda			The Automation of Science	SCIENCE			English	Article							ONTOLOGY; GROWTH	The basis of science is the hypothetico-deductive method and the recording of experiments in sufficient detail to enable reproducibility. We report the development of Robot Scientist "Adam," which advances the automation of both. Adam has autonomously generated functional genomics hypotheses about the yeast Saccharomyces cerevisiae and experimentally tested these hypotheses by using laboratory automation. We have confirmed Adam's conclusions through manual experiments. To describe Adam's research, we have developed an ontology and logical language. The resulting formalization involves over 10,000 different research units in a nested treelike structure, 10 levels deep, that relates the 6.6 million biomass measurements to their logical description. This formalization describes how a machine contributed to scientific knowledge.	[King, Ross D.; Rowland, Jem; Aubrey, Wayne; Byrne, Emma; Liakata, Maria; Markham, Magdalena; Soldatova, Larisa N.; Sparkes, Andrew; Whelan, Kenneth E.; Clare, Amanda] Aberystwyth Univ, Dept Comp Sci, Aberystwyth SY23 3DB, Dyfed, Wales; [Oliver, Stephen G.; Pir, Pinar] Univ Cambridge, Dept Biochem, Cambridge Syst Biol Ctr, Cambridge CB2 1GA, England; [Young, Michael] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth SY23 3DD, Dyfed, Wales	Aberystwyth University; University of Cambridge; Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS)	King, RD (corresponding author), Aberystwyth Univ, Dept Comp Sci, Aberystwyth SY23 3DB, Dyfed, Wales.	rdk@aber.ac.uk	Soldatova, Larisa/AAE-4656-2020; Aubrey, Wayne/AAE-7321-2021; Oliver, Stephen/AAQ-5992-2021; Pir, Pinar/AAA-5103-2022	Oliver, Stephen/0000-0003-3410-6439; King, Ross/0000-0001-7208-4387; Pir, Pinar/0000-0002-0078-4904; Clare, Amanda/0000-0001-8315-3659; Soldatova, Larisa/0000-0001-6489-3029; Liakata, Maria/0000-0001-5765-0416	Biotechnology and Biological Sciences Research Council; SRIF 2 award; fellowships from the Royal Commission; Engineering and Physical Sciences Research Council; Royal Academy of Engineering; RC-UK Fellowship; BBSRC [BB/F008228/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F008228/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); SRIF 2 award; fellowships from the Royal Commission; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Royal Academy of Engineering(Royal Academy of Engineering - UK); RC-UK Fellowship(UK Research & Innovation (UKRI)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by grants from the Biotechnology and Biological Sciences Research Council to R.D.K., S.G.O., and M.Y.; by a SRIF 2 award to R.D.K.; by fellowships from the Royal Commission for the Great Exhibition of 1851, the Engineering and Physical Sciences Research Council, and the Royal Academy of Engineering to A.C.; and by a RC-UK Fellowship to L.N.S. We thank D. Struttman for help with yeast and M. Benway for help with Adam.	[Anonymous], 2006, NATURE, V440, P383, DOI 10.1038/440383a; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Berners-Lee T, 2001, SCI AM, V284, P34, DOI 10.1038/scientificamerican0501-34; BUCHANAN BG, 1969, MACH INTELL, V5, P209; Herrgard MJ, 2008, NAT BIOTECHNOL, V26, P1155, DOI 10.1038/nbt1492; HEY T, 2003, GRID COMPUTING MAKIN, V36, P809; Hood L, 2004, SCIENCE, V306, P640, DOI 10.1126/science.1104635; Horrocks I., 2003, J WEB SEM, V1, P7, DOI DOI 10.1016/J.WEBSEM.2003.07.001; King RD, 2004, NATURE, V427, P247, DOI 10.1038/nature02236; KING RD, 2008, ROBOT SCI PROJECT; Langley P., 1987, SCI DISCOVERY COMPUT; Soldatova LN, 2006, BIOINFORMATICS, V22, pE464, DOI 10.1093/bioinformatics/btl207; Soldatova LN, 2006, J R SOC INTERFACE, V3, P795, DOI 10.1098/rsif.2006.0134; TOULMIN S, 2003, ENCY BRITANNICA DELU; Turing AM., 1950, MIND, V49, P433, DOI DOI 10.1093/MIND/LIX.236.433; Ullman J., 1988, PRINCIPLES DATABASE, V1; Warringer J, 2003, P NATL ACAD SCI USA, V100, P15724, DOI 10.1073/pnas.2435976100; Whelan KE, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-97; YOUNG M, 1973, J EXP BOT, V24, P1172, DOI 10.1093/jxb/24.6.1172; Zabriskie TM, 2000, NAT PROD REP, V17, P85, DOI 10.1039/a801345d; ZYTKOW JM, 1990, PROCEEDINGS : EIGHTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE, VOLS 1 AND 2, P889	21	302	310	3	111	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2009	324	5923					85	89		10.1126/science.1165620	http://dx.doi.org/10.1126/science.1165620			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427TN	19342587	Green Published			2022-12-01	WOS:000264802100037
J	Gertsman, I; Gan, L; Guttman, M; Lee, K; Speir, JA; Duda, RL; Hendrix, RW; Komives, EA; Johnson, JE				Gertsman, Ilya; Gan, Lu; Guttman, Miklos; Lee, Kelly; Speir, Jeffrey A.; Duda, Robert L.; Hendrix, Roger W.; Komives, Elizabeth A.; Johnson, John E.			An unexpected twist in viral capsid maturation	NATURE			English	Article							X-RAY CRYSTALLOGRAPHY; VIRUS MATURATION; COMMON ANCESTRY; COAT PROTEIN; BACTERIOPHAGES; TRANSITION; DYNAMICS; DOMAIN; MODEL; DNA	Lambda-like double-stranded (ds) DNA bacteriophage undergo massive conformational changes in their capsid shell during the packaging of their viral genomes. Capsid shells are complex organizations of hundreds of protein subunits that assemble into intricate quaternary complexes that ultimately are able to withstand over 50 atm of pressure during genome packaging(1). The extensive integration between subunits in capsids requires the formation of an intermediate complex, termed a procapsid, from which individual subunits can undergo the necessary refolding and structural rearrangements needed to transition to the more stable capsid. Although various mature capsids have been characterized at atomic resolution, no such procapsid structure is available for a dsDNA virus or bacteriophage. Here we present a procapsid X-ray structure at 3.65 angstrom resolution, termed prohead II, of the lambda-like bacteriophage HK97, the mature capsid structure of which was previously solved to 3.44 angstrom (ref. 2). A comparison of the two largely different capsid forms has unveiled an unprecedented expansion mechanism that describes the transition. Crystallographic and hydrogen/deuterium exchange data presented here demonstrate that the subunit tertiary structures are significantly different between the two states, with twisting and bending motions occurring in both helical and beta-sheet regions. We also identified subunit interactions at each three-fold axis of the capsid that are maintained throughout maturation. The interactions sustain capsid integrity during subunit refolding and provide a fixed hinge from which subunits undergo rotational and translational motions during maturation. Previously published calorimetric data of a closely related bacteriophage, P22, showed that capsid maturation was an exothermic process that resulted in a release of 90 kJ mol(-1) of energy(3). We propose that the major tertiary changes presented in this study reveal a structural basis for an exothermic maturation process probably present in many dsDNA bacteriophage and possibly viruses such as herpesvirus, which share the HK97 subunit fold(4).	[Gertsman, Ilya; Gan, Lu; Lee, Kelly; Speir, Jeffrey A.; Johnson, John E.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Gertsman, Ilya; Guttman, Miklos; Komives, Elizabeth A.; Johnson, John E.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92037 USA; [Duda, Robert L.; Hendrix, Roger W.] Univ Pittsburgh, Pittsburgh Bacteriophage Inst, Pittsburgh, PA 15260 USA; [Duda, Robert L.; Hendrix, Roger W.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA	Scripps Research Institute; University of California System; University of California San Diego; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Johnson, JE (corresponding author), Scripps Res Inst, Dept Mol Biol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jackj@scripps.edu	Johnson, Johnson/HDL-9124-2022; Gan, Lu/F-8317-2011	Gan, Lu/0000-0002-8685-4896; Duda, Robert/0000-0002-9517-2731	NIH [RO1 AI40101, RO1 GM47795]; NIH Training Grant [GM08326]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008326, R01GM047795] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank V. Reddy for assistance with crystallographic studies and for discussions. We thank R. Huang for providing HK97 capsomer samples and for discussions, and T. Matsui for help with X-ray data collection. We thank B. Firek and C. Moyer for mutagenesis of the HK97 constructs used in the study. We also thank B. Szymczyma for material used in the study. We also thank I. Wilson for discussions. Wethank the staffs at beamlines 14-BMC and 23-ID- D of the Advanced Photon Source for assistance in data collection. This work was supported by NIH grants RO1 AI40101 (to J.E.J), RO1 GM47795 ( to R. W. H) and NIH Training Grant GM08326.	Agirrezabala X, 2007, STRUCTURE, V15, P461, DOI 10.1016/j.str.2007.03.004; Baker ML, 2005, J VIROL, V79, P14967, DOI 10.1128/JVI.79.23.14967-14970.2005; Conway JF, 2007, J STRUCT BIOL, V158, P224, DOI 10.1016/j.jsb.2006.11.006; CONWAY JF, 1995, J MOL BIOL, V253, P86, DOI 10.1006/jmbi.1995.0538; Conway JF, 2001, SCIENCE, V292, P744, DOI 10.1126/science.1058069; Croy CH, 2004, PROTEIN SCI, V13, P1767, DOI 10.1110/ps.04731004; DUDA RL, 1995, J MOL BIOL, V247, P636, DOI 10.1006/jmbi.1994.0169; DUDA RL, 1995, J MOL BIOL, V247, P618, DOI 10.1016/S0022-2836(05)80143-3; Duda RL, 1998, CELL, V94, P55, DOI 10.1016/S0092-8674(00)81221-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fokine A, 2005, P NATL ACAD SCI USA, V102, P7163, DOI 10.1073/pnas.0502164102; Gan L, 2006, STRUCTURE, V14, P1655, DOI 10.1016/j.str.2006.09.006; Helgstrand Charlotte, 2003, Journal of Molecular Biology, V334, P885, DOI 10.1016/j.jmb.2003.09.035; Ivanov D, 2007, P NATL ACAD SCI USA, V104, P4353, DOI 10.1073/pnas.0609477104; Jiang W, 2003, NAT STRUCT BIOL, V10, P131, DOI 10.1038/nsb891; Kang SB, 2005, J MOL BIOL, V347, P935, DOI 10.1016/j.jmb.2005.02.021; Korostelev A, 2002, ACTA CRYSTALLOGR D, V58, P761, DOI 10.1107/S0907444902003402; Lata R, 2000, CELL, V100, P253, DOI 10.1016/S0092-8674(00)81563-9; Lee KK, 2008, STRUCTURE, V16, P1491, DOI 10.1016/j.str.2008.06.014; Lee KK, 2005, J MOL BIOL, V352, P723, DOI 10.1016/j.jmb.2005.07.024; Lee KK, 2004, J MOL BIOL, V340, P419, DOI 10.1016/j.jmb.2004.05.008; Mandell JG, 2001, J MOL BIOL, V306, P575, DOI 10.1006/jmbi.2000.4416; Morais MC, 2005, MOL CELL, V18, P149, DOI 10.1016/j.molcel.2005.03.013; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Smith DE, 2001, NATURE, V413, P748, DOI 10.1038/35099581; Steven AC, 2005, CURR OPIN STRUC BIOL, V15, P227, DOI 10.1016/j.sbi.2005.03.008; TONG L, 1990, ACTA CRYSTALLOGR A, V46, P783, DOI 10.1107/S0108767390005530; Tuma R, 1998, P NATL ACAD SCI USA, V95, P9885, DOI 10.1073/pnas.95.17.9885; Wikoff WR, 2006, J STRUCT BIOL, V153, P300, DOI 10.1016/j.jsb.2005.11.009; Wikoff WR, 2000, SCIENCE, V289, P2129, DOI 10.1126/science.289.5487.2129; XIE ZH, 1995, J MOL BIOL, V253, P74, DOI 10.1006/jmbi.1995.0537	31	98	101	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 2	2009	458	7238					646	U114		10.1038/nature07686	http://dx.doi.org/10.1038/nature07686			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RK	19204733	Green Submitted, Green Accepted			2022-12-01	WOS:000264796200044
J	Burlingham, WJ				Burlingham, William J.			A Lesson in Tolerance - Maternal Instruction to Fetal Cells	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ANTIGENS		Univ Wisconsin, Dept Surg, Div Transplantat, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Burlingham, WJ (corresponding author), Univ Wisconsin, Dept Surg, Div Transplantat, Madison, WI 53706 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066219] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI066219, R01 AI066219-04] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Burlingham WJ, 1998, NEW ENGL J MED, V339, P1657, DOI 10.1056/NEJM199812033392302; Mold JE, 2008, SCIENCE, V322, P1562, DOI 10.1126/science.1164511; Molitor-Dart ML, 2007, J IMMUNOL, V179, P6749, DOI 10.4049/jimmunol.179.10.6749; Streilein JW, 2003, NAT REV IMMUNOL, V3, P879, DOI 10.1038/nri1224; van Rood JJ, 2002, BLOOD, V99, P1572, DOI 10.1182/blood.V99.5.1572	5	35	36	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 26	2009	360	13					1355	1357		10.1056/NEJMcibr0810752	http://dx.doi.org/10.1056/NEJMcibr0810752			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	423VP	19321873	Green Accepted			2022-12-01	WOS:000264524100015
J	Lee, P; Lee, DJ; Chan, C; Chen, SW; Ch'en, I; Jamora, C				Lee, Pedro; Lee, Dai-Jen; Chan, Carol; Chen, Shih-Wei; Ch'en, Irene; Jamora, Colin			Dynamic expression of epidermal caspase 8 simulates a wound healing response	NATURE			English	Article							INFLAMMATORY SKIN-DISEASE; NF-KAPPA-B; STEM-CELLS; INNATE IMMUNITY; CUTTING EDGE; INTERLEUKIN-1-ALPHA; KERATINOCYTES; HOMEOSTASIS; ACTIVATION; CONTRIBUTE	Tissue homeostasis and regeneration are regulated by an intricate balance of seemingly competing processes-proliferation versus differentiation, and cell death versus survival(1). Here we demonstrate that the loss of epidermal caspase 8, an important mediator of apoptosis(2), recapitulates several phases of a wound healing response in the mouse. The epidermal hyperplasia in the caspase 8 null skin is the culmination of signals exchanged between epidermal keratinocytes, dermal fibroblasts and leukocytic cells. This reciprocal interaction is initiated by the paracrine signalling of interleukin 1 alpha (IL1 alpha), which activates both skin stem cell proliferation and cutaneous inflammation. The non-canonical secretion of IL1a is induced by a p38-MAPK-mediated upregulation of NALP3 (also known as NLRP3), leading to inflammasome assembly and caspase 1 activation. Notably, the increased proliferation of basal keratinocytes is counterbalanced by the growth arrest of suprabasal keratinocytes in the stratified epidermis by IL1 alpha-dependent NF kappa B signalling. Altogether, our findings illustrate how the loss of caspase 8 can affect more than programmed cell death to alter the local microenvironment and elicit processes common to wound repair and many neoplastic skin disorders.	[Lee, Pedro; Lee, Dai-Jen; Chan, Carol; Chen, Shih-Wei; Jamora, Colin] Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; [Ch'en, Irene] Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA; [Jamora, Colin] Dept Med Dermatol, La Jolla, CA 92093 USA		Jamora, C (corresponding author), Div Biol Sci, Sect Cell & Dev Biol, Nat Sci Bldg,Room 6311,9500 Gilman Dr,MC 0380, La Jolla, CA 92093 USA.	cjamora@ucsd.edu			National Institutes of Health (NIAMS) [5R01AR053185-03]; American Skin Association; Dermatology Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053185] Funding Source: NIH RePORTER	National Institutes of Health (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); American Skin Association; Dermatology Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank S. Hedrick, W. Havran, B. Yu, D. Witherden, A. Hoffmann, D. Stachura and members of the Jamora laboratory for providing reagents and helpful discussions. This work was supported by grants from the National Institutes of Health (NIAMS grant number 5R01AR053185-03) and the American Skin Association, and a Career Award from the Dermatology Foundation.	Al-Mashat HA, 2006, DIABETES, V55, P487, DOI 10.2337/diabetes.55.02.06.db05-1201; Alonso L, 2003, P NATL ACAD SCI USA, V100, P11830, DOI 10.1073/pnas.1734203100; Anderson JP, 2004, GENE, V338, P25, DOI 10.1016/j.gene.2004.05.002; Aravalli RN, 2005, J IMMUNOL, V175, P4189, DOI 10.4049/jimmunol.175.7.4189; Beisner DR, 2005, J IMMUNOL, V175, P3469, DOI 10.4049/jimmunol.175.6.3469; Chun HJ, 2002, NATURE, V419, P395, DOI 10.1038/nature01063; Cotsarelis G, 2006, J INVEST DERMATOL, V126, P1459, DOI 10.1038/sj.jid.5700376; Faustin B, 2008, TRENDS CELL BIOL, V18, P4, DOI 10.1016/j.tcb.2007.10.004; Feldmeyer L, 2007, CURR BIOL, V17, P1140, DOI 10.1016/j.cub.2007.05.074; GROVES RW, 1995, P NATL ACAD SCI USA, V92, P11874, DOI 10.1073/pnas.92.25.11874; HAUSER C, 1986, J IMMUNOL, V136, P3317; Hobbs RM, 2003, J BIOL CHEM, V278, P19798, DOI 10.1074/jbc.M300513200; Hobbs RM, 2004, J INVEST DERMATOL, V123, P503, DOI 10.1111/j.0022-202X.2004.23225.x; HOHL D, 1991, J BIOL CHEM, V266, P6626; Ichinohe M, 2007, BIOCHEM BIOPH RES CO, V356, P912, DOI 10.1016/j.bbrc.2007.03.082; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Jameson J, 2007, IMMUNOL REV, V215, P114, DOI 10.1111/j.1600-065X.2006.00483.x; Johansen C, 2007, J INVEST DERMATOL, V127, P2857, DOI 10.1038/sj.jid.5700922; Kaufman CK, 2000, J CELL BIOL, V149, P999, DOI 10.1083/jcb.149.5.999; Kobielak A, 2006, P NATL ACAD SCI USA, V103, P2322, DOI 10.1073/pnas.0510422103; Levy V, 2005, DEV CELL, V9, P855, DOI 10.1016/j.devcel.2005.11.003; Li JY, 2008, J CELL BIOL, V181, P321, DOI 10.1083/jcb.200711082; Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002; Murphy JE, 2000, J INVEST DERMATOL, V114, P602, DOI 10.1046/j.1523-1747.2000.00917.x; Murphy JE, 2003, J IMMUNOL, V170, P5697, DOI 10.4049/jimmunol.170.11.5697; Perez-Moreno M, 2006, CELL, V124, P631, DOI 10.1016/j.cell.2005.11.043; Raj D, 2006, J INVEST DERMATOL, V126, P243, DOI 10.1038/sj.jid.5700008; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Werner S, 2001, TRENDS CELL BIOL, V11, P143, DOI 10.1016/S0962-8924(01)01955-9; Yamanaka K, 2000, J IMMUNOL, V165, P997, DOI 10.4049/jimmunol.165.2.997	30	115	124	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2009	458	7237					519	U7		10.1038/nature07687	http://dx.doi.org/10.1038/nature07687			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423YJ	19204729	Green Accepted			2022-12-01	WOS:000264532400047
J	Aliev, AE; Oh, JY; Kozlov, ME; Kuznetsov, AA; Fang, SL; Fonseca, AF; Ovalle, R; Lima, MD; Haque, MH; Gartstein, YN; Zhang, M; Zakhidov, AA; Baughman, RH				Aliev, Ali E.; Oh, Jiyoung; Kozlov, Mikhail E.; Kuznetsov, Alexander A.; Fang, Shaoli; Fonseca, Alexandre F.; Ovalle, Raquel; Lima, Marcio D.; Haque, Mohammad H.; Gartstein, Yuri N.; Zhang, Mei; Zakhidov, Anvar A.; Baughman, Ray H.			Giant-Stroke, Superelastic Carbon Nanotube Aerogel Muscles	SCIENCE			English	Article							ACTUATORS; ELASTOMERS; NANOCOMPOSITES; SHEETS; MEMORY	Improved electrically powered artificial muscles are needed for generating force, moving objects, and accomplishing work. Carbon nanotube aerogel sheets are the sole component of new artificial muscles that provide giant elongations and elongation rates of 220% and (3.7 x 10(4))% per second, respectively, at operating temperatures from 80 to 1900 kelvin. These solid-state-fabricated sheets are enthalpic rubbers having gaslike density and specific strength in one direction higher than those of steel plate. Actuation decreases nanotube aerogel density and can be permanently frozen for such device applications as transparent electrodes. Poisson's ratios reach 15, a factor of 30 higher than for conventional rubbers. These giant Poisson's ratios explain the observed opposite sign of width and length actuation and result in rare properties: negative linear compressibility and stretch densification.	[Aliev, Ali E.; Oh, Jiyoung; Kozlov, Mikhail E.; Kuznetsov, Alexander A.; Fang, Shaoli; Fonseca, Alexandre F.; Ovalle, Raquel; Lima, Marcio D.; Haque, Mohammad H.; Gartstein, Yuri N.; Zhang, Mei; Zakhidov, Anvar A.; Baughman, Ray H.] Univ Texas Dallas, Alan G MacDiarmid NanoTech Inst, Richardson, TX 75083 USA	University of Texas System; University of Texas Dallas	Baughman, RH (corresponding author), Univ Texas Dallas, Alan G MacDiarmid NanoTech Inst, Richardson, TX 75083 USA.	ray.baughman@utdallas.edu	Baughman, Ray/A-8628-2018; Fonseca, Alexandre/H-3105-2011; Lima, Marcio/G-4634-2012; Aliev, Ali/R-3034-2019; Fonseca, Alexandre F./K-5477-2019	Baughman, Ray/0000-0001-5845-5137; Fonseca, Alexandre/0000-0001-8413-9744; Zakhidov, Anvar/0000-0003-3983-2229; Aliev, Ali/0000-0003-0034-9707	Air Force Office of Scientific Research [FA9550-05-C-0088]; NSF [DMI-0609115]; Office of Naval Research [N00014-08-1-0654]; Robert A. Welch Foundation [AT-0029]; Honda Corporation; Lintec Corporation; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); NSF(National Science Foundation (NSF)); Office of Naval Research(Office of Naval Research); Robert A. Welch Foundation(The Welch Foundation); Honda Corporation; Lintec Corporation; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	We thank T. Mirfakhrai, J. D. W. Madden, and V. M. Agranovich for their contributions. Supported by Air Force Office of Scientific Research grant FA9550-05-C-0088, NSF grant DMI-0609115, Office of Naval Research MURI grant N00014-08-1-0654, Robert A. Welch Foundation Grant AT-0029, Honda Corporation, Lintec Corporation, and the Brazilian agency CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico). A provisional patent for nanofiber actuators and strain amplifiers has been filed by the authors (Patent Office Provisional Filing No. 61089275).	Ahir SV, 2005, NAT MATER, V4, P491, DOI 10.1038/nmat1391; Baughman RH, 1999, SCIENCE, V284, P1340, DOI 10.1126/science.284.5418.1340; Baughman RH, 1998, SCIENCE, V279, P1522, DOI 10.1126/science.279.5356.1522; Baughman RH, 2003, NATURE, V425, P667, DOI 10.1038/425667a; Courty S, 2003, EUROPHYS LETT, V64, P654, DOI 10.1209/epl/i2003-00277-9; Deshpande VV, 2006, NANO LETT, V6, P1092, DOI 10.1021/nl052513f; Evans KE, 2000, ADV MATER, V12, P617, DOI 10.1002/(SICI)1521-4095(200005)12:9<617::AID-ADMA617>3.0.CO;2-3; Gupta S, 2004, J APPL PHYS, V95, P2038, DOI 10.1063/1.1641518; Kim P, 1999, SCIENCE, V286, P2148, DOI 10.1126/science.286.5447.2148; Koerner H, 2004, NAT MATER, V3, P115, DOI 10.1038/nmat1059; Madden JDW, 2004, IEEE J OCEANIC ENG, V29, P706, DOI 10.1109/JOE.2004.833135; Miaudet P, 2007, SCIENCE, V318, P1294, DOI 10.1126/science.1145593; Pelrine R, 2000, SCIENCE, V287, P836, DOI 10.1126/science.287.5454.836; Rueckes T, 2000, SCIENCE, V289, P94, DOI 10.1126/science.289.5476.94; Sapmaz S, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.235414; Spinks GM, 2002, ADV MATER, V14, P1728, DOI 10.1002/1521-4095(20021203)14:23<1728::AID-ADMA1728>3.0.CO;2-8; Vohrer U, 2004, CARBON, V42, P1159, DOI 10.1016/j.carbon.2003.12.044; Yakobson BI, 2006, J NANOPART RES, V8, P105, DOI 10.1007/s11051-005-8335-3; Zhang M, 2005, SCIENCE, V309, P1215, DOI 10.1126/science.1115311	19	420	438	30	661	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2009	323	5921					1575	1578		10.1126/science.1168312	http://dx.doi.org/10.1126/science.1168312			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421EN	19299612				2022-12-01	WOS:000264342300030
J	Fuentes, R; Petersson, P; Siesser, WB; Caron, MG; Nicolelis, MAL				Fuentes, Romulo; Petersson, Per; Siesser, William B.; Caron, Marc G.; Nicolelis, Miguel A. L.			Spinal Cord Stimulation Restores Locomotion in Animal Models of Parkinson's Disease	SCIENCE			English	Article							TRIGEMINAL NERVE-STIMULATION; DEEP BRAIN-STIMULATION; L-DOPA; SUBTHALAMIC NUCLEUS; MOTOR; RAT; MOVEMENT; NEURONS; CORTEX	Dopamine replacement therapy is useful for treating motor symptoms in the early phase of Parkinson's disease, but it is less effective in the long term. Electrical deep-brain stimulation is a valuable complement to pharmacological treatment but involves a highly invasive surgical procedure. We found that epidural electrical stimulation of the dorsal columns in the spinal cord restores locomotion in both acute pharmacologically induced dopamine-depleted mice and in chronic 6-hydroxydopamine-lesioned rats. The functional recovery was paralleled by a disruption of aberrant low-frequency synchronous corticostriatal oscillations, leading to the emergence of neuronal activity patterns that resemble the state normally preceding spontaneous initiation of locomotion. We propose that dorsal column stimulation might become an efficient and less invasive alternative for treatment of Parkinson's disease in the future.	[Fuentes, Romulo; Petersson, Per; Caron, Marc G.; Nicolelis, Miguel A. L.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Petersson, Per] Lund Univ, Dept Expt Med Sci, Neuronano Res Ctr, BMC F10, S-22184 Lund, Sweden; [Siesser, William B.; Caron, Marc G.] Duke Univ, Dept Cell Biol, Durham, NC 27710 USA; [Nicolelis, Miguel A. L.] Duke Univ, Ctr Neuroengn, Durham, NC 27710 USA; [Nicolelis, Miguel A. L.] Duke Univ, Dept Biomed Engn, Durham, NC 27710 USA; [Nicolelis, Miguel A. L.] Duke Univ, Dept Psychol & Neurosci, Durham, NC 27710 USA; [Nicolelis, Miguel A. L.] ELS IINN, BR-59066060 Natal, RN, Brazil; [Nicolelis, Miguel A. L.] Ecole Polytech Fed Lausanne, CH-1015 Lausanne, Switzerland	Duke University; Lund University; Duke University; Duke University; Duke University; Duke University; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Fuentes, R (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	fuentes@neuro.duke.edu	Petersson, Per/A-5740-2010; Petersson, Per/P-1878-2019; Fuentes, Romulo/N-4258-2019; Fuentes, Romulo/AFR-1296-2022	Petersson, Per/0000-0001-6697-0171; Petersson, Per/0000-0001-6697-0171; Fuentes, Romulo/0000-0002-6282-7287; Fuentes, Romulo/0000-0002-6282-7287	National Institute of Neurological Disorders and Stroke (NINDS) [R33NS049534]; International Neuroscience Network Foundation; Ruth K. Broad Postdoctoral Award; NRC; Knut and Alice Wallenberg Foundation;  [R01NS019576];  [R01MH073853]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019576, R33NS049534, R21NS049534] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); International Neuroscience Network Foundation; Ruth K. Broad Postdoctoral Award; NRC(National Research Centre (NRC)); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); ; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank W. M. Chan, G. Lehew, and J. Meloy for outstanding technical assistance; R. Gainetdinov, S.-C. Lin, H. Zhang, and K. Dzirasa for valuable comments; and S. Halkiotis for proofreading the manuscript. This work was supported by the National Institute of Neurological Disorders and Stroke (NINDS) R33NS049534 and the International Neuroscience Network Foundation to M.A.L.N., R01NS019576 and R01MH073853 to M.G.C., Ruth K. Broad Postdoctoral Award to R.F., and NRC and Knut and Alice Wallenberg Foundation to P.P. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NINDS or the National Institutes of Health. M.A.L.N. dedicates this paper to Lily Safra for her continuing support and to the memory of his grandfather, Angelo Nicolelis, who suffered from Parkinson's disease. M.A.L.N. acknowledges a visiting professorship, Chaire Blaise Pascal, from the Region Ile de France at the Ecole Superieure de Physique et de Chimie Industrielles, Paris.	Benabid AL, 2003, CURR OPIN NEUROBIOL, V13, P696, DOI 10.1016/j.conb.2003.11.001; Berke JD, 2004, NEURON, V43, P883, DOI 10.1016/j.neuron.2004.08.035; Brooks DJ, 2006, BIOL PSYCHIAT, V59, P908, DOI 10.1016/j.biopsych.2005.12.017; Brown P, 2001, J NEUROSCI, V21, P1033, DOI 10.1523/JNEUROSCI.21-03-01033.2001; BRUDZYNSKI SM, 1993, CAN J PHYSIOL PHARM, V71, P394, DOI 10.1139/y93-060; CARLSSON A, 1972, ACTA NEUROL SCAND, V48, P11; Cenci MA, 2002, NAT REV NEUROSCI, V3, P574, DOI 10.1038/nrn877; Costa RM, 2006, NEURON, V52, P359, DOI 10.1016/j.neuron.2006.07.030; DeGiorgio CM, 2006, EPILEPSIA, V47, P1213, DOI 10.1111/j.1528-1167.2006.00594.x; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; Drouot' X, 2004, NEURON, V44, P769, DOI 10.1016/j.neuron.2004.11.023; Fahn S, 2003, ANN NY ACAD SCI, V991, P1, DOI 10.1111/j.1749-6632.2003.tb07458.x; Fanselow EE, 2000, J NEUROSCI, V20, P8160; GLICKSTEIN M, 1991, TRENDS NEUROSCI, V14, P480, DOI 10.1016/0166-2236(91)90055-Y; Grillner S, 2008, BRAIN RES REV, V57, P2, DOI 10.1016/j.brainresrev.2007.06.027; Hammond C, 2007, TRENDS NEUROSCI, V30, P357, DOI 10.1016/j.tins.2007.05.004; Hornykiewicz O, 2002, AMINO ACIDS, V23, P65, DOI 10.1007/s00726-001-0111-9; LLOYD KG, 1975, J PHARMACOL EXP THER, V195, P453; Perlmutter JS, 2006, ANNU REV NEUROSCI, V29, P229, DOI 10.1146/annurev.neuro.29.051605.112824; Plaha P, 2006, BRAIN, V129, P1732, DOI 10.1093/brain/awl127; SAKAI K, 1994, BRAIN RES, V633, P144, DOI 10.1016/0006-8993(94)91533-4; Schlesinger I, 2007, MOVEMENT DISORD, V22, P2394, DOI 10.1002/mds.21739; SHAW KM, 1980, Q J MED, V49, P283; Smith Y, 2004, TRENDS NEUROSCI, V27, P520, DOI 10.1016/j.tins.2004.07.004; Sotnikova TD, 2005, PLOS BIOL, V3, P1488, DOI 10.1371/journal.pbio.0030271; WALL PD, 1970, BRAIN, V93, P505, DOI 10.1093/brain/93.3.505; Wilson CJ, 2005, NEURON, V45, P575, DOI 10.1016/j.neuron.2004.12.053; Winkler C, 2002, NEUROBIOL DIS, V10, P165, DOI 10.1006/nbdi.2002.0499	28	189	223	2	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2009	323	5921					1578	1582		10.1126/science.1164901	http://dx.doi.org/10.1126/science.1164901			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421EN	19299613	Green Accepted			2022-12-01	WOS:000264342300031
J	Mao, YW; Ge, XC; Frank, CL; Madison, JM; Koehler, AN; Doud, MK; Tassa, C; Berry, EM; Soda, T; Singh, KK; Biechele, T; Petryshen, TL; Moon, RT; Haggarty, SJ; Tsai, LH				Mao, Yingwei; Ge, Xuecai; Frank, Christopher L.; Madison, Jon M.; Koehler, Angela N.; Doud, Mary Kathryn; Tassa, Carlos; Berry, Erin M.; Soda, Takahiro; Singh, Karun K.; Biechele, Travis; Petryshen, Tracey L.; Moon, Randall T.; Haggarty, Stephen J.; Tsai, Li-Huei			Disrupted in Schizophrenia 1 Regulates Neuronal Progenitor Proliferation via Modulation of GSK3 beta/beta-Catenin Signaling	CELL			English	Article							GLYCOGEN-SYNTHASE KINASE-3; BETA-CATENIN; HIPPOCAMPAL NEUROGENESIS; DISC1; BRAIN; MICE; LITHIUM; CELLS; DISRUPTED-IN-SCHIZOPHRENIA-1; EXPRESSION	The Disrupted in Schizophrenia 1 (DISC1) gene is disrupted by a balanced chromosomal translocation (1; 11) (q42; q14.3) in a Scottish family with a high incidence of major depression, schizophrenia, and bipolar disorder. Subsequent studies provided indications that DISC1 plays a role in brain development. Here, we demonstrate that suppression of DISC1 expression reduces neural progenitor proliferation, leading to premature cell cycle exit and differentiation. Several lines of evidence suggest that DISC1 mediates this function by regulating GSK3 beta. First, DISC1 inhibits GSK3 beta activity through direct physical interaction, which reduces beta-catenin phosphorylation and stabilizes beta-catenin. Importantly, expression of stabilized beta-catenin overrides the impairment of progenitor proliferation caused by DISC1 loss of function. Furthermore, GSK3 inhibitors normalize progenitor proliferation and behavioral defects caused by DISC1 loss of function. Together, these results implicate DISC1 inGSK3 beta/beta-catenin signaling pathways and provide a framework for understanding how alterations in this pathway may contribute to the etiology of psychiatric disorders.	[Mao, Yingwei; Ge, Xuecai; Frank, Christopher L.; Soda, Takahiro; Singh, Karun K.; Biechele, Travis; Moon, Randall T.; Tsai, Li-Huei] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Mao, Yingwei; Ge, Xuecai; Frank, Christopher L.; Soda, Takahiro; Singh, Karun K.; Tsai, Li-Huei] MIT, Picower Inst Learning & Memory, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Mao, Yingwei] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; [Soda, Takahiro] Harvard Univ, Sch Med, Phd Program, Boston, MA 02115 USA; [Soda, Takahiro] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Koehler, Angela N.; Doud, Mary Kathryn; Tassa, Carlos; Berry, Erin M.; Petryshen, Tracey L.; Haggarty, Stephen J.] Massachusetts Gen Hosp, Psychiat & Neurodev Genet Unit, Ctr Human Genet Res, Boston, MA 02114 USA; [Koehler, Angela N.; Doud, Mary Kathryn; Tassa, Carlos; Berry, Erin M.; Petryshen, Tracey L.; Haggarty, Stephen J.] Massachusetts Gen Hosp, Mol Neurogenet Unit, Ctr Human Genet Res, Boston, MA 02114 USA; [Madison, Jon M.; Berry, Erin M.; Petryshen, Tracey L.; Haggarty, Stephen J.; Tsai, Li-Huei] Broad Inst Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02139 USA; [Madison, Jon M.; Berry, Erin M.; Petryshen, Tracey L.; Haggarty, Stephen J.; Tsai, Li-Huei] MIT, Cambridge, MA 02139 USA; [Biechele, Travis; Moon, Randall T.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Biechele, Travis; Moon, Randall T.] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Northwell Health; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Tsai, LH (corresponding author), MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA.	lhtsai@mit.edu	Petryshen, Tracey/X-5850-2019; Moon, Randall T/B-1743-2014; Moon, Randall/M-5605-2019; Haggarty, Stephen J/M-9495-2016; Soda, Takahiro/AHC-3347-2022	Petryshen, Tracey/0000-0002-7972-4612; Moon, Randall T/0000-0002-9352-1408; Moon, Randall/0000-0002-9352-1408; Haggarty, Stephen J/0000-0002-7872-168X; Soda, Takahiro/0000-0001-6268-2965; Mao, Yingwei/0000-0001-7339-1565	National Alliance for Research on Schizophrenia and Depression Young Investigator Award; Natural Sciences and Engineering Research Council Postdoctoral Award; National Institutes of Health [NS37007]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037007] Funding Source: NIH RePORTER	National Alliance for Research on Schizophrenia and Depression Young Investigator Award(NARSAD); Natural Sciences and Engineering Research Council Postdoctoral Award(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. Sawa for providing the human DISC1 cDNA construct, C. Lois for the FUGW construct, X. He for FLAG-Dvl2, HA-GSK3 beta, FLAG-WT-beta-catenin, and SA-beta-catenin constructs, Y. Ma and M. Greenberg for Ngn2 antibodies, and F. Gage for the AHP cells. We acknowledge E. Scolnick, B. A. Samuels, Z. Xie, D. Meletis, M. Carlen, C. Bragg, J. Buchman, P. Thanawala, and M. Dobbin for technical support, helpful discussion, and critical reading of the manuscript. L.-H. T. is an investigator of the Howard Hughes Medical Institute and the director of the neurobiology program at the Stanley Center for Psychiatric Research. Y. M. is a recipient of the National Alliance for Research on Schizophrenia and Depression Young Investigator Award. K. K. S. is a recipient of a Natural Sciences and Engineering Research Council Postdoctoral Award and a Human Frontiers Science Program Research Fellowship. T. S. is a recipient of the Singleton Fellowship. This work was partially supported by a National Institutes of Health grant (NS37007) to L.-H. T.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Adachi K, 2007, STEM CELLS, V25, P2827, DOI 10.1634/stemcells.2007-0177; Beaulieu JM, 2008, CELL, V132, P125, DOI 10.1016/j.cell.2007.11.041; Beaulieu JM, 2004, P NATL ACAD SCI USA, V101, P5099, DOI 10.1073/pnas.0307921101; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Blackwood DHR, 2001, AM J HUM GENET, V69, P428, DOI 10.1086/321969; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Chubb JE, 2008, MOL PSYCHIATR, V13, P36, DOI 10.1038/sj.mp.4002106; Clapcote SJ, 2007, NEURON, V54, P387, DOI 10.1016/j.neuron.2007.04.015; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Duan X, 2007, CELL, V130, P1146, DOI 10.1016/j.cell.2007.07.010; Farioli-Vecchioli S, 2008, PLOS BIOL, V6, P2188, DOI 10.1371/journal.pbio.0060246; Flagstad P, 2004, NEUROPSYCHOPHARMACOL, V29, P2052, DOI 10.1038/sj.npp.1300516; Gould TD, 2008, BEHAV BRAIN RES, V189, P117, DOI 10.1016/j.bbr.2007.12.028; Gould TD, 2007, NEUROPSYCHOPHARMACOL, V32, P2173, DOI 10.1038/sj.npp.1301338; Gregorieff A, 2005, GENE DEV, V19, P877, DOI 10.1101/gad.1295405; Harwood AJ, 2005, MOL PSYCHIATR, V10, P117, DOI 10.1038/sj.mp.4001618; Hikida T, 2007, P NATL ACAD SCI USA, V104, P14501, DOI 10.1073/pnas.0704774104; Hirabayashi Y, 2004, DEVELOPMENT, V131, P2791, DOI 10.1242/dev.01165; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kvajo M, 2008, P NATL ACAD SCI USA, V105, P7076, DOI 10.1073/pnas.0802615105; Leung JY, 2002, J BIOL CHEM, V277, P21657, DOI 10.1074/jbc.M200139200; Li W, 2007, P NATL ACAD SCI USA, V104, P18280, DOI 10.1073/pnas.0706900104; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Lochhead PA, 2006, MOL CELL, V24, P627, DOI 10.1016/j.molcel.2006.10.009; Ma L, 2002, GENOMICS, V80, P662, DOI 10.1006/geno.2002.7012; Ma YC, 2008, NEURON, V58, P65, DOI 10.1016/j.neuron.2008.01.037; Murdoch H, 2007, J NEUROSCI, V27, P9513, DOI 10.1523/JNEUROSCI.1493-07.2007; Newton SS, 2007, CNS DRUGS, V21, P715, DOI 10.2165/00023210-200721090-00002; Peters HC, 2005, NAT NEUROSCI, V8, P51, DOI 10.1038/nn1375; Pletnikov MV, 2008, MOL PSYCHIATR, V13, P173, DOI [10.1038/sj.mp.4002079, 10.1038/sj.mp.4002144]; Plotkin B, 2003, J PHARMACOL EXP THER, V305, P974, DOI 10.1124/jpet.102.047381; Reif A, 2006, MOL PSYCHIATR, V11, P514, DOI 10.1038/sj.mp.4001791; Ross CA, 2006, NEURON, V52, P139, DOI 10.1016/j.neuron.2006.09.015; Ross SE, 1999, MOL CELL BIOL, V19, P8433; Sanada K, 2005, CELL, V122, P119, DOI 10.1016/j.cell.2005.05.009; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Schuller U, 2007, BRAIN RES, V1140, P161, DOI 10.1016/j.brainres.2006.05.105; Selenica ML, 2007, BRIT J PHARMACOL, V152, P959, DOI 10.1038/sj.bjp.0707471; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Thomas GM, 1999, FEBS LETT, V458, P247, DOI 10.1016/S0014-5793(99)01161-8; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Zechner D, 2003, DEV BIOL, V258, P406, DOI 10.1016/S0012-1606(03)00123-4	46	600	634	0	71	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 20	2009	136	6					1017	1031		10.1016/j.cell.2008.12.044	http://dx.doi.org/10.1016/j.cell.2008.12.044			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	422CE	19303846	Green Published, Bronze, Green Accepted			2022-12-01	WOS:000264403900009
J	Montes-Hugo, M; Doney, SC; Ducklow, HW; Fraser, W; Martinson, D; Stammerjohn, SE; Schofield, O				Montes-Hugo, Martin; Doney, Scott C.; Ducklow, Hugh W.; Fraser, William; Martinson, Douglas; Stammerjohn, Sharon E.; Schofield, Oscar			Recent Changes in Phytoplankton Communities Associated with Rapid Regional Climate Change Along the Western Antarctic Peninsula	SCIENCE			English	Article							SEA-ICE EXTENT; DISTRIBUTIONS; CHLOROPHYLL; VARIABILITY; ECOSYSTEMS; SEDIMENTS; RETREAT; SHELF; OCEAN; KRILL	The climate of the western shelf of the Antarctic Peninsula (WAP) is undergoing a transition from a cold-dry polar-type climate to a warm-humid sub-Antarctic-type climate. Using three decades of satellite and field data, we document that ocean biological productivity, inferred from chlorophyll a concentration (Chl a), has significantly changed along the WAP shelf. Summertime surface Chl a (summer integrated Chl a similar to 63% of annually integrated Chl a) declined by 12% along the WAP over the past 30 years, with the largest decreases equatorward of 63 S and with substantial increases in Chl a occurring farther south. The latitudinal variation in Chl a trends reflects shifting patterns of ice cover, cloud formation, and windiness affecting water-column mixing. Regional changes in phytoplankton coincide with observed changes in krill (Euphausia superba) and penguin populations.	[Montes-Hugo, Martin; Schofield, Oscar] Rutgers State Univ, Sch Biol & Environm Sci, Inst Marine & Coastal Sci, Coastal Ocean Observat Lab, New Brunswick, NJ 08901 USA; [Doney, Scott C.] Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA; [Ducklow, Hugh W.] Marine Biol Lab, Ctr Ecosyst, Woods Hole, MA 02543 USA; [Fraser, William] Polar Oceans Res Grp, Sheridan, MT 59749 USA; [Martinson, Douglas] Lamont Doherty Earth Inst, Palisades, NY 10964 USA; [Stammerjohn, Sharon E.] Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA	Rutgers State University New Brunswick; Woods Hole Oceanographic Institution; Marine Biological Laboratory - Woods Hole; University of California System; University of California Santa Cruz	Montes-Hugo, M (corresponding author), Rutgers State Univ, Sch Biol & Environm Sci, Inst Marine & Coastal Sci, Coastal Ocean Observat Lab, New Brunswick, NJ 08901 USA.	montes@marine.rutgers.edu	Doney, Scott C/F-9247-2010; Schofield, Oscar/H-4169-2018	Doney, Scott C/0000-0002-3683-2437; Schofield, Oscar/0000-0003-2359-4131; STAMMERJOHN, SHARON/0000-0002-1697-8244	NSF Office of Polar Programs [0217282]; Virginia Institute of Marine Science [0823101]; Marine Biological Laboratory	NSF Office of Polar Programs(National Science Foundation (NSF)); Virginia Institute of Marine Science; Marine Biological Laboratory	This research is part of the Palmer Antarctica Long-Term Ecological Research (LTER) project (http://pal.lternet.edu). It was supported by NSF Office of Polar Programs grants 0217282 to H.W.D. and the Virginia Institute of Marine Science and 0823101 to H.W.D. at the Marine Biological Laboratory.	Barcena MA, 2002, DEEP-SEA RES PT II, V49, P935, DOI 10.1016/S0967-0645(01)00132-1; Bentley MJ, 2005, GEOLOGY, V33, P173, DOI 10.1130/G21203.1; BURKHOLDER PR, 1965, LIMNOL OCEANOGR, V57, P437; Cook AJ, 2005, SCIENCE, V308, P541, DOI 10.1126/science.1104235; DOMACK EW, 1996, ANTARCTIC RES SERIES, V70; Ducklow HW, 2007, PHILOS T R SOC B, V362, P67, DOI 10.1098/rstb.2006.1955; Dunbar RB, 1998, J GEOPHYS RES-OCEANS, V103, P30741, DOI 10.1029/1998JC900001; Fabres J, 2000, HOLOCENE, V10, P703, DOI 10.1191/09596830094953; Fraser WR, 2003, MAR ECOL PROG SER, V265, P1, DOI 10.3354/meps265001; Garibotti IA, 2003, MAR ECOL PROG SER, V261, P21, DOI 10.3354/meps261021; Gregg WW, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL014689; Jin X, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002532; Knox G.A., 2006, BIOL SO OCEAN, DOI 10.1201/9781420005134; Leventer A, 1996, GEOL SOC AM BULL, V108, P1626, DOI 10.1130/0016-7606(1996)108<1626:PCOYIT>2.3.CO;2; Loeb V, 1997, NATURE, V387, P897, DOI 10.1038/43174; Marrari M, 2008, DEEP-SEA RES PT II, V55, P377, DOI 10.1016/j.dsr2.2007.11.011; MITCHELL G, 1991, DEEP-SEA RES, V38, P981; Moline MA, 2008, ANN NY ACAD SCI, V1134, P267, DOI 10.1196/annals.1439.010; Pritchard HD, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000597; Pudsey CJ, 2001, GEOLOGY, V29, P787, DOI 10.1130/0091-7613(2001)029<0787:FSOASI>2.0.CO;2; Smith RC, 2008, DEEP-SEA RES PT II, V55, P1949, DOI 10.1016/j.dsr2.2008.04.027; Smith RC, 1999, BIOSCIENCE, V49, P393, DOI 10.2307/1313632; Smith RC, 2001, ANN GLACIOL-SER, V33, P493, DOI 10.3189/172756401781818662; Stammerjohn SE, 2008, DEEP-SEA RES PT II, V55, P2041, DOI 10.1016/j.dsr2.2008.04.026; THOMPSON LG, 1994, ANN GLACIOL, V20, P420, DOI 10.3189/172756494794587438; Turner J, 2005, INT J CLIMATOL, V25, P279, DOI 10.1002/joc.1130; Vaughan DG, 2003, CLIMATIC CHANGE, V60, P243, DOI 10.1023/A:1026021217991; Vernet M, 2008, DEEP-SEA RES PT II, V55, P2068, DOI 10.1016/j.dsr2.2008.05.021	28	473	484	7	227	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 13	2009	323	5920					1470	1473		10.1126/science.1164533	http://dx.doi.org/10.1126/science.1164533			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417TP	19286554				2022-12-01	WOS:000264101700039
J	Schiff, GD; Galanter, WL				Schiff, Gordon D.; Galanter, William L.			Promoting More Conservative Prescribing	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DRUG; TRIAL; CARE		[Schiff, Gordon D.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Gen Med,Ctr Patient Safety Res & Practice, Boston, MA 02120 USA; [Galanter, William L.] Univ Illinois, Dept Med, Chicago, IL USA; [Galanter, William L.] Univ Illinois, Dept Pharm Practice, Chicago, IL USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Schiff, GD (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Gen Med,Ctr Patient Safety Res & Practice, 1620 Tremont,3rd Floor, Boston, MA 02120 USA.	gschiff@partners.org	Callahan, Charles D/L-1641-2013	Galanter, William/0000-0001-7811-5391	AHRQ [5U18HS016973-03, 5U18HS016973-04] Funding Source: Federal RePORTER; AHRQ HHS [U18HS016973] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS016973] Funding Source: NIH RePORTER	AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Association of American Medical Colleges, 2008, IND FUND MED ED REP; Association of American Medical Colleges, 2008, CONT ISS MED ED SAF; DeAngelis CD, 2004, JAMA-J AM MED ASSOC, V292, P1363, DOI 10.1001/jama.292.11.1363; Gandhi TK, 2003, NEW ENGL J MED, V348, P1556, DOI 10.1056/NEJMsa020703; Jones OAH, 2004, CRIT REV TOXICOL, V34, P335, DOI 10.1080/10408440490464697; Kravitz RL, 2005, JAMA-J AM MED ASSOC, V293, P1995, DOI 10.1001/jama.293.16.1995; Lasser KE, 2002, JAMA-J AM MED ASSOC, V287, P2215, DOI 10.1001/jama.287.17.2215; Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200; Macht D I, 1994, Osler Libr Newsl, P1; Padwal RS, 2007, LANCET, V369, P71, DOI 10.1016/S0140-6736(07)60033-6; Schiff GD, 2003, ARCH INTERN MED, V163, P893, DOI 10.1001/archinte.163.8.893; Sigurgceirsson B, 2002, ARCH DERMATOL, V138, P353, DOI 10.1001/archderm.138.3.353; Waxman HA, 2005, NEW ENGL J MED, V352, P2576, DOI 10.1056/NEJMp058136; Zhan Chunliu, 2001, JAMA (Journal of the American Medical Association), V286, P2823	14	35	36	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 25	2009	301	8					865	867		10.1001/jama.2009.195	http://dx.doi.org/10.1001/jama.2009.195			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	410WV	19244196				2022-12-01	WOS:000263609900030
J	Bonetta, L				Bonetta, Laura			RNA-Based Therapeutics: Ready for Delivery?	CELL			English	Editorial Material								Delivery of RNA-based therapeutics to specific tissues for treating a variety of diseases faces many hurdles. But with several clinical trials and a slew of studies in animal models underway, the future of RNA-based therapeutics seems bright.											0	46	50	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 20	2009	136	4					581	584		10.1016/j.cell.2009.02.010	http://dx.doi.org/10.1016/j.cell.2009.02.010			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	411XX	19239878	Bronze			2022-12-01	WOS:000263688200008
J	Westerheide, SD; Anckar, J; Stevens, SM; Sistonen, L; Morimoto, RI				Westerheide, Sandy D.; Anckar, Julius; Stevens, Stanley M., Jr.; Sistonen, Lea; Morimoto, Richard I.			Stress-Inducible Regulation of Heat Shock Factor 1 by the Deacetylase SIRT1	SCIENCE			English	Article							DNA-BINDING ACTIVITY; TRANSCRIPTION FACTOR-1; IN-VIVO; INHIBITION; ACTIVATION; LONGEVITY; SIRTUINS; DOMAIN; P53	Heat shock factor 1 ( HSF1) is essential for protecting cells from protein- damaging stress associated with misfolded proteins and regulates the insulin- signaling pathway and aging. Here, we show that human HSF1 is inducibly acetylated at a critical residue that negatively regulates DNA binding activity. Activation of the deacetylase and longevity factor SIRT1 prolonged HSF1 binding to the heat shock promoter Hsp70 by maintaining HSF1 in a deacetylated, DNA- binding competent state. Conversely, down- regulation of SIRT1 accelerated the attenuation of the heat shock response ( HSR) and release of HSF1 from its cognate promoter elements. These results provide a mechanistic basis for the requirement of HSF1 in the regulation of life span and establish a role for SIRT1 in protein homeostasis and the HSR.	[Westerheide, Sandy D.; Morimoto, Richard I.] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA; [Anckar, Julius; Sistonen, Lea] Abo Akad Univ, Dept Biol, Turku Ctr Biotechnol, FI-20520 Turku, Finland; [Stevens, Stanley M., Jr.] Univ Florida, Prot Chem Core Facil, Interdisciplinary Ctr Biotechnol Res, Gainesville, FL 32610 USA	Northwestern University; Abo Akademi University; University of Turku; State University System of Florida; University of Florida	Morimoto, RI (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA.	r-morimoto@northwestern.edu	Longo, Kenneth A/A-5631-2010; Stevens, Stanley M./E-4120-2013	Sistonen, Lea/0000-0003-1341-2867; Stevens, Stanley/0000-0002-1399-0256	NIH; Turku Graduate School of Biomedical Sciences; Academy of Finland; Sigrid Juselius Foundation; Abo Akademi University; National Institute for General Medical Science; National Institute for Aging; Rice Institute for Biomedical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038109, R37GM038109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026647] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Turku Graduate School of Biomedical Sciences; Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Abo Akademi University; National Institute for General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute for Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Rice Institute for Biomedical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank N. Denslow, S. McClung, A. Schilling, and the Chicago Biomedical Consortium for assistance with the mass spectrometry; A. Mondragon for assistance with the molecular modeling; S. Raju for technical assistance; I. Benjamin for the hsf1<SUP>-/-</SUP> fibroblasts; and J. Brickner and members of the Morimoto laboratory for critical reading of the manuscript. This work was supported by an NIH training grant (S.D.W); Turku Graduate School of Biomedical Sciences (J.A.); Academy of Finland, Sigrid Juselius Foundation, and Abo Akademi University (L.S.); and the National Institute for General Medical Science, the National Institute for Aging, and the Rice Institute for Biomedical Research (R.I.M.).	Anckar J, 2006, MOL CELL BIOL, V26, P955, DOI 10.1128/MCB.26.3.955-964.2006; Anckar J, 2007, ADV EXP MED BIOL, V594, P78; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Dali-Youcef N, 2007, ANN MED, V39, P335, DOI 10.1080/07853890701408194; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; HUBL ST, 1994, NAT STRUCT BIOL, V1, P615, DOI 10.1038/nsb0994-615; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jolly C, 2002, J CELL BIOL, V156, P775, DOI 10.1083/jcb.200109018; Kline MP, 1997, MOL CELL BIOL, V17, P2107, DOI 10.1128/MCB.17.4.2107; Kregel KC, 2002, J APPL PHYSIOL, V92, P2177, DOI 10.1152/japplphysiol.01267.2001; Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383; Littlefield O, 1999, NAT STRUCT BIOL, V6, P464; McMillan DR, 1998, J BIOL CHEM, V273, P7523, DOI 10.1074/jbc.273.13.7523; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; RABINDRAN SK, 1994, MOL CELL BIOL, V14, P6552, DOI 10.1128/MCB.14.10.6552; SARGE KD, 1993, MOL CELL BIOL, V13, P1392, DOI 10.1128/MCB.13.3.1392; Shi YH, 1998, GENE DEV, V12, P654, DOI 10.1101/gad.12.5.654; TORRES FAG, 1995, MOL CELL BIOL, V15, P5063; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174	23	525	553	0	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2009	323	5917					1063	1066		10.1126/science.1165946	http://dx.doi.org/10.1126/science.1165946			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409AK	19229036	Green Accepted			2022-12-01	WOS:000263478400043
J	Greenhalgh, T				Greenhalgh, Trisha			Patient and public involvement in chronic illness: beyond the expert patient	BRITISH MEDICAL JOURNAL			English	Editorial Material							SELF-MANAGEMENT; CHRONIC DISEASE; EDUCATION-PROGRAMS; HEALTH-CARE; PEOPLE		UCL, London N19 5LW, England	University of London; University College London	Greenhalgh, T (corresponding author), UCL, London N19 5LW, England.	p.greenhalgh@pcps.ucl.ac.uk	Greenhalgh, Trisha/B-1825-2015	Greenhalgh, Trisha/0000-0003-2369-8088				[Anonymous], ED CRITICAL CONSCIOU; Bate P, 2004, QUAL SAF HEALTH CARE, V13, P62, DOI 10.1136/qshc.2003.006965; Baum F. E., 2007, NEW PUBLIC HLTH; Chodosh J, 2005, ANN INTERN MED, V143, P427, DOI 10.7326/0003-4819-143-6-200509200-00007; Clarke J, 2005, CRIT SOC POLICY, V25, P447, DOI 10.1177/0261018305057024; Dieterich A, 2007, PATIENT EDUC COUNS, V67, P279, DOI 10.1016/j.pec.2007.03.017; Donaldson L, 2003, BRIT MED J, V326, P1279, DOI 10.1136/bmj.326.7402.1279; Fisher EB, 2005, AM J PUBLIC HEALTH, V95, P1523, DOI 10.2105/AJPH.2005.066084; Glass TA, 2006, SOC SCI MED, V62, P1650, DOI 10.1016/j.socscimed.2005.08.044; Greenhalgh T, 2005, BRIT MED J, V330, P628, DOI 10.1136/bmj.330.7492.628; Griffiths C, 2007, BMJ-BRIT MED J, V334, P1254, DOI 10.1136/bmj.39227.698785.47; Kennedy A, 2007, J EPIDEMIOL COMMUN H, V61, P254, DOI 10.1136/jech.2006.053538; Kralik D, 2004, J CLIN NURS, V13, P259, DOI 10.1046/j.1365-2702.2003.00826.x; Levy Jennifer M, 2007, Anthropol Med, V14, P55, DOI 10.1080/13648470601106343; Mol A., 2008, LOGIC CARE HLTH PROB, DOI DOI 10.4324/9780203927076; Newbould J, 2006, CHRONIC ILLN, V2, P249, DOI 10.1179/174592006X157508; O'Donnell CA, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-75; OMI S, 2007, PEOPLE CTR HLTH CARE; Osborne RH, 2008, NAT CLIN PRACT RHEUM, V4, P224, DOI 10.1038/ncprheum0765; Osborne RH, 2007, PATIENT EDUC COUNS, V66, P192, DOI 10.1016/j.pec.2006.12.002; St John of God Health Care, 2019, OUR VIS; WANLESS D, 2004, SECURING PUBLIC HLTH; Warsi A, 2004, ARCH INTERN MED, V164, P1641, DOI 10.1001/archinte.164.15.1641; WHO, 1997, JAK DECL LEAD HLTH P	24	83	82	1	14	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 17	2009	338								b49	10.1136/bmj.b49	http://dx.doi.org/10.1136/bmj.b49			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	417CE	19223339	Green Submitted			2022-12-01	WOS:000264051900027
J	McGirk, J				McGirk, Jan			Gaza's health and humanitarian situation remains fragile	LANCET			English	Editorial Material																			0	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 14	2009	373	9663					531	531		10.1016/S0140-6736(09)60182-3	http://dx.doi.org/10.1016/S0140-6736(09)60182-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	406ZO	19230075				2022-12-01	WOS:000263333600012
J	Dobson, JE				Dobson, Jerome E.			Big Brother has evolved	NATURE			English	Editorial Material									Univ Kansas, Dept Geog, Lawrence, KS 66045 USA	University of Kansas	Dobson, JE (corresponding author), Univ Kansas, Dept Geog, Lawrence, KS 66045 USA.	dobson@ku.edu						Dobson JE, 2007, GEOGR REV, V97, P307, DOI 10.1111/j.1931-0846.2007.tb00508.x; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958	2	3	3	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 23	2009	458	7241					968	968		10.1038/458968a	http://dx.doi.org/10.1038/458968a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	436KL	19396123	Bronze			2022-12-01	WOS:000265412900017
J	Persson, A; Gross, E; Laurent, P; Busch, KE; Bretes, H; de Bono, M				Persson, Annelie; Gross, Einav; Laurent, Patrick; Busch, Karl Emanuel; Bretes, Hugo; de Bono, Mario			Natural variation in a neural globin tunes oxygen sensing in wild Caenorhabditis elegans	NATURE			English	Article							NUCLEOTIDE DISSOCIATION INHIBITOR; C-ELEGANS; HUMAN NEUROGLOBIN; BODY-FLUID; EXPRESSION; BEHAVIOR; NEURONS; FAMILY; AGGREGATION; ENVIRONMENT	Behaviours evolve by iterations of natural selection, but we have few insights into the molecular and neural mechanisms involved. Here we show that some Caenorhabditis elegans wild strains switch between two foraging behaviours in response to subtle changes in ambient oxygen. This finely tuned switch is conferred by a naturally variable hexacoordinated globin, GLB-5. GLB-5 acts with the atypical soluble guanylate cyclases(1-3), which are a different type of oxygen binding protein, to tune the dynamic range of oxygen-sensing neurons close to atmospheric (21%) concentrations. Calcium imaging indicates that one group of these neurons is activated when oxygen rises towards 21%, and is inhibited as oxygen drops below 21%. The soluble guanylate cyclase GCY-35 is required for high oxygen to activate the neurons; GLB-5 provides inhibitory input when oxygen decreases below 21%. Together, these oxygen binding proteins tune neuronal and behavioural responses to a narrow oxygen concentration range close to atmospheric levels. The effect of the glb-5 gene on oxygen sensing and foraging is modified by the naturally variable neuropeptide receptor npr-1 (refs 4, 5), providing insights into how polygenic variation reshapes neural circuit function.	[Persson, Annelie; Gross, Einav; Laurent, Patrick; Busch, Karl Emanuel; Bretes, Hugo; de Bono, Mario] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Persson, Annelie] Univ Gothenburg, Dept Cell & Mol Biol, S-40530 Gothenburg, Sweden	MRC Laboratory Molecular Biology; University of Gothenburg	de Bono, M (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	debono@mrc-lmb.cam.ac.uk	laurent, patrick/ABD-9373-2021; Gross, Einav/AAS-7417-2021	laurent, patrick/0000-0001-5360-5597; Busch, Karl Emanuel/0000-0001-7886-3226; de Bono, Mario/0000-0001-8347-0443	Medical Research Council; EU Marie Curie Actions; European Molecular Biology Organization; Fondation Wiener-Anspach; MRC [MC_U105178786] Funding Source: UKRI; Medical Research Council [MC_U105178786] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU Marie Curie Actions(European Commission); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Fondation Wiener-Anspach; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the Caenorhabditis Genetics Center, A. Chisholm, M.-A. Felix and E. Dolgin for C. elegans strains, A. Couto, B. Olofsson, I. Rabinovitch and K. Weber for comments on the manuscript, and I. Johnston and C. Tan for microfluidic devices. This work was supported by the Medical Research Council, a Human Frontier Science Program (HFSP) long-term fellowship (E. G.) and program grant (M. d. B.), the EU Marie Curie Actions (K. E. B.), the European Molecular Biology Organization (K. E. B. and P. L.) and the Fondation Wiener-Anspach (P. L.).	Anholt RRH, 2004, NAT REV GENET, V5, P838, DOI 10.1038/nrg1472; Antonini E, 1971, FRONTIERS BIOL; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BAUMGARTL H, 1994, ACTA OECOL, V15, P781; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Bouchard TJ, 2003, J NEUROBIOL, V54, P4, DOI 10.1002/neu.10160; Chang AJ, 2006, PLOS BIOL, V4, P1588, DOI 10.1371/journal.pbio.0040274; Cheung BHH, 2005, CURR BIOL, V15, P905, DOI 10.1016/j.cub.2005.04.017; Cheung BHH, 2004, CURR BIOL, V14, P1105, DOI 10.1016/j.cub.2004.06.027; Coates JC, 2002, NATURE, V419, P925, DOI 10.1038/nature01170; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; Dewilde S, 2001, J BIOL CHEM, V276, P38949, DOI 10.1074/jbc.M106438200; Gray JM, 2004, NATURE, V430, P317, DOI 10.1038/nature02714; Hodgkin J, 1997, GENETICS, V146, P149; Hoogewijs D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-356; Hou SB, 2000, NATURE, V403, P540, DOI 10.1038/35000570; Kerr Rex A., 2006, V351, P253; Kitatsuji C, 2007, J MOL BIOL, V368, P150, DOI 10.1016/j.jmb.2007.02.002; Korol A, 2006, P NATL ACAD SCI USA, V103, P18184, DOI 10.1073/pnas.0608777103; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Oka T, 2001, J BIOL CHEM, V276, P33079, DOI 10.1074/jbc.M101652200; OKKEMA PG, 1993, GENETICS, V135, P385; Ota M, 1997, FEBS LETT, V415, P129, DOI 10.1016/S0014-5793(97)01110-1; Rogers C, 2006, CURR BIOL, V16, P649, DOI 10.1016/j.cub.2006.03.023; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Sambrook J, 1989, MOL CLONING LAB MANU; Sulston J.E., 1988, NEMATODE CAENORHABDI, P587; Trandafir F, 2007, GENE, V398, P103, DOI 10.1016/j.gene.2007.02.038; Valdar W, 2006, NAT GENET, V38, P879, DOI 10.1038/ng1840; Wakasugi K, 2003, J BIOL CHEM, V278, P36505, DOI 10.1074/jbc.M305519200; Ward JPT, 2008, BBA-BIOENERGETICS, V1777, P1, DOI 10.1016/j.bbabio.2007.10.010; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878; Yu S, 1997, P NATL ACAD SCI USA, V94, P3384, DOI 10.1073/pnas.94.7.3384	33	102	107	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	2009	458	7241					1030	U106		10.1038/nature07820	http://dx.doi.org/10.1038/nature07820			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436KL	19262507				2022-12-01	WOS:000265412900043
J	Sainz, M; del Pozo, JG; Arias, LHM; Carvajal, A				Sainz, Maria; Garcia del Pozo, Javier; Martin Arias, Luis H.; Carvajal, Alfonso			Drug Point Strontium ranelate may cause alopecia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BISPHOSPHONATES		[Carvajal, Alfonso] Univ Valladolid, Fac Med, Inst Farmacoepidemiol, Reg Ctr Pharmacovigilance Castilla & Leon, E-47005 Valladolid, Spain	Universidad de Valladolid	Carvajal, A (corresponding author), Univ Valladolid, Fac Med, Inst Farmacoepidemiol, Reg Ctr Pharmacovigilance Castilla & Leon, Ramon & Cajal 7, E-47005 Valladolid, Spain.	carvajal@ife.uva.es	MARTIN ARIAS, LUIS/H-6438-2015; Sainz-Gil, María/V-5390-2017	MARTIN ARIAS, LUIS/0000-0002-3815-8781; Sainz-Gil, María/0000-0002-4353-055X				Hunt N, 2005, BRIT MED J, V331, P951, DOI 10.1136/bmj.331.7522.951; Lenzer J, 2008, BRIT MED J, V336, P117, DOI 10.1136/bmj.39461.527650.4E; POWIS SJA, 1976, BRIT MED J, V2, P1166, DOI 10.1136/bmj.2.6045.1166; Woo SB, 2006, ANN INTERN MED, V144, P753, DOI 10.7326/0003-4819-144-10-200605160-00009	4	6	7	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 22	2009	338								b1494	10.1136/bmj.b1494	http://dx.doi.org/10.1136/bmj.b1494			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437OP	19386675				2022-12-01	WOS:000265497100005
J	Kaji, K; Norrby, K; Paca, A; Mileikovsky, M; Mohseni, P; Woltjen, K				Kaji, Keisuke; Norrby, Katherine; Paca, Agnieszka; Mileikovsky, Maria; Mohseni, Paria; Woltjen, Knut			Virus-free induction of pluripotency and subsequent excision of reprogramming factors	NATURE			English	Article							EMBRYONIC STEM-CELLS; HUMAN SOMATIC-CELLS; C-MYC; MOUSE; GENERATION; FIBROBLASTS; EXPRESSION; DIFFERENTIATION; BLOCKS	Reprogramming of somatic cells to pluripotency, thereby creating induced pluripotent stem (iPS) cells, promises to transform regenerative medicine. Most instances of direct reprogramming have been achieved by forced expression of defined factors using multiple viral vectors(1-7). However, such iPS cells contain a large number of viral vector integrations(1,8), any one of which could cause unpredictable genetic dysfunction. Whereas c-Myc is dispensable for reprogramming(9,10), complete elimination of the other exogenous factors is also desired because ectopic expression of either Oct4 (also known as Pou5f1) or Klf4 can induce dysplasia(11,12). Two transient transfection-reprogramming methods have been published to address this issue(13,14). However, the efficiency of both approaches is extremely low, and neither has been applied successfully to human cells so far. Here we show that non-viral transfection of a single multiprotein expression vector, which comprises the coding sequences of c-Myc, Klf4, Oct4 and Sox2 linked with 2A peptides, can reprogram both mouse and human fibroblasts. Moreover, the transgene can be removed once reprogramming has been achieved. iPS cells produced with this nonviral vector show robust expression of pluripotency markers, indicating a reprogrammed state confirmed functionally by in vitro differentiation assays and formation of adult chimaeric mice. When the single-vector reprogramming system was combined with a piggyBac transposon(15,16), we succeeded in establishing reprogrammed human cell lines from embryonic fibroblasts with robust expression of pluripotency markers. This system minimizes genome modification in iPS cells and enables complete elimination of exogenous reprogramming factors, efficiently providing iPS cells that are applicable to regenerative medicine, drug screening and the establishment of disease models.	[Kaji, Keisuke; Norrby, Katherine; Paca, Agnieszka] Univ Edinburgh, Inst Stem Cell Res, Ctr Regenerat Med, MRC, Edinburgh EH9 3JQ, Midlothian, Scotland; [Mileikovsky, Maria; Mohseni, Paria; Woltjen, Knut] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Mohseni, Paria] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada	University of Edinburgh; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Kaji, K (corresponding author), Univ Edinburgh, Inst Stem Cell Res, Ctr Regenerat Med, MRC, Edinburgh EH9 3JQ, Midlothian, Scotland.	keisuke.kaji@ed.ac.uk	Wilson, Matthew H/K-3193-2013	Woltjen, Knut/0000-0003-2293-1183; Kaji, Keisuke/0000-0001-5946-8415	MRC; BBSRC; Canadian Stem Cell Network; Juvenile Diabetes Research Foundation; MRC [G0700672] Funding Source: UKRI; Medical Research Council [G0700711B, G0700672] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Canadian Stem Cell Network; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank A. Tsakiridis for advice on using the 2A peptide sequence and A. Nagy for providing data from his laboratory on generating human reprogrammed cell lines by combining the PB transposon system and the 2A-sequence-joined reprogramming factors (or MKOS single vector reprogramming system) as well as for his comments on the manuscript. We also thank I. Chambers for providing TNG MEFs and for discussion and comments on the manuscript, V. Wilson for advice on teratoma analysis, T. Kunath, S. Lowell, C. Blackburn and K. Vintersten for discussions and comments on the manuscript, and B. Hendrich for permission to start preliminary experiments of this work in his laboratory. We also thank J. Ure, L. Robertson, R. McLay and R. Wilkie for technical assistance, and Biomed unit staff for mouse husbandry. K. K. is the recipient of MRC career development fellowship in stem cell research. A. P. is the recipient of a BBSRC CASE PhD studentship. M. M., P. M. and K. W. were supported by grants from the Canadian Stem Cell Network and Juvenile Diabetes Research Foundation.	Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Brueckner B, 2007, CANCER J, V13, P17, DOI 10.1097/PPO.0b013e31803c7245; Carey BW, 2009, P NATL ACAD SCI USA, V106, P157, DOI 10.1073/pnas.0811426106; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Foster KW, 2005, ONCOGENE, V24, P1491, DOI 10.1038/sj.onc.1208307; Hasegawa K, 2007, STEM CELLS, V25, P1707, DOI 10.1634/stemcells.2006-0813; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, NATURE, V451, P141, DOI 10.1038/natureO6534; SOMMER CA, 2008, STEM CELLS, DOI DOI 10.1634/STEMCELLS.2008; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wang W, 2008, P NATL ACAD SCI USA, V105, P9290, DOI 10.1073/pnas.0801017105; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	27	919	1102	3	170	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 9	2009	458	7239					771	U112		10.1038/nature07864	http://dx.doi.org/10.1038/nature07864			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433GZ	19252477	Green Accepted			2022-12-01	WOS:000265193600043
J	Nicholson, M; Hoye, R				Nicholson, Matthew; Hoye, Russell			Reducing Adolescents' Exposure to Alcohol Advertising and Promotion During Televised Sports	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							YOUTH		[Hoye, Russell] La Trobe Univ, Sch Management, Bundoora, Vic 3086, Australia; [Nicholson, Matthew] Univ Ballarat, Sch Human Movement & Sport Sci, Ballarat, Vic 3353, Australia	La Trobe University; Federation University Australia	Hoye, R (corresponding author), La Trobe Univ, Sch Management, Bundoora, Vic 3086, Australia.	r.hoye@latrobe.edu.au	Hoye, Russell/AAW-5890-2020	Hoye, Russell/0000-0001-9000-1848; Nicholson, Matthew/0000-0002-7229-6037				*ALC OTH DRUGS COU, 2005, SUBM NAT ALC STRAT 2; *AM MED ASS OFF AL, 2002, PARTN FOE ALC IND YO; Anderson P, 2009, ALCOHOL ALCOHOLISM, V44, P229, DOI 10.1093/alcalc/agn115; *CTR ALC MARK YOUT, 2008, YOUTH EXP ALC ADV TE; Federal Trade Commission, 2008, SELF REG ALC IND; Fortin RB, 2005, EFFECTIVENESS REGULA; Hastings G, 2005, J PUBLIC HEALTH POL, V26, P296, DOI 10.1057/palgrave.jphp.3200039; Jernigan DH, 2005, J PUBLIC HEALTH POL, V26, P287, DOI 10.1057/palgrave.jphp.3200042; *NAT AC SCI NAT AC, 2003, RED UND DRINK COLL R; Ringel JS, 2006, J ADOLESCENT HEALTH, V39, P473, DOI 10.1016/j.jadohealth.2006.02.006; *SEN STAND COMM CO, 2008, ALC TOLL RED BILL 20, P75; Shifrin DL, 2006, PEDIATRICS, V118, P2563, DOI 10.1542/peds.2006-2698; Statistical Research Inc., 2001, AAF ESPN CHILDR SPOR; *WHO DEP MENT HLTH, 2004, GLOB STAT REP ALC PO; Winter MV, 2008, J STUD ALCOHOL DRUGS, V69, P676, DOI 10.15288/jsad.2008.69.676	15	6	6	0	10	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 8	2009	301	14					1479	1482		10.1001/jama.2009.469	http://dx.doi.org/10.1001/jama.2009.469			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	429MN	19351947				2022-12-01	WOS:000264924900030
J	Yamanaka, S				Yamanaka, Shinya			A Fresh Look at iPS Cells	CELL			English	Article							PLURIPOTENT STEM-CELLS; HUMAN FIBROBLASTS; GENERATION; MOUSE; DIFFERENTIATION; EXPRESSION; INDUCTION; THERAPY; NEURONS; ALS	The potential of induced pluripotent stem (iPS) cells is enormous, but many obstacles remain before their medical and pharmaceutical applications can be fully realized.	Kyoto Univ, Ctr iPS Cell Res & Applicat, Kyoto 6068507, Japan; [Yamanaka, Shinya] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA	Kyoto University; University of California System; University of California San Francisco; The J David Gladstone Institutes	Yamanaka, S (corresponding author), Kyoto Univ, Ctr iPS Cell Res & Applicat, Kyoto 6068507, Japan.	yamanaka@frontier.kyoto-u.ac.jp						Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Daley GQ, 2009, CELL STEM CELL, V4, P200, DOI 10.1016/j.stem.2009.02.009; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Ellis J, 2009, CELL STEM CELL, V4, P198, DOI 10.1016/j.stem.2009.02.010; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; KAJI K, 2009, NATURE, DOI DOI 10.1038/NA-TURE07864; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Lamba DA, 2009, CELL STEM CELL, V4, P73, DOI 10.1016/j.stem.2008.10.015; Li JY, 2008, TRENDS NEUROSCI, V31, P146, DOI 10.1016/j.tins.2007.12.001; Liao J, 2009, CELL STEM CELL, V4, P11, DOI 10.1016/j.stem.2008.11.013; Liu HS, 2008, CELL STEM CELL, V3, P587, DOI 10.1016/j.stem.2008.10.014; Loh YH, 2009, BLOOD, V113, P5476, DOI 10.1182/blood-2009-02-204800; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Park IH, 2008, NATURE, V451, P141, DOI 10.1038/natureO6534; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Stadtfeld M, 2008, CURR BIOL, V18, P890, DOI 10.1016/j.cub.2008.05.010; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Yamanaka S, 2000, EMBO J, V19, P5533, DOI 10.1093/emboj/19.20.5533; Yang DL, 2008, STEM CELLS, V26, P55, DOI 10.1634/stemcells.2007-0494; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	41	517	565	8	185	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 2	2009	137	1					13	17		10.1016/j.cell.2009.03.034	http://dx.doi.org/10.1016/j.cell.2009.03.034			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	427XV	19345179	Bronze			2022-12-01	WOS:000264813300006
J	Feachem, RGA; Phillips, AA				Feachem, Richard G. A.; Phillips, Allison A.			Malaria: 2 years in the fast lane	LANCET			English	Editorial Material									[Feachem, Richard G. A.; Phillips, Allison A.] UCSF Global Hlth Sci, Global Hlth Grp, San Francisco, CA 94105 USA	University of California System; University of California San Francisco	Feachem, RGA (corresponding author), UCSF Global Hlth Sci, Global Hlth Grp, San Francisco, CA 94105 USA.	feachemr@globalhealth.ucsf.edu						BARRETT C, 2009, BRISBANE TIMES  0210; *EXXONMOBIL, AFR HLTH IN; Feachem RG., 2009, SHRINKING MALARIA MA; GATES B, 2007, BILL M GAT MAL FOR S; *GLOB FUND FIGHT A, GRANT PORTF FUND DEC; Greenwood BM, 2008, TRENDS PARASITOL, V24, P449, DOI 10.1016/j.pt.2008.07.002; *PATH, MACEPA MAL CONTR PAR; PAYNE DM, 2008, 1 LADY L BUSH RAISE; Roll Back Malaria, 2008, GLOB MAL ACT PLAN MA; *USAID, 2008, PRES MAL IN PROGR PA; *WORLD BANK BOOST, 2007, SCAL UP IMP SUFI 2 Y; World Health Organization, 2009, FIN CRIS GLOB HLTH, DOI 10.1186/1744-8603-5-17	12	7	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR-MAY	2009	373	9673					1409	1411		10.1016/S0140-6736(09)60801-1	http://dx.doi.org/10.1016/S0140-6736(09)60801-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	437QL	19394520				2022-12-01	WOS:000265501900009
J	Lim, DA; Huang, YC; Swigut, T; Mirick, AL; Garcia-Verdugo, JM; Wysocka, J; Ernst, P; Alvarez-Buylla, A				Lim, Daniel A.; Huang, Yin-Cheng; Swigut, Tomek; Mirick, Anika L.; Manuel Garcia-Verdugo, Jose; Wysocka, Joanna; Ernst, Patricia; Alvarez-Buylla, Arturo			Chromatin remodelling factor Mll1 is essential for neurogenesis from postnatal neural stem cells	NATURE			English	Article							ADULT MAMMALIAN BRAIN; SUBVENTRICULAR ZONE; NEURONAL MIGRATION; SELF-RENEWAL; PROGENITORS; MICE; OLIGODENDROCYTES; PROLIFERATION; EXPRESSION; POLYCOMB	Epigenetic mechanisms that maintain neurogenesis throughout adult life remain poorly understood(1). Trithorax group (trxG) and Polycomb group (PcG) gene products are part of an evolutionarily conserved chromatin remodelling system that activate or silence gene expression, respectively(2). Although PcG member Bmi1 has been shown to be required for postnatal neural stem cell self-renewal(3,4), the role of trxG genes remains unknown. Here we show that the trxG member Mll1 (mixed-lineage leukaemia 1) is required for neurogenesis in the mouse postnatal brain. Mll1-deficient subventricular zone neural stem cells survive, proliferate and efficiently differentiate into glial lineages; however, neuronal differentiation is severely impaired. In Mll1-deficient cells, early proneural Mash1 (also known as Ascl1) and gliogenic Olig2 expression are preserved, but Dlx2, a key downstream regulator of subventricular zone neurogenesis, is not expressed. Overexpression of Dlx2 can rescue neurogenesis in Mll1-deficient cells. Chromatin immunoprecipitation demonstrates that Dlx2 is a direct target of MLL in subventricular zone cells. In differentiating wild-type subventricular zone cells, Mash1, Olig2 and Dlx2 loci have high levels of histone 3 trimethylated at lysine 4 (H3K4me3), consistent with their transcription. In contrast, in Mll1-deficient subventricular zone cells, chromatin at Dlx2 is bivalently marked by both H3K4me3 and histone 3 trimethylated at lysine 27 (H3K27me3), and the Dlx2 gene fails to properly activate. These data support a model in which Mll1 is required to resolve key silenced bivalent loci in postnatal neural precursors to the actively transcribed state for the induction of neurogenesis, but not for gliogenesis.	[Lim, Daniel A.; Huang, Yin-Cheng; Alvarez-Buylla, Arturo] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Lim, Daniel A.; Huang, Yin-Cheng; Alvarez-Buylla, Arturo] Univ Calif San Francisco, Inst Regenerat Med, San Francisco, CA 94143 USA; [Lim, Daniel A.] Univ Calif San Francisco, Vet Affairs Med Ctr, San Francisco, CA 94143 USA; [Swigut, Tomek; Wysocka, Joanna] Stanford Univ, Sch Med, Dept Dev Biol, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Mirick, Anika L.; Ernst, Patricia] Dartmouth Med Sch, Dept Genet, Hanover, NH 03755 USA; [Manuel Garcia-Verdugo, Jose] Univ Valencia, Inst Cavanilles, Lab Neurobiol Comparada, Valencia 46012, Spain; [Manuel Garcia-Verdugo, Jose] CIBERNED, Ctr Invest Principe Felipe, Lab Morfol Celular, Valencia 46012, Spain	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); Stanford University; Dartmouth College; University of Valencia; CIBERNED; Prince Felipe Research Center	Lim, DA (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, 505 Parnassus St M779, San Francisco, CA 94143 USA.	limd@neurosurg.ucsf.edu; abuylla@stemcell.ucsf.edu	García-Verdugo, José Manuel/L-8421-2017	García-Verdugo, José Manuel/0000-0001-9872-6499; Lim, Daniel/0000-0001-7221-3425; Alvarez-Buylla, Arturo/0000-0003-4426-8925; Ernst, Patricia/0000-0001-7638-2939; Swigut, Tomek/0000-0002-7649-6781	Neurosurgery Research and Education Foundation/American Association of Neurological Surgeons; Sandler Family Foundation; Northern California Institute for Research and Education; Clinical and Translational Research Institute at the University of California, San Francisco; California Institute for Regenerative Medicine New Faculty Award; Chicago Community Trust Searle Scholar Award; Goldhirsch Foundation; J. G. Bowes Research Fund; National Institutes of Health (NIH) [5R37-NS028478]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS028478] Funding Source: NIH RePORTER	Neurosurgery Research and Education Foundation/American Association of Neurological Surgeons; Sandler Family Foundation; Northern California Institute for Research and Education; Clinical and Translational Research Institute at the University of California, San Francisco; California Institute for Regenerative Medicine New Faculty Award(California Institute for Regenerative Medicine); Chicago Community Trust Searle Scholar Award; Goldhirsch Foundation; J. G. Bowes Research Fund; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Rubenstein for anti-DLX2 antibodies and the pCAG-Dlx2 plasmid, D. Rowitch for anti-OLIG2 antibodies, and Y. Dou and R. Roeder for anti-MLL1 antibodies. This work was supported by the Neurosurgery Research and Education Foundation/American Association of Neurological Surgeons, Sandler Family Foundation, Northern California Institute for Research and Education, and the Clinical and Translational Research Institute at the University of California, San Francisco (D. A. L.), California Institute for Regenerative Medicine New Faculty Award and The Chicago Community Trust Searle Scholar Award (J. W.), and the Goldhirsch Foundation, J. G. Bowes Research Fund, and National Institutes of Health (NIH) 5R37-NS028478 (A. A.-B.).	Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Daser A, 2004, GENE DEV, V18, P965, DOI 10.1101/gad.1195504; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Fasano CA, 2007, CELL STEM CELL, V1, P87, DOI 10.1016/j.stem.2007.04.001; Han YG, 2008, NAT NEUROSCI, V11, P277, DOI 10.1038/nn2059; Hsieh J, 2004, CURR OPIN GENET DEV, V14, P461, DOI 10.1016/j.gde.2004.07.006; Jude CD, 2007, CELL STEM CELL, V1, P324, DOI 10.1016/j.stem.2007.05.019; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; Lim DA, 2006, MOL CELL NEUROSCI, V31, P131, DOI 10.1016/j.mcn.2005.10.005; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Long JE, 2007, J NEUROSCI, V27, P3230, DOI 10.1523/JNEUROSCI.5265-06.2007; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Marshall CAG, 2003, GLIA, V43, P52, DOI 10.1002/glia.10213; Menn B, 2006, J NEUROSCI, V26, P7907, DOI 10.1523/JNEUROSCI.1299-06.2006; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Parras CM, 2004, EMBO J, V23, P4495, DOI 10.1038/sj.emboj.7600447; Picard-Riera N, 2002, P NATL ACAD SCI USA, V99, P13211, DOI 10.1073/pnas.192314199; Scheffler B, 2005, P NATL ACAD SCI USA, V102, P9353, DOI 10.1073/pnas.0503965102; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Spassky N, 2005, J NEUROSCI, V25, P10, DOI 10.1523/JNEUROSCI.1108-04.2005; Swigut T, 2007, CELL, V131, P29, DOI 10.1016/j.cell.2007.09.026; Wichterle H, 1997, NEURON, V18, P779, DOI 10.1016/S0896-6273(00)80317-7; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0; Zappone MV, 2000, DEVELOPMENT, V127, P2367; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	31	285	292	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2009	458	7237					529	U9		10.1038/nature07726	http://dx.doi.org/10.1038/nature07726			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423YJ	19212323	Green Accepted			2022-12-01	WOS:000264532400049
J	Ju, SY; Kopcha, WP; Papadimitrakopoulos, F				Ju, Sang-Yong; Kopcha, William P.; Papadimitrakopoulos, Fotios			Brightly Fluorescent Single-Walled Carbon Nanotubes via an Oxygen-Excluding Surfactant Organization	SCIENCE			English	Article							OPTICAL SENSORS; SPECTROSCOPY; SUSPENSIONS; DISPERSION; EXCITONS; SPECTRA	Attaining high photoluminescence quantum yields for single-walled carbon nanotubes (SWNTs) in order to broaden their optoelectronics and sensing applications has been a challenging task. Among various nonradiative pathways, sidewall chemisorption of oxygen provides a known defect for exciton quenching through nanotube hole doping. We found that an aliphatic ( dodecyl) analog of flavin mononucleotide, FC12, leads to high dispersion of SWNTs, which tend to aggregate into bundles. Unlike other surfactants, the surface organization of FC12 is sufficiently tight to exclude oxygen from the SWNT surface, which led to quantum yields as high as 20%. Toluene-dispersed, FC12-wrapped nanotubes exhibited an absorption spectrum with ultrasharp peaks (widths of 12 to 25 milli-electron volts) devoid of the characteristic background absorption of most nanotube dispersions.	[Ju, Sang-Yong; Papadimitrakopoulos, Fotios] Univ Connecticut, Polymer Program, Nanomat Optoelect Lab, Storrs, CT 06269 USA; [Kopcha, William P.; Papadimitrakopoulos, Fotios] Univ Connecticut, Inst Mat Sci, Dept Chem, Storrs, CT 06269 USA	University of Connecticut; University of Connecticut	Papadimitrakopoulos, F (corresponding author), Univ Connecticut, Polymer Program, Nanomat Optoelect Lab, Storrs, CT 06269 USA.	papadim@mail.ims.uconn.edu	Ju, Sang-Yong/GQG-8696-2022; Ju, Sang-Yong/A-5257-2009	Ju, Sang-Yong/0000-0002-6939-5296; Kopcha, William/0000-0001-8811-1669	Air Force Office of Scientific Research [FA9550-06-1-0030]; NSF [NIRT DMI-0422724, CBET-0828771/0828824]; NIH [ES013557]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013557] Funding Source: NIH RePORTER	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank S. Vaddiraju, J. Doll, D. Abanulo, A. Nish, and R. J. Nicholas for useful discussions. Supported mainly by Air Force Office of Scientific Research grant FA9550-06-1-0030, and in part by NSF grants NIRT DMI-0422724 and CBET-0828771/0828824 and NIH grant ES013557.	Bachilo SM, 2003, J AM CHEM SOC, V125, P11186, DOI 10.1021/ja036622c; Bachilo SM, 2002, SCIENCE, V298, P2361, DOI 10.1126/science.1078727; Badaire S, 2004, LANGMUIR, V20, P10367, DOI 10.1021/la049096r; Barone PW, 2005, NAT MATER, V4, P86, DOI 10.1038/nmat1276; Cognet L, 2007, SCIENCE, V316, P1465, DOI 10.1126/science.1141316; Crochet J, 2007, J AM CHEM SOC, V129, P8058, DOI 10.1021/ja071553d; Dukovic G, 2004, J AM CHEM SOC, V126, P15269, DOI 10.1021/ja046526r; Fantini C, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.147406; Hagen A, 2003, NANO LETT, V3, P383, DOI 10.1021/nl020237o; Heller DA, 2005, ADV MATER, V17, P2793, DOI 10.1002/adma.200500477; Ju SY, 2008, NAT NANOTECHNOL, V3, P356, DOI 10.1038/nnano.2008.148; Kiowski O, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.075421; Krevelen D.W.V., 1990, PROPERTIES POLYM; Lin CS, 2007, J PHYS CHEM C, V111, P4069, DOI 10.1021/jp068846y; Luo ZT, 2006, J AM CHEM SOC, V128, P15511, DOI 10.1021/ja0657096; Miyamoto Y, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.121413; Nish A, 2007, NAT NANOTECHNOL, V2, P640, DOI 10.1038/nnano.2007.290; O'Connell MJ, 2002, SCIENCE, V297, P593, DOI 10.1126/science.1072631; Oyama Y, 2006, CARBON, V44, P873, DOI 10.1016/j.carbon.2005.10.024; Perebeinos V, 2005, NANO LETT, V5, P2495, DOI 10.1021/nl051828s; Reich S, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.077402; Strano MS, 2003, J PHYS CHEM B, V107, P6979, DOI 10.1021/jp027664a; Strano MS, 2003, SCIENCE, V301, P1519, DOI 10.1126/science.1087691; Tan PH, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.137402; Tan YQ, 2005, J PHYS CHEM B, V109, P14454, DOI 10.1021/jp052217r; Tsyboulski DA, 2007, NANO LETT, V7, P3080, DOI 10.1021/nl071561s; Wang B, 2007, J AM CHEM SOC, V129, P9014, DOI 10.1021/ja070808k; Wang F, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.241403; Wang F, 2005, SCIENCE, V308, P838, DOI 10.1126/science.1110265; Zheng M, 2007, J AM CHEM SOC, V129, P6084, DOI 10.1021/ja071577k	30	192	192	2	116	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2009	323	5919					1319	1323		10.1126/science.1166265	http://dx.doi.org/10.1126/science.1166265			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414PC	19265015				2022-12-01	WOS:000263876700035
J	Schwamborn, JC; Berezikov, E; Knoblich, JA				Schwamborn, Jens C.; Berezikov, Eugene; Knoblich, Juergen A.			The TRIM-NHL Protein TRIM32 Activates MicroRNAs and Prevents Self-Renewal in Mouse Neural Progenitors	CELL			English	Article							ASYMMETRIC CELL-DIVISION; EMBRYONIC STEM-CELLS; DYSTROPHY TYPE 2H; UBIQUITIN LIGASE; LET-7 MICRORNA; NEURONAL DIFFERENTIATION; PLASMA-MEMBRANE; PAR-COMPLEX; IN-VIVO; DROSOPHILA	In the mouse neocortex, neural progenitor cells generate both differentiating neurons and daughter cells that maintain progenitor fate. Here, we show that the TRIM-NHL protein TRIM32 regulates protein degradation and microRNA activity to control the balance between those two daughter cell types. In both horizontally and vertically dividing progenitors, TRIM32 becomes polarized in mitosis and is concentrated in one of the two daughter cells. TRIM32 overexpression induces neuronal differentiation while inhibition of TRIM32 causes both daughter cells to retain progenitor cell fate. TRIM32 ubiquitinates and degrades the transcription factor c-Myc but also binds Argonaute-1 and thereby increases the activity of specific microRNAs. We show that Let-7 is one of the TRIM32 targets and is required and sufficient for neuronal differentiation. TRIM32 is the mouse ortholog of Drosophila Brat and Mei-P26 and might be part of a protein family that regulates the balance between differentiation and proliferation in stem cell lineages.	[Schwamborn, Jens C.; Knoblich, Juergen A.] IMBA, Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria; [Berezikov, Eugene] Hubrecht Inst, NL-3584 CT Utrecht, Netherlands	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	Knoblich, JA (corresponding author), IMBA, Austrian Acad Sci, Inst Mol Biotechnol, Dr Bohr Gasse 3, A-1030 Vienna, Austria.	juergen.knoblich@imba.oeaw.ac.at	Knoblich, Juergen A/C-2974-2015; Schwamborn, Jens C/F-9395-2011; Berezikov, Eugene/D-3363-2013	Knoblich, Juergen A/0000-0002-6751-3404; Schwamborn, Jens C/0000-0003-4496-0559; Berezikov, Eugene/0000-0002-1145-2884	Austrian Academy of Sciences, the Wiener Wissenschafts-, Forschungs und Technologiefonds (WWTF); Austrian Science Fund (FWF)	Austrian Academy of Sciences, the Wiener Wissenschafts-, Forschungs und Technologiefonds (WWTF); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The authors would like to thank Andrea Ballabio (Milan), Stephen Hann (Nashville), Dirk Bohmann (Rochester), Judy Lieberman (Boston), and Witold Filipowicz ( Basel) for plasmids; Gunter Meister Munich) for the anti- Ago1 antibody; Xiao- Bing Yuan (Shanghai) for teaching the in utero electroporation,; Jo r rg Betschinger for initiating production of the anti- TRIM32 antibody; Maria Novatchkova for sequence analysis; Katrin Heindl for help with the RNA end-labeling; and Angela M. Peer for excellent technical assistance. J. C. S. was supported by EMBO and HFSP. Work in J. A. K.' s lab is supported by the Austrian Academy of Sciences, the Wiener Wissenschafts-, Forschungs und Technologiefonds (WWTF), the Austrian Science Fund (FWF), the EU FP6 network ONCASYM, and the EU FP7 network EUROSYSTEM.	Albor A, 2007, MOL CARCINOGEN, V46, P585, DOI 10.1002/mc.20344; Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Bello B, 2006, DEVELOPMENT, V133, P2639, DOI 10.1242/dev.02429; Berdnik D, 2002, DEV CELL, V3, P221, DOI 10.1016/S1534-5807(02)00215-0; Betschinger J, 2006, CELL, V124, P1241, DOI 10.1016/j.cell.2006.01.038; Bowman SK, 2008, DEV CELL, V14, P535, DOI 10.1016/j.devcel.2008.03.004; Bussing I, 2008, TRENDS MOL MED, V14, P400, DOI 10.1016/j.molmed.2008.07.001; Butcher BA, 2000, MOL BIOCHEM PARASIT, V107, P207, DOI 10.1016/S0166-6851(00)00189-4; Chiang AP, 2006, P NATL ACAD SCI USA, V103, P6287, DOI 10.1073/pnas.0600158103; Choksi SP, 2006, DEV CELL, V11, P775, DOI 10.1016/j.devcel.2006.09.015; Coskun Volkan, 2007, Sci STKE, V2007, ppe58, DOI 10.1126/stke.4102007pe58; Costa MR, 2008, DEVELOPMENT, V135, P11, DOI 10.1242/dev.009951; Doe CQ, 2008, DEVELOPMENT, V135, P1575, DOI 10.1242/dev.014977; Dyer MA, 2003, NAT GENET, V34, P53, DOI 10.1038/ng1144; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Esquela-Kerscher A, 2008, CELL CYCLE, V7, P759, DOI 10.4161/cc.7.6.5834; Fishell G, 2003, CURR OPIN NEUROBIOL, V13, P34, DOI 10.1016/S0959-4388(03)00013-8; Frank DJ, 2002, DEVELOPMENT, V129, P399; Frosk P, 2002, AM J HUM GENET, V70, P663, DOI 10.1086/339083; Fults D, 2002, NEOPLASIA, V4, P32, DOI 10.1038/sj.neo.7900200; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Guo M, 1996, NEURON, V17, P27, DOI 10.1016/S0896-6273(00)80278-0; Hatfield SD, 2005, NATURE, V435, P974, DOI 10.1038/nature03816; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Haydar TF, 2003, P NATL ACAD SCI USA, V100, P2890, DOI 10.1073/pnas.0437969100; Imai F, 2006, DEVELOPMENT, V133, P1735, DOI 10.1242/dev.02330; Jin ZG, 2007, CURR BIOL, V17, P539, DOI 10.1016/j.cub.2007.01.050; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kano S, 2008, CANCER RES, V68, P5572, DOI 10.1158/0008-5472.CAN-07-6231; Ke YH, 2007, MOL CELL BIOL, V27, P6706, DOI 10.1128/MCB.01225-07; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Klezovitch O, 2004, GENE DEV, V18, P559, DOI 10.1101/gad.1178004; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Knoepfler PS, 2002, GENE DEV, V16, P2699, DOI 10.1101/gad.1021202; Konno D, 2008, NAT CELL BIOL, V10, P93, DOI 10.1038/ncb1673; Kosodo Y, 2004, EMBO J, V23, P2314, DOI 10.1038/sj.emboj.7600223; Kudryashova E, 2005, J MOL BIOL, V354, P413, DOI 10.1016/j.jmb.2005.09.068; Lassman AB, 2004, NEURON GLIA BIOL, V1, P157, DOI 10.1017/S1740925X04000249; Lee CY, 2006, DEV CELL, V10, P441, DOI 10.1016/j.devcel.2006.01.017; Lee CY, 2006, NATURE, V439, P594, DOI 10.1038/nature04299; Li HS, 2003, NEURON, V40, P1105, DOI 10.1016/S0896-6273(03)00755-4; Li L, 2000, GENE DEV, V14, P147; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Neumuller RA, 2008, NATURE, V454, P241, DOI 10.1038/nature07014; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Noctor SC, 2008, J COMP NEUROL, V508, P28, DOI 10.1002/cne.21669; Pan L, 2007, CELL STEM CELL, V1, P458, DOI 10.1016/j.stem.2007.09.010; Park JK, 2007, CURR BIOL, V17, P533, DOI 10.1016/j.cub.2007.01.060; Peng Y, 2008, MOL CANCER RES, V6, P663, DOI 10.1158/1541-7786.MCR-07-0370; Petersen PH, 2002, NATURE, V419, P929, DOI 10.1038/nature01124; Qian XM, 1998, DEVELOPMENT, V125, P3143; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; Rasin MR, 2007, NAT NEUROSCI, V10, P819, DOI 10.1038/nn1924; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Rolls MM, 2003, J CELL BIOL, V163, P1089, DOI 10.1083/jcb.200306079; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Schmitter D, 2006, NUCLEIC ACIDS RES, V34, P4801, DOI 10.1093/nar/gkl646; Schwamborn JC, 2007, EMBO J, V26, P1410, DOI 10.1038/sj.emboj.7601580; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Tabata H, 2002, J NEUROSCI RES, V69, P723, DOI 10.1002/jnr.10345; Tay YMS, 2008, STEM CELLS, V26, P17, DOI 10.1634/stemcells.2007-0295; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Wirtz-Peitz F, 2008, CELL, V135, P161, DOI 10.1016/j.cell.2008.07.049; Wodarz A, 2003, MECH DEVELOP, V120, P1297, DOI 10.1016/j.mod.2003.06.003; Wulczyn FG, 2007, FASEB J, V21, P415, DOI 10.1096/fj.06-6130com; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642; Yingling J, 2008, CELL, V132, P474, DOI 10.1016/j.cell.2008.01.026; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zhong WM, 1996, NEURON, V17, P43, DOI 10.1016/S0896-6273(00)80279-2; Zhong WM, 2000, P NATL ACAD SCI USA, V97, P6844, DOI 10.1073/pnas.97.12.6844	74	321	330	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 6	2009	136	5					913	925		10.1016/j.cell.2008.12.024	http://dx.doi.org/10.1016/j.cell.2008.12.024			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	415JU	19269368	Green Accepted, Bronze			2022-12-01	WOS:000263930900014
J	van der Flier, LG; van Gijn, ME; Hatzis, P; Kujala, P; Haegebarth, A; Stange, DE; Begthel, H; van den Born, M; Guryev, V; Oving, I; van Es, JH; Barker, N; Peters, PJ; van de Wetering, M; Clevers, H				van der Flier, Laurens G.; van Gijn, Marielle E.; Hatzis, Pantelis; Kujala, Pekka; Haegebarth, Andrea; Stange, Daniel E.; Begthel, Harry; van den Born, Maaike; Guryev, Victor; Oving, Irma; van Es, Johan H.; Barker, Nick; Peters, Peter J.; van de Wetering, Marc; Clevers, Hans			Transcription Factor Achaete Scute-Like 2 Controls Intestinal Stem Cell Fate	CELL			English	Article							PERIPHERAL NERVOUS-SYSTEM; COLORECTAL-CANCER CELLS; MOUSE SMALL INTESTINE; GENE-EXPRESSION; BETA-CATENIN; PANETH CELLS; ADULT-MOUSE; IN-VIVO; DIFFERENTIATION; EPITHELIUM	The small intestinal epithelium is the most rapidly self-renewing tissue of mammals. Proliferative cells are confined to crypts, while differentiated cell types predominantly occupy the villi. We recently demonstrated the existence of a long-lived pool of cycling stem cells defined by Lgr5 expression and intermingled with post-mitotic Paneth cells at crypt bottoms. We have now determined a gene signature for these Lgr5 stem cells. One of the genes within this stem cell signature is the Wnt target Achaete scute-like 2 (Ascl2). Transgenic expression of the Ascl2 transcription factor throughout the intestinal epithelium induces crypt hyperplasia and ectopic crypts on villi. Induced deletion of the Ascl2 gene in adult small intestine leads to disappearance of the Lgr5 stem cells within days. The combined results from these gain- and loss-of-function experiments imply that Ascl2 controls intestinal stem cell fate.	[van der Flier, Laurens G.; van Gijn, Marielle E.; Hatzis, Pantelis; Haegebarth, Andrea; Stange, Daniel E.; Begthel, Harry; van den Born, Maaike; Guryev, Victor; Oving, Irma; van Es, Johan H.; Barker, Nick; van de Wetering, Marc; Clevers, Hans] Hubert Inst KNAW, NL-3584 CT Utrecht, Netherlands; [van der Flier, Laurens G.; van Gijn, Marielle E.; Hatzis, Pantelis; Haegebarth, Andrea; Stange, Daniel E.; Begthel, Harry; van den Born, Maaike; Guryev, Victor; Oving, Irma; van Es, Johan H.; Barker, Nick; van de Wetering, Marc; Clevers, Hans] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Kujala, Pekka; Peters, Peter J.] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Netherlands Cancer Institute	Clevers, H (corresponding author), Hubert Inst KNAW, Uppsalaan 8, NL-3584 CT Utrecht, Netherlands.	clevers@niob.knaw.nl	Barker, Nick/AAE-9833-2021; van+Es, Johan/ABD-5411-2021; Barker, Nick/AAS-2774-2020; Barker, Nick/A-5535-2011; Stange, Daniel E/O-1837-2015	Barker, Nick/0000-0003-3566-4475; Stange, Daniel E/0000-0003-4246-2230; Guryev, Victor/0000-0002-5810-6022; Oving, Irma/0000-0002-6149-2171				Barker N, 2008, GENE DEV, V22, P1856, DOI 10.1101/gad.1674008; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bastide P, 2007, J CELL BIOL, V178, P635, DOI 10.1083/jcb.200704152; BJERKNES M, 1981, AM J ANAT, V160, P51, DOI 10.1002/aja.1001600105; BJERKNES M, 1981, AM J ANAT, V160, P77, DOI 10.1002/aja.1001600107; Bjerknes M, 1999, GASTROENTEROLOGY, V116, P7, DOI 10.1016/S0016-5085(99)70222-2; Blache P, 2004, J CELL BIOL, V166, P37, DOI 10.1083/jcb.200311021; CABRERA CV, 1991, EMBO J, V10, P2965, DOI 10.1002/j.1460-2075.1991.tb07847.x; CAIRNIE AB, 1975, CELL TISSUE KINET, V8, P189, DOI 10.1111/j.1365-2184.1975.tb01219.x; Calleja M, 2002, GENE, V292, P1, DOI 10.1016/S0378-1119(02)00628-5; CAUDY M, 1988, CELL, V55, P1061, DOI 10.1016/0092-8674(88)90250-4; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; CHENG H, 1974, AM J ANAT, V141, P461, DOI 10.1002/aja.1001410403; Fevr T, 2007, MOL CELL BIOL, V27, P7551, DOI 10.1128/MCB.01034-07; Gregorieff A, 2005, GASTROENTEROLOGY, V129, P626, DOI 10.1053/j.gastro.2005.06.007; Gregorieff A, 2005, GENE DEV, V19, P877, DOI 10.1101/gad.1295405; GUILLEMOT F, 1995, NAT GENET, V9, P235, DOI 10.1038/ng0395-235; GUILLEMOT F, 1994, NATURE, V371, P333, DOI 10.1038/371333a0; Hatzis P, 2008, MOL CELL BIOL, V28, P2732, DOI 10.1128/MCB.02175-07; Hughes M, 2004, DEV BIOL, V271, P26, DOI 10.1016/j.ydbio.2004.03.029; Inomata H, 2008, CELL, V134, P854, DOI 10.1016/j.cell.2008.07.008; Ireland H, 2004, GASTROENTEROLOGY, V126, P1236, DOI 10.1053/j.gastro.2004.03.020; JOHNSON JE, 1990, NATURE, V346, P858, DOI 10.1038/346858a0; JOHNSON JE, 1992, P NATL ACAD SCI USA, V89, P3596, DOI 10.1073/pnas.89.8.3596; Jubb AM, 2006, ONCOGENE, V25, P3445, DOI 10.1038/sj.onc.1209382; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Kosinski C, 2007, P NATL ACAD SCI USA, V104, P15418, DOI 10.1073/pnas.0707210104; Kuhnert F, 2004, P NATL ACAD SCI USA, V101, P266, DOI 10.1073/pnas.2536800100; Mori-Akiyama Y, 2007, GASTROENTEROLOGY, V133, P539, DOI 10.1053/j.gastro.2007.05.020; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Muncan V, 2006, MOL CELL BIOL, V26, P8418, DOI 10.1128/MCB.00821-06; PHILLIPS RG, 1993, DEVELOPMENT, V118, P427; Pinto D, 1999, J BIOL CHEM, V274, P6476, DOI 10.1074/jbc.274.10.6476; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; POTTEN CS, 1974, CELL TISSUE KINET, V7, P271, DOI 10.1111/j.1365-2184.1974.tb00907.x; POTTEN CS, 1977, NATURE, V269, P518, DOI 10.1038/269518a0; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Scott IC, 2000, MOL CELL BIOL, V20, P530, DOI 10.1128/MCB.20.2.530-541.2000; SIMPSON P, 1990, DEVELOPMENT, V109, P509; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; Van Der Flier LG, 2007, GASTROENTEROLOGY, V132, P628, DOI 10.1053/j.gastro.2006.08.039; van Es JH, 2005, NAT CELL BIOL, V7, P381, DOI 10.1038/ncb1240; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; Zhang JC, 2002, GENE, V283, P83, DOI 10.1016/S0378-1119(01)00763-6	49	503	515	1	42	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 6	2009	136	5					903	912		10.1016/j.cell.2009.01.031	http://dx.doi.org/10.1016/j.cell.2009.01.031			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	415JU	19269367	Bronze			2022-12-01	WOS:000263930900013
J	Weisswange, I; Newsome, TP; Schleich, S; Way, M				Weisswange, Ina; Newsome, Timothy P.; Schleich, Sibylle; Way, Michael			The rate of N-WASP exchange limits the extent of ARP2/3-complex-dependent actin-based motility	NATURE			English	Article							VACCINIA VIRUS; INHIBITION; MEMBRANES; PATHWAYS; KINASES; COMPLEX	Understanding cell motility will require detailed knowledge not only of the localization of signalling networks regulating actin polymerization, but also of their dynamics. Unfortunately, many signalling networks are not amenable to such analysis, as they are frequently transient and dispersed. By contrast, the signalling pathways used by pathogens undergoing actin-based motility are highly localized and operate in a constitutive fashion(1-5). Taking advantage of this, we have analysed the dynamics of neuronal Wiskott-Aldrich syndrome protein (N-WASP), WASP-interacting protein (WIP), GRB2 and NCK, which are required to stimulate actin-related protein (ARP) 2/3-complex-dependent actin-based motility of vaccinia virus(6-9), using fluorescence recovery after photobleaching. Here we show that all four proteins are rapidly exchanging, albeit at different rates, and that the turnover of N-WASP depends on its ability to stimulate ARP2/3-complex-mediated actin polymerization. Conversely, disruption of the interaction of N-WASP with GRB2 and/or the barbed ends of actin filaments increases its exchange rate and results in a faster rate of virus movement. We suggest that the exchange rate of N-WASP controls the rate of ARP2/3-complex-dependent actin-based motility by regulating the extent of actin polymerization by antagonizing filament capping.	[Weisswange, Ina; Newsome, Timothy P.; Schleich, Sibylle; Way, Michael] London Res Inst, Canc Res UK, Cell Motil Lab, London WC2A 3PX, England	Cancer Research UK	Way, M (corresponding author), London Res Inst, Canc Res UK, Cell Motil Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	michael.way@cancer.org.uk	Newsome, Timothy P/AAB-4033-2019	Newsome, Timothy P/0000-0002-2193-596X; Way, Michael/0000-0001-7207-2722	Human Frontier Science Program (HFSP); Cancer Research UK	Human Frontier Science Program (HFSP)(Human Frontier Science Program); Cancer Research UK(Cancer Research UK)	We would like to thank T. Pawson and S. Snapper for NCK-and N-WASP-null cell lines and the FACS laboratory (Cancer Research UK, London) for help sorting stable cell lines. We are also very grateful to the members of the Way laboratory, J. Beaudouin, M.- F. Carlier, H. Gerhardt, B. Mayer, K. Rottner, M. Rosen and M. Welch for discussions and comments on the manuscript. T. P. N. was funded in part by a fellowship from the Human Frontier Science Program (HFSP). This work was funded by Cancer Research UK.	Akin O, 2008, CELL, V133, P841, DOI 10.1016/j.cell.2008.04.011; Arakawa Y, 2007, CELL HOST MICROBE, V1, P227, DOI 10.1016/j.chom.2007.04.006; Arakawa Y, 2007, CELL HOST MICROBE, V1, P213, DOI 10.1016/j.chom.2007.04.007; Backert S, 2008, TRENDS BIOCHEM SCI, V33, P80, DOI 10.1016/j.tibs.2007.10.006; Bhavsar AP, 2007, NATURE, V449, P827, DOI 10.1038/nature06247; Bladt F, 2003, MOL CELL BIOL, V23, P4586, DOI 10.1128/MCB.23.13.4586-4597.2003; Co C, 2007, CELL, V128, P901, DOI 10.1016/j.cell.2006.12.049; Delatour V, 2008, BIOPHYS J, V94, P4890, DOI 10.1529/biophysj.107.118653; Frischknecht F, 1999, NATURE, V401, P926, DOI 10.1038/44860; Frishknecht F, 2001, TRENDS CELL BIOL, V11, P30, DOI 10.1016/S0962-8924(00)01871-7; HILLER G, 1985, J VIROL, V55, P651, DOI 10.1128/JVI.55.3.651-659.1985; Kueh HY, 2008, J CELL BIOL, V182, P341, DOI 10.1083/jcb.200801027; Moreau V, 2000, NAT CELL BIOL, V2, P441, DOI 10.1038/35017080; Munter S., 2006, SCI STKE, V2006, pre5, DOI DOI 10.1126/STKE.3352006RE5; Newsome TP, 2006, CELL MICROBIOL, V8, P233, DOI 10.1111/j.1462-5822.2005.00613.x; Newsome TP, 2004, SCIENCE, V306, P124, DOI 10.1126/science.1101509; Pantaloni D, 2000, NAT CELL BIOL, V2, P385, DOI 10.1038/35017011; Pawson T, 2007, ONCOGENE, V26, P1268, DOI 10.1038/sj.onc.1210255; Reeves PM, 2005, NAT MED, V11, P731, DOI 10.1038/nm1265; Rubio CA, 2003, EUR J CLIN INVEST, V33, P406, DOI 10.1046/j.1365-2362.2003.01151.x; Scaplehorn N, 2002, CURR BIOL, V12, P740, DOI 10.1016/S0960-9822(02)00812-6; Shewan AM, 2005, MOL BIOL CELL, V16, P4531, DOI 10.1091/mbc.E05-04-0330; Snapper SB, 2001, NAT CELL BIOL, V3, P897, DOI 10.1038/ncb1001-897; Zettl M, 2002, CURR BIOL, V12, P1617, DOI 10.1016/S0960-9822(02)01112-0	24	104	104	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 5	2009	458	7234					87	U6		10.1038/nature07773	http://dx.doi.org/10.1038/nature07773			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414AJ	19262673				2022-12-01	WOS:000263836000038
J	McCartney, M				McCartney, Margaret			Hospital Hygiene Are superbug fears turning patients into hospital cleaners?	BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Coombes R, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b833	1	3	3	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 25	2009	338								b729	10.1136/bmj.b729	http://dx.doi.org/10.1136/bmj.b729			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417DR	19244305				2022-12-01	WOS:000264056200002
J	Erb, RM; Son, HS; Samanta, B; Rotello, VM; Yellen, BB				Erb, Randall M.; Son, Hui S.; Samanta, Bappaditya; Rotello, Vincent M.; Yellen, Benjamin B.			Magnetic assembly of colloidal superstructures with multipole symmetry	NATURE			English	Article							PARTICLES; CRYSTALS; CRYSTALLIZATION; CLUSTERS	The assembly of complex structures out of simple colloidal building blocks is of practical interest for building materials with unique optical properties ( for example photonic crystals(1) and DNA biosensors(2)) and is of fundamental importance in improving our understanding of self- assembly processes occurring on molecular to macroscopic length scales(3-5). Here we demonstrate a self-assembly principle that is capable of organizing a diverse set of colloidal particles into highly reproducible, rotationally symmetric arrangements. The structures are assembled using the magneto-static interaction between effectively diamagnetic and paramagnetic particles within a magnetized ferrofluid. The resulting multipolar geometries resemble electrostatic charge configurations such as axial quadrupoles ('Saturn rings'), axial octupoles ('flowers'), linear quadrupoles (poles) and mixed multipole arrangements ('two tone'), which represent just a few examples of the type of structure that can be built using this technique.	[Erb, Randall M.; Son, Hui S.; Yellen, Benjamin B.] Duke Univ, Dept Mech Engn & Mat Sci, Ctr Biol Inspired Mat & Mat Syst, Durham, NC 27708 USA; [Samanta, Bappaditya; Rotello, Vincent M.] Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA	Duke University; University of Massachusetts System; University of Massachusetts Amherst	Yellen, BB (corresponding author), Duke Univ, Dept Mech Engn & Mat Sci, Ctr Biol Inspired Mat & Mat Syst, Box 90300,Hudson Hall, Durham, NC 27708 USA.	yellen@duke.edu	Erb, Randall M/E-6337-2014; Erb, Randall M/B-1986-2012; Erb, Randall M/O-1984-2018	Erb, Randall M/0000-0002-6351-395X	US National Science Foundation [NSEC DMI-0531171, MRSEC DMR-0213695, CMMI-0608819, CMMI-0625480]	US National Science Foundation(National Science Foundation (NSF))	The authors would like to thank the US National Science Foundation (grants NSEC DMI-0531171 and MRSEC DMR-0213695 to V. M. R. and grants CMMI-0608819 and CMMI-0625480 to B.B.Y.) for supporting this work.	Biswal SL, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.041406; Cho YS, 2005, J AM CHEM SOC, V127, P15968, DOI 10.1021/ja0550632; Dinsmore AD, 2002, SCIENCE, V298, P1006, DOI 10.1126/science.1074868; Dreyfus R, 2005, NATURE, V437, P862, DOI 10.1038/nature04090; Elghanian R, 1997, SCIENCE, V277, P1078, DOI 10.1126/science.277.5329.1078; Erb RM, 2008, J APPL PHYS, V103, DOI 10.1063/1.2831789; HALSEY TC, 1992, SCIENCE, V258, P761, DOI 10.1126/science.258.5083.761; HELGESEN G, 1990, PHYS REV A, V42, P7271, DOI 10.1103/PhysRevA.42.7271; Kim SH, 2008, LANGMUIR, V24, P2365, DOI 10.1021/la703037g; Leunissen ME, 2005, NATURE, V437, P235, DOI 10.1038/nature03946; Manoharan VN, 2003, SCIENCE, V301, P483, DOI 10.1126/science.1086189; Musevic I, 2006, SCIENCE, V313, P954, DOI 10.1126/science.1129660; Ozin GA, 2001, ADV FUNCT MATER, V11, P95, DOI 10.1002/1616-3028(200104)11:2<95::AID-ADFM95>3.0.CO;2-O; PANOFSKY WKH, 1955, CLASSICAL ELECT MAGN, P84; Shevchenko EV, 2006, NATURE, V439, P55, DOI 10.1038/nature04414; SKJELTORP AT, 1983, PHYS REV LETT, V51, P2306, DOI 10.1103/PhysRevLett.51.2306; Velev OD, 2000, SCIENCE, V287, P2240, DOI 10.1126/science.287.5461.2240; Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821; Xia YN, 2001, ADV MATER, V13, P409, DOI 10.1002/1521-4095(200103)13:6<409::AID-ADMA409>3.0.CO;2-C; Yellen BB, 2005, P NATL ACAD SCI USA, V102, P8860, DOI 10.1073/pnas.0500409102; Yin YD, 2001, J AM CHEM SOC, V123, P8718, DOI 10.1021/ja011048v; Zerrouki D, 2008, NATURE, V455, P380, DOI 10.1038/nature07237; Zhuang JQ, 2008, ANGEW CHEM INT EDIT, V47, P2208, DOI 10.1002/anie.200705049	23	357	370	7	341	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2009	457	7232					999	1002		10.1038/nature07766	http://dx.doi.org/10.1038/nature07766			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	408HF	19225522				2022-12-01	WOS:000263425400039
J	Budd, GE; Telford, MJ				Budd, Graham E.; Telford, Maximilian J.			The origin and evolution of arthropods	NATURE			English	Review							AMINO-ACID REPLACEMENTS; GENOME-WIDE ANALYSIS; BURGESS SHALE; PHYLOGENETIC ANALYSIS; HEAD SEGMENTATION; FOSSIL RECORD; ECDYSOZOA; CRUSTACEAN; SUPPORT; COELOMATA	The past two decades have witnessed profound changes in our understanding of the evolution of arthropods. Many of these insights derive from the adoption of molecular methods by systematists and developmental biologists, prompting a radical reordering of the relationships among extant arthropod classes and their closest non- arthropod relatives, and shedding light on the developmental basis for the origins of key characteristics. A complementary source of data is the discovery of fossils from several spectacular Cambrian faunas. These fossils form well- characterized groupings, making the broad pattern of Cambrian arthropod systematics increasingly consensual.	[Budd, Graham E.] Uppsala Univ, Dept Earth Sci, SE-75236 Uppsala, Sweden; [Telford, Maximilian J.] UCL, Dept Genet Evolut & Environm, London WC1E 6BT, England	Uppsala University; University of London; University College London	Budd, GE (corresponding author), Uppsala Univ, Dept Earth Sci, Villavagen 16, SE-75236 Uppsala, Sweden.	graham.budd@pal.uu.se; m.telford@ucl.ac.uk	Telford, Maximilian J/B-7178-2008	Telford, Maximilian J/0000-0002-3749-5620; Budd, Graham/0000-0001-9007-4369	Marie Curie Research Training Network ZOONET [MRTN-CT-2004-005624]	Marie Curie Research Training Network ZOONET(European Commission)	We thank A. Daley for assistance with photography and R. Copley for critically reading an earlier draft. Our research is supported by the Marie Curie Research Training Network ZOONET (grant number MRTN-CT-2004-005624).	Aguinaldo AMA, 1997, NATURE, V387, P489, DOI 10.1038/387489a0; BALLARD JWO, 1992, SCIENCE, V258, P1345, DOI 10.1126/science.1455227; BERGSTROM J, 1986, LETHAIA, V19, P241, DOI 10.1111/j.1502-3931.1986.tb00738.x; Boore JL, 1998, NATURE, V392, P667, DOI 10.1038/33577; Bourlat SJ, 2008, MOL PHYLOGENET EVOL, V49, P23, DOI 10.1016/j.ympev.2008.07.008; Bowler PJ., 1996, LIFES SPLENDID DRAMA; Boxshall GA, 2007, ZOOTAXA, P313, DOI 10.11646/zootaxa.1668.1.16; Briggs DEG, 1999, PALAEONTOLOGY, V42, P953, DOI 10.1111/1475-4983.00104; BUDD G, 1993, NATURE, V364, P709, DOI 10.1038/364709a0; Budd GE, 1998, LETHAIA, V31, P197, DOI 10.1111/j.1502-3931.1998.tb00508.x; Budd GE, 1999, T ROY SOC EDIN-EARTH, V89, P249, DOI 10.1017/S0263593300002418; Budd GE, 2003, INTEGR COMP BIOL, V43, P157, DOI 10.1093/icb/43.1.157; Budd GE, 2002, NATURE, V417, P271, DOI 10.1038/417271a; Budd GE, 1996, LETHAIA, V29, P1, DOI 10.1111/j.1502-3931.1996.tb01831.x; Budd GE, 2008, PALAEONTOLOGY, V51, P561, DOI 10.1111/j.1475-4983.2008.00752.x; Carapelli A, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S2-S8; CHEN JY, 1995, SCIENCE, V268, P1339, DOI 10.1126/science.268.5215.1339; Chen JY, 2004, LETHAIA, V37, P3, DOI 10.1080/00241160410004764; Cook CE, 2005, P ROY SOC B-BIOL SCI, V272, P1295, DOI 10.1098/rspb.2004.3042; Copley RR, 2004, EVOL DEV, V6, P164, DOI 10.1111/j.1525-142X.2004.04021.x; Cotton TJ, 2004, T ROY SOC EDIN-EARTH, V94, P169, DOI 10.1017/S0263593300000596; Damen WGM, 2002, CURR BIOL, V12, P1711, DOI 10.1016/S0960-9822(02)01126-0; Darwin C., 1859, ORIGIN SPECIES MEANS; DUNLOP JA, 2005, ACTA ZOOL BULG S, V1, P9; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; DZIK J, 1989, LETHAIA, V22, P169, DOI 10.1111/j.1502-3931.1989.tb01679.x; Edgecombe GD, 2004, CONTRIB ZOOL, V73, P207, DOI 10.1163/18759866-07303002; EERNISSE DJ, 1992, SYST BIOL, V41, P305, DOI 10.1093/sysbio/41.3.305; Eriksson BJ, 2003, J MORPHOL, V255, P1, DOI 10.1002/jmor.10034; Eriksson BJ, 2000, ARTHROPOD STRUCT DEV, V29, P197, DOI 10.1016/S1467-8039(00)00027-X; Fanenbruck M, 2005, ARTHROPOD STRUCT DEV, V34, P343, DOI 10.1016/j.asd.2005.01.007; Fayers SR, 2005, PALAEONTOLOGY, V48, P1117, DOI 10.1111/j.1475-4983.2005.00501.x; Fortey RA, 1996, BIOL J LINN SOC, V57, P13, DOI 10.1006/bijl.1995.0002; FRIEDRICH M, 1995, NATURE, V376, P165, DOI 10.1038/376165a0; GEHLING JG, 1991, MEMOIRS GEOLOGICAL S, V20, P181; Giribet G, 2001, NATURE, V413, P157, DOI 10.1038/35093097; Harzsch S, 2006, ARTHROPOD STRUCT DEV, V35, P319, DOI 10.1016/j.asd.2006.08.009; Hou X. -G., 2004, CAMBRIAN FOSSILS CHE; HOU XG, 1997, FOSSILS STRATA, V45; Irimia M, 2007, MOL BIOL EVOL, V24, P1604, DOI 10.1093/molbev/msm105; Ivantsov A.Y., 2001, PALEONTOL J+, V35, P335; Jensen S, 2003, INTEGR COMP BIOL, V43, P219, DOI 10.1093/icb/43.1.219; Liu JN, 2007, ACTA ZOOL-STOCKHOLM, V88, P279, DOI 10.1111/j.1463-6395.2007.00281.x; Mallatt JM, 2004, MOL PHYLOGENET EVOL, V31, P178, DOI 10.1016/j.ympev.2003.07.013; Mallatt J, 2006, MOL PHYLOGENET EVOL, V40, P772, DOI 10.1016/j.ympev.2006.04.021; Manton, 1977, ARTHROPODA HABITS FU; MORRIS SC, 1987, NATURE, V326, P181, DOI 10.1038/326181a0; Nielsen C, 2012, ANIMAL EVOLUTION: INTERRELATIONSHIPS OF THE LIVING PHYLA, 3RD EDITION, P1; Papillon D, 2004, MOL BIOL EVOL, V21, P2122, DOI 10.1093/molbev/msh229; Philip GK, 2005, MOL BIOL EVOL, V22, P1175, DOI 10.1093/molbev/msi102; Philippe H, 2005, MOL BIOL EVOL, V22, P1246, DOI 10.1093/molbev/msi111; Philippe H, 2006, TRENDS ECOL EVOL, V21, P614, DOI 10.1016/j.tree.2006.08.004; Pisani D, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-1; Richter S, 2002, ORG DIVERS EVOL, V2, P217, DOI 10.1078/1439-6092-00048; Rogozin IB, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-7; Rogozin IB, 2007, MOL BIOL EVOL, V24, P2594, DOI 10.1093/molbev/msm218; Rogozin IB, 2007, MOL BIOL EVOL, V24, P1080, DOI 10.1093/molbev/msm029; Rota-Stabelli O, 2008, MOL PHYLOGENET EVOL, V48, P103, DOI 10.1016/j.ympev.2008.03.033; SANDERS HL, 1957, SYST ZOOL, V6, P112, DOI 10.2307/2411750; Schmidt-Rhaesa A, 1998, J MORPHOL, V238, P263, DOI 10.1002/(SICI)1097-4687(199812)238:3<263::AID-JMOR1>3.0.CO;2-L; Scholtz G, 2006, DEV GENES EVOL, V216, P395, DOI 10.1007/s00427-006-0085-4; Siveter DJ, 2007, P ROY SOC B-BIOL SCI, V274, P2099, DOI 10.1098/rspb.2007.0429; Siveter DJ, 2001, SCIENCE, V293, P479, DOI 10.1126/science.1061697; StOrmer L., 1944, SKR NORSKE VIDENS MN, V5, P1; Telford MJ, 2008, PHILOS T R SOC B, V363, P1529, DOI 10.1098/rstb.2007.2243; TELFORD MJ, 1995, NATURE, V376, P123, DOI 10.1038/376123a0; Thomas RH, 1999, ACTA ZOOL-STOCKHOLM, V80, P193, DOI 10.1046/j.1463-6395.1999.00016.x; Ungerer P, 2008, P ROY SOC B-BIOL SCI, V275, P369, DOI 10.1098/rspb.2007.1391; Wagele JW, 1999, J ZOOL SYST EVOL RES, V37, P211; Waggoner BM, 1996, SYST BIOL, V45, P190, DOI 10.2307/2413615; WALOSSEK D, 1990, LETHAIA, V23, P409, DOI 10.1111/j.1502-3931.1990.tb01373.x; Waloszek D, 2005, ARTHROPOD STRUCT DEV, V34, P189, DOI 10.1016/j.asd.2005.01.005; Webster BL, 2006, EVOL DEV, V8, P502, DOI 10.1111/j.1525-142X.2006.00123.x; WHITTINGTON HB, 1978, PHILOS T R SOC B, V284, P165, DOI 10.1098/rstb.1978.0061; Wilson HM, 2006, J PALEONTOL, V80, P638, DOI 10.1666/0022-3360(2006)80[638:JMFTLD]2.0.CO;2; Zhang XG, 2007, NATURE, V449, P595, DOI 10.1038/nature06138; Zheng J, 2007, MOL BIOL EVOL, V24, P2583, DOI 10.1093/molbev/msm207	77	134	142	4	115	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2009	457	7231					812	817		10.1038/nature07890	http://dx.doi.org/10.1038/nature07890			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406AF	19212398				2022-12-01	WOS:000263266700030
J	Makarov, V; Manina, G; Mikusova, K; Mollmann, U; Ryabova, O; Saint-Joanis, B; Dhar, N; Pasca, MR; Buroni, S; Lucarelli, AP; Milano, A; De Rossi, E; Belanova, M; Bobovska, A; Dianiskova, P; Kordulakova, J; Sala, C; Fullam, E; Schneider, P; McKinney, JD; Brodin, P; Christophe, T; Waddell, S; Butcher, P; Albrethsen, J; Rosenkrands, I; Brosch, R; Nandi, V; Bharath, S; Gaonkar, S; Shandil, RK; Balasubramanian, V; Balganesh, T; Tyagi, S; Grosset, J; Riccardi, G; Cole, ST				Makarov, Vadim; Manina, Giulia; Mikusova, Katarina; Moellmann, Ute; Ryabova, Olga; Saint-Joanis, Brigitte; Dhar, Neeraj; Pasca, Maria Rosalia; Buroni, Silvia; Lucarelli, Anna Paola; Milano, Anna; De Rossi, Edda; Belanova, Martina; Bobovska, Adela; Dianiskova, Petronela; Kordulakova, Jana; Sala, Claudia; Fullam, Elizabeth; Schneider, Patricia; McKinney, John D.; Brodin, Priscille; Christophe, Thierry; Waddell, Simon; Butcher, Philip; Albrethsen, Jakob; Rosenkrands, Ida; Brosch, Roland; Nandi, Vrinda; Bharath, Sowmya; Gaonkar, Sheshagiri; Shandil, Radha K.; Balasubramanian, Venkataraman; Balganesh, Tanjore; Tyagi, Sandeep; Grosset, Jacques; Riccardi, Giovanna; Cole, Stewart T.			Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis	SCIENCE			English	Article							CELL-WALL; IDENTIFICATION	New drugs are required to counter the tuberculosis (TB) pandemic. Here, we describe the synthesis and characterization of 1,3-benzothiazin-4-ones (BTZs), a new class of antimycobacterial agents that kill Mycobacterium tuberculosis in vitro, ex vivo, and in mouse models of TB. Using genetics and biochemistry, we identified the enzyme decaprenylphosphoryl-beta-D-ribose 2'-epimerase as a major BTZ target. Inhibition of this enzymatic activity abolishes the formation of decaprenylphosphoryl arabinose, a key precursor that is required for the synthesis of the cell-wall arabinans, thus provoking cell lysis and bacterial death. The most advanced compound, BTZ043, is a candidate for inclusion in combination therapies for both drug-sensitive and extensively drug-resistant TB.	[Makarov, Vadim; Ryabova, Olga] Russian Acad Sci, AN Bakh Biochem Inst, Moscow 119071, Russia; [Manina, Giulia; Pasca, Maria Rosalia; Buroni, Silvia; Lucarelli, Anna Paola; Milano, Anna; De Rossi, Edda; Riccardi, Giovanna] Univ Pavia, Dipartimento Genet & Microbiol, I-27100 Pavia, Italy; [Mikusova, Katarina; Belanova, Martina; Bobovska, Adela; Dianiskova, Petronela; Kordulakova, Jana] Comenius Univ, Fac Nat Sci, Dept Biochem, Bratislava 84215, Slovakia; [Moellmann, Ute] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Dept Mol & Appl Microbiol, D-07745 Jena, Germany; [Saint-Joanis, Brigitte; Brosch, Roland] Inst Pasteur, F-75724 Paris 15, France; [Dhar, Neeraj; Sala, Claudia; Fullam, Elizabeth; Schneider, Patricia; McKinney, John D.; Cole, Stewart T.] Ecole Polytech Fed Lausanne, Global Hlth Inst, CH-1015 Lausanne, Switzerland; [Brodin, Priscille; Christophe, Thierry] Inst Pasteur Korea, Inserm Avenir Grp, Seoul 136791, South Korea; [Waddell, Simon; Butcher, Philip] Univ London St Georges Hosp, Div Cellular & Mol Med, London SE17 ORE, England; [Albrethsen, Jakob; Rosenkrands, Ida] Statens Serum Inst, Dept Infect Dis Immunol, DK-2300 Copenhagen S, Denmark; [Nandi, Vrinda; Bharath, Sowmya; Gaonkar, Sheshagiri; Shandil, Radha K.; Balasubramanian, Venkataraman; Balganesh, Tanjore] AstraZeneca India, Bangalore, Karnataka, India; [Tyagi, Sandeep; Grosset, Jacques] Johns Hopkins Univ, Sch Med, Ctr TB Res, Baltimore, MD 21231 USA	Research Center of Biotechnology RAS; Russian Academy of Sciences; University of Pavia; Comenius University Bratislava; Hans Knoll Institute (HKI); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Institut Pasteur Korea; St Georges University London; Statens Serum Institut; AstraZeneca; Johns Hopkins University		stewart.cole@epfl.ch	Brosch, Roland/AAZ-3850-2021; Waddell, Simon J/A-9170-2013; Brodin, Priscille/N-6979-2019; Brodin, Priscille/E-5802-2014; Dhar, Neeraj/K-8171-2013; Sala, Claudia/AAM-8395-2020; Brosch, Roland/ABB-4108-2021; riccardi, gabriele/A-9269-2012; Sala, Claudia/R-6037-2017; Mikusova, Katarina/I-3622-2014; Buroni, Silvia/AAX-5454-2020; Kordulakova, Jana/I-3887-2014; Manina, Giulia/AAI-5496-2020; Makarov, Vadim/AAE-5483-2021; Pasca, Maria Rosalia/J-8752-2016	Brosch, Roland/0000-0003-2587-3863; Waddell, Simon J/0000-0002-3684-9116; Brodin, Priscille/0000-0003-0991-7344; Brodin, Priscille/0000-0003-0991-7344; Dhar, Neeraj/0000-0002-5887-8137; Sala, Claudia/0000-0003-4031-4648; Sala, Claudia/0000-0003-4031-4648; Kordulakova, Jana/0000-0003-2834-0165; Makarov, Vadim/0000-0001-8746-2694; Pasca, Maria Rosalia/0000-0002-8906-4937; Mikusova, Katarina/0000-0002-0100-4877; Albrethsen, Jakob/0000-0002-2842-1128; Butcher, Philip/0000-0003-1223-9097; Buroni, Silvia/0000-0002-6979-2275; deboosere, Nathalie/0000-0002-2873-5485; MANINA, GIULIA/0000-0001-9905-6095; RICCARDI, Giovanna/0000-0003-3295-0070	European Commission [LHSP-CT-2005-018923]; Wellcome Trust [062511]	European Commission(European CommissionEuropean Commission Joint Research Centre); Wellcome Trust(Wellcome TrustEuropean Commission)	We thank A. Deshpande, I. Heinemann, P. Hojrup, K. Johnsson, M. K. N. Kumar, N. Kumar, L. Pagani, P. Marone, M. R. McNeil, I. Old, J. Reddy, S. Schmitt, P. Vachaspati, and C. Weigel for their help and support. Patents related to this work have been filed (WO/2007/134625, WO/2009/010163, and PCT/EP2008/001088). The NM4TB Consortium is funded by the European Commission (LHSP-CT-2005-018923), and microarray work at St Georges Hospital, University of London, is supported by the Wellcome Trust (grant 062511). Microarray data are Minimum Information About a Microarray Experiment (MIAME) compliant and deposited under accession number E-BUGS-80 at http://bugs.sgul.ac.uk/E-BUGS-80.	Abraham VC, 2004, TRENDS BIOTECHNOL, V22, P15, DOI 10.1016/j.tibtech.2003.10.012; Alderwick LJ, 2005, J BIOL CHEM, V280, P32362, DOI 10.1074/jbc.M506339200; Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Balganesh TS, 2008, TRENDS PHARMACOL SCI, V29, P576, DOI 10.1016/j.tips.2008.08.001; Barry C, 2001, TUBERCULOSIS, V81, P1, DOI 10.1054/tube.2001.0288; Barry Clifton E., 2007, Infectious Disorders - Drug Targets, V7, P182; Dye C, 2006, LANCET, V367, P938, DOI 10.1016/S0140-6736(06)68384-0; Fenistein D, 2008, CYTOM PART A, V73A, P958, DOI 10.1002/cyto.a.20627; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Makarov V., 2007, [No title captured], Patent No. [2029583, EP 2029583]; Manjunatha UH, 2006, P NATL ACAD SCI USA, V103, P431, DOI 10.1073/pnas.0508392103; MARKAROV V, 2006, J ANTIMICROB CHEMOTH, V57, P1134; Matsumoto M, 2006, PLOS MED, V3, P2131, DOI 10.1371/journal.pmed.0030466; Mikusova K, 2005, J BACTERIOL, V187, P8020, DOI 10.1128/JB.187.23.8020-8025.2005; MIKUSOVA K, 1995, ANTIMICROB AGENTS CH, V39, P2484, DOI 10.1128/AAC.39.11.2484; Sassetti CM, 2001, P NATL ACAD SCI USA, V98, P12712, DOI 10.1073/pnas.231275498; Singh R, 2008, SCIENCE, V322, P1392, DOI 10.1126/science.1164571; Stover CK, 2000, NATURE, V405, P962, DOI 10.1038/35016103; Waddell SJ, 2007, CURR MOL MED, V7, P287, DOI 10.2174/156652407780598548; Wolucka BA, 2008, FEBS J, V275, P2691, DOI 10.1111/j.1742-4658.2008.06395.x; Young DB, 2008, J CLIN INVEST, V118, P1255, DOI 10.1172/JCI34614; Zhang Y, 2005, TUBERCULOSIS AND THE TUBERCLE BACILLUS, P115; Zignol M, 2006, J INFECT DIS, V194, P479, DOI 10.1086/505877	24	522	557	2	108	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	2009	324	5928					801	804		10.1126/science.1171583	http://dx.doi.org/10.1126/science.1171583			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442HN	19299584	Green Accepted			2022-12-01	WOS:000265832400051
J	Serneels, L; Van Biervliet, J; Craessaerts, K; Dejaegere, T; Horre, K; Van Houtvin, T; Esselmann, H; Paul, S; Schafer, MK; Berezovska, O; Hyman, BT; Sprangers, B; Sciot, R; Moons, L; Jucker, M; Yang, ZX; May, PC; Karran, E; Wiltfang, J; D'Hooge, R; De Strooper, B				Serneels, Lutgarde; Van Biervliet, Jerome; Craessaerts, Katleen; Dejaegere, Tim; Horre, Katrien; Van Houtvin, Tine; Esselmann, Hermann; Paul, Sabine; Schaefer, Martin K.; Berezovska, Oksana; Hyman, Bradley T.; Sprangers, Ben; Sciot, Raf; Moons, Lieve; Jucker, Mathias; Yang, Zhixiang; May, Patrick C.; Karran, Eric; Wiltfang, Jens; D'Hooge, Rudi; De Strooper, Bart			gamma-Secretase Heterogeneity in the Aph1 Subunit: Relevance for Alzheimer's Disease	SCIENCE			English	Article							AMYLOID PRECURSOR PROTEIN; MODERATE REDUCTION; TRANSGENIC MODEL; IN-VIVO; MICE; PRESENILIN-1; COMPLEXES; DEFICIENCY; EXPRESSION; CLEAVAGE	The gamma-secretase complex plays a role in Alzheimer's disease and cancer progression. The development of clinically useful inhibitors, however, is complicated by the role of the gamma-secretase complex in regulated intramembrane proteolysis of Notch and other essential proteins. Different gamma-secretase complexes containing different Presenilin or Aph1 protein subunits are present in various tissues. Here we show that these complexes have heterogeneous biochemical and physiological properties. Specific inactivation of the Aph1B gamma-secretase in a mouse Alzheimer's disease model led to improvements of Alzheimer's disease-relevant phenotypic features without any Notch-related side effects. The Aph1B complex contributes to total gamma-secretase activity in the human brain, and thus specific targeting of Aph1B-containing gamma-secretase complexes may help generate less toxic therapies for Alzheimer's disease.	[Serneels, Lutgarde; Van Biervliet, Jerome; Craessaerts, Katleen; Dejaegere, Tim; Horre, Katrien; Van Houtvin, Tine; De Strooper, Bart] Katholieke Univ Leuven VIB, Dept Mol & Dev Genet, B-3000 Louvain, Belgium; [Serneels, Lutgarde; Van Biervliet, Jerome; Craessaerts, Katleen; Dejaegere, Tim; Horre, Katrien; Van Houtvin, Tine; De Strooper, Bart] Katholieke Univ Leuven, Ctr Human Genet, B-3000 Louvain, Belgium; [Esselmann, Hermann; Paul, Sabine; Wiltfang, Jens] Univ Erlangen Nurnberg, Dept Psychiat & Psychotherapy, D-91054 Erlangen, Germany; [Esselmann, Hermann; Paul, Sabine; Wiltfang, Jens] Univ Duisburg Essen, Rhine State Hosp Essen, Dept Psychiat & Psychotherapy, D-45147 Essen, Germany; [Schaefer, Martin K.] Univ Marburg, Inst Anat & Cell Biol, Dept Mol Neurosci, D-35032 Marburg, Germany; [Berezovska, Oksana; Hyman, Bradley T.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, MassGen Inst Neurodegenerat Disorders, Charlestown, MA 02129 USA; [Sprangers, Ben] Katholieke Univ Leuven, Lab Expt Transplantat, B-3000 Louvain, Belgium; [Sciot, Raf] Katholieke Univ Leuven, Lab Morphol & Mol Pathol, B-3000 Louvain, Belgium; [Moons, Lieve] Katholieke Univ Leuven, Lab Neural Circuit Dev & Regenerat, Dept Biol, B-3000 Louvain, Belgium; [Jucker, Mathias] Univ Tubingen, Dept Cellular Neurol, Hertie Inst Clin Brain Res, D-72076 Tubingen, Germany; [Yang, Zhixiang; May, Patrick C.] Eli Lilly & Co, Lilly Res Labs, Neurosci Discovery Res, Indianapolis, IN 46285 USA; [Karran, Eric] Lilly Res Ctr Ltd, Windlesham GU20 6PH, Surrey, England; [D'Hooge, Rudi] Katholieke Univ Leuven, Dept Psychol, Lab Biol Psychol, B-3000 Louvain, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; University of Erlangen Nuremberg; University of Duisburg Essen; Philipps University Marburg; Harvard University; Massachusetts General Hospital; KU Leuven; KU Leuven; KU Leuven; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eli Lilly; Eli Lilly; KU Leuven	De Strooper, B (corresponding author), Katholieke Univ Leuven VIB, Dept Mol & Dev Genet, Herestr 49, B-3000 Louvain, Belgium.	bart.destrooper@med.kuleuven.be	De Strooper, Bart/F-6507-2012; Sprangers, Ben/T-6559-2017; de+Strooper, Bart/Z-1638-2019; Cruz e Silva, Odete/AAH-5595-2020	De Strooper, Bart/0000-0001-5455-5819; Sprangers, Ben/0000-0003-1314-9675; Serneels, Lutgarde/0000-0002-5463-4231; Wiltfang, Jens/0000-0003-1492-5330; Moons, Lieve (Godelieve)/0000-0003-0186-1411; sciot, raf/0000-0003-2244-5839; Horre, Katrien/0000-0002-6801-3137	Alzheimers Association; Fund for Scientific Research Flanders; KULeuven (Geconcerteerde onderzoeksacties); Federal Office for Scientific Affairs, Belgium; Flemish Government [Methusalem]; MEMOSAD of the European Union [F2-2007-200611]; NIH [P01AG015379, R01AG026593, AG026593, AG 13579]; NATIONAL INSTITUTE ON AGING [R01AG026593, P01AG015379] Funding Source: NIH RePORTER	Alzheimers Association(Alzheimer's Association); Fund for Scientific Research Flanders(FWO); KULeuven (Geconcerteerde onderzoeksacties)(KU Leuven); Federal Office for Scientific Affairs, Belgium; Flemish Government(European Commission); MEMOSAD of the European Union; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank C. Peeters for assistance in pathological evaluations, C. Mathieu for FACS analysis, L. Van Aerschot for assistance with behavioral testing, S. Terclavers and H. Schieb for technical assistance, and A. Thathiah for proofreading the manuscript. This work was supported by a Pioneer award from the Alzheimers Association; the Fund for Scientific Research Flanders (to R.D. and B.D.S.); KULeuven (Geconcerteerde onderzoeksacties); Federal Office for Scientific Affairs, Belgium; a Methusalem grant of the Flemish Government; MEMOSAD (F2-2007-200611) of the European Union; and NIH grants P01AG015379, R01AG026593, and AG026593 (to B.T.H.) and NIH AG 13579 (to B.T.H. and O.B.). B.D.S. is a paid consultant for Eli Lilly and Envivo Pharmaceuticals; B.T.H. is a paid consultant for Elan, Genentech, Pfizer, Takeda, Link, and Neurophage.	Berezovska O, 2005, J NEUROSCI, V25, P3009, DOI 10.1523/JNEUROSCI.0364-05.2005; Choi SH, 2007, J NEUROSCI, V27, P13579, DOI 10.1523/JNEUROSCI.4821-07.2007; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Dejaegere T, 2008, P NATL ACAD SCI USA, V105, P9775, DOI 10.1073/pnas.0800507105; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hebert SS, 2004, NEUROBIOL DIS, V17, P260, DOI 10.1016/j.nbd.2004.08.002; Hollingworth P, 2006, J AM GERIATR SOC, V54, P1348, DOI 10.1111/j.1532-5415.2006.00854.x; HSIAO KK, 1995, NEURON, V15, P1203, DOI 10.1016/0896-6273(95)90107-8; Kawai T, 2005, NEUROSCI LETT, V380, P17, DOI 10.1016/j.neulet.2005.01.005; King DL, 2002, PHYSIOL BEHAV, V75, P627, DOI 10.1016/S0031-9384(02)00639-X; Li T, 2007, J NEUROSCI, V27, P10849, DOI 10.1523/JNEUROSCI.2152-07.2007; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Ma GJ, 2005, J NEUROSCI, V25, P192, DOI 10.1523/JNEUROSCI.3814-04.2005; Pugh PL, 2007, BEHAV BRAIN RES, V178, P18, DOI 10.1016/j.bbr.2006.11.044; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Savonenko AV, 2008, P NATL ACAD SCI USA, V105, P5585, DOI 10.1073/pnas.0710373105; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Serneels L, 2005, P NATL ACAD SCI USA, V102, P1719, DOI 10.1073/pnas.0408901102; Shirotani K, 2004, J BIOL CHEM, V279, P41340, DOI 10.1074/jbc.M405768200; Shirotani K, 2007, NEUROBIOL DIS, V27, P102, DOI 10.1016/j.nbd.2007.04.011; Sivere JT, 2008, GASTROENTEROLOGY, V134, P544, DOI 10.1053/j.gastro.2007.11.003; Tournoy J, 2004, HUM MOL GENET, V13, P1321, DOI 10.1093/hmg/ddh151; Wong GT, 2004, J BIOL CHEM, V279, P12876, DOI 10.1074/jbc.M311652200	24	194	209	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 1	2009	324	5927					639	642		10.1126/science.1171176	http://dx.doi.org/10.1126/science.1171176			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439DW	19299585	Green Accepted			2022-12-01	WOS:000265608800043
J	Watanabe, Y; Farquhar, J; Ohmoto, H				Watanabe, Yumiko; Farquhar, James; Ohmoto, Hiroshi			Anomalous Fractionations of Sulfur Isotopes During Thermochemical Sulfate Reduction	SCIENCE			English	Article							RISE; SEDIMENTS; BACTERIAL; EVOLUTION; SULFITE	Anomalously fractionated sulfur isotopes in many sedimentary rocks older than 2.4 billion years have been widely believed to be the products of ultraviolet photolysis of volcanic sulfur dioxide in an anoxic atmosphere. Our laboratory experiments have revealed that reduced-sulfur species produced by reactions between powders of amino acids and sulfate at 150 to 200 C possess anomalously fractionated sulfur isotopes: Delta S-33 = +0.1 to +2.1 per mil and Delta S-36 = -1.1 to +1.1 per mil. These results suggest that reactions between organic matter in sediments and sulfate-rich hydrothermal solutions may have produced anomalous sulfur isotope signatures in some sedimentary rocks. If so, the sulfur isotope record of sedimentary rocks may be linked to the biological and thermal evolution of Earth in ways different than previously thought.	[Watanabe, Yumiko; Ohmoto, Hiroshi] Penn State Univ, NASA Astrobiol Inst, University Pk, PA 16802 USA; [Watanabe, Yumiko; Ohmoto, Hiroshi] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; [Farquhar, James] Univ Maryland, Dept Geol, Coll Med, College Pk, MD 20742 USA; [Farquhar, James] Univ Maryland, Earth Syst Sci Interdisciplinary Ctr, Coll Med, College Pk, MD 20742 USA	National Aeronautics & Space Administration (NASA); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Watanabe, Y (corresponding author), Penn State Univ, NASA Astrobiol Inst, University Pk, PA 16802 USA.	yumiko@geosc.psu.edu			NASA Astrobiology Institute [CA#NNA04CC06A, CA#NNG04GK00G]; NASA Exobiology Program; NSF [EAR-0229556]	NASA Astrobiology Institute; NASA Exobiology Program(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF))	We are grateful to H. Naraoka for the suggestion to use amino acids in SO42 reduction and for discussions. We thank D. Walizer, H. Hamasaki, A. Klarke, B. Wing, A. L. Masterson, and S.-T. Kim for technical assistance; A. C. Lasaga, T. Otake, S. R. Poulson, and I. Johnson for discussions and review of an earlier manuscript; and three anonymous reviewers for useful comments. This study was supported by grants to H.O. from the NASA Astrobiology Institute (CA#NNA04CC06A), NASA Exobiology Program (CA#NNG04GK00G), and NSF (EAR-0229556).	Bekker A, 2004, NATURE, V427, P117, DOI 10.1038/nature02260; Buchachenko AL, 2000, PURE APPL CHEM, V72, P2243, DOI 10.1351/pac200072122243; CANFIELD DE, 1986, CHEM GEOL, V54, P149, DOI 10.1016/0009-2541(86)90078-1; Farquhar J, 2000, SCIENCE, V289, P756, DOI 10.1126/science.289.5480.756; Farquhar J, 2003, EARTH PLANET SC LETT, V213, P1, DOI 10.1016/S0012-821X(03)00296-6; Farquhar J, 2001, J GEOPHYS RES-PLANET, V106, P32829, DOI 10.1029/2000JE001437; Farquhar J, 2007, NATURE, V449, P706, DOI 10.1038/nature06202; Goldhaber MB, 1995, ACS SYM SER, V612, P412; HULSTON JR, 1965, J GEOPHYS RES, V70, P3475, DOI 10.1029/JZ070i014p03475; Hunt J.M., 1996, PETROLEUM GEOLOGY GE; Johnston DT, 2005, AM J SCI, V305, P645, DOI 10.2475/ajs.305.6-8.645; Kasting JF, 2001, SCIENCE, V293, P819, DOI 10.1126/science.1063811; Kaufman AJ, 2007, SCIENCE, V317, P1900, DOI 10.1126/science.1138700; KEMP ALW, 1968, GEOCHIM COSMOCHIM AC, V32, P71, DOI 10.1016/0016-7037(68)90088-4; Knoll AH, 2003, GEOBIOLOGY, V1, P3, DOI 10.1046/j.1472-4669.2003.00002.x; Lasaga AC, 2008, EARTH PLANET SC LETT, V268, P225, DOI 10.1016/j.epsl.2008.01.016; Libes S.M., 1992, INTRO MARINE BIOGEOC; Machel HG, 2001, SEDIMENT GEOL, V140, P143, DOI 10.1016/S0037-0738(00)00176-7; Madigan M.T., 2000, BROCK BIOL MICROORGA, V9th ed., P29; Mojzsis SJ, 2003, GEOCHIM COSMOCHIM AC, V67, P1635, DOI 10.1016/S0016-7037(03)00059-0; Ohmoto H., 1997, GEOCHEMISTRY HYDROTH, P517; Ohmoto H, 2006, GEOL SOC AM MEM, V198, P291, DOI 10.1130/2006.1198(17); Ohmoto H, 2006, NATURE, V442, P908, DOI 10.1038/nature05044; Ono S, 2003, EARTH PLANET SC LETT, V213, P15, DOI 10.1016/S0012-821X(03)00295-4; Otake T, 2008, CHEM GEOL, V249, P357, DOI 10.1016/j.chemgeo.2008.01.020; Papineau D, 2007, EARTH PLANET SC LETT, V255, P188, DOI 10.1016/j.epsl.2006.12.015; Sasaki A., 1979, CHISHITSU CHOSAJO GE, V30, P241; SKYRING GW, 1982, PRECAMBRIAN RES, V17, P41, DOI 10.1016/0301-9268(82)90153-X; Strauss H., 1992, PROTEROZOIC BIOSPHER, P709; Watanabe K, 1997, GEOCHIM COSMOCHIM AC, V61, P3441	30	115	118	5	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2009	324	5925					370	373		10.1126/science.1169289	http://dx.doi.org/10.1126/science.1169289			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433QT	19372427				2022-12-01	WOS:000265221600037
J	Sancho, D; Joffre, OP; Keller, AM; Rogers, NC; Martinez, D; Hernanz-Falcon, P; Rosewell, I; Sousa, CRE				Sancho, David; Joffre, Olivier P.; Keller, Anna M.; Rogers, Neil C.; Martinez, Dolores; Hernanz-Falcon, Patricia; Rosewell, Ian; Reis e Sousa, Caetano			Identification of a dendritic cell receptor that couples sensing of necrosis to immunity	NATURE			English	Article							ACTIVATION; ADJUVANTS; DANGER; CLEC9A; DEATH	Injury or impaired clearance of apoptotic cells leads to the pathological accumulation of necrotic corpses, which induce an inflammatory response that initiates tissue repair(1). In addition, antigens present in necrotic cells can sometimes provoke a specific immune response(2-4) and it has been argued that necrosis could explain adaptive immunity in seemingly infection-free situations, such as after allograft transplantation or in spontaneous and therapy-induced tumour rejection(5,6). In the mouse, the CD8 alpha(+) subset of dendritic cells phagocytoses dead cell remnants and cross-primes CD8(+) T cells against cell-associated antigens(7). Here we show that CD8 alpha(+) dendritic cells use CLEC9A (also known as DNGR-1), a recently-characterized C-type lectin(8-10), to recognize a preformed signal that is exposed on necrotic cells. Loss or blockade of CLEC9A does not impair the uptake of necrotic cell material by CD8 alpha(+) dendritic cells, but specifically reduces cross-presentation of dead-cell-associated antigens in vitro and decreases the immunogenicity of necrotic cells in vivo. The function of CLEC9A requires a key tyrosine residue in its intracellular tail that allows the recruitment and activation of the tyrosine kinase SYK, which is also essential for cross-presentation of dead-cell-associated antigens. Thus, CLEC9A functions as a SYK-coupled C-type lectin receptor to mediate sensing of necrosis by the principal dendritic-cell subset involved in regulating cross-priming to cell-associated antigens.	[Sancho, David; Joffre, Olivier P.; Keller, Anna M.; Rogers, Neil C.; Hernanz-Falcon, Patricia; Reis e Sousa, Caetano] Lincolns Inn Fields Labs, Immunobiol Lab, London WC2A 3PX, England; [Sancho, David; Joffre, Olivier P.; Keller, Anna M.; Rogers, Neil C.; Hernanz-Falcon, Patricia; Reis e Sousa, Caetano] Lincolns Inn Fields Labs, London Res Inst, Canc Res UK, FACS Lab, London WC2A 3PX, England; [Martinez, Dolores; Rosewell, Ian] Imperial Canc Res Fund, Clare Hall Labs, Canc Res UK, Trangen Serv, Potters Bar EN6 3LD, Herts, England	Cancer Research UK; Cancer Research UK	Sousa, CRE (corresponding author), Lincolns Inn Fields Labs, Immunobiol Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	caetano@cancer.org.uk	Joffre, Olivier P/K-1235-2014; Sancho, David/D-3433-2009; Reis e Sousa, Caetano/ABD-7322-2021; Reis e Sousa, Caetano/O-1657-2014; Martinez, Lola/ABG-2474-2020; Martinez, Lola/L-2308-2014	Joffre, Olivier P/0000-0003-1168-8165; Sancho, David/0000-0003-2890-3984; Reis e Sousa, Caetano/0000-0001-7392-2119; Reis e Sousa, Caetano/0000-0001-7392-2119; Martinez, Lola/0000-0001-6273-6724; Rogers, Neil/0000-0001-8977-7585	Cancer Research UK; EMBO [ALTF 336-2004]; European Community [MEIF-CT-2005-009205]	Cancer Research UK(Cancer Research UK); EMBO(European Molecular Biology Organization (EMBO)); European Community(European Commission)	This work was funded by Cancer Research UK. D. S. was supported by an EMBO long-term fellowship (ALTF 336-2004) and by a Marie Curie Intra-European Fellowship within the sixth European Community Framework Programme (MEIF-CT-2005-009205). We thank E. Schweighoffer and V. Tybulewicz for fetal liver from Syk<SUP>-/-</SUP> embryos. We also thank N. Shastri for B3Z and BWZ cell lines and A. Eddaoudi for assistance with cell sorting. We are grateful to members of the Immunobiology Laboratory, Cancer Research UK, for advice and discussions and the Biological Resources staff for animal care and assistance with mouse experiments.	Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Burgdorf S, 2007, SCIENCE, V316, P612, DOI 10.1126/science.1137971; Caminschi I, 2008, BLOOD, V112, P3264, DOI 10.1182/blood-2008-05-155176; Casares N, 2005, J EXP MED, V202, P1691, DOI 10.1084/jem.20050915; Cavassani KA, 2008, J EXP MED, V205, P2609, DOI 10.1084/jem.20081370; Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200; Huysamen C, 2008, J BIOL CHEM, V283, P16693, DOI 10.1074/jbc.M709923200; Janssen E, 2006, IMMUNITY, V24, P787, DOI 10.1016/j.immuni.2006.03.024; KARTTUNEN J, 1992, P NATL ACAD SCI USA, V89, P6020, DOI 10.1073/pnas.89.13.6020; Kim HS, 2007, IMMUNITY, V27, P321, DOI 10.1016/j.immuni.2007.06.010; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; LeibundGut-Landmann S, 2008, BLOOD, V112, P4971, DOI 10.1182/blood-2008-05-158469; Mahnke K, 2000, J CELL BIOL, V151, P673, DOI 10.1083/jcb.151.3.673; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Naik SH, 2005, J IMMUNOL, V174, P6592, DOI 10.4049/jimmunol.174.11.6592; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Robinson MJ, 2006, NAT IMMUNOL, V7, P1258, DOI 10.1038/ni1417; Rock KL, 2008, ANNU REV PATHOL-MECH, V3, P99, DOI 10.1146/annurev.pathmechdis.3.121806.151456; Sancho D, 2008, J CLIN INVEST, V118, P2098, DOI 10.1172/JCI34584; Sauter B, 2000, J EXP MED, V191, P423, DOI 10.1084/jem.191.3.423; Shi Y, 2000, P NATL ACAD SCI USA, V97, P14590, DOI 10.1073/pnas.260497597; Villadangos JA, 2007, NAT REV IMMUNOL, V7, P543, DOI 10.1038/nri2103; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651; Ziegenfuss JS, 2008, NATURE, V453, P935, DOI 10.1038/nature06901	26	500	522	4	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 16	2009	458	7240					899	903		10.1038/nature07750	http://dx.doi.org/10.1038/nature07750			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433CS	19219027	Green Accepted			2022-12-01	WOS:000265182500045
J	Kiatpongsan, S; Sipp, D				Kiatpongsan, Sorapop; Sipp, Douglas			Monitoring and Regulating Offshore Stem Cell Clinics	SCIENCE			English	Editorial Material									[Sipp, Douglas] RIKEN, Ctr Dev Biol, Kobe, Hyogo 6500047, Japan; [Kiatpongsan, Sorapop] Chulalongkorn Univ, Fac Med, Dept Obstet & Gynecol, Bangkok 10330, Thailand; [Kiatpongsan, Sorapop] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Vincent Obstet & Gynecol Serv,Vincent Ctr Reprod, Boston, MA 02114 USA; [Kiatpongsan, Sorapop] Harvard Univ, John F Kennedy Sch Govt, Sci Technol & Publ Policy Program, Sci Technol & Globalizat Project,Belfer Ctr Sci &, Cambridge, MA 02138 USA; [Sipp, Douglas] Kyoto Univ, Ctr iPS Res & Applicat, Inst Integrated Cell Mat Sci, Kyoto 6068501, Japan	RIKEN; Chulalongkorn University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Kyoto University	Sipp, D (corresponding author), RIKEN, Ctr Dev Biol, Kobe, Hyogo 6500047, Japan.	sipp@cdb.riken.jp	Sipp, Doug/C-9218-2017; Kiatpongsan, Sorapop/ABG-7845-2021	Sipp, Doug/0000-0002-5979-0938; 				Amariglio N, 2009, PLOS MED, V6, P221, DOI 10.1371/journal.pmed.1000029; Arom Kitipan V, 2008, Asian Cardiovasc Thorac Ann, V16, P143; BOSELEY S, 2006, GUARDIAN        0501; DU J, 2005, STEM CELL MISSION CH; EBBIN M, 2007, BERMUDA SUN     0914; EINHORN B, 2005, BUSINESS WEEK   0110, P34; Enserink M, 2006, SCIENCE, V313, P160, DOI 10.1126/science.313.5784.160; Halme DG, 2006, NEW ENGL J MED, V355, P1730, DOI 10.1056/NEJMhpr063086; International Society for Stem Cell Research, 2008, GUID CLIN TRANSL STE; *JUV DIAB RES FDN, PART CLIN TRIAL; Lau D, 2008, CELL STEM CELL, V3, P591, DOI 10.1016/j.stem.2008.11.001; ONO D, 2007, KABC TV NEWS; Porat Y, 2006, BRIT J HAEMATOL, V135, P703, DOI 10.1111/j.1365-2141.2006.06344.x; PRENTICE D, 2004, MONITORING STEM CELL; PRICE S, 2007, NATION NEWS BAR 1126; SIPP D, 2007, STEM CELL REPORT, V2, P62; STEELE J, 2007, VESCELL ADULT S 1219; *US FTC, FREQ ASK ADV QUEST G; Zarembo A., 2005, LOS ANGELES TIM 0220; 2008, ROYAL GAZETTE   0818; 2008, BANGKOK POST    0622	21	76	77	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 20	2009	323	5921					1564	1565		10.1126/science.1168451	http://dx.doi.org/10.1126/science.1168451			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421EN	19299604				2022-12-01	WOS:000264342300022
J	Wollert, T; Wunder, C; Lippincott-Schwartz, J; Hurley, JH				Wollert, Thomas; Wunder, Christian; Lippincott-Schwartz, Jennifer; Hurley, James H.			Membrane scission by the ESCRT-III complex	NATURE			English	Article							MULTIVESICULAR ENDOSOMES; STRUCTURAL BASIS; CELL-DIVISION; PROTEINS; VPS4; RECOGNITION; BIOGENESIS; MACHINERY; HIV-1; ALIX	The endosomal sorting complex required for transport (ESCRT) system is essential for multivesicular body biogenesis, in which cargo sorting is coupled to the invagination and scission of intralumenal vesicles. The ESCRTs are also needed for budding of enveloped viruses including human immunodeficiency virus 1, and for membrane abscission in cytokinesis. In Saccharomyces cerevisiae, ESCRT-III consists of Vps20, Snf7, Vps24 and Vps2 (also known as Did4), which assemble in that order and require the ATPase Vps4 for their disassembly. In this study, the ESCRT-III-dependent budding and scission of intralumenal vesicles into giant unilamellar vesicles was reconstituted and visualized by fluorescence microscopy. Here we show that three subunits of ESCRT-III, Vps20, Snf7 and Vps24, are sufficient to detach intralumenal vesicles. Vps2, the ESCRT-III subunit responsible for recruiting Vps4, and the ATPase activity of Vps4 were required for ESCRT-III recycling and supported additional rounds of budding. The minimum set of ESCRT-III and Vps4 proteins capable of multiple cycles of vesicle detachment corresponds to the ancient set of ESCRT proteins conserved from archaea to animals.	[Wollert, Thomas; Hurley, James H.] NIDDK, Mol Biol Lab, Bethesda, MD 20892 USA; [Wunder, Christian; Lippincott-Schwartz, Jennifer] NICHHD, Cell Biol & Metab Branch, NIH, US Dept HHS, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Hurley, JH (corresponding author), NIDDK, Mol Biol Lab, Bethesda, MD 20892 USA.	hurley@helix.nih.gov	Wunder, Christian/K-8542-2017	Wunder, Christian/0000-0001-9091-0080; Wollert, Thomas/0000-0001-9732-4789	Intramural NIH HHS [Z01 DK036123-01] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZICHD008874, ZIAHD001609] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK036123, ZIADK036123, ZIADK036125] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANGELOVA MI, 1986, FARADAY DISCUSS, V81, P303, DOI 10.1039/dc9868100303; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4; Bieniasz PD, 2006, VIROLOGY, V344, P55, DOI 10.1016/j.virol.2005.09.044; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; EVANS WH, 1985, BIOCHEM J, V232, P33, DOI 10.1042/bj2320033; Fujii K, 2007, NAT REV MICROBIOL, V5, P912, DOI 10.1038/nrmicro1790; Ghazi-Tabatabai S, 2008, STRUCTURE, V16, P1345, DOI 10.1016/j.str.2008.06.010; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Hanson PI, 2008, J CELL BIOL, V180, P389, DOI 10.1083/jcb.200707031; Hinshaw JE, 2000, ANNU REV CELL DEV BI, V16, P483, DOI 10.1146/annurev.cellbio.16.1.483; Hurley JH, 2008, CURR OPIN CELL BIOL, V20, P4, DOI 10.1016/j.ceb.2007.12.002; Kieffer C, 2008, DEV CELL, V15, P62, DOI 10.1016/j.devcel.2008.05.014; Kobayashi T, 2002, J BIOL CHEM, V277, P32157, DOI 10.1074/jbc.M202838200; Kostelansky MS, 2007, CELL, V129, P485, DOI 10.1016/j.cell.2007.03.016; Lata S, 2008, SCIENCE, V321, P1354, DOI 10.1126/science.1161070; Lindas AC, 2008, P NATL ACAD SCI USA, V105, P18942, DOI 10.1073/pnas.0809467105; Matsuo H, 2004, SCIENCE, V303, P531, DOI 10.1126/science.1092425; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; Muziol T, 2006, DEV CELL, V10, P821, DOI 10.1016/j.devcel.2006.03.013; Nickerson Daniel P, 2006, J Cell Biol, V175, P715, DOI 10.1083/jcb.200606113; Obita T, 2007, NATURE, V449, P735, DOI 10.1038/nature06171; Piper RC, 2007, ANNU REV CELL DEV BI, V23, P519, DOI 10.1146/annurev.cellbio.23.090506.123319; Romer W, 2007, NATURE, V450, P670, DOI 10.1038/nature05996; Russell MRG, 2006, CURR OPIN CELL BIOL, V18, P422, DOI 10.1016/j.ceb.2006.06.002; Saksena S, 2007, TRENDS BIOCHEM SCI, V32, P561, DOI 10.1016/j.tibs.2007.09.010; Samson RY, 2008, SCIENCE, V322, P1710, DOI 10.1126/science.1165322; Sens P, 2008, CURR OPIN CELL BIOL, V20, P476, DOI 10.1016/j.ceb.2008.04.004; Shim S, 2007, TRAFFIC, V8, P1068, DOI 10.1111/j.1600-0854.2007.00584.x; Slagsvold T, 2006, TRENDS CELL BIOL, V16, P317, DOI 10.1016/j.tcb.2006.04.004; Stuchell-Brereton MD, 2007, NATURE, V449, P740, DOI 10.1038/nature06172; Teis D, 2008, DEV CELL, V15, P578, DOI 10.1016/j.devcel.2008.08.013; Teo H, 2004, DEV CELL, V7, P559, DOI 10.1016/j.devcel.2004.09.003; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Zamborlini A, 2006, P NATL ACAD SCI USA, V103, P19140, DOI 10.1073/pnas.0603788103	38	431	437	1	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 12	2009	458	7235					172	U2		10.1038/nature07836	http://dx.doi.org/10.1038/nature07836			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417EQ	19234443	Green Accepted			2022-12-01	WOS:000264059700036
J	Epstein, SS				Epstein, Slava S.			Microbial awakenings	NATURE			English	Editorial Material									Northeastern Univ, Dept Biol, Boston, MA 02115 USA	Northeastern University	Epstein, SS (corresponding author), Northeastern Univ, Dept Biol, Boston, MA 02115 USA.	s.epstein@neu.edu							0	121	123	1	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 26	2009	457	7233					1083	1083		10.1038/4571083a	http://dx.doi.org/10.1038/4571083a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411VI	19242455				2022-12-01	WOS:000263680100020
J	Cam, HP; Chen, ES; Grewal, SIS				Cam, Hugh P.; Chen, Ee Sin; Grewal, Shiv I. S.			Transcriptional Scaffolds for Heterochromatin Assembly	CELL			English	Article							RNA; CHROMATIN; COMPLEX; GENES; ROLES	Heterochromatin is dynamically regulated during the cell cycle and in response to developmental signals. Recent findings from diverse systems suggest an extensive role for transcription in the assembly of heterochromatin, highlighting the emerging theme that transcription and noncoding RNAs can provide the initial scaffold for the formation of heterochromatin, which serves as a versatile recruiting platform for diverse factors involved in many cellular processes.	[Cam, Hugh P.; Chen, Ee Sin; Grewal, Shiv I. S.] NCI, Biochem & Mol Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Grewal, SIS (corresponding author), NCI, Biochem & Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	grewals@mail.nih.gov		Grewal, Shiv/0000-0002-4552-9261	NATIONAL CANCER INSTITUTE [Z01BC010523, ZIABC010523, ZIABC011208] Funding Source: NIH RePORTER; Intramural NIH HHS [ZIA BC011208-04, Z01 BC010523-05, Z01 BC010523-04, ZIA BC011208-05, Z99 CA999999] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Bayne EH, 2008, SCIENCE, V322, P602, DOI 10.1126/science.1164029; Buhler M, 2007, NAT STRUCT MOL BIOL, V14, P1041, DOI 10.1038/nsmb1315; Chen ES, 2008, NATURE, V451, P734, DOI 10.1038/nature06561; Djupedal I, 2005, GENE DEV, V19, P2301, DOI 10.1101/gad.344205; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Gullerova M, 2008, CELL, V132, P983, DOI 10.1016/j.cell.2008.02.040; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; Kloc A, 2008, CURR BIOL, V18, P490, DOI 10.1016/j.cub.2008.03.016; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lu J, 2007, J CELL BIOL, V179, P411, DOI 10.1083/jcb.200706176; Mochizuki K, 2004, CURR OPIN GENET DEV, V14, P181, DOI 10.1016/j.gde.2004.01.004; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Nagano T, 2008, SCIENCE, V322, P1717, DOI 10.1126/science.1163802; Nicolas E, 2007, NAT STRUCT MOL BIOL, V14, P372, DOI 10.1038/nsmb1239; Pandey RR, 2008, MOL CELL, V32, P232, DOI 10.1016/j.molcel.2008.08.022; Quivy JP, 2004, EMBO J, V23, P3516, DOI 10.1038/sj.emboj.7600362; Sugiyama T, 2007, CELL, V128, P491, DOI 10.1016/j.cell.2006.12.035; Wierzbicki AT, 2008, CELL, V135, P635, DOI 10.1016/j.cell.2008.09.035; Zhang K, 2008, NAT STRUCT MOL BIOL, V15, P381, DOI 10.1038/nsmb.1406; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045	20	58	60	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 20	2009	136	4					610	614		10.1016/j.cell.2009.02.004	http://dx.doi.org/10.1016/j.cell.2009.02.004			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	411XX	19239883	Bronze, Green Accepted			2022-12-01	WOS:000263688200013
J	Ricardo, S; Lehmann, R				Ricardo, Sara; Lehmann, Ruth			An ABC Transporter Controls Export of a Drosophila Germ Cell Attractant	SCIENCE			English	Article							GENE ENCODES; A-FACTOR; P-GLYCOPROTEIN; MELANOGASTER; PROTEOLYSIS; SECRETION; MIGRATION; RAS; RHO	Directed cell migration, which is critical for embryonic development, leukocyte trafficking, and cell metastasis, depends on chemoattraction. 3-hydroxy-3-methylglutaryl coenzyme A reductase regulates the production of an attractant for Drosophila germ cells that may itself be geranylated. Chemoattractants are commonly secreted through a classical, signal peptide- dependent pathway, but a geranyl- modified attractant would require an alternative pathway. In budding yeast, pheromones produced by a-cells are farnesylated and secreted in a signal peptide- independent manner, requiring the adenosine triphosphate- binding cassette ( ABC) transporter Ste6p. Here we show that Drosophila germ cell migration uses a similar pathway, demonstrating that invertebrate germ cells, like yeast cells, are attracted to lipid- modified peptides. Components of this unconventional export pathway are highly conserved, suggesting that this pathway may control the production of similarly modified chemoattractants in organisms ranging from yeast to humans.	[Ricardo, Sara; Lehmann, Ruth] NYU, Helen L & Martin S Kimmel Ctr Biol & Med, Howard Hughes Med Inst, Sch Med,Skirball Inst,Dept Cell Biol, New York, NY 10016 USA	Howard Hughes Medical Institute; New York University	Lehmann, R (corresponding author), NYU, Helen L & Martin S Kimmel Ctr Biol & Med, Howard Hughes Med Inst, Sch Med,Skirball Inst,Dept Cell Biol, 550 1st Ave, New York, NY 10016 USA.	lehmann@saturn.med.nyu.edu	Ricardo, Sara/I-1653-2015	Lehmann, Ruth/0000-0002-8454-5651; Ricardo, Sara/0000-0002-8605-2500	NIH [HD49100]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD041900] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K12HD049100] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank P. Lopez and G. de la Cruz for FACS sorting; S. Michaelis for reagents and discussions; J. Treisman, Blomington stock center, and the Drosophila Genomics Resource Center for fly lines and reagents; the Lehmann Lab; and D. Siekhaus and S. Burden for comments on the manuscript. This work was supported by NIH grant HD49100. S. R. is a HHMI research associate; R. L. is an HHMI investigator and a member of the Kimmel Stem Cell Center.	Bard F, 2006, NATURE, V439, P604, DOI 10.1038/nature04377; Boyartchuk VL, 1997, SCIENCE, V275, P1796, DOI 10.1126/science.275.5307.1796; Christensen PU, 1997, MOL GEN GENET, V255, P226, DOI 10.1007/s004380050493; Dean M, 2001, J LIPID RES, V42, P1007; ECHALIER G, 1969, CR ACAD SCI D NAT, V268, P1771; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cellbio.8.1.67; HRYCYNA CA, 1991, EMBO J, V10, P1699, DOI 10.1002/j.1460-2075.1991.tb07694.x; Johndrow JE, 2004, BIOCHEM CELL BIOL, V82, P643, DOI 10.1139/O04-118; Leung GK, 2001, J BIOL CHEM, V276, P29051, DOI 10.1074/jbc.M102908200; Magie CR, 1999, DEVELOPMENT, V126, P5353; MCGRATH JP, 1989, NATURE, V340, P400, DOI 10.1038/340400a0; RAYMOND M, 1992, SCIENCE, V256, P232, DOI 10.1126/science.1348873; RONINSON IB, 1986, P NATL ACAD SCI USA, V83, P4538, DOI 10.1073/pnas.83.12.4538; Sano H, 2005, J CELL BIOL, V171, P675, DOI 10.1083/jcb.200506038; Santos AC, 2004, CURR BIOL, V14, pR578, DOI 10.1016/j.cub.2004.07.018; Schinkel AH, 1997, SEMIN CANCER BIOL, V8, P161, DOI 10.1006/scbi.1997.0068; Settleman J, 2001, DEV CELL, V1, P321, DOI 10.1016/S1534-5807(01)00053-3; SMIT JJM, 1993, CELL, V75, P451, DOI 10.1016/0092-8674(93)90380-9; Tam A, 1998, J CELL BIOL, V142, P635, DOI 10.1083/jcb.142.3.635; Van Doren M, 1998, NATURE, V396, P466, DOI 10.1038/24871; Winter-Vann AM, 2005, NAT REV CANCER, V5, P405, DOI 10.1038/nrc1612	21	83	84	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 13	2009	323	5916					943	946		10.1126/science.1166239	http://dx.doi.org/10.1126/science.1166239			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406KW	19213920	Green Accepted			2022-12-01	WOS:000263295400045
J	Wang, RH; Farrona, S; Vincent, C; Joecker, A; Schoof, H; Turck, F; Alonso-Blanco, C; Coupland, G; Albani, MC				Wang, Renhou; Farrona, Sara; Vincent, Coral; Joecker, Anika; Schoof, Heiko; Turck, Franziska; Alonso-Blanco, Carlos; Coupland, George; Albani, Maria C.			PEP1 regulates perennial flowering in Arabis alpina	NATURE			English	Article							ARABIDOPSIS-THALIANA; VERNALIZATION; GENE; FLC; PROTEIN; EVOLUTION; REPRESSOR; TRIMETHYLATION; BRASSICACEAE; METHYLATION	Annual plants complete their life cycle in one year and initiate flowering only once, whereas perennials live for many years and flower repeatedly. How perennials undergo repeated cycles of vegetative growth and flowering that are synchronized to the changing seasons has not been extensively studied(1). Flowering is best understood in annual Arabidopsis thaliana 2,3, but many closely related species, such as Arabis alpina(4,5), are perennials. We identified the A. alpina mutant perpetual flowering 1 (pep1), and showed that PEP1 contributes to three perennial traits. It limits the duration of flowering, facilitating a return to vegetative development, prevents some branches from undergoing the floral transition allowing polycarpic growth habit, and confers a flowering response to winter temperatures that restricts flowering to spring. Here we show that PEP1 is the orthologue of the A. thaliana gene FLOWERING LOCUS C (FLC). The FLC transcription factor inhibits flowering until A. thaliana is exposed to winter temperatures(6,7), which trigger chromatin modifications that stably repress FLC transcription(8-11). In contrast, PEP1 is only transiently repressed by low temperatures, causing repeated seasonal cycles of repression and activation of PEP1 transcription that allow it to carry out functions characteristic of the cyclical life history of perennials. The patterns of chromatin modifications at FLC and PEP1 differ correlating with their distinct expression patterns. Thus we describe a critical mechanism by which flowering regulation differs between related perennial and annual species, and propose that differences in chromatin regulation contribute to this variation.	[Wang, Renhou; Farrona, Sara; Vincent, Coral; Joecker, Anika; Schoof, Heiko; Turck, Franziska; Coupland, George; Albani, Maria C.] Max Planck Inst Plant Breeding Res, D-50829 Cologne, Germany; [Alonso-Blanco, Carlos] CSIC, Ctr Nacl Biotecnol, Dept Genet Mol Plantas, E-28049 Madrid, Spain	Max Planck Society; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Coupland, G (corresponding author), Max Planck Inst Plant Breeding Res, Carl von Linne Weg 10, D-50829 Cologne, Germany.	coupland@mpiz-koeln.mpg.de; albani@mpiz-koeln.mpg.de	Turck, Franziska/G-1240-2013; Schoof, Heiko/Y-7073-2018; Alonso-Blanco, Carlos/F-8864-2016; Coupland, George/AAP-8609-2020	Turck, Franziska/0000-0002-4982-5949; Schoof, Heiko/0000-0002-1527-3752; Alonso-Blanco, Carlos/0000-0002-4738-5556; Coupland, George/0000-0001-6988-4172; Albani, Maria/0000-0002-8215-020X; Farrona, Sara/0000-0002-6855-2237	Max Planck Society	Max Planck Society(Max Planck Society)	The authors would like to thank P. Sharma for growing plants and R. Bruggmann for running the gene prediction pipeline. The laboratories of H. S. and G. C. are partly funded by a core grant from the Max Planck Society.	Ansell SW, 2008, MOL ECOL, V17, P2245, DOI 10.1111/j.1365-294X.2008.03739.x; Apweiler R, 2000, BIOINFORMATICS, V16, P1145, DOI 10.1093/bioinformatics/16.12.1145; Bastow R, 2004, NATURE, V427, P164, DOI 10.1038/nature02269; Battey NH, 2002, CURR OPIN PLANT BIOL, V5, P62, DOI 10.1016/S1369-5266(01)00229-1; Battey NH, 2000, J EXP BOT, V51, P1769, DOI 10.1093/jexbot/51.352.1769; Baurle I, 2006, CELL, V125, P655, DOI 10.1016/j.cell.2006.05.005; Bayraktaroglu L., 2002, GENOME BIOL, V3, DOI DOI 10.1186/GB-2002-3-12-RESEARCH0082; Beilstein MA, 2006, AM J BOT, V93, P607, DOI 10.3732/ajb.93.4.607; Bena G, 1998, P ROY SOC B-BIOL SCI, V265, P1141, DOI 10.1098/rspb.1998.0410; Bohlenius H, 2006, SCIENCE, V312, P1040, DOI 10.1126/science.1126038; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; D'Aloia M, 2008, NEW PHYTOL, V178, P755, DOI 10.1111/j.1469-8137.2008.02404.x; DIOMAIUTO J, 1988, Phytomorphology, V38, P163; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Finnegan EJ, 2007, CURR BIOL, V17, P1978, DOI 10.1016/j.cub.2007.10.026; Foster T, 2003, ANN BOT-LONDON, V92, P199, DOI 10.1093/aob/mcg120; Gendall AR, 2001, CELL, V107, P525, DOI 10.1016/S0092-8674(01)00573-6; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Greb T, 2007, CURR BIOL, V17, P73, DOI 10.1016/j.cub.2006.11.052; Gremme G, 2005, INFORM SOFTWARE TECH, V47, P965, DOI 10.1016/j.infsof.2005.09.005; Hanikenne M, 2008, NATURE, V453, P391, DOI 10.1038/nature06877; Hay A, 2006, NAT GENET, V38, P942, DOI 10.1038/ng1835; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; Koch MA, 2006, MOL ECOL, V15, P825, DOI 10.1111/j.1365-294X.2005.02848.x; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Prud'homme B, 2007, P NATL ACAD SCI USA, V104, P8605, DOI 10.1073/pnas.0700488104; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5467; Schranz ME, 2002, GENETICS, V162, P1457; Schubert D, 2006, EMBO J, V25, P4638, DOI 10.1038/sj.emboj.7601311; Searle I, 2006, GENE DEV, V20, P898, DOI 10.1101/gad.373506; Sheldon CC, 1999, PLANT CELL, V11, P445, DOI 10.1105/tpc.11.3.445; Shindo C, 2006, GENE DEV, V20, P3079, DOI 10.1101/gad.405306; Sung SB, 2004, NATURE, V427, P159, DOI 10.1038/nature02195; Sung SB, 2006, GENE DEV, V20, P3244, DOI 10.1101/gad.1493306; Thomas H, 2000, J EXP BOT, V51, P1781, DOI 10.1093/jexbot/51.352.1781; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; Yan LL, 2004, SCIENCE, V303, P1640, DOI 10.1126/science.1094305	41	263	269	1	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 21	2009	459	7245					423	U138		10.1038/nature07988	http://dx.doi.org/10.1038/nature07988			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448DQ	19369938	Green Published			2022-12-01	WOS:000266243700045
J	Airan, RD; Thompson, KR; Fenno, LE; Bernstein, H; Deisseroth, K				Airan, Raag D.; Thompson, Kimberly R.; Fenno, Lief E.; Bernstein, Hannah; Deisseroth, Karl			Temporally precise in vivo control of intracellular signalling	NATURE			English	Article							ACTIVATION; NUCLEUS; PHOTOSTIMULATION; ADDICTION; RECEPTORS; REVEALS	In the study of complex mammalian behaviours, technological limitations have prevented spatiotemporally precise control over intracellular signalling processes. Here we report the development of a versatile family of genetically encoded optical tools ('optoXRs') that leverage common structure -function relationships(1) among G-protein-coupled receptors (GPCRs) to recruit and control, with high spatiotemporal precision, receptor-initiated biochemical signalling pathways. In particular, we have developed and characterized two optoXRs that selectively recruit distinct, targeted signalling pathways in response to light. The two optoXRs exerted opposing effects on spike firing in nucleus accumbens in vivo, and precisely timed optoXR photostimulation in nucleus accumbens by itself sufficed to drive conditioned place preference in freely moving mice. The optoXR approach allows testing of hypotheses regarding the causal impact of biochemical signalling in behaving mammals, in a targetable and temporally precise manner.	[Airan, Raag D.; Thompson, Kimberly R.; Fenno, Lief E.; Bernstein, Hannah; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA	Stanford University; Stanford University	Deisseroth, K (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	deissero@stanford.edu	Fenno, Lief/AAK-2924-2020; Fenno, Lief/AAF-9638-2019	Airan, Raag/0000-0001-5259-5606; Bernstein, Hannah/0000-0002-6512-1378	NIH/NIMH National Research Service Award; Stanford Medical Scientist Training Program; NARSAD Young Investigator Award; CIRM; McKnight; Coulter; Klingenstein; Keck; NSF; NIDA; NIH Pioneer Award; Albert Yu and Mary Bechmann Foundation; Kinetics Foundation	NIH/NIMH National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Stanford Medical Scientist Training Program; NARSAD Young Investigator Award(NARSAD); CIRM(California Institute for Regenerative Medicine); McKnight; Coulter; Klingenstein(Klingenstein Philanthropies); Keck; NSF(National Science Foundation (NSF)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIH Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Albert Yu and Mary Bechmann Foundation; Kinetics Foundation	We thank B. Kobilka, B. Knutson, M. P. Bokoch, T. Sudhof, R. Malenka and the Deisseroth Laboratory for comments and discussion. We appreciate the gifts of pCNGA2-C460W/E583M from J. W. Karpen, pcDNA3.1-beta<INF>2</INF>AR from B. Kobilka and pDT-alpha<INF>1</INF>AR from C. Hague. We thank T. Jardetzky for use of a Biotek Synergy4 plate reader. R. D. A. is supported by a NIH/NIMH National Research Service Award and the Stanford Medical Scientist Training Program. K. R. T. is supported by a NARSAD Young Investigator Award. K. D. is supported by CIRM, McKnight, Coulter, Klingenstein, Keck, NSF, NIMH, NIDA, the NIH Pioneer Award, the Albert Yu and Mary Bechmann Foundation and the Kinetics Foundation.	Airan RD, 2007, CURR OPIN NEUROBIOL, V17, P587, DOI 10.1016/j.conb.2007.11.003; Azzi M, 2003, P NATL ACAD SCI USA, V100, P11406, DOI 10.1073/pnas.1936664100; Carelli RM, 2004, CURR OPIN NEUROBIOL, V14, P763, DOI 10.1016/j.conb.2004.10.001; COHEN GB, 1993, BIOCHEMISTRY-US, V32, P6111, DOI 10.1021/bi00074a024; Conklin BR, 2008, NAT METHODS, V5, P673, DOI 10.1038/nmeth.1232; Deisseroth K, 2003, CURR OPIN NEUROBIOL, V13, P354, DOI 10.1016/S0959-4388(03)00076-X; Dunn TA, 2006, J NEUROSCI, V26, P12807, DOI 10.1523/JNEUROSCI.3238-06.2006; Furuta T, 1999, P NATL ACAD SCI USA, V96, P1193, DOI 10.1073/pnas.96.4.1193; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Karnik SS, 2003, TRENDS ENDOCRIN MET, V14, P431, DOI 10.1016/j.tem.2003.09.007; Kenakin T, 2007, TRENDS PHARMACOL SCI, V28, P359, DOI 10.1016/j.tips.2007.06.010; Kim JM, 2005, BIOCHEMISTRY-US, V44, P2284, DOI 10.1021/bi048328i; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Lima SQ, 2005, CELL, V121, P141, DOI 10.1016/j.cell.2005.02.004; Oliveira L, 1999, PROTEIN ENG, V12, P1087, DOI 10.1093/protein/12.12.1087; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Pettit DL, 1997, NEURON, V19, P465, DOI 10.1016/S0896-6273(00)80361-X; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Potts JT, 2005, NEUROSCIENCE, V132, P1123, DOI 10.1016/j.neuroscience.2004.12.018; Rich TC, 2001, J GEN PHYSIOL, V118, P63, DOI 10.1085/jgp.118.1.63; Schroder-Lang S, 2007, NAT METHODS, V4, P39, DOI 10.1038/NMETH975; Shukla AK, 2008, P NATL ACAD SCI USA, V105, P9988, DOI 10.1073/pnas.0804246105; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; WHITE FJ, 1986, J NEUROSCI, V6, P274; WILSON CJ, 2003, SYNAPTIC ORG BRAIN, P361; Zemelman BV, 2002, NEURON, V33, P15, DOI 10.1016/S0896-6273(01)00574-8; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936	30	480	534	3	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	2009	458	7241					1025	1029		10.1038/nature07926	http://dx.doi.org/10.1038/nature07926			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436KL	19295515				2022-12-01	WOS:000265412900042
J	Saudek, CD				Saudek, Christopher D.			Can Diabetes Be Cured? Potential Biological and Mechanical Approaches	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ISLET TRANSPLANTATION; BETA-CELLS; MELLITUS; TRIAL; INSULIN		Johns Hopkins Univ, Sch Med, Div Endocrinol & Metab, Baltimore, MD 21287 USA	Johns Hopkins University	Saudek, CD (corresponding author), Johns Hopkins Univ, Sch Med, Div Endocrinol & Metab, Osler 575,700 N Wolfe St, Baltimore, MD 21287 USA.	csaudek@jhu.edu						Bollyky J, 2008, MT SINAI J MED, V75, P385, DOI 10.1002/msj.20054; Bonner-Weir S, 2008, BIOCHEM SOC T, V36, P353, DOI 10.1042/BST0360353; Couri CEB, 2009, JAMA-J AM MED ASSOC, V301, P1573, DOI 10.1001/jama.2009.470; Dixon JB, 2008, JAMA-J AM MED ASSOC, V299, P316, DOI 10.1001/jama.299.3.316; Herold KC, 2002, NEW ENGL J MED, V346, P1692, DOI 10.1056/NEJMoa012864; Mallett AG, 2009, TISSUE ENG PT A, V15, P1301, DOI 10.1089/ten.tea.2008.0118; Resnick HE, 2006, DIABETES CARE, V29, P531, DOI 10.2337/diacare.29.03.06.dc05-1254; Rubino F, 2006, ANN SURG, V244, P741, DOI 10.1097/01.sla.0000224726.61448.1b; Saudek CD, 1996, JAMA-J AM MED ASSOC, V276, P1322, DOI 10.1001/jama.276.16.1322; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Tamborlane WV, 2008, NEW ENGL J MED, V359, P1464, DOI 10.1056/NEJMoa0805017; Waki Kayo, 2007, Clin Transpl, P9; Weinzimer SA, 2008, DIABETES CARE, V31, P934, DOI 10.2337/dc07-1967; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	15	16	16	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 15	2009	301	15					1588	1590		10.1001/jama.2009.508	http://dx.doi.org/10.1001/jama.2009.508			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	432MH	19366779				2022-12-01	WOS:000265137900030
J	Kim, J; Ashenhurst, JA; Movassaghi, M				Kim, Justin; Ashenhurst, James A.; Movassaghi, Mohammad			Total Synthesis of (+)-11,11 '-Dideoxyverticillin A	SCIENCE			English	Article							CONCISE TOTAL-SYNTHESIS; PERMANGANATE; OXIDATION; ACID; EPIDITHIODIOXOPIPERAZINES; BIOSYNTHESIS; CONSTRUCTION; VERTICILLIN; DERIVATIVES; EXPRESSION	The fungal metabolite (+)-11,11'-dideoxyverticillin A, a cytotoxic alkaloid isolated from a marine Penicillium sp., belongs to a fascinating family of densely functionalized, stereochemically complex, and intricate dimeric epidithiodiketopiperazine natural products. Although the dimeric epidithiodiketopiperazines have been known for nearly 4 decades, none has succumbed to total synthesis. We report a concise enantioselective total synthesis of (+)-11,11'- dideoxyverticillin A via a strategy inspired by our biosynthetic hypothesis for this alkaloid. Highly stereo- and chemoselective advanced-stage tetrahydroxylation and tetrathiolation reactions, as well as a mild strategy for the introduction of the epidithiodiketopiperazine core in the final step, were developed to address this highly sensitive substructure. Our rapid functionalization of the advanced molecular framework aims to mimic plausible biosynthetic steps and offers an effective strategy for the chemical synthesis of other members of this family of alkaloids.	[Kim, Justin; Ashenhurst, James A.; Movassaghi, Mohammad] MIT, Dept Chem, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Movassaghi, M (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.	movassag@mit.edu			Amgen; AstraZeneca; Boehringer Ingelheim; GlaxoSmithKline; Merck; Lilly; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089732] Funding Source: NIH RePORTER	Amgen(Amgen); AstraZeneca(AstraZeneca); Boehringer Ingelheim(Boehringer Ingelheim); GlaxoSmithKline(GlaxoSmithKline); Merck(Merck & Company); Lilly(Eli Lilly); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	M.M. is an Alfred P. Sloan Research Fellow and a Beckman Young Investigator. J.K. and J.A.A. acknowledge predoctoral (National Defense Science and Engineering Graduate) and postdoctoral [Fonds quebecois de la recherche sur la nature et les technologies (FQRNT)] fellowships, respectively. We thank P. Muller for assistance with x-ray structures of (+)-1 and (+)-14. We acknowledge generous support from Amgen, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Merck, and Lilly. Structural parameters for (+)-1 and (+)-14 are freely available from the Cambridge Crystallographic Data Centre under CCDC-719219 and CCDC-719218, respectively.	Chen H, 2002, CHEM BIOL, V9, P103, DOI 10.1016/S1074-5521(02)00090-X; Chen Y, 2005, FEBS LETT, V579, P3683, DOI 10.1016/j.febslet.2005.05.053; Chen Y, 2005, BIOCHEM BIOPH RES CO, V329, P1334, DOI 10.1016/j.bbrc.2005.02.115; CUTHBERTSON E, 1975, TETRAHEDRON LETT, V16, P1345; FIROUZABADI H, 1982, TETRAHEDRON LETT, V23, P1847, DOI 10.1016/S0040-4039(00)86758-1; Fox EM, 2008, MYCOL RES, V112, P162, DOI 10.1016/j.mycres.2007.08.017; FUKUYAMA T, 1981, TETRAHEDRON, V37, P2045, DOI 10.1016/S0040-4020(01)97960-8; Gardiner DM, 2005, MICROBIOL-SGM, V151, P1021, DOI 10.1099/mic.0.27847-0; Gardiner DM, 2005, FEMS MICROBIOL LETT, V248, P241, DOI 10.1016/j.femsle.2005.05.046; GARDNER KA, 1995, SCIENCE, V269, P1849, DOI 10.1126/science.7569922; HAUSER D, 1970, HELV CHIM ACTA, V53, P1061, DOI 10.1002/hlca.19700530521; HERSCHEID JDM, 1980, J ORG CHEM, V45, P1880, DOI 10.1021/jo01298a023; KATAGIRI K, 1970, J ANTIBIOT, V23, P420, DOI 10.7164/antibiotics.23.420; KIRBY GW, 1980, BIOSYNTH MYCOTOX, P301; KISHI Y, 1973, J AM CHEM SOC, V95, P6490, DOI 10.1021/ja00800a077; Movassaghi M, 2008, ANGEW CHEM INT EDIT, V47, P1485, DOI 10.1002/anie.200704960; Movassaghi M, 2007, ANGEW CHEM INT EDIT, V46, P3725, DOI 10.1002/anie.200700705; Overman LE, 2007, ORG LETT, V9, P5267, DOI 10.1021/ol702518t; Rauk A, 1999, BIOCHEMISTRY-US, V38, P9089, DOI 10.1021/bi990249x; Ruble JC, 1998, J AM CHEM SOC, V120, P11532, DOI 10.1021/ja982890c; SALA T, 1978, J CHEM SOC CHEM COMM, P253, DOI 10.1039/c39780000253; Schoendorf A, 2001, P NATL ACAD SCI USA, V98, P1501, DOI 10.1073/pnas.98.4.1501; SEEBACH D, 1983, J AM CHEM SOC, V105, P5390, DOI 10.1021/ja00354a034; Son BW, 1999, NAT PROD LETT, V13, P213, DOI 10.1080/10575639908048788; Strassner T, 2000, J AM CHEM SOC, V122, P7821, DOI 10.1021/ja000981f; WILLIAMS RM, 1980, J ORG CHEM, V45, P2625, DOI 10.1021/jo01301a017; WOODWARD RB, 1958, J AM CHEM SOC, V80, P209, DOI 10.1021/ja01534a053; Wu ZC, 2000, ANGEW CHEM INT EDIT, V39, P3866, DOI 10.1002/1521-3773(20001103)39:21<3866::AID-ANIE3866>3.0.CO;2-E; Zhang YX, 2005, ANTI-CANCER DRUG, V16, P515, DOI 10.1097/00001813-200506000-00007	29	250	256	4	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 10	2009	324	5924					238	241		10.1126/science.1170777	http://dx.doi.org/10.1126/science.1170777			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	430WX	19359584	Green Submitted, Green Accepted			2022-12-01	WOS:000265024400043
J	Gao, P; Tchernyshyov, I; Chang, TC; Lee, YS; Kita, K; Ochi, T; Zeller, KI; De Marzo, AM; Van Eyk, JE; Mendell, JT; Dang, CV				Gao, Ping; Tchernyshyov, Irina; Chang, Tsung-Cheng; Lee, Yun-Sil; Kita, Kayoko; Ochi, Takafumi; Zeller, Karen I.; De Marzo, Angelo M.; Van Eyk, Jennifer E.; Mendell, Joshua T.; Dang, Chi V.			c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism	NATURE			English	Article							TUMOR-CELLS; PROTEIN; GROWTH; INHIBITION; APOPTOSIS; DATABASE; GENES; ACID	Altered glucose metabolism in cancer cells is termed the Warburg effect, which describes the propensity of most cancer cells to take up glucose avidly and convert it primarily to lactate, despite available oxygen(1,2). Notwithstanding the renewed interest in the Warburg effect, cancer cells also depend on continued mitochondrial function for metabolism, specifically glutaminolysis that catabolizes glutamine to generate ATP and lactate(3). Glutamine, which is highly transported into proliferating cells(4,5), is a major source of energy and nitrogen for biosynthesis, and a carbon substrate for anabolic processes in cancer cells, but the regulation of glutamine metabolism is not well understood(1,6). Here we report that the c-Myc (hereafter referred to as Myc) oncogenic transcription factor, which is known to regulate microRNAs(7,8) and stimulate cell proliferation(9), transcriptionally represses miR-23a and miR-23b, resulting in greater expression of their target protein, mitochondrial glutaminase, in human P-493 B lymphoma cells and PC3 prostate cancer cells. This leads to upregulation of glutamine catabolism(10). Glutaminase converts glutamine to glutamate, which is further catabolized through the tricarboxylic acid cycle for the production of ATP or serves as substrate for glutathione synthesis(11). The unique means by which Myc regulates glutaminase uncovers a previously unsuspected link between Myc regulation of miRNAs, glutamine metabolism, and energy and reactive oxygen species homeostasis.	[Gao, Ping; Zeller, Karen I.; Dang, Chi V.] Johns Hopkins Univ, Sch Med, Dept Med, Div Hematol, Baltimore, MD 21205 USA; [Tchernyshyov, Irina; Van Eyk, Jennifer E.] Johns Hopkins Univ, Sch Med, Div Cardiol, Dept Med, Baltimore, MD 21205 USA; [Chang, Tsung-Cheng; Lee, Yun-Sil; Mendell, Joshua T.; Dang, Chi V.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Mendell, Joshua T.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Mendell, Joshua T.; Dang, Chi V.] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [De Marzo, Angelo M.; Dang, Chi V.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [De Marzo, Angelo M.; Dang, Chi V.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [De Marzo, Angelo M.] Johns Hopkins Univ, Sch Med, Dept Urol, Baltimore, MD 21205 USA; [Van Eyk, Jennifer E.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Dang, Chi V.] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA; [Kita, Kayoko; Ochi, Takafumi] Teikyo Univ, Fac Pharmaceut Sci, Toxicol Lab, Kanagawa 2290195, Japan	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Teikyo University	Dang, CV (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Hematol, Baltimore, MD 21205 USA.	pgao2@jhmi.edu; cvdang@jhmi.edu	Chang, Tsung-Cheng/C-2761-2008; Zhang, Huafeng/A-7188-2012; Dang, Chi/Y-3375-2019	Chang, Tsung-Cheng/0000-0003-4706-0468; Dang, Chi/0000-0002-4031-2522	NIH [NHLBI NO1-HV-28180, NCI R01CA051497, NCI R01CA57341, NCI R01CA120185, NCI P50CA58236]; Rita Allen Foundation; Leukemia and Lymphoma Society; Sol Goldman Center for Pancreatic Cancer Research; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028180] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA051497, R01CA120185, P50CA058236, R37CA051497, R01CA057341] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085434] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rita Allen Foundation; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Sol Goldman Center for Pancreatic Cancer Research; DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors want to thank L. Blosser and A. Tam for their help in flow cytometry analysis, and H. Y. Zhang for her help with statistical analysis. This work was partially supported by NIH Awards NHLBI NO1-HV-28180, NCI R01CA051497, NCI R01CA57341, NCI R01CA120185, NCI P50CA58236, Rita Allen Foundation, Leukemia and Lymphoma Society, and Sol Goldman Center for Pancreatic Cancer Research.	Anderson TJ, 2007, PROTEOMICS, V7, P1197, DOI 10.1002/pmic.200600374; Berns K, 2000, ONCOGENE, V19, P3330, DOI 10.1038/sj.onc.1203639; Bode BP, 2001, J NUTR, V131, p2475S, DOI 10.1093/jn/131.9.2475S; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; CURTHOYS NP, 1995, ANNU REV NUTR, V15, P133, DOI 10.1146/annurev.nu.15.070195.001025; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Gallagher FA, 2008, MAGN RESON MED, V60, P253, DOI 10.1002/mrm.21650; Gao P, 2007, CANCER CELL, V12, P230, DOI 10.1016/j.ccr.2007.08.004; Gurel B, 2008, MODERN PATHOL, V21, P1156, DOI 10.1038/modpathol.2008.111; Kersey PJ, 2004, PROTEOMICS, V4, P1985, DOI 10.1002/pmic.200300721; Kita K, 2007, TOXICOL APPL PHARM, V220, P262, DOI 10.1016/j.taap.2007.01.009; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Li F, 2005, MOL CELL BIOL, V25, P6225, DOI 10.1128/MCB.25.14.6225-6234.2005; Lobo C, 2000, BIOCHEM J, V348, P257, DOI 10.1042/0264-6021:3480257; LOMBARDI L, 1987, CELL, V49, P161, DOI 10.1016/0092-8674(87)90556-3; Lora J, 2004, EUR J BIOCHEM, V271, P4298, DOI 10.1111/j.1432-1033.2004.04370.x; MATSUNO T, 1986, J CELL PHYSIOL, V128, P397, DOI 10.1002/jcp.1041280308; Nikiforov MA, 2000, ONCOGENE, V19, P4828, DOI 10.1038/sj.onc.1203880; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Perez-Gomez C, 2005, BIOCHEM J, V386, P535, DOI 10.1042/BJ20040996; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Rabilloud T, 2001, PROTEOMICS, V1, P1105, DOI 10.1002/1615-9861(200109)1:9<1105::AID-PROT1105>3.0.CO;2-M; REITZER LJ, 1979, J BIOL CHEM, V254, P2669; Schuhmacher M, 1999, CURR BIOL, V9, P1255, DOI 10.1016/S0960-9822(99)80507-7; Turner A, 2003, BIOCHEM J, V370, P403, DOI 10.1042/BJ20021360; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020; Yuneva M, 2007, J CELL BIOL, V178, P93, DOI 10.1083/jcb.200703099	30	1480	1546	9	214	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 9	2009	458	7239					762	U100		10.1038/nature07823	http://dx.doi.org/10.1038/nature07823			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433GZ	19219026	Green Accepted			2022-12-01	WOS:000265193600041
J	Cantone, I; Marucci, L; Iorio, F; Ricci, MA; Belcastro, V; Bansal, M; Santini, S; di Bernardo, M; di Bernardo, D; Cosma, MP				Cantone, Irene; Marucci, Lucia; Iorio, Francesco; Ricci, Maria Aurelia; Belcastro, Vincenzo; Bansal, Mukesh; Santini, Stefania; di Bernardo, Mario; di Bernardo, Diego; Cosma, Maria Pia			A Yeast Synthetic Network for In Vivo Assessment of Reverse-Engineering and Modeling Approaches	CELL			English	Article							ASH1 MESSENGER-RNA; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTOR; REGULATORY NETWORKS; CELL-CYCLE; EXPRESSION PROFILES; ORDERED RECRUITMENT; ESCHERICHIA-COLI; GENE NETWORKS; BUDDING YEAST	Systems biology approaches are extensively used to model and reverse engineer gene regulatory networks from experimental data. Conversely, synthetic biology allows "de novo'' construction of a regulatory network to seed new functions in the cell. At present, the usefulness and predictive ability of modeling and reverse engineering cannot be assessed and compared rigorously. We built in the yeast Saccharomyces cerevisiae a synthetic network, IRMA, for in vivo "benchmarking'' of reverse-engineering and modeling approaches. The network is composed of five genes regulating each other through a variety of regulatory interactions; it is negligibly affected by endogenous genes, and it is responsive to small molecules. We measured time series and steady-state expression data after multiple perturbations. These data were used to assess state-of-the-art modeling and reverse-engineering techniques. A semiquantitative model was able to capture and predict the behavior of the network. Reverse engineering based on differential equations and Bayesian networks correctly inferred regulatory interactions from the experimental data.	[Cantone, Irene; Marucci, Lucia; Iorio, Francesco; Ricci, Maria Aurelia; Belcastro, Vincenzo; Bansal, Mukesh; di Bernardo, Diego; Cosma, Maria Pia] TIGEM, I-80131 Naples, Italy; [Marucci, Lucia; Santini, Stefania; di Bernardo, Mario; di Bernardo, Diego] Univ Naples Federico 2, Dept Syst & Comp Engn, I-80125 Naples, Italy	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); University of Naples Federico II	di Bernardo, D (corresponding author), TIGEM, I-80131 Naples, Italy.	dibernardo@tigem.it; cosma@tigem.it	Marucci, Lucia/P-1582-2016; Cosma, Maria Pia/E-8731-2015; di Bernardo, Diego/AAF-5881-2021; di Bernardo, Diego/I-9440-2012; Iorio, Francesco/H-3284-2019; Iorio, Francesco/H-3282-2019; di Bernardo, Mario/I-2805-2012; di Bernardo, Mario/AAL-9311-2021; Cantone, Irene/AAB-1071-2020	Marucci, Lucia/0000-0002-7553-6358; Cosma, Maria Pia/0000-0003-4207-5097; di Bernardo, Diego/0000-0002-1911-7407; di Bernardo, Diego/0000-0002-1911-7407; Iorio, Francesco/0000-0001-7063-8913; di Bernardo, Mario/0000-0002-2171-4745; Cantone, Irene/0000-0002-8156-7126; Belcastro, Vincenzo/0000-0003-3749-0018	EC; "Fondazione Telethon" Institutional; SEMM (European School of Molecular Medicine); Italian MIUR-FIRB ITALBIONET	EC(European CommissionEuropean Commission Joint Research Centre); "Fondazione Telethon" Institutional(Fondazione Telethon); SEMM (European School of Molecular Medicine); Italian MIUR-FIRB ITALBIONET(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB))	This work was supported by EC Framework 6 (COBIOS) and by a "Fondazione Telethon" Institutional grant to TIGEM; I.C. and M.B. were supported by SEMM (European School of Molecular Medicine). F.I. is part of the University of Salerno Ph.D. program. M.A.R. is part of University of Naples "Federico II" undergraduate program. V.B. is part of the Open University Ph.D. program and supported by Italian MIUR-FIRB ITALBIONET to D.d.B. We thank Graciana Diez-Roux, Andrea Ballabio, and Joerg Stelling for helping with the manuscript; Kim Nasmyth for providing the K2072 yeast strain; Mark Johnston for providing the YM4271 strain; and Susan Lindquist for providing Gateway vectors.	Alberti S, 2007, YEAST, V24, P913, DOI 10.1002/yea.1502; ALON U, 2006, DESIGN PRINCIPLES BI, V10; Bansal M, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100120; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Bhoite LT, 2001, GENE DEV, V15, P2457, DOI 10.1101/gad.921601; Bobola N, 1996, CELL, V84, P699, DOI 10.1016/S0092-8674(00)81048-X; Cosma MP, 2004, EMBO REP, V5, P953, DOI 10.1038/sj.embor.7400251; Cosma MP, 2002, MOL CELL, V10, P227, DOI 10.1016/S1097-2765(02)00604-4; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; Della Gatta G, 2008, GENOME RES, V18, P939, DOI 10.1101/gr.073601.107; di Bernardo D, 2005, NAT BIOTECHNOL, V23, P377, DOI 10.1038/nbt1075; Di Ventura B, 2006, NATURE, V443, P527, DOI 10.1038/nature05127; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Ferreiro JA, 2004, NUCLEIC ACIDS RES, V32, P1617, DOI 10.1093/nar/gkh324; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900; Gonsalvez GB, 2003, RNA, V9, P1383, DOI 10.1261/rna.5120803; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Hasty J, 2002, NATURE, V420, P224, DOI 10.1038/nature01257; Hayete B, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100118; Jansen RP, 1996, CELL, V84, P687, DOI 10.1016/S0092-8674(00)81047-8; Jona G, 2000, BBA-GENE STRUCT EXPR, V1491, P37, DOI 10.1016/S0167-4781(00)00016-6; Kaern M, 2003, ANNU REV BIOMED ENG, V5, P179, DOI 10.1146/annurev.bioeng.5.040202.121553; Khosla C, 2003, NAT REV DRUG DISCOV, V2, P1019, DOI 10.1038/nrd1256; KURAS L, 1995, FEBS LETT, V367, P15, DOI 10.1016/0014-5793(95)00528-H; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Liu Jingdong, 1993, Methods (Orlando), V5, P125, DOI 10.1006/meth.1993.1017; Long RM, 1997, SCIENCE, V277, P383, DOI 10.1126/science.277.5324.383; MELLOR J, 1990, EMBO J, V9, P4017, DOI 10.1002/j.1460-2075.1990.tb07623.x; MOLL T, 1991, CELL, V66, P743, DOI 10.1016/0092-8674(91)90118-I; Muratani M, 2005, CELL, V120, P887, DOI 10.1016/j.cell.2004.12.025; Nalley K, 2006, NATURE, V442, P1054, DOI 10.1038/nature05067; NASMYTH K, 1990, CELL, V62, P631, DOI 10.1016/0092-8674(90)90110-Z; NASMYTH K, 1987, CELL, V48, P579, DOI 10.1016/0092-8674(87)90236-4; OCONNELL KF, 1995, MOL CELL BIOL, V15, P1879; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Sprinzak D, 2005, NATURE, V438, P443, DOI 10.1038/nature04335; Stolovitzky G, 2007, ANN NY ACAD SCI, V1115, P1, DOI 10.1196/annals.1407.021; Szallasi Z., 2006, SYST MOD CELL BIOL, DOI 10.7551/mitpress/9780262195485.001.0001.; Traven A, 2006, EMBO REP, V7, P496, DOI 10.1038/sj.embor.7400679; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Voth WP, 2007, EMBO J, V26, P4324, DOI 10.1038/sj.emboj.7601859; Yu J, 2004, BIOINFORMATICS, V20, P3594, DOI 10.1093/bioinformatics/bth448	44	278	286	0	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 2	2009	137	1					172	181		10.1016/j.cell.2009.01.055	http://dx.doi.org/10.1016/j.cell.2009.01.055			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	427XV	19327819	Bronze			2022-12-01	WOS:000264813300023
J	Sun, YX; Kucej, M; Fan, HY; Yu, H; Sun, QY; Zou, H				Sun, Yuxiao; Kucej, Martin; Fan, Heng-Yu; Yu, Hong; Sun, Qing-Yuan; Zou, Hui			Separase Is Recruited to Mitotic Chromosomes to Dissolve Sister Chromatid Cohesion in a DNA-Dependent Manner	CELL			English	Article							CELL-CYCLE; CLEAVAGE; ANAPHASE; SECURIN; PHOSPHORYLATION; COMPLEX; PROTEIN; ARMS; CTCF; LOCALIZATION	Sister chromatid separation is triggered by the separase-catalyzed cleavage of cohesin. This process is temporally controlled by cell-cycle-dependent factors, but its biochemical mechanism and spatial regulation remain poorly understood. We report that cohesin cleavage by human separase requires DNA in a sequence-nonspecific manner. Separase binds to DNA in vitro, but its proteolytic activity, measured by its autocleavage, is not stimulated by DNA. Instead, biochemical characterizations suggest that DNA mediates cohesin cleavage by bridging the interaction between separase and cohesin. In human cells, a fraction of separase localizes to the mitotic chromosome. The importance of the chromosomal DNA in cohesin cleavage is further demonstrated by the observation that the cleavage of the chromosome-associated cohesins is sensitive to nuclease treatment. Our observations explain why chromosome-associated cohesins are specifically cleaved by separase and the soluble cohesins are left intact in anaphase.	[Sun, Yuxiao; Kucej, Martin; Zou, Hui] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Yu, Hong] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Fan, Heng-Yu] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Sun, Qing-Yuan] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Baylor College of Medicine; Chinese Academy of Sciences; Institute of Zoology, CAS	Zou, H (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	hui.zou@utsouthwestern.edu		Kucej, Martin/0000-0001-9129-4216	Damon Runyon Cancer Foundation (DRS) [35-03]; American Cancer Society [RSG-04-171-01-CCG]; Welch Foundation [I-1594]; NIH [R01GM081466-02]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081466] Funding Source: NIH RePORTER	Damon Runyon Cancer Foundation (DRS); American Cancer Society(American Cancer Society); Welch Foundation(The Welch Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Lydia Chiu and Julie Covino for technical support, Hongtao Yu for helpful discussions, and Eric Olson for critical reading and comments of the manuscript. We also thank Hongtao Yu, David Pellman, and Stephen Taylor for generously providing the myc<INF>6</INF>-SCC1, separase-V5, and myc-separase stable cell lines, respectively. H.Z. is the Kenneth G. and Elaine A. Langone Scholar supported by the Damon Runyon Cancer Foundation (DRS-#35-03). This work is also supported by a Research Scholar Grant from the American Cancer Society (RSG-04-171-01-CCG), a research grant from the Welch Foundation (I-1594), and a NIH R01 grant (R01GM081466-02) to H.Z.	Akhmedov AT, 1999, J BIOL CHEM, V274, P38216, DOI 10.1074/jbc.274.53.38216; Alexandru G, 2001, CELL, V105, P459, DOI 10.1016/S0092-8674(01)00362-2; Bembenek JN, 2007, DEVELOPMENT, V134, P3837, DOI 10.1242/dev.011361; Chestukhin A, 2003, P NATL ACAD SCI USA, V100, P4574, DOI 10.1073/pnas.0730733100; Fan HY, 2006, CELL CYCLE, V5, P198, DOI 10.4161/cc.5.2.2321; Fousteri MI, 2000, EMBO J, V19, P1691, DOI 10.1093/emboj/19.7.1691; Gullerova M, 2008, CELL, V132, P983, DOI 10.1016/j.cell.2008.02.040; Haering CH, 2008, NATURE, V454, P297, DOI 10.1038/nature07098; Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069; Hauf S, 2001, SCIENCE, V293, P1320, DOI 10.1126/science.1061376; Hirano M, 2006, MOL CELL, V21, P175, DOI 10.1016/j.molcel.2005.11.026; Hornig NCD, 2004, EMBO J, V23, P3144, DOI 10.1038/sj.emboj.7600303; Huang CE, 2005, PHILOS T ROY SOC B, V360, P537, DOI 10.1098/rstb.2004.1609; Huang XX, 2005, MOL BIOL CELL, V16, P4725, DOI 10.1091/mbc.E05-03-0190; Ivanov D, 2005, CELL, V122, P849, DOI 10.1016/j.cell.2005.07.018; Jallepalli PV, 2001, CELL, V105, P445, DOI 10.1016/S0092-8674(01)00340-3; Kitajima TS, 2006, NATURE, V441, P46, DOI 10.1038/nature04663; Kitajima TS, 2005, CURR BIOL, V15, P353, DOI 10.1016/j.cub.2004.12.044; McGuinness BE, 2005, PLOS BIOL, V3, P433, DOI 10.1371/journal.pbio.0030086; Mei JJ, 2001, CURR BIOL, V11, P1197, DOI 10.1016/S0960-9822(01)00325-6; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Nakajima M, 2007, J CELL SCI, V120, P4188, DOI 10.1242/jcs.011528; Nasmyth K, 2005, PHILOS T R SOC B, V360, P483, DOI 10.1098/rstb.2004.1604; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Pfleghaar K, 2005, PLOS BIOL, V3, P2127, DOI 10.1371/journal.pbio.0030416; Rollins RA, 1999, GENETICS, V152, P577; Rubio ED, 2008, P NATL ACAD SCI USA, V105, P8309, DOI 10.1073/pnas.0801273105; Stedman W, 2008, EMBO J, V27, P654, DOI 10.1038/emboj.2008.1; Stemmann O, 2001, CELL, V107, P715, DOI 10.1016/S0092-8674(01)00603-1; Sun YX, 2006, CELL CYCLE, V5, P2537, DOI 10.4161/cc.5.21.3407; Tang ZY, 2006, DEV CELL, V10, P575, DOI 10.1016/j.devcel.2006.03.010; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Waizenegger IC, 2002, CURR BIOL, V12, P1368, DOI 10.1016/S0960-9822(02)01073-4; Waizenegger IC, 2000, CELL, V103, P399, DOI 10.1016/S0092-8674(00)00132-X; Wang ZY, 2001, MOL ENDOCRINOL, V15, P1870, DOI 10.1210/me.15.11.1870; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Zou H, 2002, FEBS LETT, V528, P246, DOI 10.1016/S0014-5793(02)03238-6; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418	38	43	44	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 2	2009	137	1					123	132		10.1016/j.cell.2009.01.040	http://dx.doi.org/10.1016/j.cell.2009.01.040			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	427XV	19345191	Green Accepted, Bronze			2022-12-01	WOS:000264813300019
J	Kizhatil, K; Baker, SA; Arshavsky, VY; Bennett, V				Kizhatil, Krishnakumar; Baker, Sheila A.; Arshavsky, Vadim Y.; Bennett, Vann			Ankyrin-G Promotes Cyclic Nucleotide-Gated Channel Transport to Rod Photoreceptor Sensory Cilia	SCIENCE			English	Article							BRONCHIAL EPITHELIAL-CELLS; MEMBRANE-PROTEINS; LATERAL MEMBRANE; INITIAL SEGMENTS; SPECTRIN; REQUIRES; SUBUNIT; AXON; BETA(2)-SPECTRIN; CARDIOMYOCYTES	Cyclic nucleotide-gated (CNG) channels localize exclusively to the plasma membrane of photosensitive outer segments of rod photoreceptors where they generate the electrical response to light. Here, we report the finding that targeting of CNG channels to the rod outer segment required their interaction with ankyrin-G. Ankyrin-G localized exclusively to rod outer segments, coimmunoprecipitated with the CNG channel, and bound to the C-terminal domain of the channel beta 1 subunit. Ankyrin-G depletion in neonatal mouse retinas markedly reduced CNG channel expression. Transgenic expression of CNG channel beta-subunit mutants in Xenopus rods showed that ankyrin-G binding was necessary and sufficient for targeting of the beta 1 subunit to outer segments. Thus, ankyrin-G is required for transport of CNG channels to the plasma membrane of rod outer segments.	[Kizhatil, Krishnakumar; Bennett, Vann] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Baker, Sheila A.; Arshavsky, Vadim Y.] Duke Univ, Med Ctr, Dept Ophthalmol, Durham, NC 27710 USA	Duke University; Duke University	Bennett, V (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA.	benne012@mc.duke.edu	Kizhatil, Krish/AAR-5868-2021	Kizhatil, Krishnakumar/0000-0003-3755-6101; Baker, Sheila/0000-0002-0259-0652	NIH [EY12859]; Howard Hughes Medical Institute (HHMI); NATIONAL EYE INSTITUTE [R01EY012859, P30EY005722] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank J. Hoffman for constructing the plasmids used in the study. V.Y.A. was funded by NIH grant EY12859. V.B. is an investigator of Howard Hughes Medical Institute (HHMI) and was funded by HHMI.	Ayalon G, 2008, CELL, V135, P1189, DOI 10.1016/j.cell.2008.10.018; Baker SA, 2008, J CELL BIOL, V183, P485, DOI 10.1083/jcb.200806009; Bennett V, 2008, TRENDS MOL MED, V14, P28, DOI 10.1016/j.molmed.2007.11.005; CHEN TY, 1993, NATURE, V362, P764, DOI 10.1038/362764a0; Hedstrom KL, 2008, J CELL BIOL, V183, P635, DOI 10.1083/jcb.200806112; Huttl S, 2005, J NEUROSCI, V25, P130, DOI 10.1523/JNEUROSCI.3764-04.2005; Insinna C, 2008, DEV BIOL, V316, P160, DOI 10.1016/j.ydbio.2008.01.025; Jenkins PM, 2006, CURR BIOL, V16, P1211, DOI 10.1016/j.cub.2006.04.034; Jenkins SM, 2001, J CELL BIOL, V155, P739, DOI 10.1083/jcb.200109026; Kizhatil K, 2004, J BIOL CHEM, V279, P16706, DOI 10.1074/jbc.M314296200; Kizhatil K, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703158200; Kizhatil K, 2007, J BIOL CHEM, V282, P2029, DOI 10.1074/jbc.M608921200; Kizhatil K, 2009, EXP EYE RES, V88, P55, DOI 10.1016/j.exer.2008.09.022; Kondo H, 2004, INVEST OPHTH VIS SCI, V45, P4433, DOI 10.1167/iovs.04-0544; Lowe JS, 2008, J CELL BIOL, V180, P173, DOI 10.1083/jcb.200710107; MADREPERLA SA, 1989, J CELL BIOL, V109, P1483, DOI 10.1083/jcb.109.4.1483; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Matulef K, 2003, ANNU REV CELL DEV BI, V19, P23, DOI 10.1146/annurev.cellbio.19.110701.154854; Michalakis S, 2006, J BIOL CHEM, V281, P35156, DOI 10.1074/jbc.M606409200; Mohler PJ, 2004, P NATL ACAD SCI USA, V101, P17533, DOI 10.1073/pnas.0403711101; Mohler PJ, 2004, J BIOL CHEM, V279, P40185, DOI 10.1074/jbc.M406018200; Muresan V, 2001, MOL CELL, V7, P173, DOI 10.1016/S1097-2765(01)00165-4; Nguyen-Legros J, 2000, INT REV CYTOL, V196, P245; Pan ZM, 2006, J NEUROSCI, V26, P2599, DOI 10.1523/JNEUROSCI.4314-05.2006; Poetsch A, 2001, J BIOL CHEM, V276, P48009, DOI 10.1074/jbc.M108941200; Wiesner B, 1998, J CELL BIOL, V142, P473, DOI 10.1083/jcb.142.2.473; WOHLFART P, 1992, J BIOL CHEM, V267, P644; Zhang X, 1998, J BIOL CHEM, V273, P30785, DOI 10.1074/jbc.273.46.30785; Zhou DX, 1998, J CELL BIOL, V143, P1295, DOI 10.1083/jcb.143.5.1295	29	57	61	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2009	323	5921					1614	1617		10.1126/science.1169789	http://dx.doi.org/10.1126/science.1169789			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421EN	19299621	Green Accepted			2022-12-01	WOS:000264342300041
J	Bibbins-Domingo, K; Pletcher, MJ; Lin, F; Vittinghoff, E; Gardin, JM; Arynchyn, A; Lewis, CE; Williams, OD; Hulley, SB				Bibbins-Domingo, Kirsten; Pletcher, Mark J.; Lin, Feng; Vittinghoff, Eric; Gardin, Julius M.; Arynchyn, Alexander; Lewis, Cora E.; Williams, O. Dale; Hulley, Stephen B.			Racial Differences in Incident Heart Failure among Young Adults	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LEFT-VENTRICULAR MASS; DENSITY-LIPOPROTEIN CHOLESTEROL; HIGH BLOOD-PRESSURE; ATHEROSCLEROSIS RISK; LIFETIME RISK; RENAL-DISEASE; WORKING GROUP; HYPERTENSION; BLACK; HYPERTROPHY	Background The antecedents and epidemiology of heart failure in young adults are poorly understood. Methods We prospectively assessed the incidence of heart failure over a 20-year period among 5115 blacks and whites of both sexes who were 18 to 30 years of age at baseline. Using Cox models, we examined predictors of hospitalization or death from heart failure. Results Over the course of 20 years, heart failure developed in 27 participants (mean [+/- SD] age at onset, 39 +/- 6 years), all but 1 of whom were black. The cumulative incidence of heart failure before the age of 50 years was 1.1% (95% confidence interval [CI], 0.6 to 1.7) in black women, 0.9% (95% CI, 0.5 to 1.4) in black men, 0.08% (95% CI, 0.0 to 0.5) in white women, and 0% (95% CI, 0 to 0.4) in white men (P = 0.001 for the comparison of black participants and white participants). Among blacks, independent predictors at 18 to 30 years of age of heart failure occurring 15 years, on average, later included higher diastolic blood pressure (hazard ratio per 10.0 mm Hg, 2.1; 95% CI, 1.4 to 3.1), higher body-mass index (the weight in kilograms divided by the square of the height in meters) (hazard ratio per 5.7 units, 1.4; 95% CI, 1.0 to 1.9), lower high-density lipoprotein cholesterol (hazard ratio per 13.3 mg per deciliter [0.34 mmol per liter], 0.6; 95% CI, 0.4 to 1.0), and kidney disease (hazard ratio, 19.8; 95% CI, 4.5 to 87.2). Three quarters of those in whom heart failure subsequently developed had hypertension by the time they were 40 years of age. Depressed systolic function, as assessed on a study echocardiogram when the participants were 23 to 35 years of age, was independently associated with the development of heart failure 10 years, on average, later (hazard ratio for abnormal systolic function, 36.9; 95% CI, 6.9 to 198.3; hazard ratio for borderline systolic function, 3.5; 95% CI, 1.2 to 10.2). Myocardial infarction, drug use, and alcohol use were not associated with the risk of heart failure. Conclusions Incident heart failure before 50 years of age is substantially more common among blacks than among whites. Hypertension, obesity, and systolic dysfunction that are present before a person is 35 years of age are important antecedents that may be targets for the prevention of heart failure. (ClinicalTrials.govnumber, NCT00005130.)	[Bibbins-Domingo, Kirsten; Pletcher, Mark J.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Bibbins-Domingo, Kirsten; Pletcher, Mark J.; Lin, Feng; Vittinghoff, Eric; Hulley, Stephen B.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Div Gen Med, San Francisco, CA 94143 USA; [Bibbins-Domingo, Kirsten] Univ Calif San Francisco, UCSF Ctr Vulnerable Populat, San Francisco Gen Hosp, San Francisco, CA 94143 USA; [Gardin, Julius M.] Hackensack Univ, Med Ctr, Dept Med, Hackensack, NJ USA; [Arynchyn, Alexander; Lewis, Cora E.; Williams, O. Dale] Univ Alabama Birmingham, Div Prevent Med, Birmingham, AL USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Hackensack University Medical Center; University of Alabama System; University of Alabama Birmingham	Bibbins-Domingo, K (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.				National Heart, Lung, and Blood Institute [N01-HC-95095, N01-HC-48047, N01-HC-48048, N01-HC-48049, N01-HC-48050, N01-HC-45134, N01-HC-05187, N01-HC-45205, N01-HC-45204]; Robert Wood Johnson Amos Faculty Development Program; National Institute of Diabetes and Digestive and Kidney Diseases [1R01DK078124]; University of California, San Francisco; Hellman Family Faculty Award; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095095, N01HC045134, N01HC048050, N01HC048049, N01HC005187, N01HC048048, N01HC048047] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081257, R29HL048048, R01HL048048, R01HL048050, R01HL048049] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078124] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Robert Wood Johnson Amos Faculty Development Program; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); University of California, San Francisco(University of California System); Hellman Family Faculty Award; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by grants from the National Heart, Lung, and Blood Institute (a diversity supplement to CARDIA contract N01-HC-95095), the Robert Wood Johnson Amos Faculty Development Program, and the National Institute of Diabetes and Digestive and Kidney Diseases (1R01DK078124), and a University of California, San Francisco, Hellman Family Faculty Award (all to Dr. Bibbins-Domingo). The CARDIA study is supported by contracts from the National Heart, Lung, and Blood Institute (N01-HC-95095, N01-HC-48047, N01-HC-48048, N01-HC-48049, N01-HC-48050, N01-HC-45134, N01-HC-05187, N01-HC-45205, and N01-HC-45204).	Bahrarni H, 2008, ARCH INTERN MED, V168, P2138, DOI 10.1001/archinte.168.19.2138; Bakris GL, 2003, ARCH INTERN MED, V163, P1555, DOI 10.1001/archinte.163.13.1555; Bibbins-Domingo K, 2006, ARCH INTERN MED, V166, P1396, DOI 10.1001/archinte.166.13.1396; Bleumink GS, 2004, EUR HEART J, V25, P1614, DOI 10.1016/j.ehj.2004.06.038; Cohn JN, 2002, J CARD FAIL, V8, P56, DOI 10.1054/jcaf.2002.32950; DESIMONE G, 1992, J AM COLL CARDIOL, V20, P1251, DOI 10.1016/0735-1097(92)90385-Z; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Douglas JG, 2003, ARCH INTERN MED, V163, P525, DOI 10.1001/archinte.163.5.525; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; FRIEDMAN GD, 1988, J CLIN EPIDEMIOL, V41, P1105, DOI 10.1016/0895-4356(88)90080-7; GARDIN JM, 1995, CIRCULATION, V92, P380, DOI 10.1161/01.CIR.92.3.380; Goldberg LR, 2006, CIRCULATION, V113, P2851, DOI 10.1161/CIRCULATIONAHA.105.600437; Gu QP, 2006, CIRCULATION, V113, P213, DOI 10.1161/CIRCULATIONAHA.105.542290; Haider AW, 2003, ANN INTERN MED, V138, P10, DOI 10.7326/0003-4819-138-1-200301070-00006; HO KKL, 1993, J AM COLL CARDIOL, V22, pA6, DOI 10.1016/0735-1097(93)90455-A; Horio T, 2003, AM J HYPERTENS, V16, P938, DOI 10.1016/S0895-7061(03)01015-X; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Jessup M, 2003, NEW ENGL J MED, V348, P2007, DOI 10.1056/NEJMra021498; KALOGEROPOULOS A, ARCH INTERN IN PRESS; Kannel W B, 2000, Heart Fail Rev, V5, P167; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; KONSTAM MA, 1993, CIRCULATION, V88, P2277, DOI 10.1161/01.CIR.88.5.2277; LAUER MS, 1991, JAMA-J AM MED ASSOC, V266, P231, DOI 10.1001/jama.266.2.231; LAUER MS, 1991, J AM COLL CARDIOL, V18, P1287, DOI 10.1016/0735-1097(91)90549-O; Lee DS, 2007, HYPERTENSION, V50, P869, DOI 10.1161/HYPERTENSIONAHA.107.095380; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Lewis CE, 2000, AM J EPIDEMIOL, V151, P1172, DOI 10.1093/oxfordjournals.aje.a010167; Liu K, 1996, CIRCULATION, V93, P60, DOI 10.1161/01.CIR.93.1.60; Lloyd-Jones DM, 2002, CIRCULATION, V106, P3068, DOI 10.1161/01.CIR.0000039105.49749.6F; Loehr LR, 2008, AM J CARDIOL, V101, P1016, DOI 10.1016/j.amjcard.2007.11.061; *NAT I ALC AB ALC, WHAT IS SAF LEV DRIN; Nunez E, 2005, HYPERTENSION, V45, P58, DOI 10.1161/01.HYP.0000149951.70491.4c; Ong KL, 2007, HYPERTENSION, V49, P69, DOI 10.1161/01.HYP.0000252676.46043.18; Ostchega Y, 2008, AM J HYPERTENS, V21, P159, DOI 10.1038/ajh.2007.32; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; Roger VL, 2004, JAMA-J AM MED ASSOC, V292, P344, DOI 10.1001/jama.292.3.344; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Sarnak MJ, 2005, ANN INTERN MED, V142, P497, DOI 10.7326/0003-4819-142-7-200504050-00008; Schocken DD, 2008, CIRCULATION, V117, P2544, DOI 10.1161/CIRCULATIONAHA.107.188965; Stehman-Breen CO, 2003, J AM SOC NEPHROL, V14, P2352, DOI 10.1097/01.ASN.0000083392.11042.14; Struthers AD, 2002, LANCET, V359, P1430, DOI 10.1016/S0140-6736(02)08358-7; Victor RG, 2008, ARCH INTERN MED, V168, P1285, DOI 10.1001/archinte.168.12.1285; Wang TJ, 2003, ANN INTERN MED, V138, P907, DOI 10.7326/0003-4819-138-11-200306030-00012; Wright JT, 2005, JAMA-J AM MED ASSOC, V293, P1595, DOI 10.1001/jama.293.13.1595; Yancy CW, 2005, AM J CARDIOL, V96, p3I, DOI 10.1016/j.amjcard.2005.07.028; 2005, MMWR MORB MORTAL WKL, V54, P7	46	381	381	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 19	2009	360	12					1179	1190		10.1056/NEJMoa0807265	http://dx.doi.org/10.1056/NEJMoa0807265			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	420IU	19297571	Bronze, Green Accepted			2022-12-01	WOS:000264283400004
J	Lee, SJR; Escobedo-Lozoya, Y; Szatmari, EM; Yasuda, R				Lee, Seok-Jin R.; Escobedo-Lozoya, Yasmin; Szatmari, Erzsebet M.; Yasuda, Ryohei			Activation of CaMKII in single dendritic spines during long-term potentiation	NATURE			English	Article							PROTEIN-KINASE-II; YELLOW FLUORESCENT PROTEIN; RESONANCE ENERGY-TRANSFER; CA2+ CHANNELS; SYNAPTIC PLASTICITY; LTP; INDUCTION; NEURONS; RAS; PHOSPHORYLATION	Calcium/calmodulin-dependent kinase II (CaMKII) plays a central part in long-term potentiation (LTP), which underlies some forms of learning and memory. Here we monitored the spatiotemporal dynamics of CaMKII activation in individual dendritic spines during LTP using two-photon fluorescence lifetime imaging microscopy, in combination with two-photon glutamate uncaging. Induction of LTP and associated spine enlargement in single spines triggered transient (similar to 1 min) CaMKII activation restricted to the stimulated spines. CaMKII in spines was specifically activated by NMDA receptors and L-type voltage-sensitive calcium channels, presumably by nanodomain Ca2+ near the channels, in response to glutamate uncaging and depolarization, respectively. The high degree of compartmentalization and channel specificity of CaMKII signalling allow stimuli-specific spatiotemporal patterns of CaMKII signalling and may be important for synapse-specificity of synaptic plasticity.	[Lee, Seok-Jin R.; Escobedo-Lozoya, Yasmin; Szatmari, Erzsebet M.; Yasuda, Ryohei] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Duke University	Yasuda, R (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	yasuda@neuro.duke.edu	Yasuda, Ryohei/E-7726-2011	Yasuda, Ryohei/0000-0001-6263-9297	Burroughs Wellcome Fund; Dana Foundation; Alfred P. Sloan Foundation; Autism Speaks; National Alliance of Autism Research; Whitehall Foundation; Alzheimer's Association; National Institute of Mental Health [R01MH08004]; National Science Foundation [0642000]; Duke University Undergraduate Research Support Grants; Howard Hughes Neuroscience Forum Fellowship; Ruth K. Broad Biomedical Research Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080047] Funding Source: NIH RePORTER	Burroughs Wellcome Fund(Burroughs Wellcome Fund); Dana Foundation; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Autism Speaks; National Alliance of Autism Research; Whitehall Foundation; Alzheimer's Association(Alzheimer's Association); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Science Foundation(National Science Foundation (NSF)); Duke University Undergraduate Research Support Grants; Howard Hughes Neuroscience Forum Fellowship; Ruth K. Broad Biomedical Research Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank H. Murakoshi for purified mEGFP and technical advice, Y. Hayashi for complementary DNAs and shRNA, A. Wang for cultured slices, T. Zimmerman and D. Kloetzer for laboratory management, and M. Ehlers, C. Harvey, J. Lisman, M. Patterson, S. Raghavachari, K. Svoboda, R. Weinberg and H. Zhong for comments on the manuscript. This study was funded by Burroughs Wellcome Fund, Dana Foundation, Alfred P. Sloan Foundation, Autism Speaks, National Alliance of Autism Research, Whitehall Foundation, Alzheimer's Association, National Institute of Mental Health (R01MH08004), National Science Foundation (0642000), Duke University Undergraduate Research Support Grants (S.- J. R. L.), Howard Hughes Neuroscience Forum Fellowship (S.- J. R. L.), and Ruth K. Broad Biomedical Research Foundation (E.M.S.).	Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Chen HX, 2001, J NEUROPHYSIOL, V85, P1368, DOI 10.1152/jn.2001.85.4.1368; Cheng DM, 2006, MOL CELL PROTEOMICS, V5, P1158, DOI 10.1074/mcp.D500009-MCP200; Conti R, 2002, HIPPOCAMPUS, V12, P667, DOI 10.1002/hipo.10096; Dan Y, 2004, NEURON, V44, P23, DOI 10.1016/j.neuron.2004.09.007; FUKUNAGA K, 1995, J BIOL CHEM, V270, P6119, DOI 10.1074/jbc.270.11.6119; Ganesan S, 2006, P NATL ACAD SCI USA, V103, P4089, DOI 10.1073/pnas.0509922103; GROVER LM, 1990, NATURE, V347, P477, DOI 10.1038/347477a0; Harvey CD, 2008, SCIENCE, V321, P136, DOI 10.1126/science.1159675; Harvey CD, 2007, NATURE, V450, P1195, DOI 10.1038/nature06416; Hudmon A, 2005, J CELL BIOL, V171, P537, DOI 10.1083/jcb.200505155; KULLMANN DM, 1992, NEURON, V9, P1175, DOI 10.1016/0896-6273(92)90075-O; Kwok S, 2008, BIOCHEM BIOPH RES CO, V369, P519, DOI 10.1016/j.bbrc.2008.02.070; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Lisman JE, 2001, NEURON, V31, P191, DOI 10.1016/S0896-6273(01)00364-6; MAGEE JC, 1995, J PHYSIOL-LONDON, V487, P67, DOI 10.1113/jphysiol.1995.sp020862; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; MCALLISTER AK, 2000, SCI STKE, pPL1; Merrill MA, 2005, TRENDS PHARMACOL SCI, V26, P645, DOI 10.1016/j.tips.2005.10.003; Murakoshi H, 2008, BRAIN CELL BIOL, V36, P31, DOI 10.1007/s11068-008-9024-9; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Neher E, 1998, CELL CALCIUM, V24, P345, DOI 10.1016/S0143-4160(98)90058-6; Noguchi J, 2005, NEURON, V46, P609, DOI 10.1016/j.neuron.2005.03.015; Ohno M, 2002, CURR BIOL, V12, P654, DOI 10.1016/S0960-9822(02)00767-4; Okamoto KI, 2007, P NATL ACAD SCI USA, V104, P6418, DOI 10.1073/pnas.0701656104; Otmakhov N, 2004, J NEUROSCI, V24, P9324, DOI 10.1523/JNEUROSCI.2350-04.2004; Remy S, 2007, P NATL ACAD SCI USA, V104, P17192, DOI 10.1073/pnas.0707919104; Rosenberg OS, 2006, FEBS J, V273, P682, DOI 10.1111/j.1742-4658.2005.05088.x; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Schwille P, 1999, BIOPHYS J, V77, P2251, DOI 10.1016/S0006-3495(99)77065-7; Sobczyk A, 2005, J NEUROSCI, V25, P6037, DOI 10.1523/JNEUROSCI.1221-05.2005; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Takao K, 2005, J NEUROSCI, V25, P3107, DOI 10.1523/JNEUROSCI.0085-05.2005; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Wheeler DG, 2008, J CELL BIOL, V183, P849, DOI 10.1083/jcb.200805048; Yasuda R, 2006, NAT NEUROSCI, V9, P283, DOI 10.1038/nn1635; Yasuda R, 2003, NAT NEUROSCI, V6, P948, DOI 10.1038/nn1112; YASUDA R, 2004, SCI STKE, pPL5; Yasuda R, 2006, CURR OPIN NEUROBIOL, V16, P551, DOI 10.1016/j.conb.2006.08.012; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8	45	454	461	0	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 19	2009	458	7236					299	U58		10.1038/nature07842	http://dx.doi.org/10.1038/nature07842			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420JH	19295602	Green Accepted			2022-12-01	WOS:000264285600033
J	Schacherer, J; Shapiro, JA; Ruderfer, DM; Kruglyak, L				Schacherer, Joseph; Shapiro, Joshua A.; Ruderfer, Douglas M.; Kruglyak, Leonid			Comprehensive polymorphism survey elucidates population structure of Saccharomyces cerevisiae	NATURE			English	Article							QUANTITATIVE TRAIT; NUCLEOTIDE RESOLUTION; GENETIC DIVERSITY; GENOME EVOLUTION; DNA-SEQUENCES; YEAST; STRAINS; MAP	Comprehensive identification of polymorphisms among individuals within a species is essential both for studying the genetic basis of phenotypic differences and for elucidating the evolutionary history of the species. Large-scale polymorphism surveys have recently been reported for human(1), mouse(2) and Arabidopsis thaliana(3). Here we report a nucleotide-level survey of genomic variation in a diverse collection of 63 Saccharomyces cerevisiae strains sampled from different ecological niches (beer, bread, vineyards, immunocompromised individuals, various fermentations and nature) and from locations on different continents. We hybridized genomic DNA from each strain to whole-genome tiling microarrays and detected 1.89 million single nucleotide polymorphisms, which were grouped into 101,343 distinct segregating sites. We also identified 3,985 deletion events of length >200 base pairs among the surveyed strains. We analysed the genome-wide patterns of nucleotide polymorphism and deletion variants, and measured the extent of linkage disequilibrium in S. cerevisiae. These results and the polymorphism resource we have generated lay the foundation for genome-wide association studies in yeast. We also examined the population structure of S. cerevisiae, providing support for multiple domestication events as well as insight into the origins of pathogenic strains.	[Schacherer, Joseph; Shapiro, Joshua A.; Ruderfer, Douglas M.; Kruglyak, Leonid] Princeton Univ, Lewis Sigler Inst Integrat Gen, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Schacherer, Joseph; Shapiro, Joshua A.; Ruderfer, Douglas M.; Kruglyak, Leonid] Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08544 USA	Princeton University; Howard Hughes Medical Institute; Princeton University	Kruglyak, L (corresponding author), Princeton Univ, Lewis Sigler Inst Integrat Gen, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	leonid@genomics.princeton.edu	Ruderfer, Douglas M/M-5795-2016; Shapiro, Joshua/B-5948-2008	Ruderfer, Douglas M/0000-0002-2365-386X; Shapiro, Joshua/0000-0002-6224-0347	NIH [R37 MH059520, GM071508]; James S. McDonnell Foundation Centennial Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH059520] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James S. McDonnell Foundation Centennial Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are grateful to all the researchers and institutions, and especially J. Fay, for sharing yeast strains. We thank K. Dolinski and J. Matese for technical support and D. Gresham for comments on the manuscript. The authors acknowledge discussions with members of the Kruglyak and Botstein laboratories. This work was supported by NIH grant R37 MH059520 and a James S. McDonnell Foundation Centennial Fellowship to L. K., and NIH grant GM071508 to the Lewis- Sigler Institute.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; CARTER DM, NATURE UNPUB; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; de Llanos R, 2006, INT J FOOD MICROBIOL, V110, P286, DOI 10.1016/j.ijfoodmicro.2006.04.023; Deutschbauer AM, 2005, NAT GENET, V37, P1333, DOI 10.1038/ng1674; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Dujon B, 2006, TRENDS GENET, V22, P375, DOI 10.1016/j.tig.2006.05.007; Enache-Angoulvant A, 2005, CLIN INFECT DIS, V41, P1559, DOI 10.1086/497832; Fay JC, 2005, PLOS GENET, V1, P66, DOI 10.1371/journal.pgen.0010005; Frazer KA, 2007, NATURE, V448, P1050, DOI 10.1038/nature06067; FU YX, 1994, GENETICS, V138, P1375; Gatbonton T, 2006, PLOS GENET, V2, P304, DOI 10.1371/journal.pgen.0020035; Gerton JL, 2000, P NATL ACAD SCI USA, V97, P11383, DOI 10.1073/pnas.97.21.11383; Gresham D, 2006, SCIENCE, V311, P1932, DOI 10.1126/science.1123726; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Marjoram P, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-16; MORTIMER RK, 1986, GENETICS, V113, P35; Perlstein EO, 2007, NAT GENET, V39, P496, DOI 10.1038/ng1991; Pritchard JK, 2000, GENETICS, V155, P945; Pryde FE, 1997, CURR OPIN GENET DEV, V7, P822, DOI 10.1016/S0959-437X(97)80046-9; Schacherer J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000322; Steinmetz LM, 2002, NATURE, V416, P326, DOI 10.1038/416326a; TAJIMA F, 1983, GENETICS, V105, P437; Thornton K, 2003, BIOINFORMATICS, V19, P2325, DOI 10.1093/bioinformatics/btg316; Winzeler EA, 2003, GENETICS, V163, P79; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555	30	334	342	0	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 19	2009	458	7236					342	U103		10.1038/nature07670	http://dx.doi.org/10.1038/nature07670			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420JH	19212320	Green Accepted			2022-12-01	WOS:000264285600042
J	Sheridan, DJ; Heusch, G				Sheridan, Desmond John; Heusch, Gerd			Threats to the future of cardiovascular research	LANCET			English	Editorial Material							ACADEMIC MEDICINE; DISEASE; BURDEN		[Sheridan, Desmond John] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW3 6LY, England; [Heusch, Gerd] Univ Klinikum Essen, Inst Pathophysiol, Essen, Germany	Imperial College London; University of Duisburg Essen	Sheridan, DJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW3 6LY, England.	d.sheridan@ic.ac.uk	Heusch, Gerd/ABE-6675-2020					Garnier JP, 2008, HARVARD BUS REV, V86, P68; HERPER M, 2008, FORBES          0930; Heusch G, 2008, CIRCULATION, V117, pF67, DOI 10.1161/CIRCULATIONAHA.107.189067; Kaplan W., 2004, PRIORITY MED EUROPE; Ley TJ, 2005, JAMA-J AM MED ASSOC, V294, P1343, DOI 10.1001/jama.294.11.1343; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; OXTOBY K, 2009, BMJ CAREERS, V338, P11; Sheridan DJ, 2006, LANCET, V367, P1698, DOI 10.1016/S0140-6736(06)68739-4; Stuckler D, 2008, LANCET, V372, P1563, DOI 10.1016/S0140-6736(08)61656-6	9	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 14	2009	373	9667					875	876		10.1016/S0140-6736(09)60525-0	http://dx.doi.org/10.1016/S0140-6736(09)60525-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	418OU	19286070				2022-12-01	WOS:000264158700008
J	Ghosh, B; Urban, MW				Ghosh, Biswajit; Urban, Marek W.			Self-Repairing Oxetane-Substituted Chitosan Polyurethane Networks	SCIENCE			English	Article								Polyurethanes have many properties that qualify them as high-performance polymeric materials, but they still suffer from mechanical damage. We report the development of polyurethane networks that exhibit self-repairing characteristics upon exposure to ultraviolet light. The network consists of an oxetane-substituted chitosan precursor incorporated into a two-component polyurethane. Upon mechanical damage of the network, four-member oxetane rings open to create two reactive ends. When exposed to ultraviolet light, chitosan chain scission occurs, which forms crosslinks with the reactive oxetane ends, thus repairing the network. These materials are capable of repairing themselves in less than an hour and can be used in many coatings applications, ranging from transportation to packaging or fashion and biomedical industries.	[Ghosh, Biswajit; Urban, Marek W.] Univ So Mississippi, Sch Polymers & High Performance Mat, Shelby F Thames Polymer Sci Res Ctr, Hattiesburg, MS 39406 USA	University of Southern Mississippi	Urban, MW (corresponding author), Univ So Mississippi, Sch Polymers & High Performance Mat, Shelby F Thames Polymer Sci Res Ctr, Hattiesburg, MS 39406 USA.	marek.urban@usm.edu			National Science Foundation MRSEC [DMR 0213883]; Materials Research Instrumentation (MRI) program [DMR 0215873]; Mississippi Division of Marine Resources	National Science Foundation MRSEC(National Science Foundation (NSF)); Materials Research Instrumentation (MRI) program; Mississippi Division of Marine Resources	These studies were primarily supported by the National Science Foundation MRSEC under DMR 0213883 and the Materials Research Instrumentation (MRI) Program under DMR 0215873. We thank the Mississippi Division of Marine Resources for partial support.	Brown EN, 2004, J MATER SCI, V39, P1703, DOI 10.1023/B:JMSC.0000016173.73733.dc; Brown EN, 2003, J MICROENCAPSUL, V20, P719, DOI 10.1080/0265204031000154160; Chen XX, 2002, SCIENCE, V295, P1698, DOI 10.1126/science.1065879; Cordier P, 2008, NATURE, V451, P977, DOI 10.1038/nature06669; Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184; Gheneim R, 2002, MACROMOLECULES, V35, P7246, DOI 10.1021/ma020343c; Henry G, 2003, LANCET, V361, P574, DOI 10.1016/S0140-6736(03)12510-X; Kessler MR, 2003, COMPOS PART A-APPL S, V34, P743, DOI 10.1016/S1359-835X(03)00138-6; Leon J, 2001, J EXP BOT, V52, P1, DOI 10.1093/jexbot/52.354.1; Mann KG, 2006, BLOOD CELL MOL DIS, V36, P108, DOI 10.1016/j.bcmd.2005.12.034; Nagaya K, 2006, JSME INT J C-MECH SY, V49, P379, DOI 10.1299/jsmec.49.379; Otts DB, 2002, LANGMUIR, V18, P6473, DOI 10.1021/la025684y; Pang JWC, 2005, COMPOS PART A-APPL S, V36, P183, DOI 10.1016/j.compositesa.2004.06.016; Pang JWC, 2005, COMPOS SCI TECHNOL, V65, P1791, DOI 10.1016/j.compscitech.2005.03.008; Paris R, 2007, PLANT PHYSIOL BIOCH, V45, P80, DOI 10.1016/j.plaphy.2006.12.001; Sonntag P, 2004, NAT MATER, V3, P311, DOI 10.1038/nmat1113; Toohey KS, 2007, NAT MATER, V6, P581, DOI 10.1038/nmat1934; Trask RS, 2007, BIOINSPIR BIOMIM, V2, pP1, DOI 10.1088/1748-3182/2/1/P01; Urban MW., 1996, ATTENUATED TOTAL REF; Wan Y, 2004, J POLYM SCI POL PHYS, V42, P1379, DOI 10.1002/polb.20007	20	552	575	20	683	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2009	323	5920					1458	1460		10.1126/science.1167391	http://dx.doi.org/10.1126/science.1167391			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417TP	19286550				2022-12-01	WOS:000264101700035
J	Tsuji, M; Komatsu, N; Kawamoto, S; Suzuki, K; Kanagawa, O; Honjo, T; Hori, S; Fagarasan, S				Tsuji, Masayuki; Komatsu, Noriko; Kawamoto, Shimpei; Suzuki, Keiichiro; Kanagawa, Osami; Honjo, Tasuku; Hori, Shohei; Fagarasan, Sidonia			Preferential Generation of Follicular B Helper T Cells from Foxp3(+) T Cells in Gut Peyer's Patches	SCIENCE			English	Article							GERMINAL CENTER FORMATION; CXC CHEMOKINE RECEPTOR-5; RETINOIC-ACID; DENDRITIC CELLS; LAMINA PROPRIA; DIFFERENTIATION; INTERLEUKIN-21; POPULATION; ACTIVATION; EXPRESSION	Most of the immunoglobulin A (IgA) in the gut is generated by B cells in the germinal centers of Peyer's patches through a process that requires the presence of CD4(+) follicular B helper T (T-FH) cells. The nature of these T-FH cells in Peyer's patches has been elusive. Here, we demonstrate that suppressive Foxp3(+)CD4(+) T cells can differentiate into T-FH cells in mouse Peyer's patches. The conversion of Foxp3(+) T cells into T-FH cells requires the loss of Foxp3 expression and subsequent interaction with B cells. Thus, environmental cues present in gut Peyer's patches promote the selective differentiation of distinct helper T cell subsets, such as T-FH cells.	[Komatsu, Noriko; Hori, Shohei] RIKEN, Res Unit Immune Homeostasis, Yokohama, Kanagawa 2300045, Japan; [Tsuji, Masayuki; Kawamoto, Shimpei; Suzuki, Keiichiro; Fagarasan, Sidonia] RIKEN, Lab Mucosal Immun, Yokohama, Kanagawa 2300045, Japan; [Kanagawa, Osami] RIKEN, Res Ctr Allergy & Immunol, Lab Autoimmune Regulat, Yokohama, Kanagawa 2300045, Japan; [Kawamoto, Shimpei; Honjo, Tasuku] Kyoto Univ, Grad Sch Med, Dep Immunol & Genom Med, Sakyo Ku, Kyoto 6068501, Japan	RIKEN; RIKEN; RIKEN; Kyoto University	Hori, S (corresponding author), RIKEN, Res Unit Immune Homeostasis, Yokohama 1-7-22, Yokohama, Kanagawa 2300045, Japan.	shohei@rcai.riken.jp; sidonia-f@rcai.riken.jp	Hori, Shohei/O-6163-2019; Fagarasan, Sidonia/A-5258-2016; Honjo, Tasuku/N-4470-2016	Hori, Shohei/0000-0001-8770-4593; Fagarasan, Sidonia/0000-0003-2086-6402; 	Uehara Memorial Foundation;  [Grants-in-Aid]	Uehara Memorial Foundation(Uehara Memorial Foundation); 	We thank Y. Doi, A. Yagisawa, T. Miyao, and H. Fujimoto for technical assistance; B. Malissen and K. Itoh for mice; D. Littman and A. Coutinho for inspiring discussions; I. Taniuchi for discussion and for critically reading of the manuscript. This work is supported in part by Grants-in-Aid for Scientific Research in Priority Areas (S.F., S.H.) and for Young Scientists (A) (S.H.), and by the Uehara Memorial Foundation (S.H.). S.H. and S.F. contributed as senior authors.	Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Fagarasan S, 2006, CURR TOP MICROBIOL, V308, P137; Fagarasan S, 2001, NATURE, V413, P639, DOI 10.1038/35098100; Fillatreau S, 2003, J EXP MED, V197, P195, DOI 10.1084/jem.20021750; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; FOY TM, 1994, J EXP MED, V180, P157, DOI 10.1084/jem.180.1.157; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Komatsu N, 2009, P NATL ACAD SCI USA, V106, P1903, DOI 10.1073/pnas.0811556106; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; Macpherson AJ, 2006, CURR TOP MICROBIOL, V308, P117; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Tsuji M, 2008, IMMUNITY, V29, P261, DOI 10.1016/j.immuni.2008.05.014; Vinuesa CG, 2005, NAT REV IMMUNOL, V5, P853, DOI 10.1038/nri1714; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Walker LSK, 1999, J EXP MED, V190, P1115, DOI 10.1084/jem.190.8.1115; Wang Y, 2008, J IMMUNOL, V180, P1565, DOI 10.4049/jimmunol.180.3.1565; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Wen L, 1996, J EXP MED, V183, P2271, DOI 10.1084/jem.183.5.2271; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007	29	455	477	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 13	2009	323	5920					1488	1492		10.1126/science.1169152	http://dx.doi.org/10.1126/science.1169152			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417TP	19286559				2022-12-01	WOS:000264101700044
J	Krattinger, SG; Lagudah, ES; Spielmeyer, W; Singh, RP; Huerta-Espino, J; McFadden, H; Bossolini, E; Selter, LL; Keller, B				Krattinger, Simon G.; Lagudah, Evans S.; Spielmeyer, Wolfgang; Singh, Ravi P.; Huerta-Espino, Julio; McFadden, Helen; Bossolini, Eligio; Selter, Liselotte L.; Keller, Beat			A Putative ABC Transporter Confers Durable Resistance to Multiple Fungal Pathogens in Wheat	SCIENCE			English	Article							LEAF RUST RESISTANCE; TRITICUM-AESTIVUM L.; NONHOST RESISTANCE; COMMON WHEAT; BREAD WHEAT; STRIPE RUST; GENE LR34; SENESCENCE; ASSOCIATION; LOCUS	Agricultural crops benefit from resistance to pathogens that endures over years and generations of both pest and crop. Durable disease resistance, which may be partial or complete, can be controlled by several genes. Some of the most devastating fungal pathogens in wheat are leaf rust, stripe rust, and powdery mildew. The wheat gene Lr34 has supported resistance to these pathogens for more than 50 years. Lr34 is now shared by wheat cultivars around the world. Here, we show that the LR34 protein resembles adenosine triphosphate-binding cassette transporters of the pleiotropic drug resistance subfamily. Alleles of Lr34 conferring resistance or susceptibility differ by three genetic polymorphisms. The Lr34 gene, which functions in the adult plant, stimulates senescence-like processes in the flag leaf tips and edges.	[Lagudah, Evans S.; Spielmeyer, Wolfgang; McFadden, Helen] Commonwealth Sci & Ind Res Org Plant Ind, Canberra, ACT 2601, Australia; [Krattinger, Simon G.; Bossolini, Eligio; Selter, Liselotte L.; Keller, Beat] Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland; [Singh, Ravi P.] CIMMYT, Int Maize & Wheat Improvement Ctr, Mexico City 06600, DF, Mexico; [Huerta-Espino, Julio] Campo Expt Valle Mexico INIFAP, Chapingo 56230, Edo De Mexico, Mexico	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Zurich; CGIAR; International Maize & Wheat Improvement Center (CIMMYT)	Lagudah, ES (corresponding author), Commonwealth Sci & Ind Res Org Plant Ind, GPO Box 1600, Canberra, ACT 2601, Australia.	evans.lagudah@csiro.au; bkeller@botinst.uzh.ch	Huerta-Espino, Julio JH/N-9840-2018; Keller, Beat/K-3093-2019; Huerta-Espino, Julio/E-7345-2010; Krattinger, Simon/AAA-2098-2021; Lagudah, Evans/A-2007-2010; Spielmeyer, Wolfgang/M-3254-2018; Krattinger, Simon/C-2863-2012; Singh, Ravi Prakash/I-5575-2019	Huerta-Espino, Julio JH/0000-0001-8334-9862; Keller, Beat/0000-0003-2379-9225; Huerta-Espino, Julio/0000-0001-8334-9862; Lagudah, Evans/0000-0002-6234-1789; Spielmeyer, Wolfgang/0000-0002-5115-7820; Krattinger, Simon/0000-0001-6912-7411	Swiss National Science Foundation; Indo-Swiss Collaboration in Biotechnology; Grains Research and Development Corporation, Australia	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Indo-Swiss Collaboration in Biotechnology; Grains Research and Development Corporation, Australia(Grains R&D Corp)	This work was supported by the Swiss National Science Foundation (B.K.), the Indo-Swiss Collaboration in Biotechnology (B.K.), and the Grains Research and Development Corporation, Australia (E.S.L and R.P.S.). We thank B. Senger for support in field experiments; P. Streckeisen for advice on infection; L. Viccars and S. Chandramohan for technical assistance; M. Ayliffe, M. Talbot, and R. White for assistance with histology; T. Wicker for bioinformatic support; and S. Hortensteiner for nonfluorescent chlorophyll catabolite analysis. GenBank accession numbers: FJ436983 and FJ436985. Patents: CSIRO, Grains Research and Development Corporation, University of Zurich, Australian Provisional Patent Application 2008904364.	Bossolini E, 2006, THEOR APPL GENET, V113, P1049, DOI 10.1007/s00122-006-0364-5; BOWDEN RL, 2007, PLANT BIOTECHNOL J, V1083, P5; Cloutier S, 2007, PLANT MOL BIOL, V65, P93, DOI 10.1007/s11103-007-9201-8; DYCK PL, 1991, CROP SCI, V31, P309, DOI 10.2135/cropsci1991.0011183X003100020016x; DYCK PL, 1966, CAN J GENET CYTOL, V8, P665, DOI 10.1139/g66-082; DYCK PL, 1987, GENOME, V29, P467, DOI 10.1139/g87-081; Ellis JG, 2007, ANNU REV PHYTOPATHOL, V45, P289, DOI 10.1146/annurev.phyto.45.062806.094331; Graveley BR, 2008, NATURE, V453, P1197, DOI 10.1038/4531197b; Gregersen PL, 2007, PLANT BIOTECHNOL J, V5, P192, DOI 10.1111/j.1467-7652.2006.00232.x; GREGERSEN PL, 2007, ANNU REV PLANT BIOL, P192; Hortensteiner S, 2006, ANNU REV PLANT BIOL, V57, P55, DOI 10.1146/annurev.arplant.57.032905.105212; Hulbert SH, 2007, PHYTOPATHOLOGY, V97, P1083, DOI 10.1094/PHYTO-97-9-1083; Keller Beat, 2007, P103, DOI 10.1007/978-1-4020-6297-1_5; Krupinska K, 2002, PLANT PHYSIOL, V130, P1172, DOI 10.1104/pp.008565; KRUPINSKA K, 2002, REV PLANT BIOL, V1172, P57; LIM PO, 2007, PLANT PHYSIOL, V115, P130; Lim PO, 2007, ANNU REV PLANT BIOL, V58, P115, DOI 10.1146/annurev.arplant.57.032905.105316; Lipka U, 2008, CURR OPIN PLANT BIOL, V11, P404, DOI 10.1016/j.pbi.2008.04.004; Marasas CN, 2003, AGR ECON, V29, P253, DOI 10.1111/j.1574-0862.2003.tb00162.x; Panter SN, 2002, ADV BOT RES, V38, P251, DOI 10.1016/S0065-2296(02)38032-7; Rogers B, 2001, J MOL MICROB BIOTECH, V3, P207; RUBIALES D, 1995, PLANT DIS, V79, P1208, DOI 10.1094/PD-79-1208; Singh Ravi P., 2007, P109; SINGH RP, 1992, PHYTOPATHOLOGY, V82, P835, DOI 10.1094/Phyto-82-835; SINGH RP, 1992, CROP SCI, V32, P874, DOI 10.2135/cropsci1992.0011183X003200040008x; Spielmeyer W, 2008, THEOR APPL GENET, V116, P481, DOI 10.1007/s00122-007-0684-0; Spielmeyer W, 2005, THEOR APPL GENET, V111, P731, DOI 10.1007/s00122-005-2058-9; Stein M, 2006, PLANT CELL, V18, P731, DOI 10.1105/tpc.105.038372; Webb CA, 2002, GENETICS, V162, P381	29	806	891	11	272	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2009	323	5919					1360	1363		10.1126/science.1166453	http://dx.doi.org/10.1126/science.1166453			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414PC	19229000				2022-12-01	WOS:000263876700047
J	Soldner, F; Hockemeyer, D; Beard, C; Gao, Q; Bell, GW; Cook, EG; Hargus, G; Blak, A; Cooper, O; Mitalipova, M; Isacson, O; Jaenisch, R				Soldner, Frank; Hockemeyer, Dirk; Beard, Caroline; Gao, Qing; Bell, George W.; Cook, Elizabeth G.; Hargus, Gunnar; Blak, Alexandra; Cooper, Oliver; Mitalipova, Maisam; Isacson, Ole; Jaenisch, Rudolf			Parkinson's Disease Patient-Derived Induced Pluripotent Stem Cells Free of Viral Reprogramming Factors	CELL			English	Article							HUMAN SOMATIC-CELLS; DOPAMINERGIC-NEURONS; HUMAN FIBROBLASTS; GENERATION; MOUSE; INDUCTION; EXPRESSION; EFFICIENT; UPDATE; SYSTEM	Induced pluripotent stem cells (iPSCs) derived from somatic cells of patients represent a powerful tool for biomedical research and may provide a source for replacement therapies. However, the use of viruses encoding the reprogramming factors represents a major limitation of the current technology since even low vector expression may alter the differentiation potential of the iPSCs or induce malignant transformation. Here, we show that fibroblasts from five patients with idiopathic Parkinson's disease can be efficiently reprogrammed and subsequently differentiated into dopaminergic neurons. Moreover, we derived hiPSCs free of reprogramming factors using Cre-recombinase excisable viruses. Factor-free hiPSCs maintain a pluripotent state and show a global gene expression profile, more closely related to hESCs than to hiPSCs carrying the transgenes. Our results indicate that residual transgene expression in virus-carrying hiPSCs can affect their molecular characteristics and that factor-free hiPSCs therefore represent a more suitable source of cells for modeling of human disease.	[Soldner, Frank; Hockemeyer, Dirk; Beard, Caroline; Gao, Qing; Bell, George W.; Cook, Elizabeth G.; Mitalipova, Maisam; Jaenisch, Rudolf] Whitehead Inst, Cambridge, MA 02142 USA; [Jaenisch, Rudolf] MIT, Dept Biol, Cambridge, MA 02139 USA; [Hargus, Gunnar; Blak, Alexandra; Cooper, Oliver; Isacson, Ole] Harvard Univ, Sch Med, McLean Hosp, Ctr Neurodegenerat Res,Udall Parkinson Dis Res Ct, Belmont, MA 02478 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Harvard University; McLean Hospital	Jaenisch, R (corresponding author), Whitehead Inst, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	jaenisch@wi.mit.edu		Isacson, Ole/0000-0001-8091-8302; Hockemeyer, Dirk/0000-0002-5598-5092; Cooper, Oliver/0000-0001-6567-7491	NIH [R37-CA084198, RO1-CA087869, RO1-HD045022]; Udall Parkinson's Disease Center [P50NS39793]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045022] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R37CA084198, R01CA087869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS039793] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Udall Parkinson's Disease Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Tobias Brambrink for providing the FUGW- loxP plasmid. We thank Raaji Alagappan, Ping Xu, Kristen Lee, and Elizabeth Marlow for technical support and Jessica Daussman, Ruth Flannery, and Dongdong Fu for their help with animal husbandry and processing of teratomas. We would like to thank the members of the Whitehead Genome Technology Core for their help with the microarray expression analysis. We thank all the members of the Jaenisch lab for helpful discussions and comments on the manuscript. D. H. is a Merck Fellow of the Life Science Research Foundation. R. J. was supported by NIH grants R37-CA084198, RO1-CA087869, and RO1-HD045022. This research was supported in part by a Collaborative Innovation Award from the Howard Hughes Medical Institute. O. I. is supported by Udall Parkinson's Disease Center of Excellence grant P50NS39793 and the Michael Stern Foundation. R. J. is an advisor to Stemgent, which has obtained a license from the Massachusetts Institute of Technology (MIT) to distribute some of the reagents used in this paper. F. S., D. H., and R. J. designed the experiments and wrote the paper. C. B. designed and performed Southern blot analysis. Q. G. analyzed all teratomas. G. B. analyzed the gene expression profile. E. G. C. assisted with the NotI/BSU36I sites of the FUGW- loxP, which contains a loxP site in the 30 LTR (Hanna et al., 2007).	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Allen JD, 1996, SEMIN CANCER BIOL, V7, P299, DOI 10.1006/scbi.1996.0038; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Carey BW, 2009, P NATL ACAD SCI USA, V106, P157, DOI 10.1073/pnas.0811426106; Costa M, 2007, NAT PROTOC, V2, P792, DOI 10.1038/nprot.2007.105; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208; Gasser T, 2007, MOVEMENT DISORD, V22, pS343, DOI 10.1002/mds.21676; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Hockemeyer D, 2008, CELL STEM CELL, V3, P346, DOI 10.1016/j.stem.2008.08.014; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kim BK, 2006, FEBS LETT, V580, P5869, DOI 10.1016/j.febslet.2006.09.053; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Markoulaki S, 2009, NAT BIOTECHNOL, V27, P169, DOI 10.1038/nbt.1520; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Park IH, 2008, NATURE, V451, P141, DOI 10.1038/natureO6534; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Roy NS, 2006, NAT MED, V12, P1259, DOI 10.1038/nm1495; Schulz JB, 2008, J NEUROL, V255, P3, DOI 10.1007/s00415-008-5011-4; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Sonntag KC, 2007, STEM CELLS, V25, P411, DOI 10.1634/stemcells.2006-0380; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Taniguchi M, 1998, NUCLEIC ACIDS RES, V26, P679, DOI 10.1093/nar/26.2.679; Trounson A, 2009, CELL STEM CELL, V4, P3, DOI 10.1016/j.stem.2008.12.002; von Kalle C, 2004, SEMIN HEMATOL, V41, P303, DOI 10.1053/j.seminhematol.2004.07.007; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	39	1125	1241	1	218	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 6	2009	136	5					964	977		10.1016/j.cell.2009.02.013	http://dx.doi.org/10.1016/j.cell.2009.02.013			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	415JU	19269371	Green Accepted, Bronze, Green Published			2022-12-01	WOS:000263930900018
J	Garvin, J; Buick, R; Anbar, AD; Arnold, GL; Kaufman, AJ				Garvin, Jessica; Buick, Roger; Anbar, Ariel D.; Arnold, Gail L.; Kaufman, Alan J.			Isotopic Evidence for an Aerobic Nitrogen Cycle in the Latest Archean	SCIENCE			English	Article							FIXATION; PARTICLES; EVOLUTION; SINKING; RECORD; OCEAN	The nitrogen cycle provides essential nutrients to the biosphere, but its antiquity in modern form is unclear. In a drill core though homogeneous organic- rich shale in the 2.5- billion- year- old Mount McRae Shale, Australia, nitrogen isotope values vary from +1.0 to +7.5 per mil (parts per thousand) and back to +2.5 parts per thousand over similar to 30 meters. These changes evidently record a transient departure from a largely anaerobic to an aerobic nitrogen cycle complete with nitrification and denitrification. Complementary molybdenum abundance and sulfur isotopic values suggest that nitrification occurred in response to a small increase in surface- ocean oxygenation. These data imply that nitrifying and denitrifying microbes had already evolved by the late Archean and were present before oxygen first began to accumulate in the atmosphere.	[Garvin, Jessica; Buick, Roger] Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA; [Garvin, Jessica; Buick, Roger] Univ Washington, Astrobiol Program, Seattle, WA 98195 USA; [Anbar, Ariel D.; Arnold, Gail L.] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA; [Anbar, Ariel D.; Arnold, Gail L.] Arizona State Univ, Sch Earth & Space Sci, Tempe, AZ 85287 USA; [Anbar, Ariel D.] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; [Kaufman, Alan J.] Univ Maryland, Dept Geol, College Pk, MD 20742 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; University System of Maryland; University of Maryland College Park	Buick, R (corresponding author), Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA.	buick@ess.washington.edu	Arnold, Gail L/A-5572-2010	Arnold, Gail L/0000-0001-9631-9830; Buick, Roger/0000-0003-0139-1659	NASA Astrobiology Drilling Program; NSF Geobiology and Low Temperature Geochemistry	NASA Astrobiology Drilling Program(National Aeronautics & Space Administration (NASA)); NSF Geobiology and Low Temperature Geochemistry(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank L. C. Bonser, J.S.R. Dunlop, A. H. Hickman, M. van Kranendonk, the Geological Survey of Western Australia, P. van Loenhout, and Mount Magnet Drilling for assistance with core recovery; the NASA Astrobiology Drilling Program and NSF Geobiology and Low Temperature Geochemistry for funding; and H. Knoll, J. Farquhar, R. E. Summons, and T. W. Lyons for advice.	Altabet MA, 1999, DEEP-SEA RES PT I, V46, P655, DOI 10.1016/S0967-0637(98)00084-3; ALTABET MA, 1988, DEEP-SEA RES, V35, P535, DOI 10.1016/0198-0149(88)90130-6; Anbar AD, 2002, SCIENCE, V297, P1137, DOI 10.1126/science.1069651; Anbar AD, 2007, SCIENCE, V317, P1903, DOI 10.1126/science.1140325; Beaumont V, 1999, PRECAMBRIAN RES, V96, P63, DOI 10.1016/S0301-9268(99)00005-4; BEBOUT GE, 1992, GEOCHIM COSMOCHIM AC, V56, P2839, DOI 10.1016/0016-7037(92)90363-N; Berman-Frank I., 2005, BIOGEOSCIENCES DISCU, V2005, P261, DOI DOI 10.5194/BGD-2-261-2005; Brocks JJ, 2003, GEOCHIM COSMOCHIM AC, V67, P4289, DOI 10.1016/S0016-7037(03)00208-4; Fogel M.L., 1993, ORGANIC GEOCHEMISTRY, P73, DOI DOI 10.1007/978-1-4615-2890-6_3; Holland HD, 2002, GEOCHIM COSMOCHIM AC, V66, P3811, DOI 10.1016/S0016-7037(02)00950-X; Jia YF, 2004, TERRA NOVA, V16, P102, DOI 10.1111/j.1365-3121.2004.00535.x; Kaplan WA., 1983, NITROGEN MARINE ENV, P139; Kaufman AJ, 2007, SCIENCE, V317, P1900, DOI 10.1126/science.1138700; Mincer TJ, 2007, ENVIRON MICROBIOL, V9, P1162, DOI 10.1111/j.1462-2920.2007.01239.x; Navarro-Gonzalez R, 2001, NATURE, V412, P61, DOI 10.1038/35083537; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; PINTI DL, 2005, LECT ASTROBIOLOGY, V1; Rasmussen B, 2005, GEOLOGY, V33, P725, DOI 10.1130/G21616.1; Schleper C, 2005, NAT REV MICROBIOL, V3, P479, DOI 10.1038/nrmicro1159; SHEN Y, 2005, ARCHEAN GEODYNAMIC E, P309; Sigman D.M., 2001, ENCY OCEAN SCI, P1884, DOI DOI 10.1006/RWOS.2001.0172; SUMMERS DP, 1993, NATURE, V365, P630, DOI 10.1038/365630a0; Thunell RC, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI [10.1029/2002GB002028, 10.1029/2003GB002185]; WADA E., 1990, NITROGEN SEA FORMS A; YUNG YL, 1979, SCIENCE, V203, P1002, DOI 10.1126/science.203.4384.1002; Zehr JP, 2002, APPL ENVIRON MICROB, V68, P1015, DOI 10.1128/AEM.68.3.1015-1024.2002; ZERKLE AL, 2006, GEOBIOLOGY, V4, P285	27	162	171	2	107	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2009	323	5917					1045	1048		10.1126/science.1165675	http://dx.doi.org/10.1126/science.1165675			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409AK	19229033				2022-12-01	WOS:000263478400037
J	Sokol, DK				Sokol, Daniel K.			Observations Ethics Man The death of DNR	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ALLOW NATURAL DEATH; CARDIOPULMONARY-RESUSCITATION		Univ London, London WC1E 7HU, England	University of London	Sokol, DK (corresponding author), Univ London, London WC1E 7HU, England.	daniel.sokol@talk21.com						Adams DH, 2006, J AM OSTEOPATH ASSOC, V106, P402; Chen YY, 2008, J MED ETHICS, V34, P887, DOI 10.1136/jme.2008.024570; Chessa F, 2004, HASTINGS CENT REP, V34, P4, DOI 10.2307/3527579; Cohen RW, 2004, HASTINGS CENT REP, V34, P4; Conroy SP, 2006, BRIT MED J, V332, P479, DOI 10.1136/bmj.332.7539.479; Jones GK, 2000, ACAD EMERG MED, V7, P48, DOI 10.1111/j.1553-2712.2000.tb01891.x; Jonsen AR, 2006, CLIN ETHICS; Venneman SS, 2008, J MED ETHICS, V34, P2, DOI 10.1136/jme.2006.018317	8	9	9	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 30	2009	338								b1723	10.1136/bmj.b1723	http://dx.doi.org/10.1136/bmj.b1723			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	440JY	19406889				2022-12-01	WOS:000265697800010
J	Iversen, A; Rushforth, B; Forrest, K				Iversen, Amy; Rushforth, Bruno; Forrest, Kirsty			Practice The Competent Novice How to handle stress and look after your mental health	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HOSPITAL CONSULTANTS; DOCTORS; BURNOUT; PRACTITIONERS; SATISFACTION; DEPRESSION; DISTRESS; GENDER; RISK		[Iversen, Amy] Inst Psychiat, Dept Psychol Med, London SE5 9RJ, England; [Rushforth, Bruno] Dewsbury & Dist Hosp, Dewsbury WF13 4HS, England; [Forrest, Kirsty] Leeds Gen Infirm, Leeds Teaching Hosp NHS Trust, Leeds LS1 3EX, W Yorkshire, England	University of London; King's College London; Leeds General Infirmary; University of Leeds	Iversen, A (corresponding author), Inst Psychiat, Dept Psychol Med, London SE5 9RJ, England.	a.iversen@iop.kcl.ac.uk	Iversen, Amy/D-1112-2011					Churchill R, 2001, HEALTH TECHNOL ASSES, V5, P1, DOI DOI 10.3310/HTA5350; Davidson SK, 2003, MED J AUSTRALIA, V179, P302, DOI 10.5694/j.1326-5377.2003.tb05552.x; Epstein RM, 1999, JAMA-J AM MED ASSOC, V282, P833, DOI 10.1001/jama.282.9.833; Firth-Cozens J, 2003, BRIT MED J, V326, P670, DOI 10.1136/bmj.326.7391.670; Firth-Cozens J, 2001, SOC SCI MED, V52, P215, DOI 10.1016/S0277-9536(00)00221-5; Firth-Cozens J., 1999, STRESS HLTH PROFESSI; FirthCozens J, 1997, SOC SCI MED, V44, P1017, DOI 10.1016/S0277-9536(96)00227-4; FIRTHCOZENS J, 1987, BRIT MED J, V295, P533, DOI 10.1136/bmj.295.6597.533; Forsythe M, 1999, BRIT MED J, V319, P605, DOI 10.1136/bmj.319.7210.605; General Medical Council, 2006, GOOD MED PRACT; GHODSE H, 2000, DOCTORS THEIR HLTH; Hawton K, 2001, J EPIDEMIOL COMMUN H, V55, P296, DOI 10.1136/jech.55.5.296; JONES JW, 1988, J APPL PSYCHOL, V73, P727, DOI 10.1037/0021-9010.73.4.727; JONES P, 2005, DOCTORS PATIENTS; Kjeldmand D, 2008, ANN FAM MED, V6, P138, DOI 10.1370/afm.813; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lazarus R.S., 1984, STRESS APPRAISAL COP; Leichsenring F, 2008, JAMA-J AM MED ASSOC, V300, P1551, DOI 10.1001/jama.300.13.1551; MANN MP, 1992, MED TEACH, V14, P311, DOI 10.3109/01421599209018849; McCray LW, 2008, FAM MED, V40, P626; McManus IC, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-29; Mead GE, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004366.pub3; *NAT I HLTH CLIN E, 2007, CLIN GUID NAT I HLTH, V23; Ospina-Kammerer Veronika, 2003, Int J Emerg Ment Health, V5, P29; Paice E, 2002, MED EDUC, V36, P56, DOI 10.1046/j.1365-2923.2002.01101.x; Ramirez AJ, 1996, LANCET, V347, P724, DOI 10.1016/S0140-6736(96)90077-X; Rosenzweig S, 2003, TEACH LEARN MED, V15, P88, DOI 10.1207/S15328015TLM1502_03; Sambunjak D, 2006, JAMA-J AM MED ASSOC, V296, P1103, DOI 10.1001/jama.296.9.1103; Taylor C, 2005, LANCET, V366, P742, DOI 10.1016/S0140-6736(05)67178-4; Taylor C, 2007, BRIT J PSYCHIAT, V190, P268, DOI 10.1192/bjp.bp.106.023234; Teasdale JD, 2000, J CONSULT CLIN PSYCH, V68, P615, DOI 10.1037//0022-006X.68.4.615; Wall TD, 1997, BRIT J PSYCHIAT, V171, P519, DOI 10.1192/bjp.171.6.519; Whelan P, 2008, J ROY SOC MED, V101, P313, DOI 10.1258/jrsm.2008.070449	33	10	10	2	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 27	2009	338								b1368	10.1136/bmj.b1368	http://dx.doi.org/10.1136/bmj.b1368			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	440JR	19398476				2022-12-01	WOS:000265697100009
J	Meijsing, SH; Pufall, MA; So, AY; Bates, DL; Chen, L; Yamamoto, KR				Meijsing, Sebastiaan H.; Pufall, Miles A.; So, Alex Y.; Bates, Darren L.; Chen, Lin; Yamamoto, Keith R.			DNA Binding Site Sequence Directs Glucocorticoid Receptor Structure and Activity	SCIENCE			English	Article							RESPONSE ELEMENTS; NUCLEAR RECEPTOR; GENE; EXPRESSION; REPRESSION; MOTIF	Genes are not simply turned on or off, but instead their expression is fine-tuned to meet the needs of a cell. How genes are modulated so precisely is not well understood. The glucocorticoid receptor (GR) regulates target genes by associating with specific DNA binding sites, the sequences of which differ between genes. Traditionally, these binding sites have been viewed only as docking sites. Using structural, biochemical, and cell-based assays, we show that GR binding sequences, differing by as little as a single base pair, differentially affect GR conformation and regulatory activity. We therefore propose that DNA is a sequence-specific allosteric ligand of GR that tailors the activity of the receptor toward specific target genes.	[Meijsing, Sebastiaan H.; Pufall, Miles A.; So, Alex Y.; Yamamoto, Keith R.] Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94158 USA; [So, Alex Y.; Yamamoto, Keith R.] Univ Calif San Francisco, Chem & Chem Biol Program, San Francisco, CA 94107 USA; [Bates, Darren L.; Chen, Lin] Univ So Calif, Dept Mol & Computat Biol, Los Angeles, CA 90089 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Southern California	Yamamoto, KR (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94158 USA.	yamamoto@cmp.ucsf.edu	chen, Lin/A-3392-2008	chen, Lin/0000-0003-4798-6199; Pufall, Miles/0000-0002-7022-6916	NIH [GM08537]; NATIONAL CANCER INSTITUTE [R01CA020535] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064642, T32GM008537, R01GM077320] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E.C. Bolton, A. Kroch, J. J. Miranda, and A. Frankel for reviewing the manuscript. Work by M.A.P. was performed under NIH grant GM08537 and by M.A.P. and S.H.M. as fellows of the Leukemia and Lymphoma Society. We received research support from NIH grants (to K.R.Y., D.L.B., and L.C.). Coordinates and structure factors have been deposited in the Protein Data Bank with accession codes 3FYL, 3G6P, 3G6Q, 3G6R, 3G6T, 3G6U, 3G8U, 3G97, 3G8X, 3G99, 3G9I, 3G9J, 3G9M, 3G9O, and 3G9P. K.R.Y. is a paid consultant with Merck and Company.	GODOWSKI PJ, 1987, NATURE, V325, P365, DOI 10.1038/325365a0; Hall JM, 2002, MOL ENDOCRINOL, V16, P469, DOI 10.1210/me.16.3.469; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Iniguez-Lluhi JA, 2000, MOL CELL BIOL, V20, P6040, DOI 10.1128/MCB.20.16.6040-6050.2000; Ismaili N, 2004, ANN NY ACAD SCI, V1024, P86, DOI 10.1196/annals.1321.007; KASAI Y, 1990, FEBS LETT, V274, P99, DOI 10.1016/0014-5793(90)81339-P; Kumar R, 1999, J BIOL CHEM, V274, P24737, DOI 10.1074/jbc.274.35.24737; LABAER J, 1994, J MOL BIOL, V239, P664, DOI 10.1006/jmbi.1994.1405; Lefstin JA, 1998, NATURE, V392, P885, DOI 10.1038/31860; Leung TH, 2004, CELL, V118, P453, DOI 10.1016/j.cell.2004.08.007; LUISI BF, 1991, NATURE, V352, P497, DOI 10.1038/352497a0; Ma H, 2001, CURR BIOL, V11, P1981, DOI 10.1016/S0960-9822(01)00600-5; Meyer T, 1997, DNA CELL BIOL, V16, P919, DOI 10.1089/dna.1997.16.919; MUCHARDT C, 1993, EMBO J, V12, P4279, DOI 10.1002/j.1460-2075.1993.tb06112.x; Nagy L, 2004, TRENDS BIOCHEM SCI, V29, P317, DOI 10.1016/j.tibs.2004.04.006; Roemer SC, 2006, MOL ENDOCRINOL, V20, P3042, DOI 10.1210/me.2005-0511; Rogatsky I, 1997, MOL CELL BIOL, V17, P3181, DOI 10.1128/MCB.17.6.3181; Rogatsky I, 2003, P NATL ACAD SCI USA, V100, P13845, DOI 10.1073/pnas.2336092100; Scully KM, 2000, SCIENCE, V290, P1127, DOI 10.1126/science.290.5494.1127; So AYL, 2007, PLOS GENET, V3, P927, DOI 10.1371/journal.pgen.0030094; STRAHLE U, 1987, P NATL ACAD SCI USA, V84, P7871, DOI 10.1073/pnas.84.22.7871; van Tilborg MAA, 2000, J MOL BIOL, V301, P947, DOI 10.1006/jmbi.2000.4001; Wang JC, 2004, P NATL ACAD SCI USA, V101, P15603, DOI 10.1073/pnas.0407008101	23	499	514	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2009	324	5925					407	410		10.1126/science.1164265	http://dx.doi.org/10.1126/science.1164265			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433QT	19372434	Green Accepted			2022-12-01	WOS:000265221600048
J	Povelones, M; Waterhouse, RM; Kafatos, FC; Christophides, GK				Povelones, Michael; Waterhouse, Robert M.; Kafatos, Fotis C.; Christophides, George K.			Leucine-Rich Repeat Protein Complex Activates Mosquito Complement in Defense Against Plasmodium Parasites	SCIENCE			English	Article							VECTOR ANOPHELES-GAMBIAE; IMMUNE-RESPONSES; MALARIA; PHAGOCYTOSIS; LAMPREY; GENES	Leucine-rich repeat-containing proteins are central to host defense in plants and animals. We show that in the mosquito Anopheles gambiae, two such proteins that antagonize malaria parasite infections, LRIM1 and APL1C, circulate in the hemolymph as a high-molecular-weight complex held together by disulfide bridges. The complex interacts with the complement C3-like protein, TEP1, promoting its cleavage or stabilization and its subsequent localization on the surface of midgut-invading Plasmodium berghei parasites, targeting them for destruction. LRIM1 and APL1C are members of a protein family with orthologs in other disease vector mosquitoes and appear to be important effectors in innate mosquito defenses against human pathogens.	[Povelones, Michael; Waterhouse, Robert M.; Kafatos, Fotis C.; Christophides, George K.] Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, Dept Life Sci, London SW7 2AZ, England	Imperial College London	Christophides, GK (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, Dept Life Sci, Exhibit Rd, London SW7 2AZ, England.	g.christophides@imperial.ac.uk	Waterhouse, Robert M/A-1858-2010	Waterhouse, Robert M/0000-0003-4199-9052; Christophides, George/0000-0002-3323-1687; Povelones, Michael/0000-0002-3766-2097	Wellcome Trust Program [GR077229/Z/05/Z]; NIH [2PO1AI044220-06A1]; Biotechnology and Biological Sciences Research Council [BB/E002641/1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI044220] Funding Source: NIH RePORTER; BBSRC [BB/E002641/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C519670/1] Funding Source: researchfish	Wellcome Trust Program(Wellcome Trust); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors thank A. C. Koutsos for generating the LRIM1 antibody and sharing it before publication and F. M. Ausubel for critically reviewing the manuscript. Fluorescence microscopy was performed at the Imperial College Facility for Imaging by Light Microscopy imaging facility. This work was supported by a Wellcome Trust Program grant (GR077229/Z/05/Z), an NIH Program Project (2PO1AI044220-06A1), and a Biotechnology and Biological Sciences Research Council grant (BB/E002641/1). R.M.W. was supported by a Wellcome Trust Ph.D. fellowship.	Aguilar R, 2005, INSECT BIOCHEM MOLEC, V35, P709, DOI 10.1016/j.ibmb.2005.02.019; Baxter RHG, 2007, P NATL ACAD SCI USA, V104, P11615, DOI 10.1073/pnas.0704967104; Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4; Blandin SA, 2008, CELL HOST MICROBE, V3, P364, DOI 10.1016/j.chom.2008.05.007; Cohuet A, 2006, EMBO REP, V7, P1285, DOI 10.1038/sj.embor.7400831; COLLINS FH, 1986, SCIENCE, V234, P607, DOI 10.1126/science.3532325; Dimopoulos G, 1997, P NATL ACAD SCI USA, V94, P11508, DOI 10.1073/pnas.94.21.11508; DONG Y, J BIOL CHEM; Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052; Frolet C, 2006, IMMUNITY, V25, P677, DOI 10.1016/j.immuni.2006.08.019; Habtewold T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000070; Herrin BR, 2008, P NATL ACAD SCI USA, V105, P2040, DOI 10.1073/pnas.0711619105; Levashina EA, 2001, CELL, V104, P709, DOI 10.1016/S0092-8674(01)00267-7; Moita LF, 2005, IMMUNITY, V23, P65, DOI 10.1016/j.immuni.2005.05.006; Muller HM, 1999, J BIOL CHEM, V274, P11727, DOI 10.1074/jbc.274.17.11727; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; Osta MA, 2004, SCIENCE, V303, P2030, DOI 10.1126/science.1091789; Pancer Z, 2004, NATURE, V430, P174, DOI 10.1038/nature02740; Riehle MM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003672; Riehle MM, 2006, SCIENCE, V312, P577, DOI 10.1126/science.1124153; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Warr E, 2006, INSECT BIOCHEM MOLEC, V36, P769, DOI 10.1016/j.ibmb.2006.07.006	22	181	183	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 10	2009	324	5924					258	261		10.1126/science.1171400	http://dx.doi.org/10.1126/science.1171400			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430WX	19264986	Green Accepted			2022-12-01	WOS:000265024400048
J	Cypess, AM; Lehman, S; Williams, G; Tal, I; Rodman, D; Goldfine, AB; Kuo, FC; Palmer, EL; Tseng, Y; Doria, A; Kolodny, GM; Kahn, CR				Cypess, Aaron M.; Lehman, Sanaz; Williams, Gethin; Tal, Ilan; Rodman, Dean; Goldfine, Allison B.; Kuo, Frank C.; Palmer, Edwin L.; Tseng, Yu-Hua; Doria, Alessandro; Kolodny, Gerald M.; Kahn, C. Ronald			Identification and Importance of Brown Adipose Tissue in Adult Humans.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; DIET-INDUCED THERMOGENESIS; F-18-FDG PET/CT; FDG-UPTAKE; USA-FAT; OBESITY; TEMPERATURE; PATIENT; MUSCLE; SCANS	Background: Obesity results from an imbalance between energy intake and expenditure. In rodents and newborn humans, brown adipose tissue helps regulate energy expenditure by thermogenesis mediated by the expression of uncoupling protein 1 (UCP1), but brown adipose tissue has been considered to have no physiologic relevance in adult humans. Methods: We analyzed 3640 consecutive (sup 18)F-fluorodeoxyglucose ((sup 18)F-FDG) positron-emission tomographic and computed tomographic (PET-CT) scans performed for various diagnostic reasons in 1972 patients for the presence of substantial depots of putative brown adipose tissue. Such depots were defined as collections of tissue that were more than 4 mm in diameter, had the density of adipose tissue according to CT, and had maximal standardized uptake values of (sup 18)F-FDG of at least 2.0 g per milliliter, indicating high metabolic activity. Clinical indexes were recorded and compared with those of date-matched controls. Immunostaining for UCP1 was performed on biopsy specimens from the neck and supraclavicular regions in patients undergoing surgery. Results: Substantial depots of brown adipose tissue were identified by PET-CT in a region extending from the anterior neck to the thorax. Tissue from this region had UCP1-immunopositive, multilocular adipocytes indicating brown adipose tissue. Positive scans were seen in 76 of 1013 women (7.5%) and 30 of 959 men (3.1%), corresponding to a female:male ratio greater than 2:1 (P<0.001). Women also had a greater mass of brown adipose tissue and higher (sup 18)F-FDG uptake activity. The probability of the detection of brown adipose tissue was inversely correlated with years of age (P<0.001), outdoor temperature at the time of the scan (P=0.02), beta-blocker use (P<0.001), and among older patients, body-mass index (P=0.007). Conclusions: Defined regions of functionally active brown adipose tissue are present in adult humans, are more frequent in women than in men, and may be quantified noninvasively with the use of (sup 18)F-FDG PET-CT. Most important, the amount of brown adipose tissue is inversely correlated with body-mass index, especially in older people, suggesting a potential role of brown adipose tissue in adult human metabolism. N Engl J Med 2009;360:1509-17.	[Kahn, C. Ronald] Joslin Diabet Ctr, Sect Obes & Hormone Act, Div Res, Boston, MA 02215 USA; [Lehman, Sanaz; Williams, Gethin; Tal, Ilan; Rodman, Dean; Kolodny, Gerald M.] Beth Israel Deaconess Med Ctr, Div Nucl Med, Boston, MA 02215 USA; [Kuo, Frank C.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Palmer, Edwin L.] Massachusetts Gen Hosp, Div Nucl Med, Boston, MA 02114 USA; [Cypess, Aaron M.; Lehman, Sanaz; Williams, Gethin; Tal, Ilan; Rodman, Dean; Goldfine, Allison B.; Kuo, Frank C.; Palmer, Edwin L.; Tseng, Yu-Hua; Doria, Alessandro; Kolodny, Gerald M.; Kahn, C. Ronald] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Kahn, CR (corresponding author), Joslin Diabet Ctr, Sect Obes & Hormone Act, Div Res, 1 Joslin Pl, Boston, MA 02215 USA.	c.ronald.kahn@joslin.harvard.edu	Kahn, Ronald/AAY-2435-2021; Tseng, Yu-Hua/AAE-6471-2021; Doria, Alessandro/H-9157-2018	Kahn, Ronald/0000-0002-7583-9228; Tseng, Yu-Hua/0000-0003-2053-9559; Doria, Alessandro/0000-0002-3830-4304; mcmurry, andy/0000-0001-5604-0704	National Institutes of Health [DK070722, P30 DK46200, DK33201, DK55545, DK046200-16]; Eli Lilly Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025757, UL1RR025758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033201, P30DK046200, T32DK007260, R21DK070722, R01DK055545, R01DK056690, P30DK040561] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eli Lilly Foundation(Eli Lilly); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by the Clinical Investigator Training Program, Beth Israel Deaconess Medical Center-Harvard/MIT Health Sciences and Technology, in collaboration with Pfizer and Merck; grants from the National Institutes of Health (DK070722 and P30 DK46200 [to Dr. Tseng], DK33201 and DK55545 [to Dr. Kahn], and DK046200-16 [to Dr. Cypess]); and the Eli Lilly Foundation.	Aldhahi Waleed, 2003, Curr Diab Rep, V3, P293, DOI 10.1007/s11892-003-0020-2; Almind K, 2007, P NATL ACAD SCI USA, V104, P2366, DOI 10.1073/pnas.0610416104; ASTRUP A, 1984, CLIN SCI, V66, P179, DOI 10.1042/cs0660179; Baba S, 2007, J NUCL MED, V48, P1715, DOI 10.2967/jnumed.107.041715; Barbaras L, 2007, AM J ROENTGENOL, V188, pW565, DOI 10.2214/AJR.06.1058; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cinti S, 2005, PROSTAG LEUKOTR ESS, V73, P9, DOI 10.1016/j.plefa.2005.04.010; Cohade C, 2003, J NUCL MED, V44, P1267; Cohade C, 2003, J NUCL MED, V44, P170; Dobert N, 2004, Q J NUCL MED MOL IM, V48, P33; ENGLISH JT, 1973, RADIOLOGY, V107, P279, DOI 10.1148/107.2.279; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Fukuchi K, 2004, EXP CLIN ENDOCR DIAB, V112, P601, DOI 10.1055/s-2004-830407; Garcia CA, 2004, MOL IMAGING BIOL, V6, P368, DOI 10.1016/j.mibio.2004.08.003; GARRUTI G, 1992, INT J OBESITY, V16, P383; Gelfand MJ, 2005, PEDIATR RADIOL, V35, P984, DOI 10.1007/s00247-005-1505-8; Gesta S, 2008, CELL, V135, P366, DOI 10.1016/j.cell.2008.09.048; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Hany TF, 2002, EUR J NUCL MED MOL I, V29, P1393, DOI 10.1007/s00259-002-0902-6; HEATON JM, 1972, J ANAT, V112, P35; HIMMSHAGEN J, 1979, CAN MED ASSOC J, V121, P1361; Hossain P, 2007, NEW ENGL J MED, V356, P973; HUTTUNEN P, 1981, EUR J APPL PHYSIOL O, V46, P339, DOI 10.1007/BF00422121; Lazar MA, 2005, SCIENCE, V307, P373, DOI 10.1126/science.1104342; Lowell BB, 1997, ANNU REV MED, V48, P307; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Parodi K, 2007, INT J RADIAT ONCOL, V68, P920, DOI 10.1016/j.ijrobp.2007.01.063; Parysow O, 2007, CLIN NUCL MED, V32, P351, DOI 10.1097/01.rlu.0000259570.69163.04; Ronti T, 2006, CLIN ENDOCRINOL, V64, P355, DOI 10.1111/j.1365-2265.2006.02474.x; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; ROSS R, 1991, J APPL PHYSIOL, V70, P2164, DOI 10.1152/jappl.1991.70.5.2164; ROTHWELL NJ, 1983, CLIN SCI, V64, P19, DOI 10.1042/cs0640019; ROTHWELL NJ, 1979, NATURE, V281, P31, DOI 10.1038/281031a0; Rousseau C, 2006, EUR J NUCL MED MOL I, V33, P785, DOI 10.1007/s00259-006-0066-x; Sharma AM, 2001, HYPERTENSION, V37, P250, DOI 10.1161/01.HYP.37.2.250; Tatsumi M, 2004, J NUCL MED, V45, P1189; Truong MT, 2004, AM J ROENTGENOL, V183, P1127, DOI 10.2214/ajr.183.4.1831127; Williams G, 2008, AM J ROENTGENOL, V190, P1406, DOI 10.2214/AJR.07.3205; Yang XL, 2003, OBES RES, V11, P1182, DOI 10.1038/oby.2003.163; Yeung HWD, 2003, J NUCL MED, V44, P1789	41	2954	3093	13	366	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 9	2009	360	15					1509	1517		10.1056/NEJMoa0810780	http://dx.doi.org/10.1056/NEJMoa0810780			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	430GL	19357406	Green Accepted			2022-12-01	WOS:000264976800007
J	Cho, DH; Nakamura, T; Fang, JG; Cieplak, P; Godzik, A; Gu, Z; Lipton, SA				Cho, Dong-Hyung; Nakamura, Tomohiro; Fang, Jianguo; Cieplak, Piotr; Godzik, Adam; Gu, Zezong; Lipton, Stuart A.			S-Nitrosylation of Drp1 Mediates beta-Amyloid-Related Mitochondrial Fission and Neuronal Injury	SCIENCE			English	Article							NITRIC-OXIDE; ALZHEIMERS-DISEASE; DYNAMIN; PROTEIN; NEURODEGENERATION; APOPTOSIS	Mitochondria continuously undergo two opposing processes, fission and fusion. The disruption of this dynamic equilibrium may herald cell injury or death and may contribute to developmental and neurodegenerative disorders. Nitric oxide functions as a signaling molecule, but in excess it mediates neuronal injury, in part via mitochondrial fission or fragmentation. However, the underlying mechanism for nitric oxide-induced pathological fission remains unclear. We found that nitric oxide produced in response to beta-amyloid protein, thought to be a key mediator of Alzheimer's disease, triggered mitochondrial fission, synaptic loss, and neuronal damage, in part via S-nitrosylation of dynamin-related protein 1 (forming SNO-Drp1). Preventing nitrosylation of Drp1 by cysteine mutation abrogated these neurotoxic events. SNO-Drp1 is increased in brains of human Alzheimer's disease patients and may thus contribute to the pathogenesis of neurodegeneration.	[Cho, Dong-Hyung; Nakamura, Tomohiro; Fang, Jianguo; Gu, Zezong; Lipton, Stuart A.] Burnham Inst Med Res, Ctr Neurosci Aging & Stem Cell Res, La Jolla, CA 92037 USA; [Cieplak, Piotr; Godzik, Adam] Burnham Inst Med Res, Bioinformat & Syst Biol Program, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute	Lipton, SA (corresponding author), Burnham Inst Med Res, Ctr Neurosci Aging & Stem Cell Res, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	slipton@burnham.org	Fang, Jianguo/K-8058-2016; Godzik, Adam/A-7279-2009; Godzik, Adam/AAW-1467-2020	Godzik, Adam/0000-0002-2425-852X; Godzik, Adam/0000-0002-2425-852X; Lipton, Stuart/0000-0002-3490-1259	Japan Society for the Promotion of Science; NIH [P01 HD29587, R01 EY05477, P01 ES016738, P30 NS057096]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD029587] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY005477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES016738] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057096] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank T. Newmeyer, J. Zaremba, J. Russo, E. Masliah, H. Xu, and Y. Zhang for help or reagents. Supported by the Japan Society for the Promotion of Science (T.N.) and NIH grants P01 HD29587, R01 EY05477, P01 ES016738, and P30 NS057096 (S.A.L.).	Baloyannis SJ, 2006, J ALZHEIMERS DIS, V9, P119; Barsoum MJ, 2006, EMBO J, V25, P3900, DOI 10.1038/sj.emboj.7601253; Bush AI, 2003, P NATL ACAD SCI USA, V100, P11193, DOI 10.1073/pnas.2135061100; Chen YJ, 2004, NAT STRUCT MOL BIOL, V11, P574, DOI 10.1038/nsmb762; Estaquier J, 2007, CELL DEATH DIFFER, V14, P1086, DOI 10.1038/sj.cdd.4402107; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Kang-Decker N, 2007, J CELL SCI, V120, P492, DOI 10.1242/jcs.03361; Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417; Li H, 2008, P NATL ACAD SCI USA, V105, P2169, DOI 10.1073/pnas.0711647105; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Low HH, 2006, NATURE, V444, P766, DOI 10.1038/nature05312; Pitts KR, 2004, J BIOL CHEM, V279, P50286, DOI 10.1074/jbc.M405531200; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Stamler JS, 1997, NEURON, V18, P691, DOI 10.1016/S0896-6273(00)80310-4; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; Wang GF, 2006, P NATL ACAD SCI USA, V103, P1295, DOI 10.1073/pnas.0508354103; Wang XL, 2008, P NATL ACAD SCI USA, V105, P19318, DOI 10.1073/pnas.0804871105; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697; Yuan H, 2007, CELL DEATH DIFFER, V14, P462, DOI 10.1038/sj.cdd.4402046; Zhu PP, 2004, J BIOL CHEM, V279, P35967, DOI 10.1074/jbc.M404105200	21	789	824	1	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2009	324	5923					102	105		10.1126/science.1171091	http://dx.doi.org/10.1126/science.1171091			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427TN	19342591	Green Accepted			2022-12-01	WOS:000264802100042
J	Maeda, S; Nakagawa, S; Suga, M; Yamashita, E; Oshima, A; Fujiyoshi, Y; Tsukihara, T				Maeda, Shoji; Nakagawa, So; Suga, Michihiro; Yamashita, Eiki; Oshima, Atsunori; Fujiyoshi, Yoshinori; Tsukihara, Tomitake			Structure of the connexin 26 gap junction channel at 3.5 angstrom resolution	NATURE			English	Article							AMINO-ACID-RESIDUES; EXTRACELLULAR LOOP; GATING POLARITY; 3-DIMENSIONAL STRUCTURE; CHARGE SELECTIVITY; DIFFRACTION DATA; PORE; MODEL; IDENTIFICATION; TERMINUS	Gap junctions consist of arrays of intercellular channels between adjacent cells that permit the exchange of ions and small molecules. Here we report the crystal structure of the gap junction channel formed by human connexin 26 (Cx26, also known as GJB2) at 3.5 angstrom resolution, and discuss structural determinants of solute transport through the channel. The density map showed the two membrane-spanning hemichannels and the arrangement of the four transmembrane helices of the six protomers forming each hemichannel. The hemichannels feature a positively charged cytoplasmic entrance, a funnel, a negatively charged transmembrane pathway, and an extracellular cavity. The pore is narrowed at the funnel, which is formed by the six amino-terminal helices lining the wall of the channel, which thus determines the molecular size restriction at the channel entrance. The structure of the Cx26 gap junction channel also has implications for the gating of the channel by the transjunctional voltage.	[Maeda, Shoji; Nakagawa, So; Suga, Michihiro; Yamashita, Eiki; Tsukihara, Tomitake] Osaka Univ, OLABB, Inst Prot Res, Osaka 5650874, Japan; [Oshima, Atsunori; Fujiyoshi, Yoshinori] Kyoto Univ, Grad Sch Sci, Dept Biophys, Sakyo Ku, Kyoto 6068502, Japan; [Tsukihara, Tomitake] Univ Hyogo, Grad Sch Life Sci, Picobiol Inst, Akoh, Hyogo 6781297, Japan	Osaka University; Kyoto University; University of Hyogo	Tsukihara, T (corresponding author), Osaka Univ, OLABB, Inst Prot Res, 6-2-3 Furuedai, Osaka 5650874, Japan.	tsuki@protein.osaka-u.ac.jp	Yamashita, Eiki/V-6758-2019; Fujiyoshi, Yoshinori/E-5989-2012; Oshima, Atsunori/F-8346-2010; Suga, Michi/C-2870-2015	Yamashita, Eiki/0000-0002-4278-0039; Fujiyoshi, Yoshinori/0000-0002-8070-1493; Oshima, Atsunori/0000-0003-1174-1368; Maeda, Shoji/0000-0002-7762-9793	Ministry of Education, Culture, Sports, Science, and Technology of Japan [10687101, 16087206, 18207006, A-041]; Japan Biological Informatics Consortium; Strategic Japan-UK Cooperation Program of the Japan Science and Technology Agency; New Energy and Industrial Technology Development Organization; Grants-in-Aid for Specially Promoted Research	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Biological Informatics Consortium; Strategic Japan-UK Cooperation Program of the Japan Science and Technology Agency; New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); Grants-in-Aid for Specially Promoted Research	We thank T. Tomizaki for help in the diffraction data collection on X06SA at the Swiss Light Source. This work was supported by Grants-in-Aid for Scientific Research ( 10687101, 16087206 and 18207006) and the GCOE program (A-041) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan ( to T. T.), the Japan Biological Informatics Consortium ( to T. T.), the Strategic Japan-UK Cooperation Program of the Japan Science and Technology Agency ( to T. T.), and Grants-in-Aid for Specially Promoted Research ( to Y. F.) and the New Energy and Industrial Technology Development Organization ( to Y. F.). We thank T. Walz for critical reading of this manuscript.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bellizzi JJ, 1999, STRUCTURE, V7, pR263, DOI 10.1016/S0969-2126(00)80020-9; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bukauskas FF, 2004, BBA-BIOMEMBRANES, V1662, P42, DOI 10.1016/j.bbamem.2004.01.008; Bukauskas FF, 2001, BIOPHYS J, V81, P137, DOI 10.1016/S0006-3495(01)75687-1; Cowtan K., 1994, JT CCP4 ESF EACBM NE, V31, P34; Cowtan KD, 1999, PROG BIOPHYS MOL BIO, V72, P245, DOI 10.1016/S0079-6107(99)00008-5; DeLano W. L., 2006, PYMOL MOL GRAPHICS S; Delmar M, 2004, CARDIOVASC RES, V62, P268, DOI 10.1016/j.cardiores.2003.12.030; Dodson E, 1996, ACTA CRYSTALLOGR D, V52, P228, DOI 10.1107/S0907444995010638; EBIHARA L, 1995, BIOPHYS J, V68, P1796, DOI 10.1016/S0006-3495(95)80356-5; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fleishman SJ, 2004, MOL CELL, V15, P879, DOI 10.1016/j.molcel.2004.08.016; Foote CI, 1998, J CELL BIOL, V140, P1187, DOI 10.1083/jcb.140.5.1187; Gong XQ, 2001, CELL COMMUN ADHES, V8, P187, DOI 10.3109/15419060109080721; Harris AL, 2001, Q REV BIOPHYS, V34, P325, DOI 10.1017/S0033583501003705; HARRIS AL, 1981, J GEN PHYSIOL, V77, P95, DOI 10.1085/jgp.77.1.95; JAN LY, 1992, ANNU REV PHYSIOL, V54, P535, DOI 10.1146/annurev.physiol.54.1.535; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kelsell DP, 2001, TRENDS CELL BIOL, V11, P2, DOI 10.1016/S0962-8924(00)01866-3; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; Kronengold J, 2003, J GEN PHYSIOL, V122, P389, DOI 10.1085/jgp.200308861; Kumar NM, 1996, CELL, V84, P381, DOI 10.1016/S0092-8674(00)81282-9; Laird DW, 2006, BIOCHEM J, V394, P527, DOI 10.1042/BJ20051922; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Levin M, 2007, PROG BIOPHYS MOL BIO, V94, P186, DOI 10.1016/j.pbiomolbio.2007.03.005; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Muller DJ, 2002, EMBO J, V21, P3598, DOI 10.1093/emboj/cdf365; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oh S, 2000, J GEN PHYSIOL, V116, P13, DOI 10.1085/jgp.116.1.13; Oh S, 2004, BIOPHYS J, V87, P912, DOI 10.1529/biophysj.103.038448; Oh S, 2008, J PHYSIOL-LONDON, V586, P2445, DOI 10.1113/jphysiol.2008.150805; Oshima A, 2003, J BIOL CHEM, V278, P1807, DOI 10.1074/jbc.M207713200; Oshima A, 2008, CELL COMMUN ADHES, V15, P85, DOI 10.1080/15419060802013588; Oshima A, 2007, P NATL ACAD SCI USA, V104, P10034, DOI 10.1073/pnas.0703704104; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peracchia C, 2004, BBA-BIOMEMBRANES, V1662, P61, DOI 10.1016/j.bbamem.2003.10.020; Perkins GA, 1998, J MOL BIOL, V277, P171, DOI 10.1006/jmbi.1997.1580; Purnick PEM, 2000, ARCH BIOCHEM BIOPHYS, V381, P181, DOI 10.1006/abbi.2000.1989; Purnick PEM, 2000, BIOPHYS J, V79, P2403, DOI 10.1016/S0006-3495(00)76485-X; Saez JC, 2003, PHYSIOL REV, V83, P1359, DOI 10.1152/physrev.00007.2003; SHERIDAN RP, 1982, P NATL ACAD SCI-BIOL, V79, P4545, DOI 10.1073/pnas.79.15.4545; Simon AM, 1998, TRENDS CELL BIOL, V8, P477, DOI 10.1016/S0962-8924(98)01372-5; Skerrett IM, 2002, J CELL BIOL, V159, P349, DOI 10.1083/jcb.200207060; STAUFFER KA, 1991, J CELL BIOL, V115, P141, DOI 10.1083/jcb.115.1.141; SUCHYNA TM, 1993, NATURE, V365, P847, DOI 10.1038/365847a0; Tao L, 2007, MOL PHARMACOL, V71, P570, DOI 10.1124/mol.106.027508; Trexler EB, 2000, BIOPHYS J, V79, P3036, DOI 10.1016/S0006-3495(00)76539-8; Trexler EB, 1996, P NATL ACAD SCI USA, V93, P5836, DOI 10.1073/pnas.93.12.5836; Unger VM, 1999, SCIENCE, V283, P1176, DOI 10.1126/science.283.5405.1176; UNWIN PNT, 1980, NATURE, V283, P545, DOI 10.1038/283545a0; UNWIN PNT, 1984, NATURE, V307, P609, DOI 10.1038/307609a0; VERSELIS VK, 1994, NATURE, V368, P348, DOI 10.1038/368348a0; Weber PA, 2004, BIOPHYS J, V87, P958, DOI 10.1529/biophysj.103.036350; Zhou XW, 1997, BIOPHYS J, V72, P1946, DOI 10.1016/S0006-3495(97)78840-4	58	518	529	2	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 2	2009	458	7238					597	U61		10.1038/nature07869	http://dx.doi.org/10.1038/nature07869			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RK	19340074				2022-12-01	WOS:000264796200033
J	Cohen, D				Cohen, Deborah			Medicine and the Media PSA testing: press coverage in UK and US is an ocean apart	BRITISH MEDICAL JOURNAL			English	Editorial Material												dcohen@bmj.com							0	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 27	2009	338								b1287	10.1136/bmj.b1287	http://dx.doi.org/10.1136/bmj.b1287			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	425LS	19329514				2022-12-01	WOS:000264639800004
J	Phipps, RJ; Gaunt, MJ				Phipps, Robert J.; Gaunt, Matthew J.			A Meta-Selective Copper-Catalyzed C-H Bond Arylation	SCIENCE			English	Article							FUNCTIONALIZATION; ARENES; ALKENYLATION; METALATION; MECHANISM; EFFICIENT; INDOLES	For over a century, chemical transformations of benzene derivatives have been guided by the high selectivity for electrophilic attack at the ortho/para positions in electron-rich substrates and at the meta position in electron-deficient molecules. We have developed a copper-catalyzed arylation reaction that, in contrast, selectively substitutes phenyl electrophiles at the aromatic carbon-hydrogen sites meta to an amido substituent. This previously elusive class of transformation is applicable to a broad range of aromatic compounds.	[Phipps, Robert J.; Gaunt, Matthew J.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	University of Cambridge	Gaunt, MJ (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.	mjg32@cam.ac.uk		Gaunt, Matthew/0000-0002-7214-608X	Biotechnology and Biological Sciences Research Council [Industrial Case Award]; GlaxoSmithKline [Industrial Case Award]; Royal Society [University Research Fellowship];  [Next Generation Fellowship]; Engineering and Physical Sciences Research Council [EP/D074487/1] Funding Source: researchfish; EPSRC [EP/D074487/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); GlaxoSmithKline(GlaxoSmithKline); Royal Society(Royal Society of London); ; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We gratefully acknowledge the Biotechnology and Biological Sciences Research Council and GlaxoSmithKline for an Industrial Case Award to R.J.P., the Royal Society for a University Research Fellowship to M.J.G., and Philip and Patricia Brown for a Next Generation Fellowship to M.J.G. We also thank S. Peace (GSK Medicines Research Center, UK) for useful discussion.	Alberico D, 2007, CHEM REV, V107, P174, DOI 10.1021/cr0509760; BARTON DHR, 1987, TETRAHEDRON LETT, V28, P887, DOI 10.1016/S0040-4039(01)81015-7; Beck EM, 2006, J AM CHEM SOC, V128, P2528, DOI 10.1021/ja058141u; Bielawski M, 2007, ADV SYNTH CATAL, V349, P2610, DOI 10.1002/adsc.200700373; Brasche G, 2008, ORG LETT, V10, P2207, DOI 10.1021/ol800619c; Campeau LC, 2008, J AM CHEM SOC, V130, P3266, DOI 10.1021/ja710451s; Chen X, 2006, J AM CHEM SOC, V128, P6790, DOI 10.1021/ja061715q; Cho JY, 2002, SCIENCE, V295, P305, DOI 10.1126/science.1067074; Daugulis O, 2005, ANGEW CHEM INT EDIT, V44, P4046, DOI 10.1002/anie.200500589; Davies DL, 2005, J AM CHEM SOC, V127, P13754, DOI 10.1021/ja052047w; Deprez NR, 2006, J AM CHEM SOC, V128, P4972, DOI 10.1021/ja060809x; Desai LV, 2008, J AM CHEM SOC, V130, P13285, DOI 10.1021/ja8045519; Evindar G, 2006, J ORG CHEM, V71, P1802, DOI 10.1021/jo051927q; Flemming JP, 2008, ORG BIOMOL CHEM, V6, P1215, DOI 10.1039/b716954j; Friedel C. A. C., 1877, CR HEBD ACAD SCI, V84, P1392; Garcia-Cuadrado D, 2006, J AM CHEM SOC, V128, P1066, DOI 10.1021/ja056165v; Godula K, 2006, SCIENCE, V312, P67, DOI 10.1126/science.1114731; Grimster NP, 2005, ANGEW CHEM INT EDIT, V44, P3125, DOI 10.1002/anie.200500468; Hassan J, 2002, CHEM REV, V102, P1359, DOI 10.1021/cr000664r; Jia CG, 2001, ACCOUNTS CHEM RES, V34, P633, DOI 10.1021/ar000209h; Lafrance M, 2006, J AM CHEM SOC, V128, P16496, DOI 10.1021/ja067144j; Li BJ, 2008, SYNLETT, P949, DOI 10.1055/s-2008-1042907; Mulvey RE, 2007, ANGEW CHEM INT EDIT, V46, P3802, DOI 10.1002/anie.200604369; MURAI S, 1993, NATURE, V366, P529, DOI 10.1038/366529a0; Murphy JM, 2007, J AM CHEM SOC, V129, P15434, DOI 10.1021/ja076498n; OLAH GA, 1963, FRIEDELCRAFTS RELATE; Phipps RJ, 2008, J AM CHEM SOC, V130, P8172, DOI 10.1021/ja801767s; Rohbogner CJ, 2008, ANGEW CHEM INT EDIT, V47, P1503, DOI 10.1002/anie.200703382; SNIECKUS V, 1990, CHEM REV, V90, P879, DOI 10.1021/cr00104a001; Stuart DR, 2007, J AM CHEM SOC, V129, P12072, DOI 10.1021/ja0745862; Thalji RK, 2004, J AM CHEM SOC, V126, P7192, DOI 10.1021/ja0394986; WANG DH, 2008, J AM CHEM SOC, V130, P14082	32	806	806	7	281	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2009	323	5921					1593	1597		10.1126/science.1169975	http://dx.doi.org/10.1126/science.1169975			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	421EN	19299616				2022-12-01	WOS:000264342300035
J	Cole, A				Cole, Andrew			Feature Environment Saving the planet as well as lives	BRITISH MEDICAL JOURNAL			English	Editorial Material												a.cole71@ntlworld.com						Hutchins DCJ, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b609; NHS Sustainable Development Unit, 2008, NHS ENGL CARB EM CAR; NHS Sustainable Development Unit, 2009, SAV CARB IMPR HLTH N	3	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 16	2009	338								b933	10.1136/bmj.b933	http://dx.doi.org/10.1136/bmj.b933			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	422NT	19289415				2022-12-01	WOS:000264435700004
J	Parashar, UD; Glass, RI				Parashar, Umesh D.; Glass, Roger I.			Global Health: Rotavirus Vaccines - Early Success, Remaining Questions.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							EFFICACY; SAFETY		[Parashar, Umesh D.] Ctr Dis Control & Prevent, Div Viral Dis, Viral Gastroenteritis Epidemiol Team, Atlanta, GA USA; [Glass, Roger I.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	Centers for Disease Control & Prevention - USA; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Parashar, UD (corresponding author), Ctr Dis Control & Prevent, Div Viral Dis, Viral Gastroenteritis Epidemiol Team, Atlanta, GA USA.							Centers for Disease Control and Prevention (CDC), 2008, MMWR Morb Mortal Wkly Rep, V57, P398; Haber P, 2008, PEDIATRICS, V121, P1206, DOI 10.1542/peds.2007-3793; Ruiz-Palacios GM, 2006, NEW ENGL J MED, V354, P11, DOI 10.1056/NEJMoa052434; Staat A. M., 2008, Morbidity and Mortality Weekly Report, V57, P697; Vesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664	5	60	62	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 12	2009	360	11					1063	1065		10.1056/NEJMp0810154	http://dx.doi.org/10.1056/NEJMp0810154			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	417BW	19279338				2022-12-01	WOS:000264051000003
J	Wu, PYJ; Nurse, P				Wu, Pei-Yun Jenny; Nurse, Paul			Establishing the Program of Origin Firing during S Phase in Fission Yeast	CELL			English	Article							DNA-REPLICATION ORIGINS; CYCLE-DEPENDENT REGULATION; CEREVISIAE CHROMOSOME VI; SACCHAROMYCES-CEREVISIAE; RECOGNITION COMPLEX; CELL-CYCLE; SCHIZOSACCHAROMYCES-POMBE; EGG EXTRACTS; CHROMATIN; PROTEINS	Initiation of eukaryotic DNA synthesis occurs at origins of replication that are utilized with characteristic times and frequencies during S phase. We have investigated origin usage by evaluating the kinetics of replication factor binding in fission yeast and show that similar to metazoa, ORC binding is periodic during the cell cycle, increasing during mitosis and peaking at M/G1. At an origin, the timing of ORC binding in M and pre-RC assembly in G1 correlates with the timing of firing during S, and the level of pre-IC formation reflects origin efficiency. Extending mitosis allows ORC to become more equally associated with origins and leads to genome-wide changes in origin usage, while overproduction of pre-IC factors increases replication of both efficient and inefficient origins. We propose that differential recruitment of ORC to origins during mitosis followed by competition among origins for limiting replication factors establishes the timing and efficiency of origin firing.	[Wu, Pei-Yun Jenny; Nurse, Paul] Rockefeller Univ, Lab Yeast Genet & Cell Biol, New York, NY 10065 USA	Rockefeller University	Wu, PYJ (corresponding author), Rockefeller Univ, Lab Yeast Genet & Cell Biol, 1230 York Ave, New York, NY 10065 USA.	pwu@rockefeller.edu		Wu, Pei-Yun/0000-0002-7965-583X	National Institutes of Health Postdoctoral Fellowship [GM075572]; Stanley Shuman Postdoctoral Fellowship; Breast Cancer Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM075572] Funding Source: NIH RePORTER	National Institutes of Health Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanley Shuman Postdoctoral Fellowship; Breast Cancer Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Shah-an Yang for help with the bioinformatics analysis. We are grateful to Supriya Prasanth and Bruce Stillman for sharing unpublished data and to all the members of the Laboratory of Yeast Genetics and Cell Biology for critical reading of the manuscript. This study was supported by National Institutes of Health Postdoctoral Fellowship GM075572, the Sydney and Stanley Shuman Postdoctoral Fellowship, and the Breast Cancer Research Foundation.	Aggarwal BD, 2004, NATURE, V430, P372, DOI 10.1038/nature02694; Aladjem MI, 2007, NAT REV GENET, V8, P588, DOI 10.1038/nrg2143; Aparicio JG, 2004, MOL CELL BIOL, V24, P4769, DOI 10.1128/MCB.24.11.4769-4780.2004; Aparicio OM, 1999, P NATL ACAD SCI USA, V96, P9130, DOI 10.1073/pnas.96.16.9130; Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; BROACH JR, 1982, COLD SPRING HARB SYM, V47, P1165, DOI 10.1101/SQB.1983.047.01.132; Brown GW, 1998, J BIOL CHEM, V273, P22083, DOI 10.1074/jbc.273.34.22083; Dai JL, 2005, P NATL ACAD SCI USA, V102, P337, DOI 10.1073/pnas.0408811102; DePamphilis ML, 2005, CELL CYCLE, V4, P70, DOI 10.4161/cc.4.1.1333; DIFFLEY JFX, 1994, CURR OPIN CELL BIOL, V6, P368, DOI 10.1016/0955-0674(94)90028-0; Dimitrova DS, 1999, MOL CELL, V4, P983, DOI 10.1016/S1097-2765(00)80227-0; Edwards MC, 2002, J BIOL CHEM, V277, P33049, DOI 10.1074/jbc.M204438200; Feng WY, 2006, NAT CELL BIOL, V8, P148, DOI 10.1038/ncb1358; Friedman KL, 1997, GENES CELLS, V2, P667, DOI 10.1046/j.1365-2443.1997.1520350.x; Grallert B, 1996, GENE DEV, V10, P2644, DOI 10.1101/gad.10.20.2644; Hayashi M, 2007, EMBO J, V26, P1327, DOI 10.1038/sj.emboj.7601585; HAYLES J, 1992, ANNU REV GENET, V26, P373, DOI 10.1146/annurev.ge.26.120192.002105; Heichinger C, 2006, EMBO J, V25, P5171, DOI 10.1038/sj.emboj.7601390; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; HYRIEN O, 1992, NUCLEIC ACIDS RES, V20, P1463, DOI 10.1093/nar/20.7.1463; Kim SM, 2001, EMBO J, V20, P6115, DOI 10.1093/emboj/20.21.6115; Li CJ, 2002, MOL CELL BIOL, V22, P105, DOI 10.1128/MCB.22.1.105-116.2002; Lucas I, 2007, EMBO REP, V8, P770, DOI 10.1038/sj.embor.7401026; Lygerou Z, 1999, J CELL SCI, V112, P3703; Martens JA, 2002, GENE DEV, V16, P2231, DOI 10.1101/gad.1009902; MAUNDRELL K, 1988, EMBO J, V7, P2203, DOI 10.1002/j.1460-2075.1988.tb03059.x; Meister P, 2007, EMBO J, V26, P1315, DOI 10.1038/sj.emboj.7601538; Mesner LD, 2006, MOL CELL, V21, P719, DOI 10.1016/j.molcel.2006.01.015; Mickle KL, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-112; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; Nguyen VQ, 2001, NATURE, V411, P1068, DOI 10.1038/35082600; Nishitani H, 2000, NATURE, V404, P625, DOI 10.1038/35007110; Ogawa Y, 1999, MOL CELL BIOL, V19, P7228; Okuno Y, 1999, MOL CELL BIOL, V19, P6699; Okuno Y, 2001, EMBO J, V20, P4263, DOI 10.1093/emboj/20.15.4263; Okuno Y, 1997, NUCLEIC ACIDS RES, V25, P530, DOI 10.1093/nar/25.3.530; Patel PK, 2006, MOL BIOL CELL, V17, P308, DOI 10.1091/mbc.E05-07-0657; Patel PK, 2008, MOL BIOL CELL, V19, P5550, DOI 10.1091/mbc.E08-06-0645; Pollok S, 2007, FEBS J, V274, P3669, DOI 10.1111/j.1742-4658.2007.05900.x; Poloumienko A, 2001, MOL BIOL CELL, V12, P3317, DOI 10.1091/mbc.12.11.3317; Raghuraman MK, 1997, SCIENCE, V276, P806, DOI 10.1126/science.276.5313.806; Remus D, 2005, J BIOL CHEM, V280, P39740, DOI 10.1074/jbc.M508515200; Romanowski P, 1996, CURR BIOL, V6, P1416, DOI 10.1016/S0960-9822(96)00746-4; ROWLEY A, 1995, EMBO J, V14, P2631, DOI 10.1002/j.1460-2075.1995.tb07261.x; Santocanale C, 1996, EMBO J, V15, P6671, DOI 10.1002/j.1460-2075.1996.tb01057.x; SHINOMIYA T, 1991, NUCLEIC ACIDS RES, V19, P3935, DOI 10.1093/nar/19.14.3935; STINCHCOMB DT, 1979, NATURE, V282, P39, DOI 10.1038/282039a0; Sun WH, 2002, EMBO J, V21, P1437, DOI 10.1093/emboj/21.6.1437; Takahashi T, 2003, EMBO J, V22, P964, DOI 10.1093/emboj/cdg079; Vogelauer M, 2002, MOL CELL, V10, P1223, DOI 10.1016/S1097-2765(02)00702-5; Yabuuchi H, 2006, EMBO J, V25, P4663, DOI 10.1038/sj.emboj.7601347; Yamashita M, 1997, GENES CELLS, V2, P655, DOI 10.1046/j.1365-2443.1997.1530351.x; Zou L, 2000, MOL CELL BIOL, V20, P3086, DOI 10.1128/MCB.20.9.3086-3096.2000	56	103	103	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 6	2009	136	5					852	864		10.1016/j.cell.2009.01.017	http://dx.doi.org/10.1016/j.cell.2009.01.017			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	415JU	19269364	Green Accepted, Bronze			2022-12-01	WOS:000263930900009
J	Durham, WM; Kessler, JO; Stocker, R				Durham, William M.; Kessler, John O.; Stocker, Roman			Disruption of Vertical Motility by Shear Triggers Formation of Thin Phytoplankton Layers	SCIENCE			English	Article							MICROORGANISMS; BLOOM; MECHANISMS; PATTERNS; PLANKTON; MODEL; FLOW	Thin layers of phytoplankton are important hotspots of ecological activity that are found in the coastal ocean, meters beneath the surface, and contain cell concentrations up to two orders of magnitude above ambient concentrations. Current interpretations of their formation favor abiotic processes, yet many phytoplankton species found in these layers are motile. We demonstrated that layers formed when the vertical migration of phytoplankton was disrupted by hydrodynamic shear. This mechanism, which we call gyrotactic trapping, can be responsible for the thin layers of phytoplankton commonly observed in the ocean. These results reveal that the coupling between active microorganism motility and ambient fluid motion can shape the macroscopic features of the marine ecological landscape.	[Durham, William M.; Stocker, Roman] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; [Kessler, John O.] Univ Arizona, Dept Phys, Tucson, AZ 85721 USA	Massachusetts Institute of Technology (MIT); University of Arizona	Stocker, R (corresponding author), MIT, Dept Civil & Environm Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	romans@mit.edu	Stocker, Roman/T-9456-2017; Stocker, Roman/N-8987-2019	Stocker, Roman/0000-0002-3199-0508; 	National Defense Science and Engineering Graduate Fellowship; Department of Energy [W31-109-ENG38]; NSF [OCE 0526241, OCE CAREER 0744641]; MIT's Earth Systems Initiative; Doherty Professorship	National Defense Science and Engineering Graduate Fellowship; Department of Energy(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); MIT's Earth Systems Initiative; Doherty Professorship	We thank P. Franks, W. Young, D. Grunbaum, T. Cowles, R. Bearon, M. Bees, D. Hader, D. Anderson, M. McManus, and L. Karp-Boss for helpful discussions; T. Peacock for the loan of experimental equipment; T. Clay and S. Stransky for developing BacTrack; R. A. Cattolico for providing H. akashiwo; and J. Mitchell, E. DeLong, S. Chisholm, M. Polz, H. Nepf, J. Seymour, J. Bragg, B. Kirkup, P. Reis, D. Birch, and S. Sunghwan for comments on the manuscript. W. M. D. acknowledges a National Defense Science and Engineering Graduate Fellowship. J.O.K. acknowledges support from Department of Energy grant W31-109-ENG38. R. S. acknowledges support from NSF (OCE 0526241 and OCE CAREER 0744641), MIT's Earth Systems Initiative, and a Doherty Professorship.	Alldredge AL, 2002, MAR ECOL PROG SER, V233, P1, DOI 10.3354/meps233001; Azam F, 2007, NAT REV MICROBIOL, V5, P782, DOI 10.1038/nrmicro1747; Birch DA, 2008, DEEP-SEA RES PT I, V55, P277, DOI 10.1016/j.dsr.2007.11.009; BJORNSEN PK, 1991, MAR ECOL PROG SER, V73, P263, DOI 10.3354/meps073263; BRETHERTON F, 1961, PROC R SOC SER B-BIO, V153, P490, DOI 10.1098/rspb.1961.0014; Cowles T., 2003, HDB SCALING METHODS, P31; Cowles T. J., 1998, OCEANOGRAPHY, V11, P4, DOI DOI 10.5670/0CEAN0G.1998.08; Dekshenieks MM, 2001, MAR ECOL PROG SER, V223, P61, DOI 10.3354/meps223061; Donaghay PL, 1997, LIMNOL OCEANOGR, V42, P1283, DOI 10.4319/lo.1997.42.5_part_2.1283; FRANKS PJS, 1995, DEEP-SEA RES PT I, V42, P75, DOI 10.1016/0967-0637(94)00028-Q; Genin A, 2005, SCIENCE, V308, P860, DOI 10.1126/science.1107834; Hill J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.068101; Hill NA, 1997, J THEOR BIOL, V186, P503, DOI 10.1006/jtbi.1997.0421; JONES MS, 1994, J FLUID MECH, V281, P137, DOI 10.1017/S002211209400306X; KAMYKOWSKI D, 1992, MAR BIOL, V113, P319; Kessler J.O., 1986, Progress phycol. Res., V4, P257; KESSLER JO, 1985, NATURE, V313, P218, DOI 10.1038/313218a0; LASKER R, 1975, FISH B-NOAA, V73, P453; Lebert M, 1996, NATURE, V379, P590, DOI 10.1038/379590a0; McManus MA, 2003, MAR ECOL PROG SER, V261, P1, DOI 10.3354/meps261001; Mitchell JG, 2008, J MARINE SYST, V69, P247, DOI 10.1016/j.jmarsys.2006.01.019; Mouritsen LT, 2003, J PLANKTON RES, V25, P783, DOI 10.1093/plankt/25.7.783; NIELSEN TG, 1990, MAR ECOL PROG SER, V62, P21, DOI 10.3354/meps062021; PEDLEY TJ, 1988, J FLUID MECH, V195, P223, DOI 10.1017/S0022112088002393; Roberts AM, 2002, J FLUID MECH, V452, P405, DOI 10.1017/S0022112001006772; Ryan JP, 2008, MAR ECOL PROG SER, V354, P21, DOI 10.3354/meps07222; Stacey MT, 2007, LIMNOL OCEANOGR, V52, P1523, DOI 10.4319/lo.2007.52.4.1523; Stocker R, 2008, P NATL ACAD SCI USA, V105, P4209, DOI 10.1073/pnas.0709765105; Townsend DW, 2005, DEEP-SEA RES PT II, V52, P2603, DOI 10.1016/j.dsr2.2005.06.028; YAMOCHI S, 1984, MAR BIOL, V83, P255, DOI 10.1007/BF00397457	30	201	203	1	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2009	323	5917					1067	1070		10.1126/science.1167334	http://dx.doi.org/10.1126/science.1167334			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409AK	19229037				2022-12-01	WOS:000263478400044
J	Bristol, N				Bristol, Nellie			Medicare drug expansion causes controversy in the USA	LANCET			English	Editorial Material																			0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 14	2009	373	9663					532	532		10.1016/S0140-6736(09)60183-5	http://dx.doi.org/10.1016/S0140-6736(09)60183-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	406ZO	19230076	Green Submitted			2022-12-01	WOS:000263333600013
J	Gerber, LR; Morissette, L; Kaschner, K; Pauly, D				Gerber, Leah R.; Morissette, Lyne; Kaschner, Kristin; Pauly, Daniel			ECOLOGY Should Whales Be Culled to Increase Fishery Yield?	SCIENCE			English	Editorial Material							DIVERSITY; ISSUE		[Gerber, Leah R.; Morissette, Lyne; Kaschner, Kristin] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Morissette, Lyne] Inst Sci Mer Rimouski, Rimouski, PQ G5L 3A1, Canada; [Kaschner, Kristin] Univ Freiburg, Inst Biol & Zool, Evolut Biol & Ecol Lab, Freiburg, Germany; [Pauly, Daniel] Univ British Columbia, Sea Around Us Project, Fisheries Ctr, Vancouver, BC V6T 1Z4, Canada	Arizona State University; Arizona State University-Tempe; University of Freiburg; University of British Columbia	Gerber, LR (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	leah.gerber@asu.edu	Pauly, Daniel Marc/AAY-2316-2021; Kaschner, Kristin/GQQ-6475-2022	Gerber, Leah/0000-0002-6763-6842; Pauly, Daniel/0000-0003-3756-4793; Kaschner, Kristin/0000-0002-4061-626X				3rd Millennium Foundation, 2007, JAP VOT CONS OP INT; Acevedo J, 2007, MAR MAMMAL SCI, V23, P453, DOI 10.1111/j.1748-7692.2007.00116.x; Bogstad Bjarte, 1997, Journal of Northwest Atlantic Fishery Science, V22, P317; BUSBY L, 2004, GLOBAL CORRUPTION RE, P76; Clapham PJ, 2007, MAR POLICY, V31, P314, DOI 10.1016/j.marpol.2006.09.004; Corkeron PJ, 2009, MAR ECOL PROG SER, V375, P305, DOI 10.3354/meps07882; Corkeron PJ, 2004, CONSERV BIOL, V18, P847, DOI 10.1111/j.1523-1739.2004.00255.x; Corkeron PJ, 1999, MAR MAMMAL SCI, V15, P1228, DOI 10.1111/j.1748-7692.1999.tb00887.x; Duffy JE, 2003, ECOL LETT, V6, P680, DOI 10.1046/j.1461-0248.2003.00494.x; Gales NJ, 2005, NATURE, V435, P883, DOI 10.1038/435883a; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Herrera GE, 2006, MAR POLICY, V30, P261, DOI 10.1016/j.marpol.2004.12.005; Higham JES, 2007, CONSERV BIOL, V21, P554, DOI 10.1111/j.1523-1739.2006.00580.x; Holt SJ, 2007, MAR POLLUT BULL, V54, P1081, DOI 10.1016/j.marpolbul.2007.05.011; Hoyt E, 2002, COAST MANAGE, V30, P381, DOI 10.1080/089207502900273; *IWC, 2002, ICES J MAR SCI, V4, P325; *IWC, 2008, S UT DUR RESS MAR VI; *IWC, 2008, SCI COMM REP 60 ANN; *IWC, 2006, CHAIRM REP INT WHAL; *IWC, 2004, ICES J MAR SCI S, V6, P413; Jann B., 2003, Journal of Cetacean Research and Management, V5, P125; KASCHNER K, 2005, STATE ANIMALS, V3, P95; Katona, 1990, REPORT INT WHALING C, V12, P295; Komatsu M., 2001, TRUTH WHALING DISPUT; Miller AR, 2007, GLOBAL ENVIRON POLIT, V7, P69, DOI 10.1162/glep.2007.7.1.69; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Paine RT, 1998, ECOSYSTEMS, V1, P535, DOI 10.1007/s100219900049; PAULY D, 2008, SEA AROUND US PROJEC; Perrin W.F., 2002, ENCY MARINE MAMMALS; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Springer AM, 2003, P NATL ACAD SCI USA, V100, P12223, DOI 10.1073/pnas.1635156100; Stefansson Gunnar, 1997, Journal of Northwest Atlantic Fishery Science, V22, P357; Stringer KD, 2006, DIPL STATECRAFT, V17, P547, DOI 10.1080/09592290600867636; Tamura T, 2003, RESPONSIBLE FISHERIES IN THE MARINE ECOSYSTEM, P143, DOI 10.1079/9780851996332.0143; Worm B, 2005, SCIENCE, V309, P1365, DOI 10.1126/science.1113399	37	48	49	0	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 13	2009	323	5916					880	881		10.1126/science.1169981	http://dx.doi.org/10.1126/science.1169981			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406KW	19213900				2022-12-01	WOS:000263295400022
J	Gielen, M; Retchless, BS; Mony, L; Johnson, JW; Paoletti, P				Gielen, Marc; Retchless, Beth Siegler; Mony, Laetitia; Johnson, Jon W.; Paoletti, Pierre			Mechanism of differential control of NMDA receptor activity by NR2 subunits	NATURE			English	Article							D-ASPARTATE RECEPTOR; GLUTAMATE-RECEPTOR; ZINC INHIBITION; LIGAND-BINDING; MOLECULAR DETERMINANTS; CHANNEL; DOMAIN; AFFINITY; ACTIVATION; PROTON	N-methyl-D-aspartate ( NMDA) receptors (NMDARs) are a major class of excitatory neurotransmitter receptors in the central nervous system. They form glutamate-gated ion channels that are highly permeable to calcium and mediate activity-dependent synaptic plasticity(1). NMDAR dysfunction is implicated in multiple brain disorders, including stroke, chronic pain and schizophrenia(2). NMDARs exist as multiple subtypes with distinct pharmacological and biophysical properties that are largely determined by the type of NR2 subunit (NR2A to NR2D) incorporated in the heteromeric NR1/NR2 complex(1,3,4). A fundamental difference between NMDAR subtypes is their channel maximal open probability (Po), which spans a 50-fold range from about 0.5 for NR2A-containing receptors to about 0.01 for receptors containing NR2C and NR2D; NR2B-containing receptors have an intermediate value (about 0.1)(5-9). These differences in Po confer unique charge transfer capacities and signalling properties on each receptor subtype(4,6,10,11). The molecular basis for this profound difference in activity between NMDAR subtypes is unknown. Here we show that the subunit-specific gating of NMDARs is controlled by the region formed by the NR2 amino-terminal domain (NTD), an extracellular clamshell-like domain previously shown to bind allosteric inhibitors(12-15), and the short linker connecting the NTD to the agonist-binding domain (ABD). The subtype specificity of NMDAR Po largely reflects differences in the spontaneous (ligand-independent) equilibrium between open-cleft and closed-cleft conformations of the NR2-NTD. This NTD-driven gating control also affects pharmacological properties by setting the sensitivity to the endogenous inhibitors zinc and protons. Our results provide a proof of concept for a drug-based bidirectional control of NMDAR activity by using molecules acting either as NR2-NTD 'closers' or 'openers' promoting receptor inhibition or potentiation, respectively.	[Gielen, Marc; Mony, Laetitia; Paoletti, Pierre] CNRS, Ecole Normale Super, Neurobiol Lab, F-75005 Paris, France; [Retchless, Beth Siegler; Johnson, Jon W.] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Universite Paris Cite; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Paoletti, P (corresponding author), CNRS, Ecole Normale Super, Neurobiol Lab, 46 Rue Ulm, F-75005 Paris, France.	paoletti@biologie.ens.fr	Mony, Laetitia/AAZ-9340-2020; Gielen, Marc/AAA-8760-2020; Paoletti, Pierre/L-7358-2013; Mony, Laetitia/F-3790-2017	Paoletti, Pierre/0000-0002-3681-4845; Mony, Laetitia/0000-0001-7753-6231; Gielen, Marc/0000-0003-0941-4325	Ministere de la Recherche; Universite Pierre et Marie Curie (UPMC); Fondation pour la Recherche Medicale (FRM); NIH [R01 MH045817]; Institut National de la Sante et de la Recherche Medicale (INSERM); Agence Nationale pour la Recherche (ANR); GlaxoSmith Kline; Equipe FRM; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH079755, R01MH045817] Funding Source: NIH RePORTER	Ministere de la Recherche(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, France); Universite Pierre et Marie Curie (UPMC); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Agence Nationale pour la Recherche (ANR)(French National Research Agency (ANR)); GlaxoSmith Kline(GlaxoSmithKline); Equipe FRM; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank B. Barbour, P.-J. Corringer, J. Neyton and D. Stroebel for comments on the manuscript, and S. Carvalho, M. Casado and M. Gendrel for experimental help. This work was supported by the Ministere de la Recherche (M. G., L. M.), the Universite Pierre et Marie Curie (UPMC) and the Fondation pour la Recherche Medicale (FRM) ( M. G.), NIH grant R01 MH045817 ( J. W. J.), the Institut National de la Sante et de la Recherche Medicale (INSERM), the Agence Nationale pour la Recherche (ANR), GlaxoSmith Kline and an Equipe FRM grant (P. P.).	Blanke ML, 2008, J BIOL CHEM, V283, P21519, DOI 10.1074/jbc.M709190200; Chen NS, 1999, J NEUROSCI, V19, P6844, DOI 10.1523/JNEUROSCI.19-16-06844.1999; Choi YB, 1999, NEURON, V23, P171, DOI 10.1016/S0896-6273(00)80763-1; Colquhoun David, 1995, P483; Cull-Candy Stuart G, 2004, Sci STKE, V2004, pre16, DOI 10.1126/stke.2552004re16; Dingledine R, 1999, PHARMACOL REV, V51, P7; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Dravid SM, 2008, J PHYSIOL-LONDON, V586, P4425, DOI 10.1113/jphysiol.2008.158634; Erreger K, 2005, J PHYSIOL-LONDON, V563, P345, DOI 10.1113/jphysiol.2004.080028; Erreger K, 2008, J PHYSIOL-LONDON, V586, P763, DOI 10.1113/jphysiol.2007.143941; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Gielen M, 2008, NEURON, V57, P80, DOI 10.1016/j.neuron.2007.11.021; JACKSON MB, 1983, BIOPHYS J, V42, P109, DOI 10.1016/S0006-3495(83)84375-6; Jones KS, 2002, J NEUROSCI, V22, P2044, DOI 10.1523/JNEUROSCI.22-06-02044.2002; Kemp JA, 2002, NAT NEUROSCI, V5, P1039, DOI 10.1038/nn936; Kniazeff J, 2004, J NEUROSCI, V24, P370, DOI 10.1523/JNEUROSCI.3141-03.2004; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Lisman JE, 2008, TRENDS NEUROSCI, V31, P234, DOI 10.1016/j.tins.2008.02.005; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007; Low CM, 2003, MOL PHARMACOL, V63, P1212, DOI 10.1124/mol.63.6.1212; Low CM, 2000, P NATL ACAD SCI USA, V97, P11062, DOI 10.1073/pnas.180307497; Marvin JS, 2001, NAT STRUCT BIOL, V8, P795, DOI 10.1038/nsb0901-795; Mayer ML, 2006, NATURE, V440, P456, DOI 10.1038/nature04709; Mony L, 2009, MOL PHARMACOL, V75, P60, DOI 10.1124/mol.108.050971; Paoletti P, 2000, NEURON, V28, P911, DOI 10.1016/S0896-6273(00)00163-X; Paoletti P, 1997, J NEUROSCI, V17, P5711; Paoletti P, 2007, CURR OPIN PHARMACOL, V7, P39, DOI 10.1016/j.coph.2006.08.011; Perin-Dureau F, 2002, J NEUROSCI, V22, P5955; Popescu G, 2004, NATURE, V430, P790, DOI 10.1038/nature02775; Rachline J, 2005, J NEUROSCI, V25, P308, DOI 10.1523/JNEUROSCI.3967-04.2005; Schorge S, 2005, J PHYSIOL-LONDON, V569, P395, DOI 10.1113/jphysiol.2005.095349; SIGWORTH FJ, 1987, BIOPHYS J, V52, P1047, DOI 10.1016/S0006-3495(87)83298-8; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Tang C, 2007, NATURE, V449, P1078, DOI 10.1038/nature06232; Wyllie DJA, 1998, J PHYSIOL-LONDON, V510, P1, DOI 10.1111/j.1469-7793.1998.001bz.x; Yuan HJ, 2005, J BIOL CHEM, V280, P29708, DOI 10.1074/jbc.M414215200; Zheng F, 2001, NAT NEUROSCI, V4, P894, DOI 10.1038/nn0901-894	38	236	247	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 4	2009	459	7247					703	U107		10.1038/nature07993	http://dx.doi.org/10.1038/nature07993			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453KF	19404260	Green Accepted, Green Submitted			2022-12-01	WOS:000266608600044
J	Ma, Y; Szostkiewicz, I; Korte, A; Moes, D; Yang, Y; Christmann, A; Grill, E				Ma, Yue; Szostkiewicz, Izabela; Korte, Arthur; Moes, Daniele; Yang, Yi; Christmann, Alexander; Grill, Erwin			Regulators of PP2C Phosphatase Activity Function as Abscisic Acid Sensors	SCIENCE			English	Article							EARLY SEEDLING DEVELOPMENT; CRYSTAL-STRUCTURE; ABA CONTROL; ARABIDOPSIS; PROTEIN; ABI1; GERMINATION; RECEPTOR; SIGNAL; TRANSDUCTION	The plant hormone abscisic acid (ABA) acts as a developmental signal and as an integrator of environmental cues such as drought and cold. Key players in ABA signal transduction include the type 2C protein phosphatases (PP2Cs) ABI1 and ABI2, which act by negatively regulating ABA responses. In this study, we identify interactors of ABI1 and ABI2, which we have named regulatory components of ABA receptor (RCARs). In Arabidopsis, RCARs belong to a family with 14 members that share structural similarity with class 10 pathogen-related proteins. RCAR1 was shown to bind ABA, to mediate ABA-dependent inactivation of ABI1 or ABI2 in vitro, and to antagonize PP2C action in planta. Other RCARs also mediated ABA-dependent regulation of ABI1 and ABI2, consistent with a combinatorial assembly of receptor complexes.	[Ma, Yue; Szostkiewicz, Izabela; Korte, Arthur; Moes, Daniele; Yang, Yi; Christmann, Alexander; Grill, Erwin] Tech Univ Munich, Lehrstuhl Bot, D-85354 Freising Weihenstephan, Germany	Technical University of Munich	Grill, E (corresponding author), Tech Univ Munich, Lehrstuhl Bot, Hochanger 4, D-85354 Freising Weihenstephan, Germany.	erwin.grill@wzw.tum.de	Christmann, Alexander/I-2655-2017; Korte, Arthur/H-3190-2019	Christmann, Alexander/0000-0002-3242-0814; Korte, Arthur/0000-0003-0831-1463; Yang, Yi/0000-0001-6051-4992	Deutsche Forschungsgemeinschaft [CH-182/5]; European Union Marie-Curie-Program [MEST-CT-2005-020232]; Fonds der Chemischen Industrie	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union Marie-Curie-Program(European Commission); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This study was funded by the Deutsche Forschungsgemeinschaft CH-182/5, European Union Marie-Curie-Program MEST-CT-2005-020232, and the Fonds der Chemischen Industrie. We thank J. Berger, C. Heidersberger, and C. Kornbauer for technical assistance. We are grateful to D. Weinfurtner, Chemistry Department TUM, and K. Berendzen, University of Tubingen, for help in conducting the ITC and FACS analysis, respectively. The cytokinin reporter and the At5g46790 cDNA clone were kindly provided by J. Sheen, Harvard University, and the Arabidopsis Biological Resource Center, USA, respectively. We thank F. Assaad for critical reading of the manuscript. This contribution is dedicated to Hubert Ziegler, who passed away on 17 April 2009.	Adie BAT, 2007, PLANT CELL, V19, P1665, DOI 10.1105/tpc.106.048041; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Christmann A, 2007, PLANT J, V52, P167, DOI 10.1111/j.1365-313X.2007.03234.x; Fernandes H, 2008, J MOL BIOL, V378, P1040, DOI 10.1016/j.jmb.2008.03.027; Gao YJ, 2007, PLANT J, V52, P1001, DOI 10.1111/j.1365-313X.2007.03291.x; Guo JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002982; Guo Y, 2002, DEV CELL, V3, P233, DOI 10.1016/S1534-5807(02)00229-0; Himmelbach A, 2002, EMBO J, V21, P3029, DOI 10.1093/emboj/cdf316; Hirayama T, 2007, TRENDS PLANT SCI, V12, P343, DOI 10.1016/j.tplants.2007.06.013; Johnston CA, 2007, SCIENCE, V318, DOI 10.1126/science.1143230; Kuhn JM, 2006, PLANT PHYSIOL, V140, P127, DOI 10.1104/pp.105.070318; Leube MP, 1998, FEBS LETT, V424, P100, DOI 10.1016/S0014-5793(98)00149-5; Levchenko V, 2005, P NATL ACAD SCI USA, V102, P4203, DOI 10.1073/pnas.0500146102; Liu XG, 2007, SCIENCE, V318, DOI 10.1126/science.1143320; Liu XG, 2007, SCIENCE, V315, P1712, DOI 10.1126/science.1135882; Markovic-Housley Z, 2003, J MOL BIOL, V325, P123, DOI 10.1016/S0022-2836(02)01197-X; McCourt P, 2008, CURR OPIN PLANT BIOL, V11, P474, DOI 10.1016/j.pbi.2008.06.014; Melotto M, 2006, CELL, V126, P969, DOI 10.1016/j.cell.2006.06.054; Merlot S, 2001, PLANT J, V25, P295, DOI 10.1046/j.1365-313x.2001.00965.x; Moes D, 2008, PLANT J, V54, P806, DOI 10.1111/j.1365-313X.2008.03454.x; Muller AH, 2009, PLANT PHYSIOL, V150, P157, DOI 10.1104/pp.109.135277; Nishimura N, 2007, PLANT J, V50, P935, DOI 10.1111/j.1365-313X.2007.03107.x; Pandey S, 2009, CELL, V136, P136, DOI 10.1016/j.cell.2008.12.026; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Pasternak O, 2006, PLANT CELL, V18, P2622, DOI 10.1105/tpc.105.037119; Priest DM, 2006, PLANT J, V46, P492, DOI 10.1111/j.1365-313X.2006.02701.x; Saez A, 2006, PLANT PHYSIOL, V141, P1389, DOI 10.1104/pp.106.081018; Shen YY, 2006, NATURE, V443, P823, DOI 10.1038/nature05176; Vahisalu T, 2008, NATURE, V452, P487, DOI 10.1038/nature06608; Yang Y, 2006, P NATL ACAD SCI USA, V103, P6061, DOI 10.1073/pnas.0501720103; Yoshida T, 2006, PLANT PHYSIOL, V140, P115, DOI 10.1104/pp.105.070128	31	1508	1663	11	446	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2009	324	5930					1064	1068		10.1126/science.1172408	http://dx.doi.org/10.1126/science.1172408			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448EU	19407143				2022-12-01	WOS:000266246700040
J	Tsai, HC; Zhang, F; Adamantidis, A; Stuber, GD; Bonci, A; de Lecea, L; Deisseroth, K				Tsai, Hsing-Chen; Zhang, Feng; Adamantidis, Antoine; Stuber, Garret D.; Bonci, Antonello; de Lecea, Luis; Deisseroth, Karl			Phasic Firing in Dopaminergic Neurons Is Sufficient for Behavioral Conditioning	SCIENCE			English	Article							PLACE PREFERENCE; DEFICIENT MICE; REWARD; ADDICTION; SYSTEMS; CHANNELRHODOPSIN-2; DYSREGULATION; MOTIVATION; CIRCUIT; HABITS	Natural rewards and drugs of abuse can alter dopamine signaling, and ventral tegmental area (VTA) dopaminergic neurons are known to fire action potentials tonically or phasically under different behavioral conditions. However, without technology to control specific neurons with appropriate temporal precision in freely behaving mammals, the causal role of these action potential patterns in driving behavioral changes has been unclear. We used optogenetic tools to selectively stimulate VTA dopaminergic neuron action potential firing in freely behaving mammals. We found that phasic activation of these neurons was sufficient to drive behavioral conditioning and elicited dopamine transients with magnitudes not achieved by longer, lower-frequency spiking. These results demonstrate that phasic dopaminergic activity is sufficient to mediate mammalian behavioral conditioning.	[Tsai, Hsing-Chen] Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; [Tsai, Hsing-Chen; Zhang, Feng; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Adamantidis, Antoine; de Lecea, Luis; Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Stuber, Garret D.; Bonci, Antonello] Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, Dept Neurol, Wheeler Ctr Neurobiol Drug Addict, San Francisco, CA 94158 USA	Stanford University; Stanford University; Stanford University; University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center	Deisseroth, K (corresponding author), Stanford Univ, Neurosci Program, W080 Clark Ctr,318 Campus Dr W, Stanford, CA 94305 USA.	deissero@stanford.edu	Stuber, Garret/E-1160-2011; de Lecea, Luis/ABE-4005-2021; de Lecea, Luis/B-3171-2009; Macrae, Rhiannon/AAX-1536-2020	de Lecea, Luis/0000-0002-8921-5942; de Lecea, Luis/0000-0002-8921-5942; Adamantidis, Antoine/0000-0003-2531-5175; Stuber, Garret/0000-0003-1730-4855	Stanford Graduate Fellowship; NIH National Research Service award; Fonds National de la Recherche Scientifique; NARSAD; Fondation Leon Fredericq; National Institute on Drug Abuse (NIDA); Defense Advanced Research Projects Agency; NSF; National Institute of Mental Health; McKnight, Coulter, Snyder, Albert Yu and Mary Bechmann, and Keck foundations; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH087592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K99NS065009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA021880] Funding Source: NIH RePORTER	Stanford Graduate Fellowship(Stanford University); NIH National Research Service award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); NARSAD(NARSAD); Fondation Leon Fredericq; National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NSF(National Science Foundation (NSF)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); McKnight, Coulter, Snyder, Albert Yu and Mary Bechmann, and Keck foundations; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank M. Wightman, P. Phillips, and the entire Deisseroth laboratory for their support. All reagents and protocols are freely distributed and supported by the authors (www.optogenetics.org); because these tools are not protected by patents, Stanford University has applied for a patent to ensure perpetual free distribution to the international academic nonprofit community. H.C.T. is supported by a Stanford Graduate Fellowship. F.Z. and G.D.S. are supported by NIH National Research Service award. A.R.A. is supported by the Fonds National de la Recherche Scientifique, NARSAD, and the Fondation Leon Fredericq. L.d.L. is supported by National Institute on Drug Abuse (NIDA), Defense Advanced Research Projects Agency, and NARSAD. K.D. is supported by NSF; National Institute of Mental Health; NIDA; and the McKnight, Coulter, Snyder, Albert Yu and Mary Bechmann, and Keck foundations.	Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Bjorklund A, 2007, TRENDS NEUROSCI, V30, P194, DOI 10.1016/j.tins.2007.03.006; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Cannon CM, 2003, J NEUROSCI, V23, P10827; Dani JA, 2007, ANNU REV PHARMACOL, V47, P699, DOI 10.1146/annurev.pharmtox.47.120505.105214; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Grace AA, 2007, TRENDS NEUROSCI, V30, P220, DOI 10.1016/j.tins.2007.03.003; Graybiel AM, 2008, ANNU REV NEUROSCI, V31, P359, DOI 10.1146/annurev.neuro.29.051605.112851; Harris GC, 2003, NEUROPSYCHOPHARMACOL, V28, P865, DOI 10.1038/sj.npp.1300122; Hnasko TS, 2007, J NEUROSCI, V27, P12484, DOI 10.1523/JNEUROSCI.3133-07.2007; Kalivas PW, 2007, AM J ADDICTION, V16, P71, DOI 10.1080/10550490601184142; Koob GF, 1997, SCIENCE, V278, P52, DOI 10.1126/science.278.5335.52; Liu QS, 2005, NATURE, V437, P1027, DOI 10.1038/nature04050; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Phillips PEM, 2003, NATURE, V422, P614, DOI 10.1038/nature01566; Picciotto MR, 2002, J NEUROSCI, V22, P3338; Robinson S, 2004, P NATL ACAD SCI USA, V101, P13329, DOI 10.1073/pnas.0405084101; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; Shen WX, 2008, SCIENCE, V321, P848, DOI 10.1126/science.1160575; Stuber GD, 2008, SCIENCE, V321, P1690, DOI 10.1126/science.1160873; Tzschentke TM, 2007, ADDICT BIOL, V12, P227, DOI 10.1111/j.1369-1600.2007.00070.x; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; Williams J, 2005, J CHILD ADOL PSYCHOP, V15, P160, DOI 10.1089/cap.2005.15.160; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Zhang F., 2008, COLD SPRING HARB LAB; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	29	826	875	3	145	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2009	324	5930					1080	1084		10.1126/science.1168878	http://dx.doi.org/10.1126/science.1168878			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448EU	19389999	Green Accepted			2022-12-01	WOS:000266246700044
J	Heintzman, ND; Hon, GC; Hawkins, RD; Kheradpour, P; Stark, A; Harp, LF; Ye, Z; Lee, LK; Stuart, RK; Ching, CW; Ching, KA; Antosiewicz-Bourget, JE; Liu, H; Zhang, XM; Green, RD; Lobanenkov, VV; Stewart, R; Thomson, JA; Crawford, GE; Kellis, M; Ren, B				Heintzman, Nathaniel D.; Hon, Gary C.; Hawkins, R. David; Kheradpour, Pouya; Stark, Alexander; Harp, Lindsey F.; Ye, Zhen; Lee, Leonard K.; Stuart, Rhona K.; Ching, Christina W.; Ching, Keith A.; Antosiewicz-Bourget, Jessica E.; Liu, Hui; Zhang, Xinmin; Green, Roland D.; Lobanenkov, Victor V.; Stewart, Ron; Thomson, James A.; Crawford, Gregory E.; Kellis, Manolis; Ren, Bing			Histone modifications at human enhancers reflect global cell-type-specific gene expression	NATURE			English	Article							HUMAN GENOME; BINDING-SITES; TRANSCRIPTION; PROMOTERS; ELEMENTS; SEQUENCE; RECEPTOR; MAP	The human body is composed of diverse cell types with distinct functions. Although it is known that lineage specification depends on cell-specific gene expression, which in turn is driven by promoters, enhancers, insulators and other cis-regulatory DNA sequences for each gene(1-3), the relative roles of these regulatory elements in this process are not clear. We have previously developed a chromatin-immunoprecipitation-based microarray method (ChIP-chip) to locate promoters, enhancers and insulators in the human genome(4-6). Here we use the same approach to identify these elements in multiple cell types and investigate their roles in cell-type-specific gene expression. We observed that the chromatin state at promoters and CTCF-binding at insulators is largely invariant across diverse cell types. In contrast, enhancers are marked with highly cell-type-specific histone modification patterns, strongly correlate to cell-type-specific gene expression programs on a global scale, and are functionally active in a cell-type-specific manner. Our results define over 55,000 potential transcriptional enhancers in the human genome, significantly expanding the current catalogue of human enhancers and highlighting the role of these elements in cell-type-specific gene expression.	[Heintzman, Nathaniel D.; Hon, Gary C.; Hawkins, R. David; Harp, Lindsey F.; Ye, Zhen; Lee, Leonard K.; Stuart, Rhona K.; Ching, Christina W.; Ching, Keith A.; Ren, Bing] Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Heintzman, Nathaniel D.] Univ Calif San Diego, Sch Med, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Hon, Gary C.] Univ Calif San Diego, Sch Med, Bioinformat Program, La Jolla, CA 92093 USA; [Ren, Bing] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Kheradpour, Pouya; Stark, Alexander; Kellis, Manolis] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Stark, Alexander; Kellis, Manolis] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Antosiewicz-Bourget, Jessica E.; Stewart, Ron; Thomson, James A.] Morgridge Inst Res, Madison, WI 53707 USA; [Liu, Hui; Zhang, Xinmin; Green, Roland D.] Roche NimbleGen Inc, Madison, WI 53719 USA; [Lobanenkov, Victor V.] NIAID, Rockville, MD 20852 USA; [Thomson, James A.] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Crawford, Gregory E.] Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA; [Crawford, Gregory E.] Duke Univ, Dept Pediat, Durham, NC 27708 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Wisconsin System; University of Wisconsin Madison; The Morgridge Institute for Research, Inc.; Roche Holding; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Wisconsin System; University of Wisconsin Madison; Duke University; Duke University	Ren, B (corresponding author), Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, 9500 Gilman Dr, La Jolla, CA 92093 USA.	biren@ucsd.edu	Kellis, Manolis/ABE-7385-2020; Lobanenkov, Victor V./AGQ-8903-2022; Stark, Alexander/D-1473-2012; Lobanenkov, Victor/ABD-5710-2021	Kellis, Manolis/0000-0001-7113-9630; Stark, Alexander/0000-0003-2611-0841; Lobanenkov, Victor/0000-0001-6665-3635; Stuart, Rhona/0000-0001-5916-9693	American Cancer Society; NIAID; LICR; NHGRI; NCI; CIRM; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004037, U01HG003151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000860] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); LICR; NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CIRM(California Institute for Regenerative Medicine); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank members of the Ren laboratory for comments. This work was supported by funding from American Cancer Society (R. D. H.), NIAID Intramural Research Program (V. V. L.), LICR (B. R.), NHGRI (B. R.), NCI (B. R.) and CIRM (B. R.).	Brivanlou AH, 2002, SCIENCE, V295, P813, DOI 10.1126/science.1066355; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Crawford GE, 2006, NAT METHODS, V3, P503, DOI 10.1038/NMETH888; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Heintzman ND, 2007, CELL MOL LIFE SCI, V64, P386, DOI 10.1007/s00018-006-6295-0; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kheradpour P, 2007, GENOME RES, V17, P1919, DOI 10.1101/gr.7090407; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; King DC, 2005, GENOME RES, V15, P1051, DOI 10.1101/gr.3642605; Kleinjan DA, 2001, HUM MOL GENET, V10, P2049, DOI 10.1093/hmg/10.19.2049; Koch CM, 2007, GENOME RES, V17, P691, DOI 10.1101/gr.5704207; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Maston GA, 2006, ANNU REV GENOM HUM G, V7, P29, DOI 10.1146/annurev.genom.7.080505.115623; Nightingale KP, 2006, CURR OPIN GENET DEV, V16, P125, DOI 10.1016/j.gde.2006.02.015; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Schug J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r33; Song JS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r178; Wang QB, 2005, MOL CELL, V19, P631, DOI 10.1016/j.molcel.2005.07.018; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Wolf AT, 2005, BLOOD, V105, P1060, DOI 10.1182/blood-2003-12-4383; Xi HL, 2007, PLOS GENET, V3, P1377, DOI 10.1371/journal.pgen.0030136; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yang A, 2006, MOL CELL, V24, P593, DOI 10.1016/j.molcel.2006.10.018	25	1708	1748	3	182	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 7	2009	459	7243					108	112		10.1038/nature07829	http://dx.doi.org/10.1038/nature07829			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441WN	19295514	Green Accepted, Green Submitted			2022-12-01	WOS:000265801300039
J	Sathyapalan, T; Atkin, SL				Sathyapalan, T.; Atkin, Stephen L.			Rational testing Investigating hirsutism	BRITISH MEDICAL JOURNAL			English	Editorial Material							POLYCYSTIC-OVARY-SYNDROME; CONGENITAL ADRENAL-HYPERPLASIA; INSULIN-RESISTANCE; DIAGNOSTIC-VALUE; PREVALENCE; WOMEN; HYPERANDROGENISM; CRITERIA		[Atkin, Stephen L.] Hull Royal Infirm, Hull York Med Sch, Kingston Upon Hull HU3 2RW, England; [Sathyapalan, T.] Hull Royal Infirm, Michael White Diabet Ctr, Kingston Upon Hull HU3 2RW, England	University of Hull; University of York - UK; University of Hull	Atkin, SL (corresponding author), Hull Royal Infirm, Hull York Med Sch, Kingston Upon Hull HU3 2RW, England.	Stephen.Atkin@hyms.ac.uk	Sathyapalan, Thozhukat/J-5212-2012; atkin, stephen/D-7400-2014; Atkin, stephen/ABE-7047-2020	Sathyapalan, Thozhukat/0000-0003-3544-2231; atkin, stephen/0000-0002-5887-7257; 				[Anonymous], 2004, HUM REPROD, V19, P41; Azziz R., 2006, ANDROGEN EXCESS DISO, V2nd; Azziz R, 2006, J CLIN ENDOCR METAB, V91, P4237, DOI 10.1210/jc.2006-0178; Carmina E, 2006, J CLIN ENDOCR METAB, V91, P2, DOI 10.1210/jc.2005-1457; CARMINA E, 1992, AM J OBSTET GYNECOL, V167, P1807, DOI 10.1016/0002-9378(92)91779-A; Chang WY, 2005, FERTIL STERIL, V83, P1717, DOI 10.1016/j.fertnstert.2005.01.096; Escobar-Morreale HF, 2008, J CLIN ENDOCR METAB, V93, P527, DOI 10.1210/jc.2007-2053; Escobar-Morreale HF, 2001, EUR J ENDOCRINOL, V145, P619, DOI 10.1530/eje.0.1450619; Hahn S, 2007, CLIN CHEM LAB MED, V45, P202, DOI 10.1515/CCLM.2007.031; Hopkinson ZEC, 1998, BRIT MED J, V317, P329, DOI 10.1136/bmj.317.7154.329; MENGDEN T, 1992, CLIN INVESTIGATOR, V70, P545; Sowers M, 2003, J CLIN ENDOCR METAB, V88, P4904, DOI 10.1210/jc.2003-030350; White PC, 2000, ENDOCR REV, V21, P245, DOI 10.1210/er.21.3.245	13	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 28	2009	338								b912	10.1136/bmj.b912	http://dx.doi.org/10.1136/bmj.b912			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	440JV	19401328				2022-12-01	WOS:000265697500009
J	Kim, T; Buratowski, S				Kim, TaeSoo; Buratowski, Stephen			Dimethylation of H3K4 by Set1 Recruits the Set3 Histone Deacetylase Complex to 5 ' Transcribed Regions	CELL			English	Article							RNA-POLYMERASE-II; SACCHAROMYCES-CEREVISIAE; GENOME-WIDE; PHD FINGER; TRANSCRIPTIONAL ELONGATION; H2B MONOUBIQUITINATION; LYSINE-4 METHYLATION; GENE-EXPRESSION; BINDING MODULES; YEAST	Cotranscriptional histone methylations by Set1 and Set2 have been shown to affect histone acetylation at promoters and 3' regions of genes, respectively. While histone H3K4 trimethylation (H3K4me3) is thought to promote nucleosome acetylation and remodeling near promoters, we show here that H3K4 dimethylation (H3K4me2) by Set1 leads to reduced histone acetylation levels near 5' ends of genes. H3K4me2 recruits the Set3 complex via the Set3 PHD finger, localizing the Hos2 and Hst1 subunits to deacetylate histones in 5' transcribed regions. Cells lacking the Set1-Set3 complex pathway are sensitive to mycophenolic acid and have reduced polymerase levels at a Set3 target gene, suggesting a positive role in transcription. We propose that Set1 establishes two distinct chromatin zones on genes: H3K4me3 leads to high levels of acetylation and low nucleosome density at promoters, while H3K4me2 just downstream recruits the Set3 complex to suppress nucleosome acetylation and remodeling.	[Kim, TaeSoo; Buratowski, Stephen] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Buratowski, S (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 240 Longwood Ave, Boston, MA 02115 USA.	steveb@hms.harvard.edu		Kim, TaeSoo/0000-0002-3902-1058	United States National Institutes of Health [GM46498]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046498, R29GM046498] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank O. Gozani (Stanford) for histone peptides, S. Briggs (Purdue) for plasmids, L. Howe (University of British Columbia) and M. Keogh (Albert Einstein College of Medicine) for strains, and N. Krogan (University of California, San Francisco), O. Rando (University of Massachusetts, Worcester), and all members of the Buratowski lab for helpful advice and discussions. T. K. is a Special Fellow of the Leukemia and Lymphoma Society. This research was supported by grant GM46498 to S.B. from the United States National Institutes of Health.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Boa S, 2003, YEAST, V20, P827, DOI 10.1002/yea.995; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Chu Y, 2007, EMBO J, V26, P4646, DOI 10.1038/sj.emboj.7601887; Cohen TJ, 2008, EUKARYOT CELL, V7, P1191, DOI 10.1128/EC.00059-08; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Dehe PM, 2006, BIOCHEM CELL BIOL, V84, P536, DOI 10.1139/O06-081; Dehe PM, 2005, J MOL BIOL, V353, P477, DOI 10.1016/j.jmb.2005.08.059; Emerling BM, 2002, ONCOGENE, V21, P4849, DOI 10.1038/sj.onc.1205615; Fingerman IM, 2005, J BIOL CHEM, V280, P28761, DOI 10.1074/jbc.C500097200; Flanagan JF, 2007, J MOL BIOL, V369, P334, DOI 10.1016/j.jmb.2007.03.024; Gould KL, 2004, METHODS, V33, P239, DOI 10.1016/j.ymeth.2003.11.019; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kim T, 2007, J BIOL CHEM, V282, P20827, DOI 10.1074/jbc.M703034200; Kizer KO, 2005, MOL CELL BIOL, V25, P3305, DOI 10.1128/MCB.25.8.3305-3316.2005; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Laribee RN, 2005, CURR BIOL, V15, P1487, DOI 10.1016/j.cub.2005.07.028; Lee JS, 2007, CELL, V131, P1084, DOI 10.1016/j.cell.2007.09.046; Li B, 2007, GENE DEV, V21, P1422, DOI 10.1101/gad.1539307; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li B, 2007, SCIENCE, V316, P1050, DOI 10.1126/science.1139004; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Li JX, 2002, J BIOL CHEM, V277, P49383, DOI 10.1074/jbc.M209294200; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Margaritis T, 2008, CELL, V133, P581, DOI 10.1016/j.cell.2008.04.027; Martin DGE, 2006, MOL CELL BIOL, V26, P3018, DOI 10.1128/MCB.26.8.3018-3028.2006; Morillon A, 2005, MOL CELL, V18, P723, DOI 10.1016/j.molcel.2005.05.009; Mueller JE, 2006, GENETICS, V173, P557, DOI 10.1534/genetics.106.055400; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Okuda M, 2007, J MOL BIOL, V365, P1047, DOI 10.1016/j.jmb.2006.10.039; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Pijnappel WWMP, 2001, GENE DEV, V15, P2991, DOI 10.1101/gad.207401; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Reid JL, 2004, MOL CELL BIOL, V24, P757, DOI 10.1128/MCB.24.2.757-764.2004; Santos-Rosa H, 2004, J BIOL CHEM, V279, P47506, DOI 10.1074/jbc.M407949200; Schaft D, 2003, NUCLEIC ACIDS RES, V31, P2475, DOI 10.1093/nar/gkg372; Schlichter A, 2005, EMBO J, V24, P1222, DOI 10.1038/sj.emboj.7600607; Shahbazian MD, 2005, MOL CELL, V19, P271, DOI 10.1016/j.molcel.2005.06.010; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shi XB, 2007, J BIOL CHEM, V282, P2450, DOI 10.1074/jbc.C600286200; Sims RJ, 2005, J BIOL CHEM, V280, P41789, DOI 10.1074/jbc.C500395200; Sims RJ, 2006, GENE DEV, V20, P2779, DOI 10.1101/gad.1468206; Strahl BD, 2002, MOL CELL BIOL, V22, P1298, DOI 10.1128/MCB.22.5.1298-1306.2002; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Taverna SD, 2006, MOL CELL, V24, P785, DOI 10.1016/j.molcel.2006.10.026; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; van Leeuwen F, 2002, CURR OPIN CELL BIOL, V14, P756, DOI 10.1016/S0955-0674(02)00393-9; Venkatasubrahmanyam S, 2007, P NATL ACAD SCI USA, V104, P16609, DOI 10.1073/pnas.0700914104; Wang A, 2002, SCIENCE, V298, P1412, DOI 10.1126/science.1077790; Wood A, 2005, MOL CELL, V20, P589, DOI 10.1016/j.molcel.2005.09.010; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Xiao TJ, 2003, GENE DEV, V17, P654, DOI 10.1101/gad.1055503; Xie JX, 1999, EMBO J, V18, P6448, DOI 10.1093/emboj/18.22.6448; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346	59	228	233	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 17	2009	137	2					259	272		10.1016/j.cell.2009.02.045	http://dx.doi.org/10.1016/j.cell.2009.02.045			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	437AB	19379692	Bronze, Green Accepted			2022-12-01	WOS:000265456800019
J	Viel, KR; Ameri, A; Abshire, TC; Iyer, RV; Watts, RG; Lutcher, C; Channell, C; Cole, SA; Fernstrom, KM; Nakaya, S; Kasper, CK; Thompson, AR; Almasy, L; Howard, TE				Viel, Kevin R.; Ameri, Afshin; Abshire, Thomas C.; Iyer, Rathi V.; Watts, Raymond G.; Lutcher, Charles; Channell, Cynthia; Cole, Shelley A.; Fernstrom, Karl M.; Nakaya, Shelley; Kasper, Carol K.; Thompson, Arthur R.; Almasy, Laura; Howard, Tom E.			Inhibitors of Factor VIII in Black Patients with Hemophilia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	48th Annual Meeting of the American-Society-of-Hematology	DEC 09-12, 2006	Orlando, FL	Amer Soc Hematol			PREVIOUSLY UNTREATED PATIENTS; RECOMBINANT FACTOR-VIII; GENETIC ASSOCIATION; AFRICAN-AMERICANS; F8 GENE; MUTATIONS; RISK; INVERSION; IDENTIFICATION; POLYMORPHISMS	BACKGROUND Black patients with hemophilia A (factor VIII deficiency) are twice as likely as white patients to produce inhibitors against factor VIII proteins given as replacement therapy. There are six wild-type factor VIII proteins, designated H1 through H6, but only two (H1 and H2) match the recombinant factor VIII products used clinically. H1 and H2 are found in all racial groups and are the only factor VIII proteins found in the white population to date. H3, H4, and H5 have been found only in blacks. We hypothesized that mismatched factor VIII transfusions contribute to the high incidence of inhibitors among black patients. METHODS We sequenced the factor VIII gene (F8) in black patients with hemophilia A to identify causative mutations and the background haplotypes on which they reside. Results from previous Bethesda assays and information on the baseline severity of hemophilia, age at enrollment, and biologic relationships among study patients were obtained from review of the patients' medical charts. We used multivariable logistic regression to control for these potential confounders while testing for associations between F8 haplotype and the development of inhibitors. RESULTS Of the 78 black patients with hemophilia enrolled, 24% had an H3 or H4 background haplotype. The prevalence of inhibitors was higher among patients with either of these haplotypes than among patients with haplotype H1 or H2 (odds ratio, 3.6; 95% confidence interval, 1.1 to 12.3; P = 0.04), despite a similar spectrum of hemophilic mutations and degree of severity of illness in these two subgroups. CONCLUSIONS These preliminary results suggest that mismatched factor VIII replacement therapy may be a risk factor for the development of anti-factor VIII alloantibodies.	[Viel, Kevin R.; Cole, Shelley A.; Almasy, Laura] SW Fdn Biomed Res, San Antonio, TX 78284 USA; [Ameri, Afshin; Lutcher, Charles] Med Coll Georgia, Augusta, GA 30912 USA; [Abshire, Thomas C.; Channell, Cynthia; Fernstrom, Karl M.] Emory Univ, Atlanta, GA 30322 USA; [Iyer, Rathi V.] Univ Mississippi, Med Ctr, Jackson, MS USA; [Watts, Raymond G.] Univ Alabama Birmingham, Birmingham, AL USA; [Nakaya, Shelley; Thompson, Arthur R.] Univ Washington, Seattle, WA 98195 USA; [Kasper, Carol K.; Howard, Tom E.] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA; [Kasper, Carol K.] Orthoped Hosp, Los Angeles, CA USA; [Howard, Tom E.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Howard, Tom E.] Greater Los Angeles Vet Affairs Hosp, Los Angeles, CA USA	Texas Biomedical Research Institute; University System of Georgia; Augusta University; Emory University; University of Mississippi; University of Mississippi Medical Center; University of Alabama System; University of Alabama Birmingham; University of Washington; University of Washington Seattle; University of Southern California; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Howard, TE (corresponding author), Vet Affairs Greater Los Angeles Healthcare Syst, Dept Pathol & Lab Med, 11301 Wilshire Blvd,Bldg 500,Rm 12S4, Los Angeles, CA 90073 USA.	tom.howard@va.gov	Almasy, Laura/V-3156-2019		NHLBI NIH HHS [HL-72533, K08 HL071130, K08 HL071130-06, R01 HL070751-07, HL-70751, HL-71130, R01 HL070751, HL-07109, R01 HL072533, R01 HL072533-05] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070751, R01HL072533, K08HL071130] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADDIEGO JE, 1994, BLOOD, V84, pA239; Aledort LM, 1998, HAEMOPHILIA, V4, P68; Astermark J, 2007, J THROMB HAEMOST, V5, P263, DOI 10.1111/j.1538-7836.2007.02290.x; Astermark J, 2006, BLOOD, V107, P3167, DOI 10.1182/blood-2005-09-3918; Astermark J, 2001, HAEMOPHILIA, V7, P267, DOI 10.1046/j.1365-2516.2001.00510.x; Astermark J, 2006, BLOOD, V108, P3739, DOI 10.1182/blood-2006-05-024711; Bagnall RD, 2006, J THROMB HAEMOST, V4, P591, DOI 10.1111/j.1538-7836.2006.01840.x; Bagnall RD, 2002, BLOOD, V99, P168, DOI 10.1182/blood.V99.1.168; Benjamin RJ, 2008, TRANSFUSION, V48, P295, DOI 10.1111/j.1537-2995.2007.01523.x; BRAY GL, 1994, BLOOD, V83, P2428; Castaman G, 2007, HAEMOPHILIA, V13, P311, DOI 10.1111/j.1365-2516.2007.01459.x; David D, 2006, HAEMATOLOGICA, V91, P840; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Garratty G, 2004, TRANSFUSION, V44, P703, DOI 10.1111/j.1537-2995.2004.03338.x; Gill F M, 1984, Prog Clin Biol Res, V150, P19; Gitschier J, 2004, J THROMB HAEMOST, V2, P383, DOI 10.1111/j.1538-7933.2004.00614.x; GITSCHIER J, 1984, NATURE, V312, P326, DOI 10.1038/312326a0; Glynn SA, 2006, TRANSFUSION, V46, P980, DOI 10.1111/j.1537-2995.2006.00831.x; Goodeve A, 2003, BLOOD COAGUL FIBRIN, V14, pS17, DOI 10.1097/00001721-200306001-00005; Goudemand J, 2006, BLOOD, V107, P46, DOI 10.1182/blood-2005-04-1371; Howard T, 2004, BLOOD, V104, p113A, DOI 10.1182/blood.V104.11.384.384; Howard TE, 2005, BLOOD, V106, p896A; Howard TE, 2006, BLOOD, V108, p230A; Jayandharan G, 2005, HAEMOPHILIA, V11, P481, DOI 10.1111/j.1365-2516.2005.01121.x; KASPER CK, 1975, THROMB DIATH HAEMOST, V34, P612; Kemball-Cook G, 1998, NUCLEIC ACIDS RES, V26, P216, DOI 10.1093/nar/26.1.216; Kempton CL, 2006, J THROMB HAEMOST, V4, P2576, DOI 10.1111/j.1538-7836.2006.02233.x; Kittles RA, 2002, HUM GENET, V110, P553, DOI 10.1007/s00439-002-0731-5; Lollar P, 2004, J THROMB HAEMOST, V2, P1082, DOI 10.1111/j.1538-7836.2004.00802.x; Lorenzo JI, 2001, BRIT J HAEMATOL, V113, P600, DOI 10.1046/j.1365-2141.2001.02828.x; LUSHER JM, 1993, NEW ENGL J MED, V328, P453, DOI 10.1056/NEJM199302183280701; Ma GC, 2008, HAEMOPHILIA, V14, P787, DOI 10.1111/j.1365-2516.2008.01687.x; Mansvelt EPG, 1998, THROMB HAEMOSTASIS, V80, P561; Oldenburg J, 2006, HAEMOPHILIA, V12, P15, DOI 10.1111/j.1365-2516.2006.01361.x; Oldenburg J, 2004, SEMIN HEMATOL, V41, P82, DOI 10.1053/j.seminhematol.2003.11.016; Oldenburg J, 1997, BEITR INFUS, V34, P224; Redden DT, 2006, BEHAV GENET, V36, P678, DOI 10.1007/s10519-006-9060-0; Repesse Y, 2007, J THROMB HAEMOST, V5, P1469, DOI 10.1111/j.1538-7836.2007.02591.x; Rossetti LC, 2005, CLIN CHEM, V51, P1154, DOI 10.1373/clinchem.2004.046490; Rothschild C, 1998, THROMB HAEMOSTASIS, V80, P779; Santacroce R, 2008, J HUM GENET, V53, P275, DOI 10.1007/s10038-007-0238-y; Schroder J, 2006, J THROMB HAEMOST, V4, P1141, DOI 10.1111/j.1538-7836.2006.01884.x; Schwaab R, 1995, THROMB HAEMOSTASIS, V74, P1402; Thompson AR, 2003, SEMIN THROMB HEMOST, V29, P11, DOI 10.1055/s-2003-37935; TOOLE JJ, 1984, NATURE, V312, P342, DOI 10.1038/312342a0; Tsai HJ, 2006, HUM GENET, V118, P626, DOI 10.1007/s00439-005-0080-2; VEHAR GA, 1984, NATURE, V312, P337, DOI 10.1038/312337a0; VERBRUGGEN B, 1995, THROMB HAEMOSTASIS, V73, P247; Viel KR, 2007, BLOOD, V109, P3713, DOI 10.1182/blood-2006-06-026104; Wang B, 2004, TRANSFUSION, V44, P1243, DOI 10.1111/j.1537-2995.2004.04034.x; White GC, 2001, THROMB HAEMOSTASIS, V85, P560, DOI 10.1055/s-0037-1615621; Wight J, 2003, HAEMOPHILIA, V9, P418, DOI 10.1046/j.1365-2516.2003.00780.x	53	147	157	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 16	2009	360	16					1618	1627		10.1056/NEJMoa075760	http://dx.doi.org/10.1056/NEJMoa075760			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	433BH	19369668	Green Accepted			2022-12-01	WOS:000265178000006
J	Kahn, SE				Kahn, Steven E.			Glucose Control in Type 2 Diabetes Still Worthwhile and Worth Pursuing	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARDIOVASCULAR-DISEASE; HYPOGLYCEMIA		[Kahn, Steven E.] VA Puget Sound Hlth Care Syst, Div Metab Endocrinol & Nutr, Dept Med, Seattle, WA USA; [Kahn, Steven E.] Univ Washington, Seattle, WA 98195 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle	Kahn, SE (corresponding author), VA Puget Sound Hlth Care Syst 151, 1660 S Columbian Way, Seattle, WA 98108 USA.	skahn@u.washington.edu		Kahn, Steven/0000-0001-7307-9002				Bottini P, 1997, DIABETES, V46, P814, DOI 10.2337/diabetes.46.5.814; Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5; Cryer PE, 2005, DIABETES, V54, P3592, DOI 10.2337/diabetes.54.12.3592; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Gerstein HC, 2000, LANCET, V355, P253; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Jemal A, 2005, JAMA-J AM MED ASSOC, V294, P1255, DOI 10.1001/jama.294.10.1255; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Selvin E, 2004, ANN INTERN MED, V141, P421, DOI 10.7326/0003-4819-141-6-200409210-00007; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Vinik AI, 2007, CIRCULATION, V115, P387, DOI 10.1161/CIRCULATIONAHA.106.634949	15	10	10	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 15	2009	301	15					1590	1592		10.1001/jama.2009.511	http://dx.doi.org/10.1001/jama.2009.511			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	432MH	19366780				2022-12-01	WOS:000265137900031
J	Ekiert, DC; Bhabha, G; Elsliger, MA; Friesen, RHE; Jongeneelen, M; Throsby, M; Goudsmit, J; Wilson, IA				Ekiert, Damian C.; Bhabha, Gira; Elsliger, Marc-Andre; Friesen, Robert H. E.; Jongeneelen, Mandy; Throsby, Mark; Goudsmit, Jaap; Wilson, Ian A.			Antibody Recognition of a Highly Conserved Influenza Virus Epitope	SCIENCE			English	Article							A VIRUSES; MEMBRANE-FUSION; HIV-1 NEUTRALIZATION; STRUCTURAL BASIS; AVIAN INFLUENZA; BINDING SITE; HEMAGGLUTININ; RECEPTOR; COMPLEX; PH	Influenza virus presents an important and persistent threat to public health worldwide, and current vaccines provide immunity to viral isolates similar to the vaccine strain. High-affinity antibodies against a conserved epitope could provide immunity to the diverse influenza subtypes and protection against future pandemic viruses. Cocrystal structures were determined at 2.2 and 2.7 angstrom resolutions for broadly neutralizing human antibody CR6261 Fab in complexes with the major surface antigen (hemagglutinin, HA) from viruses responsible for the 1918 H1N1 influenza pandemic and a recent lethal case of H5N1 avian influenza. In contrast to other structurally characterized influenza antibodies, CR6261 recognizes a highly conserved helical region in the membrane-proximal stem of HA1 and HA2. The antibody neutralizes the virus by blocking conformational rearrangements associated with membrane fusion. The CR6261 epitope identified here should accelerate the design and implementation of improved vaccines that can elicit CR6261-like antibodies, as well as antibody-based therapies for the treatment of influenza.	[Ekiert, Damian C.; Bhabha, Gira; Elsliger, Marc-Andre; Wilson, Ian A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Friesen, Robert H. E.; Jongeneelen, Mandy; Throsby, Mark; Goudsmit, Jaap] Crucell Holland BV, NL-2301 CA Leiden, Netherlands; [Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Johnson & Johnson; Scripps Research Institute	Wilson, IA (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	wilson@scripps.edu		Ekiert, Damian/0000-0002-2570-0404; Elsliger, Marc Andre/0000-0002-1989-7626	NIH [AI-058113]; predoctoral fellowship from the Achievement Rewards for College Scientists Foundation; Skaggs Institute; NIH National Institute of General Medical Sciences (NIGMS) [U54 GM074898, Y1-GM-1104]; National Cancer Institute [Y1-CO-1020]; U.S. Department of Energy, Basic Energy Sciences, Office of Science [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI058113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074898] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); predoctoral fellowship from the Achievement Rewards for College Scientists Foundation; Skaggs Institute; NIH National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); U.S. Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by NIH grant AI-058113 (I.A.W.) and a predoctoral fellowship from the Achievement Rewards for College Scientists Foundation (D.C.E.) and the Skaggs Institute. The Joint Center for Structural Genomics (JCSG) is supported by NIH National Institute of General Medical Sciences (NIGMS) (U54 GM074898). The GM/CA CAT 23-ID-B beamline has been funded in whole or in part with federal funds from National Cancer Institute (Y1-CO-1020) and NIGMS (Y1-GM-1104). Use of the Advanced Photon Source (APS) was supported by the U.S. Department of Energy, Basic Energy Sciences, Office of Science, under contract no. DE-AC02-06CH11357. The content is solely the responsibility of the authors and does not necessarily represent the official views of NIGMS or the NIH. The authors thank H. Tien and D. Marciano of the Robotics Core at the JCSG for automated crystal screening; C. Ogata and the staff of the APS GM/CA CAT 23-ID-B for beamline support; X. Dai and R. Stanfield for excellent assistance with data collection and processing and analyses; R. Pejchal, M. Crispin, M. Wormald, and D. Wolan for valuable comments; and R. Lerner for insightful discussion. This is publication 19980 from the Scripps Research Institute. Coordinates and structure factors are deposited in the Protein Data Bank (PDB) (3GBN and 3GBM for CR6261-SC1918/H1 and CR6261-Viet04/H5, respectively).	Barbey-Martin C, 2002, VIROLOGY, V294, P70, DOI 10.1006/viro.2001.1320; BEAN WJ, 1992, J VIROL, V66, P1129, DOI 10.1128/JVI.66.2.1129-1138.1992; Beigel J, 2008, ANTIVIR RES, V78, P91, DOI 10.1016/j.antiviral.2008.01.003; Bright RA, 2006, JAMA-J AM MED ASSOC, V295, P891, DOI 10.1001/jama.295.8.joc60020; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; Burton DR, 2005, P NATL ACAD SCI USA, V102, P14943, DOI 10.1073/pnas.0505126102; Chen J, 1999, P NATL ACAD SCI USA, V96, P8967, DOI 10.1073/pnas.96.16.8967; CHOTHIA C, 1992, J MOL BIOL, V227, P799, DOI 10.1016/0022-2836(92)90224-8; Davis MM, 2004, SEMIN IMMUNOL, V16, P239, DOI 10.1016/j.smim.2004.08.003; Fleury D, 1999, NAT STRUCT BIOL, V6, P530, DOI 10.1038/9299; Fleury D, 1998, NAT STRUCT BIOL, V5, P119, DOI 10.1038/nsb0298-119; Fleury D, 2000, PROTEINS, V40, P572; Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; GERHARD W, 1981, NATURE, V290, P713, DOI 10.1038/290713a0; Huang CC, 2004, P NATL ACAD SCI USA, V101, P2706, DOI 10.1073/pnas.0308527100; Kashyap AK, 2008, P NATL ACAD SCI USA, V105, P5986, DOI 10.1073/pnas.0801367105; KAWAOKA Y, 1989, J VIROL, V63, P4603, DOI 10.1128/JVI.63.11.4603-4608.1989; Kiso M, 2004, LANCET, V364, P759, DOI 10.1016/S0140-6736(04)16934-1; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Lerner RA, 2006, ANGEW CHEM INT EDIT, V45, P8106, DOI 10.1002/anie.200603381; Lowen Anice C., 2007, Infectious Disorders - Drug Targets, V7, P318; Luftig MA, 2006, NAT STRUCT MOL BIOL, V13, P740, DOI 10.1038/nsmb1127; OKUNO Y, 1993, J VIROL, V67, P2552, DOI 10.1128/JVI.67.5.2552-2558.1993; Reid AH, 1999, P NATL ACAD SCI USA, V96, P1651, DOI 10.1073/pnas.96.4.1651; Russell RJ, 2008, P NATL ACAD SCI USA, V105, P17736, DOI 10.1073/pnas.0807142105; Salzberg S, 2008, NATURE, V454, P160, DOI 10.1038/454160a; SCHAFER JR, 1993, VIROLOGY, V194, P781, DOI 10.1006/viro.1993.1319; SKEHEL JJ, 1982, P NATL ACAD SCI-BIOL, V79, P968, DOI 10.1073/pnas.79.4.968; Smirnov YA, 1999, ACTA VIROL, V43, P237; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Walker BD, 2008, SCIENCE, V320, P760, DOI 10.1126/science.1152622; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zwick MB, 2007, CURR HIV RES, V5, P608, DOI 10.2174/157016207782418443; 2008, MMWR MORB MORTAL WKL, V57, P393	39	993	1121	2	207	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 10	2009	324	5924					246	251		10.1126/science.1171491	http://dx.doi.org/10.1126/science.1171491			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430WX	19251591	Green Accepted			2022-12-01	WOS:000265024400045
J	Hansen, DM; Galetti, M				Hansen, Dennis M.; Galetti, Mauro			The Forgotten Megafauna	SCIENCE			English	Editorial Material							SEED DISPERSAL; ANACHRONISMS; EXTINCTIONS; FRUITS		[Hansen, Dennis M.; Galetti, Mauro] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Galetti, Mauro] UNESP Sao Paulo State Univ, Dept Ecol, BR-13506900 Sao Paulo, Brazil	Stanford University; Universidade Estadual Paulista	Hansen, DM (corresponding author), Stanford Univ, Dept Biol, 371 Serra Mall, Stanford, CA 94305 USA.	dmhansen@stanford.edu	Hansen, Dennis M/A-3307-2008; Galetti, Mauro/M-8751-2013; Galetti, Mauro/C-5275-2008	Hansen, Dennis M/0000-0002-9584-2766; Galetti, Mauro/0000-0002-8187-8696; Galetti, Mauro/0000-0002-8187-8696				Barnosky AD, 2004, SCIENCE, V306, P70, DOI 10.1126/science.1101476; Collevatti RG, 2003, MOL ECOL, V12, P105, DOI 10.1046/j.1365-294X.2003.01701.x; Dirzo R., 1991, PLANT ANIMAL INTERAC, P273; Guimaraes Paulo R. Jr, 2008, PLoS ONE, V3, pUnpaginated, DOI 10.1371/journal.pone.0001745; HALLWACHS W, 1986, FRUGIVORES SEED DISP, P285, DOI DOI 10.1007/978-94-009-4812-9_25; Hansen DM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002111; JANZEN DH, 1982, SCIENCE, V215, P19, DOI 10.1126/science.215.4528.19; Koch PL, 2006, ANNU REV ECOL EVOL S, V37, P215, DOI 10.1146/annurev.ecolsys.34.011802.132415; Martin P. S., 1995, QUATERNARY EXTINCTIO; Meehan HJ, 2002, J BIOGEOGR, V29, P695, DOI 10.1046/j.1365-2699.2002.00718.x; Owen-Smith R.N., 1988, MEGAHERBIVORES INFLU; Wallace A.R., 1876, GEOGRAPHICAL DISTRIB, p.; Wright SJ, 2007, BIOTROPICA, V39, P289, DOI 10.1111/j.1744-7429.2007.00293.x	13	144	147	0	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2009	324	5923					42	43		10.1126/science.1172393	http://dx.doi.org/10.1126/science.1172393			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427TN	19342573				2022-12-01	WOS:000264802100021
J	Neugebauer, JM; Amack, JD; Peterson, AG; Bisgrove, BW; Yost, HJ				Neugebauer, Judith M.; Amack, Jeffrey D.; Peterson, Annita G.; Bisgrove, Brent W.; Yost, H. Joseph			FGF signalling during embryo development regulates cilia length in diverse epithelia	NATURE			English	Article							LEFT-RIGHT ASYMMETRY; LEFT-RIGHT AXIS; ZEBRAFISH FIN REGENERATION; KUPFFERS VESICLE; LEFTWARD FLOW; CELLS; SPECIFICATION; INHIBITION; XENOPUS; MUTANT	Cilia are cell surface organelles found on most epithelia in vertebrates. Specialized groups of cilia have critical roles in embryonic development, including left-right axis formation. Recently, cilia have been implicated as recipients of cell-cell signalling(1,2). However, little is known about cell-cell signalling pathways that control the length of cilia(3). Here we provide several lines of evidence showing that fibroblast growth factor (FGF) signalling regulates cilia length and function in diverse epithelia during zebrafish and Xenopus development. Morpholino knockdown of FGF receptor 1 (Fgfr1) in zebrafish cell-autonomously reduces cilia length in Kupffer's vesicle and perturbs directional fluid flow required for left-right patterning of the embryo. Expression of a dominant-negative FGF receptor (DN-Fgfr1), treatment with SU5402 ( a pharmacological inhibitor of FGF signalling) or genetic and morpholino reduction of redundant FGF ligands Fgf8 and Fgf24 reproduces this cilia length phenotype. Knockdown of Fgfr1 also results in shorter tethering cilia in the otic vesicle and shorter motile cilia in the pronephric ducts. In Xenopus, expression of a dn-fgfr1 results in shorter monocilia in the gastrocoel roof plate that control left-right patterning(4) and in shorter multicilia in external mucociliary epithelium. Together, these results indicate a fundamental and highly conserved role for FGF signalling in the regulation of cilia length in multiple tissues. Abrogation of Fgfr1 signalling downregulates expression of two ciliogenic transcription factors, foxj1 and rfx2, and of the intraflagellar transport gene ift88 (also known as polaris), indicating that FGF signalling mediates cilia length through an Fgf8/Fgf24-Fgfr1-intraflagellar transport pathway. We propose that a subset of developmental defects and diseases ascribed to FGF signalling are due in part to loss of cilia function.	[Neugebauer, Judith M.; Amack, Jeffrey D.; Peterson, Annita G.; Bisgrove, Brent W.; Yost, H. Joseph] Univ Utah, Sch Med, Dept Neurobiol & Anat, Eccles Inst Human Genet, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Yost, HJ (corresponding author), Univ Utah, Sch Med, Dept Neurobiol & Anat, Eccles Inst Human Genet, Bldg 533,Room 3160,15 North 2030 East, Salt Lake City, UT 84112 USA.	jyost@genetics.utah.edu		Amack, Jeffrey/0000-0002-5465-9754	American Heart Association; NRSA Postdoctoral fellowship; NHLBI; NICHD; Primary Children's Medical Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD048886] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066292, R01HL075472] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NRSA Postdoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Primary Children's Medical Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank A. Moon and M. Condic for critical discussions on the manuscript; M. Karthikeyan, J. Shen, D. Coombs and E. Martini for technical help; and S. Miyagawa- Tomita, K. Poss and H. Issacs for reagents. This work was supported by American Heart Association predoctoral fellowship to J. M. N., NRSA Postdoctoral fellowship to J. D. A. and grants from NHLBI, NICHD and Primary Children's Medical Foundation to H. J. Y.	Albertson RC, 2005, DEV BIOL, V283, P310, DOI 10.1016/j.ydbio.2005.04.025; Amack JD, 2004, CURR BIOL, V14, P685, DOI 10.1016/j.cub.2004.04.002; Amack JD, 2007, DEV BIOL, V310, P196, DOI 10.1016/j.ydbio.2007.05.039; AMAYA E, 1991, CELL, V66, P257, DOI 10.1016/0092-8674(91)90616-7; Bisgrove BW, 2005, DEV BIOL, V287, P274, DOI 10.1016/j.ydbio.2005.08.047; Boettger T, 1999, CURR BIOL, V9, P277, DOI 10.1016/S0960-9822(99)80119-5; Bonnafe E, 2004, MOL CELL BIOL, V24, P4417, DOI 10.1128/MCB.24.10.4417-4427.2004; Brody SL, 2000, AM J RESP CELL MOL, V23, P45, DOI 10.1165/ajrcmb.23.1.4070; Draper BW, 2003, DEVELOPMENT, V130, P4639, DOI 10.1242/dev.00671; Draper BW, 2001, GENESIS, V30, P154, DOI 10.1002/gene.1053; Eggenschwiler JT, 2007, ANNU REV CELL DEV BI, V23, P345, DOI 10.1146/annurev.cellbio.23.090506.123249; Essner JJ, 2005, DEVELOPMENT, V132, P1247, DOI 10.1242/dev.01663; Fischer A, 2002, CURR BIOL, V12, P1807, DOI 10.1016/S0960-9822(02)01222-8; Fischer S, 2003, DEVELOPMENT, V130, P3515, DOI 10.1242/dev.00537; Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12; Kramer-Zucker AG, 2005, DEVELOPMENT, V132, P1907, DOI 10.1242/dev.01772; Lee Y, 2005, DEVELOPMENT, V132, P5173, DOI 10.1242/dev.02101; Long S, 2003, DEVELOPMENT, V130, P2303, DOI 10.1242/dev.00436; Meyers EN, 1999, SCIENCE, V285, P403, DOI 10.1126/science.285.5426.403; Millimaki BB, 2007, DEVELOPMENT, V134, P295, DOI 10.1242/dev.02734; Nieuwkoop P.D., 1994, SYSTEMATICAL CHRONOL, DOI 10.1201/9781003064565-29; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Park TJ, 2008, NAT GENET, V40, P871, DOI 10.1038/ng.104; Pownall ME, 2003, DEV BIOL, V256, P89, DOI 10.1016/S0012-1606(02)00120-3; R Development Core Team, 2007, R FDN STAT COMP; Riley BB, 1997, DEV BIOL, V191, P191, DOI 10.1006/dbio.1997.8736; Roehl H, 2001, CURR BIOL, V11, P503, DOI 10.1016/S0960-9822(01)00143-9; Scholpp S, 2004, DEV GENES EVOL, V214, P285, DOI 10.1007/s00427-004-0409-1; Schweickert A, 2007, CURR BIOL, V17, P60, DOI 10.1016/j.cub.2006.10.067; Tanaka Y, 2005, NATURE, V435, P172, DOI 10.1038/nature03494; Thummel R, 2006, DEV DYNAM, V235, P336, DOI 10.1002/dvdy.20630; Urban AE, 2006, DEV BIOL, V297, P103, DOI 10.1016/j.ydbio.2006.04.469; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200	33	186	188	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 2	2009	458	7238					651	U119		10.1038/nature07753	http://dx.doi.org/10.1038/nature07753			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RK	19242413	Green Accepted			2022-12-01	WOS:000264796200045
J	Xu, P; Duong, DM; Seyfried, NT; Cheng, DM; Xie, Y; Robert, J; Rush, J; Hochstrasser, M; Finley, D; Peng, J				Xu, Ping; Duong, Duc M.; Seyfried, Nicholas T.; Cheng, Dongmei; Xie, Yang; Robert, Jessica; Rush, John; Hochstrasser, Mark; Finley, Daniel; Peng, Junmin			Quantitative Proteomics Reveals the Function of Unconventional Ubiquitin Chains in Proteasomal Degradation	CELL			English	Article							DOA4 DEUBIQUITINATING ENZYME; MASS-SPECTROMETRY; POLYUBIQUITIN CHAINS; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; PROTEIN LIGASES; 26S PROTEASOME; IN-VITRO; YEAST; COMPLEX	All seven lysine residues in ubiquitin contribute to the synthesis of polyubiquitin chains on protein substrates. Whereas K48-linked chains are well established as mediators of proteasomal degradation, and K63-linked chains act in nonproteolytic events, the roles of unconventional polyubiquitin chains linked through K6, K11, K27, K29, or K33 are not well understood. Here, we report that the unconventional linkages are abundant in vivo and that all non-K63 linkages may target proteins for degradation. Ubiquitin with K48 as the single lysine cannot support yeast viability, and different linkages have partially redundant functions. By profiling both the entire yeast proteome and ubiquitinated proteins in wild-type and ubiquitin K11R mutant strains using mass spectrometry, we identified K11 linkage-specific substrates, including Ubc6, a ubiquitin-conjugating enzyme involved in endoplasmic reticulum-associated degradation (ERAD). Ubc6 primarily synthesizes K11-linked chains, and K11 linkages function in the ERAD pathway. Thus, unconventional polyubiquitin chains are critical for ubiquitin-proteasome system function.	[Xu, Ping; Duong, Duc M.; Seyfried, Nicholas T.; Cheng, Dongmei; Peng, Junmin] Emory Univ, Dept Human Genet, Ctr Neurodegenerat Dis, Atlanta, GA 30322 USA; [Xie, Yang; Hochstrasser, Mark] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Robert, Jessica; Finley, Daniel] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Rush, John] Cell Signaling Technol, Beverly, MA 01915 USA	Emory University; Yale University; Harvard University; Harvard Medical School	Peng, J (corresponding author), Emory Univ, Dept Human Genet, Ctr Neurodegenerat Dis, Atlanta, GA 30322 USA.	jpeng@emory.edu	Peng, Junmin/N-2614-2018	Peng, Junmin/0000-0003-0472-7648; Duong, Duc/0000-0001-5880-1888; Hochstrasser, Mark/0000-0002-1131-5484	National Institutes of Health [GM046904, GM043601, DK069580, CA126222, AG025688]; NATIONAL CANCER INSTITUTE [R21CA126222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK069580] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM046904, R01GM043601, R37GM043601, R01GM046904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG025688] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank P. Coffino, A. Corbett, G. Crouse, R. Cohen, E. Dammer, J. Fridovich-Keil, M. Hoyt, M. Jonikas, C. Kahana, C.-W. Liu, J. Mullally, P. Philippsen, D. Reines, J. Roelofs, R. Rothstein, T. Sommer, Y. Tone, P. Walter, J. Weissman, K. Wilkinson, Q. Xia, and T. Yao for reagents and discussion. We also thank D. Kirkpatrick and K. Wilkinson for critical reading and H. Boldt and C. Strauss for editing. This work was funded by National Institutes of Health grants (GM046904 to M.H.; GM043601 to D.F.; and DK069580, CA126222, and AG025688 to J.P.).	Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; Amerik AY, 2000, BIOL CHEM, V381, P981, DOI 10.1515/BC.2000.121; Amerik AY, 2000, MOL BIOL CELL, V11, P3365, DOI 10.1091/mbc.11.10.3365; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baboshina OV, 1996, J BIOL CHEM, V271, P2823, DOI 10.1074/jbc.271.5.2823; Bazirgan OA, 2008, J BIOL CHEM, V283, P12797, DOI 10.1074/jbc.M801122200; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; CHEN P, 1993, CELL, V74, P357, DOI 10.1016/0092-8674(93)90426-Q; Coffino P, 2001, NAT REV MOL CELL BIO, V2, P188, DOI 10.1038/35056508; Crosas B, 2006, CELL, V127, P1401, DOI 10.1016/j.cell.2006.09.051; Eddins MJ, 2006, NAT STRUCT MOL BIOL, V13, P915, DOI 10.1038/nsmb1148; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; FINLEY D, 1994, MOL CELL BIOL, V14, P5501, DOI 10.1128/MCB.14.8.5501; Hatakeyama S, 2001, J BIOL CHEM, V276, P33111, DOI 10.1074/jbc.M102755200; Jin LY, 2008, CELL, V133, P653, DOI 10.1016/j.cell.2008.04.012; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Kee Y, 2006, J BIOL CHEM, V281, P36724, DOI 10.1074/jbc.M608756200; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Liu CW, 2006, MOL CELL, V24, P39, DOI 10.1016/j.molcel.2006.08.025; Lopez-Fanarraga M, 2001, J STRUCT BIOL, V135, P219, DOI 10.1006/jsbi.2001.4386; Meierhofer D, 2008, J PROTEOME RES, V7, P4566, DOI 10.1021/pr800468j; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Nielsen ML, 2008, NAT METHODS, V5, P459, DOI 10.1038/nmeth0608-459; Nishikawa H, 2004, J BIOL CHEM, V279, P3916, DOI 10.1074/jbc.M308540200; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Ravid T, 2006, EMBO J, V25, P533, DOI 10.1038/sj.emboj.7600946; Rodrigo-Brenni MC, 2007, CELL, V130, P127, DOI 10.1016/j.cell.2007.05.027; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Seyfried NT, 2008, ANAL CHEM, V80, P4161, DOI 10.1021/ac702516a; SOMMER T, 1993, NATURE, V365, P176, DOI 10.1038/365176a0; SPENCE J, 1995, MOL CELL BIOL, V15, P1265; Swaminathan S, 1999, MOL BIOL CELL, V10, P2583, DOI 10.1091/mbc.10.8.2583; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Wang M, 2006, EMBO J, V25, P1710, DOI 10.1038/sj.emboj.7601061; Xu P, 2006, ISRAEL J CHEM, V46, P171, DOI 10.1560/1JVL-J4EE-FVW4-MXRE	43	795	829	4	105	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 2	2009	137	1					133	145		10.1016/j.cell.2009.01.041	http://dx.doi.org/10.1016/j.cell.2009.01.041			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	427XV	19345192	Green Accepted, Bronze			2022-12-01	WOS:000264813300020
J	Jonikas, MC; Collins, SR; Denic, V; Oh, E; Quan, EM; Schmid, V; Weibezahn, J; Schwappach, B; Walter, P; Weissman, JS; Schuldiner, M				Jonikas, Martin C.; Collins, Sean R.; Denic, Vladimir; Oh, Eugene; Quan, Erin M.; Schmid, Volker; Weibezahn, Jimena; Schwappach, Blanche; Walter, Peter; Weissman, Jonathan S.; Schuldiner, Maya			Comprehensive Characterization of Genes Required for Protein Folding in the Endoplasmic Reticulum	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE GENOME; TAIL-ANCHORED PROTEINS; QUALITY-CONTROL; MISFOLDED PROTEINS; SECRETORY PATHWAY; YEAST; ER; DEGRADATION; INSERTION; MEMBRANE	Protein folding in the endoplasmic reticulum is a complex process whose malfunction is implicated in disease and aging. By using the cell's endogenous sensor (the unfolded protein response), we identified several hundred yeast genes with roles in endoplasmic reticulum folding and systematically characterized their functional interdependencies by measuring unfolded protein response levels in double mutants. This strategy revealed multiple conserved factors critical for endoplasmic reticulum folding, including an intimate dependence on the later secretory pathway, a previously uncharacterized six-protein transmembrane complex, and a co-chaperone complex that delivers tail-anchored proteins to their membrane insertion machinery. The use of a quantitative reporter in a comprehensive screen followed by systematic analysis of genetic dependencies should be broadly applicable to functional dissection of complex cellular processes from yeast to human.	[Jonikas, Martin C.; Collins, Sean R.; Denic, Vladimir; Oh, Eugene; Quan, Erin M.; Weibezahn, Jimena; Weissman, Jonathan S.; Schuldiner, Maya] Univ Calif San Francisco, Dept Cellular & Mol Physiol, San Francisco, CA 94143 USA; [Jonikas, Martin C.; Walter, Peter] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Jonikas, Martin C.; Collins, Sean R.; Denic, Vladimir; Oh, Eugene; Quan, Erin M.; Weibezahn, Jimena; Walter, Peter; Weissman, Jonathan S.; Schuldiner, Maya] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Jonikas, Martin C.; Collins, Sean R.; Denic, Vladimir; Oh, Eugene; Quan, Erin M.; Weibezahn, Jimena; Weissman, Jonathan S.; Schuldiner, Maya] Calif Inst Quantitat Biomed Res, San Francisco, CA 94143 USA; [Schmid, Volker; Schwappach, Blanche] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of Manchester	Weissman, JS (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Physiol, San Francisco, CA 94143 USA.	weissman@cmp.ucsf.edu	Schuldiner, Maya/C-9488-2009	Weissman, Jonathan/0000-0003-2445-670X; Oh, Eugene/0000-0003-1970-8423; Schwappach, Blanche/0000-0003-0225-6432; Schuldiner, Maya/0000-0001-9947-115X; Collins, Sean/0000-0002-4276-5840	Howard Hughes Medical Institute; NSF; International Human Frontier Science Program; NIH [K99/R00]; European Molecular Biology Organization long-term fellowship; Deutsche Forschungsgemeinschaft; Wellcome Trust	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NSF(National Science Foundation (NSF)); International Human Frontier Science Program(Human Frontier Science Program); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Molecular Biology Organization long-term fellowship(European Molecular Biology Organization (EMBO)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Wellcome Trust(Wellcome TrustEuropean Commission)	We thank C.-S. Chin for flow cytometry software development; C. Boone, D. Breslow, N. Krogan, D. Ng, and C. Wang for reagents; K. Thorn for microscopy assistance; S. Zhou, D. King, G. Cagney, and N. Krogan for mass spectrometry analyses; J. Metz, P. Nittler, A. Carroll, J. Hill, J. Ihmels, S. Wang, and C. Chu for technical help; R. Andino, T. Aragon, A. Battle, N. Bradshaw, J. DeRisi, N. Friedman, J. Hollien, J. Newman, D. Koller, R. Kupferman, H. Madhani, L. Osherovich, F. Papa, and members of the Weissman, Walter, and Schwappach labs for stimulating discussion; B. Toyama for graphics; and M. Bassik, D. Breslow, O. Brandman, S. Churchman, and S. Neher for comments on the manuscript. This work was supported by the Howard Hughes Medical Institute (J.S.W. and P.W.), the NSF (M.C.J. and E.M.Q.), the International Human Frontier Science Program (M.S. and J.W.), an NIH K99/R00 award (M.S.), a European Molecular Biology Organization long-term fellowship (J.W.), the Deutsche Forschungsgemeinschaft (V.S.), and the Wellcome Trust (B.S.).	Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Borgese N, 2003, BIOCHEM SOC T, V31, P1238; Boutros M, 2008, NAT REV GENET, V9, P554, DOI 10.1038/nrg2364; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Burri L, 2004, TRAFFIC, V5, P45, DOI 10.1046/j.1600-0854.2003.00151.x; Casagrande R, 2000, MOL CELL, V5, P729, DOI 10.1016/S1097-2765(00)80251-8; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Decourty L, 2008, P NATL ACAD SCI USA, V105, P5821, DOI 10.1073/pnas.0710533105; Favaloro V, 2008, J CELL SCI, V121, P1832, DOI 10.1242/jcs.020321; Fleischer TC, 2006, GENE DEV, V20, P1294, DOI 10.1101/gad.1422006; Friedlander R, 2000, NAT CELL BIOL, V2, P379, DOI 10.1038/35017001; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Girgis HS, 2007, PLOS GENET, V3, P1644, DOI 10.1371/journal.pgen.0030154; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Lin JH, 2008, ANNU REV PATHOL-MECH, V3, P399, DOI 10.1146/annurev.pathmechdis.3.121806.151434; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Pollard MG, 1998, MOL CELL, V1, P171, DOI 10.1016/S1097-2765(00)80018-0; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Scheuner D, 2008, ENDOCR REV, V29, P317, DOI 10.1210/er.2007-0039; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Schuldiner M, 2008, CELL, V134, P634, DOI 10.1016/j.cell.2008.06.025; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; Stefanovic S, 2007, CELL, V128, P1147, DOI 10.1016/j.cell.2007.01.036; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Trombetta ES, 2003, ANNU REV CELL DEV BI, V19, P649, DOI 10.1146/annurev.cellbio.19.110701.153949; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	33	502	520	3	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2009	323	5922					1693	1697		10.1126/science.1167983	http://dx.doi.org/10.1126/science.1167983			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	424IG	19325107	Green Accepted			2022-12-01	WOS:000264559800030
J	Adhiyaman, V; Adhiyaman, S				Adhiyaman, Vedamurthy; Adhiyaman, Sonja			10-Minute Consultation Transient ischaemic attack	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Adhiyaman, Vedamurthy] Glan Clwyd Gen Hosp, Rhyl LL18 5UJ, Denbigh, Wales; [Adhiyaman, Sonja] Laurels Surg, Flint CH6 5AF, England		Adhiyaman, V (corresponding author), Glan Clwyd Gen Hosp, Rhyl LL18 5UJ, Denbigh, Wales.	adhiyamanv@yahoo.co.uk							0	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 23	2009	338								a2343	10.1136/bmj.a2343	http://dx.doi.org/10.1136/bmj.a2343			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	425LO	19307272				2022-12-01	WOS:000264639400001
J	Mazzone, M; Dettori, D; de Oliveira, RL; Loges, S; Schmidt, T; Jonckx, B; Tian, YM; Lanahan, AA; Pollard, P; de Almodovar, CR; De Smet, F; Vinckier, S; Aragones, J; Debackere, K; Luttun, A; Wyns, S; Jordan, B; Pisacane, A; Gallez, B; Lampugnani, MG; Dejana, E; Simons, M; Ratcliffe, P; Maxwell, P; Carmeliet, P				Mazzone, Massimiliano; Dettori, Daniela; de Oliveira, Rodrigo Leite; Loges, Sonja; Schmidt, Thomas; Jonckx, Bart; Tian, Ya-Min; Lanahan, Anthony A.; Pollard, Patrick; de Almodovar, Carmen Ruiz; De Smet, Frederik; Vinckier, Stefan; Aragones, Julian; Debackere, Koen; Luttun, Aemout; Wyns, Sabine; Jordan, Benedicte; Pisacane, Alberto; Gallez, Bernard; Lampugnani, Maria Grazia; Dejana, Elisabetta; Simons, Michael; Ratcliffe, Peter; Maxwell, Patrick; Carmeliet, Peter			Heterozygous Deficiency of PHD2 Restores Tumor Oxygenation and Inhibits Metastasis via Endothelial Normalization	CELL			English	Article							INDUCIBLE FACTOR-I; VASCULAR NORMALIZATION; ANGIOGENESIS; VEGF; HYPOXIA; CADHERIN; CELLS; ACTIVATION; VESSELS; CANCER	A key function of blood vessels, to supply oxygen, is impaired in tumors because of abnormalities in their endothelial lining. PHD proteins serve as oxygen sensors and may regulate oxygen delivery. We therefore studied the role of endothelial PHD2 in vessel shaping by implanting tumors in PHD2(+/-) mice. Haplodeficiency of PHD2 did not affect tumor vessel density or lumen size, but normalized the endothelial lining and vessel maturation. This resulted in improved tumor perfusion and oxygenation and inhibited tumor cell invasion, intravasation, and metastasis. Haplodeficiency of PHD2 redirected the specification of endothelial tip cells to a more quiescent cell type, lacking filopodia and arrayed in a phalanx formation. This transition relied on HIF-driven upregulation of (soluble) VEGFR-1 and VE-cadherin. Thus, decreased activity of an oxygen sensor in hypoxic conditions prompts endothelial cells to readjust their shape and phenotype to restore oxygen supply. Inhibition of PHD2 may offer alternative therapeutic opportunities for anticancer therapy.	[Mazzone, Massimiliano; Dettori, Daniela; de Oliveira, Rodrigo Leite; Loges, Sonja; Schmidt, Thomas; Jonckx, Bart; de Almodovar, Carmen Ruiz; De Smet, Frederik; Vinckier, Stefan; Aragones, Julian; Debackere, Koen; Wyns, Sabine; Carmeliet, Peter] VIB Vlaams Inst Biotechnol, Vesalius Res Ctr, B-3000 Louvain, Belgium; [Mazzone, Massimiliano; Dettori, Daniela; de Oliveira, Rodrigo Leite; Loges, Sonja; Schmidt, Thomas; Jonckx, Bart; de Almodovar, Carmen Ruiz; De Smet, Frederik; Vinckier, Stefan; Aragones, Julian; Debackere, Koen; Wyns, Sabine; Carmeliet, Peter] Katholieke Univ Leuven, Vesalius Res Ctr, B-3000 Louvain, Belgium; [Dettori, Daniela] Univ Turin, Sch Med, Canc Genet Lab, Inst Canc Res & Treatment, I-10060 Turin, Italy; [Tian, Ya-Min; Pollard, Patrick; Ratcliffe, Peter] Henry Wellcome Bldg Genom Med, Oxford OX3 7BN, England; [Lanahan, Anthony A.] Yale Univ, New Haven, CT 06510 USA; [Luttun, Aemout] Katholieke Univ Leuven, Ctr Mol & Vasc Biol, B-3000 Louvain, Belgium; [Jordan, Benedicte; Gallez, Bernard] Med Chem & Radiopharm UC Louvain, Biomed Magnet Resonance Unit, B-1000 Brussels, Belgium; [Pisacane, Alberto] Inst Canc Res & Treatment, Anat Pathol Unit, I-10060 Turin, Italy; [Lampugnani, Maria Grazia; Dejana, Elisabetta] Italian Fdn Canc Res, Inst Mol Oncol, Vasc Biol Unit, I-20139 Milan, Italy; [Maxwell, Patrick] UCL, Rayne Inst, London WC1E 6JJ, England	Flanders Institute for Biotechnology (VIB); KU Leuven; University of Turin; University of Oxford; Yale University; KU Leuven; IFOM - FIRC Institute of Molecular Oncology; University of London; King's College London; University College London	Carmeliet, P (corresponding author), VIB Vlaams Inst Biotechnol, Vesalius Res Ctr, B-3000 Louvain, Belgium.	peter.carmeliet@med.kuleuven.be	Maxwell, Patrick H/C-5557-2008; Loges, Sonja/ABE-9868-2021; De Smet, Frederik/Q-7808-2016; Luttun, Aernout/AAZ-6540-2020; Carmeliet, Peter/AAQ-5140-2020; Simons, Michael/G-8553-2014; Pollard, Patrick/F-7516-2012; pisacane, alberto/AAB-9001-2020; Schmidt, Thomas/Y-8431-2019	Maxwell, Patrick H/0000-0002-0338-2679; Loges, Sonja/0000-0002-7650-8527; De Smet, Frederik/0000-0002-6669-3335; Luttun, Aernout/0000-0001-7902-9524; Carmeliet, Peter/0000-0001-7961-1821; Simons, Michael/0000-0003-0348-7734; Pollard, Patrick/0000-0002-4459-4993; pisacane, alberto/0000-0002-5143-8980; Schmidt, Thomas/0000-0002-7166-3675; Ruiz de Almodovar, Carmen/0000-0001-5975-7815; Ratcliffe, Peter/0000-0002-2853-806X; Debackere, Koen/0000-0002-7701-326X; Lampugnani, Maria Grazia/0000-0002-4802-7064; Aragones Lopez, Julian/0000-0002-0193-4679; Mazzone, Massimiliano/0000-0001-8824-4015; DEJANA, ELISABETTA/0000-0002-0007-0426; Leite de Oliveira, Rodrigo/0000-0002-9696-2014	FWO [G0125.00, G0121.02]; British Heart Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053793] Funding Source: NIH RePORTER	FWO(FWO); British Heart Foundation(British Heart Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	M. M. is supported by the European Molecular Biology Organization, R. L. O. by the Fonds Wetenschappelijk Onderzoek ( FWO), S. L. by the Deutsche Krebshilfe, T. S. by the Deutsche Forschungsgemeinschaft, C. R. A. by the Federation of European Biochemical Societies and the FWO, and A. L. by the FWO and a Katholieke Universiteit Leuven Center of Excellence grant. The authors thank Vesalius Research Center technicians for assistance. This work was supported by grants from (to P. C.) Methusalem, the FWO (G0125.00; G0121.02), the European Union (QLRT- 2001- 0195), the Concerted Research Activities (# GOA2001/ 09; GOA/2006/11), the Belgian Science Policy (IAP- P5/02), and (to P. H. M. and P. J. R.) the British Heart Foundation (Programme Grant). P. R. and P. M. are scientific cofounders of and hold equity in ReOx Ltd., a University spin-out company that aims to develop inhibitors of the HIF hydroxylases.	Baluk P, 2005, CURR OPIN GENET DEV, V15, P102, DOI 10.1016/j.gde.2004.12.005; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; Couvelard A, 2008, CLIN CANCER RES, V14, P6634, DOI 10.1158/1078-0432.CCR-07-5258; Dutta D, 2008, J BIOL CHEM, V283, P25404, DOI 10.1074/jbc.M804349200; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Fischer C, 2007, CELL, V131, P463, DOI 10.1016/j.cell.2007.08.038; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Gerhardt H, 2008, J MOL MED, V86, P135, DOI 10.1007/s00109-007-0258-2; Greenberg JI, 2008, NATURE, V456, P809, DOI 10.1038/nature07424; Hamzah J, 2008, NATURE, V453, P410, DOI 10.1038/nature06868; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Jones CA, 2008, NAT MED, V14, P448, DOI 10.1038/nm1742; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kappas NC, 2008, J CELL BIOL, V181, P847, DOI 10.1083/jcb.200709114; Kashiwagi S, 2008, NAT MED, V14, P255, DOI 10.1038/nm1730; Kearney JB, 2004, BLOOD, V103, P4527, DOI 10.1182/blood-2003-07-2315; Kitamura T, 2008, NAT CELL BIOL, V10, P329, DOI 10.1038/ncb1695; Kuhlencordt PJ, 2004, AM J PHYSIOL-CELL PH, V286, pC1195, DOI 10.1152/ajpcell.00546.2002; Lampugnani MG, 2003, J CELL BIOL, V161, P793, DOI 10.1083/jcb.200209019; Le Bras A, 2007, ONCOGENE, V26, P7480, DOI 10.1038/sj.onc.1210566; Lee K, 2008, MOL CANCER RES, V6, P829, DOI 10.1158/1541-7786.MCR-07-2113; Lofstedt T, 2007, CELL CYCLE, V6, P919, DOI 10.4161/cc.6.8.4133; Marxsen JH, 2004, BIOCHEM J, V381, P761, DOI 10.1042/BJ20040620; Milkiewicz M, 2004, J PHYSIOL-LONDON, V560, P21, DOI 10.1113/jphysiol.2004.069757; Minamishima YA, 2008, BLOOD, V111, P3236, DOI 10.1182/blood-2007-10-117812; Nangaku M, 2007, ARTERIOSCL THROM VAS, V27, P2548, DOI 10.1161/ATVBAHA.107.148551; Peng J, 2000, P NATL ACAD SCI USA, V97, P8386, DOI 10.1073/pnas.140087397; Pospisilik JA, 2007, CELL, V131, P476, DOI 10.1016/j.cell.2007.08.047; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Stockmann C, 2008, NATURE, V456, P814, DOI 10.1038/nature07445; Sullivan R, 2007, CANCER METAST REV, V26, P319, DOI 10.1007/s10555-007-9062-2; Taddei A, 2008, NAT CELL BIOL, V10, P923, DOI 10.1038/ncb1752; Takeda K, 2008, BLOOD, V111, P3229, DOI 10.1182/blood-2007-09-114561; Takeda K, 2007, CIRCULATION, V116, P774, DOI 10.1161/CIRCULATIONAHA.107.701516; Takeda K, 2007, HYPERTENSION, V49, P178, DOI 10.1161/01.HYP.0000251360.40838.0f; Thurston G, 2007, NAT REV CANCER, V7, P327, DOI 10.1038/nrc2130; Winkler F, 2004, CANCER CELL, V6, P553, DOI 10.1016/S1535-6108(04)00305-8; Wu SR, 2008, MOL THER, V16, P1227, DOI 10.1038/mt.2008.90; Yamashita T, 2008, J BIOL CHEM, V283, P18926, DOI 10.1074/jbc.M709133200	41	592	613	1	56	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 6	2009	136	5					839	851		10.1016/j.cell.2009.01.020	http://dx.doi.org/10.1016/j.cell.2009.01.020			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	415JU	19217150	Green Accepted, Bronze			2022-12-01	WOS:000263930900008
J	Padmanabhan, S; Mukhopadhyay, A; Narasimhan, SD; Tesz, G; Czech, MP; Tissenbaum, HA				Padmanabhan, Srivatsan; Mukhopadhyay, Arnab; Narasimhan, Sri Devi; Tesz, Gregory; Czech, Michael P.; Tissenbaum, Heidi A.			A PP2A Regulatory Subunit Regulates C-elegans Insulin/IGF-1 Signaling by Modulating AKT-1 Phosphorylation	CELL			English	Article							PROTEIN-KINASE-B; FORKHEAD TRANSCRIPTION FACTOR; TUMOR-SUPPRESSOR GENE; AGE-1 PI3 KINASE; CAENORHABDITIS-ELEGANS; LIFE-SPAN; STRESS RESISTANCE; DAUER FORMATION; CELL-PROLIFERATION; LARVAL DEVELOPMENT	The C. elegans insulin/IGF-1 signaling (IIS) cascade plays a central role in regulating life span, dauer, metabolism, and stress. The major regulatory control of IIS is through phosphorylation of its components by serine/threonine-specific protein kinases. An RNAi screen for serine/threonine protein phosphatases that counterbalance the effect of the kinases in the IIS pathway identified pptr-1, a B56 regulatory subunit of the PP2A holoenzyme. Modulation of pptr-1 affects IIS pathway-associated phenotypes including life span, dauer, stress resistance, and fat storage. We show that PPTR-1 functions by regulating worm AKT-1 phosphorylation at Thr 350. With striking conservation, mammalian B56 beta regulates Akt phosphorylation at Thr 308 in 3T3-L1 adipocytes. In C. elegans, this ultimately leads to changes in subcellular localization and transcriptional activity of the forkhead transcription factor DAF-16. This study reveals a conserved role for the B56 regulatory subunit in regulating insulin signaling through AKT dephosphorylation, thereby having widespread implications in cancer and diabetes research.	[Padmanabhan, Srivatsan; Mukhopadhyay, Arnab; Narasimhan, Sri Devi; Tissenbaum, Heidi A.] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA; [Tesz, Gregory; Czech, Michael P.; Tissenbaum, Heidi A.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Tissenbaum, HA (corresponding author), Univ Massachusetts, Sch Med, Program Gene Funct & Express, 364 Plantat St, Worcester, MA 01605 USA.	heidi.tissenbaum@umassmed.edu	Mukhopadhyay, Arnab/N-6005-2016	Mukhopadhyay, Arnab/0000-0002-5266-7849; Padmanabhan, Srivatsan/0000-0003-2958-1390	National Institute of Aging [AG025891]; Glenn Foundation; William Randolph Hearst Foundation; NATIONAL INSTITUTE ON AGING [R01AG025891] Funding Source: NIH RePORTER	National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Glenn Foundation; William Randolph Hearst Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are grateful to Eun-soo Kwon, Kelvin Yen, Craig Mello, and Marian Walhout for advice and critical comments on the manuscript, Paul Furcinitti of the UMass Medical School Digital Light Microscopy Core Facility for help with the confocal microscopy, Nina Bhabhalia for technical support, and Sandhya Pande for help with the phospho- westerns. We thank Marian Walhout, Gary Ruvkun, Maren Hertweck, and Ralf Baumeister for plasmids and strains. Some of the strains were kindly provided by Theresa Stiernagle at the Caenorhabditis Genetics Center, which is funded by the National Institutes of Health National Center for Research Resources. H. A. T. is a William Randolph Hearst Young Investigator. This project was funded in part by the National Institute of Aging (AG025891), the Glenn Foundation, and an endowment from the William Randolph Hearst Foundation.	Andjelkovic M, 1996, P NATL ACAD SCI USA, V93, P5699, DOI 10.1073/pnas.93.12.5699; Antebi A, 2007, PLOS GENET, V3, P1565, DOI 10.1371/journal.pgen.0030129; Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Barbieri M, 2003, AM J PHYSIOL-ENDOC M, V285, pE1064, DOI 10.1152/ajpendo.00296.2003; Brazil DP, 2001, TRENDS BIOCHEM SCI, V26, P657, DOI 10.1016/S0968-0004(01)01958-2; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; da Graca LS, 2004, DEVELOPMENT, V131, P435, DOI 10.1242/dev.00922; DORMAN JB, 1995, GENETICS, V141, P1399; Eichhorn P.J., 2008, BBA-REV CANCER, V1795, P1, DOI DOI 10.1016/J.BBCAN.2008.05.005; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Gems D, 1998, GENETICS, V150, P129; Gil EB, 1999, P NATL ACAD SCI USA, V96, P2925, DOI 10.1073/pnas.96.6.2925; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Gunther CV, 2000, DEVELOPMENT, V127, P3337; Hakem R, 2001, ANNU REV GENET, V35, P209, DOI 10.1146/annurev.genet.35.102401.090432; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Hertweck M, 2004, DEV CELL, V6, P577, DOI 10.1016/S1534-5807(04)00095-4; Hojlund K, 2002, EUR J CLIN INVEST, V32, P918, DOI 10.1046/j.1365-2362.2002.01098.x; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; Inoue T, 2000, DEV BIOL, V217, P192, DOI 10.1006/dbio.1999.9545; Janssens V, 2008, TRENDS BIOCHEM SCI, V33, P113, DOI 10.1016/j.tibs.2007.12.004; Jensen VL, 2007, GENETICS, V177, P661, DOI 10.1534/genetics.107.076703; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; KIMBLE J, 1984, DEV BIOL, V105, P234, DOI 10.1016/0012-1606(84)90279-3; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kuo YC, 2008, J BIOL CHEM, V283, P1882, DOI 10.1074/jbc.M709585200; LARSEN PL, 1995, GENETICS, V139, P1567; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; Lithgow GJ, 2002, MECH AGEING DEV, V123, P765, DOI 10.1016/S0047-6374(01)00422-5; McElwee J, 2003, AGING CELL, V2, P111, DOI 10.1046/j.1474-9728.2003.00043.x; Mihaylova VT, 1999, P NATL ACAD SCI USA, V96, P7427, DOI 10.1073/pnas.96.13.7427; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; Mukhopadhyay A, 2006, EXP GERONTOL, V41, P928, DOI 10.1016/j.exger.2006.05.020; Munoz MJ, 2003, GENETICS, V163, P171; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Ogg S, 1998, MOL CELL, V2, P887, DOI 10.1016/S1097-2765(00)80303-2; Oh SW, 2006, NAT GENET, V38, P251, DOI 10.1038/ng1723; Oh SW, 2005, P NATL ACAD SCI USA, V102, P4494, DOI 10.1073/pnas.0500749102; Paradis S, 1999, GENE DEV, V13, P1438, DOI 10.1101/gad.13.11.1438; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; Patterson GI, 1997, GENE DEV, V11, P2679, DOI 10.1101/gad.11.20.2679; Patterson GI, 2000, TRENDS GENET, V16, P27, DOI 10.1016/S0168-9525(99)01916-2; PILGRIM D, 1995, MOL BIOL CELL, V6, P1159, DOI 10.1091/mbc.6.9.1159; Powelka AM, 2006, J CLIN INVEST, V116, P125, DOI 10.1172/JCI26040; Reboul J, 2003, NAT GENET, V34, P35, DOI 10.1038/ng1140; Ren PF, 1996, SCIENCE, V274, P1389, DOI 10.1126/science.274.5291.1389; Resjo S, 2002, CELL SIGNAL, V14, P231, DOI 10.1016/S0898-6568(01)00238-8; RIDDLE DL, 1981, NATURE, V290, P668, DOI 10.1038/290668a0; Riddle DL, 1997, C ELEGANS; Rondinone CM, 1999, DIABETOLOGIA, V42, P819, DOI 10.1007/s001250051232; Rouault JP, 1999, CURR BIOL, V9, P329, DOI 10.1016/S0960-9822(99)80143-2; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sasaoka T, 2006, PHARMACOL THERAPEUT, V112, P799, DOI 10.1016/j.pharmthera.2006.06.001; Savage-Dunn C., 2005, WORMBOOK; Smith U, 1999, ANN NY ACAD SCI, V892, P119, DOI 10.1111/j.1749-6632.1999.tb07790.x; SRINIVASAN M, 1994, J BIOL CHEM, V269, P12514; Stiernagle T., 2006, WORMBOOK; Stiles B, 2002, MOL CELL BIOL, V22, P3842, DOI 10.1128/MCB.22.11.3842-3851.2002; Tang XQ, 2006, P NATL ACAD SCI USA, V103, P2087, DOI 10.1073/pnas.0507660103; Testa JR, 2001, P NATL ACAD SCI USA, V98, P10983, DOI 10.1073/pnas.211430998; Tesz GJ, 2007, J BIOL CHEM, V282, P19302, DOI 10.1074/jbc.M700665200; Toker A, 2006, CANCER RES, V66, P3963, DOI 10.1158/0008-5472.CAN-06-0743; Toker A, 2000, J BIOL CHEM, V275, P8271, DOI 10.1074/jbc.275.12.8271; Ugi S, 2004, MOL CELL BIOL, V24, P8778, DOI 10.1128/MCB.24.19.8778-8789.2004; VOWELS JJ, 1992, GENETICS, V130, P105; Watson RT, 2004, ENDOCR REV, V25, P177, DOI 10.1210/er.2003-0011; Wolff S, 2006, EXP GERONTOL, V41, P894, DOI 10.1016/j.exger.2006.06.054; Wolkow CA, 2002, J BIOL CHEM, V277, P49591, DOI 10.1074/jbc.M207866200; Zdychova J, 2005, PHYSIOL RES, V54, P1, DOI 10.33549/physiolres.930582	80	122	142	1	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 6	2009	136	5					939	951		10.1016/j.cell.2009.01.025	http://dx.doi.org/10.1016/j.cell.2009.01.025			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	415JU	19249087	Green Accepted, Bronze			2022-12-01	WOS:000263930900016
J	Rosen, CJ				Rosen, Clifford J.			Serotonin Rising - The Bone, Brain, Bowel Connection	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Haney E. M., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P133; Rosen CJ, 2008, CELL METAB, V7, P7, DOI 10.1016/j.cmet.2007.12.004; Tam J, 2008, FASEB J, V22, P285, DOI 10.1096/fj.06-7957com; Warden SJ, 2008, MENOPAUSE, V15, P1176, DOI 10.1097/gme.0b013e318173566b; Yadav VK, 2008, CELL, V135, P825, DOI 10.1016/j.cell.2008.09.059	5	42	45	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 5	2009	360	10					957	959		10.1056/NEJMp0810058	http://dx.doi.org/10.1056/NEJMp0810058			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	413WX	19264685				2022-12-01	WOS:000263824500003
J	Benazet, JD; Bischofberger, M; Tiecke, E; Goncalves, A; Martin, JF; Zuniga, A; Naef, F; Zeller, R				Benazet, Jean-Denis; Bischofberger, Mirko; Tiecke, Eva; Goncalves, Alexandre; Martin, James F.; Zuniga, Aimee; Naef, Felix; Zeller, Rolf			A Self-Regulatory System of Interlinked Signaling Feedback Loops Controls Mouse Limb Patterning	SCIENCE			English	Article							VERTEBRATE LIMB; BUD; EXPRESSION; ROBUSTNESS; OUTGROWTH; EXPANSION; MESODERM; BMP4; SHH; CRE	Embryogenesis depends on self- regulatory interactions between spatially separated signaling centers, but few of these are well understood. Limb development is regulated by epithelial- mesenchymal (e-m) feedback loops between sonic hedgehog ( SHH) and fibroblast growth factor ( FGF) signaling involving the bone morphogenetic protein ( BMP) antagonist Gremlin1 ( GREM1). By combining mouse molecular genetics with mathematical modeling, we showed that BMP4 first initiates and SHH then propagates e- m feedback signaling through differential transcriptional regulation of Grem1 to control digit specification. This switch occurs by linking a fast BMP4/ GREM1 module to the slower SHH/ GREM1/ FGF e- m feedback loop. This self- regulatory signaling network results in robust regulation of distal limb development that is able to compensate for variations by interconnectivity among the three signaling pathways.	[Benazet, Jean-Denis; Tiecke, Eva; Goncalves, Alexandre; Zuniga, Aimee; Zeller, Rolf] Univ Basel, Dept Biomed, CH-4058 Basel, Switzerland; [Bischofberger, Mirko; Naef, Felix] Swiss Inst Expt Canc Res, Computat Syst Biol Grp, Ecole Polytech Fed Lausanne, CH-1015 Lausanne, Switzerland; [Bischofberger, Mirko; Naef, Felix] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Martin, James F.] Texas A&M Univ, Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX 77030 USA	University of Basel; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; Swiss Institute of Bioinformatics; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston	Zeller, R (corresponding author), Univ Basel, Dept Biomed, Mattenstr 28, CH-4058 Basel, Switzerland.	rolf.zeller@unibas.ch	Benazet, Jean-Denis/I-8495-2016; Naef, Felix/C-9527-2011; Zuniga, Aimée/Q-2692-2018; Zeller, Rolf/C-2610-2013	Zuniga, Aimée/0000-0002-9953-3637; Zeller, Rolf/0000-0002-3186-7403; Naef, Felix/0000-0001-9786-3037; Bischofberger, Mirko/0000-0002-0878-8184	Swiss National Science Foundation [3100A0-100240, 3100A0-113866, 3100A0- 113617, 3100A0- 112607]; Novartis Foundation; NIH [2R01DE12324-12, R01DE16329]; FCT [SFRH/BD/24301/2005]; University of Basel; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE012324] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016329] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Novartis Foundation(Novartis); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); University of Basel; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank B. Hogan, C. Hoffmann, and G. Hollander for making Bmp mutant alleles available to us; F. Lehembre for help with quantitative polymerase chain reaction (QPCR); J. Lopez-Rios for input into the design of the network architecture; and M. Affolter, M. Kmita, and group members for input. This research is supported by the Swiss National Science Foundation (grants 3100A0-100240 and 3100A0-113866 to R.Z., grant 3100A0- 113617 to F.N., and grant 3100A0-112607 to AZ), the Novartis Foundation (to R.Z. and E.T.), the NIH (grants 2R01DE12324-12 and R01DE16329 to J.F.M.), the FCT (SFRH/BD/24301/2005 to A.G.), and the University of Basel. The authors declare no competing financial interests.	Ahn K, 2001, DEVELOPMENT, V128, P4449; Bandyopadhyay A, 2006, PLOS GENET, V2, P2116, DOI 10.1371/journal.pgen.0020216; Ben-Haim N, 2006, DEV CELL, V11, P313, DOI 10.1016/j.devcel.2006.07.005; De Robertis EM, 2006, NAT REV MOL CELL BIO, V7, P296, DOI 10.1038/nrm1855; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hockman D, 2008, P NATL ACAD SCI USA, V105, P16982, DOI 10.1073/pnas.0805308105; Hofmann C, 1996, DEV GENET, V19, P43, DOI 10.1002/(SICI)1520-6408(1996)19:1&lt;43::AID-DVG5&gt;3.0.CO;2-0; Kerszberg M, 2004, CURR OPIN GENET DEV, V14, P440, DOI 10.1016/j.gde.2004.06.001; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Kulessa H, 2002, GENESIS, V32, P66, DOI 10.1002/gene.10032; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Mariani FV, 2008, NATURE, V453, P401, DOI 10.1038/nature06876; Michos O, 2004, DEVELOPMENT, V131, P3401, DOI 10.1242/dev.01251; Nissim S, 2006, DEV BIOL, V299, P12, DOI 10.1016/j.ydbio.2006.05.026; Ovchinnikov DA, 2006, DEV BIOL, V295, P103, DOI 10.1016/j.ydbio.2006.03.013; Pajni-Underwood S, 2007, DEVELOPMENT, V134, P2359, DOI 10.1242/dev.001677; Panman L, 2006, DEVELOPMENT, V133, P3419, DOI 10.1242/dev.02529; Robert B, 2007, DEV GROWTH DIFFER, V49, P455, DOI 10.1111/j.1440-169x.2007.00946.x; Scherz PJ, 2004, SCIENCE, V305, P396, DOI 10.1126/science.1096966; Selever J, 2004, DEV BIOL, V276, P268, DOI 10.1016/j.ydbio.2004.08.024; Tickle C, 2006, NAT REV MOL CELL BIO, V7, P45, DOI 10.1038/nrm1830; Towers M, 2008, NATURE, V452, P882, DOI 10.1038/nature06718; Verheyden JM, 2008, NATURE, V454, P638, DOI 10.1038/nature07085; Wagner A, 2005, BIOESSAYS, V27, P176, DOI 10.1002/bies.20170; Zhu JJ, 2008, DEV CELL, V14, P624, DOI 10.1016/j.devcel.2008.01.008; Zuniga A, 1999, NATURE, V401, P598, DOI 10.1038/44157	27	149	152	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2009	323	5917					1050	1053		10.1126/science.1168755	http://dx.doi.org/10.1126/science.1168755			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	409AK	19229034				2022-12-01	WOS:000263478400039
J	Jones, R; Sleet, S				Jones, Roger; Sleet, Sarah			Easily Missed? Coeliac disease	BRITISH MEDICAL JOURNAL			English	Article							PRIMARY-CARE; DIAGNOSIS; POPULATION; PEOPLE; LESSON		[Jones, Roger] Kings Coll London, Dept Gen Practice & Primary Care, London SE11 6SP, England; [Sleet, Sarah] Coeliac UK, High Wycombe HP11 2HS, Bucks, England	University of London; King's College London	Jones, R (corresponding author), Kings Coll London, Dept Gen Practice & Primary Care, London SE11 6SP, England.	roger.jones@kcl.ac.uk						Corazza GR, 1999, AM J GASTROENTEROL, V94, P391; Dube C, 2005, GASTROENTEROLOGY, V128, pS57, DOI 10.1053/j.gastro.2005.02.014; DUBE C, 2005, GASTROENTEROLOGY, V128, pS1; Furse RM, 2005, BMJ-BRIT MED J, V330, P773, DOI 10.1136/bmj.330.7494.773; GODLEE F, 2009, BRIT MED J, V338, pB821; Graber ML, 2007, BRIT MED J, V334, P732, DOI 10.1136/bmj.39161.587720.BE; Green PHR, 2005, GASTROENTEROLOGY, V128, pS74, DOI 10.1053/j.gastro.2005.02.016; Harnden A, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b491; Hin H, 1999, BMJ-BRIT MED J, V318, P164, DOI 10.1136/bmj.318.7177.164; Jones R, 2007, BRIT MED J, V334, P704, DOI 10.1136/bmj.39170.410347.80; Lewis NR, 2006, ALIMENT PHARM THER, V24, P47, DOI 10.1111/j.1365-2036.2006.02967.x; *NIH CLIN EXC, 2008, CLIN GUID NICE, V61; Rostom A, 2006, GASTROENTEROLOGY, V131, P1981, DOI 10.1053/j.gastro.2006.10.004; Sanders DS, 2005, BMJ-BRIT MED J, V330, P775, DOI 10.1136/bmj.330.7494.775; Sanders DS, 2003, EUR J GASTROEN HEPAT, V15, P407, DOI 10.1097/00042737-200304000-00012; Silvester JA, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b380; Tikkakoski S, 2007, SCAND J GASTROENTERO, V42, P60, DOI 10.1080/00365520600789974; Watson RGP, 2005, BRIT MED J, V330, P739, DOI 10.1136/bmj.330.7494.739; West J, 2004, BRIT MED J, V329, P716, DOI 10.1136/bmj.38169.486701.7C; Willis HWM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3066	20	10	10	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 19	2009	338								a3058	10.1136/bmj.a3058	http://dx.doi.org/10.1136/bmj.a3058			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417CH	19228763				2022-12-01	WOS:000264052200002
J	Williamson, CE; Saros, JE; Schindler, DW				Williamson, Craig E.; Saros, Jasmine E.; Schindler, David W.			CLIMATE CHANGE Sentinels of Change	SCIENCE			English	Editorial Material							TERRESTRIAL; LAKES		[Williamson, Craig E.] Miami Univ, Dept Zool, Oxford, OH 45056 USA; [Saros, Jasmine E.] Univ Maine, Climate Change Inst, Orono, ME 04469 USA; [Saros, Jasmine E.] Univ Maine, Sch Biol & Ecol, Orono, ME 04469 USA; [Schindler, David W.] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada	University System of Ohio; Miami University; University of Maine System; University of Maine Orono; University of Maine System; University of Maine Orono; University of Alberta	Williamson, CE (corresponding author), Miami Univ, Dept Zool, Oxford, OH 45056 USA.	craig.williamson@muohio.edu; jasmine.saros@maine.edu; d.schindler@ualberta.ca	Schindler, David/A-3752-2014					[Anonymous], 2005, MILLENNIUM ECOSYSTEM; Cole JJ, 2007, ECOSYSTEMS, V10, P171, DOI 10.1007/s10021-006-9013-8; Ding JQ, 2008, BIOSCIENCE, V58, P317, DOI 10.1641/B580407; Downing JA, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2006GB002854; Duarte CM, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000637; Flannigan MD, 2005, CLIMATIC CHANGE, V72, P1, DOI 10.1007/s10584-005-5935-y; JOHNSON PTJ, 2008, FRONT ECOL ENVIRON, V6, P359, DOI DOI 10.1890/070156; Kelly EN, 2006, P NATL ACAD SCI USA, V103, P19380, DOI 10.1073/pnas.0609798104; Lewis C.F.M., 2008, EOS T AM GEOPHYS UN, V89, P541, DOI DOI 10.1029/2008EO520001; Lewis CFM, 2001, GEOLOGY, V29, P743, DOI 10.1130/0091-7613(2001)029<0743:UDEDBM>2.0.CO;2; Monteith DT, 2007, NATURE, V450, P537, DOI 10.1038/nature06316; Ricciardi A, 1999, CONSERV BIOL, V13, P1220, DOI 10.1046/j.1523-1739.1999.98380.x; Ricciardi A, 2001, CAN J FISH AQUAT SCI, V58, P2513, DOI 10.1139/f01-178; Stow C.A., 2008, EOS T AM GEOPHYSICAL, V89, P389; van der Kamp G, 2008, CAN WATER RESOUR J, V33, P23, DOI 10.4296/cwrj3301023; von Wachenfeldt E, 2008, LIMNOL OCEANOGR, V53, P2416, DOI 10.4319/lo.2008.53.6.2416; Wilcox D.A., 2007, GEOL SURV CIRCULAR, P1, DOI [10.3133/cir1311, DOI 10.3133/CIR1311]; Williamson CE, 2008, FRONT ECOL ENVIRON, V6, P247, DOI 10.1890/070140; Woodhouse CA, 1998, B AM METEOROL SOC, V79, P2693, DOI 10.1175/1520-0477(1998)079<2693:YODVIT>2.0.CO;2	19	186	192	9	139	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 13	2009	323	5916					887	888		10.1126/science.1169443	http://dx.doi.org/10.1126/science.1169443			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406KW	19213905				2022-12-01	WOS:000263295400027
J	Eilken, HM; Nishikawa, SI; Schroeder, T				Eilken, Hanna M.; Nishikawa, Shin-Ichi; Schroeder, Timm			Continuous single-cell imaging of blood generation from haemogenic endothelium	NATURE			English	Article							HEMATOPOIETIC STEM-CELLS; DEFINITIVE HEMATOPOIESIS; MOUSE EMBRYO; EXPRESSION; ORIGIN; CD41; DIFFERENTIATION; VASCULOGENESIS; PROGENITORS; COMMITMENT	Despite decades of research, the identity of the cells generating the first haematopoietic cells in mammalian embryos is unknown(1). Indeed, whether blood cells arise from mesodermal cells, mesenchymal progenitors, bipotent endothelial - haematopoietic precursors or haemogenic endothelial cells remains controversial(2-9). Proximity of endothelial and blood cells at sites of embryonic haematopoiesis, as well as their similar gene expression, led to the hypothesis of the endothelium generating blood. However, owing to lacking technology(10) it has been impossible to observe blood cell emergence continuously at the single- cell level, and the postulated existence of haemogenic endothelial cells remains disputed(1). Here, using new imaging and cell- tracking methods, we show that embryonic endothelial cells can be haemogenic. By continuous long- term single- cell observation of mouse mesodermal cells generating endothelial cell and blood colonies, it was possible to detect haemogenic endothelial cells giving rise to blood cells. Living endothelial and haematopoietic cells were identified by simultaneous detection of morphology and multiple molecular and functional markers. Detachment of nascent blood cells from endothelium is not directly linked to asymmetric cell division, and haemogenic endothelial cells are specified from cells already expressing endothelial markers. These results improve our understanding of the developmental origin of mammalian blood and the potential generation of haematopoietic stem cells from embryonic stem cells.	[Eilken, Hanna M.; Schroeder, Timm] Helmholtz Ctr Munich, German Res Ctr Environm Hlth GmbH, Inst Stem Cell Res, D-85764 Neuherberg, Germany; [Nishikawa, Shin-Ichi] RIKEN, Ctr Dev Biol, Lab Stem Cell Biol, Kobe, Hyogo 6500047, Japan	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; RIKEN	Schroeder, T (corresponding author), Helmholtz Ctr Munich, German Res Ctr Environm Hlth GmbH, Inst Stem Cell Res, D-85764 Neuherberg, Germany.	timm.schroeder@helmholtz-muenchen.de	Schroeder, Timm/F-8448-2010	Schroeder, Timm/0000-0001-9320-0252	Deutsche Forschungsgemeinschaft; Leading Project for the Realization of Regenerative Medicine	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Leading Project for the Realization of Regenerative Medicine	We are grateful to S. Nishikawa, M. A. Rieger, A. Hermann and M. Yoder for technical advice and discussions, M. Ogawa and H. Niwa for the VEVC2 and EB3 ESC lines, respectively, B. Schauberger for programming contributions, and A. Roth and C. Raithel for technical support. We thank M. Goetz, A. Hermann, M. A. Rieger and A. IJpenberg for critical reading of the manuscript. Part of this study was financed by the Deutsche Forschungsgemeinschaft to T. S. and by the Leading Project for the Realization of Regenerative Medicine to S.-I.N.	Bertrand JY, 2005, P NATL ACAD SCI USA, V102, P134, DOI 10.1073/pnas.0402270102; Choi K, 1998, DEVELOPMENT, V125, P725; de Bruijn MFTR, 2002, IMMUNITY, V16, P673, DOI 10.1016/S1074-7613(02)00313-8; Ferkowicz MJ, 2003, DEVELOPMENT, V130, P4393, DOI 10.1242/dev.00632; Fraser ST, 2002, EXP HEMATOL, V30, P1070, DOI 10.1016/S0301-472X(02)00887-1; Godin I, 2002, NAT REV IMMUNOL, V2, P593, DOI 10.1038/nri857; Guo RY, 2007, J CELL PHYSIOL, V211, P327, DOI 10.1002/jcp.20937; Hirashima M, 1999, BLOOD, V93, P1253, DOI 10.1182/blood.V93.4.1253.404k31_1253_1263; Huber TL, 2004, NATURE, V432, P625, DOI 10.1038/nature03122; Jaffredo T, 2005, EXP HEMATOL, V33, P1029, DOI 10.1016/j.exphem.2005.06.005; Jaffredo T, 1998, DEVELOPMENT, V125, P4575; Kataoka H, 1997, DEV GROWTH DIFFER, V39, P729; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; LAMPUGNANI MG, 1992, J CELL BIOL, V118, P1511, DOI 10.1083/jcb.118.6.1511; Mikkola HKA, 2003, BLOOD, V101, P508, DOI 10.1182/blood-2002-06-1699; Mitjavila-Garcia MT, 2002, DEVELOPMENT, V129, P2003; Morita K, 1999, J CELL BIOL, V147, P185, DOI 10.1083/jcb.147.1.185; Nakano T, 1996, SCIENCE, V272, P722, DOI 10.1126/science.272.5262.722; Nishikawa S, 1998, IMMUNITY, V8, P761, DOI 10.1016/S1074-7613(00)80581-6; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Schroeder T, 2003, P NATL ACAD SCI USA, V100, P4018, DOI 10.1073/pnas.0438008100; Schroeder T, 2008, NATURE, V453, P345, DOI 10.1038/nature07043; Schroeder T, 2006, MECH DEVELOP, V123, P570, DOI 10.1016/j.mod.2006.05.002; Shalaby F, 1997, CELL, V89, P981, DOI 10.1016/S0092-8674(00)80283-4; Sugiyama D, 2003, BLOOD, V101, P4733, DOI 10.1182/blood-2002-09-2799; Taoudi S, 2008, CELL STEM CELL, V3, P99, DOI 10.1016/j.stem.2008.06.004; Ueno H, 2006, DEV CELL, V11, P519, DOI 10.1016/j.devcel.2006.08.001; VOYTA JC, 1984, J CELL BIOL, V99, P2034, DOI 10.1083/jcb.99.6.2034; Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568; Zovein AC, 2008, CELL STEM CELL, V3, P625, DOI 10.1016/j.stem.2008.09.018	30	437	451	2	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2009	457	7231					896	900		10.1038/nature07760	http://dx.doi.org/10.1038/nature07760			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406AF	19212410				2022-12-01	WOS:000263266700048
J	Sohal, VS; Zhang, F; Yizhar, O; Deisseroth, K				Sohal, Vikaas S.; Zhang, Feng; Yizhar, Ofer; Deisseroth, Karl			Parvalbumin neurons and gamma rhythms enhance cortical circuit performance	NATURE			English	Article							IN-VIVO; POSITIVE INTERNEURONS; NEURAL CIRCUITRY; TRANSGENIC MICE; PYRAMIDAL CELLS; OSCILLATIONS; SYNCHRONIZATION; NEOCORTEX; CONNECTIONS; MODULATION	Synchronized oscillations and inhibitory interneurons have important and interconnected roles within cortical microcircuits. In particular, interneurons defined by the fast-spiking phenotype and expression of the calcium-binding protein parvalbumin(1,2) have been suggested to be involved in gamma (30-80 Hz) oscillations(3-7), which are hypothesized to enhance information processing(8,9). However, because parvalbumin interneurons cannot be selectively controlled, definitive tests of their functional significance in gamma oscillations, and quantitative assessment of the impact of parvalbumin interneurons and gamma oscillations on cortical circuits, have been lacking despite potentially enormous significance (for example, abnormalities in parvalbumin interneurons may underlie altered gamma-frequency synchronization and cognition in schizophrenia(10) and autism(11)). Here we use a panel of optogenetic technologies(12-14) in mice to selectively modulate multiple distinct circuit elements in neocortex, alone or in combination. We find that inhibiting parvalbumin interneurons suppresses gamma oscillations in vivo, whereas driving these interneurons (even by means of non-rhythmic principal cell activity) is sufficient to generate emergent gamma-frequency rhythmicity. Moreover, gamma-frequency modulation of excitatory input in turn was found to enhance signal transmission in neocortex by reducing circuit noise and amplifying circuit signals, including inputs to parvalbumin interneurons. As demonstrated here, optogenetics opens the door to a new kind of informational analysis of brain function, permitting quantitative delineation of the functional significance of individual elements in the emergent operation and function of intact neural circuitry.	[Sohal, Vikaas S.; Zhang, Feng; Yizhar, Ofer; Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Dept Bioengn, Stanford, CA 94305 USA	Stanford University	Deisseroth, K (corresponding author), Stanford Univ, Dept Psychiat & Behav Sci, Dept Bioengn, W083 Clark Ctr,318 Campus Dr W, Stanford, CA 94305 USA.	deissero@stanford.edu	Sohal, Vikaas/M-9327-2016; Macrae, Rhiannon/AAX-1536-2020; YIZHAR, OFER/AAV-8497-2021	Sohal, Vikaas/0000-0002-2238-4186; Yizhar, Ofer/0000-0003-4228-1448	President and Provost of Stanford University; BioX; Bioengineering; NIMH; NIDA; CIRM; NSF; Keck, McKnight and Coulter Foundations; NINDS; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS059160] Funding Source: NIH RePORTER	President and Provost of Stanford University(Stanford University); BioX; Bioengineering; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); CIRM(California Institute for Regenerative Medicine); NSF(National Science Foundation (NSF)); Keck, McKnight and Coulter Foundations; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank S. Arber for her gift of the PV:: Cre mice, and we acknowledge the advice and suggestions of R. C. Malenka, J. Huguenard and S. Baccus on this work. All materials are freely distributed and supported by the Deisseroth laboratory (http://www.optogenetics.org). K. D. is supported by the President and Provost of Stanford University, BioX, Bioengineering, and by NIMH, NIDA, CIRM, NSF, and the Keck, McKnight and Coulter Foundations. F. Z. is supported by NINDS, and V. S. S. is supported by a T32 postdoctoral research training fellowship from NIMH.	Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Baccus SA, 2002, NEURON, V36, P909, DOI 10.1016/S0896-6273(02)01050-4; Bannister AP, 2005, NEUROSCI RES, V53, P95, DOI 10.1016/j.neures.2005.06.019; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Conde F, 1996, DEV BRAIN RES, V96, P261, DOI 10.1016/S0165-3806(96)00126-5; Freund TF, 2003, TRENDS NEUROSCI, V26, P489, DOI 10.1016/S0166-2236(03)00227-3; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Fuchs EC, 2007, NEURON, V53, P591, DOI 10.1016/j.neuron.2007.01.031; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; Howard MW, 2003, CEREB CORTEX, V13, P1369, DOI 10.1093/cercor/bhg084; Kawaguchi Y, 1998, NEUROSCIENCE, V85, P677, DOI 10.1016/S0306-4522(97)00685-4; Konig P, 1996, TRENDS NEUROSCI, V19, P130, DOI 10.1016/S0166-2236(96)80019-1; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Luczak A, 2007, P NATL ACAD SCI USA, V104, P347, DOI 10.1073/pnas.0605643104; Meyer AH, 2002, J NEUROSCI, V22, P7055; Orekhova EV, 2007, BIOL PSYCHIAT, V62, P1022, DOI 10.1016/j.biopsych.2006.12.029; Raghavachari S, 2001, J NEUROSCI, V21, P3175, DOI 10.1523/JNEUROSCI.21-09-03175.2001; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Szabadics J, 2006, SCIENCE, V311, P233, DOI 10.1126/science.1121325; Tamas G, 2000, NAT NEUROSCI, V3, P366, DOI 10.1038/73936; Toledo-Rodriguez M, 2004, CEREB CORTEX, V14, P1310, DOI 10.1093/cercor/bhh092; vanSteveninck RRD, 1997, SCIENCE, V275, P1805, DOI 10.1126/science.275.5307.1805; Wang H, 2007, P NATL ACAD SCI USA, V104, P8143, DOI 10.1073/pnas.0700384104; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]; YLINEN A, 1995, HIPPOCAMPUS, V5, P78, DOI 10.1002/hipo.450050110; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	30	1665	1717	7	348	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 4	2009	459	7247					698	702		10.1038/nature07991	http://dx.doi.org/10.1038/nature07991			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453KF	19396159	Green Accepted			2022-12-01	WOS:000266608600043
J	Yang, L; Garbe, DS; Bashaw, GJ				Yang, Long; Garbe, David S.; Bashaw, Greg J.			A Frazzled/DCC-Dependent Transcriptional Switch Regulates Midline Axon Guidance	SCIENCE			English	Article							CNS MIDLINE; GROWTH CONE; DROSOPHILA-MIDLINE; COMMISSURAL AXONS; RECEPTOR; ATTRACTION; ROUNDABOUT; OUTGROWTH; SLIT; ROBO	Precise wiring of the nervous system depends on coordinating the action of conserved families of proteins that direct axons to their appropriate targets. Slit-roundabout repulsion and netrin-deleted in colorectal cancer (DCC) (frazzled) attraction must be tightly regulated to control midline axon guidance in vertebrates and invertebrates, but the mechanism mediating this regulation is poorly defined. Here, we show that the Fra receptor has two genetically separable functions in regulating midline guidance in Drosophila. First, Fra mediates canonical chemoattraction in response to netrin, and, second, it functions independently of netrin to activate commissureless transcription, allowing attraction to be coupled to the down-regulation of repulsion in precrossing commissural axons.	[Yang, Long; Garbe, David S.; Bashaw, Greg J.] Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA	University of Pennsylvania	Bashaw, GJ (corresponding author), Univ Penn, Sch Med, Dept Neurosci, 1113 BRB2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.	gbashaw@mail.med.upenn.edu			NIH [NS054739, NS046333]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS046333, R01NS046333, R01NS054739] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grants NS054739 and NS046333 to G.J.B.	Brankatschk M, 2006, NAT NEUROSCI, V9, P188, DOI 10.1038/nn1625; Forcet C, 2002, NATURE, V417, P443, DOI 10.1038/nature748; Garbe DS, 2007, DEVELOPMENT, V134, P4325, DOI 10.1242/dev.012872; Garbe DS, 2007, J NEUROSCI, V27, P3584, DOI 10.1523/JNEUROSCI.0301-07.2007; Garbe DS, 2004, CRIT REV BIOCHEM MOL, V39, P319, DOI 10.1080/10409230490906797; Gitai Z, 2003, NEURON, V37, P53, DOI 10.1016/S0896-6273(02)01149-2; Gong QZ, 1999, DEVELOPMENT, V126, P1451; Goulding M, 2005, CURR OPIN NEUROBIOL, V15, P14, DOI 10.1016/j.conb.2005.01.017; Graef IA, 2003, CELL, V113, P657, DOI 10.1016/S0092-8674(03)00390-8; Harris R, 1996, NEURON, V17, P217, DOI 10.1016/S0896-6273(00)80154-3; Hiramoto M, 2000, NATURE, V406, P886, DOI 10.1038/35022571; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Keleman K, 2005, NAT NEUROSCI, V8, P156, DOI 10.1038/nn1388; Keleman K, 2002, CELL, V110, P415, DOI 10.1016/S0092-8674(02)00901-7; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kidd T, 1998, NEURON, V20, P25, DOI 10.1016/S0896-6273(00)80431-6; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; Ladle DR, 2007, NEURON, V56, P270, DOI 10.1016/j.neuron.2007.09.026; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; Murray MJ, 1999, J NEUROSCI, V19, P7901; *NIH, NS054739 NIH; Stein E, 2001, SCIENCE, V291, P1976, DOI 10.1126/science.1059391; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445	25	62	62	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 15	2009	324	5929					944	947		10.1126/science.1171320	http://dx.doi.org/10.1126/science.1171320			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	19325078	Green Accepted			2022-12-01	WOS:000266048800041
J	Chandramohanadas, R; Davis, PH; Beiting, DP; Harbut, MB; Darling, C; Velmourougane, G; Lee, MY; Greer, PA; Roos, DS; Greenbaum, DC				Chandramohanadas, Rajesh; Davis, Paul H.; Beiting, Daniel P.; Harbut, Michael B.; Darling, Claire; Velmourougane, Geetha; Lee, Ming Yeh; Greer, Peter A.; Roos, David S.; Greenbaum, Doron C.			Apicomplexan Parasites Co-Opt Host Calpains to Facilitate Their Escape from Infected Cells	SCIENCE			English	Article							RED-BLOOD-CELLS; MALARIA PARASITE; TOXOPLASMA-GONDII; PLASMODIUM-FALCIPARUM; EMBRYONIC-DEVELOPMENT; PROTEASE INHIBITORS; ERYTHROCYTE; CALPASTATIN; DISRUPTION; MEMBRANE	Apicomplexan parasites, including Plasmodium falciparum and Toxoplasma gondii (the causative agents of malaria and toxoplasmosis, respectively), are responsible for considerable morbidity and mortality worldwide. These pathogenic protozoa replicate within an intracellular vacuole inside of infected host cells, from which they must escape to initiate a new lytic cycle. By integrating cell biological, pharmacological, and genetic approaches, we provide evidence that both Plasmodium and Toxoplasma hijack host cell calpain proteases to facilitate parasite egress. Immunodepletion or inhibition of calpain-1 in hypotonically lysed and resealed erythrocytes prevented the escape of P. falciparum parasites, which was restored by adding purified calpain-1. Similarly, efficient egress of T. gondii from mammalian fibroblasts was blocked by either small interfering RNA-mediated suppression or genetic deletion of calpain activity and could be restored by genetic complementation.	[Chandramohanadas, Rajesh; Harbut, Michael B.; Darling, Claire; Velmourougane, Geetha; Greenbaum, Doron C.] Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA; [Davis, Paul H.; Beiting, Daniel P.; Lee, Ming Yeh; Roos, David S.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Davis, Paul H.; Beiting, Daniel P.; Lee, Ming Yeh; Roos, David S.] Univ Penn, Penn Genome Frontiers Inst, Philadelphia, PA 19104 USA; [Greer, Peter A.] Queens Univ, Dept Pathol & Mol Med, Queens Canc Res Inst, Kingston, ON K7L 3N6, Canada	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; McMaster University; Queens University - Canada	Greenbaum, DC (corresponding author), Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA.	dorong@upenn.edu	Chandramohanadas, Rajesh/GLT-0218-2022; Davis, Paul H/J-6141-2012; Beiting, Daniel/AAG-6275-2019	Davis, Paul H/0000-0002-0526-3841; Chandramohanadas, Rajesh/0000-0002-8760-0396; Roos, David Siker/0000-0001-6725-4089	National Research Service Awards; Ellison Medical Foundation; NIH; Ritter Foundation; Penn Genome Frontiers Institute; Penn Institute for Translational Medicine and Therapeutics; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI077268, R37AI028724, F32AI075846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008076] Funding Source: NIH RePORTER	National Research Service Awards(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ritter Foundation; Penn Genome Frontiers Institute; Penn Institute for Translational Medicine and Therapeutics; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. W. Doms, M. Marti, and M. Klemba for critical discussions; the Penn Proteomics Core for mass spectrometry; and M. A. Lampson for help with imaging. P. falciparum expressing GFP were provided by O. S. Harb. P.H.D. and D.P.B. are funded by National Research Service Awards, and D.S.R. is an Ellison Medical Foundation Senior Scholar in Global Infectious Disease, supported by grants from NIH. D.C.G. was supported by the Ritter Foundation, the Penn Genome Frontiers Institute, and the Penn Institute for Translational Medicine and Therapeutics.	Arastu-Kapur S, 2008, NAT CHEM BIOL, V4, P203, DOI 10.1038/nchembio.70; Arthur JSC, 2000, MOL CELL BIOL, V20, P4474, DOI 10.1128/MCB.20.12.4474-4481.2000; BIANCO AE, 1986, EXP PARASITOL, V62, P275, DOI 10.1016/0014-4894(86)90032-9; Black MW, 2000, MOL CELL BIOL, V20, P9399, DOI 10.1128/MCB.20.24.9399-9408.2000; Croall DE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-218; Dourdin N, 2001, J BIOL CHEM, V276, P48382, DOI 10.1074/jbc.M108893200; Dutt P, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-3; Gil-Parrado S, 2003, BIOL CHEM, V384, P395, DOI 10.1515/BC.2003.045; Glushakova S, 2005, CURR BIOL, V15, P1645, DOI 10.1016/j.cub.2005.07.067; Glushakova S, 2009, CELL MICROBIOL, V11, P95, DOI 10.1111/j.1462-5822.2008.01242.x; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Greenbaum DC, 2002, SCIENCE, V298, P2002, DOI 10.1126/science.1077426; HADLEY T, 1983, EXP PARASITOL, V55, P306, DOI 10.1016/0014-4894(83)90027-9; Hanna RA, 2008, NATURE, V456, P409, DOI 10.1038/nature07451; Hanspal M, 2002, MOL BIOCHEM PARASIT, V122, P227, DOI 10.1016/S0166-6851(02)00104-4; Hu K, 2002, MOL BIOL CELL, V13, P593, DOI 10.1091/mbc.01-06-0309; Huttenlocher A, 1997, J BIOL CHEM, V272, P32719, DOI 10.1074/jbc.272.52.32719; Kafsack BFC, 2009, SCIENCE, V323, P530, DOI 10.1126/science.1165740; Moldoveanu T, 2008, NATURE, V456, P404, DOI 10.1038/nature07353; Murphy SC, 2006, PLOS MED, V3, P2403, DOI 10.1371/journal.pmed.0030528; Nishi M, 2008, J CELL SCI, V121, P1559, DOI 10.1242/jcs.021089; Pasini EM, 2006, BLOOD, V108, P791, DOI 10.1182/blood-2005-11-007799; ROOS DS, 1994, METHOD CELL BIOL, V45, P27; Rosenthal PJ, 2004, INT J PARASITOL, V34, P1489, DOI 10.1016/j.ijpara.2004.10.003; Russo I, 2009, P NATL ACAD SCI USA, V106, P1554, DOI 10.1073/pnas.0806926106; Salmon BL, 2001, P NATL ACAD SCI USA, V98, P271, DOI 10.1073/pnas.011413198; WEISS L, 1989, AM J TROP MED HYG, V41, P135, DOI 10.4269/ajtmh.1989.41.135; Wickham ME, 2003, J BIOL CHEM, V278, P37658, DOI 10.1074/jbc.M305252200; Yeoh S, 2007, CELL, V131, P1072, DOI 10.1016/j.cell.2007.10.049	29	118	125	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 8	2009	324	5928					794	797		10.1126/science.1171085	http://dx.doi.org/10.1126/science.1171085			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442HN	19342550	Green Accepted			2022-12-01	WOS:000265832400049
J	Mabberley, DJ				Mabberley, David J.			Exploring Terra Incognita	SCIENCE			English	Editorial Material							KORUP NATIONAL-PARK		Royal Bot Gardens, Richmond TW9 3AE, Surrey, England	Royal Botanic Gardens, Kew	Mabberley, DJ (corresponding author), Royal Bot Gardens, Richmond TW9 3AE, Surrey, England.	d.mabberley@kew.org						Magurran AE, 2005, CURR BIOL, V15, pR116, DOI 10.1016/j.cub.2005.02.006; Prance GT, 2000, ANN MO BOT GARD, V87, P67, DOI 10.2307/2666209; THULIN M, 1989, PLANT SYST EVOL, V166, P249, DOI 10.1007/BF00935953; Thulin M, 2001, NORD J BOT, V21, P393, DOI 10.1111/j.1756-1051.2001.tb00783.x; Thulin M., 2006, FLORA SOMALIA, V3; Thulin Mats, 2008, Kew Bulletin, V63, P617, DOI 10.1007/s12225-008-9060-8; Thulin M, 2008, NORD J BOT, V26, P218, DOI 10.1111/j.1756-1051.2008.00245.x; van der Burgt XM, 2007, ADANSONIA, V29, P59; van der Burgt Xander M., 2006, Kew Bulletin, V61, P79	9	6	8	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 24	2009	324	5926					472	472		10.1126/science.1173323	http://dx.doi.org/10.1126/science.1173323			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	436JU	19390032				2022-12-01	WOS:000265411200031
J	Roberts, RM; Smith, GW; Bazer, FW; Cibelli, J; Seidel, GE; Bauman, DE; Reynolds, LP; Ireland, JJ				Roberts, R. M.; Smith, G. W.; Bazer, F. W.; Cibelli, J.; Seidel, G. E., Jr.; Bauman, D. E.; Reynolds, L. P.; Ireland, J. J.			Farm Animal Research in Crisis	SCIENCE			English	Editorial Material							BIOMEDICAL-RESEARCH; DOMESTIC-ANIMALS; RESOURCES		[Smith, G. W.; Cibelli, J.; Ireland, J. J.] Michigan State Univ, Dept Anim Sci, E Lansing, MI 48824 USA; [Roberts, R. M.] Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA; [Bazer, F. W.] Texas A&M Univ, Dept Anim Sci, College Stn, TX 77843 USA; [Seidel, G. E., Jr.] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA; [Bauman, D. E.] Cornell Univ, Dept Anim Sci, Ithaca, NY 14853 USA; [Reynolds, L. P.] N Dakota State Univ, Dept Anim Sci, Fargo, ND 58105 USA	Michigan State University; University of Missouri System; University of Missouri Columbia; Texas A&M University System; Texas A&M University College Station; Colorado State University; Cornell University; North Dakota State University Fargo	Ireland, JJ (corresponding author), Michigan State Univ, Dept Anim Sci, E Lansing, MI 48824 USA.	lreland@msu.edu	Seidel, George/AAE-2371-2019; Bazer, Fuller/AAF-4317-2021; Reynolds, Lawrence P/I-5267-2015	Bazer, Fuller/0000-0002-5823-5086; Reynolds, Lawrence P/0000-0002-6838-7809; Cibelli, Jose/0000-0002-2176-3854				BROOKS DL, 2006, LAB ANIMAL MED, P273; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; *FDN BIOM RES, NOB PRIZ; *FOOD AGR ED INF S, 2007, AN SCI GRAD ENR; Fulton JE, 2003, SCIENCE, V300, P1667, DOI 10.1126/science.1085407; GIBBS R, 2004, BOVINE GENOMIC SEQUE; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Huffman WE, 2006, AM J AGR ECON, V88, P783, DOI 10.1111/j.1467-8276.2006.00898.x; Ireland JJ, 2008, J ANIM SCI, V86, P2797, DOI 10.2527/jas.2008-1088; King AJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE1837, DOI 10.1152/ajpendo.00668.2006; Mirando MA, 2006, BIOL REPROD, V74, P459, DOI 10.1095/biolreprod.105.048686; NRC, 1989, INV RES PROP STRENGT; NRC, 2000, NAT RES IN VIT COMP; NRC (National Research Council), 1972, REP COMM RES ADV US; Padmanabhan V, 2007, REV ENDOCR METAB DIS, V8, P67, DOI 10.1007/s11154-007-9051-3; Reynolds LP, 2008, J ANIM SCI, V86, P2445, DOI 10.2527/jas.2008-1387; Reynolds LP, 2009, J NUTR, V139, P427, DOI 10.3945/jn.108.103564; Rogers CS, 2008, SCIENCE, V321, P1837, DOI 10.1126/science.1163600; *US DHHS, BUDG BRIEF; *USDA, USDA FY2007 BUDG SUM; *USDA RES ED EC IN, 2007, USDA RES ED EC INF S; 2007 CENSUS AGR EC	22	60	62	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 24	2009	324	5926					468	469		10.1126/science.1168521	http://dx.doi.org/10.1126/science.1168521			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	436JU	19390030				2022-12-01	WOS:000265411200029
J	Brenner, MJ				Brenner, Michael J.			Collateral Damage	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												mbrenner@siumed.edu							0	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 22	2009	301	16					1637	1638		10.1001/jama.2009.543	http://dx.doi.org/10.1001/jama.2009.543			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	435NN	19383945				2022-12-01	WOS:000265350700001
J	Menuz, V; Howell, KS; Gentina, S; Epstein, S; Riezman, I; Fornallaz-Mulhauser, M; Hengartner, MO; Gomez, M; Riezman, H; Martinou, JC				Menuz, Vincent; Howell, Kate S.; Gentina, Sebastien; Epstein, Sharon; Riezman, Isabelle; Fornallaz-Mulhauser, Monique; Hengartner, Michael O.; Gomez, Marie; Riezman, Howard; Martinou, Jean-Claude			Protection of C-elegans from Anoxia by HYL-2 Ceramide Synthase	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; (DIHYDRO)CERAMIDE SYNTHASE; SUSPENDED ANIMATION; FAMILY-MEMBERS; SPHINGOID BASE; GENE LAG1; PROTEIN; APOPTOSIS; REQUIRES; HYPOXIA	Oxygen deprivation is rapidly deleterious for most organisms. However, Caenorhabditis elegans has developed the ability to survive anoxia for at least 48 hours. Mutations in the DAF-2/DAF-16 insulin-like signaling pathway promote such survival. We describe a pathway involving the HYL-2 ceramide synthase that acts independently of DAF-2. Loss of the ceramide synthase gene hyl-2 results in increased sensitivity of C. elegans to anoxia. C. elegans has two ceramide synthases, hyl-1 and hyl-2, that participate in ceramide biogenesis and affect its ability to survive anoxic conditions. In contrast to hyl-2(lf) mutants, hyl-1(lf) mutants are more resistant to anoxia than normal animals. HYL-1 and HYL-2 have complementary specificities for fatty acyl chains. These data indicate that specific ceramides produced by HYL-2 confer resistance to anoxia.	[Howell, Kate S.; Epstein, Sharon; Riezman, Isabelle; Riezman, Howard] Univ Geneva, Dept Biochem, CH-1211 Geneva 4, Switzerland; [Menuz, Vincent; Gentina, Sebastien; Fornallaz-Mulhauser, Monique; Martinou, Jean-Claude] Univ Geneva, Dept Cell Biol, CH-1211 Geneva 4, Switzerland; [Howell, Kate S.] Univ Melbourne, Fac Land & Food Resource, Parkville, Vic 3010, Australia; [Hengartner, Michael O.] Univ Zurich, Inst Mol Biol, CH-8057 Zurich, Switzerland; [Gomez, Marie] Univ Geneva, Dept Zool & Anim Biol, CH-1211 Geneva 4, Switzerland	University of Geneva; University of Geneva; University of Melbourne; University of Zurich; University of Geneva	Riezman, H (corresponding author), Univ Geneva, Dept Biochem, CH-1211 Geneva 4, Switzerland.	Howard.Riezman@unige.ch; Jean-Claude.Martinou@unige.ch	Howell, Kate/M-2370-2013; Hengartner, Michael O/E-6235-2011	Howell, Kate/0000-0001-6498-0472; martinou, Jean-claude/0000-0002-9847-2051; Riezman, Howard/0000-0003-4680-9422; Hengartner, Michael/0000-0002-7584-596X	Swiss National Science Foundation [3100A0-109419/2, 3100A0-114189, 3100A0-105907/1, 3100A0-113889]; Human Frontiers Science Program Organization; Swiss SystemsX.ch initiative; Roche Foundation; Ernest Boninchi; Canton of Zurich; Ernst Hadorm Foundation; Geneva Department of Education	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Human Frontiers Science Program Organization(Human Frontier Science Program); Swiss SystemsX.ch initiative; Roche Foundation; Ernest Boninchi; Canton of Zurich; Ernst Hadorm Foundation; Geneva Department of Education	We thank F. Solary for help with analysis of aging; Y. Mattenberger and D. Courvoisier from the Clinical Research Center University of Geneva and Geneva University Hospitals for statistical support; S. Herzig for artwork; S. Mitani and the Japanese National Bioresource Project for tm strains; and J. Hodgkin for providing strains CB5670, CB6166, CB5439, and CB5430. Some nematodes were provided by the Caenorhabditis Genome Center, which is funded by the NIH National Center for Research Resources. This work was funded by the Swiss National Science Foundation [subsidies 3100A0-109419/2 (J.-C.M.), 3100A0-114189 (H.R.), 3100A0-105907/1 (M.G.), and 3100A0-113889 (M.O.H.)], the Human Frontiers Science Program Organization (H.R.), the Swiss SystemsX.ch initiative (H.R.) evaluated by the Swiss National Science Foundation, the Roche Foundation (V.M.), Ernest Boninchi subsidy for the purchase of the anoxic chamber, the Canton of Zurich (M.O.H.), the Ernst Hadorm Foundation (M.O.H.), and the Geneva Department of Education.	CHITWOOD DJ, 1995, LIPIDS, V30, P567, DOI 10.1007/BF02537032; Dasgupta N, 2007, CURR BIOL, V17, P1954, DOI 10.1016/j.cub.2007.10.017; Deng XZ, 2008, SCIENCE, V322, P110, DOI 10.1126/science.1158111; Hajeri VA, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-6; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hoogewijs D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-356; Jiang HQ, 2001, P NATL ACAD SCI USA, V98, P7916, DOI 10.1073/pnas.141234698; Jiang JC, 1998, GENOME RES, V8, P1259, DOI 10.1101/gr.8.12.1259; Kageyama-Yahara N, 2006, BIOCHEM J, V398, P585, DOI 10.1042/BJ20060697; Mendenhall AR, 2006, GENETICS, V174, P1173, DOI 10.1534/genetics.106.061390; Mizutani Y, 2005, BIOCHEM J, V390, P263, DOI 10.1042/BJ20050291; Mizutani Y, 2006, BIOCHEM J, V398, P531, DOI 10.1042/BJ20060379; Nystul TG, 2003, SCIENCE, V302, P1038, DOI 10.1126/science.1089705; Padilla PA, 2002, MOL BIOL CELL, V13, P1473, DOI 10.1091/mbc.01-12-0594; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; Riebeling C, 2003, J BIOL CHEM, V278, P43452, DOI 10.1074/jbc.M307104200; Scott BA, 2002, SCIENCE, V296, P2388, DOI 10.1126/science.1072302; Shen C, 2005, J BIOL CHEM, V280, P20580, DOI 10.1074/jbc.M501894200; Spassieva S, 2006, J BIOL CHEM, V281, P33931, DOI 10.1074/jbc.M608092200; Vallee B, 2005, EMBO J, V24, P730, DOI 10.1038/sj.emboj.7600562; Zanolari B, 2000, EMBO J, V19, P2824, DOI 10.1093/emboj/19.12.2824	21	123	134	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2009	324	5925					381	384		10.1126/science.1168532	http://dx.doi.org/10.1126/science.1168532			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433QT	19372430	Green Published			2022-12-01	WOS:000265221600040
J	Ashall, L; Horton, CA; Nelson, DE; Paszek, P; Harper, CV; Sillitoe, K; Ryan, S; Spiller, DG; Unitt, JF; Broomhead, DS; Kell, DB; Rand, DA; See, V; White, MRH				Ashall, Louise; Horton, Caroline A.; Nelson, David E.; Paszek, Pawel; Harper, Claire V.; Sillitoe, Kate; Ryan, Sheila; Spiller, David G.; Unitt, John F.; Broomhead, David S.; Kell, Douglas B.; Rand, David A.; See, Violaine; White, Michael R. H.			Pulsatile Stimulation Determines Timing and Specificity of NF-kappa B-Dependent Transcription	SCIENCE			English	Article							DEUBIQUITINATING ENZYME; TEMPORAL CONTROL; FEEDBACK LOOP; OSCILLATIONS; DYNAMICS	The nuclear factor kappa B (NF-kappa B) transcription factor regulates cellular stress responses and the immune response to infection. NF-kappa B activation results in oscillations in nuclear NF-kappa B abundance. To define the function of these oscillations, we treated cells with repeated short pulses of tumor necrosis factor-alpha at various intervals to mimic pulsatile inflammatory signals. At all pulse intervals that were analyzed, we observed synchronous cycles of NF-kappa B nuclear translocation. Lower frequency stimulations gave repeated full-amplitude translocations, whereas higher frequency pulses gave reduced translocation, indicating a failure to reset. Deterministic and stochastic mathematical models predicted how negative feedback loops regulate both the resetting of the system and cellular heterogeneity. Altering the stimulation intervals gave different patterns of NF-kappa B-dependent gene expression, which supports the idea that oscillation frequency has a functional role.	[Ashall, Louise; Horton, Caroline A.; Nelson, David E.; Paszek, Pawel; Harper, Claire V.; Sillitoe, Kate; Ryan, Sheila; Spiller, David G.; See, Violaine; White, Michael R. H.] Sch Biol Sci, Ctr Cell Imaging, Liverpool L69 7ZB, Merseyside, England; [Unitt, John F.] AstraZeneca R&D Charnwood, Dept Mol Biol, Loughborough LE11 5RH, Leics, England; [Broomhead, David S.] Univ Manchester, Sch Math, Manchester M13 9PL, Lancs, England; [Kell, Douglas B.] Univ Manchester, Sch Chem, Manchester Ctr Integrat Syst Biol, Manchester M1 7DN, Lancs, England; [Kell, Douglas B.] Univ Manchester, Manchester Interdisciplinary Bioctr, Manchester M1 7DN, Lancs, England; [Rand, David A.] Univ Warwick, Coventry CV4 7AL, W Midlands, England	University of Liverpool; AstraZeneca; University of Manchester; University of Manchester; University of Manchester; University of Warwick	White, MRH (corresponding author), Sch Biol Sci, Ctr Cell Imaging, Biosci Res Bldg,Crown St, Liverpool L69 7ZB, Merseyside, England.	mwhite@liv.ac.uk	Spiller, David G/I-3645-2012; Kell, Douglas/E-8318-2011; Nelson, David/AAX-5648-2021; Broomhead, David S/C-6836-2009; Paszek, Pawel/J-2840-2012; Rand, David A/J-9085-2012	Kell, Douglas/0000-0001-5838-7963; Nelson, David/0000-0002-5034-0885; Paszek, Pawel/0000-0002-0363-0716; Rand, David A/0000-0002-2217-3274; White, Michael/0000-0002-3617-3232; Spiller, David Geoffrey/0000-0003-2502-6787; harper, claire/0000-0001-6228-4078	Biotechnology and Biological Sciences Research Council (BBSRC) [BBD0107481, BBF0059381, BBC0082191, BBC0071581]; Medical Research Council [G0500346]; Professor John Glover Memorial Research Fellowship; Engineering and Physical Sciences Research Council Senior Fellowship [EP/C544587/1, GR/S29256/01]; European Union [005137]; Royal Society/Wolfson Merit Award; BBSRC David Phillips Research Fellowship [BBC5204711]; BBSRC [BB/E004210/1, BB/F005938/1, BB/D010748/1, BB/E012965/1] Funding Source: UKRI; EPSRC [EP/C544587/1] Funding Source: UKRI; MRC [G0500346] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C007158/1, BB/D010748/1, BB/C520471/1, BB/C008219/1, BB/E004210/1, BB/E012965/1, BB/F005938/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/C544587/1, GR/S29256/01] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Professor John Glover Memorial Research Fellowship; Engineering and Physical Sciences Research Council Senior Fellowship(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Union(European Commission); Royal Society/Wolfson Merit Award(Royal Society of London); BBSRC David Phillips Research Fellowship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank N. Perkins for reading the manuscript and D. Jackson, M. Kimmel, and T. Lipniacki for discussion. The work was supported by Biotechnology and Biological Sciences Research Council (BBSRC) grants BBD0107481, BBF0059381, BBC0082191, and BBC0071581; BBSRC studentships to L.A. and K.S. (AstraZeneca Collaborative Awards in Science and Engineering); and Medical Research Council grant G0500346. C.V.H. holds a Professor John Glover Memorial Research Fellowship; D.A.R. held an Engineering and Physical Sciences Research Council Senior Fellowship [EP/C544587/1, GR/S29256/01 and European Union (BioSim Network contract 005137)]; D.B.K. holds a Royal Society/Wolfson Merit Award; and V.S. holds a BBSRC David Phillips Research Fellowship (BBC5204711). Hamamatsu Photonics and Carl Zeiss Limited provided training and technical support.	Barken D, 2005, SCIENCE, V308, DOI 10.1126/science.1107904; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Cai L, 2008, NATURE, V455, P485, DOI 10.1038/nature07292; Covert MW, 2005, SCIENCE, V309, P1854, DOI 10.1126/science.1112304; Enesa K, 2008, J BIOL CHEM, V283, P7036, DOI 10.1074/jbc.M708690200; Friedrichsen S, 2006, ENDOCRINOLOGY, V147, P773, DOI 10.1210/en.2005-0967; HACKER H, 2006, SCI STKE, pRE13, DOI DOI 10.1126/STKE.3572006RE13; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hayot F, 2006, J THEOR BIOL, V240, P583, DOI 10.1016/j.jtbi.2005.10.018; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Hutti JE, 2007, MOL CELL BIOL, V27, P7451, DOI 10.1128/MCB.01101-07; Ihekwaba AEC, 2005, IEE P SYST BIOL, V152, P153, DOI 10.1049/ip-syb:20050050; KEAMS JD, 2006, J CELL BIOL, V173, P659; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Lipniacki T, 2006, BIOPHYS J, V90, P725, DOI 10.1529/biophysj.104.056754; Lipniacki T, 2004, J THEOR BIOL, V228, P195, DOI 10.1016/j.jtbi.2004.01.001; Nelson DE, 2005, SCIENCE, V308, DOI 10.1126/science.1108198; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Sun SC, 2008, NAT REV IMMUNOL, V8, P501, DOI 10.1038/nri2337; Tian B, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-137; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Werner SL, 2005, SCIENCE, V309, P1857, DOI 10.1126/science.1113319	24	406	414	0	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 10	2009	324	5924					242	246		10.1126/science.1164860	http://dx.doi.org/10.1126/science.1164860			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430WX	19359585	Green Accepted, Green Submitted			2022-12-01	WOS:000265024400044
J	Zhu, M; Zhao, WJ; Jia, LT; Lu, J; Qiao, T; Qu, QM				Zhu, Min; Zhao, Wenjin; Jia, Liantao; Lu, Jing; Qiao, Tuo; Qu, Qingming			The oldest articulated osteichthyan reveals mosaic gnathostome characters	NATURE			English	Article							BONY FISHES; INTERRELATIONSHIPS	The evolutionary history of osteichthyans (bony fishes plus tetrapods) extends back to the Ludlow epoch of the Silurian period. However, these Silurian forms have been documented exclusively by fragmentary fossils. Here we report the discovery of an exceptionally preserved primitive fish from the Ludlow of Yunnan, China, that represents the oldest near-complete gnathostome (jawed vertebrate). The postcranial skeleton of this fish includes a primitive pectoral girdle and median fin spine as in non-osteichthyan gnathostomes, but a derived macromeric squamation as in crown osteichthyans, and substantiates the unexpected mix of postcranial features in basal sarcopterygians, previously restored from the disarticulated remains of Psarolepis. As the oldest articulated sarcopterygian, the new taxon offers insights into the origin and early divergence of osteichthyans, and indicates that the minimum date for the actinopterygian-sarcopterygian split was no later than 419 million years ago.	[Zhu, Min; Zhao, Wenjin; Jia, Liantao; Lu, Jing; Qiao, Tuo; Qu, Qingming] Chinese Acad Sci, IVPP, Key Lab Evolutionary Systemat Vertebrates, Beijing 100044, Peoples R China; [Lu, Jing; Qiao, Tuo; Qu, Qingming] Chinese Acad Sci, Grad Sch, Beijing 100039, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhu, M (corresponding author), Chinese Acad Sci, IVPP, Key Lab Evolutionary Systemat Vertebrates, POB 643, Beijing 100044, Peoples R China.	zhumin@ivpp.ac.cn	Qiao, Tuo/AAJ-6317-2021; Zhu, Min/E-8728-2012; min, zhu/AAL-6712-2021; Qu, Qingming/R-7194-2016	Qiao, Tuo/0000-0002-0488-7265; Zhu, Min/0000-0002-4786-0898; Qu, Qingming/0000-0002-8291-8493	MST of China [2006CB806400]; Chinese Academy of Sciences; National Natural Science Foundation of China; CAS/SAFEA International Partnership Program for Creative Research Teams; Australian Research Council Discovery [DP0772138]	MST of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAS/SAFEA International Partnership Program for Creative Research Teams(Chinese Academy of Sciences); Australian Research Council Discovery(Australian Research Council)	We thank M.-M. Chang, P. Janvier, J. Long, P. Ahlberg, X.-B. Yu and B. Choo for discussions, X.-B. Yu and B. Choo for improving the manuscript, J. Zhang and C.-H. Xiong for field work, X.-F. Lu and C.-H. Xiong for specimen preparation, W.-D. Zhang and W. Wang for making thin sections, B. Choo for life restoration, J.-L. Huang for illustrations, and J. Zhang for photography. This work was supported by the Major State Basic Research Projects (2006CB806400) of MST of China, the Chinese Academy of Sciences, the National Natural Science Foundation of China, and the CAS/SAFEA International Partnership Program for Creative Research Teams. M. Z., J. L. and T. Q. thank G. Young and J. Long for the examination of Australian specimens with the support of an Australian Research Council Discovery Grant (DP0772138).	Andrews S. M., 2006, T ROY SOC EDINBURGH, V96, P197, DOI DOI 10.1017/S0263593300001309; Basden AM, 2000, NATURE, V403, P185, DOI 10.1038/35003183; Basden AM, 2001, J VERTEBR PALEONTOL, V21, P754, DOI 10.1671/0272-4634(2001)021[0754:APANFT]2.0.CO;2; Bemis WE, 1997, ENVIRON BIOL FISH, V48, P25, DOI 10.1023/A:1007370213924; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; Botella H, 2007, NATURE, V448, P583, DOI 10.1038/nature05989; Burrow Carole J., 1999, Records of the Western Australian Museum Supplement, V57, P1; Cumbaa SL, 2002, CAN J EARTH SCI, V39, P1457, DOI 10.1139/E02-047; Denison R., 1978, Handbook of Paleoichthyology, V2, P1; DENISON R H, 1968, Fieldiana Geology, V17, P353; Fang R.S., 1985, MIDDLE SILURIAN EARL; Friedman M, 2007, J SYST PALAEONTOL, V5, P289, DOI 10.1017/S1477201907002052; Friedman M, 2006, J PALEONTOL, V80, P1186, DOI 10.1666/0022-3360(2006)80[1186:ANAFTF]2.0.CO;2; Gagnier P.-Y., 1989, Courier Forschungsinstitut Senckenberg, V110, P123; Gardiner B.G., 1984, Bulletin of the British Museum (Natural History) Geology, V37, P173; GRADSTEIN F.M., 2005, GEOLOGIC TIME SCALE; Grande L., 1991, J VERTEBRATE PALEO S, DOI DOI 10.1080/02724634.1991.10011424; GROSS W, 1969, LETHAIA, V2, P15, DOI 10.1111/j.1502-3931.1969.tb01249.x; GROSS W, 1968, LETHAIA, V1, P184, DOI 10.1111/j.1502-3931.1968.tb01736.x; Janvier P., 1978, Eesti NSV Teaduste Akadeemia Toimetised Geoloogia, V27, P88; JANVIER P., 1996, EARLY VERTEBRATES; Janvier Philippe, 1999, Geodiversitas, V21, P33; JARVIK E, 1972, Meddelelser om Gronland, V187, P1; Jarvik E., 1980, BASIC STRUCTURE EVOL, V1; Long M., 1988, U HAWAII WORKING PAP, V7, P1; Miller RF, 2003, NATURE, V425, P501, DOI 10.1038/nature02001; Min Z, 1997, LETHAIA, V30, P293; Muller J, 2005, BIOESSAYS, V27, P1069, DOI 10.1002/bies.20286; Nelson J.S., 2006, FISHES WORLD; PAN J, 1986, B CHINESE ACAD GEOLO, V15, P227; PEARSON D M, 1979, Transactions of the Royal Society of Edinburgh, V70, P337; RICHTER M, 1995, ZOOL J LINN SOC-LOND, V114, P173, DOI 10.1006/zjls.1995.0023; Rong J.-y., 1990, Journal of Stratigraphy, V14, P161; Sansom IJ, 2001, SYST ASSOC SPEC VOL, V61, P156; Schultze H. P., 1968, Bulletin of the British Museum (Natural History) Geology, V16, P341; Schultze HP, 2001, SYST ASSOC SPEC VOL, V61, P315; SCHULTZE HP, 1992, FOSSIL FISHES LIVING, P233; Swofford DL, 2002, PAUP VERSION 40 B10; Ting V. K., 1937, Bulletin of the Geological Society of China, V16, P1; Walliser O.H., 1989, Courier Forschungsinstitut Senckenberg, V110, P111; Wang Cheng-yuan, 2001, Journal of Stratigraphy, V25, P125; Wang N.-z., 1989, Acta Palaeontologica Sinica, V28, P192; Yu XB, 1998, J VERTEBR PALEONTOL, V18, P261, DOI 10.1080/02724634.1998.10011055; Zhang YT, 2001, INT J ENG SCI, V39, P1, DOI 10.1016/S0020-7225(00)00013-6; Zhu M, 2001, SYST ASSOC SPEC VOL, V61, P289; Zhu M, 1999, NATURE, V397, P607, DOI 10.1038/17594; Zhu M, 2006, NATURE, V441, P77, DOI 10.1038/nature04563; Zhu M, 2002, NATURE, V418, P767, DOI 10.1038/nature00871; Zhu M, 2001, NATURE, V410, P81, DOI 10.1038/35065078; Zhu M., 2004, RECENT ADV ORIGIN EA, P271	50	163	181	7	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2009	458	7237					469	474		10.1038/nature07855	http://dx.doi.org/10.1038/nature07855			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423YJ	19325627				2022-12-01	WOS:000264532400036
J	Good, M; Tang, G; Singleton, J; Remenyi, A; Lim, WA				Good, Matthew; Tang, Grace; Singleton, Julie; Remenyi, Attila; Lim, Wendell A.			The Ste5 Scaffold Directs Mating Signaling by Catalytically Unlocking the Fus3 MAP Kinase for Activation	CELL			English	Article							PHEROMONE RESPONSE; SACCHAROMYCES-CEREVISIAE; PROTEIN-KINASE; DOCKING INTERACTIONS; MUTATIONAL ANALYSIS; BINDING DOMAIN; YEAST; SPECIFICITY; PATHWAY; MECHANISMS	The scaffold protein Ste5 is required to properly direct signaling through the yeast mating pathway to the mitogen-activated protein kinase (MAPK), Fus3. Scaffolds are thought to function by tethering kinase and substrate in proximity. We find, however, that the previously identified Fus3-binding site on Ste5 is not required for signaling, suggesting an alternative mechanism controls Fus3's activation by the MAPKK Ste7. Reconstituting MAPK signaling in vitro, we find that Fus3 is an intrinsically poor substrate for Ste7, although the related filamentation MAPK, Kss1, is an excellent substrate. We identify and structurally characterize a domain in Ste5 that catalytically unlocks Fus3 for phosphorylation by Ste7. This domain selectively increases the k(cat) of Ste7 -> Fus3 phosphorylation but has no effect on Ste7 -> Kss1 phosphorylation. The dual requirement for both Ste7 and this Ste5 domain in Fus3 activation explains why Fus3 is selectively activated by the mating pathway and not by other pathways that also utilize Ste7.	[Good, Matthew; Tang, Grace; Singleton, Julie; Remenyi, Attila; Lim, Wendell A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Lim, Wendell A.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Remenyi, Attila] Eotvos Lorand Univ, Dept Biochem, H-1117 Budapest, Hungary; [Good, Matthew] Univ Calif San Francisco, Program Biol Sci, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Eotvos Lorand University; University of California System; University of California San Francisco	Lim, WA (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, 600 16th St, San Francisco, CA 94158 USA.	lim@cmp.ucsf.edu	Remenyi, Attila/N-1345-2016; Good, Matthew C/GLS-0964-2022	Remenyi, Attila/0000-0002-8345-1311; Good, Matthew/0000-0002-6367-1034	Genentech; Achievement Rewards for College Scientists; Leukemia and Lymphoma Society; National Institutes of Health; Packard Foundation; Wellcome Trust; Marie Curie Reintegration Grant; Howard Hughes Medical Institute; NATIONAL EYE INSTITUTE [PN2EY016546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055040] Funding Source: NIH RePORTER	Genentech(Roche HoldingGenentech); Achievement Rewards for College Scientists; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Packard Foundation(The David & Lucile Packard Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); Marie Curie Reintegration Grant(European Commission); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by fellowships from Genentech (M. C. G.) and Achievement Rewards for College Scientists (M. C. G.), and the Leukemia and Lymphoma Society (A. R.). It was also supported by the National Institutes of Health (W. A. L.) and the Packard Foundation (W. A. L.), The Wellcome Trust (A. R.) a Marie Curie Reintegration Grant (A. R.) and the Howard Hughes Medical Institute. Thanks to P. Egea for help with structure determination, and to G. Narlikar, A. Chau, N. Helman, and J. Zalatan for assistance and advice. Also thanks to J. Weissman, D. Morgan, E. McCullagh, and H. Ramage, and members of the Lim Lab for thoughtful discussions. W. A. L. would like to dedicate this paper to the memory of Jeremy R. Knowles and Frederic M. Richards, two of his teachers.	Bao MZ, 2004, CELL, V119, P991, DOI 10.1016/j.cell.2004.11.052; Bardwell L, 1996, MOL CELL BIOL, V16, P3637; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Bhattacharyya RP, 2006, SCIENCE, V311, P822, DOI 10.1126/science.1120941; BRILL JA, 1994, MOL BIOL CELL, V5, P297, DOI 10.1091/mbc.5.3.297; Burack WR, 2000, CURR OPIN CELL BIOL, V12, P211, DOI 10.1016/S0955-0674(99)00078-2; Burack WR, 2002, CURR OPIN IMMUNOL, V14, P312, DOI 10.1016/S0952-7915(02)00347-3; CHOI KY, 1994, CELL, V78, P499; Chou S, 2004, CELL, V119, P981, DOI 10.1016/j.cell.2004.11.053; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Flatauer LJ, 2005, MOL CELL BIOL, V25, P1793, DOI 10.1128/MCB.25.5.1793-1803.2005; Hao N, 2008, MOL CELL, V30, P649, DOI 10.1016/j.molcel.2008.04.016; Harris K, 2001, CURR BIOL, V11, P1815, DOI 10.1016/S0960-9822(01)00567-X; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Inouye C, 1997, GENETICS, V147, P479; Inouye C, 1997, SCIENCE, V278, P103, DOI 10.1126/science.278.5335.103; Loog M, 2005, NATURE, V434, P104, DOI 10.1038/nature03329; Maeder CI, 2007, NAT CELL BIOL, V9, P1319, DOI 10.1038/ncb1652; Maleri S, 2004, MOL CELL BIOL, V24, P9221, DOI 10.1128/MCB.24.20.9221-9238.2004; Park SH, 2003, SCIENCE, V299, P1061, DOI 10.1126/science.1076979; Pavletich NP, 1999, J MOL BIOL, V287, P821, DOI 10.1006/jmbi.1999.2640; Remenyi A, 2005, MOL CELL, V20, P951, DOI 10.1016/j.molcel.2005.10.030; Remenyi A, 2006, CURR OPIN STRUC BIOL, V16, P676, DOI 10.1016/j.sbi.2006.10.008; Schwartz MA, 2006, CURR GENET, V49, P351, DOI 10.1007/s00294-006-0061-6; Sette C, 2000, MOL BIOL CELL, V11, P4033, DOI 10.1091/mbc.11.11.4033; van Drogen F, 2002, CURR BIOL, V12, pR53, DOI 10.1016/S0960-9822(01)00672-8; van Drogen F, 2001, NAT CELL BIOL, V3, P1051, DOI 10.1038/ncb1201-1051; WHITEWAY MS, 1995, SCIENCE, V269, P1572, DOI 10.1126/science.7667635; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259; Winters MJ, 2005, MOL CELL, V20, P21, DOI 10.1016/j.molcel.2005.08.020	31	139	143	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 20	2009	136	6					1085	1097		10.1016/j.cell.2009.01.049	http://dx.doi.org/10.1016/j.cell.2009.01.049			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	422CE	19303851	Green Accepted, Bronze			2022-12-01	WOS:000264403900014
J	Herzog, F; Primorac, I; Dube, P; Lenart, P; Sander, B; Mechtler, K; Stark, H; Peters, JM				Herzog, Franz; Primorac, Ivana; Dube, Prakash; Lenart, Peter; Sander, Bjoern; Mechtler, Karl; Stark, Holger; Peters, Jan-Michael			Structure of the Anaphase-Promoting Complex/Cyclosome Interacting with a Mitotic Checkpoint Complex	SCIENCE			English	Article							SPINDLE ASSEMBLY CHECKPOINT; DESTRUCTION BOX; BUDDING YEAST; PROTEIN MAD2; AURORA-B; APC/C; CDC20; INHIBITION; MITOSIS; BUBR1	Once all chromosomes are connected to the mitotic spindle (bioriented), anaphase is initiated by the protein ubiquitylation activity of the anaphase-promoting complex/cyclosome (APC/C) and its coactivator Cdc20 (APC/C-Cdc20). Before chromosome biorientation, anaphase is delayed by a mitotic checkpoint complex (MCC) that inhibits APC/C-Cdc20. We used single-particle electron microscopy to obtain three-dimensional models of human APC/C in various functional states: bound to MCC, to Cdc20, or to neither (apo-APC/C). These experiments revealed that MCC associates with the Cdc20 binding site on APC/C, locks the otherwise flexible APC/C in a "closed" state, and prevents binding and ubiquitylation of a wide range of different APC/C substrates. These observations clarify the structural basis for the inhibition of APC/C by spindle checkpoint proteins.	[Dube, Prakash; Sander, Bjoern; Stark, Holger] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany; [Herzog, Franz; Primorac, Ivana; Mechtler, Karl; Peters, Jan-Michael] Res Inst Mol Pathol, A-1030 Vienna, Austria; [Lenart, Peter] European Mol Biol Lab, D-69117 Heidelberg, Germany	Max Planck Society; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); European Molecular Biology Laboratory (EMBL)	Stark, H (corresponding author), Max Planck Inst Biophys Chem, Fassberg 11, D-37077 Gottingen, Germany.	hstark1@gwdg.de; peters@imp.univie.ac.at	Sander, Bjoern/AAO-9021-2021; Mechtler, Karl/AAF-2717-2019; Herzog, Franz/G-4832-2012	Sander, Bjoern/0000-0001-8495-2321; Mechtler, Karl/0000-0002-3392-9946; Herzog, Franz/0000-0001-8270-1449; Lenart, Peter/0000-0002-3927-248X; Holger, Stark/0000-0002-6161-1118	Federal Ministry of Education and Research, Germany; Sixth Framework Programme of the European Union; Boehringer Ingelheim; Vienna Spots of Excellence Programme; Austrian Science Fund	Federal Ministry of Education and Research, Germany(Federal Ministry of Education & Research (BMBF)); Sixth Framework Programme of the European Union(European Commission); Boehringer Ingelheim(Boehringer Ingelheim); Vienna Spots of Excellence Programme; Austrian Science Fund(Austrian Science Fund (FWF))	We are grateful to M. Madalinski, M. Gmachl, and G. Kohlmaier for reagents; J. Deckert and R. Luhrmann for support; and S. Westermann for comments on the manuscript. Research in the laboratory of H.S. was supported by grants from the Federal Ministry of Education and Research, Germany, and the Sixth Framework Programme of the European Union via the Integrated Project 3DRepertoire. Research in the laboratories of J.-M.P. and K.M. were supported by Boehringer Ingelheim, the Vienna Spots of Excellence Programme, and the Austrian Science Fund. The structural coordinates have been deposited in the Electron Microscopy Data Bank Database at the European Molecular Biology Laboratory European Bioinformatics Institute. The structures of APC/CMCC and apo-APC/C can be accessed under the codes EMD-1591 and EMD-1592, respectively.	Baker DJ, 2005, CURR OPIN CELL BIOL, V17, P583, DOI 10.1016/j.ceb.2005.09.011; Braunstein I, 2007, P NATL ACAD SCI USA, V104, P4870, DOI 10.1073/pnas.0700523104; Burton JL, 2007, GENE DEV, V21, P655, DOI 10.1101/gad.1511107; Burton JL, 2005, MOL CELL, V18, P533, DOI 10.1016/j.molcel.2005.04.022; DeAntoni A, 2005, PHILOS T R SOC B, V360, P637, DOI 10.1098/rstb.2004.1618; Dube P, 2005, MOL CELL, V20, P867, DOI 10.1016/j.molcel.2005.11.008; Fang GW, 2002, MOL BIOL CELL, V13, P755, DOI 10.1091/mbc.01-09-0437; Fang GW, 1998, GENE DEV, V12, P1871, DOI 10.1101/gad.12.12.1871; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Hayes MJ, 2006, NAT CELL BIOL, V8, P607, DOI 10.1038/ncb1410; Hwang LH, 1998, SCIENCE, V279, P1041, DOI 10.1126/science.279.5353.1041; Kallio M, 1998, J CELL BIOL, V141, P1393, DOI 10.1083/jcb.141.6.1393; Kim SH, 1998, SCIENCE, V279, P1045, DOI 10.1126/science.279.5353.1045; Kraft C, 2005, MOL CELL, V18, P543, DOI 10.1016/j.molcel.2005.04.023; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; Luo XL, 2002, MOL CELL, V9, P59, DOI 10.1016/S1097-2765(01)00435-X; Morrow CJ, 2005, J CELL SCI, V118, P3639, DOI 10.1242/jcs.02487; Ohi MD, 2007, MOL CELL, V28, P871, DOI 10.1016/j.molcel.2007.10.003; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; RIEDER CL, 1995, J CELL BIOL, V130, P941, DOI 10.1083/jcb.130.4.941; Sczaniecka M, 2008, J BIOL CHEM, V283, P23039, DOI 10.1074/jbc.M803594200; Sironi L, 2002, EMBO J, V21, P2496, DOI 10.1093/emboj/21.10.2496; Stern BM, 2001, CURR BIOL, V11, P1462, DOI 10.1016/S0960-9822(01)00451-1; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Tang ZY, 2001, DEV CELL, V1, P227, DOI 10.1016/S1534-5807(01)00019-3; Wassmann K, 1998, P NATL ACAD SCI USA, V95, P11193, DOI 10.1073/pnas.95.19.11193; Wolthuis R, 2008, MOL CELL, V30, P290, DOI 10.1016/j.molcel.2008.02.027; Yamano H, 2004, MOL CELL, V13, P137, DOI 10.1016/S1097-2765(03)00480-5	28	170	177	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2009	323	5920					1477	1481		10.1126/science.1163300	http://dx.doi.org/10.1126/science.1163300			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417TP	19286556	Green Accepted			2022-12-01	WOS:000264101700041
J	Sanchez, PA				Sanchez, Pedro A.			A smarter way to combat hunger	NATURE			English	Editorial Material									Columbia Univ, Earth Inst, Palisades, NY 10964 USA	Columbia University	Sanchez, PA (corresponding author), Columbia Univ, Earth Inst, 61 Route 9W, Palisades, NY 10964 USA.	psanchez@ei.columbia.edu						*CHIC IN GLOB AGR, 2009, REN AM LEAD FIGHT GL; Denning G, 2009, PLOS BIOL, V7, P2, DOI 10.1371/journal.pbio.1000023; DIOUF J, 2009, HIGH LEV M FOOD SEC; Garrett Laurie, 2008, FOOD FAILURES FUTURE; JURY A, 2008, WORLD FOOD PRIZ S 22; Sanchez PA, 2005, SCIENCE, V307, P357, DOI 10.1126/science.1109057; Sanchez PA, 2009, FOOD SECUR, V1, P37, DOI 10.1007/s12571-009-0011-5; von Braun J, 2008, NATURE, V456, P701, DOI 10.1038/456701a	8	11	11	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 12	2009	458	7235					148	148		10.1038/458148a	http://dx.doi.org/10.1038/458148a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	417EQ	19279615	Bronze			2022-12-01	WOS:000264059700022
J	Gore, J; Youk, H; van Oudenaarden, A				Gore, Jeff; Youk, Hyun; van Oudenaarden, Alexander			Snowdrift game dynamics and facultative cheating in yeast	NATURE			English	Article							COOPERATION; EVOLUTION; CONFLICT; POPULATIONS; COMPETITION; GENE	The origin of cooperation is a central challenge to our understanding of evolution(1-3). The fact that microbial interactions can be manipulated in ways that animal interactions cannot has led to a growing interest in microbial models of cooperation(4-10) and competition(11,12). For the budding yeast Saccharomyces cerevisiae to grow on sucrose, the disaccharide must first be hydrolysed by the enzyme invertase(13,14). This hydrolysis reaction is performed outside the cytoplasm in the periplasmic space between the plasma membrane and the cell wall. Here we demonstrate that the vast majority ( 99 per cent) of the monosaccharides created by sucrose hydrolysis diffuse away before they can be imported into the cell, serving to make invertase production and secretion a cooperative behaviour(15,16). A mutant cheater strain that does not produce invertase is able to take advantage of and invade a population of wild-type cooperator cells. However, over a wide range of conditions, the wild-type cooperator can also invade a population of cheater cells. Therefore, we observe steady-state coexistence between the two strains in well-mixed culture resulting from the fact that rare strategies outperform common strategies-the defining features of what game theorists call the snowdrift game(17). A model of the cooperative interaction incorporating nonlinear benefits explains the origin of this coexistence. We are able to alter the outcome of the competition by varying either the cost of cooperation or the glucose concentration in the media. Finally, we note that glucose repression of invertase expression in wild-type cells produces a strategy that is optimal for the snowdrift game-wild-type cells cooperate only when competing against cheater cells.	[Gore, Jeff; Youk, Hyun; van Oudenaarden, Alexander] MIT, Dept Phys, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	van Oudenaarden, A (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.	avano@mit.edu	van Oudenaarden, Alexander/AAA-1705-2019; Youk, Hyun/E-2661-2016	Youk, Hyun/0000-0003-1687-5760	Pappalardo Postdoctoral Fellowship; NIH K99 Pathways to Independence; Lester Wolfe Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068957, K99GM085279] Funding Source: NIH RePORTER	Pappalardo Postdoctoral Fellowship; NIH K99 Pathways to Independence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lester Wolfe Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to thank D. Kim, A. Raj, K. Gora, D. Muzzey and B. Pando for discussions and/or experimental help. This work was supported by grants from the US National Institutes of Health (NIH) and National Science Foundation to A. v. O. J. G. is supported through a Pappalardo Postdoctoral Fellowship and an NIH K99 Pathways to Independence Award. H. Y. was supported by a Lester Wolfe Fellowship.	AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; CARLSON M, 1982, CELL, V28, P145, DOI 10.1016/0092-8674(82)90384-1; CHAO L, 1981, P NATL ACAD SCI-BIOL, V78, P6324, DOI 10.1073/pnas.78.10.6324; DICKINSON JR, 2004, METABOLISM MOL PHYSL, P54; Diggle SP, 2007, NATURE, V450, P411, DOI 10.1038/nature06279; Doebeli M, 2005, ECOL LETT, V8, P748, DOI 10.1111/j.1461-0248.2005.00773.x; Fiegna F, 2003, P ROY SOC B-BIOL SCI, V270, P1527, DOI 10.1098/rspb.2003.2387; Gancedo JM, 1998, MICROBIOL MOL BIOL R, V62, P334, DOI 10.1128/MMBR.62.2.334-361.1998; Greig D, 2004, P ROY SOC LOND B BIO, V271, P25, DOI [10.1098/rsbl.2003.0083, DOI 10.1098/RSBL.2003.0083)]; Griffin AS, 2004, NATURE, V430, P1024, DOI 10.1038/nature02744; Hauert C, 2004, NATURE, V428, P643, DOI 10.1038/nature02360; Kerr B, 2002, NATURE, V418, P171, DOI 10.1038/nature00823; Keymer JE, 2006, P NATL ACAD SCI USA, V103, P17290, DOI 10.1073/pnas.0607971103; Maclean RC, 2008, J EVOLUTION BIOL, V21, P1836, DOI 10.1111/j.1420-9101.2008.01579.x; MacLean RC, 2006, NATURE, V441, P498, DOI 10.1038/nature04624; Maynard Smith J., 1982, pi; MOTRO U, 1991, J THEOR BIOL, V151, P145, DOI 10.1016/S0022-5193(05)80358-3; Nadell CD, 2009, FEMS MICROBIOL REV, V33, P206, DOI 10.1111/j.1574-6976.2008.00150.x; Naumov GI, 1996, FEMS MICROBIOL LETT, V135, P31, DOI 10.1016/0378-1097(95)00424-6; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Ozcan S, 1997, YEAST, V13, P127; Rainey PB, 2003, NATURE, V425, P72, DOI 10.1038/nature01906; Santorelli LA, 2008, NATURE, V451, P1107, DOI 10.1038/nature06558; Shou WY, 2007, P NATL ACAD SCI USA, V104, P1877, DOI 10.1073/pnas.0610575104; Skyrms B., 2004, STAG HUNT EVOLUTION, DOI DOI 10.1017/CBO9781139165228; Smukalla S, 2008, CELL, V135, P726, DOI 10.1016/j.cell.2008.09.037; Velicer GJ, 2003, TRENDS MICROBIOL, V11, P330, DOI 10.1016/S0966-842X(03)00152-5; West SA, 2006, NAT REV MICROBIOL, V4, P597, DOI 10.1038/nrmicro1461	29	434	441	3	106	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 14	2009	459	7244					253	256		10.1038/nature07921	http://dx.doi.org/10.1038/nature07921			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445FR	19349960	Green Accepted			2022-12-01	WOS:000266036100041
J	Liu, K; Victora, GD; Schwickert, TA; Guermonprez, P; Meredith, MM; Yao, KH; Chu, FF; Randolph, GJ; Rudensky, AY; Nussenzweig, M				Liu, Kang; Victora, Gabriel D.; Schwickert, Tanja A.; Guermonprez, Pierre; Meredith, Matthew M.; Yao, Kaihui; Chu, Fei-Fan; Randolph, Gwendalyn J.; Rudensky, Alexander Y.; Nussenzweig, Michel			In Vivo Analysis of Dendritic Cell Development and Homeostasis	SCIENCE			English	Article							BONE-MARROW; MONOCYTES; SUBSETS; DIFFERENTIATION; PROGENITORS; PRECURSORS; SUBTYPES; DISTINCT; TISSUE; MOUSE	Dendritic cells (DCs) in lymphoid tissue arise from precursors that also produce monocytes and plasmacytoid DCs (pDCs). Where DC and monocyte lineage commitment occurs and the nature of the DC precursor that migrates from the bone marrow to peripheral lymphoid organs are unknown. We show that DC development progresses from the macrophage and DC precursor to common DC precursors that give rise to pDCs and classical spleen DCs (cDCs), but not monocytes, and finally to committed precursors of cDCs (pre-cDCs). Pre-cDCs enter lymph nodes through and migrate along high endothelial venules and later disperse and integrate into the DC network. Further cDC development involves cell division, which is controlled in part by regulatory T cells and fms-like tyrosine kinase receptor-3.	[Liu, Kang; Victora, Gabriel D.; Schwickert, Tanja A.; Guermonprez, Pierre; Meredith, Matthew M.; Yao, Kaihui; Chu, Fei-Fan; Nussenzweig, Michel] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Randolph, Gwendalyn J.] Mt Sinai Sch Med, Dept Gene & Cell Med, New York, NY 10029 USA; [Rudensky, Alexander Y.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Rudensky, Alexander Y.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Rudensky, Alexander Y.; Nussenzweig, Michel] Rockefeller Univ, HHMI, New York, NY 10021 USA	Rockefeller University; Icahn School of Medicine at Mount Sinai; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; Rockefeller University	Liu, K (corresponding author), Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA.	liuk@rockefeller.edu; nussen@rockefeller.edu	Victora, Gabriel/C-5946-2011; Nussenzweig, Michel/AAE-7292-2019; Guermonprez, Pierre/ABE-7718-2020	Guermonprez, Pierre/0000-0001-5621-2262; Victora, Gabriel/0000-0001-8807-348X; Schwickert, Tanja/0000-0002-3371-2376	Rockefeller University; Schering Foundation; NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI051573] Funding Source: NIH RePORTER	Rockefeller University; Schering Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank S. Bhuvanendran for two-photon microscopy, K. Velinzon and T. Shengelia for cell sorting, and R. Steinman and A. Silva for discussions and critical reading of the manuscript. K.L. was supported by a C. H. Li Memorial Scholarship Award from the Rockefeller University. T.A.S. was supported by the Schering Foundation. This work was supported in part by grants from the NIH to M.C.N. M.C.N. is an HHMI investigator.	Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Catalina MD, 1996, J EXP MED, V184, P2341, DOI 10.1084/jem.184.6.2341; Diao J, 2006, J IMMUNOL, V176, P7196, DOI 10.4049/jimmunol.176.12.7196; DIPUCCHIO D, 2008, SCIENCE, V9, P551; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Iyoda T, 2002, J EXP MED, V195, P1289, DOI 10.1084/jem.20020161; Jakubzick C, 2008, J IMMUNOL, V180, P3019, DOI 10.4049/jimmunol.180.5.3019; Jakubzick C, 2008, J EXP MED, V205, P2839, DOI 10.1084/jem.20081430; Karsunky H, 2003, J EXP MED, V198, P305, DOI 10.1084/jem.20030323; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Liu K, 2007, NAT IMMUNOL, V8, P578, DOI 10.1038/ni1462; Naik SH, 2006, NAT IMMUNOL, V7, P663, DOI 10.1038/ni1340; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Randolph GJ, 1998, SCIENCE, V282, P480, DOI 10.1126/science.282.5388.480; Randolph GJ, 1999, IMMUNITY, V11, P753, DOI 10.1016/S1074-7613(00)80149-1; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Steinman RM, 2007, NAT MED, V13, P1155, DOI 10.1038/nm1643; Tussiwand R, 2005, J IMMUNOL, V175, P3674, DOI 10.4049/jimmunol.175.6.3674; Varol C, 2007, J EXP MED, V204, P171, DOI 10.1084/jem.20061011; Waskow C, 2008, NAT IMMUNOL, V9, P676, DOI 10.1038/ni.1615	25	961	979	1	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 17	2009	324	5925					392	397		10.1126/science.1170540	http://dx.doi.org/10.1126/science.1170540			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433QT	19286519	Green Accepted			2022-12-01	WOS:000265221600044
J	Hawkes, N				Hawkes, Nigel			Observations Body Politic Fools rush in?	BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com						Dancer SJ, 2008, J HOSP INFECT, V69, P315, DOI 10.1016/j.jhin.2008.05.002; 2008, JAMA-J AM MED ASSOC, V299, P1149	2	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	APR 15	2009	338								b1533	10.1136/bmj.b1533	http://dx.doi.org/10.1136/bmj.b1533			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	434TJ	19369279				2022-12-01	WOS:000265296700005
J	Kosiborod, M; Inzucchi, SE; Goyal, A; Krumholz, HM; Masoudi, FA; Xiao, L; Spertus, JA				Kosiborod, Mikhail; Inzucchi, Silvio E.; Goyal, Abhinav; Krumholz, Harlan M.; Masoudi, Frederick A.; Xiao, Lan; Spertus, John A.			Relationship Between Spontaneous and Iatrogenic Hypoglycemia and Mortality in Patients Hospitalized With Acute Myocardial Infarction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTENSIVE INSULIN THERAPY; STRESS HYPERGLYCEMIA; BLOOD-GLUCOSE; ADVERSE OUTCOMES; NONDIABETIC PATIENTS; DIABETIC-PATIENTS; PLASMA-GLUCOSE; ASSOCIATION; ADMISSION; RISK	Context While glucose control is recommended by professional societies for patients with hyperglycemia hospitalized with acute myocardial infarction (AMI), enthusiasm for glucose lowering is tempered, in part, by concerns of inducing hypoglycemia. Yet, whether episodic hypoglycemia that occurs as a result of glucose-lowering therapy is harmful in patients with AMI is unknown. Objective To determine whether the mortality risk associated with hypoglycemic events is similar in patients who develop hypoglycemia spontaneously and those who develop it as a result of insulin therapy. Design, Setting, and Patients Retrospective cohort study using data from Health Facts, a contemporary database of patients hospitalized across the United States in 40 hospitals between January 1, 2000, and December 31, 2005. Of all the patients in the database, 7820 patients were hospitalized with AMI and were hyperglycemic on admission (glucose level >= 140 mg/dL). Patients were stratified based on whether they developed a hypoglycemic event (random glucose level <60 mg/dL) during subsequent hospitalization. Logistic regression models were used to evaluate the association between hypoglycemia and in-hospital mortality within subgroups of patients who were and were not treated with insulin therapy. Main Outcome Measure All-cause in-hospital mortality. Results Among patients treated or not treated with insulin, those with hypoglycemia were older and had more comorbidity. Hypoglycemia was associated with increased mortality in patients not treated with insulin (18.4% [25/136] mortality in patients with hypoglycemia vs 9.2% [425/4639] in those without hypoglycemia; P<.001), but not in those treated with insulin (10.4% [36/346] mortality in patients with hypoglycemia vs 10.2% [276/2699] in those without hypoglycemia; P=.92). After multivariable adjustment, there was a significant interaction between hypoglycemia and insulin therapy (P value for interaction=.01). Hypoglycemia was a predictor of higher mortality in patients who were not treated with insulin (odds ratio, 2.32 [95% confidence interval, 1.31-4.12] vs patients without hypoglycemia), but not in patients treated with insulin (odds ratio, 0.92 [95% confidence interval, 0.58-1.45] vs patients without hypoglycemia). Conclusions While hypoglycemia was associated with increased mortality in patients with AMI, this risk was confined to patients who developed hypoglycemia spontaneously. In contrast, iatrogenic hypoglycemia after insulin therapy was not associated with higher mortality risk.	[Kosiborod, Mikhail; Xiao, Lan; Spertus, John A.] St Lukes Hosp, Mid Amer Heart Inst, Kansas City, MO 64111 USA; [Kosiborod, Mikhail; Spertus, John A.] Univ Missouri, Dept Med, Kansas City, MO USA; [Inzucchi, Silvio E.; Krumholz, Harlan M.] Yale Univ, Dept Med, New Haven, CT 06520 USA; [Inzucchi, Silvio E.; Krumholz, Harlan M.] Yale New Haven Med Ctr, New Haven, CT 06504 USA; [Goyal, Abhinav] Emory Rollins Sch Publ Hlth, Atlanta, GA USA; [Goyal, Abhinav] Emory Sch Med, Atlanta, GA USA; [Masoudi, Frederick A.] Univ Colorado, Hlth Sci Ctr, Denver Hlth Med Ctr, Denver, CO USA; [Masoudi, Frederick A.] Univ Colorado, Hlth Sci Ctr, Dept Med, Denver, CO 80262 USA	Saint Luke's Hospital - Missouri; Saint Luke's Mid America Heart Institute; University of Missouri System; University of Missouri Kansas City; Yale University; Yale University; Emory University; Rollins School Public Health; Emory University; Denver Health Medical Center; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Kosiborod, M (corresponding author), St Lukes Hosp, Mid Amer Heart Inst, 4401 Wornall Rd, Kansas City, MO 64111 USA.	mkosiborod@cc-pc.com	Masoudi, Frederick/Q-7467-2019; , Harlan/AAI-2875-2020; Spertus, John/ABD-3075-2021; Inzucchi, Silvio/ABF-4121-2021; Goyal, Abhinav/J-5086-2012	Goyal, Abhinav/0000-0002-6286-2349	American Heart Association; Cerner Corporation	American Heart Association(American Heart Association); Cerner Corporation	Funding/Support: The research for this article was supported by the American Heart Association Career Development Award in Implementation Research awarded to Dr Kosiborod and by the Cerner Corporation.	Anderson JL, 2007, CIRCULATION, V116, pE148, DOI 10.1161/CIRCULATIONAHA.107.181940; ANTMAN EM, ACC AHA GUIDELINES M; BELLODI G, 1989, AM J CARDIOL, V64, P885, DOI 10.1016/0002-9149(89)90836-9; Bolk J, 2001, INT J CARDIOL, V79, P207, DOI 10.1016/S0167-5273(01)00422-3; Capes SE, 2000, LANCET, V355, P773, DOI 10.1016/S0140-6736(99)08415-9; Childs BP, 2005, DIABETES CARE, V28, P1245; Deedwania P, 2008, CIRCULATION, V117, P1610, DOI 10.1161/CIRCULATIONAHA.107.188629; Foo K, 2003, HEART, V89, P512, DOI 10.1136/heart.89.5.512; Goldberg PA, 2004, DIABETES CARE, V27, P461, DOI 10.2337/diacare.27.2.461; Goyal A, 2006, EUR HEART J, V27, P1289, DOI 10.1093/eurheartj/ehi884; Hadjadj S, 2004, DIABETIC MED, V21, P305, DOI 10.1111/j.1464-5491.2004.01112.x; Ishihara M, 2003, AM HEART J, V146, P674, DOI 10.1016/S0002-8703(03)00167-4; Iwakura K, 2003, J AM COLL CARDIOL, V41, P1, DOI 10.1016/S0735-1097(02)02626-8; Kadri Z, 2006, HEART, V92, P910, DOI 10.1136/hrt.2005.073791; Kosiborod M, 2005, CIRCULATION, V111, P3078, DOI 10.1161/CIRCULATIONAHA.104.517839; Kosiborod M, 2008, CIRCULATION, V117, P1018, DOI 10.1161/CIRCULATIONAHA.107.740498; LEOR J, 1993, AM J MED, V94, P265, DOI 10.1016/0002-9343(93)90058-W; MADSEN JK, 1986, ACTA MED SCAND, V220, P329; Mak K. H., 1993, Annals Academy of Medicine Singapore, V22, P291; Malmberg K, 1997, BRIT MED J, V314, P1512, DOI 10.1136/bmj.314.7093.1512; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Meier JJ, 2005, DIABETES CARE, V28, P2551, DOI 10.2337/diacare.28.10.2551; MELLBIN LG, 2008, HEART           1124, DOI DOI 10.1136/HRT.2008.152835; MITRAKOU A, 1991, AM J PHYSIOL, V260, pE67, DOI 10.1152/ajpendo.1991.260.1.E67; OSULLIVAN JJ, 1991, DIABETES CARE, V14, P758, DOI 10.2337/diacare.14.8.758; OSWALD GA, 1986, BMJ-BRIT MED J, V293, P917, DOI 10.1136/bmj.293.6552.917; OSWALD GA, 1984, LANCET, V1, P1264; OSWALD GA, 1987, DIABETIC MED, V4, P68, DOI 10.1111/j.1464-5491.1987.tb00833.x; Pinto DS, 2005, J AM COLL CARDIOL, V46, P178, DOI 10.1016/j.jacc.2005.03.052; Sala J, 2002, J EPIDEMIOL COMMUN H, V56, P707, DOI 10.1136/jech.56.9.707; SEWDARSEN M, 1987, DIABETES RES CLIN EX, V6, P47; Wiener RS, 2008, JAMA-J AM MED ASSOC, V300, P933, DOI 10.1001/jama.300.8.933; Stranders I, 2004, ARCH INTERN MED, V164, P982, DOI 10.1001/archinte.164.9.982; Suleiman M, 2005, CIRCULATION, V111, P754, DOI 10.1161/01.CIR.0000155235.48601.2A; Svensson AM, 2005, EUR HEART J, V26, P1255, DOI 10.1093/eurheartj/ehi230; Swinnen S, 2009, DIABETOLOGIA, V52, P38, DOI 10.1007/s00125-008-1147-0; Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Van den Berghe G, 2006, DIABETES, V55, P3151, DOI 10.2337/db06-0855; Wahab NN, 2002, J AM COLL CARDIOL, V40, P1748, DOI 10.1016/S0735-1097(02)02483-X; Wong VW, 2004, DIABETES RES CLIN PR, V64, P85, DOI 10.1016/j.diabres.2003.10.016; YUDKIN JS, 1987, BRIT MED J, V294, P773, DOI 10.1136/bmj.294.6574.773	42	233	241	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 15	2009	301	15					1556	1564		10.1001/jama.2009.496	http://dx.doi.org/10.1001/jama.2009.496			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	432MH	19366775	Bronze			2022-12-01	WOS:000265137900026
J	Crisp, MD; Arroyo, MTK; Cook, LG; Gandolfo, MA; Jordan, GJ; McGlone, MS; Weston, PH; Westoby, M; Wilf, P; Linder, HP				Crisp, Michael D.; Arroyo, Mary T. K.; Cook, Lyn G.; Gandolfo, Maria A.; Jordan, Gregory J.; McGlone, Matt S.; Weston, Peter H.; Westoby, Mark; Wilf, Peter; Linder, H. Peter			Phylogenetic biome conservatism on a global scale	NATURE			English	Article							GENUS OREOMYRRHIS APIACEAE; LONG-DISTANCE DISPERSAL; MOLECULAR PHYLOGENY; NEW-ZEALAND; NICHE CONSERVATISM; SEQUENCE DATA; SENSU-LATO; EVOLUTION; BIOGEOGRAPHY; CHLOROPLAST	How and why organisms are distributed as they are has long intrigued evolutionary biologists(1-4). The tendency for species to retain their ancestral ecology has been demonstrated in distributions on local and regional scales(5-7), but the extent of ecological conservatism over tens of millions of years and across continents has not been assessed(8-13). Here we show that biome stasis at speciation has outweighed biome shifts by a ratio of more than 25:1, by inferring ancestral biomes for an ecologically diverse sample of more than 11,000 plant species from around the Southern Hemisphere. Stasis was also prevalent in transocean colonizations. Availability of a suitable biome could have substantially influenced which lineages establish on more than one landmass, in addition to the influence of the rarity of the dispersal events themselves. Conversely, the taxonomic composition of biomes has probably been strongly influenced by the rarity of species' transitions between biomes. This study has implications for the future because if clades have inherently limited capacity to shift biomes(13), then their evolutionary potential could be strongly compromised by biome contraction as climate changes.	[Crisp, Michael D.] Australian Natl Univ, Sch Bot & Zool, Canberra, ACT 0200, Australia; [Arroyo, Mary T. K.] Univ Chile, Inst Ecol & Biodivers, Santiago, Chile; [Cook, Lyn G.] Univ Queensland, Sch Integrat Biol, Brisbane, Qld 4072, Australia; [Gandolfo, Maria A.] Cornell Univ, Dept Plant Biol, LH Bailey Hortorium, Ithaca, NY 14853 USA; [Jordan, Gregory J.] Univ Tasmania, Sch Plant Sci, Hobart, Tas 7001, Australia; [McGlone, Matt S.] Landcare Res, Lincoln 7640, New Zealand; [Weston, Peter H.] Natl Herbarium New S Wales, Sydney, NSW 2000, Australia; [Westoby, Mark] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia; [Wilf, Peter] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; [Linder, H. Peter] Univ Zurich, Inst Systemat Biol, CH-8008 Zurich, Switzerland	Australian National University; Universidad de Chile; University of Queensland; Cornell University; University of Tasmania; Landcare Research - New Zealand; Macquarie University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Zurich	Crisp, MD (corresponding author), Australian Natl Univ, Sch Bot & Zool, GPO Box 4, Canberra, ACT 0200, Australia.	mike.crisp@anu.edu.au	Jordan, Gregory/B-3932-2013; Linder, Hans Peter/F-5316-2010; Crisp, Michael D/A-4888-2008; Cook, Lyn/G-7336-2012	Jordan, Gregory/0000-0002-6033-2766; Crisp, Michael D/0000-0002-8255-6349; Cook, Lyn/0000-0002-3172-4920; Westoby, Mark/0000-0001-7690-4530; Wilf, Peter/0000-0001-6813-1937; Weston, Peter/0000-0001-8920-5376	Australian Research Council-New Zealand Research Network for Vegetation Function; US National Science Foundation	Australian Research Council-New Zealand Research Network for Vegetation Function(Australian Research Council); US National Science Foundation(National Science Foundation (NSF))	We thank the Australian Research Council-New Zealand Research Network for Vegetation Function for facilitating this collaboration. Participation by M. A. G. and P. W. was supported in part by a grant from the US National Science Foundation.	Aagesen L, 2005, PLANT SYST EVOL, V250, P197, DOI 10.1007/s00606-004-0204-5; Ackerly DD, 2006, ECOLOGY, V87, pS50, DOI 10.1890/0012-9658(2006)87[50:NEAART]2.0.CO;2; Alsos IG, 2007, SCIENCE, V316, P1606, DOI 10.1126/science.1139178; Anderson CL, 2005, AM J BOT, V92, P1737, DOI 10.3732/ajb.92.10.1737; Barker NP, 2007, PLANT SYST EVOL, V264, P135, DOI 10.1007/s00606-006-0479-9; Barker NP, 2007, J BIOGEOGR, V34, P2012, DOI 10.1111/j.1365-2699.2007.01749.x; Barnes RW, 2001, AUST J BOT, V49, P301, DOI 10.1071/BT00036; Barreda V, 2007, BOT REV, V73, P31, DOI 10.1663/0006-8101(2007)73[31:PVTDTP]2.0.CO;2; Berry PE, 2004, AM J BOT, V91, P601, DOI 10.3732/ajb.91.4.601; Bogler DJ, 2004, BOT REV, V70, P260, DOI 10.1663/0006-8101(2004)070[0260:MSSICE]2.0.CO;2; Bradford JC, 2002, ANN MO BOT GARD, V89, P491, DOI 10.2307/3298592; Bremer K, 2004, SYST BIOL, V53, P496, DOI 10.1080/10635150490445913; Briggs BG, 2000, MONOCOTS SYSTEMATICS, P661; Burgoyne PM, 2005, J AFR EARTH SCI, V43, P13, DOI 10.1016/j.jafrearsci.2005.07.015; Bytebier B, 2007, MOL PHYLOGENET EVOL, V43, P75, DOI 10.1016/j.ympev.2006.08.014; Case AL, 2008, INT J PLANT SCI, V169, P141, DOI 10.1086/523368; Chandler GT, 2007, AUST SYST BOT, V20, P390, DOI 10.1071/SB07004; Chung KF, 2005, AM J BOT, V92, P2054, DOI 10.3732/ajb.92.12.2054; Chung KF, 2007, SYST BOT, V32, P671, DOI 10.1600/036364407782250517; Clements Mark A., 2002, Lindleyana, V17, P135; Cook LG, 2005, P ROY SOC B-BIOL SCI, V272, P2535, DOI 10.1098/rspb.2005.3219; Cook LG, 2005, J BIOGEOGR, V32, P741, DOI 10.1111/j.1365-2699.2005.01261.x; Crayn DM, 2006, AM J BOT, V93, P1328, DOI 10.3732/ajb.93.9.1328; Crayn DM, 1998, AUST J BOT, V46, P187, DOI 10.1071/BT97019; Crepet WL, 2004, AM J BOT, V91, P1666, DOI 10.3732/ajb.91.10.1666; Crisp M, 2004, PHILOS T R SOC B, V359, P1551, DOI 10.1098/rstb.2004.1528; Crisp MD, 2007, MOL PHYLOGENET EVOL, V43, P1106, DOI 10.1016/j.ympev.2007.02.030; Crisp M, 2006, J BIOGEOGR, V33, P1332, DOI 10.1111/j.1365-2699.2006.01551.x; DARWIN CR, 1855, GARDENERS CHRONICLE, V21, P356; de Queiroz A, 2005, TRENDS ECOL EVOL, V20, P68, DOI 10.1016/j.tree.2004.11.006; Ford KA, 2007, TAXON, V56, P783, DOI 10.2307/25065861; Gadek PA, 2000, AM J BOT, V87, P1044, DOI 10.2307/2657004; Goldblatt P, 2004, BOT J LINN SOC, V144, P41, DOI 10.1111/j.0024-4074.2004.00246.x; Goldblatt Peter, 2006, Aliso, V22, P399; Hallam A., 1994, OUTLINE PHANEROZOIC; Heenan PB, 1998, NEW ZEAL J BOT, V36, P53; Hershkovitz MA, 2006, PLANT SYST EVOL, V260, P1, DOI 10.1007/s00606-006-0428-7; Hershkovitz MA, 2006, MOL PHYLOGENET EVOL, V41, P594, DOI 10.1016/j.ympev.2006.05.003; Hill K.D., 1998, FLORA AUSTR, V48, P717; Hill KD, 2003, INT J PLANT SCI, V164, P933, DOI 10.1086/378538; Hill RS, 2004, PHILOS T R SOC B, V359, P1537, DOI 10.1098/rstb.2004.1526; Hopper SD, 1999, BOT J LINN SOC, V131, P285, DOI 10.1111/j.1095-8339.1999.tb00770.x; Howarth DG, 2003, AM J BOT, V90, P915, DOI 10.3732/ajb.90.6.915; Humphries C.J., 1999, CLADISTIC BIOGEOGRAP; Irwin H. S., 1982, The American Cassiinae: a synoptical revision of Leguminosae tribe Cassieae subtribe Cassiinae in the New World.; Jones D.L., 2002, AUSTR ORCHID REV, V4, P125; Jones DL., 2002, AUSTR ORCHID REV, V67, P3; Kadereit G, 2005, ORG DIVERS EVOL, V5, P59, DOI 10.1016/j.ode.2004.07.002; Kadereit G, 2006, TAXON, V55, P617, DOI 10.2307/25065639; Klak C, 2004, NATURE, V427, P63, DOI 10.1038/nature02243; Klak C, 2003, AM J BOT, V90, P1433, DOI 10.3732/ajb.90.10.1433; Knapp M, 2005, PLOS BIOL, V3, P38, DOI 10.1371/journal.pbio.0030014; Knapp M, 2007, SYST BIOL, V56, P862, DOI 10.1080/10635150701636412; Kores PJ, 2001, AM J BOT, V88, P1903, DOI 10.2307/3558366; Kron KA, 1999, PLANT SYST EVOL, V218, P55, DOI 10.1007/BF01087034; Ladiges PY, 2007, AUST SYST BOT, V20, P383, DOI 10.1071/SB07018; Lavin M, 2005, SYST BIOL, V54, P575, DOI 10.1080/10635150590947131; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Linder HP, 2005, NOVA ACT LC, V92, P29; Linder HP, 1995, CLADISTICS, V11, P5, DOI 10.1111/j.1096-0031.1995.tb00002.x; LINDER HP, 2000, GRASS SYSTEMATIC EVO, V2; Losos JB, 2003, NATURE, V424, P542, DOI 10.1038/nature01814; Losos JB, 2008, ECOL LETT, V11, P995, DOI 10.1111/j.1461-0248.2008.01229.x; Maddison W., 2007, MESQUITE 2 MODULAR S; Manos PS, 1997, AM J BOT, V84, P1137, DOI 10.2307/2446156; Marazzi B, 2006, AM J BOT, V93, P288, DOI 10.3732/ajb.93.2.288; Mast AR, 2008, AM J BOT, V95, P843, DOI 10.3732/ajb.0700006; Mckenzie RJ, 2006, AM J BOT, V93, P1222, DOI 10.3732/ajb.93.8.1222; McLoughlin S, 2001, AUST J BOT, V49, P271, DOI 10.1071/BT00023; Meudt HM, 2006, BIOL J LINN SOC, V87, P479, DOI 10.1111/j.1095-8312.2006.00584.x; Mitchell AD, 2000, NEW ZEAL J BOT, V38, P409; Orians GH, 2007, BIOL REV, V82, P393, DOI 10.1111/j.1469-185X.2007.00017.x; ORNLAND KE, 2008, BIOESSAYS, V30, P854; Orthia LA, 2005, AUST SYST BOT, V18, P133, DOI 10.1071/SB04028; Pearman PB, 2008, TRENDS ECOL EVOL, V23, P149, DOI 10.1016/j.tree.2007.11.005; Perez F, 2006, AM J BOT, V93, P1029, DOI 10.3732/ajb.93.7.1029; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Peterson AT, 2003, Q REV BIOL, V78, P419, DOI 10.1086/378926; Plunkett GM, 2005, ANN MO BOT GARD, V92, P202; Plunkett GM, 2004, INT J PLANT SCI, V165, P861, DOI 10.1086/421855; Poole I, 1999, REV PALAEOBOT PALYNO, V107, P97, DOI 10.1016/S0034-6667(99)00013-5; Prinzing A, 2001, P ROY SOC B-BIOL SCI, V268, P2383, DOI 10.1098/rspb.2001.1801; Pye MG, 2003, AUST SYST BOT, V16, P505, DOI 10.1071/SB02019; Qian H, 2004, J ECOL, V92, P253, DOI 10.1111/j.0022-0477.2004.00868.x; Quinn CJ, 2005, AUST SYST BOT, V18, P439, DOI 10.1071/SB05005; Quinn CJ, 2003, AUST SYST BOT, V16, P581, DOI 10.1071/SB03012; RAVEN PH, 1974, ANN MO BOT GARD, V61, P539, DOI 10.2307/2395021; Reeves G, 2001, AM J BOT, V88, P2074, DOI 10.2307/3558433; Renner SS, 2000, SYST BIOL, V49, P579, DOI 10.1080/10635159950127402; Richardson JE, 2000, AM J BOT, V87, P1309, DOI 10.2307/2656724; Ricklefs RE, 2007, AM NAT, V170, pS56, DOI 10.1086/519402; Rivadavia F, 2003, AM J BOT, V90, P123, DOI 10.3732/ajb.90.1.123; Sanmartin I, 2004, SYST BIOL, V53, P216, DOI 10.1080/10635150490423430; Sauquet H, 2009, P NATL ACAD SCI USA, V106, P221, DOI 10.1073/pnas.0805607106; Schonenberger J, 2003, AM J BOT, V90, P293, DOI 10.3732/ajb.90.2.293; Schuettpelz E, 2004, AM J BOT, V91, P247, DOI 10.3732/ajb.91.2.247; Setoguchi H, 1998, AM J BOT, V85, P1507, DOI 10.2307/2446478; Silvertown J, 2006, P ROY SOC B-BIOL SCI, V273, P39, DOI 10.1098/rspb.2005.3288; SIMPSON MG, 1990, ANN MO BOT GARD, V77, P722, DOI 10.2307/2399670; Smissen RD, 2003, AUST SYST BOT, V16, P301, DOI 10.1071/SB01032; Smissen RD, 2002, BOT J LINN SOC, V140, P15, DOI 10.1046/j.1095-8339.2002.00081.x; Steane DA, 2003, MOL PHYLOGENET EVOL, V28, P47, DOI 10.1016/S1055-7903(03)00028-9; Steane DA, 2002, AUST SYST BOT, V15, P49, DOI 10.1071/SB00039; Stockey RA., 2005, MONOGRAPH CUPRESSACE, P54; Stromberg CAE, 2005, P NATL ACAD SCI USA, V102, P11980, DOI 10.1073/pnas.0505700102; Svenning JC, 2003, ECOL LETT, V6, P646, DOI 10.1046/j.1461-0248.2003.00477.x; Sweeney PW, 2004, ANN MO BOT GARD, V91, P266; SWENSON U, 1995, PLANT SYST EVOL, V197, P149, DOI 10.1007/BF00984638; Thompson Joy, 1993, Telopea, V5, P427; Thuiller W, 2005, GLOBAL CHANGE BIOL, V11, P2234, DOI 10.1111/j.1365-2486.2005.001018.x; Treutlein J, 2005, PLANT BIOLOGY, V7, P79, DOI 10.1055/s-2004-830478; Verboom GA, 2003, EVOLUTION, V57, P1008, DOI 10.1111/j.0014-3820.2003.tb00312.x; Vinnersten A, 2003, AM J BOT, V90, P1455, DOI 10.3732/ajb.90.10.1455; Wagstaff SJ, 2006, TAXON, V55, P95, DOI 10.2307/25065531; Wagstaff SJ, 1999, AM J BOT, V86, P1346, DOI 10.2307/2656781; Wagstaff SJ, 2000, SYST BOT, V25, P134, DOI 10.2307/2666679; Weston Peter H., 2006, Telopea, V11, P314; Wiens JJ, 2004, TRENDS ECOL EVOL, V19, P639, DOI 10.1016/j.tree.2004.09.011; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Wilson P.G., 1984, FLORA AUSTR, V4, P81; Wilson PG, 2005, PLANT SYST EVOL, V251, P3, DOI 10.1007/s00606-004-0162-y; Winkworth RC, 2002, MOL PHYLOGENET EVOL, V24, P180, DOI 10.1016/S1055-7903(02)00210-5; Wojciechowski MF, 2005, BRITTONIA, V57, P382, DOI 10.1663/0007-196X(2005)057[0382:AFAMPP]2.0.CO;2; Won H, 2006, SYST BIOL, V55, P610, DOI 10.1080/10635150600812619; Woodward FI, 2004, PHILOS T ROY SOC B, V359, P1465, DOI 10.1098/rstb.2004.1525; Yesson C, 2006, SYST BIOL, V55, P785, DOI 10.1080/1063515060081570; Yokoyama J, 2000, MOL PHYLOGENET EVOL, V14, P11, DOI 10.1006/mpev.1999.0672	127	496	505	5	232	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 9	2009	458	7239					754	U90		10.1038/nature07764	http://dx.doi.org/10.1038/nature07764			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433GZ	19219025				2022-12-01	WOS:000265193600039
J	Hayashi, MK; Tang, CY; Verpelli, C; Narayanan, R; Stearns, MH; Xu, RM; Li, HL; Sala, C; Hayashi, Y				Hayashi, Mariko Kato; Tang, Chunyan; Verpelli, Chiara; Narayanan, Radhakrishnan; Stearns, Marissa H.; Xu, Rui-Ming; Li, Huilin; Sala, Carlo; Hayashi, Yasunori			The Postsynaptic Density Proteins Homer and Shank Form a Polymeric Network Structure	CELL			English	Article							CRYSTAL-STRUCTURE; COMPLEX REVEALS; RAT FOREBRAIN; EVH1 DOMAIN; KINASE-II; FAMILY; RECEPTOR; SYNAPSES; BINDS; RECOGNITION	The postsynaptic density (PSD) is crucial for synaptic functions, but the molecular architecture retaining its structure and components remains elusive. Homer and Shank are among the most abundant scaffolding proteins in the PSD, working synergistically for maturation of dendritic spines. Here, we demonstrate that Homer and Shank, together, form a mesh-like matrix structure. Crystallographic analysis of this region revealed a pair of parallel dimeric coiled coils intercalated in a tail-to-tail fashion to form a tetramer, giving rise to the unique configuration of a pair of N-terminal EVH1 domains at each end of the coiled coil. In neurons, the tetramerization is required for structural integrity of the dendritic spines and recruitment of proteins to synapses. We propose that the Homer-Shank complex serves as a structural framework and as an assembly platform for other PSD proteins.	[Hayashi, Mariko Kato; Narayanan, Radhakrishnan; Stearns, Marissa H.; Hayashi, Yasunori] MIT, Dept Brain & Cognit Sci, RIKEN MIT Neurosci Res Ctr, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Hayashi, Mariko Kato; Hayashi, Yasunori] RIKEN, Brain Sci Inst, Wako, Saitama 3510198, Japan; [Tang, Chunyan; Li, Huilin] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; [Verpelli, Chiara; Sala, Carlo] Univ Milan, Consiglio Nazl Ric, Inst Neurosci, I-20129 Milan, Italy; [Verpelli, Chiara; Sala, Carlo] Univ Milan, Dept Pharmacol, I-20129 Milan, Italy; [Xu, Rui-Ming] New York Univ, Structural Biol Program, Skirball Inst Biomol Med, Helen L & Martin S Kimmel Ctr Biol & Med,Sch Med, New York, NY 10016 USA; [Xu, Rui-Ming] New York Univ, Sch Med, Dept Pharmacol, New York, NY 10016 USA	Massachusetts Institute of Technology (MIT); Northwell Health; RIKEN; RIKEN; United States Department of Energy (DOE); Brookhaven National Laboratory; Consiglio Nazionale delle Ricerche (CNR); University of Milan; University of Milan; New York University; New York University	Hayashi, MK (corresponding author), MIT, Dept Brain & Cognit Sci, RIKEN MIT Neurosci Res Ctr, Picower Inst Learning & Memory, E25-618, Cambridge, MA 02139 USA.	hayashim@mit.edu	Tang, Chunyan/E-8352-2010; Verpelli, Chiara/K-6673-2016; Hayashi, Yasunori/C-2249-2008; Hayashi, Mariko K/L-1187-2013; xu, rui/GRX-5734-2022; Hayashi, Yasunori/AAF-1408-2019; Verpelli, Chiara/AAH-1140-2020; Sala, Carlo/A-2493-2009	Verpelli, Chiara/0000-0003-2949-9725; Hayashi, Yasunori/0000-0002-7560-3004; Hayashi, Mariko K/0000-0001-8296-4599; Hayashi, Yasunori/0000-0002-7560-3004; Verpelli, Chiara/0000-0003-2949-9725; Sala, Carlo/0000-0003-0662-9523; Li, Huilin/0000-0001-8085-8928	NIH [GM68762, R01DA17310]; RIKEN; Ministry of Education, Science, and Culture of Japan; Telethon Italy [GGP06208]; Fondazione Cariplo [2006-0779/109251]; Compagnia di San Paolo [2005-1964];  [NSF-0070319]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074985, P50GM068762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017310] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); RIKEN; Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Telethon Italy(Fondazione Telethon); Fondazione Cariplo(Fondazione Cariplo); Compagnia di San Paolo(Compagnia di San Paolo); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The crystallographic data were deposited in PDB with accession number 3CVE (Homer1b) and 3CVF (Homer3a). We thank Doctors Amy E. Keating, Robert T. Sauer, Myung Jong Kim, Amanda Mower, Teiichi Furuichi, and Morgan Sheng for helpful discussion and sharing of resources, as well as Ms. Cristina Zucchi and Ms. Valentina Giannini for technical help. The Biophysical Instrumentation Facility for the Study of Complex Macromolecular Systems (supported by NSF-0070319 and NIH GM68762) at Massachusetts Institute of Technology is gratefully acknowledged. This work was supported by RIKEN; NIH grant R01DA17310; Grant-in-Aid from the Ministry of Education, Science, and Culture of Japan (Y.H.); Telethon Italy (grant number GGP06208); Fondazione Cariplo (project number 2006-0779/109251); and Compagnia di San Paolo (project number 2005-1964) (C.S.).	Baron MK, 2006, SCIENCE, V311, P531, DOI 10.1126/science.1118995; Beneken J, 2000, NEURON, V26, P143, DOI 10.1016/S0896-6273(00)81145-9; Boeckers TM, 2005, J NEUROCHEM, V92, P519, DOI 10.1111/j.1471-4159.2004.02910.x; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; Cheng DM, 2006, MOL CELL PROTEOMICS, V5, P1158, DOI 10.1074/mcp.D500009-MCP200; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Fritschy JM, 2008, TRENDS NEUROSCI, V31, P257, DOI 10.1016/j.tins.2008.02.006; Hayashi MK, 2006, J NEUROSCI, V26, P8492, DOI 10.1523/JNEUROSCI.2731-06.2006; Hayashi Y, 2005, NEURON, V46, P529, DOI 10.1016/j.neuron.2005.05.006; Im YJ, 2003, J BIOL CHEM, V278, P48099, DOI 10.1074/jbc.M306919200; Irie K, 2002, J MOL BIOL, V318, P1117, DOI 10.1016/S0022-2836(02)00170-5; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Lee SH, 2008, SCIENCE, V319, P1253, DOI 10.1126/science.1150541; Lim S, 1999, J BIOL CHEM, V274, P29510, DOI 10.1074/jbc.274.41.29510; Lu J, 2007, NEURON, V55, P874, DOI 10.1016/j.neuron.2007.06.041; Mears JA, 2007, STRUCTURE, V15, P1190, DOI 10.1016/j.str.2007.08.012; Minakami R, 2000, BIOCHEM BIOPH RES CO, V272, P466, DOI 10.1006/bbrc.2000.2777; Mio K, 2007, J MOL BIOL, V367, P373, DOI 10.1016/j.jmb.2006.12.043; Mizutani A, 2008, J NEUROSCI, V28, P5369, DOI 10.1523/JNEUROSCI.4738-07.2008; Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0; Okabe S, 2007, MOL CELL NEUROSCI, V34, P503, DOI 10.1016/j.mcn.2007.01.006; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Peng JM, 2004, J BIOL CHEM, V279, P21003, DOI 10.1074/jbc.M400103200; Petersen JD, 2003, J NEUROSCI, V23, P11270; Romorini S, 2004, J NEUROSCI, V24, P9391, DOI 10.1523/JNEUROSCI.3314-04.2004; Sala C, 2003, J NEUROSCI, V23, P6327; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Sato C, 2004, J MOL BIOL, V336, P155, DOI 10.1016/j.jmb.2003.11.024; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Shiraishi-Yamaguchi Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-206; Spacek J, 1997, J NEUROSCI, V17, P190, DOI 10.1523/JNEUROSCI.17-01-00190.1997; Sugiyama Y, 2005, NAT METHODS, V2, P677, DOI 10.1038/NMETH783; Tu JC, 1999, NEURON, V23, P583, DOI 10.1016/S0896-6273(00)80810-7; Worley PF, 2007, CELL CALCIUM, V42, P363, DOI 10.1016/j.ceca.2007.05.007; Yuan JP, 2003, CELL, V114, P777, DOI 10.1016/S0092-8674(03)00716-5	35	245	248	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 2	2009	137	1					159	171		10.1016/j.cell.2009.01.050	http://dx.doi.org/10.1016/j.cell.2009.01.050			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	427XV	19345194	Green Accepted, Green Published, Bronze			2022-12-01	WOS:000264813300022
J	Takeuchi, K; Nakano, Y; Kato, U; Kaneda, M; Aizu, M; Awano, W; Yonemura, S; Kiyonaka, S; Mori, Y; Yamamoto, D; Umeda, M				Takeuchi, Ken-ichi; Nakano, Yoshiro; Kato, Utako; Kaneda, Mizuho; Aizu, Masako; Awano, Wakae; Yonemura, Shigenobu; Kiyonaka, Shigeki; Mori, Yasuo; Yamamoto, Daisuke; Umeda, Masato			Changes in Temperature Preferences and Energy Homeostasis in Dystroglycan Mutants	SCIENCE			English	Article							DEHYDROGENASE COMPLEX; DROSOPHILA; CELLS; EXTINCTION; METABOLISM	Temperature affects the physiology, behavior, and evolution of organisms. We conducted mutagenesis and screens for mutants with altered temperature preference in Drosophila melanogaster and identified a cryophilic (cold-seeking) mutant, named atsugari (atu). Reduced expression of the Drosophila ortholog of dystroglycan (DmDG) induced tolerance to cold as well as preference for the low temperature. A sustained increase in mitochondrial oxidative metabolism caused by the reduced expression of DmDG accounted for the cryophilic phenotype of the atu mutant. Although most ectothermic animals do not use metabolically produced heat to regulate body temperature, our results indicate that their thermoregulatory behavior is closely linked to rates of mitochondrial oxidative metabolism and that a mutation in a single gene can induce a sustained change in energy homeostasis and the thermal responses.	[Takeuchi, Ken-ichi; Kato, Utako; Umeda, Masato] Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan; [Takeuchi, Ken-ichi; Kaneda, Mizuho; Aizu, Masako; Umeda, Masato] Tokyo Metropolitan Inst Med Sci, Bunkyo Ku, Tokyo 1138613, Japan; [Nakano, Yoshiro] Hyogo Coll Med, Dept Genet, Nishinomiya, Hyogo 6638501, Japan; [Awano, Wakae] Mitsubishi Kasei Inst Life Sci, Tokyo 1948511, Japan; [Yonemura, Shigenobu] RIKEN Ctr Dev Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Kiyonaka, Shigeki; Mori, Yasuo] Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Kyoto 6068501, Japan; [Yamamoto, Daisuke] Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi 9808578, Japan	Kyoto University; Tokyo Metropolitan Institute of Medical Science; Hyogo College of Medicine; RIKEN; Kyoto University; Tohoku University	Umeda, M (corresponding author), Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan.	umeda@scl.kyoto-u.ac.jp	Kiyonaka, Shigeki/AAM-7303-2021	, Daisuke/0000-0002-4623-0106	MEXT (Ministry of Education, Culture, Sports, Science and Technology), Japan [1802012]; The Novartis Foundation (Japan); The Tohoku Neuroscience Global Centers of Excellence program; Grants-in-Aid for Scientific Research [20249015] Funding Source: KAKEN	MEXT (Ministry of Education, Culture, Sports, Science and Technology), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); The Novartis Foundation (Japan); The Tohoku Neuroscience Global Centers of Excellence program; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Y. Nakano for statistical analysis; H. Suzuki and J. Ikenouchi for assistance with electron microscopy; R. Niwa, M. O'Connor, A. P. Gould, and M. Kamakura for providing GAL4 flies; N. Juni for helpful discussions; A. Yamaguchi, Y. Yamaguchi, and M. Nishikawa for technical assistance; and R. Matsuda, H. Takeshima, Y. Nagai, and M. Ui for valuable advice and encouragement. This work was supported in part by Special Coordination Funds for Promoting Science and Technology from MEXT (Ministry of Education, Culture, Sports, Science and Technology), Japan, and by a research grant from The Novartis Foundation (Japan) for the Promotion of Science. D.Y. was supported by Specially Promoted Research grant 1802012 from MEXT and The Tohoku Neuroscience Global Centers of Excellence program.	Angilletta MJ, 2002, J THERM BIOL, V27, P249, DOI 10.1016/S0306-4565(01)00094-8; Barresi R, 2006, J CELL SCI, V119, P199, DOI 10.1242/jcs.02814; BULLOCK TH, 1955, BIOL REV, V30, P311, DOI 10.1111/j.1469-185X.1955.tb01211.x; CROWLEY TJ, 1988, SCIENCE, V240, P996, DOI 10.1126/science.240.4855.996; Deng WM, 2003, DEVELOPMENT, V130, P173, DOI 10.1242/dev.00199; Gailly P, 2002, BBA-PROTEINS PROTEOM, V1600, P38, DOI 10.1016/S1570-9639(02)00442-9; Gisolfi C., 2000, HOT BRAIN SURVIVAL T; Greener MJ, 2000, FEBS LETT, V482, P13, DOI 10.1016/S0014-5793(00)02018-4; Heinrich B., 1993, HOT BLOODED INSECTS; Johnston I.A., 1996, ANIMALS TEMPERATURE; Kammenga JE, 2007, PLOS GENET, V3, P358, DOI 10.1371/journal.pgen.0030034; Kim SK, 2004, NATURE, V431, P316, DOI 10.1038/nature02897; Liu L, 2003, NAT NEUROSCI, V6, P267, DOI 10.1038/nn1009; Mahajan S, 2005, ARCH BIOCHEM BIOPHYS, V444, P139, DOI 10.1016/j.abb.2005.10.018; Mayhew PJ, 2008, P ROY SOC B-BIOL SCI, V275, P47, DOI 10.1098/rspb.2007.1302; MCCORMACK JG, 1981, BIOCHEM J, V196, P619, DOI 10.1042/bj1960619; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; Patel MS, 2006, BIOCHEM SOC T, V34, P217, DOI 10.1042/BST0340217; Steiner AA, 2002, ANNU REV PHYSIOL, V64, P263, DOI 10.1146/annurev.physiol.64.081501.155856	19	43	45	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2009	323	5922					1740	1743		10.1126/science.1165712	http://dx.doi.org/10.1126/science.1165712			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	424IG	19325118				2022-12-01	WOS:000264559800043
J	Venables, KM; Brooks, C; Linsell, L; Keegan, TJ; Langdon, T; Fletcher, T; Nieuwenhuijsen, MJ; Maconochie, NES; Doyle, P; Beral, V; Carpenter, LM				Venables, K. M.; Brooks, C.; Linsell, L.; Keegan, T. J.; Langdon, T.; Fletcher, T.; Nieuwenhuijsen, M. J.; Maconochie, N. E. S.; Doyle, P.; Beral, V.; Carpenter, L. M.			Mortality in British military participants in human experimental research into chemical warfare agents at Porton Down: cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MUSTARD-GAS INJURY; LUNG-CANCER; WORLD-WAR-1 VETERANS; EXPOSURES; NEOPLASIA	Objective To investigate any long term effects on mortality in participants in experimental research related to chemical warfare agents from 1941 to 1989. Design Historical cohort study. Data sources Archive of UK government research facility at Porton Down, UK military personnel records, and national death and cancer records. Participants 18 276 male members of the UK armed forces who had spent one or more short periods (median 4 days between first and last test) at Porton Down and a comparison group of 17 600 non-Porton Down veterans followed to 31 December 2004. Main outcome measures Mortality rate ratio of Porton Down compared with non-Porton Down veterans and standardised mortality ratio of each veteran group compared with the general population. Both ratios adjusted for age group and calendar period. Results Porton Down veterans were similar to non-Porton Down veterans in year of enlistment (median 1951) but had longer military service (median 6.2 v 5.0 years). After a median follow-up of 43 years, 40% (7306) of Porton Down and 39% (6900) of non-Porton Down veterans had died. All cause mortality was slightly greater in Porton Down veterans (rate ratio 1.06, 95% confidence interval 1.03 to 1.10, P<0.001), more so for deaths outside the UK (1.26, 1.09 to 1.46). Of 12 cause specific groups examined, rate ratios in Porton Down veterans were increased for deaths attributed to infectious and parasitic (1.57, 1.07 to 2.29), genitourinary (1.46, 1.04 to 2.04), circulatory (1.07, 1.01 to 1.12), and external (non-medical) (1.17, 1.00 to 1.37) causes and decreased for deaths attributed to in situ, benign, and unspecified neoplasms (0.60, 0.37 to 0.99). There was no clear relation between type of chemical exposure and cause specific mortality. The mortality in both groups of veterans was lower than that in the general population (standardised mortality ratio 0.88, 0.85 to 0.90; 0.82, 0.80 to 0.84). Conclusions Mortality was slightly higher in Porton Down than non-Porton Down veterans. With lack of information on other important factors, such as smoking or service overseas, it is not possible to attribute the small excess mortality to chemical exposures at Porton Down.	[Venables, K. M.; Brooks, C.; Linsell, L.; Keegan, T. J.; Langdon, T.; Carpenter, L. M.] Univ Oxford, Dept Publ Hlth, Oxford OX3 7LF, England; [Fletcher, T.] London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1, England; [Nieuwenhuijsen, M. J.] IMIM, Ctr Res Environm Epidemiol, Barcelona 08003, Spain; [Nieuwenhuijsen, M. J.] CIBERESP, Barcelona 08003, Spain; [Nieuwenhuijsen, M. J.] Univ London Imperial Coll Sci Technol & Med, Div Epidemiol Publ Hlth & Primary Care, London SW7 2AZ, England; [Maconochie, N. E. S.; Doyle, P.] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England; [Beral, V.] Univ Oxford, Canc Epidemiol Unit, Oxford OX3 7LF, England	University of Oxford; University of London; London School of Hygiene & Tropical Medicine; Institut Hospital del Mar d'Investigacions Mediques (IMIM); CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Imperial College London; University of London; London School of Hygiene & Tropical Medicine; University of Oxford	Venables, KM (corresponding author), Univ Oxford, Dept Publ Hlth, Oxford OX3 7LF, England.	kate.venables@dphpc.ox.ac.uk; lucy.carpenter@dphpc.ox.ac.uk	Fletcher, Tony/D-2394-2011; Nieuwenhuijsen, Mark J/C-3914-2017	Fletcher, Tony/0000-0003-3385-200X; Nieuwenhuijsen, Mark J/0000-0001-9461-7981; Brooks, Claire/0000-0002-3410-8971; Keegan, Thomas/0000-0003-3691-953X	MRC; Department of Public Health; Nuffield College, University of Oxford; MRC [G0200288] Funding Source: UKRI; Medical Research Council [G0200288] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Public Health; Nuffield College, University of Oxford; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding: This study was funded by the MRC with funds provided to it by the MoD. Additional funds were provided by the Department of Public Health and Nuffield College, University of Oxford. The MRC set up a liaison group to oversee the progress of the study. The MoD had no role in study design, analysis, and interpretation of data. The MoD facilitated access to its archives but had no role in deciding which data were abstracted. The MoD was sent a copy of the paper for factual comment but had no role in writing the paper or in the decision to submit for publication. The universities of Oxford and London are independent of both the MRC and the MoD.	Allender S, 2006, OCCUP MED-OXFORD, V56, P329, DOI 10.1093/occmed/kql059; Balali-Mood M, 2005, FUND CLIN PHARMACOL, V19, P713, DOI 10.1111/j.1472-8206.2005.00364.x; BEEBE GW, 1960, J NATL CANCER I, V25, P1231; Bullman T, 2000, ANN EPIDEMIOL, V10, P333, DOI 10.1016/S1047-2797(00)00060-0; CARPENTER LM, 2009, BMJ-BRIT MED J, pB655; Carter G. B., 2000, CHEM BIOL DEFENCE PO; Case RAM, 1955, BRIT J PREV SOC MED, V9, P62; Clayton D., 1993, STAT MODELS EPIDEMIO; Coleman K, 2005, HISTORY OF CHEMICAL WARFARE, P1, DOI 10.1057/9780230501836; Council N. R, 1985, POSSIBLE LONG TERM H, V3; DARBY SC, 1990, BRIT J IND MED, V47, P793; EASTON DF, 1988, BRIT J IND MED, V45, P652; EVANS R, 2000, GASSED; HARRIS R, 1982, HIGHER FORM KILLING; Inskip H, 1997, OCCUP ENVIRON MED, V54, P209, DOI 10.1136/oem.54.3.209; International Agency for Research on Cancer, IARC MON EV CARC RIS; Keegan TJ, 2007, ANN OCCUP HYG, V51, P441, DOI 10.1093/annhyg/mem017; Keegan TJ, 2009, ANN OCCUP HYG, V53, P83, DOI 10.1093/annhyg/men040; MANTEL N, 1959, J NATL CANCER I, V22, P719; Ministry of Defence, 2006, HIST SURV PORT SERV; *NAT RES COUNC, 1982, POSS LONG TERM EFF S, V1; *NAT RES COUNC, 1982, POSS LONG TERM EFF S, V2; NORMAN JE, 1975, JNCI-J NATL CANCER I, V54, P311, DOI 10.1093/jnci/54.2.311; Pechura C., 1993, VETERANS RISK HLTH E; WADA S, 1968, LANCET, V1, P1161	25	4	4	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 24	2009	338								b613	10.1136/bmj.b613	http://dx.doi.org/10.1136/bmj.b613			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	425LP	19318699	hybrid, Green Published, Green Submitted, Green Accepted			2022-12-01	WOS:000264639500009
J	Okuda, S; Tsutsui, H; Shiina, K; Sprunck, S; Takeuchi, H; Yui, R; Kasahara, RD; Hamamura, Y; Mizukami, A; Susaki, D; Kawano, N; Sakakibara, T; Namiki, S; Itoh, K; Otsuka, K; Matsuzaki, M; Nozaki, H; Kuroiwa, T; Nakano, A; Kanaoka, MM; Dresselhaus, T; Sasaki, N; Higashiyama, T				Okuda, Satohiro; Tsutsui, Hiroki; Shiina, Keiko; Sprunck, Stefanie; Takeuchi, Hidenori; Yui, Ryoko; Kasahara, Ryushiro D.; Hamamura, Yuki; Mizukami, Akane; Susaki, Daichi; Kawano, Nao; Sakakibara, Takashi; Namiki, Shoko; Itoh, Kie; Otsuka, Kurataka; Matsuzaki, Motomichi; Nozaki, Hisayoshi; Kuroiwa, Tsuneyoshi; Nakano, Akihiko; Kanaoka, Masahiro M.; Dresselhaus, Thomas; Sasaki, Narie; Higashiyama, Tetsuya			Defensin-like polypeptide LUREs are pollen tube attractants secreted from synergid cells	NATURE			English	Article							TORENIA-FOURNIERI; FEMALE GAMETOPHYTE; ANTIMICROBIAL PEPTIDES; DOUBLE FERTILIZATION; EMBRYO SAC; IN-VITRO; GUIDANCE; ARABIDOPSIS; GENES; PROTEIN	For more than 140 years, pollen tube guidance in flowering plants has been thought to be mediated by chemoattractants derived from target ovules(1). However, there has been no convincing evidence of any particular molecule being the true attractant that actually controls the navigation of pollen tubes towards ovules. Emerging data indicate that two synergid cells on the side of the egg cell emit a diffusible, species-specific signal to attract the pollen tube at the last step of pollen tube guidance(1-3). Here we report that secreted, cysteine-rich polypeptides (CRPs) in a subgroup of defensin-like proteins are attractants derived from the synergid cells. We isolated synergid cells of Torenia fournieri, a unique plant with a protruding embryo sac, to identify transcripts encoding secreted proteins as candidate molecules for the chemoattractant(s). We found two CRPs, abundantly and predominantly expressed in the synergid cell, which are secreted to the surface of the egg apparatus. Moreover, they showed activity in vitro to attract competent pollen tubes of their own species and were named as LUREs. Injection of morpholino antisense oligomers against the LUREs impaired pollen tube attraction, supporting the finding that LUREs are the attractants derived from the synergid cells of T. fournieri.	[Okuda, Satohiro; Tsutsui, Hiroki; Shiina, Keiko; Takeuchi, Hidenori; Yui, Ryoko; Kasahara, Ryushiro D.; Hamamura, Yuki; Mizukami, Akane; Susaki, Daichi; Kawano, Nao; Sakakibara, Takashi; Namiki, Shoko; Kanaoka, Masahiro M.; Sasaki, Narie; Higashiyama, Tetsuya] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Aichi 4648602, Japan; [Sprunck, Stefanie; Dresselhaus, Thomas] Univ Regensburg, D-93053 Regensburg, Germany; [Itoh, Kie] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Chiba 2778562, Japan; [Otsuka, Kurataka; Matsuzaki, Motomichi; Nozaki, Hisayoshi; Nakano, Akihiko] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Kuroiwa, Tsuneyoshi] Rikkyo St Pauls Univ, Grad Sch Sci, Res Informat Ctr Extremophile, Tokyo 1718501, Japan; [Nakano, Akihiko] RIKEN, Adv Sci Inst, Mol Membrane Biol Lab, Wako, Saitama 3510198, Japan	Nagoya University; University of Regensburg; University of Tokyo; University of Tokyo; Rikkyo University; RIKEN	Higashiyama, T (corresponding author), Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Furo Cho, Aichi 4648602, Japan.	higashi@bio.nagoya-u.ac.jp	Takeuchi, Hidenori/AFG-8500-2022; Nakano, Akihiko/G-4942-2014; Tsutsui, Hiroki/ABC-1564-2021; Nakano, Akihiko/C-6185-2009; NOZAKI, HISAYOSHI/G-4926-2014; Matsuzaki, Motomichi/D-4043-2016; KANAOKA, Masahiro/I-7192-2014; Higashiyama, Tetsuya/C-2882-2012; Nakano, Akihiko/A-6420-2016	Takeuchi, Hidenori/0000-0002-0719-3736; Nakano, Akihiko/0000-0003-3635-548X; Tsutsui, Hiroki/0000-0001-5710-3367; Matsuzaki, Motomichi/0000-0001-5811-798X; KANAOKA, Masahiro/0000-0003-4913-6278; Higashiyama, Tetsuya/0000-0002-7346-360X; Nakano, Akihiko/0000-0003-3635-548X; Susaki, Daichi/0000-0002-9465-9222; Nozaki, Hisayoshi/0000-0002-9308-4498	Grant-in-Aid for Young Scientists (Start-up); Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan [20870020]; Creative Scientific Research, MEXT, Japan [18GS0314-01]; Yamada Science Foundation, Japan; Grant-in-Aid for Scientific Research (B), MEXT, Japan [19370017]; Grant-in-Aid for Scientific Research on Priority Areas [18075004]; PRESTO project; Japan Science and Technology Agency, Japan	Grant-in-Aid for Young Scientists (Start-up)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Creative Scientific Research, MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Yamada Science Foundation, Japan; Grant-in-Aid for Scientific Research (B), MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grant-in-Aid for Scientific Research on Priority Areas(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); PRESTO project; Japan Science and Technology Agency, Japan(Japan Science & Technology Agency (JST))	We thank T. Suzuki for help with the analysis of the EST sequences, S. Takayama for providing chemically synthesized and refolded SP11 peptides, W. Uchida for checking the diameter of the glass needles for microinjection by scanning electron microscopy and N. Iwata for assistance in preparing plant materials. This work was supported in part by a Grant-in-Aid for Young Scientists (Start-up), Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan (20870020 to M. M. K.); a Grant-in-Aid for Creative Scientific Research, MEXT, Japan (18GS0314-01 to N. S.); a grant from Yamada Science Foundation, Japan (to T. H.); a Grant-in-Aid for Scientific Research (B), MEXT, Japan (19370017 to T. H.); a Grant-in-Aid for Scientific Research on Priority Areas (18075004 to T. H.), and PRESTO project, Japan Science and Technology Agency, Japan (to T. H.).	Berger F, 2008, TRENDS PLANT SCI, V13, P437, DOI 10.1016/j.tplants.2008.05.011; Cheung AY, 2001, SCIENCE, V293, P1441, DOI 10.1126/science.1065051; Cordts S, 2001, PLANT J, V25, P103, DOI 10.1046/j.0960-7412.2000.00944.x; CORNET B, 1995, STRUCTURE, V3, P435, DOI 10.1016/S0969-2126(01)00177-0; Doughty J, 1998, PLANT CELL, V10, P1333, DOI 10.1105/tpc.10.8.1333; Escobar-Restrepo JM, 2007, SCIENCE, V317, P656, DOI 10.1126/science.1143562; Han YZ, 2000, PLANTA, V211, P158, DOI 10.1007/s004250000289; Higashiyama T, 2001, SCIENCE, V293, P1480, DOI 10.1126/science.1062429; Higashiyama T, 1998, PLANT CELL, V10, P2019, DOI 10.1105/tpc.10.12.2019; Higashiyama T, 2002, J PLANT RES, V115, P149, DOI 10.1007/s102650200020; Higashiyama T, 2008, SEX PLANT REPROD, V21, P17, DOI 10.1007/s00497-007-0064-6; Higashiyama T, 2006, PLANT CELL MONOGR, V3, P265, DOI 10.1007/7089_053; Higashiyama T, 2006, PLANT PHYSIOL, V142, P481, DOI 10.1104/pp.106.083832; Imre K, 1999, SEX PLANT REPROD, V12, P152, DOI 10.1007/s004970050186; Ingouff M, 2007, CURR BIOL, V17, P1032, DOI 10.1016/j.cub.2007.05.019; Jones-Rhoades MW, 2007, PLOS GENET, V3, P1848, DOI 10.1371/journal.pgen.0030171; Karkare S, 2006, APPL MICROBIOL BIOT, V71, P575, DOI 10.1007/s00253-006-0434-2; Kasahara RD, 2005, PLANT CELL, V17, P2981, DOI 10.1105/tpc.105.034603; Kim S, 2003, P NATL ACAD SCI USA, V100, P16125, DOI 10.1073/pnas.2533800100; Marton ML, 2008, SEX PLANT REPROD, V21, P37, DOI 10.1007/s00497-007-0062-8; Marton ML, 2005, SCIENCE, V307, P573, DOI 10.1126/science.1104954; Palanivelu R, 2003, CELL, V114, P47, DOI 10.1016/S0092-8674(03)00479-3; Park SY, 2000, PLANT CELL, V12, P151, DOI 10.1105/tpc.12.1.151; Punwani JA, 2008, SEX PLANT REPROD, V21, P7, DOI 10.1007/s00497-007-0059-3; Punwani JA, 2007, PLANT CELL, V19, P2557, DOI 10.1105/tpc.107.052076; Silverstein KAT, 2005, PLANT PHYSIOL, V138, P600, DOI 10.1104/pp.105.060079; Silverstein KAT, 2007, PLANT J, V51, P262, DOI 10.1111/j.1365-313X.2007.03136.x; Sprunck S, 2005, PLANT J, V41, P660, DOI 10.1111/j.1365-313X.2005.02332.x; Takayama S, 2001, NATURE, V413, P534, DOI 10.1038/35097104; Wolters-Arts M, 1998, NATURE, V392, P818, DOI 10.1038/33929; Yang HP, 2006, PLANTA, V224, P1004, DOI 10.1007/s00425-006-0283-3; Yount NY, 2004, P NATL ACAD SCI USA, V101, P7363, DOI 10.1073/pnas.0401567101	32	429	456	4	148	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 19	2009	458	7236					357	U122		10.1038/nature07882	http://dx.doi.org/10.1038/nature07882			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420JH	19295610				2022-12-01	WOS:000264285600045
J	Han, JH; Kushner, SA; Yiu, AP; Hsiang, HL; Buch, T; Waisman, A; Bontempi, B; Neve, RL; Frankland, PW; Josselyn, SA				Han, Jin-Hee; Kushner, Steven A.; Yiu, Adelaide P.; Hsiang, Hwa-Lin (Liz); Buch, Thorsten; Waisman, Ari; Bontempi, Bruno; Neve, Rachael L.; Frankland, Paul W.; Josselyn, Sheena A.			Selective Erasure of a Fear Memory	SCIENCE			English	Article							BINDING PROTEIN OVEREXPRESSION; DIPHTHERIA-TOXIN; CONDITIONED FEAR; AMYGDALA; EXPRESSION; RECONSOLIDATION; HIPPOCAMPUS; RETRIEVAL; CIRCUITS; NEURONS	Memories are thought to be encoded by sparsely distributed groups of neurons. However, identifying the precise neurons supporting a given memory (the memory trace) has been a long-standing challenge. We have shown previously that lateral amygdala (LA) neurons with increased cyclic adenosine monophosphate response element-binding protein (CREB) are preferentially activated by fear memory expression, which suggests that they are selectively recruited into the memory trace. We used an inducible diphtheria-toxin strategy to specifically ablate these neurons. Selectively deleting neurons overexpressing CREB (but not a similar portion of random LA neurons) after learning blocked expression of that fear memory. The resulting memory loss was robust and persistent, which suggests that the memory was permanently erased. These results establish a causal link between a specific neuronal subpopulation and memory expression, thereby identifying critical neurons within the memory trace.	[Han, Jin-Hee; Kushner, Steven A.; Yiu, Adelaide P.; Hsiang, Hwa-Lin (Liz); Frankland, Paul W.; Josselyn, Sheena A.] Hosp Sick Children, Program Neurosci & Mental Hlth, Toronto, ON M5G 1X8, Canada; [Han, Jin-Hee; Yiu, Adelaide P.; Hsiang, Hwa-Lin (Liz); Frankland, Paul W.; Josselyn, Sheena A.] Univ Toronto, Inst Med Sci, Toronto, ON M5G 1X8, Canada; [Han, Jin-Hee; Frankland, Paul W.; Josselyn, Sheena A.] Univ Toronto, Dept Physiol, Toronto, ON M5G 1X8, Canada; [Kushner, Steven A.] Erasmus Univ, Med Ctr, Dept Psychiat, NL-3015 CE Rotterdam, Netherlands; [Buch, Thorsten] Univ Zurich, Dept Pathol, CH-8057 Zurich, Switzerland; [Waisman, Ari] Johannes Gutenberg Univ Mainz, Med Klin & Poliklin 1, D-55131 Mainz, Germany; [Bontempi, Bruno] CNRS, UMR 5228, Ctr Neurosci Integrat & Cognit, F-33405 Talence, France; [Bontempi, Bruno] Univ Bordeaux 1, F-33405 Talence, France; [Neve, Rachael L.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; Erasmus University Rotterdam; Erasmus MC; University of Zurich; Johannes Gutenberg University of Mainz; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Massachusetts Institute of Technology (MIT)	Josselyn, SA (corresponding author), Hosp Sick Children, Program Neurosci & Mental Hlth, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	sheena.josselyn@sickkids.ca	Waisman, Ari/C-7383-2015; Buch, Thorsten/P-1659-2019; Han, Jin-Hee/C-2069-2011	Waisman, Ari/0000-0003-4304-8234; Buch, Thorsten/0000-0002-2236-9074; Kushner, Steven/0000-0002-9777-3338; Han, Jin-Hee/0000-0002-2139-5596	Canadian Institutes of Health Research [MOP74650, MOP77561]; EJLB Foundation; National Alliance for Research on Schizophrenia and Depression [fellowship]; France-Canada Research Foundation [travel fellowship]; Agence Nationale de la Recherche (France) [06-NEURO-027-03]; Hospital for Sick Children [Restracomp Fellowships]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); EJLB Foundation; National Alliance for Research on Schizophrenia and Depression(NARSAD); France-Canada Research Foundation; Agence Nationale de la Recherche (France)(French National Research Agency (ANR)); Hospital for Sick Children(University of Toronto)	We thank T. Pekar, J. Park, and J. Guo for technical assistance. Supported by Canadian Institutes of Health Research (MOP74650, MOP77561) and EJLB Foundation grants to S.A.J. and P.W.F., National Alliance for Research on Schizophrenia and Depression fellowship to J.H.H., travel fellowship (France-Canada Research Foundation), Agence Nationale de la Recherche (France) grant (06-NEURO-027-03) to B.B., and Restracomp Fellowships from the Hospital for Sick Children to A.P.Y. and J.H.H.	BERGER TW, 1983, J NEUROPHYSIOL, V50, P1197, DOI 10.1152/jn.1983.50.5.1197; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.neuro.15.1.353; DORLAND RB, 1979, J BIOL CHEM, V254, P1337; Dudai Y, 2004, NEURON, V44, P93, DOI 10.1016/j.neuron.2004.09.003; Fanselow MS, 2003, ANN NY ACAD SCI, V985, P125; Guzowski JF, 2005, CURR OPIN NEUROBIOL, V15, P599, DOI 10.1016/j.conb.2005.08.018; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Hall J, 2001, J NEUROSCI, V21, P2186, DOI 10.1523/JNEUROSCI.21-06-02186.2001; Han JH, 2008, LEARN MEMORY, V15, P443, DOI 10.1101/lm.993608; Han JH, 2007, SCIENCE, V316, P457, DOI [10.1126/science.1139438, 10.1126/science.1134697]; Jasnow AM, 2005, BEHAV NEUROSCI, V119, P1125, DOI 10.1037/0735-7044.119.4.1125; Josselyn SA, 2001, J NEUROSCI, V21, P2404, DOI 10.1523/JNEUROSCI.21-07-02404.2001; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Levine ES, 1997, ANN NY ACAD SCI, V835, P12, DOI 10.1111/j.1749-6632.1997.tb48614.x; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; NAGLICH JG, 1990, P NATL ACAD SCI USA, V87, P7250, DOI 10.1073/pnas.87.18.7250; Pare D, 2004, J NEUROPHYSIOL, V92, P1, DOI 10.1152/jn.00153.2004; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; QUIRK GJ, 1995, NEURON, V15, P1029, DOI 10.1016/0896-6273(95)90092-6; Reijmers LG, 2007, SCIENCE, V317, P1230, DOI 10.1126/science.1143839; Roediger H. L., 2007, SCI MEMORY CONCEPTS; Saraste A, 2000, CARDIOVASC RES, V45, P528, DOI 10.1016/S0008-6363(99)00384-3; Wallace TL, 2004, BIOL PSYCHIAT, V56, P151, DOI 10.1016/j.biopsych.2004.04.010	26	370	377	1	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2009	323	5920					1492	1496		10.1126/science.1164139	http://dx.doi.org/10.1126/science.1164139			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417TP	19286560				2022-12-01	WOS:000264101700045
J	Shen, GJ; Gao, X; Gao, B; Granger, DE				Shen, Guanjun; Gao, Xing; Gao, Bin; Granger, Darryl E.			Age of Zhoukoudian Homo erectus determined with Al-26/Be-10 burial dating	NATURE			English	Article							MIDDLE PLEISTOCENE; CHINA; SITE; CALIBRATION; LOCALITY-1; CHRONOLOGY; LOESS	The age of Zhoukoudian Homo erectus, commonly known as 'Peking Man', has long been pursued, but has remained problematic owing to the lack of suitable dating methods(1-7). Here we report cosmogenic Al-26/Be-10 burial dating of quartz sediments and artefacts from the lower strata of Locality 1 in the southwestern suburb of Beijing, China, where early representatives of Zhoukoudian Homo erectus were discovered. This study marks the first radioisotopic dating of any early hominin site in China beyond the range of mass spectrometric U-series dating. The weighted mean of six meaningful age measurements, 0.77 +/- 0.08 million years (Myr, mean +/- s.e.m.), provides the best age estimate for lower cultural layers 7-10. Together with previously reported U-series dating of speleothem calcite(3) and palaeomagnetic stratigraphy(4), as well as sedimentological considerations(8,9), these layers may be further correlated to S6-S7 in Chinese loess stratigraphy or marine isotope stages (MIS) 17-19, in the range of similar to 0.68 to 0.78 Myr ago. These ages are substantially older than previously supposed and may imply early hominin's presence at the site in northern China through a relatively mild glacial period corresponding to MIS 18.	[Shen, Guanjun; Gao, Bin] Nanjing Normal Univ, Coll Geog Sci, Nanjing 210046, Jiangsu, Peoples R China; [Gao, Xing] Acad Sinica, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China; [Granger, Darryl E.] Purdue Univ, Dept Earth & Atmospher Sci, W Lafayette, IN 47907 USA	Nanjing Normal University; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Shen, GJ (corresponding author), Nanjing Normal Univ, Coll Geog Sci, Nanjing 210046, Jiangsu, Peoples R China.	gjshen@njnu.edu.cn; dgranger@purdue.edu			National Natural Science Foundation of China; Wenner-Gren Foundation; NSF	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Wenner-Gren Foundation; NSF(National Science Foundation (NSF))	This project was jointly supported by the National Natural Science Foundation of China and Wenner-Gren Foundation. Accelerator mass spectrometer 26 Al and 10 Be measurements were supported by an NSF facility grant to PRIME Lab. We thank Zhoukoudian Site Museum for assistance in sample collection, L. Zhou, T.-	Aigner J. S., 1986, ANTHROPOS, V23, P157; Carbonell E, 2008, NATURE, V452, P465, DOI 10.1038/nature06815; CLARK JD, 1994, SCIENCE, V264, P1907, DOI 10.1126/science.8009220; Dong W., 2000, ACTA ANTHR SINICA, V19, P246; Gaboardi M, 2005, QUATERNARY RES, V63, P329, DOI 10.1016/j.yqres.2005.02.006; Goldberg P, 2001, J HUM EVOL, V41, P483, DOI 10.1006/jhev.2001.0498; Granger DE, 2006, GEOL SOC AM SPEC PAP, V415, P1, DOI 10.1130/2006.2415(01); Granger DE, 2001, EARTH PLANET SC LETT, V188, P269, DOI 10.1016/S0012-821X(01)00309-0; Grun R, 1997, J HUM EVOL, V32, P83; GUO SL, 1991, ACTA ANTHR SINICA, V10, P73; LIU ZC, 1985, QUATERNARY RES, V23, P139; Ludwig KR, 2000, EVOL ANTHROPOL, V9, P101, DOI 10.1002/(SICI)1520-6505(2000)9:2<101::AID-EVAN4>3.3.CO;2-N; Nishiizumi K, 2007, NUCL INSTRUM METH B, V258, P403, DOI 10.1016/j.nimb.2007.01.297; Partridge TC, 2003, SCIENCE, V300, P607, DOI 10.1126/science.1081651; Pike AWG, 2003, REV MINERAL GEOCHEM, V52, P607, DOI 10.2113/0520607; QIAN F, 1985, MULTIDISCIPLINARY ST, P251; Richards DA, 2003, REV MINERAL GEOCHEM, V52, P407, DOI 10.2113/0520407; Rightmire GP, 1998, EVOL ANTHROPOL, V6, P218, DOI 10.1002/(SICI)1520-6505(1998)6:6<218::AID-EVAN4>3.0.CO;2-6; SHACKLETON NJ, 1990, T ROY SOC EDIN-EARTH, V81, P251, DOI 10.1017/S0263593300020782; Shen GJ, 2004, QUATERNARY RES, V62, P208, DOI 10.1016/j.yqres.2004.06.004; Shen GJ, 2001, J HUM EVOL, V41, P679, DOI 10.1006/jhev.2001.0516; Stone JO, 2000, J GEOPHYS RES-SOL EA, V105, P23753, DOI 10.1029/2000JB900181; Wu, 1990, ACTA ANTHR SINICA, V9, P312; Wu R., 1985, MULTIDISCIPLINARY ST; YANG Z, 1985, MULTIDISCIPLINARY ST, P1; Yuan S., 1991, ACTA ANTHROPOL SIN, V10, P189; Zhao JX, 2001, GEOLOGY, V29, P27, DOI 10.1130/0091-7613(2001)029<0027:TIMSUS>2.0.CO;2; Zhao S.S., 1985, MULTIDISCIPLINARY ST, P239; Zhou C, 2000, J ARCHAEOL SCI, V27, P101, DOI 10.1006/jasc.1999.0428; Zhou LP, 1999, EARTH PLANET SC LETT, V168, P117, DOI 10.1016/S0012-821X(99)00052-7	30	148	191	4	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 12	2009	458	7235					198	200		10.1038/nature07741	http://dx.doi.org/10.1038/nature07741			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	417EQ	19279636				2022-12-01	WOS:000264059700042
J	Roehr, B				Roehr, Bob			Should men who have ever had sex with men be allowed to give blood? Yes	BRITISH MEDICAL JOURNAL			English	Editorial Material							TRANSFUSION					bobroehr@aol.com						Brooks JP, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b318; Germain M, 2003, TRANSFUSION, V43, P25, DOI 10.1046/j.1537-2995.2003.00281.x; Hladik W, 2006, NEW ENGL J MED, V355, P1331, DOI 10.1056/NEJMoa055009; Hurley R, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b779; Lebbe Celeste, 2008, Transplant Rev (Orlando), V22, P252, DOI 10.1016/j.trre.2008.05.004; Moore R J, 1991, Transfus Med, V1, P201, DOI 10.1111/j.1365-3148.1991.tb00034.x; O'Brien SF, 2007, TRANSFUSION, V47, P316, DOI 10.1111/j.1537-2995.2007.01108.x; Schrimshaw EW, 2006, ARCH SEX BEHAV, V35, P225, DOI 10.1007/s10508-005-9006-2; VAMVAKAS EC, 2009, BLOOD           0202; Weber B, 2006, EXPERT REV MOL DIAGN, V6, P399, DOI 10.1586/14737159.6.3.399	10	12	12	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 26	2009	338								b311	10.1136/bmj.b311	http://dx.doi.org/10.1136/bmj.b311			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	417DS	19246548				2022-12-01	WOS:000264056300006
J	Strangfeld, A; Listing, J; Herzer, P; Liebhaber, A; Rockwitz, K; Richter, C; Zink, A				Strangfeld, Anja; Listing, Joachim; Herzer, Peter; Liebhaber, Anke; Rockwitz, Karin; Richter, Constanze; Zink, Angela			Risk of Herpes Zoster in Patients With Rheumatoid Arthritis Treated With Anti-TNF-alpha Agents	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TUMOR-NECROSIS-FACTOR; POSTHERPETIC NEURALGIA; MONOCLONAL-ANTIBODY; INFECTIONS; THERAPY; EPIDEMIOLOGY; METHOTREXATE; ETANERCEPT; INFLIXIMAB; ADALIMUMAB	Context The risk of bacterial infection is increased in patients treated with drugs that inhibit tumor necrosis factor alpha ( TNF- alpha). Little is known about the reactivation of latent viral infections during treatment with TNF- alpha inhibitors. Objective To investigate whether TNF- alpha inhibitors together as a class, or separately as either monoclonal anti-TNF-alpha antibodies (adalimumab, infliximab) or a fusion protein ( etanercept), are related to higher rates of herpes zoster in patients with rheumatoid arthritis. Design, Setting, and Patients Patients were enrolled in the German biologics register RABBIT, a prospective cohort, between May 2001 and December 2006 at the initiation of treatment with infliximab, etanercept, adalimumab, or anakinra, or when they changed conventional disease- modifying antirheumatic drug ( DMARD). Treatment, clinical status, and adverse events were assessed by rheumatologists at fixed points during follow- up. Main Outcome Measures Hazard ratio ( HR) of herpes zoster episodes following anti - TNF- alpha treatment. Study aims were to detect a clinically significant difference ( HR, 2.0) between TNF- alpha inhibitors as a class compared with DMARDs and to detect an HR of at least 2.5 for each of 2 types of TNF- alpha inhibitors, the monoclonal antibodies or the fusion protein, compared with conventional DMARDs. Results Among 5040 patients receiving TNF- alpha inhibitors or conventional DMARDs, 86 episodes of herpes zoster occurred in 82 patients. Thirty- nine occurrences could be attributed to treatment with anti - TNF- alpha antibodies, 23 to etanercept, and 24 to conventional DMARDs. The crude incidence rate per 1000 patient- years was 11.1 ( 95% confidence interval [ CI], 7.9- 15.1) for the monoclonal antibodies, 8.9 ( 95% CI, 5.6-13.3) for etanercept, and 5.6 ( 95% CI, 3.6- 8.3) for conventional DMARDs. Adjusted for age, rheumatoid arthritis severity, and glucocorticoid use, a significantly increased risk was observed for treatment with the monoclonal antibodies ( HR, 1.82 [ 95% CI, 1.05- 3.15]), although this risk was lower than the threshold for clinical significance. No significant associations were found for etanercept use ( HR, 1.36 [ 95% CI, 0.73-2.55]) or for anti - TNF- alpha treatment ( HR, 1.63 [ 95% CI, 0.97- 2.74]) as a class. Conclusion Treatment with monoclonal anti - TNF- alpha antibodies may be associated with increased risk of herpes zoster, but this requires further study.	[Strangfeld, Anja; Listing, Joachim; Zink, Angela] German Rheumatism Res Ctr, Epidemiol Unit, D-10117 Berlin, Germany; [Zink, Angela] Charite, Dept Rheumatol & Clin Immunol, D-13353 Berlin, Germany	Deutsches Rheuma-Forschungszentrum (DRFZ); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Strangfeld, A (corresponding author), German Rheumatism Res Ctr, Epidemiol Unit, Charitepl 1, D-10117 Berlin, Germany.	strangfeld@drfz.de						ANDERSEN PK, 1982, ANN STAT, V10, P1100, DOI 10.1214/aos/1176345976; Arvin AM, 1996, CLIN MICROBIOL REV, V9, P361, DOI 10.1128/CMR.9.3.361; Askling J, 2007, ANN RHEUM DIS, V66, P1339, DOI 10.1136/ard.2006.062760; Bongartz T, 2006, JAMA-J AM MED ASSOC, V295, P2275, DOI 10.1001/jama.295.19.2275; Curtis JR, 2007, ARTHRITIS RHEUM-US, V56, P1125, DOI 10.1002/art.22504; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Dixon WG, 2007, ARTHRITIS RHEUM, V56, P2896, DOI 10.1002/art.22808; Furst DE, 2003, J RHEUMATOL, V30, P2563; GLYNN C, 1990, J ROY SOC MED, V83, P617, DOI 10.1177/014107689008301007; Gupta G, 2006, CLIN GASTROENTEROL H, V4, P1483, DOI 10.1016/j.cgh.2006.09.019; *INT C HARM, CLIN SAF DAT MAN DEF; Kengsakul Kitisak, 2002, J Med Assoc Thai, V85, P131; Keystone EC, 2004, ARTHRITIS RHEUM, V50, P1400, DOI 10.1002/art.20217; Kost RG, 1996, NEW ENGL J MED, V335, P32, DOI 10.1056/NEJM199607043350107; Lautenschlager J, 1997, Z RHEUMATOL, V56, P144, DOI 10.1007/s003930050030; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Lipsky PE, 2000, NEW ENGL J MED, V343, P1594, DOI 10.1056/NEJM200011303432202; Listing J, 2005, ARTHRITIS RHEUM-US, V52, P3403, DOI 10.1002/art.21386; Listing J, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1933; LOCKSLEY RM, 1985, J INFECT DIS, V152, P1172, DOI 10.1093/infdis/152.6.1172; Maini RN, 2004, ARTHRITIS RHEUM-US, V50, P1051, DOI 10.1002/art.20159; Moreland LW, 2006, J RHEUMATOL, V33, P854; Oxman MN, 2005, NEW ENGL J MED, V352, P2271, DOI 10.1056/NEJMoa051016; Pham Thao, 2005, Joint Bone Spine, V72 Suppl 1, pS1; Pope JE, 2004, J RHEUMATOL, V31, P274; Schrauder A, 2007, LANCET, V369, P1232, DOI 10.1016/S0140-6736(07)60567-4; Smitten AL, 2007, ARTHRIT RHEUM-ARTHR, V57, P1431, DOI 10.1002/art.23112; Strangfeld A, 2006, BEST PRACT RES CL RH, V20, P1181, DOI 10.1016/j.berh.2006.08.010; The British Society for Rheumatology, 2002, VACC IMM PERS GUID P; THEMEAU TM, 2000, MODELLING SURVIVAL D; Thomas SL, 2004, LANCET INFECT DIS, V4, P26, DOI 10.1016/S1473-3099(03)00857-0; VEENSTRA J, 1995, AIDS, V9, P1153, DOI 10.1097/00002030-199510000-00006; Wallis RS, 2004, CLIN INFECT DIS, V39, P1254, DOI 10.1086/424455; Wallis RS, 2005, SEMIN ARTHRITIS RHEU, V34, P34, DOI 10.1016/j.semarthrit.2005.01.009; Wallis RS, 2004, CLIN INFECT DIS, V38, P1261, DOI 10.1086/383317; Wolfe F, 2006, RHEUMATOLOGY, V45, P1370, DOI 10.1093/rheumatology/kel328; Woodworth TG, 2001, J RHEUMATOL, V28, P1163; Zink A, 2005, ANN RHEUM DIS, V64, P1274, DOI 10.1136/ard.2004.031476	38	397	414	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 18	2009	301	7					737	744		10.1001/jama.2009.146	http://dx.doi.org/10.1001/jama.2009.146			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	407MX	19224750	Bronze			2022-12-01	WOS:000263370100016
J	Bezier, A; Annaheim, M; Herbiniere, J; Wetterwald, C; Gyapay, G; Bernard-Samain, S; Wincker, P; Roditi, I; Heller, M; Belghazi, M; Pfister-Wilhem, R; Periquet, G; Dupuy, C; Huguet, E; Volkoff, AN; Lanzrein, B; Drezen, JM				Bezier, Annie; Annaheim, Marc; Herbiniere, Juline; Wetterwald, Christoph; Gyapay, Gabor; Bernard-Samain, Sylvie; Wincker, Patrick; Roditi, Isabel; Heller, Manfred; Belghazi, Maya; Pfister-Wilhem, Rita; Periquet, Georges; Dupuy, Catherine; Huguet, Elisabeth; Volkoff, Anne-Nathalie; Lanzrein, Beatrice; Drezen, Jean-Michel			Polydnaviruses of Braconid Wasps Derive from an Ancestral Nudivirus	SCIENCE			English	Article							GENOME SEQUENCE; CHELONUS-INANITUS; VIRUS; DNA; EVOLUTION; REPLICATION; GENES; SYMBIOSIS; INSIGHTS; REVEALS	Many species of parasitoid wasps inject polydnavirus particles in order to manipulate host defenses and development. Because the DNA packaged in these particles encodes almost no viral structural proteins, their relation to viruses has been debated. Characterization of complementary DNAs derived from braconid wasp ovaries identified genes encoding subunits of a viral RNA polymerase and structural components of polydnavirus particles related most closely to those of nudiviruses- a sister group of baculoviruses. The conservation of this viral machinery in different braconid wasp lineages sharing polydnaviruses suggests that parasitoid wasps incorporated a nudivirus- related genome into their own genetic material. We found that the nudiviral genes themselves are no longer packaged but are actively transcribed and produce particles used to deliver genes essential for successful parasitism in lepidopteran hosts.	[Bezier, Annie; Herbiniere, Juline; Periquet, Georges; Dupuy, Catherine; Huguet, Elisabeth; Drezen, Jean-Michel] Univ Tours, Inst Rech Biol Insecte, CNRS, UMR 6035, F-37200 Tours, France; [Annaheim, Marc; Wetterwald, Christoph; Roditi, Isabel; Pfister-Wilhem, Rita; Lanzrein, Beatrice] Univ Bern, Inst Cell Biol, CH-3012 Bern, Switzerland; [Heller, Manfred] Univ Bern, Dept Clin Res, CH-3010 Bern, Switzerland; [Gyapay, Gabor; Bernard-Samain, Sylvie; Wincker, Patrick] Genoscope Ctr Natl Sequencage, CEA, F-91057 Evry, France; [Belghazi, Maya] Ctr Anal Proteom Marseille, Inst Federatif Rech J Roche IFR11, INSERM, Fac Med, F-13916 Marseille 20, France; [Volkoff, Anne-Nathalie] Univ Montpellier 2, INRA, UMR 1231, F-34095 Montpellier 5, France	Centre National de la Recherche Scientifique (CNRS); Universite de Tours; University of Bern; University of Bern; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Franche-Comte; INRAE; Universite de Montpellier	Drezen, JM (corresponding author), Univ Tours, Inst Rech Biol Insecte, CNRS, UMR 6035, Parc Grandmont, F-37200 Tours, France.	drezen@univ-tours.fr	Dupuy, Catherine/AFK-5583-2022; BEZIER, Annie/B-4429-2016; Huguet, Elisabeth/D-3321-2009	Dupuy, Catherine/0000-0002-3947-3580; BEZIER, Annie/0000-0002-2528-4260; Huguet, Elisabeth/0000-0002-0096-0330; Heller, Manfred/0000-0002-6364-7325; Drezen, Jean-Michel/0000-0001-7578-635X; Roditi, Isabel/0000-0003-2812-6513	Agence Nationale de la Recherche (France); CNRS [GDR 2153, GDR 2157, IFR 136]; Swiss National Science Foundation [3100A0-103964, 3100A0-116067]	Agence Nationale de la Recherche (France)(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Investigations of C. congregata and H. didymator were performed as part of the project EVPARASITOID supported by the agencies Agence Nationale de la Recherche ( France) and CNRS (GDR 2153, GDR 2157, and IFR 136). C. inanitus study was supported by the Swiss National Science Foundation ( grants 3100A0- 103964 and 116067 to B. L.). We thank E. Herniou for helpful discussions and C. Menoret and C. Labrousse for insect- rearing. Sequences have been deposited in the EMBL Nucleotide Sequence Database, accession numbers FM201559- 80, FM201582- 97, and FM877774 for the viral cDNAs and FM212911- 15 for the chromosomally integrated form of nudivirus- related genes.	Abd-Alla AMM, 2008, J VIROL, V82, P4595, DOI 10.1128/JVI.02588-07; Annaheim M, 2007, J GEN VIROL, V88, P450, DOI 10.1099/vir.0.82396-0; Braunagel SC, 2007, CURR DRUG TARGETS, V8, P1084, DOI 10.2174/138945007782151315; Cheng CH, 2002, J VIROL, V76, P9024, DOI 10.1128/JVI.76.18.9024-9034.2002; Deng LQ, 2000, VIROLOGY, V269, P440, DOI 10.1006/viro.2000.0248; Desjardins CA, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-61; Espagne E, 2005, J VIROL, V79, P9765, DOI 10.1128/JVI.79.15.9765-9776.2005; Espagne E, 2004, SCIENCE, V306, P286, DOI 10.1126/science.1103066; Federici BA, 2003, J INSECT PHYSIOL, V49, P419, DOI 10.1016/S0022-1910(03)00059-3; GRANADOS RR, 1978, INTERVIROLOGY, V10, P309, DOI 10.1159/000148993; Herniou EA, 2003, ANNU REV ENTOMOL, V48, P211, DOI 10.1146/annurev.ento.48.091801.112756; Kroemer JA, 2004, ANNU REV ENTOMOL, V49, P431, DOI 10.1146/annurev.ento.49.072103.120132; Mallet F, 2004, P NATL ACAD SCI USA, V101, P1731, DOI 10.1073/pnas.0305763101; Moran NA, 2007, P NATL ACAD SCI USA, V104, P8627, DOI 10.1073/pnas.0611659104; Murphy N, 2008, MOL PHYLOGENET EVOL, V47, P378, DOI 10.1016/j.ympev.2008.01.022; Pasquier-Barre F, 2002, J GEN VIROL, V83, P2035, DOI 10.1099/0022-1317-83-8-2035; Passarelli AL, 2007, CURR DRUG TARGETS, V8, P1103, DOI 10.2174/138945007782151324; Provost B, 2004, J VIROL, V78, P13090, DOI 10.1128/JVI.78.23.13090-13103.2004; Raina AK, 2000, J INVERTEBR PATHOL, V76, P6, DOI 10.1006/jipa.2000.4942; Thoetkiattikul H, 2005, P NATL ACAD SCI USA, V102, P11426, DOI 10.1073/pnas.0505240102; van Oers MM, 2007, CURR DRUG TARGETS, V8, P1051, DOI 10.2174/138945007782151333; Vanarsdall AL, 2007, CURR DRUG TARGETS, V8, P1096, DOI 10.2174/138945007782151397; Wang YJ, 2008, J VIROL METHODS, V152, P106, DOI 10.1016/j.jviromet.2008.06.003; Wang YJ, 2007, J VIROL, V81, P5395, DOI 10.1128/JVI.02781-06; WEBB BA, 2005, COMPREHENSIVE MOL IN, V6, P323, DOI DOI 10.1016/B0-44-451924-6/00086-7; Weber B, 2007, ARCH INSECT BIOCHEM, V66, P9, DOI 10.1002/arch.20190; Whitfield JB, 2002, P NATL ACAD SCI USA, V99, P7508, DOI 10.1073/pnas.112067199; Whitfield JB, 2003, J INSECT PHYSIOL, V49, P397, DOI 10.1016/S0022-1910(03)00057-X; Wyder S, 2003, J INSECT PHYSIOL, V49, P491, DOI 10.1016/S0022-1910(03)00056-8	29	223	234	1	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 13	2009	323	5916					926	930		10.1126/science.1166788	http://dx.doi.org/10.1126/science.1166788			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406KW	19213916	Green Published			2022-12-01	WOS:000263295400040
J	Kawase, T; Ohki, R; Shibata, T; Tsutsumi, S; Kamimura, N; Inazawa, J; Ohta, T; Ichikawa, H; Aburatani, H; Tashiro, F; Taya, Y				Kawase, Tatsuya; Ohki, Rieko; Shibata, Tatsuhiro; Tsutsumi, Shuichi; Kamimura, Naoko; Inazawa, Johji; Ohta, Tsutomu; Ichikawa, Hitoshi; Aburatani, Hiroyuki; Tashiro, Fumio; Taya, Yoichi			PH Domain-Only Protein PHLDA3 Is a p53-Regulated Repressor of Akt	CELL			English	Article							GENOMIC HYBRIDIZATION ANALYSIS; PLECKSTRIN-HOMOLOGY DOMAINS; CANDIDATE MEDIATOR; KINASE B; P53; ACTIVATION; PATHWAY; LUNG; FAMILY; CANCER	p53 and Akt are critical players regulating tumorigenesis with opposite effects: whereas p53 transactivates target genes to exert its function as a tumor suppressor, Akt phosphorylates its substrates and transduces downstream survival signals. In addition, p53 and Akt negatively regulate each other to balance survival and death signals within a cell. We now identify PHLDA3 as a p53 target gene that encodes a PH domain-only protein. We find that PHLDA3 competes with the PH domain of Akt for binding of membrane lipids, thereby inhibiting Akt translocation to the cellular membrane and activation. Ablation of endogenous PHLDA3 results in enhanced Akt activity and decrease of p53-dependent apoptosis. We also demonstrate the suppression of anchorage-independent cell growth by PHLDA3. Loss of the PHLDA3 genomic locus was frequently observed in primary lung cancers, suggesting a role of PHLDA3 in tumor suppression. Our results reveal a new mode of coordination between the p53 and Akt pathways.	[Kawase, Tatsuya; Ohki, Rieko; Taya, Yoichi] Natl Canc Ctr, Res Inst, Div Radiobiol, Chuo Ku, Tokyo 1040045, Japan; [Shibata, Tatsuhiro] Natl Canc Ctr, Res Inst, Canc Genom Project, Chuo Ku, Tokyo 1040045, Japan; [Shibata, Tatsuhiro] Natl Canc Ctr, Res Inst, Div Pathol, Chuo Ku, Tokyo 1040045, Japan; [Ohta, Tsutomu] Natl Canc Ctr, Res Inst, Ctr Med Genom, Chuo Ku, Tokyo 1040045, Japan; [Ichikawa, Hitoshi] Natl Canc Ctr, Res Inst, Canc Transcriptome Project, Chuo Ku, Tokyo 1040045, Japan; [Inazawa, Johji] Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Cytogenet, Bunkyo Ku, Tokyo 1138510, Japan; [Tsutsumi, Shuichi; Kamimura, Naoko; Aburatani, Hiroyuki] Univ Tokyo, Adv Sci & Technol Res Ctr, Genome Sci Div, Meguro Ku, Tokyo 1538904, Japan; [Kawase, Tatsuya; Tashiro, Fumio] Tokyo Univ Sci, Fac Ind Sci & Technol, Dept Biol Sci & Technol, Noda, Chiba 2708510, Japan; [Kawase, Tatsuya; Ohki, Rieko; Taya, Yoichi] SORST JST, Kawaguchi, Saitama 3320012, Japan; [Taya, Yoichi] Natl Univ Singapore, Ctr Life Sci, Canc Res Ctr Excellence, Singapore 117456, Singapore	National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; Tokyo Medical & Dental University (TMDU); University of Tokyo; Tokyo University of Science; Japan Science & Technology Agency (JST); National University of Singapore	Ohki, R (corresponding author), Natl Canc Ctr, Res Inst, Div Radiobiol, Chuo Ku, Tsukiji 5-1-1, Tokyo 1040045, Japan.	rohki@ncc.go.jp	Shibata, Tatsuhiro/ABA-8234-2020; Shibata, Tatsuhiro/AAO-1278-2021		Fundamental Studies in Health Sciences of the Pharmaceuticals and Medical Devices Agency; Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor and Welfare, Japan; Japan Society for the Promotion of Science for Young Scientists	Fundamental Studies in Health Sciences of the Pharmaceuticals and Medical Devices Agency; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We are grateful to Atsushi Okabe for production of ChIP-chip and ChIP sequence data and Hiroko Meguro and Kaori Shiina for analysis of ChIP-chip and ChIP sequence samples. This study was supported by the program for the promotion of Fundamental Studies in Health Sciences of the Pharmaceuticals and Medical Devices Agency ( to T. O. and H. I.), a Grant-in-Aid for Scientific Research and a grant of the Genome Network Project from the Ministry of Education, Culture, Sports, Science and Technology of Japan ( to H. A.), a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan ( to Y. T.), and a Grant-in-Aid for Third Term Comprehensive Control Research for Cancer from the Ministry of Health, Labor and Welfare, Japan ( to T. S. and Y. T.). T. K. is a recipient of a research fellowship from the Japan Society for the Promotion of Science for Young Scientists.	Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Engelman JA, 2006, CLIN CANCER RES, V12, p4372S, DOI 10.1158/1078-0432.CCR-06-0795; Frank D, 2002, P NATL ACAD SCI USA, V99, P7490, DOI 10.1073/pnas.122039999; Frank D, 1999, MAMM GENOME, V10, P1150, DOI 10.1007/s003359901182; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Harriague J, 2002, NAT IMMUNOL, V3, P1090, DOI 10.1038/ni847; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Jen KY, 2005, CANCER RES, V65, P7666, DOI 10.1158/0008-5472.CAN-05-1039; Kawase T, 2008, ONCOGENE, V27, P3797, DOI 10.1038/onc.2008.32; Kerley-Hamilton JS, 2005, ONCOGENE, V24, P6090, DOI 10.1038/sj.onc.1208755; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; Liu G, 2006, J CELL BIOCHEM, V97, P448, DOI 10.1002/jcb.20700; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Maffucci T, 2001, FEBS LETT, V506, P173, DOI 10.1016/S0014-5793(01)02909-X; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mayo LD, 2002, TRENDS BIOCHEM SCI, V27, P462, DOI 10.1016/S0968-0004(02)02166-7; Moore SM, 1998, CANCER RES, V58, P5239; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Ohki R, 2000, J BIOL CHEM, V275, P22627, DOI 10.1074/jbc.C000235200; Ohki R, 2007, CANCER SCI, V98, P189, DOI 10.1111/j.1349-7006.2006.00375.x; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; Peng WX, 2005, CANCER SCI, V96, P661, DOI 10.1111/j.1349-7006.2005.00092.x; Ren Y, 2003, ANTICANCER RES, V23, P3231; Righi L, 2007, VIRCHOWS ARCH, V451, pS51, DOI 10.1007/s00428-007-0445-0; Saxena A, 2002, J BIOL CHEM, V277, P49935, DOI 10.1074/jbc.M206497200; Scheid MP, 2003, FEBS LETT, V546, P108, DOI 10.1016/S0014-5793(03)00562-3; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Shibata T, 2005, CLIN CANCER RES, V11, P6177, DOI 10.1158/1078-0432.CCR-05-0293; Stambolic V, 1999, ONCOGENE, V18, P6094, DOI 10.1038/sj.onc.1203126; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Varnai P, 2005, J CELL SCI, V118, P4879, DOI 10.1242/jcs.02606; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2005, CELL, V120, P7, DOI 10.1016/j.cell.2004.12.027; West KA, 2003, J CLIN INVEST, V111, P81, DOI 10.1172/JCI200316147; Zhou SY, 1997, P NATL ACAD SCI USA, V94, P11345, DOI 10.1073/pnas.94.21.11345	37	151	160	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 6	2009	136	3					535	550		10.1016/j.cell.2008.12.002	http://dx.doi.org/10.1016/j.cell.2008.12.002			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	403ZN	19203586	Bronze			2022-12-01	WOS:000263120600022
J	Schnabel, RB; Sullivan, LM; Levy, D; Pencina, M; Massaro, JM; D'Agostino, RB; Newton-Cheh, C; Yamamoto, JF; Magnani, JW; Tadros, TM; Kannel, WB; Wang, TJ; Ellinor, PT; Wolf, PA; Vasan, RS; Benjamin, EJ				Schnabel, Renate B.; Sullivan, Lisa M.; Levy, Daniel; Pencina, Michael; Massaro, Joseph M.; D'Agostino, Ralph B., Sr.; Newton-Cheh, Christopher; Yamamoto, Jennifer F.; Magnani, Jared W.; Tadros, Thomas M.; Kannel, William B.; Wang, Thomas J.; Ellinor, Patrick T.; Wolf, Philip A.; Vasan, Ramachandran S.; Benjamin, Emelia J.			Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study	LANCET			English	Article							PHYSICAL-ACTIVITY; PREVENTION; OBESITY; PREDICTION; MORTALITY; FAILURE; EVENTS; ADULTS; ONSET	Background Atrial fibrillation contributes to substantial increases in morbidity and mortality. We aimed to develop a risk score to predict individuals' absolute risk of developing the condition, and to provide a framework for researchers to assess new risk markers. Methods We assessed 4764 participants in the Framingham Heart Study from 8044 examinations (55% women, 45-95 years of age) undertaken between June, 1968, and September, 1987. Thereafter, participants were monitored for the first event of atrial fibrillation for a maximum of 10 years. Multivariable Cox regression identified clinical risk factors associated with development of atrial fibrillation in 10 years. Secondary analyses incorporated routine echocardiographic measurements (5152 participants, 7156 examinations) to reclassify the risk of atrial fibrillation and to assess whether these measurements improved risk prediction. Findings 457 (10%) of the 4764 participants developed atrial fibrillation. Age, sex, body-mass index, systolic blood pressure, treatment for hypertension, PR interval, clinically significant cardiac murmur, and heart failure were associated with atrial fibrillation and incorporated in a risk score (p<0.05, except body-mass index p=0.08), clinical model C statistic 0.78 (95% Cl 0.76-0.80). Risk of atrial fibrillation in 10 years varied with age: more than 15% risk was recorded in 53 (1%) participants younger than 65 years, compared with 783 (27%) older than 65 years. Additional incorporation of echocardiographic measurements to enhance the risk prediction model only slightly improved the C statistic from 0.78 (95% CI 0.75-0.80) to 0.79 (0.77-0.82), p=0.005. Echocardiographic measurements did not improve risk reclassification (p=0.18). Interpretation From clinical factors readily accessible in primary care, our risk score could help to identify risk of atrial fibrillation for individuals in the community; assess technologies or markers for improvement of risk prediction, and target high-risk individuals for preventive measures.	[Benjamin, Emelia J.] Boston Univ, Sch Med, Framingham Heart Study, Framingham, MA 01702 USA; [Sullivan, Lisa M.; Pencina, Michael; Massaro, Joseph M.; Yamamoto, Jennifer F.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Kannel, William B.; Benjamin, Emelia J.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [D'Agostino, Ralph B., Sr.] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA; [Vasan, Ramachandran S.; Benjamin, Emelia J.] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Evans Mem Dept Med, Boston, MA 02118 USA; [Levy, Daniel; Massaro, Joseph M.; Tadros, Thomas M.; Vasan, Ramachandran S.; Benjamin, Emelia J.] Boston Univ, Sch Med, Cardiol Sect, Evans Mem Dept Med, Boston, MA 02118 USA; [Levy, Daniel; Kannel, William B.; Vasan, Ramachandran S.; Benjamin, Emelia J.] Boston Univ, Sch Med, Prevent Med Sect, Evans Mem Dept Med, Boston, MA 02118 USA; [Wolf, Philip A.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Levy, Daniel] NHLBI, Ctr Populat Studies, Bethesda, MD 20892 USA; [Ellinor, Patrick T.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Ellinor, Patrick T.] Massachusetts Gen Hosp, Cardiac Arrhythmia Serv, Boston, MA 02114 USA; [Newton-Cheh, Christopher; Wang, Thomas J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Cardiol, Boston, MA USA; [Newton-Cheh, Christopher] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA USA; [Schnabel, Renate B.] Johannes Gutenberg Univ Mainz, Dept Med 2, Mainz, Germany	Boston University; Framingham Heart Study; Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Johannes Gutenberg University of Mainz	Benjamin, EJ (corresponding author), Boston Univ, Sch Med, Framingham Heart Study, 73 Mt Wayte Ave, Framingham, MA 01702 USA.	emelia@bu.edu	Ramachandran, Vasan/Y-2527-2019; Schnabel, Renate B/ABE-6668-2021; Schnabel, Renate B/F-6527-2014; Levy, Daniel/ABB-2752-2021; Levy, Daniel/ABF-6873-2021; Benjamin, Emelia/E-7103-2011	Ramachandran, Vasan/0000-0001-7357-5970; Schnabel, Renate B/0000-0001-7170-9509; Levy, Daniel/0000-0003-1843-8724; Wang, Thomas/0000-0003-4063-6508; Wolf, Philip/0000-0002-3628-301X; Sullivan, Lisa/0000-0003-0726-7149; Massaro, Joseph/0000-0002-2682-4812; Ellinor, Patrick/0000-0002-2067-0533; Benjamin, Emelia/0000-0003-4076-2336; Pencina, Michael/0000-0001-5798-8855	US National Institutes of Health (NIH)/National Heart, Lung and Blood Institute [N01-HC-25195]; NIH [HL076784, AG028321, AG029451, HL092577, HL080124, HL077477, HL71039, HL093328, R01 NS 17950, 2K24 HL04334]; Deutsche Forschungsgemeinschaft (German Research Foundation) [SCHN 1149/1-1]; Doris Duke Charitable Foundation Clinical Scientist Development Award [HL080025]; Burroughs Wellcome Fund Career Award for Medical Scientists; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006001] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)/National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG)); Doris Duke Charitable Foundation Clinical Scientist Development Award(American Heart AssociationDoris Duke Charitable Foundation (DDCF)); Burroughs Wellcome Fund Career Award for Medical Scientists(Burroughs Wellcome Fund); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by US National Institutes of Health (NIH)/National Heart, Lung and Blood Institute contract N01-HC-25195 and NIH grants HL076784, AG028321. and AG029451 (E)B) HL092577 (EJB, PTE); HL080124, HL077477, HL71039, and HL093328 (RSV); R01 NS 17950 (PAW). NIH Research Career Award 2K24 HL04334 (RSV); Deutsche Forschungsgemeinschaft (German Research Foundation) Research Fellowship SCHN 1149/1-1 (RBS); HL080025, Doris Duke Charitable Foundation Clinical Scientist Development Award, and Burroughs Wellcome Fund Career Award for Medical Scientists (CN-C).	Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840; Benjamin EJ, 2009, CIRCULATION, V119, P606, DOI 10.1161/CIRCULATIONAHA.108.825380; Cappola AR, 2006, JAMA-J AM MED ASSOC, V295, P1033, DOI 10.1001/jama.295.9.1033; D'Agostino RB, 2004, HDB STAT, P1; DAGOSTINO RB, 1990, STAT MED, V9, P1501, DOI 10.1002/sim.4780091214; Darbar D, 2002, PACE, V25, P1447, DOI 10.1046/j.1460-9592.2002.01447.x; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; Dilaveris PE, 1998, AM HEART J, V135, P733, DOI 10.1016/S0002-8703(98)70030-4; Eichler K, 2007, AM HEART J, V153, P722, DOI 10.1016/j.ahj.2007.02.027; Fauchier L, 2008, J AM COLL CARDIOL, V51, P828, DOI 10.1016/j.jacc.2007.09.063; Frost L, 2005, AM J MED, V118, P489, DOI 10.1016/j.amjmed.2005.01.031; Fuster V, 2006, CIRCULATION, V114, pE257, DOI 10.1161/CIRCULATIONAHA.106.177292; Gami AS, 2007, J AM COLL CARDIOL, V49, P565, DOI 10.1016/j.jacc.2006.08.060; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Healey JS, 2005, J AM COLL CARDIOL, V45, P1832, DOI 10.1016/j.jacc.2004.11.070; HO KKL, 1993, CIRCULATION, V88, P107, DOI 10.1161/01.CIR.88.1.107; KANNEL WB, 1998, AM J CARDIOL, V0082; KRAHN AD, 1995, AM J MED, V98, P476, DOI 10.1016/S0002-9343(99)80348-9; Lloyd-Jones DM, 2004, CIRCULATION, V110, P1042, DOI 10.1161/01.CIR.0000140263.20897.42; Miyasaka Y, 2007, AM J MED, V120, P357, DOI 10.1016/j.amjmed.2006.06.042; Miyasaka Y, 2006, CIRCULATION, V114, P119, DOI 10.1161/CIRCULATIONAHA.105.595140; Mont L, 2008, EUROPACE, V10, P15, DOI 10.1093/europace/eum263; Mozaffarian D, 2008, CIRCULATION, V118, P800, DOI 10.1161/CIRCULATIONAHA.108.785626; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Psaty BM, 1997, CIRCULATION, V96, P2455; Quan SF, 1997, SLEEP, V20, P1077; Ringborg A, 2008, EUROPACE, V10, P403, DOI 10.1093/europace/eun048; Shinbane JS, 1997, J AM COLL CARDIOL, V29, P709, DOI 10.1016/S0735-1097(96)00592-X; Soliman EZ, 2008, J NATL MED ASSOC, V100, P447, DOI 10.1016/S0027-9684(15)31282-7; Sullivan LM, 2004, STAT MED, V23, P1631, DOI 10.1002/sim.1742; VAZIRI SM, 1994, CIRCULATION, V89, P724, DOI 10.1161/01.CIR.89.2.724; Wang TJ, 2004, JAMA-J AM MED ASSOC, V292, P2471, DOI 10.1001/jama.292.20.2471; Wang TJ, 2003, CIRCULATION, V107, P2920, DOI 10.1161/01.CIR.0000072767.89944.6E; Yamada T, 1999, EUR HEART J, V20, P211, DOI 10.1053/euhj.1998.1281	35	750	771	1	51	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB-MAR	2009	373	9665					739	745		10.1016/S0140-6736(09)60443-8	http://dx.doi.org/10.1016/S0140-6736(09)60443-8			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	412LD	19249635	Green Accepted			2022-12-01	WOS:000263725400033
J	Cardin, JA; Carlen, M; Meletis, K; Knoblich, U; Zhang, F; Deisseroth, K; Tsai, LH; Moore, CI				Cardin, Jessica A.; Carlen, Marie; Meletis, Konstantinos; Knoblich, Ulf; Zhang, Feng; Deisseroth, Karl; Tsai, Li-Huei; Moore, Christopher I.			Driving fast-spiking cells induces gamma rhythm and controls sensory responses	NATURE			English	Article							NEURONAL SYNCHRONIZATION; ELECTRICAL SYNAPSES; CORTICAL NETWORKS; FAST OSCILLATIONS; CORTEX; INTERNEURONS; BRAIN; SCHIZOPHRENIA; GENERATION; ATTENTION	Cortical gamma oscillations (20-80 Hz) predict increases in focused attention, and failure in gamma regulation is a hallmark of neurological and psychiatric disease. Current theory predicts that gamma oscillations are generated by synchronous activity of fast-spiking inhibitory interneurons, with the resulting rhythmic inhibition producing neural ensemble synchrony by generating a narrow window for effective excitation. We causally tested these hypotheses in barrel cortex in vivo by targeting optogenetic manipulation selectively to fast-spiking interneurons. Here we show that light-driven activation of fast-spiking interneurons at varied frequencies (8-200 Hz) selectively amplifies gamma oscillations. In contrast, pyramidal neuron activation amplifies only lower frequency oscillations, a cell-type-specific double dissociation. We found that the timing of a sensory input relative to a gamma cycle determined the amplitude and precision of evoked responses. Our data directly support the fast-spiking-gamma hypothesis and provide the first causal evidence that distinct network activity states can be induced in vivo by cell-type-specific activation.	[Cardin, Jessica A.; Knoblich, Ulf; Moore, Christopher I.] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Cardin, Jessica A.] Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA; [Carlen, Marie; Meletis, Konstantinos; Tsai, Li-Huei] MIT, Picower Inst Learning & Memory, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Carlen, Marie; Meletis, Konstantinos; Tsai, Li-Huei] Broad Inst Harvard & Massachusetts Inst Technol, Stanley Ctr Psychiat Res, Cambridge, MA 02139 USA; [Zhang, Feng; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Tsai, Li-Huei] Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); University of Pennsylvania; Massachusetts Institute of Technology (MIT); Northwell Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Stanford University; Howard Hughes Medical Institute	Moore, CI (corresponding author), MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	deissero@stanford.edu; lhtsai@mit.edu; cim@mit.edu	Macrae, Rhiannon/AAX-1536-2020; Meletis, Konstantinos/ABE-6777-2020; Knoblich, Ulf/A-1762-2010; Moore, Christopher/C-5588-2009; Carlen, Marie Carlen/C-9112-2014	Knoblich, Ulf/0000-0002-0756-5587; Carlen, Marie Carlen/0000-0003-1658-1631; Meletis, Konstantinos/0000-0001-5665-4781; Moore, Christopher/0000-0003-4534-1602	NIH/NEI; Knut och Alice Wallenberg Foundation; NARSAD Young Investigator Award; NIH NRSA; Tom F. Petersen; NIH; NSF; Simons Foundation Autism Research Initiative; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045130] Funding Source: NIH RePORTER	NIH/NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Knut och Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); NARSAD Young Investigator Award(NARSAD); NIH NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tom F. Petersen; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Simons Foundation Autism Research Initiative; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to S. Arber for the PV-Cre mice, S. Tonegawa for the CW2 mice, and A. Bradshaw, C. Ruehlmann and S. Su for technical assistance. We thank members of the Boyden laboratory and J. Bernstein for help in setting up optical techniques. We thank members of the Tsai and Moore laboratories, D. Vierling-Claassen and M. J. Higley for discussions and comments on the paper. This study was supported by grants from Tom F. Petersen, the NIH and the NSF to C. I. M. and by the Simons Foundation Autism Research Initiative to L.-H. T. K. D. is supported by the NIH Pioneer Program. L.-H. T. is an investigator of the Howard Hughes Medical Institute. J. A. C. is supported by a K99 from the NIH/NEI, M. C. and K. M. by postdoctoral fellowships from the Knut och Alice Wallenberg Foundation, M. C. by a NARSAD Young Investigator Award, and F. Z. by an NIH NRSA.	Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Berger H, 1969, ELECTROENCEPHALOGR S, P37; Borgers C, 2005, P NATL ACAD SCI USA, V102, P7002, DOI 10.1073/pnas.0502366102; Borgers C, 2005, NEURAL COMPUT, V17, P557, DOI 10.1162/0899766053019908; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Burchell TR, 1998, NEUROSCI LETT, V255, P151, DOI 10.1016/S0304-3940(98)00676-4; Cauli B, 1997, J NEUROSCI, V17, P3894; Deans MR, 2001, NEURON, V31, P477, DOI 10.1016/S0896-6273(01)00373-7; Deisseroth K, 2006, J NEUROSCI, V26, P10380, DOI 10.1523/JNEUROSCI.3863-06.2006; Engel AK, 2001, TRENDS COGN SCI, V5, P16, DOI 10.1016/S1364-6613(00)01568-0; Fries P, 2001, NAT NEUROSCI, V4, P194, DOI 10.1038/84032; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Fries P, 2007, TRENDS NEUROSCI, V30, P309, DOI 10.1016/j.tins.2007.05.005; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; Hasenstaub A, 2005, NEURON, V47, P423, DOI 10.1016/j.neuron.2005.06.016; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Hubbard JI., 1969, ELECTROPHYSIOLOGICAL; Huber D, 2008, NATURE, V451, P61, DOI 10.1038/nature06445; Kuhlman SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002005; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Orekhova EV, 2007, BIOL PSYCHIAT, V62, P1022, DOI 10.1016/j.biopsych.2006.12.029; REN JQ, 1992, EXP BRAIN RES, V92, P1; Spencer KM, 2008, BIOL PSYCHIAT, V63, P744, DOI 10.1016/j.biopsych.2007.10.017; Steriade M, 2006, NEUROSCIENCE, V137, P1087, DOI 10.1016/j.neuroscience.2005.10.029; Traub RD, 1997, J COMPUT NEUROSCI, V4, P141, DOI 10.1023/A:1008839312043; Traub RD, 1996, NATURE, V383, P621, DOI 10.1038/383621a0; Uhlhaas PJ, 2008, SCHIZOPHRENIA BULL, V34, P927, DOI 10.1093/schbul/sbn062; Wang XJ, 1996, J NEUROSCI, V16, P6402; Whittington MA, 1997, P NATL ACAD SCI USA, V94, P12198, DOI 10.1073/pnas.94.22.12198; Whittington MA, 2000, PHARMACOL THERAPEUT, V86, P171, DOI 10.1016/S0163-7258(00)00038-3; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; Zeng HK, 2001, CELL, V107, P617, DOI 10.1016/S0092-8674(01)00585-2	33	1673	1729	10	256	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 4	2009	459	7247					663	U63		10.1038/nature08002	http://dx.doi.org/10.1038/nature08002			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453KF	19396156	Green Accepted			2022-12-01	WOS:000266608600035
J	Hardy, J; Singleton, A				Hardy, John; Singleton, Andrew			CURRENT CONCEPTS Genomewide Association Studies and Human Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							FACTOR-H POLYMORPHISM; MACULAR DEGENERATION; GENE-EXPRESSION; PARKINSONS-DISEASE; WIDE ASSOCIATION; RISK; LOCUS; DROSOPHILA-PINK1; SUSCEPTIBILITY; CHOLESTEROL		[Hardy, John] UCL, Inst Neurol, London WC1N 3BG, England; [Singleton, Andrew] Neurogenet Lab, Bethesda, MD USA	University of London; University College London	Hardy, J (corresponding author), UCL, Inst Neurol, Queen Sq, London WC1N 3BG, England.	jhardy@ion.ucl.ac.uk	Singleton, Andrew B/C-3010-2009; Hardy, John/C-2451-2009	Hardy, John/0000-0002-3122-0423	National Institute on Aging of the National Institutes of Health [1-Z01-AG000949-02]; Medical Research Council; MRC [G0701075] Funding Source: UKRI; Medical Research Council [G0701075] Funding Source: researchfish; Parkinson&quot;s UK [G-0907] Funding Source: researchfish; NATIONAL INSTITUTE ON AGING [ZIAAG000932, Z01AG000949, ZIAAG000949] Funding Source: NIH RePORTER	National Institute on Aging of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Parkinson&quot;s UK(Parkinson&apos;s UK); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported in part by the Intramural Research Program of the National Institute on Aging of the National Institutes of Health ( project number, 1-Z01-AG000949-02) and by the Medical Research Council.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bouzigon E, 2008, NEW ENGL J MED, V359, P1985, DOI 10.1056/NEJMoa0806604; Brenner S, 2000, NAT BIOTECHNOL, V18, P1021; Brenner S, 2000, NAT BIOTECHNOL, V18, P630, DOI 10.1038/76469; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Farrer M, 2001, HUM MOL GENET, V10, P1847, DOI 10.1093/hmg/10.17.1847; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Goldstein JL, 2001, SCIENCE, V292, P1310, DOI 10.1126/science.1061815; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hardy J, 2000, NEUROBIOL DIS, V7, P65, DOI 10.1006/nbdi.2000.0291; Hirschhorn JN, 2009, NEW ENGL J MED, V360, P1699, DOI 10.1056/NEJMp0808934; Hunter DJ, 2007, NEW ENGL J MED, V357, P436, DOI 10.1056/NEJMp078120; KENNEDY GC, 1995, NAT GENET, V9, P293, DOI 10.1038/ng0395-293; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kraft P, 2009, NEW ENGL J MED, V360, P1701, DOI 10.1056/NEJMp0810107; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li M, 2006, NAT GENET, V38, P1049, DOI 10.1038/ng1871; Lupski JR, 2007, NEW ENGL J MED, V356, P1169, DOI 10.1056/NEJMcibr067658; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Melquist S, 2007, AM J HUM GENET, V80, P769, DOI 10.1086/513320; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Myers AJ, 2007, NEUROBIOL DIS, V25, P561, DOI 10.1016/j.nbd.2006.10.018; Need AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000373; Ng PC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000160; *NIH RODAM MED RES, GEN TISS EXPR GTEX P; Olson M, 2007, NAT METHODS, V4, P891, DOI 10.1038/nmeth1107-891; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sethupathy P, 2008, TRENDS GENET, V24, P489, DOI 10.1016/j.tig.2008.07.004; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Terwilliger JD, 2006, EUR J HUM GENET, V14, P426, DOI 10.1038/sj.ejhg.5201583; Venter JC, 2001, SCIENCE, V292, P1838; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; 1000 GENOMES DEEP CA	46	531	563	1	54	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 23	2009	360	17					1759	1768		10.1056/NEJMra0808700	http://dx.doi.org/10.1056/NEJMra0808700			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	435XY	19369657	Green Accepted			2022-12-01	WOS:000265377800010
J	Thompson, MJ; Harnden, A; Del Mar, C				Thompson, Matthew J.; Harnden, Anthony; Del Mar, Chris			Diagnosis in General Practice Excluding serious illness in feverish children in primary care: restricted rule-out method for diagnosis	BRITISH MEDICAL JOURNAL			English	Article							RECOGNIZING MENINGOCOCCAL DISEASE; BACTERIAL-MENINGITIS; CLINICAL-FEATURES; SIGNS; INFECTIONS; SYMPTOMS; RASH		[Thompson, Matthew J.; Harnden, Anthony] Univ Oxford, Dept Primary Hlth Care, Oxford OX1 2JD, England; [Del Mar, Chris] Bond Univ, Fac Hlth Sci & Med, Southport, Qld 4229, Australia	University of Oxford; Bond University	Thompson, MJ (corresponding author), Univ Oxford, Dept Primary Hlth Care, Oxford OX1 2JD, England.	matthew.thompson@dphpc.ox.ac.uk	Del Mar, Chris/B-1136-2008	Del Mar, Chris/0000-0003-3821-8163				Attia J, 1999, JAMA-J AM MED ASSOC, V282, P175, DOI 10.1001/jama.282.2.175; Brogan PA, 2000, ARCH DIS CHILD, V83, P506, DOI 10.1136/adc.83.6.506; Granier S, 1998, BRIT MED J, V316, P276, DOI 10.1136/bmj.316.7127.276; Granier S, 1998, BRIT J GEN PRACT, V48, P1167; Harnden A, 2006, BRIT MED J, V332, P1295, DOI 10.1136/bmj.38789.723611.55; Inkelis SH, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.1.e3; Kai J, 1996, BRIT MED J, V313, P983; Margolis P, 1998, JAMA-J AM MED ASSOC, V279, P308, DOI 10.1001/jama.279.4.308; MARZOUK O, 1991, ARCH DIS CHILD, V66, P485, DOI 10.1136/adc.66.4.485; Murtagh J, 1990, Aust Fam Physician, V19, P733; Nadel S, 1998, J ACCID EMERG MED, V15, P298; *SIGN, 2008, SIGN GUID, V102; SORENSEN HT, 1992, J CLIN EPIDEMIOL, V45, P1289; Thompson M, 2008, BRIT J GEN PRACT, V58, P236, DOI 10.3399/bjgp08X279689; Thompson MJ, 2006, LANCET, V367, P397, DOI 10.1016/S0140-6736(06)67932-4; VALMARI P, 1987, EUR J PEDIATR, V146, P515, DOI 10.1007/BF00441607; van de Beek D, 2004, NEW ENGL J MED, V351, P1849, DOI 10.1056/NEJMoa040845; Van den Bruel A, 2007, BRIT J GEN PRACT, V57, P538; Van den Bruel Ann, 2006, BMC Fam Pract, V7, P23, DOI 10.1186/1471-2296-7-23; VOSS L, 1989, NEW ZEAL MED J, V102, P243	20	6	6	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	APR 20	2009	338								b1187	10.1136/bmj.b1187	http://dx.doi.org/10.1136/bmj.b1187			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437ON	19380412				2022-12-01	WOS:000265496900001
J	Parker, SCJ; Hansen, L; Abaan, HO; Tullius, TD; Margulies, EH				Parker, Stephen C. J.; Hansen, Loren; Abaan, Hatice Ozel; Tullius, Thomas D.; Margulies, Elliott H.			Local DNA Topography Correlates with Functional Noncoding Regions of the Human Genome	SCIENCE			English	Article							REGULATORY SEQUENCES; MOUSE GENOME; CONSTRAINT; ELEMENTS; SITES; IDENTIFICATION; TRANSCRIPTION; RECOGNITION; 1-PERCENT	The three-dimensional molecular structure of DNA, specifically the shape of the backbone and grooves of genomic DNA, can be dramatically affected by nucleotide changes, which can cause differences in protein-binding affinity and phenotype. We developed an algorithm to measure constraint on the basis of similarity of DNA topography among multiple species, using hydroxyl radical cleavage patterns to interrogate the solvent-accessible surface area of DNA. This algorithm found that 12% of bases in the human genome are evolutionarily constrained-double the number detected by nucleotide sequence-based algorithms. Topography-informed constrained regions correlated with functional noncoding elements, including enhancers, better than did regions identified solely on the basis of nucleotide sequence. These results support the idea that the molecular shape of DNA is under selection and can identify evolutionary history.	[Parker, Stephen C. J.; Hansen, Loren; Tullius, Thomas D.] Boston Univ, Bioinformat Program, Boston, MA 02215 USA; [Hansen, Loren] NIH, Natl Ctr Biotechnol Informat, Bethesda, MD 20892 USA; [Abaan, Hatice Ozel; Margulies, Elliott H.] NIH, NHGRI, Genome Technol Branch, Bethesda, MD 20892 USA; [Tullius, Thomas D.] Boston Univ, Dept Chem, Boston, MA 02215 USA	Boston University; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Boston University	Margulies, EH (corresponding author), Boston Univ, Bioinformat Program, Boston, MA 02215 USA.	tullius@bu.edu; elliott@nhgri.nih.gov	Tullius, Thomas D./A-9685-2008; Parker, Stephen/ABF-1063-2021	Tullius, Thomas D./0000-0003-4425-796X; 	National Human Genome Research Institute (NHGRI), NIH [R01 HG003541]; Research Corporation for Science Advancement; Intramural Research Program of the NHGRI, NIH; National Academies Ford Foundation Dissertation Fellowship; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003541, ZIAHG200341] Funding Source: NIH RePORTER	National Human Genome Research Institute (NHGRI), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Research Corporation for Science Advancement(Research Corporation for Science Advancement); Intramural Research Program of the NHGRI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Academies Ford Foundation Dissertation Fellowship; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank E. D. Green and L. C. Brody for feedback on the manuscript, E. Bishop and D. Landsman for discussion, and G. K. McEwen for assistance with experimental steps. Funded by the National Human Genome Research Institute (NHGRI) of the NIH (grant R01 HG003541) to T.D.T. and by the Research Corporation for Science Advancement. E.H.M. was supported by the Intramural Research Program of the NHGRI, NIH. S.C.J.P. was supported by a National Academies Ford Foundation Dissertation Fellowship.	Asthana S, 2007, PLOS COMPUT BIOL, V3, P2559, DOI 10.1371/journal.pcbi.0030254; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bulyk ML, 2002, NUCLEIC ACIDS RES, V30, P1255, DOI 10.1093/nar/30.5.1255; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; DICKERSON RE, 1992, METHOD ENZYMOL, V211, P67; Elnitski L, 2003, GENOME RES, V13, P64, DOI 10.1101/gr.817703; Fisher S, 2006, SCIENCE, V312, P276, DOI 10.1126/science.1124070; Giardine B, 2007, HUM MUTAT, V28, P554, DOI 10.1002/humu.20484; Greenbaum JA, 2007, GENOME RES, V17, P947, DOI 10.1101/gr.6073107; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Joshi R, 2007, CELL, V131, P530, DOI 10.1016/j.cell.2007.09.024; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Margulies EH, 2003, GENOME RES, V13, P2507, DOI 10.1101/gr.1602203; Margulies EH, 2007, GENOME RES, V17, P760, DOI 10.1101/gr.6034307; McGaughey DM, 2008, GENOME RES, V18, P252, DOI 10.1101/gr.6929408; Misteli T, 2005, BIOESSAYS, V27, P477, DOI 10.1002/bies.20226; Ohyama T., 2005, DNA CONFORMATION TRA; Olson WK, 1998, P NATL ACAD SCI USA, V95, P11163, DOI 10.1073/pnas.95.19.11163; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; Pennacchio LA, 2001, NAT REV GENET, V2, P100, DOI 10.1038/35052548; Petrykowska HM, 2008, GENOME RES, V18, P1238, DOI 10.1101/gr.073817.107; PRICE MA, 1992, METHOD ENZYMOL, V212, P194; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Wasserman WW, 2000, NAT GENET, V26, P225, DOI 10.1038/79965; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wilson MD, 2008, SCIENCE, V322, P434, DOI 10.1126/science.1160930	27	152	159	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2009	324	5925					389	392		10.1126/science.1169050	http://dx.doi.org/10.1126/science.1169050			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433QT	19286520	Green Accepted			2022-12-01	WOS:000265221600043
J	Flames, N; Hobert, O				Flames, Nuria; Hobert, Oliver			Gene regulatory logic of dopamine neuron differentiation	NATURE			English	Article							OLFACTORY-BULB INTERNEURONS; C-ELEGANS; TRANSCRIPTIONAL CODES; EXPRESSION; BRAIN; ARCHITECTURE; INSIGHTS; IDENTITY; ER81; AXON	Dopamine signalling regulates a variety of complex behaviours, and defects in dopamine neuron function or survival result in severe human pathologies, such as Parkinson's disease(1). The common denominator of all dopamine neurons is the expression of dopamine pathway genes, which code for a set of phylogenetically conserved proteins involved in dopamine synthesis and transport. Gene regulatory mechanisms that result in the direct activation of dopamine pathway genes and thereby ultimately determine the identity of dopamine neurons are poorly understood in all systems studied so far(2). Here we show that a simple cis-regulatory element, the dopamine (DA) motif, controls the expression of all dopamine pathway genes in all dopaminergic cell types in Caenorhabditis elegans. The DA motif is activated by the ETS transcription factor AST-1. Loss of ast-1 results in the failure of all distinct dopaminergic neuronal subtypes to terminally differentiate. Ectopic expression of ast-1 is sufficient to activate the dopamine pathway in some cellular contexts. Vertebrate dopamine pathway genes also contain phylogenetically conserved DA motifs that can be activated by the mouse ETS transcription factor Etv1 (also known as ER81), and a specific class of dopamine neurons fails to differentiate in mice lacking Etv1. Moreover, ectopic Etv1 expression induces dopaminergic fate marker expression in neuronal primary cultures. Mouse Etv1 can also functionally substitute for ast-1 in C. elegans. Our studies reveal a simple and apparently conserved regulatory logic of dopamine neuron terminal differentiation and may provide new entry points into the diagnosis or therapy of conditions in which dopamine neurons are defective.	[Flames, Nuria; Hobert, Oliver] Columbia Univ, Dept Biochem & Mol Biophys, Med Ctr, Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute	Flames, N (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, Med Ctr, Howard Hughes Med Inst, 630 W 168th St, New York, NY 10032 USA.	nf2171@columbia.edu; or38@columbia.edu	Flames, Nuria/L-2290-2017	Flames, Nuria/0000-0003-0961-0609; Hobert, Oliver/0000-0002-7634-2854	National Institutes of Health [R01NS039996-05, R01NS050266-03]; Howard Hughes Medical Institute; EMBO; Marie Curie Outgoing International fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039996, R01NS050266] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); EMBO(European Molecular Biology Organization (EMBO)); Marie Curie Outgoing International fellowship(European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Q. Chen for injection assistance, M. Doitsidou and J. Chen for providing the ot417 allele, E. Savner for initiating some of the promoter analysis, A. Kruyer for technical help, the CGC for strains, the C. elegans Gene Knockout Consortia, led by S. Mitani at Tokyo Women's Medical University School of Medicine and by D. Moerman at the University of British Columbia, for knockout alleles, H. Hutter, N. Tavernarakis and T. Jessell for strains and reagents, several members of Columbia University community for sharing their equipment, Hobert laboratory members, especially M. Doitsidou, for discussion, and A. Abeliovich, R. J. Johnston and I. Greenwald for comments on the manuscript. This work was funded by the National Institutes of Health (R01NS039996-05; R01NS050266-03), the Howard Hughes Medical Institute and a EMBO long term fellowship and Marie Curie Outgoing International fellowship to N. F.	Abeliovich A, 2007, DEV BIOL, V304, P447, DOI 10.1016/j.ydbio.2007.01.032; Allen ZJ, 2007, J MOL HISTOL, V38, P517, DOI 10.1007/s10735-007-9115-4; Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; BROWN TA, 1992, GENE DEV, V6, P2502, DOI 10.1101/gad.6.12b.2502; Cobos I, 2007, NEURON, V54, P873, DOI 10.1016/j.neuron.2007.05.024; Doitsidou M, 2008, NAT METHODS, V5, P869, DOI 10.1038/NMETH.1250; Duggan A, 1998, DEVELOPMENT, V125, P4107; Etchberger JF, 2008, NAT METHODS, V5, P3, DOI 10.1038/nmeth0108-3; Etchberger JF, 2007, GENE DEV, V21, P1653, DOI 10.1101/gad.1560107; Flames N, 2007, J NEUROSCI, V27, P9682, DOI 10.1523/JNEUROSCI.2750-07.2007; Fukushige T, 2005, DEVELOPMENT, V132, P1795, DOI 10.1242/dev.01774; Gray PA, 2004, SCIENCE, V306, P2255, DOI 10.1126/science.1104935; HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602; Hobert O, 2008, P NATL ACAD SCI USA, V105, P20067, DOI 10.1073/pnas.0806070105; Iversen SD, 2007, TRENDS NEUROSCI, V30, P188, DOI 10.1016/j.tins.2007.03.002; Li W, 2006, NATURE, V440, P684, DOI 10.1038/nature04538; Lichtneckert R, 2005, HEREDITY, V94, P465, DOI 10.1038/sj.hdy.6800664; Nass R, 2003, ANNU REV PHARMACOL, V43, P521, DOI 10.1146/annurev.pharmtox.43.100901.135934; ROSEN GD, 1990, J NEUROSCI METH, V35, P115, DOI 10.1016/0165-0270(90)90101-K; Saino-Saito S, 2007, J COMP NEUROL, V502, P485, DOI 10.1002/cne.21293; Schmid C, 2006, DEV BIOL, V293, P403, DOI 10.1016/j.ydbio.2006.02.042; Shirasaki R, 2002, ANNU REV NEUROSCI, V25, P251, DOI 10.1146/annurev.neuro.25.112701.142916; Voglis G, 2008, EMBO J, V27, P3288, DOI 10.1038/emboj.2008.252; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434; Wenick AS, 2004, DEV CELL, V6, P757, DOI 10.1016/j.devcel.2004.05.004	25	163	180	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 16	2009	458	7240					885	U7		10.1038/nature07929	http://dx.doi.org/10.1038/nature07929			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433CS	19287374	Green Accepted			2022-12-01	WOS:000265182500042
J	Purnell, JQ; Flum, DR				Purnell, Jonathan Q.; Flum, David R.			Bariatric Surgery and Diabetes Who Should Be Offered the Option of Remission?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							GASTRIC BYPASS		[Purnell, Jonathan Q.] Oregon Hlth & Sci Univ, Dept Med, Portland, OR 97239 USA; [Flum, David R.] Univ Washington, Dept Surg, Seattle, WA 98195 USA	Oregon Health & Science University; University of Washington; University of Washington Seattle	Purnell, JQ (corresponding author), Oregon Hlth & Sci Univ, Dept Med, Mailstop L481,3181 Sam Jackson Pk Rd, Portland, OR 97239 USA.	purnellj@ohsu.edu	Flum, David/GPX-7976-2022		NIDDK NIH HHS [U01 DK066568] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK066568] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adams TD, 2007, NEW ENGL J MED, V357, P753, DOI 10.1056/NEJMoa066603; Bays HE, 2007, INT J CLIN PRACT, V61, P737, DOI 10.1111/j.1742-1241.2007.01336.x; Buchwald H, 2004, JAMA-J AM MED ASSOC, V292, P1724, DOI 10.1001/jama.292.14.1724; *DARTM HITCHC MED, WEIGHT MAN; *DEP HLTH HUM SERV, CMS PROGR INF; Dixon JB, 2008, JAMA-J AM MED ASSOC, V299, P316, DOI 10.1001/jama.299.3.316; Ferrannini E, 2009, DIABETES CARE, V32, P514, DOI 10.2337/dc08-1762; Laferrere B, 2008, J CLIN ENDOCR METAB, V93, P2479, DOI 10.1210/jc.2007-2851; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Rubino F, 2008, DIABETES CARE, V31, pS290, DOI 10.2337/dc08-s271; Sturm R, 2007, PUBLIC HEALTH, V121, P492, DOI 10.1016/j.puhe.2007.01.006; Tarnoff M, 2009, SURG ENDOSC, V23, P650, DOI 10.1007/s00464-008-0125-4; Whitson BA, 2007, J SURG RES, V141, P31, DOI 10.1016/j.jss.2007.02.022	13	17	18	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 15	2009	301	15					1593	1595		10.1001/jama.2009.541	http://dx.doi.org/10.1001/jama.2009.541			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	432MH	19366781	Green Accepted			2022-12-01	WOS:000265137900032
J	Schmidt, M; Lipson, H				Schmidt, Michael; Lipson, Hod			Distilling Free-Form Natural Laws from Experimental Data	SCIENCE			English	Article							PRINCIPLES; DISCOVERY; SCIENCE	For centuries, scientists have attempted to identify and document analytical laws that underlie physical phenomena in nature. Despite the prevalence of computing power, the process of finding natural laws and their corresponding equations has resisted automation. A key challenge to finding analytic relations automatically is defining algorithmically what makes a correlation in observed data important and insightful. We propose a principle for the identification of nontriviality. We demonstrated this approach by automatically searching motion-tracking data captured from various physical systems, ranging from simple harmonic oscillators to chaotic double-pendula. Without any prior knowledge about physics, kinematics, or geometry, the algorithm discovered Hamiltonians, Lagrangians, and other laws of geometric and momentum conservation. The discovery rate accelerated as laws found for simpler systems were used to bootstrap explanations for more complex systems, gradually uncovering the "alphabet" used to describe those systems.	[Lipson, Hod] Cornell Univ, Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA	Cornell University	Lipson, H (corresponding author), Cornell Univ, Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA.	hod.lipson@cornell.edu	Müller-Tidow, Carsten/O-7207-2018; Giagounidis, Aristoteles/S-7097-2019	Müller-Tidow, Carsten/0000-0002-7166-5232; 	Integrative Graduate Education and Research Traineeship program; U.S. NSF graduate research fellowship; NSF Creative-IT [0757478]; CAREER [0547376]	Integrative Graduate Education and Research Traineeship program(National Science Foundation (NSF)); U.S. NSF graduate research fellowship; NSF Creative-IT; CAREER(National Science Foundation (NSF))	This research was supported in part by Integrative Graduate Education and Research Traineeship program in nonlinear systems, a U.S. NSF graduate research fellowship, and NSF Creative-IT grant 0757478 and CAREER grant 0547376. We thank M. Kurman for editorial consultation and substantive editing of the manuscript.	ANDERSON PW, 1972, SCIENCE, V177, P393, DOI 10.1126/science.177.4047.393; Bongard J, 2007, P NATL ACAD SCI USA, V104, P9943, DOI 10.1073/pnas.0609476104; Clery D, 2005, SCIENCE, V308, P809, DOI 10.1126/science.308.5723.809; CYRIL F, 2007, 2007 IEEE C EV COMP, P23; De Jong E. D., 2003, Genetic Programming and Evolvable Machines, V4, P211, DOI 10.1023/A:1025122906870; Duffy J, 2002, STUD FUZZ SOFT COMP, V100, P61; ELENA B, 2005, 7 INT S SYMB NUM ALG, P321; FORREST S, 1993, SCIENCE, V261, P872, DOI 10.1126/science.8346439; GREGORY P, 2003, EV ART 6 INT C, V2936, P267; Hanc J, 2004, AM J PHYS, V72, P428, DOI 10.1119/1.1591764; Jackel P, 1998, P ROY SOC A-MATH PHY, V454, P3257, DOI 10.1098/rspa.1998.0300; Jones RM, 2005, COMPUT INTELL-US, V21, P480, DOI 10.1111/j.1467-8640.2005.00283.x; King RD, 2004, NATURE, V427, P247, DOI 10.1038/nature02236; Koza J.R, 1997, GENETIC PROGRAMMING; LANGLEY P, 1981, COGNITIVE SCI, V5, P31, DOI 10.1016/S0364-0213(81)80025-0; Liang Y, 2008, NONLINEAR DYNAM, V52, P181, DOI 10.1007/s11071-007-9270-x; Marquet PA, 2002, NATURE, V418, P723, DOI 10.1038/418723c; MOR M, 2007, P 21 ASME BIENN C ME, P1; Nee S, 2005, SCIENCE, V309, P1236, DOI 10.1126/science.1114488; Noether E., 1918, NACHR GES WISS GOTT, V1918, P235, DOI DOI 10.1080/00411457108231446; SHINBROT T, 1992, AM J PHYS, V60, P491, DOI 10.1119/1.16860; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Szalay A, 2006, NATURE, V440, P413, DOI 10.1038/440413a; Valdes-Perez RE, 1999, COMMUN ACM, V42, P37, DOI 10.1145/319382.319389	24	1179	1204	32	263	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2009	324	5923					81	85		10.1126/science.1165893	http://dx.doi.org/10.1126/science.1165893			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427TN	19342586				2022-12-01	WOS:000264802100036
J	Cyranoski, D				Cyranoski, David			Retracted paper rattles Korean science	NATURE			English	News Item																			0	1	1	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 2	2009	458	7238					561	561		10.1038/458561b	http://dx.doi.org/10.1038/458561b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RK	19340046	Bronze			2022-12-01	WOS:000264796200012
J	Jencks, SF; Williams, MV; Coleman, EA				Jencks, Stephen F.; Williams, Mark V.; Coleman, Eric A.			Rehospitalizations among Patients in the Medicare Fee-for-Service Program	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	Meeting on Reducing Hospital Readmissions	JAN 25, 2008	Washington, DC	Commwlth Fund, Acad Hlth			HEART-FAILURE; HOSPITAL READMISSIONS; RANDOMIZED-TRIAL; CARE	Background Reducing rates of rehospitalization has attracted attention from policymakers as a way to improve quality of care and reduce costs. However, we have limited information on the frequency and patterns of rehospitalization in the United States to aid in planning the necessary changes. Methods We analyzed Medicare claims data from 2003-2004 to describe the patterns of rehospitalization and the relation of rehospitalization to demographic characteristics of the patients and to characteristics of the hospitals. Results Almost one fifth (19.6%) of the 11,855,702 Medicare beneficiaries who had been discharged from a hospital were rehospitalized within 30 days, and 34.0% were rehospitalized within 90 days; 67.1% of patients who had been discharged with medical conditions and 51.5% of those who had been discharged after surgical procedures were rehospitalized or died within the first year after discharge. In the case of 50.2% of the patients who were rehospitalized within 30 days after a medical discharge to the community, there was no bill for a visit to a physician's office between the time of discharge and rehospitalization. Among patients who were rehospitalized within 30 days after a surgical discharge, 70.5% were rehospitalized for a medical condition. We estimate that about 10% of rehospitalizations were likely to have been planned. The average stay of rehospitalized patients was 0.6 day longer than that of patients in the same diagnosis-related group whose most recent hospitalization had been at least 6 months previously. We estimate that the cost to Medicare of unplanned rehospitalizations in 2004 was $17.4 billion. Conclusions Rehospitalizations among Medicare beneficiaries are prevalent and costly.	[Williams, Mark V.] Northwestern Univ, Feinberg Sch Med, Div Hosp Med, Chicago, IL 60611 USA; [Coleman, Eric A.] Univ Colorado, Div Hlth Care Policy & Res, Care Transit Program, Denver, CO 80202 USA	Northwestern University; Feinberg School of Medicine; University of Colorado System; University of Colorado Denver			Greiver, Michelle/N-8764-2015	Greiver, Michelle/0000-0001-8957-0285; Williams, Mark V/0000-0001-6107-0457				A Path to Bundled Payment Around a Rehospitalization, 2005, REP C REF DEL SYST, P83; Adeyemo D, 2007, ANN ROY COLL SURG, V89, P363, DOI 10.1308/003588407X183409; ANDERSON GF, 1984, NEW ENGL J MED, V311, P1349, DOI 10.1056/NEJM198411223112105; [Anonymous], 2007, MED MED STAT SUPPL; BARR M, 2006, ADV MED HOME PATIENT; BLUSTEIN J, 1994, AM J PUBLIC HEALTH, V84, P1018, DOI 10.2105/AJPH.84.6.1018; Brumley R, 2007, J AM GERIATR SOC, V55, P993, DOI 10.1111/j.1532-5415.2007.01234.x; Centers for Medicare Medicaid Services, 2008, FED REGISTER, V73, P23673; Coleman EA, 2006, ARCH INTERN MED, V166, P1822, DOI 10.1001/archinte.166.17.1822; Connolly Ceci, 2009, WASHINGTON POST 0130, pA1; Eicheldinger C, 2008, HEALTH CARE FINANC R, V29, P27; Fisher LS, 2000, HEALTH SERV RES, V34, P1351; Friedman B, 2004, MED CARE RES REV, V61, P225, DOI 10.1177/1077558704263799; Gohler A, 2006, J CARD FAIL, V12, P554, DOI 10.1016/j.cardfail.2006.03.003; *IOW FDN MED CAR, 2008, CHRON COND DAT WAR C; Jack BW, 2009, ANN INTERN MED, V150, P178, DOI 10.7326/0003-4819-150-3-200902030-00007; National Quality Forum, 2007, CAND HOSP CAR ADD PR; Naylor MD, 2004, J AM GERIATR SOC, V52, P675, DOI 10.1111/j.1532-5415.2004.52202.x; Peikes D, 2009, JAMA-J AM MED ASSOC, V301, P603, DOI 10.1001/jama.2009.126; Rollow W, 2006, ANN INTERN MED, V145, P342, DOI 10.7326/0003-4819-145-5-200609050-00134; Ross JS, 2008, ARCH INTERN MED, V168, P1371, DOI 10.1001/archinte.168.13.1371; *SAS I, SAS WIND VERS 8 2	22	3593	3644	2	105	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 2	2009	360	14					1418	1428		10.1056/NEJMsa0803563	http://dx.doi.org/10.1056/NEJMsa0803563			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	427AL	19339721				2022-12-01	WOS:000264751800007
J	Yang, XF; Figueiredo, LM; Espinal, A; Okubo, E; Li, B				Yang, Xiaofeng; Figueiredo, Luisa M.; Espinal, Amin; Okubo, Eiji; Li, Bibo			RAP1 Is Essential for Silencing Telomeric Variant Surface Glycoprotein Genes in Trypanosoma brucei	CELL			English	Article							DNA-BINDING DOMAIN; CELL-CYCLE ARREST; ANTIGENIC VARIATION; AFRICAN TRYPANOSOMES; SACCHAROMYCES-CEREVISIAE; EXPRESSION SITES; FISSION YEAST; HISTONE H3; PROTEIN; KU	Trypanosoma brucei expresses variant surface glycoprotein (VSG) genes in a strictly monoallelic fashion in its mammalian hosts, but it is unclear how this important virulence mechanism is enforced. Telomere position effect, an epigenetic phenomenon, has been proposed to play a critical role in VSG regulation, yet no telomeric protein has been identified whose disruption led to VSG derepression. We now identify tbRAP1 as an intrinsic component of the T. brucei telomere complex and a major regulator for silencing VSG expression sites (ESs). Knockdown of tbRAP1 led to derepression of all VSGs in silent ESs, but not VSGs located elsewhere, and resulted in stronger derepression of genes located within 10 kb from telomeres than genes located further upstream. This graduated silencing pattern suggests that telomere integrity plays a key role in tbRAP1-dependent silencing and VSG regulation.	[Yang, Xiaofeng; Li, Bibo] Cleveland State Univ, Dept Biol Geol & Environm Sci, Ctr Gene Regulat Hlth Dis, Cleveland, OH 44115 USA; [Yang, Xiaofeng] Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 1, Dept Obstet & Gynecol, Xian 710061, Shaanxi Prov, Peoples R China; [Figueiredo, Luisa M.; Espinal, Amin; Okubo, Eiji; Li, Bibo] Rockefeller Univ, Mol Parasitol Lab, New York, NY 10065 USA	University System of Ohio; Cleveland State University; Xi'an Jiaotong University; Rockefeller University	Li, B (corresponding author), Cleveland State Univ, Dept Biol Geol & Environm Sci, Ctr Gene Regulat Hlth Dis, Cleveland, OH 44115 USA.	b.li37@csuohio.edu	Figueiredo, Luisa Miranda/C-3908-2018	Figueiredo, Luisa Miranda/0000-0002-5752-6586	National Institute of Health [AI050614, AI21729, AI066095]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021729, R01AI066095, R01AI050614, R37AI021729] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are grateful to Piet Borst for the VSG9 antibody and Keith Gull for the RNA Pol I and tubulin antibodies. We greatly appreciate Titia de Lange and George A.M. Cross for insightful discussions, and we thank Margaret J. Irwin, Audrey Lynn, and members of the Li and Cross labs for comments on the manuscript, critical discussions, and technical support. DeltaVision Microscopy was carried out at the RU Bio-Imaging Resource Center with guidance from Alison North and in BGES Department at CSU. FACS analysis was done at the Flow Cytometry Resource Center at RU and the Flow Cytometry Core at CCF. This work was supported by National Institute of Health grants to G.A.M. Cross (AI050614 and AI21729) and to B.L. (AI066095).	Alsford S, 2005, MOL BIOCHEM PARASIT, V144, P142, DOI 10.1016/j.molbiopara.2005.08.009; Alsford S, 2001, MOL BIOCHEM PARASIT, V113, P79, DOI 10.1016/S0166-6851(00)00388-1; Alsford S, 2007, MOL MICROBIOL, V63, P724, DOI 10.1111/j.1365-2958.2006.05553.x; Barry JD, 2001, ADV PARASIT, V49, P1, DOI 10.1016/S0065-308X(01)49037-3; Bastin P, 1996, MOL BIOCHEM PARASIT, V77, P235, DOI 10.1016/0166-6851(96)02598-4; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Bork P, 1997, FASEB J, V11, P68, DOI 10.1096/fasebj.11.1.9034168; Boulton SJ, 1998, EMBO J, V17, P1819, DOI 10.1093/emboj/17.6.1819; Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; Callebaut I, 1997, FEBS LETT, V400, P25, DOI 10.1016/S0014-5793(96)01312-9; Chaves I, 1999, EMBO J, V18, P4846, DOI 10.1093/emboj/18.17.4846; Conway C, 2002, J BIOL CHEM, V277, P21269, DOI 10.1074/jbc.M200550200; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; DELANGE T, 1982, NATURE, V299, P451, DOI 10.1038/299451a0; Dreesen O, 2005, NUCLEIC ACIDS RES, V33, P4536, DOI 10.1093/nar/gki769; Dreesen O, 2007, NAT REV MICROBIOL, V5, P70, DOI 10.1038/nrmicro1577; Duraisingh MT, 2005, CELL, V121, P13, DOI 10.1016/j.cell.2005.01.036; Evans SK, 1998, CHROMOSOMA, V107, P352, DOI 10.1007/s004120050318; Figueiredo LM, 2008, PLOS BIOL, V6, P1539, DOI 10.1371/journal.pbio.0060161; Freitas-Junior LH, 2005, CELL, V121, P25, DOI 10.1016/j.cell.2005.01.037; Gao Q, 2007, STEM CELLS, V25, P3085, DOI 10.1634/stemcells.2007-0478; Gasser SM, 2001, GENE, V279, P1, DOI 10.1016/S0378-1119(01)00741-7; Glover L, 2006, EMBO REP, V7, P93, DOI 10.1038/sj.embor.7400575; Glover L, 2007, NUCLEIC ACIDS RES, V35, P872, DOI 10.1093/nar/gkl1100; GOMMERSAMPT J, 1991, NUCLEIC ACIDS RES, V19, P1745, DOI 10.1093/nar/19.8.1745; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Grunstein M, 1997, CURR OPIN CELL BIOL, V9, P383, DOI 10.1016/S0955-0674(97)80011-7; Gunzl A, 2003, EUKARYOT CELL, V2, P542, DOI 10.1128/EC.2.3.542-551.2003; Hanaoka S, 2001, J MOL BIOL, V312, P167, DOI 10.1006/jmbi.2001.4924; Hertz-Fowler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003527; Hoek M, 2002, MOL BIOCHEM PARASIT, V120, P269, DOI 10.1016/S0166-6851(02)00009-9; Horn D, 2005, CHROMOSOME RES, V13, P525, DOI 10.1007/s10577-005-0991-8; Horn D, 1997, EMBO J, V16, P7422, DOI 10.1093/emboj/16.24.7422; HORN D, 1995, CELL, V83, P555, DOI 10.1016/0092-8674(95)90095-0; Hughes K, 2007, EMBO J, V26, P2400, DOI 10.1038/sj.emboj.7601678; Janzen CJ, 2004, NUCLEIC ACIDS RES, V32, P6575, DOI 10.1093/nar/gkh991; Kanoh J, 2001, CURR BIOL, V11, P1624, DOI 10.1016/S0960-9822(01)00503-6; Konig P, 1996, CELL, V85, P125, DOI 10.1016/S0092-8674(00)81088-0; Konig P, 1997, TRENDS BIOCHEM SCI, V22, P43, DOI 10.1016/S0968-0004(97)01008-6; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Landeira D, 2007, J CELL BIOL, V176, P133, DOI 10.1083/jcb.200607174; Li B, 2005, MOL CELL BIOL, V25, P5011, DOI 10.1128/MCB.25.12.5011-5021.2005; Li BB, 2000, CELL, V101, P471, DOI 10.1016/S0092-8674(00)80858-2; Li BB, 1996, GENE DEV, V10, P1310, DOI 10.1101/gad.10.11.1310; Lowell JE, 2004, J CELL SCI, V117, P5937, DOI 10.1242/jcs.01515; Marcello L, 2007, GENOME RES, V17, P1344, DOI 10.1101/gr.6421207; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Mishra K, 1999, CURR BIOL, V9, P1123, DOI 10.1016/S0960-9822(99)80483-7; Navarro M, 1996, MOL CELL BIOL, V16, P3615; Navarro M, 2001, NATURE, V414, P759, DOI 10.1038/414759a; OGATA K, 1994, CELL, V79, P639, DOI 10.1016/0092-8674(94)90549-5; Park MJ, 2002, MOL CELLS, V13, P327; Pays E, 2004, CURR OPIN MICROBIOL, V7, P369, DOI 10.1016/j.mib.2004.05.001; Pedram M, 2006, MOL CELL BIOL, V26, P1865, DOI 10.1128/MCB.26.5.1865-1878.2006; Pina B, 2003, MOL GENET GENOMICS, V268, P791, DOI 10.1007/s00438-002-0801-3; Pryde FE, 1999, EMBO J, V18, P2538, DOI 10.1093/emboj/18.9.2538; RENAULD H, 1993, GENE DEV, V7, P1133, DOI 10.1101/gad.7.7a.1133; Sheader K, 2005, P NATL ACAD SCI USA, V102, P8716, DOI 10.1073/pnas.0501886102; SHORE D, 1994, TRENDS GENET, V10, P408, DOI 10.1016/0168-9525(94)90058-2; Siegel TN, 2005, MOL CELL BIOL, V25, P9586, DOI 10.1128/MCB.25.21.9586-9594.2005; Teixeira MT, 2005, CHROMOSOME RES, V13, P535, DOI 10.1007/s10577-005-0999-0; VANDERPLOEG LHT, 1984, CELL, V36, P459, DOI 10.1016/0092-8674(84)90239-3; Vanhamme L, 2000, MOL MICROBIOL, V36, P328, DOI 10.1046/j.1365-2958.2000.01844.x; vanLeeuwen F, 1996, NUCLEIC ACIDS RES, V24, P2476, DOI 10.1093/nar/24.13.2476; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; Wang RC, 2004, CELL, V119, P355, DOI 10.1016/j.cell.2004.10.011; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Zhang XD, 1998, EMBO J, V17, P6404, DOI 10.1093/emboj/17.21.6404	68	125	125	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 2	2009	137	1					99	109		10.1016/j.cell.2009.01.037	http://dx.doi.org/10.1016/j.cell.2009.01.037			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	427XV	19345190	Green Accepted, Bronze, Green Submitted			2022-12-01	WOS:000264813300017
J	Yu, YC; Bultje, RS; Wang, XQ; Shi, SH				Yu, Yong-Chun; Bultje, Ronald S.; Wang, Xiaoqun; Shi, Song-Hai			Specific synapses develop preferentially among sister excitatory neurons in the neocortex	NATURE			English	Article							RADIAL GLIAL-CELLS; CORTICAL-NEURONS; SYNAPTIC CONNECTIONS; CEREBRAL-CORTEX; VISUAL-CORTEX; RAT; PLASTICITY; CIRCUITS; LAYERS; MIGRATION	Neurons in the mammalian neocortex are organized into functional columns(1,2). Within a column, highly specific synaptic connections are formed to ensure that similar physiological properties are shared by neuron ensembles spanning from the pia to the white matter. Recent studies indicate that synaptic connectivity in the neocortex is sparse and highly specific(3-8) to allow even adjacent neurons to convey information independently(9-12). How this fine-scale microcircuit is constructed to create a functional columnar architecture at the level of individual neurons largely remains a mystery. Here we investigate whether radial clones of excitatory neurons arising from the same mother cell in the developing neocortex serve as a substrate for the formation of this highly specific microcircuit. We labelled ontogenetic radial clones of excitatory neurons in the mouse neocortex by in utero intraventricular injection of enhanced green fluorescent protein (EGFP)-expressing retroviruses around the onset of the peak phase of neocortical neurogenesis. Multiple-electrode whole-cell recordings were performed to probe synapse formation among these EGFP-labelled sister excitatory neurons in radial clones and the adjacent non-siblings during postnatal stages. We found that radially aligned sister excitatory neurons have a propensity for developing unidirectional chemical synapses with each other rather than with neighbouring non-siblings. Moreover, these synaptic connections display the same interlaminar directional preference as those observed in the mature neocortex. These results indicate that specific microcircuits develop preferentially within ontogenetic radial clones of excitatory neurons in the developing neocortex and contribute to the emergence of functional columnar micro-architectures in the mature neocortex.	[Yu, Yong-Chun; Bultje, Ronald S.; Wang, Xiaoqun; Shi, Song-Hai] Mem Sloan Kettering Canc Ctr, Dev Biol Program, New York, NY 10065 USA; [Bultje, Ronald S.] Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Cornell University	Shi, SH (corresponding author), Mem Sloan Kettering Canc Ctr, Dev Biol Program, 1275 York Ave, New York, NY 10065 USA.	shis@mskcc.org			March of Dimes Foundation; Whitehall Foundation; Klingenstein Foundation; DANA Foundation; Autism Speaks Foundation; National Alliance for Research on Schizophrenia and Depression (NARSAD); National Institutes of Health; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH083624] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024681] Funding Source: NIH RePORTER	March of Dimes Foundation(March of Dimes); Whitehall Foundation; Klingenstein Foundation(Klingenstein Philanthropies); DANA Foundation; Autism Speaks Foundation; National Alliance for Research on Schizophrenia and Depression (NARSAD)(French National Research Agency (ANR)NARSAD); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank A. L. Joyner, J. Kaltschmidt, Y. Hayashi and Y. Chin for comments on the manuscript; and S. C. Noctor and F. H. Gage for providing the 293gp NIT - GFP retrovirus packaging cell line; and the Shi laboratory members for insightful discussion. We are grateful for support from the March of Dimes Foundation, the Whitehall Foundation, the Klingenstein Foundation, the DANA Foundation, the Autism Speaks Foundation, the National Alliance for Research on Schizophrenia and Depression (NARSAD) and the National Institutes of Health ( to S.-H. S.).	CEPKO CL, 1990, COLD SH Q B, V55, P265; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; KORNACK DR, 1995, NEURON, V15, P311, DOI 10.1016/0896-6273(95)90036-5; Kozloski J, 2001, SCIENCE, V293, P868, DOI 10.1126/science.293.5531.868; Kriegstein A, 2006, NAT REV NEUROSCI, V7, P883, DOI 10.1038/nrn2008; Malatesta P, 2000, DEVELOPMENT, V127, P5253; Maldonado PE, 1997, SCIENCE, V276, P1551, DOI 10.1126/science.276.5318.1551; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; Micheva KD, 1996, J COMP NEUROL, V373, P340, DOI 10.1002/(SICI)1096-9861(19960923)373:3<340::AID-CNE3>3.0.CO;2-2; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P374, DOI 10.1152/jn.1957.20.4.374; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Ohki K, 2006, NATURE, V442, P925, DOI 10.1038/nature05019; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; Sato TR, 2007, PLOS BIOL, V5, P1440, DOI 10.1371/journal.pbio.0050189; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/S0896-6273(01)00542-6; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Stern EA, 2001, NEURON, V31, P305, DOI 10.1016/S0896-6273(01)00360-9; Tamamaki N, 2001, NEUROSCI RES, V41, P51, DOI 10.1016/S0168-0102(01)00259-0; Thomson AM, 2002, CEREB CORTEX, V12, P936, DOI 10.1093/cercor/12.9.936; Thomson AM, 2003, CEREB CORTEX, V13, P5, DOI 10.1093/cercor/13.1.5; WALSH C, 1993, NATURE, V362, P632, DOI 10.1038/362632a0; WALSH C, 1988, SCIENCE, V241, P1342, DOI 10.1126/science.3137660; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252; Yoshimura Y, 2005, NAT NEUROSCI, V8, P1552, DOI 10.1038/nn1565	30	226	228	1	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2009	458	7237					501	U3		10.1038/nature07722	http://dx.doi.org/10.1038/nature07722			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423YJ	19204731	Green Accepted			2022-12-01	WOS:000264532400043
J	Pouget, EM; Bomans, PHH; Goos, JACM; Frederik, PM; de With, G; Sommerdijk, NAJM				Pouget, Emilie M.; Bomans, Paul H. H.; Goos, Jeroen A. C. M.; Frederik, Peter M.; de With, Gijsbertus; Sommerdijk, Nico A. J. M.			The Initial Stages of Template-Controlled CaCO3 Formation Revealed by Cryo-TEM	SCIENCE			English	Article							CRYSTALLIZATION; MONOLAYERS; CALCITE; PHASE; MINERALIZATION; NANOSCALE	Biogenic calcium carbonate forms the inorganic component of seashells, otoliths, and many marine skeletons, and its formation is directed by an ordered template of macromolecules. Classical nucleation theory considers crystal formation to occur from a critical nucleus formed by the assembly of ions from solution. Using cryotransmission electron microscopy, we found that template-directed calcium carbonate formation starts with the formation of prenucleation clusters. Their aggregation leads to the nucleation of amorphous nanoparticles in solution. These nanoparticles assemble at the template and, after reaching a critical size, develop dynamic crystalline domains, one of which is selectively stabilized by the template. Our findings have implications for template-directed mineral formation in biological as well as in synthetic systems.	[Pouget, Emilie M.; Bomans, Paul H. H.; Goos, Jeroen A. C. M.; de With, Gijsbertus; Sommerdijk, Nico A. J. M.] Eindhoven Univ Technol, Lab Mat & Interface Chem, NL-5600 MB Eindhoven, Netherlands; [Pouget, Emilie M.; Bomans, Paul H. H.; Frederik, Peter M.; de With, Gijsbertus; Sommerdijk, Nico A. J. M.] Eindhoven Univ Technol, SoftMatter CryoTEM Unit, NL-5600 MB Eindhoven, Netherlands; [Frederik, Peter M.] Univ Maastricht, Dept Pathol, EM Unit, NL-6229 ER Maastricht, Netherlands	Eindhoven University of Technology; Eindhoven University of Technology; Maastricht University	Sommerdijk, NAJM (corresponding author), Eindhoven Univ Technol, Lab Mat & Interface Chem, POB 513, NL-5600 MB Eindhoven, Netherlands.	n.sommerdijk@tue.nl	Sommerdijk, Nico A.J.M./B-7239-2013; de With, G./E-3235-2014; goos, jeroen/AAL-8405-2020	Sommerdijk, Nico A.J.M./0000-0002-8956-195X; Goos, Jeroen/0000-0003-2010-7377; Pouget, Emilie/0000-0002-3175-6201	European Community [NMP4-CT-2006-033277]; Netherlands Organization for Scientific Research (NWO)	European Community(European Commission); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	Supported by the European Community (project code NMP4-CT-2006-033277) and the Netherlands Organization for Scientific Research (NWO). We thank A. Volkel and H. Colfen for performing and evaluating the ultracentrifugation measurements; D. Gebauer and A. Verch for time-dependent solution composition determination of the mineralization solutions; F. L. Boogaard, E. J. Creusen, J. J. van Roosmalen, and P. Moeskops for their contribution to the 3D reconstructions of the tomograms; and P. T. K. Chin for providing the CdSe nanorods.	Addadi L, 2006, CHEM-EUR J, V12, P981, DOI 10.1002/chem.200500980; Aizenberg J, 2005, SCIENCE, V309, P275, DOI 10.1126/science.1112255; Aizenberg J, 2003, SCIENCE, V299, P1205, DOI 10.1126/science.1079204; Beniash E, 1997, P ROY SOC B-BIOL SCI, V264, P461, DOI 10.1098/rspb.1997.0066; BRECEVIC L, 1989, J CRYST GROWTH, V98, P504, DOI 10.1016/0022-0248(89)90168-1; Davis ME, 2004, SCIENCE, V305, P480, DOI 10.1126/science.1099773; DiMasi E, 2003, CRYSTENGCOMM, V5, P346, DOI 10.1039/b309800a; Donners JJJM, 2002, CHEM-EUR J, V8, P2561, DOI 10.1002/1521-3765(20020603)8:11<2561::AID-CHEM2561>3.0.CO;2-3; Freeman CL, 2008, LANGMUIR, V24, P9607, DOI 10.1021/la800389g; Gebauer D, 2008, SCIENCE, V322, P1819, DOI 10.1126/science.1164271; Lam RSK, 2007, CRYSTENGCOMM, V9, P1226, DOI 10.1039/b710895h; Lee JRI, 2007, J AM CHEM SOC, V129, P10370, DOI 10.1021/ja071535w; Loste E, 2003, LANGMUIR, V19, P2830, DOI 10.1021/la026837k; Lowenstam H.A., 1989, BIOMINERALISATION; Luquet G, 2004, CR PALEVOL, V3, P515, DOI 10.1016/j.crpv.2004.07.015; MANN S, 1988, NATURE, V334, P692, DOI 10.1038/334692a0; Michel FM, 2008, CHEM MATER, V20, P4720, DOI 10.1021/cm800324v; Nickell S, 2006, NAT REV MOL CELL BIO, V7, P225, DOI 10.1038/nrm1861; Pichon BP, 2008, J AM CHEM SOC, V130, P4034, DOI 10.1021/ja710416h; Politi Y, 2004, SCIENCE, V306, P1161, DOI 10.1126/science.1102289; Politi Y, 2006, ADV FUNCT MATER, V16, P1289, DOI 10.1002/adfm.200600134; POSNER AS, 1975, ACCOUNTS CHEM RES, V8, P273, DOI 10.1021/ar50092a003; Quigley D, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2940322; RAJAM S, 1991, J CHEM SOC FARADAY T, V87, P727, DOI 10.1039/ft9918700727; Smith BL, 1999, NATURE, V399, P761, DOI 10.1038/21607; Sommerdijk NAJM, 2008, CHEM REV, V108, P4499, DOI 10.1021/cr078259o; Tang RK, 2004, ANGEW CHEM INT EDIT, V43, P2697, DOI 10.1002/anie.200353652; VOLMER M, 1939, KINETIK PHASENDBILDU; YOUNG JR, 1992, NATURE, V356, P516, DOI 10.1038/356516a0	29	688	701	18	608	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2009	323	5920					1455	1458		10.1126/science.1169434	http://dx.doi.org/10.1126/science.1169434			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417TP	19286549				2022-12-01	WOS:000264101700034
J	Harmon, JP; Moran, NA; Ives, AR				Harmon, Jason P.; Moran, Nancy A.; Ives, Anthony R.			Species Response to Environmental Change: Impacts of Food Web Interactions and Evolution	SCIENCE			English	Article							CLIMATE-CHANGE; GENETIC RESPONSES; PLANT; BIODIVERSITY; POPULATIONS; SYMBIONTS; STRESS; APHIDS; COSTS	How environmental change affects species abundances depends on both the food web within which species interact and their potential to evolve. Using field experiments, we investigated both ecological and evolutionary responses of pea aphids (Acyrthosiphon pisum), a common agricultural pest, to increased frequency of episodic heat shocks. One predator species ameliorated the decrease in aphid population growth with increasing heat shocks, whereas a second predator did not, with this contrast caused by behavioral differences between predators. We also compared aphid strains with stably inherited differences in heat tolerance caused by bacterial endosymbionts and showed the potential for rapid evolution for heat-shock tolerance. Our results illustrate how ecological and evolutionary complexities should be incorporated into predictions of the consequences of environmental change for species' populations.	[Harmon, Jason P.; Ives, Anthony R.] Univ Wisconsin, Dept Zool, Madison, WI 53706 USA; [Moran, Nancy A.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA	University of Wisconsin System; University of Wisconsin Madison; University of Arizona	Harmon, JP (corresponding author), Univ Wisconsin, Dept Zool, Madison, WI 53706 USA.	jharmon@wisc.edu	Harmon, Jason/AAW-3036-2021; Ives, Anthony/A-5698-2008; Moran, Nancy A/G-1591-2010	Harmon, Jason/0000-0002-2533-5005; Ives, Anthony/0000-0001-9375-9523; 	US-NSF;  [0313737]	US-NSF(National Science Foundation (NSF)); 	We thank G. Burke for screening aphids for symbionts; M. Meisner, D. Rowlands, and K. Smith for assistance with experiments; D. Frye and the staff of the University of Wisconsin Arlington Research Station for establishment and maintenance of alfalfa fields; and K. C. Abbott, S. R. Carpenter, M. A. Duffy, R. T. Gilman, C. Gratton, and W. E Snyder for insights and help with the manuscript. Supported by US-NSF grants 0313737 to N.A.M. and A.R.I.	Agrawal AA, 2006, Q REV BIOL, V81, P349, DOI 10.1086/511529; Cardinale BJ, 2003, ECOL LETT, V6, P857, DOI 10.1046/j.1461-0248.2003.00508.x; Clarke A, 2003, TRENDS ECOL EVOL, V18, P573, DOI 10.1016/j.tree.2003.08.007; DAVIS JJ, 1915, USDA B, V276, P5; de Mazancourt C, 2008, ECOL LETT, V11, P380, DOI 10.1111/j.1461-0248.2008.01152.x; Diffenbaugh NS, 2005, P NATL ACAD SCI USA, V102, P15774, DOI 10.1073/pnas.0506042102; Dunbar HE, 2007, PLOS BIOL, V5, P1006, DOI 10.1371/journal.pbio.0050096; Durant JM, 2007, CLIM RES, V33, P271, DOI 10.3354/cr033271; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; FROST TM, 1995, LINKING SPECIES & ECOSYSTEMS, P224; Gienapp P, 2008, MOL ECOL, V17, P167, DOI 10.1111/j.1365-294X.2007.03413.x; Hoffmann AA, 2008, NAT REV GENET, V9, P421, DOI 10.1038/nrg2339; IVES AR, 1995, ECOLOGY, V76, P926, DOI 10.2307/1939357; Jiang L, 2004, J ANIM ECOL, V73, P569, DOI 10.1111/j.0021-8790.2004.00830.x; Losey JE, 1997, NATURE, V388, P269, DOI 10.1038/40849; Memmott J, 2007, ECOL LETT, V10, P710, DOI 10.1111/j.1461-0248.2007.01061.x; Millenium Ecosystem Assessment, 2005, EC HUM WELLB GEN SYN; Montllor CB, 2002, ECOL ENTOMOL, V27, P189, DOI 10.1046/j.1365-2311.2002.00393.x; Moran NA, 2007, P NATL ACAD SCI USA, V104, P8627, DOI 10.1073/pnas.0611659104; Morris WF, 2008, ECOLOGY, V89, P19, DOI 10.1890/07-0774.1; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Post E, 2008, P NATL ACAD SCI USA, V105, P12353, DOI 10.1073/pnas.0802421105; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; Russell JA, 2006, P ROY SOC B-BIOL SCI, V273, P603, DOI 10.1098/rspb.2005.3348; Suttle KB, 2007, SCIENCE, V315, P640, DOI 10.1126/science.1136401; Tylianakis JM, 2008, ECOL LETT, V11, P1351, DOI 10.1111/j.1461-0248.2008.01250.x; Webster PJ, 2005, SCIENCE, V309, P1844, DOI 10.1126/science.1116448	27	167	178	6	175	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 6	2009	323	5919					1347	1350		10.1126/science.1167396	http://dx.doi.org/10.1126/science.1167396			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	414PC	19265021				2022-12-01	WOS:000263876700043
J	Gillick, MR				Gillick, Muriel R.			Controlling Off-Label Medication Use	ANNALS OF INTERNAL MEDICINE			English	Article							DRUGS	Off-label prescribing may lead to innovative new uses of old medications, is essential in such fields as pediatrics, and avoids the lengthy and expensive process of modifying U. S. Food and Drug Administration (FDA) drug labeling. Using medications for unapproved indications, however, raises concerns about patient safety when the drugs have a high potential for toxicity and generates economic concerns when their cost is high. A possible means of controlling the use of off-label drugs is to focus on medications used off-label that are both expensive and potentially risky. These are principally biotechnology drugs, such as recombinant enzymes, cytokines, and monoclonal antibodies. This article suggests a 2-step process for controlling use of such drugs, analogous to that used for devices. Once a drug is FDA approved, it would undergo scrutiny using the Centers for Medicare & Medicaid Services (CMS) National Coverage Determination method if its cost exceeds a specified benchmark-for example, $12 000, which is the average cost of a pacemaker. The CMS would pay only for off-label uses for which there is adequate evidence in its National Coverage Determination process. Other insurance companies would probably adopt the recommendations of CMS.	Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA 02215 USA	Harvard University; Harvard Medical School	Gillick, MR (corresponding author), Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, 133 Brookline Ave,6th Floor, Boston, MA 02215 USA.	mgillick@partners.org						Aggarwal S, 2008, NAT BIOTECHNOL, V26, P1227, DOI 10.1038/nbt1108-1227; [Anonymous], 2005, J ONCOL PRACT, V1, P102; Ansani N, 2006, AM J MED QUAL, V21, P255, DOI 10.1177/1062860606289020; Bennett WM, 2004, J AM SOC NEPHROL, V15, P830, DOI 10.1097/01.ASN.0000118323.41076.01; *BIOT IND ORG, GUID BIOT 2007; Boos J, 2003, ANN ONCOL, V14, P1, DOI 10.1093/annonc/mdg035; Centers for Medicare & Medicaid Services, 2021, MED COV DET PROC; *CTR MED MED SERV, NAT HLTH EXP 2007; EASTMAN P, 2005, ONCOLOGY TIMES, V27, P10; Eastman P., 2005, ONCOLOGY TIMES, V27, P8, DOI DOI 10.1097/01.COT.0000290944.45158.35; Gazarian M, 2006, MED J AUSTRALIA, V185, P544, DOI 10.5694/j.1326-5377.2006.tb00689.x; Giezen TJ, 2008, JAMA-J AM MED ASSOC, V300, P1887, DOI 10.1001/jama.300.16.1887; Graves Julia E, 2007, J Am Acad Dermatol, V56, pe55, DOI 10.1016/j.jaad.2006.07.019; Jacobson PD, 2007, JAMA-J AM MED ASSOC, V297, P205, DOI 10.1001/jama.297.2.205; Keenan PS, 2006, HEALTH AFFAIR, V25, P1260, DOI 10.1377/hlthaff.25.5.1260; Kocs D, 2003, AM J MANAG CARE, V9, P393; Maisel WH, 2004, ANN INTERN MED, V140, P296, DOI 10.7326/0003-4819-140-4-200402170-00012; Moore TJ, 2007, ARCH INTERN MED, V167, P1752, DOI 10.1001/archinte.167.16.1752; Rader RA, 2008, NAT BIOTECHNOL, V26, P743, DOI 10.1038/nbt0708-743; Radley DC, 2006, ARCH INTERN MED, V166, P1021, DOI 10.1001/archinte.166.9.1021; Ramsey SD, 2007, J CLIN ONCOL, V25, P175, DOI 10.1200/JCO.2006.08.9805; Stafford RS, 2008, NEW ENGL J MED, V358, P1427, DOI 10.1056/NEJMp0802107; Tunis SR, 2006, HEALTH AFFAIR, V25, P1218, DOI 10.1377/hlthaff.25.5.1218; Ward RM, 2002, PEDIATRICS, V110, P181; [No title captured]; 2003, HCUP FACT BOOK	26	52	56	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 3	2009	150	5					344	347		10.7326/0003-4819-150-5-200903030-00108	http://dx.doi.org/10.7326/0003-4819-150-5-200903030-00108			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417CC	19221367				2022-12-01	WOS:000264051700006
J	Kwiatkowski, TJ; Bosco, DA; LeClerc, AL; Tamrazian, E; Vanderburg, CR; Russ, C; Davis, A; Gilchrist, J; Kasarskis, EJ; Munsat, T; Valdmanis, P; Rouleau, GA; Hosler, BA; Cortelli, P; de Jong, PJ; Yoshinaga, Y; Haines, JL; Pericak-Vance, MA; Yan, J; Ticozzi, N; Siddique, T; McKenna-Yasek, D; Sapp, PC; Horvitz, HR; Landers, JE; Brown, RH				Kwiatkowski, T. J., Jr.; Bosco, D. A.; LeClerc, A. L.; Tamrazian, E.; Vanderburg, C. R.; Russ, C.; Davis, A.; Gilchrist, J.; Kasarskis, E. J.; Munsat, T.; Valdmanis, P.; Rouleau, G. A.; Hosler, B. A.; Cortelli, P.; de Jong, P. J.; Yoshinaga, Y.; Haines, J. L.; Pericak-Vance, M. A.; Yan, J.; Ticozzi, N.; Siddique, T.; McKenna-Yasek, D.; Sapp, P. C.; Horvitz, H. R.; Landers, J. E.; Brown, R. H., Jr.			Mutations in the FUS/TLS Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis	SCIENCE			English	Article							RNA-BINDING PROTEIN; PRO-ONCOPROTEIN TLS/FUS; TARDBP MUTATIONS; TLS; IDENTIFICATION; TRANSCRIPTION; LIPOSARCOMA; ACTIVATION; NUCLEAR; DISEASE	Amyotrophic lateral sclerosis (ALS) is a fatal degenerative motor neuron disorder. Ten percent of cases are inherited; most involve unidentified genes. We report here 13 mutations in the fused in sarcoma/translated in liposarcoma (FUS/TLS) gene on chromosome 16 that were specific for familial ALS. The FUS/TLS protein binds to RNA, functions in diverse processes, and is normally located predominantly in the nucleus. In contrast, the mutant forms of FUS/TLS accumulated in the cytoplasm of neurons, a pathology that is similar to that of the gene TAR DNA-binding protein 43 (TDP43), whose mutations also cause ALS. Neuronal cytoplasmic protein aggregation and defective RNA metabolism thus appear to be common pathogenic mechanisms involved in ALS and possibly in other neurodegenerative disorders.	[Kwiatkowski, T. J., Jr.; Bosco, D. A.; LeClerc, A. L.; Tamrazian, E.; Russ, C.; Davis, A.; Hosler, B. A.; Yan, J.; Ticozzi, N.; McKenna-Yasek, D.; Sapp, P. C.; Landers, J. E.; Brown, R. H., Jr.] Massachusetts Gen Hosp, Dept Neurol, Charlestown, MA 02129 USA; [Bosco, D. A.; LeClerc, A. L.; Landers, J. E.; Brown, R. H., Jr.] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA 01655 USA; [Vanderburg, C. R.] Massachusetts Gen Hosp, Massachusetts Gen Inst Neurodegenerat, Charlestown, MA 02129 USA; [Russ, C.] MIT, Broad Inst, Cambridge, MA 02141 USA; [Gilchrist, J.] Rhode Isl Hosp, Dept Neurol, Providence, RI 02912 USA; [Kasarskis, E. J.] Univ Kentucky, Vet Affairs Med Ctr, Dept Neurol, Lexington, KY 40511 USA; [Munsat, T.] Tufts Univ, Tufts New England Med Ctr, Dept Neurol, Boston, MA 02111 USA; [Valdmanis, P.; Rouleau, G. A.] Univ Montreal, Ctr Hosp, Ctr Rech, Dept Neurol, Montreal, PQ H2L 4M1, Canada; [Cortelli, P.] Univ Bologna, Dipartimento Sci Neurol, Neurol Clin, I-40123 Bologna, Italy; [de Jong, P. J.; Yoshinaga, Y.] Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA; [Haines, J. L.] Vanderbilt Univ, Ctr Human Genet Res Mol Physiol & Biophys, Nashville, TN 37240 USA; [Pericak-Vance, M. A.] Miami Inst Human Genet, Miami, FL 33136 USA; [Yan, J.; Siddique, T.] NW Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA; [Yan, J.; Siddique, T.] NW Feinberg Sch Med, Dept Mol & Cell Biol, Chicago, IL 60611 USA; [Ticozzi, N.] Univ Milan, Sch Med, Dept Neurol, Dino Ferrari Ctr,Ist Auxol Italiano, I-20149 Milan, Italy; [Sapp, P. C.; Horvitz, H. R.] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA	Harvard University; Massachusetts General Hospital; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Lifespan Health Rhode Island; Rhode Island Hospital; University of Kentucky; US Department of Veterans Affairs; Veterans Health Administration (VHA); Lexington VA Medical Center; Tufts Medical Center; Tufts University; Universite de Montreal; University of Bologna; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; Vanderbilt University; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; IRCCS Istituto Auxologico Italiano; University of Milan; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Kwiatkowski, TJ (corresponding author), Massachusetts Gen Hosp, Dept Neurol, 114 16th St, Charlestown, MA 02129 USA.	tkwiatkowski@partners.org; robert.brown@umassmed.edu	Siddique, Teepu/AAT-8166-2021; Ticozzi, Nicola/K-8094-2016; Cortelli, Pietro/K-6063-2016; Haines, Jonathan/C-3374-2012; Vanderburg, Charles/C-4516-2013	Ticozzi, Nicola/0000-0001-5963-7426; Haines, Jonathan/0000-0002-4351-4728; Vanderburg, Charles/0000-0001-8979-5054; Valdmanis, Paul/0000-0001-8840-6969; Siddique, Teepu/0000-0001-7293-9146; Cortelli, Pietro/0000-0002-3633-8818; Tamrazian, Eric/0000-0003-1935-5277	NIH [NS050557, NS050641]; Angel Fund; ALS Therapy Alliance; ALS Association Project ALS; Al-Athel ALS Research Foundation; Pierre L. de Bourgknecht ALS Research Foundation; The Les Turner ALS Foundation; Vena E. Schaff ALS Research Fund; Harold Post Research Professorship; Herbert and Florence C. Wenske Foundation; Ralph and Marian Falk Medical Research Trust; The David C. Asselin M.D. Memorial Fund; Les Turner ALS Foundation/Herbert C. Wenske Foundation Professorship; Help America Foundation; ALS Therapy Alliance, Inc.; Howard Hughes Medical Institute	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Angel Fund; ALS Therapy Alliance; ALS Association Project ALS; Al-Athel ALS Research Foundation; Pierre L. de Bourgknecht ALS Research Foundation; The Les Turner ALS Foundation; Vena E. Schaff ALS Research Fund; Harold Post Research Professorship; Herbert and Florence C. Wenske Foundation; Ralph and Marian Falk Medical Research Trust; The David C. Asselin M.D. Memorial Fund; Les Turner ALS Foundation/Herbert C. Wenske Foundation Professorship; Help America Foundation; ALS Therapy Alliance, Inc.; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We gratefully acknowledge I. Carr (University of Leeds, UK) for support with AutoSNPa and IBDfinder software, A. Storey for assistance with sequencing, C. LeClerc for genealogical investigations, and D. Crowe for administrative assistance. This work was supported by NIH grants NS050557 (R.H.B. and T.K.) and NS050641 (T.S., R.H.B., J.L. H., and M.P.-V.). R.H.B. also receives support from the Angel Fund, the ALS Therapy Alliance, the ALS Association Project ALS, the Al-Athel ALS Research Foundation, and the Pierre L. de Bourgknecht ALS Research Foundation. T.S. also receives support from The Les Turner ALS Foundation, Vena E. Schaff ALS Research Fund, Harold Post Research Professorship, Herbert and Florence C. Wenske Foundation, Ralph and Marian Falk Medical Research Trust, The David C. Asselin M.D. Memorial Fund, Les Turner ALS Foundation/Herbert C. Wenske Foundation Professorship, Help America Foundation and the ALS Therapy Alliance, Inc. H.R.H. is an investigator of and was supported by the Howard Hughes Medical Institute. R.H.B. is a cofounder of AviTx Inc., which targets development of ALS therapies. R.H.B. and T.J.K. have applied for a patent covering FUS mutations in ALS. We dedicate this report to the memories of Jimmy and Christopher Kennedy, Sharon Timlin, and Ginny Delvecchio.	Baechtold H, 1999, J BIOL CHEM, V274, P34337, DOI 10.1074/jbc.274.48.34337; Bertrand P, 1999, ONCOGENE, V18, P4515, DOI 10.1038/sj.onc.1203048; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; CROZAT A, 1993, NATURE, V363, P640, DOI 10.1038/363640a0; Doi H, 2008, J BIOL CHEM, V283, P6489, DOI 10.1074/jbc.M705306200; Fujii R, 2005, CURR BIOL, V15, P587, DOI 10.1016/j.cub.2005.01.058; Hicks GG, 2000, NAT GENET, V24, P175, DOI 10.1038/72842; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kuroda M, 2000, EMBO J, V19, P453, DOI 10.1093/emboj/19.3.453; Law Warren J., 2006, Briefings in Functional Genomics & Proteomics, V5, P8, DOI 10.1093/bfgp/ell015; Lerga A, 2001, J BIOL CHEM, V276, P6807, DOI 10.1074/jbc.M008304200; Morohoshi F, 1998, GENE, V221, P191, DOI 10.1016/S0378-1119(98)00463-6; Nelson LM, 1996, CLIN NEUROSCI, V3, P327; RABBITTS TH, 1993, NAT GENET, V4, P175, DOI 10.1038/ng0693-175; ROSEN DR, 1993, NATURE, V364, P362, DOI 10.1038/364362c0; Sapp PC, 2003, AM J HUM GENET, V73, P397, DOI 10.1086/377158; Simpson CL, 2009, HUM MOL GENET, V18, P472, DOI 10.1093/hmg/ddn375; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Van Deerlin VM, 2008, LANCET NEUROL, V7, P409, DOI 10.1016/S1474-4422(08)70071-1; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200; Yang L, 1998, J BIOL CHEM, V273, P27761, DOI 10.1074/jbc.273.43.27761	22	1852	1914	3	139	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2009	323	5918					1205	1208		10.1126/science.1166066	http://dx.doi.org/10.1126/science.1166066			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411XT	19251627				2022-12-01	WOS:000263687600036
J	Myint, PK; Luben, RN; Wareham, NJ; Bingham, SA; Khaw, KT				Myint, Phyo K.; Luben, Robert N.; Wareham, Nicholas J.; Bingham, Sheila A.; Khaw, Kay-Tee			Combined effect of health behaviours and risk of first ever stroke in 20 040 men and women over 11 years' follow-up in Norfolk cohort of European Prospective Investigation of Cancer (EPIC Norfolk): prospective population study	BRITISH MEDICAL JOURNAL			English	Article							PHYSICAL-ACTIVITY QUESTIONNAIRE; CORONARY HEART-DISEASE; MYOCARDIAL-INFARCTION; CARDIOVASCULAR-DISEASE; CIGARETTE-SMOKING; VITAMIN-C; MORTALITY; REPEATABILITY; VALIDITY; MARKERS	Objective To quantify the potential combined impact of four health behaviours on incidence of stroke in men and women living in the general community. Design Population based prospective study (EPIC-Norfolk). Setting Norfolk, United Kingdom. Participants 20 040 men and women aged 40-79 with no known stroke or myocardial infarction at baseline survey in 1993-7, living in the general community, and followed up to 2007. Main outcome measure Participants scored one point for each health behaviour: current non-smoking, physically not inactive, moderate alcohol intake (1-14 units a week), and plasma concentration of vitamin C >= 50 mu mol/l, indicating fruit and vegetable intake of at least five servings a day, for a total score ranging from 0 to 4. Results There were 599 incident strokes over 229 993 person years of follow-up; the average follow-up was 11. 5 years. After adjustment for age, sex, body mass index (BMI), systolic blood pressure, cholesterol concentration, history of diabetes and aspirin use, and social class, compared with people with the four health behaviours the relative risks for stroke for men and women were 1.15 (95% confidence interval 0.89 to 1.49) for three health behaviours, 1.58 (1.22 to 2.05) for two, 2.18 (1.63 to 2.92) for one, and 2.31 (1.33 to 4.02) for none (P<0.001 for trend). The relations were consistent in subgroups stratified by sex, age, body mass index, and social class, and after exclusion of deaths within two years. Conclusion Four health behaviours combined predict more than a twofold difference in incidence of stroke in men and women.	[Myint, Phyo K.] Univ E Anglia, Sch Med Hlth Policy & Practice, Norwich NR4 7TJ, Norfolk, England; [Myint, Phyo K.; Luben, Robert N.; Khaw, Kay-Tee] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Wareham, Nicholas J.] MRC, Epidemiol Unit, Cambridge, England; [Bingham, Sheila A.] MRC, Ctr Nutr Epidemiol Canc Prevent & Survival, Cambridge, England	University of East Anglia; University of Cambridge	Myint, PK (corresponding author), Univ E Anglia, Sch Med Hlth Policy & Practice, Norwich NR4 7TJ, Norfolk, England.	phyo.k.myint@uea.ac.uk	Khaw, Kay-Tee/AAZ-3209-2021; Luben, Robert N/H-5519-2015	Luben, Robert N/0000-0002-5088-6343	Cancer Research UK; Medical Research Council; Stroke Association; British Heart Foundation; Research Into Ageing; Academy of Medical Sciences; Wellcome Trust; MRC [MC_U105630924] Funding Source: UKRI; Medical Research Council [MC_U106179471, G0401527, MC_U105630924] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Stroke Association; British Heart Foundation(British Heart Foundation); Research Into Ageing; Academy of Medical Sciences(Academy of Medical Sciences (AMS)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	EPIC-Norfolk is supported by research programme grant funding from Cancer Research UK and the Medical Research Council with additional support from the Stroke Association, British Heart Foundation, Research Into Ageing, Academy of Medical Sciences, and Wellcome Trust.	Andersson SW, 2004, EUR J CLIN NUTR, V58, P1378, DOI 10.1038/sj.ejcn.1601980; BAIN C, 1978, LANCET, V1, P1087; BINGHAM SA, 1995, BRIT J NUTR, V73, P531, DOI 10.1079/BJN19950057; Day N, 1999, BRIT J CANCER, V80, P95; *DEP HLTH, 2005, NAT AUD OFF REP RED; Department of Health, 1999, SAV LIV OUR HLTH NAT; Goldstein LB, 2006, CIRCULATION, V113, pE873, DOI 10.1161/01.STR.0000223048.70103.F1; Hardoon SL, 2008, CIRCULATION, V117, P598, DOI 10.1161/CIRCULATIONAHA.107.705947; Hu G, 2005, STROKE, V36, P1994, DOI 10.1161/01.STR.0000177868.89946.0c; Jakes RW, 2003, EUR J CLIN NUTR, V57, P1089, DOI 10.1038/sj.ejcn.1601648; Kelly TN, 2008, STROKE, V39, P1688, DOI 10.1161/STROKEAHA.107.505305; Khaw KT, 2008, PLOS MED, V5, P39, DOI 10.1371/journal.pmed.0050012; Khaw KT, 2001, LANCET, V357, P657, DOI 10.1016/S0140-6736(00)04128-3; Liu S, 2000, AM J CLIN NUTR, V72, P922; Myint PK, 2008, AM J CLIN NUTR, V87, P64, DOI 10.1093/ajcn/87.1.64; Myint PK, 2006, NEUROEPIDEMIOLOGY, V27, P122, DOI 10.1159/000095551; PARISH S, 1995, BMJ-BRIT MED J, V311, P471, DOI 10.1136/bmj.311.7003.471; Psaltopoulou T, 2004, AM J CLIN NUTR, V80, P1012, DOI 10.1093/ajcn/80.4.1012; PURDON S, 1997, HLTH SURVEY ENGLAND, P123; RIEMERSMA RA, 1990, EUR J CLIN NUTR, V44, P143; Sauvaget C, 2003, STROKE, V34, P2355, DOI 10.1161/01.STR.0000089293.29739.97; Shohaimi S, 2004, EUR RESPIR J, V24, P157, DOI 10.1183/09031936.04.00088303; Wagner A, 2002, CIRCULATION, V105, P2247, DOI 10.1161/01.CIR.0000016345.58696.4F; Wareham NJ, 2003, PUBLIC HEALTH NUTR, V6, P407, DOI 10.1079/PHN2002439; Wareham NJ, 2002, INT J EPIDEMIOL, V31, P168, DOI 10.1093/ije/31.1.168	25	108	110	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 19	2009	338								b349	10.1136/bmj.b349	http://dx.doi.org/10.1136/bmj.b349			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417CH	19228771	Green Published, hybrid			2022-12-01	WOS:000264052200001
J	Solberg, KE				Solberg, Kristin Elisabeth			Iranian doctors' conviction could damage public health	LANCET			English	Editorial Material																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 14	2009	373	9663					533	533		10.1016/S0140-6736(09)60184-7	http://dx.doi.org/10.1016/S0140-6736(09)60184-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	406ZO	19230077	Green Published, Bronze			2022-12-01	WOS:000263333600014
J	Wang, K; Zhang, HT; Ma, DQ; Bucan, M; Glessner, JT; Abrahams, BS; Salyakina, D; Imielinski, M; Bradfield, JP; Sleiman, PMA; Kim, CE; Hou, CP; Frackelton, E; Chiavacci, R; Takahashi, N; Sakurai, T; Rappaport, E; Lajonchere, CM; Munson, J; Estes, A; Korvatska, O; Piven, J; Sonnenblick, LI; Retuerto, AIA; Herman, EI; Dong, HM; Hutman, T; Sigman, M; Ozonoff, S; Klin, A; Owley, T; Sweeney, JA; Brune, CW; Cantor, RM; Bernier, R; Gilbert, JR; Cuccaro, ML; McMahon, WM; Miller, J; State, MW; Wassink, TH; Coon, H; Levy, SE; Schultz, RT; Nurnberger, JI; Haines, JL; Sutcliffe, JS; Cook, EH; Minshew, NJ; Buxbaum, JD; Dawson, G; Grant, SFA; Geschwind, DH; Pericak-Vance, MA; Schellenberg, GD; Hakonarson, H				Wang, Kai; Zhang, Haitao; Ma, Deqiong; Bucan, Maja; Glessner, Joseph T.; Abrahams, Brett S.; Salyakina, Daria; Imielinski, Marcin; Bradfield, Jonathan P.; Sleiman, Patrick M. A.; Kim, Cecilia E.; Hou, Cuiping; Frackelton, Edward; Chiavacci, Rosetta; Takahashi, Nagahide; Sakurai, Takeshi; Rappaport, Eric; Lajonchere, Clara M.; Munson, Jeffrey; Estes, Annette; Korvatska, Olena; Piven, Joseph; Sonnenblick, Lisa I.; Retuerto, Ana I. Alvarez; Herman, Edward I.; Dong, Hongmei; Hutman, Ted; Sigman, Marian; Ozonoff, Sally; Klin, Ami; Owley, Thomas; Sweeney, John A.; Brune, Camille W.; Cantor, Rita M.; Bernier, Raphael; Gilbert, John R.; Cuccaro, Michael L.; McMahon, William M.; Miller, Judith; State, Matthew W.; Wassink, Thomas H.; Coon, Hilary; Levy, Susan E.; Schultz, Robert T.; Nurnberger, John I., Jr.; Haines, Jonathan L.; Sutcliffe, James S.; Cook, Edwin H.; Minshew, Nancy J.; Buxbaum, Joseph D.; Dawson, Geraldine; Grant, Struan F. A.; Geschwind, Daniel H.; Pericak-Vance, Margaret A.; Schellenberg, Gerard D.; Hakonarson, Hakon			Common genetic variants on 5p14.1 associate with autism spectrum disorders	NATURE			English	Article							GENOME-WIDE ASSOCIATION; BIPOLAR DISORDER; FAMILIAL RISK; LINKAGE; LOCI; UNDERCONNECTIVITY; DISCONNECTION; EXPRESSION; IDENTIFICATION; CHROMOSOME	Autism spectrum disorders (ASDs) represent a group of childhood neurodevelopmental and neuropsychiatric disorders characterized by deficits in verbal communication, impairment of social interaction, and restricted and repetitive patterns of interests and behaviour. To identify common genetic risk factors underlying ASDs, here we present the results of genome-wide association studies on a cohort of 780 families (3,101 subjects) with affected children, and a second cohort of 1,204 affected subjects and 6,491 control subjects, all of whom were of European ancestry. Six single nucleotide polymorphisms between cadherin 10 (CDH10) and cadherin 9 (CDH9)-two genes encoding neuronal cell-adhesion molecules-revealed strong association signals, with the most significant SNP being rs4307059 (P = 3.4 x 10(-8), odds ratio = 1.19). These signals were replicated in two independent cohorts, with combined P values ranging from 7.4 x 10(-8) to 2.1 x 10(-10). Our results implicate neuronal cell-adhesion molecules in the pathogenesis of ASDs, and represent, to our knowledge, the first demonstration of genome-wide significant association of common variants with susceptibility to ASDs.	[Wang, Kai; Zhang, Haitao; Glessner, Joseph T.; Imielinski, Marcin; Bradfield, Jonathan P.; Sleiman, Patrick M. A.; Kim, Cecilia E.; Hou, Cuiping; Frackelton, Edward; Chiavacci, Rosetta; Grant, Struan F. A.; Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Gen, Philadelphia, PA 19104 USA; [Ma, Deqiong; Salyakina, Daria; Gilbert, John R.; Cuccaro, Michael L.; Pericak-Vance, Margaret A.] Univ Miami, Miami Inst Human Genom, Miami, FL 33101 USA; [Ma, Deqiong; Salyakina, Daria; Gilbert, John R.; Cuccaro, Michael L.; Pericak-Vance, Margaret A.] Univ Miami, Dept Human Genet, Miami, FL 33101 USA; [Bucan, Maja] Univ Penn, Dept Genet, Philadelphia, PA 19014 USA; [Abrahams, Brett S.; Sonnenblick, Lisa I.; Retuerto, Ana I. Alvarez; Herman, Edward I.; Dong, Hongmei; Hutman, Ted; Sigman, Marian; Geschwind, Daniel H.] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90095 USA; [Abrahams, Brett S.; Sonnenblick, Lisa I.; Retuerto, Ana I. Alvarez; Herman, Edward I.; Dong, Hongmei; Hutman, Ted; Sigman, Marian; Geschwind, Daniel H.] Univ Calif Los Angeles, Ctr Autism Res & Treatment, Los Angeles, CA 90095 USA; [Takahashi, Nagahide; Sakurai, Takeshi; Buxbaum, Joseph D.] Mt Sinai Sch Med, Dept Psychiat, Seaver Autism Ctr Res & Treatment, New York, NY 10029 USA; [Rappaport, Eric; Levy, Susan E.; Schultz, Robert T.; Grant, Struan F. A.; Hakonarson, Hakon] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19014 USA; [Lajonchere, Clara M.] Univ So Calif & Autism Speaks, Dept Biomed Engn, Los Angeles, CA 90089 USA; [Munson, Jeffrey; Estes, Annette; Korvatska, Olena; Bernier, Raphael; Dawson, Geraldine] Univ Washington, Dept Psychiat, Seattle, WA 98105 USA; [Piven, Joseph] Univ N Carolina, Dept Psychiat, Chapel Hill, NC 27599 USA; [Piven, Joseph] Carolina Inst Dev Disabil, Chapel Hill, NC 27599 USA; [Ozonoff, Sally] Univ Calif Davis, MIND Inst, Sacramento, CA 95817 USA; [Ozonoff, Sally] Univ Calif Davis, Dept Psychiat & Behav Sci, Sacramento, CA 95817 USA; [Klin, Ami; State, Matthew W.] Yale Univ, Dept Genet, New Haven, CT 06520 USA; [Klin, Ami; State, Matthew W.] Yale Univ, Ctr Child Study, New Haven, CT 06520 USA; [Owley, Thomas; Sweeney, John A.; Brune, Camille W.; Cook, Edwin H.] Univ Illinois, Inst Juvenile Res, Chicago, IL 60608 USA; [Owley, Thomas; Sweeney, John A.; Brune, Camille W.; Cook, Edwin H.] Univ Illinois, Dept Psychiat, Chicago, IL 60608 USA; [Cantor, Rita M.] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; [McMahon, William M.; Miller, Judith; Coon, Hilary] Univ Utah, Dept Psychiat, Salt Lake City, UT 84132 USA; [Wassink, Thomas H.] Univ Iowa, Dept Psychiat, Iowa City, IA USA; [Nurnberger, John I., Jr.] Indiana Univ, Inst Psychiat Res, Indianapolis, IN 46202 USA; [Haines, Jonathan L.] Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN 37232 USA; [Sutcliffe, James S.] Vanderbilt Univ, Ctr Mol Neurosci, Nashville, TN 37232 USA; [Sutcliffe, James S.] Vanderbilt Univ, Vanderbilt Kennedy Ctr, Nashville, TN 37232 USA; [Minshew, Nancy J.] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15260 USA; [Minshew, Nancy J.] Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15260 USA; [Buxbaum, Joseph D.] Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA; [Buxbaum, Joseph D.] Mt Sinai Sch Med, Dept Neurosci, New York, NY 10029 USA; [Buxbaum, Joseph D.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA; [Schellenberg, Gerard D.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Miami; University of Miami; University of Pennsylvania; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Icahn School of Medicine at Mount Sinai; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Washington; University of Washington Seattle; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California Davis; University of California System; University of California Davis; Yale University; Yale University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of California System; University of California Los Angeles; Utah System of Higher Education; University of Utah; University of Iowa; Indiana University System; Indiana University-Purdue University Indianapolis; Vanderbilt University; Vanderbilt University; Vanderbilt University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Pennsylvania	Hakonarson, H (corresponding author), Childrens Hosp Philadelphia, Ctr Appl Gen, Philadelphia, PA 19104 USA.	hakonarson@chop.edu	Sutcliffe, James S/C-1348-2012; Haines, Jonathan/C-3374-2012; State, Matthew/W-2256-2019; Buxbaum, Joseph D/G-6001-2010; Rappaport, Eric/GRO-4051-2022; Takahashi, Nagahide/AAR-6268-2020	Sutcliffe, James S/0000-0001-5200-6007; Haines, Jonathan/0000-0002-4351-4728; Takahashi, Nagahide/0000-0002-7711-0297; Estes, Annette/0000-0003-2687-4155; Salyakina, Daria/0000-0003-3283-3691; Buxbaum, Joseph/0000-0001-8898-8313; Wassink, Thomas/0000-0002-0952-8333; Glessner, Joseph/0000-0001-5131-2811; Nurnberger, John/0000-0002-7674-1767; State, Matthew/0000-0003-1624-8302; Dawson, Geraldine/0000-0003-1410-2764; Munson, Jeffrey A/0000-0003-1798-8927; Sweeney, John/0000-0003-1752-2828; Grant, Struan/0000-0003-2025-5302	National Institute of Mental Health [1U24MH081810]; National Institute of Child Health and Human Development [NO1-HD-4-3368, NO1-HD-4-3383]; Institutional Development Award; Margaret Q. Landenberger Foundation; Cotswold Foundation [UL1-RR024134-03]; Mental Retardation and Developmental Disability Research Center; Beatrice and Stanley A. Seaver Foundation; Department of Veterans Affairs; NIH [MH64547, HD055782-01, MH0666730, MH061009, NS049261, HD055751, MH69359, M01-RR00064, MH081754, HD055784, NS26630, NS36768, MH080647]; Autism Genome Project Consortium; Autism Speaks; Medical Research Council (UK) and the Health Research Board (Ireland); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD055784] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P50HD055751, P50HD055782, P50HD055748] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000064, UL1RR024134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081754, U54MH066673, U24MH081810, R01MH064547, R01MH061009, R01MH080647, R01MH069359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036768, P01NS026630, R01NS049261] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Institutional Development Award; Margaret Q. Landenberger Foundation; Cotswold Foundation; Mental Retardation and Developmental Disability Research Center; Beatrice and Stanley A. Seaver Foundation; Department of Veterans Affairs(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Autism Genome Project Consortium; Autism Speaks; Medical Research Council (UK) and the Health Research Board (Ireland)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We gratefully thank all the children with ASDs and their families at the participating study sites who were enrolled in this study and all the control subjects who donated blood samples to Children's Hospital of Philadelphia (CHOP) for genetic research purposes. We also acknowledge the resources provided by the AGRE Consortium (D. H. Geschwind, M. Bucan, W. T. Brown, J. D. Buxbaum, R. M. Cantor, J. N. Constantino, T. C. Gilliam, C. M. Lajonchere, D. H. Ledbetter, C. Lese-Martin, J. Miller, S. F. Nelson, G. D. Schellenberg, C. A. Samango-Sprouse, S. Spence, M. State, R. E. Tanzi) and the participating families. AGRE is a program of Autism Speaks and is at present supported, in part, by grant 1U24MH081810 from the National Institute of Mental Health to C. M. Lajonchere (PI), and formerly by grant MH64547 to D. H. Geschwind (PI). We thank the technical staff at the Center for Applied Genomics at CHOP for producing the genotypes used for analyses, and the nursing, medical assistant and medical staff for their help with recruitment of patient and control subjects for the study. We thank R. Liu and I. Lindquist for helping with CNV validation. We thank D. J. Hedges, H. N. Cukier, J. L. McCauley, G. W. Beecham, H. H. Wright, R. K. Abramson, E. R. Martin and J. P. Hussman for their comments, advice and statistical support, and the laboratory core and the autism clinical personnel at the Miami Institute for Human Genomics and the autism clinical staff at the Vanderbilt Center for Human Genetics Research. A subset of the CAP participants was ascertained while M. A. P.-V. was a faculty member at Duke University. We thank the National Institutes of Health (NIH)-funded Developmental Brain and Tissue Bank at University of Maryland for access to the fetal brain tissues used in these studies (National Institute of Child Health and Human Development Contract no. NO1-HD-4-3368 and NO1-HD-4-3383). All genotyping of the AGRE and ACC cohort was supported by an Institutional Development Award to the Center for Applied Genomics (H. H.) at the Children's Hospital of Philadelphia. The study was supported in part by a Research Award from the Margaret Q. Landenberger Foundation (H. H.), a Research Development Award from the Cotswold Foundation (H. H. and S. F. A. G), UL1-RR024134-03 (H. H.), an Alavi-Dabiri fellowship from Mental Retardation and Developmental Disability Research Center at CHOP (K. W.), the Beatrice and Stanley A. Seaver Foundation (J. D. B.), the Department of Veterans Affairs (G. D. S.), NIH grants HD055782-01 (J. Munson, A. E., O. K., G. D. and G. D. S.), MH0666730 (J. D. B.), MH061009 and NS049261 (J. S. S.), HD055751 (E. H. C.), MH69359, M01-RR00064 and the Utah Autism Foundation (H. C., J. Miller and W. M. M.), MH64547, MH081754 (D. H. G.), HD055784 (D. H. G. and M. S.), NS26630, NS36768, MH080647 and a gift from the Hussman Foundation (M. A. P.-V.), the Autism Genome Project Consortium (B. S. A., J. P., C. W. B., D. H. G., T. H. W., W. M. M., H. C., J. I. N., J. S. S., E. H. C., J. Munson, A. E., O. K., J. D. B., B. D. and G. D. S.) funded by Autism Speaks, the Medical Research Council (UK) and the Health Research Board (Ireland). We also acknowledge the partial support to CAP cohort from the Autism Genome Project.	Abrahams BS, 2007, P NATL ACAD SCI USA, V104, P17849, DOI 10.1073/pnas.0706128104; Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Alarcon M, 2008, AM J HUM GENET, V82, P150, DOI 10.1016/j.ajhg.2007.09.005; ALKELAI A, 2008, AM J MED GENET B, V174, P233; Amaral DG, 2008, TRENDS NEUROSCI, V31, P137, DOI 10.1016/j.tins.2007.12.005; Arking DE, 2008, AM J HUM GENET, V82, P160, DOI 10.1016/j.ajhg.2007.09.015; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Bakkaloglu B, 2008, AM J HUM GENET, V82, P165, DOI 10.1016/j.ajhg.2007.09.017; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chung RH, 2007, AM J HUM GENET, V80, P59, DOI 10.1086/510630; Courchesne E, 2005, CURR OPIN NEUROBIOL, V15, P225, DOI 10.1016/j.conb.2005.03.001; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Freitag CM, 2007, MOL PSYCHIATR, V12, P2, DOI 10.1038/sj.mp.4001896; Frith C, 2004, LANCET NEUROL, V3, P577, DOI 10.1016/S1474-4422(04)00875-0; Geschwind DH, 2007, CURR OPIN NEUROBIOL, V17, P103, DOI 10.1016/j.conb.2007.01.009; Geschwind DH, 2001, AM J HUM GENET, V69, P463, DOI 10.1086/321292; Ghoussaini M, 2008, JNCI-J NATL CANCER I, V100, P962, DOI 10.1093/jnci/djn190; Gupta AR, 2007, BIOL PSYCHIAT, V61, P429, DOI 10.1016/j.biopsych.2006.06.020; Heinzen EL, 2008, PLOS BIOL, V6, P2869, DOI 10.1371/journal.pbio.1000001; Hughes JR, 2007, EPILEPSY BEHAV, V11, P20, DOI 10.1016/j.yebeh.2007.03.010; Just MA, 2004, BRAIN, V127, P1811, DOI 10.1093/brain/awh199; Kim HG, 2008, AM J HUM GENET, V82, P199, DOI 10.1016/j.ajhg.2007.09.011; Kools P, 1999, FEBS LETT, V452, P328, DOI 10.1016/S0014-5793(99)00672-9; Koshino H, 2008, CEREB CORTEX, V18, P289, DOI 10.1093/cercor/bhm054; Kuhn RM, 2009, NUCLEIC ACIDS RES, V37, pD755, DOI 10.1093/nar/gkn875; Kumar RA, 2008, HUM MOL GENET, V17, P628, DOI 10.1093/hmg/ddm376; Lauritsen MB, 2005, J CHILD PSYCHOL PSYC, V46, P963, DOI 10.1111/j.1469-7610.2004.00391.x; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; MA DQ, ANN HUM GEN IN PRESS, DOI DOI 10.1111/J.1469-1809.2008.00523.X; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Martin ER, 2000, AM J HUM GENET, V67, P146, DOI 10.1086/302957; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; Ovcharenko I, 2005, GENOME RES, V15, P137, DOI 10.1101/gr.3015505; Redies C, 2000, PROG NEUROBIOL, V61, P611, DOI 10.1016/S0301-0082(99)00070-2; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; Sklar P, 2008, MOL PSYCHIATR, V13, P558, DOI 10.1038/sj.mp.4002151; Sykes Nuala H., 2007, Expert Reviews in Molecular Medicine, V9, DOI 10.1017/S1462399407000452; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Veenstra-VanderWeele J, 2004, MOL PSYCHIATR, V9, P819, DOI 10.1038/sj.mp.4001505; Visel A, 2004, NUCLEIC ACIDS RES, V32, pD552, DOI 10.1093/nar/gkh029; Vorstman JAS, 2006, MOL PSYCHIATR, V11, P18, DOI 10.1038/sj.mp.4001757; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Witte JS, 2007, NAT GENET, V39, P579, DOI 10.1038/ng0507-579; 2009, AUTISM DEV DISABILIT	51	704	730	0	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2009	459	7246					528	533		10.1038/nature07999	http://dx.doi.org/10.1038/nature07999			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449ZS	19404256	Green Accepted, Green Published			2022-12-01	WOS:000266370500030
J	Nowacki, M; Higgins, BP; Maquilan, GM; Swart, EC; Doak, TG; Landweber, LF				Nowacki, Mariusz; Higgins, Brian P.; Maquilan, Genevieve M.; Swart, Estienne C.; Doak, Thomas G.; Landweber, Laura F.			A Functional Role for Transposases in a Large Eukaryotic Genome	SCIENCE			English	Article							INTERNAL ELIMINATED SEQUENCES; CILIATED PROTOZOA; OXYTRICHA-FALLAX; PRECISE EXCISION; ELEMENTS; DNA; REARRANGEMENT; TETRAHYMENA; TRIFALLAX; EVOLUTION	Despite comprising much of the eukaryotic genome, few transposons are active, and they usually confer no benefit to the host. Through an exaggerated process of genome rearrangement, Oxytricha trifallax destroys 95% of its germline genome during development. This includes the elimination of all transposon DNA. We show that germline-limited transposase genes play key roles in this process of genome-wide DNA excision, which suggests that transposases function in large eukaryotic genomes containing thousands of active transposons. We show that transposase gene expression occurs during germline-soma differentiation and that silencing of transposase by RNA interference leads to abnormal DNA rearrangement in the offspring. This study suggests a new important role in Oxytricha for this large portion of genomic DNA that was previously thought of as junk.	[Nowacki, Mariusz; Higgins, Brian P.; Maquilan, Genevieve M.; Swart, Estienne C.; Landweber, Laura F.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Doak, Thomas G.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Princeton University; Indiana University System; Indiana University Bloomington	Landweber, LF (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	lfl@princeton.edu	Nowacki, Mariusz/E-4485-2011	Nowacki, Mariusz/0000-0003-4894-2905; Doak, Thomas/0000-0001-5487-553X	NSF [0622112]; NIH [GM59708]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059708] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NSF grant 0622112 and NIH grant GM59708. We thank J. Wang for technical assistance. DNA sequences have been deposited in GenBank under accession numbers FJ666213 [GenBank] -FJ666314 [GenBank] (TBE transposases), FJ545743 [GenBank] [ribosomal DNA (rDNA) macronucleus], and FJ545744 [GenBank] (rDNA micronucleus).	Chalker DL, 1996, MOL CELL BIOL, V16, P3658; DOAK TG, 1994, P NATL ACAD SCI USA, V91, P942, DOI 10.1073/pnas.91.3.942; Doak TG, 1997, GENETICA, V101, P75, DOI 10.1023/A:1018331118647; Duharcourt S, 1998, MOL CELL BIOL, V18, P7075, DOI 10.1128/MCB.18.12.7075; HERRICK G, 1985, CELL, V43, P759, DOI 10.1016/0092-8674(85)90249-1; HUNTER DJ, 1989, GENE DEV, V3, P2101, DOI 10.1101/gad.3.12b.2101; Kapitonov VV, 2005, PLOS BIOL, V3, P998, DOI 10.1371/journal.pbio.0030181; Kidwell MG, 2001, EVOLUTION, V55, P1, DOI 10.1111/j.0014-3820.2001.tb01268.x; Klobutcher LA, 1997, PROG NUCLEIC ACID RE, V56, P1, DOI 10.1016/S0079-6603(08)61001-6; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Mollenbeck M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002330; Morgante M, 2007, CURR OPIN PLANT BIOL, V10, P149, DOI 10.1016/j.pbi.2007.02.001; Nowacki M, 2008, NATURE, V451, P153, DOI 10.1038/nature06452; ORGEL LE, 1980, NATURE, V284, P604, DOI 10.1038/284604a0; PRESCOTT DM, 1994, MICROBIOL REV, V58, P233, DOI 10.1128/MMBR.58.2.233-267.1994; Robertson HM, 1997, GENE, V205, P203, DOI 10.1016/S0378-1119(97)00472-1; Sarkar A, 2003, MOL GENET GENOMICS, V270, P173, DOI 10.1007/s00438-003-0909-0; Seegmiller A, 1996, MOL BIOL EVOL, V13, P1351, DOI 10.1093/oxfordjournals.molbev.a025581; WILLIAMS K, 1993, EMBO J, V12, P4593, DOI 10.1002/j.1460-2075.1993.tb06148.x; Witherspoon DJ, 1997, MOL BIOL EVOL, V14, P696, DOI 10.1093/oxfordjournals.molbev.a025809	20	84	86	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 15	2009	324	5929					935	938		10.1126/science.1170023	http://dx.doi.org/10.1126/science.1170023			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	19372392	Green Accepted			2022-12-01	WOS:000266048800038
J	Tahiliani, M; Koh, KP; Shen, YH; Pastor, WA; Bandukwala, H; Brudno, Y; Agarwal, S; Iyer, LM; Liu, DR; Aravind, L; Rao, A				Tahiliani, Mamta; Koh, Kian Peng; Shen, Yinghua; Pastor, William A.; Bandukwala, Hozefa; Brudno, Yevgeny; Agarwal, Suneet; Iyer, Lakshminarayan M.; Liu, David R.; Aravind, L.; Rao, Anjana			Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1	SCIENCE			English	Article							ACUTE MYELOID-LEUKEMIA; GLYCOSYLASE ACTIVITY; CXXC DOMAIN; BASE-J; DEMETHYLATION; CYTOSINE; METHYLATION; PROTEIN; METHYLTRANSFERASE; T(10/11)(Q22,Q23)	DNA cytosine methylation is crucial for retrotransposon silencing and mammalian development. In a computational search for enzymes that could modify 5-methylcytosine (5mC), we identified TET proteins as mammalian homologs of the trypanosome proteins JBP1 and JBP2, which have been proposed to oxidize the 5-methyl group of thymine. We show here that TET1, a fusion partner of the MLL gene in acute myeloid leukemia, is a 2-oxoglutarate (2OG)- and Fe(II)-dependent enzyme that catalyzes conversion of 5mC to 5-hydroxymethylcytosine (hmC) in cultured cells and in vitro. hmC is present in the genome of mouse embryonic stem cells, and hmC levels decrease upon RNA interference-mediated depletion of TET1. Thus, TET proteins have potential roles in epigenetic regulation through modification of 5mC to hmC.	[Shen, Yinghua; Brudno, Yevgeny; Liu, David R.] Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; [Shen, Yinghua; Brudno, Yevgeny; Liu, David R.] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Tahiliani, Mamta; Koh, Kian Peng; Pastor, William A.; Bandukwala, Hozefa; Rao, Anjana] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Tahiliani, Mamta; Koh, Kian Peng; Pastor, William A.; Bandukwala, Hozefa; Rao, Anjana] Immune Dis Inst, Boston, MA 02115 USA; [Agarwal, Suneet] Childrens Hosp Boston, Div Pediat Hematol Oncol, Boston, MA 02115 USA; [Agarwal, Suneet] Dana Farber Canc Inst, Boston, MA 02115 USA; [Iyer, Lakshminarayan M.; Aravind, L.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20894 USA	Harvard University; Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Liu, DR (corresponding author), Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA.	drliu@fas.harvard.edu; aravind@ncbi.nlm.nih.gov; arao@idi.harvard.edu	Iyer, Lakshminarayan M./H-2996-2019; Erlitzki, Noa/AHC-5346-2022; Koh, Kian Peng/S-6279-2016; Liu, David R./HCH-3132-2022	Koh, Kian Peng/0000-0003-2523-5175; Aravind, L/0000-0003-0771-253X; Brudno, Yevgeny/0000-0003-2963-3293	NIH [AI44432, K08 HL089150]; a Scholar Award from the Juvenile Diabetes Research Foundation; Harvard Stem Cell Institute [Seed]; Howard Hughes Medical Institute; NIH/NIGMS [R01GM065865]; American Heart Association postdoctoral fellowship; National Library of Medicine, NIH; Lady Tata Memorial postdoctoral fellowship; NSF Graduate Fellowships; Department of Defense graduate fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL089150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065865] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [ZIALM594244] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); a Scholar Award from the Juvenile Diabetes Research Foundation; Harvard Stem Cell Institute; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Heart Association postdoctoral fellowship(American Heart Association); National Library of Medicine, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Lady Tata Memorial postdoctoral fellowship; NSF Graduate Fellowships; Department of Defense graduate fellowship(United States Department of Defense); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We thank K. Kreuzer for the gift of the T4 phage and E. coli ER1656 and CR63; Charles Richardson, Udi Qimron, and Ben Beauchamp for advice and assistance in culturing T4 phage; Melissa Call for advice on production of recombinant proteins in insect cells; and Patrick Hogan for many helpful discussions. This work was supported by NIH grant AI44432, a Scholar Award from the Juvenile Diabetes Research Foundation, and a Seed grant from the Harvard Stem Cell Institute (to A.R.); Howard Hughes Medical Institute and NIH/NIGMS (R01GM065865) funding (to D.R.L.); an American Heart Association postdoctoral fellowship (to K.P.K.); intramural funds of the National Library of Medicine, NIH (to L.A. and L.M.I.); a Lady Tata Memorial postdoctoral fellowship (to H.B.); NIH award K08 HL089150 (to S.A.); NSF Graduate Fellowships (to W.A.P. and Y.B.); and a Department of Defense graduate fellowship (to W.A.P.).	ALEGRIA AH, 1967, BIOCHIM BIOPHYS ACTA, V149, P317, DOI 10.1016/0005-2787(67)90159-1; Allen MD, 2006, EMBO J, V25, P4503, DOI 10.1038/sj.emboj.7601340; ARAVIND L, 2001, GENOME BIOL, V2; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Borst P, 2008, ANNU REV MICROBIOL, V62, P235, DOI 10.1146/annurev.micro.62.081307.162750; CANNON SV, 1988, BIOCHEM BIOPH RES CO, V151, P1173, DOI 10.1016/S0006-291X(88)80489-3; CEDAR H, 1979, NUCLEIC ACIDS RES, V6, P2125, DOI 10.1093/nar/6.6.2125; Cliffe LJ, 2009, NUCLEIC ACIDS RES, V37, P1452, DOI 10.1093/nar/gkn1067; DELHOMMEAU F, 2008, AM SOC HEM ANN M EXP; EHRLICH M, 1981, SCIENCE, V212, P1350, DOI 10.1126/science.6262918; FLAKS JG, 1959, J BIOL CHEM, V234, P1501; Gal-Yam EN, 2008, ANNU REV MED, V59, P267, DOI 10.1146/annurev.med.59.061606.095816; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Jiricny J, 2008, CELL, V135, P1167, DOI 10.1016/j.cell.2008.12.008; Kangaspeska S, 2008, NATURE, V452, P112, DOI 10.1038/nature06640; Loenarz C, 2008, NAT CHEM BIOL, V4, P152, DOI 10.1038/nchembio0308-152; Lorsbach RB, 2003, LEUKEMIA, V17, P637, DOI 10.1038/sj.leu.2402834; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Netto LES, 1996, ARCH BIOCHEM BIOPHYS, V333, P233, DOI 10.1006/abbi.1996.0386; Ono R, 2002, CANCER RES, V62, P4075; Ooi SKT, 2008, CELL, V133, P1145, DOI 10.1016/j.cell.2008.06.009; Privat E, 1996, CHEM RES TOXICOL, V9, P745, DOI 10.1021/tx950182o; Que L, 1996, CHEM REV, V96, P2607, DOI 10.1021/cr960039f; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Rusmintratip V, 2000, P NATL ACAD SCI USA, V97, P14183, DOI 10.1073/pnas.97.26.14183; Simmen MW, 2008, GENOMICS, V92, P33, DOI 10.1016/j.ygeno.2008.03.009; Valinluck V, 2004, NUCLEIC ACIDS RES, V32, P4100, DOI 10.1093/nar/gkh739; Valinluck V, 2007, CANCER RES, V67, P946, DOI 10.1158/0008-5472.CAN-06-3123; Viguie F, 2005, LEUKEMIA, V19, P1411, DOI 10.1038/sj.leu.2403818; WYATT GR, 1953, BIOCHEM J, V55, P774, DOI 10.1042/bj0550774; Yu Z, 2007, NUCLEIC ACIDS RES, V35, P2107, DOI 10.1093/nar/gkm049; Zhu B, 2000, P NATL ACAD SCI USA, V97, P5135, DOI 10.1073/pnas.100107597	33	3955	4164	12	604	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 15	2009	324	5929					930	935		10.1126/science.1170116	http://dx.doi.org/10.1126/science.1170116			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	19372391	Green Submitted, Green Accepted			2022-12-01	WOS:000266048800037
J	Zimetbaum, PJ				Zimetbaum, Peter J.			Dronedarone for Atrial Fibrillation - An Odyssey	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RHYTHM		[Zimetbaum, Peter J.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Zimetbaum, Peter J.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Zimetbaum, PJ (corresponding author), Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.							Hohnloser SH, 2009, NEW ENGL J MED, V360, P668, DOI 10.1056/NEJMoa0803778; Kober L, 2008, NEW ENGL J MED, V358, P2678, DOI 10.1056/NEJMoa0800456; Singh BN, 2005, NEW ENGL J MED, V352, P1861, DOI 10.1056/NEJMoa041705; Singh BN, 2007, NEW ENGL J MED, V357, P987, DOI 10.1056/NEJMoa054686; Wyse DG, 2002, NEW ENGL J MED, V347, P1825, DOI 10.1056/nejmoa021328	5	49	58	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 30	2009	360	18					1811	1813		10.1056/NEJMp0902248	http://dx.doi.org/10.1056/NEJMp0902248			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	438MU	19403901				2022-12-01	WOS:000265560300003
J	Isalan, M; Morrison, M				Isalan, Mark; Morrison, Matthew			This title is false	NATURE			English	Editorial Material									[Isalan, Mark] Ctr Genom Regulat, EMBL Syst Biol Unit, Barcelona, Spain; [Morrison, Matthew] Univ Westminster, London W1R 8AL, England	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); European Molecular Biology Laboratory (EMBL); University of Westminster	Isalan, M (corresponding author), Ctr Genom Regulat, EMBL Syst Biol Unit, Barcelona, Spain.	isalan@crg.es		Isalan, Mark/0000-0002-4652-0365					0	7	7	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 23	2009	458	7241					969	969		10.1038/458969a	http://dx.doi.org/10.1038/458969a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	436KL	19396124	Bronze			2022-12-01	WOS:000265412900018
J	Patel, JC; Hueffer, K; Lam, TT; Galan, JE				Patel, Jayesh C.; Hueffer, Karsten; Lam, Tukiet T.; Galan, Jorge E.			Diversification of a Salmonella Virulence Protein Function by Ubiquitin-Dependent Differential Localization	CELL			English	Article							III SECRETION SYSTEMS; HOST-CELL; RECEPTOR ENDOCYTOSIS; NUCLEAR RESPONSES; GROWTH-FACTOR; RHO GTPASES; TYPHIMURIUM; DEGRADATION; INVASION; EFFECTORS	Many bacterial pathogens and symbionts utilize type III secretion systems to deliver bacterial effector proteins into host cells. These effector proteins have the capacity to modulate a large variety of cellular functions in a highly regulated manner. Here, we report that the phosphoinositide phosphatase SopB, a Salmonella Typhimurium type III secreted effector protein, diversifies its function by localizing to different cellular compartments in a ubiquitin-dependent manner. We show that SopB utilizes the same enzymatic activity to modulate actin-mediated bacterial internalization and Akt activation at the plasma membrane and vesicular trafficking and intracellular bacterial replication at the phagosome. Thus, by exploiting the host cellular machinery, Salmonella Typhimurium has evolved the capacity to broaden the functional repertoire of a virulence factor to maximize its ability to modulate cellular functions.	[Patel, Jayesh C.; Hueffer, Karsten; Galan, Jorge E.] Yale Univ, Sch Med, Sect Microbial Pathogenesis, New Haven, CT 06536 USA; [Lam, Tukiet T.] Yale Univ, Sch Med, WM Keck Fdn Biotechnol Resource Lab, New Haven, CT 06511 USA	Yale University; Yale University	Galan, JE (corresponding author), Yale Univ, Sch Med, Sect Microbial Pathogenesis, 295 Congress Ave, New Haven, CT 06536 USA.	jorge.galan@yale.edu		Hueffer, Karsten/0000-0001-7154-9066	Damon Runyon Cancer Research Foundation; Public Health Research [AI055472]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055472] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation; Public Health Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Walther Mothes for providing reagents, Christopher Case and Catarina Nogueira for caspase-1-deficient bone-marrow-derived macrophages, and members of the J.E.G. laboratory for critical review of this manuscript. K. H. was supported by a fellowship from the Damon Runyon Cancer Research Foundation. This work was supported by Public Health Research Grant AI055472 to J.E.G.	Bache KG, 2006, MOL BIOL CELL, V17, P2513, DOI 10.1091/mbc.E05-10-0915; Chen H, 1998, NATURE, V394, P793, DOI 10.1038/29555; Chen LM, 1996, SCIENCE, V274, P2115, DOI 10.1126/science.274.5295.2115; Collazo CM, 1997, MOL MICROBIOL, V24, P747, DOI 10.1046/j.1365-2958.1997.3781740.x; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Dikic I, 2003, BIOCHEM SOC T, V31, P1178; Drecktrah D, 2005, CELL MICROBIOL, V7, P105, DOI 10.1111/j.1462-5822.2004.00436.x; Fu YX, 1999, NATURE, V401, P293, DOI 10.1038/45829; GALAN JE, 1990, INFECT IMMUN, V58, P1879; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; Galan JE, 2007, CELL, V130, P192, DOI 10.1016/j.cell.2007.06.042; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Galyov E. E., 1997, MOL MICROBIOL, V25, P1903; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Haglund K, 2003, TRENDS BIOCHEM SCI, V28, P598, DOI 10.1016/j.tibs.2003.09.005; Hardt WD, 1998, CELL, V93, P815, DOI 10.1016/S0092-8674(00)81442-7; Hernandez LD, 2004, SCIENCE, V304, P1805, DOI 10.1126/science.1098188; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Hong KH, 1998, J BACTERIOL, V180, P1793, DOI 10.1128/JB.180.7.1793-1802.1998; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; KANIGA K, 1994, MOL MICROBIOL, V13, P555, DOI 10.1111/j.1365-2958.1994.tb00450.x; Kubori T, 2003, CELL, V115, P333, DOI 10.1016/S0092-8674(03)00849-3; Lee SY, 2004, P NATL ACAD SCI USA, V101, P546, DOI 10.1073/pnas.0307813100; Malerod L, 2007, TRAFFIC, V8, P1617, DOI 10.1111/j.1600-0854.2007.00630.x; Mallo GV, 2008, J CELL BIOL, V182, P741, DOI 10.1083/jcb.200804131; Marcus SL, 2002, CELL MICROBIOL, V4, P435, DOI 10.1046/j.1462-5822.2002.00202.x; Miao EA, 1999, MOL MICROBIOL, V34, P850, DOI 10.1046/j.1365-2958.1999.01651.x; Norris FA, 1998, P NATL ACAD SCI USA, V95, P14057, DOI 10.1073/pnas.95.24.14057; Patel JC, 2008, METHOD ENZYMOL, V439, P145, DOI 10.1016/S0076-6879(07)00411-9; Patel JC, 2006, J CELL BIOL, V175, P453, DOI 10.1083/jcb.200605144; Quezada CM, 2009, P NATL ACAD SCI USA, V106, P4864, DOI 10.1073/pnas.0811058106; Raiborg C, 2008, EXP CELL RES, V314, P801, DOI 10.1016/j.yexcr.2007.10.014; Rogers LD, 2008, J PROTEOMICS, V71, P97, DOI 10.1016/j.jprot.2008.01.011; Rohde JR, 2007, CELL HOST MICROBE, V1, P77, DOI 10.1016/j.chom.2007.02.002; Saksena S, 2007, TRENDS BIOCHEM SCI, V32, P561, DOI 10.1016/j.tibs.2007.09.010; Stebbins CE, 2001, NATURE, V412, P701, DOI 10.1038/35089000; Steele-Mortimer O, 2000, J BIOL CHEM, V275, P37718, DOI 10.1074/jbc.M008187200; Urbe S, 2005, ESSAYS BIOCHEM, V41, P81, DOI 10.1042/EB0410081; Waterman SR, 2003, CELL MICROBIOL, V5, P501, DOI 10.1046/j.1462-5822.2003.00294.x; Zhang Y, 2006, MOL MICROBIOL, V62, P786, DOI 10.1111/j.1365-2958.2006.05407.x; Zhou DG, 2001, MOL MICROBIOL, V39, P248, DOI 10.1046/j.1365-2958.2001.02230.x	42	121	125	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 17	2009	137	2					283	294		10.1016/j.cell.2009.01.056	http://dx.doi.org/10.1016/j.cell.2009.01.056			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	437AB	19379694	Bronze, Green Accepted			2022-12-01	WOS:000265456800021
J	Fischer, J; Koch, L; Emmerling, C; Vierkotten, J; Peters, T; Bruning, JC; Ruther, U				Fischer, Julia; Koch, Linda; Emmerling, Christian; Vierkotten, Jeanette; Peters, Thomas; Bruening, Jens C.; Ruether, Ulrich			Inactivation of the Fto gene protects from obesity	NATURE			English	Article							FUSED TOES FT; GENOME-WIDE ASSOCIATION; INSULIN-RESISTANCE; HORMONAL-CONTROL; ADULT OBESITY; FAT MASS; ADIPONECTIN; WEIGHT; HUMANS; MICE	Several independent, genome-wide association studies have identified a strong correlation between body mass index and polymorphisms in the human FTO gene(1-4). Common variants in the first intron define a risk allele predisposing to obesity, with homozygotes for the risk allele weighing approximately 3 kilograms more than homozygotes for the low risk allele(1). Nevertheless, the functional role of FTO in energy homeostasis remains elusive. Here we show that the loss of Fto in mice leads to postnatal growth retardation and a significant reduction in adipose tissue and lean body mass. The leanness of Fto-deficient mice develops as a consequence of increased energy expenditure and systemic sympathetic activation, despite decreased spontaneous locomotor activity and relative hyperphagia. Taken together, these experiments provide, to our knowledge, the first direct demonstration that Fto is functionally involved in energy homeostasis by the control of energy expenditure.	[Fischer, Julia; Emmerling, Christian; Vierkotten, Jeanette; Peters, Thomas; Ruether, Ulrich] Univ Dusseldorf, Inst Anim Dev & Mol Biol, D-40225 Dusseldorf, Germany; [Koch, Linda; Bruening, Jens C.] Univ Cologne, Dept Mouse Genet & Metab, Inst Genet, D-50674 Cologne, Germany; [Koch, Linda; Bruening, Jens C.] Univ Cologne, Dept Internal Med 2, D-50674 Cologne, Germany; [Koch, Linda; Bruening, Jens C.] Univ Cologne, CMMC, D-50674 Cologne, Germany; [Koch, Linda; Bruening, Jens C.] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50674 Cologne, Germany; [Koch, Linda; Bruening, Jens C.] Max Planck Inst Biol Ageing, D-50674 Cologne, Germany	Heinrich Heine University Dusseldorf; University of Cologne; University of Cologne; University of Cologne; University of Cologne; Max Planck Society	Ruther, U (corresponding author), Univ Dusseldorf, Inst Anim Dev & Mol Biol, Univ Str 1, D-40225 Dusseldorf, Germany.	jens.bruening@uni-koeln.de; ruether@uni-duesseldorf.de	Peters, Thomas/GQB-3622-2022	Koch, Linda/0000-0002-2943-1993	Deutsche Forschungsgemeinschaft; NGFNplus	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NGFNplus	The authors thank S. Kuschel and B. Hampel for technical assistance, S. Fischer for critical reading of this manuscript, as well as W. Stoffel, B. Jehnke and H. Bronneke for support during assessment of energy expenditure. This work was supported by the Deutsche Forschungsgemeinschaft (to U.R. and J.C.B.) and in part by NGFNplus (to U.R.).	Caro JF, 1996, DIABETES, V45, P1455, DOI 10.2337/diab.45.11.1455; Coll AP, 2007, CELL, V129, P251, DOI 10.1016/j.cell.2007.04.001; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Fredriksson R, 2008, ENDOCRINOLOGY, V149, P2062, DOI 10.1210/en.2007-1457; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Grunnet LG, 2009, J CLIN ENDOCR METAB, V94, P596, DOI 10.1210/jc.2008-1592; Jeon JY, 2006, DIABETES, V55, P428, DOI 10.2337/diabetes.55.02.06.db05-0203; Lara-Castro C, 2006, DIABETES, V55, P249, DOI 10.2337/diabetes.55.1.249; Lowell BB, 2003, J BIOL CHEM, V278, P29385, DOI 10.1074/jbc.R300011200; MIYOSHI H, 1988, J CLIN INVEST, V81, P1545, DOI 10.1172/JCI113487; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Pajvani UB, 2004, J BIOL CHEM, V279, P12152, DOI 10.1074/jbc.M311113200; Peters T, 1999, MAMM GENOME, V10, P983, DOI 10.1007/s003359901121; Peters T, 2002, MAMM GENOME, V13, P186, DOI 10.1007/s00335-001-2142-7; Sanchez-Pulido Luis, 2007, BMC Biochemistry, V8, P23, DOI 10.1186/1471-2091-8-23; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Speakman JR, 2008, OBESITY, V16, P1961, DOI 10.1038/oby.2008.318; Stratigopoulos G, 2008, AM J PHYSIOL-REG I, V294, pR1185, DOI 10.1152/ajpregu.00839.2007; Timpson NJ, 2008, AM J CLIN NUTR, V88, P971, DOI 10.1093/ajcn/88.4.971; VANDERHOEVEN F, 1994, DEVELOPMENT, V120, P2601; Vierkotten J, 2007, DEVELOPMENT, V134, P2569, DOI 10.1242/dev.003715; Waki H, 2003, J BIOL CHEM, V278, P40352, DOI 10.1074/jbc.M300365200; Wardle J, 2008, J CLIN ENDOCR METAB, V93, P3640, DOI 10.1210/jc.2008-0472; Wilson SW, 2004, DEV CELL, V6, P167, DOI 10.1016/S1534-5807(04)00027-9; WOLFE RR, 1987, NEW ENGL J MED, V317, P403, DOI 10.1056/NEJM198708133170702; Xu AM, 2005, J BIOL CHEM, V280, P18073, DOI 10.1074/jbc.M414231200; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	30	687	729	2	119	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 16	2009	458	7240					894	U10		10.1038/nature07848	http://dx.doi.org/10.1038/nature07848			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433CS	19234441				2022-12-01	WOS:000265182500044
J	Halford, J; Hunt, L; Millington, G				Halford, Julie; Hunt, Laura; Millington, George			A Patient's Journey Hyperhidrosis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Halford, Julie] Hampshire Clin, Old Basing RG24 7AL, England; [Millington, George] Norfolk & Norwich Univ Hosp, Norwich NR4 7UY, Norfolk, England	Norfolk & Norwich University Hospitals NHS Foundation Trust; Norfolk & Norwich University Hospital	Halford, J (corresponding author), Hampshire Clin, Old Basing RG24 7AL, England.	info@hyperhidrosisuk.org							0	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 7	2009	338								b1166	10.1136/bmj.b1166	http://dx.doi.org/10.1136/bmj.b1166			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	431ZH	19351672				2022-12-01	WOS:000265102800002
J	Perros, P; Neoh, C; Dickinson, J				Perros, Petros; Neoh, Christopher; Dickinson, Jane			Thyroid eye disease	BRITISH MEDICAL JOURNAL			English	Review							GRAVES OPHTHALMOPATHY; EUROPEAN GROUP; ORBITOPATHY; MANAGEMENT; GLUCOCORTICOIDS; HYPERTHYROIDISM; PATHOGENESIS; THERAPY		[Perros, Petros] Royal Victoria Infirm, Dept Endocrinol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Neoh, Christopher; Dickinson, Jane] Royal Victoria Infirm, Dept Ophthalmol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Perros, P (corresponding author), Royal Victoria Infirm, Dept Endocrinol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.	petros.perros@ncl.ac.uk		Perros, Petros/0000-0001-7320-5574				BALDESCHI L, 2008, GRAVES ORBITOPATHY M, P160; Bartalena L, 2005, EUR J ENDOCRINOL, V153, P13, DOI 10.1530/eje.1.01938; Bartalena L, 2008, EUR J ENDOCRINOL, V158, P273, DOI 10.1530/EJE-07-0666; BARTLEY GB, 1995, AM J OPHTHALMOL, V120, P511, DOI 10.1016/S0002-9394(14)72666-2; Boboridis K, 2008, GRAVES ORBITOPATHY M, P88; Coulter I, 2007, EUR J ENDOCRINOL, V157, P127, DOI 10.1530/EJE-07-0205; Dickinson AJ, 2001, CLIN ENDOCRINOL, V55, P283, DOI 10.1046/j.1365-2265.2001.01349.x; Gianoukakis AG, 2008, THYROID, V18, P953, DOI 10.1089/thy.2007.0405; Hart R H, 2003, Minerva Endocrinol, V28, P223; Hart RH, 2005, J OCUL PHARMACOL TH, V21, P328, DOI 10.1089/jop.2005.21.328; KENDALLTAYLOR P, 2008, GRAVES ORBITOPATHY M, P78; Khoo TK, 2007, THYROID, V17, P1013, DOI 10.1089/thy.2007.0185; Krassas Gerasimos E, 2007, Pediatr Endocrinol Rev, V4, P218; Mourits MP, 2002, BRIT J OPHTHALMOL, V86, P104; NEOH C, 2008, GRAVES ORBITOPATHY M, P188; ORGIAZZI J, 2008, GRAVES ORBITOPATHY M, P41; Perros P, 2006, EUR J ENDOCRINOL, V155, P207, DOI 10.1530/eje.1.02201; Perros P, 2005, J CLIN ENDOCR METAB, V90, P5321, DOI 10.1210/jc.2005-0507; Prabhakar BS, 2003, ENDOCR REV, V24, P802, DOI 10.1210/er.2002-0020; SALVI M, 1990, J CLIN ENDOCR METAB, V70, P89, DOI 10.1210/jcem-70-1-89; Wiersinga WM, 2006, EUR J ENDOCRINOL, V155, P387, DOI 10.1530/eje.1.02230; Wiersinga WM, 2007, NAT CLIN PRACT ENDOC, V3, P396, DOI 10.1038/ncpendmet0497	22	44	46	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 6	2009	338								b560	10.1136/bmj.b560	http://dx.doi.org/10.1136/bmj.b560			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417EE	19270020				2022-12-01	WOS:000264058500001
J	Hurley, R				Hurley, Richard			Public Health Bad blood: gay men and blood donation	BRITISH MEDICAL JOURNAL			English	Editorial Material							EVER HAD SEX		BMJ, London WC1H 9JR, England		Hurley, R (corresponding author), BMJ, London WC1H 9JR, England.	rhurley@bmj.com						[Anonymous], 2008, BBC NEWS        1104; Brooks JP, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b318; *CAN BLOOD SERV, IND DEF; *CARE2PETITIONSITE, ALL GAY PEOPL BLOOD; *DEP HLTH HUM SERV, 2006, BLOOD SAF AV ADV COM; *FOOD DRUG ADM, FDA POL BLOOD DON ME; *HLTH PROT AG, 2007, TEST TIM HIV OTH SEX; IRVINE C, 2008, DAILY TELEGRAPH 1112; *NAT BLOOD SERV EN, WHO CAN GIV BLOOD; *NHS BLOOD TRANSP, 2008, EXCL MEN WHO HAV SEX; *PRIM MIN OFF, 2007, BLOODB EP RESP; Roehr B, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b311; *SCOTT PARL INF CT, 2008, BRIEF PUBL PET COMM; Soldan K, 2003, VOX SANG, V84, P265, DOI 10.1046/j.1423-0410.2003.00295.x; *STON, STON CALLS END BLOOD; *TERR HIGG TRUST, BLOOD DON PEOPL HIGH; *UK BLOOD TRANSF S, 2007, BLOOD DON SEL MIN RI; 2008, BEHAV DONOR DEFERRAL; 2007, MCGILL TRIBUNE  0306; 2008, US NEWS         0204	20	12	12	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 26	2009	338								b779	10.1136/bmj.b779	http://dx.doi.org/10.1136/bmj.b779			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417DS	19246551				2022-12-01	WOS:000264056300003
J	Lauren, J; Gimbel, DA; Nygaard, HB; Gilbert, JW; Strittmatter, SM				Lauren, Juha; Gimbel, David A.; Nygaard, Haakon B.; Gilbert, John W.; Strittmatter, Stephen M.			Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers	NATURE			English	Article							ALZHEIMERS-DISEASE; NATURAL OLIGOMERS; TRANSGENIC MICE; BINDING-SITES; PRP; RECEPTORS; MEMORY; IDENTIFICATION; TRANSMISSION; A-BETA(1-42)	A pathological hallmark of Alzheimer's disease is an accumulation of insoluble plaque containing the amyloid-beta peptide of 40-42 amino acid residues(1). Prefibrillar, soluble oligomers of amyloid-beta have been recognized to be early and key intermediates in Alzheimer's-disease-related synaptic dysfunction(2-9). At nanomolar concentrations, soluble amyloid-beta oligomers block hippocampal long-term potentiation(7), cause dendritic spine retraction from pyramidal cells(5,8) and impair rodent spatial memory(2). Soluble amyloid-beta oligomers have been prepared from chemical syntheses, transfected cell culture supernatants, transgenic mouse brain and human Alzheimer's disease brain(2,4,7,9). Together, these data imply a high-affinity cell-surface receptor for soluble amyloid-beta oligomers on neurons-one that is central to the pathophysiological process in Alzheimer's disease. Here we identify the cellular prion protein (PrPC) as an amyloid-beta-oligomer receptor by expression cloning. Amyloid-beta oligomers bind with nanomolar affinity to PrPC, but the interaction does not require the infectious PrPSc conformation. Synaptic responsiveness in hippocampal slices from young adult PrP null mice is normal, but the amyloid-beta oligomer blockade of long-term potentiation is absent. Anti-PrP antibodies prevent amyloid-beta-oligomer binding to PrPC and rescue synaptic plasticity in hippocampal slices from oligomeric amyloid-beta. Thus, PrPC is a mediator of amyloid-beta-oligomer-induced synaptic dysfunction, and PrPC-specific pharmaceuticals may have therapeutic potential for Alzheimer's disease.	[Lauren, Juha; Gimbel, David A.; Nygaard, Haakon B.; Gilbert, John W.; Strittmatter, Stephen M.] Yale Univ, Sch Med, Cellular Neurosci Neurodegenerat & Repair Program, New Haven, CT 06536 USA	Yale University	Strittmatter, SM (corresponding author), Yale Univ, Sch Med, Cellular Neurosci Neurodegenerat & Repair Program, 333 Cedar St, New Haven, CT 06536 USA.	stephen.strittmatter@yale.edu	Strittmatter, Stephen/F-5739-2011	Strittmatter, Stephen/0000-0001-8188-3092	Brown-Coxe Postdoctoral Fellow; NIH [5T32GN07205]; Kavli Institute for Neuroscience at Yale University; Falk Medical Research Trust; NIDA; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS033020, R01NS042304, R01NS039962] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018343] Funding Source: NIH RePORTER	Brown-Coxe Postdoctoral Fellow; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kavli Institute for Neuroscience at Yale University; Falk Medical Research Trust; NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank S. Tomita for cRNAs encoding GluR1-4 and stargazin (also known as CACNG2), B. Chesebro for providing us the Prnp null mice, M. Schachner for providing the PrP-Fc expression vector, E. Flechsig, C. Weismann and D. Harris for providing the PrP C deletion expression plasmids, D. Westaway for the Sprn expression plasmid and P. Seeburg for N-methyl-D-aspartate receptor subunit cDNAs. We thank S. Sodi for assistance with mouse husbandry. We thank E. Folta-Stogniew for SEC, and C. Rahner and M. Graham for electron microscopy. J.L. is a Brown-Coxe Postdoctoral Fellow, J.W.G. is supported by NIH Medical Scientist training Program grant 5T32GN07205, and S. M. S. is a member of the Kavli Institute for Neuroscience at Yale University. This work was supported by research grants from the Falk Medical Research Trust and the NIH to S. M. S. The SEC was supported by a NIDA-funded Neuroproteomic Center.	Baumann F, 2007, EMBO J, V26, P538, DOI 10.1038/sj.emboj.7601510; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Chen SZ, 2003, MOL CELL NEUROSCI, V22, P227, DOI 10.1016/S1044-7431(02)00014-3; Chromy BA, 2003, BIOCHEMISTRY-US, V42, P12749, DOI 10.1021/bi030029q; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Curtis J, 2003, NEUROBIOL DIS, V13, P55, DOI 10.1016/S0969-9961(03)00017-2; Folta-Stogniew Ewa, 2006, V328, P97; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hepler RW, 2006, BIOCHEMISTRY-US, V45, P15157, DOI 10.1021/bi061850f; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Jackson GS, 2001, P NATL ACAD SCI USA, V98, P8531, DOI 10.1073/pnas.151038498; Khosravani H, 2008, J CELL BIOL, V181, P551, DOI 10.1083/jcb.200711002; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Li AM, 2007, EMBO J, V26, P548, DOI 10.1038/sj.emboj.7601507; Lledo PM, 1996, P NATL ACAD SCI USA, V93, P2403, DOI 10.1073/pnas.93.6.2403; MANSON JC, 1994, MOL NEUROBIOL, V8, P121, DOI 10.1007/BF02780662; Papassotiropoulos A, 2005, HUM MOL GENET, V14, P2241, DOI 10.1093/hmg/ddi228; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rajagopalan S, 2004, NAT CELL BIOL, V6, P756, DOI 10.1038/ncb1156; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Riemenschneider M, 2004, NEUROLOGY, V63, P364, DOI 10.1212/01.WNL.0000130198.72589.69; Schmitt-Ulms G, 2004, NAT BIOTECHNOL, V22, P724, DOI 10.1038/nbt969; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Takahashi T, 1998, NAT NEUROSCI, V1, P487, DOI 10.1038/2203; Venkitaramani DV, 2007, J NEUROSCI, V27, P11832, DOI 10.1523/JNEUROSCI.3478-07.2007; Viles JH, 1999, P NATL ACAD SCI USA, V96, P2042, DOI 10.1073/pnas.96.5.2042; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang HY, 2000, J BIOL CHEM, V275, P5626, DOI 10.1074/jbc.275.8.5626; Weissmann C, 2003, BRIT MED BULL, V66, P43, DOI 10.1093/bmb/66.1.43; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Yehiely F, 1997, NEUROBIOL DIS, V3, P339, DOI 10.1006/nbdi.1997.0130	37	1206	1262	2	260	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 26	2009	457	7233					1128	U84		10.1038/nature07761	http://dx.doi.org/10.1038/nature07761			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411VI	19242475	Green Accepted			2022-12-01	WOS:000263680100040
J	Mammoto, A; Connor, KM; Mammoto, T; Yung, CW; Huh, D; Aderman, CM; Mostoslavsky, G; Smith, LEH; Ingber, DE				Mammoto, Akiko; Connor, Kip M.; Mammoto, Tadanori; Yung, Chong Wing; Huh, Dongeun; Aderman, Christopher M.; Mostoslavsky, Gustavo; Smith, Lois E. H.; Ingber, Donald E.			A mechanosensitive transcriptional mechanism that controls angiogenesis	NATURE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CELL-SHAPE; EXTRACELLULAR-MATRIX; RETINAL NEOVASCULARIZATION; LINEAGE SPECIFICATION; CYTOSKELETAL TENSION; REGULATORY NETWORKS; GEOMETRIC CONTROL; TFII-I; VEGF	Angiogenesis is controlled by physical interactions between cells and extracellular matrix as well as soluble angiogenic factors, such as VEGF. However, the mechanism by which mechanical signals integrate with other microenvironmental cues to regulate neovascularization remains unknown. Here we show that the Rho inhibitor, p190RhoGAP (also known as GRLF1), controls capillary network formation in vitro in human microvascular endothelial cells and retinal angiogenesis in vivo by modulating the balance of activities between two antagonistic transcription factors, TFII-I (also known as GTF2I) and GATA2, that govern gene expression of the VEGF receptor VEGFR2 (also known as KDR). Moreover, this new angiogenesis signalling pathway is sensitive to extracellular matrix elasticity as well as soluble VEGF. This is, to our knowledge, the first known functional cross-antagonism between transcription factors that controls tissue morphogenesis, and that responds to both mechanical and chemical cues.	[Mammoto, Akiko; Mammoto, Tadanori; Yung, Chong Wing; Huh, Dongeun; Ingber, Donald E.] Childrens Hosp, Dept Pathol, Vasc Biol Program, Boston, MA 02115 USA; [Mammoto, Akiko; Mammoto, Tadanori; Yung, Chong Wing; Huh, Dongeun; Ingber, Donald E.] Childrens Hosp, Dept Pathol, Dept Surg, Boston, MA 02115 USA; [Connor, Kip M.; Aderman, Christopher M.; Smith, Lois E. H.] Childrens Hosp, Dept Ophthalmol, Boston, MA 02115 USA; [Mostoslavsky, Gustavo] Harvard Univ, Sch Med, Harvard Inst Med, Dept Genet, Boston, MA 02115 USA; [Ingber, Donald E.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Ingber, Donald E.] Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University	Ingber, DE (corresponding author), Childrens Hosp, Dept Pathol, Vasc Biol Program, Boston, MA 02115 USA.	donald.ingber@childrens.harvard.edu	Huh, Dong Eun/J-5715-2012; Ingber, Donald E/AAC-5894-2019; Huh, Dongeun/I-4152-2013	Connor, Kip/0000-0002-2048-9080; Mostoslavsky, Gustavo/0000-0002-0784-2169	NIH; V. Kann Rasmussen Foundation; Children's Hospital Mental Retardation and Developmental Disabilities Research Center; Research to Prevent Blindness Lew Wasserman Merit Award; American Heart Association; Children's Hospital House Officer Development Award; DoD Breast Cancer Innovator Award; NATIONAL CANCER INSTITUTE [P01CA045548] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); V. Kann Rasmussen Foundation; Children's Hospital Mental Retardation and Developmental Disabilities Research Center; Research to Prevent Blindness Lew Wasserman Merit Award(Research to Prevent Blindness (RPB)); American Heart Association(American Heart Association); Children's Hospital House Officer Development Award; DoD Breast Cancer Innovator Award(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank T. Polte, E. Pravda, M. de Bruijn and K. Johnson for their technical suggestions and assistance, T. Nakano and H. Sabe for providing plasmids, the National Institutes of Health (NIH) for providing VEGF, and D. Weitz for providing assistance with rheometry measurements. This work was supported by funds from the NIH (to D. E. I., L. E. H. S. and K. M. C.), V. Kann Rasmussen Foundation (to L. E. H. S.), Children's Hospital Mental Retardation and Developmental Disabilities Research Center (to L. E. H. S.), a Research to Prevent Blindness Lew Wasserman Merit Award (to L. E. H. S.), American Heart Association (to A. M.), and a Children's Hospital House Officer Development Award (to A. M.); D. E. I. is a recipient of a DoD Breast Cancer Innovator Award.	Arthur WT, 2000, CURR BIOL, V10, P719, DOI 10.1016/S0960-9822(00)00537-6; Cantor AB, 2001, CURR OPIN GENET DEV, V11, P513, DOI 10.1016/S0959-437X(00)00226-4; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Clark ER, 1939, AM J ANAT, V64, P251, DOI 10.1002/aja.1000640203; Connor KM, 2007, NAT MED, V13, P868, DOI 10.1038/nm1591; Dike LE, 1999, IN VITRO CELL DEV-AN, V35, P441; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 2007, ANNU REV MED, V58, P491, DOI 10.1146/annurev.med.58.061705.145635; Folkman J, 2004, NATURE, V427, P787, DOI 10.1038/427787a; FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0; Francke U, 1999, HUM MOL GENET, V8, P1947, DOI 10.1093/hmg/8.10.1947; Gottgens B, 2002, EMBO J, V21, P3039, DOI 10.1093/emboj/cdf286; Grogan JL, 2002, CURR OPIN IMMUNOL, V14, P366, DOI 10.1016/S0952-7915(02)00340-0; Huang S, 1999, NAT CELL BIOL, V1, pE131, DOI 10.1038/13043; INGBER DE, 1989, J CELL BIOL, V109, P317, DOI 10.1083/jcb.109.1.317; Jackson TA, 2005, J BIOL CHEM, V280, P29856, DOI 10.1074/jbc.M500335200; Kouros-Mehr H, 2006, CELL, V127, P1041, DOI 10.1016/j.cell.2006.09.048; Kumar S, 2006, BIOPHYS J, V90, P3762, DOI 10.1529/biophysj.105.071506; Mammoto A, 2004, J BIOL CHEM, V279, P26323, DOI 10.1074/jbc.M402725200; Mammoto A, 2007, J CELL SCI, V120, P456, DOI 10.1242/jcs.03353; Mammoto T, 2007, J BIOL CHEM, V282, P23910, DOI 10.1074/jbc.M702169200; Matsumoto T, 2001, Sci STKE, V2001, pre21, DOI 10.1126/stke.2001.112.re21; Matthews BD, 2006, J CELL SCI, V119, P508, DOI 10.1242/jcs.02760; Minami T, 2004, J BIOL CHEM, V279, P20626, DOI 10.1074/jbc.M308730200; Minami T, 2001, J BIOL CHEM, V276, P5395, DOI 10.1074/jbc.M008798200; Moore KA, 2005, DEV DYNAM, V232, P268, DOI 10.1002/dvdy.20237; Numaguchi Yasushi, 2003, Angiogenesis, V6, P55, DOI 10.1023/A:1025821517679; Pai SY, 2004, P NATL ACAD SCI USA, V101, P1993, DOI 10.1073/pnas.0308697100; Parker KK, 2002, FASEB J, V16, DOI 10.1096/fj.02-0038com; PATTERSON C, 1995, J BIOL CHEM, V270, P23111, DOI 10.1074/jbc.270.39.23111; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; PIERCE EA, 1995, P NATL ACAD SCI USA, V92, P905, DOI 10.1073/pnas.92.3.905; Polte TR, 2004, AM J PHYSIOL-CELL PH, V286, pC518, DOI 10.1152/ajpcell.00280.2003; Robinson CJ, 2001, J CELL SCI, V114, P853; Roy AL, 2001, GENE, V274, P1, DOI 10.1016/S0378-1119(01)00625-4; Roy AL, 2007, BBA-GENE STRUCT EXPR, V1769, P613, DOI 10.1016/j.bbaexp.2007.10.002; Sheibani N, 1998, MOL BIOL CELL, V9, P701, DOI 10.1091/mbc.9.4.701; Singh H, 2005, P NATL ACAD SCI USA, V102, P4949, DOI 10.1073/pnas.0500480102; Stalmans I, 2002, J CLIN INVEST, V109, P327, DOI 10.1172/jci0214362; Su ZJ, 2004, P NATL ACAD SCI USA, V101, P12212, DOI 10.1073/pnas.0404631101; Swiers G, 2006, DEV BIOL, V294, P525, DOI 10.1016/j.ydbio.2006.02.051; Wang N, 2002, AM J PHYSIOL-CELL PH, V282, pC606, DOI 10.1152/ajpcell.00269.2001; Wei J, 2005, MOL CELL, V17, P23, DOI 10.1016/j.molcel.2004.11.024; Wong CG, 2001, CURR EYE RES, V22, P140, DOI 10.1076/ceyr.22.2.140.5528; Yung CW, 2007, J BIOMED MATER RES A, V83A, P1039, DOI 10.1002/jbm.a.31431	47	386	405	3	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 26	2009	457	7233					1103	U57		10.1038/nature07765	http://dx.doi.org/10.1038/nature07765			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	411VI	19242469	Green Accepted			2022-12-01	WOS:000263680100034
J	Tricoci, P; Allen, JM; Kramer, JM; Califf, RM; Smith, SC				Tricoci, Pierluigi; Allen, Joseph M.; Kramer, Judith M.; Califf, Robert M.; Smith, Sidney C., Jr.			Scientific Evidence Underlying the ACC/AHA Clinical Practice Guidelines	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ASSOCIATION TASK-FORCE; ACUTE MYOCARDIAL-INFARCTION; PERIOPERATIVE CARDIOVASCULAR EVALUATION; ACUTE CORONARY SYNDROMES; CHRONIC HEART-FAILURE; CHRONIC STABLE ANGINA; ACC AHA GUIDELINES; AMERICAN-COLLEGE; EUROPEAN-SOCIETY; CARDIAC-CATHETERIZATION	Context The joint cardiovascular practice guidelines of the American College of Cardiology ( ACC) and the American Heart Association ( AHA) have become important documents for guiding cardiology practice and establishing benchmarks for quality of care. Objective To describe the evolution of recommendations in ACC/ AHA cardiovascular guidelines and the distribution of recommendations across classes of recommendations and levels of evidence. Data Sources and Study Selection Data from all ACC/ AHA practice guidelines issued from 1984 to September 2008 were abstracted by personnel in the ACC Science and Quality Division. Fifty- three guidelines on 22 topics, including a total of 7196 recommendations, were abstracted. Data Extraction The number of recommendations and the distribution of classes of recommendation ( I, II, and III) and levels of evidence ( A, B, and C) were determined. The subset of guidelines that were current as of September 2008 was evaluated to describe changes in recommendations between the first and current versions as well as patterns in levels of evidence used in the current versions. Results Among guidelines with at least 1 revision or update by September 2008, the number of recommendations increased from 1330 to 1973 ( + 48%) from the first to the current version, with the largest increase observed in use of class II recommendations. Considering the 16 current guidelines reporting levels of evidence, only 314 recommendations of 2711 total are classified as level of evidence A ( median, 11%), whereas 1246 ( median, 48%) are level of evidence C. Level of evidence significantly varies across categories of guidelines ( disease, intervention, or diagnostic) and across individual guidelines. Recommendations with level of evidence A are mostly concentrated in class I, but only 245 of 1305 class I recommendations have level of evidence A ( median, 19%). Conclusions Recommendations issued in current ACC/ AHA clinical practice guidelines are largely developed from lower levels of evidence or expert opinion. The proportion of recommendations for which there is no conclusive evidence is also growing. These findings highlight the need to improve the process of writing guidelines and to expand the evidence base from which clinical practice guidelines are derived.	[Tricoci, Pierluigi] Duke Univ, Duke Clin Res Inst, Durham, NC 27705 USA; [Tricoci, Pierluigi; Califf, Robert M.] Duke Univ, Div Cardiol, Durham, NC 27705 USA; [Kramer, Judith M.] Duke Univ, Div Gen Internal Med, Durham, NC 27705 USA; [Kramer, Judith M.] Duke Univ, Duke Ctr Educ & Res Therapeut, Durham, NC 27705 USA; [Califf, Robert M.] Duke Univ, Duke Translat Med Inst, Durham, NC 27705 USA; [Allen, Joseph M.] Amer Coll Cardiol Sci, Washington, DC USA; [Allen, Joseph M.] Qual Div, Washington, DC USA; [Smith, Sidney C., Jr.] Univ N Carolina, Ctr Cardiovasc Sci & Med, Chapel Hill, NC USA	Duke University; Duke University; Duke University; Duke University; Duke University; American College of Cardiology; University of North Carolina; University of North Carolina Chapel Hill	Tricoci, P (corresponding author), Duke Univ, Duke Clin Res Inst, 2400 Pratt St,Room 0311,Terrace Level, Durham, NC 27705 USA.	trico001@dcri.duke.edu			Agency for Healthcare Research and Quality [U18HS010548]; Rose Azus Cardiac Research Education Fund; Sharp Hospital Foundation, San Diego, California; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS010548] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Rose Azus Cardiac Research Education Fund; Sharp Hospital Foundation, San Diego, California; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This project was supported by grant U18HS010548 from the Agency for Healthcare Research and Quality. Dr Smith's efforts in this work were supported by a Distinguished Scholarship from the Rose Azus Cardiac Research Education Fund, Sharp Hospital Foundation, San Diego, California.	*ACC AHA SUBC NUCL, 1986, J AM COLL CARDIOL, V8, P1471; American College of Cardiology, 2006, J Am Coll Cardiol, V48, pe1, DOI 10.1016/j.jacc.2006.05.021; Anderson HV, 2005, CIRCULATION, V112, P2786, DOI 10.1161/CIRCULATIONAHA.105.553727; Anderson JL, 2007, J AM COLL CARDIOL, V50, P652, DOI 10.1016/j.jacc.2007.02.028; [Anonymous], 2001, CIRCULATION, V104, P2118; Antman Elliott M., 2004, J Am Coll Cardiol, V44, pE1, DOI 10.1016/j.jacc.2004.07.014; Armstrong PW, 2003, HEART, V89, P349, DOI 10.1136/heart.89.3.349; Bassand JP, 2008, EUR HEART J SUPPL, V10, pC22, DOI 10.1093/eurheartj/sun001; Bassand JP, 2007, EUR HEART J, V28, P1598, DOI 10.1093/eurheartj/ehm161; Blomstrom-Lundqvist Carina, 2003, Journal of the American College of Cardiology, V42, P1493, DOI 10.1016/j.jacc.2003.08.013; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Bonow RO, 1998, J AM COLL CARDIOL, V32, P1486, DOI 10.1016/S0735-1097(98)00454-9; Bonow RO, 2008, J AM COLL CARDIOL, V52, pE1, DOI 10.1016/j.jacc.2008.10.001; Braunwald E, 2002, J AM COLL CARDIOL, V40, P1366, DOI 10.1016/S0735-1097(02)02336-7; Braunwald E, 2000, J AM COLL CARDIOL, V36, P970, DOI 10.1016/S0735-1097(00)00889-5; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Califf RM, 2007, EUR HEART J SUPPL, V9, pB8, DOI 10.1093/eurheartj/sum002; Cheitlin MD, 2003, CIRCULATION, V108, P1146, DOI 10.1161/01.CIR.0000073597.57414.A9; Cheitlin MD, 1997, CIRCULATION, V95, P1686; Choudhry NK, 2002, JAMA-J AM MED ASSOC, V287, P612, DOI 10.1001/jama.287.5.612; Crawford MH, 1999, J AM COLL CARDIOL, V34, P912, DOI 10.1016/S0735-1097(99)00354-X; Crowley WF, 2004, JAMA-J AM MED ASSOC, V291, P1120, DOI 10.1001/jama.291.9.1120; Dubois Robert W, 2006, Dis Manag, V9, P210, DOI 10.1089/dis.2006.9.210; Eagle KA, 2002, J AM COLL CARDIOL, V39, P542, DOI 10.1016/S0735-1097(01)01788-0; Eagle KA, 1999, J AM COLL CARDIOL, V34, P1262, DOI 10.1016/S0735-1097(99)00389-7; Eagle KA, 1996, J AM COLL CARDIOL, V27, P910; Eagle Kim A, 2004, Circulation, V110, pe340; FEILD DJ, 1987, J AM COLL CARDIOL, V10, P935, DOI 10.1016/S0735-1097(87)80294-2; Field MJ, 1992, GUIDELINES CLIN PRAC; Fleisher LA, 2007, J AM COLL CARDIOL, V50, P1707, DOI 10.1016/j.jacc.2007.09.001; FORCINITO M, 1991, J AM COLL CARDIOL, V18, P1, DOI 10.1016/S0735-1097(10)80209-8; FORCINITO M, 1989, J AM COLL CARDIOL, V14, P1827; FORCINITO M, 1990, J AM COLL CARDIOL, V16, P1505; Frye R L, 1984, Circulation, V70, p331A; Furberg CD, 2000, JAMA-J AM MED ASSOC, V283, P1967; Fuster V, 2006, CIRCULATION, V114, pE257, DOI 10.1161/CIRCULATIONAHA.106.177292; Gibbons RJ, 2002, CIRCULATION, V106, P1883, DOI 10.1161/01.CIR.0000034670.06526.15; Gibbons RJ, 2003, CIRCULATION, V107, P149, DOI 10.1161/01.CIR.0000047041.66447.29; Gibbons RJ, 1997, J AM COLL CARDIOL, V30, P260; Gibbons RJ, 1999, J AM COLL CARDIOL, V33, P2092, DOI 10.1016/S0735-1097(99)00150-3; Gregoratos G, 2002, J AM COLL CARDIOL, V40, P1703, DOI 10.1016/S0735-1097(02)02528-7; Gregoratos G, 1998, J AM COLL CARDIOL, V31, P1175; Gunnar R M, 1990, Circulation, V82, P664; Hirsch AT, 2006, CIRCULATION, V113, pE463, DOI 10.1161/CIRCULATIONAHA.106.174526; Hoekstra JW, 2002, ACAD EMERG MED, V9, P1146, DOI 10.1111/j.1553-2712.2002.tb01569.x; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Hunt SA, 2001, CIRCULATION, V104, P2996, DOI 10.1161/hc4901.102568; KIRKLIN JW, 1991, CIRCULATION, V83, P1125; Klocke FJ, 2003, J AM COLL CARDIOL, V42, P1318, DOI 10.1016/j.jacc.2003.08.011; KNOEBEL SB, 1989, J AM COLL CARDIOL, V13, P249, DOI 10.1016/0735-1097(89)90578-0; Ko DT, 2008, J AM COLL CARDIOL, V51, P716, DOI 10.1016/j.jacc.2007.10.039; LaBresh KA, 2004, ARCH INTERN MED, V164, P203, DOI 10.1001/archinte.164.2.203; Manchanda Puneet, 2005, Yale J Health Policy Law Ethics, V5, P785; McMurray J, 2006, EUR HEART J, V27, P1773, DOI 10.1093/eurheartj/ehl123; Mehta RH, 2002, JAMA-J AM MED ASSOC, V287, P1269, DOI 10.1001/jama.287.10.1269; Moses H, 2005, JAMA-J AM MED ASSOC, V294, P1333, DOI 10.1001/jama.294.11.1333; PEPINE CJ, 1991, CIRCULATION, V84, P2213, DOI 10.1161/01.CIR.84.5.2213; RITCHIE JL, 1995, J AM COLL CARDIOL, V25, P521, DOI 10.1016/0735-1097(95)90027-6; RYAN TJ, 1993, CIRCULATION, V88, P2987, DOI 10.1161/01.CIR.88.6.2987; RYAN TJ, 1988, CIRCULATION, V78, P486, DOI 10.1161/01.CIR.78.2.486; Ryan TJ, 1996, J AM COLL CARDIOL, V28, P1328; Ryan TJ, 1999, J AM COLL CARDIOL, V34, P890, DOI 10.1016/S0735-1097(99)00351-4; Sawaya GF, 2007, ANN INTERN MED, V147, P871, DOI 10.7326/0003-4819-147-12-200712180-00007; Scanlon PJ, 1999, J AM COLL CARDIOL, V33, P1756, DOI 10.1016/S0735-1097(99)00126-6; SCHLANT RC, 1992, J AM COLL CARDIOL, V19, P473; SCHLANT RC, 1986, CIRCULATION, V74, pA653; Shea AM, 2007, AM J MED QUAL, V22, P170, DOI 10.1177/1062860607300291; Smith SC, 2001, J AM COLL CARDIOL, V37, P2215, DOI 10.1016/S0735-1097(01)01344-4; Smith SC, 2006, J AM COLL CARDIOL, V47, P2130, DOI 10.1016/j.jacc.2006.04.026; Sood R, 2007, NETH J MED, V65, P167; Strom BL, 2006, JAMA-J AM MED ASSOC, V295, P2072, DOI 10.1001/jama.295.17.2072; Taylor R, 2005, NATURE, V437, P1070, DOI 10.1038/4371070a; Tunis SR, 2007, HEALTH AFFAIR, V26, pW500, DOI 10.1377/hlthaff.26.4.w500; Tunis SR, 2003, JAMA-J AM MED ASSOC, V290, P1624, DOI 10.1001/jama.290.12.1624; *US FOOD DRUG ADM, FDA DUK LAUNCH PUBL; Wilensky GR, 2006, HEALTH AFFAIR, V25, pW572, DOI 10.1377/hlthaff.25.w572; WILLIAMS JF, 1995, J AM COLL CARDIOL, V26, P1376; Win HK, 2007, JAMA-J AM MED ASSOC, V297, P2001, DOI 10.1001/jama.297.18.2001; ZIPES DP, 1995, J AM COLL CARDIOL, V26, P555, DOI 10.1016/0735-1097(95)80037-H; Zipes DP, 2006, J AM COLL CARDIOL, V48, pe247, DOI [10.1016/j.jacc.2006.07.010, DOI 10.1016/J.JACC.2006.07.010]	80	643	658	0	22	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 25	2009	301	8					831	841		10.1001/jama.2009.205	http://dx.doi.org/10.1001/jama.2009.205			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	410WV	19244190	Green Published, Bronze			2022-12-01	WOS:000263609900024
J	Cruz, JA; Westhof, E				Cruz, Jose Almeida; Westhof, Eric			The Dynamic Landscapes of RNA Architecture	CELL			English	Article							GROUP-II INTRON; RIBOSOMAL-SUBUNIT; CRYSTAL-STRUCTURE; INDUCED FIT; TRANSCRIPTION; RIBOSWITCH; KINETICS; RIBOZYME; INTERMEDIATE; CATALYSIS	A wealth of information on RNA folding and ribonucleoprotein assembly has emerged from analyses of structures and from the use of innovative biophysical tools. Although integrating data obtained from static structures with dynamic measurements presents major challenges, such efforts are opening new vistas on the RNA folding landscape.	[Cruz, Jose Almeida; Westhof, Eric] Univ Strasbourg, CNRS, Inst Biol Mol & Cellulaire, Architecture & React ARN, F-67084 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Westhof, E (corresponding author), Univ Strasbourg, CNRS, Inst Biol Mol & Cellulaire, Architecture & React ARN, F-67084 Strasbourg, France.	e.westhof@ibmc.u-strasbg.fr		Almeida Cruz, Jose/0000-0003-1425-1444				Adilakshmi T, 2008, NATURE, V455, P1268, DOI 10.1038/nature07298; Amaral PP, 2008, SCIENCE, V319, P1787, DOI 10.1126/science.1155472; Bhaskaran H, 2007, NATURE, V449, P1014, DOI 10.1038/nature06235; Breaker RR, 2008, SCIENCE, V319, P1795, DOI 10.1126/science.1152621; Brodersen DE, 2002, J MOL BIOL, V316, P725, DOI 10.1006/jmbi.2001.5359; Chauhan S, 2008, J AM CHEM SOC, V130, P1296, DOI 10.1021/ja076166i; Geis M, 2008, J MOL BIOL, V379, P160, DOI 10.1016/j.jmb.2008.02.064; Greenleaf WJ, 2008, SCIENCE, V319, P630, DOI 10.1126/science.1151298; Jackson SA, 2006, RNA, V12, P2149, DOI 10.1261/rna.184206; Larson MH, 2008, CELL, V132, P971, DOI 10.1016/j.cell.2008.01.027; Lemay JF, 2006, CHEM BIOL, V13, P857, DOI 10.1016/j.chembiol.2006.06.010; Leontis NB, 2002, NUCLEIC ACIDS RES, V30, P3497, DOI 10.1093/nar/gkf481; Lescoute A, 2006, NUCLEIC ACIDS RES, V34, P6587, DOI 10.1093/nar/gkl963; Mahen EM, 2005, MOL CELL, V19, P27, DOI 10.1016/j.molcel.2005.05.025; Martick M, 2006, CELL, V126, P309, DOI 10.1016/j.cell.2006.06.036; Merino E, 2005, TRENDS GENET, V21, P260, DOI 10.1016/j.tig.2005.03.002; Montange RK, 2008, ANNU REV BIOPHYS, V37, P117, DOI 10.1146/annurev.biophys.37.032807.130000; Noeske J, 2007, NUCLEIC ACIDS RES, V35, P572, DOI 10.1093/nar/gkl1094; Pereira MJB, 2008, J MOL BIOL, V382, P496, DOI 10.1016/j.jmb.2008.07.020; Russell R, 2006, J MOL BIOL, V363, P531, DOI 10.1016/j.jmb.2006.08.024; Schultes EA, 2000, SCIENCE, V289, P448, DOI 10.1126/science.289.5478.448; STEINER M, 2008, NATL ACAD SCI US, V105, P13853; Stone MD, 2007, NATURE, V446, P458, DOI 10.1038/nature05600; Talkington MWT, 2005, NATURE, V438, P628, DOI 10.1038/nature04261; Tinoco I, 1999, J MOL BIOL, V293, P271, DOI 10.1006/jmbi.1999.3001; Toor N, 2008, SCIENCE, V320, P77, DOI 10.1126/science.1153803; Wagner A, 2008, P ROY SOC B-BIOL SCI, V275, P91, DOI 10.1098/rspb.2007.1137; Waldsich C, 2008, J MOL BIOL, V375, P572, DOI 10.1016/j.jmb.2007.10.052; Wickiser JK, 2005, MOL CELL, V18, P49, DOI 10.1016/j.molcel.2005.02.032; Wong TN, 2007, P NATL ACAD SCI USA, V104, P17995, DOI 10.1073/pnas.0705038104; Woodside MT, 2006, SCIENCE, V314, P1001, DOI 10.1126/science.1133601	31	226	231	2	36	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 20	2009	136	4					604	609		10.1016/j.cell.2009.02.003	http://dx.doi.org/10.1016/j.cell.2009.02.003			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	411XX	19239882	Bronze			2022-12-01	WOS:000263688200012
J	Sharp, PA				Sharp, Phillip A.			The Centrality of RNA	CELL			English	Article							GENE; TRANSCRIPTION; INTERFERENCE; ARGONAUTE; DNA	New roles for RNAs in biology continue to emerge, and a glance at the history of RNAs may prepare molecular biologists for future discoveries about these powerful molecules. A striking new role for RNAs is their widespread involvement in the regulation of numerous genes, suggesting that there is much yet to discover about these amazing cellular components.	[Sharp, Phillip A.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Sharp, Phillip A.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Sharp, PA (corresponding author), MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	sharppa@mit.edu						Aronica L, 2008, GENE DEV, V22, P2228, DOI 10.1101/gad.481908; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; Iida T, 2008, MOL CELL, V31, P178, DOI 10.1016/j.molcel.2008.07.003; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Ketting RF, 2000, NATURE, V404, P296, DOI 10.1038/35005113; Lacadie SA, 2006, GENE DEV, V20, P2055, DOI 10.1101/gad.1434706; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Salgado PS, 2006, PLOS BIOL, V4, P2274, DOI 10.1371/journal.pbio.0040434; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang YL, 2008, NATURE, V456, P921, DOI 10.1038/nature07666; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4	25	296	304	1	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 20	2009	136	4					577	580		10.1016/j.cell.2009.02.007	http://dx.doi.org/10.1016/j.cell.2009.02.007			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	411XX	19239877	Bronze, Green Published			2022-12-01	WOS:000263688200007
J	Visel, A; Blow, MJ; Li, ZR; Zhang, T; Akiyama, JA; Holt, A; Plajzer-Frick, I; Shoukry, M; Wright, C; Chen, F; Afzal, V; Ren, B; Rubin, EM; Pennacchio, LA				Visel, Axel; Blow, Matthew J.; Li, Zirong; Zhang, Tao; Akiyama, Jennifer A.; Holt, Amy; Plajzer-Frick, Ingrid; Shoukry, Malak; Wright, Crystal; Chen, Feng; Afzal, Veena; Ren, Bing; Rubin, Edward M.; Pennacchio, Len A.			ChIP-seq accurately predicts tissue-specific activity of enhancers	NATURE			English	Article							GENOME; CHROMATIN; SEQUENCE; VERTEBRATE; CONSTRAINT; PROMOTERS; DATABASE; IDENTIFICATION; COACTIVATOR; RECRUITMENT	A major yet unresolved quest in decoding the human genome is the identification of the regulatory sequences that control the spatial and temporal expression of genes. Distant- acting transcriptional enhancers are particularly challenging to uncover because they are scattered among the vast non- coding portion of the genome. Evolutionary sequence constraint can facilitate the discovery of enhancers, but fails to predict when and where they are active in vivo. Here we present the results of chromatin immunoprecipitation with the enhancer- associated protein p300 followed by massively parallel sequencing, and map several thousand in vivo binding sites of p300 in mouse embryonic forebrain, midbrain and limb tissue. We tested 86 of these sequences in a transgenic mouse assay, which in nearly all cases demonstrated reproducible enhancer activity in the tissues that were predicted by p300 binding. Our results indicate that in vivo mapping of p300 binding is a highly accurate means for identifying enhancers and their associated activities, and suggest that such data sets will be useful to study the role of tissue- specific enhancers in human biology and disease on a genome- wide scale.	[Visel, Axel; Blow, Matthew J.; Akiyama, Jennifer A.; Holt, Amy; Plajzer-Frick, Ingrid; Shoukry, Malak; Afzal, Veena; Rubin, Edward M.; Pennacchio, Len A.] Univ Calif Berkeley, Lawrence Berkeley Lab, Genom Div, Berkeley, CA 94720 USA; [Blow, Matthew J.; Zhang, Tao; Wright, Crystal; Chen, Feng; Rubin, Edward M.; Pennacchio, Len A.] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; [Li, Zirong; Ren, Bing] Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, La Jolla, CA 92093 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Ludwig Institute for Cancer Research; University of California System; University of California San Diego	Pennacchio, LA (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Genom Div, MS 84-171, Berkeley, CA 94720 USA.	LAPennacchio@lbl.gov	Visel, Axel/A-9398-2009; Ding, Cheng-Qiang/B-6287-2011; Blow, Matthew/G-6369-2012	Visel, Axel/0000-0002-4130-7784; Blow, Matthew/0000-0002-8844-9149; Pennacchio, Len/0000-0002-8748-3732	Berkeley-PGA; National Heart, Lung, & Blood Institute; National Human Genome Research Institute; American Heart Association; Ludwig Institute for Cancer Research; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062859] Funding Source: NIH RePORTER	Berkeley-PGA; National Heart, Lung, & Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); American Heart Association(American Heart Association); Ludwig Institute for Cancer Research; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We wish to thank R. Hosseini and S. Phouanenavong for technical support, and J. Rubenstein, J. Long, J. Choi and Y. Zhu for help with microarray experiments. This work was performed under the auspices of the US Department of Energy's Office of Science, Biological and Environmental Research Program and by the University of California, Lawrence Berkeley National Laboratory under contract no. DE-AC02-05CH11231, Lawrence Livermore National Laboratory under contract no. DE-AC52-07NA27344, and Los Alamos National Laboratory under contract no. DE-AC02-06NA25396. L. A. P. and E. M. R. were supported by the Berkeley-PGA, under the Programs for Genomic Applications, funded by National Heart, Lung, & Blood Institute, and L. A. P. by the National Human Genome Research Institute. A. V. was supported by an American Heart Association postdoctoral fellowship. B. R. was supported by grants from the National Human Genome Research Institute and the Ludwig Institute for Cancer Research.	Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Barrera LO, 2008, GENOME RES, V18, P46, DOI 10.1101/gr.6654808; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Blow MJ, 2008, GENOME RES, V18, P1347, DOI 10.1101/gr.076091.108; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cheng Y, 2008, GENOME RES, V18, P1896, DOI 10.1101/gr.083089.108; Cooper GM, 2008, GENOME RES, V18, P201, DOI 10.1101/gr.7205808; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; de la Calle-Mustienes E, 2005, GENOME RES, V15, P1061, DOI 10.1101/gr.4004805; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; Eckner R, 1996, GENE DEV, V10, P2478, DOI 10.1101/gad.10.19.2478; Ge K, 2002, NATURE, V417, P563, DOI 10.1038/417563a; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Hallikas O, 2006, CELL, V124, P47, DOI 10.1016/j.cell.2005.10.042; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Holland LZ, 2008, GENOME RES, V18, P1100, DOI 10.1101/gr.073676.107; Karolchik D, 2008, NUCLEIC ACIDS RES, V36, pD773, DOI 10.1093/nar/gkm966; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; KOTHARY R, 1988, NATURE, V335, P435, DOI 10.1038/335435a0; Krawchuk D, 2008, DEV DYNAM, V237, P1183, DOI 10.1002/dvdy.21514; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Margulies EH, 2007, GENOME RES, V17, P760, DOI 10.1101/gr.6034307; MARSHALL H, 1994, NATURE, V370, P567, DOI 10.1038/370567a0; Maston GA, 2006, ANNU REV GENOM HUM G, V7, P29, DOI 10.1146/annurev.genom.7.080505.115623; McGaughey DM, 2008, GENOME RES, V18, P252, DOI 10.1101/gr.6929408; Merika M, 1998, MOL CELL, V1, P277, DOI 10.1016/S1097-2765(00)80028-3; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mikkelsen TS, 2007, NATURE, V447, P167, DOI 10.1038/nature05805; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Pennacchio LA, 2007, GENOME RES, V17, P201, DOI 10.1101/gr.5972507; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Prabhakar S, 2006, GENOME RES, V16, P855, DOI 10.1101/gr.4717506; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Robertson AG, 2008, GENOME RES, V18, P1906, DOI 10.1101/gr.078519.108; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Schones DE, 2008, NAT REV GENET, V9, P179, DOI 10.1038/nrg2270; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Visel A, 2008, NAT GENET, V40, P158, DOI 10.1038/ng.2007.55; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wederell ED, 2008, NUCLEIC ACIDS RES, V36, P4549, DOI 10.1093/nar/gkn382; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Xi HL, 2007, PLOS GENET, V3, P1377, DOI 10.1371/journal.pgen.0030136; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4	53	1191	1231	4	177	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2009	457	7231					854	858		10.1038/nature07730	http://dx.doi.org/10.1038/nature07730			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406AF	19212405	Green Submitted, Green Accepted			2022-12-01	WOS:000263266700039
J	Steigemann, P; Wurzenberger, C; Schmitz, MHA; Held, M; Guizetti, J; Maar, S; Gerlich, DW				Steigemann, Patrick; Wurzenberger, Claudia; Schmitz, Michael H. A.; Held, Michael; Guizetti, Julien; Maar, Sandra; Gerlich, Daniel W.			Aurora B-Mediated Abscission Checkpoint Protects against Tetraploidization	CELL			English	Article							CHROMOSOME SEGREGATION; ANAPHASE BRIDGES; IN-VITRO; CYTOKINESIS; CELLS; CANCER; PHOSPHORYLATION; NONDISJUNCTION; LOCALIZATION; PROGRESSION	Genomic abnormalities are often seen in tumor cells, and tetraploidization, which results from failures during cytokinesis, is presumed to be an early step in cancer formation. Here, we report a cell division control mechanism that prevents tetraploidization in human cells with perturbed chromosome segregation. First, we found that Aurora B inactivation promotes completion of cytokinesis by abscission. Chromosome bridges sustained Aurora B activity to posttelophase stages and thereby delayed abscission at stabilized intercellular canals. This was essential to suppress tetraploidization by furrow regression in a pathway further involving the phosphorylation of mitotic kinesin-like protein 1 (Mklp1). We propose that Aurora B is part of a sensor that responds to unsegregated chromatin at the cleavage site. Our study provides evidence that in human cells abscission is coordinated with the completion of chromosome segregation to protect against tetraploidization by furrow regression.	[Steigemann, Patrick; Wurzenberger, Claudia; Schmitz, Michael H. A.; Held, Michael; Guizetti, Julien; Maar, Sandra; Gerlich, Daniel W.] Swiss Inst Technol Zurich ETHZ, Inst Biochem, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Gerlich, DW (corresponding author), Swiss Inst Technol Zurich ETHZ, Inst Biochem, Schafmattstr 18, CH-8093 Zurich, Switzerland.	daniel.gerlich@bc.biol.ethz.ch	Gerlich, Daniel Wolfram W/A-6991-2016; Guizetti, Julien/AAF-3793-2020	Gerlich, Daniel Wolfram W/0000-0003-1637-3365; Guizetti, Julien/0000-0002-8762-4259; Guizetti, Julien/0000-0002-7735-4689				Acilan C, 2007, GENE CHROMOSOME CANC, V46, P522, DOI 10.1002/gcc.20425; Caldwell CM, 2007, J CELL BIOL, V178, P1109, DOI 10.1083/jcb.200703186; Chan KL, 2007, EMBO J, V26, P3397, DOI 10.1038/sj.emboj.7601777; Chestukhin A, 2003, P NATL ACAD SCI USA, V100, P4574, DOI 10.1073/pnas.0730733100; Chin K, 2004, NAT GENET, V36, P984, DOI 10.1038/ng1409; Cimini D, 2003, MOL BIOL CELL, V14, P3821, DOI 10.1091/mbc.E03-01-0860; Eggert US, 2006, ANNU REV BIOCHEM, V75, P543, DOI 10.1146/annurev.biochem.74.082803.133425; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; Girdler F, 2006, J CELL SCI, V119, P3664, DOI 10.1242/jcs.03145; Gisselsson D, 2000, P NATL ACAD SCI USA, V97, P5357, DOI 10.1073/pnas.090013497; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Guse A, 2005, CURR BIOL, V15, P778, DOI 10.1016/j.cub.2005.03.041; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Jensen CG, 1996, CARCINOGENESIS, V17, P2013, DOI 10.1093/carcin/17.9.2013; Kelly AE, 2007, DEV CELL, V12, P31, DOI 10.1016/j.devcel.2006.11.001; Keppler A, 2006, BIOTECHNIQUES, V41, P167, DOI 10.2144/000112216; Leonhardt H, 2000, J CELL BIOL, V149, P271, DOI 10.1083/jcb.149.2.271; Maser RS, 2002, SCIENCE, V297, P565, DOI 10.1126/science.297.5581.565; Muhlhausser P, 2007, J CELL BIOL, V178, P595, DOI 10.1083/jcb.200703002; MULLINS JM, 1977, J CELL BIOL, V73, P672, DOI 10.1083/jcb.73.3.672; Neef R, 2006, CURR BIOL, V16, P301, DOI 10.1016/j.cub.2005.12.030; Norden C, 2006, CELL, V125, P85, DOI 10.1016/j.cell.2006.01.045; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; PELIN K, 1992, TOXICOL IN VITRO, V6, P445, DOI 10.1016/0887-2333(92)90051-R; Rosasco-Nitcher SE, 2008, SCIENCE, V319, P469, DOI 10.1126/science.1148980; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Shi QH, 2005, NATURE, V437, P1038, DOI 10.1038/nature03958; Stewenius Y, 2005, P NATL ACAD SCI USA, V102, P5541, DOI 10.1073/pnas.0408454102; Uetake Y, 2004, J CELL BIOL, V165, P609, DOI 10.1083/jcb.200403014; Weaver BAA, 2006, NATURE, V442, pE9, DOI 10.1038/nature05139; Yan XM, 2005, GENES CELLS, V10, P617, DOI 10.1111/j.1365-2443.2005.00863.x; Yasui Y, 2004, J BIOL CHEM, V279, P12997, DOI 10.1074/jbc.M311128200; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	34	436	439	2	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 6	2009	136	3					473	484		10.1016/j.cell.2008.12.020	http://dx.doi.org/10.1016/j.cell.2008.12.020			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	403ZN	19203582	Bronze			2022-12-01	WOS:000263120600017
J	Riviere, S; Challet, L; Fluegge, D; Spehr, M; Rodriguez, I				Riviere, Stephane; Challet, Ludivine; Fluegge, Daniela; Spehr, Marc; Rodriguez, Ivan			Formyl peptide receptor-like proteins are a novel family of vomeronasal chemosensors	NATURE			English	Article							PUTATIVE PHEROMONE RECEPTORS; MULTIGENE FAMILY; MAMMALS; INDIVIDUALS; RECOGNITION; NEURONS; GENES	Mammals rely heavily on olfaction to interact adequately with each other and with their environment(1). They make use of seven-transmembrane G-protein-coupled receptors to identify odorants and pheromones. These receptors are present on dendrites of olfactory sensory neurons located in the main olfactory or vomeronasal sensory epithelia, and pertain to the odorant(2), trace amine-associated receptor(3) and vomeronasal type 1 (ref. 4) or 2 (refs 5-7) receptor superfamilies. Whether these four sensor classes represent the complete olfactory molecular repertoire used by mammals to make sense of the outside world is unknown. Here we report the expression of formyl peptide receptor-related genes by vomeronasal sensory neurons, in multiple mammalian species. Similar to the four known olfactory receptor gene classes, these genes encode seven-transmembrane proteins, and are characterized by monogenic transcription and a punctate expression pattern in the sensory neuroepithelium. In vitro expression of mouse formyl peptide receptor-like 1, 3, 4, 6 and 7 provides sensitivity to disease/inflammation-related ligands. Establishing an in situ approach that combines whole-mount vomeronasal preparations with dendritic calcium imaging in the intact neuroepithelium, we show neuronal responses to the same molecules, which therefore represent a new class of vomeronasal agonists. Taken together, these results suggest that formyl peptide receptor-like proteins have an olfactory function associated with the identification of pathogens, or of pathogenic states.	[Riviere, Stephane; Challet, Ludivine; Rodriguez, Ivan] Univ Geneva, Dept Zool & Anim Biol, CH-1205 Geneva, Switzerland; [Riviere, Stephane; Challet, Ludivine; Rodriguez, Ivan] Univ Geneva, Natl Ctr Competence Frontiers Genet, CH-1205 Geneva, Switzerland; [Fluegge, Daniela; Spehr, Marc] Ruhr Univ Bochum, Dept Cellular Physiol, D-44780 Bochum, Germany	University of Geneva; University of Geneva; Ruhr University Bochum	Rodriguez, I (corresponding author), Univ Geneva, Dept Zool & Anim Biol, CH-1205 Geneva, Switzerland.	ivan.rodriguez@unige.ch	Spehr, Marc/AAK-3162-2021; Spehr, Marc/B-3140-2011	Spehr, Marc/0000-0001-6616-4196; Spehr, Marc/0000-0001-6616-4196; rodriguez, ivan/0000-0002-6468-0565	Swiss National Science Foundation; Claraz, Schmidheiny; Volkswagen; Schlumberger Foundations; Deutsche Forschungsgemeinschaft	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Claraz, Schmidheiny; Volkswagen(Volkswagen); Schlumberger Foundations(Schlumberger); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank C.-D. K. Ballif, C. Engelhardt and H. Bartel for technical help, and C. Bauer and P. Descombes for assistance on the NCCR 'Frontiers in Genetics' bioimaging and genomic platforms, respectively. We also thank H. Hatt for unlimited access to departmental infrastructure, and P. Vassalli for comments on the manuscript. This work was supported by the Swiss National Science Foundation, the Claraz, Schmidheiny, Volkswagen and Schlumberger Foundations, and the Emmy Noether program of the Deutsche Forschungsgemeinschaft.	BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Casella R, 2002, CANCER, V95, P2494, DOI 10.1002/cncr.10989; Chromek M, 2006, NAT MED, V12, P636, DOI 10.1038/nm1407; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; Herrada G, 1997, CELL, V90, P763, DOI 10.1016/S0092-8674(00)80536-X; Kavaliers M, 2006, P NATL ACAD SCI USA, V103, P4293, DOI 10.1073/pnas.0600410103; Kavaliers M, 2005, TRENDS PARASITOL, V21, P423, DOI 10.1016/j.pt.2005.07.008; Kavaliers M, 2004, HORM BEHAV, V46, P272, DOI 10.1016/j.yhbeh.2004.03.005; Kelliher KR, 2007, HORM BEHAV, V52, P561, DOI 10.1016/j.yhbeh.2007.08.012; Le YY, 2007, PROTEIN PEPTIDE LETT, V14, P846, DOI 10.2174/092986607782110211; Le YY, 2002, TRENDS IMMUNOL, V23, P541, DOI 10.1016/S1471-4906(02)02316-5; Leinders-Zufall T, 2000, NATURE, V405, P792, DOI 10.1038/35015572; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; Matsunami H, 1997, CELL, V90, P775, DOI 10.1016/S0092-8674(00)80537-1; Migeotte I, 2006, CYTOKINE GROWTH F R, V17, P501, DOI 10.1016/j.cytogfr.2006.09.009; Nodari F, 2008, J NEUROSCI, V28, P6407, DOI 10.1523/JNEUROSCI.1425-08.2008; Roppolo D, 2007, EMBO J, V26, P3423, DOI 10.1038/sj.emboj.7601782; Ryba NJP, 1997, NEURON, V19, P371, DOI 10.1016/S0896-6273(00)80946-0; Spehr M, 2002, J NEUROSCI, V22, P8429; Takata M, 2008, NEUROSCI LETT, V435, P126, DOI 10.1016/j.neulet.2008.02.019	20	246	263	3	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2009	459	7246					574	577		10.1038/nature08029	http://dx.doi.org/10.1038/nature08029			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449ZS	19387439				2022-12-01	WOS:000266370500040
J	Park, SY; Fung, P; Nishimura, N; Jensen, DR; Fujii, H; Zhao, Y; Lumba, S; Santiago, J; Rodrigues, A; Chow, TFF; Alfred, SE; Bonetta, D; Finkelstein, R; Provart, NJ; Desveaux, D; Rodriguez, PL; McCourt, P; Zhu, JK; Schroeder, JI; Volkman, BF; Cutler, SR				Park, Sang-Youl; Fung, Pauline; Nishimura, Noriyuki; Jensen, Davin R.; Fujii, Hiroaki; Zhao, Yang; Lumba, Shelley; Santiago, Julia; Rodrigues, Americo; Chow, Tsz-Fung F.; Alfred, Simon E.; Bonetta, Dario; Finkelstein, Ruth; Provart, Nicholas J.; Desveaux, Darrell; Rodriguez, Pedro L.; McCourt, Peter; Zhu, Jian-Kang; Schroeder, Julian I.; Volkman, Brian F.; Cutler, Sean R.			Abscisic Acid Inhibits Type 2C Protein Phosphatases via the PYR/PYL Family of START Proteins	SCIENCE			English	Article							NEGATIVE REGULATOR; SEED-GERMINATION; GENE-EXPRESSION; LIGAND-BINDING; ARABIDOPSIS; RECEPTORS; HORMONE; REVEAL; FOLD; ABI1	Type 2C protein phosphatases (PP2Cs) are vitally involved in abscisic acid (ABA) signaling. Here, we show that a synthetic growth inhibitor called pyrabactin functions as a selective ABA agonist. Pyrabactin acts through PYRABACTIN RESISTANCE 1 (PYR1), the founding member of a family of START proteins called PYR/PYLs, which are necessary for both pyrabactin and ABA signaling in vivo. We show that ABA binds to PYR1, which in turn binds to and inhibits PP2Cs. We conclude that PYR/PYLs are ABA receptors functioning at the apex of a negative regulatory pathway that controls ABA signaling by inhibiting PP2Cs. Our results illustrate the power of the chemical genetic approach for sidestepping genetic redundancy.	[Park, Sang-Youl; Fujii, Hiroaki; Zhu, Jian-Kang; Cutler, Sean R.] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA; [Fung, Pauline; Zhao, Yang; Lumba, Shelley; Chow, Tsz-Fung F.; Alfred, Simon E.; Provart, Nicholas J.; Desveaux, Darrell; McCourt, Peter] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON M5S 3B2, Canada; [Provart, Nicholas J.; Desveaux, Darrell] Univ Toronto, Ctr Anal Genome Evolut & Funct, Toronto, ON M5S 3B2, Canada; [Nishimura, Noriyuki; Schroeder, Julian I.] Univ Calif San Diego, Div Biol Sci, Cell & Dev Biol Sect, La Jolla, CA 92093 USA; [Santiago, Julia; Rodrigues, Americo; Rodriguez, Pedro L.] Univ Politecn Valencia, Inst Biol Mol & Celular Plantas, ES-46022 Valencia, Spain; [Bonetta, Dario] Univ Ontario Inst Technol, Fac Sci, Oshawa, ON L1H 7K4, Canada; [Finkelstein, Ruth] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Jensen, Davin R.; Volkman, Brian F.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Cutler, Sean R.] Univ Calif Riverside, Ctr Plant Cell Biol, Riverside, CA 92521 USA; [Cutler, Sean R.] Univ Calif Riverside, Inst Genome Biol, Riverside, CA 92521 USA; [Cutler, Sean R.] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of Toronto; University of Toronto; University of California System; University of California San Diego; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institute of Molecular & Cellular Biology of Plants (IBMCP); Universitat Politecnica de Valencia; Ontario Tech University; University of California System; University of California Santa Barbara; Medical College of Wisconsin; University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside	Cutler, SR (corresponding author), Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA.	sean.cutler@ucr.edu	Rodriguez, Pedro L./K-4605-2014; Volkman, Brian F./ABE-7306-2020; Nishimura, Noriyuki/E-3580-2010; Cutler, Sean R/D-6617-2011; Finkelstein, Ruth/Y-3274-2019; Volkman, Brian F./ABE-7312-2020; Rodrigues, Americo/F-9573-2010; Zhu, Jian-Kang/F-7658-2011	Rodriguez, Pedro L./0000-0002-5886-9425; Volkman, Brian F./0000-0002-6681-5179; Nishimura, Noriyuki/0000-0003-2946-3124; Volkman, Brian F./0000-0002-6681-5179; Rodrigues, Americo/0000-0002-5293-5583; Zhu, Jian-Kang/0000-0001-5134-731X; Cutler, Sean/0000-0002-8593-0885; Fujii, Hiroaki/0000-0002-0013-5891; Santiago, Julia/0000-0002-5765-6495	CRC; NSERC; NSF [IOS0820508, MCB0417118]; NIH [R01GM060396, 01GM59138, U54GM074901]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074901, R01GM059138, R01GM060396] Funding Source: NIH RePORTER	CRC(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank N. Raikhel, J. Bailey-Serres, and C. Larive for comments; K. Nito and T. Demura for materials. Supported by CRC (S.R.C., P.M., D.D.); NSERC (S.R.C., D.D., N.J.P.); NSF awards IOS0820508 (S.R.C.) and MCB0417118 (J.I.S.); NIH awards R01GM060396 (J.I.S.), 01GM59138 (J.-K.Z.), and U54GM074901 (B.V.). S.R.C. thanks J.R. Coleman for early support. Patent application "Control of plant stress tolerance, water use efficiency and gene expression using novel ABA recpetor proteins and synthetic agonists" inventors: S.R. Cutler, S.Y. Park, N. Nishimura, J.I. Schroeder, and A. Defries. Author contributions are as follows. Microarrays: P.F. and N.J.P.; pyr1 mutants: P.F. ; mutant analyses: P.F. and T.F.C.; yeast two-hybrid assays, biochemistry, and Pyr/Pyl genetics: S.Y.P.; pyr1 complementation and allele sequencing: Y.Z.; in planta pull-downs: N.N. and J.I.S.; PYL12-AHG3 and SnRK2-PP2C asinteractions: R.F.; HSQC experiments: D.J. and B.V.; SnRK2 assays: H.F. and J.-K.Z.; GFP-PYR1 localization: S.E.A.: PP2C assays: S.Y.P., J.S., A.R., and P.R.; EMS seed: D.B.; ABA orfeome: S.L., D.D., and P.M.; project conception, positional cloning, phone calls, and writing: S.R.C.	Allen GJ, 1999, PLANT CELL, V11, P1785, DOI 10.1105/tpc.11.9.1785; Bassel GW, 2008, PLANT PHYSIOL, V147, P143, DOI 10.1104/pp.107.110841; Cutler S, 2005, PLANT PHYSIOL, V138, P558, DOI 10.1104/pp.104.900152; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Fujii H, 2007, PLANT CELL, V19, P485, DOI 10.1105/tpc.106.048538; Fujii H, 2009, P NATL ACAD SCI USA, V106, P8380, DOI 10.1073/pnas.0903144106; Goda H, 2008, PLANT J, V55, P526, DOI 10.1111/j.1365-313X.2008.03510.x; Gosti F, 1999, PLANT CELL, V11, P1897, DOI 10.1105/tpc.11.10.1897; Huang DQ, 2007, PLANT J, V50, P414, DOI 10.1111/j.1365-313X.2007.03056.x; Iyer LM, 2001, PROTEINS, V43, P134, DOI 10.1002/1097-0134(20010501)43:2<134::AID-PROT1025>3.3.CO;2-9; Leonhardt N, 2004, PLANT CELL, V16, P596, DOI 10.1105/tpc.019000; Liu JJ, 2006, PHYSIOL MOL PLANT P, V68, P3, DOI 10.1016/j.pmpp.2006.06.004; Liu XG, 2007, SCIENCE, V318, DOI 10.1126/science.1143320; LYTLE B, PROTEINS IN PRESS, DOI DOI 10.1002/PROT.22396; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; McCourt P, 1999, ANNU REV PLANT PHYS, V50, P219, DOI 10.1146/annurev.arplant.50.1.219; McCourt P, 2008, CURR OPIN PLANT BIOL, V11, P474, DOI 10.1016/j.pbi.2008.06.014; Meyer B, 2003, ANGEW CHEM INT EDIT, V42, P864, DOI 10.1002/anie.200390233; Mustilli AC, 2002, PLANT CELL, V14, P3089, DOI 10.1105/tpc.007906; Nakabayashi K, 2005, PLANT J, V41, P697, DOI 10.1111/j.1365-313X.2005.02337.x; Nishimura N, 2007, PLANT J, V50, P935, DOI 10.1111/j.1365-313X.2007.03107.x; Pandey S, 2009, CELL, V136, P136, DOI 10.1016/j.cell.2008.12.026; Radauer C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-286; Robert N, 2006, FEBS LETT, V580, P4691, DOI 10.1016/j.febslet.2006.07.047; Saez A, 2004, PLANT J, V37, P354, DOI 10.1046/j.1365-313X.2003.01966.x; Saez A, 2006, PLANT PHYSIOL, V141, P1389, DOI 10.1104/pp.106.081018; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Shen YY, 2006, NATURE, V443, P823, DOI 10.1038/nature05176; SONDHEIM.E, 1971, SCIENCE, V174, P829, DOI 10.1126/science.174.4011.829; Toh S, 2008, PLANT PHYSIOL, V146, P1368, DOI 10.1104/pp.107.113738; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Yang YZ, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-6; Yoshida R, 2002, PLANT CELL PHYSIOL, V43, P1473, DOI 10.1093/pcp/pcf188; Zhao Y, 2007, NAT CHEM BIOL, V3, P716, DOI 10.1038/nchembio.2007.32	34	1790	1967	35	694	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2009	324	5930					1068	1071		10.1126/science.1173041	http://dx.doi.org/10.1126/science.1173041			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448EU	19407142	Green Accepted			2022-12-01	WOS:000266246700041
J	Tishkoff, SA; Reed, FA; Friedlaender, FR; Ehret, C; Ranciaro, A; Froment, A; Hirbo, JB; Awomoyi, AA; Bodo, JM; Doumbo, O; Ibrahim, M; Juma, AT; Kotze, MJ; Lema, G; Moore, JH; Mortensen, H; Nyambo, TB; Omar, SA; Powell, K; Pretorius, GS; Smith, MW; Thera, MA; Wambebe, C; Weber, JL; Williams, SM				Tishkoff, Sarah A.; Reed, Floyd A.; Friedlaender, Francoise R.; Ehret, Christopher; Ranciaro, Alessia; Froment, Alain; Hirbo, Jibril B.; Awomoyi, Agnes A.; Bodo, Jean-Marie; Doumbo, Ogobara; Ibrahim, Muntaser; Juma, Abdalla T.; Kotze, Maritha J.; Lema, Godfrey; Moore, Jason H.; Mortensen, Holly; Nyambo, Thomas B.; Omar, Sabah A.; Powell, Kweli; Pretorius, Gideon S.; Smith, Michael W.; Thera, Mahamadou A.; Wambebe, Charles; Weber, James L.; Williams, Scott M.			The Genetic Structure and History of Africans and African Americans	SCIENCE			English	Article							PYGMY HUNTER-GATHERERS; Y-CHROMOSOME; HUMAN-POPULATIONS; MTDNA VARIATION; DIVERSITY; ORIGINS; POLYMORPHISMS; PROPORTIONS; EVOLUTION; ANCESTRY	Africa is the source of all modern humans, but characterization of genetic variation and of relationships among populations across the continent has been enigmatic. We studied 121 African populations, four African American populations, and 60 non-African populations for patterns of variation at 1327 nuclear microsatellite and insertion/deletion markers. We identified 14 ancestral population clusters in Africa that correlate with self-described ethnicity and shared cultural and/or linguistic properties. We observed high levels of mixed ancestry in most populations, reflecting historical migration events across the continent. Our data also provide evidence for shared ancestry among geographically diverse hunter-gatherer populations (Khoesan speakers and Pygmies). The ancestry of African Americans is predominantly from Niger-Kordofanian (similar to 71%), European (similar to 13%), and other African (similar to 8%) populations, although admixture levels varied considerably among individuals. This study helps tease apart the complex evolutionary history of Africans and African Americans, aiding both anthropological and genetic epidemiologic studies.	[Tishkoff, Sarah A.; Reed, Floyd A.; Ranciaro, Alessia; Hirbo, Jibril B.; Awomoyi, Agnes A.; Mortensen, Holly; Powell, Kweli] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Tishkoff, Sarah A.; Ranciaro, Alessia; Hirbo, Jibril B.] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA; [Tishkoff, Sarah A.; Ranciaro, Alessia; Hirbo, Jibril B.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Ehret, Christopher] Univ Calif Los Angeles, Dept Hist, Los Angeles, CA 90095 USA; [Ranciaro, Alessia] Univ Ferrara, Dipartimento Biol & Evoluz, I-44100 Ferrara, Italy; [Froment, Alain] Musee Homme Paris, IRD MNHN, UMR 208, F-75116 Paris, France; [Bodo, Jean-Marie] Minist Rech Sci & Innovat, Yaounde, Cameroon; [Doumbo, Ogobara; Thera, Mahamadou A.] Univ Bamako, Malaria Res & Training Ctr, Bamako, Mali; [Ibrahim, Muntaser; Juma, Abdalla T.] Univ Khartoum, Inst Endem Dis, Dept Mol Biol, Khartoum 1513, Sudan; [Kotze, Maritha J.] Univ Stellenbosch, Fac Hlth Sci, Dept Pathol, ZA-7505 Tygerberg, South Africa; [Lema, Godfrey; Nyambo, Thomas B.] Muhimbili Univ Hlth & Allied Sci, Dept Biochem, Dar Es Salaam, Tanzania; [Moore, Jason H.] Dartmouth Med Sch, Dept Genet, Lebanon, NH 03756 USA; [Moore, Jason H.] Dartmouth Med Sch, Dept Community & Family Med, Lebanon, NH 03756 USA; [Omar, Sabah A.] Ctr Biotechnol Res & Dev, Kenya Med Res Inst, Nairobi 5484000200, Kenya; [Pretorius, Gideon S.] Univ Stellenbosch, Fac Hlth Sci, Div Human Genet, ZA-7505 Tygerberg, South Africa; [Smith, Michael W.] NCI, Lab Genom Div, Frederick, MD 21702 USA; [Wambebe, Charles] Int Biomed Res Africa, Abuja, Nigeria; [Weber, James L.] Marshfield Clin Res Fdn, Marshfield, WI 54449 USA; [Williams, Scott M.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Ctr Human Genet Res, Nashville, TN 37232 USA	University System of Maryland; University of Maryland College Park; University of Pennsylvania; University of Pennsylvania; University of California System; University of California Los Angeles; University of Ferrara; Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); University of Bamako; University of Khartoum; Stellenbosch University; Muhimbili University of Health & Allied Sciences; Dartmouth College; Dartmouth College; Kenya Medical Research Institute; Stellenbosch University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Vanderbilt University	Tishkoff, SA (corresponding author), Univ Maryland, Dept Biol, College Pk, MD 20742 USA.	tishkoff@mail.med.upenn.edu	Kotze, Maritha J/GMX-0989-2022; Williams, Scott/Q-4812-2019; Smith, Michael/B-5341-2012; Williams, Scott/B-9491-2012; Moore, Jason H./AAV-9645-2021	Williams, Scott/0000-0002-4835-9544; Moore, Jason H./0000-0002-5015-1099; Kotze, Martha/0000-0002-6050-2876; Reed, Floyd/0000-0003-4703-530X; Hirbo, Jibril/0000-0002-8932-7311; Thera, Mahamadou A/0000-0002-2679-035X	L. S. B. Leakey and Wenner Gren Foundation; NSF [BCS-0196183, BSC-0552486, BCS-0827436]; NIH [R01GM076637, 1R01GM083606-01, F32HG03801, R01 HL65234]; NHLBI Mammalian Genotyping Service; National Cancer Institute [N01-CO-12400]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065234] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [F32HG003801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083606, R01GM076637] Funding Source: NIH RePORTER	L. S. B. Leakey and Wenner Gren Foundation; NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI Mammalian Genotyping Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the thousands of people who donated DNA samples used in this study. We thank D. Bygott, S. J. Deo, D. Guracha, J. Hanby, D. Kariuki, P. Lufungulo, A. Mabulla, A. A. Mohamed, W. Ntandu, L. A. Nyindodo, C. Plowe, and A. Tibwitta for assisting with sample collection; K. Panchapakesan and L. Pfeiffer for assistance in sample preparation; S. Dobrin for assistance with genotyping; J. Giles, J. Bartlett, N. Kodaman, and J. Jarvis for assistance with analyses; and N. Rosenberg, J. Pritchard, A. Brooks, J. S. Friedlaender, J. Jarvis, C. Lambert, B. Payseur, N. Patterson, and J. Plotkin for helpful suggestions and discussions. Conducted in part using the ACCRE computing facility at Vanderbilt University, Nashville, TN. Supported by L. S. B. Leakey and Wenner Gren Foundation grants, NSF grants BCS-0196183, BSC-0552486, and BCS-0827436, NIH grants R01GM076637 and 1R01GM083606-01, and David and Lucile Packard and Burroughs Wellcome Foundation Career Awards (S.A.T.); NIH grant F32HG03801 (F.A.R.); and NIH grant R01 HL65234 (S.M.W. and J.H.M.). Genotyping was supported by the NHLBI Mammalian Genotyping Service. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. government. The project included in this manuscript has been funded in part with federal funds from the National Cancer Institute under contract N01-CO-12400. Original genotype data are available at http://research.marshfieldclinic.org/genetics/genotypingData_Statistics/humanDiversityPanel.asp. Data used for analyses in the current manuscript are available at www.med.upenn.edu/tishkoff/Supplemental/files.html and at http://chgr.mc.vanderbilt.edu/page/supplementary-data.	[Anonymous], TRANSATLANTIC SLAVE; [Anonymous], 1982, ARCHAEOLOGICAL LINGU; Batini C, 2007, MOL PHYLOGENET EVOL, V43, P635, DOI 10.1016/j.ympev.2006.09.014; Behar DM, 2008, AM J HUM GENET, V82, P1130, DOI 10.1016/j.ajhg.2008.04.002; Bereir RE, 2007, EUR J HUM GENET, V15, P1183, DOI 10.1038/sj.ejhg.5201892; Campbell MC, 2008, ANNU REV GENOM HUM G, V9, P403, DOI 10.1146/annurev.genom.9.081307.164258; Cann HM, 2002, SCIENCE, V296, P261; Cavalli-Sforza L.L., 1994, HIST GEOGRAPHY HUMAN; Cerny V, 2007, ANN HUM GENET, V71, P433, DOI 10.1111/j.1469-1809.2006.00339.x; Chen YS, 2000, AM J HUM GENET, V66, P1362, DOI 10.1086/302848; Coia V, 2004, AM J HUM BIOL, V16, P57, DOI 10.1002/ajhb.10236; Destro-Bisol G, 2004, MOL BIOL EVOL, V21, P1673, DOI 10.1093/molbev/msh186; Destro-Bisol G, 2004, AM NAT, V163, P212, DOI 10.1086/381405; Ehret C, 2001, INT J AFR HIST STUD, V34, P5, DOI 10.2307/3097285; Ehret C., 1983, CULTURE HIST SO SUDA, P19; Ehret C., 2006, W AFRICAN LINGUISTIC, P56; Ehret C., 1998, AFRICAN CLASSICAL AG; Ehret C, 2008, SOUTH AFR HUMANIT, V20, P7; Ehret Christopher, 1974, ETHIOPIANS E AFRICAN; Ehret Christopher, 1980, HIST RECONSTRUCTION; Ehret Christopher, 1986, SPRACHE GESCH AFRIKA, V7, P105; Elderkin ED, 1982, SPRACHE GESCH AFRIKA, V4, P67; Forster P, 2005, SCIENCE, V308, P965, DOI 10.1126/science.1113261; Forster P, 2007, SCIENCE, V316, P50, DOI 10.1126/science.316.5821.50; Francois O, 2006, GENETICS, V174, P805, DOI 10.1534/genetics.106.059923; Friedlaender JS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040019; Gonder MK, 2007, MOL BIOL EVOL, V24, P757, DOI 10.1093/molbev/msl209; Hassan HY, 2008, AM J PHYS ANTHROPOL, V137, P316, DOI 10.1002/ajpa.20876; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Klieman K. A., 2003, PYGMIES WERE OUR COM; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; LIM L, 1992, THESIS BROWN U; Lind JM, 2007, HUM GENET, V120, P713, DOI 10.1007/s00439-006-0261-7; LOMAX A, 1968, FOLK SONG STYLE CULT, P16; Mellars P, 2006, P NATL ACAD SCI USA, V103, P9381, DOI 10.1073/pnas.0510792103; NEWMAN J, 1997, PEOPLING AFRICA; Nurse GT., 1985, PEOPLES SO AFRICA TH; Parra EJ, 2001, AM J PHYS ANTHROPOL, V114, P18, DOI 10.1002/1096-8644(200101)114:1<18::AID-AJPA1002>3.0.CO;2-2; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Patin E, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000448; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Pritchard JK, 2000, GENETICS, V155, P945; Quintana-Murci L, 2008, P NATL ACAD SCI USA, V105, DOI 10.1073/pnas.0711467105; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Reed FA, 2006, CURR OPIN GENET DEV, V16, P597, DOI 10.1016/j.gde.2006.10.008; REYNOLDS J, 1983, GENETICS, V105, P767; Rosenberg NA, 2005, PLOS GENET, V1, P660, DOI 10.1371/journal.pgen.0010070; ROSENBERG NA, 2002, PLOS GENET, V298, P2381; Rosenberg NA, 2006, PLOS GENET, V2, P2052, DOI 10.1371/journal.pgen.0020215; Salas A, 2005, AM J PHYS ANTHROPOL, V128, P855, DOI 10.1002/ajpa.20117; SANDS B, 1998, LANGUAGE IDENTITY CO, V15, P266; Scozzari R, 1999, AM J HUM GENET, V65, P829, DOI 10.1086/302538; Semino O, 2002, AM J HUM GENET, V70, P265, DOI 10.1086/338306; Sirugo G, 2008, HUM GENET, V123, P557, DOI 10.1007/s00439-008-0511-y; Smith MW, 2004, AM J HUM GENET, V74, P1001, DOI 10.1086/420856; Tishkoff SA, 2002, NAT REV GENET, V3, P611, DOI 10.1038/nrg865; Tishkoff SA, 2007, MOL BIOL EVOL, V24, P2180, DOI 10.1093/molbev/msm155; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Verdu P, 2009, CURR BIOL, V19, P312, DOI 10.1016/j.cub.2008.12.049; Walter RC, 2000, NATURE, V405, P65, DOI 10.1038/35011048; Wang S, 2007, PLOS GENET, V3, P2049, DOI 10.1371/journal.pgen.0030185; Wood ET, 2005, EUR J HUM GENET, V13, P867, DOI 10.1038/sj.ejhg.5201408	63	983	1011	2	153	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2009	324	5930					1035	1044		10.1126/science.1172257	http://dx.doi.org/10.1126/science.1172257			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448EU	19407144	Green Accepted			2022-12-01	WOS:000266246700033
J	Ramsey, KM; Yoshino, J; Brace, CS; Abrassart, D; Kobayashi, Y; Marcheva, B; Hong, HK; Chong, JL; Buhr, ED; Lee, C; Takahashi, JS; Imai, SI; Bass, J				Ramsey, Kathryn Moynihan; Yoshino, Jun; Brace, Cynthia S.; Abrassart, Dana; Kobayashi, Yumiko; Marcheva, Biliana; Hong, Hee-Kyung; Chong, Jason L.; Buhr, Ethan D.; Lee, Choogon; Takahashi, Joseph S.; Imai, Shin-ichiro; Bass, Joseph			Circadian Clock Feedback Cycle Through NAMPT-Mediated NAD(+) Biosynthesis	SCIENCE			English	Article							NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; GLUCOSE-HOMEOSTASIS; CALORIE RESTRICTION; LIFE-SPAN; SIRT1; TRANSCRIPTION; EXTENSION; COMPONENT; BINDING; CELLS	The circadian clock is encoded by a transcription-translation feedback loop that synchronizes behavior and metabolism with the light-dark cycle. Here we report that both the rate-limiting enzyme in mammalian nicotinamide adenine dinucleotide (NAD(+)) biosynthesis, nicotinamide phosphoribosyltransferase (NAMPT), and levels of NAD(+) display circadian oscillations that are regulated by the core clock machinery in mice. Inhibition of NAMPT promotes oscillation of the clock gene Per2 by releasing CLOCK: BMAL1 from suppression by SIRT1. In turn, the circadian transcription factor CLOCK binds to and up-regulates Nampt, thus completing a feedback loop involving NAMPT/NAD(+) and SIRT1/CLOCK:BMAL1.	[Yoshino, Jun; Brace, Cynthia S.; Imai, Shin-ichiro] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [Ramsey, Kathryn Moynihan; Abrassart, Dana; Kobayashi, Yumiko; Marcheva, Biliana; Bass, Joseph] Northwestern Univ, Feinberg Sch Med, Dept Med, Evanston, IL 60208 USA; [Ramsey, Kathryn Moynihan; Abrassart, Dana; Kobayashi, Yumiko; Marcheva, Biliana; Hong, Hee-Kyung; Chong, Jason L.; Buhr, Ethan D.; Takahashi, Joseph S.; Bass, Joseph] Northwestern Univ, Feinberg Sch Med, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; [Ramsey, Kathryn Moynihan; Kobayashi, Yumiko; Bass, Joseph] NorthShore Univ Hlth Syst Res Inst, Evanston, IL 60201 USA; [Ramsey, Kathryn Moynihan; Kobayashi, Yumiko; Bass, Joseph] Evanston Hosp Corp, Dept Med, Evanston, IL 60201 USA; [Lee, Choogon] Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA; [Takahashi, Joseph S.] Northwestern Univ, Howard Hughes Med Inst, Evanston, IL 60208 USA	Washington University (WUSTL); Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; NorthShore University Health System; NorthShore University Health System; State University System of Florida; Florida State University; Howard Hughes Medical Institute; Northwestern University	Imai, SI (corresponding author), Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA.	imaishin@wustl.edu; j-bass@northwestern.edu	Takahashi, Joseph S./Y-2781-2019; Takahashi, Joseph S/E-8482-2012	Takahashi, Joseph S./0000-0003-0384-8878; Takahashi, Joseph S/0000-0003-0384-8878; Buhr, Ethan/0000-0002-9250-6644; Marcheva, Biliana/0000-0001-8697-2625; Yoshino, Jun/0000-0001-9833-4356	National Institute of Diabetes and Digestive and Kidney Diseases [T32 DK007169]; National Institute on Aging [AG02150]; Ellison Medical Foundation; Longer Life Foundation; NIH [PO1 AG011412]; Chicago Biomedical Consortium Searle Funds; Juvenile Diabetes Research Foundation; National Institute of Mental Health [P50 MH074924]; Japan Research Foundation for Clinical Pharmacology; Keio University Medical Science Fund; Amylin Pharmaceuticals; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH074924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024150, P01AG011412] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Ellison Medical Foundation(Lawrence Ellison Foundation); Longer Life Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chicago Biomedical Consortium Searle Funds; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Japan Research Foundation for Clinical Pharmacology; Keio University Medical Science Fund; Amylin Pharmaceuticals(Bristol-Myers Squibb); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank S.-H. Yoo and members of the Bass, Imai, and Takahashi laboratories for discussions. Work was supported by grants from the National Institute of Diabetes and Digestive and Kidney Diseases (T32 DK007169) to K.M.R.; the National Institute on Aging (AG02150), the Ellison Medical Foundation, and the Longer Life Foundation to S.I.; NIH (PO1 AG011412), the Chicago Biomedical Consortium Searle Funds, and the Juvenile Diabetes Research Foundation to J.B.; and a grant from the National Institute of Mental Health (P50 MH074924) to J.S.T. J.Y. is supported by the Japan Research Foundation for Clinical Pharmacology and Keio University Medical Science Fund, J.S.T. is an Investigator in the Howard Hughes Medical Institute and a cofounder of ReSet Therapeutics, and J.S.T. and J.B. are members of its scientific advisory board. J.B. is also an adviser and receives support from Amylin Pharmaceuticals. S.I. holds a patent related to the work reported in this paper, specifically NAMPT and NMN.	Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Anderson RM, 2002, J BIOL CHEM, V277, P18881, DOI 10.1074/jbc.M111773200; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Barnea M, 2009, ENDOCRINOLOGY, V150, P161, DOI 10.1210/en.2008-0944; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Chen D, 2008, GENE DEV, V22, P1753, DOI 10.1101/gad.1650608; Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004; Hasmann M, 2003, CANCER RES, V63, P7436; Imai S, 2009, CURR PHARM DESIGN, V15, P20, DOI 10.2174/138161209787185814; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Revollo JR, 2007, CELL METAB, V6, P363, DOI 10.1016/j.cmet.2007.09.003; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; van der Veer E, 2007, J BIOL CHEM, V282, P10841, DOI 10.1074/jbc.C700018200; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035	25	779	826	9	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 1	2009	324	5927					651	654		10.1126/science.1171641	http://dx.doi.org/10.1126/science.1171641			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439DW	19299583	Green Accepted			2022-12-01	WOS:000265608800047
J	Park, BS; Song, DH; Kim, HM; Choi, BS; Lee, H; Lee, JO				Park, Beom Seok; Song, Dong Hyun; Kim, Ho Min; Choi, Byong-Seok; Lee, Hayyoung; Lee, Jie-Oh			The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex	NATURE			English	Article							TOLL-LIKE RECEPTORS; CRYSTAL-STRUCTURE; HUMAN MD-2; LIPID-A; ENDOTOXIN; RESPONSIVENESS; BINDING; ROLES; TLR4; BACTERIAL	The lipopolysaccharide (LPS) of Gram negative bacteria is a well-known inducer of the innate immune response(1). Toll-like receptor (TLR) 4 and myeloid differentiation factor 2 (MD-2) form a heterodimer that recognizes a common 'pattern' in structurally diverse LPS molecules. To understand the ligand specificity and receptor activation mechanism of the TLR4-MD-2-LPS complex we determined its crystal structure. LPS binding induced the formation of an m-shaped receptor multimer composed of two copies of the TLR4-MD-2-LPS complex arranged symmetrically. LPS interacts with a large hydrophobic pocket in MD-2 and directly bridges the two components of the multimer. Five of the six lipid chains of LPS are buried deep inside the pocket and the remaining chain is exposed to the surface of MD-2, forming a hydrophobic interaction with the conserved phenylalanines of TLR4. The F126 loop of MD-2 undergoes localized structural change and supports this core hydrophobic interface by making hydrophilic interactions with TLR4. Comparison with the structures of tetra-acylated antagonists bound to MD-2 indicates that two other lipid chains in LPS displace the phosphorylated glucosamine backbone by similar to 5 angstrom towards the solvent area(2,3). This structural shift allows phosphate groups of LPS to contribute to receptor multimerization by forming ionic interactions with a cluster of positively charged residues in TLR4 and MD-2. The TLR4-MD-2-LPS structure illustrates the remarkable versatility of the ligand recognition mechanisms employed by the TLR family(4,5), which is essential for defence against diverse microbial infection.	[Park, Beom Seok; Song, Dong Hyun; Kim, Ho Min; Choi, Byong-Seok; Lee, Jie-Oh] Korea Adv Inst Sci & Technol, Dept Chem, Taejon 305701, South Korea; [Lee, Jie-Oh] Korea Adv Inst Sci & Technol, Inst BioCentury, Taejon 305701, South Korea; [Lee, Hayyoung] Chungnam Natl Univ, Sch Biosci & Biotechnol, Dept Biol, Taejon 305764, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Chungnam National University	Lee, JO (corresponding author), Korea Adv Inst Sci & Technol, Dept Chem, Taejon 305701, South Korea.	jieoh.lee@kaist.ac.kr	Choi, Byong-Seok/C-1937-2011; Lee, Jie-Oh/AAG-4302-2020; Kim, Ho Min/G-2712-2011; Lee, Jie-Oh/C-1581-2011	Lee, Jie-Oh/0000-0001-6519-6049	Ministry of Education, Science and Technology of Korea	Ministry of Education, Science and Technology of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	We thank the staff of beamline 4A at the Pohang Accelerator Laboratory and beamline ID23-2 at ESRF for help with data collection. We thank J. Gross for critical reading of the manuscript. J.-O.L and co-workers are funded by the Creative Research Initiative (Center for Membrane Receptor Research) from the Ministry of Education, Science and Technology of Korea.	Bell JK, 2005, P NATL ACAD SCI USA, V102, P10976, DOI 10.1073/pnas.0505077102; Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Choe J, 2005, SCIENCE, V309, P581, DOI 10.1126/science.1115253; Erridge C, 2002, MICROBES INFECT, V4, P837, DOI 10.1016/S1286-4579(02)01604-0; GALANOS C, 1985, EUR J BIOCHEM, V148, P1, DOI 10.1111/j.1432-1033.1985.tb08798.x; Jin MS, 2008, IMMUNITY, V29, P182, DOI 10.1016/j.immuni.2008.07.007; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kawasaki K, 2003, J IMMUNOL, V170, P413, DOI 10.4049/jimmunol.170.1.413; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Kobayashi M, 2006, J IMMUNOL, V176, P6211, DOI 10.4049/jimmunol.176.10.6211; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; Matsushima N, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-124; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; MEDZHITOV R, 1997, NATURE, V388, P397; Miyake K, 2006, J ENDOTOXIN RES, V12, P195, DOI 10.1179/096805106X118807; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; RAETZ CRH, 1990, ANNU REV BIOCHEM, V59, P129, DOI 10.1146/annurev.bi.59.070190.001021; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Re F, 2003, J IMMUNOL, V171, P5272, DOI 10.4049/jimmunol.171.10.5272; RIETSCHEL ET, 1994, FASEB J, V8, P217, DOI 10.1096/fasebj.8.2.8119492; RIETSCHEL ET, 1993, IMMUNOBIOLOGY, V187, P169, DOI 10.1016/S0171-2985(11)80338-4; Rossignol Daniel P, 2005, Curr Opin Investig Drugs, V6, P496; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Teghanemt A, 2005, J IMMUNOL, V175, P4669, DOI 10.4049/jimmunol.175.7.4669; Teghanemt A, 2008, J BIOL CHEM, V283, P1257, DOI 10.1074/jbc.M705994200; ULMER AJ, 1992, INFECT IMMUN, V60, P3309, DOI 10.1128/IAI.60.8.3309-3314.1992; Visintin A, 2003, J BIOL CHEM, V278, P48313, DOI 10.1074/jbc.M306802200; Walsh C, 2008, J IMMUNOL, V181, P1245, DOI 10.4049/jimmunol.181.2.1245	34	1476	1544	10	268	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2009	458	7242					1191	U130		10.1038/nature07830	http://dx.doi.org/10.1038/nature07830			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441FL	19252480				2022-12-01	WOS:000265754600051
J	Katz, DJ; Edwards, TM; Reinke, V; Kelly, WG				Katz, David J.; Edwards, T. Matthew; Reinke, Valerie; Kelly, William G.			A C. elegans LSD1 Demethylase Contributes to Germline Immortality by Reprogramming Epigenetic Memory	CELL			English	Article							CAENORHABDITIS-ELEGANS; DROSOPHILA-MELANOGASTER; GENE-EXPRESSION; MAMMALIAN DEVELOPMENT; CELL DEVELOPMENT; POLE CELLS; CHROMATIN; COMPLEX; LINEAGE; NANOS	Epigenetic information undergoes extensive reprogramming in the germline between generations. This reprogramming may be essential to establish a developmental ground state in the zygote. We show that mutants in spr-5, the Caenorhabditis elegans ortholog of the H3K4me2 demethylase LSD1/KDM1, exhibit progressive sterility over many generations. This sterility correlates with the misregulation of spermatogenesis-expressed genes and transgenerational accumulation of the histone modification dimethylation of histone H3 on lysine 4 (H3K4me2). This suggests that H3K4me2 can serve as a stable epigenetic memory, and that erasure of H3K4me2 by LSD/KDM1 in the germline prevents the inappropriate transmission of this epigenetic memory from one generation to the next. Thus, our results provide direct mechanistic insights into the processes that are required for epigenetic reprogramming between generations.	[Katz, David J.; Edwards, T. Matthew; Kelly, William G.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Reinke, Valerie] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA	Emory University; Yale University	Kelly, WG (corresponding author), Emory Univ, Dept Biol, Atlanta, GA 30322 USA.	bkelly@biology.emory.edu	Katz, David J/H-4555-2017	Katz, David J/0000-0002-3040-1142	National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077600] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Baumeister for providing strains; A. Printz for help with data presentation; C. Bean, B. Lakowski, G. Reuter, T. Schedl, Y. Shi, and J. Waddle for helpful discussions on the work; T. Caspary, J. Lucchesi, and S. Tilghman for critical comments on the manuscript; and all of our laboratory members for assistance throughout. This work was supported by grants from the National Institutes of Health to D. J. K. and W. G. K.	Ahmed S, 2000, NATURE, V403, P159, DOI 10.1038/35003120; Ballas N, 2001, NEURON, V31, P353, DOI 10.1016/S0896-6273(01)00371-3; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Campbell KHS, 1996, NATURE, V380, P64, DOI 10.1038/380064a0; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Eimer S, 2002, EMBO J, V21, P5787, DOI 10.1093/emboj/cdf561; Hochedlinger K, 2009, DEVELOPMENT, V136, P509, DOI 10.1242/dev.020867; Jaenisch R, 1997, TRENDS GENET, V13, P323, DOI 10.1016/S0168-9525(97)01180-3; Jarriault S, 2002, GENE DEV, V16, P2713, DOI 10.1101/gad.1022402; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jones SJM, 2001, GENOME RES, V11, P1346, DOI 10.1101/gr.184401; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Katz DJ, 2005, MOL CELL BIOL, V25, P3855, DOI 10.1128/MCB.25.10.3855-3863.2005; Kelly WG, 1998, DEVELOPMENT, V125, P2451; Kobayashi S, 1996, NATURE, V380, P708, DOI 10.1038/380708a0; Koprunner M, 2001, GENE DEV, V15, P2877; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Mito Y, 2005, NAT GENET, V37, P1090, DOI 10.1038/ng1637; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Ng RK, 2008, NAT CELL BIOL, V10, P102, DOI 10.1038/ncb1674; Nishikawa S, 2007, NAT BIOTECHNOL, V25, P877, DOI 10.1038/nbt0807-877; Petruk S, 2001, SCIENCE, V294, P1331, DOI 10.1126/science.1065683; Poux S, 2002, DEVELOPMENT, V129, P2483; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Reinke V, 2004, DEVELOPMENT, V131, P311, DOI 10.1242/dev.00914; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Rudolph T, 2007, MOL CELL, V26, P103, DOI 10.1016/j.molcel.2007.02.025; Schaner CE, 2003, DEV CELL, V5, P747, DOI 10.1016/S1534-5807(03)00327-7; Seydoux G, 1997, DEVELOPMENT, V124, P2191; Seydoux G, 1996, NATURE, V382, P713, DOI 10.1038/382713a0; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; STROME S, 1983, CELL, V35, P15, DOI 10.1016/0092-8674(83)90203-9; Subramaniam K, 1999, DEVELOPMENT, V126, P4861; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; SZABAD J, 1988, MOL GEN GENET, V211, P56, DOI 10.1007/BF00338393; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TECHNAU GM, 1986, ROUX ARCH DEV BIOL, V195, P489, DOI 10.1007/BF00375889; Tsuda M, 2003, SCIENCE, V301, P1239, DOI 10.1126/science.1085222; UNDERWOOD EM, 1980, DEV BIOL, V77, P303, DOI 10.1016/0012-1606(80)90476-5; Unhavaithaya Y, 2002, CELL, V111, P991, DOI 10.1016/S0092-8674(02)01202-3	44	227	245	3	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 17	2009	137	2					308	320		10.1016/j.cell.2009.02.015	http://dx.doi.org/10.1016/j.cell.2009.02.015			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	437AB	19379696	Bronze, Green Accepted			2022-12-01	WOS:000265456800023
J	Bolhuis, JJ; Wynne, CDL				Bolhuis, Johan J.; Wynne, Clive D. L.			Can evolution explain how minds work?	NATURE			English	Editorial Material									[Bolhuis, Johan J.] Univ Utrecht, Dept Biol, NL-3508 TC Utrecht, Netherlands; [Wynne, Clive D. L.] Univ Florida, Dept Psychol, Gainesville, FL 32611 USA; [Bolhuis, Johan J.] Univ Utrecht, Helmholtz Inst, NL-3508 TC Utrecht, Netherlands	Utrecht University; State University System of Florida; University of Florida; Utrecht University	Bolhuis, JJ (corresponding author), Univ Utrecht, Dept Biol, NL-3508 TC Utrecht, Netherlands.	j.j.bolhuis@uu.nl; wynne@ufl.edu	Carroll, Joseph/D-1158-2011; Bolhuis, Johan J/B-9080-2011	Carroll, Joseph/0000-0003-2656-1378; Wynne, Clive/0000-0001-8408-1466				Bolhuis J., 2009, TINBERGENS LEGACY FU; Cosmides Leda., 1997, EVOLUTIONARY PSYCHOL; Penn DC, 2008, BEHAV BRAIN SCI, V31, P109, DOI 10.1017/S0140525X08003543; PINKER S, 1994, LANGUAGE INSTINCT MI; Richardson R. C., 2007, EVOLUTIONARY PSYCHOL; Wynne CDL, 2004, NATURE, V428, P140, DOI [10.1038/428140a, 10.1038/428140b]	6	67	69	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 16	2009	458	7240					832	833		10.1038/458832a	http://dx.doi.org/10.1038/458832a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	433CS	19370014				2022-12-01	WOS:000265182500022
J	Bethke, A; Fielenbach, N; Wang, Z; Mangelsdorf, DJ; Antebi, A				Bethke, Axel; Fielenbach, Nicole; Wang, Zhu; Mangelsdorf, David J.; Antebi, Adam			Nuclear Hormone Receptor Regulation of MicroRNAs Controls Developmental Progression	SCIENCE			English	Article							C-ELEGANS; CAENORHABDITIS-ELEGANS; DAUER FORMATION; DAF-12; IDENTIFICATION; MUTATIONS; ENCODES; MIR-48; LARVAL; LIN-14	In response to small-molecule signals such as retinoids or steroids, nuclear receptors activate gene expression to regulate development in different tissues. MicroRNAs turn off target gene expression within cells by binding complementary regions in messenger RNA transcripts, and they have been broadly implicated in development and disease. Here we show that the Caenorhabditis elegans nuclear receptor DAF-12 and its steroidal ligand directly activate promoters of let-7 microRNA family members to down-regulate the microRNA target hbl-1, which drives progression of epidermal stem cells from second to third larval stage patterns of cell division. Conversely, the receptor without the ligand represses microRNA expression during developmental arrest. These findings identify microRNAs as components of a hormone-coupled molecular switch that shuts off earlier developmental programs to allow for later ones.	[Bethke, Axel; Fielenbach, Nicole; Antebi, Adam] Baylor Coll Med, Dept Mol & Cellular Biol, Huffington Ctr Aging, Houston, TX 77030 USA; [Bethke, Axel] Univ Osnabruck, Fachbereich Biol Chem, D-49069 Osnabruck, Germany; [Wang, Zhu; Mangelsdorf, David J.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Wang, Zhu; Mangelsdorf, David J.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Antebi, Adam] Max Planck Inst Biol Ageing, D-50931 Cologne, Germany	Baylor College of Medicine; University Osnabruck; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Max Planck Society	Antebi, A (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Huffington Ctr Aging, 1 Baylor Plaza, Houston, TX 77030 USA.	aantebi@bcm.edu	Wang, Zhu/H-3844-2013	Mangelsdorf, David/0000-0002-4355-0796	NIH [GM077201]; Ellison Medical Foundation; Howard Hughes Medical Institute; Robert A. Welch Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077201] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Robert A. Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Our thanks go to G. Hayes, G. Ruvkun, V. Ambros, and A. Rougvie for strains; N. Timchenko for gel shift support; and D. Magner, S. Greene, and F. Schroeder for manuscript comments. This work was supported by NIH grant GM077201 and the Ellison Medical Foundation (A.A.), and the Howard Hughes Medical Institute and the Robert A. Welch Foundation (D.J.M.).	Abbott AL, 2005, DEV CELL, V9, P403, DOI 10.1016/j.devcel.2005.07.009; Antebi A, 2000, GENE DEV, V14, P1512; Antebi A, 1998, DEVELOPMENT, V125, P1191; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; CHALFIE M, 1981, CELL, V24, P59, DOI 10.1016/0092-8674(81)90501-8; Fielenbach N, 2008, GENE DEV, V22, P2149, DOI 10.1101/gad.1701508; Gerisch B, 2001, DEV CELL, V1, P841, DOI 10.1016/S1534-5807(01)00085-5; Grosshans H, 2005, DEV CELL, V8, P321, DOI 10.1016/j.devcel.2004.12.019; Hayes GD, 2006, DEVELOPMENT, V133, P4631, DOI 10.1242/dev.02655; Jia KL, 2002, DEVELOPMENT, V129, P221; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li M, 2005, DEV CELL, V9, P415, DOI 10.1016/j.devcel.2005.08.002; Ludewig AH, 2004, GENE DEV, V18, P2120, DOI 10.1101/gad.312604; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Motola DL, 2006, CELL, V124, P1209, DOI 10.1016/j.cell.2006.01.037; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Repa JJ, 2000, SCIENCE, V289, P1524, DOI 10.1126/science.289.5484.1524; Rougvie AE, 2005, DEVELOPMENT, V132, P3787, DOI 10.1242/dev.01972; Shostak Y, 2004, GENE DEV, V18, P2529, DOI 10.1101/gad.1218504; Varghese J, 2007, GENE DEV, V21, P2277, DOI 10.1101/gad.439807; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4	21	122	134	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2009	324	5923					95	98		10.1126/science.1164899	http://dx.doi.org/10.1126/science.1164899			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427TN	19342589	Green Accepted			2022-12-01	WOS:000264802100040
J	Kloxin, AM; Kasko, AM; Salinas, CN; Anseth, KS				Kloxin, April M.; Kasko, Andrea M.; Salinas, Chelsea N.; Anseth, Kristi S.			Photodegradable Hydrogels for Dynamic Tuning of Physical and Chemical Properties	SCIENCE			English	Article							MESENCHYMAL STEM-CELLS; CHONDROGENIC DIFFERENTIATION; BEHAVIOR; TISSUE; DEGRADATION; MIGRATION; GROWTH; BIOMATERIALS; NETWORKS; POLYMERS	We report a strategy to create photodegradable poly(ethylene glycol)-based hydrogels through rapid polymerization of cytocompatible macromers for remote manipulation of gel properties in situ. Postgelation control of the gel properties was demonstrated to introduce temporal changes, creation of arbitrarily shaped features, and on-demand pendant functionality release. Channels photodegraded within a hydrogel containing encapsulated cells allow cell migration. Temporal variation of the biochemical gel composition was used to influence chondrogenic differentiation of encapsulated stem cells. Photodegradable gels that allow real-time manipulation of material properties or chemistry provide dynamic environments with the scope to answer fundamental questions about material regulation of live cell function and may affect an array of applications from design of drug delivery vehicles to tissue engineering systems.	[Kloxin, April M.; Kasko, Andrea M.; Salinas, Chelsea N.; Anseth, Kristi S.] Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA; [Kasko, Andrea M.; Anseth, Kristi S.] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder	Anseth, KS (corresponding author), Univ Colorado, Dept Chem & Biol Engn, 424 UCB ECCH 111, Boulder, CO 80309 USA.	Kristi.Anseth@colorado.edu			Howard Hughes Medical Institute; NIH [DE12998, DE16523]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016523] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE012998] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The authors thank C. Bowman, T. Scott, and C. Kloxin for comments on early versions of this manuscript and valuable discussions; A. Aimetti for peptide synthesis training; J. McCall and S. Anderson for cell culture assistance; M. Schwartz for cell migration discussions; C. Bowman and his laboratory for use of and assistance with the rheometer and profilometer; C. Kloxin for assistance with image analysis; C. DeForest, Carl Zeiss, Inc., and the Howard Hughes Medical Institute Janelia Farms campus for assistance with and use of the Zeiss 710 two-photon confocal LSM; and the Howard Hughes Medical Institute and the NIH (grants DE12998 and DE16523) for research support. A.K. thanks the NASA Graduate Student Researchers Program fellowship and the Department of Education Graduate Assistance in Areas of National Need fellowship for support. A patent related to this work has been submitted (U.S. Patent Application No. 11/374,471).	Alvarez M, 2008, ADV MATER, V20, P4563, DOI 10.1002/adma.200800746; [Anonymous], 1991, INTRO POLYM; Boontheekul T, 2003, CURR OPIN BIOTECH, V14, P559, DOI 10.1016/j.copbio.2003.08.004; Bryant SJ, 2000, J BIOMAT SCI-POLYM E, V11, P439, DOI 10.1163/156856200743805; BRYANT SJ, 2005, SCAFFOLDING TISSUE E, P69; Chan G, 2008, TRENDS BIOTECHNOL, V26, P382, DOI 10.1016/j.tibtech.2008.03.011; DeLise AM, 2000, OSTEOARTHR CARTILAGE, V8, P309, DOI 10.1053/joca.1999.0306; Ehrbar M, 2004, CIRC RES, V94, P1124, DOI 10.1161/01.RES.0000126411.29641.08; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Hahn MS, 2006, ADV MATER, V18, P2679, DOI 10.1002/adma.200600647; Hudalla GA, 2008, BIOMACROMOLECULES, V9, P842, DOI 10.1021/bm701179s; Kenny PA, 2003, INT J CANCER, V107, P688, DOI 10.1002/ijc.11491; Khademhosseini A, 2007, BIOMATERIALS, V28, P5087, DOI 10.1016/j.biomaterials.2007.07.021; KHAN SA, 1992, RHEOL ACTA, V31, P151, DOI 10.1007/BF00373237; Langer R, 2003, AICHE J, V49, P2990, DOI 10.1002/aic.690491202; Luo Y, 2004, NAT MATER, V3, P249, DOI 10.1038/nmat1092; Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055; Mahoney MJ, 2006, BIOMATERIALS, V27, P2265, DOI 10.1016/j.biomaterials.2005.11.007; Metters A, 2005, BIOMACROMOLECULES, V6, P290, DOI 10.1021/bm049607o; Nuttelman CR, 2005, MATRIX BIOL, V24, P208, DOI 10.1016/j.matbio.2005.03.004; Raeber GP, 2005, BIOPHYS J, V89, P1374, DOI 10.1529/biophysj.104.050682; Rice MA, 2006, BIOMACROMOLECULES, V7, P1968, DOI 10.1021/bm060086+; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; Salinas CN, 2008, BIOMATERIALS, V29, P2370, DOI 10.1016/j.biomaterials.2008.01.035; Salinas CN, 2007, TISSUE ENG, V13, P1025, DOI 10.1089/ten.2006.0126; Sands RW, 2007, CURR OPIN BIOTECH, V18, P448, DOI 10.1016/j.copbio.2007.10.004; Seliktar D, 2004, J BIOMED MATER RES A, V68A, P704, DOI 10.1002/jbm.a.20091; Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783; Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587; Tavella S, 1997, J CELL SCI, V110, P2261; Tayalia P, 2008, ADV MATER, V20, P4494, DOI 10.1002/adma.200801319; Weibel DB, 2007, NAT REV MICROBIOL, V5, P209, DOI 10.1038/nrmicro1616; Wosnick JH, 2008, CHEM MATER, V20, P55, DOI 10.1021/cm071158m; Zhao YR, 2004, J AM CHEM SOC, V126, P4653, DOI 10.1021/ja036958m	34	1286	1337	40	1035	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2009	324	5923					59	63		10.1126/science.1169494	http://dx.doi.org/10.1126/science.1169494			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	427TN	19342581	Green Accepted			2022-12-01	WOS:000264802100030
J	Rhee, HJ; June, YG; Lee, JS; Lee, KK; Ha, JH; Kim, ZH; Jeon, SJ; Cho, MH				Rhee, Hanju; June, Young-Gun; Lee, Jang-Soo; Lee, Kyung-Koo; Ha, Jeong-Hyon; Kim, Zee Hwan; Jeon, Seung-Joon; Cho, Minhaeng			Femtosecond characterization of vibrational optical activity of chiral molecules	NATURE			English	Article							CIRCULAR-DICHROISM; SPECTROSCOPY; POLYPEPTIDES	Optical activity(1-3) is the result of chiral molecules interacting differently with left versus right circularly polarized light. Because of this intrinsic link to molecular structure, the determination of optical activity through circular dichroism (CD) spectroscopy has long served as a routine method for obtaining structural information about chemical and biological systems in condensed phases(4-6). A recent development is time-resolved CD spectroscopy, which can in principle map the structural changes associated with biomolecular function(7) and thus lead to mechanistic insights into fundamental biological processes. But implementing time-resolved CD measurements is experimentally challenging because CD is a notoriously weak effect (a factor of 10(-4)-10(-6) smaller than absorption). In fact, this problem has so far prevented time-resolved vibrational CD experiments. Here we show that vibrational CD spectroscopy with femtosecond time resolution can be realized when using heterodyned spectral interferometry to detect(8-10) the phase and amplitude of the infrared optical activity free-induction-decay field in time (much like in a pulsed NMR experiment). We show that we can detect extremely weak signals in the presence of large achiral background contributions, by simultaneously measuring with a femtosecond laser pulse the vibrational CD and optical rotatory dispersion spectra of dissolved chiral limonene molecules. We have so far only targeted molecules in equilibrium, but it would be straightforward to extend the method for the observation of ultrafast structural changes such as those occurring during protein folding or asymmetric chemical reactions. That is, we should now be in a position to produce 'molecular motion pictures'(11) of fundamental molecular processes from a chiral perspective.	[Rhee, Hanju; June, Young-Gun; Lee, Jang-Soo; Lee, Kyung-Koo; Kim, Zee Hwan; Jeon, Seung-Joon; Cho, Minhaeng] Korea Univ, Dept Chem, Seoul 136701, South Korea; [Rhee, Hanju; Lee, Jang-Soo; Lee, Kyung-Koo; Cho, Minhaeng] Korea Univ, Ctr Multidimens Spect, Seoul 136701, South Korea; [Ha, Jeong-Hyon; Jeon, Seung-Joon; Cho, Minhaeng] Korea Basic Sci Inst, Multidimens Spect Lab, Seoul 136713, South Korea	Korea University; Korea University; Korea Basic Science Institute (KBSI)	Cho, MH (corresponding author), Korea Univ, Dept Chem, Seoul 136701, South Korea.	mcho@korea.ac.kr	Kim, Zee Hwan/A-9273-2010; Cho, Minhaeng/C-9983-2011	Cho, Minhaeng/0000-0003-1618-1056; Lee, Jangsoo/0000-0002-0255-1629	Creative Research Initiatives of MEST/KOSEF; Frontier Research Laboratory Program of KBSI	Creative Research Initiatives of MEST/KOSEF(Korea Science and Engineering Foundation); Frontier Research Laboratory Program of KBSI	This work was supported by Creative Research Initiatives (CMDS) of MEST/KOSEF ( M. C.) and the Frontier Research Laboratory Program of KBSI (S.--J.J)	BRIDGES TJ, 1965, APPL OPTICS, V4, P1121, DOI 10.1364/AO.4.001121; Brixner T, 2005, NATURE, V434, P625, DOI 10.1038/nature03429; Brixner T, 2004, OPT LETT, V29, P884, DOI 10.1364/OL.29.000884; Chin DH, 2002, P NATL ACAD SCI USA, V99, P15416, DOI 10.1073/pnas.232591399; CHIRGADZE YN, 1971, BIOPOLYMERS, V10, P809, DOI 10.1002/bip.360100505; Cho MH, 2008, CHEM REV, V108, P1331, DOI 10.1021/cr078377b; Cho M, 2006, NATURE, V444, P431, DOI 10.1038/444431a; Choi JH, 2004, J CHEM PHYS, V120, P4383, DOI 10.1063/1.1644100; Choi JH, 2008, PHYS CHEM CHEM PHYS, V10, P3839, DOI 10.1039/b719263k; Choi JH, 2006, BIOPOLYMERS, V83, P519, DOI 10.1002/bip.20583; Clarke DT, 1999, P NATL ACAD SCI USA, V96, P7232, DOI 10.1073/pnas.96.13.7232; Cowan ML, 2005, NATURE, V434, P199, DOI 10.1038/nature03383; Gallagher SM, 1998, J OPT SOC AM B, V15, P2338, DOI 10.1364/JOSAB.15.002338; GILLARD RD, 1990, NATURE, V347, P594; Goldbeck RA, 1997, ANNU REV PHYS CHEM, V48, P453, DOI 10.1146/annurev.physchem.48.1.453; Guo CN, 2006, VIB SPECTROSC, V42, P254, DOI 10.1016/j.vibspec.2006.05.013; KEIDERLING TA, 1986, NATURE, V322, P851, DOI 10.1038/322851a0; Lepetit L, 1995, J OPT SOC AM B, V12, P2467, DOI 10.1364/JOSAB.12.002467; LEWIS JW, 1985, J PHYS CHEM-US, V89, P289, DOI 10.1021/j100248a023; Nakanishi K., 2000, CIRCULAR DICHROISM P; Niezborala C, 2006, J OPT SOC AM B, V23, P2418, DOI 10.1364/JOSAB.23.002418; Rhee H, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2968130; Rosenfeld L, 1929, Z PHYS, V52, P161, DOI 10.1007/BF01342393; SCHRADER VB, 1972, ANGEW CHEM, V84, P218; Silva RAGD, 2000, P NATL ACAD SCI USA, V97, P8318, DOI 10.1073/pnas.140161997; TINOCO I, 1987, ANNU REV BIOPHYS BIO, V16, P319, DOI 10.1146/annurev.bb.16.060187.001535; Walecki WJ, 1997, OPT LETT, V22, P81, DOI 10.1364/OL.22.000081; XIE XL, 1990, J AM CHEM SOC, V112, P7802, DOI 10.1021/ja00177a054; Zanni MT, 2001, P NATL ACAD SCI USA, V98, P11265, DOI 10.1073/pnas.201412998	29	138	139	5	104	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 19	2009	458	7236					310	313		10.1038/nature07846	http://dx.doi.org/10.1038/nature07846			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420JH	19295604				2022-12-01	WOS:000264285600035
J	Panstruga, R; Parker, JE; Schulze-Lefert, P				Panstruga, Ralph; Parker, Jane E.; Schulze-Lefert, Paul			SnapShot: Plant Immune Response Pathways	CELL			English	Editorial Material							RESISTANCE		[Panstruga, Ralph; Parker, Jane E.; Schulze-Lefert, Paul] Max Planck Inst Plant Breeding Res, D-50829 Cologne, Germany	Max Planck Society	Panstruga, R (corresponding author), Max Planck Inst Plant Breeding Res, D-50829 Cologne, Germany.		Schulze-Lefert, Paul/B-6707-2011; Panstruga, Ralph/F-3340-2011	Panstruga, Ralph/0000-0002-3756-8957	Deutsche Forschungsgemeinschaft [SFB670]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Authors are supported by the Deutsche Forschungsgemeinschaft (SFB670).	Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Dodds PN, 2006, P NATL ACAD SCI USA, V103, P8888, DOI 10.1073/pnas.0602577103; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; Mou Z, 2003, CELL, V113, P935, DOI 10.1016/S0092-8674(03)00429-X; Rooney HCE, 2005, SCIENCE, V308, P1783, DOI 10.1126/science.1111404; Wang D, 2006, PLOS PATHOG, V2, P1042, DOI 10.1371/journal.ppat.0020123; Wirthmueller L, 2007, CURR BIOL, V17, P2023, DOI 10.1016/j.cub.2007.10.042	9	74	81	2	61	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 6	2009	136	5					978	U6	978.e1	10.1016/j.cell.2009.02.020	http://dx.doi.org/10.1016/j.cell.2009.02.020			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	415JU	19269372	Bronze			2022-12-01	WOS:000263930900019
J	Saito, K; Chen, M; Bard, F; Chen, SH; Zhou, HL; Woodley, D; Polischuk, R; Schekman, R; Malhotra, V				Saito, Kota; Chen, Mei; Bard, Fred; Chen, Shenghong; Zhou, Huilin; Woodley, David; Polischuk, Roman; Schekman, Randy; Malhotra, Vivek			TANGO1 Facilitates Cargo Loading at Endoplasmic Reticulum Exit Sites	CELL			English	Article							VII COLLAGEN EXPRESSION; COPII COAT; PROTEIN SECRETION; ER; TRANSPORT; ERGIC-53; GOLGI; IDENTIFICATION; FIBROBLASTS; VESICLES	A genome-wide screen revealed previously unidentified components required for transport and Golgi organization ( TANGO). We now provide evidence that one of these proteins, TANGO1, is an integral membrane protein localized to endoplasmic reticulum ( ER) exit sites, with a luminal SH3 domain and a cytoplasmic proline-rich domain (PRD). Knockdown of TANGO1 inhibits export of bulky collagen VII from the ER. The SH3 domain of TANGO1 binds to collagen VII; the PRD binds to the COPII coat subunits, Sec23/24. In this scenario, PRD binding to Sec23/24 subunits could stall COPII carrier biogenesis to permit the luminal domain of TANGO1 to guide SH3-bound cargo into a growing carrier. All cells except those of hematopoietic origin express TANGO1. We propose that TANGO1 exports other cargoes in cells that do not secrete collagen VII. However, TANGO1 does not enter the budding carrier, which represents a unique mechanism to load cargo into COPII carriers.	[Saito, Kota; Malhotra, Vivek] CRG, Dept Cell & Dev Biol, Barcelona 08003, Spain; [Malhotra, Vivek] Inst Catalana Rec & Estudis Avancats, Barcelona 08003, Spain; [Chen, Mei; Woodley, David] Univ So Calif, USC Norris Comprehens Canc Ctr, Dept Dermatol, Los Angeles, CA 90033 USA; [Bard, Fred] Inst Mol & Cell Biol, Proteos 138673, Singapore; [Chen, Shenghong; Zhou, Huilin] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Polischuk, Roman] Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, Dept Cell Biol & Oncol, I-66030 Santa Maria Imbaro, Chieti, Italy; [Schekman, Randy] Univ Calif Berkeley, HHMI, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); ICREA; University of Southern California; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); University of California System; University of California San Diego; Consorzio Mario Negri Sud; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Malhotra, V (corresponding author), CRG, Dept Cell & Dev Biol, Dr Aiguader 88, Barcelona 08003, Spain.	vivek.malhotra@crg.es	Malhotra, Vivek/O-9811-2014; BARD, Frederic/G-9914-2011; Chen, Sheng-hong/AAU-4018-2021	Malhotra, Vivek/0000-0001-6198-7943; BARD, Frederic/0000-0002-3783-4805; Chen, Sheng-hong/0000-0002-7722-2221; Zhou, Huilin/0000-0002-1350-4430; Saito, Kota/0000-0003-2478-2687	Japanese Society for Promotion of Science; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080469] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	Japanese Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); ICREA(ICREA)	We thank members of the Malhotra lab, especially Yuichi Wakana and Matt Pecot, for valuable discussions and Anne-Marie Alleaume for drawing the model shown in Figure 7. We also thank Kanika Bajaj of the Schekman lab for technical help. K. S. was supported by a fellowship from the Japanese Society for Promotion of Science.	Baines AC, 2007, TRENDS BIOCHEM SCI, V32, P381, DOI 10.1016/j.tibs.2007.06.006; Bard F, 2006, NATURE, V439, P604, DOI 10.1038/nature04377; Belden WJ, 2001, SCIENCE, V294, P1528, DOI 10.1126/science.1065224; Bi XP, 2007, DEV CELL, V13, P635, DOI 10.1016/j.devcel.2007.10.006; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Bosserhoff AK, 2004, GENE EXPR PATTERNS, V4, P473, DOI 10.1016/j.modgep.2003.12.002; Chen M, 2002, NAT GENET, V32, P670, DOI 10.1038/ng1041; Chen M, 1997, J INVEST DERMATOL, V108, P125, DOI 10.1111/1523-1747.ep12332300; CHEN YQ, 1994, J INVEST DERMATOL, V102, P205, DOI 10.1111/1523-1747.ep12371763; Fromme JC, 2007, DEV CELL, V13, P623, DOI 10.1016/j.devcel.2007.10.005; Herrmann JM, 1999, TRENDS CELL BIOL, V9, P5, DOI 10.1016/S0962-8924(98)01414-7; Kadler KE, 2007, J CELL SCI, V120, P1955, DOI 10.1242/jcs.03453; Kim J, 2007, J CELL BIOL, V179, P951, DOI 10.1083/jcb.200709012; Kim J, 2007, CELL HOST MICROBE, V2, P160, DOI 10.1016/j.chom.2007.07.010; Kota J, 2007, J CELL BIOL, V176, P617, DOI 10.1083/jcb.200612100; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Muniz M, 2000, J CELL BIOL, V148, P925, DOI 10.1083/jcb.148.5.925; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Nichols WC, 1998, CELL, V93, P61, DOI 10.1016/S0092-8674(00)81146-0; Nyfeler B, 2008, J CELL BIOL, V180, P705, DOI 10.1083/jcb.200709100; Pfeffer SR, 2007, ANNU REV BIOCHEM, V76, P629, DOI 10.1146/annurev.biochem.76.061705.130002; PINNELL SR, 1987, ARCH DERMATOL, V123, P1684, DOI 10.1001/archderm.123.12.1684; Shaywitz DA, 1997, J BIOL CHEM, V272, P25413, DOI 10.1074/jbc.272.41.25413; Shugrue CA, 1999, J CELL SCI, V112, P4547; Townley AK, 2008, J CELL SCI, V121, P3025, DOI 10.1242/jcs.031070; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Vollenweider F, 1998, J CELL BIOL, V142, P377, DOI 10.1083/jcb.142.2.377; WIELAND FT, 1987, CELL, V50, P289, DOI 10.1016/0092-8674(87)90224-8; Woodley DT, 2007, CLIN REV ALLERG IMMU, V33, P78, DOI 10.1007/s12016-007-0027-6	29	238	243	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 6	2009	136	5					891	902		10.1016/j.cell.2008.12.025	http://dx.doi.org/10.1016/j.cell.2008.12.025			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	415JU	19269366	Bronze			2022-12-01	WOS:000263930900012
J	Moscona, A				Moscona, Anne			Global Transmission of Oseltamivir-Resistant Influenza	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							VIRUS NEURAMINIDASE		[Moscona, Anne] Cornell Univ, Weill Med Coll, Dept Pediat, New York, NY 10021 USA; [Moscona, Anne] Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA	Cornell University; Cornell University	Moscona, A (corresponding author), Cornell Univ, Weill Med Coll, Dept Pediat, New York, NY 10021 USA.							Collins PJ, 2008, NATURE, V453, P1258, DOI 10.1038/nature06956; DIAS A, 2009, NATURE          0204; Hauge SH, 2009, EMERG INFECT DIS, V15, P155, DOI 10.3201/eid1502.081031; Moscona A, 2008, ANNU REV MED, V59, P397, DOI 10.1146/annurev.med.59.061506.213121; Varghese JN, 1998, STRUCT FOLD DES, V6, P735, DOI 10.1016/S0969-2126(98)00075-6	5	380	438	0	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 5	2009	360	10					953	956		10.1056/NEJMp0900648	http://dx.doi.org/10.1056/NEJMp0900648			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	413WX	19258250				2022-12-01	WOS:000263824500002
J	Neovius, M; Sundstrom, J; Rasmussen, F				Neovius, Martin; Sundstrom, Johan; Rasmussen, Finn			Combined effects of overweight and smoking in late adolescence on subsequent mortality: nationwide cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BODY-MASS INDEX; FOLLOW-UP; OBESITY; MEN; UNDERWEIGHT; WEIGHT; METAANALYSIS; PREVALENCE; HEIGHT; TRENDS	Objective To investigate the combined effects on adult mortality of overweight and smoking in late adolescence. Design Record linkage study with Cox proportional hazard ratios adjusted for muscle strength, socioeconomic position, and age. Setting Swedish military service conscription register, cause of death register, and census data. Participants 45920 Swedish men (mean age 18.7, SD 0.5) followed for 38 years. Main outcome measures Body mass index (underweight (BMI < 18.5), normal weight (18.5-24.9), overweight (25-29.9), and obesity (>= 30)), muscle strength, and self reported smoking (non-smoker, light smoker (1-10 cigarettes/day), heavy smoker (> 10/day)) at mandatory military conscription tests in 1969-70. All cause mortality. Results Over 1.7 million person years, 2897 men died. Compared with normal weight men (incidence rate 17/10000 person years, 95% confidence interval 16 to 18), risk of mortality was increased in overweight (hazard ratio 1.33, 1.15 to 1.53; incidence rate 23, 20 to 26) and obese men (hazard ratio 2.14,1.61 to 2.85; incidence rate 38,27 to 48), with similar relative estimates in separate analyses of smokers and non-smokers. No increased risk was detected in underweight men (hazard ratio 0.97, 0.86 to 1.08; incidence rate 18, 16 to 19), though extreme underweight (BMI < 17) was associated with increased mortality (hazard ratio 1.33, 1.07 to 1.64; incidence rate 24, 19 to 29). The relative excess risk due to interaction between BMI and smoking status was not significant in any stratum. Furthermore, all estimates of interaction were of small magnitude, except for the combination of obesity and heavy smoking (relative excess risk 1.5,-0.7 to 3.7). Compared with non-smokers (incidence rate 14, 13 to 15), risk was increased in both light (hazard ratio 1.54, 1.41 to 1.70; incidence rate 15, 14 to 16) and heavy smokers (hazard ratio 2.11, 1.92 to 2.31; incidence rate 26, 24 to 27). Conclusions Regardless of smoking status, overweight and obesity in late adolescence increases the risk of adult mortality. Obesity and overweight were as hazardous as heavy and light smoking, respectively, but there was no interaction between BMI and smoking status. The global obesity epidemic and smoking among adolescents remain important targets for intensified public health initiatives.	[Sundstrom, Johan] Univ Uppsala Hosp, Dept Med Sci, SE-75185 Uppsala, Sweden	Uppsala University; Uppsala University Hospital		martin.neovius@ki.se	Sundstrom, Johan/R-2139-2019; Sundström, Johan/A-6286-2009	Sundstrom, Johan/0000-0003-2247-8454; Sundström, Johan/0000-0003-2247-8454; Neovius, Martin/0000-0003-2300-3055; Rasmussen, Finn/0000-0001-7915-7809	Arbetsmarknadens Forsakrings-och Aktiebolag (AFA); Swedish Heart-Lung Foundation and the Swedish Research Council [2007-5942]	Arbetsmarknadens Forsakrings-och Aktiebolag (AFA); Swedish Heart-Lung Foundation and the Swedish Research Council	MN was funded by Arbetsmarknadens Forsakrings-och Aktiebolag (AFA) and JS by the Swedish Heart-Lung Foundation and the Swedish Research Council (2007-5942). The funding sources did not read or comment on any version of the manuscript, nor influence the analyses in any way.	Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Ajani UA, 2004, ANN EPIDEMIOL, V14, P731, DOI 10.1016/j.annepidem.2003.10.008; Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x; ANDREASSON S, 1988, BRIT MED J, V296, P1021, DOI 10.1136/bmj.296.6628.1021; Bigaard J, 2003, OBES RES, V11, P895, DOI 10.1038/oby.2003.123; Bjorge T, 2008, AM J EPIDEMIOL, V168, P30, DOI 10.1093/aje/kwn096; *CAN, 2006, 95 CAN; COX DR, 1972, J R STAT SOC B, V34, P187; Engeland A, 2003, AM J EPIDEMIOL, V157, P517, DOI 10.1093/aje/kwf219; Falkstedt D, 2007, INT J OBESITY, V31, P777, DOI 10.1038/sj.ijo.0803480; Flegal KM, 2007, JAMA-J AM MED ASSOC, V298, P2028, DOI 10.1001/jama.298.17.2028; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; HOFFMANS MDAF, 1988, J CLIN EPIDEMIOL, V41, P749, DOI 10.1016/0895-4356(88)90161-8; Hu FB, 2004, NEW ENGL J MED, V351, P2694, DOI 10.1056/NEJMoa042135; Hublet A, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-280; Jee SH, 2006, NEW ENGL J MED, V355, P779, DOI 10.1056/NEJMoa054017; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Mcgee DL, 2005, ANN EPIDEMIOL, V15, P87, DOI 10.1016/j.annepidem.2004.05.012; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Neovius M, 2008, INT J OBESITY, V32, P1319, DOI 10.1038/ijo.2008.70; Neovius M, 2008, OBESITY, V16, P671, DOI 10.1038/oby.2007.115; Niedhammer I, 2000, INT J OBESITY, V24, P1111, DOI 10.1038/sj.ijo.0801375; Nyholm M, 2008, OBESITY, V16, P896, DOI 10.1038/oby.2007.134; Obesity: preventing and managing the global epidemic, 2000, WHO TECH REP SER, V894, pi; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Popkin BM, 2006, OBESITY, V14, P1846, DOI 10.1038/oby.2006.213; Rasmussen F, 2007, EUR J CLIN NUTR, V61, P870, DOI 10.1038/sj.ejcn.1602595; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Rothman KJ., 2012, EPIDEMIOLOGY INTRO, V2nd; SONNEHOLM S, 1983, BRIT MED J, V287, P795, DOI 10.1136/bmj.287.6395.795; STEVENS J, 1990, AM J EPIDEMIOL, V132, P1156, DOI 10.1093/oxfordjournals.aje.a115758; van Dam RM, 2006, ANN INTERN MED, V145, P91, DOI 10.7326/0003-4819-145-2-200607180-00006; Warren Charles W., 2008, Morbidity and Mortality Weekly Report, V57, P1; Willett WC, 2005, JAMA-J AM MED ASSOC, V294, P551, DOI 10.1001/jama.294.5.551-b	34	82	84	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 24	2009	338								b496	10.1136/bmj.b496	http://dx.doi.org/10.1136/bmj.b496			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417DQ	19244221	Green Published, hybrid			2022-12-01	WOS:000264056100004
J	Grande, D; Asch, DA				Grande, David; Asch, David A.			Commercial versus Social Goals of Tracking What Doctors Do	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Grande, David] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Asch, David A.] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; [Asch, David A.] Philadelphia Vet Affairs Med Ctr, Ctr Hlth Equ Res & Promot, Philadelphia, PA USA	University of Pennsylvania; University of Pennsylvania; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Philadelphia Veterans Affairs Medical Center	Grande, D (corresponding author), Univ Penn, Sch Med, Philadelphia, PA 19104 USA.		Grande, David/AAJ-8191-2021	Grande, David/0000-0002-6717-6735; Asch, David/0000-0002-7970-286X				*IMS HLTH, IMS CORP OV; POTTENGER B, FREECONOMICS HLTH CA	2	8	8	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 19	2009	360	8					747	749		10.1056/NEJMp0810410	http://dx.doi.org/10.1056/NEJMp0810410			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	408CN	19228616				2022-12-01	WOS:000263411300002
J	Fontanilla, D; Johannessen, M; Hajipour, AR; Cozzi, NV; Jackson, MB; Ruoho, AE				Fontanilla, Dominique; Johannessen, Molly; Hajipour, Abdol R.; Cozzi, Nicholas V.; Jackson, Meyer B.; Ruoho, Arnold E.			The Hallucinogen N,N-Dimethyltryptamine (DMT) Is an Endogenous Sigma-1 Receptor Regulator	SCIENCE			English	Article							TRACE AMINES; BINDING-SITE; IN-VIVO; CHANNELS; IDENTIFICATION; TRYPTAMINES; MODULATION; TERMINALS; LIGANDS; MOUSE	The sigma-1 receptor is widely distributed in the central nervous system and periphery. Originally mischaracterized as an opioid receptor, the sigma-1 receptor binds a vast number of synthetic compounds but does not bind opioid peptides; it is currently considered an orphan receptor. The sigma- 1 receptor pharmacophore includes an alkylamine core, also found in the endogenous compound N, N- dimethyltryptamine ( DMT). DMT acts as a hallucinogen, but its receptor target has been unclear. DMT bound to sigma- 1 receptors and inhibited voltage- gated sodium ion ( Na+) channels in both native cardiac myocytes and heterologous cells that express sigma- 1 receptors. DMT induced hypermobility in wild- type mice but not in sigma- 1 receptor knockout mice. These biochemical, physiological, and behavioral experiments indicate that DMT is an endogenous agonist for the sigma- 1 receptor.	[Fontanilla, Dominique; Cozzi, Nicholas V.; Ruoho, Arnold E.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pharmacol, Madison, WI 53706 USA; [Johannessen, Molly; Jackson, Meyer B.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Physiol, Madison, WI 53706 USA; [Hajipour, Abdol R.] Isfahan Univ Technol, Pharmaceut Res Lab, Dept Chem, Esfahan 84156, Iran	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Isfahan University of Technology	Ruoho, AE (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Pharmacol, Madison, WI 53706 USA.	aeruoho@wisc.edu	Cozzi, Nicholas/AAT-1633-2020		Molecular and Cellular Pharmacology (MCP) Graduate Program; NIH [T32 GM08688, R01 MH065503, NS30016]; NIH Ruth L. Kirschstein National Research Service Award [F31 DA022932]; National Institute on Drug Abuse; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008688] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS030016, R01NS030016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F31DA022932] Funding Source: NIH RePORTER	Molecular and Cellular Pharmacology (MCP) Graduate Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank the Corinna Burger laboratory for use of their mouse behavior equipment, and A. Paul and T. Mavlyutov for providing [<SUP>125</SUP>I] IAF and [<SUP>125</SUP>I]- IACoc, respectively. Supported by the Molecular and Cellular Pharmacology (MCP) Graduate Program training grant from NIH T32 GM08688 and by the NIH Ruth L. Kirschstein National Research Service Award (NRSA) (F31 DA022932) from the National Institute on Drug Abuse ( to D.F.). This work was funded by NIH grants R01 MH065503 ( to A. E. R.) and NS30016 ( to M. B. J.).	AXELROD J, 1961, SCIENCE, V134, P343, DOI 10.1126/science.134.3475.343; Aydar E, 2002, NEURON, V34, P399, DOI 10.1016/S0896-6273(02)00677-3; Barker S A, 1981, Int Rev Neurobiol, V22, P83, DOI 10.1016/S0074-7742(08)60291-3; BEATON JM, 1984, MECH AGEING DEV, V25, P343, DOI 10.1016/0047-6374(84)90007-1; Borowsky B, 2001, P NATL ACAD SCI USA, V98, P8966, DOI 10.1073/pnas.151105198; BOUCHARD P, 1995, EUR J NEUROSCI, V7, P1952, DOI 10.1111/j.1460-9568.1995.tb00718.x; Burchett SA, 2006, PROG NEUROBIOL, V79, P223, DOI 10.1016/j.pneurobio.2006.07.003; Chen YM, 2007, BIOCHEMISTRY-US, V46, P3532, DOI 10.1021/bi061727o; FRANZEN F, 1965, NATURE, V206, P1052, DOI 10.1038/2061052a0; GLENNON RA, 1994, J MED CHEM, V37, P1214, DOI 10.1021/jm00034a020; Hayashi T, 2004, CNS DRUGS, V18, P269, DOI 10.2165/00023210-200418050-00001; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Jacob MS, 2005, MED HYPOTHESES, V64, P930, DOI 10.1016/j.mehy.2004.11.005; JENNER P, 1980, BRIT J PHARMACOL, V69, P69, DOI 10.1111/j.1476-5381.1980.tb10884.x; JOHANNESSEN MA, 2007, ANN NEUR M SAN DIEG; KAHOUN JR, 1992, P NATL ACAD SCI USA, V89, P1393, DOI 10.1073/pnas.89.4.1393; KENNEDY C, 1990, NEUROSCIENCE, V35, P725, DOI 10.1016/0306-4522(90)90343-3; Langa F, 2003, EUR J NEUROSCI, V18, P2188, DOI 10.1046/j.1460-9568.2003.02950.x; Lindemann L, 2005, GENOMICS, V85, P372, DOI 10.1016/j.ygeno.2004.11.010; Lupardus PJ, 2000, J PHYSIOL-LONDON, V526, P527, DOI 10.1111/j.1469-7793.2000.00527.x; Matsumoto RR, 2000, EUR J PHARMACOL, V401, P155, DOI 10.1016/S0014-2999(00)00430-1; Moebius FF, 1997, BRIT J PHARMACOL, V121, P1, DOI 10.1038/sj.bjp.0701079; Pal A, 2007, MOL PHARMACOL, V72, P921, DOI 10.1124/mol.107.038307; SAAVEDRA JM, 1972, SCIENCE, V175, P1365, DOI 10.1126/science.175.4028.1365; SU TP, 1986, LIFE SCI, V38, P2199; SU TP, 1988, SCIENCE, V240, P219, DOI 10.1126/science.2832949; Wilke RA, 1999, J PHYSIOL-LONDON, V517, P391, DOI 10.1111/j.1469-7793.1999.00391.x; Zhang HL, 2005, J PHARMACOL EXP THER, V313, P1387, DOI 10.1124/jpet.105.084152; Zhang HL, 2002, J NEUROPHYSIOL, V87, P2867, DOI 10.1152/jn.2002.87.6.2867	29	374	382	0	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 13	2009	323	5916					934	937		10.1126/science.1166127	http://dx.doi.org/10.1126/science.1166127			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406KW	19213917	Green Accepted			2022-12-01	WOS:000263295400042
J	Thathiah, A; Spittaels, K; Hoffmann, M; Staes, M; Cohen, A; Horre, K; Vanbrabant, M; Coun, F; Baekelandt, V; Delacourte, A; Fischer, DF; Pollet, D; De Strooper, B; Merchiers, P				Thathiah, Amantha; Spittaels, Kurt; Hoffmann, Marcel; Staes, Mik; Cohen, Adrian; Horre, Katrien; Vanbrabant, Mieke; Coun, Frea; Baekelandt, Veerle; Delacourte, Andre; Fischer, David F.; Pollet, Dirk; De Strooper, Bart; Merchiers, Pascal			The Orphan G Protein-Coupled Receptor 3 Modulates Amyloid-Beta Peptide Generation in Neurons	SCIENCE			English	Article							GAMMA-SECRETASE ACTIVITY; ALZHEIMERS-DISEASE; TRANSGENIC MICE; LIPID RAFTS; EXPRESSION; PRESENILIN; NICASTRIN; REQUIRES; GOLGI; PEN-2	Deposition of the amyloid-beta peptide is a pathological hallmark of Alzheimer's disease. A high- throughput functional genomics screen identified G protein- coupled receptor 3 ( GPR3), a constitutively active orphan G protein- coupled receptor, as a modulator of amyloid-beta production. Overexpression of GPR3 stimulated amyloid-beta production, whereas genetic ablation of GPR3 prevented accumulation of the amyloid-beta peptide in vitro and in an Alzheimer's disease mouse model. GPR3 expression led to increased formation and cell- surface localization of the mature gamma-secretase complex in the absence of an effect on Notch processing. GPR3 is highly expressed in areas of the normal human brain implicated in Alzheimer's disease and is elevated in the sporadic Alzheimer's disease brain. Thus, GPR3 represents a potential therapeutic target for the treatment of Alzheimer's disease.	[Fischer, David F.] BioFocus DPI, Galapagos Co, NL-2333 CR Leiden, Netherlands; [Delacourte, Andre] Jean Pierre Aubert Res Ctr, INSERM, Unit 837, F-59045 Lille, France; [Thathiah, Amantha; Horre, Katrien; Vanbrabant, Mieke; De Strooper, Bart] Katholieke Univ Leuven VIB, Dept Mol & Dev Genet, B-3000 Louvain, Belgium; [Thathiah, Amantha; Horre, Katrien; Vanbrabant, Mieke; De Strooper, Bart] Catholic Univ Louvain, Ctr Human Genet, B-3000 Louvain, Belgium; [Spittaels, Kurt; Hoffmann, Marcel; Staes, Mik; Cohen, Adrian; Pollet, Dirk; Merchiers, Pascal] Galapagos, B-2800 Mechelen, Belgium; [Coun, Frea; Baekelandt, Veerle] Catholic Univ Louvain, Lab Neurobiol & Gene Therapy, Div Mol Med, B-3000 Louvain, Belgium	Galapagos NV; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Flanders Institute for Biotechnology (VIB); KU Leuven; Universite Catholique Louvain; Galapagos NV; Universite Catholique Louvain	Fischer, DF (corresponding author), BioFocus DPI, Galapagos Co, Darwinweg 24, NL-2333 CR Leiden, Netherlands.	david.fischer@glpg.com; bart.destrooper@med.kuleuven.be	Baekelandt, Veerle/ABB-9736-2020; De Strooper, Bart/F-6507-2012; de+Strooper, Bart/Z-1638-2019	Baekelandt, Veerle/0000-0001-8966-2921; De Strooper, Bart/0000-0001-5455-5819; Horre, Katrien/0000-0002-6801-3137; Fischer, David/0000-0002-6690-0197	Methusalem grant from the Flemish government [IWT990363, IWT010512, IWT030623]; Fund for Scientific Research (Flanders, Belgium); Federal Office for Scientific Affairs, Belgium [IUAP P6/43/]	Methusalem grant from the Flemish government; Fund for Scientific Research (Flanders, Belgium)(FWO); Federal Office for Scientific Affairs, Belgium	We acknowledge the contributions of W. Laenen, H. Klaassen, S. Hinnekint, S. de Vos, E. van Rossen, A. Van de Poel, M. De Raeymaeker, K. Thys, J. Vandersmissen, J. van der Schueren, R. Brown, K. Albert, V. Coose, K. Pittois, S. Theunissen, V. Hendrix, E. Maes, K. Craessaerts, J. Prennen, A. Deelder, P. Scheltens, and M. Mercken. We are grateful to G. Vassart and C. Ledent (Universit, Libre de Bruxelles, Brussels, Belgium) for the RT-GPR3 and RT-TSHr cDNA and assistance with cAMP assays, C. H. Berlot (Geisinger Medical Center, Danville, PA) for the GsDN and R280K cDNA, and Murat Bastepe (Harvard Medical School, Boston, MA) for the G<INF>s alpha</INF>-null mouse embryo fibroblasts. This project was supported by IWT990363, IWT010512, and IWT030623, a Methusalem grant from the Flemish government, the Fund for Scientific Research (Flanders, Belgium), and the Federal Office for Scientific Affairs (IUAP P6/43/), Belgium. B. D. S. has been a paid consultant for Galapagos, a drug discovery company. Galapagos holds U. S. patent 7429459 on the GPR3 findings and the technology and library used in this study.	Annaert W, 2002, ANNU REV CELL DEV BI, V18, P25, DOI 10.1146/annurev.cellbio.18.020402.142302; Blacker D, 2003, HUM MOL GENET, V12, P23, DOI 10.1093/hmg/ddg007; Chini B, 2004, J MOL ENDOCRINOL, V32, P325, DOI 10.1677/jme.0.0320325; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; Dominguez D, 2005, J BIOL CHEM, V280, P30797, DOI 10.1074/jbc.M505249200; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; HEIBER M, 1995, DNA CELL BIOL, V14, P25, DOI 10.1089/dna.1995.14.25; Herreman A, 2003, J CELL SCI, V116, P1127, DOI 10.1242/jcs.00292; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; IISMAA TP, 1994, GENOMICS, V24, P391, DOI 10.1006/geno.1994.1635; Ledent C, 2005, P NATL ACAD SCI USA, V102, P8922, DOI 10.1073/pnas.0503840102; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Ni YX, 2006, NAT MED, V12, P1390, DOI 10.1038/nm1485; Nitsch RM, 1996, J BIOL CHEM, V271, P4188; Nyabi O, 2003, J BIOL CHEM, V278, P43430, DOI 10.1074/jbc.M306957200; Oddo S, 2006, J BIOL CHEM, V281, P39413, DOI 10.1074/jbc.M608485200; Pooler AM, 2004, NEUROSCI LETT, V362, P127, DOI 10.1016/j.neulet.2004.03.013; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Saunders AJ, 1999, SCIENCE, V286; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Spasic D, 2006, J BIOL CHEM, V281, P26569, DOI 10.1074/jbc.M600592200; Tanaka S, 2007, J BIOL CHEM, V282, P10506, DOI 10.1074/jbc.M700911200; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Weidemann A, 2002, BIOCHEMISTRY-US, V41, P2825, DOI 10.1021/bi015794o; Wilquet V, 2004, CURR OPIN NEUROBIOL, V14, P582, DOI 10.1016/j.conb.2004.08.001	27	114	127	4	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 13	2009	323	5916					946	951		10.1126/science.1160649	http://dx.doi.org/10.1126/science.1160649			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406KW	19213921				2022-12-01	WOS:000263295400046
J	Slotkin, RK; Vaughn, M; Borges, F; Tanurdzic, M; Becker, JD; Feijo, JA; Martienssen, RA				Slotkin, R. Keith; Vaughn, Matthew; Borges, Filipe; Tanurdzic, Milos; Becker, Joerg D.; Feijo, Jose A.; Martienssen, Robert A.			Epigenetic Reprogramming and Small RNA Silencing of Transposable Elements in Pollen	CELL			English	Article							MALE GAMETOPHYTE DEVELOPMENT; TISSUE-SPECIFIC CONTROL; DNA METHYLATION; DROSOPHILA-MELANOGASTER; GENE-EXPRESSION; MUTATOR TRANSPOSONS; INTERFERING RNA; H3 METHYLATION; FLAMENCO GENE; ARABIDOPSIS	The mutagenic activity of transposable elements (TEs) is suppressed by epigenetic silencing and small interfering RNAs (siRNAs), especially in gametes that could transmit transposed elements to the next generation. In pollen from the model plant Arabidopsis, we show that TEs are unexpectedly reactivated and transpose, but only in the pollen vegetative nucleus, which accompanies the sperm cells but does not provide DNA to the fertilized zygote. TE expression coincides with downregulation of the heterochromatin remodeler DECREASE IN DNA METHYLATION 1 and of many TE siRNAs. However, 21 nucleotide siRNAs from Athila retrotransposons are generated and accumulate in pollen and sperm, suggesting that siRNA from TEs activated in the vegetative nucleus can target silencing in gametes. We propose a conserved role for reprogramming in germline companion cells, such as nurse cells in insects and vegetative nuclei in plants, to reveal intact TEs in the genome and regulate their activity in gametes.	[Slotkin, R. Keith; Vaughn, Matthew; Tanurdzic, Milos; Martienssen, Robert A.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Borges, Filipe; Becker, Joerg D.; Feijo, Jose A.] Ctr Biol Desenvolvimento, Inst Gulbenkian Ciencia, P-2780901 Oeiras, Portugal; [Feijo, Jose A.] Univ Lisbon, Fac Ciencias, Dept Biol Vegetal, Lisbon, MS, Portugal	Cold Spring Harbor Laboratory; Instituto Gulbenkian de Ciencia; Universidade de Lisboa	Martienssen, RA (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	martiens@cshl.edu	Feijo, Jose A./ADM-0262-2022; Tanurdzic, Milos/A-5712-2012; Becker, Jorg/A-5930-2011; Slotkin, R. Keith/H-6965-2013	Feijo, Jose A./0000-0002-1100-5478; Tanurdzic, Milos/0000-0002-7564-0868; Becker, Jorg/0000-0002-6845-6122; Slotkin, R. Keith/0000-0001-9582-3533; Vaughn, Matthew/0000-0002-1384-4283; Borges, Filipe/0000-0002-7388-2118	National Institutes of Health (NIH) [F32 CA125977]; National Science Foundation [DBI-0733857]; Robertson Research Fund; NIH [R01 GM067014]; Fundacao para a Ciencia e a Tecnologia [PPCDT/BIA-BCM/61270/2004, PTDC/AGR-GPL/70592/2006]; NATIONAL CANCER INSTITUTE [F32CA125977] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067014] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Robertson Research Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Simorowski, M. Galli, T. Nawy, M. Bayer, and S. Hearn, for assistance with GUS staining and microscopy and T. Stokes, E. Richards, R. Gardner, T. Mulligan, Y. Fang, D. Spector, D. Lisch, and R. Schwab for providing tools and stocks. We additionally thank Dennis Stevenson ( New York Botanical Garden) for discussions. R. K. S. is a recipient of a National Institutes of Health (NIH) postdoctoral fellowship (F32 CA125977). This work was supported by grants from the National Science Foundation (DBI-0733857), the Robertson Research Fund, and the NIH (R01 GM067014) to R. A. M., as well as grants PPCDT/BIA-BCM/61270/2004 and PTDC/AGR-GPL/70592/2006 from Fundacao para a Ciencia e a Tecnologia (FCT) to J. D. B.	Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Becker JD, 2003, PLANT PHYSIOL, V133, P713, DOI 10.1104/pp.103.028241; Becker JD, 2007, ANN BOT-LONDON, V100, P1117, DOI 10.1093/aob/mcm208; Borges F, 2008, PLANT PHYSIOL, V148, P1168, DOI 10.1104/pp.108.125229; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Brower-Toland B, 2007, GENE DEV, V21, P2300, DOI 10.1101/gad.1564307; CALVI BR, 1994, EMBO J, V13, P1636, DOI 10.1002/j.1460-2075.1994.tb06427.x; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Casa AM, 2004, METH MOL B, V260, P175, DOI 10.1385/1-59259-755-6:175; Chambeyron S, 2008, P NATL ACAD SCI USA, V105, P14964, DOI 10.1073/pnas.0805943105; Dunoyer P, 2005, NAT GENET, V37, P1356, DOI 10.1038/ng1675; Dupressoir A, 1996, MOL CELL BIOL, V16, P4495; EADY C, 1995, PLANT CELL, V7, P65, DOI 10.1105/tpc.7.1.65; Engel ML, 2005, PLANT PHYSIOL, V138, P2124, DOI 10.1104/pp.104.054213; Friedman WE, 1999, DEVELOPMENT, V126, P1065; Galli M, 2003, GENETICS, V165, P2093; Gendrel AV, 2002, SCIENCE, V297, P1871, DOI 10.1126/science.1074950; GOLDBERG RB, 1993, PLANT CELL, V5, P1217, DOI 10.1105/tpc.5.10.1217; Grivna ST, 2006, GENE DEV, V20, P1709, DOI 10.1101/gad.1434406; Gruntman E, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-371; Hamilton A, 2002, EMBO J, V21, P4671, DOI 10.1093/emboj/cdf464; Himber C, 2003, EMBO J, V22, P4523, DOI 10.1093/emboj/cdg431; Honys D, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r85; Ingouff M, 2007, CURR BIOL, V17, P1032, DOI 10.1016/j.cub.2007.05.019; Janousek B, 2000, PROTOPLASMA, V211, P116, DOI 10.1007/BF01279904; Johnson-Brousseau SA, 2004, PLANT J, V39, P761, DOI 10.1111/j.1365-313X.2004.02147.x; Jullien PE, 2008, PLOS BIOL, V6, P1693, DOI 10.1371/journal.pbio.0060194; Kasschau KD, 2007, PLOS BIOL, V5, P479, DOI 10.1371/journal.pbio.0050057; Kikuchi K, 2003, NATURE, V421, P167, DOI 10.1038/nature01218; Kloc A, 2008, CURR BIOL, V18, P490, DOI 10.1016/j.cub.2008.03.016; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Lippman Z, 2003, PLOS BIOL, V1, P420, DOI 10.1371/journal.pbio.0000067; Lisch D, 2002, TRENDS PLANT SCI, V7, P498, DOI 10.1016/S1360-1385(02)02347-6; McCormick S, 2004, PLANT CELL, V16, pS142, DOI 10.1105/tpc.016659; MCCORMICK S, 1993, PLANT CELL, V5, P1265, DOI 10.1105/tpc.5.10.1265; MEYER E, 2007, EPIGENETICS, P127; Miura A, 2001, NATURE, V411, P212, DOI 10.1038/35075612; Nobuta K, 2007, NAT BIOTECHNOL, V25, P473, DOI 10.1038/nbt1291; Okada T, 2006, PLANT MOL BIOL, V62, P503, DOI 10.1007/s11103-006-9036-8; Ostertag EM, 2002, NAT GENET, V32, P655, DOI 10.1038/ng1022; Pasyukova E, 1997, MOL GEN GENET, V255, P115, DOI 10.1007/s004380050479; PELISSON A, 1994, EMBO J, V13, P4401, DOI 10.1002/j.1460-2075.1994.tb06760.x; Pina C, 2005, PLANT PHYSIOL, V138, P744, DOI 10.1104/pp.104.057935; Rabinowicz PD, 2005, GENOME RES, V15, P1431, DOI 10.1101/gr.4100405; Raizada MN, 2001, PLANT J, V25, P79, DOI 10.1046/j.1365-313x.2001.00939.x; Sarot E, 2004, GENETICS, V166, P1313, DOI 10.1534/genetics.166.3.1313; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Singer T, 2001, GENE DEV, V15, P591, DOI 10.1101/gad.193701; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; SUNDARESAN V, 1995, GENE DEV, V9, P1797, DOI 10.1101/gad.9.14.1797; Talbert PB, 2002, PLANT CELL, V14, P1053, DOI 10.1105/tpc.010425; Tanurdzic M, 2008, PLOS BIOL, V6, P2880, DOI 10.1371/journal.pbio.0060302; UEDA K, 1995, DEV BIOL, V169, P210, DOI 10.1006/dbio.1995.1138; VONGS A, 1993, SCIENCE, V260, P1926, DOI 10.1126/science.8316832; Wang Y, 2008, PLANT PHYSIOL, V148, P1201, DOI 10.1104/pp.108.126375; YU S, 1989, PROTOPLASMA, V152, P29; Zheng XW, 2008, NATURE, V455, P1259, DOI 10.1038/nature07305	59	704	727	4	149	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 6	2009	136	3					461	472		10.1016/j.cell.2008.12.038	http://dx.doi.org/10.1016/j.cell.2008.12.038			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	403ZN	19203581	Green Accepted, Green Submitted, Bronze			2022-12-01	WOS:000263120600016
J	Li, LJ; Gattass, RR; Gershgoren, E; Hwang, H; Fourkas, JT				Li, Linjie; Gattass, Rafael R.; Gershgoren, Erez; Hwang, Hana; Fourkas, John T.			Achieving lambda/20 Resolution by One-Color Initiation and Deactivation of Polymerization	SCIENCE			English	Article							2-PHOTON; LITHOGRAPHY; MICROSCOPY; NANOSCOPY	In conventional photolithography, diffraction limits the resolution to about one-quarter of the wavelength of the light used. We introduce an approach to photolithography in which multiphoton absorption of pulsed 800-nanometer (nm) light is used to initiate cross-linking in a polymer photoresist and one-photon absorption of continuous-wave 800-nm light is used simultaneously to deactivate the photopolymerization. By employing spatial phase-shaping of the deactivation beam, we demonstrate the fabrication of features with scalable resolution along the beam axis, down to a 40-nm minimum feature size. We anticipate application of this technique for the fabrication of diverse two- and three-dimensional structures with a feature size that is a small fraction of the wavelength of the light employed.	[Li, Linjie; Gattass, Rafael R.; Gershgoren, Erez; Fourkas, John T.] Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA; [Hwang, Hana] Univ Maryland, Dept Phys, College Pk, MD 20742 USA; [Fourkas, John T.] Univ Maryland, Inst Phys Sci & Technol, College Pk, MD 20742 USA; [Fourkas, John T.] Univ Maryland, Maryland NanoCtr, College Pk, MD 20742 USA; [Fourkas, John T.] Univ Maryland, Ctr Nanophys & Adv Mat, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Fourkas, JT (corresponding author), Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA.	fourkas@umd.edu	li, linjie/C-7845-2009; Hwang, Hana/B-3999-2011; Fourkas, John T/B-3500-2009	Fourkas, John T/0000-0002-4522-9584	UMD-NSF-MRSEC [DMR 05-20471]	UMD-NSF-MRSEC(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We appreciate the support of the Maryland NanoCenter and its Nanoscale Imaging, Spectroscopy, and Properties Laboratory (NISPLab). NISPLab is supported in part by NSF as a Materials Research Science and Engineering Center (MRSEC) Shared Experimental Facility. This work was supported in part by the UMD-NSF-MRSEC under grant DMR 05-20471. We are grateful to E. Williams for the use of her AFM and to J. Goldhar, Y. Leng, and V. Yun for fabricating the phase mask used in this work. The University of Maryland has filed a provision patent based on the work presented in this paper.	BEIJERSBERGEN MW, 1994, OPT COMMUN, V112, P321, DOI 10.1016/0030-4018(94)90638-6; Colley CS, 2002, J AM CHEM SOC, V124, P14952, DOI 10.1021/ja026099m; Farrer RA, 2005, NANO LETT, V5, P1139, DOI 10.1021/nl050687r; Harke B, 2008, NANO LETT, V8, P1309, DOI 10.1021/nl073164n; Haske W, 2007, OPT EXPRESS, V15, P3426, DOI 10.1364/OE.15.003426; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; Hell SW, 2009, NAT METHODS, V6, P24, DOI [10.1038/NMETH.1291, 10.1038/nmeth.1291]; Hirschfelder J., 1954, MOL THEORY GASES LIQ; Ito H, 2005, ADV POLYM SCI, V172, P37, DOI 10.1007/b97574; Kawata S, 2001, NATURE, V412, P697, DOI 10.1038/35089130; Klar TA, 2000, P NATL ACAD SCI USA, V97, P8206, DOI 10.1073/pnas.97.15.8206; LaFratta CN, 2007, ANGEW CHEM INT EDIT, V46, P6238, DOI 10.1002/anie.200603995; Rumi M, 2008, ADV POLYM SCI, V213, P1, DOI 10.1007/12_2008_133; Sun HB, 2003, APPL PHYS LETT, V83, P819, DOI 10.1063/1.1598293; Sun HB, 2002, APPL PHYS LETT, V80, P3673, DOI 10.1063/1.1478128; Tan DF, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2535504; Thompson SE, 2006, MATER TODAY, V9, P20, DOI 10.1016/S1369-7021(06)71539-5; Xing JF, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2717532; Yang D, 2005, MRS BULL, V30, P976, DOI 10.1557/mrs2005.251	19	383	405	11	182	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 15	2009	324	5929					910	913		10.1126/science.1168996	http://dx.doi.org/10.1126/science.1168996			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445KD	19359543				2022-12-01	WOS:000266048800030
J	Semmelhack, JL; Wang, JW				Semmelhack, Julia L.; Wang, Jing W.			Select Drosophila glomeruli mediate innate olfactory attraction and aversion	NATURE			English	Article							ANTENNAL LOBE; BEHAVIORAL-RESPONSES; FLY BRAIN; NEURONS; RECEPTORS; MAP; MELANOGASTER; REPRESENTATION; INFORMATION; CHANNELS	Fruitflies show robust attraction to food odours, which usually excite several glomeruli. To understand how the representation of such odours leads to behaviour, we used genetic tools to dissect the contribution of each activated glomerulus. Apple cider vinegar triggers robust innate attraction at a relatively low concentration, which activates six glomeruli. By silencing individual glomeruli, here we show that the absence of activity in two glomeruli, DM1 and VA2, markedly reduces attraction. Conversely, when each of these two glomeruli was selectively activated, flies showed as robust an attraction to vinegar as wild-type flies. Notably, a higher concentration of vinegar excites an additional glomerulus and is less attractive to flies. We show that activation of the extra glomerulus is necessary and sufficient to mediate the behavioural switch. Together, these results indicate that individual glomeruli, rather than the entire pattern of active glomeruli, mediate innate behavioural output.	[Semmelhack, Julia L.; Wang, Jing W.] Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Wang, JW (corresponding author), Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA.	jw800@ucsd.edu	Wang, Jing W/C-3885-2008	Wang, Jing W/0000-0001-6291-5802; Semmelhack, Julie/0000-0002-8154-264X	Whitehall Foundation; National Institute of Deafness and other Communication Disorders [R01DC009597]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009597] Funding Source: NIH RePORTER	Whitehall Foundation; National Institute of Deafness and other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We would like to thank D. Anderson, R. Axel, C. Zuker and M. Gallio for comments on the manuscript. We thank M. Hilker for help with the design of the four- field olfactometer. We thank C. Root for generating the data presented in Supplementary Fig. 4. We thank L. Vosshall, B. Dickson and T. Lee for providing fly stocks. This work was partially supported by a research grant from the Whitehall Foundation to J. W. W. and a grant from the National Institute of Deafness and other Communication Disorders to J. W. W. (R01DC009597). J. W. W. is a Beckman Young Investigator, a Hellman Faculty scholar, and a Searle scholar.	Asahina Kenta, 2009, J Biol, V8, P9, DOI 10.1186/jbiol108; AURAND LW, 1966, J FOOD SCI, V31, P172, DOI 10.1111/j.1365-2621.1966.tb00474.x; Bargmann CI, 2006, NATURE, V444, P295, DOI 10.1038/nature05402; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Clyne Peter, 1997, Invertebrate Neuroscience, V3, P127, DOI 10.1007/BF02480367; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; Faucher C, 2006, J EXP BIOL, V209, P2739, DOI 10.1242/jeb.02297; Fiala A, 2002, CURR BIOL, V12, P1877, DOI 10.1016/S0960-9822(02)01239-3; Fishilevich E, 2005, CURR BIOL, V15, P2086, DOI 10.1016/j.cub.2005.11.016; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; Goldman AL, 2005, NEURON, V45, P661, DOI 10.1016/j.neuron.2005.01.025; Ha TS, 2006, J NEUROSCI, V26, P8727, DOI 10.1523/JNEUROSCI.0876-06.2006; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Heimbeck G, 2001, P NATL ACAD SCI USA, V98, P15336, DOI 10.1073/pnas.011314898; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Kreher SA, 2008, NEURON, V59, P110, DOI 10.1016/j.neuron.2008.06.010; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Lai SL, 2008, DEVELOPMENT, V135, P2883, DOI 10.1242/dev.024380; LAING DG, 1978, CHEM SENS FLAV, V3, P149, DOI 10.1093/chemse/3.2.149; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lin DY, 2006, NEURON, V50, P937, DOI 10.1016/j.neuron.2006.03.021; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; Olsen SR, 2007, NEURON, V54, P89, DOI 10.1016/j.neuron.2007.03.010; Root CM, 2008, NEURON, V59, P311, DOI 10.1016/j.neuron.2008.07.003; Root CM, 2007, P NATL ACAD SCI USA, V104, P11826, DOI 10.1073/pnas.0704523104; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Shang YH, 2007, CELL, V128, P601, DOI 10.1016/j.cell.2006.12.034; Stensmyr MC, 2003, J EXP BIOL, V206, P715, DOI 10.1242/jeb.00143; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; STOCKER RF, 1990, CELL TISSUE RES, V262, P9, DOI 10.1007/BF00327741; Suh GSB, 2007, CURR BIOL, V17, P905, DOI 10.1016/j.cub.2007.04.046; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; Troemel ER, 1997, CELL, V91, P161, DOI 10.1016/S0092-8674(00)80399-2; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wang YL, 2003, CURR BIOL, V13, P1900, DOI 10.1016/j.cub.2003.10.003; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4; Zhu JW, 2003, J CHEM ECOL, V29, P899, DOI 10.1023/A:1022931816351	47	219	221	1	74	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 14	2009	459	7244					218	U100		10.1038/nature07983	http://dx.doi.org/10.1038/nature07983			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	445FR	19396157	Green Accepted			2022-12-01	WOS:000266036100033
J	Odd, DE; Lewis, G; Whitelaw, A; Gunnell, D				Odd, David E.; Lewis, Glyn; Whitelaw, Andrew; Gunnell, David			Resuscitation at birth and cognition at 8 years of age: a cohort study	LANCET			English	Article							RISK-FACTORS; NEWBORN ENCEPHALOPATHY; APGAR-SCORE; CHILDREN; INFANTS; TERM	Background Mild cerebral injury might cause subtle defects in cognitive function that are only detectable as the child grows older. Our aim was to determine whether infants receiving resuscitation after birth, but with no symptoms of encephalopathy, have reduced intelligence quotient (IQ) scores in childhood. Methods Three groups of infants were selected from the Avon Longitudinal Study of Parents and Children: infants who were resuscitated at birth but were asymptomatic for encephalopathy and had no further neonatal care (n=815), those who were resuscitated and had neonatal care for symptoms of encephalopathy (n=58), and the reference group who were not resuscitated, were asymptomatic for encephalopathy, and had no further neonatal care (n=10609). Cognitive function was assessed at a mean age of 8.6 years (SD 0.33); a low IQ score was defined as less than 80. IQ scores were obtained for 5953 children with a shortened version of the Weschler intelligence scale for children (WISC-III), the remaining 5529 were non-responders. All children did not complete all parts of the test, and therefore multiplied IQ values comparable to the full-scale test were only available for 5887 children. Results were adjusted for clinical and social covariates. Chained equations were used to impute missing values of covariates. Findings In the main analysis at 8 years of age (n=5887), increased risk of a low IQ score was recorded in both resuscitated infants asymptomatic for encephalopathy (odds ratio 1.65 [95% Cl 1.13-2.43]) and those with symptoms of encephalopathy (6.22 [1.57-24.65]). However, the population of asymptomatic infants was larger than that of infants with encephalopathy, and therefore the population attributable risk fraction for an IQ score that might be attributable to the need for resuscitation at birth was 3.4% (95% CI 0.5-6.3) for asymptomatic infants and 1.2% (0.2-2.2) for those who developed encephalopathy. Interpretation Infants who were resuscitated had increased risk of a low IQ score, even if they remained healthy during the neonatal period. Resuscitated infants asymptomatic for encephalopathy might result in a larger proportion of adults with low IQs than do those who develop neurological symptoms consistent with encephalopathy.	[Lewis, Glyn] Univ Bristol, Dept Community Based Med, Bristol, Avon, England; [Gunnell, David] Univ Bristol, Dept Social Med, Bristol, Avon, England	University of Bristol; University of Bristol	Odd, DE (corresponding author), Southmead Hosp, Neonatal Intens Care Unit, Bristol BS10 5NB, Avon, England.	david.odd@nbt.nhs.uk	Gunnell, David/ABE-6653-2020; Lewis, Glyn/E-9944-2012; Odd, David/G-8418-2016	Gunnell, David/0000-0002-0829-6470; Lewis, Glyn/0000-0001-5205-8245; Odd, David/0000-0002-6416-4966	Wellcome Trust [077036]; ESRC [ES/G007543/1] Funding Source: UKRI; Economic and Social Research Council [ES/G007543/1] Funding Source: researchfish; Medical Research Council [G9815508] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the families who took part in this study, the midwives for their help in recruiting them, and the whole ALSPAC team, which includes interviewers, computer and laboratory technicians, clerical workers, research scientists, volunteers, managers, receptionists, and nurses. This research was funded by a fellowship award (077036) to DO from the Wellcome Trust. The UK Medical Research Council, the Wellcome Trust, and the University of Bristol provide core support for ALSPAC.	*AM AC PED COMM OB, 1996, OBSTET GYNECOL, V107, P1209; Badawi N, 1998, BMJ-BRIT MED J, V317, P1549, DOI 10.1136/bmj.317.7172.1549; Badawi N, 1998, BMJ-BRIT MED J, V317, P1554, DOI 10.1136/bmj.317.7172.1554; Baskett TF, 2006, BJOG-INT J OBSTET GY, V113, P769, DOI 10.1111/j.1471-0528.2006.00987.x; Blackman J A, 1988, J Perinatol, V8, P206; Draycott T, 2006, BJOG-INT J OBSTET GY, V113, P177, DOI 10.1111/j.1471-0528.2006.00800.x; Dutton G N, 2001, Semin Neonatol, V6, P477, DOI 10.1053/siny.2001.0078; Golding J, 2001, PAEDIATR PERINAT EP, V15, P74; GREENLAND S, 1993, BIOMETRICS, V49, P865, DOI 10.2307/2532206; Kaufman A.S., 1994, INTELLIGENT TESTING; KROLL L, 1994, EUR J OBSTET GYN R B, V55, P175, DOI 10.1016/0028-2243(94)90034-5; MacLennan A, 1999, BMJ-BRIT MED J, V319, P1054, DOI 10.1136/bmj.319.7216.1054; MYERS RE, 1972, AM J OBSTET GYNECOL, V112, P246, DOI 10.1016/0002-9378(72)90124-X; O'Donnell CPF, 2006, J PEDIATR-US, V149, P486, DOI 10.1016/j.jpeds.2006.05.040; Odd DE, 2008, ARCH DIS CHILD-FETAL, V93, pF115, DOI 10.1136/adc.2007.123745; Office of Population Censuses and Surveys, 1991, STAND OCC CLASS, V3; Office of Population Censuses and Surveys, 1991, STAND OCC CLASS, V1-3; Office of Population Censuses and Surveys, 1991, STAND OCC CLASS, V2; PALMEKILANDER C, 1992, ACTA PAEDIATR, V81, P739, DOI 10.1111/j.1651-2227.1992.tb12094.x; PASAMANICK B, 1956, AM J PSYCHIAT, V112, P613, DOI 10.1176/ajp.112.8.613; PASQUIER F, 1995, J NEUROL NEUROSUR PS, V58, P81, DOI 10.1136/jnnp.58.1.81; PETERS TJ, 1984, EARLY HUM DEV, V9, P225, DOI 10.1016/0378-3782(84)90033-1; *RES COUNC UK, 2001, RES BIRTH NEWB LIF S; ROYSTON P, 2005, STATA J, V5, P681; SARNAT HB, 1976, ARCH NEUROL-CHICAGO, V33, P696, DOI 10.1001/archneur.1976.00500100030012; Saugstad OD, 2007, ACTA PAEDIATR, V96, P798, DOI 10.1111/j.1651-2227.2006.00348.x; Tan A, 2005, COCHRANE DB SYST REV, V2; Veltman DJ, 2005, PSYCHOL MED, V35, P175, DOI 10.1017/S0033291704002971; Viggedal G, 2002, ACTA PAEDIATR, V91, P1218, DOI 10.1080/080352502320777469; VILLAR J, 1990, AM J OBSTET GYNECOL, V163, P151, DOI 10.1016/S0002-9378(11)90690-5; Wechsler D, 1991, WISC 3 MANUAL; WECHSLER D, 2004, WECHSLER INTELIGENCE	32	91	94	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 9	2009	373	9675					1615	1622		10.1016/S0140-6736(09)60244-0	http://dx.doi.org/10.1016/S0140-6736(09)60244-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	445QJ	19386357	Bronze, Green Published			2022-12-01	WOS:000266066300032
J	Nienborg, H; Cumming, BG				Nienborg, Hendrikje; Cumming, Bruce G.			Decision-related activity in sensory neurons reflects more than a neuron's causal effect	NATURE			English	Article							EARLY VISUAL-CORTEX; PERCEPTUAL DECISION; TASK STRATEGY; V2 NEURONS; AREA MT; CHOICE; RESPONSES; DISCRIMINATION; REPRESENTATION; VARIABILITY	During perceptual decisions, the activity of sensory neurons correlates with a subject's percept, even when the physical stimulus is identical(1-9). The origin of this correlation is unknown. Current theory proposes a causal effect of noise in sensory neurons on perceptual decisions(10-12), but the correlation could result from different brain states associated with the perceptual choice(13) (a top-down explanation). These two schemes have very different implications for the role of sensory neurons in forming decisions(14). Here we use white-noise analysis(15) to measure tuning functions of V2 neurons associated with choice and simultaneously measure how the variation in the stimulus affects the subjects' (two macaques) perceptual decisions(16-18). In causal models, stronger effects of the stimulus upon decisions, mediated by sensory neurons, are associated with stronger choice-related activity. However, we find that over the time course of the trial these measures change in different directions-at odds with causal models. An analysis of the effect of reward size also supports this conclusion. Finally, we find that choice is associated with changes in neuronal gain that are incompatible with causal models. All three results are readily explained if choice is associated with changes in neuronal gain caused by top-down phenomena that closely resemble attention(19). We conclude that top-down processes contribute to choice-related activity. Thus, even forming simple sensory decisions involves complex interactions between cognitive processes and sensory neurons.	[Nienborg, Hendrikje; Cumming, Bruce G.] NEI, Sensorimotor Res Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Nienborg, H (corresponding author), NEI, Sensorimotor Res Lab, NIH, 49 Convent Dr, Bethesda, MD 20892 USA.	hnienb@gmail.com			US National Institutes of Health; National Eye Institute; NATIONAL EYE INSTITUTE [ZIAEY000404] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by the Intramural Research Program of the US National Institutes of Health, National Eye Institute. We are grateful to J.A. Movshon and M. Shadlen for discussions and to the members of the Laboratory of Sensorimotor Research for comments on an earlier version of this manuscript. We also thank D. Parker and B. Nagy for excellent animal care.	AHUMADA AJ, 1996, PERCEPTION, V26, P18; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; Cumming BG, 1999, J NEUROSCI, V19, P5602; DEAN AF, 1981, EXP BRAIN RES, V44, P437; Dodd JV, 2001, J NEUROSCI, V21, P4809, DOI 10.1523/JNEUROSCI.21-13-04809.2001; Gilbert CD, 2007, NEURON, V54, P677, DOI 10.1016/j.neuron.2007.05.019; Gold JI, 2000, NATURE, V404, P390, DOI 10.1038/35006062; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Jazayeri M, 2006, NAT NEUROSCI, V9, P690, DOI 10.1038/nn1691; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; Krug K, 2004, PHILOS T R SOC B, V359, P929, DOI 10.1098/rstb.2003.1415; Leopold DA, 1996, NATURE, V379, P549, DOI 10.1038/379549a0; Leopold DA, 2002, NAT NEUROSCI, V5, P605, DOI 10.1038/nn0602-851; LOGOTHETIS NK, 1989, SCIENCE, V245, P761, DOI 10.1126/science.2772635; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; Martinez-Trujillo JC, 2004, CURR BIOL, V14, P744, DOI 10.1016/j.cub.2004.04.028; Mazurek ME, 2003, CEREB CORTEX, V13, P1257, DOI 10.1093/cercor/bhg097; Neri P, 1999, NATURE, V401, P695, DOI 10.1038/44409; Nienborg H, 2007, NAT NEUROSCI, V10, P1608, DOI 10.1038/nn1991; Nienborg H, 2006, J NEUROSCI, V26, P9567, DOI 10.1523/JNEUROSCI.2256-06.2006; Pasternak T, 2005, NAT REV NEUROSCI, V6, DOI 10.1038/nrn1637; Purushothaman G, 2005, NAT NEUROSCI, V8, P99, DOI 10.1038/nn1373; Ress D, 2003, NAT NEUROSCI, V6, P414, DOI 10.1038/nn1024; Ringach DL, 1997, NATURE, V387, P281, DOI 10.1038/387281a0; Schall JD, 2003, CURR OPIN NEUROBIOL, V13, P182, DOI 10.1016/S0959-4388(03)00039-4; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Uka T, 2005, J NEUROSCI, V25, P10796, DOI 10.1523/JNEUROSCI.1637-05.2005; Uka T, 2004, NEURON, V42, P297, DOI 10.1016/S0896-6273(04)00186-2; Yang T, 2007, NATURE, V447, P1075, DOI 10.1038/nature05852	31	212	213	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 7	2009	459	7243					89	U93		10.1038/nature07821	http://dx.doi.org/10.1038/nature07821			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441WN	19270683	Green Accepted			2022-12-01	WOS:000265801300035
J	Macosko, EZ; Pokala, N; Feinberg, EH; Chalasani, SH; Butcher, RA; Clardy, J; Bargmann, CI				Macosko, Evan Z.; Pokala, Navin; Feinberg, Evan H.; Chalasani, Sreekanth H.; Butcher, Rebecca A.; Clardy, Jon; Bargmann, Cornelia I.			A hub-and-spoke circuit drives pheromone attraction and social behaviour in C-elegans	NATURE			English	Article							CAENORHABDITIS-ELEGANS; NATURAL VARIATION; CHEMOSENSORY NEURONS; CHEMICAL REPELLENTS; NEUROPEPTIDE-Y; GENE; CHEMOTAXIS; INHIBITION; MODULATION; EXPRESSION	Innate social behaviours emerge from neuronal circuits that interpret sensory information on the basis of an individual's own genotype, sex and experience. The regulated aggregation behaviour of the nematode Caenorhabditis elegans, a simple animal with only 302 neurons, is an attractive system to analyse these circuits. Wild social strains of C. elegans aggregate in the presence of specific sensory cues, but solitary strains do not(1-4). Here we identify the RMG inter/motor neuron as the hub of a regulated circuit that controls aggregation and related behaviours. RMG is the central site of action of the neuropeptide receptor gene npr-1, which distinguishes solitary strains (high npr-1 activity) from wild social strains (low npr-1 activity); high RMG activity is essential for all aspects of social behaviour. Anatomical gap junctions connect RMG to several classes of sensory neurons known to promote aggregation, and to ASK sensory neurons, which are implicated in male attraction to hermaphrodite pheromones(5). We find that ASK neurons respond directly to pheromones, and that high RMG activity enhances ASK responses in social strains, causing hermaphrodite attraction to pheromones at concentrations that repel solitary hermaphrodites. The coordination of social behaviours by RMG suggests an anatomical hub-and-spoke model for sensory integration in aggregation, and points to functions for related circuit motifs in the C. elegans wiring diagram.	[Macosko, Evan Z.; Pokala, Navin; Feinberg, Evan H.; Chalasani, Sreekanth H.; Bargmann, Cornelia I.] Rockefeller Univ, Howard Hughes Med Inst, Lab Neural Circuits & Behav, New York, NY 10065 USA; [Butcher, Rebecca A.; Clardy, Jon] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Howard Hughes Medical Institute; Rockefeller University; Harvard University; Harvard Medical School	Bargmann, CI (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Neural Circuits & Behav, 1230 York Ave, New York, NY 10065 USA.	cori@rockefeller.edu	Pokala, Navin/AAH-5719-2019; Macosko, Evan/X-4664-2019	Pokala, Navin/0000-0003-2323-6190; Bargmann, Cornelia/0000-0002-8484-0618	Howard Hughes Medical Institute; Harold and Leila Y Mathers Charitable Foundation; Jensam Foundation; National Institute of Health [GM07739, CA24487, GM077943]; NATIONAL CANCER INSTITUTE [R01CA024487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM077943, T32GM007739] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Harold and Leila Y Mathers Charitable Foundation; Jensam Foundation; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Looger for GCaMP2.2b, M. Nonet for cleavage-resistant synaptobrevin, and J. Ragains for synthesizing ascarosides. This work was funded by the Howard Hughes Medical Institute, the Harold and Leila Y Mathers Charitable Foundation, the Jensam Foundation, and National Institute of Health grants GM07739 (E.Z.M. and E. H. F.), CA24487 ( J. C.) and GM077943 ( R. A. B.). C. I. B. is an Investigator of the Howard Hughes Medical Institute.	BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; BARGMANN CI, 1990, COLD SH Q B, V55, P529; Bargmann CI, 1995, METHOD CELL BIOL, V48, P225; BRENNER S, 1974, GENETICS, V77, P71; Butcher RA, 2008, P NATL ACAD SCI USA, V105, P14288, DOI 10.1073/pnas.0806676105; Butcher RA, 2007, NAT CHEM BIOL, V3, P420, DOI 10.1038/nchembio.2007.3; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; Chang AJ, 2006, PLOS BIOL, V4, P1588, DOI 10.1371/journal.pbio.0040274; Chen BL, 2006, P NATL ACAD SCI USA, V103, P4723, DOI 10.1073/pnas.0506806103; Cheung BHH, 2005, CURR BIOL, V15, P905, DOI 10.1016/j.cub.2005.04.017; Coates JC, 2002, NATURE, V419, P925, DOI 10.1038/nature01170; Davies AG, 2004, NEURON, V42, P731, DOI 10.1016/j.neuron.2004.05.004; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; de Bono M, 2002, NATURE, V419, P899, DOI 10.1038/nature01169; Gray JM, 2004, NATURE, V430, P317, DOI 10.1038/nature02714; Hammock EAD, 2006, PHILOS T R SOC B, V361, P2187, DOI 10.1098/rstb.2006.1939; HART AC, 2006, WORMBOOK BEHAV; Hilliard MA, 2005, EMBO J, V24, P63, DOI 10.1038/sj.emboj.7600493; Hilliard MA, 2002, CURR BIOL, V12, P730, DOI 10.1016/S0960-9822(02)00813-8; Hobert O, 1997, NEURON, V19, P345, DOI 10.1016/S0896-6273(00)80944-7; Hodgkin J, 1997, GENETICS, V146, P149; Kim K, 2004, J COMP NEUROL, V475, P540, DOI 10.1002/cne.20189; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Okochi Y, 2005, EMBO J, V24, P2127, DOI 10.1038/sj.emboj.7600697; PLUMMER MR, 1991, J NEUROSCI, V11, P2339; Ramot D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002208; Ribelayga C, 2008, NEURON, V59, P790, DOI 10.1016/j.neuron.2008.07.017; Rogers C, 2003, NAT NEUROSCI, V6, P1178, DOI 10.1038/nn1140; Schackwitz WS, 1996, NEURON, V17, P719, DOI 10.1016/S0896-6273(00)80203-2; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Sieburth D, 2005, NATURE, V436, P510, DOI 10.1038/nature03809; Sieburth D, 2007, NAT NEUROSCI, V10, P49, DOI 10.1038/nn1810; Srinivasan J, 2008, NATURE, V454, P1115, DOI 10.1038/nature07168; Suzuki H, 2008, NATURE, V454, P114, DOI 10.1038/nature06927; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; TOTH PT, 1993, NATURE, V364, P635, DOI 10.1038/364635a0; Ward A, 2008, NAT NEUROSCI, V11, P916, DOI 10.1038/nn.2155; White JQ, 2007, CURR BIOL, V17, P1847, DOI 10.1016/j.cub.2007.09.011; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056	40	308	312	1	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 30	2009	458	7242					1171	U110		10.1038/nature07886	http://dx.doi.org/10.1038/nature07886			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441FL	19349961	Green Accepted, Green Submitted			2022-12-01	WOS:000265754600048
J	Li, QS; Estes, JD; Schlievert, PM; Duan, LJ; Brosnahan, AJ; Southern, PJ; Reilly, CS; Peterson, ML; Schultz-Darken, N; Brunner, KG; Nephew, KR; Pambuccian, S; Lifson, JD; Carlis, JV; Haase, AT				Li, Qingsheng; Estes, Jacob D.; Schlievert, Patrick M.; Duan, Lijie; Brosnahan, Amanda J.; Southern, Peter J.; Reilly, Cavan S.; Peterson, Marnie L.; Schultz-Darken, Nancy; Brunner, Kevin G.; Nephew, Karla R.; Pambuccian, Stefan; Lifson, Jeffrey D.; Carlis, John V.; Haase, Ashley T.			Glycerol monolaurate prevents mucosal SIV transmission	NATURE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; CD4(+) T-CELLS; VAGINAL TRANSMISSION; EPITHELIAL-CELLS; INFECTION; HIV; RESPONSES; INNATE	Although there has been great progress in treating human immunodeficiency virus 1 (HIV-1) infection(1), preventing transmission has thus far proven an elusive goal. Indeed, recent trials of a candidate vaccine and microbicide have been disappointing, both for want of efficacy and concerns about increased rates of transmission(2-4). Nonetheless, studies of vaginal transmission in the simian immunodeficiency virus (SIV)-rhesus macaque (Macacca mulatta) model point to opportunities at the earliest stages of infection in which a vaccine or microbicide might be protective, by limiting the expansion of infected founder populations at the portal of entry(5,6). Here we show in this SIV-macaque model, that an outside-in endocervical mucosal signalling system, involving MIP-3 alpha (also known as CCL20), plasmacytoid dendritic cells and CCR5(+) cell-attracting chemokines produced by these cells, in combination with the innate immune and inflammatory responses to infection in both cervix and vagina, recruits CD4(+) T cells to fuel this obligate expansion. We then show that glycerol monolaurate-a widely used antimicrobial compound(7) with inhibitory activity against the production of MIP-3 alpha and other proinflammatory cytokines(8)-can inhibit mucosal signalling and the innate and inflammatory response to HIV-1 and SIV in vitro, and in vivo it can protect rhesus macaques from acute infection despite repeated intra-vaginal exposure to high doses of SIV. This new approach, plausibly linked to interfering with innate host responses that recruit the target cells necessary to establish systemic infection, opens a promising new avenue for the development of effective interventions to blockHIV-1 mucosal transmission.	[Li, Qingsheng; Schlievert, Patrick M.; Duan, Lijie; Brosnahan, Amanda J.; Southern, Peter J.; Haase, Ashley T.] Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA; [Estes, Jacob D.; Lifson, Jeffrey D.] NCI, AIDS & Canc Virus Program, Sci Applicat Int Corp Frederick Inc, Frederick, MD 21702 USA; [Reilly, Cavan S.] Univ Minnesota, Sch Publ Hlth, Div Biostat, Minneapolis, MN 55455 USA; [Peterson, Marnie L.] Univ Minnesota, Coll Pharm, Dept Expt & Clin Pharmacol, Minneapolis, MN 55455 USA; [Schultz-Darken, Nancy; Brunner, Kevin G.; Nephew, Karla R.] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53715 USA; [Pambuccian, Stefan] Univ Minnesota, Sch Med, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Carlis, John V.] Univ Minnesota, Inst Technol, Dept Comp Sci & Engn, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Wisconsin System; University of Wisconsin Madison; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Haase, AT (corresponding author), Univ Minnesota, Dept Microbiol, MMC 196,420 Delaware St SE, Minneapolis, MN 55455 USA.	haase001@umn.edu		Schlievert, Patrick/0000-0001-8314-9369	National Institute of Health (NIH) [R21 AI071976, P01 AI066314]; National Cancer Institute, NIH [N01-CO-12400, HHSN266200400088C]; National Center for Research Resources [P51 RR000167]; Research Facilities Improvement Program [RR15459-01, RR020141-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015459, P51RR000167, G20RR022780, C06RR020141] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI071976, P01AI066314] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Research Facilities Improvement Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank C. Miller and D. Lu at the California National Primate Research Center, for helpful discussion and virus stocks, J. Kemnitz at the Wisconsin National Primate Research Center, for discussion and administrative support, and C. O'Neill and T. Leonard for help with the manuscript and figures. This work was supported in part by National Institute of Health (NIH) grants R21 AI071976 and P01 AI066314 (A. T. H.), funds from the National Cancer Institute, NIH, under contracts N01-CO-12400 and HHSN266200400088C (J. D. L.), and grant number P51 RR000167 from the National Center for Research Resources, a component of the NIH, to the Wisconsin National Primate Research Center. This research was conducted in part at a facility constructed with support from Research Facilities Improvement Program grant numbers RR15459-01 and RR020141-01. This publication's contents are solely the responsibility of the authors and do not necessarily represent the official views of the NCRR or NIH.	CHECK E, 2007, NATURE, V446, P12; Cline AN, 2005, J MED PRIMATOL, V34, P303; Cohen J, 2008, SCIENCE, V319, P1026, DOI 10.1126/science.319.5866.1026b; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Crane-Godreau MA, 2005, INFECT IMMUN, V73, P476, DOI 10.1128/IAI.73.1.476-484.2005; Dieu-Nosjean MC, 1999, J LEUKOCYTE BIOL, V66, P252, DOI 10.1002/jlb.66.2.252; Estes JD, 2006, J INFECT DIS, V193, P703, DOI 10.1086/500368; Fauci AS, 2008, NATURE, V453, P289, DOI 10.1038/453289a; Haase AT, 2005, NAT REV IMMUNOL, V5, P783, DOI 10.1038/nri1706; Johnston R, 2002, AIDS PATIENT CARE ST, V16, P419, DOI 10.1089/108729102760330263; KABARA JJ, 1984, COSMETIC DRUG PRESER, P305; Klasse PJ, 2006, PLOS MED, V3, P1501, DOI 10.1371/journal.pmed.0030351; Ledford H, 2007, NATURE, V450, P325, DOI 10.1038/450325a; Li QS, 2004, J INFECT DIS, V189, P572, DOI 10.1086/381396; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; Ma ZM, 2004, J VIROL, V78, P14048, DOI 10.1128/JVI.78.24.14048-14052.2004; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Miller CJ, 2005, J VIROL, V79, P9217, DOI 10.1128/JVI.79.14.9217-9227.2005; Narimatsu R, 2005, AIDS RES HUM RETROV, V21, P228, DOI 10.1089/aid.2005.21.228; Peterson ML, 2006, BIOCHEMISTRY-US, V45, P2387, DOI 10.1021/bi051992u; Peterson ML, 2005, INFECT IMMUN, V73, P2164, DOI 10.1128/IAI.73.4.2164-2174.2005; Schlievert PM, 2008, ANTIMICROB AGENTS CH, V52, P4448, DOI 10.1128/AAC.00989-08; SCHLIEVERT PM, 1992, ANTIMICROB AGENTS CH, V36, P626, DOI 10.1128/AAC.36.3.626; Shattock RJ, 2003, NAT REV MICROBIOL, V1, P25, DOI 10.1038/nrmicro729; Wang YC, 2005, J VIROL, V79, P14355, DOI 10.1128/JVI.79.22.14355-14370.2005; Wira CR, 2005, IMMUNOL REV, V206, P306, DOI 10.1111/j.0105-2896.2005.00287.x	26	494	516	0	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	2009	458	7241					1034	U113		10.1038/nature07831	http://dx.doi.org/10.1038/nature07831			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436KL	19262509	Green Accepted, Green Published			2022-12-01	WOS:000265412900044
J	Bakker, M; Boon, D				Bakker, Martijn; Boon, Diederik			Practice 10-Minute Consultation Haematuria	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Bakker, Martijn] Vrije Univ Amsterdam, Med Ctr, EMGO Inst, NL-1007 MB Amsterdam, Netherlands; [Boon, Diederik] Dept Nephrol, NL-1620 AR Hoorn, Netherlands	Vrije Universiteit Amsterdam	Bakker, M (corresponding author), Vrije Univ Amsterdam, Med Ctr, EMGO Inst, Postbus 7057, NL-1007 MB Amsterdam, Netherlands.	mbakker72@gmail.com							0	1	1	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 17	2009	338								b1324	10.1136/bmj.b1324	http://dx.doi.org/10.1136/bmj.b1324			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	434TL	19376797				2022-12-01	WOS:000265296900001
J	Deneault, E; Cellot, S; Faubert, A; Laverdure, JP; Frechette, M; Chagraoui, J; Mayotte, N; Sauvageau, M; Ting, SB; Sauvageau, G				Deneault, Eric; Cellot, Sonia; Faubert, Amelie; Laverdure, Jean-Philippe; Frechette, Melanie; Chagraoui, Jalila; Mayotte, Nadine; Sauvageau, Martin; Ting, Stephen B.; Sauvageau, Guy			A Functional Screen to Identify Novel Effectors of Hematopoietic Stem Cell Activity	CELL			English	Article							IN-VITRO; SELF-RENEWAL; EXPANSION; OVEREXPRESSION; VIVO; HOXB4; GENE; HSC	Despite tremendous progress made toward the identification of the molecular circuitry that governs cell fate in embryonic stem cells, genes controlling this process in the adult hematopoietic stem cell have proven to be more difficult to unmask. We now report the results of a novel gain-of-function screening approach, which identified a series of 18 nuclear factors that affect hematopoietic stem cell activity. Overexpression of ten of these factors resulted in an increased repopulating activity compared to unmanipulated cells. Interestingly, at least four of the 18 factors, Fos, Tcfec, Hmgb1, and Sfpi1, show non-cell-autonomous functions. The utilization of this screening method together with the creation of a database enriched for potential determinants of hematopoietic stem cell self-renewal will serve as a resource to uncover regulatory networks in these cells.	[Deneault, Eric; Cellot, Sonia; Faubert, Amelie; Laverdure, Jean-Philippe; Frechette, Melanie; Chagraoui, Jalila; Mayotte, Nadine; Sauvageau, Martin; Ting, Stephen B.; Sauvageau, Guy] Univ Montreal, Mol Genet Stem Cells Lab, IRIC, Montreal, PQ H3C 3J7, Canada; [Sauvageau, Guy] Hop Maison Neuve Rosemont, Div Hematol & Leukemia Cell Bank Quebec BCLQ, Montreal, PQ H1T 2M4, Canada	Universite de Montreal; Universite de Montreal	Sauvageau, G (corresponding author), Univ Montreal, Mol Genet Stem Cells Lab, IRIC, Montreal, PQ H3C 3J7, Canada.	guy.sauvageau@umontreal.ca	Sauvageau, Martin/A-8967-2013	Sauvageau, Martin/0000-0001-9487-5016; Sauvageau, Guy/0000-0002-4333-7266	Canadian Institute of Health Research (CIHR) [154290, 2006-2011]; Canadian Center of Excellence in Commercialization and Research (CECR); Canada Foundation for Innovation (CFI); Fonds de Recherche en Sante du Quebec (FRSQ)	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Center of Excellence in Commercialization and Research (CECR); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Fonds de Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec)	The authors thank J. Krosl, R. Bisaillon and B. T. Wilhelm for technical help, C. Charbonneau from IRIC imagery platform, D. Gagne from IRIC flow cytometry platform, and P. Chagnon and R. Lambert from IRIC genomic platform for their expertise with quantitative RT-PCR. We also want to acknowledge C. Perreault, M. Therrien, K. J. Hope, and R. K. Humphries for discussions and critical comments about the manuscript. This work was supported by the Canadian Institute of Health Research (CIHR) Team Grant in Hematopoietic Stem Cell Self-Renewal: From Genes to Bedside (Grant number 154290, 2006-2011). G. S. holds a Canada Research Chair on molecular genetics of stem cells; E. D. and S. C. are recipients of a CIHR studentship and Clinician Scientist award, respectively; J. C. holds an American Society of Hematology fellowship; M. S. holds a National Canadian Institute of Cancer studentship; and S. B. T. is the recipient of National Health Medical Research Council and a Royal Australian College of Physicians fellowships. IRIC is supported in part by the Canadian Center of Excellence in Commercialization and Research (CECR), the Canada Foundation for Innovation (CFI), and the Fonds de Recherche en Sante du Quebec (FRSQ).	Antonchuk J, 2002, CELL, V109, P39, DOI 10.1016/S0092-8674(02)00697-9; Antonchuk J, 2001, EXP HEMATOL, V29, P1125, DOI 10.1016/S0301-472X(01)00681-6; Bowie MB, 2006, J CLIN INVEST, V116, P2808, DOI 10.1172/JCI28310; Cellot S, 2007, EXP HEMATOL, V35, P802, DOI 10.1016/j.exphem.2007.02.013; Cellot S, 2007, CELL, V129, P239, DOI 10.1016/j.cell.2007.04.002; Ema H, 2000, BLOOD, V95, P2284, DOI 10.1182/blood.V95.7.2284.007k14_2284_2288; Hai-Jiang W, 2008, AM J HEMATOL, V83, P922, DOI 10.1002/ajh.21262; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Krosl J, 2003, NAT MED, V9, P1428, DOI 10.1038/nm951; Krosl J, 2003, IMMUNITY, V18, P561, DOI 10.1016/S1074-7613(03)00090-6; Lessard J, 2004, ONCOGENE, V23, P7199, DOI 10.1038/sj.onc.1207940; Min IM, 2008, CELL STEM CELL, V2, P380, DOI 10.1016/j.stem.2008.01.015; Ohta H, 2007, EXP HEMATOL, V35, P817, DOI 10.1016/j.exphem.2007.02.012; Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924; Rosenbauer F, 2006, NAT GENET, V38, P27, DOI 10.1038/ng1679; SAUVAGEAU G, 1995, GENE DEV, V9, P1753, DOI 10.1101/gad.9.14.1753; Sauvageau G, 2004, ONCOGENE, V23, P7223, DOI 10.1038/sj.onc.1207942; Shing DC, 2007, J CLIN INVEST, V117, P3696, DOI 10.1172/JCI32390; SZILVASSY SJ, 1990, P NATL ACAD SCI USA, V87, P8736, DOI 10.1073/pnas.87.22.8736; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thorsteinsdottir U, 2002, BLOOD, V99, P121, DOI 10.1182/blood.V99.1.121; Uchida N, 2004, BLOOD, V103, P4487, DOI 10.1182/blood-2003-11-3989	23	100	102	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 17	2009	137	2					369	379		10.1016/j.cell.2009.03.026	http://dx.doi.org/10.1016/j.cell.2009.03.026			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	437AB	19379700	Bronze, Green Accepted			2022-12-01	WOS:000265456800028
J	Steemans, P; Le Herisse, A; Melvin, J; Miller, MA; Paris, F; Verniers, J; Wellman, CH				Steemans, Philippe; Le Herisse, Alain; Melvin, John; Miller, Merrell A.; Paris, Florentin; Verniers, Jacques; Wellman, Charles H.			Origin and Radiation of the Earliest Vascular Land Plants	SCIENCE			English	Article									[Wellman, Charles H.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Steemans, Philippe] Univ Liege, B-4000 Liege, Belgium; [Le Herisse, Alain] Univ Brest, UMR 6538, CNRS, Inst Univ Europeen Mer, F-29238 Brest 3, France; [Melvin, John; Miller, Merrell A.] Saudi Aramco, Dhahran 31311, Saudi Arabia; [Paris, Florentin] Univ Rennes 1, CNRS, UMR 6118, F-35042 Rennes, France; [Verniers, Jacques] Univ Ghent, Res Unit Palaentol, B-9000 Ghent, Belgium	University of Sheffield; University of Liege; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Bretagne Occidentale; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Rennes 1; Ghent University	Wellman, CH (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.	c.wellman@sheffield.ac.uk	Verniers, Jacques/B-8024-2009; Paris, francois E/L-4915-2015	Verniers, Jacques/0000-0002-2939-7684; Paris, francois E/0000-0002-0176-7348; Steemans, Philippe/0000-0003-1183-6324	NERC [NE/E006612/1] Funding Source: UKRI; Natural Environment Research Council [NE/E006612/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		EDWARDS D, 2001, PLANTS INVADE LAND, pCH2; GRAY J, 1985, PHILOS T ROY SOC B, V309, P167, DOI 10.1098/rstb.1985.0077; RICHARDSON JB, 1996, PALYNOLOGY PRINCIPLE, V2, pCHA18; Steemans P, 2000, REV PALAEOBOT PALYNO, V113, P189, DOI 10.1016/S0034-6667(00)00059-2; Strother P.K., 2000, PHANEROZOIC TERRESTR, P3; Wellman CH, 2003, NATURE, V425, P282, DOI 10.1038/nature01884	6	189	202	0	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2009	324	5925					353	353		10.1126/science.1169659	http://dx.doi.org/10.1126/science.1169659			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	433QT	19372423	Green Published			2022-12-01	WOS:000265221600032
J	Baugh, LR; DeModena, J; Sternberg, PW				Baugh, L. Ryan; DeModena, John; Sternberg, Paul W.			RNA Pol II Accumulates at Promoters of Growth Genes During Developmental Arrest	SCIENCE			English	Article							POLYMERASE-II; IN-VIVO; RECEPTOR NHR-49; HUMAN GENOME; C-ELEGANS; TRANSCRIPTION; DROSOPHILA; NELF; PHOSPHORYLATION	When Caenorhabditis elegans larvae hatch from the egg case in the absence of food, their development is arrested (L1 arrest), and they show increased stress resistance until food becomes available. To study nutritional control of larval development, we analyzed growth and gene expression profiles during L1 arrest and recovery. Larvae that were fed responded relatively slowly to starvation compared with the rapid response of arrested larvae to feeding. Chromatin immunoprecipitation of RNA polymerase II (Pol II) followed by deep sequencing showed that during L1 arrest, Pol II continued transcribing starvation-response genes, but the enzyme accumulated on the promoters of growth and development genes. In response to feeding, promoter accumulation decreased, and elongation and messenger RNA levels increased. Therefore, accumulation of Pol II at promoters anticipates nutritionally controlled gene expression during C. elegans development.	[Sternberg, Paul W.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology	Sternberg, PW (corresponding author), CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA.	pws@caltech.edu	Baugh, L. Ryan/GRS-0507-2022	Baugh, L. Ryan/0000-0003-2148-5492; Sternberg, Paul/0000-0002-7699-0173	American Cancer Society; Howard Hughes Medical Institute	American Cancer Society(American Cancer Society); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank L. Schaeffer, D. Trout, A. Mortazavi, J. L. Riechmann, and B. Wold for assistance and discussions. We thank E. H. Davidson for sharing his COPAS Biosorter and B. Hwang for sharing his destabilized YFP plasmid. L.R.B. was supported by the American Cancer Society. P.W.S. is an investigator with the Howard Hughes Medical Institute, which supported this work. Microarray analysis and sequencing were performed in the Millard and Muriel Jacobs Genetics and Genomics Laboratory at Caltech. Data and analysis available for download from NCBI Gene Expression Omnibus (accession GSE14009) at www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE14009.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Baugh LR, 2006, CURR BIOL, V16, P780, DOI 10.1016/j.cub.2006.03.021; Boehm AK, 2003, MOL CELL BIOL, V23, P7628, DOI 10.1128/MCB.23.21.7628-7637.2003; Gilchrist DA, 2008, GENE DEV, V22, P1921, DOI 10.1101/gad.1643208; Gilmour DS, 2009, CHROMOSOMA, V118, P1, DOI 10.1007/s00412-008-0182-4; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Lee CY, 2008, MOL CELL BIOL, V28, P3290, DOI 10.1128/MCB.02224-07; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Radonjic M, 2005, MOL CELL, V18, P171, DOI 10.1016/j.molcel.2005.03.010; Taubert S, 2006, GENE DEV, V20, P1137, DOI 10.1101/gad.1395406; Van Gilst MR, 2005, P NATL ACAD SCI USA, V102, P13496, DOI 10.1073/pnas.0506234102; Van Gilst MR, 2005, PLOS BIOL, V3, P301, DOI 10.1371/journal.pbio.0030053; WEEKS JR, 1993, GENE DEV, V7, P2329, DOI 10.1101/gad.7.12a.2329; Whittle CM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000187; Wu CH, 2003, GENE DEV, V17, P1402, DOI 10.1101/gad.1091403; Xie SQ, 2006, MOL BIOL CELL, V17, P1723, DOI 10.1091/mbc.E05-08-0726; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26	20	128	130	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2009	324	5923					92	94		10.1126/science.1169628	http://dx.doi.org/10.1126/science.1169628			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427TN	19251593				2022-12-01	WOS:000264802100039
J	Starr, TK; Allaei, R; Silverstein, KAT; Staggs, RA; Sarver, AL; Bergemann, TL; Gupta, M; O'Sullivan, MG; Matise, I; Dupuy, AJ; Collier, LS; Powers, S; Oberg, AL; Asmann, YW; Thibodeau, SN; Tessarollo, L; Copeland, NG; Jenkins, NA; Cormier, RT; Largaespada, DA				Starr, Timothy K.; Allaei, Raha; Silverstein, Kevin A. T.; Staggs, Rodney A.; Sarver, Aaron L.; Bergemann, Tracy L.; Gupta, Mihir; O'Sullivan, M. Gerard; Matise, Ilze; Dupuy, Adam J.; Collier, Lara S.; Powers, Scott; Oberg, Ann L.; Asmann, Yan W.; Thibodeau, Stephen N.; Tessarollo, Lino; Copeland, Neal G.; Jenkins, Nancy A.; Cormier, Robert T.; Largaespada, David A.			A Transposon-Based Genetic Screen in Mice Identifies Genes Altered in Colorectal Cancer	SCIENCE			English	Article							TUMOR-SUPPRESSOR; EXPRESSION; CELLS; METHYLATION; INSTABILITY; MUTAGENESIS; EPITHELIUM; MOUSE	Human colorectal cancers (CRCs) display a large number of genetic and epigenetic alterations, some of which are causally involved in tumorigenesis (drivers) and others that have little functional impact (passengers). To help distinguish between these two classes of alterations, we used a transposon-based genetic screen in mice to identify candidate genes for CRC. Mice harboring mutagenic Sleeping Beauty (SB) transposons were crossed with mice expressing SB transposase in gastrointestinal tract epithelium. Most of the offspring developed intestinal lesions, including intraepithelial neoplasia, adenomas, and adenocarcinomas. Analysis of over 16,000 transposon insertions identified 77 candidate CRC genes, 60 of which are mutated and/or dysregulated in human CRC and thus are most likely to drive tumorigenesis. These genes include APC, PTEN, and SMAD4. The screen also identified 17 candidate genes that had not previously been implicated in CRC, including POLI, PTPRK, and RSPO2.	[Starr, Timothy K.; Allaei, Raha; Largaespada, David A.] Univ Minnesota, Dept Genet Cell Biol & Dev, Ctr Genome Engn, Masonic Canc Ctr, Minneapolis, MN 55455 USA; [Silverstein, Kevin A. T.; Staggs, Rodney A.; Sarver, Aaron L.] Univ Minnesota, Dept Biostat & Informat, Masonic Canc Ctr, Minneapolis, MN 55455 USA; [Bergemann, Tracy L.] Univ Minnesota, Sch Publ Hlth, Dept Biostat, Minneapolis, MN 55455 USA; [Gupta, Mihir] Harvard Univ, Dept Phys & Chem Biol, Cambridge, MA 02138 USA; [O'Sullivan, M. Gerard; Matise, Ilze] Univ Minnesota, Coll Vet Med, St Paul, MN 55108 USA; [Dupuy, Adam J.] Univ Iowa, Dept Anat & Cell Biol, Iowa City, IA 52242 USA; [Collier, Lara S.] Univ Wisconsin, Sch Pharm, Madison, WI 53705 USA; [Powers, Scott] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Oberg, Ann L.; Asmann, Yan W.; Thibodeau, Stephen N.] Mayo Clin, Coll Med, Rochester, MN 55905 USA; [Tessarollo, Lino] NCI, Neural Dev Grp, Mouse Canc Genet Program, Ctr Canc Res, Frederick, MD 21702 USA; [Copeland, Neal G.; Jenkins, Nancy A.] Inst Mol & Cell Biol, Singapore 138673, Singapore; [Cormier, Robert T.] Univ Minnesota, Sch Med, Duluth, MN 55812 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Harvard University; University of Minnesota System; University of Minnesota Twin Cities; University of Iowa; University of Wisconsin System; University of Wisconsin Madison; Cold Spring Harbor Laboratory; Mayo Clinic; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); University of Minnesota System; University of Minnesota Duluth	Starr, TK (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, Ctr Genome Engn, Masonic Canc Ctr, Minneapolis, MN 55455 USA.	star0044@umn.edu; larga002@umn.edu	Starr, Tim/AAX-9342-2021; Largaespada, David/C-9832-2014	Starr, Timothy/0000-0002-6308-3451; Dupuy, Adam/0000-0002-8561-4911; Powers, Scott/0000-0003-2769-1932; Bergemann, Tracy/0000-0003-3902-2605	American Cancer Society fellowship [PF-06-282-01-MGO]; NIH [R01CA113636-01A1]; NCI [K01CA122183-03]; Biomedical Research Council of A*STAR, Singapore; NCI Intramural Research Program of NIH; University of Minnesota Academic Health Center; NATIONAL CANCER INSTITUTE [R01CA113636, ZICBC011198] Funding Source: NIH RePORTER	American Cancer Society fellowship(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Biomedical Research Council of A*STAR, Singapore(Agency for Science Technology & Research (A*STAR)); NCI Intramural Research Program of NIH; University of Minnesota Academic Health Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Insertion data are deposited in the Retrovirus Tagged Cancer Gene Database (RTCGD). We thank S. Singh for help with GSFlex 454 sequencing; K. Akagi for maintaining the RTCGD; A. Weber-Main and K. Stone for editing assistance; the Masonic Cancer Center shared resources including Biostatistics and Bioinformatics, Comparative Pathology, and the Mouse Genetics Laboratory; and the Minnesota Supercomputing Institute for providing computational resources. Research was funded by the American Cancer Society fellowship PF-06-282-01-MGO (to T.K.S.), NIH grant R01CA113636-01A1 (to D.A.L.), NCI grant K01CA122183-03 (to L.S.C.), the Biomedical Research Council of A*STAR (Agency for Science, Technology and Research) Singapore (N.A.J. and N.G.C.), and the NCI Intramural Research Program of NIH (L.T.). A University of Minnesota Academic Health Center Faculty Development Grant provided additional funding to D.A.L. and R.T.C. D.A.L. is a cofounder of, and has an equity interest in, Discovery Genomics, Inc., a biotechnology company that is pursuing SB technology for human gene therapy. The University of Minnesota has filed a patent related to the work described in this paper.	Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Collier LS, 2005, NATURE, V436, P272, DOI 10.1038/nature03681; Dupuy AJ, 2005, NATURE, V436, P221, DOI 10.1038/nature03691; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Firestein R, 2008, NATURE, V455, P547, DOI 10.1038/nature07179; Forbes S, 2006, BRIT J CANCER, V94, P318, DOI 10.1038/sj.bjc.6602928; Fukuyama R, 2008, ONCOGENE, V27, P6044, DOI 10.1038/onc.2008.204; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Hayashi H, 2007, HUM GENET, V120, P701, DOI 10.1007/s00439-006-0254-6; Kim KA, 2006, CELL CYCLE, V5, P23, DOI 10.4161/cc.5.1.2305; KINZLER KW, 1991, SCIENCE, V251, P1366, DOI 10.1126/science.1848370; Kohonen-Corish MRJ, 2007, ONCOGENE, V26, P4435, DOI 10.1038/sj.onc.1210210; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Rajagopalan H, 2004, NATURE, V428, P77, DOI 10.1038/nature02313; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Segditsas S, 2006, ONCOGENE, V25, P7531, DOI 10.1038/sj.onc.1210059; Shi L, 2008, BRAIN RES, V1236, P185, DOI 10.1016/j.brainres.2008.07.085; Staub E, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-79; Stoler DL, 1999, P NATL ACAD SCI USA, V96, P15121, DOI 10.1073/pnas.96.26.15121; Sullivan A, 2007, BRIT J CANCER, V96, P196, DOI 10.1038/sj.bjc.6603525; Tsuchiya N, 2007, CANCER RES, V67, P9568, DOI 10.1158/0008-5472.CAN-06-2707; Wang Y, 2007, CANCER RES, V67, P3018, DOI 10.1158/0008-5472.CAN-06-3073; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yant SR, 2005, MOL CELL BIOL, V25, P2085, DOI 10.1128/MCB.25.6.2085-2094.2005; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789	25	263	270	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2009	323	5922					1747	1750		10.1126/science.1163040	http://dx.doi.org/10.1126/science.1163040			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	424IG	19251594	Green Accepted			2022-12-01	WOS:000264559800045
J	Pryke, SR; Griffith, SC				Pryke, Sarah R.; Griffith, Simon C.			Genetic Incompatibility Drives Sex Allocation and Maternal Investment in a Polymorphic Finch	SCIENCE			English	Article							MALE ATTRACTIVENESS; NATURAL-SELECTION; COLOR MORPHS; RATIO; BIRDS; EGGS; CHOICE	Genetic compatibility may drive individual mate choice decisions because of predictable fitness effects associated with breeding with incompatible partners. In Gouldian finches (Erythrura gouldiae), females paired with genetically incompatible males of alternative color morphs overproduce sons, presumably to reduce investment in inviable daughters. We also observed a reduced overall investment in clutch size, egg size, and care to offspring resulting from incompatible matings. Within-female experimental pairings demonstrate that female birds have the ability to adaptively adjust the sex of their eggs and allocate resources on the basis of partner quality. Female Gouldian finches thus make cumulative strategic allocation decisions to minimize the costs of poor-quality pairings when faced with a genetically incompatible partner.	[Pryke, Sarah R.; Griffith, Simon C.] Macquarie Univ, Dept Brain Behav & Evolut, Sydney, NSW 2109, Australia	Macquarie University	Pryke, SR (corresponding author), Macquarie Univ, Dept Brain Behav & Evolut, Sydney, NSW 2109, Australia.	sarah.pryke@mq.edu.au	Pryke, Sarah/G-7484-2011; Griffith, Simon/AAH-3706-2021; Griffith, Simon/A-1996-2010	Griffith, Simon/0000-0001-7612-4999; Griffith, Simon/0000-0001-7612-4999	Australian Research Council; L'Oreal [Women in Science Fellowship]; Save The Gouldian Fund;  [New South Global Postdoctoral Fellowship]	Australian Research Council(Australian Research Council); L'Oreal(L'Oreal Group); Save The Gouldian Fund; 	We thank A. Badyaev, R. Montgomerie, T. Price, A. Russell, and B. Sinervo for comments; D. Briscoe, R. Brooks, R. Bonduriansky, T. Burke, and M. Olsson for discussion; and R. Merrill, J. Brazill-Boast, and L. A. Rollins for technical help. Funded by the Australian Research Council (grants awarded to S.R.P. and S.C.G.), a New South Global Postdoctoral Fellowship (to S.R.P.), a L'Oreal For Women in Science Fellowship (to S.R.P.), and the Save The Gouldian Fund. The Animal Care and Ethics Committee of the University of New South Wales and Macquarie University approved this research.	BIRKHEAD TR, 1993, BIOL J LINN SOC, V50, P295, DOI 10.1111/j.1095-8312.1993.tb00933.x; BURLEY N, 1986, EVOLUTION, V40, P1191, DOI 10.1111/j.1558-5646.1986.tb05744.x; CHARNOV E L, 1982; Cordero PJ, 2000, BEHAV ECOL SOCIOBIOL, V48, P353, DOI 10.1007/s002650000252; Cunningham EJA, 2000, NATURE, V404, P74, DOI 10.1038/35003565; DELOPE F, 1993, EVOLUTION, V47, P1152, DOI 10.1111/j.1558-5646.1993.tb02142.x; Ewen JG, 2004, P ROY SOC B-BIOL SCI, V271, P1277, DOI 10.1098/rspb.2004.2735; Fawcett TW, 2007, BEHAV ECOL, V18, P71, DOI 10.1093/beheco/arl052; Gil D, 1999, SCIENCE, V286, P126, DOI 10.1126/science.286.5437.126; Griffith SC, 1999, NATURE, V400, P358, DOI 10.1038/22536; Komdeur J, 2002, PHILOS T R SOC B, V357, P373, DOI 10.1098/rstb.2001.0927; PETRIE M, 1993, P ROY SOC B-BIOL SCI, V251, P127, DOI 10.1098/rspb.1993.0018; Pryke SR, 2007, J EVOLUTION BIOL, V20, P1512, DOI 10.1111/j.1420-9101.2007.01332.x; Pryke SR, 2009, EVOLUTION, V63, P793, DOI 10.1111/j.1558-5646.2008.00584.x; RICE WR, 1992, SCIENCE, V256, P1436, DOI 10.1126/science.1604317; Sheldon BC, 1999, NATURE, V402, P874, DOI 10.1038/47239; Sheldon BC, 2000, TRENDS ECOL EVOL, V15, P397, DOI 10.1016/S0169-5347(00)01953-4; SOUTHERN HN, 1945, J GENET, V47, P51, DOI 10.1007/BF02989037; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; Veen T, 2001, NATURE, V411, P45, DOI 10.1038/35075000; West SA, 2002, SCIENCE, V295, P1685, DOI 10.1126/science.1069043; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461; WILLIAMS TD, 1994, BIOL REV, V69, P35, DOI 10.1111/j.1469-185X.1994.tb01485.x	23	77	80	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2009	323	5921					1605	1607		10.1126/science.1168928	http://dx.doi.org/10.1126/science.1168928			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421EN	19299618	Green Submitted			2022-12-01	WOS:000264342300038
J	Lourenco, D; Brauner, R; Lin, L; De Perdigo, A; Weryha, G; Muresan, M; Boudjenah, R; Guerra, G; Maciel-Guerra, AT; Achermann, JC; McElreavey, K; Bashamboo, A				Lourenco, Diana; Brauner, Raja; Lin, Lin; De Perdigo, Arantzazu; Weryha, Georges; Muresan, Mihaela; Boudjenah, Radia; Guerra-Junior, Gil; Maciel-Guerra, Andrea T.; Achermann, John C.; McElreavey, Ken; Bashamboo, Anu			Mutations in NR5A1 Associated with Ovarian Insufficiency	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							STEROIDOGENIC FACTOR-I; LIGAND-BINDING DOMAIN; XY SEX REVERSAL; ADRENAL INSUFFICIENCY; NUCLEAR RECEPTOR; GONADAL DEVELOPMENT; GENETIC-DISEASE; 46,XY PATIENT; FACTOR-1; FAILURE	Background The genetic causes of nonsyndromic ovarian insufficiency are largely unknown. A nuclear receptor, NR5A1 (also called steroidogenic factor 1), is a key transcriptional regulator of genes involved in the hypothalamic-pituitary-steroidogenic axis. Mutation of NR5A1 causes 46, XY disorders of sex development, with or without adrenal failure, but growing experimental evidence from studies in mice suggests a key role for this factor in ovarian development and function as well. Methods To test the hypothesis that mutations in NR5A1 cause disorders of ovarian development and function, we sequenced NR5A1 in four families with histories of both 46, XY disorders of sex development and 46, XX primary ovarian insufficiency and in 25 subjects with sporadic ovarian insufficiency. None of the affected subjects had clinical signs of adrenal insufficiency. Results Members of each of the four families and 2 of the 25 subjects with isolated ovarian insufficiency carried mutations in the NR5A1 gene. In-frame deletions and frame-shift and missense mutations were detected. Functional studies indicated that these mutations substantially impaired NR5A1 transactivational activity. Mutations were associated with a range of ovarian anomalies, including 46, XX gonadal dysgenesis and 46, XX primary ovarian insufficiency. We did not observe these mutations in more than 700 control alleles. Conclusions NR5A1 mutations are associated with 46, XX primary ovarian insufficiency and 46, XY disorders of sex development.	[Lourenco, Diana; Boudjenah, Radia; McElreavey, Ken; Bashamboo, Anu] Inst Pasteur, F-75724 Paris, France; [Brauner, Raja] Univ Paris 05, Paris, France; [Brauner, Raja] AP HP, Paris, France; [Brauner, Raja] Hop Bicetre, Le Kremlin Bicetre, France; [Lin, Lin; Achermann, John C.] UCL Inst Child Hlth, Clin & Mol Genet Unit, Dev Endocrinol Res Grp, London, England; [De Perdigo, Arantzazu] Lab Cytogenet, Luxembourg, Luxembourg; [Weryha, Georges] CHU Brabois, Serv Endocrinol, Vandoeuvre Les Nancy, France; [Muresan, Mihaela] Hop Notre Dame de Bon Secours, Unite Endocrinol, Metz, France; [Guerra-Junior, Gil] Univ Estadual Campinas, Dept Pediat, Fac Med Sci, Campinas, Brazil; [Maciel-Guerra, Andrea T.] Univ Estadual Campinas, Dept Med Genet, Fac Med Sci, Campinas, Brazil	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; University of London; University College London; CHU de Nancy; CHR Metz-Thionville; Universidade Estadual de Campinas; Universidade Federal de Sao Paulo (UNIFESP); Universidade Estadual de Campinas	Bashamboo, A (corresponding author), Inst Pasteur, 25 Rue Doctor Roux, F-75724 Paris, France.	kenmce@pasteur.fr	Maciel-Guerra, Andrea T/E-9130-2016; Lin, Lin/A-3532-2010; Guerra-Junior, Gil/C-1609-2012; Achermann, John/C-5476-2008; Achermann, John/N-2906-2019	Maciel-Guerra, Andrea T/0000-0002-4850-8079; Guerra-Junior, Gil/0000-0002-2991-7678; Achermann, John/0000-0001-8787-6272; Achermann, John/0000-0001-8787-6272; WERYHA, Georges/0000-0003-2062-3419	March of Dimes Foundation [1-FY07-490)]; National Institute for Health Research; Wellcome Trust Senior Research Fellowship in Clinical Science [079666]	March of Dimes Foundation(March of Dimes); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust Senior Research Fellowship in Clinical Science(Wellcome Trust)	Supported by grants from the Agence Nationale de la Recherche- GIS Institut des Maladies Rares (to Dr. McElreavey and Ms. Lourenco); by a research grant (1-FY07-490) from the March of Dimes Foundation (to Dr. McElreavey); by the National Institute for Health Research (to UCL Institute of Child Health Biomedical Research Centre); and a Wellcome Trust Senior Research Fellowship in Clinical Science (079666, to Dr. Achermann).	Aaltonen J, 1997, NAT GENET, V17, P399, DOI 10.1038/ng1297-399; Achermann JC, 1999, NAT GENET, V22, P125, DOI 10.1038/9629; Achermann JC, 2002, J CLIN ENDOCR METAB, V87, P1829, DOI 10.1210/jc.87.4.1829; Biason-Lauber A, 2000, AM J HUM GENET, V67, P1563, DOI 10.1086/316893; Correa RV, 2004, J CLIN ENDOCR METAB, V89, P1767, DOI 10.1210/jc.2003-031240; COULAM CB, 1983, FERTIL STERIL, V40, P693; Coutant R, 2007, J CLIN ENDOCR METAB, V92, P2868, DOI 10.1210/jc.2007-0024; Desclozeaux M, 2002, MOL CELL BIOL, V22, P7193, DOI 10.1128/MCB.22.20.7193-7203.2002; Fan WQ, 2003, BIOCHEM BIOPH RES CO, V311, P987, DOI 10.1016/j.bbrc.2003.10.096; Fogli Anne, 2004, BMC Womens Health, V4, P8, DOI 10.1186/1472-6874-4-8; Gurates B, 2003, MOL CELL ENDOCRINOL, V208, P61, DOI 10.1016/S0303-7207(03)00198-9; Hanley NA, 1999, MECH DEVELOP, V87, P175, DOI 10.1016/S0925-4773(99)00123-9; Hanley NA, 2001, MOL ENDOCRINOL, V15, P57, DOI 10.1210/me.15.1.57; Hasegawa T, 2004, J CLIN ENDOCR METAB, V89, P5930, DOI 10.1210/jc.2004-0935; Jeyasuria P, 2004, MOL ENDOCRINOL, V18, P1610, DOI 10.1210/me.2003-0404; Keri RA, 1996, J BIOL CHEM, V271, P10782, DOI 10.1074/jbc.271.18.10782; Khajavi M, 2006, EUR J HUM GENET, V14, P1074, DOI 10.1038/sj.ejhg.5201649; Kohler B, 2008, HUM MUTAT, V29, P59, DOI 10.1002/humu.20588; Lacombe A, 2006, AM J HUM GENET, V79, P113, DOI 10.1086/505406; Laissue P, 2008, MOL CELL ENDOCRINOL, V282, P101, DOI 10.1016/j.mce.2007.11.005; LAVORGNA G, 1991, SCIENCE, V252, P848, DOI 10.1126/science.1709303; Leslie ND, 2003, ANNU REV NUTR, V23, P59, DOI 10.1146/annurev.nutr.23.011702.073135; Lin L, 2008, SEX DEV, V2, P200, DOI 10.1159/000152036; Lin L, 2007, J CLIN ENDOCR METAB, V92, P991, DOI 10.1210/jc.2006-1672; Luborsky JL, 2003, HUM REPROD, V18, P199, DOI 10.1093/humrep/deg005; LUO XR, 1994, CELL, V77, P481, DOI 10.1016/0092-8674(94)90211-9; Mallet D, 2004, J CLIN ENDOCR METAB, V89, P4829, DOI 10.1210/jc.2004-0670; Mendelson CR, 2007, J STEROID BIOCHEM, V106, P62, DOI 10.1016/j.jsbmb.2007.05.001; Nelson LM, 2009, NEW ENGL J MED, V360, P606, DOI 10.1056/NEJMcp0808697; Philibert P, 2007, HUM REPROD, V22, P3255, DOI 10.1093/humrep/dem278; Qin YY, 2007, AM J HUM GENET, V81, P576, DOI 10.1086/519496; Reuter AL, 2007, EUR J ENDOCRINOL, V157, P233, DOI 10.1530/EJE-07-0113; SHEN WH, 1994, CELL, V77, P651, DOI 10.1016/0092-8674(94)90050-7; Sugawara T, 1997, BIOCHEMISTRY-US, V36, P7249, DOI 10.1021/bi9628984; TAKAYAMA K, 1995, J CLIN ENDOCR METAB, V80, P2815, DOI 10.1210/jc.80.9.2815; Toniolo D, 2007, SEMIN REPROD MED, V25, P264, DOI 10.1055/s-2007-980220; van Kasteren YM, 1999, HUM REPROD, V14, P2455, DOI 10.1093/humrep/14.10.2455; Weck J, 2006, MOL ENDOCRINOL, V20, P1090, DOI 10.1210/me.2005-0199; Zhao HJ, 2007, FRONT BIOSCI-LANDMRK, V12, P3398, DOI 10.2741/2321	39	251	271	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 19	2009	360	12					1200	1210		10.1056/NEJMoa0806228	http://dx.doi.org/10.1056/NEJMoa0806228			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	420IU	19246354	Green Accepted, Bronze			2022-12-01	WOS:000264283400006
J	Richter, DD; Jenkins, DH; Karakash, JT; Knight, J; McCreery, LR; Nemestothy, KP				Richter, Daniel deB., Jr.; Jenkins, Dylan H.; Karakash, John T.; Knight, Josiah; McCreery, Lew R.; Nemestothy, Kasimir P.			Wood Energy in America	SCIENCE			English	Editorial Material									[Richter, Daniel deB., Jr.] Duke Univ, Nicholas Sch Environm, So Ctr Sustainable Forests, Univ Program Ecol, Durham, NC 27708 USA; [Jenkins, Dylan H.] Penn Forest Conservat Program, Nat Conservancy, Williamsport, PA 17701 USA; [Karakash, John T.] Resource Profess Grp, Durham, NC 27707 USA; [Knight, Josiah] Duke Univ, Pratt Sch Engn, Durham, NC 27708 USA; [McCreery, Lew R.] USDA, Forest Serv, State & Private Forestry, Morgantown, WV 26505 USA; [Nemestothy, Kasimir P.] Austrian Chamber Agr, Dept Forestry & Energy, A-1014 Vienna, Austria	Duke University; Nature Conservancy; Duke University; United States Department of Agriculture (USDA); United States Forest Service	Richter, DD (corresponding author), Duke Univ, Nicholas Sch Environm, So Ctr Sustainable Forests, Univ Program Ecol, Durham, NC 27708 USA.	drichter@duke.edu	Richter, D.D./AAN-4583-2021					*EIA, 2008, ANN EN REV 2007; *EIA, 2008, NAT GAS PRIC; *EIA, 2008, HEAT OIL PROP UPD; *EN EFF REN EN OFF, 2007, BUILD EN DAT BOOK; HACKSTOCK R, 2008, RENEWABLE ENERGY WAY; Hagauer D, 2008, INSTRUCTION MANUAL C; Keoleian GA, 2005, CRIT REV PLANT SCI, V24, P385, DOI 10.1080/07352680500316334; KIPPEL N, 2007, EINFLUSS BETRIEBSWEI; *LACAPRA ASS TEAM, 2006, AN REN PORTF STAND N; Madlener R, 2007, ENERG POLICY, V35, P1075, DOI 10.1016/j.enpol.2006.01.022; *NAT COMM SCI SUST, 2007, CONS BIOD SUST FOR; PERLACK RD, 2005, TM200566 ORNL USDA D; Perlin J., 1989, FOREST JOURNEY ROLE; Perry D.A., 2008, FOR ECOSYST; Rakos C, 2005, BIOENERGY - REALIZING THE POTENTIAL, P47, DOI 10.1016/B978-008044661-5/50005-2; *REN21 CENT, 2008, REN 2007 GLOB STAT R; RISTINEN RA, 2005, ENERGY ENV; SCHILL SR, 2008, BIOMASS; Serup H., 2002, WOOD ENERGY PRODUCTI, VSecond Revised; Victor DG, 2008, FOREIGN AFF, V87, P70; VOGLAUER B, 2004, AUSTRIAN BIOMASS BOI; WORGETTER M, 2002, BIOENERGY AUSTRIA PO; 2008, TIMBER MART S	23	58	60	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 13	2009	323	5920					1432	1433		10.1126/science.1166214	http://dx.doi.org/10.1126/science.1166214			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	417TP	19286539				2022-12-01	WOS:000264101700023
J	Silverberg, MJ; Leyden, W; Hurley, L; Go, AS; Quesenberry, CP; Klein, D; Horberg, MA				Silverberg, Michael J.; Leyden, Wendy; Hurley, Leo; Go, Alan S.; Quesenberry, Charles P., Jr.; Klein, Daniel; Horberg, Michael A.			Response to Newly Prescribed Lipid-Lowering Therapy in Patients With and Without HIV Infection	ANNALS OF INTERNAL MEDICINE			English	Article							ANTIRETROVIRAL THERAPY; CLINICAL-TRIALS; MYOCARDIAL-INFARCTION; PROTEASE INHIBITORS; STATINS; RISK; HYPERLIPIDEMIA; DYSLIPIDEMIA; PRAVASTATIN; MANAGEMENT	Background: Antiretroviral agents, particularly protease inhibitors (PIs), may adversely affect lipid levels in patients with HIV infection. However, it is not known whether HIV-associated dyslipidemia is more difficult to treat. Objective: To compare the effectiveness and safety of lipid-lowering therapy in patients with and without HIV infection. Design: Retrospective cohort study. Setting: Integrated health care delivery system from 1996 to 2005. Patients: 829 patients with HIV infection and 6941 patients without HIV infection beginning lipid-lowering therapy for elevated low-density lipoprotein cholesterol or triglyceride levels. Measurements: Percentage change in lipids within 12 months and adverse liver- and muscle-related clinical and laboratory events. Results: Compared with patients without HIV infection, patients with HIV infection beginning statin therapy had smaller reductions in low-density lipoprotein cholesterol levels (25.6% vs. 28.3%; P = 0.001), which did not vary by antiretroviral therapy class. Patients with HIV infection beginning gemfibrozil therapy had substantially smaller reductions in triglyceride levels than patients without HIV infection (44.2% vs. 59.3%; P < 0.001), and reductions with gemfibrozil varied by antiretroviral therapy class (44.0% [P = 0.001] in patients receiving PIs only, 26.4% [P < 0.001] in patients receiving PIs and nonnucleoside reverse transcriptase inhibitors [NNRTIs], and 60.3% [P = 0.94] in patients receiving NNRTIs only). Rhabdomyolysis was diagnosed in 3 patients with HIV infection and 1 patient without HIV infection. No clinically recognized cases of myositis or myopathy were observed. The risk for laboratory adverse events was low (< 5%), although it was increased in patients with HIV infection. Limitations: Laboratory measurements were not uniformly performed according to HIV status, and adequate fasting before lipoprotein testing could not be verified. Results may not be completely generalizable to uninsured persons, women, or certain racial or ethnic minorities. Conclusion: Dyslipidemia, particularly hypertriglyceridemia, is more difficult to treat in patients with HIV infection than in the general population. However, patients with HIV infection receiving NNRTI-based antiretroviral therapy and gemfibrozil had triglyceride responses similar to those in patients without HIV infection.	[Silverberg, Michael J.] Kaiser Permanente No Calif, Div Res, Oakland, CA 94612 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA	Kaiser Permanente; University of California System; University of California San Francisco	Silverberg, MJ (corresponding author), Kaiser Permanente No Calif, Div Res, 2000 Broadway, Oakland, CA 94612 USA.	Michael.J.Silverberg@kp.org	Go, Alan S./AAE-7745-2019		GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	Funding: GlaxoSmithKline.	Aberg JA, 2005, AIDS RES HUM RETROV, V21, P757, DOI 10.1089/aid.2005.21.757; Andrade SE, 2006, PHARMACOEPIDEM DR S, V15, P565, DOI 10.1002/pds.1230; Badiou S, 2004, ATHEROSCLEROSIS, V172, P273, DOI 10.1016/j.atherosclerosis.2003.10.006; Benard A, 2006, INT J TUBERC LUNG D, V10, P378; Benesic A, 2004, INFECTION, V32, P229, DOI 10.1007/s15010-004-3136-7; Bennett MT, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-15; Bonnet F, 2004, HIV MED, V5, P133, DOI 10.1111/j.1468-1293.2004.00200.x; *CAL DEP HLTH SERV, 2005, CAL AIDS SURV REP CU; Calza L, 2005, AIDS, V19, P1103, DOI 10.1097/01.aids.0000174458.86121.43; Calza L, 2003, AIDS, V17, P851, DOI 10.1097/00002030-200304110-00010; Dube MP, 2003, CLIN INFECT DIS, V37, P613, DOI 10.1086/378131; Friis-Moller N, 2007, NEW ENGL J MED, V356, P1723, DOI 10.1056/NEJMoa062744; Gerber MT, 2004, CLIN INFECT DIS, V39, P419, DOI 10.1086/422144; Gordon N.P., 2006, DOES ADULT KAISER PE; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Henry K, 1998, LANCET, V352, P1031, DOI 10.1016/S0140-6736(98)00022-1; Hsue PY, 2004, CIRCULATION, V109, P1603, DOI 10.1161/01.CIR.0000124480.32233.8A; Hurlimann D, 2006, HEART, V92, P110, DOI 10.1136/hrt.2004.056523; Johns KW, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-27; Jones P, 1998, AM J CARDIOL, V81, P582, DOI 10.1016/S0002-9149(97)00965-X; Kamal-Bahl SJ, 2007, AM J CARDIOL, V99, P530, DOI 10.1016/j.amjcard.2006.08.063; Klein D, 2002, J ACQ IMMUN DEF SYND, V30, P471, DOI 10.1097/00126334-200208150-00002; Koppel K, 2002, J ACQ IMMUN DEF SYND, V29, P441, DOI 10.1097/00042560-200204150-00003; Miller J, 2002, AIDS, V16, P2195, DOI 10.1097/00002030-200211080-00012; *NAT I ALL INF DIS, 2004, TABL GRAD SEV AD PED; Negredo E, 2006, AIDS, V20, P2159, DOI 10.1097/01.aids.0000247573.95880.db; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; *PAN ANT GUID AD A, 2008, DEP HLTH HUMAN  0109, P1; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Riddler SA, 2007, HIV MED, V8, P280, DOI 10.1111/j.1468-1293.2007.00470.x; Sabin CA, 2008, LANCET, V371, P1417, DOI 10.1016/S0140-6736(08)60423-7; Sax PE, 2006, AIDS CARE, V18, P149, DOI 10.1080/09540120500161843; Selby JV, 1997, DIABETES CARE, V20, P1396, DOI 10.2337/diacare.20.9.1396; Silverberg MJ, 2007, ARCH INTERN MED, V167, P684, DOI 10.1001/archinte.167.7.684; Stein JH, 2004, AM HEART J, V147, DOI 10.1016/j.ahj.2003.10.018; Townsend ML, 2007, INT J STD AIDS, V18, P851, DOI 10.1258/095646207782716974; Triant VA, 2007, J CLIN ENDOCR METAB, V92, P2506, DOI 10.1210/jc.2006-2190; Visnegarwala F, 2004, J INFECTION, V49, P283, DOI 10.1016/j.jinf.2003.09.006	39	76	77	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 3	2009	150	5					301	+		10.7326/0003-4819-150-5-200903030-00006	http://dx.doi.org/10.7326/0003-4819-150-5-200903030-00006			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417CC	19258558				2022-12-01	WOS:000264051700002
J	Antonakis, J; Dalgas, O				Antonakis, John; Dalgas, Olaf			Predicting Elections: Child's Play!	SCIENCE			English	Article							INTELLIGENCE; ORIGINS		[Antonakis, John; Dalgas, Olaf] Univ Lausanne, Fac Business & Econ, CH-1015 Lausanne, Switzerland	University of Lausanne	Antonakis, J (corresponding author), Univ Lausanne, Fac Business & Econ, CH-1015 Lausanne, Switzerland.	john.antonakis@unil.ch	Antonakis, John/B-3409-2008	Antonakis, John/0000-0001-8811-5117				PLATO, 1901, REPUBLIC; Ramsey JL, 2004, DEVELOPMENTAL SCI, V7, P201, DOI 10.1111/j.1467-7687.2004.00339.x; Schmidt FL, 1998, PSYCHOL BULL, V124, P262, DOI 10.1037/0033-2909.124.2.262; Simonton DK, 2002, ADV PSY RES, V14, P143; Slater A, 2001, INFANT CHILD DEV, V10, P21, DOI 10.1002/icd.241; Todorov A, 2005, SCIENCE, V308, P1623, DOI 10.1126/science.1110589; Zebrowitz LA, 2002, PERS SOC PSYCHOL B, V28, P238, DOI 10.1177/0146167202282009	7	236	237	1	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 27	2009	323	5918					1183	1183		10.1126/science.1167748	http://dx.doi.org/10.1126/science.1167748			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	411XT	19251621	Green Submitted			2022-12-01	WOS:000263687600029
J	Baillargeon, J; Giordano, TP; Rich, JD; Wu, ZH; Wells, K; Pollock, BH; Paar, DP				Baillargeon, Jacques; Giordano, Thomas P.; Rich, Josiah D.; Wu, Z. Helen; Wells, Katherine; Pollock, Brad H.; Paar, David P.			Accessing Antiretroviral Therapy Following Release From Prison	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARE; ADHERENCE; INFECTION; STIGMA; COHORT; INCARCERATION; INTERRUPTION; COMMUNITY; OUTCOMES; INMATES	from prison may increase risk for adverse clinical outcomes, transmission of human immunodeficiency virus ( HIV), and drug- resistant HIV reservoirs in the community. The extent to which HIV- infected inmates experience ART interruption following release from prison is unknown. Objectives To determine the proportion of inmates who filled an ART prescription within 60 days after release from prison and to examine predictors of this outcome. Design, Setting, and Participants Retrospective cohort study of all 2115 HIV-infected inmates released from the Texas Department of Criminal Justice prison system between January 2004 and December 2007 and who were receiving ART before release. Main Outcome Measure Proportion of inmates who filled an ART prescription within 10, 30, and 60 days of release from prison. Results Among the entire study cohort ( N= 2115), an initial prescription for ART was filled by 115 ( 5.4%) inmates within 10 days of release ( 95% confidence interval [ CI], 4.5%- 6.5%), by 375 ( 17.7%) within 30 days ( 95% CI, 16.2%- 19.4%), and by 634 ( 30.0%) within 60 days ( 95% CI, 28.1%- 32.0%). In a multivariate analysis of predictors ( including sex, age, race/ ethnicity, viral load, duration of ART, year of discharge, duration of incarceration, parole, and AIDS Drug Assistance Program application assistance), Hispanic and African American inmates were less likely to fill a prescription within 10 days ( adjusted estimated risk ratio [ RR], 0.4 [ 95% CI, 0.2- 0.8] and 0.4 [ 95% CI, 0.3- 0.7], respectively) and 30 days ( adjusted estimated RR, 0.7 [ 95% CI, 0.5- 0.9] and 0.7 [ 95% CI, 0.5- 0.9]). Inmates with an undetectable viral load were more likely to fill a prescription within 10 days ( adjusted estimated RR, 1.8 [ 95% CI, 1.2- 2.7]), 30 days ( 1.5 [ 95% CI, 1.2- 1.8]), and 60 days ( 1.3 [ 95% CI, 1.1- 1.5]). Inmates released on parole were more likely to fill a prescription within 30 days ( adjusted estimated RR, 1.3 [ 95% CI, 1.1- 1.6]) and 60 days ( 1.5 [ 95% CI, 1.4- 1.7]). Inmates who received assistance completing a Texas AIDS Drug Assistance Program application were more likely to fill a prescription within 10 days ( adjusted estimated RR, 3.1 [ 95% CI, 2.0- 4.9]), 30 days ( 1.8 [ 95% CI, 1.4- 2.2]), and 60 days ( 1.3 [ 95% CI, 1.1- 1.4]). Conclusion Only a small percentage of Texas prison inmates receiving ART while incarcerated filled an initial ART prescription within 60 days of their release.	[Baillargeon, Jacques] Univ Texas Med Branch, Dept Prevent Med & Community Hlth, Galveston, TX 77555 USA; [Baillargeon, Jacques; Paar, David P.] Univ Texas Med Branch, Correct Managed Care Div, Galveston, TX 77555 USA; [Wu, Z. Helen] Univ Texas Med Branch, Dept Obstet & Gynecol, Galveston, TX 77555 USA; [Paar, David P.] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA; [Giordano, Thomas P.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Giordano, Thomas P.] Michael E DeBakey VA Med Ctr, Houston Ctr Qual Care & Utilizat Studies, Houston, TX USA; [Rich, Josiah D.] Brown Med Sch, Dept Med, Providence, RI USA; [Wells, Katherine] Dept State Hlth Serv, Texas HIV Medicat Program, Austin, TX USA; [Pollock, Brad H.] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, San Antonio, TX 78229 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Baylor College of Medicine; Baylor College of Medicine; Brown University; University of Texas System; University of Texas Health San Antonio	Baillargeon, J (corresponding author), Univ Texas Med Branch, Dept Prevent Med & Community Hlth, 301 Univ Blvd,Mail Route 1007, Galveston, TX 77555 USA.	jbaillar@utmb.edu		Giordano, Thomas/0000-0002-9346-5530	National Institute on Drug Abuse [R03DA023870-02, K24DA022112]; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA023870, K24DA022112] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by grant R03DA023870-02 from the National Institute on Drug Abuse. Dr Rich was supported by National Institute on Drug Abuse grant K24DA022112.	Altice FL, 2001, J ACQ IMMUN DEF SYND, V28, P47, DOI 10.1097/00042560-200109010-00008; Baillargeon J, 2000, CLIN INFECT DIS, V31, P1476, DOI 10.1086/317478; Baillargeon J, 2009, AM J PSYCHIAT, V166, P103, DOI 10.1176/appi.ajp.2008.08030416; Binswanger IA, 2007, NEW ENGL J MED, V356, P157, DOI 10.1056/NEJMsa064115; Boutwell A, 2004, CLIN INFECT DIS, V38, P1761, DOI 10.1086/421410; *COUNC STAT GOV JU, EXPL FED MED DIS PRO; Derlega VJ, 2008, INT J STD AIDS, V19, P259, DOI 10.1258/ijsa.2007.007141; DIXON PS, 1993, AM J MED, V95, P629, DOI 10.1016/0002-9343(93)90359-W; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Gardner LI, 2005, AIDS, V19, P423, DOI 10.1097/01.aids.0000161772.51900.eb; Giordano TP, 2005, AIDS CARE, V17, P773, DOI 10.1080/09540120412331336652; Glass TR, 2006, JAIDS-J ACQ IMM DEF, V41, P385, DOI 10.1097/01.qai.0000186371.95301.52; Gordillo V, 1999, AIDS, V13, P1763, DOI 10.1097/00002030-199909100-00021; *HJ KAIS FAM FDN N, 2008, NAT ADAP MON PROJ AN; Hsieh FY, 1998, STAT MED, V17, P1623, DOI 10.1002/(SICI)1097-0258(19980730)17:14<1623::AID-SIM871>3.0.CO;2-S; Kahn JG, 2002, PUBLIC HEALTH REP, V117, P252, DOI 10.1016/S0033-3549(04)50159-0; Li XH, 2005, JAIDS-J ACQ IMM DEF, V38, P320; MacGowan RJ, 2003, INT J STD AIDS, V14, P519, DOI 10.1258/095646203767869110; Mallik-Kane K., 2008, HLTH PRISONER REENTR; MARUSCHAK L, 2007, HIV PRISONS 2005; Menke TJ, 2003, J NATL MED ASSOC, V95, P853; Morrow K. M., 2007, Journal of Correctional Health Care, V13, P27, DOI 10.1177/1078345807299457; Mumola C. J., 1999, SUBSTANCE ABUSE TREA; Palacio H, 2002, PUBLIC HEALTH REP, V117, P233, DOI 10.1016/S0033-3549(04)50158-9; Palepu A, 2004, ANTIVIR THER, V9, P713; *PAN ANT GUID AD A, 2008, GUID US ANT AG HIV 1; Pence BW, 2007, JAIDS-J ACQ IMM DEF, V44, P159, DOI 10.1097/QAI.0b013e31802c2f51; *PEW CTR STAT, ONE 100 BARS AM 2008; Raimer BG, 2004, JAMA-J AM MED ASSOC, V292, P485, DOI 10.1001/jama.292.4.485; Rao D, 2008, AIDS BEHAV, V12, P265, DOI 10.1007/s10461-007-9268-x; Rich JD, 2001, J URBAN HEALTH, V78, P279, DOI 10.1093/jurban/78.2.279; Rintamaki LS, 2006, AIDS PATIENT CARE ST, V20, P359, DOI 10.1089/apc.2006.20.359; Shannon Kate, 2005, J Int Assoc Physicians AIDS Care (Chic), V4, P66, DOI 10.1177/1545109705284353; Springer SA, 2004, CLIN INFECT DIS, V38, P1754, DOI 10.1086/421392; Stephenson BL, 2005, PUBLIC HEALTH REP, V120, P84, DOI 10.1177/003335490512000114; Stokes ME, 2000, CATEGORICAL DATA ANA; Wainberg MA, 1998, JAMA-J AM MED ASSOC, V279, P1977, DOI 10.1001/jama.279.24.1977; WOHL DA, 2003, 10 C RETR OPP INF FE; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	39	202	205	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 25	2009	301	8					848	857		10.1001/jama.2009.202	http://dx.doi.org/10.1001/jama.2009.202			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	410WV	19244192	Green Accepted			2022-12-01	WOS:000263609900026
J	Bergkessel, M; Wilmes, GM; Guthrie, C				Bergkessel, Megan; Wilmes, Gwendolyn M.; Guthrie, Christine			SnapShot: Formation of mRNPs	CELL			English	Editorial Material							MESSENGER-RNA; CYTOPLASM; CODE		[Bergkessel, Megan; Wilmes, Gwendolyn M.; Guthrie, Christine] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Bergkessel, M (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.			Bergkessel, Megan/0000-0002-4530-1224				Cheng H, 2006, CELL, V127, P1389, DOI 10.1016/j.cell.2006.10.044; Egloff S, 2008, TRENDS GENET, V24, P280, DOI 10.1016/j.tig.2008.03.008; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Kohler A, 2007, NAT REV MOL CELL BIO, V8, P761, DOI 10.1038/nrm2255; Mandel CR, 2008, CELL MOL LIFE SCI, V65, P1099, DOI 10.1007/s00018-007-7474-3; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Rougemaille M, 2008, BIOL CELL, V100, P327, DOI 10.1042/BC20070143; Sanford JR, 2005, BIOCHEM SOC T, V33, P443, DOI 10.1042/BST0330443; Shatkin AJ, 2000, NAT STRUCT BIOL, V7, P838, DOI 10.1038/79583; Wang ZF, 2008, RNA, V14, P802, DOI 10.1261/rna.876308	10	1	1	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 20	2009	136	4					794	U1	794.e1	10.1016/j.cell.2009.01.047	http://dx.doi.org/10.1016/j.cell.2009.01.047			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	411XX	19239896	Bronze			2022-12-01	WOS:000263688200026
J	Burton, DC; Edwards, JR; Horan, TC; Jernigan, JA; Fridkin, SK				Burton, Deron C.; Edwards, Jonathan R.; Horan, Teresa C.; Jernigan, John A.; Fridkin, Scott K.			Methicillin-Resistant Staphylococcus aureus Central Line-Associated Bloodstream Infections in US Intensive Care Units, 1997-2007	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CATHETER-RELATED INFECTIONS; SURVEILLANCE SYSTEM; NOSOCOMIAL INFECTIONS; SAFETY NETWORK; RISK-FACTORS; PREVENTION; BACTEREMIA; IMPACT; INTERVENTION; TRANSMISSION	Context Concerns about rates of methicillin- resistant Staphylococcus aureus ( MRSA) health care - associated infections have prompted calls for mandatory screening or reporting in efforts to reduce MRSA infections. Objective To examine trends in the incidence of MRSA central line - associated blood-stream infections ( BSIs) in US intensive care units ( ICUs). Design, Setting, and Participants Data reported by hospitals to the Centers for Disease Control and Prevention ( CDC) from 1997- 2007 were used to calculate pooled mean annual central line - associated BSI incidence rates for 7 types of adult and non-neonatal pediatric ICUs. Percent MRSA was defined as the proportion of S aureus central line - associated BSIs that were MRSA. We used regression modeling to estimate percent changes in central line - associated BSI metrics over the analysis period. Main Outcome Measures Incidence rate of central line - associated BSIs per 1000 central line days; percent MRSA among S aureus central line - associated BSIs. Results Overall, 33 587 central line - associated BSIs were reported from 1684 ICUs representing 16 225 498 patient- days of surveillance; 2498 reported central line - associated BSIs ( 7.4%) were MRSA and 1590 ( 4.7%) were methicillin- susceptible S aureus ( MSSA). Of evaluated ICU types, surgical, nonteaching- affiliated medical- surgical, cardiothoracic, and coronary units experienced increases in MRSA central line - associated BSI incidence in the 1997- 2001 period; however, medical, teaching- affiliated medical-surgical, and pediatric units experienced no significant changes. From 2001 through 2007, MRSA central line - associated BSI incidence declined significantly in all ICU types except in pediatric units, for which incidence rates remained static. Declines in MRSA central line associated BSI incidence ranged from - 51.5% ( 95% CI, - 33.7% to - 64.6%; P <. 001) in nonteaching- affiliated medical- surgical ICUs ( 0.31 vs 0.15 per 1000 central line days) to - 69.2% ( 95% CI, - 57.9% to - 77.7%; P <. 001) in surgical ICUs ( 0.58 vs 0.18 per 1000 central line days). In all ICU types, MSSA central line - associated BSI incidence declined from 1997 through 2007, with changes in incidence ranging from - 60.1% ( 95% CI, - 41.2% to - 73.1%; P <. 001) in surgical ICUs ( 0.24 vs 0.10 per 1000 central line days) to - 77.7% ( 95% CI, - 68.2% to - 84.4%; P <. 001) in medical ICUs ( 0.40 vs 0.09 per 1000 central line days). Although the overall proportion of S aureus central line associated BSIs due to MRSA increased 25.8% ( P=. 02) in the 1997- 2007 period, overall MRSA central line - associated BSI incidence decreased 49.6% ( P <. 001) over this period. Conclusions The incidence of MRSA central line - associated BSI has been decreasing in recent years in most ICU types reporting to the CDC. These trends are not apparent when only percent MRSA is monitored.	[Burton, Deron C.; Edwards, Jonathan R.; Horan, Teresa C.; Jernigan, John A.; Fridkin, Scott K.] Ctr Dis Control & Prevent, Surveillance Branch, Div Healthcare Qual Promot, Natl Ctr Preparedness Detect & Control Infect Dis, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Burton, DC (corresponding author), Ctr Dis Control & Prevent, Surveillance Branch, Div Healthcare Qual Promot, Natl Ctr Preparedness Detect & Control Infect Dis, Mailstop A-24,1600 Clifton Rd NE, Atlanta, GA 30333 USA.	dburton@cdc.gov		Jernigan, John/0000-0001-8163-925X				Abramson MA, 1999, INFECT CONT HOSP EP, V20, P408, DOI 10.1086/501641; [Anonymous], 2005, MMWR MORB MORTAL WKL; Bearman GML, 2005, ARCH MED RES, V36, P646, DOI 10.1016/j.arcmed.2005.02.005; Ben-David D, 2008, AM J INFECT CONTROL, V36, P93, DOI 10.1016/j.ajic.2007.05.013; Boyce JM, 2002, AM J INFECT CONTROL, V30, pS1, DOI 10.1067/mic.2002.130391; Cardo D, 2004, AM J INFECT CONTROL, V32, P470, DOI 10.1016/j.ajic.2004.10.001; *CDCP, 2000, MMWR-MORBID MORTAL W, V49, P149; *CDCP, 2000, MMWR-MORBID MORTAL W, V49, P149; Centers for Disease Control and Prevention, NAT HEALTHC SAF NETW; Cimolai N, 2007, INFECT CONT HOSP EP, V28, P896, DOI 10.1086/519913; Cosgrove SE, 2003, CLIN INFECT DIS, V36, P53, DOI 10.1086/345476; Cosgrove SE, 2005, INFECT CONT HOSP EP, V26, P166, DOI 10.1086/502522; Crum NF, 2006, AM J MED, V119, P943, DOI 10.1016/j.amjmed.2006.01.004; Edmond MB, 2007, J HOSP INFECT, V65, P182, DOI 10.1016/S0195-6701(07)60040-1; Edwards JR, 2008, AM J INFECT CONTROL, V36, P609, DOI 10.1016/j.ajic.2008.08.001; Eggimann P, 2001, CHEST, V120, P2059, DOI 10.1378/chest.120.6.2059; Eggimann P, 2000, LANCET, V355, P1864, DOI 10.1016/S0140-6736(00)02291-1; Emori TG, 1998, INFECT CONT HOSP EP, V19, P308; Gastmeier P, 2006, J HOSP INFECT, V64, P16, DOI 10.1016/j.jhin.2006.04.017; Gerberding J, 1999, AM J INFECT CONTROL, V27, P520; Gnass SA, 2004, INFECT CONT HOSP EP, V25, P675, DOI 10.1086/502461; Hageman JC, 2003, INFECT CONT HOSP EP, V24, P356, DOI 10.1086/502214; *HEALTHC ASS INF A, UK HLTH PROT AG SURV; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; HORAN TC, 2004, HOSP EPIDEMIOLOGY IN, P1659; Karchmer AW, 2000, CLIN INFECT DIS, V31, pS139, DOI 10.1086/314078; Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Larson EL, 2007, AM J INFECT CONTROL, V35, P666, DOI 10.1016/j.ajic.2006.10.006; Mermel LA, 2001, EMERG INFECT DIS, V7, P197, DOI 10.3201/eid0702.010208; Mermel LA, 2007, J HOSP INFECT, V65, P30, DOI 10.1016/S0195-6701(07)60011-5; Meyer E, 2006, INFECT CONT HOSP EP, V27, P146, DOI 10.1086/500619; Muto CA, 2003, INFECT CONT HOSP EP, V24, P362, DOI 10.1086/502213; Oztoprak N, 2006, AM J INFECT CONTROL, V34, P1, DOI 10.1016/j.ajic.2005.07.005; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; RAAD I, 1997, SUPPORT CARE CANCER, V7, P386; Raad I, 2007, LANCET INFECT DIS, V7, P645, DOI 10.1016/S1473-3099(07)70235-9; Rani S, 2022, SPAT INF RES, V30, P417, DOI 10.1007/s41324-022-00442-9; Richards C, 2001, AM J INFECT CONTROL, V29, P400, DOI 10.1067/mic.2001.118408; Seybold U, 2006, CLIN INFECT DIS, V42, P647, DOI 10.1086/499815; Warren DK, 2006, INFECT CONT HOSP EP, V27, P662, DOI 10.1086/506184; Weber SG, 2007, AM J INFECT CONTROL, V35, P73, DOI 10.1016/j.ajic.2007.01.001	42	191	204	0	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 18	2009	301	7					727	736		10.1001/jama.2009.153	http://dx.doi.org/10.1001/jama.2009.153			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	407MX	19224749	Bronze			2022-12-01	WOS:000263370100015
